Citrus Sinensis ID: 005880
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M9C5 | 670 | Probable leucine-rich rep | yes | no | 0.927 | 0.929 | 0.679 | 0.0 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.895 | 0.914 | 0.448 | 1e-136 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.872 | 0.896 | 0.436 | 1e-131 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.848 | 0.870 | 0.433 | 1e-127 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.880 | 0.925 | 0.427 | 1e-123 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.854 | 0.887 | 0.433 | 1e-120 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.876 | 0.920 | 0.413 | 1e-119 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.889 | 0.953 | 0.410 | 1e-118 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.819 | 0.881 | 0.416 | 1e-118 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.864 | 0.910 | 0.414 | 1e-112 |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/655 (67%), Positives = 528/655 (80%), Gaps = 32/655 (4%)
Query: 28 DLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSL 87
D LL+FK ++D KL +WN+T++PC WTGVSC +NRV+ LVLE++ L+GS+ LTSL
Sbjct: 31 DSETLLNFKLTADSTGKLNSWNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSISSLTSL 90
Query: 88 TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
T LRVLSLK+N +GP+P+LSNLTALKLLFLS+N F+G FP S++SL RLYRLDLSFNNF
Sbjct: 91 TSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNF 150
Query: 148 SGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
SGQIP + LTHLLTL+LE+NRFSG I ++L +LQDFNVSGN+ +GQIP SLS FP+S
Sbjct: 151 SGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNSLSQFPES 210
Query: 208 AFTQNAALCGSPMQACKTMVTDPKKPGS-DGAIASPLNPGNNPTNVVSSTPSSIPTNTDP 266
FTQN +LCG+P+ C + +DP KPG D A ASPL N V S+P+SI
Sbjct: 211 VFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPL----NKPETVPSSPTSIHGGDKS 266
Query: 267 NNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTR-SKLLESE 325
NN +S+IS++++IAI++GDF++L+ +SLLLY FWR Y NK + SK+LE E
Sbjct: 267 NN---------TSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGE 317
Query: 326 KILYSSSPYPAQQAGY--------ERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAY 377
KI+YSS+PYP ++G MVFFEGT+RFELEDLLRASAEMLGKGGFGTAY
Sbjct: 318 KIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAY 377
Query: 378 KAVLDDGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436
KAVL+DG+ VAVKRLKDA ++ GK+EFEQ MEVLGRLRH NLV LKAYYFAREEKLLV +
Sbjct: 378 KAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYD 437
Query: 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNV 496
YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CK+LKLTHG+IKSTNV
Sbjct: 438 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNV 497
Query: 497 LLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELL 556
LLD++GNARVSDFGLSIFAP TV +SNGYRAPEL DGRK +QKSDVYSFGVLLLE+L
Sbjct: 498 LLDRSGNARVSDFGLSIFAPSQTVAKSNGYRAPEL--IDGRKHTQKSDVYSFGVLLLEIL 555
Query: 557 TGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQV 616
TGKCP++++ G + GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ+
Sbjct: 556 TGKCPNMVETGHS----GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQI 611
Query: 617 AMACTSASPDQRPNMSHVVKLIEELR--GVEVSPCHENFDSVSDSPCLSEDTLGG 669
AMACT+ + D RP M HVVKLIE++R G E SPC++ +S DSPCLSEDT GG
Sbjct: 612 AMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPCNDGINSAVDSPCLSEDTCGG 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 303/675 (44%), Positives = 402/675 (59%), Gaps = 73/675 (10%)
Query: 9 FTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNR-- 66
F++L+L + + ++ + ALL F N+L WN + C+W GV C N+
Sbjct: 12 FSILLLTQR---VNSESTAEKQALLTFLQQIPHENRLQ-WNESDSACNWVGVECNSNQSS 67
Query: 67 VSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSHNNF 123
+ L L L G + L LT+LRVLSL+ NR +G +PS SNLT L+ L+L HN F
Sbjct: 68 IHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEF 127
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL 183
+GEFP S + L L RLD+S NNF+G IP +VN+LTHL L L N FSG + + L L
Sbjct: 128 SGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GL 186
Query: 184 QDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPL 243
DFNVS N+L+G IP SLS F +FT N LCG P++ CK+ P
Sbjct: 187 VDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSP------------- 233
Query: 244 NPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLL 303
S +PS I P++ + SK+S A++AI+V LV ++ L
Sbjct: 234 ----------SPSPSLI--------NPSNRLSSKKSKLSKAAIVAIIVASALVALLLLAL 275
Query: 304 LYCYFWRNYV-KNKTRSKLLESEKILYSSSPYPAQQAG---------------YERGSMV 347
L R N+ R+K + + + P + ER +V
Sbjct: 276 LLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLV 335
Query: 348 FFEG-TKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQH 406
F EG F+LEDLLRASAE+LGKG GT+YKAVL++G+ V VKRLKD + K+EFE
Sbjct: 336 FTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDV-MASKKEFETQ 394
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
MEV+G+++HPN++ L+AYY++++EKLLV ++MP GSL LLHG+RG GRTPLDW R++I
Sbjct: 395 MEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRI 454
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG 525
A AARGLA +H S KL HGNIK++N+LL + VSD+GL+ +F+ S R G
Sbjct: 455 AITAARGLAHLHV---SAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAG 511
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585
Y APE+ + RK + KSDVYSFGVLLLELLTGK P+ G G +DLPRWV S
Sbjct: 512 YHAPEVLET--RKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEG------IDLPRWVLS 563
Query: 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645
VVREEWTAEVFD+ELMRY +IEEEMV LLQ+AMAC S PDQRP M V+++IE++ E
Sbjct: 564 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSE 623
Query: 646 VSPCHENFDSVSDSP 660
+ + SD P
Sbjct: 624 TT--DDGLRQSSDDP 636
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1204), Expect = e-131, Method: Compositional matrix adjust.
Identities = 282/646 (43%), Positives = 392/646 (60%), Gaps = 60/646 (9%)
Query: 11 LLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPC-SWTGVSCLQN--RV 67
L + S A + D ALL F AS +L WNST+ C SW GV+C + V
Sbjct: 31 LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLN-WNSTNHICKSWVGVTCTSDGTSV 89
Query: 68 SHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFN 124
L L + L G + P L L LR+LSL+ N +G +P + +L +L ++L HNNF+
Sbjct: 90 HALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFS 149
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQ 184
GE P VS +L LDLSFN+F+G+IP T +L L L L+ N+ SGP+ LD +L+
Sbjct: 150 GEVPSFVSR--QLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLR 207
Query: 185 DFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLN 244
N+S NHL+G IP +L GFP S+F+ N LCG P+Q C T
Sbjct: 208 RLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATS------------------ 249
Query: 245 PGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLL 304
S PS P + P P ++ S K+ +I I G +L +I++++
Sbjct: 250 ---------SPPPSLTPHISTPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVII 300
Query: 305 YCYFWRNYVKNKTRSKLLESEKILYSSSPYPAQQAGY-----ERGSMVFFEG-TKRFELE 358
C + K+K +++ + + + Q+ G E+ +VFF G + F+LE
Sbjct: 301 LCCCIKK--KDKREDSIVKVKTLTEKAK----QEFGSGVQEPEKNKLVFFNGCSYNFDLE 354
Query: 359 DLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPN 417
DLLRASAE+LGKG +GTAYKAVL++ + V VKRLK+ + GKREFEQ ME++ R+ HP+
Sbjct: 355 DLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVA-AGKREFEQQMEIISRVGNHPS 413
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
+V L+AYY++++EKL+V +Y P G+L LLHGNRG +TPLDW +R+KI AA+G+A +
Sbjct: 414 VVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHL 473
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGYRAPELSSSDG 536
H K +HGNIKS+NV++ + +A +SDFGL+ + A P R GYRAPE+ +
Sbjct: 474 H-AAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMET-- 530
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596
RK + KSDVYSFGVL+LE+LTGK P V M VDLPRWVQSVVREEWT+EVF
Sbjct: 531 RKHTHKSDVYSFGVLILEMLTGKSP-VQSPSRDDM-----VDLPRWVQSVVREEWTSEVF 584
Query: 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
D+ELMR+++IEEEMV +LQ+AMAC + P+ RP M VV++IEE+R
Sbjct: 585 DIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 283/653 (43%), Positives = 385/653 (58%), Gaps = 83/653 (12%)
Query: 28 DLNALLDFKASSDEANKLTTWN-STSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP--L 84
D ALL +++ + WN + PC+W GV C NRV+ L L + LSG +
Sbjct: 36 DRTALLSLRSAV--GGRTFRWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIPEGIF 93
Query: 85 TSLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143
+LTQLR LSL+ N +G +P LS + L+ L+L N F+GE P+ + SL L RL+L+
Sbjct: 94 GNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLA 153
Query: 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSG 203
N+F+G+I +LT L TL LE N+ SG I LDL +Q FNVS N L+G IPK+L
Sbjct: 154 SNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLPLVQ-FNVSNNSLNGSIPKNLQR 212
Query: 204 FPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSSIPTN 263
F +F Q +LCG P++ C T P +P S G + TP S+
Sbjct: 213 FESDSFLQ-TSLCGKPLKLCPDEETVPSQPTSGG----------------NRTPPSVE-- 253
Query: 264 TDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTRSKLLE 323
S +K +K+S A+ IV+G + A+I L+L + K+ RS+ ++
Sbjct: 254 -------GSEEKKKKNKLSGGAIAGIVIGCVVGFALIVLILMVLCRK---KSNKRSRAVD 303
Query: 324 SEKILYSSSPYPAQQAGYERGS----------------------------MVFF-EGTKR 354
I P + + G+ +VFF TK
Sbjct: 304 ISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKV 363
Query: 355 FELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR 414
F+LEDLLRASAE+LGKG FGTAYKAVLD +VVAVKRLKD + K EF++ +E++G +
Sbjct: 364 FDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADK-EFKEKIELVGAMD 422
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
H NLV L+AYYF+R+EKLLV ++MP GSL LLHGNRG GR+PL+W R +IA GAARGL
Sbjct: 423 HENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGL 482
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVP-RSNGYRAPELS 532
++H + +HGNIKS+N+LL K+ +A+VSDFGL+ + +T P R+ GYRAPE+
Sbjct: 483 DYLH--SQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEV- 539
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP--SVIDGGGAGMGCGGAVDLPRWVQSVVREE 590
+D ++ SQK DVYSFGV+LLEL+TGK P SV++ G VDLPRWV+SV R+E
Sbjct: 540 -TDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEG--------VDLPRWVKSVARDE 590
Query: 591 WTAEVFDLELMRYKDIEEEMVG-LLQVAMACTSASPDQRPNMSHVVKLIEELR 642
W EVFD EL+ EEEM+ ++Q+ + CTS PDQRP MS VV+ +E LR
Sbjct: 591 WRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 278/650 (42%), Positives = 383/650 (58%), Gaps = 58/650 (8%)
Query: 9 FTLLILAVHFS-LLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPC-SWTGVSCLQN- 65
F L++ S L A D ALL+F + + KL WNST C SWTG++C +N
Sbjct: 8 FLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLN-WNSTIPICASWTGITCSKNN 66
Query: 66 -RVSHLVLENLQLSGSL--QPLTSLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSHN 121
RV+ L L L G L + L LR++SL+ N G +PS + +L ++ L+ N
Sbjct: 67 ARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHEN 126
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR 181
NF+G P +S RL LDLS N+ SG IP ++ +LT L L L+ N SGPI L R
Sbjct: 127 NFSGTIPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLPPR 184
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIAS 241
L+ N+S N+L+G +P S+ FP S+F N+ LCG+P+ C
Sbjct: 185 -LKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPC------------------ 225
Query: 242 PLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGD----FLVL 297
P N + +PS P + T+ +S+ A++ I VG F++L
Sbjct: 226 -------PENTTAPSPSPTTPTEGPGTTNIG-RGTAKKVLSTGAIVGIAVGGSVLLFIIL 277
Query: 298 AIISLLLYCYFWRNYVKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTK-RFE 356
AII+L C R+ ++ T + + + + + E+ +VFFEG+ F+
Sbjct: 278 AIITLC--CAKKRDGGQDSTAVPKAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFD 335
Query: 357 LEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-H 415
LEDLLRASAE+LGKG +GT YKA+L++G+ V VKRLK+ + GKREFEQ ME +GR+ H
Sbjct: 336 LEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVA-AGKREFEQQMEAVGRISPH 394
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
N+ L+AYYF+++EKLLV +Y G+ LLHGN GR LDW TRL+I AARG++
Sbjct: 395 VNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGIS 454
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVP-RSNGYRAPELSS 533
IH + KL HGNIKS NVLL + + VSDFG++ + + + +P RS GYRAPE +
Sbjct: 455 HIH-SASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPE--A 511
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593
+ RK +QKSDVYSFGVLLLE+LTGK G G VDLP+WVQSVVREEWT
Sbjct: 512 IETRKHTQKSDVYSFGVLLLEMLTGK------AAGKTTGHEEVVDLPKWVQSVVREEWTG 565
Query: 594 EVFDLELMRYK-DIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
EVFD+EL++ + ++EEEMV +LQ+AMAC S PD RP+M VV ++EE+R
Sbjct: 566 EVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIR 615
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1112), Expect = e-120, Method: Compositional matrix adjust.
Identities = 282/651 (43%), Positives = 374/651 (57%), Gaps = 77/651 (11%)
Query: 26 SPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP-- 83
+ D +ALL F+++ L TS PC+WTGV C RV+ L L LSG +
Sbjct: 32 AADKSALLSFRSAVGGRTLLWDVKQTS-PCNWTGVLCDGGRVTALRLPGETLSGHIPEGI 90
Query: 84 LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142
+LTQLR LSL+ N TG +P L + + L+ L+L N F+GE P+ + SL L RL+L
Sbjct: 91 FGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLNL 150
Query: 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+ N FSG+I +LT L TL LE N+ SG + LDL Q FNVS N L+G IPKSL
Sbjct: 151 AENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQ-FNVSNNLLNGSIPKSLQ 209
Query: 203 GFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSSIPT 262
F +F +LCG P+ C T P +P S G I
Sbjct: 210 KFDSDSFV-GTSLCGKPLVVCSNEGTVPSQPISVGNI----------------------- 245
Query: 263 NTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTRSKLL 322
P S +K K+S A+ IV+G + L++I ++L F + K R++ +
Sbjct: 246 ---PGTVEGSEEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRK---KGNERTRAI 299
Query: 323 ESEKILYSSSPYPAQQAGYE-------------------------RGSMVFF-EGTKRFE 356
+ I + P ++A E +VFF TK F+
Sbjct: 300 DLATIKHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFD 359
Query: 357 LEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHP 416
LEDLLRASAE+LGKG FGTAYKAVLD ++VAVKRLKD ++ REF++ +EV+G + H
Sbjct: 360 LEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMA-DREFKEKIEVVGAMDHE 418
Query: 417 NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
NLV L+AYY++ +EKLLV ++MP GSL LLHGN+G GR PL+W R IA GAARGL +
Sbjct: 419 NLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDY 478
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVP-RSNGYRAPELSSS 534
+H + +HGN+KS+N+LL + +ARVSDFGL+ + + ST P R+ GYRAPE+ +
Sbjct: 479 LH--SQDPLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEV--T 534
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
D R+ SQK+DVYSFGV+LLELLTGK PS GM DL RWV SV REEW E
Sbjct: 535 DPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGM------DLARWVHSVAREEWRNE 588
Query: 595 VFDLELMRYK---DIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
VFD ELM + +EEEM +LQ+ + CT PD+RP M VV+ I+ELR
Sbjct: 589 VFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 273/660 (41%), Positives = 395/660 (59%), Gaps = 71/660 (10%)
Query: 9 FTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCS-WTGVSCLQN-- 65
F L+LA L+ A + D ALL+F AS KL WN CS W G++C ++
Sbjct: 13 FFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLN-WNKNLSLCSSWIGITCDESNP 71
Query: 66 --RVSHLVLENLQLSGSLQPLT--SLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSH 120
RV + L + L GS+ P T L L+VLSL+ N G +PS + +L +L+ L+L H
Sbjct: 72 TSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQH 131
Query: 121 NNFNGEFP-DSVSSLFR-LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL 178
NNF+GE +S+ S+ + L LDLS+N+ SG IP + +L+ + L L+ N F GPI L
Sbjct: 132 NNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSL 191
Query: 179 DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGA 238
DL +++ N+S N+LSG IP+ L P+ +F N+ LCG P+ AC S GA
Sbjct: 192 DLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNAC-----------SGGA 240
Query: 239 IASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLA 298
I+ P +N P + N P + + S +IAIVVG +
Sbjct: 241 IS----PSSN-------LPRPLTENLHPVRR----------RQSKAYIIAIVVG----CS 275
Query: 299 IISLLLYCYFWRNYVKNKTRSKLLESEKI------LYSSSP--YPAQQAGYERGSMVFFE 350
+ L L F VK KT+ + E + + S P + + E+ + FFE
Sbjct: 276 VAVLFLGIVFLVCLVK-KTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFE 334
Query: 351 GTKR-FELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEV 409
F+LEDLL+ASAE+LGKG FGTAYKAVL+D + V VKRL++ + K+EFEQ ME+
Sbjct: 335 RCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREV-VASKKEFEQQMEI 393
Query: 410 LGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA 468
+G++ +H N V L AYY++++EKLLV +YM GSLF ++HGNR G +DW TR+KIA
Sbjct: 394 VGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNR--GDRGVDWETRMKIAT 451
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-SIFAPPSTVPRSNGYR 527
G ++ ++++H SLK HG+IKS+N+LL + +SD L ++F P+ PR+ GY
Sbjct: 452 GTSKAISYLH----SLKFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYN 507
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587
APE+ + R+ SQ+SDVYSFGV++LE+LTGK P G +DLPRWV+SVV
Sbjct: 508 APEVIET--RRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDER---VVIDLPRWVRSVV 562
Query: 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647
REEWTAEVFD+EL+++++IEEEMV +LQ+A+AC + +P+ RP M V ++IE++R ++ S
Sbjct: 563 REEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQS 622
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 276/672 (41%), Positives = 386/672 (57%), Gaps = 74/672 (11%)
Query: 1 MDAHKTLHFTLLILAVHFSLLKASTS---PDLNALLDFKASSDEANKLTTWN-STSDPCS 56
M + L +++ L V + L A TS D ALL + S + WN S S PC+
Sbjct: 1 MKYKRKLSLSVVFLFVFY--LAAVTSDLESDRRALLAVRNSVR--GRPLLWNMSASSPCN 56
Query: 57 WTGVSCLQNRVSHLVLENLQLSGSLQ--PLTSLTQLRVLSLKYNRFTGPVPS-LSNLTAL 113
W GV C RV+ L L L GSL + +LTQL+ LSL++N +GP+PS SNL L
Sbjct: 57 WHGVHCDAGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLL 116
Query: 114 KLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173
+ L+L N F+GE P + +L + R++L N FSG+IP VN T L+TL LE N+ SG
Sbjct: 117 RYLYLQGNAFSGEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSG 176
Query: 174 PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKP 233
PI + L LQ FNVS N L+G IP SLS +P +AF N LCG P+ C+
Sbjct: 177 PIPEITL-PLQQFNVSSNQLNGSIPSSLSSWPRTAFEGNT-LCGKPLDTCE--------- 225
Query: 234 GSDGAIASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGD 293
+ P D P+K S K+S+ A++ IV+G
Sbjct: 226 ------------------------AESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGC 261
Query: 294 FLVLAIISLLLYCYFWRNYVKNKTRSKLLESEKILYSSSPY----------PAQQAGYER 343
+ L ++ L+L+C + + S+ +E+ +SS PA+ G E
Sbjct: 262 VVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSES 321
Query: 344 GSM-----VFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG 398
G++ F + F+L+ LL+ASAE+LGKG G++YKA + G VVAVKRL+D +
Sbjct: 322 GAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVVVP 381
Query: 399 GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPL 458
++EF + + VLG + H NLV L AYYF+R+EKLLV EYM GSL +LHGN+G GRTPL
Sbjct: 382 -EKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPL 440
Query: 459 DWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518
+W TR IA GAAR ++++H + +HGNIKS+N+LL + A+VSD+GL+ +
Sbjct: 441 NWETRAGIALGAARAISYLH--SRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAPIISST 498
Query: 519 TVP-RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577
+ P R +GYRAPE+ +D RK SQK+DVYSFGVL+LELLTGK P+ G V
Sbjct: 499 SAPNRIDGYRAPEI--TDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEG------V 550
Query: 578 DLPRWVQSVVREEWTAEVFDLELMRYK-DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
DLPRWVQSV ++ ++V D EL RY+ + E ++ LL++ M+CT+ PD RP+M+ V +
Sbjct: 551 DLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTR 610
Query: 637 LIEELRGVEVSP 648
LIEE+ SP
Sbjct: 611 LIEEVSHSSGSP 622
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 425 bits (1092), Expect = e-118, Method: Compositional matrix adjust.
Identities = 260/625 (41%), Positives = 367/625 (58%), Gaps = 74/625 (11%)
Query: 48 WNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQ-PLTSLTQLRVLSLKYNRFTGPVP- 105
WN T+ PC+W GV C RV+ L L + LSG L + +LT+L LS ++N GP+P
Sbjct: 46 WNLTAPPCTWGGVQCESGRVTALRLPGVGLSGPLPIAIGNLTKLETLSFRFNALNGPLPP 105
Query: 106 SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLK 165
+NLT L+ L+L N F+GE P + +L + R++L+ NNF G+IP VN T L TL
Sbjct: 106 DFANLTLLRYLYLQGNAFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSATRLATLY 165
Query: 166 LEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKT 225
L+ N+ +GPI + ++ LQ FNVS N L+G IP LSG P +AF N LCG P+ AC
Sbjct: 166 LQDNQLTGPIPEIKIK-LQQFNVSSNQLNGSIPDPLSGMPKTAFLGN-LLCGKPLDAC-- 221
Query: 226 MVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVA 285
P+N N T TP K S K+S+ A
Sbjct: 222 ----------------PVNGTGNGT----VTPGG---------------KGKSDKLSAGA 246
Query: 286 VIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTRSKLLESEKILYSSS---------PYPA 336
++ IV+G F++L ++ L+++C + + +S+ +E+ + SS+ P
Sbjct: 247 IVGIVIGCFVLLLVLFLIVFCLCRKKKKEQVVQSRSIEAAPVPTSSAAVAKESNGPPAVV 306
Query: 337 QQAGYERG----------SMVFF-EGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGS 385
E G + FF + F+L+ LL+ASAE+LGKG FG++YKA D G
Sbjct: 307 ANGASENGVSKNPAAVSKDLTFFVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGL 366
Query: 386 VVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445
VVAVKRL+D + ++EF + ++VLG + H NLV L AYYF+R+EKL+V EYM GSL
Sbjct: 367 VVAVKRLRDVVV-PEKEFREKLQVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSA 425
Query: 446 LLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505
LLHGN+G GR+PL+W TR IA GAAR ++++H + +HGNIKS+N+LL ++ A+
Sbjct: 426 LLHGNKGSGRSPLNWETRANIALGAARAISYLH--SRDATTSHGNIKSSNILLSESFEAK 483
Query: 506 VSDFGLSIFAPPSTVP-RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564
VSD+ L+ P++ P R +GYRAPE+ +D RK SQK+DVYSFGVL+LELLTGK P+
Sbjct: 484 VSDYCLAPMISPTSTPNRIDGYRAPEV--TDARKISQKADVYSFGVLILELLTGKSPTHQ 541
Query: 565 DGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYK-DIEEEMVGLLQVAMACTSA 623
G VDLPRWV S+ ++ ++VFD EL RY+ D E M+ LL + ++CT+
Sbjct: 542 QLHEEG------VDLPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQ 595
Query: 624 SPDQRPNMSHVVKLIEELRGVEVSP 648
PD RP M V +LIEE+ SP
Sbjct: 596 YPDSRPTMPEVTRLIEEVSRSPASP 620
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-112, Method: Compositional matrix adjust.
Identities = 273/659 (41%), Positives = 362/659 (54%), Gaps = 78/659 (11%)
Query: 28 DLNALLDFKASSDEANKLTTWNSTSDPCS-WTGVSCLQN--RVSHLVLENLQLSGSLQP- 83
D ALL+F L WN TS C+ WTGV+C Q+ R+ + L + L+G + P
Sbjct: 29 DKRALLEFLTIMQPTRSLN-WNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQIPPN 87
Query: 84 -LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141
++ L+ LRVLSL+ N +G P L L L+L NN +G P S L ++
Sbjct: 88 TISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNLTSVN 147
Query: 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDFNVSGNH-LSGQIPK 199
LS N F+G IP +++ L + +L L N SG I L L +LQ ++S N+ L+G IP
Sbjct: 148 LSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLAGPIPD 207
Query: 200 SLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSS 259
L FP S++T G D + PG N T V PS
Sbjct: 208 WLRRFPFSSYT-----------------------GID-----IIPPGGNYTLVTPPPPSE 239
Query: 260 IPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTR- 318
+ QK S ++ ++ ++ V ++ L YV+ K R
Sbjct: 240 -----------QTHQKPSKARFLGLSETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRR 288
Query: 319 -SKLLESEKILYSSSPYPAQQAGYER---GSMVFFEGTK-RFELEDLLRASAEMLGKGGF 373
++ K+ P + + FFEG F+LEDLLRASAE+LGKG F
Sbjct: 289 GDGVISDNKLQKKGGMSPEKFVSRMEDVNNRLSFFEGCNYSFDLEDLLRASAEVLGKGTF 348
Query: 374 GTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLL 433
GT YKAVL+D + VAVKRLKD + GKR+FEQ ME++G ++H N+V LKAYY++++EKL+
Sbjct: 349 GTTYKAVLEDATSVAVKRLKDVA-AGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLM 407
Query: 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKS 493
V +Y GS+ LLHGNRG R PLDW TR+KIA GAA+G+A IH KL HGNIKS
Sbjct: 408 VYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKENNG-KLVHGNIKS 466
Query: 494 TNVLLDKTGNARVSDFGL----SIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFG 549
+N+ L+ N VSD GL S APP + R GYRAPE+ +D RK SQ SDVYSFG
Sbjct: 467 SNIFLNSESNGCVSDLGLTAVMSPLAPP--ISRQAGYRAPEV--TDTRKSSQLSDVYSFG 522
Query: 550 VLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEE 609
V+LLELLTGK P G + L RWV SVVREEWTAEVFD+EL+RY +IEEE
Sbjct: 523 VVLLELLTGKSPIHTTAGDE------IIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEE 576
Query: 610 MVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV--------EVSPCHENFDSVSDSP 660
MV +LQ+AM+C + DQRP MS +V+LIE + E+ P EN S + +P
Sbjct: 577 MVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENGASETSTP 635
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | ||||||
| 225424043 | 671 | PREDICTED: probable leucine-rich repeat | 0.979 | 0.980 | 0.759 | 0.0 | |
| 224108443 | 677 | predicted protein [Populus trichocarpa] | 0.976 | 0.968 | 0.736 | 0.0 | |
| 356534353 | 672 | PREDICTED: probable leucine-rich repeat | 0.971 | 0.971 | 0.726 | 0.0 | |
| 357444699 | 669 | Leucine-rich repeat receptor-like protei | 0.946 | 0.950 | 0.711 | 0.0 | |
| 77417493 | 676 | putative receptor kinase [Malus x domest | 0.964 | 0.958 | 0.726 | 0.0 | |
| 449434600 | 672 | PREDICTED: probable leucine-rich repeat | 0.974 | 0.974 | 0.718 | 0.0 | |
| 449493444 | 672 | PREDICTED: probable leucine-rich repeat | 0.974 | 0.974 | 0.716 | 0.0 | |
| 297841559 | 669 | At1g68400/T2E12_5 [Arabidopsis lyrata su | 0.921 | 0.925 | 0.686 | 0.0 | |
| 15221403 | 670 | leucine-rich repeat transmembrane protei | 0.927 | 0.929 | 0.679 | 0.0 | |
| 14190425 | 671 | At1g68400/T2E12_5 [Arabidopsis thaliana] | 0.927 | 0.928 | 0.678 | 0.0 |
| >gi|225424043|ref|XP_002279580.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 992 bits (2565), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/666 (75%), Positives = 565/666 (84%), Gaps = 8/666 (1%)
Query: 6 TLHFTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQN 65
+LHF + +HF LL ASTS DL AL+ FK ++D ANKLTTWN T +PCSW GVSCLQN
Sbjct: 8 SLHFAFALFILHFFLLHASTSSDLEALMAFKETADAANKLTTWNVTVNPCSWYGVSCLQN 67
Query: 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
RVS LVLE L L GS QPL SLTQLRVLSLK NR +GP+P+LSNLTALKLLFLS+N F+G
Sbjct: 68 RVSRLVLEGLDLQGSFQPLASLTQLRVLSLKRNRLSGPIPNLSNLTALKLLFLSYNEFSG 127
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQD 185
EFP SV+SLFRLYRLDLS NN SGQIP TVNHL H+LTL+LE NRFSG ITGL+L NLQD
Sbjct: 128 EFPASVTSLFRLYRLDLSHNNLSGQIPETVNHLAHILTLRLEENRFSGSITGLNLPNLQD 187
Query: 186 FNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNP 245
FNVSGN L+G IPK+LS FP SAF +NA LCGSPM CK + DP KPGS GAIASP+ P
Sbjct: 188 FNVSGNRLAGDIPKTLSAFPVSAFDRNAVLCGSPMPTCKNVAGDPTKPGSGGAIASPVIP 247
Query: 246 GNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLY 305
G NP V SS S + T +P + + ++ K+S VA+IAI++GD LVLAI+SLLLY
Sbjct: 248 GGNPAIVASSPSSIPISTT--PIQPQNTRHGATGKVSPVAMIAIILGDILVLAIVSLLLY 305
Query: 306 CYFWRNY---VKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELEDLLR 362
CYFWRNY +++ S++LE EKI+YSSSPYPA QAGYERG MVFFEG KRFELEDLLR
Sbjct: 306 CYFWRNYAGKMRDGKSSQILEGEKIVYSSSPYPA-QAGYERGRMVFFEGVKRFELEDLLR 364
Query: 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
ASAEMLGKGGFGTAYKAVLDDG+VVAVKRLKDA +GGKREFEQHMEVLGRLRHPN+V L+
Sbjct: 365 ASAEMLGKGGFGTAYKAVLDDGNVVAVKRLKDAHVGGKREFEQHMEVLGRLRHPNVVNLR 424
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
AYYFAR+EKLLV +YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CK
Sbjct: 425 AYYFARDEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHNSCK 484
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQK 542
+LKLTHGNIKSTN+LLDK G+ARVSDFGLS+FA + PRSNGYRAPE+ DGRK SQK
Sbjct: 485 TLKLTHGNIKSTNILLDKCGSARVSDFGLSVFASSTAAPRSNGYRAPEI--LDGRKGSQK 542
Query: 543 SDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMR 602
SDVYSFGVLLLELLTGKCPSV++ GG G G GG VDLPRWVQSVVREEWTAEVFDLELMR
Sbjct: 543 SDVYSFGVLLLELLTGKCPSVMENGGPGSGYGGVVDLPRWVQSVVREEWTAEVFDLELMR 602
Query: 603 YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDSPCL 662
YKDIEEEMVGLLQ+AMACT+ SPDQRP MS+VVK+IEE+RGVEVSP HE FDSVSDSP +
Sbjct: 603 YKDIEEEMVGLLQIAMACTTPSPDQRPKMSYVVKMIEEIRGVEVSPSHETFDSVSDSPSV 662
Query: 663 SEDTLG 668
SEDT G
Sbjct: 663 SEDTCG 668
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108443|ref|XP_002314848.1| predicted protein [Populus trichocarpa] gi|222863888|gb|EEF01019.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2503), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/668 (73%), Positives = 574/668 (85%), Gaps = 12/668 (1%)
Query: 10 TLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSH 69
T ++++HFSLL+AS++PD LL FK SD NKL WNS+++PC+WTG++CL +RVS
Sbjct: 13 TFFLISLHFSLLQASSNPDSEPLLQFKTLSDTDNKLQDWNSSTNPCTWTGIACLNDRVSR 72
Query: 70 LVLENLQLSGS-LQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEF 127
LVLENL L GS LQ LTSLTQLRVLSLK N +GP+P ++SNL+ALKLLFLSHN+F+G F
Sbjct: 73 LVLENLNLQGSSLQTLTSLTQLRVLSLKRNNLSGPIPQNISNLSALKLLFLSHNHFSGTF 132
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
P SV SL RLYRLDLS NNFSG IP+ VN LTHLLTL+LE N+F+G I+ L+L +LQDFN
Sbjct: 133 PVSVLSLSRLYRLDLSHNNFSGNIPVIVNRLTHLLTLRLEENQFTGSISSLNLPSLQDFN 192
Query: 188 VSGNHLSGQIPKSLSGFPDSAFTQN--AALCGSPMQACKTMVTDPKKPGSDGAIASPLNP 245
VS N +SG+IPKSLSGFP+SAF Q+ A LCGSP+QACK++ +DP +PGSDGAIASPL P
Sbjct: 193 VSNNRVSGEIPKSLSGFPESAFAQSLPAGLCGSPLQACKSLASDPTRPGSDGAIASPLLP 252
Query: 246 GNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLY 305
G NPT++VSSTPSS+ P N KTS+ KIS +A+IAI++GD L+LA++SLLLY
Sbjct: 253 GTNPTSIVSSTPSSVVAPNKPTNTNHKISKTST-KISPLALIAIILGDILILAVVSLLLY 311
Query: 306 CYFWRNY---VKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELEDLLR 362
CYFWRNY ++N SKLLE+EKI+YSSSPYP Q G+ERG MVFFEG +RFELEDLLR
Sbjct: 312 CYFWRNYAAKMRNGKGSKLLETEKIVYSSSPYP-NQPGFERGRMVFFEGVERFELEDLLR 370
Query: 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
ASAEMLGKGGFGTAYKAVLDDG+VVAVKRLKDA++GGKRE EQHMEVLGRLRHPNLV K
Sbjct: 371 ASAEMLGKGGFGTAYKAVLDDGNVVAVKRLKDANVGGKRELEQHMEVLGRLRHPNLVSFK 430
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+YYFAREEKLLV +YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF+H +CK
Sbjct: 431 SYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFMHNSCK 490
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-TVPRSNGYRAPELSSSDGRKQSQ 541
+LKL HGNIKSTN+LLDK GNARVSDFGL++FA + + PRSNGYRAPE ++SDGRKQ+Q
Sbjct: 491 ALKLVHGNIKSTNILLDKAGNARVSDFGLTLFASSTNSAPRSNGYRAPE-ATSDGRKQTQ 549
Query: 542 KSDVYSFGVLLLELLTGKCPSVID-GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLEL 600
KSDVYSFGVLLLE+LTGKCPS++D G G G G GG VDLPRWVQSVVREEWTAEVFDLEL
Sbjct: 550 KSDVYSFGVLLLEILTGKCPSIVDCGAGPGNGYGGPVDLPRWVQSVVREEWTAEVFDLEL 609
Query: 601 MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDSP 660
MRYKDIEEEMVGLLQ+A+ACT+ SPD RP M HVV++IEE+RGVE+SPCH+ FDSVSDSP
Sbjct: 610 MRYKDIEEEMVGLLQIALACTTPSPDHRPRMGHVVRMIEEIRGVEMSPCHDTFDSVSDSP 669
Query: 661 CLSEDTLG 668
CLSE+T G
Sbjct: 670 CLSEETSG 677
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534353|ref|XP_003535720.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2419), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/673 (72%), Positives = 555/673 (82%), Gaps = 20/673 (2%)
Query: 12 LILAVHFS-------LLKASTSPDLNALLDFKASSDEANKLTTWN-STSDPCSWTGVSCL 63
L+ HF ++ ++PD +ALL FK +SD + KLTTWN ++++PCSW GVSC+
Sbjct: 8 LVAVFHFLILLLLLLMVHGFSNPDFDALLSFKTASDTSQKLTTWNINSTNPCSWKGVSCI 67
Query: 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
++RVS LVLENL L GS+ PLTSLTQLRVLSLK NRF+GPVP+LSNLTALKLLFLS N F
Sbjct: 68 RDRVSRLVLENLDLEGSIHPLTSLTQLRVLSLKGNRFSGPVPNLSNLTALKLLFLSRNAF 127
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL 183
+GEFP +V SLFRLYRLDLS NNFSG+IP TV+HLTHLLTL+L+ N+FSG I ++L L
Sbjct: 128 SGEFPATVKSLFRLYRLDLSNNNFSGEIPATVSHLTHLLTLRLDGNKFSGHIPDVNLPGL 187
Query: 184 QDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPL 243
Q+FNVSGN LSG+IPKSLS FP+S+F QN LCG+P++ C DP KPGS+GAIASPL
Sbjct: 188 QEFNVSGNRLSGEIPKSLSNFPESSFGQNPFLCGAPIKNC---APDPTKPGSEGAIASPL 244
Query: 244 NPGNN--PTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIIS 301
P NN T V SS S T + K SKIS VA+IAI+V D LVLAI+S
Sbjct: 245 VPPNNNPTTTVSSSPSSMPKTPASASTKSNKSHGKGGSKISPVALIAIIVCDVLVLAIVS 304
Query: 302 LLLYCYFWRNY-VKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELEDL 360
LLLYCYFWRNY +K SKL ESEKI+YSSSPYPA Q G+ERG MVFFEG KRFELEDL
Sbjct: 305 LLLYCYFWRNYKLKEGKGSKLFESEKIVYSSSPYPA-QGGFERGRMVFFEGEKRFELEDL 363
Query: 361 LRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG 420
LRASAEMLGKGGFGTAYKAVLDDG+VVAVKRLKDA I GKREFEQHME+LGRLRHPN+V
Sbjct: 364 LRASAEMLGKGGFGTAYKAVLDDGNVVAVKRLKDAQITGKREFEQHMELLGRLRHPNVVS 423
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+AYYFAREEKLLV +YMPN +LFWLLHGNRGPGRTPLDWTTRLKIAAGAARG+AFIH +
Sbjct: 424 LRAYYFAREEKLLVYDYMPNATLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGVAFIHNS 483
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV-PRSNGYRAPELSSSDGRKQ 539
CKSLKLTHGNIKSTNVLLDK GNARVSDFGLS+FA P V RSNGYRAPE +S+GRKQ
Sbjct: 484 CKSLKLTHGNIKSTNVLLDKQGNARVSDFGLSVFAGPGPVGGRSNGYRAPE--ASEGRKQ 541
Query: 540 SQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599
+QKSDVYSFGVLLLELLTGKCPSV++ GG+ GG VDLPRWVQSVVREEWTAEVFDLE
Sbjct: 542 TQKSDVYSFGVLLLELLTGKCPSVVESGGSAY--GGVVDLPRWVQSVVREEWTAEVFDLE 599
Query: 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDS 659
LMRYKDIEEEMVGLLQ+AM CT+ +PDQRP M+HV+K+IEELRGVEVSPCH++ DSVS+S
Sbjct: 600 LMRYKDIEEEMVGLLQIAMTCTAPAPDQRPRMTHVLKMIEELRGVEVSPCHDSLDSVSES 659
Query: 660 PCLSEDTLGGLSQ 672
P LSED G SQ
Sbjct: 660 PSLSEDACGTTSQ 672
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444699|ref|XP_003592627.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355481675|gb|AES62878.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/665 (71%), Positives = 549/665 (82%), Gaps = 29/665 (4%)
Query: 17 HFSLL-KASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENL 75
HF L+ ++S +PD LL FK SD +NKLTTW + +DPC+WTGVSC++NRV+ L+LENL
Sbjct: 18 HFVLIVQSSVNPDYEPLLTFKTGSDPSNKLTTWKTNTDPCTWTGVSCVKNRVTRLILENL 77
Query: 76 QLSG-SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSL 134
L G +++PLTSLTQLRVLSLK NRF+G +P+LSN T+LKLLFLSHN+F+G+FP +V+SL
Sbjct: 78 NLQGGTIEPLTSLTQLRVLSLKGNRFSGSLPNLSNFTSLKLLFLSHNHFSGDFPSTVTSL 137
Query: 135 FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194
FRLYRLDLS+NNFSG+IP VN LTHLLTL+L+ N+FSG I L+L LQDFNVSGN S
Sbjct: 138 FRLYRLDLSYNNFSGEIPTMVNRLTHLLTLRLDENKFSGVIPELNLPGLQDFNVSGNRFS 197
Query: 195 GQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVS 254
G+IPK+LSGF S+F QN LCG+P++ C +P KPGSDGAIASPL P VVS
Sbjct: 198 GEIPKTLSGFSGSSFGQNPFLCGAPLEKCGD---EPNKPGSDGAIASPLVPAT----VVS 250
Query: 255 STPSSIPT-NTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYV 313
S+PS++PT NT + K SK+S + ++AI+VGD LVL I+ LLLYCYFW+NY
Sbjct: 251 SSPSTMPTRNTKTHEK-------RGSKMSPIVLVAIIVGDVLVLGIVCLLLYCYFWKNYC 303
Query: 314 ---KNKTRSKLLESEKILYSSSPYPAQQAG---YERGSMVFFEGTKRFELEDLLRASAEM 367
K K KL ESEKI+YSSSPYP Q G +ERG MVFFEG KRFELEDLLRASAEM
Sbjct: 304 SKSKEKKGLKLFESEKIVYSSSPYPTQGGGGGGFERGRMVFFEGEKRFELEDLLRASAEM 363
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LGKGGFGTAYKAVLDDG+VVAVKRLKDA I GKREFEQHME+LGR+RHPN+V L+AYYFA
Sbjct: 364 LGKGGFGTAYKAVLDDGNVVAVKRLKDAQIAGKREFEQHMEILGRIRHPNVVSLRAYYFA 423
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLT 487
R+EKLLV +YMPN +LFWLLHGNRGPGRTPLDWTTRLKIAAGAA+G+AFIH +CKSLKLT
Sbjct: 424 RDEKLLVYDYMPNATLFWLLHGNRGPGRTPLDWTTRLKIAAGAAQGVAFIHNSCKSLKLT 483
Query: 488 HGNIKSTNVLLDKTGNARVSDFGLSIF---APPSTVPRSNGYRAPELSSSDGRKQSQKSD 544
HGNIKSTN+LLDK G+ARVSDFGLS+F +P RSNGYRAPE+ DGRKQSQKSD
Sbjct: 484 HGNIKSTNILLDKQGDARVSDFGLSVFNGSSPSGAGSRSNGYRAPEV--LDGRKQSQKSD 541
Query: 545 VYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYK 604
VYSFGVLLLE+LTGKCPS ++ GG+G GG +DLPRWVQSVVREEWTAEVFDLELMRYK
Sbjct: 542 VYSFGVLLLEMLTGKCPSAVESGGSGYN-GGVIDLPRWVQSVVREEWTAEVFDLELMRYK 600
Query: 605 DIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDSPCLSE 664
DIEEEMVGLLQ+AM+CT+ASPDQRP MSHVVK+IEELRGVEVSPCH+ DSVSDSP LSE
Sbjct: 601 DIEEEMVGLLQIAMSCTAASPDQRPRMSHVVKMIEELRGVEVSPCHDTMDSVSDSPSLSE 660
Query: 665 DTLGG 669
D G
Sbjct: 661 DACAG 665
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|77417493|gb|ABA82079.1| putative receptor kinase [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2400), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/662 (72%), Positives = 545/662 (82%), Gaps = 14/662 (2%)
Query: 18 FSLLKASTSPDLNALLDFKASSDEANKLTTWNSTS-DPCSWTGVSCLQNRVSHLVLENLQ 76
F+ S++PD LL FKA+SD +NKLTTWNSTS DPC+WTGVSC NRVS LVLENL
Sbjct: 17 FAAFHVSSNPDTKPLLSFKATSDASNKLTTWNSTSVDPCTWTGVSCTNNRVSRLVLENLD 76
Query: 77 LSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136
L GS QPLT+LTQLRVLSLK NR +GP+P LSN T LKLLFLS+N +G+FP SVSSLFR
Sbjct: 77 LRGSFQPLTALTQLRVLSLKRNRLSGPIPDLSNFTTLKLLFLSYNELSGDFPASVSSLFR 136
Query: 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQ 196
LYRLDLS+NN SG+IP TVNHL HLLTL+LEANR SG I+GL L NLQD NVS N L+G+
Sbjct: 137 LYRLDLSYNNLSGEIPATVNHLNHLLTLRLEANRLSGSISGLTLPNLQDLNVSANRLTGE 196
Query: 197 IPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSST 256
IPKS + FP +AF QN LCGSPMQ+CK DP +PGSDGAIASP+ P NPT VV+S+
Sbjct: 197 IPKSFTTFPITAFAQNPGLCGSPMQSCKGTPNDPTRPGSDGAIASPVMPAANPT-VVASS 255
Query: 257 PSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYV--- 313
PSS+P N+ NK +P + S+K+S A+IAI+VGD LVL ++SLLLYCYFWRN+
Sbjct: 256 PSSLPGNS-ALNKSGNPHRNGSTKMSPEALIAIIVGDALVLVLVSLLLYCYFWRNFSAKM 314
Query: 314 -KNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELEDLLRASAEMLGKGG 372
+ K SKLLE+EKI+YSSSPY A Q +ERG MVFFEG KRFELEDLLRASAEMLGKGG
Sbjct: 315 RQGKGGSKLLETEKIVYSSSPYSAAQPVFERGRMVFFEGVKRFELEDLLRASAEMLGKGG 374
Query: 373 FGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKL 432
FGTAYKAVLDDG+VVAVKRLKDA IGGK +FEQHM VLGRL HPN+V L+AYYFAREEKL
Sbjct: 375 FGTAYKAVLDDGNVVAVKRLKDAQIGGKTQFEQHMAVLGRLSHPNIVSLRAYYFAREEKL 434
Query: 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIK 492
LV +YMPNGSLFW+LHGNRGPGRTPLDWTTRLKIAAGAARGLA IH +C+ LKLTHGNIK
Sbjct: 435 LVYDYMPNGSLFWVLHGNRGPGRTPLDWTTRLKIAAGAARGLACIHDSCRPLKLTHGNIK 494
Query: 493 STNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDGRKQSQKSDVYSF 548
STN+LLD TGNARVSDFGLS+F PP S GYRAPE + DGRK +QKSDVY+F
Sbjct: 495 STNILLDNTGNARVSDFGLSVFVPPPPSTSSAPRSCGYRAPE--TLDGRKLTQKSDVYAF 552
Query: 549 GVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEE 608
GVLLLELLTGKCPSV+D GG+G G GG VDLPRWVQSVVREEWT EVFDLELMRYKDIEE
Sbjct: 553 GVLLLELLTGKCPSVMDNGGSGGGFGGLVDLPRWVQSVVREEWTVEVFDLELMRYKDIEE 612
Query: 609 EMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHE-NFDSVSDSPCLSEDTL 667
EMVGLLQ+AMACT+ASPDQRP MS VVK+I+E+RG+ SP HE F+S+S+S LSEDT
Sbjct: 613 EMVGLLQIAMACTAASPDQRPRMSQVVKMIDEIRGLSGSPSHEAGFESMSESSALSEDTC 672
Query: 668 GG 669
G
Sbjct: 673 GA 674
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434600|ref|XP_004135084.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 927 bits (2395), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/667 (71%), Positives = 565/667 (84%), Gaps = 12/667 (1%)
Query: 8 HFTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRV 67
HF + ++F+ + AS++ DL+AL+ FKA+SD+ NKLTTWNSTS+PC+W GVSCL++RV
Sbjct: 9 HFACFVSFLYFTCVYASSNIDLDALVAFKAASDKGNKLTTWNSTSNPCAWDGVSCLRDRV 68
Query: 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
S LVLENL L+G++ PLT+LTQLRVLSLK NR +GP+P LSN ALKL+FLS+N F+G
Sbjct: 69 SRLVLENLDLTGTIGPLTALTQLRVLSLKRNRLSGPIPDLSNFKALKLVFLSYNAFSGNL 128
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
P S+ SL RLYRLDLS NN +G+IP +VN LTHLLTL+LE NRFSGPI L+L NLQDFN
Sbjct: 129 PASLLSLVRLYRLDLSHNNLTGEIPASVNRLTHLLTLRLEDNRFSGPILELNLPNLQDFN 188
Query: 188 VSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGN 247
+S N LSG+IPKSLS FP+S+F QN LCGSP+Q+CK++V+ P +PGS+GAIASP+ P
Sbjct: 189 ISENRLSGEIPKSLSAFPESSFGQNMGLCGSPLQSCKSIVSKPTEPGSEGAIASPITPPR 248
Query: 248 NPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCY 307
N T VSS+P+S+P T KP + + KI S+A+IAI++GD +VLA++SLLLYCY
Sbjct: 249 NLT--VSSSPTSLPEVT-AETKPENTHHHGTGKIGSLALIAIILGDVVVLALVSLLLYCY 305
Query: 308 FWRNYV----KNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELEDLLRA 363
FW+N + K SKLLESEKI+YSSSPYPAQ AG ERG MVFFEG K+FELEDLLRA
Sbjct: 306 FWKNSADKAREGKGSSKLLESEKIVYSSSPYPAQ-AGTERGRMVFFEGVKKFELEDLLRA 364
Query: 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
SAEMLGKGGFGT+YKA+LDDG+VVAVKRLKDA +GGKREFEQHMEVLGRLRH N+V L+A
Sbjct: 365 SAEMLGKGGFGTSYKAILDDGNVVAVKRLKDAQVGGKREFEQHMEVLGRLRHANIVSLRA 424
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
YYFAREEKLLV +YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CKS
Sbjct: 425 YYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHNSCKS 484
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKS 543
LKL HGN+KSTNVLLD++GNARVSD+GLS+F PPST PR+NGYRAPE D RK +QKS
Sbjct: 485 LKLAHGNVKSTNVLLDQSGNARVSDYGLSLFTPPST-PRTNGYRAPE--CGDDRKLTQKS 541
Query: 544 DVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV-DLPRWVQSVVREEWTAEVFDLELMR 602
DVYSFGVLLLELLTGKCPSV++ GG G G G+V DLPRWVQSVVREEWTAEVFDLELMR
Sbjct: 542 DVYSFGVLLLELLTGKCPSVVENGGPGGGGYGSVLDLPRWVQSVVREEWTAEVFDLELMR 601
Query: 603 YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDSPCL 662
YKDIEEEMVGLLQ+A+ACT+ASPDQRP M+HVVK+I+ELRGVEVSP H+ DSV++SP +
Sbjct: 602 YKDIEEEMVGLLQIALACTAASPDQRPKMNHVVKMIDELRGVEVSPFHDGSDSVTESPSV 661
Query: 663 SEDTLGG 669
SE T GG
Sbjct: 662 SEGTCGG 668
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449493444|ref|XP_004159291.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/667 (71%), Positives = 565/667 (84%), Gaps = 12/667 (1%)
Query: 8 HFTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRV 67
HF + ++F+ + AS++ DL+AL+ FKA+SD+ NKLTTWNSTS+PC+W GVSCL++RV
Sbjct: 9 HFACFVSFLYFTCVYASSNIDLDALVAFKAASDKGNKLTTWNSTSNPCAWDGVSCLRDRV 68
Query: 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
S LVLENL L+G++ PLT+LTQLRVLSLK NR +GP+P LSN ALKL+FLS+N F+G
Sbjct: 69 SRLVLENLDLTGTIGPLTALTQLRVLSLKRNRLSGPIPDLSNFKALKLVFLSYNAFSGNL 128
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
P S+ SL RLYRLDLS NN +G+IP +VN LTHLLTL+LE NRFSGPI L+L NLQDFN
Sbjct: 129 PASLLSLVRLYRLDLSHNNLTGEIPASVNRLTHLLTLRLEDNRFSGPILELNLPNLQDFN 188
Query: 188 VSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGN 247
+S N LSG+IPKSLS FP+S+F QN LCGSP+Q+CK++V+ P +PGS+GAIASP+ P
Sbjct: 189 ISENRLSGEIPKSLSAFPESSFGQNMGLCGSPLQSCKSIVSKPTEPGSEGAIASPITPPR 248
Query: 248 NPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCY 307
N T VSS+P+S+P T KP + + KI S+A+IAI++GD +VLA++SLLLYCY
Sbjct: 249 NLT--VSSSPTSLPEVT-AETKPENTHHHGTGKIGSLALIAIILGDVVVLALVSLLLYCY 305
Query: 308 FWRNYV----KNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELEDLLRA 363
FW+N + K SKLLESEKI+YSSSPYPAQ AG ERG MVFFEG K+FELEDLLRA
Sbjct: 306 FWKNSADKAREGKGSSKLLESEKIVYSSSPYPAQ-AGTERGRMVFFEGVKKFELEDLLRA 364
Query: 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
SAEMLGKGGFGT+YKA+LDDG+VVAVKRLKDA +GGKREFEQHMEVLGRLRH N+V L+A
Sbjct: 365 SAEMLGKGGFGTSYKAILDDGNVVAVKRLKDAQVGGKREFEQHMEVLGRLRHANIVSLRA 424
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
YYFAREEKLLV +YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CKS
Sbjct: 425 YYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHNSCKS 484
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKS 543
LKL HGN+KSTNVLLD++GNARVSD+GLS+F PPST PR+NGYRAPE D RK +QKS
Sbjct: 485 LKLAHGNVKSTNVLLDQSGNARVSDYGLSLFTPPST-PRTNGYRAPE--CGDDRKLTQKS 541
Query: 544 DVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV-DLPRWVQSVVREEWTAEVFDLELMR 602
DVYSFGVLLLELLTGKCPSV++ GG G G G++ DLPRWVQSVVREEWTAEVFDLELMR
Sbjct: 542 DVYSFGVLLLELLTGKCPSVVENGGPGGGGYGSILDLPRWVQSVVREEWTAEVFDLELMR 601
Query: 603 YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDSPCL 662
YKDIEEEMVGLLQ+A+ACT+ASPDQRP M+HVVK+I+ELRGVEVSP H+ DSV++SP +
Sbjct: 602 YKDIEEEMVGLLQIALACTAASPDQRPKMNHVVKMIDELRGVEVSPFHDGSDSVTESPSV 661
Query: 663 SEDTLGG 669
SE T GG
Sbjct: 662 SEGTCGG 668
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297841559|ref|XP_002888661.1| At1g68400/T2E12_5 [Arabidopsis lyrata subsp. lyrata] gi|297334502|gb|EFH64920.1| At1g68400/T2E12_5 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/650 (68%), Positives = 532/650 (81%), Gaps = 31/650 (4%)
Query: 33 LDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRV 92
L+FK ++D KL +WN T++PC WTGVSC +NRV+ LVLE+++L+GS+ PLTSLT LRV
Sbjct: 34 LNFKLTADSTGKLNSWNKTTNPCQWTGVSCNRNRVTRLVLEDIELTGSISPLTSLTSLRV 93
Query: 93 LSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP 152
LSLK+N +GP+P+LSNLTALKLLFLSHN F+G FP S++SL RLYRLDLSFNNFSG+IP
Sbjct: 94 LSLKHNSLSGPIPNLSNLTALKLLFLSHNQFSGNFPSSITSLTRLYRLDLSFNNFSGEIP 153
Query: 153 LTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212
+ +L HLLTL+LE+NRFSG I + + +LQDFNVSGN+ +GQIP SLS FP+S FTQN
Sbjct: 154 PDLTNLNHLLTLRLESNRFSGQIPNIIISDLQDFNVSGNNFNGQIPNSLSQFPESVFTQN 213
Query: 213 AALCGSPMQACKTMVTDPKKPGS-DGAIASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPA 271
+LCG+P+ C + +DP KPG DGA ASPL N + V S+P+SI
Sbjct: 214 PSLCGAPLLKCTKLSSDPTKPGRPDGAKASPL----NNSETVPSSPTSIHGG-------- 261
Query: 272 SPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTR-SKLLESEKILYS 330
S+++IS+++++AI++GDF++L+ +SLLLY FWR Y NK + SK+LE EKI+YS
Sbjct: 262 ---DKSTTRISTISLVAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKVLEGEKIVYS 318
Query: 331 SSPYPAQ--------QAGYERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLD 382
SSPYP Q G E+G MVFFEGT+RFELEDLLRASAEMLGKGGFGTAYKAVL+
Sbjct: 319 SSPYPTSAQNNNNQNQQGGEKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLE 378
Query: 383 DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441
DG+ VAVKRLKDA ++ GK+EFEQ MEVLGRLRH NLV LKAYYFAREEKLLV +YMPNG
Sbjct: 379 DGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNG 438
Query: 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT 501
SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CK+LKLTHG+IKSTNVLLD++
Sbjct: 439 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRS 498
Query: 502 GNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
GNARVSDFGLSIFAP TV +SNGYRAPEL +DGRK +QKSDVYSFGVLLLE+LTGKCP
Sbjct: 499 GNARVSDFGLSIFAPSQTVAKSNGYRAPEL--TDGRKHTQKSDVYSFGVLLLEILTGKCP 556
Query: 562 SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACT 621
++++ G +G G GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ+AMACT
Sbjct: 557 NMVETGHSG-GAGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACT 615
Query: 622 SASPDQRPNMSHVVKLIEELR--GVEVSPCHENFDSVSDSPCLSEDTLGG 669
+ + D RP M HVVKLIE++R G E SPC++ +S DSPCLSEDT GG
Sbjct: 616 AVAADHRPKMDHVVKLIEDIRGGGSEASPCNDGINSAVDSPCLSEDTCGG 665
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15221403|ref|NP_177007.1| leucine-rich repeat transmembrane protein kinase family protein [Arabidopsis thaliana] gi|75336092|sp|Q9M9C5.1|Y1680_ARATH RecName: Full=Probable leucine-rich repeat receptor-like protein kinase At1g68400; Flags: Precursor gi|6714351|gb|AAF26042.1|AC015986_5 putative receptor kinase; 18202-20717 [Arabidopsis thaliana] gi|224589469|gb|ACN59268.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332196668|gb|AEE34789.1| leucine-rich repeat transmembrane protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/655 (67%), Positives = 528/655 (80%), Gaps = 32/655 (4%)
Query: 28 DLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSL 87
D LL+FK ++D KL +WN+T++PC WTGVSC +NRV+ LVLE++ L+GS+ LTSL
Sbjct: 31 DSETLLNFKLTADSTGKLNSWNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSISSLTSL 90
Query: 88 TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
T LRVLSLK+N +GP+P+LSNLTALKLLFLS+N F+G FP S++SL RLYRLDLSFNNF
Sbjct: 91 TSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNF 150
Query: 148 SGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
SGQIP + LTHLLTL+LE+NRFSG I ++L +LQDFNVSGN+ +GQIP SLS FP+S
Sbjct: 151 SGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNSLSQFPES 210
Query: 208 AFTQNAALCGSPMQACKTMVTDPKKPGS-DGAIASPLNPGNNPTNVVSSTPSSIPTNTDP 266
FTQN +LCG+P+ C + +DP KPG D A ASPL N V S+P+SI
Sbjct: 211 VFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPL----NKPETVPSSPTSIHGGDKS 266
Query: 267 NNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTR-SKLLESE 325
NN +S+IS++++IAI++GDF++L+ +SLLLY FWR Y NK + SK+LE E
Sbjct: 267 NN---------TSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGE 317
Query: 326 KILYSSSPYPAQQAGY--------ERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAY 377
KI+YSS+PYP ++G MVFFEGT+RFELEDLLRASAEMLGKGGFGTAY
Sbjct: 318 KIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAY 377
Query: 378 KAVLDDGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436
KAVL+DG+ VAVKRLKDA ++ GK+EFEQ MEVLGRLRH NLV LKAYYFAREEKLLV +
Sbjct: 378 KAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYD 437
Query: 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNV 496
YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CK+LKLTHG+IKSTNV
Sbjct: 438 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNV 497
Query: 497 LLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELL 556
LLD++GNARVSDFGLSIFAP TV +SNGYRAPEL DGRK +QKSDVYSFGVLLLE+L
Sbjct: 498 LLDRSGNARVSDFGLSIFAPSQTVAKSNGYRAPEL--IDGRKHTQKSDVYSFGVLLLEIL 555
Query: 557 TGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQV 616
TGKCP++++ G + GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ+
Sbjct: 556 TGKCPNMVETGHS----GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQI 611
Query: 617 AMACTSASPDQRPNMSHVVKLIEELR--GVEVSPCHENFDSVSDSPCLSEDTLGG 669
AMACT+ + D RP M HVVKLIE++R G E SPC++ +S DSPCLSEDT GG
Sbjct: 612 AMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPCNDGINSAVDSPCLSEDTCGG 666
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14190425|gb|AAK55693.1|AF378890_1 At1g68400/T2E12_5 [Arabidopsis thaliana] gi|20857353|gb|AAM26714.1| At1g68400/T2E12_5 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2212), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/656 (67%), Positives = 526/656 (80%), Gaps = 33/656 (5%)
Query: 28 DLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSL 87
D LL+FK ++D KL +WN+T++PC WTGVSC +NRV+ LVLE++ L+GS+ LTSL
Sbjct: 31 DSETLLNFKLTADSTGKLNSWNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSISSLTSL 90
Query: 88 TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
T LRVLSLK+N +GP+P+LSNLTALKLLFLS+N F+G FP S++SL RLYRLDLSFNNF
Sbjct: 91 TSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNF 150
Query: 148 SGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
SGQIP + LTHLLTL+LE+NRFSG I ++L +LQDFNVSGN+ +GQIP SLS FP+S
Sbjct: 151 SGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNSLSQFPES 210
Query: 208 AFTQNAALCGSPMQACKTMVTDPKKPGS-DGAIASPLNPGNNPTNVVSSTPSSIPTNTDP 266
FTQN +LCG+P+ C + +DP KPG D A ASPL N V S+P+SI
Sbjct: 211 VFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPL----NKPETVPSSPTSIHGGDKS 266
Query: 267 NNKPASPQKTSSSKISSVAVIAIVVGDFLVLAIISLLLYCYFWRNYVKNKTR-SKLLESE 325
NN +S+IS++++IAI++GDF++L+ +SLLLY FWR Y NK + SK+LE E
Sbjct: 267 NN---------TSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGE 317
Query: 326 KILYSSSPYPAQQAGY--------ERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAY 377
KI+YSS+PYP ++G MVFFEGT+RFELEDLLRASAEMLGKGGFGTAY
Sbjct: 318 KIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAY 377
Query: 378 KAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435
KAVL+DG+ VAVKRLKDA G K+EFEQ MEVLGRLRH NLV LKAYYFAREEKLLV
Sbjct: 378 KAVLEDGNEVAVKRLKDAVTVAGKKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVY 437
Query: 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTN 495
+YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH +CK+LKLTHG+IKSTN
Sbjct: 438 DYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTN 497
Query: 496 VLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLEL 555
VLLD++GNARVSDFGLSIFAP TV +SNGYRAPEL DGRK +QKSDVYSFGVLLLE+
Sbjct: 498 VLLDRSGNARVSDFGLSIFAPSQTVAKSNGYRAPEL--IDGRKHTQKSDVYSFGVLLLEI 555
Query: 556 LTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ 615
LTGKCP++++ G + GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ
Sbjct: 556 LTGKCPNMVETGHS----GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ 611
Query: 616 VAMACTSASPDQRPNMSHVVKLIEELR--GVEVSPCHENFDSVSDSPCLSEDTLGG 669
+AMACT+ + D RP M HVVKLIE++R G E SPC++ +S DSPCLSEDT GG
Sbjct: 612 IAMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPCNDGINSAVDSPCLSEDTCGG 667
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 672 | ||||||
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.959 | 0.962 | 0.65 | 5.1e-225 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.955 | 0.955 | 0.442 | 1.1e-128 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.897 | 0.916 | 0.436 | 1.1e-121 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.425 | 0.436 | 0.564 | 9.8e-116 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.450 | 0.468 | 0.538 | 7.9e-112 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.437 | 0.459 | 0.501 | 2.7e-111 | |
| TAIR|locus:2174190 | 625 | LRR1 [Arabidopsis thaliana (ta | 0.431 | 0.464 | 0.508 | 1.3e-107 | |
| TAIR|locus:2036499 | 652 | AT1G60630 [Arabidopsis thalian | 0.440 | 0.453 | 0.453 | 1.1e-103 | |
| TAIR|locus:2196464 | 663 | AT1G10850 [Arabidopsis thalian | 0.453 | 0.460 | 0.443 | 4.1e-102 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.796 | 0.818 | 0.400 | 6.8e-95 |
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2172 (769.6 bits), Expect = 5.1e-225, P = 5.1e-225
Identities = 442/680 (65%), Positives = 518/680 (76%)
Query: 4 HKTLHFTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCL 63
+K L +LLIL + LL +S+S D LL+FK ++D KL +WN+T++PC WTGVSC
Sbjct: 8 NKHLLLSLLIL-LQSCLLSSSSSTDSETLLNFKLTADSTGKLNSWNTTTNPCQWTGVSCN 66
Query: 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
+NRV+ LVLE++ L+GS+ LTSLT LRVLSLK+N +GP+P+LSNLTALKLLFLS+N F
Sbjct: 67 RNRVTRLVLEDINLTGSISSLTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQF 126
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPXXXXXXXXXXXXXXEANRFSGPITGLDLRNL 183
+G FP S++SL RLYRLDLSFNNFSGQIP E+NRFSG I ++L +L
Sbjct: 127 SGNFPTSITSLTRLYRLDLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDL 186
Query: 184 QDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGS-DGAIASP 242
QDFNVSGN+ +GQIP SLS FP+S FTQN +LCG+P+ C + +DP KPG D A ASP
Sbjct: 187 QDFNVSGNNFNGQIPNSLSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASP 246
Query: 243 LNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTXXXXXXXXXXXXXXXGDFLVLAIISL 302
LN P V SS P+SI NN GDF++L+ +SL
Sbjct: 247 LN---KPETVPSS-PTSIHGGDKSNN---------TSRISTISLIAIILGDFIILSFVSL 293
Query: 303 LLYCYFWRNYVKNKTR-SKLLESEKILYSSSPYPA---------QQAGYERGSMVFFEGT 352
LLY FWR Y NK + SK+LE EKI+YSS+PYP QQ G ++G MVFFEGT
Sbjct: 294 LLYYCFWRQYAVNKKKHSKILEGEKIVYSSNPYPTSTQNNNNQNQQVG-DKGKMVFFEGT 352
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDA-SIGGKREFEQHMEVLG 411
+RFELEDLLRASAEMLGKGGFGTAYKAVL+DG+ VAVKRLKDA ++ GK+EFEQ MEVLG
Sbjct: 353 RRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLG 412
Query: 412 RLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 471
RLRH NLV LKAYYFAREEKLLV +YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA
Sbjct: 413 RLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 472
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPEL 531
RGLAFIH +CK+LKLTHG+IKSTNVLLD++GNARVSDFGLSIFAP TV +SNGYRAPEL
Sbjct: 473 RGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKSNGYRAPEL 532
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVDLPRWVQSVVREEW 591
DGRK +QKSDVYSFGVLLLE+LTGKCP++++ VDLPRWVQSVVREEW
Sbjct: 533 I--DGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGA----VDLPRWVQSVVREEW 586
Query: 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG--VEVSPC 649
TAEVFDLELMRYKDIEEEMVGLLQ+AMACT+ + D RP M HVVKLIE++RG E SPC
Sbjct: 587 TAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPC 646
Query: 650 HENFDSVSDSPCLSEDTLGG 669
++ +S DSPCLSEDT GG
Sbjct: 647 NDGINSAVDSPCLSEDTCGG 666
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1263 (449.7 bits), Expect = 1.1e-128, P = 1.1e-128
Identities = 308/696 (44%), Positives = 406/696 (58%)
Query: 3 AHKTLHFTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLT-TWNSTSDPC--SWTG 59
A K L LL+L +H S+ A D NAL F+ +D L W SD C SW G
Sbjct: 2 AAKPLLLPLLLL-LHLSITLAQN--DTNALTLFRLQTDTHGNLAGNWTG-SDACTSSWQG 57
Query: 60 VSCL--QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLF 117
VSC +RV+ L L +L L G L L+SL QLR+L L NR G V L+N L+L++
Sbjct: 58 VSCSPSSHRVTELSLPSLSLRGPLTSLSSLDQLRLLDLHDNRLNGTVSPLTNCKNLRLVY 117
Query: 118 LSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPXXXXXXXXXXXXXXEANRFSGPITG 177
L+ N+ +GE P +S L R+ RLDLS NN G IP + N +G I
Sbjct: 118 LAGNDLSGEIPKEISFLKRMIRLDLSDNNIRGVIPREILGFTRVLTIRIQNNELTGRIPD 177
Query: 178 LD-LRNLQDFNVSGNHLSGQIPKSL-SGFPDSAFTQNAALCGS-PMQACKTMVTDPKKPG 234
+++L + NVS N L G + + F D +F+ N LCGS P+ C T+ DP+
Sbjct: 178 FSQMKSLLELNVSFNELHGNVSDGVVKKFGDLSFSGNEGLCGSDPLPVC-TITNDPESSN 236
Query: 235 SDGAIASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTXXXXXXXXXXXXXXXGDF 294
+D + S NPT++ S P S+ +++ P G
Sbjct: 237 TDQIVPS------NPTSIPHS-PVSVREPEIHSHRGIKP----------GIIAAVIGGCV 279
Query: 295 LVLAIISL-LLYCY--FWRNYVKNKTRSKLL------ESEK-ILYSSSPYPAQQAGYERG 344
V+ ++S +C RN ++K+ S E ++ Y + +R
Sbjct: 280 AVIVLVSFGFAFCCGRLDRNGERSKSGSVETGFVGGGEGKRRSSYGEGGESDATSATDRS 339
Query: 345 SMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSV-VAVKRLKDASIGGKREF 403
+VFFE K+FEL+DLL+ASAEMLGKG GT YKAVLDDGS VAVKRLKDA+ ++EF
Sbjct: 340 RLVFFERRKQFELDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPCPRKEF 399
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
EQ+ME++GRL+H N+V L+AYY+A+EEKLLV EY+PNGSL LLHGNRGPGR PLDWTTR
Sbjct: 400 EQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNGSLHSLLHGNRGPGRIPLDWTTR 459
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-STVPR 522
+ + GAARGLA IH K+ HGNIKS+NVLLD+ G A ++DFGLS+ P + R
Sbjct: 460 ISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRNGVALIADFGLSLLLNPVHAIAR 519
Query: 523 SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXX------ 576
GYRAPE S+ ++ SQK+DVYSFGVLLLE+LTGK PS+
Sbjct: 520 LGGYRAPE--QSEIKRLSQKADVYSFGVLLLEVLTGKAPSIFPSPSRPRSAASVAVEEEE 577
Query: 577 ---VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSH 633
VDLP+WV+SVV+EEWTAEVFD EL+RYK+IEEEMV +L + +AC P++RP M+
Sbjct: 578 EAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAMLHIGLACVVPQPEKRPTMAE 637
Query: 634 VVKLIEELRGVEVSPCHENFDSVSDSPCLSEDTLGG 669
VVK++EE+R VE SP E+FD +S S T G
Sbjct: 638 VVKMVEEIR-VEQSPVGEDFDESRNSMSPSLATTDG 672
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
Identities = 294/674 (43%), Positives = 390/674 (57%)
Query: 9 FTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVS 68
F++L+L + + ++ + ALL F N+L WN + C+W GV C N+ S
Sbjct: 12 FSILLLTQR---VNSESTAEKQALLTFLQQIPHENRLQ-WNESDSACNWVGVECNSNQSS 67
Query: 69 -H-LVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSHNNF 123
H L L L G + L LT+LRVLSL+ NR +G +PS SNLT L+ L+L HN F
Sbjct: 68 IHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEF 127
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPXXXXXXXXXXXXXXEANRFSGPITGLDLRNL 183
+GEFP S + L L RLD+S NNF+G IP N FSG + + L L
Sbjct: 128 SGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GL 186
Query: 184 QDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPL 243
DFNVS N+L+G IP SLS F +FT N LCG P++ CK+ P P S I
Sbjct: 187 VDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPS-P-SPSLI---- 240
Query: 244 NPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTXXXXXXXXXXXXXXXGDFLVLAIISLL 303
NP+N +SS S + +K A + L +++LL
Sbjct: 241 ----NPSNRLSSKKSKL-------SKAA-------------IVAIIVASALVALLLLALL 276
Query: 304 LYCYFWRNYVKNKTRSKLLESEKILYSSSPYP-----------AQQAGY----ERGSMVF 348
L+ + N+ R+K + + + P +G ER +VF
Sbjct: 277 LFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVF 336
Query: 349 FEG-TKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHM 407
EG F+LEDLLRASAE+LGKG GT+YKAVL++G+ V VKRLKD + K+EFE M
Sbjct: 337 TEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDV-MASKKEFETQM 395
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA 467
EV+G+++HPN++ L+AYY++++EKLLV ++MP GSL LLHG+RG GRTPLDW R++IA
Sbjct: 396 EVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIA 455
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGY 526
AARGLA +H S KL HGNIK++N+LL + VSD+GL+ +F+ S R GY
Sbjct: 456 ITAARGLAHLHV---SAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGY 512
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVDLPRWVQSV 586
APE+ + RK + KSDVYSFGVLLLELLTGK P+ +DLPRWV SV
Sbjct: 513 HAPEVLET--RKVTFKSDVYSFGVLLLELLTGKSPN------QASLGEEGIDLPRWVLSV 564
Query: 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646
VREEWTAEVFD+ELMRY +IEEEMV LLQ+AMAC S PDQRP M V+++IE++ E
Sbjct: 565 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSET 624
Query: 647 SPCHENFDSVSDSP 660
+ + SD P
Sbjct: 625 TD--DGLRQSSDDP 636
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 9.8e-116, Sum P(2) = 9.8e-116
Identities = 170/301 (56%), Positives = 218/301 (72%)
Query: 346 MVFF-EGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFE 404
+VFF TK F+LEDLLRASAE+LGKG FGTAYKAVLD +VVAVKRLKD + K EF+
Sbjct: 354 LVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADK-EFK 412
Query: 405 QHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
+ +E++G + H NLV L+AYYF+R+EKLLV ++MP GSL LLHGNRG GR+PL+W R
Sbjct: 413 EKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRS 472
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVP-R 522
+IA GAARGL ++H + +HGNIKS+N+LL K+ +A+VSDFGL+ + +T P R
Sbjct: 473 RIAIGAARGLDYLH--SQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNR 530
Query: 523 SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVDLPRW 582
+ GYRAPE++ D ++ SQK DVYSFGV+LLEL+TGK PS VDLPRW
Sbjct: 531 ATGYRAPEVT--DPKRVSQKGDVYSFGVVLLELITGKAPS------NSVMNEEGVDLPRW 582
Query: 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVG-LLQVAMACTSASPDQRPNMSHVVKLIEEL 641
V+SV R+EW EVFD EL+ EEEM+ ++Q+ + CTS PDQRP MS VV+ +E L
Sbjct: 583 VKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642
Query: 642 R 642
R
Sbjct: 643 R 643
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 7.9e-112, Sum P(2) = 7.9e-112
Identities = 173/321 (53%), Positives = 221/321 (68%)
Query: 329 YSSSPYPAQQAGYE-RGSMVFF-EGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSV 386
YS S A + +VFF TK F+LEDLLRASAE+LGKG FGTAYKAVLD ++
Sbjct: 330 YSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTL 389
Query: 387 VAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWL 446
VAVKRLKD ++ REF++ +EV+G + H NLV L+AYY++ +EKLLV ++MP GSL L
Sbjct: 390 VAVKRLKDVTMAD-REFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSAL 448
Query: 447 LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506
LHGN+G GR PL+W R IA GAARGL ++H + L +HGN+KS+N+LL + +ARV
Sbjct: 449 LHGNKGAGRPPLNWEVRSGIALGAARGLDYLH-SQDPLS-SHGNVKSSNILLTNSHDARV 506
Query: 507 SDFGLS-IFAPPSTVP-RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564
SDFGL+ + + ST P R+ GYRAPE++ D R+ SQK+DVYSFGV+LLELLTGK PS
Sbjct: 507 SDFGLAQLVSASSTTPNRATGYRAPEVT--DPRRVSQKADVYSFGVVLLELLTGKAPS-- 562
Query: 565 DXXXXXXXXXXXVDLPRWVQSVVREEWTAEVFDLELMRYK---DIEEEMVGLLQVAMACT 621
+DL RWV SV REEW EVFD ELM + +EEEM +LQ+ + CT
Sbjct: 563 ----NSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCT 618
Query: 622 SASPDQRPNMSHVVKLIEELR 642
PD+RP M VV+ I+ELR
Sbjct: 619 EQHPDKRPVMVEVVRRIQELR 639
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.7e-111, Sum P(2) = 2.7e-111
Identities = 155/309 (50%), Positives = 222/309 (71%)
Query: 342 ERGSMVFFEGTKR-FELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK 400
E+ + FFE F+LEDLL+ASAE+LGKG FGTAYKAVL+D + V VKRL++ + K
Sbjct: 326 EKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREV-VASK 384
Query: 401 REFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLD 459
+EFEQ ME++G++ +H N V L AYY++++EKLLV +YM GSLF ++HGNRG +D
Sbjct: 385 KEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGD--RGVD 442
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-SIFAPPS 518
W TR+KIA G ++ ++++H SLK HG+IKS+N+LL + +SD L ++F P+
Sbjct: 443 WETRMKIATGTSKAISYLH----SLKFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPT 498
Query: 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVD 578
PR+ GY APE+ + R+ SQ+SDVYSFGV++LE+LTGK P +D
Sbjct: 499 HTPRTIGYNAPEVIET--RRVSQRSDVYSFGVVILEMLTGKTPLT---QPGLEDERVVID 553
Query: 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
LPRWV+SVVREEWTAEVFD+EL+++++IEEEMV +LQ+A+AC + +P+ RP M V ++I
Sbjct: 554 LPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMI 613
Query: 639 EELRGVEVS 647
E++R ++ S
Sbjct: 614 EDVRRLDQS 622
|
|
| TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 1.3e-107, Sum P(2) = 1.3e-107
Identities = 154/303 (50%), Positives = 207/303 (68%)
Query: 348 FFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHM 407
F + F+L+ LL+ASAE+LGKG FG++YKA D G VVAVKRL+D + K EF + +
Sbjct: 329 FVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDVVVPEK-EFREKL 387
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA 467
+VLG + H NLV L AYYF+R+EKL+V EYM GSL LLHGN+G GR+PL+W TR IA
Sbjct: 388 QVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIA 447
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGY 526
GAAR ++++H + +HGNIKS+N+LL ++ A+VSD+ L+ + +P ST R +GY
Sbjct: 448 LGAARAISYLH--SRDATTSHGNIKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDGY 505
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVDLPRWVQSV 586
RAPE++ D RK SQK+DVYSFGVL+LELLTGK P+ VDLPRWV S+
Sbjct: 506 RAPEVT--DARKISQKADVYSFGVLILELLTGKSPT------HQQLHEEGVDLPRWVSSI 557
Query: 587 VREEWTAEVFDLELMRYK-DIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645
++ ++VFD EL RY+ D E M+ LL + ++CT+ PD RP M V +LIEE+
Sbjct: 558 TEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEVSRSP 617
Query: 646 VSP 648
SP
Sbjct: 618 ASP 620
|
|
| TAIR|locus:2036499 AT1G60630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.1e-103, Sum P(2) = 1.1e-103
Identities = 147/324 (45%), Positives = 205/324 (63%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL 413
R+ ++DLL+ASAE LG+G G+ YKAV++ G ++ VKRLKDA EF++H+E+LGRL
Sbjct: 342 RYTMDDLLKASAETLGRGTLGSTYKAVMESGFIITVKRLKDAGFPRMDEFKRHIEILGRL 401
Query: 414 RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR--GPGRTPLDWTTRLKIAAGAA 471
+HPNLV L+AY+ A+EE LLV +Y PNGSLF L+HG++ G G+ PL WT+ LKIA A
Sbjct: 402 KHPNLVPLRAYFQAKEECLLVYDYFPNGSLFSLIHGSKVSGSGK-PLHWTSCLKIAEDLA 460
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----YR 527
GL +IH ++ LTHGN+KS+NVLL + ++D+GLS P ++ ++ Y+
Sbjct: 461 MGLVYIH---QNPGLTHGNLKSSNVLLGPDFESCLTDYGLSDLHDPYSIEDTSAASLFYK 517
Query: 528 APELSSSDGRKQS-QKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVDLPRWVQSV 586
APE D RK S Q +DVYSFGVLLLELLTG+ S D D+ WV++V
Sbjct: 518 APECR--DLRKASTQPADVYSFGVLLLELLTGRT-SFKDLVHKYGS-----DISTWVRAV 569
Query: 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646
REE T EV + EL EE++ LL +A AC + P+ RP M V+K++++ R E
Sbjct: 570 -REEET-EVSE-EL---NASEEKLQALLTIATACVAVKPENRPAMREVLKMVKDARA-EA 622
Query: 647 SPCHENFDSVSDSPCLSEDTLGGL 670
+ +F+S SP DT+ L
Sbjct: 623 ALF--SFNSSDHSPGRWSDTIQSL 644
|
|
| TAIR|locus:2196464 AT1G10850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 4.1e-102, Sum P(2) = 4.1e-102
Identities = 145/327 (44%), Positives = 197/327 (60%)
Query: 350 EGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEV 409
E R+ +EDLL+ASAE LG+G G+ YKAV++ G +V VKRLK+A EF++H+E+
Sbjct: 345 ETVVRYTMEDLLKASAETLGRGTLGSTYKAVMESGFIVTVKRLKNARYPRMEEFKRHVEI 404
Query: 410 LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGR-TPLDWTTRLKIAA 468
LG+L+HPNLV L+AY+ A+EE+LLV +Y PNGSLF L+HG R G PL WT+ LKIA
Sbjct: 405 LGQLKHPNLVPLRAYFQAKEERLLVYDYFPNGSLFTLIHGTRASGSGKPLHWTSCLKIAE 464
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG--- 525
A L +IH ++ LTHGN+KS+NVLL + ++D+GLS P +V ++
Sbjct: 465 DLASALLYIH---QNPGLTHGNLKSSNVLLGPDFESCLTDYGLSTLHDPDSVEETSAVSL 521
Query: 526 -YRAPELSSSDGRKQS-QKSDVYSFGVLLLELLTGKCPSVIDXXXXXXXXXXXVDLPRWV 583
Y+APE D RK S Q +DVYSFGVLLLELLTG+ P D D+ RWV
Sbjct: 522 FYKAPECR--DPRKASTQPADVYSFGVLLLELLTGRTPFQ-DLVQEYGS-----DISRWV 573
Query: 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643
++V REE T + + EE++ LL +A C + PD RP M V+K++ + R
Sbjct: 574 RAV-REEETESGEEPTSSGNEASEEKLQALLSIATVCVTIQPDNRPVMREVLKMVRDARA 632
Query: 644 VEVSPCHENFDSVSDSPCLSEDTLGGL 670
+P N S SP DT+ L
Sbjct: 633 E--APFSSN--SSEHSPGRWSDTVQSL 655
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 226/564 (40%), Positives = 319/564 (56%)
Query: 88 TQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145
T + L L GP+P +L L +L++L L N +G P + SL L + L N
Sbjct: 87 TSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHN 146
Query: 146 NFSGQIPXXXXXXXXXXXXXXEANRFSG--PITGLDLRNLQDFNVSGNHLSGQIPKSLSG 203
NFSG++P N F+G P T +L+ L ++ N LSG +P +
Sbjct: 147 NFSGEVPSFVSRQLNILDLSF--NSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTV 204
Query: 204 FPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSSIPTN 263
N L GS A + G+ PL P SS P S+ +
Sbjct: 205 SLRRLNLSNNHLNGSIPSALGGFPSSSFS-GNTLLCGLPLQPC-----ATSSPPPSLTPH 258
Query: 264 TDPNNKPASPQKTXXXXXXXXXXXX-XXXGDFLVLAIISLLLYCYFWRNYVKNKTRSKLL 322
P P K G +L +I++++ C + K+K ++
Sbjct: 259 ISTPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKK--KDKREDSIV 316
Query: 323 ESEKILYSSSP-YPAQQAGYERGSMVFFEGTK-RFELEDLLRASAEMLGKGGFGTAYKAV 380
+ + + + + + E+ +VFF G F+LEDLLRASAE+LGKG +GTAYKAV
Sbjct: 317 KVKTLTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 376
Query: 381 LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439
L++ + V VKRLK+ + GKREFEQ ME++ R+ HP++V L+AYY++++EKL+V +Y P
Sbjct: 377 LEESTTVVVKRLKEVA-AGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYP 435
Query: 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD 499
G+L LLHGNRG +TPLDW +R+KI AA+G+A +H K +HGNIKS+NV++
Sbjct: 436 AGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLH-AAGGPKFSHGNIKSSNVIMK 494
Query: 500 KTGNARVSDFGLS-IFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+ +A +SDFGL+ + A P R GYRAPE+ + RK + KSDVYSFGVL+LE+LTG
Sbjct: 495 QESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMET--RKHTHKSDVYSFGVLILEMLTG 552
Query: 559 KCPSVIDXXXXXXXXXXXVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAM 618
K P VDLPRWVQSVVREEWT+EVFD+ELMR+++IEEEMV +LQ+AM
Sbjct: 553 KSP------VQSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAM 606
Query: 619 ACTSASPDQRPNMSHVVKLIEELR 642
AC + P+ RP M VV++IEE+R
Sbjct: 607 ACVAQVPEVRPTMDDVVRMIEEIR 630
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M9C5 | Y1680_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6793 | 0.9270 | 0.9298 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00030379001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (659 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 672 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 69/196 (35%), Positives = 94/196 (47%), Gaps = 17/196 (8%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
LG+GGFGT Y A G VA+K + K+ S E + +E+L +L HPN+V L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
LV EY GSL LL N G L L+I GL ++H S
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLH----SNG 112
Query: 486 LTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSSDGRKQ 539
+ H ++K N+LLD G +++DFGLS Y APE+ G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG-YY 171
Query: 540 SQKSDVYSFGVLLLEL 555
S+KSD++S GV+L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-40
Identities = 154/591 (26%), Positives = 249/591 (42%), Gaps = 89/591 (15%)
Query: 67 VSHLVLENLQLSGSLQPLT-SLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
V L + N L G + + L++LSL N+F G +P L+ L LS N F+G
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSG 489
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNL 183
P + SL L +L LS N SG+IP ++ L++L L N+ SG P + ++ L
Sbjct: 490 AVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVL 549
Query: 184 QDFNVSGNHLSGQIPKSLSGFPDSAFTQNAA---LCGS-PMQACKTMVTDPKKPGSDGAI 239
++S N LSG+IPK+L G +S N + L GS P + G+
Sbjct: 550 SQLDLSQNQLSGEIPKNL-GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608
Query: 240 ASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAI 299
G P V TPS I +G FLVLA+
Sbjct: 609 GGDTTSGLPPCKRVRKTPSWW------------------------FYITCTLGAFLVLAL 644
Query: 300 ISLLLYCYFWRNYVKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEG--TKRFEL 357
++ F R +N K +E+E + + FF+ +K +
Sbjct: 645 VAFGFV--FIRG--RNNLELKRVENEDGTWE---------------LQFFDSKVSKSITI 685
Query: 358 EDLLRASAE--MLGKGGFGTAYKAVLDDGSV-VAVKRLKDASIGGKREFEQHMEVLGRLR 414
D+L + E ++ +G G +YK + VK + D + E +G+L+
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQ 741
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
HPN+V L + + L+ EY+ +L +L L W R KIA G A+ L
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKAL 793
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSS 534
F+H C S + GN+ +++D + + + S+ Y APE +
Sbjct: 794 RFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPE--TR 850
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG------MGCGGAVDLPRWVQSVVR 588
+ + ++KSD+Y FG++L+ELLTGK P+ + G G C L W+ +R
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910
Query: 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
+ + + E+V ++ +A+ CT+ P RP + V+K +E
Sbjct: 911 GDVSVN------------QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 76/202 (37%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME--VLGRLRHPNLVGLKAY 424
LG G FGT YKA G +VAVK LK S K++ E +L RL HPN+V L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ ++ LV EY G LF L PL KIA RGL ++H S
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLH----SN 117
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN----GYRAPELSSSDGRKQ 539
+ H ++K N+LLD+ G +++DFGL+ S+ + Y APE+ G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG-GNGY 176
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
K DV+S GV+L ELLTGK P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 6e-40
Identities = 85/295 (28%), Positives = 123/295 (41%), Gaps = 54/295 (18%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+ LG+G FG YK L VAVK LK DAS +++F + V+ +L HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG----PGRTPLDWTTRLKIAAGAARGLAF 476
L E LV EYM G L L +R P ++ L L A A+G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-------AP 529
+ S K H ++ + N L+ + ++SDFGLS R AP
Sbjct: 121 LA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588
E S + KSDV+SFGVLL E+ T G P G+ ++ +++ R
Sbjct: 177 E--SLKDGIFTSKSDVWSFGVLLWEIFTLGATPY------PGL---SNEEVLEYLRKGYR 225
Query: 589 ----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
E E++ ELM C P+ RP S +V+ +E
Sbjct: 226 LPKPEYCPDELY--ELMLS----------------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 82/286 (28%), Positives = 124/286 (43%), Gaps = 45/286 (15%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV-----VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
+ LG+G FG YK L VAVK LK DAS EF + ++ +L HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E ++V EYMP G LL R L + L A ARG+ ++
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGD---LLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----YR--APELSS 533
S H ++ + N L+ + ++SDFGLS + G R APE S
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE--S 175
Query: 534 SDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592
K + KSDV+SFGVLL E+ T G+ P GM ++ +++
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPY------PGM---SNAEVLEYLKK------- 219
Query: 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
L + + E+ ++ + C + P+ RP S +V+++
Sbjct: 220 ----GYRLPKPPNCPPELY---KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 81/287 (28%), Positives = 122/287 (42%), Gaps = 48/287 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV-----VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
+ LG+G FG YK L VAVK LK DAS EF + ++ +L HPN+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E +V EYM G L L NR L + L A ARG+ ++
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLE- 119
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----YR--APELSS 533
S H ++ + N L+ + ++SDFGLS R G R APE S
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE--S 174
Query: 534 SDGRKQSQKSDVYSFGVLLLELLT-GKCP-SVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591
K + KSDV+SFGVLL E+ T G+ P + ++ ++++
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------NEEVLEYLKN------ 218
Query: 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
L + + E+ + + C + P+ RP S +V+++
Sbjct: 219 -----GYRLPQPPNCPPELY---DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE-FEQHMEVLGRLRHPNLVGLKA 423
E LG+G FG Y A G +VA+K +K I RE + +++L +L+HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+ ++ LV EY G LF LL GR D L ++H S
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEA--RFYLRQILSALEYLH----S 115
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDGRKQ 539
+ H ++K N+LLD+ G+ +++DFGL+ P + Y APE+ G+
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL--GKGY 173
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
+ D++S GV+L ELLTGK P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 83/291 (28%), Positives = 125/291 (42%), Gaps = 55/291 (18%)
Query: 366 EMLGKGGFGTAYKAVLDDGS-----VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLV 419
+ LG+G FG YK L VAVK LK+ AS + EF + ++ +L HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E +V+EYMP G L L + L L++A A+G+ ++
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE- 119
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR-----APELS 532
S H ++ + N L+ + ++SDFGLS I+ R G APE
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE-- 174
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR--- 588
S K + KSDV+SFGVLL E+ T G+ P GM ++ ++ R
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY------PGM---SNEEVLELLEDGYRLPR 225
Query: 589 -EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
E E+++ LM C + P+ RP S +V+ +
Sbjct: 226 PENCPDELYE--LMLQ----------------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 33/213 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLK 422
E+LG+G FG+ Y A+ D G ++AVK ++ + + E+ + +L L+HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63
Query: 423 AYYFAREEK-----LLVSEYMPNGSLFWLLHGNRGPGRTPL--DWTTRLKIAAGAARGLA 475
YY + ++ + EY+ GSL LL G P+ +T ++ GLA
Sbjct: 64 -YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQI------LEGLA 115
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-------YRA 528
++H S + H +IK N+L+D G +++DFG + G + A
Sbjct: 116 YLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ + + +D++S G ++E+ TGK P
Sbjct: 172 PEVIRGEE--YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 366 EMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG-LKA 423
E +GKGGFG YKA G VA+K +K S K + +++L + +HPN+V +
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
Y E +V E+ GSL LL L + + +GL ++H S
Sbjct: 66 YLKKDELW-IVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLH----S 116
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSSDGRK 538
+ H +IK+ N+LL G ++ DFGLS T R+ + APE+ + G+
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPEVIN--GKP 173
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
K+D++S G+ +EL GK P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+ +GKG FG Y DG + +K L + S + + +++L +L HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII--- 62
Query: 423 AYY--FAREEKLL-VSEYMPNGSLFWLLHGNRGPGRTP------LDWTTRLKIAAGAARG 473
YY F + KL V EY G L + + P LDW +L +A
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLA------ 115
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-------IFAPPSTVPRSNGY 526
L ++H S K+ H +IK N+ L G ++ DFG+S A TV + Y
Sbjct: 116 LKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYY 169
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+PEL + + KSD++S G +L EL T K P
Sbjct: 170 LSPELCQ--NKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 73/204 (35%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 368 LGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQ-HME--VLGRLRHPNLVGLKA 423
LGKG FG D G + A+K LK I ++E E E +L R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 424 YYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
Y F EEKL LV EY P G LF L GR + AA L ++H
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEERARF--YAAEIVLALEYLH---- 110
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPSTVPRSNGYRAPELSSSDGR 537
SL + + ++K N+LLD G+ +++DFGL+ + +T + Y APE+ G+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL--GK 168
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
+ D +S GVLL E+LTGK P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG G FG + + + VAVK LK ++ F Q +++ +LRH LV L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLT 487
E +V+EYM GSL L G G+ L + +AA A G+A++ +S
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYL----ESRNYI 125
Query: 488 HGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPELSSSDGRKQSQ 541
H ++ + N+L+ + +++DFGL+ + R + APE ++ + +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY--GRFTI 183
Query: 542 KSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL E++T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+G G FG Y AV LD G ++AVK R++D +E M+VL L+HPNLV Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 425 YFA---REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y RE+ + EY G+L LL R LD GLA++H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLH--- 116
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG--------YRAPELS 532
S + H +IK N+ LD G ++ DFG + +T Y APE+
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 533 SSDGRKQSQKS-DVYSFGVLLLELLTGKCP 561
+ K ++ D++S G ++LE+ TGK P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-24
Identities = 69/200 (34%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 9 FTLLILAVHFSLLKASTSPDLNALLDFKAS-SDEANKLTTWNSTSDPCSWTGVSCLQ-NR 66
F L L ++FS+L A +L LL FK+S +D L+ WNS++D C W G++C +R
Sbjct: 14 FMLFFLFLNFSMLHAE---ELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSR 70
Query: 67 VSHLVLENLQLSGSLQPLT-SLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNNF 123
V + L +SG + L ++ ++L N+ +GP+P + ++L+ L LS+NNF
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLR 181
G P S+ L LDLS N SG+IP + + L L L N G P + +L
Sbjct: 131 TGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 182 NLQDFNVSGNHLSGQIPKSL 201
+L+ ++ N L GQIP+ L
Sbjct: 189 SLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 367 MLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIGG-KREFEQHMEVLGRLRHPNLVG 420
LG+G FG D G VAVK L + + +FE+ +E+L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 421 LK--AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
K L+ EY+P+GSL L +R ++ L ++ +G+ ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG 126
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST---VPRSNG-----YRAPE 530
S + H ++ + N+L++ ++SDFGL+ P + G + APE
Sbjct: 127 ----SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLT 557
+ K S SDV+SFGV L EL T
Sbjct: 183 CLRTS--KFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKR-EFEQHMEVLGRLRHPNLVGLKAYY 425
LG+G G YK G + A+K++ R + + ++ L P +V +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ E +V EYM GSL LL L IA +GL ++H
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH---TKRH 120
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN--G---YRAPELSSSDGRKQS 540
+ H +IK +N+L++ G +++DFG+S + + G Y +PE G S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE--RIQGESYS 178
Query: 541 QKSDVYSFGVLLLELLTGKCP 561
+D++S G+ LLE GK P
Sbjct: 179 YAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (253), Expect = 3e-23
Identities = 68/213 (31%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHP-NLVGL 421
LG+G FG Y A D +VA+K L +E F + +++L L HP N+V L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
++ LV EY+ GSL LL G L I A L ++H
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA--LFILAQILSALEYLH--- 118
Query: 482 KSLKLTHGNIKSTNVLLDKTGN-ARVSDFGLSIFAPPSTVPR-----------SNGYRAP 529
S + H +IK N+LLD+ G ++ DFGL+ P + GY AP
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 530 E-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
E L S SD++S G+ L ELLTG P
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLK 422
+++G+G FG YK + L+ G VA+K++ I + + Q +++L L+HPN+V K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV--K 63
Query: 423 AYYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + EY NGSL ++ P + +GLA++H
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH-- 116
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA-----PPSTVPRSNGYRAPELSSSD 535
+ H +IK+ N+L K G +++DFG++ ++V + + APE+
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G S SD++S G ++ELLTG P
Sbjct: 175 GA--STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+GKG FG G VAVK LKD S + F V+ LRHPNLV L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+V+EYM GSL L R GR + +L A G+ ++ +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYL----EEKN 122
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSSSDGRKQS 540
H ++ + NVL+ + A+VSDFGL A ++ + +G + APE + +K S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGL---AKEASQGQDSGKLPVKWTAPE--ALREKKFS 177
Query: 541 QKSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL E+ + G+ P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG G FG ++ + ++ + VAVK LK ++ K +F +++ +LRHP L+ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLT 487
E +V+E M GSL L G G L + +AA A G+A++ ++
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYL----EAQNYI 125
Query: 488 HGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPELSSSDGRKQSQ 541
H ++ + NVL+ + +V+DFGL+ + R + APE + + + S
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN--RFSI 183
Query: 542 KSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL E++T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGR 412
+ F LE LG G FG ++ + + VA+K LK + +++F++ ++ L R
Sbjct: 6 EEFTLE-------RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKR 58
Query: 413 LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
LRH +L+ L A E +++E M GSL L R P L + + +A A
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAE 115
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL------SIFAPPST-VPRSNG 525
G+A++ + H ++ + N+L+ + +V+DFGL ++ +P
Sbjct: 116 GMAYL----EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-- 169
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ APE +S S KSDV+SFG+LL E+ T G+ P
Sbjct: 170 WTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+GKG FG +K V D V A+K+ L + + E VL +L ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII--- 62
Query: 423 AYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
YY F + KL +V EY NG L LL RG P D R I GLA +H
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQI--LLGLAHLH- 118
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-------SIFAPPSTVPRSNGYRAPELS 532
S K+ H +IKS N+ LD N ++ D G+ + FA +T+ + Y +PEL
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELC 173
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA 569
+ ++KSDV++ GV+L E TGK P + GA
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E +GKG FG YK VL + VAVK + KR+F Q E+L + HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
++ +V E +P GSL L + L+++ AA G+ ++ +S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV----KKLLQMSLDAAAGMEYL----ESK 112
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-------APELSSSDGR 537
H ++ + N L+ + ++SDFG+S S+G + APE + + GR
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGR 171
Query: 538 KQSQKSDVYSFGVLLLELLT-GKCP 561
S+ SDV+S+G+LL E + G P
Sbjct: 172 YTSE-SDVWSYGILLWETFSLGDTP 195
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 47/119 (39%), Positives = 71/119 (59%), Gaps = 3/119 (2%)
Query: 84 LTSLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142
LT+LT L L+L N+ G +P L + +LK ++L +NN +GE P + L L LDL
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPK 199
+NN +G IP ++ +L +L L L N+ SGPI + L+ L ++S N LSG+IP+
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLKDASIGGKR-EFEQHMEVLGRLRHPNLVG 420
+++G G FG + L VA+K LK S +R +F ++G+ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+ ++++EYM NGSL L N G + + G A G+ ++
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEM 125
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNG-----YRAPELSS 533
H ++ + N+L++ +VSDFGLS + +T G + APE +
Sbjct: 126 N----YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 534 SDGRKQSQKSDVYSFGVLLLELLT 557
RK + SDV+SFG+++ E+++
Sbjct: 182 Y--RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK-----REFEQHMEVLGRLRHPNLV 419
E+LG G FG+ Y+ + LDDG AVK + A G ++ EQ + +L +L+HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 420 GLKAYYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPL--DWTTRLKIAAGAARGLA 475
+ REE L E +P GSL LL G P+ +T ++ GL
Sbjct: 66 --QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQI------LLGLE 116
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS----IFAPPSTVPRSNGYRAPEL 531
++H H +IK N+L+D G +++DFG++ F+ + S + APE+
Sbjct: 117 YLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ G +D++S G +LE+ TGK P
Sbjct: 173 IAQQGGYGLA-ADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 366 EMLGKGGFGTA----YKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG 420
+ LGKG FG+ Y + D+ G VVAVK+L+ ++ R+FE+ +E+L L+H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 421 LKA--YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
K Y R LV EY+P GSL L + R LD L A+ +G+ ++
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYL- 124
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST---VPRSNG-----YRAPE 530
S + H ++ + N+L++ ++ DFGL+ P R G + APE
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 531 -LSSSDGRKQSQKSDVYSFGVLLLELLT 557
L+ S K S SDV+SFGV+L EL T
Sbjct: 182 SLTES---KFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 367 MLGKGGFGTAYKAVL--DDGSV---VAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVG 420
+LG G FGT YK V + V VA+K L++ + +E V+ + HP++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP--GRTPLDWTTRLKIAAGAARGLAFIH 478
L + + L+++ MP G L + ++ + L+W ++ A+G++++
Sbjct: 74 LLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL- 125
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGYRAP----ELSS 533
+ +L H ++ + NVL+ + +++DFGL+ + + G + P L S
Sbjct: 126 ---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 534 SDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
R + KSDV+S+GV + EL+T G P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 43/215 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE--FEQHMEVLGRLRHPNLVGLK 422
E +G+G G YKA G VA+K+++ + + + + ++ +HPN+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK---IAAGAA---RGLAF 476
Y +E +V EYM GSL ++ N R+ IA +GL +
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNF----------VRMNEPQIAYVCREVLQGLEY 131
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR--------- 527
+H S + H +IKS N+LL K G+ +++DFG FA T +S R
Sbjct: 132 LH----SQNVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSK--RNSVVGTPYW 182
Query: 528 -APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
APE+ + K D++S G++ +E+ G+ P
Sbjct: 183 MAPEVIK--RKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
+G G FG + + VA+K +++ ++ + +F + +V+ +L HP LV L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLT 487
R LV E+M +G L L RG T L + G+A++ + +
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN----VI 122
Query: 488 HGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQSQ 541
H ++ + N L+ + +VSDFG++ F S G + +PE+ S K S
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS--KYSS 180
Query: 542 KSDVYSFGVLLLELLT-GKCP 561
KSDV+SFGVL+ E+ + GK P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 57/129 (44%), Positives = 72/129 (55%), Gaps = 4/129 (3%)
Query: 77 LSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSL 134
LSG + + LT L L L YN TGP+P SL NL L+ LFL N +G P S+ SL
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 135 FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITG--LDLRNLQDFNVSGNH 192
+L LDLS N+ SG+IP V L +L L L +N F+G I L LQ + N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 193 LSGQIPKSL 201
SG+IPK+L
Sbjct: 344 FSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 76/292 (26%), Positives = 117/292 (40%), Gaps = 65/292 (22%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK----------RLKDASIGGKREFEQHMEVLGRLR 414
E++GKG +G Y A+ + G ++AVK R + +E L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 415 HPNLVGLKAYYFAREEKL----LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 470
H N+V Y E + EY+P GS+ L R GR
Sbjct: 67 HLNIVQ----YLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFF--TEQV 117
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPSTVPR--S 523
GLA++H S + H ++K+ N+L+D G ++SDFG+S I+ + S
Sbjct: 118 LEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 524 NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583
+ APE+ S + S K D++S G ++LE+ G+ P W
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------------W- 212
Query: 584 QSVVREEWTAEVFDL-ELMRYKDIEEEMVGLL-QVAM----ACTSASPDQRP 629
EE A +F L I ++ L VA+ AC + +PD RP
Sbjct: 213 ---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 20/202 (9%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG+G FG + + + VA+K LK ++ F Q +V+ +LRH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 428 REEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKL 486
EE + +V+EYM GSL L G G L + +AA A G+A++ + +
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYV----ERMNY 123
Query: 487 THGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQS 540
H ++++ N+L+ + +V+DFGL+ + G + APE ++ GR +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRF-T 181
Query: 541 QKSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL EL T G+ P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ LG G FG + + + VA+K LK S+ F ++ +L+HP LV L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV- 69
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+E +++EYM NGSL L G L + +AA A G+AFI +
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFI----ERKN 122
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQ 539
H ++++ N+L+ +T +++DFGL+ + G + APE + +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE--AINYGTF 180
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
+ KSDV+SFG+LL E++T G+ P
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 54/284 (19%)
Query: 368 LGKGGFGTA--YKAVLDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
LGKG FG A Y+ +D S+V K L S +R+ + +L L+HPN++ A
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII---A 63
Query: 424 YY--FAREEKLLVS-EYMPNGSLFWLL---HGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
YY F + LL+ EY G+L+ + G L + ++ A +++I
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA------VSYI 117
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-----FAPPSTVPRSNGYRAPELS 532
H + H +IK+ N+ L K G ++ DFG+S ++ TV + Y +PEL
Sbjct: 118 H----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592
G K + KSD+++ G +L ELLT K D A + V +V+ +T
Sbjct: 174 Q--GVKYNFKSDIWALGCVLYELLTLK--RTFD----------ATNPLNLVVKIVQGNYT 219
Query: 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
V Y L+ + + P++RP V+
Sbjct: 220 PVV-----SVYSS------ELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 51/218 (23%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRL-----KDA-SIGGKREFEQHMEVLGRLRHPNLVG 420
+G+G +G YKA G +VA+K++ K+ I RE +++L +LRHPN+V
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNIVR 62
Query: 421 LKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR------ 472
LK ++ + +V EYM + L LL + +K +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLD------------SPEVKFTESQIKCYMKQL 109
Query: 473 --GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG---- 525
GL ++H S + H +IK +N+L++ G +++DFGL+ + ++ +N
Sbjct: 110 LEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL 165
Query: 526 -YRAPEL---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YR PEL ++ G + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGP----EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 366 EMLGKGGFGTAYKA-VLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E+LG G GT YKA L ++AVK + D ++ +++ +E+L + P ++G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 424 YYFAREEKLLVSEYMPNGSL--FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+F + +E+M GSL + + P R IA +GL ++
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYR---------KIPEHVLGR--IAVAVVKGLTYLW--- 112
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRSNGYRAPELSSSDGRK 538
SLK+ H ++K +N+L++ G ++ DFG+S + + T +N Y APE S G +
Sbjct: 113 -SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERIS--GEQ 169
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
SDV+S G+ +EL G+ P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 368 LGKGGFGTAYKAV--LDDGSV--VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLK 422
LG G FG+ K V + G VAVK LK + GK+EF + V+ +L HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
E +LV E P G L L R P + ++ A G+A++
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL---- 111
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------------AP 529
+S H ++ + NVLL A++SDFG+S + S+ YR AP
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMS----RALGAGSDYYRATTAGRWPLKWYAP 167
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT 557
E + K S KSDV+S+GV L E +
Sbjct: 168 E--CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG G FG + + + VAVK LK ++ F + +++ +LRH LV L A +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLT 487
E +V+EYM GSL L G GR L + +AA A G+A+I + +
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYI----ERMNYI 124
Query: 488 HGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQSQ 541
H +++S N+L+ +++DFGL+ + G + APE + + +
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTI 182
Query: 542 KSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL EL+T G+ P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E+LGKG FG +K L D + VAVK K D K +F +L + HPN+V L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
R+ +V E +P G L + +T +K A AA G+A++ +S
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYL----ESK 112
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLS------IFAPPSTVPRSNGYRAPELSSSDGRK 538
H ++ + N L+ + ++SDFG+S I++ + APE + + GR
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYGRY 171
Query: 539 QSQKSDVYSFGVLLLELLT-GKCP 561
S+ SDV+S+G+LL E + G CP
Sbjct: 172 SSE-SDVWSYGILLWETFSLGVCP 194
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV--LGRLRHPNLVGLKAY 424
LGKG +G+ YK L D A+K + S+ K + E+ L + HPN++ K
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ + +V EY P G L + R R + +I RGL +H
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQ 122
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---TVPRSNGYRAPELSSSDGRKQSQ 541
K+ H ++KS N+LL ++ D G+S + T + Y APE+ GR S
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWK--GRPYSY 180
Query: 542 KSDVYSFGVLLLELLTGKCP 561
KSD++S G LL E+ T P
Sbjct: 181 KSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+ +G G +G YKA + G +VA+K +K +Q + +L RHPN+V AY
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AY 65
Query: 425 Y--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA---AGAARGLAFIH 478
+ + R +KL +V EY GSL + RGP + L+IA +GLA++H
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-------LSELQIAYVCRETLKGLAYLH 118
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGY------RAPE 530
H +IK N+LL + G+ +++DFG+S + A T+ + + APE
Sbjct: 119 ----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA---TIAKRKSFIGTPYWMAPE 171
Query: 531 LSSSDGR-KQSQKSDVYSFGVLLLELLTGKCP 561
+++ + + K D+++ G+ +EL + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 72/220 (32%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 368 LGKGGFGTAYKAVL-------DDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRH- 415
LG G +G K L D G + A+K LK A+I K + +H +VL +R
Sbjct: 8 LGTGAYG---KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 416 PNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
P LV L Y F + KL L+ +Y+ G LF L+ R + R+ IA L
Sbjct: 65 PFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFT---ESEVRVYIAEIV---L 116
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG------YR 527
A H L + + +IK N+LLD G+ ++DFGLS F R+ Y
Sbjct: 117 ALDHL--HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYM 173
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGG 567
APE+ + D +S GVL ELLTG P +DG
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK-REFEQHMEVLGRLRHPNLVGLKA 423
E LG+G +G+ YKA+ + G VVA+K + + +E + + +L + P +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFIHFT 480
YF + +V EY GS+ ++ + +T T +IAA +GL ++H
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM---KITNKT----LTEEEIAAILYQTLKGLEYLH-- 116
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPSTVPRSNGYRAPELSSSD 535
S K H +IK+ N+LL++ G A+++DFG+S A +TV + + APE+
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G + K+D++S G+ +E+ GK P
Sbjct: 175 G--YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLKA 423
+ KG +G + A G + A+K +K A + K + +Q + ++L + + P +V K
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV--KL 58
Query: 424 YY-FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
YY F ++ L LV EY+P G L LL N G LD A L ++H
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLALEYLH--- 110
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--------IFAPPSTVPRSN-----GYRA 528
S + H ++K N+L+D G+ +++DFGLS I Y A
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ G+ S+ D +S G +L E L G P
Sbjct: 170 PEVIL--GQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 368 LGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYF 426
LG G +G Y+ V VAVK LK+ ++ + EF + V+ ++HPNLV L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 427 AREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKL 486
+++E+M G+L L R R ++ L +A + + ++ +
Sbjct: 73 REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL----EKKNF 125
Query: 487 THGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQS 540
H ++ + N L+ + +V+DFGLS T G + APE S K S
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 183
Query: 541 QKSDVYSFGVLLLELLT 557
KSDV++FGVLL E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+G+G +G YKA G +VA+K++K S G + + +++L L HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ + + LV E+M + L+ L+ + L + +GLAF H S
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCH----SH 117
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPST------VPRSNGYRAPELSSSDGR 537
+ H ++K N+L++ G +++DFGL+ F P V R YRAPEL D +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRAPELLLGD-K 174
Query: 538 KQSQKSDVYSFGVLLLELLTGK 559
S D++S G + ELL+ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 59/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 360 LLRASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFE---QHMEVLGRLRH 415
LLR +GKG FG D + A+K + K +L L H
Sbjct: 4 LLRV----IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 416 PNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
P LV L Y F EE + LV + + G L + L + + L
Sbjct: 60 PFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKF-WICEIVLAL 113
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPE 530
++H S + H +IK N+LLD+ G+ ++DF ++ P T+ S GY APE
Sbjct: 114 EYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + S D +S GV E L GK P
Sbjct: 170 VLCR--QGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 53/232 (22%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM---------EVLGRL-R 414
+++G+G F T A + A+K L KR+ + EVL RL
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILD------KRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 415 HPNLVGLKAYY-FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
HP ++ L YY F EE L V EY PNG L + LD AA
Sbjct: 61 HPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILL 113
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELS 532
L ++H S + H ++K N+LLDK + +++DFG + P++ P SN A +
Sbjct: 114 ALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 533 SSDGRKQSQK-----------------------SDVYSFGVLLLELLTGKCP 561
S + + + SD+++ G ++ ++LTGK P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNL 418
LG+G FG + +D +VAVK LK+ + +++FE+ E+L +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLL--HG-------NRGPGRTPLDWTTRLKIAAG 469
V + ++V EYM +G L L HG + L + L+IA
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-- 527
A G+ ++ S H ++ + N L+ ++ DFG+S + R G+
Sbjct: 131 IASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 528 -----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
PE S RK + +SDV+SFGV+L E+ T GK P
Sbjct: 187 PIRWMPPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQ---HMEVLGRLRHPNLVGLKA 423
LG G G K + G ++AVK ++ + +Q +++L + P +VG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
++ + + EYM GSL +L GR P KIA +GL ++H +
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPER--ILGKIAVAVLKGLTYLH---EK 119
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRSNGYRAPELSSSDGRKQS 540
K+ H ++K +N+L++ G ++ DFG+S + + T ++ Y APE G S
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE--RIQGNDYS 177
Query: 541 QKSDVYSFGVLLLELLTGKCP 561
KSD++S G+ L+EL TG+ P
Sbjct: 178 VKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 361 LRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV------LGRL 413
L + +G G FG Y A + + VVA+K++ S GK+ E+ ++ L +L
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 414 RHPNLVGLKAYYFAREEKLLVSEY-MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
RHPN + + Y LV EY + + S +H + PL + GA +
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAVTHGALQ 126
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG-LSIFAPPSTVPRSNGYRAPE- 530
GLA++H S + H ++K+ N+LL + G ++ DFG SI AP + + + APE
Sbjct: 127 GLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEV 182
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + D + K DV+S G+ +EL K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG G FG VA+K +K+ S+ + EF + +V+ +L H LV L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 428 REEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKL 486
+ +V+EYM NG L +L + + L L++ G+A++ +S +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYL----ESKQF 121
Query: 487 THGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDG----RKQSQK 542
H ++ + N L+D G +VSDFGLS + S G + P S K S K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 543 SDVYSFGVLLLELLT-GKCP 561
SDV++FGVL+ E+ + GK P
Sbjct: 182 SDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 66/305 (21%)
Query: 366 EMLGKGGFGTAYKAVL--DDGSV--VAVKRLKDASIGGKREFEQHMEVLGRLR---HPNL 418
++LG+G FG+ + L DDGS VAVK +K I E E+ + ++ HPN+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 419 VGLKAYYFAREEK------LLVSEYMPNGSLFWLLHGNR---GPGRTPLDWTTRLKIAAG 469
+ L F +++ +M +G L L +R P + PL T LK
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVD 121
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAP 529
A G+ ++ + H ++ + N +L + V+DFGLS + + YR
Sbjct: 122 IALGMEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLS-----KKIYSGDYYRQG 172
Query: 530 ELS----------SSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578
++ S R + KSDV++FGV + E+ T G+ P G+
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY------PGVE------ 220
Query: 579 LPRWVQSVVREEWTAEVFDLEL--MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
E++D R K E+ + L + +C A P RP + + +
Sbjct: 221 -------------NHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267
Query: 637 LIEEL 641
++E +
Sbjct: 268 VLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 363 ASAEMLGKGGFGTA----YKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL 418
+ LG G FG ++ +D VA+K +++ ++ + +F + +V+ +L HPNL
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKID----VAIKMIREGAMS-EDDFIEEAKVMMKLSHPNL 61
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
V L + +V+EYM NG L L +G T L + + + ++
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLE 117
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSS---- 534
H ++ + N L+ + +VSDFGL+ + S G + P +
Sbjct: 118 SNG----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 535 DGRKQSQKSDVYSFGVLLLELLT-GKCP 561
D + S KSDV+SFGVL+ E+ + GK P
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 366 EMLGKGGFGTAYKA-VLDDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLK 422
++G+G +G K G +VA+K+ K++ K+ + ++VL +LRH N+V LK
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
F R+ +L LV EY+ +L LL PG P D R I + +A+ H
Sbjct: 67 E-AFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPD-AVRSYIWQ-LLQAIAYCH--- 117
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR------SNGYRAPELSSSD 535
S + H +IK N+L+ ++G ++ DFG + + YRAPEL D
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 536 GRKQSQKSDVYSFGVLLLELLTG 558
+ DV++ G ++ ELL G
Sbjct: 177 -TNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 368 LGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLKA 423
LG G FG G A+K L A I ++ E + +L +RHP LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFTCK 482
+ LV EY+P G LF L R GR P + AA L ++H
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVA---RFYAAQVVLALEYLH---- 118
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST-----VPRSNGYRAPELSSSDGR 537
SL + + ++K N+LLD G +++DFG + T P Y APE+ S G
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE---YLAPEIILSKGY 175
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
++ D ++ G+L+ E+L G P
Sbjct: 176 GKA--VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 55/159 (34%), Positives = 80/159 (50%), Gaps = 8/159 (5%)
Query: 49 NSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-S 106
N+ + + L+ L L N LSG + + S + L+VL L N G +P S
Sbjct: 128 NNFTGSIPRGSIPNLET----LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 107 LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL 166
L+NLT+L+ L L+ N G+ P + + L + L +NN SG+IP + LT L L L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 167 EANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSG 203
N +GPI +L+NLQ + N LSG IP S+
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
|
Length = 968 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (192), Expect = 1e-15
Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 38/220 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGG-----KREFEQHMEVLGRLRHPNL 418
E LG+G +G YKA G +VA+K+++ D G RE + +L L+HPN+
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNI 60
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L E KL LV EY L L G PL I RGLA+
Sbjct: 61 VKLLDVIHT-ERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYC 114
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPE- 530
H S ++ H ++K N+L+++ G +++DFGL+ F P ++ YRAPE
Sbjct: 115 H----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEI 169
Query: 531 -LSSSDGRKQSQKSDVYSFGVLLLELLTGK----CPSVID 565
L S + S D++S G + E++TGK S ID
Sbjct: 170 LLGS---KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 366 EMLGKGGFGTAYKAVLDD--GSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+ +GKG FG +L D G+ VAVK +K DA+ + F V+ +LRH NLV L
Sbjct: 12 QTIGKGEFG---DVMLGDYRGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLL 65
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ L +V+EYM GSL L R GR+ L LK + + ++
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---- 118
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYRAPELSSSDGRKQ 539
++ H ++ + NVL+ + A+VSDFGL+ + T + APE +K
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE--KKF 176
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
S KSDV+SFG+LL E+ + G+ P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG+G FG + + + VA+K LK ++ F Q +++ +LRH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 428 REEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKL 486
EE + +V+E+M GSL L G G+ L + +AA A G+A+I + +
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYI----ERMNY 123
Query: 487 THGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQS 540
H ++++ N+L+ +++DFGL+ + G + APE ++ GR +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRF-T 181
Query: 541 QKSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL EL+T G+ P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNL 418
E LG+G FG YK L + VA+K LK+ A ++EF Q E++ L+HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSL--FWLLHG-NRGPGRT--------PLDWTTRLKIA 467
V L + ++ EY+ +G L F + + + G LD + L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 468 AGAARGLAFI--HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG 525
A G+ ++ H H ++ + N L+ + ++SDFGLS + ++
Sbjct: 131 IQIAAGMEYLSSHHFV------HRDLAARNCLVGEGLTVKISDFGLS-----RDIYSADY 179
Query: 526 YRAPELSSSDGR----------KQSQKSDVYSFGVLLLEL 555
YR S R K + +SD++SFGV+L E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV------LGRLRHPNLVG 420
+G G FG Y A VVAVK++ S GK+ E+ ++ L +L+HPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 421 LKAYYFAREEKLLVSEY-MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
K Y LV EY + + S +H + PL I GA +GLA++H
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHS 139
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFG-LSIFAPPSTVPRSNGYRAPE-LSSSDGR 537
+ H +IK+ N+LL + G +++DFG S +P ++ + + APE + + D
Sbjct: 140 HN----MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
+ K DV+S G+ +EL K P
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV------LGRLRHPNLVG 420
+G G FG Y A + VVA+K++ S GK+ E+ ++ L R++HPN +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 421 LKAYYFAREEKLLVSEY-MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
K Y LV EY + + S +H + PL I GA +GLA++H
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLH- 142
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFG-LSIFAPPSTVPRSNGYRAPE-LSSSDGR 537
S + H +IK+ N+LL + G +++DFG SI +P ++ + + APE + + D
Sbjct: 143 ---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEG 199
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
+ K DV+S G+ +EL K P
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 368 LGKGGFGTAYKAVL------DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGL 421
LG+G FG + A D +VAVK LK+AS +++F++ E+L L+H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 422 KAYYFAREEKLLVSEYMPNGSL--FWLLHG--------NRGPGRTPLDWTTRLKIAAGAA 471
L+V EYM +G L F HG L L IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------ 525
G+ ++ SL H ++ + N L+ + ++ DFG+S + R G
Sbjct: 133 SGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 526 -YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ PE S RK + +SD++SFGV+L E+ T GK P
Sbjct: 189 RWMPPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG G FG + ++ + VAVK LK ++ + F + ++ L+H LV L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLT 487
E +++EYM GSL L + G G+ L + +A A G+A+I +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG-GKVLL--PKLIDFSAQIAEGMAYI----ERKNYI 125
Query: 488 HGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQSQ 541
H ++++ NVL+ ++ +++DFGL+ + G + APE + + +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGSFTI 183
Query: 542 KSDVYSFGVLLLELLT-GKCP 561
KSDV+SFG+LL E++T GK P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 84/309 (27%), Positives = 132/309 (42%), Gaps = 61/309 (19%)
Query: 368 LGKGGFGTAYKAV------LDDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
LG+G FG KA + VAVK LK+ AS R+ +L ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-------------------GPGRTPLDWT 461
L LL+ EY GSL L +R P L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPST 519
+ A +RG+ ++ +KL H ++ + NVL+ + ++SDFGLS ++ S
Sbjct: 128 DLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 520 VPRSNG-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCG 574
V RS G + A E S D +Q SDV+SFGVLL E++T GG G
Sbjct: 184 VKRSKGRIPVKWMAIE-SLFDHIYTTQ-SDVWSFGVLLWEIVT-------LGGNPYPGIA 234
Query: 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHV 634
P + ++++ + E R ++ EEM L+ + C PD+RP + +
Sbjct: 235 -----PERLFNLLKTGYRME-------RPENCSEEMYNLM---LTCWKQEPDKRPTFADI 279
Query: 635 VKLIEELRG 643
K +E++
Sbjct: 280 SKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 366 EMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASIGGKR-EFEQHMEVLGRLRHPNLVG 420
+++G G FG ++ +L VA+K LK +R +F ++G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+ + ++++EYM NG+L L + G + L+ G A G+ ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLR---GIAAGMKYL--- 123
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA---PPSTVPRSNG-----YRAPELS 532
+ H ++ + N+L++ +VSDFGLS P T S G + APE
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT 557
+ RK + SDV+SFG+++ E+++
Sbjct: 183 AY--RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK--DASIGGKRE---FEQHMEVLGRLRHPNLV 419
++LG+G FG Y +D G +AVK++ S K+E E +++L L+H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 420 GLKAYYFAREEKLLVS---EYMPNGSL--FWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
YY + +S EYMP GS+ +G L T K G+
Sbjct: 68 ---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGV 117
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI--------FAPPSTVPRSNGY 526
++H S + H +IK N+L D GN ++ DFG S +V + +
Sbjct: 118 EYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+PE+ S +G +K+DV+S G ++E+LT K P
Sbjct: 174 MSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 60/302 (19%)
Query: 368 LGKGGFGTAYKA------VLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGL 421
LG+G FG + A D +VAVK LKD ++ +++F++ E+L L+H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 422 KAYYFAREEKLLVSEYMPNGSL-----------FWLLHGNRGPGRTPLDWTTRLKIAAGA 470
+ ++V EYM +G L L+ G + L + L IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----- 525
A G+ ++ S H ++ + N L+ ++ DFG+S + R G
Sbjct: 133 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 526 --YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGC---GGAVDL 579
+ PE S RK + +SDV+SFGV+L E+ T GK P + C G ++
Sbjct: 189 IRWMPPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246
Query: 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
PR EV+D + + C P QR N+ + K++
Sbjct: 247 PRVCPK--------EVYD------------------IMLGCWQREPQQRLNIKEIYKILH 280
Query: 640 EL 641
L
Sbjct: 281 AL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV------LGRLRHPNLVG 420
+G G FG Y A + VVA+K++ S GK+ E+ ++ L +LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFI 477
K Y LV EY GS +L ++ P + ++IAA GA +GLA++
Sbjct: 80 YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQ-------EVEIAAICHGALQGLAYL 131
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG-LSIFAPPSTVPRSNGYRAPE--LSSS 534
H S + H +IK+ N+LL + G +++DFG S+ +P ++ + + APE L+
Sbjct: 132 H----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMD 187
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
+G+ K DV+S G+ +EL K P
Sbjct: 188 EGQYDG-KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 368 LGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGL 421
+G+G FG KA+L +DG +K + + + K E + + VL ++HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGLAFIH 478
+ + +V +Y G L+ ++ RG P LDW ++ +A L +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPELSS 533
K+ H +IKS N+ L K G ++ DFG+ S T + Y +PE+
Sbjct: 119 ----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-- 172
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGK 559
+ R + KSD+++ G +L E+ T K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 368 LGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGK------REFEQHMEVLGRLRHPNLVG 420
+G+G G +KA + G VA+K++ + G RE ++ L +HP +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + +LV EYMP L +L P + +G+A++H
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQ---VK-SYMRMLLKGVAYMH-- 116
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPELSSS 534
+ + H ++K N+L+ G +++DFGL+ +F+ S+ YRAPEL
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 535 DGRKQSQKSDVYSFGVLLLELLTG 558
RK D+++ G + ELL G
Sbjct: 175 -ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 75/290 (25%), Positives = 133/290 (45%), Gaps = 44/290 (15%)
Query: 362 RASAEM---LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL 418
R S ++ LG G FG + A + + VAVK +K S+ F V+ L+H L
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKL 63
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
V L A +E +++E+M GSL L + G + PL + +A A G+AFI
Sbjct: 64 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPL--PKLIDFSAQIAEGMAFI- 118
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPELS 532
+ H ++++ N+L+ + +++DFGL+ + R + APE
Sbjct: 119 ---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE-- 173
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591
+ + + KSDV+SFG+LL+E++T G+ P GM P ++++ R
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPY------PGMSN------PEVIRALER--- 218
Query: 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+ R ++ EE L + M C P++RP ++ ++++
Sbjct: 219 -----GYRMPRPENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 41/214 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E +GKG FG YKA+ VVA+K + + + + +Q ++ L + R P +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT---K 63
Query: 424 YY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
YY F + KL ++ EY GS LL PG LD T I GL ++H
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLLK----PG--KLDETYIAFILREVLLGLEYLH-- 115
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFG----LSIFAPPSTVPRSNGY------RAPE 530
H +IK+ N+LL + G+ +++DFG L+ ST+ + N + APE
Sbjct: 116 --EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT-----STMSKRNTFVGTPFWMAPE 168
Query: 531 LSSSDGRKQSQ---KSDVYSFGVLLLELLTGKCP 561
+ KQS K+D++S G+ +EL G+ P
Sbjct: 169 VI-----KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 368 LGKGGFGTAYKAVL------DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGL 421
LG+G FG + A D +VAVK LKDAS +++F + E+L L+H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 422 KAYYFAREEKLLVSEYMPNGSL--FWLLHG------NRGPGRTPLDWTTRLKIAAGAARG 473
+ ++V EYM +G L F HG G L + L IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-------Y 526
+ ++ S H ++ + N L+ + ++ DFG+S + R G +
Sbjct: 133 MVYL----ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
PE S RK + +SDV+S GV+L E+ T GK P
Sbjct: 189 MPPE--SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 51/237 (21%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVL 410
T FEL E++G+G +G YKA G +VA+K + D + E ++ +L
Sbjct: 5 TGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNIL 56
Query: 411 GRL-RHPNLVGLKAYYFAR-----EEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ HPN+ + + +++L LV E GS+ L+ G R G+ R
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-------R 109
Query: 464 LK------IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517
LK I RGLA++H K+ H +IK N+LL K ++ DFG+S
Sbjct: 110 LKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDFGVS----- 160
Query: 518 STVPRSNGYR----------APELSSSDGRKQS---QKSDVYSFGVLLLELLTGKCP 561
+ + + G R APE+ + D + + +SDV+S G+ +EL GK P
Sbjct: 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 82/318 (25%), Positives = 143/318 (44%), Gaps = 64/318 (20%)
Query: 366 EMLGKGGFGTAYKA-VLDDGSVV--AVKRLKD-ASIGGKREFEQHMEVLGRL-RHPNLVG 420
+++G+G FG KA + DG + A+KR+K+ AS R+F +EVL +L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTP-----------LDWTTRLKIAAG 469
L R L EY P+G+L L +R P L L AA
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAP 529
ARG+ ++ + H ++ + N+L+ + A+++DFGLS V ++ G R P
Sbjct: 133 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMG-RLP 186
Query: 530 ----ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQ 584
+ S + + SDV+S+GVLL E+++ G P GM C
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTC----------- 229
Query: 585 SVVREEWTAEVFD-----LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV---- 635
AE+++ L + + ++E+ L++ C P +RP+ + ++
Sbjct: 230 --------AELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLN 278
Query: 636 KLIEELRGVEVSPCHENF 653
+++EE + + +E F
Sbjct: 279 RMLEERKTYVNTTLYEKF 296
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK----DASIGGKREFEQHMEVLGRLRHPNLVG 420
E++G G Y A+ L + VA+KR+ S+ E + ++ + + HPN+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVVK 63
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLL-HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
+ +E LV Y+ GSL ++ G LD + +GL ++H
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVLKGLEYLH- 119
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNG-------YRAPE 530
S H +IK+ N+LL + G+ +++DFG+S + + + APE
Sbjct: 120 ---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ K+D++SFG+ +EL TG P
Sbjct: 177 VMEQV-HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 54 PCSWTGVSCLQNRVSHLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLT 111
P S T ++ L+ L L + QL G + + L + L+ + L YN +G +P + LT
Sbjct: 181 PNSLTNLTSLE----FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236
Query: 112 ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171
+L L L +NN G P S+ +L L L L N SG IP ++ L L++L L N
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 172 SGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
SG I L L+NL+ ++ N+ +G+IP +L+ P
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332
|
Length = 968 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 71/286 (24%), Positives = 131/286 (45%), Gaps = 42/286 (14%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFE---QHMEVLGRLRHPNLVGLKA 423
+GKG F YKA+ L DG VVA+K+++ + + + + +++L +L HPN++ A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+ E +V E G L ++ + R + T K L +H S
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEHMH----S 124
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN-G---YRAPELSSSDGRK 538
++ H +IK NV + TG ++ D GL F+ +T S G Y +PE +G
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-- 182
Query: 539 QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT---AEV 595
+ KSD++S G LL E+ + P D ++L + + + ++ A+
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDK----------MNLYSLCKKIEKCDYPPLPADH 232
Query: 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+ EL ++V C + P++RP++S+V+++ +E+
Sbjct: 233 YSEEL-------RDLVSR------CINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 367 MLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE---------FEQHMEVLGRLRHP 416
++G G FG+ Y + G ++AVK+++ S+ + + + +L L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 417 NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
N+V + + EY+P GS+ LL+ N G L +I +GL +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQIL----KGLNY 121
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSS-- 534
+H + + H +IK N+L+D G ++SDFG+S +++ P L S
Sbjct: 122 LH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 535 ----DGRKQ---SQKSDVYSFGVLLLELLTGKCP 561
+ KQ ++K+D++S G L++E+LTGK P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 368 LGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLKA 423
LGKGGFG V G + A K+L + ++ + + ++L ++ +V L A
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 424 YYFAREEKL-LVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
Y F ++ L LV M G L + + G G + AA GL +H
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-----FPEARAIFYAAQIICGLEHLH-- 112
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR----SNGYRAPELSSSDG 536
++ + ++K NVLLD GN R+SD GL++ + + GY APE+ G
Sbjct: 113 --QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ--G 168
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
D ++ G L E++ G+ P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 50/218 (22%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR---------- 414
+ LG G FG+ Y A + G +VA+K++ K++F E + LR
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECM-NLREVKSLRKLNE 56
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
HPN+V LK + +E V EYM G+L+ L+ +G P + I +GL
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGL 112
Query: 475 AFIHFTCKSLKLTHG----NIKSTNVLLDKTGNARVSDFGLSIFA------PPSTVPRSN 524
A IH HG ++K N+L+ +++DFGL A PP T S
Sbjct: 113 AHIH--------KHGFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVST 161
Query: 525 G-YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE L S+ S D+++ G ++ EL T +
Sbjct: 162 RWYRAPEILLRSTS---YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E +G+G GT Y A+ + G VA+K++ K + V+ +HPN+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
Y +E +V EY+ GSL ++ T +D + + L F+H S
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 134
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSSSDGRKQ 539
++ H +IKS N+LL G+ +++DFG P RS + APE+ + RK
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKA 191
Query: 540 -SQKSDVYSFGVLLLELLTGKCP 561
K D++S G++ +E++ G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427
LG G FG + VA+K + + ++ + +F + +V+ +L HP LV L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 428 REEKLLVSEYMPNGSLFWLLHGNRGP-GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKL 486
++ +V+E+M NG L L +G + L L + G+ ++
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN----SF 121
Query: 487 THGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSS----DGRKQSQK 542
H ++ + N L+ TG +VSDFG++ + S+G + P S + K S K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 543 SDVYSFGVLLLELLT-GKCP 561
SDV+SFGVL+ E+ T GK P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSV----VAVKRLKDASIGGKREFEQ---HMEVLGRLRHPN 417
++LG G FGT +K + + +G VA+K ++D S G++ F++ HM +G L H
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAY 70
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGL 474
+V L +L V++ P GSL + +R P R L+W ++ A+G+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRL-LNWCVQI------AKGM 122
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-SNGYRAP---- 529
++ + H N+ + N+LL +++DFG++ P + ++ P
Sbjct: 123 YYLEEHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT 557
L S + + +SDV+S+GV + E+++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 44/194 (22%), Positives = 85/194 (43%), Gaps = 18/194 (9%)
Query: 377 YKAVLDDGSVVAVKRLKDASIGGK---REFEQHMEVLGRLRHPNLVGLKAYYFAREEKL- 432
YK + ++ V+ ++ K G K E ++ L R+ N++ + + + L
Sbjct: 37 YKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 433 ---LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHG 489
L+ EY G L +L + L + T+L +A +GL ++ K +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLY---KYTNKPYK 147
Query: 490 NIKSTNVLLDKTGNARVSDFGL--SIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYS 547
N+ S + L+ + ++ GL + +PP Y + ++ + + + K D+YS
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 548 FGVLLLELLTGKCP 561
GV+L E+ TGK P
Sbjct: 208 LGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 367 MLGKGGFGTAY----KAVLDDGS---VVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNL 418
LG G FG Y +L GS VAVK L K A+ K+EF + ++ HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-----GPGRTPLDWTTRLKIAAGAARG 473
V L E + ++ E M G L L R P T + L I A+G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL---LDICLDVAKG 118
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNAR----VSDFGLSIFAPPSTVPRSNGYR- 527
++ + + H ++ + N L+ +K +A + DFGL+ S R G
Sbjct: 119 CVYL----EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 528 ------APELSSSDGRKQSQKSDVYSFGVLLLELLT 557
APE S DG+ +Q SDV+SFGVL+ E+LT
Sbjct: 175 LPVRWMAPE-SLLDGKFTTQ-SDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 46/280 (16%)
Query: 367 MLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME--VLGRLRHPNLVGLKA 423
++G+G FG + D +V +K++ + E VL L HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+ + ++V EY P G+L + T L + ++ +A L +H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVH-- 118
Query: 481 CKSLKLTHGNIKSTNVLLDKTGN-ARVSDFGLS-IFAPPS---TVPRSNGYRAPELSSSD 535
+ + H ++K+ N+LLDK ++ DFG+S I + S TV + Y +PEL +
Sbjct: 119 --TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL--CE 174
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595
G+ +QKSD+++ G +L EL + K + A +LP V ++ + A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLK--RAFE----------AANLPALVLKIMSGTF-API 221
Query: 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
D RY L Q+ ++ + P +RP +S ++
Sbjct: 222 SD----RYSP------DLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 56/188 (29%), Positives = 82/188 (43%), Gaps = 54/188 (28%)
Query: 48 WNSTSDPCS-----WTGVSC-LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFT 101
WN DPC W+G C + ++ L L LR
Sbjct: 392 WNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQ--------GLR---------- 431
Query: 102 GPVPS-LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTH 160
G +P+ +S L L+ + LS N+ G P S+ S+ L LDLS+N+F+G IP ++ LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT- 490
Query: 161 LLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP----DSAFTQNAALC 216
+L+ N++GN LSG++P +L G FT NA LC
Sbjct: 491 ---------------------SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529
Query: 217 GSP-MQAC 223
G P ++AC
Sbjct: 530 GIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E +GKG FG +K + + VVA+K + + + + +Q + VL + P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
Y + ++ EY+ GS LL PG PLD T I +GL ++H S
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLH----S 119
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQS--- 540
K H +IK+ NVLL + G +++DFG++ + + R+ P + + KQS
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 541 QKSDVYSFGVLLLELLTGKCP 561
K+D++S G+ +EL G+ P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV---VAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPNLVG 420
+++G+G FG KA + + A+KR+K+ AS R+F +EVL +L HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTP-----------LDWTTRLKIAAG 469
L R L EY P+G+L L +R P L L AA
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAP 529
ARG+ ++ + H ++ + N+L+ + A+++DFGLS V ++ G R P
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMG-RLP 174
Query: 530 ----ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD-LPRWV 583
+ S + + SDV+S+GVLL E+++ G P GM C + LP+
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTCAELYEKLPQGY 228
Query: 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAM 618
+ EV+DL +++ E Q+ +
Sbjct: 229 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E LG+G + T YK G +VA+K + DA G + + ++ L+H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 424 YYFAREEKLLVSEYMPNGSLFWL-LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ +LV EYM ++ HG RG LD T +G+AF C
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGA----LDPNTVKSFTYQLLKGIAF----CH 117
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGL--SIFAPPSTVPRSNG-----YRAPE--LSS 533
++ H ++K N+L++K G +++DFGL + P +T SN YRAP+ L S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF--SNEVVTLWYRAPDVLLGS 175
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGK 559
R S D++S G ++ E++TG+
Sbjct: 176 ---RTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 366 EMLGKGGFGTAYKAVLD----DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVG 420
E++G G FG + L VA+K LK + +R+F ++G+ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+ ++++E+M NG+L L N G T + L+ G A G+ ++
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLR---GIAAGMKYL--- 122
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF-----APPSTVPRSNG-----YRAPE 530
+ H ++ + N+L++ +VSDFGLS F + P+ G + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLT 557
+ RK + SDV+S+G+++ E+++
Sbjct: 182 AIAY--RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 32/212 (15%)
Query: 366 EMLGKGGFGTAY--KAVL--DDGSVVAVKRLKDASIGGKREFEQHME--VLGRLRHPNLV 419
++LG+G FG + + + D G + A+K LK A++ + ME +L + HP +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 420 GLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
L Y F E KL L+ +++ G LF L ++ T D L A A L +H
Sbjct: 62 KLH-YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL---AELALALDHLH 115
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---------IFAPPSTVPRSNGYRAP 529
SL + + ++K N+LLD+ G+ +++DFGLS ++ TV Y AP
Sbjct: 116 ----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE----YMAP 167
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
E+ + G +Q +D +SFGVL+ E+LTG P
Sbjct: 168 EVVNRRG--HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 368 LGKGGFGTAYKAVLDD----GSVVAVKRLKDASIGGKREFEQHM------EVLGRLRHPN 417
LG+G FG K +L + G + A+K LK I + E E M E RHP
Sbjct: 7 LGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAF 476
LV L A + + V EY G L +H + R AA GL +
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-------RAVFYAACVVLGLQY 116
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPSTVPRSNGYRAPEL 531
+H K+ + ++K N+LLD G +++DFGL ST + + APE+
Sbjct: 117 LH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ ++ D + GVL+ E+L G+ P
Sbjct: 173 LT--ETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 57/221 (25%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH---------MEVLGRLRHPN 417
LG+G + YKA + G +VA+K++K G+R+ + +++L L+HPN
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63
Query: 418 LVGLKAYYFAREEKLLVSEYMP--------NGSLFWLLHGNRGPGRTPLD---WTTRLKI 466
++GL + + LV E+M + S+ TP D +
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL----------TPADIKSYMLMT-- 111
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN- 524
RGL ++H S + H ++K N+L+ G +++DFGL+ F P+
Sbjct: 112 ----LRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 525 ---GYRAPEL---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPEL + R D++S G + ELL
Sbjct: 164 VTRWYRAPELLFGA----RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 57/184 (30%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 387 VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445
VAVK L+ DAS + +F + +++L RL PN+ L ++ EYM NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 446 LLH------GNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD 499
L L ++T L +A A G+ ++ +SL H ++ + N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLVG 164
Query: 500 KTGNARVSDFGLSIFAPPSTVPRSNGYRAP------ELSSSDGRKQSQKSDVYSFGVLLL 553
K +++DFG+S S R G RAP S K + KSDV++FGV L
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 554 ELLT 557
E+LT
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E++G+G FG + G VAVK +K D + + F + V+ +L H NLV L
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+V E M G+L L R GR + L+ + A G+ ++ +S
Sbjct: 68 IL-HNGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYL----ESK 119
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP----PSTVPRSNGYRAPELSSSDGRKQS 540
KL H ++ + N+L+ + G A+VSDFGL+ S +P + APE + +K S
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPE--ALKHKKFS 175
Query: 541 QKSDVYSFGVLLLELLT-GKCP 561
KSDV+S+GVLL E+ + G+ P
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-13
Identities = 56/153 (36%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 54 PCSWTGVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVPSL-SNLT 111
P S + LQ +L L +LSG + P + SL +L L L N +G +P L L
Sbjct: 253 PSSLGNLKNLQ----YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 112 ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171
L++L L NNF G+ P +++SL RL L L N FSG+IP + +L L L N
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 172 SG--PITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+G P NL + N L G+IPKSL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
|
Length = 968 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVV--AVKRLKD-ASIGGKREFEQHMEVLGRL-RHPNLVG 420
+++G+G FG +A++ DG + A+K LK+ AS R+F +EVL +L HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTP-----------LDWTTRLKIAAG 469
L R + EY P G+L L +R P L L+ A+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAP 529
A G+ ++ + H ++ + NVL+ + ++++DFGLS V ++ G R P
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLS-RGEEVYVKKTMG-RLP 181
Query: 530 ----ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD-LPRWV 583
+ S + + KSDV+SFGVLL E+++ G P GM C + LP+
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY------CGMTCAELYEKLPQGY 235
Query: 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAM 618
+ EV++L ++D E Q+++
Sbjct: 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 40/219 (18%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRL------KDASIGGKREFEQHMEVLGRLRHPNLV 419
E+LGKG +GT Y + + G ++AVK++ A+ + ++ +++L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 420 GLKAYYFAREEKLLVS---EYMPNGSLFWLLHGNR-GPGRTPL--DWTTRLKIAAGAARG 473
Y + +S E++P GS+ +L NR GP P+ +T ++ G
Sbjct: 66 ---QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQI------LDG 114
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG-------LSIFAPPSTVPRS-NG 525
+A++H C + H +IK NV+L G ++ DFG + + S + +S +G
Sbjct: 115 VAYLHNNC----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 526 ---YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APE+ + G +KSD++S G + E+ TGK P
Sbjct: 171 TPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHM---EVLG-RLRHPNLVG 420
+MLGKG FG + A L A+K LK + + E M VL HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + +E V EY+ G L + + D AA GL F+H
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLH-- 113
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIF--APPSTVPRSNGYRAPELSSSD 535
S + + ++K N+LLD G+ +++DFG+ ++ A T + Y APE+
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL-- 169
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G+K + D +SFGVLL E+L G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
E +GKG FG YK + + VVA+K L++A + +Q + VL + P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYY 68
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
Y + ++ EY+ GS LL PG PL+ T I +GL ++H
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLK----PG--PLEETYIATILREILKGLDYLH---- 118
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQ- 541
S + H +IK+ NVLL + G+ +++DFG++ + + R+ P + + KQS
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 542 --KSDVYSFGVLLLELLTGKCP 561
K+D++S G+ +EL G+ P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 366 EMLGKGGFGTAYKAVLDD--GSV--VAVKRLKDASIGG-KREFEQHMEVLGRLRHPNLVG 420
+ LG G FG + G V VAVK LK + +F + ++ L H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 421 LKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L Y L +V+E P GSL L G + +T A A G+ ++
Sbjct: 61 L--YGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLI--STLCDYAVQIANGMRYLE- 114
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS----------IFAPPSTVPRSNGYRAP 529
S + H ++ + N+LL ++ DFGL + VP + + AP
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA--WCAP 169
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT 557
E S R S SDV+ FGV L E+ T
Sbjct: 170 E--SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 67/211 (31%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 368 LGKGGFGTA----YKAVLDD-GSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGL 421
LG+G FG Y D G +VAVK LK + +++ + +L L H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 422 KAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
K + K L+ EY+P GSL L ++ L+ L A G+A++H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLH- 124
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV---PRSNG-----YRAPEL 531
S H ++ + NVLLD ++ DFGL+ P R +G + A E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCPS 562
+ K S SDV+SFGV L ELLT C S
Sbjct: 182 LKEN--KFSYASDVWSFGVTLYELLT-HCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 6e-13
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E +G+G GT + A+ + G VA+K++ K + V+ L++PN+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ +E +V EY+ GSL ++ T +D + + L F+H
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHAN---- 134
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSSSDGRKQ 539
++ H +IKS NVLL G+ +++DFG P RS + APE+ + +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--KAY 192
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
K D++S G++ +E++ G+ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 80/291 (27%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV----VAVKRL-KDASIGGKREFEQHMEVLGRLRHPNLVG 420
++GKG FG Y L D AVK L + + +F + ++ HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 421 LKAYYFARE-EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG--AARGLAFI 477
L E L+V YM +G L + R P T + I G A+G+ ++
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP---TVKDLIGFGLQVAKGMEYL 114
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPP-STVPRSNGYRAP----E 530
S K H ++ + N +LD++ +V+DFGL+ I+ +V G + P
Sbjct: 115 ----ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590
L S +K + KSDV+SFGVLL EL+T P D VD
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----------VD-----------S 208
Query: 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+ V+ L+ R E L +V ++C P+ RP S +V IE++
Sbjct: 209 FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKR----LKDASIGGKREFEQHMEVLGRLRHPNLVG 420
+ LGKG +G+ YK + G +A+K L ++ + +++L + P +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVD 63
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+F + EYM GSL L G P D R I +GL F+
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLK-- 119
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---YRAPELSSSDGR 537
+ + H ++K TNVL++ G ++ DFG+S S + G Y APE S G
Sbjct: 120 -EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 538 KQ----SQKSDVYSFGVLLLELLTGKCP 561
Q + +SDV+S G+ +LE+ G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME----VLGRLRHPNLVGLK 422
+GKG FG A DG AVK L+ +I K+E + M +L ++HP LVGL
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFT 480
Y F +KL V +Y+ G LF+ L R P R + AA A L ++H
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLH-- 113
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPELSSSD 535
SL + + ++K N+LLD G+ ++DFGL ST + Y APE+
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL--- 168
Query: 536 GRKQ--SQKSDVYSFGVLLLELLTGKCP 561
RKQ + D + G +L E+L G P
Sbjct: 169 -RKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 368 LGKGGFGTAYKAVLDD------GSVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
LG+G FG Y+ + + VA+K + + AS+ + EF V+ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-----GPGRTPLDWTTRLKIAAGAARGLA 475
L + L+V E M G L L R PG P +++AA A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-------- 527
++ + K H ++ + N ++ + ++ DFG++ + ++ YR
Sbjct: 134 YLA----AKKFVHRDLAARNCMVAEDLTVKIGDFGMT-----RDIYETDYYRKGGKGLLP 184
Query: 528 ----APELSSSDGRKQSQKSDVYSFGVLLLELLT 557
APE S DG + KSDV+SFGV+L E+ T
Sbjct: 185 VRWMAPE-SLKDGVFTT-KSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 368 LGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRHPNLVGLK 422
LG GGFG V A+K +K I ++H+ E+L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG-QQEHIFSEKEILEECNHPFIVKLY 59
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ ++ ++ EY G L+ +L G ++T R A ++H
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR---GLFD-EYTARF-YIACVVLAFEYLH---- 110
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFG----LSIFAPPSTVPRSNGYRAPELSSSDGRK 538
+ + + ++K N+LLD G ++ DFG L T + Y APE+ + G
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
S D +S G+LL ELLTG+ P
Sbjct: 171 FS--VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 368 LGKGGFGTAYKA-VLDDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKA 423
LGKGGFG V + G + A K+L + G++ E+L ++ P +V L A
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 424 YYFAREEKL-LVSEYMPNGSL-FWLLH-GNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
Y F + L LV M G L + + + G RG L+ + +A G+ +H
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-----LEMERVIHYSAQITCGILHLH-- 112
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP--PSTVPR--SNGYRAPELSSSDG 536
S+ + + ++K NVLLD GN R+SD GL++ + R +NGY APE+ +
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE- 169
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
S D ++ G + E++ G+ P
Sbjct: 170 -PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 38/218 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME-------VLGRLRHPN 417
+ LG G F + Y+A + G+++AVK++ E E+ +E ++ RL HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 418 LVGLKAYYFAREEKL---LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
++ + A E L E+M GS+ LL G + + ++ RGL
Sbjct: 65 IIRM---LGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLL----RGL 116
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGN-ARVSDFGLSIFAPPSTVPRSN--------- 524
+++H ++ H ++K N+L+D TG R++DFG + + +
Sbjct: 117 SYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA-RLAAKGTGAGEFQGQLLGT 171
Query: 525 -GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APE+ G + + DV+S G +++E+ T K P
Sbjct: 172 IAFMAPEVLR--GEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNL 418
++LGKG FG K +L G A+K LK I K E + VL RHP L
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
LK Y F ++L V EY G LF+ H +R R + R A L ++
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGELFF--HLSR--ERVFSEDRARF-YGAEIVSALGYL 111
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPE-L 531
H S + + ++K N++LDK G+ +++DFGL S A T + Y APE L
Sbjct: 112 H----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+D + D + GV++ E++ G+ P
Sbjct: 168 EDND---YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 72/225 (32%), Positives = 100/225 (44%), Gaps = 45/225 (20%)
Query: 360 LLRASAEMLGKGGFGTAYKAV---LDDGSV---VAVKRLKDASIGGKREFEQHMEVL--G 411
LLRA LG G FG Y+ + D +V VAVK L ++ + E + ME L
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMS 64
Query: 412 RLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG-PGR-TPLDWTTRLKIAAG 469
+ H N+V L F R + ++ E M G L L NR P R + L L A
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 470 AARGLAFIHFTCKSLK---LTHGNIKSTNVLLDKTGNARV---SDFGLSIFAPPSTVPRS 523
A+G CK L+ H +I + N LL G RV +DFG++ + R+
Sbjct: 125 VAKG-------CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA-----RDIYRA 172
Query: 524 NGYR-----------APELSSSDGRKQSQKSDVYSFGVLLLELLT 557
+ YR P + DG S K+DV+SFGVLL E+ +
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTS-KTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 24/208 (11%)
Query: 368 LGKGGFGTAYKAVLDDGSVVA---VKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+G G FG G A VK L+ A+ + F Q ++ L HPN++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
LLV E+ P G L L NRG ++A A GL ++H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----Q 118
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLS---------IFAPPSTVPRSNGYRAPELSSS 534
H ++ N L + ++ D+GL+ I VP + APEL
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--WLAPELVEI 176
Query: 535 DG-----RKQSQKSDVYSFGVLLLELLT 557
G + Q++KS+++S GV + EL T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 82/296 (27%), Positives = 135/296 (45%), Gaps = 42/296 (14%)
Query: 366 EMLGKGGFGTAYKAVL-----DDGSVVAVKRL---KDASIGGKREFEQHMEVLGRLRHPN 417
E LG G G+ Y V+ + G +VA+K+ +D + K + + +L +LRH N
Sbjct: 4 ENLGLVGEGS-YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE-IRMLKQLRHEN 61
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
LV L + ++ LV E++ + L L G LD + K RG+ F
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFC 116
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF-APPSTV----PRSNGYRAPELS 532
H S + H +IK N+L+ ++G ++ DFG + A P V + YRAPEL
Sbjct: 117 H----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP-----SVIDGGGAGMGCGGAVDLPRWVQSVV 587
D K + D+++ G L+ E+LTG+ P S ID + C G + +PR +
Sbjct: 173 VGD-TKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNL-IPRHQEIFQ 229
Query: 588 REEWTA-----EVFDLELM--RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ A EV ++E + R+ + ++ L + C PD RP+ S ++
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK---QCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 72/209 (34%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHME----VLGRLRHPNLVG 420
+++GKG FG A DGS AVK L+ +I K+E M +L L+HP LVG
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 421 LKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L Y F EKL V +Y+ G LF H R R L+ R AA A + ++H
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGELF--FHLQR--ERCFLEPRARF-YAAEVASAIGYLH- 113
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI--FAPPSTVPRSNG---YRAPELSSS 534
SL + + ++K N+LLD G+ ++DFGL P T G Y APE+
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL-- 168
Query: 535 DGRKQ--SQKSDVYSFGVLLLELLTGKCP 561
RK+ + D + G +L E+L G P
Sbjct: 169 --RKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E +G+G GT Y A+ + G VA+K++ K + V+ ++PN+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
Y +E +V EY+ GSL ++ T +D + + L F+H S
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLH----SN 134
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSSSDGRKQ 539
++ H +IKS N+LL G+ +++DFG P RS + APE+ + +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--KAY 192
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
K D++S G++ +E++ G+ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 366 EMLGKGGFGTAY----KAVLDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRH-P 416
++LG G +G + + D G + A+K LK A+I K + +H +VL +R P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 417 NLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK-----IAAGA 470
LV L Y F + KL L+ +Y+ G LF T L R K I +G
Sbjct: 66 FLVTLH-YAFQTDTKLHLILDYINGGELF-----------THLSQRERFKEQEVQIYSGE 113
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----- 525
LA H L + + +IK N+LLD G+ ++DFGLS V R+
Sbjct: 114 IV-LALEHL--HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 526 -YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566
Y AP++ + D +S GVL+ ELLTG P +DG
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM---EV--LGRLRHPNLV 419
E +GKG FGT K DG ++ K+ G E E+ EV L L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILV---WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 420 GLKAYY---FAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
YY R + L V EY G L L+ + R ++ +I L
Sbjct: 63 R---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLAL 118
Query: 475 AFIHF-TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-------IFAPPSTVPRSNGY 526
H + + H ++K N+ LD N ++ DFGL+ FA T + Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPYY 176
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+PE + +KSD++S G L+ EL P
Sbjct: 177 MSPEQLN--HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGL-KA 423
LG G FG YKA + + A K I + E E M ++L +HPN+VGL +A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAA--AKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 424 YYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
Y++ E KL ++ E+ G+L ++ L + L F+H
Sbjct: 71 YFY--ENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---- 120
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSSDGR 537
S K+ H ++K+ N+LL G+ +++DFG+S + R + APE+ + +
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 538 KQS---QKSDVYSFGVLLLELLTGKCP 561
K + K+D++S G+ L+EL + P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E +G+G GT Y A+ + G VA++++ K + V+ ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
Y +E +V EY+ GSL ++ T +D + + L F+H S
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 135
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSSSDGRKQ 539
++ H +IKS N+LL G+ +++DFG P RS + APE+ + +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--KAY 193
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
K D++S G++ +E++ G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 24/205 (11%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK---RLKDASIGGKR--EFEQHMEVLGRLRHPNLV 419
++LG G FGT YK + + +G V + ++ + + G K EF ++ + HP+LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP--GRTPLDWTTRLKIAAGAARGLAFI 477
L + +L V++ MP+G L +H ++ + L+W ++ A+G+ ++
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGYRAP----ELS 532
+ +L H ++ + NVL+ + +++DFGL+ + ++G + P L
Sbjct: 126 ----EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT 557
RK + +SDV+S+GV + EL+T
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL-----KD-ASIGGKREFEQHMEVLGRLRHPNL 418
LG+G FG YKA + G VVA+K++ KD I RE +++L +L+HPN+
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKILKKLKHPNV 69
Query: 419 VGL--------KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 470
V L R +V+ YM + L LL L++ G
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEG- 127
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL--SIFAPPSTVPRSNG--- 525
+ ++H + H +IK+ N+L+D G +++DFGL PP G
Sbjct: 128 ---INYLH--EN--HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 526 -----------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YR PEL + R+ + D++ G + E+ T +
Sbjct: 181 RKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 356 ELEDLLRASAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKRE---FEQHMEVLG 411
+L+DL +G+G FGT K + G+++AVKR++ S ++E ++V+
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKEQKRLLMDLDVVM 57
Query: 412 RLRH-PNLVGLKAYYFAREEKLLVSEYMPNGSL--FWLLHGNRGPGRTPLDWTTRLKIAA 468
R P +V F + + E M + SL F+ P + KIA
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG--KIAV 114
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV-PRSNG-- 525
+ L ++ + LK+ H ++K +N+LLD+ GN ++ DFG+S S R G
Sbjct: 115 ATVKAL---NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR 171
Query: 526 -YRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE + S +SDV+S G+ L E+ TGK P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 42/275 (15%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH----MEVLGRLRHPNLVGLK 422
LG G G+ K + G+V+A K + IG K + ++++ R P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV---HIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ + E+M GSL + + G P++ KIA GL +++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILG--KIAVAVVEGLTYLYNV-- 122
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRSNGYRAPELSSSDGRKQ 539
++ H +IK +N+L++ G ++ DFG+S I + T ++ Y +PE G K
Sbjct: 123 -HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPE--RIQGGKY 179
Query: 540 SQKSDVYSFGVLLLELLTGKCP-----SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
+ KSDV+S G+ ++EL GK P DG MG +DL +Q +V+E
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI---LDL---LQQIVQEPPPR- 232
Query: 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP 629
L + + + V AC P +RP
Sbjct: 233 ---LPSSDFPEDLRDFVD------ACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRL----KDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G +G +K + G +VA+K+ D I K+ + + +L +L+HPNLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI--KKIALREIRMLKQLKHPNLVNLI 66
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
F R+ KL LV EY + L L RG + KI + + F C
Sbjct: 67 EV-FRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNF----C 116
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPST----VPRSNGYRAPELSSSDG 536
H ++K N+L+ K G ++ DFG + I P + YRAPEL D
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD- 175
Query: 537 RKQSQKSDVYSFGVLLLELLTG 558
+ DV++ G + ELLTG
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHME----VLGRLRHPNLVG 420
+++GKG FG A DG AVK L+ + ++E + M +L ++HP LVG
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 421 LKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKI-AAGAARGLAFI 477
L Y F EKL V +++ G LF+ L R P R + AA A L ++
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-------EPRARFYAAEIASALGYL 112
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPELS 532
H S+ + + ++K N+LLD G+ ++DFGL + +T + Y APE+
Sbjct: 113 H----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 533 SSDGRKQ--SQKSDVYSFGVLLLELLTGKCP 561
RKQ D + G +L E+L G P
Sbjct: 169 ----RKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 55/232 (23%)
Query: 366 EMLGKGGFGT-----------------AYKAVLDDGSVVAVKRLK-DASIGGKREFEQHM 407
E LG+G FG + + +VAVK L+ DA+ + +F + +
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG------RTPLDWT 461
+++ RL+ PN++ L A + +++EYM NG L L + + ++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP 521
T + +A A G+ ++ SL H ++ + N L+ K +++DFG+S +
Sbjct: 131 TLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVGKNYTIKIADFGMS-----RNLY 181
Query: 522 RSNGYRAPELSSSDGR----------------KQSQKSDVYSFGVLLLELLT 557
+ YR GR K + SDV++FGV L E+LT
Sbjct: 182 SGDYYRI------QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 25/201 (12%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLKAY 424
LG G FG YKA + +A ++ + + E E +M E+L HP +V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 425 YFAREEKLLVSEYMPNGSL-FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
++ + ++ E+ P G++ +L +RG + R + A L ++H S
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA-----LQYLH----S 128
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY------RAPELSSSDGR 537
+K+ H ++K+ NVLL G+ +++DFG+S T+ R + + APE+ +
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 538 KQSQ---KSDVYSFGVLLLEL 555
K + K+D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 366 EMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASIGGK-REFEQHMEVLGRLRHPNLV 419
E LG+ FG YK L D +VA+K LKD + + EF+Q ++ L HPN+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLL-----HGNRGPG-------RTPLDWTTRLKIA 467
L + ++ EY+ G L L H + G ++ LD L IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 468 AGAARGLAFI--HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG 525
A G+ ++ HF H ++ + N+L+ + + ++SD GLS + ++
Sbjct: 131 IQIAAGMEYLSSHF------FVHKDLAARNILIGEQLHVKISDLGLS-----REIYSADY 179
Query: 526 YRAPELSSSDGR----------KQSQKSDVYSFGVLLLELLT 557
YR S R K S SD++SFGV+L E+ +
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH-----MEVLGRLRH-PNL 418
E LG+G +G K + G+++AVKR++ A++ + EQ +++ R P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIR-ATVNSQ---EQKRLLMDLDISMRSVDCPYT 62
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRT-PLDWTTRLKIAAGAARGLAFI 477
V F + + E M + SL G T P D KIA + L ++
Sbjct: 63 VTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG--KIAVSIVKALEYL 119
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----YRAPELSS 533
H L + H ++K +NVL+++ G ++ DFG+S + S + Y APE +
Sbjct: 120 H---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 534 SDGRKQ--SQKSDVYSFGVLLLELLTGKCP 561
+ ++ KSDV+S G+ ++EL TG+ P
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 47/226 (20%)
Query: 368 LGKGGFGTAYKAVL------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
+G+G FG ++A + ++VAVK LK+ AS + +F++ ++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-----------------GPGRTPLDWTTR 463
L + L+ EYM G L L G PL T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVP 521
L IA A G+A++ K H ++ + N L+ + +++DFGLS I++
Sbjct: 133 LCIAKQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS------ 182
Query: 522 RSNGYRAPE----------LSSSDGRKQSQKSDVYSFGVLLLELLT 557
++ Y+A E S + + +SDV+++GV+L E+ +
Sbjct: 183 -ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 356 ELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRL-----KDA-SIGGKREFEQHME 408
E E L R +G+G +G Y+A G +VA+K++ +D I RE +
Sbjct: 8 EFEKLNR-----IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----IT 58
Query: 409 VLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK- 465
+L LRHPN+V LK + + LV EY L LL P ++K
Sbjct: 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES-----QVKC 112
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPP--STVPR 522
+ RGL ++H + H ++K +N+LL G +++DFGL+ + P P+
Sbjct: 113 LMLQLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 523 --SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ YRAPEL + D+++ G +L ELL K
Sbjct: 169 VVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRH---PNLVG 420
E++G+G +G Y+ + G VVA+K + D + ++ + +L +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTP-LDWTTRLKIAAGAARGLAFIHF 479
Y ++ EY GS+ L+ GP + R + A L +IH
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVA-----LKYIH- 118
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSS 534
+ + H +IK+ N+L+ TGN ++ DFG++ ++ RS + APE+ +
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV-IT 174
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
+G+ K+D++S G+ + E+ TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E +G+G FG + L D + VAVK ++ K +F Q +L + HPN+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
++ +V E + G L GP L +++ AA G+ ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR-TEGP---RLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-------APELSSSDG 536
H ++ + N L+ + ++SDFG+S + G + APE + + G
Sbjct: 115 --CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYG 171
Query: 537 RKQSQKSDVYSFGVLLLELLT-GKCP 561
R S+ SDV+SFG+LL E + G P
Sbjct: 172 RYSSE-SDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 367 MLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+LGKG +G Y A L +A+K + + + + + + L+H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ E +P GSL LL GP + T + GL ++H +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ--TIIFYTKQILEGLKYLH----DNQ 128
Query: 486 LTHGNIKSTNVLLDK-TGNARVSDFGLS-----IFAPPSTVPRSNGYRAPELSSSDGRKQ 539
+ H +IK NVL++ +G ++SDFG S I T + Y APE+ R
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
+D++S G ++E+ TGK P
Sbjct: 189 GAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 370 KGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE----QHMEVLGRLRHPNLVGLKAY 424
KG FG+ Y A G A+K LK + + K + + ++ + P + L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ +++ LV EY+ G L+ + G P DW + A G+ +H
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLH----QR 116
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYRAPELSSSDGRKQSQK 542
+ H +IK N+L+D+TG+ +++DFGLS V + Y APE + G +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-YLAPE--TILGVGDDKM 173
Query: 543 SDVYSFGVLLLELLTGKCP 561
SD +S G ++ E L G P
Sbjct: 174 SDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 368 LGKGGFGTAYKAVL-DDGSVVAVKR-LKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
LG+G G+ K L + G + A+K D + +++ + +E+ + P +V YY
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV---KYY 65
Query: 426 --FAREEKLLVS---EYMPNGSLFWLL-----HGNRGPGRTPLDWTTRLKIAAGAARGLA 475
F E + EY GSL + G R G L KIA +GL+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVL-----GKIAESVLKGLS 119
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRSNGYRAPELS 532
++H S K+ H +IK +N+LL + G ++ DFG+S + + T ++ Y APE
Sbjct: 120 YLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERI 175
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566
G+ S SDV+S G+ LLE+ + P +G
Sbjct: 176 Q--GKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 368 LGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREF-----EQHMEVLGRLRH-PNLVG 420
+GKG FG Y+ D + A+K L I K+E E+++ V L P +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
LK + + LV++YM G LFW L GR D + IA LA H
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFSED-RAKFYIAELV---LALEHL- 112
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF-----APPSTVPRSNGYRAPELSSSD 535
+ + ++K N+LLD TG+ + DFGLS +T + Y APE+ +
Sbjct: 113 -HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
+ ++ D +S GVL+ E+ G P
Sbjct: 172 -KGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E +GKG FG +K + + VVA+K + + + + +Q + VL + P +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
Y + ++ EY+ GS LL P D + +GL ++H S
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH----S 119
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQS--- 540
K H +IK+ NVLL + G+ +++DFG++ + + R+ P + + +QS
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 541 QKSDVYSFGVLLLELLTGKCPS 562
K+D++S G+ +EL G+ P+
Sbjct: 180 SKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 367 MLGKGGFGTAYKAVLDDGS-VVAVKRLKDASIGGKREFEQHM---EVLG-RLRHPNLVGL 421
+LGKG FG A L + A+K LK + + E M VL HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ +E V EY+ G L + + GR AA GL F+H
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFY--AAEIICGLQFLH--- 113
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF-----APPSTVPRSNGYRAPELSSSDG 536
+ + ++K NVLLDK G+ +++DFG+ ST + Y APE+ G
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK--G 170
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
+K ++ D +SFGVLL E+L G+ P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 19/180 (10%)
Query: 387 VAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445
VA+K LK + +R+F ++G+ HPN++ L+ + ++V+EYM NGSL
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 446 LLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505
L + G T +++ G RG+A + H ++ + N+L++ +
Sbjct: 95 FLRKHDGQ-------FTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCK 146
Query: 506 VSDFGLS--IFAPPSTVPRSNG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
VSDFGLS + P + G + APE + RK + SDV+S+G+++ E+++
Sbjct: 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 367 MLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE----QHMEVLGRLRHPNLVGL 421
+LGKGGFG V G + A K+L+ I KR+ E ++L ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y ++ LV M G L + ++ PG D + AA GL +H
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG---FDEERAVFYAAEITCGLEDLH--- 119
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDGR 537
++ + ++K N+LLD G+ R+SD GL++ P R GY APE+ ++
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE-- 176
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
+ + D + G L+ E++ GK P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLK-DASIGGKREFEQHMEVLGRL-RHPN 417
+ LG+G FG KA ++ S VAVK LK DA+ + ME++ + +H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG--------RTPLDWTTRLKIAAG 469
++ L +V EY +G+L L R PG R P + T+ + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 470 A---ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
A ARG+ F+ S K H ++ + NVL+ + +++DFGL+ I +N
Sbjct: 138 AYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 525 G-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
G + APE + R + +SDV+SFGVLL E+ T
Sbjct: 194 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNL 418
++LGKG FG K +L G A+K LK I K E + VL RHP L
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR--GPGRTPLDWTTRLKIAAGAARGLAF 476
LK + ++ V EY+ G LF+ L R RT A L +
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-------YGAEIVSALDY 110
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPEL 531
+H S K+ + ++K N++LDK G+ +++DFGL + A T + Y APE+
Sbjct: 111 LH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + D + GV++ E++ G+ P
Sbjct: 167 LEDN--DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYY 425
LG G G K ++ ++L I + + + ++VL P +VG +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
++ E + E+M GSL +L + R P + ++ IA RGLA++ + +
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAV--LRGLAYLR---EKHQ 124
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRSNGYRAPELSSSDGRKQSQK 542
+ H ++K +N+L++ G ++ DFG+S I + ++ + Y +PE G S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 182
Query: 543 SDVYSFGVLLLELLTGKCP---------------SVIDGGGA 569
SD++S G+ L+EL G+ P V+DG
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 3/146 (2%)
Query: 64 QNRVSHLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHN 121
N ++ L L L+G + + L S L L L N G +P SL +L+ + L N
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DL 180
+F+GE P + L +Y LD+S NN G+I + L L L N+F G +
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFPD 206
+ L++ ++S N SG +P+ L +
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSE 500
|
Length = 968 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 55/254 (21%), Positives = 93/254 (36%), Gaps = 63/254 (24%)
Query: 346 MVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFE 404
+ F ++R+ + LG+G +G KA G +VA+K++K I +
Sbjct: 1 NMSFSISERYIQKG------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKD 54
Query: 405 QH--------------MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGN 450
+ ++++ ++H N++GL Y + LV + M L
Sbjct: 55 RQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDL------- 106
Query: 451 RGPGRTPLDWTTRLK------IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA 504
+ +D RL I GL +H H ++ N+ ++ G
Sbjct: 107 ----KKVVDRKIRLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGIC 158
Query: 505 RVSDFGLS-------IFAPPS----TVPRSN--------GYRAPELSSSDGRKQSQKSDV 545
+++DFGL+ S R YRAPEL K D+
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-AEKYHFAVDM 217
Query: 546 YSFGVLLLELLTGK 559
+S G + ELLTGK
Sbjct: 218 WSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 367 MLGKGGFGTAYKAV-LDDGS----VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
+LG G FGT YK + + DG VA+K L++ S +E V+ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP--GRTPLDWTTRLKIAAGAARGLAFIH 478
L +L V++ MP G L + N+ + L+W ++ A+G++++
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL- 125
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGYRAP----ELSS 533
+ ++L H ++ + NVL+ + +++DFGL+ + T ++G + P L S
Sbjct: 126 ---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 534 SDGRKQSQKSDVYSFGVLLLELLT 557
R+ + +SDV+S+GV + EL+T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 367 MLGKGGFGTAY--KAVLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
++G+G FG A + V D A+K ++ S + + +L +++HPN+V K
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+ A +V EY G L + RG P T L W ++ + G+ IH
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH-- 117
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPP----STVPRSNGYRAPELSSSD 535
++ H +IKS N+ L + G ++ DFG + + P T + Y PE+ +
Sbjct: 118 --EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI--WE 173
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
+ KSD++S G +L EL T K P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 41/212 (19%)
Query: 368 LGKGGFGTAYKA---------VLDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLR 414
+G G FG + L ++ V RLK EQH+ VL +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ---------EQHVHNEKRVLKEVS 59
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
HP ++ L + ++ EY+P G LF L R GR +T L A+ L
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGR--FSNSTGLFYASEIVCAL 114
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-----TVPRSNGYRAP 529
++H S ++ + ++K N+LLDK G+ +++DFG FA T+ + Y AP
Sbjct: 115 EYLH----SKEIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWTLCGTPEYLAP 167
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
E+ S G ++ D ++ G+L+ E+L G P
Sbjct: 168 EVIQSKGHNKA--VDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKR--EFEQHMEVLGRLRHPNL 418
++LG+G FG Y +D G +A K+++ ++ K E +++L L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 419 VGLKAYYFAREEKLLV--SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
V R EK L EYMP GS+ ++ L + K G+++
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSV-----KDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG----LSIFAPPSTVPRSNG----YRA 528
+H S + H +IK N+L D GN ++ DFG L T RS + +
Sbjct: 122 LH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ S +G +K+DV+S G ++E+LT K P
Sbjct: 178 PEVISGEG--YGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 366 EMLGKGGFGTAY-------KAVLDDGS--------VVAVKRLK-DASIGGKREFEQHMEV 409
E LG+G FG + L +G+ +VAVK L+ D + + +F + +++
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 410 LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLL----------HGNRGPGRTPLD 459
+ RL++PN++ L + + +++EYM NG L L H N P +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS---VS 127
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST 519
L +A A G+ ++ SL H ++ + N L+ +++DFG+S
Sbjct: 128 IANLLYMAVQIASGMKYL----ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 520 VPRSNG-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
R G R S K + SDV++FGV L E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 367 MLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHM---EVLGRL-RHPNLVGL 421
+LGKG FG A L + AVK LK I + E M VL +HP L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ + ++ V EY+ G L + + + R AA GL F+H
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFY--AAEIVLGLQFLH--- 113
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IF--APPSTVPRSNGYRAPELSSSDG 536
+ + ++K NVLLD G+ +++DFG+ I ST + Y APE+ S
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS--Y 170
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566
+ D ++ GVLL E+L G+ P D
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 366 EMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQ---HMEVLGRLRHPNLVGL 421
+G+GG+G + A D G +VA+KR+K + + E ++L + LV L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 422 KAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF- 479
Y F +E L L EY+P G RT L+ L AR F
Sbjct: 67 -LYAFQDDEYLYLAMEYVPGGDF-----------RTLLNNLGVLS--EDHARFYMAEMFE 112
Query: 480 ---TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYRAPELSSS 534
L H ++K N L+D +G+ +++DFGLS I ++V S Y APE+
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEV--L 170
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
G+ D +S G +L E L G P
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKR-----LKDASIGGKREFEQHMEVLGRLRHPNLVGL 421
+G+G F Y+A L DG VA+K+ L DA + + + +++L +L HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLNHPNVIKY 67
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
A + E +V E G L ++ + R + T K L +H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMH--- 123
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRS----NGYRAPELSSSDG 536
S ++ H +IK NV + TG ++ D GL F+ +T S Y +PE +G
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596
+ KSD++S G LL E+ + P G ++L + + E
Sbjct: 183 --YNFKSDIWSLGCLLYEMAALQSPFY----------GDKMNLYSLCKKI-------EQC 223
Query: 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643
D + EE+ L+ + C + P++RP++++V + + +
Sbjct: 224 DYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 366 EMLGKGGFGTAYKAV-LDDGS----VVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLV 419
++LG G FGT YK + + +G VA+K L++A S +E V+ + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
L +L +++ MP G L + H + + L+W ++ A+G+ ++
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGYRAP----ELS 532
+ +L H ++ + NVL+ + +++DFGL+ + + G + P L
Sbjct: 126 ----EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT 557
S R + +SDV+S+GV + EL+T
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 368 LGKGGFGTAYKAVLDDGSV--VAVKRLKDASIGGKREFEQ---HMEVLGRLRHPNLVGLK 422
LG G FG A + VA+KR + + I +++ + ++L + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ LV E++ G F L N+ R P D + A + I +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPND------VGCFYAAQIVLIFEYLQ 148
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYRAPELSSSDGRKQS 540
SL + + ++K N+LLDK G +++DFG + + T+ + Y APE+ + G
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVG--HG 206
Query: 541 QKSDVYSFGVLLLELLTGKCP 561
+ +D ++ G+ + E+L G CP
Sbjct: 207 KAADWWTLGIFIYEILVG-CP 226
|
Length = 340 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHM---EVLG-RLRHPNLVG 420
++LGKG FG A L G AVK LK + + E M VL +P L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + +E V E++ G L + + GR L T AA GL F+H
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDK---GRFDLYRATFY--AAEIVCGLQFLH-- 113
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIFAP--PSTVPRSNGYRAPELSSSD 535
S + + ++K NV+LD+ G+ +++DFG+ ++F ST + Y APE+
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ-- 169
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G K + D +SFGVLL E+L G+ P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 367 MLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE----QHMEVLGRLRHPNLVGL 421
+LGKGGFG V G + A KRL+ I KR+ E ++L ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNL 65
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y ++ LV M G L + ++ PG + L AA GL +H
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLEDLH--- 119
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDGR 537
+ ++K N+LLD G+ R+SD GL++ P R GY APE+ ++
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-- 176
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
+ + D + G L+ E++ G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 367 MLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE----QHMEVLGRLRHPNLVGL 421
+LGKGGFG V G + A K+L+ I KR+ E ++L ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSL 65
Query: 422 KAYYFAREEKLLVSEYMPNGSL-FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
Y ++ LV M G L F + H G + + AA GL +H
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYH----MGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDG 536
++ + ++K N+LLD G+ R+SD GL++ P + GY APE+ ++
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE- 176
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
+ + D ++ G LL E++ G+ P
Sbjct: 177 -RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 63/237 (26%), Positives = 92/237 (38%), Gaps = 59/237 (24%)
Query: 368 LGKGGFGT---AYKAVLDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRHPNLVG 420
+G+G FG D G V A+K L+ + + KR H+ ++L P +V
Sbjct: 9 IGRGAFGEVWLVRDK--DTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVK 65
Query: 421 LKAYYFAREEKL-LVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
L Y F EE L LV EYMP G L L+ + P T + L +A + L FIH
Sbjct: 66 LY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH 124
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-------------------------- 512
+IK N+L+D G+ +++DFGL
Sbjct: 125 ----------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 513 IFAPPSTVPR--------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ R + Y APE+ + D +S GV+L E+L G P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 47/281 (16%)
Query: 368 LGKGGFG-TAYKAVLDDGSVVAVKRL--KDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+GKG +G + DG +K+L ++AS ++ EQ ++L +L+HPN+V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 425 YFAREEKL-LVSEYMPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+ + L +V + G L+ L +G P ++W ++ +A L ++H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH-- 119
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPELSSSD 535
+ H ++K+ NV L +T +V D G+ + ST+ + Y +PEL S+
Sbjct: 120 --EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN- 176
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595
+ + KSDV++ G + E+ T K A D+ V ++ +
Sbjct: 177 -KPYNYKSDVWALGCCVYEMATLK------------HAFNAKDMNSLVYRIIEGK----- 218
Query: 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
L M KD E+ L+ + S P++RP++ +++
Sbjct: 219 --LPPMP-KDYSPELGELIATML---SKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 67/231 (29%), Positives = 97/231 (41%), Gaps = 33/231 (14%)
Query: 344 GSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKRE 402
M T ++L D E LG G FG A G A+K LK I ++
Sbjct: 4 AYMFTKPDTSSWKLSDF--EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ 61
Query: 403 FE---QHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLD 459
+ Q +L L HP +V + + + E++ G LF L R GR P D
Sbjct: 62 VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPND 118
Query: 460 WTTRLKIAA--GAARGLAF--IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515
+A A LAF +H S + + ++K N+LLD G+ +V+DFG +
Sbjct: 119 ------VAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168
Query: 516 PPST-----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P T P Y APE+ S G ++ D ++ GVLL E + G P
Sbjct: 169 PDRTFTLCGTPE---YLAPEVIQSKGHGKA--VDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME-----VLGRLRHPNLV 419
+++GKG FG A + AVK L+ +I K+E E+H+ +L ++HP LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLV 59
Query: 420 GLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
GL + F +KL V +Y+ G LF+ L R L+ R AA A L ++H
Sbjct: 60 GLH-FSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARF-YAAEIASALGYLH 113
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL--SIFAPPSTVPRSNG---YRAPELSS 533
SL + + ++K N+LLD G+ ++DFGL T G Y APE+
Sbjct: 114 ----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + D + G +L E+L G P
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGL-KA 423
LG G FG YKA + V+A ++ D + E E +M ++L HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 424 YYFAREEKLLVSEYMPNGSL-FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+Y+ +L+ E+ G++ +L R PL + L ++H
Sbjct: 71 FYYENNLWILI-EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN-- 122
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY------RAPEL---SS 533
K+ H ++K+ N+L G+ +++DFG+S T+ R + + APE+ +
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 534 SDGRKQSQKSDVYSFGVLLLEL 555
S R K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 356 ELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRL 413
EL+D LG G G +K ++ ++L I + + + ++VL
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 414 RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARG 473
P +VG +++ E + E+M GSL +L + GR P ++ IA +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKG 115
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRSNGYRAPE 530
L ++ + K+ H ++K +N+L++ G ++ DFG+S I + ++ + Y +PE
Sbjct: 116 LTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G S +SD++S G+ L+E+ G+ P
Sbjct: 173 --RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 76/279 (27%), Positives = 115/279 (41%), Gaps = 43/279 (15%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASIGGKRE-FEQHMEVLGRLRHPNL 418
E LG+ FG YK L + VA+K LKD + G RE F+ + RL+HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP----GRTPLDWTTR--------LKI 466
V L + ++ Y + L L R P G T D T + + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLV-MRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL--SIFAPPSTVPRSN 524
A G+ F+ S + H ++ + NVL+ N ++SD GL ++A N
Sbjct: 130 VTQIAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 525 G-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-------SVIDGGGAGM 571
+ +PE K S SD++S+GV+L E+ + G P VI+
Sbjct: 186 SLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEM 610
D P WV +++ E W F R+KDI +
Sbjct: 244 VLPCPDDCPAWVYTLMLECWNE--FPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 366 EMLGKGGFGTAYKA---VLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+ +G+G FG Y A + V+ L + K ++ + +L +++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGLAFIHF 479
A + +V EY G L ++ RG L W ++ + GL IH
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH- 118
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGN-ARVSDFGLSIFAPPS-----TVPRSNGYRAPELSS 533
K+ H +IKS N+ L K G A++ DFG++ S T + Y +PE+
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ R + K+D++S G +L EL T K P
Sbjct: 176 N--RPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKR--EFEQHMEVLGRLRHPNL 418
++LG+G FG Y D G +AVK++ D+ K E +++L LRH +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 419 VGLKAYYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
V EEK L EYMP GS+ ++ L + +G+++
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSI-----KDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPSTVPRSNG---YRA 528
+H S + H +IK N+L D GN ++ DFG S I + + G + +
Sbjct: 122 LH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ S +G +K+DV+S ++E+LT K P
Sbjct: 178 PEVISGEG--YGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKRE-FEQHMEVLGRLRHPNLVG 420
+G+G FG Y+ V ++ VAVK K+ + RE F Q ++ + HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L +V E P G L L N+ LD + + + + LA++
Sbjct: 72 LIGV-ITENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE-- 124
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSS 534
S + H +I + NVL+ ++ DFGLS + + +++ + APE S
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE--SI 180
Query: 535 DGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ R+ + SDV+ FGV + E+L G P
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 72/243 (29%), Positives = 98/243 (40%), Gaps = 65/243 (26%)
Query: 366 EMLGKGGFGTAYKAVLDD-GSVVAVKRL-KDASIGGKR----EFEQHMEVLGRLRHPNLV 419
++LGKG G + L G + A+K L K I + EQ E+L L HP L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ--EILATLDHPFLP 64
Query: 420 GLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI------AAGAAR 472
L A F E L LV +Y P G LF LL R PG+ L AA
Sbjct: 65 TLYA-SFQTETYLCLVMDYCPGGELFRLL--QRQPGK-------CLSEEVARFYAAEVLL 114
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP----------- 521
L ++H L + + ++K N+LL ++G+ +SDF LS + P
Sbjct: 115 ALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 522 -----------------RSNG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
RSN Y APE+ S DG D ++ G+LL E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG--HGSAVDWWTLGILLYEMLYG 228
Query: 559 KCP 561
P
Sbjct: 229 TTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 367 MLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE----QHMEVLGRLRHPNLVGL 421
+LGKGGFG V G + A K+L+ I KR+ E +L ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y ++ LV M G L + ++ PG D + AA GL +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQ--- 119
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDGR 537
++ + ++K N+LLD G+ R+SD GL++ P R GY APE+ +++
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-- 176
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
K + D + G L+ E++ G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKA 423
E +GKG +G YK DGS+ AVK L D E E +L L HPN+V
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 424 YYFAREEKL-----LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
++ ++ + LV E GS+ L+ G G+ LD I GA GL +H
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLH 145
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSS 533
+ ++ H ++K N+LL G ++ DFG+S + + R+ + APE+ +
Sbjct: 146 ----NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 534 SDGRKQSQ---KSDVYSFGVLLLELLTGKCP 561
+ + + DV+S G+ +EL G P
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 366 EMLGKGGFGTAYKA----VLDDGSV----VAVKRLKDASIGGKREFEQHMEVLGRLRHPN 417
E LG+G F +K V D G + V +K L + F + ++ +L H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
LV +E ++V EY+ GSL L N+ + W +L++A A L F+
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISW--KLEVAKQLAWALHFL 116
Query: 478 HFTCKSLKLTHGNIKSTNVLL-----DKTGNA---RVSDFGLSIFAPP-----STVPRSN 524
+ LTHGN+ + NVLL KTGN ++SD G+SI P +P
Sbjct: 117 ----EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--- 169
Query: 525 GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+ PE + + S +D +SFG L E+ +G
Sbjct: 170 -WVPPE-CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 68/291 (23%), Positives = 126/291 (43%), Gaps = 50/291 (17%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLK-----DASIGGKREFEQHMEVLGRLRHPNLVGL 421
+G+G F Y+A L D VA+K+++ DA +++ + +++L +L HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDLLKQLNHPNVIKY 67
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRG-----PGRTPLDWTTRLKIAAGAARGLAF 476
+ E +V E G L ++ + P RT + +L +
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL------CSAVEH 121
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRS----NGYRAPEL 531
+H S ++ H +IK NV + TG ++ D GL F+ +T S Y +PE
Sbjct: 122 MH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591
+G + KSD++S G LL E+ + P G ++L Q + + ++
Sbjct: 178 IHENG--YNFKSDIWSLGCLLYEMAALQSPFY----------GDKMNLFSLCQKIEQCDY 225
Query: 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
L Y + E+V + C PDQRP++ +V ++ +++
Sbjct: 226 PP----LPTEHYSEKLRELVSM------CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK-- 422
+G+G +G YKA D G +VA+K RL + G + +++L +L H N+V LK
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 423 ------AYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
A F +++ LV EYM + L LL G GL
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLES----GLVHFSEDHIKSFMKQLLEGL 129
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRA 528
+ H H +IK +N+LL+ G +++DFGL+ ++ + P +N YR
Sbjct: 130 NYCHKK----NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
PEL + R DV+S G +L EL T K
Sbjct: 186 PELLLGEER-YGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 368 LGKGGFG-----TAYKAVLDDGSV-VAVKRLKDASIGGKRE-FEQHMEVLGRL-RHPNLV 419
LG G FG TAY D + VAVK LK + +RE ++++ L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L L+++EY G L L R + L L + A+G+AF+
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 480 -TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNG-----YRAPEL 531
C H ++ + NVLL ++ DFGL+ I + V + N + APE
Sbjct: 160 KNC-----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE- 213
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLT 557
S + + SDV+S+G+LL E+ +
Sbjct: 214 SIFNCVYTFE-SDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 71/305 (23%), Positives = 114/305 (37%), Gaps = 74/305 (24%)
Query: 368 LGKGGFGTAYKAVL------DDGSVVAVKRL---KDASIGGKREFEQHMEVLGRLRHPNL 418
LG+G FG + A ++V VK L KD ++ + EF + +++ +L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKNV 70
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRT----PLDWTTRLKIAAGAARGL 474
V L E ++ EY G L L + PL ++ + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------- 527
+ + + H ++ + N L+ +VS LS V S Y+
Sbjct: 131 DHLS----NARFVHRDLAARNCLVSSQREVKVSLLSLS-----KDVYNSEYYKLRNALIP 181
Query: 528 ----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-------SVIDGGGAGMGCGG 575
APE D S KSDV+SFGVL+ E+ T G+ P V++ AG
Sbjct: 182 LRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG----- 234
Query: 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
LEL + + L+ C + +P RP+ S +V
Sbjct: 235 ---------------------KLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELV 270
Query: 636 KLIEE 640
+ E
Sbjct: 271 SALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 356 ELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRL---KDASIGGKREFEQHMEVLG 411
ELE + R +G G GT YK + G + A+K + + ++ +R+ + +E+L
Sbjct: 75 ELERVNR-----IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILR 127
Query: 412 RLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 471
+ HPN+V + E ++ E+M GSL G D +A
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLADVARQIL 178
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFA----PPSTVPRSNGY 526
G+A++H + H +IK +N+L++ N +++DFG+S I A P ++ + Y
Sbjct: 179 SGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAY 234
Query: 527 RAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCP 561
+PE ++D G D++S GV +LE G+ P
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 368 LGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIGGK-REFEQHMEVLGRLRHPNLVGL 421
LG+G FG D G VAVK LK S G + ++ +E+L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 422 KAYYFAREEK----LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
K E+ L+ E++P+GSL L N+ ++ +LK A +G+ ++
Sbjct: 72 KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYL 125
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR---------- 527
S + H ++ + NVL++ ++ DFGL+ + Y
Sbjct: 126 ----GSRQYVHRDLAARNVLVESEHQVKIGDFGLT-----KAIETDKEYYTVKDDLDSPV 176
Query: 528 ---APE-LSSSDGRKQSQKSDVYSFGVLLLELLT 557
APE L S K SDV+SFGV L ELLT
Sbjct: 177 FWYAPECLIQS---KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 361 LRASAE------MLGKGGFGTAYKAVLDDGS-VVAVKRLKDASIGGKRE---FEQHMEVL 410
LR AE ++G+G FG V A+K L + + + F + +++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 411 GRLRHPNLVGLKAYYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA 468
P +V L +Y ++++ L V EYMP G L L+ P + +T + +A
Sbjct: 98 AFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN---- 524
A + FIH ++K N+LLDK+G+ +++DFG + + R +
Sbjct: 156 DAIHSMGFIH----------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 525 --GYRAPELSSSDGRK--QSQKSDVYSFGVLLLELLTGKCPSVID 565
Y +PE+ S G ++ D +S GV L E+L G P D
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 43/232 (18%)
Query: 346 MVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE 404
+V G R L++ ++ +G+G G A G VAVK++ D +RE
Sbjct: 10 LVVDPGDPRSYLDNFVK-----IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELL 63
Query: 405 QHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ V+ R +HPN+V + + Y +E +V E++ G+L T + TR
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL------------TDIVTHTR 111
Query: 464 L---KIAA---GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517
+ +IA + L+F+H + + H +IKS ++LL G ++SDFG A
Sbjct: 112 MNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQV 165
Query: 518 ST-VPRSNG------YRAPELSSSDGRKQ-SQKSDVYSFGVLLLELLTGKCP 561
S VPR + APE+ S R + D++S G++++E++ G+ P
Sbjct: 166 SKEVPRRKSLVGTPYWMAPEVIS---RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-----DASIGGKREFEQHMEVLGRLRHPNLV 419
+ +G G +G YKA L G + AVK +K D S+ +Q + ++ +H N+V
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIV 69
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA---AGAARGLAF 476
Y +RE+ + EY GSL + H GP + L+IA +GLA+
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GP-------LSELQIAYVCRETLQGLAY 121
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPEL 531
+H K H +IK N+LL G+ +++DFG++ + R + + APE+
Sbjct: 122 LHSKGK----MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 532 SSSDGR-KQSQKSDVYSFGVLLLEL 555
++ + +Q D+++ G+ +EL
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-09
Identities = 22/38 (57%), Positives = 29/38 (76%), Gaps = 3/38 (7%)
Query: 28 DLNALLDFKAS--SDEANKLTTWN-STSDPCSWTGVSC 62
D +ALL FK+S D + L++WN S+SDPCSWTGV+C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 367 MLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHME----VLGRLRHPNL 418
+LGKGG+G ++ D G + A+K LK A+I ++ H + +L ++HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L Y F KL L+ EY+ G LF +H R ++ T ++ + LA
Sbjct: 63 VDL-IYAFQTGGKLYLILEYLSGGELF--MHLEREG--IFMEDTACFYLSEIS---LALE 114
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIF--APPSTVPRSNGYRAPELS 532
H + + ++K N+LLD G+ +++DFGL SI T + Y APE+
Sbjct: 115 HL--HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G + D +S G L+ ++LTG P
Sbjct: 173 MRSG--HGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 363 ASAEMLGKGGFGTAYKAVLD-DGSV--VAVKRLKDASIGGKREFEQHME---VLGRLRHP 416
A + LG+G FG+ + L+ D S+ VAVK +K A I + E E + + HP
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHP 60
Query: 417 NLVGLKAYYFAREEK------LLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAG 469
N++ L E +++ +M +G L +LL+ G L +K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAP 529
A G+ ++ S H ++ + N +L++ N V+DFGLS + + YR
Sbjct: 121 IASGMEYL----SSKSFIHRDLAARNCMLNENMNVCVADFGLS-----KKIYNGDYYRQG 171
Query: 530 ELS----------SSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
++ S R + KSDV+SFGV + E+ T G+ P
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 368 LGKGGFGTAYKAVLDDGS-VVAVKRLKDASIGGKREFEQHME---VLGRLRHPNLVGLKA 423
+GKG FG + D + A+K ++ A I + E + VL ++ P +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLH--GNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ + E+ LV ++ G LF L G R +T L A L +H
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARF-YTAELLCA------LENLH--- 110
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSD 535
+ + ++K N+LLD G+ + DFGL ++N Y APEL
Sbjct: 111 -KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGH 168
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G ++ D ++ GVLL E+LTG P
Sbjct: 169 G--YTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-09
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+G G +G AV G VA+K++ + I KR + +++L LRH N++GL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-IKLLRHLRHENIIGLLD 66
Query: 424 --YYFAREE--KL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK-IAAGAARGLAFI 477
+ E+ + +V+E M L ++ + PL ++ RGL ++
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-----PLT-DDHIQYFLYQILRGLKYL 119
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPST--------VPRSNGYR 527
H S + H ++K +N+L++ + ++ DFGL+ + V R YR
Sbjct: 120 H----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW--YR 173
Query: 528 APE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
APE LSSS + ++ D++S G + ELLT K
Sbjct: 174 APELLLSSS---RYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFG---TAYKAVLDDGSVVAVKRLKD---ASIGGKRE 402
FE T R+ + +G G FG +A + G VA+K++ + KR
Sbjct: 6 FEITNRY-------VDLQPVGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRT 56
Query: 403 FEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
+ + +++L LRH N++ L + + E+ V+E + L LL PL+
Sbjct: 57 YRE-LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSR------PLEKQ 108
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP 521
RGL ++H S + H ++K +N+L+++ + ++ DFGL+ P
Sbjct: 109 FIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG 164
Query: 522 --RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ YRAPE+ + +K + D++S G + E+L GK
Sbjct: 165 YVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 13/158 (8%)
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
++VL P +VG +++ E + E+M GSL +L + GR P + ++ I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISI 106
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTVPRS 523
A RGL ++ + K+ H ++K +N+L++ G ++ DFG+S I + ++ +
Sbjct: 107 AV--LRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 161
Query: 524 NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y +PE G + +SD++S G+ L+E+ G+ P
Sbjct: 162 RSYMSPE--RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 49/198 (24%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+ +G G +G YKA ++ G + A+K +K +Q + ++ +H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
Y R++ + E+ GSL + H PL + ++ +GL ++H K
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSSDGRK- 538
H +IK N+LL G+ +++DFG+S + R + + APE+++ + RK
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE-RKG 184
Query: 539 -QSQKSDVYSFGVLLLEL 555
+Q D+++ G+ +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 72/303 (23%), Positives = 123/303 (40%), Gaps = 62/303 (20%)
Query: 367 MLGKGGFGTAYKAVL--DDGSV--VAVKRLKDASIGGKREFEQHME---VLGRLRHPNLV 419
MLGKG FG+ +A L +DGS VAVK LK A I + E+ + + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 420 GLKAYYFAREEK------LLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
L K +++ +M +G L +LL G L T ++ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAP--- 529
G+ ++ S H ++ + N +L++ V+DFGLS + + YR
Sbjct: 125 GMEYL----SSKNFIHRDLAARNCMLNENMTVCVADFGLS-----KKIYSGDYYRQGCAS 175
Query: 530 -------ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPR 581
L S + SDV++FGV + E++T G+ P AG+
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY------AGVE--------- 220
Query: 582 WVQSVVREEWTAEVFDLELM--RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
+E+++ + R K + + + ++ C S P RP+ H+ +E
Sbjct: 221 ----------NSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
Query: 640 ELR 642
+
Sbjct: 271 LIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNL 418
++LGKG FG K +L G A+K L+ I K E + VL RHP L
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFI 477
LK + + V EY G LF+ L R + R + A L ++
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHL------SRERVFTEERARFYGAEIVSALEYL 111
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPE-L 531
H S + + +IK N++LDK G+ +++DFGL S A T + Y APE L
Sbjct: 112 H----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 532 SSSD-GRKQSQKSDVYSFGVLLLELLTGKCP 561
+D GR D + GV++ E++ G+ P
Sbjct: 168 EDNDYGR----AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGS--VVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVG 420
+++G+G FG + V S V A+K L + + + F + +++ P +V
Sbjct: 49 KVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + + +V EYMP G L L+ P + +T + +A A IH
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IH-- 159
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN------GYRAPELSSS 534
S+ L H ++K N+LLDK G+ +++DFG + + + R + Y +PE+ S
Sbjct: 160 --SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 535 DGRK--QSQKSDVYSFGVLLLELLTGKCPSVID 565
G ++ D +S GV L E+L G P D
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNL 418
++LGKG FG K +L G A+K LK I K E + VL RHP L
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAF 476
LK Y F ++L V EY G LF+ L R + R + A L +
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDY 110
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-----SIFAPPSTVPRSNGYRAPE- 530
+H + + ++K N++LDK G+ +++DFGL A T + Y APE
Sbjct: 111 LH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167
Query: 531 LSSSD-GRKQSQKSDVYSFGVLLLELLTGKCP 561
L +D GR D + GV++ E++ G+ P
Sbjct: 168 LEDNDYGR----AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 69/320 (21%)
Query: 368 LGKGGFGTAYKAVL--------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
LG+G FG +A D VAVK LKD A+ + ME++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG-----------RTPLDWTTRLKI 466
++ L ++ EY G+L L R PG L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
A ARG+ ++ +S + H ++ + NVL+ + +++DFGL+ + SN
Sbjct: 140 AYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 525 G-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579
G + APE + R + +SDV+SFG+L+ E+ T +G +
Sbjct: 196 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGILMWEIFT-------------LGGSPYPGI 240
Query: 580 PRWVQSVVREEWTAEVFDL-----ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHV 634
P E+F L + + + E+ L++ C A P QRP
Sbjct: 241 P-----------VEELFKLLREGHRMDKPSNCTHELYMLMR---ECWHAVPTQRPTFK-- 284
Query: 635 VKLIEELRGVEVSPCHENFD 654
+L+E L V + E D
Sbjct: 285 -QLVEALDKVLAAVSEEYLD 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
E +G+G +G YK G +VA+K RL+ G + + +L L+HPN+V L+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
L+ E++ S+ + + P +D +G+ F C
Sbjct: 66 DVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF----CH 118
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN----GYRAPE--LSSSD 535
S ++ H ++K N+L+D G +++DFGL+ F P V YRAPE L S
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP- 177
Query: 536 GRKQSQKSDVYSFGVLLLELLTGK 559
+ S D++S G + E+ T K
Sbjct: 178 --RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E++G G +G YK + G + A+K + D + + E +Q + +L + H + Y
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHR--NIATY 68
Query: 425 YFA---------REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
Y A ++ LV E+ GS+ L+ +G +W I RGL+
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAY--ICREILRGLS 125
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY------RAP 529
+H K+ H +IK NVLL + ++ DFG+S TV R N + AP
Sbjct: 126 HLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAP 180
Query: 530 ELSSSDGRKQSQ---KSDVYSFGVLLLELLTGKCP 561
E+ + D + KSD++S G+ +E+ G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 366 EMLGKGGFGTAY---KAV-LDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRH-P 416
++LG G +G + K D G + A+K L+ A++ K + +H VL +R P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 417 NLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
LV L Y F E KL L+ +Y+ G +F L+ ++ +G LA
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRFYSGEII-LA 117
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAP 529
H L + + +IK N+LLD G+ ++DFGLS R+ Y AP
Sbjct: 118 LEHL--HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566
E+ G + D +S G+L+ ELLTG P ++G
Sbjct: 176 EIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTLEG 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 382 DDGSVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVGLKAYYFAREEKLL-VSEY 437
G VA+K L+ + + + F + + RL HPN+V L A L V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497
+P +L +L G P T RL LA H + + H ++K N++
Sbjct: 61 VPGRTLREVL-AADGA--LPAGETGRL--MLQVLDALACAH----NQGIVHRDLKPQNIM 111
Query: 498 LDKTG---NARVSDFGLSIFAP------PSTVPR------SNGYRAPELSSSDGRKQSQK 542
+ +TG +A+V DFG+ P +T+ R + Y APE G +
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE--QLRGEPVTPN 169
Query: 543 SDVYSFGVLLLELLTGK 559
SD+Y++G++ LE LTG+
Sbjct: 170 SDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 367 MLGKGGFGTAYKAVLDD--GSVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVGL 421
++G+G FG + V + G + A+K +K + + + FE+ ++L P + L
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 422 KAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD------WTTRLKIAAGAARGL 474
+ Y F ++ L LV EY P G L LL NR D + L +A
Sbjct: 67 Q-YAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFDEDMAQFYLAELVLA------- 114
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRS----NGYRA 528
IH + + H +IK NVL+D+TG+ +++DFG + + A + Y A
Sbjct: 115 --IH-SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 529 PE-LSSSDGRKQSQ---KSDVYSFGVLLLELLTGKCP 561
PE L++ +G + + D +S GV+ E++ G+ P
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLKA 423
LGKGGFG + G + A K+L + ++ +E M +L ++ +V L A
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 424 YYFAREEKL-LVSEYMPNGSLFWLLHG--NRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
Y F + L LV M G L + ++ PG A GL +H
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLEHLH-- 114
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-FAPPSTVPR----SNGYRAPELSSSD 535
++ + ++K NVLLD GN R+SD GL++ + + + G+ APEL
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ-- 170
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G + D ++ GV L E++ + P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E++G G +G YK + G + A+K + D + + E + + +L + H + Y
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHR--NIATY 78
Query: 425 YFA--------REEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
Y A +++L LV E+ GS+ L+ +G DW I RGLA
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAY--ICREILRGLA 135
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY------RAP 529
+H + K+ H +IK NVLL + ++ DFG+S TV R N + AP
Sbjct: 136 HLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAP 190
Query: 530 ELSSSDGRKQSQ---KSDVYSFGVLLLELLTGKCP 561
E+ + D + +SD++S G+ +E+ G P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 52/220 (23%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREFEQHMEVLGRLR-HPNLVGLK 422
LGKG +G +KA+ VVA+K++ DA + +R F + M L L HPN+V L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM-FLQELGDHPNIVKLL 73
Query: 423 AYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR---LK------IAAGAA 471
A +K LV EYM T L R L+ I
Sbjct: 74 NVIKAENDKDIYLVFEYM----------------ETDLHAVIRANILEDVHKRYIMYQLL 117
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------ 525
+ L +IH S + H ++K +N+LL+ +++DFGL+ N
Sbjct: 118 KALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 526 ----YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE L S + ++ D++S G +L E+L GK
Sbjct: 174 ATRWYRAPEILLGS---TRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 63/239 (26%)
Query: 366 EMLGKGGFGTAYKAVLDDGS-----------------VVAVKRLK-DASIGGKREFEQHM 407
E LG+G FG + + + +VAVK L+ DA+ + +F + +
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLH--------GNRGPGRTP-- 457
++L RL+ PN++ L + +++EYM NG L L N P
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 458 ----LDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513
+ +++ L +A A G+ ++ SL H ++ + N L+ + +++DFG+S
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL----SSLNFVHRDLATRNCLVGENLTIKIADFGMS- 185
Query: 514 FAPPSTVPRSNGYRAPELSSSDGR----------------KQSQKSDVYSFGVLLLELL 556
N Y A + GR K + SDV++FGV L E+L
Sbjct: 186 ---------RNLY-AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKR--EFEQHMEVLGRLRHPNL 418
++LG+G FG Y D G +AVK+++ ++ K E +++L L H +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 419 VGLKAYYFARE--EKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
V + Y R+ E+ L E+MP GS+ ++ L K G+
Sbjct: 67 V--QYYGCLRDPMERTLSIFMEHMPGGSI-----KDQLKSYGALTENVTRKYTRQILEGV 119
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPSTVPRSNG---Y 526
+++H S + H +IK N+L D GN ++ DFG S I + + G +
Sbjct: 120 SYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+PE+ S +G +K+D++S G ++E+LT K P
Sbjct: 176 MSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
E +G+G +G YKA G VVA+K RL + G + + +L L HPN+V L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG-RTPL--DWTTRLKIAAGAARGLAFIHF 479
+ LV E++ + L + + G PL + +L +GLAF
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL------LQGLAF--- 115
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP-RSNG-------YRAPEL 531
C S ++ H ++K N+L++ G +++DFGL A VP R+ YRAPE+
Sbjct: 116 -CHSHRVLHRDLKPQNLLINTEGAIKLADFGL---ARAFGVPVRTYTHEVVTLWYRAPEI 171
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ S D++S G + E++T +
Sbjct: 172 LLG-CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 367 MLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
++G G FG Y+A+ +D VA+K++ RE + ++ L H N++ LK YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDYY 128
Query: 426 ----FAREEKLL----VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
F + EK + V E++P ++ H R PL + +L + R LA+I
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYI 186
Query: 478 H--FTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLS--IFAPPSTVPR--SNGYRAPE 530
H F C H ++K N+L+D T ++ DFG + + A +V S YRAPE
Sbjct: 187 HSKFIC------HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
L + D++S G ++ E++ G
Sbjct: 241 LMLG-ATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 368 LGKGGFGTAYKAVLDDGSVV--AVKRLKDASIGGKREFE-----QHMEVLGRLRHPNLVG 420
LGKG FGT Y V D +V +K LK+ +G E Q ++L +L HP +V
Sbjct: 8 LGKGSFGTVY-LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRT-----PLDWTTRLKIAAGAARGLA 475
A + R+ +++EY L L + G+T +W +L + G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVH 120
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-----TVPRSNGYRAPE 530
++H ++ H ++K+ N+ L K ++ DFG+S S T + Y +PE
Sbjct: 121 YMH----QRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLEL 555
G KSD++S G +L E+
Sbjct: 176 ALKHQG--YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 49/218 (22%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIG----GKREFEQHMEVLGRLRHPNL 418
E +G+G +G YKA G +VA+K RL+ G RE + +L L HPN+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNI 60
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L + E KL LV E++ L + + P T LD +G+A+
Sbjct: 61 VRLLDVVHS-ENKLYLVFEFL---DLDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAY- 114
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------------ 525
C S ++ H ++K N+L+D+ G +++DFGL+ R+ G
Sbjct: 115 ---CHSHRVLHRDLKPQNLLIDREGALKLADFGLA---------RAFGVPVRTYTHEVVT 162
Query: 526 --YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE L S R+ S D++S G + E++ +
Sbjct: 163 LWYRAPEILLGS---RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 71/230 (30%), Positives = 104/230 (45%), Gaps = 38/230 (16%)
Query: 351 GTKR-FELEDLLRASAEMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHME 408
G K +L DL +G G G YK G V+AVK++ G K E++
Sbjct: 7 GQKYPADLNDLENLG--EIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNK---EENKR 59
Query: 409 VLGRLR-----H--PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
+L L H P +V Y+ + + E M L LL +GP P D
Sbjct: 60 ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGP--IPEDIL 116
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHG----NIKSTNVLLDKTGNARVSDFGLSIFAPP 517
++ +A A +H+ LK HG ++K +N+LLD +GN ++ DFG+S
Sbjct: 117 GKMTVAIVKA-----LHY----LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167
Query: 518 STV-PRSNG---YRAPE-LSSSDGR-KQSQKSDVYSFGVLLLELLTGKCP 561
S RS G Y APE + D K ++DV+S G+ L+EL TG+ P
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 369 GKGGFGTAYKAVLDDGS---VVAVKRLKDA-------SIGGKREFEQHMEVLGRLRHPNL 418
G+G +G YKA +G A+K+ K S RE + +L L+H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 419 VGLKAYYFAREEKL--LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
V L + +K L+ +Y + L+ ++ +R R + + + G+ +
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 477 IHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLS-IFAPPSTVPRS-NG----- 525
+H S + H ++K N+L+ + G ++ D GL+ +F P +
Sbjct: 124 LH----SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 526 -YRAPELSSSDGRKQSQKS-DVYSFGVLLLELLT 557
YRAPEL G + K+ D+++ G + ELLT
Sbjct: 180 WYRAPELLL--GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 62/247 (25%)
Query: 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRHPNL 418
S +++G+G FG D G + A+K+L+ + + ++E H+ ++L +P +
Sbjct: 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWV 63
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L Y F E L L+ EY+P G + LL T + TR IA + I
Sbjct: 64 VKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAE-TILAIDSI 117
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---------------------SIFAP 516
H L H +IK N+LLD G+ ++SDFGL S F
Sbjct: 118 H----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 517 PSTVPRSNG----------------------YRAPELSSSDGRKQSQKSDVYSFGVLLLE 554
+ P S+ Y APE+ G +++ D +S GV++ E
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLGVIMYE 231
Query: 555 LLTGKCP 561
+L G P
Sbjct: 232 MLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGK---------REFEQHMEVLGRLRH 415
E LG+G F YK VL + V ++ S+ K F + ++ +L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
+LV L R+E ++V EY+ G L LH + L W +L +A A L
Sbjct: 61 KHLVKLYGV-CVRDENIMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASALH 115
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGN-------ARVSDFGLSIFAPPSTVPRSNG-YR 527
++ + KL HGN+ N+L+ + G ++SD G+ I +
Sbjct: 116 YL----EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI 171
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLEL 555
APE + + +D +SFG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 366 EMLGKGGFGTAYKAVLD--DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLK 422
E +GKG +G +K VL+ +GS AVK L D E E +L L HPN+V
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 423 AYYFAREEK-----LLVSEYMPNGSLFWLLHG--NRGPGRTPLDWTTRLKIA---AGAAR 472
Y+ ++ K LV E GS+ L+ G RG + IA A
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG------ERMEEPIIAYILHEALM 135
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YR 527
GL +H K H ++K N+LL G ++ DFG+S + + R+ +
Sbjct: 136 GLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 528 APELSSSDGRKQS---QKSDVYSFGVLLLELLTGKCP 561
APE+ + + + S + DV+S G+ +EL G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 56/310 (18%)
Query: 368 LGKGGFGTAYKAVLDD------GSVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
LG+G FG Y+ D + VAVK + + AS+ + EF V+ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-----GPGRTPLDWTTRLKIAAGAARGLA 475
L + L+V E M +G L L R PGR P +++AA A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-------YRA 528
+++ + K H ++ + N ++ ++ DFG++ + R G + A
Sbjct: 134 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588
PE S DG + SD++SFGV+L E+ + + P Q +
Sbjct: 190 PE-SLKDG-VFTTSSDMWSFGVVLWEITS------------------LAEQP--YQGLSN 227
Query: 589 EEWTAEVFD-LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647
E+ V D L + + E + L+++ C +P RP +V L+++
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD------- 277
Query: 648 PCHENFDSVS 657
H +F VS
Sbjct: 278 DLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 61/206 (29%), Positives = 88/206 (42%), Gaps = 21/206 (10%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLR-HPNLVG 420
+LGKG FG A L + G + AVK LK I + E M +L R HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + + V E++ G L + + +R D AA L F+H
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH-- 113
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIF--APPSTVPRSNGYRAPELSSSD 535
+ + ++K NVLLD G+ +++DFG+ IF ST + Y APE+
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
D ++ GVLL E+L G P
Sbjct: 172 --LYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 44/211 (20%)
Query: 371 GGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME-----------VLGRLRHPNL 418
G +G Y+A G +VA+K+LK E+ E +L +L+HPN+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK---------MEKEKEGFPITSLREINILLKLQHPNI 66
Query: 419 VGLKAYYF-AREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
V +K + +K+ +V EY+ + L L+ + P L++ G+A
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL----SGVAH 121
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN--------GYRA 528
+H + H ++K++N+LL+ G ++ DFGL A P YRA
Sbjct: 122 LH----DNWILHRDLKTSNLLLNNRGILKICDFGL---AREYGSPLKPYTQLVVTLWYRA 174
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
PEL ++ S D++S G + ELLT K
Sbjct: 175 PEL-LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGS--VVAVKRL-KDASIGGKRE----FEQHMEVLGRLRHPNL 418
+++G+G FG + V S V A+K L K I KR F + +++ +
Sbjct: 49 KVIGRGAFG-EVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWI 105
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L Y F ++ L +V EYMP G L L+ P W R A L I
Sbjct: 106 VQLH-YAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWA-RFYTAE-VVLALDAI 158
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN------GYRAPEL 531
H S+ H ++K N+LLDK+G+ +++DFG + + + R + Y +PE+
Sbjct: 159 H----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214
Query: 532 SSSDGRKQ--SQKSDVYSFGVLLLELLTGKCP 561
S G ++ D +S GV L E+L G P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 29/181 (16%)
Query: 402 EFEQHMEVLGRLRHPNLVGLK--------AYYFAREEKLLVSEYMPNGSLFWLLHGNRGP 453
+ E + LGRL H N++ ++ Y ++ + +M + + W
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------- 260
Query: 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513
PL TR I + +IH KL H +IK N+ L+ G + DFG ++
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIH----DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 514 FAPPSTVPRSNGY------RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGG 567
G+ +PE+ + DG + +D++S G++LL++L+ + DGG
Sbjct: 316 PFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHDFCPIGDGG 373
Query: 568 G 568
G
Sbjct: 374 G 374
|
Length = 501 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLK 422
E++GKG +G A+ G VA+K++ D + + +++L LRHP++V +K
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 423 AYYFA---REEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
RE K +V E M L ++ N TP L R L +I
Sbjct: 66 HIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFL---YQLLRALKYI 119
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA---PPSTV-----PRSNGYRAP 529
H + + H ++K N+L + ++ DFGL+ A P+ + + YRAP
Sbjct: 120 H----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
EL S K + D++S G + E+LTGK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 368 LGKGGFGTAY----KAVLDDG--SVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
LG+G FG Y K V+ D + VA+K + + AS+ + EF V+ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-----GPGRTPLDWTTRLKIAAGAARGLA 475
L + L++ E M G L L R P + P +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-------YRA 528
+++ K H ++ + N ++ + ++ DFG++ + R G + +
Sbjct: 134 YLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLT 557
PE S DG + SDV+SFGV+L E+ T
Sbjct: 190 PE-SLKDGVFTTY-SDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 34/178 (19%)
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNG--- 525
ARG+ F+ S K H ++ + N+LL + ++ DFGL+ I+ P V + +
Sbjct: 184 ARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 526 --YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583
+ APE S D +Q SDV+SFGVLL E+ + GA P V
Sbjct: 240 LKWMAPE-SIFDKVYTTQ-SDVWSFGVLLWEIFS----------------LGASPYPG-V 280
Query: 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
Q + EE+ + D MR + + ++ +AC P +RP S +V+++ +L
Sbjct: 281 Q--INEEFCQRLKDGTRMRAPENATPEI--YRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
E +G+G +GT +KA + +VA+KR L D G + + +L L+H N+V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ ++ LV EY + L G +D +GLAF C
Sbjct: 66 DVLHSDKKLTLVFEYC-DQDLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAF----CH 116
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP-RSNG-------YRAPELSSS 534
S + H ++K N+L++K G +++DFGL A +P R YR P++
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGL---ARAFGIPVRCYSAEVVTLWYRPPDVLF- 172
Query: 535 DGRKQSQKS-DVYSFGVLLLELLTGKCP 561
G K S D++S G + EL P
Sbjct: 173 -GAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 346 MVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE 404
MV G R L++ ++ +G+G G A V G +VAVK++ D +RE
Sbjct: 11 MVVDPGDPRTYLDNFIK-----IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELL 64
Query: 405 QHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ V+ R +H N+V + Y +E +V E++ G+L ++ R ++
Sbjct: 65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQI 118
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRS 523
+ + L+ +H + + H +IKS ++LL G ++SDFG VPR
Sbjct: 119 AAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRR 173
Query: 524 NG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APEL S + D++S G++++E++ G+ P
Sbjct: 174 KSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 367 MLGKGGFGTAYKAVLDD--GS--VVAVKRLKDASIGGKREFEQHM---EVLGRLRHPN-L 418
+LGKG FG K +L + G+ + A+K LK I + E M VL P L
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
L + + + V EY+ G L + + G + P + AA A GL F+H
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEP----HAVFYAAEIAIGLFFLH 118
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIFAPPST-----VPRSNGYRAPE 530
S + + ++K NV+LD G+ +++DFG+ +IF +T P Y APE
Sbjct: 119 ----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP---DYIAPE 171
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + +S D ++FGVLL E+L G+ P
Sbjct: 172 IIAYQPYGKS--VDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 57/247 (23%), Positives = 96/247 (38%), Gaps = 76/247 (30%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM 407
F+ R++ + G+G +G A G VA+K++ FE
Sbjct: 1 FDVGPRYQNLSYI-------GEGAYGMVCSATHKPTGVKVAIKKIS--------PFEHQT 45
Query: 408 ---------EVLGRLRHPNLVGLKAYYFAR-----EEKLLVSEYMPNGSLFWLLHGNRGP 453
++L R +H N++G+ + +V E M L+ L+
Sbjct: 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK----- 99
Query: 454 GRTPLDWTTRL----------KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN 503
T L +I RGL +IH S + H ++K +N+LL+ +
Sbjct: 100 -------TQHLSNDHIQYFLYQIL----RGLKYIH----SANVLHRDLKPSNLLLNTNCD 144
Query: 504 ARVSDFGLSIFAPPSTVPRS--------NGYRAPE--LSSSDGRKQSQKS-DVYSFGVLL 552
++ DFGL+ A P YRAPE L+S K K+ D++S G +L
Sbjct: 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS----KGYTKAIDIWSVGCIL 200
Query: 553 LELLTGK 559
E+L+ +
Sbjct: 201 AEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 368 LGKGGFGTAYKAVL--------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
LG+G FG A + VAVK LKD A+ + ME++ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG-----------RTPLDWTTRLKI 466
++ L ++ EY G+L L R PG + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
ARG+ ++ S K H ++ + NVL+ + +++DFGL+ + +N
Sbjct: 143 TYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 525 G-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
G + APE + R + +SDV+SFGVL+ E+ T
Sbjct: 199 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 364 SAEMLGKGGFGTAYKAVLDDGSV-----VAVKRLKD-ASIGGKREFEQHMEVLGRLRHPN 417
+++L +G FG + +L D V VK +KD AS Q +L L H N
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 418 LVGLKAYYFAREEKLLVSE-YMPNGSL-FWLLHGNRGPGRTPLDWTTR--LKIAAGAARG 473
++ + E V YM G+L +L G P +T+ + +A A G
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR---- 527
++++H + H +I + N ++D+ +++D LS +F N R
Sbjct: 130 MSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 528 -APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSV-ID 565
A E S ++ S SDV+SFGVLL EL+T G+ P V ID
Sbjct: 186 MALE--SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 367 MLGKGGFGTAY---KAVLDDGSVVAVKRLKDASIGGKRE-----FEQHMEVLGRLRHPNL 418
++G+GGFG Y KA D G + A+K L I K+ E+ M L
Sbjct: 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLA 475
+ +Y F +KL + + M G L + L HG AA GL
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-------YAAEIILGLE 111
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL----SIFAPPSTVPRSNGYRAPEL 531
+H + + + ++K N+LLD+ G+ R+SD GL S P ++V ++GY APE+
Sbjct: 112 HMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-THGYMAPEV 166
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCPS 562
G +D +S G +L +LL G P
Sbjct: 167 LQK-GVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 359 DLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHP 416
+LL + K ++VAVK+ L S + +Q + +L+HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 417 NLVGLKAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGL 474
N++ + E +VS M GS LL H G + + + L
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNAL 114
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS------------IFAPPSTVPR 522
+IH S H ++K++++LL G +S S + P + +
Sbjct: 115 DYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 523 SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + +PE+ + + ++KSD+YS G+ EL G P
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 29/202 (14%)
Query: 368 LGKGGFGTAYKAVLD---DGSVVAVKRLK----DASIGGKREFEQHMEVLGRLRHPNLVG 420
LG G FGT K + VAVK LK D ++ K E + V+ +L +P +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPAL--KDELLREANVMQQLDNPYIVR 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+ A E +LV E G L L N+ + ++ + G+ ++ T
Sbjct: 61 MIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEET 114
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--------IFAPPSTVPRSNGYRAPELS 532
H ++ + NVLL A++SDFGLS + + + APE
Sbjct: 115 ----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 533 SSDGRKQSQKSDVYSFGVLLLE 554
+ K S KSDV+SFGVL+ E
Sbjct: 171 NY--YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 367 MLGKGGFGTAY---KAVLDDGSVVAVKRLKDASIGGKRE-----FEQHMEVLGRLRHPNL 418
++G+GGFG Y KA D G + A+K L I K+ E+ M L
Sbjct: 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLA 475
+ Y F +KL + + M G L + L HG A GL
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-------YATEIILGLE 111
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-FA--PPSTVPRSNGYRAPELS 532
+H + + + ++K N+LLD+ G+ R+SD GL+ F+ P ++GY APE+
Sbjct: 112 HMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 167
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G +D +S G +L +LL G P
Sbjct: 168 QK-GTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 473 GLAFIHFT-----CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG- 525
GL FI S + H +IKS N+LL G ++ DFG S ++A +TV G
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGR 203
Query: 526 -------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ + S+K+D++S GVLL ELLT K P
Sbjct: 204 TFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 368 LGKGGFGTAYKAV---LDDG-----SVVAVKRLK-DASIGGKREFEQHMEVLGRL-RHPN 417
LG+G FG A LD + VAVK LK DA+ + ME++ + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG--------RTP---LDWTTRLKI 466
++ L ++ EY G+L L R PG + P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
A ARG+ ++ S K H ++ + NVL+ + +++DFGL+ I +N
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 525 G-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
G + APE + R + +SDV+SFGVLL E+ T
Sbjct: 202 GRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 46/212 (21%)
Query: 368 LGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHMEV--------LGRLR-HPN 417
+G+G F KA G A+K +K F+ +V L RL HPN
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKH-------FKSLEQVNNLREIQALRRLSPHPN 59
Query: 418 LVGLKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
++ L F R+ LV E M + +L+ L+ G + PL R +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRK----RPL----------PEKRVKS 104
Query: 476 FIHFTCKSLKLTHGN------IKSTNVLLDKTGNARVSDFG--LSIFA-PPSTVPRSNG- 525
+++ KSL H N IK N+L+ +++DFG I++ PP T S
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRW 163
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
YRAPE +DG K D+++ G + E+L+
Sbjct: 164 YRAPECLLTDGY-YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 368 LGKGGFGTAY--------KAVLDDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
LG+G FG K + VAVK LKD A+ + ME++ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG--------RTP---LDWTTRLKI 466
++ L ++ EY G+L L R PG + P L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
A ARG+ ++ S K H ++ + NVL+ + +++DFGL+ + +N
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 525 G-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
G + APE + R + +SDV+SFGVLL E+ T
Sbjct: 196 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 27/224 (12%)
Query: 346 MVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFE 404
MV +G R LE+ ++ +G+G G A G VAVK + D +RE
Sbjct: 12 MVVDQGDPRSLLENYIK-----IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELL 65
Query: 405 QHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ V+ R +H N+V + Y EE ++ E++ G+L ++ R L+
Sbjct: 66 FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQI 119
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRS 523
+ + L ++H S + H +IKS ++LL G ++SDFG VP+
Sbjct: 120 ATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCA-QISKDVPKR 174
Query: 524 NG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APE+ S + D++S G++++E++ G+ P
Sbjct: 175 KSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 36/196 (18%)
Query: 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS- 512
+ PL + + ARG+ F+ S K H ++ + N+LL + ++ DFGL+
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
Query: 513 -IFAPPSTVPRSNGYR------APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565
I+ P V R R APE S + + +SDV+SFGVLL E+ +
Sbjct: 222 DIYKDPDYV-RKGDARLPLKWMAPE--SIFDKVYTTQSDVWSFGVLLWEIFS-------- 270
Query: 566 GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASP 625
GA P VQ + EE+ + + MR + + + + C +P
Sbjct: 271 --------LGASPYPG-VQ--IDEEFCRRLKEGTRMRAPEYATPEI--YSIMLDCWHNNP 317
Query: 626 DQRPNMSHVVKLIEEL 641
+ RP S +V+++ +L
Sbjct: 318 EDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLR---HPNLVGL 421
+G G +GT YKA G VA+K R++ G + + +L RL HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 422 ----KAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
RE K+ LV E++ + L L PG P + T + RGL F
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAE--TIKDLMRQFLRGLDF 123
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL----SIFAPPSTVPRSNGYRAPE-- 530
+H C + H ++K N+L+ G +++DFGL S + V + YRAPE
Sbjct: 124 LHANC----IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
L S+ + D++S G + E+ K
Sbjct: 180 LQST----YATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 29/210 (13%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHM---EVLGRLR-HPNLVG 420
++LGKG FG A L V A+K LK I + + M +L HP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L + ++ V EY+ G L + + +R D AA L F+H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLH-- 113
Query: 481 CKSLKLTHG----NIKSTNVLLDKTGNARVSDFGLSI--FAPPSTVPRSNG---YRAPEL 531
HG ++K N+LLD G+ +++DFG+ T G Y APE+
Sbjct: 114 ------RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI 167
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ D ++ GVL+ E++ G+ P
Sbjct: 168 LQE--LEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 368 LGKGGFGTAYKA--VLDDGSVVAVKRLKDASIGGKREFEQHMEV-----LGRLRHPNLVG 420
+G+G +G +KA + + G VA+KR++ + EV L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 421 L----KAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
L RE KL LV E++ + L L PG T + RGL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL----SIFAPPSTVPRSNGYRAPE- 530
F+H S ++ H ++K N+L+ +G +++DFGL S ++V + YRAPE
Sbjct: 125 FLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 531 -LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
L SS + D++S G + E+ K
Sbjct: 181 LLQSS----YATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRH-PNLVGL 421
E +G+G +G YKA + G +VA+K RL+ G + + +L L +V L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 422 KAYYFAREEK-----LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
E+ LV EY+ + ++ RGPGR PL T +G+A
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR-PLPAKTIKSFMYQLLKGVAH 125
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNA-RVSDFGLS-IFAPPSTVPRSN--------GY 526
C + H ++K N+L+DK +++D GL F ++P + Y
Sbjct: 126 ----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF----SIPVKSYTHEIVTLWY 177
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
RAPE+ S D++S G + E+
Sbjct: 178 RAPEVLLG-STHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGL 421
E +G G +G A+ G VA+K++ A KR + +++L +H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE-LKILRHFKHDNIIAI 69
Query: 422 KAYYFAREEKL----LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
+ +V + M + L ++H ++ PL RGL +I
Sbjct: 70 RDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYI 123
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN---------GYRA 528
H S + H ++K +N+L+++ R+ DFG++ S YRA
Sbjct: 124 H----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELL 556
PEL S + D++S G + E+L
Sbjct: 180 PELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 46/185 (24%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 384 GSVVAVKRLKDASIGGKREFEQHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442
G VAVK++ D +RE + V+ R H N+V + Y +E +V E++ G+
Sbjct: 47 GKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502
L ++ R ++ + R L+++H + + H +IKS ++LL G
Sbjct: 106 LTDIVTHTR------MNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDG 155
Query: 503 NARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELL 556
++SDFG VP+ + APE+ S + D++S G++++E++
Sbjct: 156 RIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMI 212
Query: 557 TGKCP 561
G+ P
Sbjct: 213 DGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARG 473
HP LVGL + + V EY+ G L + + R P ++ + +A
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------ 108
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI--FAPPSTVPRSNG---YRA 528
L ++H + + ++K NVLLD G+ +++D+G+ P T G Y A
Sbjct: 109 LNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566
PE+ G D ++ GVL+ E++ G+ P I G
Sbjct: 165 PEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 71/248 (28%), Positives = 107/248 (43%), Gaps = 39/248 (15%)
Query: 366 EMLGKGGFG-TAYKAVLDDGSVVAVK------RLKDASIGGKREFEQHMEVLGRLRH-PN 417
+++G+G FG A + + G V A+K LK A RE E+ + V G R N
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFRE-ERDVLVNGDRRWITN 65
Query: 418 LVGLKAYYFAREEKL-LVSEYMPNGSLFWLLH--GNRGPGRTPLDWTTRLKIAAGAARGL 474
L Y F E L LV +Y G L LL +R P + + +A + L
Sbjct: 66 L----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN------GYRA 528
++H +IK NVLLDK G+ R++DFG + +SN Y +
Sbjct: 122 GYVH----------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 529 PEL--SSSDGR-KQSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAGMGCGGAVDLPR 581
PE+ + DG+ + + D +S GV + E+L G+ P S+++ G M P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP 231
Query: 582 WVQSVVRE 589
V V E
Sbjct: 232 DVTDVSEE 239
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 17/176 (9%)
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
PN+V L Y + + LV ++ G L+ + P W + +A A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR--SNGYRAPELS 532
+ C+ L + N N+LLD G+ +++ F S N Y APE+
Sbjct: 105 GIV---CRDL---NPN----NILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588
++++ D +S G +L ELLTGK ++++ +G+ +++P WV R
Sbjct: 155 GIS--EETEACDWWSLGAILFELLTGK--TLVECHPSGINTHTTLNIPEWVSEEAR 206
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 3/133 (2%)
Query: 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNN 122
L++ + L L + ++ PL +L L+ L L +N + LSNL+ L L LS N
Sbjct: 138 LKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK 197
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLR 181
+ + P + L L LDLS N+ ++ ++++L +L L+L N+ + +L
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLS 255
Query: 182 NLQDFNVSGNHLS 194
NL+ ++S N +S
Sbjct: 256 NLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
E LG+G + T YK +G +VA+K RL++ G + +L L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLH 69
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+E LV EY+ ++ ++ PG + +L + RGL++IH
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPE-NVKLFLFQ-LLRGLSYIH---- 120
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPE--LSSSD 535
+ H ++K N+L+ TG +++DFGL+ + SN YR P+ L S++
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 536 GRKQSQKSDVYSFGVLLLELLTG 558
S D++ G + +E++ G
Sbjct: 181 ---YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 41/250 (16%)
Query: 368 LGKGGFGTAYKAVLDDGSV---VAVKRLKDASIGGKR-EFEQHMEVLGRLRHPNLVGLKA 423
LG G FG K V VA+K LK+ + R E + E++ +L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFIHFT 480
A E +LV E G L L G + D T + + G+ ++
Sbjct: 63 VCEA-EALMLVMEMASGGPLNKFLSGKK-------DEITVSNVVELMHQVSMGMKYL--- 111
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTV-PRSNG-----YRAPELS 532
+ H ++ + NVLL A++SDFGLS + A S RS G + APE
Sbjct: 112 -EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT--------GKCPSVID--GGGAGMGCGGAVDLPRW 582
+ RK S +SDV+S+G+ + E + K P V+ G + C P
Sbjct: 171 NF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAEC--PPE 226
Query: 583 VQSVVREEWT 592
+ +++++ W
Sbjct: 227 MYALMKDCWI 236
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 367 MLGKGGFGTAYKAVLDD----GSVVAVKRLKDASIGGKREFEQHMEVLGRL-----RHPN 417
+LGKG FG K +L + + A+K LK + + E M V R+ + P
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTM-VEKRVLALSGKPPF 62
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
L L + + + V EY+ G L + + G + P + AA A GL F+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEP----HAVFYAAEIAIGLFFL 117
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIF--APPSTVPRSNGYRAPELS 532
H S + + ++K NV+LD G+ +++DFG+ +++ T + Y APE+
Sbjct: 118 H----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ +S D ++FGVLL E+L G+ P
Sbjct: 174 AYQPYGKS--VDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 367 MLGKGGFGTAYKAVLDDGS----VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVGL 421
+LG G FG + L S VA+ L+ S +R F LG+ H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ ++V+EYM NG+L L + G L + + G A G+ ++
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYL---- 123
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQ-- 539
+ H + + VL++ ++S F + + ++P L ++ Q
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 540 --SQKSDVYSFGVLLLELLT 557
S SDV+SFG+++ E+++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARG 473
+P LVGL + + LV EY+ G L + + R P + + IA
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------ 108
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI--FAPPSTVPRSNG---YRA 528
L F+H + + ++K NVLLD G+ +++D+G+ P T G Y A
Sbjct: 109 LNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ G + D ++ GVL+ E++ G+ P
Sbjct: 165 PEILR--GEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNG--- 525
A+G+ F+ S K H ++ + N+LL + ++ DFGL+ I+ P V + +
Sbjct: 189 AKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 526 --YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583
+ APE + R + +SDV+SFGVLL E+ + GA G +D
Sbjct: 245 LKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKID----- 288
Query: 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
EE+ + + MR D + Q + C P QRP S +V+ + L
Sbjct: 289 -----EEFCRRLKEGTRMRAPDYTTPE--MYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 33/161 (20%)
Query: 366 EMLGKGGFGTAYKAV--LDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRHPNLV 419
+++GKG FG + V D G + A+K L + + K++ H+ +VL P +V
Sbjct: 7 KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVV 64
Query: 420 GLKAYY-FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDW------TTRLKIAAGAA 471
L YY F + L L+ E++P G L +L + + TR +A
Sbjct: 65 SL--YYSFQDAQYLYLIMEFLPGGDLMTML----------IKYDTFSEDVTRFYMAE-CV 111
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512
+ +H L H +IK N+L+D+ G+ ++SDFGLS
Sbjct: 112 LAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 23/156 (14%)
Query: 409 VLGRLRHPNLVGLKAYYFAREEKLLVSEYMP--NGSLFWLLHGNRGPGRTPLDWTTRLKI 466
+L + HP+++ +K + +V +P + L+ L P L L I
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRP----LPIDQALII 162
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY 526
GL ++H + ++ H ++K+ N+ ++ + D G + F P P G
Sbjct: 163 EKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGL 216
Query: 527 ------RAPELSSSDGRKQSQKSDVYSFGVLLLELL 556
APE+ + D K + K+D++S G++L E+L
Sbjct: 217 AGTVETNAPEVLARD--KYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 34/211 (16%)
Query: 366 EMLGKGGFGTAYKA---VLDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVG 420
E +G+G +G YKA V ++ +A+K RL+ G + + +L ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG----AARGLAF 476
L+ + + LV EY+ L H + P D+ ++ RG+A+
Sbjct: 66 LQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP-----DFAKNPRLIKTYLYQILRGIAY 117
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNA-RVSDFGLS-IFAPPSTVPRSN----GYRAPE 530
C S ++ H ++K N+L+D+ NA +++DFGL+ F P YRAPE
Sbjct: 118 ----CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 531 --LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
L S R S D++S G + E++ K
Sbjct: 174 ILLGS---RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E LG+G + T YK + +G +VA+K + G + +L L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLH--GNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+E V EYM +++ G P L L RGLA+IH
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIH--- 120
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN--------GYRAPE--L 531
+ H ++K N+L+ G +++DFGL A ++P YR P+ L
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGL---ARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
++D S D++ G + +E+L G+
Sbjct: 177 GATD---YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 39/218 (17%)
Query: 368 LGKGGFGTAYKAVLDDGS---VVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G +G YKA DG A+K+++ S+ RE + +L L+HPN++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 423 AYYFAREEK--LLVSEYMPNGSLFWLL-------HGNRGPGRTPLDWTTRLKIAAGAARG 473
+ + ++ L+ +Y + W + N+ P + P R + + +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHD--LWHIIKFHRASKANKKPMQLP-----RSMVKSLLYQI 117
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLS-IFAPP-------STVP 521
L IH+ + L H ++K N+L+ + G +++D G + +F P V
Sbjct: 118 LDGIHYLHANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ YRAPEL R ++ D+++ G + ELLT +
Sbjct: 177 VTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 368 LGKGGFGTAYKAVLD-DGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
LG+G + T +K ++VA+K ++ + G + + +L L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 426 FAREEKLLVSEYMPNGSLFWLLH-GNRGPGRTPLDWTTRLKIAA-GAARGLAFIHFTCKS 483
LV EY+ + +L + GN L +KI RGL++ C
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGN-------LMSMHNVKIFMFQLLRGLSY----CHK 121
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPE--LSSSDG 536
K+ H ++K N+L+++ G +++DFGL+ T SN YR P+ L S++
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE- 180
Query: 537 RKQSQKSDVYSFGVLLLELLTGK 559
S D++ G +L E+ TG+
Sbjct: 181 --YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDG-SVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVGL 421
+++G+G FG L + V A+K L + + E F + +VL + + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 422 KAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD----WTTRLKIAAGAARGLAF 476
Y F E L LV +Y G L LL ++ R P D + + IA + L +
Sbjct: 67 H-YAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-FAPPSTVPRSNG-----YRAPE 530
+H +IK N+L+D G+ R++DFG + TV S Y +PE
Sbjct: 124 VH----------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 531 L--SSSDGR-KQSQKSDVYSFGVLLLELLTGKCP 561
+ + DG+ K + D +S GV + E+L G+ P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 40/150 (26%), Positives = 58/150 (38%), Gaps = 10/150 (6%)
Query: 60 VSCLQNRVSHL---VLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLL 116
+ +S L L N + L L++L L L L N+ S+ NL+ L+ L
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETL 260
Query: 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT 176
LS+N S+ SL L LDLS N+ S L + L LL L +
Sbjct: 261 DLSNN--QISSISSLGSLTNLRELDLSGNSLSN--ALPLIALLLLLLELLLNLLLTLKAL 316
Query: 177 GLDLRNLQDFNVSGNHLSGQIPKSLSGFPD 206
L L ++ ++ N LS S
Sbjct: 317 ELKLNSI---LLNNNILSNGETSSPEALSI 343
|
Length = 394 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 44/217 (20%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRL-----KDA-SIGGKREFEQHMEVLGRLRHPNLVG 420
+G+G FG +KA +VA+K++ K+ I RE +++L L+H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 75
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWL-----------LHGNRGPGRTPLDWTTRLKIAAG 469
L R + + Y + F+L L N+ T + +K+
Sbjct: 76 LIE--ICRTKATPYNRYKGS---FYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---- 525
GL +IH K+ H ++K+ N+L+ K G +++DFGL+ S + N
Sbjct: 131 ---GLYYIHRN----KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 526 -----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
YR PEL + R D++ G ++ E+ T
Sbjct: 184 VVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 25/60 (41%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 89 QLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
L+ L L NR T P + L LK+L LS NN P++ S L L LDLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 368 LGKGGFGTAYKAVLDDG---SVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+G G FG ++ G + V VK L+ AS+ + +F + + L+H NL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
LLV E+ P G L L R D TT ++A A GL +H
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLS-------IFAPPSTVPRSNGYRAPEL----- 531
H ++ N LL ++ D+GLS + P + + APEL
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELL 556
+ Q+++S+V+S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 36/200 (18%)
Query: 452 GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511
PLD L+ ++ A+G+ F+ S H ++ + NVLL A++ DFGL
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL----ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 512 S--IFAPPSTVPRSNG-----YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSV 563
+ I + V + N + APE S D Q SDV+S+G+LL E+ + GK P
Sbjct: 259 ARDIMNDSNYVVKGNARLPVKWMAPE-SIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYP 316
Query: 564 IDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSA 623
G V+ +V+ + D E+ +++ C +
Sbjct: 317 ----------GILVN--SKFYKMVKRGYQMSRPDFAPP-------EIYSIMK---MCWNL 354
Query: 624 SPDQRPNMSHVVKLIEELRG 643
P +RP S + +LI+ G
Sbjct: 355 EPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 41/219 (18%)
Query: 368 LGKGGFGTAYKAVLDDGSV---VAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G +G YKA DG A+K+++ S+ RE + +L L+HPN++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 423 AYYFAREEK--LLVSEYMPNGSLFWLL---HGNRGPGRTPLDWTTRLKIAAGAARGLAF- 476
+ + ++ L+ +Y + W + H + P +++ G + L +
Sbjct: 65 KVFLSHADRKVWLLFDYAEHD--LWHIIKFHRASKANKKP------VQLPRGMVKSLLYQ 116
Query: 477 ----IHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLS-IFAPP-------STV 520
IH+ + L H ++K N+L+ + G +++D G + +F P V
Sbjct: 117 ILDGIHYLHANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ YRAPEL R ++ D+++ G + ELLT +
Sbjct: 176 VVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 367 MLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHM---EVLGRL-RHPNLVGL 421
+LGKG FG A + A+K LK + + E M VL + P L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ + + V EY+ G L + + G + P + AA + GL F+H
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEP----QAVFYAAEISVGLFFLH--- 118
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGL---SIF--APPSTVPRSNGYRAPELSSSDG 536
+ + ++K NV+LD G+ +++DFG+ + T + Y APE+ +
Sbjct: 119 -RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
+S D +++GVLL E+L G+ P
Sbjct: 178 YGKS--VDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 73/228 (32%)
Query: 366 EMLGKGGFGTAYKAVLD-DGSVVAVK--RLKD---ASIGGKREFEQHMEVLGRLRHPNLV 419
+ LG+G + T YK G +VA+K RL+ A RE +L L+H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIV 66
Query: 420 GLKAYYFAREEKLLVSEYM-----------PNGS--------LFWLLHGNRGPGRTPLDW 460
L ++ LV EY+ G LF LL
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL------------- 113
Query: 461 TTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520
RGLA+ H ++ H ++K N+L+ + G +++DFGL A +V
Sbjct: 114 -----------RGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGL---ARAKSV 155
Query: 521 PR---SNG-----YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
P SN YR P+ L S++ S D++ G + E+ TG
Sbjct: 156 PSKTYSNEVVTLWYRPPDVLLGSTE---YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 30/82 (36%), Positives = 46/82 (56%), Gaps = 9/82 (10%)
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS-------IFAPPSTVPRSNGYRAPELSSSD 535
S K+ H ++KS N+ L TG ++ DFG S S+ + Y APEL +
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL--WE 244
Query: 536 GRKQSQKSDVYSFGVLLLELLT 557
++ S+K+D++S GV+L ELLT
Sbjct: 245 RKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 50/148 (33%), Positives = 67/148 (45%), Gaps = 18/148 (12%)
Query: 424 YYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
Y F E L LV +Y G L LL ++ R P D R IA + IH
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPED-MARFYIAE-MVLAIHSIH---- 119
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-FAPPSTVPRSNG-----YRAPEL--SSS 534
L H +IK NVLLD G+ R++DFG + TV S Y +PE+ +
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 535 DGR-KQSQKSDVYSFGVLLLELLTGKCP 561
DG K + D +S GV + E+L G+ P
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 368 LGKGGFGTAYK--AVLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG+G + T YK + L D ++VA+K ++ + G + + +L L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 425 YFAREEKLLVSEYMPNGSLFWLLH-GNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+ LV EY+ +L GN + +L RGL + C
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNY----CHR 122
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPE--LSSSDG 536
K+ H ++K N+L+++ G +++DFGL+ T SN YR P+ L S+D
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD- 181
Query: 537 RKQSQKSDVYSFGVLLLELLTGK 559
S + D++ G + E+ TG+
Sbjct: 182 --YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
HP LVGL + + V E++ G L + + R + P + R +A + L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLP-EEHARF-YSAEISLAL 109
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI--FAPPSTVPRSNG---YRAP 529
F+H + + ++K NVLLD G+ +++D+G+ P T G Y AP
Sbjct: 110 NFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566
E+ G D ++ GVL+ E++ G+ P I G
Sbjct: 166 EILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 39/211 (18%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+G G +GT A+ G+ VA+K+L + + KR + + + +L ++H N++GL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMKHENVIGL-- 79
Query: 424 YYFAREEKLLVSEYMPNGSL-----FWLLHGNRGPGRTPLDWTTRLK------IAAGAAR 472
+ + P+ SL F+L+ G L +L + +
Sbjct: 80 ----------LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----TVPRSNGYRA 528
GL +IH + + H ++K N+ +++ ++ DFGL+ V R YRA
Sbjct: 130 GLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR--WYRA 183
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
PE+ + +Q D++S G ++ E+LTGK
Sbjct: 184 PEVILNWMH-YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 366 EMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASIGGKREFEQ----HMEVLGRLRHP 416
E+LG G G AY VL + +VA+K+ KD+ E ++ +++L L+
Sbjct: 4 EVLGVVGEG-AYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQE 60
Query: 417 NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
N+V LK + R + LV EY+ L L P P + K+ + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPE-----KVRSYIYQLIKA 112
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS------IFAPPSTVPRSNGYRAPE 530
IH+ C + H +IK N+L+ ++ DFG + A + + YR+PE
Sbjct: 113 IHW-CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
L G + D++S G +L EL G+
Sbjct: 172 LLL--GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 363 ASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKREFEQHMEVLGRLRHPNL 418
S + +G G +G+ A+ G VA+K+L + I KR + + + +L ++H N+
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRE-LTLLKHMQHENV 76
Query: 419 VGLKAYYFAR------EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
+GL + + ++ LV YM L G PL +
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMG---HPLSEDKVQYLVYQMLC 128
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----TVPRSNGYRA 528
GL +IH S + H ++K N+ +++ ++ DFGL+ A V R YRA
Sbjct: 129 GLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--WYRA 182
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
PE+ + +Q D++S G ++ E+LTGK
Sbjct: 183 PEVILN-WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 26/176 (14%)
Query: 403 FEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
F + ++ ++ H +L + E ++V E++ +G L L +G R P+ W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAW-- 118
Query: 463 RLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA-------RVSDFGLSIFA 515
++ +A A L+++ + L HGN+ + N+LL + G A ++SD G+S F
Sbjct: 119 KITVAQQLASALSYL----EDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FT 173
Query: 516 PPSTVPRSN--GYRAPELSSSDGRKQSQKSDVYSFGVLLLEL-------LTGKCPS 562
S R + APE G S +D +SFG LLE+ L + PS
Sbjct: 174 ALSREERVERIPWIAPE-CVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 8/142 (5%)
Query: 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNN 122
+ +S + +L S +L +L L L L NR + L LT L L L +NN
Sbjct: 71 SLDLLSPSGISSLDGSENL---LNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNN 127
Query: 123 FNGEFPDSVSSL-FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR-FSGPITGLDL 180
+ P + L L LDLS N +P + +L +L L L N P +L
Sbjct: 128 IT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNL 185
Query: 181 RNLQDFNVSGNHLSGQIPKSLS 202
NL + ++SGN +S +P +
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIE 206
|
Length = 394 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 51/240 (21%), Positives = 104/240 (43%), Gaps = 30/240 (12%)
Query: 409 VLGRLRHPNLVGLKAYY-FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA 467
+L + HP+++ LK + + + L++ Y + L+ L R + L I
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKR---NIAI--CDILAIE 188
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY- 526
R + ++H ++ H +IK+ N+ ++ G+ + DFG + F + G+
Sbjct: 189 RSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 527 -----RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPR 581
APEL + D D++S G++L E+ T S+ + G C D R
Sbjct: 245 GTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCH-DSLFEKDGLDGDC----DSDR 297
Query: 582 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
++ ++R T + + +++E +GL + +S P RP +++ +L +L
Sbjct: 298 QIKLIIRRSGTHPN-EFPIDAQANLDEIYIGLAKK----SSRKPGSRPLWTNLYELPIDL 352
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 27/159 (16%)
Query: 364 SAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
S +++G+G FG D G V A+K L+ A + K E +G +R + ++
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-------EQVGHIRAERDILVE 57
Query: 423 A-------YYFAREEKL---LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
A +++ ++KL L+ E++P G + LL T + T+ IA
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAE-TVL 112
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511
+ IH L H +IK N+LLD G+ ++SDFGL
Sbjct: 113 AIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 18/97 (18%)
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-------FAPPSTVPRSN 524
RGL +IH S + H ++K +N+LL+ + ++ DFGL+ F V R
Sbjct: 119 RGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR-- 172
Query: 525 GYRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE L+ S+ + DV+S G + ELL K
Sbjct: 173 WYRAPELLLNCSE---YTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP--RSNGYRAP 529
RGL +IH S + H ++K +NV +++ R+ DFGL+ A + YRAP
Sbjct: 129 RGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAP 184
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
E+ + +Q D++S G ++ ELL GK
Sbjct: 185 EI-MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDG--SVVAVKR--LKDASIG-GKREFEQHME--------VLGR 412
E LG G FG YK + +++A+K + + + G KRE ++ + + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 413 LRHPNLVGLKAYY--FAREEKLLVS----EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
LRHPN+V YY F ++L + E P G F L + W +++
Sbjct: 66 LRHPNIV---RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG- 525
L ++H K ++ H ++ N++L + ++DFGL+ P + S
Sbjct: 123 VLA----LRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG 175
Query: 526 ---YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
Y PE+ ++ +K+DV++FG +L ++ T
Sbjct: 176 TILYSCPEIVKNE--PYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 366 EMLGKGGFGTAYK--AVLDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLK 422
E LG+G + T +K + L + ++VA+K ++ + G + + +L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ LV EY+ L G ++ + RGLA+ C
Sbjct: 71 DIVHTDKSLTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAY----CH 121
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPE--LSSSD 535
K+ H ++K N+L+++ G +++DFGL+ T SN YR P+ L SS+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 536 GRKQSQKSDVYSFGVLLLELLTGK 559
S + D++ G + E+ +G+
Sbjct: 182 ---YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 69/226 (30%)
Query: 368 LGKGGFGTAYKAVLDDGSV-VAVKRLK---DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+G G +G A VA+K+L ++I KR + + + +L + H N++GL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRE-LRLLKHMDHENVIGL-- 79
Query: 424 YYFAREEKLLVSEYMPNGSL-----FWLLHGNRGPGRTPL---DWTTRLK---------- 465
L V + P SL +L+ T L D +K
Sbjct: 80 --------LDV--FTPASSLEDFQDVYLV--------THLMGADLNNIVKCQKLSDDHIQ 121
Query: 466 -IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN 524
+ RGL +IH S + H ++K +N+ +++ ++ DFGL+ R
Sbjct: 122 FLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLA---------RHT 168
Query: 525 G-----------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE+ + +Q D++S G ++ ELLTGK
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 30/179 (16%)
Query: 404 EQHMEVLGR-------LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRT 456
E+H++ L RHPN++ + ++S +M GS LL G
Sbjct: 40 EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-- 97
Query: 457 PLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---- 512
+ I GA RGL ++H H NIK++++L+ +G+ VS GLS
Sbjct: 98 -MSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILI--SGDGLVSLSGLSHLYS 150
Query: 513 ----------IFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
++ P + +PEL D + KSD+YS G+ EL TG+ P
Sbjct: 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 14/97 (14%)
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVP-------R 522
GL +IH S + H ++K N+L++ ++ DFGL+ P
Sbjct: 116 CGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 523 SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ YRAPE+ S + ++ DV+S G +L ELL K
Sbjct: 172 TRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKREFEQHMEVLGRLRHPNLVGL-K 422
+G G +G+ A G VAVK+L + I KR + + + +L ++H N++GL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 83
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ AR + Y+ + L+ N + D + I RGL +IH
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDHVQFLIYQ-ILRGLKYIH---- 137
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP--RSNGYRAPELSSSDGRKQS 540
S + H ++K +N+ +++ ++ DFGL+ + YRAPE+ + +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML-NWMHYN 196
Query: 541 QKSDVYSFGVLLLELLTGK 559
Q D++S G ++ ELLTG+
Sbjct: 197 QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 35/208 (16%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGK-----REFEQHMEVLGRLRHPNLVG 420
+G+G +GT YKA L+ G VA+K+++ S G RE ++ L HPN+V
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIVR 65
Query: 421 L----KAYYFAREEKL-LVSEYMPNG-SLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARG 473
L RE KL LV E++ + + G P T D +L RG
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL------LRG 119
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFA---PPSTVPRSNGYRAP 529
+ F+H S ++ H ++K N+L+ G +++DFGL+ I++ ++V + YRAP
Sbjct: 120 VDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAP 175
Query: 530 E--LSSSDGRKQSQKSDVYSFGVLLLEL 555
E L SS + D++S G + EL
Sbjct: 176 EVLLQSS----YATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 49/229 (21%)
Query: 367 MLGKGGFGTAYKAVLDD---GSVVAVKRLKDASIGG---KREFEQHMEVLGRLRHPNLVG 420
++GKGG G Y A D VA+K++++ K+ F + ++ L HP +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 421 LKAYYFAREEKLLVSEYMP---NGSLFWLLHGNRGPGRTPLDWT------TRLKIAAGAA 471
+ Y + V MP +L LL + L I
Sbjct: 67 V---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF------------APPST 519
+ ++H S + H ++K N+LL G + D+G +IF
Sbjct: 124 ATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 520 VPRSN-----------GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
+ S+ Y APE G S+ +D+Y+ GV+L ++LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS- 512
PL + I LA++H + H ++K+ N+ LD+ NA + DFG +
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233
Query: 513 -IFAPPSTVPRSNGY------RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ A P T P+ G+ +PEL + D K+D++S G++L E+
Sbjct: 234 KLDAHPDT-PQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--STVPRSNGYRAPEL 531
A +L+ H KS N+LL T + + G F P S APE+
Sbjct: 20 WAVCLQCLGALRELHRQAKSGNILL--TWDGLLKLDGSVAFKTPEQSRPDPYFM--APEV 75
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G+ ++K+D+YS G+ L E L + P
Sbjct: 76 IQ--GQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR------SNG 525
RGL ++H S + H +IK N+L++ ++ DFGL+ P +
Sbjct: 114 RGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE+ R + D++S G + ELL +
Sbjct: 170 YRAPEILMG-SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.002
Identities = 16/36 (44%), Positives = 19/36 (52%), Gaps = 1/36 (2%)
Query: 88 TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
T L L L N+ T +P LSNL L+ L LS N
Sbjct: 1 TNLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 35/149 (23%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREF---EQHMEVLGRLRHPNLVGLKA 423
LG G FG A +D ++ A+K L+ + + + + ++L + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 424 YYFAREEKLLVSEYMPNGSLFWLL-HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ ++ V +Y+P G + LL P + L +A + + FIH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH---- 124
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGL 511
+IK N+L+D G+ +++DFGL
Sbjct: 125 ------RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 403 FEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
F + ++ ++ H ++V L E ++V E++ G L +H TP W
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--W-- 106
Query: 463 RLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-------NARVSDFGLSI-- 513
+ K+A A L+++ + L HGN+ + N+LL + G ++SD G+ I
Sbjct: 107 KFKVAKQLASALSYL----EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162
Query: 514 FAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLEL-LTGKCP 561
+ V R + APE D + S +D +SFG L E+ G+ P
Sbjct: 163 LSRQECVERIP-WIAPE-CVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 25/172 (14%)
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
E H+ L HPN+V +A + A E +V+ +M GS L+ + G + L
Sbjct: 49 ELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AI 103
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-SIFAP------ 516
I G + L +IH + H ++K++++L+ G +S GL S +
Sbjct: 104 AYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQR 157
Query: 517 -------PSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P + + +PE+ + + KSD+YS G+ EL G P
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 65/247 (26%)
Query: 364 SAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG-- 420
S +++G+G FG D G + A+K L+ A + E EQ + R LV
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---LEKEQVAHI--RAERDILVEAD 59
Query: 421 ----LKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
+K +Y ++++ L+ E++P G + LL T + T+ IA +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAE-TVLAI 114
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---------------IFAPPST 519
IH L H +IK N+LLD G+ ++SDFGL PPS
Sbjct: 115 DAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 520 VPRSN-------------------------GYRAPELSSSDGRKQSQKSDVYSFGVLLLE 554
N Y APE+ G ++ D +S GV++ E
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYE 228
Query: 555 LLTGKCP 561
+L G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 40/218 (18%)
Query: 368 LGKGGFGTAYKAVLDD-GSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG G G + AV D VAVK+ L D + + ++++ RL H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 425 YFAREEKL--------------LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 470
L +V EYM L +L + +L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQL------ 123
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPP--------STVP 521
RGL +IH S + H ++K NV ++ + ++ DFGL+ P S
Sbjct: 124 LRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ YR+P L S ++ D+++ G + E+LTGK
Sbjct: 180 VTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.54 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.52 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.46 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.46 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.41 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.27 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.2 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.19 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.11 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.06 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.99 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.85 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.8 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.75 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.44 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.44 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.31 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.24 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.24 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.14 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-61 Score=572.46 Aligned_cols=516 Identities=28% Similarity=0.434 Sum_probs=343.0
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..++.|+|++|.+++.++. +..+++|+.|+|++|++.+.+|....+++|+.|+|++|+++|.+|..+.++++|+.|+|+
T Consensus 428 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls 507 (968)
T PLN00113 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLS 507 (968)
T ss_pred CCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECc
Confidence 4677888888888887665 667788888888888888877765566788888888888888888888888888888888
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc---ccccccccCC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA---FTQNAALCGS 218 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~---~~~n~~lc~~ 218 (672)
+|+++|.+|..+.++++|+.|+|++|+++|.++ +..+++|+.|+|++|+++|.+|..+..++.+. +.+|+..+..
T Consensus 508 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~ 587 (968)
T PLN00113 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587 (968)
T ss_pred CCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeC
Confidence 888888888888888888888888888887443 45777888888888888888887666554443 3344433322
Q ss_pred CCccccccCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCcccceeeeehhhHHHHHHH
Q 005880 219 PMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLA 298 (672)
Q Consensus 219 ~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ii~ivvg~~~~l~ 298 (672)
|... ...........+ ++ ..+... ++.. .+.... .........+++++++++++++
T Consensus 588 p~~~------------~~~~~~~~~~~~-n~----~lc~~~-~~~~----~~~c~~--~~~~~~~~~~~~~~~~~~~~~~ 643 (968)
T PLN00113 588 PSTG------------AFLAINASAVAG-NI----DLCGGD-TTSG----LPPCKR--VRKTPSWWFYITCTLGAFLVLA 643 (968)
T ss_pred CCcc------------hhcccChhhhcC-Cc----cccCCc-cccC----CCCCcc--ccccceeeeehhHHHHHHHHHH
Confidence 2110 000000000000 00 000000 0000 000000 0111122233333333333222
Q ss_pred HHHHHHHhhheeccccccccccchhhhhhccCCCCCcccccccCCCceeeec--CccccCHHHHHHHH--hcccCcCCeE
Q 005880 299 IISLLLYCYFWRNYVKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFE--GTKRFELEDLLRAS--AEMLGKGGFG 374 (672)
Q Consensus 299 ii~~l~~~~~~rr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~--~~~lg~G~~g 374 (672)
++++ + ++++|++++.+.+. . +.+... . ....+. ..+.+.++++.... .+.||+|+||
T Consensus 644 ~~~~-~-~~~~~~~~~~~~~~-~-~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g 704 (968)
T PLN00113 644 LVAF-G-FVFIRGRNNLELKR-V-ENEDGT-----W----------ELQFFDSKVSKSITINDILSSLKEENVISRGKKG 704 (968)
T ss_pred HHHH-H-HHHHHhhhcccccc-c-cccccc-----c----------cccccccccchhhhHHHHHhhCCcccEEccCCCe
Confidence 2222 2 22222221111110 0 000000 0 000011 11345555554443 3579999999
Q ss_pred EEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCC
Q 005880 375 TAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP 453 (672)
Q Consensus 375 ~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 453 (672)
.||+|+. .+|..||||+++.... ....|++.+++++|||||+++|+|.+++..++||||+++|+|.++++
T Consensus 705 ~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----- 775 (968)
T PLN00113 705 ASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----- 775 (968)
T ss_pred eEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----
Confidence 9999996 5789999999875432 12346888999999999999999999999999999999999999995
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-CCCCCCCcccCCCcc
Q 005880 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-STVPRSNGYRAPELS 532 (672)
Q Consensus 454 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~t~~y~aPE~l 532 (672)
.++|.++.+|+.|+|+||+|||+.+ +.+|+||||||+||+++.++.+++. ||....... ....++.+|+|||++
T Consensus 776 ---~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 776 ---NLSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETR 850 (968)
T ss_pred ---cCCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccc
Confidence 2789999999999999999999655 4799999999999999999888876 665543322 244678899999976
Q ss_pred ccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccc-cChHHHHH
Q 005880 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRY-KDIEEEMV 611 (672)
Q Consensus 533 ~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~ 611 (672)
. +..+++|+|||||||++|||+||+.||+..... ...+.+|.+...........+|+..... ....++..
T Consensus 851 ~--~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (968)
T PLN00113 851 E--TKDITEKSDIYGFGLILIELLTGKSPADAEFGV-------HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921 (968)
T ss_pred c--CCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-------CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence 4 567899999999999999999999999543221 3457777766555444445555544322 22345667
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 612 GLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 612 ~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
++.+++.+||+.||++||||.||++.|+++.+...
T Consensus 922 ~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 922 EVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 88999999999999999999999999999876433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=444.43 Aligned_cols=282 Identities=46% Similarity=0.750 Sum_probs=245.2
Q ss_pred CccccCHHHHHHHHh-----cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 351 GTKRFELEDLLRASA-----EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 351 ~~~~~~~~~l~~~~~-----~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
..+.|++.++..++. +.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 346799999999884 689999999999999999999999988765432156699999999999999999999999
Q ss_pred EcCC-eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcE
Q 005880 426 FARE-EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA 504 (672)
Q Consensus 426 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~ 504 (672)
.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+. ++||||||||+|||+|+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~-~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCP-PPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCC-CCEecCCCCHHHeeECCCCCE
Confidence 9988 599999999999999999976532 78999999999999999999998764 689999999999999999999
Q ss_pred EEeccCCCccCCC-CC----C-CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q 005880 505 RVSDFGLSIFAPP-ST----V-PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVD 578 (672)
Q Consensus 505 kl~DfG~a~~~~~-~~----~-~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~ 578 (672)
||+|||+|+.... .. . .||.+|+|||++. .+..++|+|||||||+++||+||+.+.+...... ...
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~--~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~------~~~ 288 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS--TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG------ELS 288 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhc--cCCcCcccccccchHHHHHHHhCCcccCCCCCcc------ccc
Confidence 9999999987764 32 2 7899999999654 4689999999999999999999998887544222 445
Q ss_pred hhHHHHHHHhhhccccccchhhccccChH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 579 LPRWVQSVVREEWTAEVFDLELMRYKDIE-EEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
+.+|....+.+....+++|+.+....... +++..+.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999999999999987433332 6888899999999999999999999999999776644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=396.46 Aligned_cols=252 Identities=35% Similarity=0.538 Sum_probs=208.1
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcch--HHHHHHHHHHHcCCCCCceeeeEEEEEcCC-eEEEEEeecC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGG--KREFEQHMEVLGRLRHPNLVGLKAYYFARE-EKLLVSEYMP 439 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 439 (672)
.+.+.+|+|+||+||+|.+++...||||++....... .++|.+|+.+|.+++|||||+++|+|.++. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3456699999999999999854459999998644332 569999999999999999999999999887 7899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC-cEecCCCCCCEEeCCCC-cEEEeccCCCccCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK-LTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPP 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~ 517 (672)
+|+|.++++... ...+++..+++|+.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 124 ~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 124 GGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999998741 356999999999999999999999 667 99999999999999997 999999999976653
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ...||..|||||++......|+.|+||||||+++|||+||+.||..... .+....+......
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------------~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------------VQVASAVVVGGLR 264 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhcCCC
Confidence 2 3678999999998864346899999999999999999999999975421 2222333222211
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..+ ...+...+..++.+||..||+.||++.|++..|+.+..
T Consensus 265 p~~----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 PPI----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCC----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111 12245567888889999999999999999999999865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=370.05 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=209.0
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-eE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-EK 431 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~ 431 (672)
+...|+ ...+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||+++|.|+.+. +.
T Consensus 76 i~~~dl--e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDL--ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHh--hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 555565 34578999999999999965 6899999999533 3345789999999999999999999999999998 59
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
.++||||++|+|++++... ..+++...-+|+.+|++||.|||+ +++||||||||+|||++..|++||||||.
T Consensus 154 sI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 9999999999999999754 348999999999999999999993 38999999999999999999999999999
Q ss_pred CccCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 512 SIFAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 512 a~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
++.+..+ +.+||..|||||.+ .+..|+.++||||||+.++|+.+|+.||....+. ..+..+.+..++.
T Consensus 226 S~~lvnS~a~tfvGT~~YMsPERi--~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-------~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 226 SGILVNSIANTFVGTSAYMSPERI--SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-------YLDIFELLCAIVD 296 (364)
T ss_pred cHHhhhhhcccccccccccChhhh--cCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-------CCCHHHHHHHHhc
Confidence 9877654 77899999999954 5779999999999999999999999999754211 2344445555544
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.. ...+. .....++..++..||++||.+|||++|+++
T Consensus 297 ~pp---------P~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPP---------PRLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCC---------CCCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 321 11111 124456888888999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=382.94 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=215.6
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 434 (672)
++++.-.....+.||+|.||.||.|.++....||+|.++.... ..+.|.+|+++|.+|+|+|||+++|+|..++..+||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 3444444467889999999999999999888999999987644 567899999999999999999999999998899999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
||||+.|+|.++|+... +..+...+.+.++.|||+|++||+ ++++|||||.++||||+++..+||+|||+|+.
T Consensus 280 tE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999998732 356899999999999999999999 89999999999999999999999999999996
Q ss_pred CCCCCCCC------CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 515 APPSTVPR------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 515 ~~~~~~~~------t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
...+.+.. ...|.|||.+. ...++.|||||||||+||||+| |+.||.. ....+.+..+.
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~--~~~FS~kSDVWSFGVlL~E~fT~G~~py~~------------msn~ev~~~le 418 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALN--YGKFSSKSDVWSFGVLLWELFTYGRVPYPG------------MSNEEVLELLE 418 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHh--hCCcccccceeehhhhHHHHhccCCCCCCC------------CCHHHHHHHHh
Confidence 65553322 23599999775 5689999999999999999999 7888753 34445555444
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
+... .+..+.++..+.+++..||+.+|++|||++.+...|+++...
T Consensus 419 ~GyR-----------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 419 RGYR-----------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ccCc-----------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 4432 122344666789999999999999999999999999988754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=369.99 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=200.0
Q ss_pred HhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcc-------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIG-------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
+.+.||+|+||.|-+|. .++|+.||||++++.... .....++|+++|++|+|||||++++++...+..|+||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 45789999999999999 567999999999753221 2345689999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC---CcEEEeccCCC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT---GNARVSDFGLS 512 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a 512 (672)
||++||+|.+.+-.+. .+.+..-..+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999998664 4777888999999999999999 8999999999999999765 67999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQ-KSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~-~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
+..... +.+||+.|.|||++...+..+.+ |+||||+|||||-+++|.+||....... ...+++.
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----------sl~eQI~ 395 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----------SLKEQIL 395 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------cHHHHHh
Confidence 988654 77899999999999877766665 9999999999999999999997653221 1222222
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+..... ......+...+..++|.+||..||++|||+.|+++
T Consensus 396 ~G~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222110 11112334456678888999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=361.31 Aligned_cols=189 Identities=29% Similarity=0.430 Sum_probs=171.5
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..||+|+||+||+|+.+ ++..||||.+.+. .....+.+..|+++|+.++|||||++++++.+++..|+|||||.+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 45999999999999954 6899999999766 34456678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC------CcEEEeccCCCccCC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT------GNARVSDFGLSIFAP 516 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~------~~~kl~DfG~a~~~~ 516 (672)
|.++++... .+++.+...++.|+|.||++|| +++||||||||+|||++.. -.+||+|||+|+.+.
T Consensus 96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999998654 4999999999999999999999 8999999999999999864 458999999999998
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
+. +.+|++-|||||++. ..+|+.|+|+||+|+|+|++++|+.||...
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~--~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIM--SQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhHHHHhhCCccccCHHHHH--hccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 76 678999999999875 568999999999999999999999999743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=374.99 Aligned_cols=238 Identities=26% Similarity=0.424 Sum_probs=201.3
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+++||+|+|+.+|+++. ..|+.||+|++.+... ...+...+||++.+.|+|||||+++++|++.++.|+|.|+|+
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 357899999999999996 8899999999976432 356788999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.++++.. .++++.++..++.||+.||.||| +++|+|||||..|++++++.++||+|||+|......
T Consensus 102 ~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 102 RGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred CccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999843 56999999999999999999999 899999999999999999999999999999877643
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
+.+||+-|+|||++. ....+..+||||+|||+|.|+.|++||+.. .+.+-...+...+..
T Consensus 173 Erk~TlCGTPNYIAPEVl~--k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------------~vkety~~Ik~~~Y~-- 236 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLN--KSGHSFEVDIWSLGCVMYTLLVGRPPFETK------------TVKETYNKIKLNEYS-- 236 (592)
T ss_pred cccceecCCCcccChhHhc--cCCCCCchhhhhhhhHHHhhhhCCCCcccc------------hHHHHHHHHHhcCcc--
Confidence 778999999999987 456788999999999999999999999743 233333333322211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
- +.. ...+-.+||.++|+.||.+|||+++|+.
T Consensus 237 --~-----P~~---ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 --M-----PSH---LSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --c-----ccc---cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 111 2233557777999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=389.26 Aligned_cols=252 Identities=29% Similarity=0.416 Sum_probs=211.7
Q ss_pred HHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
...+.||+|+||.||+|+.. +.+.||||.+++.... ..++|++|++++..++|||||+++|+|..++..++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 45678999999999999943 3467999999987665 7889999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEE
Q 005880 436 EYMPNGSLFWLLHGNRGP---------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl 506 (672)
|||..|||.++|...... .+.+++..+.+.||.|||.|+.||- ++.+|||||..+|+||.++..+||
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccceEEEe
Confidence 999999999999764321 1345999999999999999999999 889999999999999999999999
Q ss_pred eccCCCccCCCCCCCC-------CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCC
Q 005880 507 SDFGLSIFAPPSTVPR-------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578 (672)
Q Consensus 507 ~DfG~a~~~~~~~~~~-------t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~ 578 (672)
+|||+++.....++.+ ..+|||||-+. -+++|++||||||||||||+++ |+.||.+....+
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------- 713 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------- 713 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhh--cCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence 9999999887664432 34799999665 5699999999999999999998 899987543221
Q ss_pred hhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
+-+.++.+. + ....+.++.++..|+..||+..|++||+++||-..|+...+
T Consensus 714 ----VIe~i~~g~--------l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 ----VIECIRAGQ--------L--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----HHHHHHcCC--------c--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 222233321 1 23335677789999999999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=342.37 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=206.6
Q ss_pred HHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEE-EEcCCe-EEEEEee
Q 005880 363 ASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAY-YFAREE-KLLVSEY 437 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~e~ 437 (672)
.+.++||+|.||+||++. ..+|..||.|.++-. +....++...|+.+|++|+|||||+++++ +.++.+ .+|||||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 456889999999999999 678999999998733 23356788999999999999999999984 444445 6899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
|..|+|..+++..+. +++.+++.++|+++.|+++||.++|....+.-|+||||||.||+++.+|.+||+|||+++.+..
T Consensus 102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999999987653 4567999999999999999999999544434499999999999999999999999999998877
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ..+||+.||+||.+. +..|+.|+||||+||++|||+.-++||.++ .+.+..+.+...+.
T Consensus 181 ~~tfA~S~VGTPyYMSPE~i~--~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------------n~~~L~~KI~qgd~- 245 (375)
T KOG0591|consen 181 KTTFAHSLVGTPYYMSPERIH--ESGYNFKSDIWSLGCLLYEMCALQSPFYGD------------NLLSLCKKIEQGDY- 245 (375)
T ss_pred hhHHHHhhcCCCcccCHHHHh--cCCCCcchhHHHHHHHHHHHHhcCCCcccc------------cHHHHHHHHHcCCC-
Confidence 5 578999999999765 678999999999999999999999999754 44444444433321
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
..+ + .+.....+.+||..|+..||+.||+...++..+..
T Consensus 246 ~~~--------p-~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPL--------P-DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCC--------c-HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111 1 13455678899999999999999997666655544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.59 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=204.4
Q ss_pred HHHHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCC-CCceeeeEEEEEcCC-eEEEEEe
Q 005880 361 LRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIG-GKREFEQHMEVLGRLR-HPNLVGLKAYYFARE-EKLLVSE 436 (672)
Q Consensus 361 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e 436 (672)
.|.+.++||.|.||.||+|+ ..+|..||||++++.... ++..-.+|++.|++|. |||||++.+++.+.+ ..++|||
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 45677899999999999999 567999999999865433 2334578999999998 999999999999988 8899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
||+ .+|++++++.+ .++++..+..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+||...
T Consensus 91 ~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 91 FMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred hhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEecccccccccc
Confidence 995 59999998653 68999999999999999999999 8999999999999999999999999999999887
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC----CCCCCCChhHHHHHHHh
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM----GCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 588 (672)
.. .++.|..|+|||++.. ...|+.+.||||+|||++|+.+-++-|-+..+-+++ ..-+..+...|.....
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLr-s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~- 239 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLR-SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN- 239 (538)
T ss_pred cCCCcchhhhcccccchHHhhh-ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH-
Confidence 64 5677999999999875 468999999999999999999999998765433211 0001111111211100
Q ss_pred hhccccccchhhcc--ccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 589 EEWTAEVFDLELMR--YKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 589 ~~~~~~~~d~~~~~--~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
+...+.-.+.. ... +.....+.++++.+|+++||.+||||.|+++.
T Consensus 240 ---La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 ---LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ---HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000000000 000 12244667889999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=336.50 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=198.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
...++|+|+||.||+++.+ +|+.||||++.+... .-.+-..+|+++|++++|+|+|.++.+|......+||+|||+.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3467999999999999955 699999999975433 2456779999999999999999999999999999999999988
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC-CC-
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP-PS- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~-~~- 518 (672)
.-|.+ |.... .-++...+.++++|+++|+.|+| ++++|||||||+||||+.+|.+||||||+|+.+. ++
T Consensus 86 TvL~e-Le~~p----~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 86 TVLHE-LERYP----NGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred HHHHH-HHhcc----CCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 54444 44332 23888999999999999999999 8999999999999999999999999999999887 33
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHh-hhc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVR-EEW 591 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~ 591 (672)
+++.|..|+|||++.. ..+|+..+||||+||++.||++|.+-|-+..+-++.- .-.+ ++....++++. ...
T Consensus 157 ~YTDYVATRWYRaPELLvG-DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG-~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVG-DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG-NLIPRHQSIFSSNPF 234 (396)
T ss_pred hhhhhhhhhhccChhhhcc-cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc-ccCHHHHHHhccCCc
Confidence 5667999999998764 3689999999999999999999999987654322110 0000 11111122222 222
Q ss_pred cccccchhhccccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMRYKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+.-|........+ ....-+++++..|++.||.+|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2222112211111111 12235788999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.32 Aligned_cols=282 Identities=26% Similarity=0.357 Sum_probs=211.7
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHc--CCCCCceeeeEEEEEcCC----eEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLG--RLRHPNLVGLKAYYFARE----EKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~e~~ 438 (672)
.+.+|+|+||.||||.+. ++.||||++... +.+.|+.|-+|.+ .++|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 467999999999999998 599999999743 5677877777765 468999999999987555 889999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-----CCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC-----KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
+.|+|.++|..+. ++|....+|+..+++||+|||+.. ++++|+|||||++||||..|+++.|+|||+|.
T Consensus 291 ~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 291 PKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred cCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999998765 999999999999999999999743 35679999999999999999999999999998
Q ss_pred cCCCC-------CCCCCCcccCCCccccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCC-CCCCC--CC--CCCCCC
Q 005880 514 FAPPS-------TVPRSNGYRAPELSSSDGR----KQSQKSDVYSFGVLLLELLTGKCPSVI-DGGGA--GM--GCGGAV 577 (672)
Q Consensus 514 ~~~~~-------~~~~t~~y~aPE~l~~~~~----~~~~~~DV~S~Gvvl~el~tg~~P~~~-~~~~~--~~--~~~~~~ 577 (672)
.+.+. ..+||.+|||||++...-. ..-.+.||||+|.|+|||++.-.-++. ..+.- .+ +.+...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 77654 4678999999999864311 122478999999999999996544321 11110 01 112223
Q ss_pred ChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCCCC
Q 005880 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVS 657 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 657 (672)
.+.+....+++++....+.|.-.. ...+..+.+.+..||..||+.|.|+.=|.+++.++......+..+.+.+..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~-----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~~~~~ 519 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRK-----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGESSSSLV 519 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhc-----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCccccccC
Confidence 334443334444332222221111 234567888889999999999999999999999998766655555555544
Q ss_pred CCCC
Q 005880 658 DSPC 661 (672)
Q Consensus 658 ~~~~ 661 (672)
..-.
T Consensus 520 ~~~~ 523 (534)
T KOG3653|consen 520 TPVD 523 (534)
T ss_pred CCCc
Confidence 4443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=342.58 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=203.5
Q ss_pred HHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
...+.||.|..++||+|+ ...++.||||++.-.... +...+++|+..|+.++||||++++..|..+...|+||.||.+
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence 345789999999999999 557899999999744333 358899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|++.++++..-.. -+++..+..|.+++++||.||| .+|.||||||+.||||+.+|.+||+|||.+..+..
T Consensus 109 GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 109 GSLLDIIKTYYPD---GLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred CcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999876543 3899999999999999999999 88999999999999999999999999998644322
Q ss_pred ------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 518 ------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 518 ------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
.+..+|+.|||||++......|+.|+||||||+...||.+|..||.... ..+.+...+.+..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p------------PmkvLl~tLqn~p 249 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP------------PMKVLLLTLQNDP 249 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC------------hHHHHHHHhcCCC
Confidence 3567899999999988888899999999999999999999999997432 1222222222221
Q ss_pred cc---cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TA---EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~---~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ...+.+ ........+.+++..||.+||.+|||+.++++
T Consensus 250 p~~~t~~~~~d-----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKD-----EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChH-----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 10 011111 01122346888899999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.61 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=201.1
Q ss_pred HHHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 362 RASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
|...+++|+|.||.||+|+ ..+|+.||||+++.... .-.....+|++.|+.++|+||+.++++|-..+..-||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 3455789999999999999 56799999999975432 23567789999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+. +|+..++... ..++..++..++.++++||+|+| ++.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 84 ~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred cc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 65 9999998654 67999999999999999999999 889999999999999999999999999999988754
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCCCCChhHHHHHHHhh
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG----CGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 589 (672)
..+.|..|+|||++.+ .+.|+..+||||.|||+.||+-|.+-|.++.+-+++. .-+.....+|-....-.
T Consensus 155 ~~~~~~~V~TRWYRAPELLfG-sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFG-SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CcccccceeeeeccChHHhcc-chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 2346789999999875 5789999999999999999999988776654322110 00011111110000000
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
....-..-+......-........++++..++..||.+|+|+.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000000000000000112233456889999999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=346.60 Aligned_cols=261 Identities=19% Similarity=0.252 Sum_probs=208.2
Q ss_pred CccccCHHHHHHHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcch---HHHHHHHHHHHcCCCCCceeeeEEEEEc
Q 005880 351 GTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGG---KREFEQHMEVLGRLRHPNLVGLKAYYFA 427 (672)
Q Consensus 351 ~~~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~ 427 (672)
..+.++.+|+.......||+|++|.||+|.+ +|+.||||+++...... .+.|.+|++++.+++||||++++|++.+
T Consensus 11 ~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 11 DIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred cceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 3455677777555456899999999999998 48999999997654332 4678899999999999999999999876
Q ss_pred ----CCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCC
Q 005880 428 ----REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 428 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~ 502 (672)
....++||||+++|+|.+++... ..+++....+++.|++.||.||| + .+++||||||+||++++++
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY----KYTNKPYKNLTSVSFLVTENY 160 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH----hcCCCCCCcCChhhEEECCCC
Confidence 34678999999999999999754 35899999999999999999999 4 4788999999999999999
Q ss_pred cEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChh
Q 005880 503 NARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP 580 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~ 580 (672)
.+||+|||+++..... ...++..|+|||++......++.++|||||||++|||++|+.||... ...
T Consensus 161 ~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~------------~~~ 228 (283)
T PHA02988 161 KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL------------TTK 228 (283)
T ss_pred cEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC------------CHH
Confidence 9999999999765443 34567899999987543367899999999999999999999999643 222
Q ss_pred HHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 581 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
+............. .. ......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 229 ~~~~~i~~~~~~~~-------~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 EIYDLIINKNNSLK-------LP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHhcCCCCC-------CC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 33333322211100 00 1233457888889999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=363.94 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=211.0
Q ss_pred hcccCcCCeEEEEEEEEcC----CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.++||.|.||.||+|+++- ...||||.++.... ..+.+|..|..||.+.+||||+++.|+.......+||+|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 4789999999999999762 35799999997554 356799999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST 519 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 519 (672)
+|+|+.+|+.+.+ .+++.+...++++||.|+.||- ++++|||||.++||||+.+..+|++|||+++.+.++.
T Consensus 714 NGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 714 NGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred CCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999997763 4999999999999999999999 8999999999999999999999999999999876542
Q ss_pred --CCC------CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 520 --VPR------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 520 --~~~------t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
... ..+|-|||.+. .+++|.++||||||||+||.++ |..||...... +.+.++..+-
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------------dVIkaIe~gy 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------------DVIKAIEQGY 851 (996)
T ss_pred CccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCcccccchH------------HHHHHHHhcc
Confidence 111 24699999664 5799999999999999999887 89998754322 2233222221
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCC
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSP 648 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 648 (672)
+.+...+++..|.+|++.||++|-.+||++.|++..|+++.+.-.+-
T Consensus 852 -----------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 852 -----------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred -----------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 22333567788999999999999999999999999999987654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=346.00 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=197.6
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 439 (672)
.++||+|.||.||+|+ ..+|+.||+|+++-.. .+......+||.+|++|+||||+++.+...+. ...|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4789999999999999 6689999999997544 33456678999999999999999999998876 68999999997
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+ ||.-++.... ..++..++..++.|++.||+|+| ..+|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 202 h-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 202 H-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred c-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 7 8888887542 56999999999999999999999 899999999999999999999999999999977654
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCCCCChhHHHHHHHhh
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG----CGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 589 (672)
..+.|..|+|||++.+ ...|+.++|+||.||||.||++|++.|.+..+-+++. ..+......|-...+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG-~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP- 350 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLG-ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP- 350 (560)
T ss_pred CcccccceEEeeccChHHhcC-CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC-
Confidence 2345788999999875 4689999999999999999999999998654322110 0011111112100000
Q ss_pred hccccccchhhccccChHH----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEE----EMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~----~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+.+...-...+.+ .....++|+..+|..||.+|.|+.++++
T Consensus 351 --~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 --HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred --cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111111110011111 1244667888999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.76 Aligned_cols=232 Identities=27% Similarity=0.428 Sum_probs=195.0
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..++||+|+||.||.++. ++++.+|+|++++.... +.+...+|..+|.+++||.||+++..|++.+..|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 457899999999999994 46899999999876543 34567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
||.|+.+|++.. .+++..+.-++..|+.||.||| +.+||||||||+|||+|++|+++|+|||+++....
T Consensus 109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999998654 4899999999999999999999 89999999999999999999999999999984432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
.+.+||+.|||||++. +..|+.++|.||+|+++|||++|.+||... +..++.+.+.++..
T Consensus 180 ~~t~tfcGT~eYmAPEil~--~~gy~~~vDWWsLGillYeML~G~pPF~~~------------~~~~~~~~I~~~k~--- 242 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILL--GKGYDKAVDWWSLGILLYEMLTGKPPFYAE------------DVKKMYDKILKGKL--- 242 (357)
T ss_pred CccccccCCccccChHHHh--cCCCCcccchHhHHHHHHHHhhCCCCCcCc------------cHHHHHHHHhcCcC---
Confidence 2668999999999886 458999999999999999999999999743 45566666655541
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCC
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP 629 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 629 (672)
......+.. +..+++.+.+..||++|.
T Consensus 243 -----~~~p~~ls~---~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -----PLPPGYLSE---EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CCCCccCCH---HHHHHHHHHhccCHHHhc
Confidence 001111233 345666699999999996
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=353.88 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=200.9
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
-++||+|+.|.||.|+ ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...++.|+|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3689999999999999 567899999999876666677889999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+.+.... +++.++..|++++++||+||| ..+|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 358 TDvVt~~~------~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 358 TDVVTKTR------MTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhccc------ccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 99997543 899999999999999999999 899999999999999999999999999999776543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
+.+||+.|||||+.. ...|++|+||||||++++||+-|++||..+..- +-+..+...+ .+
T Consensus 428 TmVGTPYWMAPEVvt--rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------------rAlyLIa~ng------~P 487 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVT--RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------------RALYLIATNG------TP 487 (550)
T ss_pred cccCCCCccchhhhh--hcccCccccchhhhhHHHHHhcCCCCccCCChH------------HHHHHHhhcC------CC
Confidence 678999999999765 468999999999999999999999999754321 1111111111 11
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
++. ..+.....+.+++.+||..||++||++.|+|+
T Consensus 488 ~lk---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLK---NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcC---CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 222 22333455777777999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.68 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=196.9
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--eEEEEEeecC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE--EKLLVSEYMP 439 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~ 439 (672)
...+.||+|+||.||++... +|...|||.+........+.+.+|+++|.+++|||||+++|.....+ ..++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 34688999999999999965 49999999987653333667899999999999999999999865555 5889999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPP- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~- 517 (672)
+|+|.+++.+..+ .+++..+..++.||++||+||| +++||||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999987642 5999999999999999999999 899999999999999999 79999999999986652
Q ss_pred -------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 518 -------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 518 -------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
....||+.|||||++.. +.....++||||+||++.||+||++||... .....++-.+..+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----------~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEF-----------FEEAEALLLIGRED 239 (313)
T ss_pred cccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhh-----------cchHHHHHHHhccC
Confidence 25678999999998764 333446999999999999999999999642 11222332222222
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
....+ +..+. ....+++.+|+..||++||||.|+++.---
T Consensus 240 ~~P~i-------p~~ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 SLPEI-------PDSLS---DEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCCC-------CcccC---HHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 11111 11222 345566779999999999999999876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=354.50 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=202.8
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.+.||+|+||+||+|++.+ .||||.++.... +..+.|++|+..+++-+|.||+-++|||..+.. .||+.+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 467899999999999999873 589999985443 356789999999999999999999999998877 999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
-+|+.++|..+ ..++..+.+.||+|||+|+.||| .++|||||||..||++.+++++||+|||++..-..
T Consensus 472 sSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 472 SSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred chhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999765 56999999999999999999999 89999999999999999999999999999854321
Q ss_pred ----CCCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 ----STVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ----~~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
....+..-|||||++.. +...|++.+||||||+|+|||+||..||.... .+.+. ..+-+....
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIi-----------fmVGrG~l~ 611 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQII-----------FMVGRGYLM 611 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheE-----------EEecccccC
Confidence 13345667999999864 36789999999999999999999999998332 22110 000000000
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
. | +. .....+.+++.+|+..||..++++||.+.+|+..|+++..
T Consensus 612 p---d--~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 P---D--LS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c---c--ch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 0 00 1113345578888889999999999999999999998875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=379.00 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=209.2
Q ss_pred HhcccCcCCeEEEEEEEEcC--Cc----EEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLDD--GS----VVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
....||+|+||.||+|.+.+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 45789999999999999653 43 4999999865 45567899999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 437 YMPNGSLFWLLHGNRGP--GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
||++|+|..+|+..+.. ....++....+.++.|||+|+.||+ +.++|||||.++|+|+++...+||+|||+|+.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999999977432 2356899999999999999999999 89999999999999999999999999999996
Q ss_pred CCCCCCCC-------CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 515 APPSTVPR-------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 515 ~~~~~~~~-------t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
+....+.+ ...|||||.+. .+.++.|+|||||||++||++| |..||.... -.+.....
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~--d~iFtskSDvWsFGVllWEifslG~~PY~~~~------------n~~v~~~~ 917 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLK--DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS------------NFEVLLDV 917 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHh--hcccccccchhhhHHHHHHHHhCCCCCCCCcc------------hHHHHHHH
Confidence 65442221 24699999765 4799999999999999999999 788885432 22222222
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCC
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSP 648 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 648 (672)
.+.+ +.+....+...+.+++..||+.+|++||++..+++.+..+.......
T Consensus 918 ~~gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 918 LEGG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HhCC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 2222 11222345567889999999999999999999999999987544433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.85 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=205.5
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.++||+|-||.|.++....+..||||+++..... .+.+|.+|+++|.+++|||||+++|+|..++..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 357899999999999999998899999999975544 4589999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP 521 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 521 (672)
+|.+++..+..+ .+.-....+|+.|||.|++||. +.++|||||.++|+|+|+++++||+|||+++-+....+.
T Consensus 621 DLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 621 DLNQFLSAHELP---TAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred cHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999877532 2455667789999999999999 899999999999999999999999999999976655333
Q ss_pred C-------CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 522 R-------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT--GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 522 ~-------t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ..+|||||.+. .+++|+++|||+||+.+||+++ ...||....++ +.++-.....+....
T Consensus 694 ~vqgr~vlpiRwmawEsil--lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---------~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---------QVVENAGEFFRDQGR 762 (807)
T ss_pred eeecceeeeeeehhHHHHH--hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---------HHHHhhhhhcCCCCc
Confidence 2 35799999664 5689999999999999999976 67788643321 122222222222211
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
..+. ....-+..++.+++.+||+.|-++||+++++...|++..
T Consensus 763 ~~~l-------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 QVVL-------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ceec-------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1111 111234567889999999999999999999999988753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.29 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=196.3
Q ss_pred HHhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCC-eEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFARE-EKLL 433 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~l 433 (672)
.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++...+ ..++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (338)
T cd05102 10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV 89 (338)
T ss_pred eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence 4567899999999999974 2356899999975432 2456789999999999 8999999999887644 5789
Q ss_pred EEeecCCCChhHHhhcCCCC---------------------------------------------------------CCC
Q 005880 434 VSEYMPNGSLFWLLHGNRGP---------------------------------------------------------GRT 456 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~ 456 (672)
||||+++|+|.+++...... ...
T Consensus 90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (338)
T cd05102 90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS 169 (338)
T ss_pred EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence 99999999999999753210 023
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCC
Q 005880 457 PLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAP 529 (672)
Q Consensus 457 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aP 529 (672)
++++.++..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..... ...++..|+||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 5889999999999999999999 789999999999999999999999999999765322 22345679999
Q ss_pred CccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHH
Q 005880 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEE 608 (672)
Q Consensus 530 E~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 608 (672)
|++. +..++.++|||||||++|||++ |..||...... ..... ........ .. ...
T Consensus 246 E~~~--~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----------~~~~~-~~~~~~~~--------~~--~~~ 301 (338)
T cd05102 246 ESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----------EEFCQ-RLKDGTRM--------RA--PEN 301 (338)
T ss_pred HHhh--cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----------HHHHH-HHhcCCCC--------CC--CCC
Confidence 9764 4578999999999999999997 99998643211 11111 11111100 00 011
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 609 EMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 609 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
....+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=328.26 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=198.3
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcC--CCCCceeeeEEEEEcCC----eEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGR--LRHPNLVGLKAYYFARE----EKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 438 (672)
.+.||+|+||.||+|.++ |+.||||++... +++.+.+|.++.+. |+|+||+.+++....+. +.|||++|.
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 478999999999999999 899999999644 45667777777665 59999999999876543 678999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhh----CCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT----CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+.|+|+|+|..+ .++....++++..+|.||+|||.. ..++.|.|||||+.||||..++.+.|+|+|+|..
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999764 489999999999999999999953 2467799999999999999999999999999965
Q ss_pred CCC---------CCCCCCCcccCCCccccCCC----CCCchhHHHHHHHHHHHHHh----------CCCCCCCCCCCCCC
Q 005880 515 APP---------STVPRSNGYRAPELSSSDGR----KQSQKSDVYSFGVLLLELLT----------GKCPSVIDGGGAGM 571 (672)
Q Consensus 515 ~~~---------~~~~~t~~y~aPE~l~~~~~----~~~~~~DV~S~Gvvl~el~t----------g~~P~~~~~~~~~~ 571 (672)
... ...+||.+|||||++...-. ..-..+||||||.|+||+.. -+.||.+-.+.+
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-- 443 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-- 443 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC--
Confidence 433 36789999999998754311 11247899999999999976 245665433221
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
....+. ..+ .-.+.+.|.....-...+.+..+.++++.||..+|..|-|+-.+-+.|.++.+
T Consensus 444 -----Ps~eeM-rkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 -----PSFEEM-RKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred -----CCHHHH-hcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111111 111 01111222222233346788899999999999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=342.38 Aligned_cols=235 Identities=25% Similarity=0.426 Sum_probs=196.9
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhH
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 445 (672)
+-||+|+.|.||+|+++ ++.||||+++... +.+|+-|++|+||||+.|.|+|....-++||||||..|-|+.
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 66999999999999998 6889999986432 457888999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----CCC
Q 005880 446 LLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----TVP 521 (672)
Q Consensus 446 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~~~ 521 (672)
+|+.. .++.......|..+||.|+.||| .++|||||||.-||||+.+..+||+|||-++..... ...
T Consensus 202 VLka~-----~~itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 202 VLKAG-----RPITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHhcc-----CccCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence 99865 45888999999999999999999 889999999999999999999999999998765543 567
Q ss_pred CCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhc
Q 005880 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELM 601 (672)
Q Consensus 522 ~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 601 (672)
||..|||||++. ....++|+||||||||||||+||..||..-.....+ . . +.....
T Consensus 273 GTVaWMAPEvIr--nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----------------w-----G-VGsNsL 328 (904)
T KOG4721|consen 273 GTVAWMAPEVIR--NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----------------W-----G-VGSNSL 328 (904)
T ss_pred hhHhhhCHHHhh--cCCcccccceehhHHHHHHHHhcCCCccccchheeE----------------E-----e-ccCCcc
Confidence 899999999875 568999999999999999999999999643221100 0 0 011111
Q ss_pred cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 602 RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 602 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
..+....++..+.-|+++||+..|..||++.+++..|+-.
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2233355666788889999999999999999999988653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.45 Aligned_cols=239 Identities=25% Similarity=0.353 Sum_probs=195.7
Q ss_pred HhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIG---GKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+++.||+|+|++||+|+ .++++.+|||++.+..+- ..+.+..|-.+|.+| .||.|++|+..|.++...|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 45779999999999999 557999999999754332 234567788889999 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.++|+... .+++.....++.+|+.||+||| ++|||||||||+|||+|+|+++||.|||.|+.+.+.
T Consensus 157 ~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred CCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999998764 4999999999999999999999 899999999999999999999999999999876431
Q ss_pred ------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChh
Q 005880 519 ------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP 580 (672)
Q Consensus 519 ------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~ 580 (672)
..+||..|.+||++. ....++.+|||+||||+|.|+.|++||...++.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~--~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------------ 293 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLN--DSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------------ 293 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhc--CCCCCcccchHHHHHHHHHHhcCCCCCccccHH------------
Confidence 356889999999875 568899999999999999999999999754321
Q ss_pred HHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 581 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
-.++.++.- ...-.++.. ....+|+.+.|..||.+|+|.+|+-+.
T Consensus 294 liFqkI~~l---------~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 LIFQKIQAL---------DYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHh---------cccCCCCCC---HHHHHHHHHHHccCccccccHHHHhhC
Confidence 122222221 111112222 345677779999999999999888653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.99 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=210.0
Q ss_pred HHHhcccCcCCeEEEEEEEEcCC-cEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEE-EEEc------CCeEE
Q 005880 362 RASAEMLGKGGFGTAYKAVLDDG-SVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKA-YYFA------REEKL 432 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~~~ 432 (672)
..+.+.|.+|||+.||.|....+ ..||+|++-..+....+...+|+++|++|+ |+|||.+++ .... ..+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34457899999999999997765 999999998777777889999999999997 999999999 3332 23678
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
|.||||.+|.|-+++..... ..+++.++++|+.|+++|+++||.. ..+|||||||-+||||+.+++.||||||.|
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 99999999999999975542 3499999999999999999999954 678999999999999999999999999998
Q ss_pred ccCCCC--------------CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q 005880 513 IFAPPS--------------TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577 (672)
Q Consensus 513 ~~~~~~--------------~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~ 577 (672)
...... ...-|+.|+|||++.. .+...++|+|||||||+||-|+....||+..+.-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 543221 2345789999997643 3678899999999999999999999999754221
Q ss_pred ChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCC
Q 005880 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPC 649 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 649 (672)
.+++.... .+........|.+||+.||+.||.+||++-+|+..+.++.....+..
T Consensus 265 ----------------aIlng~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 265 ----------------AILNGNYS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ----------------eEEecccc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 22222222 12224566788999999999999999999999999999987665554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.25 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=199.8
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccC----Cc-chHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA----SI-GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|.||.||.|. ..+|+.||+|++... .. ...+.+.+|+.++++++ ||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 4679999999999998 457899999977653 11 23556778999999998 99999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAP 516 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~ 516 (672)
+.+|+|.+++... .++.+....++++|++.|++|+| +++|+||||||+|||++.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 102 CSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred cCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999863 35888999999999999999999 8999999999999999999 999999999998772
Q ss_pred -C----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 517 -P----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 517 -~----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
. .+.+||+.|+|||++......-+.++||||+||+||.|++|+.||+.. +.+.....+.+...
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------------~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------------NVPNLYRKIRKGEF 240 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------------cHHHHHHHHhcCCc
Confidence 2 277899999999998754334468999999999999999999999753 22233333222211
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.-+.... ..++..++.+|+..||.+|+|+.|++ .-.-++.
T Consensus 241 ---------~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 241 ---------KIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ---------cCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1111110 34567888899999999999999998 5454443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.33 Aligned_cols=238 Identities=26% Similarity=0.420 Sum_probs=201.8
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
...+.||+|.||.||||+.+ +.+.||+|.+.+... .+.+.+.+|++++++++|||||.++++|+...+.|+|+||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 34577999999999999955 689999999875433 345678999999999999999999999999999999999996
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+ +|+.+|.... .++++.+..|+.+++.||.||| +++|+|||+||.|||++..+.+|++|||+|+.....
T Consensus 85 g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 85 G-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred h-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 6 9999998654 4999999999999999999999 899999999999999999999999999999988765
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...||+-|||||+.. +..|+..+|+||+|||+||+++|++||.. ..+.+.++.+..+...
T Consensus 155 ~vltsikGtPlYmAPElv~--e~pyd~~sDlWslGcilYE~~~G~PPF~a------------~si~~Lv~~I~~d~v~-- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVE--EQPYDHTSDLWSLGCILYELYVGQPPFYA------------RSITQLVKSILKDPVK-- 218 (808)
T ss_pred eeeeeccCcccccCHHHHc--CCCccchhhHHHHHHHHHHHhcCCCCchH------------HHHHHHHHHHhcCCCC--
Confidence 456899999999764 77999999999999999999999999973 3445555555444211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. .......+..++...+.+||.+|.|..+++.
T Consensus 219 -------~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -------P---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -------C---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 1233345677777999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=344.59 Aligned_cols=252 Identities=32% Similarity=0.423 Sum_probs=204.3
Q ss_pred HhcccCcCCeEEEEEEEEcC--C--cE-EEEEEccc---CCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD--G--SV-VAVKRLKD---ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
..++||+|+||.||+|++.. + .. ||||..+. .......+|.+|.++|++++|||||+++|++..+...++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 34899999999999999653 2 23 89999884 33446789999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
|+|.||+|.++|+... ..++..++.+++.++|.||+||| +.++|||||.++|+|++.++.+||+|||+++..
T Consensus 241 El~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 9999999999998765 25999999999999999999999 899999999999999999999999999999866
Q ss_pred CCC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 516 PPS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 516 ~~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
..- ...-...|+|||.+. ...+++++|||||||++||+++ |..||.+. ...+....+..+
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~------------~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLN--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGM------------KNYEVKAKIVKN 378 (474)
T ss_pred cceeeccccccCcceecChhhhc--cCccccccchhheeeeEEeeeccCCCCCCCC------------CHHHHHHHHHhc
Confidence 521 111235799999765 4599999999999999999999 78898643 222333333233
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCC
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 647 (672)
+..... . ......+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 379 ~~r~~~-------~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 GYRMPI-------P---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CccCCC-------C---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 221111 1 12334566777799999999999999999999999876554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.67 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=206.3
Q ss_pred HhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-----eEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-----EKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 437 (672)
+.+.||+|||+.||.++ ..++..+|+|++.....++.+..++|++..++++||||++++++...+. +.|++++|
T Consensus 25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred EeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 35779999999999999 7789999999998887778889999999999999999999999876443 48999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
...|+|.+.+..... +...+++.+++.|+.++++||.+||.. ..+++||||||.||++++++.++|.|||.+....-
T Consensus 105 y~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred hccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 999999999976553 335699999999999999999999944 34699999999999999999999999999875542
Q ss_pred C--------------CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 518 S--------------TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 518 ~--------------~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
. ....|..|+|||++.-. +...++++|||||||++|+|+.|..||+...+.
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------------- 247 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------------- 247 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------------
Confidence 1 23357889999987543 567789999999999999999999999754321
Q ss_pred HHHHHhhhcc-ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 583 VQSVVREEWT-AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 583 ~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.+.. ..+...... .+......+.+.+++..|++.||.+||++.+++..++.+.
T Consensus 248 ------GgSlaLAv~n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ------GGSLALAVQNAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------CCeEEEeeeccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 111111111 1112225567889999999999999999999999988753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.09 Aligned_cols=194 Identities=27% Similarity=0.372 Sum_probs=169.1
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 438 (672)
..+.|++|.||.||+|+. ++++.||+|+++.... +-.-.-.+||.+|.+++|||||.+-.+... -+..|+|||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 458899999999999995 4789999999985432 223456899999999999999999888764 35789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+. +|..+++... .++...++.-+..|+++|++||| .+.|+|||||++|+|++..|.+||+|||+|+.+...
T Consensus 160 Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 160 EH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred Hh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 87 9999998765 57999999999999999999999 889999999999999999999999999999988765
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGG 567 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~ 567 (672)
..+.|..|+|||++.. ...|+++.|+||+|||+.||+++++-|.+..+
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG-~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLG-AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred cccCcceEEEeeecCHHHhcC-CcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 3445789999998864 57899999999999999999999999976653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.62 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=194.5
Q ss_pred HhcccCcCCeEEEEEEEEcC-----------------CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-----------------GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
+.+.||+|+||.||+|..++ +..||+|.++.... ....+|.+|++++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 35789999999999998532 34799999876432 2456799999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRG--------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNI 491 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dl 491 (672)
.+.+..++||||+++|+|.+++..... .....++|..+++++.|+++||+||| +.+|+||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~ivH~dl 164 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFVHRDL 164 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCccccCc
Confidence 999999999999999999999865321 11235789999999999999999999 789999999
Q ss_pred CCCCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh--CCCCC
Q 005880 492 KSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT--GKCPS 562 (672)
Q Consensus 492 kp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t--g~~P~ 562 (672)
||+||++++++.+||+|||+++..... ...++..|+|||++. +..++.++||||||+++|||++ +..||
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh--cCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999765432 223366899999764 4578999999999999999987 55666
Q ss_pred CCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 563 VIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
..... ......+....+........ ... ......+.+++.+||+.||++|||+.||.+.|++
T Consensus 243 ~~~~~---------~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTD---------EQVIENAGEFFRDQGRQVYL----FRP---PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCH---------HHHHHHHHHHhhhccccccc----cCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 53221 11222222221111100000 001 1223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.91 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=196.3
Q ss_pred HHhcccCcCCeEEEEEEEEc----CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 363 ASAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.+.||+|+||.||+|.+. .+..||+|+++.... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence 34578999999999999853 357899999986432 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+.....
T Consensus 88 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 88 MSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999997543 35899999999999999999999 78999999999999999999999999998765432
Q ss_pred C------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 518 S------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 518 ~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
. ...++..|+|||++. +..++.++|||||||++||+++ |+.||.... ..+...... +.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~------------~~~~~~~~~-~~ 224 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMS------------GQDVIKAVE-DG 224 (266)
T ss_pred cchhcccCCCCceeecCHHHHh--hCCccchhHHHHHHHHHHHHhcCCCCCcCcCC------------HHHHHHHHH-CC
Confidence 2 122346799999764 5678999999999999999775 999996432 112222221 11
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.. .+........+.+++.+||+.+|.+||++.|+.+.|+.+
T Consensus 225 ~~----------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FR----------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 10 011122344678888999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=319.58 Aligned_cols=240 Identities=26% Similarity=0.437 Sum_probs=195.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||++..+++..+|+|.++.... ...++.+|++++++++||||+++++++..++..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 467999999999999988888999999875433 4567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
++++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||.++.....
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 9997543 24899999999999999999999 789999999999999999999999999998765432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||... +..+.+........ ...
T Consensus 160 ~~~~~~~y~aPE~~~--~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~------------~~~~~~~~i~~~~~---~~~ 222 (256)
T cd05114 160 GAKFPVKWSPPEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK------------SNYEVVEMISRGFR---LYR 222 (256)
T ss_pred CCCCchhhCChhhcc--cCccchhhhhHHHHHHHHHHHcCCCCCCCCC------------CHHHHHHHHHCCCC---CCC
Confidence 122345799999764 4578899999999999999999 89998643 22223333222211 001
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
+ ......+.+++.+||+.+|.+||++.|+++.|
T Consensus 223 ~--------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 P--------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C--------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 11224578899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.05 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=196.2
Q ss_pred HHhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
.+.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +||||+++++++.+.+..++|
T Consensus 38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv 117 (375)
T cd05104 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI 117 (375)
T ss_pred ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceee
Confidence 4578999999999999973 235689999997533 23456788999999999 899999999999999999999
Q ss_pred EeecCCCChhHHhhcCCC--------------------------------------------------------------
Q 005880 435 SEYMPNGSLFWLLHGNRG-------------------------------------------------------------- 452 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~-------------------------------------------------------------- 452 (672)
|||+++|+|.++++....
T Consensus 118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (375)
T cd05104 118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ 197 (375)
T ss_pred ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence 999999999999865321
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 453 --------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 453 --------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
.....+++..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 01135889999999999999999999 789999999999999999999999999999765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++ |..||...... ..+. ....+.....
T Consensus 274 ~~~~~~~~y~aPE~~~--~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-----------~~~~-~~~~~~~~~~-- 337 (375)
T cd05104 274 GNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-----------SKFY-KMIKEGYRML-- 337 (375)
T ss_pred CCCCCCcceeChhHhc--CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----------HHHH-HHHHhCccCC--
Confidence 122345799999764 5678999999999999999998 88888643211 1111 1112111000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
... ....++.+++.+||+.||++||++.||++.|++.
T Consensus 338 -----~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 -----SPE---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCC---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001 1123578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=335.94 Aligned_cols=239 Identities=28% Similarity=0.432 Sum_probs=201.1
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
++.||+|+.|.|.+|+ ..+|+.+|||++.+.. ......+++|+-+|+-+.||||+++++++.+..+.|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 5789999999999999 5689999999997652 22356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|.|++++-.. .++.+.+..+++.||+.|+.|.| ..+|+||||||+|+|+|..+++||+|||+|....++
T Consensus 97 GELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 97 GELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred chhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999755 35899999999999999999999 889999999999999999999999999999877665
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
+.+|++.|+|||++.+. ...+.++||||+|||||.|+||+.||+++ ++...+.++.++.+..
T Consensus 168 LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDd------------Nir~LLlKV~~G~f~M--- 231 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDD------------NIRVLLLKVQRGVFEM--- 231 (786)
T ss_pred ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCc------------cHHHHHHHHHcCcccC---
Confidence 78899999999998643 45578999999999999999999999843 3444444444443210
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
+..+. .+..+|+.+|+..||+.|.|++||++-
T Consensus 232 ------Ps~Is---~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ------PSNIS---SEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------CCcCC---HHHHHHHHHHhccCccccccHHHHhhC
Confidence 12222 345567779999999999999999753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=299.57 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=205.3
Q ss_pred cccCHHHHHHHHhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcC
Q 005880 353 KRFELEDLLRASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAR 428 (672)
Q Consensus 353 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 428 (672)
+.++++|. .+++.||+|.||.||.|+. +++..||+|++.+.... -.+++.+|+++-+.|+||||+++++||.+.
T Consensus 17 ~~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 45666665 4678899999999999994 56889999999764432 467899999999999999999999999999
Q ss_pred CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEec
Q 005880 429 EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 429 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
...||++||..+|.+...|...+. ..+++.....+..|+|.||.|+| ..+||||||||+|+|++.++..||+|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccC
Confidence 999999999999999999985542 45888889999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 509 FGLSIFAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 509 fG~a~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
||-+...+.. +.+||..|.+|| +..+...+.++|+|++|++.||++.|.+||.....+ +-.++
T Consensus 168 fGwsV~~p~~kR~tlcgt~dyl~pE--mv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------------etYkr 233 (281)
T KOG0580|consen 168 FGWSVHAPSNKRKTLCGTLDYLPPE--MVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------------ETYKR 233 (281)
T ss_pred CCceeecCCCCceeeecccccCCHh--hcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------------HHHHH
Confidence 9998766533 678999999999 556788999999999999999999999999754311 11222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.+ .++.++ ..+. ....++|.+|+..+|.+|.+..||++
T Consensus 234 I~k----~~~~~p-----~~is---~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 234 IRK----VDLKFP-----STIS---GGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHH----ccccCC-----cccC---hhHHHHHHHHhccCccccccHHHHhh
Confidence 211 122222 2222 34567788999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.15 Aligned_cols=236 Identities=24% Similarity=0.338 Sum_probs=190.7
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999995 468999999987532 223456788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---- 517 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 517 (672)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 999998754 35899999999999999999999 88999999999999999999999999999875322
Q ss_pred -CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 518 -STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 518 -~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..........+..
T Consensus 152 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------------~~~~~~~~~~~~~----- 212 (323)
T cd05571 152 MKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------HEKLFELILMEEI----- 212 (323)
T ss_pred ccceecCccccChhhhc--CCCCCccccCcccchhhhhhhcCCCCCCCCC------------HHHHHHHHHcCCC-----
Confidence 1345789999999764 5678999999999999999999999996431 1112222211110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
.... ....++.+++.+||+.||++|| ++.|+++
T Consensus 213 ----~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 ----RFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCC---CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0011 1223567888899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=322.54 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=191.6
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--------------chHHHHHHHHHHHcCCCCCceeeeEEEEEcC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--------------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR 428 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 428 (672)
+...||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|||||+++.+..+.
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 356799999999999994 4799999999964221 1235789999999999999999999998764
Q ss_pred --CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEE
Q 005880 429 --EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506 (672)
Q Consensus 429 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl 506 (672)
+..|||+|||..|.+.+.=. ....+++.+.++++.++..||+||| ..+||||||||+|+|++++|++||
T Consensus 181 ~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred ccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCCcEEe
Confidence 57899999999998754422 1123999999999999999999999 789999999999999999999999
Q ss_pred eccCCCccCCCC----------CCCCCCcccCCCccccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005880 507 SDFGLSIFAPPS----------TVPRSNGYRAPELSSSD--GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 507 ~DfG~a~~~~~~----------~~~~t~~y~aPE~l~~~--~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~ 574 (672)
+|||.+...... ...||+.|+|||..... ....+.+.||||+||+||.|+.|+.||.++.
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-------- 323 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-------- 323 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--------
Confidence 999998766221 46789999999987653 2345678999999999999999999997653
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
..+.+.++..+. + ..+...+....+.+||.++|.+||++|.+..+|...
T Consensus 324 ----~~~l~~KIvn~p---------L-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 324 ----ELELFDKIVNDP---------L-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ----HHHHHHHHhcCc---------c-cCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 222233332221 1 112223345567888889999999999999998643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=322.03 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=197.4
Q ss_pred HHhcccCcCCeEEEEEEEEcC-C-----cEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD-G-----SVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.+.||+|+||.||+|.... + ..||+|.++.... ....+|.+|++++.+++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 345789999999999998543 2 5799999875432 24567899999999999999999999999989999999
Q ss_pred eecCCCChhHHhhcCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcE
Q 005880 436 EYMPNGSLFWLLHGNRGPG-----------RTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA 504 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~ 504 (672)
||+++|+|.+++....... ...+++.+++.++.|+++||+||| +.+++||||||+||++++++.+
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCCCcE
Confidence 9999999999997643211 145889999999999999999999 7899999999999999999999
Q ss_pred EEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCC
Q 005880 505 RVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGA 576 (672)
Q Consensus 505 kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~ 576 (672)
||+|||+++..... ...++..|+|||.+. +..++.++|||||||++|||++ |..||....
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDv~slG~il~el~~~g~~p~~~~~---------- 231 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS---------- 231 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhc--cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC----------
Confidence 99999998765332 223456799999654 4578999999999999999998 999986432
Q ss_pred CChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 577 VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
..+....+. ..... ........++.+++.+||+.||++||++.||++.|+.
T Consensus 232 --~~~~~~~i~-~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 232 --NQEVIEMIR-SRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHH-cCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111221111 11110 0112234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.84 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=196.9
Q ss_pred HHHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEE
Q 005880 362 RASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 433 (672)
+.+.+.||+|+||.||+|+.. ++..||||+++.... .....+.+|+++++.+ +|+||+++++++...+..++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 356788999999999999842 235799999975432 2346788999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCC-------------------------------------------------------------
Q 005880 434 VSEYMPNGSLFWLLHGNRG------------------------------------------------------------- 452 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~------------------------------------------------------------- 452 (672)
||||+++|+|.++++....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 9999999999999864310
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-------CCC
Q 005880 453 ----PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVP 521 (672)
Q Consensus 453 ----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~ 521 (672)
....++++.++++++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..... ...
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 01235889999999999999999999 789999999999999999999999999998765332 122
Q ss_pred CCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhh
Q 005880 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLEL 600 (672)
Q Consensus 522 ~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 600 (672)
++..|+|||++. +..++.++|||||||++|||++ |+.||...... .-......... ...
T Consensus 276 ~~~~y~aPE~~~--~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~------------~~~~~~~~~~~-----~~~- 335 (374)
T cd05106 276 LPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------------SKFYKMVKRGY-----QMS- 335 (374)
T ss_pred CccceeCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCcccccc------------HHHHHHHHccc-----Ccc-
Confidence 345799999764 4578999999999999999997 99998643211 00111111111 000
Q ss_pred ccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 601 MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 601 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
... ....++.+++.+||+.||++|||+.+|+++|+++.
T Consensus 336 -~~~---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 -RPD---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001 11245788888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=324.22 Aligned_cols=242 Identities=34% Similarity=0.549 Sum_probs=188.7
Q ss_pred hcccCcCCeEEEEEEEEc-----CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 367999999999999977 357899999975433 34788999999999999999999999999888899999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.++|+... ...+++.++.+|+.|+++||+||| +.+++||||+++||++++++.+||+|||++......
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---cccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence 9999999998762 245899999999999999999999 789999999999999999999999999999876321
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
.......|+|||.+. ...++.++||||||+++|||++ |+.||... +..++........
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------------~~~~~~~~~~~~~ 222 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLK--DGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------------DNEEIIEKLKQGQ 222 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHH--HSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------------CHHHHHHHHHTTE
T ss_pred cccccccccccccccccccccc--ccccccccccccccccccccccccccccccc------------ccccccccccccc
Confidence 223456799999764 3458999999999999999999 68887532 3333333332221
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
. .. ........+.+++.+||+.||++|||+.++++.|
T Consensus 223 ~-~~----------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 R-LP----------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp E-TT----------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c-ce----------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 11 0111233577888999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=324.39 Aligned_cols=243 Identities=24% Similarity=0.341 Sum_probs=192.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|.. .+|+.||||.+..... .....+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999995 5799999999864332 2334678899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99998886432 235899999999999999999999 889999999999999999999999999999765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||....... ..+-+.......
T Consensus 158 ~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---------~~~~~~~~~~~~------ 220 (285)
T cd05631 158 VRGRVGTVGYMAPEVIN--NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---------KREEVDRRVKED------ 220 (285)
T ss_pred ecCCCCCCCccCHhhhc--CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---------hHHHHHHHhhcc------
Confidence 345788999999764 5678999999999999999999999997543211 011111111110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
..... ......+.+++.+||+.||.+||+ +.|+++
T Consensus 221 --~~~~~---~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 --QEEYS---EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cccCC---ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00001 112235678888999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.14 Aligned_cols=237 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchH---HHHHHHHHHHcCCCCCceeeeEEEEEcCCe
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGK---REFEQHMEVLGRLRHPNLVGLKAYYFAREE 430 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 430 (672)
+.++|. .+...||.|+||.|.+++.+ +|..+|+|++.+...-.. +...+|..+|+.+.||.++++++.+.+...
T Consensus 41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 445544 45678999999999999954 689999999987654433 445779999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++||||++||.|+.++++.. ++++....-+|.+|+.||+||| +.+|++|||||+|||+|.+|.+||.|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEecc
Confidence 999999999999999998653 5999999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 511 LSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 511 ~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+|+..... +.+||+.|+|||++. ...+..++|.|||||++|||+.|.+||..+.. .+..+.++.
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~--sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------~~iY~KI~~ 255 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQ--SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------IQIYEKILE 255 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhh--cCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------HHHHHHHHh
Confidence 99988765 678999999999876 56889999999999999999999999986532 233334433
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCC
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR 628 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 628 (672)
.+. .-+.... ..+.+|+...++.|-.+|
T Consensus 256 ~~v---------~fP~~fs---~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV---------KFPSYFS---SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc---------cCCcccC---HHHHHHHHHHHhhhhHhh
Confidence 321 1111112 235566668888888887
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.47 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=203.0
Q ss_pred HHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 362 RASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+...+.||+|+||.||+|...++..+|+|.+.........++.+|+.+++.++|+||+++++++.+.+..++||||+++|
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 45668899999999999998889999999998766556778999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ...+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||.+......
T Consensus 88 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 88 SLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred CHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999997643 245899999999999999999999 789999999999999999999999999999765433
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. ...++.++||||||+++|+|++ |+.||.... ..+.+....... .
T Consensus 161 ~~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~------------~~~~~~~~~~~~-~--- 222 (261)
T cd05148 161 SSDKKIPYKWTAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN------------NHEVYDQITAGY-R--- 222 (261)
T ss_pred ccCCCCceEecCHHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC------------HHHHHHHHHhCC-c---
Confidence 223356799999654 4578899999999999999998 899986432 111222221110 0
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 223 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 -------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001112334678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.81 Aligned_cols=234 Identities=24% Similarity=0.331 Sum_probs=188.2
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|+||.||+|+.. +++.||+|+++... ......+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 58899999987432 22445678899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 9999754 34899999999999999999999 889999999999999999999999999998754321
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||... +..+..........
T Consensus 152 ~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~pf~~~------------~~~~~~~~~~~~~~------- 210 (312)
T cd05585 152 TFCGTPEYLAPELLL--GHGYTKAVDWWTLGVLLYEMLTGLPPFYDE------------NVNEMYRKILQEPL------- 210 (312)
T ss_pred cccCCcccCCHHHHc--CCCCCCccceechhHHHHHHHhCCCCcCCC------------CHHHHHHHHHcCCC-------
Confidence 345789999999764 567899999999999999999999999643 22233333322211
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... .....+.+++.+||+.||++||++.++.+
T Consensus 211 --~~~~---~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 211 --RFPD---GFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred --CCCC---cCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 0011 12235677888999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.82 Aligned_cols=245 Identities=25% Similarity=0.421 Sum_probs=197.9
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
..++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 4578999999999999988888999999875433 457889999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.++++... ...+++..++.++.|+++||+||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 89 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 89 LDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99997543 235889999999999999999999 789999999999999999999999999999766432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+. +..++.++|||||||++|||+| |+.||..... ....... ......
T Consensus 162 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------------~~~~~~~-~~~~~~--- 223 (261)
T cd05072 162 EGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------------SDVMSAL-QRGYRM--- 223 (261)
T ss_pred CCCccceecCCHHHhc--cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------------HHHHHHH-HcCCCC---
Confidence 122345799999654 4578889999999999999998 9999864321 1111111 111100
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
+.......++.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 -------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00111234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.02 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=213.7
Q ss_pred ccccCHHHHHHHHhcccCcCCeEEEEEEEEcC---C--cEEEEEEccc-CCcchHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 352 TKRFELEDLLRASAEMLGKGGFGTAYKAVLDD---G--SVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 352 ~~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~---g--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
.+.|++..-.....++||+|-||.||+|.+.+ | -.||||..+. ....+.+.|.+|..+|++++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 45677666666778899999999999999643 3 3689999986 4455688999999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEE
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~k 505 (672)
. +...|+|||.++.|.|..+|+.++ ..++..+...++.|+..||+||| +.++|||||..+|||+....-+|
T Consensus 461 ~-e~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 461 V-EQPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred e-ccceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceee
Confidence 7 467899999999999999998765 45889999999999999999999 89999999999999999999999
Q ss_pred EeccCCCccCCCCCCCC------CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCC
Q 005880 506 VSDFGLSIFAPPSTVPR------SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578 (672)
Q Consensus 506 l~DfG~a~~~~~~~~~~------t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~ 578 (672)
|+|||+++......+.. ..-||||| ..+.+.++.++|||-|||.+||++. |..||.+-...+-+
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPE--SINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------- 602 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPE--SINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------- 602 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCcc--ccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------
Confidence 99999999988764332 23499999 5567899999999999999999987 99999764332210
Q ss_pred hhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..+- ...+.+..+.++..+..++.+||+.||.+||++.|+...|.++.+
T Consensus 603 --------------~~iE--nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 --------------GHIE--NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --------------EEec--CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1110 111233445677789999999999999999999999999988866
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=332.81 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=188.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999955 689999999865432 23567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.... ...+..+..++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 986432 2567788899999999999999 789999999999999999999999999999765432
Q ss_pred --CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 --TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. .+...+.++|||||||++|||++|+.||...... +............
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---------~~~~~~~~~~~~~--- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---------DWASLMCAICMSQ--- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---------cHHHHHHHHhccC---
Confidence 3467889999997643 2334567999999999999999999999732211 1111111111100
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ........++.+++.+||+.||++|||+.|+++
T Consensus 293 -----~~---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 -----PP---EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -----CC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000122345788889999999999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.35 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=195.7
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.++||+|.||.||+|. ...++.||+|++.-. .....+++++|+.++..++++||.+++|.+..+...+++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 3779999999999999 457899999999743 33356789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 517 (672)
+.+.++... .+++..+.-|++++..||.||| ..+.+|||||+.||++..+|.+|++|||.+.....
T Consensus 98 v~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 98 VLDLLKSGN-----ILDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hhhhhccCC-----CCccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999997543 3477888889999999999999 78999999999999999999999999999865543
Q ss_pred CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 518 STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 518 ~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
.+..||+.|||||++. ...|+.|+||||||++.+||.+|.+|+....+. ..+..+..
T Consensus 169 ~tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------------rvlflIpk 225 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------------RVLFLIPK 225 (467)
T ss_pred ccccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------------eEEEeccC
Confidence 4788999999999886 568999999999999999999999998643211 00111100
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....... ......+.+++..||++||+.||+|.++++
T Consensus 226 ~~PP~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 226 SAPPRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 0000001 133445778888999999999999998875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=316.88 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=198.4
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred eEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 4578999999999999988788999999875443 467799999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC---C
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST---V 520 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~ 520 (672)
.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++...... .
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 89 LEYLQGGA---GRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred HHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 99997543 245899999999999999999999 7899999999999999999999999999997665331 1
Q ss_pred CC---CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 521 PR---SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 521 ~~---t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
.+ +..|+|||++. +..++.++||||||+++|||+| |+.||.... ........ .....
T Consensus 162 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------------~~~~~~~~-~~~~~---- 222 (261)
T cd05068 162 EGAKFPIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT------------NAEVLQQV-DQGYR---- 222 (261)
T ss_pred CCCcCceeccCccccc--cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC------------HHHHHHHH-HcCCC----
Confidence 12 24699999654 5678999999999999999999 999986432 11111111 11110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
..........+.+++.+|++.+|.+||++.++++.|+++
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001112334688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.71 Aligned_cols=237 Identities=21% Similarity=0.289 Sum_probs=192.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 3478999999999999965 68999999986432 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 85 GGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 99999999754 34889999999999999999999 889999999999999999999999999999866543
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 156 ~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------------~~~~~~~i~~~~~------ 215 (291)
T cd05612 156 WTLCGTPEYLAPEVIQ--SKGHNKAVDWWALGILIYEMLVGYPPFFDDN------------PFGIYEKILAGKL------ 215 (291)
T ss_pred ccccCChhhcCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCc------
Confidence 345788999999764 4567899999999999999999999996432 2222222222210
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVV 635 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl 635 (672)
..... ....+.+++.+||+.||.+||+ +.|++
T Consensus 216 ---~~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 216 ---EFPRH---LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred ---CCCcc---CCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 00011 1235678888999999999995 77665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.61 Aligned_cols=245 Identities=28% Similarity=0.417 Sum_probs=197.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|... .++.||+|.++.... ...++.+|++++++++|+||+++++++..++..++||||+++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 3467999999999999955 588999999875432 45678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC---
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST--- 519 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 519 (672)
|.+++.... ...+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 89 L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 89 LLDYLRECN---RQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999997543 245899999999999999999999 7899999999999999999999999999997665431
Q ss_pred ---CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 520 ---VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 520 ---~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+..|+|||.+. +..++.++|||||||++|||++ |..||... +..+........ ...
T Consensus 162 ~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------------~~~~~~~~~~~~-~~~-- 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------------DLSQVYELLEKG-YRM-- 224 (263)
T ss_pred cCCCCCccccCCHHHhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------------CHHHHHHHHHCC-CCC--
Confidence 12245799999654 5678899999999999999998 89998532 222222222111 000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
. .. ......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 225 ---~--~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ---E--RP---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---C--CC---CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 01 11234678888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=334.58 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=201.5
Q ss_pred ccCHHHHHHHHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCC-CCceeeeEEEE
Q 005880 354 RFELEDLLRASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLR-HPNLVGLKAYY 425 (672)
Q Consensus 354 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 425 (672)
++++.+-.+.+.+.||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34444434456688999999999999853 134799999975432 34567899999999996 99999999999
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCC-----------------------------------------------------
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRG----------------------------------------------------- 452 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 452 (672)
.+.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999999865321
Q ss_pred --------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCC
Q 005880 453 --------------------------------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKST 494 (672)
Q Consensus 453 --------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~ 494 (672)
.....+++..+..++.|+++||+||| +.+|+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~ 266 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChH
Confidence 01134788999999999999999999 789999999999
Q ss_pred CEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005880 495 NVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDG 566 (672)
Q Consensus 495 NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~ 566 (672)
||++++++.+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||++ |..||....
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999999998765332 223456799999764 4578999999999999999997 999986431
Q ss_pred CCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 567 GGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. ............ ..........+.+++.+||+.||++|||+.+|.++|+++.+
T Consensus 345 ~~------------~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 345 VD------------STFYNKIKSGYR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred hh------------HHHHHHHhcCCC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11 111111111110 00111233467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=329.35 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=189.8
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||+++. .+|..||+|+++... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999995 468999999987532 223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 999988654 24899999999999999999999 889999999999999999999999999998753221
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ..........+..
T Consensus 152 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------------~~~~~~~~~~~~~----- 212 (323)
T cd05595 152 MKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------HERLFELILMEEI----- 212 (323)
T ss_pred cccccCCcCcCCccccc--CCCCCchhchhhhHHHHHHHHhCCCCCCCCC------------HHHHHHHHhcCCC-----
Confidence 345788999999764 4578999999999999999999999996432 1111222211110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ....+.+++.+||+.||.+|| ++.++++
T Consensus 213 ----~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 ----RFPRT---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCCC---CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00111 223567888899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.17 Aligned_cols=259 Identities=26% Similarity=0.370 Sum_probs=191.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe---E--EEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE---K--LLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~--~lv~e~~ 438 (672)
.+++|.|+||.||+|... +++.||||+.-... +.-.+|+++|++++|||||+++-+|....+ . .+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 378999999999999954 57999999875432 233578999999999999999988875332 2 3899999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAPP 517 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~ 517 (672)
+. +|.+.++.... .+..++...+.-+.+|+.+||+||| +.+|+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 77 99999985321 2345778888999999999999999 7899999999999999976 9999999999998876
Q ss_pred CC----CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH---hhh
Q 005880 518 ST----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV---REE 590 (672)
Q Consensus 518 ~~----~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 590 (672)
+. +..|..|+|||++.. ...|+.+.||||.|||+.||+-|++-|.++...++ +...++-.- +++
T Consensus 179 ~epniSYicSRyYRaPELifg-a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--------L~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--------LVEIIKVLGTPTRED 249 (364)
T ss_pred CCCceeEEEeccccCHHHHcC-ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--------HHHHHHHhCCCCHHH
Confidence 53 345778999998875 46899999999999999999999999987543221 111111100 000
Q ss_pred ------ccccccchhhcccc----ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHh
Q 005880 591 ------WTAEVFDLELMRYK----DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELR 642 (672)
Q Consensus 591 ------~~~~~~d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~ 642 (672)
...+.-.+...... .......+.++++.+++..+|.+|.++.|++. ..++++
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00011111111111 11123356788888999999999999999984 345554
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.60 Aligned_cols=191 Identities=26% Similarity=0.387 Sum_probs=166.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+++.. +|..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 3478999999999999965 68899999987542 224567999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 160 (331)
T cd06649 89 SLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (331)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccc
Confidence 9999997543 48899999999999999999992 246999999999999999999999999998765432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...++..|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 161 SFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCCCCcCcCCHhHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 445788999999764 55789999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=329.26 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=213.9
Q ss_pred cccCHHHHHHHHhcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeE
Q 005880 353 KRFELEDLLRASAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEK 431 (672)
Q Consensus 353 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 431 (672)
..++.+.-.....++||-|.||.||.|+|+. .-.||||.++...+ ..++|..|..+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3455554444567899999999999999874 56799999987665 678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
|||+|||.+|+|.++|+... +..++....+.++.||+.|++||. ..++|||||.++|+||.++..+|++|||+
T Consensus 339 YIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred EEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999998765 355777888999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCCCCC------CcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 512 SIFAPPSTVPRS------NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 512 a~~~~~~~~~~t------~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
++.+..+++..- .-|.|||-+. -..++.|+|||+|||+|||+.| |-.||- ++++.+.+.
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLA--yNtFSiKSDVWAFGVLLWEIATYGMsPYP------------GidlSqVY~ 477 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLA--YNTFSIKSDVWAFGVLLWEIATYGMSPYP------------GIDLSQVYG 477 (1157)
T ss_pred hhhhcCCceecccCccCcccccCccccc--ccccccchhhHHHHHHHHHHHhcCCCCCC------------CccHHHHHH
Confidence 999987754432 3499999654 4688999999999999999998 677774 455555443
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
-+.+.- +....+.+...+.+|++.||++.|.+||++.|+-+.++.+.
T Consensus 478 LLEkgy-----------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 478 LLEKGY-----------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHhccc-----------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 322221 11223456678999999999999999999999999998764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.04 Aligned_cols=270 Identities=21% Similarity=0.312 Sum_probs=200.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEccc--CCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc-----CCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKD--ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-----REEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 436 (672)
.+.||+|+||.|+.+.. .+|+.||||++.+ ......++-.+|+++|+.++|+||+.+++.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 36799999999999995 4789999999974 233356788899999999999999999999865 346899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
+| +.+|...++.+. .++.....-+.+|+++||.|+| +.+|+||||||+|++++.+...||+|||+|+...
T Consensus 107 lM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEeccccceeecc
Confidence 99 669999998653 4899999999999999999999 8999999999999999999999999999999885
Q ss_pred C-------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCC---CCCCChhHHHHHH
Q 005880 517 P-------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGC---GGAVDLPRWVQSV 586 (672)
Q Consensus 517 ~-------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~---~~~~~~~~~~~~~ 586 (672)
. ..++.|..|+|||++. ....|+.+.||||.|||+.||++|++-|.+...-+++.. ..+..-.+-+..+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll-~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLL-NSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHh-ccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 3 2556789999999874 568999999999999999999999999976543221100 0000000111111
Q ss_pred Hhhh---ccccccchh----hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHhcCCCCC
Q 005880 587 VREE---WTAEVFDLE----LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELRGVEVSP 648 (672)
Q Consensus 587 ~~~~---~~~~~~d~~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~~~~~~~ 648 (672)
..+. .+....... ...++... ...++|+.+||..||.+|+|++|+++ .|......+.-|
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCC---HHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 1000 000000000 00111222 34567777999999999999999986 355555544444
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.94 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=201.2
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++.+++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 4578999999999999842 3467999999876655667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 438 MPNGSLFWLLHGNRG--------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
+++++|.+++..... .....+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEEeccC
Confidence 999999999975431 12235899999999999999999999 789999999999999999999999999
Q ss_pred CCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhH
Q 005880 510 GLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPR 581 (672)
Q Consensus 510 G~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 581 (672)
|+++..... ...++..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~------------~~~ 230 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------------NNE 230 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------------HHH
Confidence 999755332 222356799999664 4678899999999999999998 899985432 112
Q ss_pred HHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 582 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
......... ... .. .....++.+++.+||+.||.+|||+.||.+.|+.+.+.
T Consensus 231 ~~~~i~~~~-~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 VIECITQGR-VLQ-------RP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHcCC-cCC-------CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 222221111 000 00 11223578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.42 Aligned_cols=237 Identities=23% Similarity=0.349 Sum_probs=191.0
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||+++.. +|+.||||++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999954 68999999997532 224467888999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 999988654 34899999999999999999999 889999999999999999999999999998753221
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 152 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~Pf~~~~------------~~~~~~~~~~~~~----- 212 (328)
T cd05593 152 MKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------HEKLFELILMEDI----- 212 (328)
T ss_pred cccccCCcCccChhhhc--CCCCCccCCccccchHHHHHhhCCCCCCCCC------------HHHHHHHhccCCc-----
Confidence 345789999999764 4578899999999999999999999996432 1122222211110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVKL 637 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 637 (672)
. .... ....+.+++.+||+.||++|| ++.|+++.
T Consensus 213 --~--~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 --K--FPRT---LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --c--CCCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 0111 123467788899999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.80 Aligned_cols=239 Identities=23% Similarity=0.315 Sum_probs=192.7
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999965 68999999987532 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 101 VGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999754 24788999999999999999999 889999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 172 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~------------~~~~~~~i~~~~------ 231 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQ--SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT------------PFRIYEKILAGR------ 231 (329)
T ss_pred cceecCChhhcCHHHHc--CCCCCCcceeechHHHHHHHHcCCCCCCCCC------------HHHHHHHHhcCC------
Confidence 456788999999764 4567899999999999999999999996432 112222222111
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
...... ....+.+++.+||+.||.+||+ +.++++
T Consensus 232 ---~~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 ---LKFPNW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---cCCCCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000011 1234678888999999999997 566663
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.11 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=198.4
Q ss_pred HHhcccCcCCeEEEEEEEEcC------CcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD------GSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.+.||+|+||.||+|...+ +..||||.++..... ..+.+.+|++++++++|+||+++++++......++||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 87 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVF 87 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEE
Confidence 456789999999999998643 478999999865443 4578999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEE
Q 005880 436 EYMPNGSLFWLLHGNRG---------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl 506 (672)
||+++|+|.+++..... .....+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCCeEEE
Confidence 99999999999976431 22345889999999999999999999 889999999999999999999999
Q ss_pred eccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCC
Q 005880 507 SDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578 (672)
Q Consensus 507 ~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~ 578 (672)
+|||+++..... ....+..|+|||++. +..++.++|||||||++|||++ |+.||....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~------------ 229 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS------------ 229 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhc--cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC------------
Confidence 999998754322 222356799999764 5678999999999999999998 999986432
Q ss_pred hhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
..+.+.... ....... .......+.+++.+||+.||++||++.||++.|+
T Consensus 230 ~~~~~~~~~-~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 230 NEEVIECIT-QGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHH-cCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 112222221 1111000 0122346788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.15 Aligned_cols=250 Identities=19% Similarity=0.237 Sum_probs=190.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++ |+
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 478999999999999955 689999999874332 234577899999999999999999999999999999999997 59
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 89 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 89 LKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999886442 34789999999999999999999 889999999999999999999999999998754322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh--------
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE-------- 589 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 589 (672)
...++..|+|||++.. ...++.++||||+||++|||+||+.||...... +.+....+.
T Consensus 161 ~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~------------~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 161 SNEVVTLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATGRPMFPGSTVK------------EELHLIFRLLGTPTEET 227 (288)
T ss_pred cCceecccccChHHhcC-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHHHHhCCCChHH
Confidence 3456788999997642 356789999999999999999999999654221 111111100
Q ss_pred -------hccccccchhhccccC---hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 -------EWTAEVFDLELMRYKD---IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 -------~~~~~~~d~~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........+.....+. ......+..+++.+||..||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000000 0011234678888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.04 Aligned_cols=241 Identities=23% Similarity=0.392 Sum_probs=201.9
Q ss_pred HHHhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHH---HHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 362 RASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKR---EFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.+.+.||+|.||.|-+|+. ..|+.||||.+++..+.+++ .+++||+||+.|+||||+.++.+|...+...|||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence 44567899999999999994 67999999999887665554 468999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
..+|.|++++... ..+++.+...++.||..|+.|.| .++++|||||.+|||+|.++++||+|||++-.+..
T Consensus 135 aS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 135 ASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred cCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999854 45999999999999999999999 89999999999999999999999999999987766
Q ss_pred C----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 S----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
. +.+|++-|.+||+..+ ...-++.+|-||+||+||.|+.|..||++. +....++++.+...
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG-~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~------------Dhk~lvrQIs~GaY-- 270 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNG-TPYKGPEVDSWSLGVLLYTLVYGTMPFDGR------------DHKRLVRQISRGAY-- 270 (668)
T ss_pred ccHHHHhcCCcccCCccccCC-CCCCCCccchhhHHHHHHHHhhcccccCCc------------hHHHHHHHhhcccc--
Confidence 5 6788999999998753 344478999999999999999999999743 44444444444322
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
..+. ......-||++||..+|++|-|+.+|...
T Consensus 271 --rEP~---------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 271 --REPE---------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --cCCC---------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1111 11123456779999999999999998754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=310.62 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=192.0
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 78999999886533 23456799999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCC---
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV--- 520 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 520 (672)
.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99997432 35899999999999999999999 88999999999999999999999999999875543211
Q ss_pred ----CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 521 ----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 521 ----~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
..+..|+|||.+. +..++.++|||||||++|||++ |..||..... .. ...........
T Consensus 153 ~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------------~~-~~~~~~~~~~~-- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------------QQ-TREAIEQGVRL-- 215 (252)
T ss_pred CCCCCCceeecCchhhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------------HH-HHHHHHcCCCC--
Confidence 1134699999664 4568899999999999999998 8888853211 01 11111111000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.........+.+++.+|++.+|++|||+.||+++|+
T Consensus 216 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 --------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011122346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=300.01 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=195.7
Q ss_pred HHHhcccCcCCeEEEEEEE-EcCCcEEEEEEcc--cCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 362 RASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK--DASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.+.||+|.|+.||++. ..+|+.+|+|++. +.+..+.+++.+|++|.+.|+|||||++.+.+......|+|+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 3456789999999999998 4579999999875 333347789999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC---CcEEEeccCCCccC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT---GNARVSDFGLSIFA 515 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~ 515 (672)
+|++|..-+-.. ...++...-..++||+++|.|.| .++|||||+||+|+++-.. --+||+|||+|...
T Consensus 93 ~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 93 TGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999995544322 24778888899999999999999 8999999999999999543 34899999999888
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
... ...||++|||||++. ...|+..+|||+.|||||-|+.|.+||.++. -...++.+.
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvr--kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------------~~rlye~I~---- 225 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDED------------QHRLYEQIK---- 225 (355)
T ss_pred CCccccccccCCCcccCHHHhh--cCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------------HHHHHHHHh----
Confidence 754 567899999999875 4589999999999999999999999998642 122222222
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+|-....++.+.++. .+|+++||..||.+|.|+.|.++
T Consensus 226 -~g~yd~~~~~w~~is~~A---k~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 -AGAYDYPSPEWDTVTPEA---KSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -ccccCCCCcccCcCCHHH---HHHHHHHhccChhhhccHHHHhC
Confidence 223333333344445554 45666999999999999998763
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.44 Aligned_cols=242 Identities=27% Similarity=0.408 Sum_probs=194.8
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|...++..+|||.++.... ...++.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 3467999999999999988777899999875443 456789999999999999999999999988889999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++..+++++.|++.||+||| +.+++|+||||+||++++++.+||+|||.++.....
T Consensus 87 ~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 87 LNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99997543 25899999999999999999999 889999999999999999999999999998755432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+. +..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 159 ~~~~~~~~y~~pe~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------------~~~~~~~~~~~~~~---- 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLL--YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN------------NSETVEKVSQGLRL---- 220 (256)
T ss_pred CCCccChhhCCHHHHh--cCcccchhHHHHHHHHHHHHhcCCCCCcCcCC------------HHHHHHHHhcCCCC----
Confidence 122345799999664 4568899999999999999999 999985322 11122222111110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.. . ......+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ----~~-~--~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ----YR-P--HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CC-C--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 0 112346788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=313.07 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=200.4
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+++.||||.++... ......+.+|+++++.++||||+++++++.+.+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999995 478999999876422 22345788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++..... ....+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999998864321 2245889999999999999999999 789999999999999999999999999998766432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. +..++.++||||||+++|||++|+.||.... .+...+.........
T Consensus 162 ~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----------~~~~~~~~~~~~~~~---- 225 (267)
T cd08228 162 AAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----------MNLFSLCQKIEQCDY---- 225 (267)
T ss_pred HHhcCCCCccccChhhhc--cCCCCchhhHHHHHHHHHHHhcCCCCCcccc----------ccHHHHHHHHhcCCC----
Confidence 345677899999664 4567889999999999999999999986432 122222222211110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
+.. ........+.+++.+||+.+|++||++.||++.+++++
T Consensus 226 --~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 --PPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 01223356788899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.91 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=195.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 478999999999999965 58999999997532 22446788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--C
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--S 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--~ 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.... .
T Consensus 86 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 86 GDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 9999999754 34889999999999999999999 78999999999999999999999999999976544 3
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+......... ..+..
T Consensus 157 ~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~------------~~~~~~~i~~~~---~~~~~ 219 (333)
T cd05600 157 SVVGSPDYMAPEVLR--GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST------------PNETWENLKYWK---ETLQR 219 (333)
T ss_pred CcccCccccChhHhc--CCCCCCccceecchHHHhhhhhCCCCCCCCC------------HHHHHHHHHhcc---ccccC
Confidence 456889999999765 4588999999999999999999999996432 111111111111 00000
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.... ........++.+++.+||..+|.+||++.|+++.
T Consensus 220 ~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 0001123456788889999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.22 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=200.5
Q ss_pred hcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 467999999999999842 35679999998766656678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe
Q 005880 439 PNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS 507 (672)
Q Consensus 439 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 507 (672)
++++|.+++..... .....+++..+++++.|++.||+||| +.+|+||||||+||+++.++.++|+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEEEC
Confidence 99999999975431 11234899999999999999999999 8899999999999999999999999
Q ss_pred ccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCCh
Q 005880 508 DFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDL 579 (672)
Q Consensus 508 DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~ 579 (672)
|||++...... ...++..|+|||.+. +..++.++|||||||++|||+| |+.||.... .
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------------~ 231 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQPWFQLS------------N 231 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------------H
Confidence 99999755332 233456799999654 4678899999999999999999 999986432 1
Q ss_pred hHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.+...... ....... .......+.+++.+||+.+|++|||+.+|+++|+++..
T Consensus 232 ~~~~~~~~-~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 232 TEVIECIT-QGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHh-CCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11222111 1111000 01123467889999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.21 Aligned_cols=243 Identities=23% Similarity=0.253 Sum_probs=195.2
Q ss_pred HhcccCcCCeEEEEEEEEc-C-CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-D-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 4578999999999999844 3 6788899876554445567888999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.++++.... ...++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99998864321 2346899999999999999999999 789999999999999999999999999999865432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...||.+|+|||++. +..++.++|||||||++|||++|+.||... ...+.+........
T Consensus 226 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~------------~~~~~~~~~~~~~~--- 288 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWE--RKRYSKKADMWSLGVILYELLTLHRPFKGP------------SQREIMQQVLYGKY--- 288 (478)
T ss_pred ccccccCCCccccCHhHhC--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCC---
Confidence 335788999999764 467899999999999999999999999642 12222222222211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
++. + ......+.+++.+||..||++||++.+++.
T Consensus 289 --~~~----~--~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 --DPF----P--CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCC----C--ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 0 112235778888999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.61 Aligned_cols=193 Identities=24% Similarity=0.383 Sum_probs=167.0
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
...++||+|+||.||++... +|..+|+|.++... ......+.+|++++++++||||+++++++.++++.++||||+++
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 44578999999999999965 68899999887542 22456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|+++||.|||+ ..+|+||||||+||++++++.+||+|||++......
T Consensus 88 ~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 88 GSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence 9999999754 248899999999999999999992 247999999999999999999999999998755332
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 160 NSFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccCCCCccccCHHHhc--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 445788999999764 457889999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.72 Aligned_cols=235 Identities=24% Similarity=0.328 Sum_probs=189.2
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcch---HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGG---KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+...||+|+||.||+|+. .+|..+|+|++++..... .+-++.|-.+|...++|.||+++..|.+.+..||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 457899999999999994 469999999999765543 3456788999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
||++..+|.... .+++....-++.+++-|+..+| +.|+|||||||+|+|||..|++||+|||++..+..
T Consensus 225 GGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 225 GGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999998653 5999999999999999999999 89999999999999999999999999999842110
Q ss_pred --------------------------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHH
Q 005880 518 --------------------------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYS 547 (672)
Q Consensus 518 --------------------------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S 547 (672)
...+||+.|+|||++.. ..|+..+|.||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDwWS 373 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDWWS 373 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccHHH
Confidence 02356788999999874 46899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCC
Q 005880 548 FGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ 627 (672)
Q Consensus 548 ~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~ 627 (672)
+|||+|||+.|.+||..+... +-.+.+..-...... +.-.+...+..++|.+|+. ||++
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~------------~T~rkI~nwr~~l~f--------P~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQ------------ETYRKIVNWRETLKF--------PEEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHH------------HHHHHHHHHhhhccC--------CCcCcccHHHHHHHHHHhc-CHHH
Confidence 999999999999999865432 222233222211111 1111122456678889998 9999
Q ss_pred CCC
Q 005880 628 RPN 630 (672)
Q Consensus 628 RPt 630 (672)
|.-
T Consensus 433 RLG 435 (550)
T KOG0605|consen 433 RLG 435 (550)
T ss_pred hcC
Confidence 987
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.31 Aligned_cols=263 Identities=23% Similarity=0.304 Sum_probs=190.0
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-----eEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-----EKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 435 (672)
+.+.||+|+||.||+|+.. +|..||||+++.. .......+.+|++++++++||||+++++++.... ..++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 3578999999999999954 6899999998743 2234567889999999999999999999886432 479999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||++ ++|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9995 6899888644 34899999999999999999999 889999999999999999999999999999754
Q ss_pred CCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHH
Q 005880 516 PPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQ 584 (672)
Q Consensus 516 ~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~ 584 (672)
... ...++..|+|||++......++.++|||||||++|||+||+.||.......... ...+.....+..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 321 345788999999875433578999999999999999999999996532110000 000000111111
Q ss_pred HHHhhhccccccchhhcc-ccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 585 SVVREEWTAEVFDLELMR-YKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~-~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...... ....++.-... .... ......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEK-ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred Hhhhhh-HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111000 00000000000 0000 0112356788999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.35 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=194.9
Q ss_pred HhcccCcCCeEEEEEEEEc-----CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 436 (672)
+.+.||+|+||.||++..+ ++..||+|+++.......+.+.+|++++++++||||+++++++... ...++|||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 4578999999999999843 5789999999876655667899999999999999999999987643 46789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999997543 35899999999999999999999 7899999999999999999999999999998664
Q ss_pred CCC--------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC--CCCC-CCCChhHHHHH
Q 005880 517 PST--------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG--MGCG-GAVDLPRWVQS 585 (672)
Q Consensus 517 ~~~--------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~--~~~~-~~~~~~~~~~~ 585 (672)
... ..++..|+|||++. +..++.++|||||||++|||++|..|+........ .... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhc--cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 321 11233599999664 55788999999999999999998877543211000 0000 00001111111
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
...+.. ..+........+.+++.+||+.+|++||||.||++.|+.+
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111110 0000112234688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.26 Aligned_cols=248 Identities=22% Similarity=0.364 Sum_probs=195.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCc----EEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||+|++. +|. .||+|.++... ....+++.+|+.+++.++||||++++|++... ..++|+||
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 3478999999999999853 344 48999987543 33467889999999999999999999999764 56799999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999998643 35889999999999999999999 78999999999999999999999999999986643
Q ss_pred C-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ....+..|+|||++. +..++.++|||||||++|||++ |+.||.... ..++. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------------~~~~~-~~~~~ 226 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------------ASEIS-SILEK 226 (316)
T ss_pred CCcceeccCCccceeecChHHhc--cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------------HHHHH-HHHhC
Confidence 2 112245799999664 5678999999999999999998 999986421 11111 11111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
... . +........+.+++.+||+.+|++||++.+++..+..+.+..
T Consensus 227 ~~~-------~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 GER-------L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCC-------C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 100 0 000112345788999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=313.86 Aligned_cols=239 Identities=24% Similarity=0.352 Sum_probs=188.5
Q ss_pred cccCcCCeEEEEEEEEcC-------------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEE
Q 005880 366 EMLGKGGFGTAYKAVLDD-------------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKL 432 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 432 (672)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887655445667889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc-------EE
Q 005880 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN-------AR 505 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~-------~k 505 (672)
+||||+++|+|..++.... ..+++..+++++.|+++||+||| +.+|+||||||+||+++.++. ++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999887543 35899999999999999999999 889999999999999987664 89
Q ss_pred EeccCCCccCCCC-CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 506 VSDFGLSIFAPPS-TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELL-TGKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 506 l~DfG~a~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~-tg~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++|||++...... ...++..|+|||.+. .+..++.++|||||||++|||+ +|+.||...... +.
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------------~~- 218 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------------EK- 218 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------------HH-
Confidence 9999998765433 445678899999753 2457889999999999999998 588887532111 00
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
........ .. .......+.+++.+||+.||.+||++.++++.+
T Consensus 219 ~~~~~~~~---------~~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ERFYEGQC---------ML---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHhcCc---------cC---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111100 00 011224577889999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=309.14 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=194.9
Q ss_pred HhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCc-eeeeEEEEEcCC------eEEE
Q 005880 364 SAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPN-LVGLKAYYFARE------EKLL 433 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~l 433 (672)
..++||+|+||+||+|+ ..+|+.||+|+++-... .......+|+.++++++|+| ||++++++...+ ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 34679999999999999 55799999999975433 24566789999999999999 999999999877 7789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||++. +|..++....... ..++...+..++.|+++||+|+| +++|+||||||.||+|+++|.+||+|||+|+
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 9999954 9999998655321 34666899999999999999999 8999999999999999999999999999998
Q ss_pred cCCCC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCCCCChhHHHH
Q 005880 514 FAPPS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG----CGGAVDLPRWVQ 584 (672)
Q Consensus 514 ~~~~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~~~ 584 (672)
...-. ....|..|+|||++... ..|++..||||+|||+.||+++++-|.++.+.+... .-+......|-.
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 66522 44567889999998754 469999999999999999999999987654321100 000000000100
Q ss_pred HHHhhhccccccchhhccccChHH----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEE----EMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~----~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...-.++...... ......... ......+++.+|++.+|++|.|++.+++.
T Consensus 248 v~~~~~~k~~f~~--~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPK--WPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcC--CCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000000000000 000011111 11356788889999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.81 Aligned_cols=190 Identities=25% Similarity=0.369 Sum_probs=162.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++.+++..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 478999999999999965 689999999875432 234567889999999999999999999999999999999995 68
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 89 LCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 888876543 34889999999999999999999 889999999999999999999999999998654321
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...++..|+|||++.. ...++.++||||+||++|||++|+.||..
T Consensus 161 ~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 161 SNEVVTLWYRPPDVLLG-STEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCcccCCCCChHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3456788999997642 34678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.30 Aligned_cols=236 Identities=23% Similarity=0.350 Sum_probs=189.4
Q ss_pred cccCcCCeEEEEEEEE----cCCcEEEEEEcccCC----cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDAS----IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.||+|+||.||+++. .+++.||||+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999987532 12345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... .+.+..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999997542 4788899999999999999999 78999999999999999999999999999864322
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ...++..|+|||++. +..++.++|||||||++|||++|+.||.... ....+........
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~pf~~~~------------~~~~~~~~~~~~~- 217 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILM--RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN------------RKKTIDKILKGKL- 217 (323)
T ss_pred CCCcccccCCCccccChhhcc--CCCCCCcceecccHHHHHHHhcCCCCCCCCC------------HHHHHHHHHcCCC-
Confidence 1 345788999999764 4567899999999999999999999996432 1222222222210
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ....+.+++.+||+.||++|| ++.++++
T Consensus 218 --------~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --------NLPPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --------CCCCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01111 123567888899999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.83 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=206.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe-EEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE-KLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~ 439 (672)
..+.+|+|+||.++.++.+ ++..+++|.+.-.. ...++...+|+.++++++|||||.+.+.+..++. .+|||+|++
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 4578999999999999854 67899999987433 3345578899999999999999999999998888 899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
||++.+.+...+ ...++++.+.+++.|++.|+.||| +..|+|||||+.||+++.++.+||+|||+|+...+.
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999998766 356899999999999999999999 789999999999999999999999999999988775
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...||+.|+.||++. +..|..|+||||+||++|||++-+++|... +....+.++.+..
T Consensus 161 ~~a~tvvGTp~YmcPEil~--d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------------~m~~Li~ki~~~~---- 222 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILS--DIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------------NMSELILKINRGL---- 222 (426)
T ss_pred hhhheecCCCcccCHHHhC--CCCCCccCcchhhcchHHHHHhcccccCcc------------chHHHHHHHhhcc----
Confidence 478999999999775 679999999999999999999999999743 4444555444442
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
+++ -...+..++..++..|++.+|+.||++.+++.+-
T Consensus 223 -~~P------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 -YSP------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -CCC------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 111 1133455788889999999999999999999873
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.83 Aligned_cols=238 Identities=24% Similarity=0.350 Sum_probs=186.6
Q ss_pred ccCcCCeEEEEEEEEcC-------------------------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeee
Q 005880 367 MLGKGGFGTAYKAVLDD-------------------------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGL 421 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 421 (672)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998421 13589999876544445678889999999999999999
Q ss_pred EEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC
Q 005880 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT 501 (672)
Q Consensus 422 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~ 501 (672)
++++.++...++||||+++|+|..++.... ..+++..+.+++.|+++||+||| +.+|+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEecc
Confidence 999999999999999999999999987533 35889999999999999999999 7899999999999999764
Q ss_pred C-------cEEEeccCCCccCCC-CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCCCCCCC
Q 005880 502 G-------NARVSDFGLSIFAPP-STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELL-TGKCPSVIDGGGAGMG 572 (672)
Q Consensus 502 ~-------~~kl~DfG~a~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~-tg~~P~~~~~~~~~~~ 572 (672)
+ .+|++|||.+..... ....++..|+|||.+.. ...++.++|||||||++|||+ +|+.||......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---- 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPG-GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS---- 228 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH----
Confidence 4 389999998864433 24456788999997643 356889999999999999994 799998643211
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
.... ...... .. + ......+.+++.+||+.+|++|||+.+|++.|
T Consensus 229 -----~~~~----~~~~~~-------~~---~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 -----EKER----FYEKKH-------RL---P--EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -----HHHH----HHHhcc-------CC---C--CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111 111100 00 0 01123578889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=310.14 Aligned_cols=245 Identities=28% Similarity=0.448 Sum_probs=196.1
Q ss_pred HHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 362 RASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 345688999999999999988888999999876443 4567999999999999999999999874 55688999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.++++... ...+++.++..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 86 SLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999997543 235899999999999999999999 789999999999999999999999999999765432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||.+. +..++.++||||||+++|||++ |+.||.... ..+......... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------------~~~~~~~~~~~~-~~- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------------NREVLEQVERGY-RM- 222 (260)
T ss_pred cccCCCCCccccChHHHh--cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------------HHHHHHHHHcCC-CC-
Confidence 122345799999653 5678899999999999999999 899986432 112222221110 00
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
+........+.+++.+|+..+|.+|||+.++.+.|++
T Consensus 223 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ---------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011223468889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=310.12 Aligned_cols=242 Identities=26% Similarity=0.427 Sum_probs=194.3
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.+.||+|+||.||+|..+++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 35678999999999999988778899999865433 45678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC---
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST--- 519 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 519 (672)
|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 86 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 86 LLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999997543 25899999999999999999999 7899999999999999999999999999987654321
Q ss_pred ---CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 520 ---VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 520 ---~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+..|+|||.+. +..++.++||||||+++|||++ |+.||...... +..... ....
T Consensus 158 ~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------~~~~~~-~~~~---- 218 (256)
T cd05059 158 SQGTKFPVKWAPPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------------EVVESV-SAGY---- 218 (256)
T ss_pred cCCCCCCccccCHHHhc--cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------------HHHHHH-HcCC----
Confidence 11234699999664 4578899999999999999999 89998643211 111111 1110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
.. ... .....++.+++.+||..+|++|||+.|+++.|
T Consensus 219 -~~--~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 -RL--YRP---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -cC--CCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00 001 11334688899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=311.25 Aligned_cols=245 Identities=25% Similarity=0.416 Sum_probs=196.6
Q ss_pred HhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
..+.||+|+||.||+|.+.. ...||||.++.... ....+|.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 45789999999999999642 45899999875433 24567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++|.+++.... ..+++..+++++.|++.||+||| +.+|+||||||+||++++++.++|+|||+++.....
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999997643 35899999999999999999999 789999999999999999999999999999876421
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
....+..|+|||.+. +..++.++||||||+++|||++ |..||.... ..+........
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~------------~~~~~~~~~~~- 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSYGERPYWDMS------------NQDVIKAVEDG- 224 (266)
T ss_pred ccceeccCCCCCccccChhhhc--cCCCccccchHHHHHHHHHHHccCCCCCCCCC------------HHHHHHHHHcC-
Confidence 122345799999654 4678899999999999999998 999985321 11111111111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
... +........+.+++.+||+.+|++||++.||++.|+++
T Consensus 225 ~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRL----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00112234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=310.35 Aligned_cols=245 Identities=29% Similarity=0.436 Sum_probs=195.2
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.++||+|+||.||+|...++..||+|+++.... ..+++.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 9 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred eEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 34578999999999999987777899999975433 4567899999999999999999999874 456789999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ...+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||.++.....
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 87 LLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred HHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999997543 235799999999999999999999 789999999999999999999999999999765433
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||+.. +..++.++||||||+++|||+| |+.||..... .+...... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------------~~~~~~~~-~~~---- 220 (262)
T cd05071 160 RQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVE-RGY---- 220 (262)
T ss_pred ccCCcccceecCHhHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------------HHHHHHHh-cCC----
Confidence 122345799999653 5678999999999999999999 8888854321 11111111 100
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
......+....+.+++.+|++.||++||++.++++.|++.
T Consensus 221 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.36 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=194.3
Q ss_pred HhcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.+.||+|+||.||+|.. .++..||+|.++.... ....++.+|++++++++||||+++++++......++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence 347899999999999984 2467899999975332 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEE
Q 005880 438 MPNGSLFWLLHGNRG------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~k 505 (672)
+++|+|.+++..... .....+++.++..++.|++.||+||| +.+|+||||||+||++++++.+|
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCCCcEE
Confidence 999999999863321 11235889999999999999999999 78999999999999999999999
Q ss_pred EeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCC
Q 005880 506 VSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAV 577 (672)
Q Consensus 506 l~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~ 577 (672)
|+|||+++..... ...++..|+|||++. +..++.++|||||||++|||++ |..||....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----------- 231 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----------- 231 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhc--cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----------
Confidence 9999999765332 223456799999664 4578999999999999999998 998985421
Q ss_pred ChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
...... ......... .. ......+.+++.+||+.||++||++.+|.+.|+.
T Consensus 232 -~~~~~~-~~~~~~~~~-------~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 -NQEVIE-MVRKRQLLP-------CS---EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHH-HHHcCCcCC-------CC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 111111000 00 1123457788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.36 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=194.1
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|+. .+|+.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 457899999999999995 5689999999875544455678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.++++.. .++++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 93 LQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99998643 34899999999999999999999 789999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+.. ....++.++|||||||++|||++|+.||........ . ...... .+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~----~~~~~~-----~~ 226 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------L----FLMSKS-----NF 226 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------h----eeeecC-----CC
Confidence 3346778999997643 234578899999999999999999999854321110 0 000000 00
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.+. ...........+.+++.+||..+|++|||++++++.
T Consensus 227 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 227 QPP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000 001111223467888999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.92 Aligned_cols=262 Identities=19% Similarity=0.190 Sum_probs=191.6
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 3578999999999999965 68899999987532 22356788999999999999999999999999999999999998
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+.+..+.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 85 NMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 8776554322 34899999999999999999999 889999999999999999999999999999765432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhhc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 591 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||......+... ...+.....+.........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 ANYTEYVATRWYRSPELLL--GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccCCcHHHc--CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 345788899999764 4568899999999999999999999997542211000 0000000001110000000
Q ss_pred cccccchhhccccC-----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMRYKD-----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
......+....... .......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 0112345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=317.64 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=204.3
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAY 424 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 424 (672)
+++..-.+...+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3444444456688999999999999741 24579999987542 23456789999999999 89999999999
Q ss_pred EEcCCeEEEEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 005880 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKS 493 (672)
Q Consensus 425 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp 493 (672)
+......++||||+++|+|.+++...... ....+++.++..++.|+++||+||| +.+|+||||||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp 165 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAA 165 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeeccccc
Confidence 99999999999999999999999764321 1235889999999999999999999 78999999999
Q ss_pred CCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 005880 494 TNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVID 565 (672)
Q Consensus 494 ~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~ 565 (672)
+||++++++.+||+|||+++..... ...++..|+|||++. +..++.++||||||+++|||++ |..||...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999765432 122346799999764 4578899999999999999998 78887532
Q ss_pred CCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 566 GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
...++......... .. . .......+.+++.+||+.+|.+|||+.||++.|+++....
T Consensus 244 ------------~~~~~~~~~~~~~~-~~-------~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 244 ------------PVEELFKLLKEGHR-MD-------K---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ------------CHHHHHHHHHcCCc-CC-------C---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 22333332221110 00 0 1123346778888999999999999999999999987654
Q ss_pred C
Q 005880 646 V 646 (672)
Q Consensus 646 ~ 646 (672)
+
T Consensus 301 ~ 301 (304)
T cd05101 301 T 301 (304)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=313.42 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=196.1
Q ss_pred HHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|+.++..++||||+++++++......++++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 45678999999999999853 2578999999754432 3467889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcE
Q 005880 436 EYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA 504 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~ 504 (672)
||+++++|.+++..... .....+++..+..++.|+++||+||| +.+|+||||||+||++++++.+
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCCCce
Confidence 99999999999853210 11245889999999999999999999 8899999999999999999999
Q ss_pred EEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCC
Q 005880 505 RVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGA 576 (672)
Q Consensus 505 kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~ 576 (672)
||+|||+++..... ...++..|+|||.+. +..++.++|||||||++|||++ |..||...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----------- 230 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----------- 230 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHh--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----------
Confidence 99999998765332 223356899999654 4568899999999999999998 88887532
Q ss_pred CChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 577 VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
...++...+...... .........+.+++.+||+.+|++||+++||++.|+.
T Consensus 231 -~~~~~~~~i~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 231 -SNQDVIEMIRNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -CHHHHHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122233322222110 0011233457888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.38 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=200.2
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCC-CCceeeeEEEEE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLR-HPNLVGLKAYYF 426 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 426 (672)
+++..-...+.+.||+|+||.||+|++. .+..||||+++..... ..+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3333333356789999999999999864 2468999999754322 3457889999999997 999999999999
Q ss_pred cCCeEEEEEeecCCCChhHHhhcCCC------------------------------------------------------
Q 005880 427 AREEKLLVSEYMPNGSLFWLLHGNRG------------------------------------------------------ 452 (672)
Q Consensus 427 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 452 (672)
.++..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975421
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 005880 453 ---------------------------------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKS 493 (672)
Q Consensus 453 ---------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp 493 (672)
.....+++..+.+++.|+++||+||| +.+|+||||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp 267 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAA 267 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCc
Confidence 01234788899999999999999999 78999999999
Q ss_pred CCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 005880 494 TNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVID 565 (672)
Q Consensus 494 ~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~ 565 (672)
+||++++++.+||+|||+++..... ...++..|+|||.+. +..++.++|||||||++|||++ |+.||...
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc--CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999754321 233466799999764 4568899999999999999998 88898532
Q ss_pred CCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 566 GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
. ..+........+.. ..... ....++.+++.+||..+|++||++.||++.|+.+.
T Consensus 346 ~------------~~~~~~~~~~~~~~-------~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 P------------MNEQFYNAIKRGYR-------MAKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred C------------chHHHHHHHHcCCC-------CCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11111111111110 00011 12345788888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.51 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=196.1
Q ss_pred HHHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcC-CeEE
Q 005880 362 RASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR-EEKL 432 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~ 432 (672)
+.+.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++.++ +|+||+++++++... ...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 345688999999999999732 247899999975432 2345678899999999 899999999988754 5678
Q ss_pred EEEeecCCCChhHHhhcCCCC--------------------------------------------------------CCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRGP--------------------------------------------------------GRT 456 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~ 456 (672)
++|||+++|+|.+++...... ...
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999998643210 013
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCC
Q 005880 457 PLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAP 529 (672)
Q Consensus 457 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aP 529 (672)
+++|..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..... ...++..|+||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 6899999999999999999999 789999999999999999999999999999765322 22335679999
Q ss_pred CccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHH
Q 005880 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEE 608 (672)
Q Consensus 530 E~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 608 (672)
|++. +..++.++|||||||++|||++ |+.||...... +............. ....
T Consensus 245 E~~~--~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------------~~~~~~~~~~~~~~----------~~~~ 300 (337)
T cd05054 245 ESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------------EEFCRRLKEGTRMR----------APEY 300 (337)
T ss_pred HHhc--CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------------HHHHHHHhccCCCC----------CCcc
Confidence 9664 5678999999999999999998 99998642211 11111111111000 0012
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 609 EMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 609 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
...++.+++.+||+.+|++||++.||++.|+++.+
T Consensus 301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.69 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=194.1
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|... ++..||||+++... .....++.+|+.+++.++||||+++++++..+...++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 4578999999999999853 25679999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 437 YMPNGSLFWLLHGNRGP-----GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
|+++|+|.+++...... ....+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||+
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 99999999999753311 1235788999999999999999999 78999999999999999999999999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++..... ...++..|+|||++. +..++.++|||||||++|||++ |..||.... ..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~------------~~~~~ 231 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS------------NEQVL 231 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------------HHHHH
Confidence 8755332 123356799999764 4678999999999999999999 788885331 12222
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
....... .... . ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 ~~~~~~~-~~~~-------~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGG-LLDK-------P---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCC-cCCC-------C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2211111 1000 0 1123457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=311.38 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=192.2
Q ss_pred HhcccCcCCeEEEEEEEEcC-Cc--EEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-GS--VVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKL 432 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 432 (672)
+.+.||+|+||.||+|...+ +. .||+|.++... ....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999999654 33 68999887532 33456789999999999999999999987542 2468
Q ss_pred EEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
+||||+++|+|.+++..... .....+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 99999999999988753321 12345899999999999999999999 78999999999999999999999999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++..... ....+..|+|||.+. +..++.++||||||+++|||++ |+.||.... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------------~~~~~ 224 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLA--DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE------------NSEIY 224 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHcc--CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC------------HHHHH
Confidence 9865432 123455799999654 5678999999999999999999 788885321 11122
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
........ .. .. ......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 225 ~~~~~~~~-~~-------~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 DYLRQGNR-LK-------QP---PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHcCCC-CC-------CC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22111110 00 00 11234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.31 Aligned_cols=250 Identities=26% Similarity=0.299 Sum_probs=189.2
Q ss_pred ccCcCCeEEEEEEEEcC---CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 367 MLGKGGFGTAYKAVLDD---GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 46799999875432 344578899999999999999999999999889999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.++++..........++..+..++.|+++||+||| +.+++||||||+||++++++++||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999997654323345778888999999999999999 789999999999999999999999999998654322
Q ss_pred ---CCCCCCcccCCCccccCC-----CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ---TVPRSNGYRAPELSSSDG-----RKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~-----~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...++..|+|||++.... ..++.++||||||+++|||++ |+.||...... +.......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~ 225 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE------------QVLTYTVRE 225 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH------------HHHHHHhhc
Confidence 233466799999874321 245789999999999999996 99999643211 111111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
......++.... .....+.+++..|+ .+|++|||++||++.|+
T Consensus 226 -~~~~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 -QQLKLPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -ccCCCCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111111110 11234667778998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.23 Aligned_cols=256 Identities=26% Similarity=0.353 Sum_probs=193.6
Q ss_pred HhcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 435 (672)
..+.||+|+||.||++.. .++..||+|.++.... .....+.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 347899999999988653 3578899999875432 2456788999999999999999999988754 3578999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++|+|.+++... .+++.++..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999753 3899999999999999999999 789999999999999999999999999999765
Q ss_pred CCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC--CCCCCC-CCChhHHHH
Q 005880 516 PPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA--GMGCGG-AVDLPRWVQ 584 (672)
Q Consensus 516 ~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~--~~~~~~-~~~~~~~~~ 584 (672)
... ...++..|+|||.+. +..++.++||||||+++|||+||+.||....... ...... ......+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL-I 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhc--ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh-h
Confidence 432 122345699999654 4578899999999999999999999985432110 000000 0000000 0
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.. .+... ..+.......++.+++.+||+.+|++|||+++|++.|+++.
T Consensus 235 ~~---------~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 EL---------LERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hh---------hhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 00000 00001123356888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.20 Aligned_cols=241 Identities=28% Similarity=0.424 Sum_probs=193.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
++||+|+||.||+|...++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875443 23457889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9986543 34889999999999999999999 889999999999999999999999999998754432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
....+..|+|||++. +..++.++||||||+++||+++ |..||.... ....... ........
T Consensus 153 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~------------~~~~~~~-~~~~~~~~--- 214 (250)
T cd05085 153 LKQIPIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCPYPGMT------------NQQAREQ-VEKGYRMS--- 214 (250)
T ss_pred CCCCcccccCHHHhc--cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC------------HHHHHHH-HHcCCCCC---
Confidence 112345699999664 4578899999999999999998 999986432 1111111 11111000
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
........+.+++.+|++.+|++||++.|+++.|.
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 -------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00112346788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.99 Aligned_cols=236 Identities=24% Similarity=0.333 Sum_probs=189.3
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999995 468999999997532 223456788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH----~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 999988654 34899999999999999999999 5 69999999999999999999999999998753221
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++|||||||++|||+||+.||.... .............
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tG~~Pf~~~~------------~~~~~~~i~~~~~---- 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------HEKLFELILMEEI---- 213 (325)
T ss_pred ccccccCCcccCCHHHHc--cCCCCCccccccccceeeeeccCCCCCCCCC------------HHHHHHHHhcCCC----
Confidence 345789999999764 4578899999999999999999999996432 1122222111110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ...++.+++.+||+.||++|+ ++.++++
T Consensus 214 -----~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 -----RFPRT---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----CCCCC---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 00111 123567788899999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.18 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=197.7
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|+||.||+|+.. ....+|+|.+..... ....++.+|+.+++.++||||+++++.+..++..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999853 235789998875432 245678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 437 YMPNGSLFWLLHGNRG-------------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
|+.+|+|.+++..... ....++++.+++.++.|++.||+||| +.+|+||||||+||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~nil 159 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAARNVL 159 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhheEE
Confidence 9999999999865321 12246899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005880 498 LDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGA 569 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~ 569 (672)
+++++.+||+|||+++..... ...++..|+|||.+. +..++.++||||||+++|||+| |+.||....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc--cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999754322 123356799999653 5678999999999999999999 999985321
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..++. .......... . ......++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 235 ---------~~~~~-~~~~~~~~~~-------~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 ---------PERLF-NLLKTGYRME-------R---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---------HHHHH-HHHhCCCCCC-------C---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11222 2222111000 0 11223467888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=311.17 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=188.1
Q ss_pred ccCcCCeEEEEEEEEcC---CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 367 MLGKGGFGTAYKAVLDD---GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 35788998764432 235678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++...........++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998655322334578889999999999999999 789999999999999999999999999998653221
Q ss_pred ---CCCCCCcccCCCccccC-----CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ---TVPRSNGYRAPELSSSD-----GRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~-----~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...++..|+|||++... ...++.++|||||||++|||++ |+.||..... .+.......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------------~~~~~~~~~~ 225 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------------EQVLKQVVRE 225 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------------HHHHHHHhhc
Confidence 22345679999976431 3466889999999999999999 7888853311 1111111121
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.. ....++.. .......+.+++..|+ .||++|||++||++.|.
T Consensus 226 ~~-~~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 QD-IKLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cC-ccCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 11111111 0112234566777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.78 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=193.8
Q ss_pred cccCcCCeEEEEEEEEcC-Cc--EEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLDD-GS--VVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+..+ |. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999653 43 57889887533 33456889999999999 799999999999999999999999999
Q ss_pred CChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 441 GSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 441 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
|+|.+++..... .....+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEECCC
Confidence 999999975431 11235889999999999999999999 789999999999999999999999999
Q ss_pred CCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 510 GLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 510 G~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
|++...... ....+..|+|||++. ...++.++|||||||++|||++ |+.||.... ..+...
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------------~~~~~~ 222 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------CAELYE 222 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCccccC------------HHHHHH
Confidence 998643221 122245699999653 4578899999999999999997 999985421 122222
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
...... . .+ .. ......+.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 223 ~~~~~~-~---~~----~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 KLPQGY-R---LE----KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHhCCC-C---CC----CC---CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 221110 0 00 00 112235778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.85 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=201.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 467999999999999966 79999999886422 22356889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++..... ....+++.+++.++.++++||+||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 87 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 87 GDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999875332 2345899999999999999999999 889999999999999999999999999998765432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. +..++.++|||||||++|||++|+.||.... .+..++........ ....
T Consensus 162 ~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~~~~~-~~~~ 228 (267)
T cd08224 162 AAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----------MNLYSLCKKIEKCD-YPPL 228 (267)
T ss_pred ccceecCCccccCHHHhc--cCCCCchhcHHHHHHHHHHHHHCCCCcccCC----------ccHHHHHhhhhcCC-CCCC
Confidence 235677899999664 5678899999999999999999999986432 22222222211111 0000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
........+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 229 ---------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ---------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01123346788899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.81 Aligned_cols=232 Identities=25% Similarity=0.346 Sum_probs=186.2
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 58999999987532 22345677888888776 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999887543 4899999999999999999999 88999999999999999999999999999875422
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------------~~~~~~~i~~~~~---- 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQ--EMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN------------EDDLFEAILNDEV---- 213 (320)
T ss_pred cccccccCccccCHHHHc--CCCCCCccchhhhHHHHHHHhhCCCCCCCCC------------HHHHHHHHhcCCC----
Confidence 2445788999999764 5578899999999999999999999996432 2222332222211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
. .... ....+.+++.+||+.||++||++.
T Consensus 214 ~-----~~~~---~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 V-----YPTW---LSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred C-----CCCC---CCHHHHHHHHHHcccCHHHCCCCC
Confidence 0 0011 123567888899999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.15 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=200.4
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|.. .+|..+|||.+..... ....++.+|+++++.++|+||+++++++..++..+++|||++
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 457799999999999995 5789999998864322 234678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++..... ....+++..++.++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999874321 2346899999999999999999999 889999999999999999999999999998765432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||.+. +..++.++||||||+++|||++|..||..... ....+........
T Consensus 161 ~~~~~~~~~~~~~ape~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~---- 224 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------NLYSLCKKIEQCD---- 224 (267)
T ss_pred cccccccCCcCccCHHHhc--CCCccchhhHHHHHHHHHHHHhCCCCcccccc----------hHHHHhhhhhcCC----
Confidence 235677899999664 45688899999999999999999999864321 1112211111110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.+... .......+.+++.+||+.||++||||.+|+++++++.
T Consensus 225 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 --YPPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00000 1123346788888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.65 Aligned_cols=250 Identities=19% Similarity=0.292 Sum_probs=187.9
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|++. ++
T Consensus 96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 357899999999999995 468999999753 3456789999999999999999999999999999999994 78
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|..++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 169 L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 169 LYCYLAAK-----RNIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 98888643 34889999999999999999999 789999999999999999999999999999653221
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc-----
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW----- 591 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 591 (672)
...+|..|+|||++. +..++.++|||||||++|||+||+.||........ ..+....+..+.....
T Consensus 240 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~-----~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 240 YYGWAGTIATNAPELLA--RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG-----DCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred cccccCccCCCChhhhc--CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc-----cCchhHHHHHHHHHhcCChhh
Confidence 346889999999764 45789999999999999999999988764322110 0000000111100000
Q ss_pred --------cccc---------cchhh-ccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 --------TAEV---------FDLEL-MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 --------~~~~---------~d~~~-~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ..+.. ...........++.+++.+||+.||++|||+.|+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000 000111223456888999999999999999999984
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.71 Aligned_cols=240 Identities=22% Similarity=0.280 Sum_probs=192.2
Q ss_pred HHhcccCcCCeEEEEEEEEcC--CcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD--GSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey 112 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeC
Confidence 345789999999999998543 3689999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 113 VIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999997543 4899999999999999999999 88999999999999999999999999999987654
Q ss_pred C--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 S--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 ~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
. ...+|..|+|||++. +..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 184 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------------~~~~~~~i~~~~~---- 245 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILL--NVGHGKAADWWTLGIFIYEILVGCPPFYANE------------PLLIYQKILEGII---- 245 (340)
T ss_pred CcceecCChhhcCHHHHh--CCCCCccccccchhhHHHHHhcCCCCCCCCC------------HHHHHHHHhcCCC----
Confidence 3 456889999999764 4567899999999999999999999996432 1111222221110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 637 (672)
....... ..+.+++.+|++.||++|+ +++|+++.
T Consensus 246 -----~~p~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0011112 2456788899999999995 78888653
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.33 Aligned_cols=236 Identities=24% Similarity=0.355 Sum_probs=188.5
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999965 57899999987532 22345677888888866 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|..++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999887543 4889999999999999999999 889999999999999999999999999998754221
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... .......+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------------~~~~~~~i~~~~~~--- 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQ--ELEYGPSVDWWALGVLMYEMMAGQPPFEADN------------EDDLFESILHDDVL--- 214 (321)
T ss_pred cccccccCccccCHHHHc--CCCCCCccceechhHHHHHHhcCCCCCCCCC------------HHHHHHHHHcCCCC---
Confidence 345788999999764 5578999999999999999999999996432 12222222222110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-------NMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~ 636 (672)
.... ...++.+++.+||+.||++|| ++.++++
T Consensus 215 ------~p~~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 ------YPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ------CCCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0011 123567888899999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.88 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=196.5
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||++... ++..+|+|.++.........+.+|+++++.++|+||+++++++.+....++||||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 4578999999999999732 3568999998876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe
Q 005880 438 MPNGSLFWLLHGNRG----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS 507 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 507 (672)
+++|+|.+++..... .....+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCCCEEEC
Confidence 999999999975431 11235899999999999999999999 8899999999999999999999999
Q ss_pred ccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCCh
Q 005880 508 DFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDL 579 (672)
Q Consensus 508 DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~ 579 (672)
|||+++..... ...++..|+|||.+. +..++.++|||||||++|||++ |++||.....
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------ 230 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------------ 230 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhc--cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------------
Confidence 99998755322 122356799999654 5678999999999999999998 8999853221
Q ss_pred hHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.+........... .........+.+++.+||+.||++||++.||++.|+
T Consensus 231 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 TEAIECITQGREL-----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHcCccC-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1112111111100 000112345778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.42 Aligned_cols=245 Identities=24% Similarity=0.432 Sum_probs=196.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CC---cEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DG---SVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
..+.||+|+||.||+|+.. ++ ..+|+|.++... ....+++.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 3578999999999999964 33 379999987543 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999997543 35899999999999999999999 789999999999999999999999999998765432
Q ss_pred C--------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 T--------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ~--------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...+..|+|||++. ...++.++|||||||++|||++ |+.||.... ..++...+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~------------~~~~~~~i~~~ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS------------NHEVMKAINDG 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhh--cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC------------HHHHHHHHhcC
Confidence 1 11234699999764 4578899999999999999998 999985421 12222222211
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
. ..+...+...++.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~-----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 F-----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0111122345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.92 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=189.8
Q ss_pred ccCcCCeEEEEEEEEc---CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 367 MLGKGGFGTAYKAVLD---DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999854 356799999875532 23467999999999999999999999875 457889999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC---
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST--- 519 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 519 (672)
|.+++.... ..+++..+++++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999997543 35899999999999999999999 7899999999999999999999999999987543321
Q ss_pred -----CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 520 -----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 520 -----~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
..++..|+|||.+. +..++.++|||||||++||+++ |+.||.... ..++.........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------------~~~~~~~~~~~~~-- 216 (257)
T cd05115 153 KARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK------------GPEVMSFIEQGKR-- 216 (257)
T ss_pred eccCCCCCCcccCCHHHHc--cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC------------HHHHHHHHHCCCC--
Confidence 11235799999654 4568899999999999999996 999986432 1122211111110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.+ .......++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 217 --~~-------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 --LD-------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00 0012234677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=314.03 Aligned_cols=242 Identities=23% Similarity=0.347 Sum_probs=188.7
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|+||+||++... +|+.||+|.+...... ..+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999954 6899999998653322 235677899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
..++..... ....+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 988754321 2346899999999999999999999 789999999999999999999999999999765432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||....... ............
T Consensus 156 ~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~--------- 216 (280)
T cd05608 156 GYAGTPGFMAPELLQ--GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--------ENKELKQRILND--------- 216 (280)
T ss_pred ccCCCcCccCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--------hHHHHHHhhccc---------
Confidence 345788999999764 5578899999999999999999999997532110 111111111110
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
.... .......+.+++.+||+.||++|| +++|+++
T Consensus 217 ~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 217 SVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCCC---cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0000 012234577888899999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.72 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=190.3
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|+||.||++... +|+.||+|.+..... .....+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999954 689999999864322 1234566799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----C
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----T 519 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 519 (672)
.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 98886443 245899999999999999999999 789999999999999999999999999998765433 3
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||++. +..++.++||||+||++|||++|+.||...... ....+......... ...
T Consensus 154 ~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-----~~~- 217 (277)
T cd05607 154 RAGTNGYMAPEILK--EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--------VAKEELKRRTLEDE-----VKF- 217 (277)
T ss_pred cCCCCCccCHHHHc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--------hhHHHHHHHhhccc-----ccc-
Confidence 45788999999764 446899999999999999999999999643211 11111111111111 000
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
... ....++.+++.+||+.||++||++.|+++.+.
T Consensus 218 --~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 218 --EHQ---NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred --ccc---cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 001 12335678888999999999999988764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.72 Aligned_cols=241 Identities=27% Similarity=0.379 Sum_probs=201.5
Q ss_pred ccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhH
Q 005880 367 MLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 445 (672)
+||+|.||+||-|+.. +...+|||.+........+-+..||.+-+.++|.|||+++|.+..+++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999955 467799999987766677788999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-CCCcEEEeccCCCccCCC-----
Q 005880 446 LLHGNRGPGRTPL--DWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 446 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~----- 517 (672)
+|+...+ |+ ++.++--+..||++||.||| +..|||||||-+||||+ -.|.+||+|||-++.+..
T Consensus 662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHhccC----CCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 9987763 45 78888999999999999999 88999999999999997 478999999999876643
Q ss_pred CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 518 STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 518 ~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
.+..||..|||||++....+.|+.++|||||||.+.||.||++||...+... .++++-+..+ +
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------------AAMFkVGmyK--v- 796 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------------AAMFKVGMYK--V- 796 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------------Hhhhhhccee--c-
Confidence 2677899999999998888899999999999999999999999997543221 1122221111 0
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.++-.++...+...+|.+|+.+||.+||+++++++
T Consensus 797 ----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 ----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11122344456777888999999999999999975
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.86 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=191.6
Q ss_pred HhcccCcCCeEEEEEEEEc-CCc----EEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||+|.+. +|+ .|++|.+..... ....++..|+..+++++||||+++++++. ....++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 3578999999999999964 444 478888764332 23467888888999999999999999875 4557789999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999997543 35899999999999999999999 78999999999999999999999999999976533
Q ss_pred C-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...++..|+|||.+. +..++.++|||||||++|||++ |+.||..... . -.......
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------~-~~~~~~~~ 226 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESIL--FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------------H-EVPDLLEK 226 (279)
T ss_pred CCcccccCCCCCcccccCHHHhc--cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------H-HHHHHHHC
Confidence 2 223456899999664 4578999999999999999998 9999864321 1 11111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... ...+ ......+.+++.+||..||++|||+.|+++.|..+.+
T Consensus 227 ~~~--~~~~--------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GER--LAQP--------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCc--CCCC--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 110 0000 0122356778889999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.61 Aligned_cols=244 Identities=28% Similarity=0.455 Sum_probs=196.0
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++ ..+..++||||+++|+
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~ 86 (260)
T cd05067 9 KLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGS 86 (260)
T ss_pred eeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCC
Confidence 34678999999999999988899999999875443 456889999999999999999999986 4567899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++......
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 87 LVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999987543 245899999999999999999999 889999999999999999999999999999765522
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||.... ..+...... ......
T Consensus 160 ~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------------~~~~~~~~~-~~~~~~- 223 (260)
T cd05067 160 REGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------------NPEVIQNLE-RGYRMP- 223 (260)
T ss_pred ccCCcccccccCHHHhc--cCCcCcccchHHHHHHHHHHHhCCCCCCCCCC------------hHHHHHHHH-cCCCCC-
Confidence 122346799999654 4568889999999999999999 999996432 112222111 110000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
.. .....++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ------RP---DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 1122458889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.39 Aligned_cols=236 Identities=26% Similarity=0.365 Sum_probs=185.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHH---cCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVL---GRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 468999999999999954 68999999997532 12234566666554 567899999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|..+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999888642 4899999999999999999999 88999999999999999999999999999865322
Q ss_pred -----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 -----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 -----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
....++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~G~~pf~~~~------------~~~~~~~i~~~~~- 218 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLT--ETSYTRAVDWWGLGVLIYEMLVGESPFPGDD------------EEEVFDSIVNDEV- 218 (324)
T ss_pred CCCcccccccCccccCHhHhc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCC-
Confidence 1345788999999764 5678899999999999999999999996432 1222222222111
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
..... ....+.+++.+||+.||.+||+ +.++++
T Consensus 219 --------~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --------RYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --------CCCCC---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00111 2235678888999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.90 Aligned_cols=243 Identities=27% Similarity=0.418 Sum_probs=193.5
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
..+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||+++|+|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 87 (260)
T cd05069 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSL 87 (260)
T ss_pred eeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCH
Confidence 3467999999999999988777899998875433 4567899999999999999999998875 5567899999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.++++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++......
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 88 LDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99997543 245899999999999999999999 789999999999999999999999999999765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||... +..++.++||||||+++|||+| |+.||..... .+...... .....
T Consensus 161 ~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~~~-~~~~~--- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------------REVLEQVE-RGYRM--- 222 (260)
T ss_pred CCCccchhhCCHHHhc--cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHH-cCCCC---
Confidence 123456799999653 5678999999999999999999 8999864321 11111111 11000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
.........+.+++.+||+.||++||++++|++.|++
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233467888889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.13 Aligned_cols=195 Identities=32% Similarity=0.449 Sum_probs=170.4
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-C-----CceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-H-----PNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|.||.|-+|.. ++++.||||++++... -..+-..|+.+|..|+ | -|+|++++||...++.|||+|
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 357899999999999994 5699999999986543 4566678999999986 4 489999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC--CcEEEeccCCCcc
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT--GNARVSDFGLSIF 514 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DfG~a~~ 514 (672)
.+ .-+|+++++.+.. ..++...+..|+.||+.||.+|| +.+|||+||||+|||+.+- ..+||+|||.+..
T Consensus 269 LL-~~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 269 LL-STNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred hh-hhhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99 5599999998875 45999999999999999999999 8999999999999999753 4699999999988
Q ss_pred CCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005880 515 APPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA 569 (672)
Q Consensus 515 ~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~ 569 (672)
.... .+..+..|+|||++. |..|+++.||||||||+.||++|.+-|.++.+.+
T Consensus 341 ~~q~vytYiQSRfYRAPEVIL--GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVIL--GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cCCcceeeeeccccccchhhc--cCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 7665 566788999999886 6799999999999999999999988887766544
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=315.51 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=197.4
Q ss_pred HHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
...+.||+|+||.||++... +...+|+|.++... .....++.+|++++.++ +|+||+++++++..++..++|
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34578999999999999854 23689999987532 23446788999999999 899999999999999999999
Q ss_pred EeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc
Q 005880 435 SEYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN 503 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~ 503 (672)
|||+++|+|.++++.... .....+++..+++++.|++.||+||| +.+|+||||||+||++++++.
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEEcCCCe
Confidence 999999999999975321 12346899999999999999999999 789999999999999999999
Q ss_pred EEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCC
Q 005880 504 ARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGG 575 (672)
Q Consensus 504 ~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~ 575 (672)
+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||++ |..||....
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------- 239 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--------- 239 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhc--cCCcCcccceeehhhHHHHHhcCCCCCCCCCC---------
Confidence 999999999765432 112345799999653 5678899999999999999998 898885321
Q ss_pred CCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
..+..... ...... .........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 240 ---~~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 ---VEELFKLL-KEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHHH-HcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11212111 111100 001122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.72 Aligned_cols=244 Identities=29% Similarity=0.421 Sum_probs=194.6
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeecCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYMPNG 441 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g 441 (672)
.+.+.||+|+||.||++... |..||+|.++... ..+.+.+|+.++++++|+|++++++++.. ++..++|+||+++|
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 34578999999999999876 7889999987543 35678999999999999999999998654 45789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--C
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--T 519 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~ 519 (672)
+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++..... .
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 158 (256)
T cd05082 86 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 158 (256)
T ss_pred cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceeccccCCC
Confidence 9999997543 245899999999999999999999 789999999999999999999999999998765432 2
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...+..|+|||++. +..++.++|||||||++|||++ |+.||... ...+........ .....
T Consensus 159 ~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------------~~~~~~~~~~~~-~~~~~--- 220 (256)
T cd05082 159 GKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------------PLKDVVPRVEKG-YKMDA--- 220 (256)
T ss_pred CccceeecCHHHHc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHhcC-CCCCC---
Confidence 33456799999664 4578899999999999999998 99998532 222222222111 11110
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 221 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 -------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 012234677888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.92 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=199.0
Q ss_pred HHHhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeE
Q 005880 362 RASAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEK 431 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 431 (672)
+.+.+.||+|+||.||++... ++..+|+|.++... .....++.+|++++.++ +||||+++++++...+..
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 455688999999999999842 23579999997542 23456788899999999 799999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK 500 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~ 500 (672)
++||||+++|+|.+++...... ....+++.++++++.|++.||+||| +.+++||||||+||++++
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTE 175 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheEEcC
Confidence 9999999999999999764321 1235899999999999999999999 789999999999999999
Q ss_pred CCcEEEeccCCCccCCCC-----C--CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005880 501 TGNARVSDFGLSIFAPPS-----T--VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMG 572 (672)
Q Consensus 501 ~~~~kl~DfG~a~~~~~~-----~--~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~ 572 (672)
++.+||+|||.++..... . ...+..|+|||.+. +..++.++|||||||++|||++ |+.||...
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~~~g~~p~~~~------- 246 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 246 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhc--cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-------
Confidence 999999999998765432 1 12235799999664 4578899999999999999998 88888532
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
...+..... ...... ........++.+++.+||..+|++|||+.||++.|+++...
T Consensus 247 -----~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 -----PVEELFKLL-KEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----CHHHHHHHH-HcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 222222221 111110 00112234677889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.26 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=197.4
Q ss_pred HhcccCcCCeEEEEEEEEcC-Cc--EEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-GS--VVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|...+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++|+||+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 34679999999999999653 43 47888887432 23456789999999999 7999999999999999999999999
Q ss_pred CCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe
Q 005880 439 PNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS 507 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 507 (672)
++|+|.++++..... ....+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCeEEEC
Confidence 999999999754310 1135889999999999999999999 7899999999999999999999999
Q ss_pred ccCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 508 DFGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 508 DfG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
|||++...... ....+..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~------------~~~~ 227 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT------------CAEL 227 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------------HHHH
Confidence 99998643321 112245699999654 5578899999999999999997 999996432 2222
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCC
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 647 (672)
........ . .. .. ......+.+++.+||+.+|.+||++.++++.|+.+.+....
T Consensus 228 ~~~~~~~~-~-----~~--~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 YEKLPQGY-R-----ME--KP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHhcCC-C-----CC--CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 22221110 0 00 00 11224577888999999999999999999999998764433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.17 Aligned_cols=244 Identities=31% Similarity=0.446 Sum_probs=198.1
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus 10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred ceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 4578999999999999876 78999999986544 567899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC--CC
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST--VP 521 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 521 (672)
.+++.... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||.++...... ..
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~ 160 (256)
T cd05039 88 VDYLRSRG---RAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK 160 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEcccccccccccccccCC
Confidence 99997543 235899999999999999999999 8899999999999999999999999999998764432 22
Q ss_pred CCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhh
Q 005880 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLEL 600 (672)
Q Consensus 522 ~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 600 (672)
.+..|+|||.+. +..++.++||||||+++|||++ |+.||.... ..+ +...........
T Consensus 161 ~~~~~~ape~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------------~~~-~~~~~~~~~~~~------ 219 (256)
T cd05039 161 LPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKD-VVPHVEKGYRME------ 219 (256)
T ss_pred CcccccCchhhc--CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC------------HHH-HHHHHhcCCCCC------
Confidence 345799999654 4578889999999999999997 999985321 111 111111111100
Q ss_pred ccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 601 MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 601 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
........+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 ----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112234678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.67 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=199.0
Q ss_pred HhcccCcCCeEEEEEEEEcC-----CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-----GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 436 (672)
+.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +...++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 35789999999999999765 6889999987543 3345678899999999999999999998876 467889999
Q ss_pred ecCCCChhHHhhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 437 YMPNGSLFWLLHGNRGP---GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
|+++|+|.+++...... ....+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999999999754321 1246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 514 FAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 514 ~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
..... ...++..|+|||++. +..++.++|||||||++||+++ |+.||.... ..++...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------------~~~~~~~ 231 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLV--NKEYSSASDVWSFGVLLWELMTLGQTPYVEID------------PFEMAAY 231 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHh--cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC------------HHHHHHH
Confidence 65332 233456799999664 4578999999999999999999 999996432 1122221
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
....... .........+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 232 ~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 LKDGYRL-----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHcCCCC-----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111100 0011123457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.28 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=188.9
Q ss_pred cccCcCCeEEEEEEEEcC-C----------cEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEE
Q 005880 366 EMLGKGGFGTAYKAVLDD-G----------SVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 434 (672)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999764 3 25788887654432 6788999999999999999999999988 778999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-------cEEEe
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-------NARVS 507 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~ 507 (672)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeC
Confidence 99999999999997643 25899999999999999999999 88999999999999999887 79999
Q ss_pred ccCCCccCCCC-CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 508 DFGLSIFAPPS-TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 508 DfG~a~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
|||++...... ...++..|+|||++......++.++|||||||++|||++ |..||..... ..+...
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~------------~~~~~~ 218 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS------------SEKERF 218 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc------------hhHHHH
Confidence 99999765443 344567899999775433478999999999999999999 5777753321 111111
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
..... ....+ ....+.+++.+||..+|.+|||+.||++.|+
T Consensus 219 ~~~~~---------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQH---------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCC---------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 00001 1146788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.70 Aligned_cols=246 Identities=21% Similarity=0.331 Sum_probs=195.3
Q ss_pred HHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 362 RASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345678999999999999965 5788999998765555567889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|..++.... .++++..+..++.|+++||+||| +.+++||||||+||+++.++++||+|||++......
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999886532 45899999999999999999999 789999999999999999999999999998654322
Q ss_pred ---CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ---TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||++.. .+..++.++|||||||++|||++|+.||.... ..+.+.........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------------~~~~~~~~~~~~~~ 226 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN------------PMRVLLKIAKSEPP 226 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC------------HHHHHHHHhhcCCC
Confidence 3456788999998642 24557789999999999999999999986421 11111111111100
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ......+.+++.+||+.||.+||++.++++
T Consensus 227 ------~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 ------TLAQP---SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------CCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001 112245778888999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.49 Aligned_cols=240 Identities=27% Similarity=0.315 Sum_probs=190.1
Q ss_pred ccCcCCeEEEEEEEEc---CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 367 MLGKGGFGTAYKAVLD---DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.||+|+||.||+|.++ ++..+|+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578999999874432 24567899999999999999999999875 45678999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST-- 519 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 519 (672)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999643 34899999999999999999999 7899999999999999999999999999997654321
Q ss_pred ------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 520 ------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 520 ------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
..++..|+|||.+. ...++.++|||||||++|||++ |+.||.... ..++...+. ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------------~~~~~~~i~-~~~~ 216 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK------------GNEVTQMIE-SGER 216 (257)
T ss_pred eeecCCCCCCccccCHhHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHH-CCCC
Confidence 11245799999653 4578889999999999999998 999996432 112222222 1111
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
... . .....++.+++.+||+.||++||++.+|.+.|++.
T Consensus 217 ~~~-------~---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MEC-------P---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCC-------C---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 110 0 11234577888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.69 Aligned_cols=235 Identities=27% Similarity=0.364 Sum_probs=184.3
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcC-CCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 58899999987532 1233455667777664 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 9999998754 24889999999999999999999 78999999999999999999999999999975432
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~G~~Pf~~~~------------~~~~~~~i~~~~~---- 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILK--GQKYNESVDWWSFGVLLYEMLIGQSPFHGED------------EDELFDSILNDRP---- 213 (316)
T ss_pred ccccccCCccccCHHHHc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHcCCC----
Confidence 2345789999999764 5578999999999999999999999996432 1222222221110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS-HVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 635 (672)
. .... ....+.+++.+||+.||.+||++. +++
T Consensus 214 ---~--~~~~---~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 ---H--FPRW---ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ---C--CCCC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 0011 123466788899999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.98 Aligned_cols=233 Identities=25% Similarity=0.365 Sum_probs=187.6
Q ss_pred cccCcCCeEEEEEEEE----cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999884 3589999999975332 234567789999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99999998643 35899999999999999999999 789999999999999999999999999998765332
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 153 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~~~------------~~~~~~~i~~~~~--- 215 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVN--RRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------------RKETMTMILKAKL--- 215 (318)
T ss_pred CceecccCChhhcCHHHHc--CCCCCCccceeccceEeeeeccCCCCCCCCC------------HHHHHHHHHcCCC---
Confidence 345788999999764 4567899999999999999999999996431 1222222222110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSH 633 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 633 (672)
.... .....+.+++.+||+.||++||++.+
T Consensus 216 ------~~p~---~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ------GMPQ---FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCC---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0011 11234677888999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=322.02 Aligned_cols=240 Identities=22% Similarity=0.345 Sum_probs=186.6
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999955 68899999997532 22345677888888776 899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 9999888654 34899999999999999999999 78999999999999999999999999999875322
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||........ .......++.........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~i~~~~~--- 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----PDQNTEDYLFQVILEKQI--- 222 (329)
T ss_pred ccccccCCccccCHHHHc--CCCCCCccceecccHHHHHHhhCCCCCccCCCcCC----cccccHHHHHHHHhcCCC---
Confidence 2345788999999764 56788999999999999999999999964321110 011122232222222110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
.... .....+.+++.+||+.||++||++
T Consensus 223 -----~~p~---~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -----RIPR---SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----CCCC---CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0011 122356788889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.20 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=195.2
Q ss_pred HhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe------E
Q 005880 364 SAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE------K 431 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~ 431 (672)
+.+.||+|+||.||+|.... +..||+|+++.... .....+.+|++.++.++||||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 35789999999999999642 36799999875332 234678999999999999999999999876554 6
Q ss_pred EEEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
++|+||+++|+|..++..... .....+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECCcc
Confidence 899999999999999865432 12346899999999999999999999 7899999999999999999999999999
Q ss_pred CCccCCCCC-------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 511 LSIFAPPST-------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 511 ~a~~~~~~~-------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+++...... ...+..|+|||.+ .+..++.++|||||||++|||++ |..||.... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~------------~~~~ 224 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE------------NHEI 224 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhc--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC------------HHHH
Confidence 997654321 2234579999965 35678899999999999999999 888885422 1122
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.......... . ........+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 225 ~~~~~~~~~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 YDYLRHGNRL-K----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHcCCCC-C----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2222211100 0 0112334688889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.13 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=204.8
Q ss_pred ccCHHHHHHHHhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEE
Q 005880 354 RFELEDLLRASAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKA 423 (672)
Q Consensus 354 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~ 423 (672)
++++....+.+.+.||+|+||.||+|+.. .+..||+|.++... ....+++.+|++++.++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 45555555566789999999999999742 12368999887533 22456889999999999 7999999999
Q ss_pred EEEcCCeEEEEEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 005880 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIK 492 (672)
Q Consensus 424 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlk 492 (672)
++..++..++++||+++|+|.+++..... .....+++.++..++.|+++||+||| +.+|+|||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlk 161 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLA 161 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccc
Confidence 99999999999999999999999975431 11245899999999999999999999 7899999999
Q ss_pred CCCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 005880 493 STNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVI 564 (672)
Q Consensus 493 p~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~ 564 (672)
|+||++++++.+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||++ |..||..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc--cCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999765432 112235699999764 4578899999999999999998 8888853
Q ss_pred CCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 565 DGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
. +..++......... ... .......+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 240 ~------------~~~~~~~~~~~~~~-~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 240 I------------PVEELFKLLKEGHR-MDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred C------------CHHHHHHHHHcCCC-CCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 2 22333332222110 000 012234678899999999999999999999999999854
Q ss_pred C
Q 005880 645 E 645 (672)
Q Consensus 645 ~ 645 (672)
.
T Consensus 297 ~ 297 (334)
T cd05100 297 T 297 (334)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.89 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=189.4
Q ss_pred cccCcCCeEEEEEEEEc----CCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVLD----DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 439 (672)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643 23345688899999999999999999998764 556789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++.... ...++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999997543 23678888999999999999999 789999999999999999999999999998754321
Q ss_pred --------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 --------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG-KCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 --------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...++..|+|||.+. +..++.++|||||||++|||++| .+||... +..+........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------------~~~~~~~~~~~~ 218 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------------DSFDITVYLLQG 218 (262)
T ss_pred ceeecccccCcCCccccChhHhc--cCccchHHHHHHHHHHHHHHHcCCCCCCCCC------------CHHHHHHHHhcC
Confidence 223356799999654 45788999999999999999995 5555322 112222222111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... ... ......+.+++.+||+.+|++||++.||++.|+++..
T Consensus 219 ~~~--------~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 RRL--------LQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCC--------CCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 100 000 1122457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.54 Aligned_cols=242 Identities=30% Similarity=0.392 Sum_probs=192.0
Q ss_pred cccCcCCeEEEEEEEEcC----CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
++||+|+||.||+|++.. +..||+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999875543 34568899999999999999999999876 4567999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC-
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST- 519 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 519 (672)
|+|.+++.... .+++..+..++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999997543 5899999999999999999999 7899999999999999999999999999987654331
Q ss_pred -------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 520 -------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 520 -------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
..++..|+|||.+. +..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~------------~~~~~~~~~~~~~ 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK------------GAEVIAMLESGER 216 (257)
T ss_pred ccccccCccccccccCHHHhc--CCCCCccchHHHHHHHHHHHHcCCCCCcccCC------------HHHHHHHHHcCCc
Confidence 11134699999653 5678999999999999999998 999986432 1122222111110
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
. .........+.+++.+||..+|++||++.++++.|+++.
T Consensus 217 -~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 -L----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -C----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 001122346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=321.68 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=190.0
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||||+++.... .....+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999954 689999999975322 2345678899999888 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 9999888644 34899999999999999999999 88999999999999999999999999999874321
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||......+. ......++......+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~--- 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----PDQNTEDYLFQVILEKQI--- 222 (329)
T ss_pred ccccccCCccccCHHHHc--CCCCCCccceechHHHHHHHHHCCCCccccccccc----ccccchHHHHHHHHcCCC---
Confidence 2456788999999764 46788999999999999999999999964321110 011122233222222111
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCC------HHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN------MSHVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl 635 (672)
..... ....+.+++.+||+.||.+||+ +.+++
T Consensus 223 -----~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 223 -----RIPRS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -----CCCCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 00111 1235678888999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.21 Aligned_cols=194 Identities=22% Similarity=0.391 Sum_probs=159.3
Q ss_pred hcccCcCCeEEEEEEEEc---CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD---DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 439 (672)
..+||+|+||.||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999954 46889999987543 23567889999999999999999998864 456789999995
Q ss_pred CCChhHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe----CCCCcEEEeccCC
Q 005880 440 NGSLFWLLHGNRG----PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGL 511 (672)
Q Consensus 440 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~ 511 (672)
++|.+++..... .....+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 588888754321 11235899999999999999999999 8899999999999999 4567899999999
Q ss_pred CccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 512 SIFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 512 a~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
++..... ...+|..|+|||++.. ...++.++||||+||++|||++|++||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcC-CCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9765432 3456888999997653 2467899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=303.35 Aligned_cols=240 Identities=24% Similarity=0.376 Sum_probs=203.0
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.++||+|.||.||+|.. ..|+.||+|.+.-.. +.+++.+|+.+|++++.|++|++||.|+.....|+|||||.-|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 457899999999999995 479999999987544 67899999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 517 (672)
..++++..+ .++++.++..++++.++||+||| ...-||||||+.|||++.+|.+||+|||.|-.+..
T Consensus 115 iSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 115 ISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred HHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999998654 67999999999999999999999 77889999999999999999999999999966544
Q ss_pred CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 518 STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 518 ~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
.+..||+-|||||++.. -.|..++||||+|+...||..|++||.+-.+- +. ..-+..
T Consensus 187 NTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------------------RA--IFMIPT 243 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------------------RA--IFMIPT 243 (502)
T ss_pred CccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccccccc-------------------ce--eEeccC
Confidence 37789999999998864 46888999999999999999999999642110 00 000111
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.....+...++...++.++++.||-+.|++|-|+.++++
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 112233445677788999999999999999999988765
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=309.04 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=195.1
Q ss_pred cccCcCCeEEEEEEEEcC--C--cEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLDD--G--SVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999987665 566789999999999999999999999988 888999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++..... ..+++..++.++.|+++||+||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999976531 45899999999999999999999 889999999999999999999999999998766442
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...++..|+|||.+. +..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------------~~~~~~~~~~~~~ 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS------------GSQILKKIDKEGE 218 (257)
T ss_pred ceecccCCCCCceecCHHHhc--ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHHhcCC
Confidence 233567899999654 5578999999999999999999 999985321 1222222221110
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
. ..........+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 R----------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred c----------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0001122346888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.55 Aligned_cols=193 Identities=22% Similarity=0.312 Sum_probs=162.8
Q ss_pred hcccCcC--CeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKG--GFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.++||+| +|++||+++. .+|+.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7899999985 5789999999975432 234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++++||+.......
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999965431 34899999999999999999999 78999999999999999999999999986533211
Q ss_pred ----------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 518 ----------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 518 ----------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
....++..|+|||++......++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 12234567999998754435688999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.50 Aligned_cols=244 Identities=28% Similarity=0.439 Sum_probs=197.6
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|..++++.||||.+..... ..+++.+|++++++++|+||+++++++......++||||+++++|
T Consensus 10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 88 (261)
T cd05034 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCH
Confidence 4578999999999999988888999999875443 457899999999999999999999999988999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||++......
T Consensus 89 ~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 89 LDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred HHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 99997643 235899999999999999999999 789999999999999999999999999998766432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....+..|+|||.+. +..++.++||||||+++|||++ |+.||.... .............
T Consensus 162 ~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~------------~~~~~~~~~~~~~----- 222 (261)
T cd05034 162 EGAKFPIKWTAPEAAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT------------NREVLEQVERGYR----- 222 (261)
T ss_pred hccCCCccccCHHHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHHcCCC-----
Confidence 222345799999654 5578899999999999999999 999985321 1112222211100
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
.... ......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ---~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRP---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000 1123467888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.37 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=192.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 4578999999999999964 68999999986432 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... .++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999998643 3788889999999999999999 889999999999999999999999999998765432
Q ss_pred -----CCCCCCcccCCCccccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 -----TVPRSNGYRAPELSSSD--GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~--~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...+|..|+|||++... ...++.++|||||||++|||++|+.||.... .......+.....
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------------~~~~~~~i~~~~~ 264 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------------LVGTYSKIMDHKN 264 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC------------HHHHHHHHHcCCC
Confidence 34578899999987543 2357899999999999999999999997432 2222222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ--RPNMSHVVKL 637 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 637 (672)
... .+........+.+++.+||+.+|.+ ||++.|+++.
T Consensus 265 ~~~--------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLT--------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCC--------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0110112345677888999999987 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.71 Aligned_cols=235 Identities=27% Similarity=0.378 Sum_probs=185.8
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcC-CCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 57899999987532 1234556677788776 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 9999999753 34889999999999999999999 78999999999999999999999999999875322
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~G~~pf~~~~------------~~~~~~~i~~~~----- 212 (316)
T cd05619 152 KTCTFCGTPDYIAPEILL--GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD------------EEELFQSIRMDN----- 212 (316)
T ss_pred ceeeecCCccccCHHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCC-----
Confidence 1345788999999764 4578999999999999999999999996432 112222211111
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS-HVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 635 (672)
+.. .. .....+.+++.+||+.||++||++. ++.
T Consensus 213 --~~~--~~---~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 --PCY--PR---WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CCC--Cc---cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 000 01 1123467788899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.87 Aligned_cols=244 Identities=20% Similarity=0.316 Sum_probs=193.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+++.. +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 3478999999999999954 689999999975322 245678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999997653 35899999999999999999999 889999999999999999999999999999765432
Q ss_pred -----CCCCCCcccCCCccccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 -----TVPRSNGYRAPELSSSD----GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~----~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...+|..|+|||++... ...++.++|||||||++|||++|+.||.... ....+..+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------------~~~~~~~i~~~ 224 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT------------SAKTYNNIMNF 224 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC------------HHHHHHHHHcC
Confidence 23578899999986531 3467889999999999999999999996432 11222222221
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... .+........+.+++..|+. +|.+|||+.++++
T Consensus 225 ~~~~~--------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 QRFLK--------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCccC--------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11000 01101122346677789997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.61 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=196.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCc--EEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGS--VVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|... +|. .+|+|.++... ......+.+|++++.++ +||||+++++++..++..++||||+
T Consensus 11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 4578999999999999964 454 46888776532 23456788999999999 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe
Q 005880 439 PNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS 507 (672)
Q Consensus 439 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 507 (672)
++|+|.++++.... .....+++.+++.++.|+++||+||| +.+|+||||||+||++++++.+||+
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCCcEEeC
Confidence 99999999975431 11235899999999999999999999 8899999999999999999999999
Q ss_pred ccCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 508 DFGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 508 DfG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
|||++...... ....+..|+|||++. +..++.++|||||||++|||+| |..||.... ..+.
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------------~~~~ 232 (303)
T cd05088 167 DFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------CAEL 232 (303)
T ss_pred ccccCcccchhhhcccCCCcccccCHHHHh--ccCCcccccchhhhhHHHHHHhcCCCCcccCC------------hHHH
Confidence 99998643221 112245799999653 4568899999999999999998 999986432 1122
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
..... ..... ... ......+.+++.+||+.+|++||++.++++.|+++.....
T Consensus 233 ~~~~~-~~~~~-------~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 233 YEKLP-QGYRL-------EKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHh-cCCcC-------CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 22111 10000 000 1122357788999999999999999999999999865444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=335.63 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=193.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--------eEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE--------EKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l 433 (672)
.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++..++|+||+++++.+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 47899999999999984 579999999986533 234567889999999999999999988775432 3579
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||+++|+|.++++.... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 117 V~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 9999999999999975432 2346899999999999999999999 8899999999999999999999999999987
Q ss_pred cCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 514 FAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 514 ~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||... +..+.+...
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------------~~~~~~~~~ 257 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWR--RKPYSKKADMFSLGVLLYELLTLKRPFDGE------------NMEEVMHKT 257 (496)
T ss_pred eccccccccccccccCCcceeCHHHhC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------------CHHHHHHHH
Confidence 65421 345788999999764 467899999999999999999999999642 223333333
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
..... ++ .. .....++.+++.+||+.||.+||++.++++.
T Consensus 258 ~~~~~-----~~---~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRY-----DP---LP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCC-----CC---CC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22211 10 00 1123457788889999999999999999863
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.65 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=192.3
Q ss_pred HhcccCcCCeEEEEEEEEcC---------------CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEc
Q 005880 364 SAEMLGKGGFGTAYKAVLDD---------------GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 427 (672)
+.+.||+|+||.||+++..+ ...||+|.++... ......|.+|++++.+++|+||+++++++..
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 45779999999999988542 2358999987542 2245679999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChhHHhhcCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC
Q 005880 428 REEKLLVSEYMPNGSLFWLLHGNRG-------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK 500 (672)
Q Consensus 428 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~ 500 (672)
.+..++||||+++++|.+++..... .....+++..++.++.|+++||+||| +.+++||||||+||++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNCLVGN 164 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhEEEcC
Confidence 9999999999999999999865321 11234789999999999999999999 789999999999999999
Q ss_pred CCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCCCCC
Q 005880 501 TGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT--GKCPSVIDGGGAGM 571 (672)
Q Consensus 501 ~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t--g~~P~~~~~~~~~~ 571 (672)
++.+||+|||++...... ...++..|+|||++. +..++.++|||||||++|||++ |..||......
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--- 239 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--- 239 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhc--cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH---
Confidence 999999999998755332 122356799999654 4568999999999999999998 56676532211
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
.................... .. ......+.+++.+||+.||++||++.+|++.|++
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ------QVIENTGEFFRNQGRQIYLS----QT---PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ------HHHHHHHHhhhhccccccCC----CC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111110000000 00 1123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.20 Aligned_cols=239 Identities=24% Similarity=0.393 Sum_probs=193.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++....+.++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 46799999999999995 46899999998766555667889999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 9998643 3789999999999999999999 789999999999999999999999999998755432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||.+. +..++.++|||||||++|||++|+.||...... ..+.. ..... ..
T Consensus 175 ~~~~~~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----------~~~~~-~~~~~-~~----- 234 (296)
T cd06654 175 TMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYL-IATNG-TP----- 234 (296)
T ss_pred cccCCccccCHHHHc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----------HhHHH-HhcCC-CC-----
Confidence 345677899999654 456789999999999999999999999643211 11111 11110 00
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .........+.+++.+||..+|++||++.|+++
T Consensus 235 ~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 EL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CC---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00 011122345778889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=309.16 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=188.7
Q ss_pred cccCcCCeEEEEEEEEcC--------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDD--------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998542 234888888655544567889999999999999999999999998999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc--------EEEecc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN--------ARVSDF 509 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Df 509 (672)
+++|+|.++++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999997653 35899999999999999999999 889999999999999987765 699999
Q ss_pred CCCccCCCC-CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 510 GLSIFAPPS-TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK-CPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 510 G~a~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
|++...... ...++..|+|||++.. ...++.++|||||||++|||++|. .||.... ...... ..
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~------------~~~~~~-~~ 218 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIEN-PQNLSLAADKWSFGTTLWEIFSGGDKPLSALD------------SQKKLQ-FY 218 (258)
T ss_pred ccccccCCchhccccCCccCchhccC-CCCCCchhhHHHHHHHHHHHHcCCCCChhhcc------------HHHHHH-HH
Confidence 998765443 4567788999997642 345788999999999999999995 5553211 111111 11
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.... .. + .....++.+++.+||+.||++|||++++++.|+
T Consensus 219 ~~~~-------~~---~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDRH-------QL---P--APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hccc-------cC---C--CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1100 00 0 111235788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.57 Aligned_cols=236 Identities=26% Similarity=0.358 Sum_probs=188.8
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||||+++... ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 57899999997532 22345677888888877 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999887542 4899999999999999999999 889999999999999999999999999998653221
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 152 ~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------------~~~~~~~i~~~~~---- 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILS--YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------------EDELFQSILEDEV---- 213 (318)
T ss_pred cccceecCccccCHHHhc--CCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------------HHHHHHHHHcCCC----
Confidence 345788999999764 5678899999999999999999999996432 1222222221110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM-----SHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 636 (672)
.... .....+.+++.+||+.||.+||++ .++++
T Consensus 214 -----~~~~---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 -----RYPR---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CCCC---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011 122357788889999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.12 Aligned_cols=190 Identities=25% Similarity=0.372 Sum_probs=165.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++.+++|+||+++++++.+....++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 478999999999999854 689999999975322 2345678899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 86 GDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999754 35899999999999999999999 88999999999999999999999999999865421
Q ss_pred -------------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 005880 518 -------------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKC 560 (672)
Q Consensus 518 -------------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~ 560 (672)
....||..|+|||++. +..++.++|||||||++|||++|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM--QTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc--CCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1235788999999765 4578899999999999999999999
Q ss_pred CCCCC
Q 005880 561 PSVID 565 (672)
Q Consensus 561 P~~~~ 565 (672)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.27 Aligned_cols=232 Identities=26% Similarity=0.398 Sum_probs=183.8
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHH-HHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHME-VLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +|+.||+|++..... ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999965 689999999874322 12334455544 56789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 9999998754 35889999999999999999999 78999999999999999999999999999875322
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....++..|+|||++. +..++.++|||||||++|||++|+.||... +..+.........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~------------~~~~~~~~i~~~~----- 212 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLR--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------DTAEMYDNILNKP----- 212 (323)
T ss_pred ccccccCChhhcChhhhc--CCCCCccccccccchhhhhhhcCCCCCCCC------------CHHHHHHHHHcCC-----
Confidence 1345788999999764 567889999999999999999999999643 2222222222211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
....... ...+.+++.+||+.||.+||++.
T Consensus 213 ----~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 ----LRLKPNI---SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCCCCCC---CHHHHHHHHHHhhcCHHhCCCCC
Confidence 0011111 33567888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.75 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=195.9
Q ss_pred HHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (288)
T cd05061 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVM 88 (288)
T ss_pred eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34578999999999999753 24589999986443 223456888999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 436 EYMPNGSLFWLLHGNRG-----PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
||+++|+|.+++..... .+....++..+.+++.|++.||+||| +++|+||||||+||++++++.++|+|||
T Consensus 89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999975321 12345688899999999999999999 8899999999999999999999999999
Q ss_pred CCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 511 LSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 511 ~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+++..... ...++..|+|||.+. +..++.++|||||||++|||++ |+.||... ...++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~DvwslG~~l~el~~~~~~p~~~~------------~~~~~ 230 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL------------SNEQV 230 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhc--cCCCChHhHHHHHHHHHHHHHhCCCCCCCCC------------CHHHH
Confidence 98754332 122355799999654 4578999999999999999998 78888532 11222
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.......... .. .......+.+++.+|++.||++|||+.|+++.|++..
T Consensus 231 ~~~~~~~~~~---------~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKFVMDGGYL---------DQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHcCCCC---------CC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2222211110 00 0112346888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.10 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=193.9
Q ss_pred HHhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 4567899999999999995 468999999987655445567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 92 SLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 999998643 35899999999999999999999 789999999999999999999999999998654322
Q ss_pred --CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++.. ....++.++|||||||++|||++|+.||....... .+...........
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------------~~~~~~~~~~~~~- 229 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------------ALFLMTKSNFQPP- 229 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------------hHHhhhccCCCCC-
Confidence 3457889999997632 23457889999999999999999999986432110 0111111111000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... .......+.+++.+|++.+|++||++.+|++
T Consensus 230 ---~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 ---KLKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ---cccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 0011234678888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.85 Aligned_cols=243 Identities=24% Similarity=0.335 Sum_probs=191.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||++... +++.||||++...... ....+.+|++++++++||||+++++++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 468999999999999954 6899999998753321 235678899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99998886432 245899999999999999999999 789999999999999999999999999999765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++||||+||++|||++|+.||...... ...+.+........
T Consensus 158 ~~~~~~~~~y~aPE~~~--~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---------~~~~~~~~~~~~~~----- 221 (285)
T cd05605 158 IRGRVGTVGYMAPEVVK--NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---------VKREEVERRVKEDQ----- 221 (285)
T ss_pred cccccCCCCccCcHHhc--CCCCCccccchhHHHHHHHHHHCCCCCCCCchh---------hHHHHHHHHhhhcc-----
Confidence 345688999999764 457889999999999999999999999753211 11111111111100
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
. .........+.+++.+||+.||++|| ++.++++
T Consensus 222 ----~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ----E--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ----c--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0 00112234577888999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.51 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=189.3
Q ss_pred HhcccCcCCeEEEEEEEE----cCCcEEEEEEcccCC----cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDAS----IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
+.+.||+|+||.||+++. .+|+.||+|++++.. ....+.+.+|++++..+ +|+||+++++++..++..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 357899999999999985 357899999986432 12345678899999999 599999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 84 LDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999998753 34899999999999999999999 78999999999999999999999999999975
Q ss_pred CCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 515 APPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 515 ~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.... ...+|..|+|||++.. ...++.++|||||||++|||+||+.||....... ...........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~~~~~~~~ 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--------TQSEVSRRILK 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcC-CCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--------CHHHHHHHHhc
Confidence 4322 3457889999997642 2347889999999999999999999997543211 11111111111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
. ++.. .. .....+.+++.+||+.||++|| +++++++
T Consensus 226 ~-------~~~~--~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 C-------DPPF--PS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C-------CCCC--CC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 1111 01 1223467788899999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.88 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=184.5
Q ss_pred HhcccCcCCeEEEEEEEEc--CCcEEEEEEcccCCc--chHHHHHHHHHHHcCC---CCCceeeeEEEEEc-----CCeE
Q 005880 364 SAEMLGKGGFGTAYKAVLD--DGSVVAVKRLKDASI--GGKREFEQHMEVLGRL---RHPNLVGLKAYYFA-----REEK 431 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~ 431 (672)
+.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+++++.+ +||||+++++++.. ....
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 3578999999999999853 478899999864322 2234566677766655 69999999999862 3467
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
++||||++ ++|.+++.... ...+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred EEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 89999996 69999987543 235899999999999999999999 78999999999999999999999999999
Q ss_pred CccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 512 SIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 512 a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
++..... ...++..|+|||++. +..++.++|||||||++|||++|++||...... +.+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~------------~~~~~i~ 222 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------------DQLGKIL 222 (290)
T ss_pred eEeccCCcccccccccccccChHHHh--CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH------------HHHHHHH
Confidence 9765432 345688999999764 457889999999999999999999999754321 1111111
Q ss_pred hh-------hccc------cccchhhcc-c-cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 RE-------EWTA------EVFDLELMR-Y-KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~-------~~~~------~~~d~~~~~-~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .+.. ..+...... . .........+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 10 0000 000000000 0 000012235678899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.60 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=194.6
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+++++.++||||+++++++..++..++||||++++
T Consensus 15 ~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (292)
T cd06644 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGG 94 (292)
T ss_pred hhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCC
Confidence 34578999999999999965 58999999998766556778899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|..++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 95 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 95 AVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred cHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9988876433 35899999999999999999999 889999999999999999999999999998654322
Q ss_pred --CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 --TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ....++.++|||||||++|||++|+.||.... ....+.......
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------------~~~~~~~~~~~~--- 231 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------------PMRVLLKIAKSE--- 231 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc------------HHHHHHHHhcCC---
Confidence 3346778999997643 23456889999999999999999999986431 111111111110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+... ........+.+++.+||..+|++||++.|+++
T Consensus 232 ---~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 ---PPTLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CccCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 01122345778889999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.09 Aligned_cols=235 Identities=27% Similarity=0.361 Sum_probs=185.6
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +|+.||+|.++... ......+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 68999999987532 12345567788887654 899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 9999998653 34889999999999999999999 88999999999999999999999999999874321
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~el~~g~~Pf~~~~------------~~~~~~~~~~~~----- 212 (316)
T cd05620 152 RASTFCGTPDYIAPEILQ--GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD------------EDELFESIRVDT----- 212 (316)
T ss_pred ceeccCCCcCccCHHHHc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCC-----
Confidence 2456789999999764 5578999999999999999999999996432 112222211110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS-HVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 635 (672)
+... .. ...++.+++.+||+.||++||++. +++
T Consensus 213 --~~~~--~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 --PHYP--RW---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCC--CC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000 11 123467788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=304.30 Aligned_cols=241 Identities=26% Similarity=0.427 Sum_probs=194.7
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|...++..+|+|.++.... ...++.+|++++++++|||++++++++......++||||+++++|
T Consensus 8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 3578999999999999987788999999875443 456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.++.....
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 87 SDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99997543 35889999999999999999999 789999999999999999999999999998755332
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....+.+|+|||.+. +..++.++||||||+++|||++ |+.||.... ............ ...
T Consensus 159 ~~~~~~~~~~aPe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------------~~~~~~~~~~~~---~~~ 221 (256)
T cd05112 159 TGTKFPVKWSSPEVFS--FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------------NSEVVETINAGF---RLY 221 (256)
T ss_pred CCCccchhhcCHhHhc--cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------------HHHHHHHHhCCC---CCC
Confidence 122345799999664 4678899999999999999998 999986432 112222221110 001
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
.+. .....+.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ~~~--------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPR--------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCC--------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111 1224688899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=304.34 Aligned_cols=240 Identities=28% Similarity=0.407 Sum_probs=194.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|... +|+.|++|.+... ......++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 467999999999999965 6899999998643 2335678899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.++++... ...+++..++.++.|+++||.||| +.+++||||||+||++++++.++|+|||+++.....
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999998643 246899999999999999999999 789999999999999999999999999998765443
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ............ ...
T Consensus 158 ~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~-~~~-- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCE--DKPYNEKSDVWALGVVLYECCTGKHPFDANN------------QGALILKIIRGV-FPP-- 220 (256)
T ss_pred hhccccCccccCHHHhc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHcCC-CCC--
Confidence 234677899999764 4568899999999999999999999996432 111111111110 000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........+.+++.+||+.+|++||++.++++
T Consensus 221 --------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 --------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --------CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 00123346888999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.88 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=195.6
Q ss_pred HHhcccCcCCeEEEEEEEEcC------CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD------GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++||||+++++++......++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEE
Confidence 345789999999999998642 3689999987543 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 436 EYMPNGSLFWLLHGNRGP-----GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
||+++|+|.+++...... ....++|..++.++.|++.||.||| +.+|+||||||+||++++++.+||+|||
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEECCcc
Confidence 999999999999754321 1235789999999999999999999 8899999999999999999999999999
Q ss_pred CCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 511 LSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 511 ~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+++..... ...++..|+|||.+. +..++.++|||||||++||++| |+.||.... ..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------------~~~~ 230 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS------------NEEV 230 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHh--cCCCCcccchHHHHHHHHHhhccCCCCCccCC------------HHHH
Confidence 98754332 223456899999654 4568899999999999999998 899985322 1111
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
..... ....... .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 ~~~~~-~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVI-DGGHLDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHh-cCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 1110000 0112446788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=321.52 Aligned_cols=240 Identities=26% Similarity=0.374 Sum_probs=193.9
Q ss_pred ccCHHHHHHHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCC-CCCceeeeEEEEEcC
Q 005880 354 RFELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRL-RHPNLVGLKAYYFAR 428 (672)
Q Consensus 354 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 428 (672)
++.+++. .+..+||+|.||+|+++..+ +++.+|||.+++..+- +.+..+.|-+++... +||.++.++.+|...
T Consensus 364 ~~~l~~F--~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDF--RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccce--EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 3444443 34578999999999999965 5889999999976543 345567777777666 699999999999999
Q ss_pred CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEec
Q 005880 429 EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 429 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
++.|.||||+.||++..+.+. ..+++..+.-++..|+.||.||| +++||+||||.+|||+|.+|++||+|
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred CeEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEecc
Confidence 999999999999996555443 34899999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCC-----CCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 509 FGLSIFAP-----PSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 509 fG~a~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
||+++..- .++.+||+.|+|||++. +..|+.++|.|||||+||||+.|..||.+++++ +.+
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~--e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------e~F 577 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLT--EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------EVF 577 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhc--cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------HHH
Confidence 99998654 23788999999999886 569999999999999999999999999866433 233
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
..+..++. .-+.. ...+.+.++.+++.++|++|.-+
T Consensus 578 dsI~~d~~---------~yP~~---ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEV---------RYPRF---LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCC---------CCCCc---ccHHHHHHHHHHhccCcccccCC
Confidence 33333321 11122 23456677779999999999876
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.00 Aligned_cols=259 Identities=26% Similarity=0.347 Sum_probs=196.4
Q ss_pred HHHhcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEE
Q 005880 362 RASAEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLL 433 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 433 (672)
+.+.+.||+|+||.||++.+ .++..||+|.++... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 45567899999999999984 357889999987543 23456799999999999999999999998875 56789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||+++++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999996542 35899999999999999999999 8899999999999999999999999999997
Q ss_pred cCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC--CCC-CCCCCChhHH
Q 005880 514 FAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA--GMG-CGGAVDLPRW 582 (672)
Q Consensus 514 ~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~--~~~-~~~~~~~~~~ 582 (672)
..... ...++..|+|||++. +..++.++|||||||++|||+|++.|+....... ... .........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLI--QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhc--cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 65432 233455799999764 4578899999999999999999887653221100 000 0001111111
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
+.. ...... .+........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 236 ~~~-~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRV-LEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHH-HHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111 111100 000112334688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.90 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=194.7
Q ss_pred HhcccCcCCeEEEEEEEEcC-----------------CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-----------------GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
+.+.||+|+||.||+|...+ +..||+|.+.... ....+++.+|++++++++||||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 45789999999999998542 2468999987543 23466889999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRGP------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD 499 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~ 499 (672)
..++..++||||+++++|.+++...... ....+++..++.++.|+++||+||| +.+|+||||||+||+++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATRNCLVG 164 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchhceeec
Confidence 9999999999999999999999765421 1236899999999999999999999 78999999999999999
Q ss_pred CCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 005880 500 KTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT--GKCPSVIDGGGAG 570 (672)
Q Consensus 500 ~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t--g~~P~~~~~~~~~ 570 (672)
.++.++|+|||+++..... ...++..|+|||.+. +..++.++|||||||++|||++ |..||.....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL--LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--- 239 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh--cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---
Confidence 9999999999998754332 223456799999654 4578999999999999999998 6777753211
Q ss_pred CCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 571 MGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
...........+......... .......++.+++.+||+.||++|||+.||++.|+
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ------QQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ------HHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 011111111111100000000 01112346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=303.49 Aligned_cols=245 Identities=31% Similarity=0.434 Sum_probs=197.7
Q ss_pred cccCcCCeEEEEEEEEcC----CcEEEEEEcccCCcch-HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASIGG-KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7899999998654433 67899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 441 GSLFWLLHGNRGP----GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 441 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
++|.+++...... ....+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999865210 1256899999999999999999999 8899999999999999999999999999998765
Q ss_pred CC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 PS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.. ...++..|+|||.+. ...++.++||||+|+++|||++ |+.||.... ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------------~~~~~~~~~~ 222 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------------NEEVLEYLRK 222 (262)
T ss_pred cccccccccCCCcCccccCHHHhc--cCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------------HHHHHHHHHc
Confidence 43 234567899999664 4478999999999999999999 699986431 1222222221
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.. . . ........++.+++.+||+.+|.+|||+.|+++.|+
T Consensus 223 ~~-~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GY-R-------L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC-C-------C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 10 0 0 001122356888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.25 Aligned_cols=239 Identities=23% Similarity=0.342 Sum_probs=187.9
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999954 578999999975432 2345678899998888 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|..++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 9999988644 34899999999999999999999 78999999999999999999999999999875321
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||....... .....++..........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~--- 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILR--GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP------DMNTEDYLFQVILEKPI--- 220 (327)
T ss_pred ceecccCCcccCCHHHHC--CCCCCchheeehhHHHHHHHHhCCCCCCccCCCc------ccccHHHHHHHHHhCCC---
Confidence 1456789999999764 5678899999999999999999999996432211 11222333322222110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
..... ....+.+++.+||+.||++||++.
T Consensus 221 -----~~p~~---~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 -----RIPRF---LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -----CCCCC---CCHHHHHHHHHHhccCHHHcCCCC
Confidence 00111 123466788899999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=307.23 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=193.5
Q ss_pred HhcccCcCCeEEEEEEEEcC------CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLDD------GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|+||.||+|...+ +..||+|.+..... .....|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 34789999999999999653 57899998875432 245678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEeccCC
Q 005880 437 YMPNGSLFWLLHGNRG--PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVSDFGL 511 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~ 511 (672)
|+++|+|.++++.... .....+++..+++++.|+++||+||| +.+++||||||+||+++.++ .+||+|||+
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999976542 11235899999999999999999999 78999999999999998654 599999999
Q ss_pred CccCCCCC-------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPST-------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~~-------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++...... ...+..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~~g~~pf~~~~------------~~~~~ 231 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------------NQEVM 231 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------------HHHHH
Confidence 98663321 12235799999764 4678999999999999999997 999986432 11222
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
......... ... ......+.+++.+|++.+|++||++.+|++.|+
T Consensus 232 ~~~~~~~~~--------~~~---~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGGGRL--------DPP---KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCcC--------CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 221111100 000 112346788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.12 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=195.8
Q ss_pred HHhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
...+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 45678999999999999742 345799999875432 2356789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++|+|.++++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++.
T Consensus 118 ~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999975432 33899999999999999999999 78999999999999999999999999999975
Q ss_pred CCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 515 APPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 515 ~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
.... ...++..|+|||.+. +..++.++|||||||++|||++ |+.||...... .-....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------------~~~~~~ 256 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------------SKFYKL 256 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhc--cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------------HHHHHH
Confidence 5432 123456799999664 4568899999999999999998 99998643211 111111
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
....... .... .....+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 257 ~~~~~~~-------~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRM-------AQPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcC-------CCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111100 0001 1124578888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.10 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=189.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 4578999999999999965 58899999986422 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999643 3788999999999999999999 889999999999999999999999999999765432
Q ss_pred -----CCCCCCcccCCCccccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 -----TVPRSNGYRAPELSSSDG--RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~--~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...+|..|+|||++.... ..++.++||||+||++|||++|+.||.... .......+.....
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~------------~~~~~~~i~~~~~ 264 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS------------LVGTYSKIMDHKN 264 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCc
Confidence 445889999999875432 347889999999999999999999996432 1222222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPD--QRPNMSHVVKL 637 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~--~RPt~~evl~~ 637 (672)
... .+........+.+++..|+..++. .||++.|+++.
T Consensus 265 ~~~--------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLN--------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccC--------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 011011223456677788875554 38899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=306.27 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=193.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCc----EEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGS----VVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.++||+|+||.||+|.+ .+|. .||+|.++... ....+++.+|+.++..++||||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 47899999999999984 3454 48999987543 2345678899999999999999999999875 4567999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.++++... ..+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 91 PYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 9999999997543 35899999999999999999999 889999999999999999999999999999766432
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++..|+|||.+. +..++.++|||||||++|||++ |..||..... ..+..++ ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~----~~~ 227 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLL----EKG 227 (279)
T ss_pred cceeecCCCccchhhCCHHHhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHH----HCC
Confidence 122345799999654 5578999999999999999998 8999854221 1111111 111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
... .........+.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ERL----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CcC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000 000122346788899999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.12 Aligned_cols=242 Identities=21% Similarity=0.304 Sum_probs=187.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 47899999999999995 4689999999975332 2345788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999997543 4889999999999999999999 78999999999999999999999999999753210
Q ss_pred -------------------------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHH
Q 005880 518 -------------------------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSF 548 (672)
Q Consensus 518 -------------------------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~ 548 (672)
....||..|+|||++. +..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL--RKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc--CCCCCCccceeeh
Confidence 1235788999999764 4568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHh--ccCCCCC
Q 005880 549 GVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMA--CTSASPD 626 (672)
Q Consensus 549 Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~--Cl~~dP~ 626 (672)
||++|||+||+.||...... ........... .. ......... .++.+++.+ |+..+|.
T Consensus 235 G~il~elltG~~Pf~~~~~~------------~~~~~i~~~~~--~~---~~~~~~~~s---~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT------------ETQLKVINWEN--TL---HIPPQVKLS---PEAVDLITKLCCSAEERL 294 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH------------HHHHHHHcccc--cc---CCCCCCCCC---HHHHHHHHHHccCccccc
Confidence 99999999999999643211 11111111000 00 000111112 234555655 6677777
Q ss_pred CCCCHHHHHHH
Q 005880 627 QRPNMSHVVKL 637 (672)
Q Consensus 627 ~RPt~~evl~~ 637 (672)
.||++.|+++.
T Consensus 295 ~R~~~~~~l~h 305 (381)
T cd05626 295 GRNGADDIKAH 305 (381)
T ss_pred CCCCHHHHhcC
Confidence 89999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=325.03 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 478999999999999965 68999999987532 13456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 86 GDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999754 34899999999999999999999 789999999999999999999999999998755432
Q ss_pred --------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 519 --------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 519 --------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR--GTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHc--CCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 235788999999765 4578999999999999999999999996432
Q ss_pred CCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 005880 567 GGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-MSHVVKL 637 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~ 637 (672)
.......+.... ... ..... ......+.+++.+|+. ||.+||+ +.|+++.
T Consensus 235 ------------~~~~~~~i~~~~--~~~---~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ------------LQETYNKIINWK--ESL---RFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------------HHHHHHHHhccC--Ccc---cCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111122221100 000 00000 1123457788889997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.37 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=191.6
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
..||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999954 67889999988766556778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCCCC---
Q 005880 445 WLLHGNRGPGRTPL--DWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~--- 518 (672)
+++.... .++ ++..+..++.|+++||+||| +.+|+||||||+||+++. ++.++|+|||++......
T Consensus 94 ~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 94 ALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 9997543 224 78889999999999999999 789999999999999986 679999999998755332
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++......++.++||||||+++|||++|+.||...... ....+.......
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~------- 229 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---------QAAMFKVGMFKI------- 229 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---------hhhHhhhhhhcc-------
Confidence 23467889999987544445789999999999999999999998642211 001110000000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+.. . .....++.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~~~~--~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEI--P---ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCC--C---cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000 0 112245778888999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=306.76 Aligned_cols=244 Identities=27% Similarity=0.420 Sum_probs=191.1
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|+. .+++.||+|.+... .....+++.+|++++++++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 357899999999999995 56899999998644 2334567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|..+. .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred ChHHhh---------cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence 996542 2678899999999999999999 889999999999999999999999999999765433
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||........ ......+......+. .+
T Consensus 152 ~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~------~~ 218 (279)
T cd06619 152 TYVGTNAYMAPERIS--GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-----SLMPLQLLQCIVDED------PP 218 (279)
T ss_pred CCCCChhhcCceeec--CCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-----ccchHHHHHHHhccC------CC
Confidence 446788999999764 45788999999999999999999999965322110 011111111111111 00
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.... .....++.+++.+|++.+|++||+++|+++.
T Consensus 219 ~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 1122357788889999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.42 Aligned_cols=240 Identities=29% Similarity=0.433 Sum_probs=198.3
Q ss_pred cccCcCCeEEEEEEE-EcCCcEEEEEEcccC---CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..||.|+||.||-|+ ..+.+.||||++.-. +.....++.+|++.|.+++|||++.+-|+|..+...||||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 459999999999999 557899999998743 3335678999999999999999999999999999999999999 66
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-CC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-TV 520 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 520 (672)
+-.+++.-.+ .++.+.++..|+.+.+.||+||| +++.||||||+.|||+++.|.+||+|||.|....+. ..
T Consensus 111 SAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF 182 (948)
T KOG0577|consen 111 SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF 182 (948)
T ss_pred cHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence 8888887654 57999999999999999999999 899999999999999999999999999999877765 78
Q ss_pred CCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 521 PRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 521 ~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
+||+.|||||++.. +.+.|+-|+||||+|++..||.-.++|....+.- ...+. +..++ .|.
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----------SALYH-IAQNe------sPt 244 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYH-IAQNE------SPT 244 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----------HHHHH-HHhcC------CCC
Confidence 99999999998753 5678999999999999999999999998654311 00000 00110 011
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+. ..+....+.+++..||++-|.+|||..++++
T Consensus 245 Lq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11 1345556788888999999999999988764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.17 Aligned_cols=237 Identities=23% Similarity=0.357 Sum_probs=185.8
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHH-HHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHME-VLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999954 68999999986432 123345555554 46779999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|..++... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 9999888643 35899999999999999999999 78999999999999999999999999999875322
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~G~~pf~~~~------------~~~~~~~~~~~~----- 212 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIR--KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------------VAEMYDNILHKP----- 212 (325)
T ss_pred CcccccCChhhCCHHHHc--CCCCCCcCccccccceehhhhcCCCCCCCCC------------HHHHHHHHHcCC-----
Confidence 1345788999999764 5578899999999999999999999996432 222222222211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
....+. ....+.+++.+|++.+|.+||++.+.++.
T Consensus 213 ----~~~~~~---~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 213 ----LVLRPG---ASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred ----ccCCCC---CCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 000111 22346678889999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.14 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=198.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.++||+|+||.||+|+.. +|+.||+|+++.... ...+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 478999999999999965 589999999975322 2356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 441 GSLFWLLHGNRG------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 441 g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|+|.+++..... ......++..+++++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 999999864221 11234678889999999999999999 78999999999999999999999999999976
Q ss_pred CCC-----------------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005880 515 APP-----------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM 571 (672)
Q Consensus 515 ~~~-----------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~ 571 (672)
... ....||..|+|||++. +..++.++|||||||++|||+||+.||.......
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~--g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-- 238 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL--GVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-- 238 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhc--CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence 511 1235788999999654 5678999999999999999999999996532111
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHhcCCC
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-NMSHVVKLIEELRGVEV 646 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~~~ 646 (672)
.. ... ...++... ....+....+.+++.+|++.||++|| +++++++.|+...+...
T Consensus 239 -------i~-------~~~---~i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 -------IS-------YRD---VILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred -------hh-------hhh---hccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 00 000 00010000 00012234577888899999999996 67888888888765433
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.19 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=195.5
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|... ++..||+|.+..... ....++.+|++++++++||||+++++++.+++..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 3478999999999999853 467899999875432 345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC
Q 005880 437 YMPNGSLFWLLHGNRG-----------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD 499 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~ 499 (672)
|+++|+|.+++..... .....+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATRNCLVG 164 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHhheEec
Confidence 9999999999974321 11235789999999999999999999 78999999999999999
Q ss_pred CCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005880 500 KTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGM 571 (672)
Q Consensus 500 ~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~ 571 (672)
+++.++|+|||++...... ....+..|+|||.+. +..++.++|||||||++|||++ |..||...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~~~~~p~~~~------ 236 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGMQPYYGM------ 236 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHh--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------
Confidence 9999999999998754322 222345799999653 5678999999999999999998 88888532
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
...++.......... . .......++.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ------~~~~~~~~~~~~~~~---------~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 ------AHEEVIYYVRDGNVL---------S--CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------CHHHHHHHHhcCCCC---------C--CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 222222222211110 0 001123467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.18 Aligned_cols=245 Identities=24% Similarity=0.435 Sum_probs=194.6
Q ss_pred HhcccCcCCeEEEEEEEEc-C---CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-D---GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|+.. + +..+|+|.++.... ...+.+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 4578999999999999853 2 34799999875432 24568899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999997543 35899999999999999999999 889999999999999999999999999999765432
Q ss_pred C--------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 T--------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ~--------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...+..|+|||.+. +..++.++||||||+++||+++ |+.||..... .+........
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------------~~~~~~~~~~ 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------------QDVIKAIEEG 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhc--cCccCchhhhHHHHHHHHHHhcCCCCCcccCCH------------HHHHHHHhCC
Confidence 1 11234699999664 4578999999999999999886 9999864321 1111111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.. .+........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 226 -~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 -YR----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -Cc----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 000111234577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=304.76 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=187.4
Q ss_pred ccCcCCeEEEEEEEEcCC---cEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 367 MLGKGGFGTAYKAVLDDG---SVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.||+|+||.||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985443 356677765433 2356789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 517 (672)
|.++++.... .....++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999976432 1234677888999999999999999 78999999999999999999999999999864321
Q ss_pred --CCCCCCCcccCCCccccC-----CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 --STVPRSNGYRAPELSSSD-----GRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~-----~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
....++..|+|||++... ...++.++|||||||++|||++ |..||... ...+.......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~------------~~~~~~~~~~~~ 224 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL------------SDREVLNHVIKD 224 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHHhh
Confidence 234567789999976421 2345789999999999999997 46677432 122233333322
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.. ....++.... .....+.+++..|| .+|++||+++||++.|.
T Consensus 225 ~~-~~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 QQ-VKLFKPQLEL-----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cc-cccCCCccCC-----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 21 2222222211 12234667778999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.34 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=195.0
Q ss_pred HhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
..+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 45789999999999999643 2468999887544 3456689999999999999999999998865 5578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999997543 35899999999999999999999 789999999999999999999999999998765433
Q ss_pred C------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 T------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ~------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
. ..++..|+|||.+. ...++.++||||||+++||+++ |+.||..... .+..........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------------~~~~~~~~~~~~ 226 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN------------NDVIGRIENGER 226 (270)
T ss_pred cceecCCCCccccccChhhhc--cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHHcCCc
Confidence 1 12235799999653 4578899999999999999996 9999964321 111111111110
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
. ... ......+.+++.+|+..+|.+|||+.++++.|+++...
T Consensus 227 ~--------~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 L--------PMP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C--------CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 001 12234678888899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.02 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=193.9
Q ss_pred HhcccCcCCeEEEEEEEEc-----------------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-----------------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
+.+.||+|+||.||++... ++..||+|.++... .....++.+|++++++++|+||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4578999999999998632 24579999997543 33456899999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRGP------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD 499 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~ 499 (672)
...+..++||||+++|+|.+++...... ....+++.++..++.|++.||+||| +.+++||||||+||+++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRNCLVG 164 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChheEEEc
Confidence 9999999999999999999999764321 1235788999999999999999999 78999999999999999
Q ss_pred CCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 005880 500 KTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT--GKCPSVIDGGGAG 570 (672)
Q Consensus 500 ~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t--g~~P~~~~~~~~~ 570 (672)
+++.++|+|||+++..... ....+..|+|||... +..++.++|||||||++|||++ |..||......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-- 240 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-- 240 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh--cCCccchhhhhHHHHHHHHHHHhCCCCCccccChH--
Confidence 9999999999999765332 122245799999653 4578999999999999999998 67887533211
Q ss_pred CCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 571 MGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
................. ..+. .......+.+++.+||+.||.+||++.||++.|++
T Consensus 241 -------~~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 -------QVIENTGEFFRDQGRQV-YLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -------HHHHHHHHHHhhccccc-cCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111110000 0000 11123568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=289.70 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=195.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc-----c---hHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI-----G---GKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-----~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
.+.||.|..+.|.++.. .+|..+|+|++..... . -.+.-.+|+.+|+++ .||+|+++.++|..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 46799999999999884 4688999998853211 1 123456799999998 699999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+|.|+.|.|+++|... ..+++....+|+.|+.+|++||| ..+||||||||+|||+|++.++||+|||+++.
T Consensus 102 Fdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999754 46999999999999999999999 88999999999999999999999999999998
Q ss_pred CCCC----CCCCCCcccCCCcccc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 515 APPS----TVPRSNGYRAPELSSS----DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~----~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
+.++ ..+||+||.|||.+.- ....|+..+|+||+|||+|.|+.|.+||.... -.-.++.+
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------------QmlMLR~I 240 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------------QMLMLRMI 240 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------------HHHHHHHH
Confidence 8876 6789999999997643 34568889999999999999999999995321 01111112
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... .- +.+...+......+||.+||+.||.+|.|++|+++
T Consensus 241 meGky-----qF---~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGKY-----QF---RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhccc-----cc---CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22211 11 11223344455777888999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.43 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=185.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--------CeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--------EEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv 434 (672)
..+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 3578999999999999964 68999999885432 2345799999999999999999987532 135689
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSI 513 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~ 513 (672)
|||+++ +|.+++..... ....+++..+..++.|+++||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 146 mE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 999975 77777653221 2246899999999999999999999 88999999999999999664 79999999998
Q ss_pred cCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH---
Q 005880 514 FAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV--- 586 (672)
Q Consensus 514 ~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 586 (672)
..... ...+|..|+|||++.. ...++.++|||||||++|||++|++||......+ .+...++..
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--------~~~~i~~~~~~p 290 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--------QLVRIIQVLGTP 290 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhCCC
Confidence 65432 3456889999997642 3468999999999999999999999997542211 011110000
Q ss_pred -------HhhhccccccchhhccccCh-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHh
Q 005880 587 -------VREEWTAEVFDLELMRYKDI-----EEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELR 642 (672)
Q Consensus 587 -------~~~~~~~~~~d~~~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~ 642 (672)
.........+. .. ..... .....++.+++.+||..||.+|||+.|+++ .++.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~-~~-~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFP-DV-KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CHHHHHHhchhhhcccCC-cc-CchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00000000000 00 00000 012246788899999999999999999983 344443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=326.16 Aligned_cols=240 Identities=22% Similarity=0.315 Sum_probs=188.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 478999999999999965 68999999997532 22345678899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 86 GDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred cHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999754 24899999999999999999999 889999999999999999999999999998643211
Q ss_pred -----------------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh
Q 005880 519 -----------------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557 (672)
Q Consensus 519 -----------------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t 557 (672)
...||..|+|||++. ...++.++|||||||++|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--QTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc--CCCCCCeeeeecchhHHHHhhc
Confidence 134788999999764 4578899999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 005880 558 GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN---MSHV 634 (672)
Q Consensus 558 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~ev 634 (672)
|+.||.... ..+.............. + ..... ...+.+++.+|+. +|.+|++ +.|+
T Consensus 235 G~~Pf~~~~------------~~~~~~~i~~~~~~~~~--~---~~~~~---s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 235 GYPPFCSDN------------PQETYRKIINWKETLQF--P---DEVPL---SPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCCCCCCC------------HHHHHHHHHcCCCccCC--C---CCCCC---CHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 999996432 11122222111100000 0 00011 2345677778886 9999998 8888
Q ss_pred HH
Q 005880 635 VK 636 (672)
Q Consensus 635 l~ 636 (672)
++
T Consensus 294 l~ 295 (364)
T cd05599 294 KS 295 (364)
T ss_pred hc
Confidence 76
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.30 Aligned_cols=236 Identities=24% Similarity=0.345 Sum_probs=184.2
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHH-HHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHM-EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999965 578899999874321 1223444444 456788999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++.... .+.+.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999997542 4778888999999999999999 88999999999999999999999999999875322
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~------------~~~~~~~i~~~~----- 212 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------------TAEMYDNILNKP----- 212 (325)
T ss_pred CcccccCCccccCHHHHc--CCCCCCccccccccHHHHHHhcCCCCCCCCC------------HHHHHHHHHhCC-----
Confidence 1345789999999764 5678899999999999999999999996432 222222222211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+. ....+.+++.+|++.||.+||++.+.+.
T Consensus 213 ----~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 213 ----LQLKPN---ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----cCCCCC---CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 000111 2234677888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.23 Aligned_cols=233 Identities=25% Similarity=0.315 Sum_probs=184.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCC-ceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHP-NLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..++|+ +|+++++++.+.+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 3578999999999999965 57899999987532 22445678899999999765 6888999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP- 517 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 517 (672)
++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 84 NGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999998654 34889999999999999999999 78999999999999999999999999999864321
Q ss_pred ----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 ----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
....+|..|+|||++. +..++.++|||||||++|||+||+.||.... ..+....+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~pf~~~~------------~~~~~~~i~~~~--- 217 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------------EDELFQSIMEHN--- 217 (324)
T ss_pred CCceeeecCCccccChhhhc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCC------------HHHHHHHHHcCC---
Confidence 1345789999999764 4578899999999999999999999996432 112222222111
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
...... ...++.+++.+||..||.+|++.
T Consensus 218 ------~~~~~~---~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ------VSYPKS---LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCC---CCHHHHHHHHHHhhcCHHHcCCC
Confidence 000111 12356788889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.15 Aligned_cols=240 Identities=24% Similarity=0.392 Sum_probs=193.5
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 347899999999999995 5789999999976555566778999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 103 LTDVVTET------CMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 99998643 3789999999999999999999 789999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+. +..++.++|||||||++|+|++|+.||........ ........ .
T Consensus 173 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------------~~~~~~~~------~ 232 (297)
T cd06656 173 STMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------------LYLIATNG------T 232 (297)
T ss_pred CcccCCccccCHHHHc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------------eeeeccCC------C
Confidence 335677899999654 46778999999999999999999999965432110 00000000 0
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.. .........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PEL---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 001122234677888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=311.34 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=197.6
Q ss_pred HHHhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeE
Q 005880 362 RASAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEK 431 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 431 (672)
..+.+.||+|+||.||+|... ....||+|.++... .....++.+|++++.++ +||||+++++++..++..
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 345688999999999999742 24579999987543 23456788999999999 699999999999998999
Q ss_pred EEEEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK 500 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~ 500 (672)
++||||+++|+|.+++..... .....+++.++.+++.|++.||.||| +.+|+||||||+||++++
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVLVTE 169 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEEEcC
Confidence 999999999999999975431 11245899999999999999999999 789999999999999999
Q ss_pred CCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005880 501 TGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMG 572 (672)
Q Consensus 501 ~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~ 572 (672)
++.+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||++ |+.||...
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~~g~~p~~~~------- 240 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSPYPGI------- 240 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHc--cCCcCccchhhHHHHHHHHHHhCCCCCCCCC-------
Confidence 999999999999765432 112234699999764 4578899999999999999999 88888532
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
...+..... ....... . ......++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 241 -----~~~~~~~~~-~~~~~~~-------~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 241 -----PVEELFKLL-REGHRMD-------K---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -----CHHHHHHHH-HcCCCCC-------C---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111222211 1111000 0 01123357788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.15 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=194.8
Q ss_pred HHHhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcC-CeEE
Q 005880 362 RASAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR-EEKL 432 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~ 432 (672)
+.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|++++.++ +||||+++++++... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 35668899999999999973 3478999999975432 2345788999999999 689999999988654 4578
Q ss_pred EEEeecCCCChhHHhhcCCCC-----------------------------------------------------------
Q 005880 433 LVSEYMPNGSLFWLLHGNRGP----------------------------------------------------------- 453 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------- 453 (672)
+||||+++|+|.++++.....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998753210
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-------CCCCC
Q 005880 454 ---GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRS 523 (672)
Q Consensus 454 ---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t 523 (672)
....+++..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||++...... ...++
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 0124788999999999999999999 889999999999999999999999999998764322 22334
Q ss_pred CcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhcc
Q 005880 524 NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMR 602 (672)
Q Consensus 524 ~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 602 (672)
..|+|||++. +..++.++||||||+++|||++ |..||..... .........+..... .
T Consensus 245 ~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~~-------~ 303 (343)
T cd05103 245 LKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------------DEEFCRRLKEGTRMR-------A 303 (343)
T ss_pred cceECcHHhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc------------cHHHHHHHhccCCCC-------C
Confidence 5799999764 4578899999999999999997 8999854211 011111111111100 0
Q ss_pred ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 603 YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 603 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. ....++.+++..||+.||++|||+.||++.|+.+.+
T Consensus 304 ~~---~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 112357888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.96 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=189.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcC------CeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR------EEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~~~lv~ 435 (672)
..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++... ...++||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 4567999999999999954 58899999986543 2456788999999998 799999999998753 4578999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 89 EFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999997643 245899999999999999999999 789999999999999999999999999998765
Q ss_pred CCC-----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 516 PPS-----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 516 ~~~-----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
... ...++..|+|||++... ...++.++|||||||++|||++|+.||..... ...+. ..
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----------~~~~~-~~- 228 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALF-LI- 228 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----------HHHHH-HH-
Confidence 432 34567789999987532 34678899999999999999999999853211 11111 00
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ..... . ......+.+++.+||..+|.+|||+.|+++
T Consensus 229 ~~~~-----~~~~~-~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNP-----APRLK-S---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCC-----CCCCC-C---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 00000 0 112235778888999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.72 Aligned_cols=241 Identities=27% Similarity=0.432 Sum_probs=194.2
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
++||+|+||.||++...+++.||+|.++..... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999777999999998765443 4578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..+++..+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9997543 35789999999999999999999 789999999999999999999999999998765422
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....+..|+|||.+. +..++.++|||||||++|||+| |..||..... ....... ....
T Consensus 153 ~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------------~~~~~~~-~~~~----- 212 (251)
T cd05041 153 GLKQIPIKWTAPEALN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------------QQTRERI-ESGY----- 212 (251)
T ss_pred ccCcceeccCChHhhc--cCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------------HHHHHHH-hcCC-----
Confidence 112245699999654 4578899999999999999999 8888854321 1111111 1110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
. ..........+.+++.+|++.+|.+|||+.||++.|+
T Consensus 213 --~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 --R---MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0 0001122346888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=304.12 Aligned_cols=245 Identities=25% Similarity=0.460 Sum_probs=194.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CC---cEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DG---SVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|... ++ ..||||.++... .....+|..|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 4578999999999999964 33 369999987542 334568999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999997543 35899999999999999999999 789999999999999999999999999998755432
Q ss_pred C----C---C---CCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 519 T----V---P---RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 519 ~----~---~---~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
. . . .+..|+|||.+. +..++.++|||||||++||+++ |..||.... ..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~------------~~~~~~~i~ 225 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------------NQDVINAIE 225 (269)
T ss_pred ccccccccccCCCcceeecCHhHhc--cCcccchhhhhhhHHHHHHHhcCCCCCCCCCC------------HHHHHHHHH
Confidence 1 1 1 124699999654 5678899999999999999886 999986431 111111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.. . .. +...+....+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 226 ~~-~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QD-Y-------RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cC-C-------cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 0 00 01112334577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.38 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=190.3
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-----eEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-----EKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 435 (672)
..+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 357899999999999995 47899999998653 2234567889999999999999999999998776 789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+. ++|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9996 5888877543 35899999999999999999999 789999999999999999999999999999765
Q ss_pred CCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCCCCChhHHHHH
Q 005880 516 PPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG----CGGAVDLPRWVQS 585 (672)
Q Consensus 516 ~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~~~~ 585 (672)
... ...++..|+|||++.. ...++.++|||||||++|||++|+.||.......... ..+......+...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMG-SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcC-CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 432 2345778999997653 2457899999999999999999999997543211000 0000001000000
Q ss_pred H--Hhhhccccccchh-hc-cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 586 V--VREEWTAEVFDLE-LM-RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 586 ~--~~~~~~~~~~d~~-~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. ...........+. .. ..........++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000000000 00 000001113457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=312.13 Aligned_cols=193 Identities=22% Similarity=0.399 Sum_probs=158.3
Q ss_pred hcccCcCCeEEEEEEEEc---CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD---DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 439 (672)
+.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999965 35789999987543 23567889999999999999999999864 456789999986
Q ss_pred CCChhHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe----CCCCcEEEeccCC
Q 005880 440 NGSLFWLLHGNRG----PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGL 511 (672)
Q Consensus 440 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~ 511 (672)
++|.+++..... .....+++..+..++.|+++||.||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 478777753221 12235899999999999999999999 7899999999999999 4667899999999
Q ss_pred CccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 512 SIFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 512 a~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
++..... ...+|..|+|||++.. ...++.++|||||||++|||+||++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcC-CCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9765432 2345788999997642 346789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.45 Aligned_cols=232 Identities=27% Similarity=0.396 Sum_probs=182.7
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHH-HHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHME-VLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 689999999864322 12334555554 67889999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|..++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 9999888643 34788999999999999999999 78999999999999999999999999999875322
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....++..|+|||++. +..++.++|||||||++|||++|+.||... +............
T Consensus 152 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~------------~~~~~~~~i~~~~----- 212 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLR--KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------DVSQMYDNILHKP----- 212 (321)
T ss_pred ccccccCCcccCCHHHhc--CCCCCCcCcccccchhhhhhhcCCCCCCCC------------CHHHHHHHHhcCC-----
Confidence 1345788999999764 457889999999999999999999999643 2222222222211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
..... .....+.+++.+||+.||.+||++.
T Consensus 213 ----~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ----LQLPG---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----CCCCC---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00011 1223577888899999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=309.16 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||.|++|.||+|.. .+|+.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 36799999999999984 57899999998765555667889999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... .+++.++..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9998643 4899999999999999999999 889999999999999999999999999998765432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||.+. +..++.++|||||||++|+|++|+.||..... ........... ...
T Consensus 174 ~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------------~~~~~~~~~~~-~~~---- 234 (296)
T cd06655 174 TMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------------LRALYLIATNG-TPE---- 234 (296)
T ss_pred CcCCCccccCcchhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhcC-Ccc----
Confidence 235677899999654 45688999999999999999999999964321 11111111110 000
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .......+.+++.+||..||++||++.++++
T Consensus 235 -~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -LQN---PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cCC---cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 001 1112335778888999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.20 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=195.5
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||++++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 45677999999999999964 68999999987665556678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 88 ~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 88 ALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 9999987543 35899999999999999999999 789999999999999999999999999988654332
Q ss_pred --CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 --TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ....++.++||||||+++|||++|+.||.... ..+..........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~~-- 225 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN------------PMRVLLKILKSEP-- 225 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC------------HHHHHHHHhcCCC--
Confidence 2346788999997642 23457789999999999999999999986431 1111111111100
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.... .......+.+++.+||+.+|.+||++.++++
T Consensus 226 ----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 ----PTLDQ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ----CCcCC---cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00000 0112235778888999999999999999965
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.57 Aligned_cols=241 Identities=22% Similarity=0.316 Sum_probs=187.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 47899999999999985 468999999986432 22345688899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 86 GDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999754 34889999999999999999999 889999999999999999999999999998632110
Q ss_pred --------------------------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHH
Q 005880 519 --------------------------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSF 548 (672)
Q Consensus 519 --------------------------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~ 548 (672)
...||..|+|||++. +..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSl 234 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--QQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc--cCCCCCceeeEec
Confidence 135788999999764 4578999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCC
Q 005880 549 GVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR 628 (672)
Q Consensus 549 Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 628 (672)
||++|||++|+.||..... .+....+..... ... .+........+.+++.+|+. +|.+|
T Consensus 235 Gvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~--~~~------~p~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS------------HETYRKIINWRE--TLY------FPDDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred chhhhhhhcCCCCCCCCCH------------HHHHHHHHccCC--ccC------CCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence 9999999999999964321 111222211100 000 01001112346677789997 77665
Q ss_pred ---CCHHHHHHH
Q 005880 629 ---PNMSHVVKL 637 (672)
Q Consensus 629 ---Pt~~evl~~ 637 (672)
+++.|+++.
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 599988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=310.46 Aligned_cols=258 Identities=19% Similarity=0.299 Sum_probs=189.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 478999999999999965 678999999874332 2345678899999999999999999999999999999999975 8
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 90 LKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 888876542 34789999999999999999999 789999999999999999999999999998754322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCC----CCCCChhHHHHHHHhhhccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGC----GGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ...++.++|||||||++|||+||+.||......+.... .+......| .......
T Consensus 162 ~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--- 236 (309)
T cd07872 162 SNEVVTLWYRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW-PGISSND--- 236 (309)
T ss_pred ccccccccccCCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH-hhhcchh---
Confidence 3346788999997643 35678999999999999999999999965432110000 000000000 0000000
Q ss_pred cccchhhccc------cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRY------KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+...... ........++.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000112235678888999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=310.83 Aligned_cols=190 Identities=25% Similarity=0.390 Sum_probs=165.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||++... +|..+|+|.++... .....++.+|++++.+++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 3478999999999999954 68889999887542 223467889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.++++.. ..+++..+..++.|+++||+||| + .+++||||||+||++++++.+||+|||++......
T Consensus 85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence 999999754 34889999999999999999999 4 58999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 156 NSFVGTRSYMSPERLQ--GTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ccCCCCcCccChhHhc--CCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 445678999999753 55788999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=306.91 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=198.6
Q ss_pred HhcccCcCCeEEEEEEEEc-----CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 435 (672)
..+.||+|+||.||+|.+. ++..||||.++..... ..++|.+|+++++.++|+||+++++++.. ....++||
T Consensus 8 ~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred hheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 4478999999999999854 3689999999865443 46789999999999999999999999887 55789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||.+...
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999997543 35899999999999999999999 789999999999999999999999999999876
Q ss_pred CCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC--CCCCC-CChhHHHH
Q 005880 516 PPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM--GCGGA-VDLPRWVQ 584 (672)
Q Consensus 516 ~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~--~~~~~-~~~~~~~~ 584 (672)
... ....+..|+|||.+. +..++.++||||||+++|||+||+.|+......... ..... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLR--TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHc--cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 532 122345699999654 457889999999999999999999998643211100 00000 01111111
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
...... ..........++.+++.+||+.+|++||||.||+++|+.++
T Consensus 238 -~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 -LLKEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred -HHHcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111110 00111122356889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=313.30 Aligned_cols=240 Identities=26% Similarity=0.414 Sum_probs=198.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ....+.+|+++|+++. |||||.+++.|.+....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 467999999999999965 5999999999865543 3468999999999998 9999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC----CCcEEEeccCCCccC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK----TGNARVSDFGLSIFA 515 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DfG~a~~~ 515 (672)
||.|.+.+... .+++.....++.|++.++.||| +.+|+||||||+|+|+.. ++.+|++|||++...
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999754 2899999999999999999999 899999999999999963 257999999999887
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
... ...||+.|+|||++. ...|+..+||||+||++|.|++|.+||..+.... -...+...++
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~--~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------------~~~~i~~~~~ 255 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLG--GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE------------IFLAILRGDF 255 (382)
T ss_pred cCCceEeeecCCccccCchhhc--CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH------------HHHHHHcCCC
Confidence 763 678999999999774 4689999999999999999999999998764321 1112222221
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+-....++. ......+++..|+..||.+|+|+.++++
T Consensus 256 -----~f~~~~w~~---is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DFTSEPWDD---ISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCCCccc---cCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111111222 3345667777999999999999999987
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.88 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=191.0
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc-----hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG-----GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|++|.||+|.. .+++.||+|.++..... ..+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 357899999999999995 46899999998643211 235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||+|+||++++++.++|+|||+++....
T Consensus 86 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 86 MPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999998754 34889999999999999999999 88999999999999999999999999999875433
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...++..|+|||++. +..++.++||||||+++|||++|+.||..... ..-.......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~~ 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVIS--GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------------MAAIFKIATQ 222 (263)
T ss_pred cccccccccCCCcCccccCcceec--cCCCCchhhhHHHHHHHHHHHhCCCCccccch------------HHHHHHHhcc
Confidence 1 234567899999765 45688999999999999999999999864211 1111111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.... . ........+.+++.+||..+|.+|||+.|+++.
T Consensus 223 ~~~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNP-----Q-----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCC-----C-----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1000 0 001223457788889999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.49 Aligned_cols=232 Identities=25% Similarity=0.336 Sum_probs=184.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +++.||||++++... ...+.+..|..++..+ +|++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 478999999999999965 578999999875322 2334566778888777 58999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999998654 24889999999999999999999 78999999999999999999999999999875432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....+|..|+|||++. +..++.++|||||||++|||+||+.||.... .......+.....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------------~~~~~~~i~~~~~--- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------------EDELFQSIMEHNV--- 218 (323)
T ss_pred CccccCCCChhhcCHHHhc--CCCCCCccchhchhHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCC---
Confidence 2455788999999765 4578999999999999999999999996432 1122222222110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
.... ....++.+++.+|++.||.+|++.
T Consensus 219 ------~~p~---~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ------AYPK---SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCC---cCCHHHHHHHHHHcccCHHhcCCC
Confidence 0011 122356788889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.99 Aligned_cols=190 Identities=24% Similarity=0.372 Sum_probs=164.3
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 47899999999999995 4688999999875322 2345788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 86 g~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 86 GDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999754 24788999999999999999999 78999999999999999999999999999753210
Q ss_pred -------------------------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHH
Q 005880 518 -------------------------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSF 548 (672)
Q Consensus 518 -------------------------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~ 548 (672)
....||..|+|||++. +..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DiwSl 234 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL--RTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc--CCCCCCeeeEEec
Confidence 0135788999999775 4578899999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 005880 549 GVLLLELLTGKCPSVID 565 (672)
Q Consensus 549 Gvvl~el~tg~~P~~~~ 565 (672)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=301.14 Aligned_cols=240 Identities=26% Similarity=0.381 Sum_probs=193.5
Q ss_pred HhcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|...+ ++.+|+|.++... ..+++.+|++++++++|+||+++++++..+...++++||+++++
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 45679999999999999764 7899999987543 26789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||.||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 85 L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 85 VSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred HHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999996533 45899999999999999999999 789999999999999999999999999998765443
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||....... -.... .... .
T Consensus 157 ~~~~~~~~y~~PE~~~--~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------------~~~~~-~~~~-----~ 216 (256)
T cd06612 157 NTVIGTPFWMAPEVIQ--EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------------AIFMI-PNKP-----P 216 (256)
T ss_pred ccccCCccccCHHHHh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------------hhhhh-ccCC-----C
Confidence 234677899999764 4578899999999999999999999986432111 00000 0000 0
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
............+.+++.+||+.||++|||+.||++
T Consensus 217 ---~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 ---PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000111122345788889999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=302.24 Aligned_cols=243 Identities=26% Similarity=0.448 Sum_probs=194.2
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
..+.||+|+||.||+|...++..+|+|.++.... ..+.+.+|++++++++|+||+++++++.. ...+++|||+++|+|
T Consensus 10 ~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL 87 (260)
T ss_pred EEeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence 3578999999999999987788899998875432 45678999999999999999999999877 778999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ...+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 88 LDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred HHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 99997643 245889999999999999999999 789999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. ...++.++|||||||++|+++| |+.||..... .+..... .......
T Consensus 161 ~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------------~~~~~~~-~~~~~~~-- 223 (260)
T cd05073 161 EGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------------PEVIRAL-ERGYRMP-- 223 (260)
T ss_pred cCCcccccccCHhHhc--cCCcCccccchHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHH-hCCCCCC--
Confidence 122345699999764 4578889999999999999999 8999864321 1111111 1111000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
.......++.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 --------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223467888899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=324.16 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=200.4
Q ss_pred HHhcccCcCCeEEEEEEEE-cCC----cEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 363 ASAEMLGKGGFGTAYKAVL-DDG----SVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~-~~g----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.-.++||+|+||+||+|.+ ..| -+||+|++.... .+...++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999994 344 468999987543 345788999999999999999999999998665 789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
||+.|+|.++++.++ ..+.....+.|..|||+||.||| +.+++||||.++||||..-..+||.|||+++...
T Consensus 778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999765 46888999999999999999999 8899999999999999999999999999999887
Q ss_pred CCCC-C----C--CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 PSTV-P----R--SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~~~-~----~--t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.... . + ...|||=|.+. ...++.++|||||||.+||++| |..|+++....+ + ...++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~--~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I----~dlle 914 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIR--IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------I----PDLLE 914 (1177)
T ss_pred cccccccccccccCcHHHHHHHhh--ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------h----hHHHh
Confidence 6521 1 1 23588888554 5789999999999999999998 888987543211 1 11222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.+. +....+-+...+..++.+||..|+..||+++++...+.++.+
T Consensus 915 ~ge----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 KGE----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ccc----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 110 112223355678889999999999999999999999988764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.80 Aligned_cols=242 Identities=20% Similarity=0.285 Sum_probs=186.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+|+.. +++.||||++.+... .....+.+|++++.+++||||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999954 689999999864322 234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 85 GGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999754 34788999999999999999999 88999999999999999999999999999742210
Q ss_pred ----------------------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHH
Q 005880 518 ----------------------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVL 551 (672)
Q Consensus 518 ----------------------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvv 551 (672)
....||..|+|||++. +..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL--RTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc--CCCCCcceeeeeccce
Confidence 0235788999999764 4578899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC--
Q 005880 552 LLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-- 629 (672)
Q Consensus 552 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-- 629 (672)
+|||++|+.||..... .+.......... ... ...... ....+.+++.+|+ .+|.+|+
T Consensus 234 lyell~G~~Pf~~~~~------------~~~~~~i~~~~~--~~~---~~~~~~---~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 234 LYEMLVGQPPFLADTP------------AETQLKVINWET--TLH---IPSQAK---LSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eeehhhCCCCCCCCCH------------HHHHHHHhccCc--ccc---CCCCCC---CCHHHHHHHHHHh-cCHhhcCCC
Confidence 9999999999965321 112121111110 000 000011 1223555666765 5999999
Q ss_pred -CHHHHHHH
Q 005880 630 -NMSHVVKL 637 (672)
Q Consensus 630 -t~~evl~~ 637 (672)
++.|+++.
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=301.34 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=194.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.++++++|+||+++++++.+.+..++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 3578999999999999954 6899999998643 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ...+++..++.++.|+++||.||| +.+|+|+||||+||++++++.++++|||.+......
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999886543 235789999999999999999999 889999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++||||||+++|+|++|+.||.... ............ ....
T Consensus 157 ~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------------~~~~~~~~~~~~-~~~~- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWE--NMPYNNKSDIWSLGCILYELCTLKHPFQANS------------WKNLILKVCQGS-YKPL- 220 (255)
T ss_pred cccccCCccccCHHHHc--cCCcCchhhhhhhchhheehhhccCCCCCCC------------HHHHHHHHhcCC-CCCC-
Confidence 345677899999764 4568899999999999999999999996431 122222221111 0000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.......+.+++.+||+.||++||++.|++..
T Consensus 221 ---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122357788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.56 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=196.0
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCc----EEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.+.||+|+||.||+|... +|. .||+|.++.... ....++.+|+.++++++||||+++++++.. ...++|||
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 34578999999999999954 343 589998875543 345678999999999999999999999987 78899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||.++...
T Consensus 89 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 89 LMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred cCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999997653 34899999999999999999999 7899999999999999999999999999997654
Q ss_pred CCC-------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 PST-------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~~-------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
... ...+..|+|||.+. ...++.++||||||+++||+++ |+.||.... ..++......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------------~~~~~~~~~~ 226 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESIL--HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP------------AVEIPDLLEK 226 (279)
T ss_pred CcccceecCCCcccccccCHHHhh--cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC------------HHHHHHHHhC
Confidence 321 11245799999653 4578899999999999999999 999986432 2222222221
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... . ... ......+.+++.+||..+|.+||++.++++.|+++.+
T Consensus 227 ~~~----~----~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 GER----L----PQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC----C----CCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 0 000 1122357788889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.59 Aligned_cols=184 Identities=20% Similarity=0.331 Sum_probs=157.3
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+..++|+||+ .|
T Consensus 69 ~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~ 141 (357)
T PHA03209 69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS 141 (357)
T ss_pred EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence 34578999999999999965 5788999985433 2356899999999999999999999999999999999 56
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... .++++..+..|+.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 142 ~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 142 DLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence 8888886533 45899999999999999999999 789999999999999999999999999999754322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSV 563 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~ 563 (672)
...+|..|+|||++. +..++.++|||||||++|||+++..|+.
T Consensus 214 ~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 214 LGLAGTVETNAPEVLA--RDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccccCCeecC--CCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 345788999999764 4578999999999999999999766654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.51 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=192.7
Q ss_pred cccCcCCeEEEEEEEEcC-------CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDD-------GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.||+|+||.||+|+..+ +..+|+|.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999999642 2579999886543 23466889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-----cEEEeccC
Q 005880 438 MPNGSLFWLLHGNRGP--GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-----NARVSDFG 510 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~DfG 510 (672)
+++|+|.+++...... ....+++.+++.++.|++.||+||| +.+++|+||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999754321 1234789999999999999999999 78999999999999999877 89999999
Q ss_pred CCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 511 LSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 511 ~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+++..... ....+..|+|||++. +..++.++|||||||++|||+| |+.||.... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~------------~~~~ 222 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLL--DGKFTTQSDVWSFGVLMWEILTLGQQPYPALN------------NQEV 222 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHc--cCCcccchhHHHHHHHHHHHHHcCCCCCcccC------------HHHH
Confidence 98755332 223356799999764 4578999999999999999998 999986332 1111
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
........ ..... ......+.+++.+||+.+|.+||++.++++.|++
T Consensus 223 ~~~~~~~~--------~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 223 LQHVTAGG--------RLQKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHhcCC--------ccCCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111110 00011 1223467788999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.34 Aligned_cols=240 Identities=26% Similarity=0.381 Sum_probs=192.9
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 34577999999999999854 57899999987443 23456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.. ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 87 ~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 87 GSALDLLKP------GPLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999864 24889999999999999999999 789999999999999999999999999998765443
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. +..++.++|||||||++|||++|+.||...... .+... .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~~~~~-~~~~~---- 217 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIK--QSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------------RVLFL-IPKNS---- 217 (277)
T ss_pred hhhcccCcccccCHHHhC--cCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------------hHHhh-hhcCC----
Confidence 234677899999764 457889999999999999999999998643211 01111 11100
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.+.. .......+.+++.+||+.+|++||++.++++.
T Consensus 218 -~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 -PPTL-----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCC-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 01233457888999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.59 Aligned_cols=183 Identities=22% Similarity=0.297 Sum_probs=158.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+.. .++.||||... ...+.+|++++++++|+|||++++++...+..++|||++ .++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence 467999999999999965 57899999643 234678999999999999999999999999999999999 5789
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..++|.+++.|+.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 88886432 35999999999999999999999 789999999999999999999999999999765332
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...||..|+|||++. +..++.++|||||||++|||++|..|+..
T Consensus 319 ~~~~~GT~~Y~APE~~~--~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLA--GDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred ccccCCCcCCcCHHHHc--CCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 245789999999764 56789999999999999999999877643
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.59 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=189.5
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999965 68899999986422 223456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++... .++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 126 ~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 126 PGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999998643 3788889999999999999999 889999999999999999999999999999765432
Q ss_pred ------CCCCCCcccCCCccccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 ------TVPRSNGYRAPELSSSDG--RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~--~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...+|..|+|||++.... ..++.++|||||||++|||++|+.||.... .......+....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------------~~~~~~~i~~~~ 263 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------------LVGTYSKIMNHK 263 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------------HHHHHHHHHcCC
Confidence 345789999999875432 347899999999999999999999996432 222222222211
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ--RPNMSHVVKL 637 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 637 (672)
...... .. ......+.+++..|+..++.+ ||++.|+++.
T Consensus 264 ~~~~~~-----~~---~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NSLTFP-----DD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CcccCC-----Cc---CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111110 11 112334667778999844432 7788888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=339.48 Aligned_cols=249 Identities=19% Similarity=0.282 Sum_probs=191.5
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|... ++..||+|.+.... ......|..|+.++.+++|||||++++++.+ ....|+||||+
T Consensus 17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 3478999999999999954 57889999887432 2245678999999999999999999998865 35688999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC---CCCCcEecCCCCCCEEeCCC--------------
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC---KSLKLTHGNIKSTNVLLDKT-------------- 501 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~~~iiH~Dlkp~NIll~~~-------------- 501 (672)
++|+|.++|..... ....+++..++.|+.||+.||+|||... ...+||||||||+||||+.+
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999975321 1245899999999999999999999421 01469999999999999642
Q ss_pred ---CcEEEeccCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005880 502 ---GNARVSDFGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 502 ---~~~kl~DfG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~ 574 (672)
+.+||+|||++...... ...+|+.|+|||++......++.++||||||||+|||+||+.||....
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-------- 247 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-------- 247 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC--------
Confidence 34899999999765432 346789999999876555678999999999999999999999996421
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.....+..+. ... ... .......+.+||..||..+|.+||++.|++.
T Consensus 248 ---~~~qli~~lk-~~p-------~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 ---NFSQLISELK-RGP-------DLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ---cHHHHHHHHh-cCC-------CCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2222222211 110 000 0112345778889999999999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.54 Aligned_cols=189 Identities=27% Similarity=0.362 Sum_probs=160.8
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 434 (672)
..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 457899999999999995 4688999999875322 2345678899999999999999999887543 356899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+|++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.
T Consensus 99 ~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 99 TNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred eecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 9988 78998887532 4899999999999999999999 88999999999999999999999999999986
Q ss_pred CCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 515 APPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 515 ~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
.... ...++..|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 168 ADDEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred cCCCcCCccccccccCchHhcC-CccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 6543 4567889999997643 24678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.09 Aligned_cols=242 Identities=28% Similarity=0.457 Sum_probs=192.2
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++||||+++++++..+ ..++||||+++|+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 3457899999999999975 57889999986543 346789999999999999999999998654 5789999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--CC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TV 520 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~ 520 (672)
|.+++.... ...+++..++.++.|+++||+||| +.+++||||||+||+++.++.+||+|||++...... ..
T Consensus 85 L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 85 LVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred HHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 999997543 235889999999999999999999 789999999999999999999999999998764432 22
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..+..|+|||.+. +..++.++|||||||++|||++ |+.||... ...++.....+. .. .+
T Consensus 158 ~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------------~~~~~~~~~~~~-~~---~~-- 217 (254)
T cd05083 158 KLPVKWTAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM------------SLKEVKECVEKG-YR---ME-- 217 (254)
T ss_pred CCCceecCHHHhc--cCCcCchhhHHHHHHHHHHHHhCCCCCCccC------------CHHHHHHHHhCC-CC---CC--
Confidence 3346799999654 4578899999999999999998 99998632 222222222111 10 00
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
........+.+++.+||+.+|++||+++++++.|++
T Consensus 218 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223467788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.48 Aligned_cols=188 Identities=24% Similarity=0.335 Sum_probs=159.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv 434 (672)
..+.||+|+||.||++... +|..||||++... .......+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 3478999999999999954 6899999998643 2234567889999999999999999999986543 46899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++ +|.+.++. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 999965 67666642 3788999999999999999999 88999999999999999999999999999976
Q ss_pred CCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 515 APPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
.... ...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cccCccCCCCcccCCCCCchhcc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 5432 345688899999764 567889999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=296.40 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=195.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 467999999999999964 5789999999866555677899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 99987542 35899999999999999999999 789999999999999999999999999998765432
Q ss_pred CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+... ...++.++||||||+++|||+||+.||..... ..-........ +.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------------~~~~~~~~~~~-----~~ 222 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------------MRALFLISKSN-----FP 222 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhcc-----CC
Confidence 33567789999976422 12678899999999999999999999864321 11111111110 00
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.. ..........+.+++.+||..+|.+|||+.+|+.
T Consensus 223 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0111233456888999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.10 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=199.2
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCC
Confidence 45688999999999999954 68999999886433 33467889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... .++++..+..++.+++.||.|||+ .++++||||||+||++++++.++|+|||++......
T Consensus 88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 9999998653 358999999999999999999993 258999999999999999999999999998654322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++|||||||++|||+||+.||........ ..........++.....+..
T Consensus 160 ~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~------ 230 (284)
T cd06620 160 DTFVGTSTYMSPERIQ--GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD-GQDDPMGILDLLQQIVQEPP------ 230 (284)
T ss_pred CccccCcccCCHHHHc--cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh-hhhhhhHHHHHHHHHhhccC------
Confidence 345788999999764 45788899999999999999999999975432210 00001112223332222210
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.... ..+....+.+++.+|++.||++|||+.|+++..-
T Consensus 231 ---~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 ---PRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ---CCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 0123346788899999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.36 Aligned_cols=244 Identities=26% Similarity=0.362 Sum_probs=199.5
Q ss_pred HHhcccCcCCeEEEEEEEEcC--C--cEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD--G--SVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
...++||+|.||.|++|.|.. | ..||||.++..... ...+|.+|+.+|.+|+|||++++||+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 456789999999999999763 4 46899999876655 67899999999999999999999999887 677899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
++.|+|.+.|+.. .+..+-......++.|||.|+.||. ..++|||||..+|+++-..-.+||+|||+.+.+..
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999873 2456888999999999999999999 88999999999999999988999999999987765
Q ss_pred CC--------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 518 ST--------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 518 ~~--------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.. ..-...|+|||.+. ...++.++|||+|||.+|||+| |..||.+-. -.+.++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLr--h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~------------g~qIL~~--- 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLR--HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR------------GIQILKN--- 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhc--cccccccchhhhhhhhHHhhhccCCCCCCCCC------------HHHHHHh---
Confidence 41 11235699999664 6799999999999999999999 688886432 2222222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
+| +-.+......+.+.+.+++.+||..+|++|||+..+.+.+-
T Consensus 328 -------iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 328 -------ID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -------cc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 22 11122223456678999999999999999999999985443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.03 Aligned_cols=193 Identities=26% Similarity=0.370 Sum_probs=163.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|+.. +|..||||.++... ......+.+|+.++.+++||||+++++++.+++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 467999999999999964 68999999986432 2234678899999999999999999999999999999999997 6
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++..... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 89888865431 245899999999999999999999 789999999999999999999999999998755332
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...++..|+|||++.. ...++.++|||||||++|||+||+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLG-SPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred ccCCcccccccChHHhcC-CCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2344678999997643 345788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.70 Aligned_cols=193 Identities=25% Similarity=0.352 Sum_probs=165.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 3578999999999999954 68999999986422 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999997532 34889999999999999999999 889999999999999999999999999998655432
Q ss_pred -----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 -----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...+|..|+|||++... ...++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 23578899999987531 24578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.65 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=194.1
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
...+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+++
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 34577999999999999965 58899999987443 33456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ++++.++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 87 GSALDLLRAG------PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999998642 4789999999999999999999 789999999999999999999999999999665432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++|||||||++|||+||+.||...... ...... ....
T Consensus 157 ~~~~~~~~~~y~apE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~~~~~~-~~~~---- 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQ--QSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------------RVLFLI-PKNN---- 217 (277)
T ss_pred ccccccCcccccCHhHhc--cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------------hHhhhh-hcCC----
Confidence 234567899999764 456889999999999999999999998643211 011100 0000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 ------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011112345568889999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.41 Aligned_cols=240 Identities=23% Similarity=0.393 Sum_probs=192.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcc--c--CCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe--EEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLK--D--ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE--KLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~--~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 437 (672)
.++||+|+|-+||+|... +|..||--.++ + ......++|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999964 58888754433 2 222345789999999999999999999999987665 6689999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAP 516 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~ 516 (672)
+..|+|+.|+++.+ .++...+..|++||++||.|||.+ .++|||||||-+||+|+. -|.+||+|+|+|....
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999998765 488899999999999999999976 789999999999999986 5899999999998776
Q ss_pred CC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 517 PS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 517 ~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
.+ ...||+.|||||++. ..|.+.+||||||+.++||+|+..||..- .+..+.++++..+....
T Consensus 198 ~s~aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----------~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----------TNPAQIYKKVTSGIKPA 263 (632)
T ss_pred ccccceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhh-----------CCHHHHHHHHHcCCCHH
Confidence 54 467999999999653 57999999999999999999999999632 22333444443332111
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+...+ ..++.++|.+|+.. ..+|||+.|+++
T Consensus 264 -----sl~kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 -----ALSKVK-----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----HhhccC-----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111111 13467788899999 999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=308.26 Aligned_cols=240 Identities=20% Similarity=0.326 Sum_probs=191.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
...||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999954 6899999998765555567789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... .+++.++..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 107 TDIVTHT------RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9988532 3889999999999999999999 789999999999999999999999999998654322
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||.+. +..++.++||||||+++|||++|+.||..... ...+... ... +.+
T Consensus 177 ~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------------~~~~~~~-~~~-----~~~ 236 (292)
T cd06658 177 SLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------------LQAMRRI-RDN-----LPP 236 (292)
T ss_pred eeecCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHH-Hhc-----CCC
Confidence 234677899999654 45788999999999999999999999864321 1111111 111 111
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
..... ......+.+++.+|+..||++|||+.|+++.
T Consensus 237 ~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 RVKDS---HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccc---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11110 1122346677889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.21 Aligned_cols=243 Identities=25% Similarity=0.335 Sum_probs=189.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||+||+|... +++.||+|.+...... ....+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 367999999999999954 6899999998654322 234578899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99998886432 235999999999999999999999 889999999999999999999999999998655332
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||....... ...-+.......
T Consensus 158 ~~~~~g~~~~~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---------~~~~~~~~~~~~------ 220 (285)
T cd05632 158 IRGRVGTVGYMAPEVLN--NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---------KREEVDRRVLET------ 220 (285)
T ss_pred ccCCCCCcCccChHHhc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHHhhhcc------
Confidence 345788999999764 4578899999999999999999999996432110 000011101100
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
..... ......+.+++..|++.||++||+ +.++++
T Consensus 221 --~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 --EEVYS---AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --ccccC---ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00000 112235678888999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=287.35 Aligned_cols=267 Identities=21% Similarity=0.322 Sum_probs=204.1
Q ss_pred CHHHHHHHHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEE
Q 005880 356 ELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 356 ~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 433 (672)
.++|+-+-+.+.||+|+|+.|--++ +.+|..+|||++.+.....+.++.+|++++...+ |+||++++++|.++...||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4667666688999999999999998 7789999999998887667889999999999985 9999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEeccC
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVSDFG 510 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG 510 (672)
|||.|.||+|..+++.. ..+++.+..++..+||.||.||| ..+|.||||||+|||...-. -+||+||.
T Consensus 154 VfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999865 45999999999999999999999 89999999999999987544 38999998
Q ss_pred CCccCCC------------CCCCCCCcccCCCcc---ccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q 005880 511 LSIFAPP------------STVPRSNGYRAPELS---SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575 (672)
Q Consensus 511 ~a~~~~~------------~~~~~t~~y~aPE~l---~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~ 575 (672)
+..-... .+.+|+..|||||+. ..+...|+.++|.||+|||+|-|++|.+||.+.-+.+ -+-..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d-CGWdr 303 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD-CGWDR 303 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-CCccC
Confidence 7643221 145677789999964 3345678999999999999999999999998764322 11111
Q ss_pred CCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...-...+..+-+......+.-.-..+..+.+ +-.+++...+..|+.+|-++.++++
T Consensus 304 -Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~---eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 -GEVCRVCQNKLFESIQEGKYEFPDKDWAHISS---EAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -CCccHHHHHHHHHHHhccCCcCChhhhHHhhH---HHHHHHHHHHhccHHhhhhhhhccC
Confidence 11122222222222211111111111222333 3445666788899999999998876
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.50 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=190.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+||+++++.+.+++..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 367999999999999954 6899999998653322 234577899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999986433 235899999999999999999999 789999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|+.||....... ............ .
T Consensus 158 ~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---------~~~~~~~~~~~~-~---- 221 (285)
T cd05630 158 IKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---------KREEVERLVKEV-Q---- 221 (285)
T ss_pred ccCCCCCccccChHHHc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---------hHHHHHhhhhhh-h----
Confidence 245788999999764 4578999999999999999999999997532110 000011111100 0
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
... . ......+.+++.+||+.||++||| +.|+++
T Consensus 222 -~~~--~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EEY--S---EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhc--C---ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 0 112235678888999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=297.53 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=195.9
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 347899999999999994 468999999886432 33456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ...+++.++..++.|+++||+||| +.+++||||+|+||++++++.+||+|||++......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999997553 245899999999999999999999 789999999999999999999999999998765443
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... ...+............
T Consensus 157 ~~~~~~~~~~y~ape~~~--~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------------~~~~~~~~~~~~~~~~-- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQ--GVKYNFKSDIWALGCVLYELLTLKRTFDAT------------NPLNLVVKIVQGNYTP-- 220 (256)
T ss_pred cccccCCCccccCHhhcC--CCCCCCcchhHHHHHHHHHHHHCCCCCCCC------------CHHHHHHHHHcCCCCC--
Confidence 345678899999654 456788999999999999999999998642 1222333222221110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 221 ---~------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ---V------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---C------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0 01223457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.21 Aligned_cols=260 Identities=20% Similarity=0.256 Sum_probs=188.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||++ ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 467999999999999965 68899999987433 2234567889999999999999999999999999999999996 58
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 90 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 90 LKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 988886543 35889999999999999999999 889999999999999999999999999998754322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCCCCChhHHHHHHHhhhccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG----CGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ...++.++|||||||++|||+||+.||......+... .........| ..........
T Consensus 162 ~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (301)
T cd07873 162 SNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGILSNEEFK 239 (301)
T ss_pred cccceeecccCcHHHhC-CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc-hhhhcccccc
Confidence 2345778999997643 3457889999999999999999999996432110000 0000000000 0000000000
Q ss_pred cccchhhccccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..-.+.. .... .......+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCcc-ccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0000 0011235678888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.96 Aligned_cols=231 Identities=25% Similarity=0.359 Sum_probs=179.0
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCC---CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRL---RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
||+|+||.||+|+.. +|+.||||++...... ....+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 6899999998643221 223345566666554 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 9999998753 34899999999999999999999 789999999999999999999999999998754221
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+..........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGvil~elltG~~Pf~~~~------------~~~~~~~i~~~~~---- 214 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLD-EKGYTKHVDFWSLGVLVFEMCCGWSPFYAED------------TQQMYRNIAFGKV---- 214 (330)
T ss_pred CccCccCCccccCHHHHcC-CCCCCCccceeccccEEEEeccCCCCCCCCC------------HHHHHHHHHcCCC----
Confidence 3457889999997642 3457899999999999999999999996432 2222222221110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
.... . .....+.+++.+||+.||.+||++
T Consensus 215 ---~~~~-~---~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 215 ---RFPK-N---VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred ---CCCC-c---cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 0000 0 112346678889999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.56 Aligned_cols=233 Identities=24% Similarity=0.311 Sum_probs=185.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|... +|+.||+|+++... ....+.+..|.+++..+. |++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 467999999999999954 68999999987532 223456778888888885 5778889999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999998654 34899999999999999999999 789999999999999999999999999998754322
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~pf~~~~------------~~~~~~~i~~~~~--- 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED------------EDELFQSIMEHNV--- 218 (323)
T ss_pred ccccCccCCccccCHHHHc--CCCCCCccchhhhHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCC---
Confidence 345788999999764 4578899999999999999999999996432 1122222222111
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
.... .....+.+++.+||+.+|.+|++..
T Consensus 219 ------~~p~---~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 ------SYPK---SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------CCCc---cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0011 1223567788899999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.94 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=193.7
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.+.||+|+||.||++... +|..||+|.++.. .......+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45678999999999999965 7899999988653 222346788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.... ....+++..+..++.|+++||.|||+ +.+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 99999987542 12358999999999999999999992 258999999999999999999999999998755332
Q ss_pred -CCCCCCcccCCCccccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 -TVPRSNGYRAPELSSSD----GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~----~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||.+... ...++.++|||||||++|||++|+.||...... .....+.......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~--- 226 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---------NIFAQLSAIVDGD--- 226 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---------hHHHHHHHHhhcC---
Confidence 34567789999976432 124588999999999999999999999643110 1111111111110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .........+.+++.+||+.+|++||++.++++
T Consensus 227 ------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 ------PP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------CC--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00 001123445778888999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.93 Aligned_cols=239 Identities=25% Similarity=0.364 Sum_probs=193.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 4567999999999999965 68999999987543 334567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++... ++++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++.....
T Consensus 85 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 999998743 5899999999999999999999 789999999999999999999999999999766533
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+. +..++.++||||||+++|||+||+.||..... ........ .......
T Consensus 155 ~~~~~~~~~y~~PE~~~--~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------------~~~~~~~~-~~~~~~~- 218 (274)
T cd06609 155 RNTFVGTPFWMAPEVIK--QSGYDEKADIWSLGITAIELAKGEPPLSDLHP------------MRVLFLIP-KNNPPSL- 218 (274)
T ss_pred cccccCCccccChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCcccCch------------HHHHHHhh-hcCCCCC-
Confidence 345677899999764 44589999999999999999999999964321 11111111 1111110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. . .....+.+++.+||..+|++|||++++++
T Consensus 219 ----~~-~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 ----EG-N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----cc-c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 0 02335778888999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=297.53 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=190.4
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||+|...+|+.+|||.++.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 3567999999999999988899999998864321 1235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++++|.+++... .++++..+..++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 84 VPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999753 24789999999999999999999 78999999999999999999999999999865421
Q ss_pred -----------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 518 -----------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 518 -----------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
....++..|+|||++. +..++.++|||||||++|||++|+.||..... ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------~~~~~-~~ 220 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----------LAAMF-YI 220 (265)
T ss_pred ccccccccccccccCCCccccChhhhc--CCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----------HHHHH-Hh
Confidence 1234677899999764 45678999999999999999999999964321 00110 00
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ..+... ......+.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~~~----~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GAHRG----LMPRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhccC----CCCCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000010 112345678888999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.58 Aligned_cols=186 Identities=20% Similarity=0.299 Sum_probs=160.9
Q ss_pred HhcccCcCCeEEEEEEEEc---CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD---DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.+.||+|+||.||++... .+..||||.+... ..+.+|++++++++||||+++++++......++|||++.
T Consensus 96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 4578999999999999853 3578999988643 345689999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 170 CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 6888888432 45899999999999999999999 789999999999999999999999999998765432
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLA--LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccCccCHhHhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 345789999999764 4578899999999999999999999997643
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=304.69 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=191.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCc----EEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||+|... +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3478999999999999853 454 578998875432 2345788999999999999999999998754 46799999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999987543 35889999999999999999999 78999999999999999999999999999976543
Q ss_pred C-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...++..|+|||.+. +..++.++|||||||++|||++ |+.||.... ... .......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------------~~~-~~~~~~~ 226 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------------TRE-IPDLLEK 226 (303)
T ss_pred cccccccCCCccccccCCHHHhc--cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------------HHH-HHHHHHC
Confidence 2 122356799999653 5678999999999999999997 899985421 111 1111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... . ... ......+.+++..||..+|++||++.++++.|+++..
T Consensus 227 ~~~---~----~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 227 GER---L----PQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCC---C----CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 110 0 000 1123457788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.75 Aligned_cols=239 Identities=21% Similarity=0.327 Sum_probs=191.9
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
..||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999954 68999999987554445677889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----C
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-----T 519 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----~ 519 (672)
+++.. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...... .
T Consensus 107 ~~~~~------~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 107 DIVSQ------TRLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHhh------cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 98754 24899999999999999999999 889999999999999999999999999998654332 3
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||++. +..++.++|||||||++|||++|+.||..... .+..... .... ...
T Consensus 177 ~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------------~~~~~~~-~~~~-----~~~ 236 (297)
T cd06659 177 LVGTPYWMAPEVIS--RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------------VQAMKRL-RDSP-----PPK 236 (297)
T ss_pred eecCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHH-hccC-----CCC
Confidence 45678899999764 45688999999999999999999999964321 1111111 1110 000
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.... ......+.+++.+||+.+|++||++.|+++.
T Consensus 237 ~~~~---~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LKNA---HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccc---CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001 1122346788889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=295.58 Aligned_cols=241 Identities=22% Similarity=0.356 Sum_probs=191.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 439 (672)
+.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++||||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 4578999999999999954 57899999986432 2345678899999999999999999998764 446789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++.... ...+++.++..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999997543 245899999999999999999999 889999999999999999999999999998765432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... +...+........ ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~~~~~~------------~~~~~~~~~~~~~-~~~ 221 (257)
T cd08223 157 DMASTLIGTPYYMSPELFS--NKPYNYKSDVWALGCCVYEMATLKHAFNAK------------DMNSLVYRIIEGK-LPP 221 (257)
T ss_pred CccccccCCcCccChhHhc--CCCCCchhhhHHHHHHHHHHHcCCCCCCCC------------CHHHHHHHHHhcC-CCC
Confidence 345678899999654 457888999999999999999999998632 2222222222211 100
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........+.+++.+|++.+|++|||+.|+++
T Consensus 222 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 ----------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00123346788899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.95 Aligned_cols=189 Identities=22% Similarity=0.358 Sum_probs=154.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC------CCceeeeEEEEEcC-CeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR------HPNLVGLKAYYFAR-EEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~-~~~~lv~ 435 (672)
+.+.||+|+||.||+|... +++.||||+++.... ..+++..|++++++++ |.+++++++++..+ .+.++||
T Consensus 133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 3478999999999999954 588999999975322 3345566777666654 45689999988764 4678999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCC------------
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTG------------ 502 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~------------ 502 (672)
|++ +++|.+++... ..+++..+..|+.|++.||+||| + .+||||||||+|||++.++
T Consensus 212 ~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH----~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 212 PKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH----TELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred ecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----hcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 988 77898888643 35899999999999999999999 5 5999999999999998765
Q ss_pred ----cEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 503 ----NARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 503 ----~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
.+||+|||.+...... ...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL--GLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhh--cCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999988654332 456889999999775 567899999999999999999999999754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.14 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=189.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 478999999999999965 57889999986422 12334588899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 86 GDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999997532 35899999999999999999999 889999999999999999999999999998654322
Q ss_pred ----CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ----TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...||..|+|||++.. ....++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------------~~~~~~~~i~~~~~ 225 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------------SLVETYGKIMNHKE 225 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------------CHHHHHHHHhCCCc
Confidence 2457899999998642 1346788999999999999999999999643 22233333322211
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSAS--PDQRPNMSHVVKL 637 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~ 637 (672)
... + ..........+.+++.+|+..+ +..|+++.|+++.
T Consensus 226 ~~~-~------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQ-F------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccc-C------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 0 0001112234566777777544 4447899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=302.24 Aligned_cols=243 Identities=27% Similarity=0.404 Sum_probs=192.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|+.. +|+.||+|.+..... ...+++.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 3478999999999999964 689999999864322 234578899999999999999999999999999999999996
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
|++.+++.... ..+++..+..++.|++.||.||| +.+|+||||+|+||++++++.++|+|||++......
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 67777775432 35899999999999999999999 789999999999999999999999999998766543
Q ss_pred CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++.. ....++.++||||||+++|||+||+.||.... .............
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------------~~~~~~~~~~~~~------ 231 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------------AMSALYHIAQNDS------ 231 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------------HHHHHHHHhcCCC------
Confidence 4557788999997642 24568899999999999999999999986431 1111111111100
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
+.. ........+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 012234468888999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.70 Aligned_cols=188 Identities=22% Similarity=0.318 Sum_probs=159.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 434 (672)
..+.||+|+||.||+|+.. .++.||||++.... ......+.+|+.+++.++||||+++++++... ...++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 3478999999999999954 68899999987532 23456788999999999999999999987643 356899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++ +|.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 999965 77777642 3788999999999999999999 88999999999999999999999999999976
Q ss_pred CCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 515 APPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
.... ...++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHh--CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 6543 345788999999764 567899999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=296.97 Aligned_cols=248 Identities=19% Similarity=0.359 Sum_probs=193.2
Q ss_pred HhcccCcCCeEEEEEEEEcC--CcEEEEEEcccCC----------cchHHHHHHHHHHHcC-CCCCceeeeEEEEEcCCe
Q 005880 364 SAEMLGKGGFGTAYKAVLDD--GSVVAVKRLKDAS----------IGGKREFEQHMEVLGR-LRHPNLVGLKAYYFAREE 430 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~ 430 (672)
..+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..++.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 35679999999999999764 6889999875321 1123457778888865 799999999999999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++||||+++++|.+++..... ....+++..+++++.|++.||.|||. ..+++||||+|+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 9999999999999998854321 12458999999999999999999992 2579999999999999999999999999
Q ss_pred CCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 511 LSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 511 ~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
.+...... ...++..|+|||.+. +..++.++||||||+++|||++|+.||... +........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~------------~~~~~~~~~ 225 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYST------------NMLSLATKI 225 (269)
T ss_pred ceeecccccccccccCcccCcChhhhc--CCCCchHHHHHHHHHHHHHHHhCCCccccc------------CHHHHHHHH
Confidence 99765543 345677899999764 456899999999999999999999998632 222222222
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
..... ... . .......+.+++.+||+.||++||++.||.++++
T Consensus 226 ~~~~~-~~~----~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVY-EPL----P-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccC-CcC----C-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 21111 000 0 0112345788888999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=297.90 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=191.4
Q ss_pred hcccCcCCeEEEEEEEEc----CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEE
Q 005880 365 AEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKL 432 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 432 (672)
.+.||+|+||.||+|... +++.||||+++... ....+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999853 36889999987532 224567889999999999999999999886542 247
Q ss_pred EEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
+++||+++|+|.+++..... .....+++....+++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECcccc
Confidence 89999999999988754321 12235789999999999999999999 78999999999999999999999999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++..... ...++..|++||.+. ...++.++|||||||++|||++ |++||.... ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~sDi~slG~il~el~~~g~~p~~~~~------------~~~~~ 225 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE------------NSEIY 225 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHh--cCccchhhhhHHHHHHHHHHhhCCCCCCCCCC------------HHHHH
Confidence 8765432 222345799999653 4567889999999999999999 888885332 11111
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
......... .. .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 226 ~~~~~~~~~--------~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 NYLIKGNRL--------KQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHcCCcC--------CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111100 00 012234688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.72 Aligned_cols=238 Identities=23% Similarity=0.328 Sum_probs=198.7
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|.|+.|-+|+ .-+|..||||++.+.... ....+.+|++.|+-++|||||++|.+.......|||+|.-++|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 4679999999999998 457999999999865543 3567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~-- 518 (672)
+|++|+..+. .-+.+....+++.||+.|+.|.| +..+|||||||+||.+-+ -|-+||.|||++-.+.+.
T Consensus 103 Dl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH----qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 103 DLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH----QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred hHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh----hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 9999997765 34899999999999999999999 789999999999998754 688999999999887765
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
+.+|+..|-|||++.++ ..-.+++||||+|||||.|+.|++||+..++.+ .+..++
T Consensus 175 L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------------TLTmIm 232 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------------TLTMIM 232 (864)
T ss_pred hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------------hhhhhh
Confidence 67788899999998754 344689999999999999999999998765543 122233
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
|-+..-+ .....+..+||..||..||.+|-+.+|++
T Consensus 233 DCKYtvP---shvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 233 DCKYTVP---SHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred cccccCc---hhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 3333222 23344567788899999999999988885
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.79 Aligned_cols=246 Identities=25% Similarity=0.341 Sum_probs=188.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEE-----cCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYF-----AREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|... +++.+|+|.+..... ...++.+|+.++.++ +||||+++++++. .++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 467999999999999954 588999998865322 346788899999999 6999999999885 34568999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.++++.... ....+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 102 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 102 CNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred cCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 999999998864321 1245889999999999999999999 78999999999999999999999999999876543
Q ss_pred C-----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S-----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...++..|+|||++... +..++.++|||||||++|||++|+.||...... ... ......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----------~~~-~~~~~~ 244 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----------RAL-FKIPRN 244 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----------HHH-hhcccc
Confidence 2 34577889999976421 345788999999999999999999998643211 000 000000
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
......++ ......+.+++.+||+.||++|||+.||++.
T Consensus 245 -~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 245 -PPPTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -CCCcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000010 1112357788999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=295.44 Aligned_cols=242 Identities=30% Similarity=0.446 Sum_probs=195.0
Q ss_pred hcccCcCCeEEEEEEEEcC-----CcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDD-----GSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+++..+ +..||+|+++..... ..+.+.+|++++..++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4789999999999999653 388999999765443 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++|.+++..... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++.....
T Consensus 84 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 84 EGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred CCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999975431 12899999999999999999999 889999999999999999999999999999766543
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...++..|+|||.+ .+..++.++||||+|+++|||++ |+.||... +.............
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------------~~~~~~~~~~~~~~ 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------------SNEEVLEYLKKGYR 222 (258)
T ss_pred cccccccCCCcccccChHHh--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHhcCCC
Confidence 12245789999965 45678899999999999999998 78887532 22222222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
. . ........+.+++.+|+..||++|||+.|+++.|
T Consensus 223 ~-~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 L-P----------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C-C----------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 0 0011334678889999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.12 Aligned_cols=241 Identities=23% Similarity=0.401 Sum_probs=194.9
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||++.. .+|+.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 357899999999999995 468999999986432 23456889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++..... ..+++.++.+++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 84 GDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999875431 35789999999999999999999 789999999999999999999999999999765442
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++|||||||++|+|++|+.||... +..+.+.........
T Consensus 157 ~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------------~~~~~~~~~~~~~~~--- 219 (256)
T cd08218 157 LARTCIGTPYYLSPEICE--NRPYNNKSDIWALGCVLYEMCTLKHAFEAG------------NMKNLVLKIIRGSYP--- 219 (256)
T ss_pred hhhhccCCccccCHHHhC--CCCCCCccchhHHHHHHHHHHcCCCCccCC------------CHHHHHHHHhcCCCC---
Confidence 234677899999754 457888999999999999999999998632 222233322222110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.........+.+++.+||+.+|.+||++.||++
T Consensus 220 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 --------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 001122345788889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=296.67 Aligned_cols=238 Identities=24% Similarity=0.392 Sum_probs=189.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 434 (672)
...||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 467999999999999954 6889999988643322 124688999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||.++.
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 85 LEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999754 34889999999999999999999 78999999999999999999999999999876
Q ss_pred CCCC-----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 515 APPS-----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 515 ~~~~-----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
.... ...++..|+|||.+. +..++.++|||||||++|||++|+.||..... ..-+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------~~~~ 221 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVK--QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------------LQAI 221 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhc--cCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------------HHHH
Confidence 6421 123567899999664 45678899999999999999999999964211 0111
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ...+.. .......+.+++.+||+.||.+||++.|+++
T Consensus 222 ~~~~~------~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 FKIGE------NASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHhc------cCCCcC-----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11100 000111 0112345778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.42 Aligned_cols=245 Identities=34% Similarity=0.526 Sum_probs=192.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHH--HHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKR--EFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+++.. +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 478999999999999966 4678999999876543322 3456999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---- 517 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 517 (672)
+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.++|+|||.+.....
T Consensus 84 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 84 SLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp BHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccc-----ccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccc
Confidence 999999822 35899999999999999999999 78999999999999999999999999999975311
Q ss_pred -CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 518 -STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 518 -~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....++..|+|||++. .+...+.++||||+|+++|+|++|+.||..... .+.............
T Consensus 155 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---------~~~~~~~~~~~~~~~----- 219 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQ-QGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---------DDQLEIIEKILKRPL----- 219 (260)
T ss_dssp BSSSSSSGGGSCHHHHT-TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---------HHHHHHHHHHHHTHH-----
T ss_pred ccccccccccccccccc-ccccccccccccccccccccccccccccccccc---------hhhhhhhhhcccccc-----
Confidence 2455688899999754 256889999999999999999999999964310 011111111111110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ........+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00111257889999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.55 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=189.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+++.. +++.||+|.+.+.. ......+.+|..++..++|+||+++++++.+++..++||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999965 67899999986422 2234557889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999997532 35889999999999999999999 889999999999999999999999999998765432
Q ss_pred -----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++.+|+|||++... ...++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------------~~~~~~~i~~~~ 224 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------------LVETYGKIMNHE 224 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------------HHHHHHHHHcCC
Confidence 24578899999976532 1357889999999999999999999996432 222222222211
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ--RPNMSHVVKL 637 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 637 (672)
.. ............++.+++.+|+..++.+ |++++++++.
T Consensus 225 ~~-------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ER-------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Cc-------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0000111112345667777888765544 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.54 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=191.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 467999999999999965 58999999986432 223456889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|..++... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 86 VLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 888877543 24899999999999999999999 789999999999999999999999999999766543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh--------
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR-------- 588 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 588 (672)
...++..|+|||++.. ...++.++||||||+++|||++|+.||......+ ..........
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 157 YTDYVATRWYRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD---------QLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred ccCcccccccCCHHHHhC-CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHHHhCCCChHHhh
Confidence 2345678999997642 3457889999999999999999999996543211 0000000000
Q ss_pred ----hhccccccchhhccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 ----EEWTAEVFDLELMRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ----~~~~~~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.........+........ ......+.+++.+||+.+|++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000000000 112346788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.73 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=184.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCC---CCCceeeeEEEEEc-----CCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRL---RHPNLVGLKAYYFA-----REEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~l 433 (672)
.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ....++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 467999999999999955 689999999874322 1234556677776655 79999999998864 235789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||++ ++|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 999997 58988887543 234899999999999999999999 7899999999999999999999999999997
Q ss_pred cCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH--
Q 005880 514 FAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV-- 587 (672)
Q Consensus 514 ~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 587 (672)
..... ...++..|+|||++. +..++.++||||+||++|||++|++||....... .+........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--------~~~~~~~~~~~~ 226 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--------QLGKIFDLIGLP 226 (288)
T ss_pred cccCcccCCCccccccccCchHhh--CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--------HHHHHHHHhCCC
Confidence 65432 345678899999764 4578999999999999999999999986432110 0111100000
Q ss_pred -hhhccc------cccchhhccc--cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 -REEWTA------EVFDLELMRY--KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 -~~~~~~------~~~d~~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+.. ..+.+..... ....+....+.+++.+||+.||++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0000000000 000112345678899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=297.58 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=191.0
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc----------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG----------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKL 432 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 432 (672)
..+.||+|+||.||+|... +|+.||+|.++..... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3478999999999999854 6899999988532110 1246788999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
+||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999754 35899999999999999999999 789999999999999999999999999998
Q ss_pred ccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 513 IFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 513 ~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
+..... ...++..|+|||.+......++.++||||||+++||+++|+.||..... . .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----------~-~~~~~ 223 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----------I-AAMFK 223 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----------H-HHHHH
Confidence 765422 2346778999997654434578999999999999999999999853211 1 11111
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ....+.... ..+....+.+++.+||..+|.+||++.+|++
T Consensus 224 ~~~~~-~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGNKR-SAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhccc-cCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11110 011111110 0112346778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.81 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=191.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc-----hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG-----GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|... +|+.||||.++..... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 467999999999999964 6899999999754332 3456778999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+|+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999999997543 35899999999999999999999 889999999999999999999999999999766443
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh---
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE--- 590 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 590 (672)
...++..|+|||.+.. ...++.++|||||||++|||++|.+||......+ ........-
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~------------~~~~~~~~~~~~ 222 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFG-ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID------------QLGKIFEALGTP 222 (298)
T ss_pred CccccccccceeeeCHHHHhC-CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH------------HHHHHHHHcCCC
Confidence 2234567999997642 3567899999999999999999987776432110 001110000
Q ss_pred ---------ccccccchhhcccc----ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 ---------WTAEVFDLELMRYK----DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ---------~~~~~~d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.............. ........+.+++.+||+.||++|||+.||++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000 00122356788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.31 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=202.7
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 433 (672)
...+|... +...||.|+||.||+|..++ +...|-|++...+....++|.-||+||+.++||+||++++.|+.++..|+
T Consensus 28 lnP~d~We-IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 28 LNPRDHWE-IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred CCHHHHHH-HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 34444432 34568999999999999664 45556788877666678899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
+.|||.||-.+.++-.-. .++.+.++.-+++|++.||.||| +.+|||||||+.|||++-+|.++|+|||.+.
T Consensus 107 liEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccc
Confidence 999999999988876443 56999999999999999999999 8999999999999999999999999999885
Q ss_pred cCC-----CCCCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 514 FAP-----PSTVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 514 ~~~-----~~~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
... .+...||+.|||||+... ....|+.++||||||+.|.||..+.+|... .+....+-.
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------------lnpMRVllK 246 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------------LNPMRVLLK 246 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------------cchHHHHHH
Confidence 443 247789999999998654 357889999999999999999999999652 222223322
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+...+. |.+.. .......+.+++.+||.+||..||++.++++
T Consensus 247 iaKSeP------PTLlq---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 247 IAKSEP------PTLLQ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HhhcCC------CcccC---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222211 11221 2345567888888999999999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.51 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=197.0
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEcCCcEEEEEEccc--CCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKD--ASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEK 431 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 431 (672)
+.+.+-.+...+.||+||.+.||++...+.+.+|+|++.. .+.....-|.+|++.|.+++ |.+||++++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3444445556688999999999999988889999988753 33445678999999999995 99999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
|+||||- ..+|..+|..... ....| .+..+..|++.++.+.| .+||||.||||.|+|+- .|.+||+|||+
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlV-kG~LKLIDFGI 505 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLV-KGRLKLIDFGI 505 (677)
T ss_pred EEEeecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEE-eeeEEeeeech
Confidence 9999987 5699999987652 33445 78889999999999999 88999999999999984 57899999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCC---------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGR---------KQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~---------~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~ 575 (672)
|..+... ...||..||+||.+..... +.+.++||||+|||||+|+.|+.||..-
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------- 575 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------- 575 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------
Confidence 9877654 5678999999997654322 3678999999999999999999999521
Q ss_pred CCChhHHHHHHHhhhccccccchhhc-cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 576 AVDLPRWVQSVVREEWTAEVFDLELM-RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... .+..+.|+... .++...+ ..+++++++.||+.||.+||+..|+++
T Consensus 576 ----~n~~a------Kl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 576 ----INQIA------KLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHHH------HHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11111 12333444221 1222221 123889999999999999999999975
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=297.65 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.+ +...|++|.+...... ...++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999954 2467999988754433 456899999999999999999999999988899999999
Q ss_pred cCCCChhHHhhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 438 MPNGSLFWLLHGNRGPG----RTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
+++|+|.+++....... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++++|||++.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999997554211 125899999999999999999999 7899999999999999999999999999986
Q ss_pred cCCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 514 FAPPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 514 ~~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
..... ...++..|+|||.+. +...+.++||||||+++|||++ |..||.... ....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~------------~~~~~~~~ 231 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS------------DEEVLNRL 231 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccc------------hHHHHHHH
Confidence 54322 223355699999654 4567889999999999999999 788885321 11122211
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.... ... .........+.+++.+||+.+|++|||+.|+++.|.
T Consensus 232 ~~~~-~~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGK-LEL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCC-cCC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111 000 000122346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.88 Aligned_cols=188 Identities=22% Similarity=0.300 Sum_probs=159.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 434 (672)
..+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 3478999999999999954 68999999987532 22456778899999999999999999988643 246899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++ +|.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 999965 67766642 3788999999999999999999 88999999999999999999999999999986
Q ss_pred CCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 515 APPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
.... ...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CCCccccCCccccCCccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6443 345788999999764 557889999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.30 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=188.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 467999999999999964 689999999864322 223567889999999999999999999999999999999996 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 84 DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 8888776432 35899999999999999999999 789999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc-----
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW----- 591 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 591 (672)
...++..|+|||++.. ...++.++|||||||++|||+||+.|+...... .+......+.-.
T Consensus 156 ~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 223 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----------DDQLKRIFRLLGTPTEE 223 (284)
T ss_pred cCCCccccCCcChHHHhC-CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----------HHHHHHHHHHhCCCChH
Confidence 2345778999997643 345789999999999999999999997532211 111111110000
Q ss_pred ----cccccchh-hccc-------cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 ----TAEVFDLE-LMRY-------KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ----~~~~~d~~-~~~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.....+.. .... ........++.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 0000 000112345678888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=301.05 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=189.0
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEc------CCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFA------REEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~ 435 (672)
+.+.||+|+||.||+|.. .+++.||+|.+..... ...++..|+.++.++ +|+||+++++++.. ....+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 447899999999999996 4689999998865432 446788899999998 69999999999863 45779999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++|+|.+++..... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.++|+|||++...
T Consensus 99 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 99 EFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 99999999999975432 34788899999999999999999 789999999999999999999999999998754
Q ss_pred CC-----CCCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 516 PP-----STVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 516 ~~-----~~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
.. ....++..|+|||++... ...++.++|||||||++|||++|+.||....... -....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------------~~~~~- 238 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------------ALFLI- 238 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh------------hhhhH-
Confidence 32 234567889999976532 3467889999999999999999999996432110 00000
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ..... .......+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~-----~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 PRNP-----PPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhCC-----CCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 00000 0122346888999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=298.21 Aligned_cols=240 Identities=24% Similarity=0.408 Sum_probs=191.7
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCC---CCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLR---HPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
..+.||+|+||.||+|.. .+++.||+|.++... .....++.+|++++++++ |||++++++++......++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 357899999999999995 578999999986532 234567889999998886 999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++|.+++... .+++..++.++.|+++||.||| +.+|+||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 85 EGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred CCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999998643 4899999999999999999999 789999999999999999999999999998765433
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||.+.. +..++.++|||||||++|+|++|+.||..... ..+.... ...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------------~~~~~~~-~~~--- 217 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDA------------FRAMMLI-PKS--- 217 (277)
T ss_pred ccccccccCCcceeCHHHhcc-CCccccchhHHHHHHHHHHHHhCCCCCCCCCh------------hhhhhcc-ccC---
Confidence 3356778999997642 35578899999999999999999999964321 1111100 000
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+.... ......+.+++.+||+.||++||++.|+++
T Consensus 218 --~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 --KPPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --CCCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0001100 012346788889999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=286.19 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=171.9
Q ss_pred CHHHHHH-HHhcccCcCCeEEEEEEEEcC-----CcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEc
Q 005880 356 ELEDLLR-ASAEMLGKGGFGTAYKAVLDD-----GSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFA 427 (672)
Q Consensus 356 ~~~~l~~-~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 427 (672)
.+|++.+ .....||+|.||.||+|...+ ...+|+|+++.... +-.....+|+.+++.++||||+.+..++..
T Consensus 19 rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 19 RVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred hHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 3444442 345789999999999997432 23799999985432 234567899999999999999999998877
Q ss_pred -CCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC----C
Q 005880 428 -REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT----G 502 (672)
Q Consensus 428 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~----~ 502 (672)
+...++++||.+. +|..+++.++......++...+..|+.||+.|+.||| ++=|+||||||.||||..+ |
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccC
Confidence 7788999999988 8999998776655567999999999999999999999 7789999999999999877 8
Q ss_pred cEEEeccCCCccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
.+||+|||+++.+... ..+.|..|+|||++.+ ...||.+.||||.|||+.||+|-++-|..+.
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-ARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc-cccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999999999877543 4456889999998764 5789999999999999999999999887654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.38 Aligned_cols=190 Identities=25% Similarity=0.381 Sum_probs=165.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||++... +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 478999999999999965 68999999987432 22345788899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 86 GDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred ccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999754 34899999999999999999999 889999999999999999999999999998644211
Q ss_pred --------------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 005880 519 --------------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKC 560 (672)
Q Consensus 519 --------------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~ 560 (672)
...||..|+|||++. +..++.++|||||||++|||++|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM--QTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc--CCCCCCcceeccccceeeecccCCC
Confidence 235788999999764 5678899999999999999999999
Q ss_pred CCCCC
Q 005880 561 PSVID 565 (672)
Q Consensus 561 P~~~~ 565 (672)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 99643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=299.99 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=189.3
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcC-----CeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR-----EEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e~ 437 (672)
.+.||+|+||.||++.. .+++.+|+|.+..... ...++.+|+.++.++ +|||++++++++... +..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 36799999999999996 4689999999865432 346778899999998 899999999998754 357999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.++++.... ....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 106 ~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 106 CNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred CCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 999999998864321 1245899999999999999999999 78999999999999999999999999999876543
Q ss_pred C-----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S-----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...++..|+|||++... +..++.++|||||||++|||++|+.||..... ..-+....+.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------------~~~~~~~~~~ 248 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------------VKTLFKIPRN 248 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------------HHHHHHHhcC
Confidence 2 34567789999976432 12368899999999999999999999864321 1111111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+. ..+.....+.+++.+||+.+|++||++.|+++
T Consensus 249 -~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 -PPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -CCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000111 11223345888999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.21 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=193.0
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++..+...++||||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 3577999999999999964 68999999987544 224568999999999999999999999999999999999999 9
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.... .++++.+++.++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999987543 45899999999999999999999 789999999999999999999999999998766433
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh----
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE---- 590 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 590 (672)
...++..|+|||.+.. ...++.++||||+|+++|||+||++||....... ...++.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYG-ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---------QLAIVFRTLGTPNEET 224 (286)
T ss_pred CccccccCcccccCceeeec-cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---------HHHHHHHHcCCCChHH
Confidence 2346778999997643 3456899999999999999999988875432110 000110000000
Q ss_pred ---------ccccccchhh-ccc-cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 ---------WTAEVFDLEL-MRY-KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ---------~~~~~~d~~~-~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+....+.... ... ....+....+.+++.+|++.+|++|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 000 000112356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=301.12 Aligned_cols=241 Identities=23% Similarity=0.381 Sum_probs=192.8
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 347899999999999985 4688999999875554456778999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99998643 3789999999999999999999 889999999999999999999999999988655432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+. ...++.++|||||||++||+++|+.||........ +.......
T Consensus 173 ~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------------~~~~~~~~------- 231 (293)
T cd06647 173 STMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------------LYLIATNG------- 231 (293)
T ss_pred ccccCChhhcCchhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------------eeehhcCC-------
Confidence 234667899999764 45678999999999999999999999965432110 00000000
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. ............+.+++.+||..+|++||++.+++..
T Consensus 232 -~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 -T-PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -C-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0001111223457788899999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.94 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=194.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|+.. +|..||+|++..... .....+.+|++++++++|||++++++++.+++..++||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 3477999999999999954 689999999864322 234578899999999999999999999999999999999996
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
|+|.+++.... .++++.++..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 109 -g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 109 -GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 58877775433 45899999999999999999999 789999999999999999999999999998765543
Q ss_pred CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++.. ....++.++|||||||++|||++|+.||.... ..............
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------------~~~~~~~~~~~~~~----- 242 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------------AMSALYHIAQNESP----- 242 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------------HHHHHHHHHhccCC-----
Confidence 4567788999997642 24568899999999999999999999986431 11111111111100
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
..........+.+++.+||+.+|.+||++.++++.+-.+
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 000112334578888899999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=297.94 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=192.0
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCC------eEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFARE------EKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~lv~ 435 (672)
+.+.||+|++|.||+|... +++.+++|++..... ...++.+|+++++++ +|+||+++++++.... ..++||
T Consensus 10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred heeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 3578999999999999965 578999999875543 456799999999999 6999999999997644 479999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++++|.+++..... ....+++..+..++.|+++||+||| +.+++||||+|+||++++++.+||+|||++...
T Consensus 89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 89 ELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999865331 1246899999999999999999999 889999999999999999999999999998755
Q ss_pred CCC-----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 516 PPS-----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 516 ~~~-----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
... ...++..|+|||++... ...++.++|||||||++|||++|+.||...... .......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~~~~~~ 231 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------------RALFKIP 231 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------------HHHHHhh
Confidence 432 34467789999976432 345778999999999999999999999632110 1111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .. + ...........+.+++.+||..||++|||+.|+++
T Consensus 232 ~~-~~-----~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN-PP-----P---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc-CC-----C---CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 00 0 01111223456788899999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.20 Aligned_cols=241 Identities=26% Similarity=0.421 Sum_probs=193.2
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|++++++++||||+++++.+..++..++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 357899999999999995 468999999986543 23456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCCCC-
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~- 518 (672)
++|.+++.... ...+++..+..++.++++||+||| +.+++||||||+||+++++ +.+||+|||.+......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999997543 245899999999999999999999 7899999999999999865 46899999999766543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. +..++.++||||||+++|+|++|+.||.... ....+........ ..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~------------~~~~~~~~~~~~~-~~~ 221 (256)
T cd08220 157 KAYTVVGTPCYISPELCE--GKPYNQKSDIWALGCVLYELASLKRAFEAAN------------LPALVLKIMSGTF-API 221 (256)
T ss_pred cccccccCCcccCchhcc--CCCCCcccchHHHHHHHHHHHhCCCCcccCc------------hHHHHHHHHhcCC-CCC
Confidence 345677899999764 4567889999999999999999999986432 2222222222111 000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ......+.+++.+||+.+|.+|||+.|+++
T Consensus 222 ~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 S----------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C----------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 112345778889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=288.76 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=193.8
Q ss_pred HhcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcch---HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGG---KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||.|..|+||++++++ +..+|+|++.+..... ..+.+.|-+||+.++||.+..+|+.+..++..++|||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45789999999999999764 5899999998755443 3467789999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
||+|..+.+.+.. ..+++..+.-++..++-||+||| -.|||.|||||+||||.++|++.|+||.++.....
T Consensus 161 GGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 161 GGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred CccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999987653 56999999999999999999999 78999999999999999999999999998632100
Q ss_pred -----------------------------------------------------------CCCCCCCcccCCCccccCCCC
Q 005880 518 -----------------------------------------------------------STVPRSNGYRAPELSSSDGRK 538 (672)
Q Consensus 518 -----------------------------------------------------------~~~~~t~~y~aPE~l~~~~~~ 538 (672)
...+||-.|.|||++. +..
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~--G~G 311 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR--GEG 311 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee--cCC
Confidence 0123456699999886 456
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHH
Q 005880 539 QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAM 618 (672)
Q Consensus 539 ~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~ 618 (672)
.+.++|.|+|||++|||+.|+-||.+.+..+ -+..++.+ .+ .++...+......+||+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~------------Tl~NIv~~---------~l-~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE------------TLRNIVGQ---------PL-KFPEEPEVSSAAKDLIR 369 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh------------hHHHHhcC---------CC-cCCCCCcchhHHHHHHH
Confidence 7889999999999999999999998765432 11111111 11 12222244566788999
Q ss_pred hccCCCCCCCCC----HHHHH
Q 005880 619 ACTSASPDQRPN----MSHVV 635 (672)
Q Consensus 619 ~Cl~~dP~~RPt----~~evl 635 (672)
+.|.+||.+|.. +.||-
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHhccChhhhhccccchHHhh
Confidence 999999999998 55553
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.21 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=195.0
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+...+..++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 3578999999999999954 68899999987533 225678899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++..... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++......
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999975431 235899999999999999999999 889999999999999999999999999998655432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||.+... ..++.++|||||||++|||++|+.||...... +.+........
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------------~~~~~~~~~~~- 224 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPM------------KVLMLTLQNDP- 224 (267)
T ss_pred cccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChh------------hhHHHHhcCCC-
Confidence 22467789999976532 46889999999999999999999999643211 11111111110
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+..............+.+++.+||+.||++||++.|+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 -----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -----CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001000001123356778888999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.48 Aligned_cols=239 Identities=20% Similarity=0.342 Sum_probs=192.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|++|.||++.. .+++.+|+|++........+.+.+|+.+++.++||||+++++++...++.++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999995 46899999998755444566788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... ++++..+..++.|++.||+||| +.+|+||||+|+||+++.++.++|+|||.+......
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9998752 3889999999999999999999 889999999999999999999999999988654332
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||.+. +..++.++|||||||++|||++|+.||.... ........... .. +
T Consensus 174 ~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------------~~~~~~~~~~~-~~-----~ 233 (285)
T cd06648 174 SLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------------PLQAMKRIRDN-LP-----P 233 (285)
T ss_pred cccCCccccCHHHhc--CCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------------HHHHHHHHHhc-CC-----C
Confidence 234678899999754 4568899999999999999999999986431 12222222111 00 0
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... .......+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 234 KLKN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCcc---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0000 0112346788899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=279.62 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=195.1
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEK 431 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 431 (672)
.++.|+ .....||.|..|.|++++.+ +|...|||.+.... .++.+++...++++.+-+ +|.||+.+|||..+...
T Consensus 89 ~dindl--~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDL--ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHh--hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 455555 45577999999999999965 58999999997643 345567777777766654 89999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
++.||.| .-.++.+++.-. .++++..+=++...+.+||.||.+ .++|+|||+||+|||+|+.|++|+||||+
T Consensus 167 ~IcMelM-s~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEeecccc
Confidence 9999998 446777776554 468888888999999999999984 68999999999999999999999999999
Q ss_pred CccCCCC----CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 512 SIFAPPS----TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 512 a~~~~~~----~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
+-.+..+ ...|-+.|||||-+... ...|+.++||||||+.++||.||+.||..-.. + .+.+..+
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----------d-Fe~ltkv 307 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----------D-FEVLTKV 307 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----------c-HHHHHHH
Confidence 9665443 44566779999976544 56788999999999999999999999975321 1 1222333
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..++. +.+.... .....+.+++..||.+|+.+||...++++
T Consensus 308 ln~eP------P~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 308 LNEEP------PLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HhcCC------CCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 33221 1111111 13345778888999999999999999875
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.81 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=196.5
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|++|.||++... +++.||+|++..... ...+++.+|++++++++||||+++++++...+..++|+||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 4567999999999999965 689999999876432 34567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++.... .++++..+..++.|+++||+||| + .+++||||||+||++++++.++|+|||.+......
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999997543 45889999999999999999999 7 89999999999999999999999999998655322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+. +..++.++||||||+++|+|++|+.||...... .....+.++........
T Consensus 157 ~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~----- 222 (265)
T cd06605 157 KTFVGTSSYMAPERIQ--GNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-------PDGIFELLQYIVNEPPP----- 222 (265)
T ss_pred hcccCChhccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-------cccHHHHHHHHhcCCCC-----
Confidence 355678899999764 457899999999999999999999999644211 11222222222221100
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .. ......+.+++.+||..+|++|||+.|++.
T Consensus 223 -~~--~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 -RL--PS--GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CC--Ch--hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 00 113345788889999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=301.90 Aligned_cols=262 Identities=25% Similarity=0.335 Sum_probs=190.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 478999999999999975 589999999864322 23567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.++.... ..+++.++..++.|+++||+||| +.+++||||+|+||++++++.++|+|||++......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 86 VLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 998877543 23899999999999999999999 789999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCChhHHHHHHHhhh-ccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGC--GGAVDLPRWVQSVVREE-WTA 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~ 593 (672)
...++..|+|||++.. ...++.++||||||+++|||++|++||......+.... .....+........... ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 YTDYVATRWYRAPELLVG-DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred cCcccceeeccCcHHhcc-ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2345778999997643 34577899999999999999999999864321000000 00000000000000000 000
Q ss_pred cccchhhccccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+....... .......+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 0112346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.89 Aligned_cols=244 Identities=19% Similarity=0.278 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||++... +++.||+|.+..... .....+.+|++++..++||||+++++++..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 478999999999999955 578999999875432 2345788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
++|.+++... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 86 GDCATLLKNI-----GALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999654 34899999999999999999999 78999999999999999999999999998863211
Q ss_pred -----------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChh
Q 005880 518 -----------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP 580 (672)
Q Consensus 518 -----------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~ 580 (672)
....++..|+|||.+. ...++.++|||||||++|||++|+.||.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------------~~ 222 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------------PE 222 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HH
Confidence 0124567899999764 4578899999999999999999999996321 22
Q ss_pred HHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 581 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
++......... ..+.. . ......+.+++.+||+.||++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~----~~~~~---~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 ELFGQVISDDI----EWPEG---D--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHhccc----CCCCc---c--ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22222222111 00000 0 1123357788889999999999998877777776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=293.23 Aligned_cols=239 Identities=24% Similarity=0.363 Sum_probs=184.1
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc-----chHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI-----GGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 435 (672)
..+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.++++++||||+++++++.+ +...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 347899999999999995 4689999998864321 234568899999999999999999998875 35678999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999997542 4889999999999999999999 789999999999999999999999999998754
Q ss_pred CCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 516 PPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 516 ~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
... ...++..|+|||.+. +..++.++|||||||++|||++|+.||.... ....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------------~~~~~~~~~ 222 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVIS--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------------AMAAIFKIA 222 (266)
T ss_pred ccccccCCccccCCccccccCHHHhC--CCCCCchhhhHHHHHHHHHHHHCCCCccccc------------hHHHHHHHh
Confidence 321 234677899999764 5678899999999999999999999996321 111111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... ..+.. .......+..++ +||..+|++||+++||++
T Consensus 223 ~~~-----~~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQP-----TNPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCC-----CCCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 110 01111 011122344455 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=292.73 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=192.3
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++.+++||||+++++++..++..++||||++++
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 457899999999999985 468999999886433 224567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++... .+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 999998642 4889999999999999999999 789999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+. +..++.++|||||||++|||++|..||.... ...+........ . ..+
T Consensus 158 ~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------------~~~~~~~~~~~~-~-~~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELAKGEPPHSELH------------PMKVLFLIPKNN-P-PTL 221 (277)
T ss_pred hccccCCccccChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCccc------------hHHHHHHHhcCC-C-CCC
Confidence 234677899999654 4577889999999999999999999985321 111111111110 0 000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01223457788889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.57 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=187.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||++... +|+.||+|.+..... .....+.+|+.++.++. |+||+++++++..++..+++|||++
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 3478999999999999954 689999999875432 34567889999999996 9999999999999999999999985
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+++.++...........+++..+..++.|+++||+|||+ ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 465554321111112458999999999999999999992 258999999999999999999999999998754432
Q ss_pred --CCCCCCcccCCCccccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDG-RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~-~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++.... ..++.++|||||||++|||++|+.||.... ...+.+.......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----------~~~~~~~~~~~~~----- 227 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----------SVFDQLTQVVKGD----- 227 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----------hHHHHHhhhcCCC-----
Confidence 345678899999765321 368899999999999999999999986321 1111111111110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+.... ........++.+++.+||+.+|++|||+.||++
T Consensus 228 -~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 -PPILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCcCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001100 110123446788899999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=291.38 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=191.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-----cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-----IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 467999999999999976 78999999886433 123467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++|.+++... .++++..+..++.|+++||+||| +.+|+|+||+|+||+++.++.+||+|||.+......
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 85 PGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999754 24889999999999999999999 789999999999999999999999999998765432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||.+... ..++.++||||||+++|+|++|+.||.... ................
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------------~~~~~~~~~~~~~~~~ 222 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLE------------GVAAVFKIGRSKELPP 222 (258)
T ss_pred ccccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCc------------HHHHHHHHHhcccCCC
Confidence 34467789999976432 248899999999999999999999986421 1111111111000000
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+ . ......+.+++.+||+.+|++||++.+++.
T Consensus 223 -~------~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 -I------P---DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -c------C---CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 0 112245677888999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.71 Aligned_cols=192 Identities=27% Similarity=0.395 Sum_probs=163.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 467999999999999964 689999999874322 234578899999999999999999999999999999999995 6
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|..++.... ...+++..+..++.|+++||+||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 8988886543 245899999999999999999999 789999999999999999999999999998755432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...++..|+|||++.. ...++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 157 YTHEVVTLWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cccccccccccCCeEEec-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2334678999997643 344688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.06 Aligned_cols=253 Identities=21% Similarity=0.219 Sum_probs=189.3
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.+|.|+++.||++.. +|+.||||+++.. .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566666766666665 6899999998754 3335578999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++..... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999976432 34889999999999999999999 789999999999999999999999999988644221
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...++..|+|||++......++.++|||||||++|||++|+.||....... ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-----------~~~~~-~~~ 225 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-----------MLLEK-VRG 225 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-----------HHHHH-Hhc
Confidence 233566799999876443568899999999999999999999997432110 00000 000
Q ss_pred hc---------------ccc----ccchhhc---cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EW---------------TAE----VFDLELM---RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~---------------~~~----~~d~~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ... ..++... ...........+.+++.+||..||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 226 TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00 000 0000000 00011122346788999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.78 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=191.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 467999999999999965 5899999999754332 446788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999987543 245899999999999999999999 789999999999999999999999999998644221
Q ss_pred --------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 519 --------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 519 --------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
...++..|+|||++. +..++.++||||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS--GDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc--CCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 124577899999764 5578899999999999999999999996432
Q ss_pred CCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 567 GGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.. ........... ...........+.+++.+||+.||++||++...++.+.
T Consensus 237 ~~------------~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 237 RD------------ETFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred hH------------HHHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 11 11111111110 01111113456888889999999999999444433333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.16 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=192.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 3478999999999999954 6899999998755442 567899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... ..+++..+..++.|+++||+||| +.+|+||||+|+||++++++.+||+|||++......
T Consensus 84 ~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 84 GTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999753 24789999999999999999999 789999999999999999999999999998765432
Q ss_pred -------CCCCCCcccCCCccccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDG-RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~-~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++..|+|||++.... ...+.++||||||+++||+++|+.||..... .......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~-~ 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----------EFQIMFHVGA-G 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----------hHHHHHHHhc-C
Confidence 234567899999775432 2378899999999999999999999963211 0011111110 0
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+.. +........+.+++.+||+.+|.+|||+.|++.
T Consensus 223 -----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -----HKPPI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCCC---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00011 111112345678888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.68 Aligned_cols=191 Identities=24% Similarity=0.353 Sum_probs=162.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||++ ++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence 468999999999999965 6899999998643321 23457789999999999999999999999999999999997 49
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++.....++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 89 LKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999887543 35889999999999999999999 789999999999999999999999999998654321
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...++..|+|||++.. ...++.++||||+|+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 161 SNEVVTLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccccCCcHHhhc-CcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2234678999997642 345788999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=293.44 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 440 (672)
.+.||.|++|.||+|... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 367999999999999964 589999999875332 3457789999999999999999999998654 367899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++..... ....+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999998764321 2245889999999999999999999 789999999999999999999999999998654432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+. +..++.++|||||||++|||++|+.||...... .....+......... ... +.
T Consensus 161 ~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~-~~ 229 (287)
T cd06621 161 GTFTGTSFYMAPERIQ--GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-------PLGPIELLSYIVNMP-NPE-LK 229 (287)
T ss_pred ccccCCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-------CCChHHHHHHHhcCC-chh-hc
Confidence 344677899999654 567889999999999999999999999754221 011112222111111 000 00
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .........+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 000112356788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.26 Aligned_cols=193 Identities=24% Similarity=0.285 Sum_probs=160.7
Q ss_pred cccCcC--CeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKG--GFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+| +||+||+++. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999996 4799999999874332 2346788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+......
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 999999876432 34889999999999999999999 789999999999999999999999999854322111
Q ss_pred ----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 ----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 ----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...++..|+|||++......++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 11234569999987544456789999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=293.97 Aligned_cols=239 Identities=22% Similarity=0.325 Sum_probs=182.4
Q ss_pred ccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHH---HHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 367 MLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHME---VLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.||+|+||.||++... +|+.||+|.+...... ....+.+|.. ++...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6899999988653221 2233444443 3344579999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 99999998744 34899999999999999999999 789999999999999999999999999998755432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+.. +..++.++|||||||++|||++|+.||....... . ......... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~-~~~~~~~~~------~ 214 (279)
T cd05633 152 PHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------K-HEIDRMTLT------V 214 (279)
T ss_pred ccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---------H-HHHHHHhhc------C
Confidence 3457889999997542 3567899999999999999999999996542211 1 111111100 0
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
.... .......+.+++.+||+.||++|| +++|+++
T Consensus 215 ~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 NVEL-----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CcCC-----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 0000 011234577888899999999999 5888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.73 Aligned_cols=240 Identities=29% Similarity=0.406 Sum_probs=190.6
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+||.|.||.||-|. .++|...|||.++-.. ........+|+.++..++|||+|+++|+-.+++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999999 6679999999886432 223457789999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+.+...+ -.++.....+..|++.|++||| +++||||||||.||+++.+|.+|++|||.|..+...
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999998654 2566667788999999999999 899999999999999999999999999999877653
Q ss_pred ------CCCCCCcccCCCccccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDG-RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~-~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...||+.|||||++.... ....-++||||+|||+.||+||+.||...+. +|.-...-.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------------e~aIMy~V~-- 1455 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------------EWAIMYHVA-- 1455 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------------hhHHHhHHh--
Confidence 456899999999987543 4456789999999999999999999964322 121111100
Q ss_pred cccccchhhccccCh-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMRYKDI-EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+.+ +....+=.+++..|+..||+.|.++.|+++
T Consensus 1456 --------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 --------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 0000111 112223445666999999999999887653
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.44 Aligned_cols=196 Identities=24% Similarity=0.392 Sum_probs=163.9
Q ss_pred hcccCcCCeEEEEEEEEc---CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD---DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 436 (672)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 467999999999999964 47999999998633 23346778899999999999999999999988 78999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC----CCcEEEeccCCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK----TGNARVSDFGLS 512 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DfG~a 512 (672)
|+++ +|.+++..........+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9965 7777775443323346899999999999999999999 889999999999999999 899999999998
Q ss_pred ccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 513 IFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 513 ~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
+..... ...++..|+|||++.. ...++.++|||||||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 765332 2345778999997542 3467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.86 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=194.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|++|.||+|... ++..||+|++..... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999976 689999999976544 567889999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 103 TDIITQNF----VRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 99998643 36999999999999999999999 789999999999999999999999999988654432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||.+. +..++.++|||||||++|+|++|+.||..... ........... ...
T Consensus 175 ~~~~~~~y~~PE~~~--~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------------~~~~~~~~~~~-~~~---- 235 (286)
T cd06614 175 SVVGTPYWMAPEVIK--RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------------LRALFLITTKG-IPP---- 235 (286)
T ss_pred cccCCcccCCHhHhc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhcC-CCC----
Confidence 334567899999764 45688999999999999999999999864321 11111111111 000
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..........+.+++.+||+.+|.+||++.++++
T Consensus 236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111112346778899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.05 Aligned_cols=238 Identities=21% Similarity=0.356 Sum_probs=191.2
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+||+|+||.||++.. .+|+.||||++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 6799999999999986 468999999986554445677899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----C
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-----T 519 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----~ 519 (672)
+++... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++...... .
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 987532 3789999999999999999999 789999999999999999999999999988655332 2
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||.+. +..++.++||||||+++|||++|+.||.... ..+.+... .... ...
T Consensus 176 ~~~~~~y~~pE~~~--~~~~~~~~Dv~slGvil~el~tg~~p~~~~~------------~~~~~~~~-~~~~-----~~~ 235 (292)
T cd06657 176 LVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------------PLKAMKMI-RDNL-----PPK 235 (292)
T ss_pred cccCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHH-HhhC-----Ccc
Confidence 44678899999653 4567899999999999999999999986431 11111111 1110 001
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ........+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~---~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 LK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cC---CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 10 11112335677888999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.62 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=187.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHH-HcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEV-LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|+.+ ++.++||||+++++++..++..++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 467999999999999965 699999999875432 234556666665 566789999999999999999999999996 6
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC-CcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL-KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++..... ....+++..++.++.|++.||+||| +. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 85 SLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred cHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 89888865432 2256899999999999999999999 65 8999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCCccccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 --TVPRSNGYRAPELSSSD--GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~--~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||.+... ...++.++|||||||++|||++|+.||..... . .+.........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~-~~~~~~~~~~~---- 224 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----------P-FQQLKQVVEEP---- 224 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----------C-HHHHHHHHhcC----
Confidence 24467789999976431 14568899999999999999999999853211 1 11111111110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+.... .....++.+++.+||..+|++||++.++++
T Consensus 225 --~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 112345788889999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=294.09 Aligned_cols=190 Identities=26% Similarity=0.366 Sum_probs=159.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|... +|..||+|++..... .....+.+|+++++.++|+||+++++++..++..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 367999999999999854 689999999865432 234567889999999999999999999999999999999995 67
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+.+..+..++.|+++||+||| +.+|+||||||+||+++.++++||+|||+++.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 777765432 34788889999999999999999 789999999999999999999999999998754322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...++..|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 161 SSEVVTLWYRPPDVLLG-ATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCccccccccCCceeec-CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2345778999997642 23578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=292.31 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=191.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|++|.||+|.. .+++.||+|.++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999994 5789999999864321 1246789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAP 516 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~ 516 (672)
+++++|.+++... .++++..+..++.|++.||+||| +.+++||||||+||+++.++ .+||+|||.+....
T Consensus 85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 85 MAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred cCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999753 35889999999999999999999 88999999999999998776 59999999987654
Q ss_pred CC---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 517 PS---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 517 ~~---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
.. ...++..|+|||++. +..++.++||||+|+++|+|++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~ 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLR--GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---------NHLALIFKIA 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---------chHHHHHHHh
Confidence 32 234577899999764 457789999999999999999999999643211 1111111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... + .........+.+++.+|+..+|.+||++.|+++
T Consensus 225 ~~~~~-----~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 SATTA-----P-----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ccCCC-----C-----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11000 0 011223356788899999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=295.00 Aligned_cols=193 Identities=26% Similarity=0.367 Sum_probs=163.2
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEee
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEY 437 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 437 (672)
...+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++.+++||||+++++++... ...++||||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 34578999999999999965 5899999998743322 234677899999999999999999999877 889999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
++ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 88 VE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred cC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 96 59999887543 35899999999999999999999 78999999999999999999999999999876544
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
. ...++..|+|||.+.. ...++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CccccccccccccccCchhhcC-CccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3 2345678999997643 234688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=289.17 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=193.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||++.. .+|..||+|.++... ....+++.+|++++++++||||+++++++.. ....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 46799999999999995 468999999987433 2345678899999999999999999998864 346789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-CCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC-KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+++|.+++..... ...++++..++.++.|+++||+|||..+ .+.+++||||||+||++++++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999975432 2356899999999999999999999332 1368999999999999999999999999999876543
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||.+. +..++.++||||||+++|+|++|+.||.... ......... .....
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~-~~~~~ 228 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLN--HMSYDEKSDIWSLGCLIYELCALSPPFTARN------------QLQLASKIK-EGKFR 228 (265)
T ss_pred cccccccccCCCccChhhhc--CCCCCchhHHHHHHHHHHHHHHCCCcccCcC------------HHHHHHHHh-cCCCC
Confidence 235678899999764 4568899999999999999999999996432 112222111 11100
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.........+.+++.+|++.+|++||++.+|++
T Consensus 229 ----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 ----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 001123356788899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=294.46 Aligned_cols=260 Identities=20% Similarity=0.209 Sum_probs=187.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCC-CCceeeeEEEEEcC--CeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAR--EEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+||+++++++.+. +..++|+||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 467999999999999954 689999999875422 22334557888888885 99999999999987 88999999996
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
|+|.+.+.... ..+++.++..++.|++.||+||| +.+++||||||+||+++. +.+||+|||+++.....
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 58888886533 35899999999999999999999 789999999999999999 99999999999765432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhhcc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||++.. +..++.++|||||||++|||++|+.||......+... ...+.....|... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (282)
T cd07831 154 PYTEYISTRWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRH 231 (282)
T ss_pred CcCCCCCCcccCChhHhhc-CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh-hccccc
Confidence 3346778999996543 3467889999999999999999999996542111000 0000001111110 000000
Q ss_pred ccccchhhcc---ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMR---YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.....+.... ..........+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 0000123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=289.18 Aligned_cols=238 Identities=23% Similarity=0.297 Sum_probs=184.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-----cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-----IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 436 (672)
.+.||+|+||.||+|... +|..||||.+.... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 478999999999999964 58999999875321 12245788899999999999999999988764 45779999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++++|.+++... ..+++....+++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 87 HMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 99999999998743 24788999999999999999999 7899999999999999999999999999987543
Q ss_pred C--------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 P--------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~--------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
. ....++..|+|||++. +..++.++|||||||++|||++|+.||..... ..-+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~ 223 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVIS--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------------MAAIFKIAT 223 (265)
T ss_pred cccccccccccCCCCccccChhhhc--CCCCCcchhHHHHHHHHHHHhhCCCCCCccch------------HHHHHHHhc
Confidence 2 1234677899999764 45688999999999999999999999863210 111111111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ..+ .........+.+++.+|+. +|++||+++|+++
T Consensus 224 ~~-----~~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QP-----TNP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC-----CCC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 000 0112223456677778884 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=288.31 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=196.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|++|.||+|+.. +++.||||++..... .....+.+|++.+.+++|+||+++++++...+..++||||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 3478999999999999966 589999999876543 35678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++... .++++..++.++.|+++||+||| + .+++||||+|+||+++.++.++|+|||.+......
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999754 35899999999999999999999 7 89999999999999999999999999998766543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. +..++.++||||||+++|||+||+.||..... ....+..........
T Consensus 156 ~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---------~~~~~~~~~~~~~~~---- 220 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQ--GESYSYAADIWSLGLTLLECALGKFPFLPPGQ---------PSFFELMQAICDGPP---- 220 (264)
T ss_pred cccceeecccccCHhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCccccc---------cCHHHHHHHHhcCCC----
Confidence 234567899999654 45788999999999999999999999965421 011222222221110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
+... . ......+.+++.+||+.+|++||++.|+++.
T Consensus 221 --~~~~--~--~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 --PSLP--A--EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCC--c--ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 0 0033467888889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=292.74 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=190.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|++|.||+|... +|..||+|++.... ......+.+|++++++++|||++++++++.+.+..++||||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 3478999999999999954 79999999987433 2234678899999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++..... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 689999875431 35899999999999999999999 789999999999999999999999999998755322
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH--------
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV-------- 587 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 587 (672)
...++..|+|||++.. +..++.++||||||+++|||++|+.||....... .+...+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--------QLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCccccccCCCCCceeec-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhCCCChHHhh
Confidence 2234678999997643 3456889999999999999999999996432110 0000000000
Q ss_pred ----hhhccccccchhhcc-ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 ----REEWTAEVFDLELMR-YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ----~~~~~~~~~d~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+............ ..........+.+++.+|++.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000000 0000111245778999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=285.21 Aligned_cols=241 Identities=28% Similarity=0.451 Sum_probs=196.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|++++++++..+...++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999975 6899999999866555667899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----C
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----T 519 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 519 (672)
.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||.+...... .
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 99987643 45899999999999999999999 789999999999999999999999999998776543 3
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||.+. +..++.++||||||+++|+|++|+.||.... .......... ......
T Consensus 157 ~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~-~~~~~~---- 217 (253)
T cd05122 157 MVGTPYWMAPEVIN--GKPYDYKADIWSLGITAIELAEGKPPYSELP------------PMKALFKIAT-NGPPGL---- 217 (253)
T ss_pred eecCCcccCHHHHc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCc------------hHHHHHHHHh-cCCCCc----
Confidence 45677899999764 4458899999999999999999999986431 1111111111 100010
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.........+.+++.+||+.||++|||+.|+++
T Consensus 218 ----~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 ----RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000111346788899999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=294.90 Aligned_cols=237 Identities=23% Similarity=0.323 Sum_probs=189.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||++... +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 3478999999999999965 68999999986532 2234678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++... ..+++..+..++.|+++||+||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 85 ~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 85 GGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 99999999754 35899999999999999999999 789999999999999999999999999999776544
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+. +...+.++||||||+++|+|++|+.||.... ............
T Consensus 156 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~------- 214 (290)
T cd05580 156 YTLCGTPEYLAPEIIL--SKGYGKAVDWWALGILIYEMLAGYPPFFDDN------------PIQIYEKILEGK------- 214 (290)
T ss_pred CCCCCCccccChhhhc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHhcCC-------
Confidence 345678899999664 4567889999999999999999999986432 111111111111
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVV 635 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl 635 (672)
...... ....+.+++.+||..||.+|| +++|++
T Consensus 215 --~~~~~~---~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 --VRFPSF---FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --ccCCcc---CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 000111 123567888899999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=289.25 Aligned_cols=240 Identities=26% Similarity=0.399 Sum_probs=192.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999965 58899999986432 234567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++.... ...+++..+..++.|+++||+||| +.+++|+||||+||++++++ .+||+|||.+......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999997543 235799999999999999999999 78999999999999999886 4699999998766443
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... +..+++........
T Consensus 158 ~~~~~~~~~~~~ape~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------------~~~~~~~~~~~~~~---- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGN------------NLHQLVLKICQGYF---- 219 (257)
T ss_pred cccccCCCccccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCc------------cHHHHHHHHhcccC----
Confidence 234677899999654 457889999999999999999999998532 23333333222211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+. . ......+.+++.+|+..+|++|||+.|+++
T Consensus 220 -~~~---~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -API---S---PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCC---C---CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 100 0 112235778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.46 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=188.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCe-----EEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREE-----KLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv~ 435 (672)
.+.||+|+||.||+|... +|+.||||.++.... .....+.+|+.+++.++ ||||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999965 689999998764322 23467888999999995 6999999999887665 79999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCcc
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIF 514 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~ 514 (672)
||+++ +|.+++..........+++..++.++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++.
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 99975 8988887544322356899999999999999999999 789999999999999998 88999999999875
Q ss_pred CCCC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 515 APPS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 515 ~~~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
.... ...++..|+|||++.. ...++.++||||||+++|||++|..||..... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------------~~~~~~~~~~ 227 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE------------LQQLLHIFKL 227 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhC-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHHHH
Confidence 5332 2245678999997642 34578999999999999999999999964321 1111111110
Q ss_pred hc--ccccc----chh----hc--ccc----ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EW--TAEVF----DLE----LM--RYK----DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~--~~~~~----d~~----~~--~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
-. ..... +.. .. ... .......++.+++.+||..||.+||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000 000 00 000 00112345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=287.80 Aligned_cols=232 Identities=24% Similarity=0.344 Sum_probs=187.7
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 589999999875332 2456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----C
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----T 519 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 519 (672)
.+++.... .+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99997542 4889999999999999999999 789999999999999999999999999999766543 3
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||.+. +..++.++||||||+++|||++|+.||..... +..+...........
T Consensus 152 ~~~~~~~~~PE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~~------- 212 (262)
T cd05572 152 FCGTPEYVAPEIIL--NKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----------DPMEIYNDILKGNGK------- 212 (262)
T ss_pred ccCCcCccChhHhc--CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----------CHHHHHHHHhccCCC-------
Confidence 45678899999754 45688999999999999999999999975421 122233322211100
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCC
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPN 630 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 630 (672)
. ..+ ......+.+++.+||+.+|++||+
T Consensus 213 ~-~~~--~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 213 L-EFP--NYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred C-CCC--cccCHHHHHHHHHHccCChhhCcC
Confidence 0 001 111346888999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=282.38 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=193.7
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcC-CCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGR-LRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..||.|+||+|+|-..+ .|+..|||+++.... .+.+++..|.+...+ -+.||||+++|.++.++..|+.||.| ..+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 57999999999999854 699999999986554 466788888886544 47999999999999999999999999 446
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|+.+-+.-..-....+++...-.|+...++||.||.+ ..+|||||+||+|||++..|.+||||||++-.+..+
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 6544322111123458889899999999999999985 478999999999999999999999999998665543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...|-..|||||-+...+..|+.++||||+|++|||+.||+.|+..- .+..+.+..+.......-..+.
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----------~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----------DSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----------HHHHHHHHHHHcCCCCeecCcc
Confidence 44567789999988766667999999999999999999999998532 2233333333333322111111
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...+....+..++..|+.+|-..||...++.+.
T Consensus 295 ------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112234568888889999999999999998653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=296.17 Aligned_cols=243 Identities=27% Similarity=0.394 Sum_probs=190.6
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC---CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA---SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|+.. ++..||+|.+... .....+++.+|+++++.++|+|++++++++......++||||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 4577999999999999954 6789999988642 22234578889999999999999999999999999999999996
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
|++.+++.... .++++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 68887775432 35899999999999999999999 789999999999999999999999999998765543
Q ss_pred CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||.+.. ....++.++|||||||++|||++|+.||..... ............
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~~~~------ 231 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNES------ 231 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------------HHHHHHHhhcCC------
Confidence 4557789999997642 234578899999999999999999999854211 111111111110
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
+... .......+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0000 01233457788899999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.33 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=190.6
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 3467999999999999965 58899999987432 23457889999999999999999999999999999999999998
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+.+..+.... ..+++.++..++.|+++||+||| +.+++||||+|+||++++++.+||+|||++......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 85 TLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 7776665432 34899999999999999999999 789999999999999999999999999998765443
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhhc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 591 (672)
...++..|+|||++.. ...++.++||||||+++|+|++|+.||......+... ...+.....+.........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcC-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2345678999997653 2377899999999999999999999986432110000 0000000000000000000
Q ss_pred cc-----cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TA-----EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~-----~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ...+..............++.+++.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0000000000000112456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.48 Aligned_cols=243 Identities=21% Similarity=0.273 Sum_probs=186.6
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHH-cCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVL-GRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|... +|+.||||+++..... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 6899999998754322 223344555444 455899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-CC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-ST 519 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-~~ 519 (672)
++|.+++... ..+++..+..++.|+++||.||| +.+++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence 9999999754 24889999999999999999999 78999999999999999999999999999876543 24
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||.+. +..++.++||||||+++|||++|..||.... .............. ...
T Consensus 153 ~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~~~---~~~- 214 (260)
T cd05611 153 FVGTPDYLAPETIL--GVGDDKMSDWWSLGCVIFEFLFGYPPFHAET------------PDAVFDNILSRRIN---WPE- 214 (260)
T ss_pred CCCCcCccChhhhc--CCCCcchhhhHHHHHHHHHHHHCCCCCCCCC------------HHHHHHHHHhcccC---CCC-
Confidence 55778899999764 4458899999999999999999999996432 11222222111100 000
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.........+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 ----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 000112346788888999999999998877766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.93 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=193.2
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE 430 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 430 (672)
.+.+++ +...+.||+|+||.||+|+.. +|+.||+|.+..... .....+.+|++++++++|||++++++++.+...
T Consensus 17 ~~~~~~-~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 17 DDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred CCHHHH-hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 344444 233467999999999999954 689999999864322 233568889999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++||||+. |++.+++.... .++++.++..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecC
Confidence 999999995 57877776433 35899999999999999999999 7899999999999999999999999999
Q ss_pred CCccCCCC-CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 511 LSIFAPPS-TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 511 ~a~~~~~~-~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
++...... ...++..|+|||++.. ....++.++|||||||++|||++|+.||.... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~------------~~~~~~~~~~ 234 (313)
T cd06633 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------------AMSALYHIAQ 234 (313)
T ss_pred CCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------hHHHHHHHHh
Confidence 98654332 4556788999997642 23567889999999999999999999986432 1111222111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ... . ......+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~------~~~-~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 235 NDSP------TLQ-S---NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cCCC------CCC-c---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 000 0 112235778888999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.39 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=187.7
Q ss_pred HHhcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCc-chHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASI-GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.+.||+|+||.||+|...+ ++.||||+++.... ....++.+|++++.+.. ||||+++++++.+....++||||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456889999999999999764 89999999975432 23456677887776664 9999999999999999999999985
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+++.+++.... .++++..+..++.|+++||+||| + .+|+||||+|+||++++++.+||+|||++......
T Consensus 98 -~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH----~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 98 -TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK----EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred -cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 57777765432 36899999999999999999999 4 58999999999999999999999999998765432
Q ss_pred ----CCCCCCcccCCCccccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ----TVPRSNGYRAPELSSSDG--RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~--~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||.+.... ..++.++||||||+++|||++|+.||..... ..+..........
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~- 236 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----------EFEVLTKILQEEP- 236 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----------HHHHHHHHhcCCC-
Confidence 233567899999765332 3478899999999999999999999853210 0111111111110
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.. .........++.+++.+||+.||++||++.++++.
T Consensus 237 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PS--------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00001123457888899999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=291.54 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=190.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++|+|++++++++.+. +..++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 467999999999999965 58999999998653 23456788999999999999999999999988 78999999997
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+ +|.+++.... ..+++..++.++.|+++||+||| +.+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 4 8988886542 35899999999999999999999 789999999999999999999999999999766543
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh---
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE--- 590 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 590 (672)
...++..|+|||.+.. ...++.++||||||+++|||+||+.||...... ..+....+..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~------------~~~~~~~~~~~~~ 221 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL------------EQLEKIFELCGSP 221 (287)
T ss_pred cccccccccccccCCceeeEc-cccCChHHHHHHHHHHHHHHHhCCCCCCCCChH------------HHHHHHHHHhCCC
Confidence 2334677999996542 345789999999999999999999999654311 1111111100
Q ss_pred ---ccccc--------cchhhcccc----ChHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 ---WTAEV--------FDLELMRYK----DIEE-EMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ---~~~~~--------~d~~~~~~~----~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ......... .... +...+.+++.+||..+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 000000000 0001 1456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=307.54 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=199.6
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 436 (672)
.+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3679999999999999 5679999999998643 345677889999999999999999998865443 5689999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC--CCCc--EEEeccCCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD--KTGN--ARVSDFGLS 512 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~--~~~~--~kl~DfG~a 512 (672)
||.+|+|+..|.... +..-+++.+.+.+..+++.||.||| +++|+||||||.||++- ++|+ .||+|||.|
T Consensus 98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999997654 3456999999999999999999999 88999999999999984 4454 799999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+..+.+ ..+||..|.+||++.. ...|+..+|.|||||++||.+||..||....... ...-..|.....+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk------~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPK------NNKEIMWHIITKK 244 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc------ccchhhhhhhccC
Confidence 998876 5678999999997643 4688999999999999999999999997654321 0001112211111
Q ss_pred hhccccccchhhcc---------cc--ChHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHHhc
Q 005880 589 EEWTAEVFDLELMR---------YK--DIEEEMVGLLQVAMACTSASPDQRP--NMSHVVKLIEELRG 643 (672)
Q Consensus 589 ~~~~~~~~d~~~~~---------~~--~~~~~~~~l~~li~~Cl~~dP~~RP--t~~evl~~L~~i~~ 643 (672)
........+++..+ .+ -.......+..+...+|..+|++|. ...+....+..|.+
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11111111111110 00 0122334455666688889999999 77777777777654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=289.44 Aligned_cols=239 Identities=24% Similarity=0.388 Sum_probs=191.0
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|+||.||+++.. +|+.+|+|.+..... ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 3456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99997542 5899999999999999999999 789999999999999999999999999998654322
Q ss_pred --------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 --------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 --------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++..|+|||... ....+.++||||||+++|||++|+.||.... ..+.........
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------------~~~~~~~~~~~~ 217 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVIL--GQGHSKTVDWWSLGCILYEFLVGIPPFHGET------------PEEIFQNILNGK 217 (265)
T ss_pred ccccccccCcccCccccCHHHhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHhcCC
Confidence 234567899999654 4457889999999999999999999996432 122222221111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
. . .+........+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 218 ~-----~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 I-----E-----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c-----C-----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0 0000001346788888999999999999977766655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.44 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=179.2
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--------------
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-------------- 429 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------------- 429 (672)
+.||+||||.||+++.+ ||+.||||++.-. +........+|++.+++|+|||||+++..+.+..
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 68999999999999965 8999999999744 3334567889999999999999999976553100
Q ss_pred --------------------------------------------------------------------------------
Q 005880 430 -------------------------------------------------------------------------------- 429 (672)
Q Consensus 430 -------------------------------------------------------------------------------- 429 (672)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred -------------------------eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC
Q 005880 430 -------------------------EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484 (672)
Q Consensus 430 -------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 484 (672)
..||=||||+..+|+++++.+... -.-...++++.+|++||+|+| +.
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH----~~ 716 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIH----DQ 716 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHH----hC
Confidence 025778899888888888765421 135678999999999999999 88
Q ss_pred CcEecCCCCCCEEeCCCCcEEEeccCCCccCC-----------------------CCCCCCCCcccCCCccccCC-CCCC
Q 005880 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP-----------------------PSTVPRSNGYRAPELSSSDG-RKQS 540 (672)
Q Consensus 485 ~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~-----------------------~~~~~~t~~y~aPE~l~~~~-~~~~ 540 (672)
+||||||||.||++|++..+||+|||+|.... .....||.-|+|||++.... ..|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999997621 01345678899999876443 2799
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhc
Q 005880 541 QKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMAC 620 (672)
Q Consensus 541 ~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~C 620 (672)
.|+|+||+|||++||+. ||....+ -...+. .++......- + ....+.+..=.++|.++
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsME-----------Ra~iL~-~LR~g~iP~~--~-----~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSME-----------RASILT-NLRKGSIPEP--A-----DFFDPEHPEEASLIRWL 854 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHH-----------HHHHHH-hcccCCCCCC--c-----ccccccchHHHHHHHHH
Confidence 99999999999999987 5643211 111111 1111111111 0 01122333445788899
Q ss_pred cCCCCCCCCCHHHHHH
Q 005880 621 TSASPDQRPNMSHVVK 636 (672)
Q Consensus 621 l~~dP~~RPt~~evl~ 636 (672)
++.||.+||||.|+++
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999975
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.00 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=184.4
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|+||+||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 689999999864322 2345677899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----C
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----T 519 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 519 (672)
.+++..... ..+++..+..++.|+++||.||| +.+++||||+|+||++++++.+||+|||.+...... .
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 999975432 45899999999999999999999 789999999999999999999999999998765432 3
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..++..|+|||++. +..++.++|||||||++|+|++|+.||....... ..... ..... ...
T Consensus 154 ~~~~~~y~~PE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~-----~~~~~----~~~ 214 (277)
T cd05577 154 RAGTPGYMAPEVLQ--GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--------EKEEL-----KRRTL----EMA 214 (277)
T ss_pred ccCCCCcCCHHHhc--CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--------cHHHH-----Hhccc----ccc
Confidence 34567899999764 4558899999999999999999999996432110 00111 00000 000
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSH 633 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 633 (672)
.... ......+.+++.+||+.||++||+..|
T Consensus 215 ~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 215 VEYP---DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCC---ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0000 112335778888999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.59 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=191.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|++|.||+|+.. +|..||||.++..... ....+.+|++++++++|+||+++++++.+.+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 478999999999999965 6899999998754332 346678899999999999999999999999999999999975 8
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++..... ...+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||++......
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 8888865431 245899999999999999999999 789999999999999999999999999998754332
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh-------
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE------- 590 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 590 (672)
...++..|+|||++.. ...++.++|||||||++|||++|+.||......+ ......+..
T Consensus 158 ~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~~~~ 224 (284)
T cd07836 158 SNEVVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED------------QLLKIFRIMGTPTEST 224 (284)
T ss_pred ccccccccccChHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH------------HHHHHHHHhCCCChhh
Confidence 3345778999997643 3457889999999999999999999997542211 111111000
Q ss_pred ----ccccccchhhccc------cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 ----WTAEVFDLELMRY------KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ----~~~~~~d~~~~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
............. .........+.+++.+|++.||.+||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 225 WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000000 000112345778999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.65 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=186.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|++++++++|+||+++++++.+. +..++||||++
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 467999999999999964 6899999998643221 234567899999999999999999998765 46799999996
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
++|.+++.... ..+++.++..++.|+++||+||| +.+++||||||+||++++++.+||+|||++......
T Consensus 92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 58988887543 45899999999999999999999 789999999999999999999999999999765432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh----
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE---- 590 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 590 (672)
....+..|+|||++.. ...++.++||||+||++|||++|+.||..... .+.+.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~~f~~~~~------------~~~~~~~~~~~~~~~ 229 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHKPLLPGKSE------------IEQLDLIIQLLGTPN 229 (309)
T ss_pred CCCCcccccccccChhhhcC-CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHHhcCCCC
Confidence 1223567999997642 34578999999999999999999999964321 11111111100
Q ss_pred --c--------cccccchhhccccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 --W--------TAEVFDLELMRYKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 --~--------~~~~~d~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ....+........... .....+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000000000 12345678899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.98 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=186.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-----eEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-----EKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 437 (672)
.+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 47899999999999985 468999999986432 224566888999999999999999999876543 57899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
++ ++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 90 ME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 96 5888887543 4899999999999999999999 88999999999999999999999999999876533
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...++..|+|||.+.. ...++.++|||||||++|||++|+.||...... .....+......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---------~~~~~~~~~~~~ 228 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---------HQLNLILGVLGT 228 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHcCC
Confidence 2 2356778999997532 356789999999999999999999999643210 000000000000
Q ss_pred h---ccccccchh-------h--ccccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 590 E---WTAEVFDLE-------L--MRYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 590 ~---~~~~~~d~~-------~--~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. ....+.+.. . ..... ......++.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000000000 0 00000 01123457889999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=314.86 Aligned_cols=193 Identities=21% Similarity=0.330 Sum_probs=152.6
Q ss_pred HHhcccCcCCeEEEEEEEEcC--CcEEEEE------------------EcccCCcchHHHHHHHHHHHcCCCCCceeeeE
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD--GSVVAVK------------------RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 422 (672)
.+.+.||+|+||.||++..+. +..+++| .+. ........+.+|++++++++||||++++
T Consensus 151 ~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 345789999999999987542 2222222 111 1112345688999999999999999999
Q ss_pred EEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 423 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
+++...+..++|+|++ .++|.+++..................|+.|++.||+||| +.+|+||||||+|||++.++
T Consensus 230 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 230 EILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred EEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCC
Confidence 9999999999999999 457877776443221223446677889999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSV 563 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~ 563 (672)
.+||+|||+++..... ...||..|+|||++. +..++.++|||||||++|||++|+.++.
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA--GDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhc--CCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 9999999999766432 345789999999765 4578999999999999999999986543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=286.09 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=182.8
Q ss_pred ccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---hHHHHHHHH---HHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 367 MLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---GKREFEQHM---EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.||+|+||.||+|.. .+|+.||+|.+...... ....+..|. +.++...||||+++++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999995 46899999998654321 122233343 34555689999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 99999988643 35899999999999999999999 789999999999999999999999999998755432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++.. +..++.++||||+||++|||++|+.||....... .... ...... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---------~~~~-~~~~~~------~ 214 (278)
T cd05606 152 PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KHEI-DRMTLT------M 214 (278)
T ss_pred CcCcCCCcCCcCcHHhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---------hHHH-HHHhhc------c
Confidence 3457889999997642 3457899999999999999999999997542111 1111 000000 0
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... . .....+.+++.+|+..+|.+|| ++.|+++
T Consensus 215 ~~~~~--~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 AVELP--D---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCC--C---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00110 1 1134577888899999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.82 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=188.9
Q ss_pred HhcccCcCCeEEEEEEEE----cCCcEEEEEEcccCCc----chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASI----GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
..+.||+|+||.||++.. .+|..||+|+++.... ...+.+.+|++++.++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 346899999999999985 3689999999875322 2346788899999999 599999999999988899999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++++|.+++... .++++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 84 LDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999754 34889999999999999999999 78999999999999999999999999999876
Q ss_pred CCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 515 APPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 515 ~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.... ...++..|+|||.+......++.++||||||+++|+|++|+.||...... .....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~ 226 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--------NSQAEISRRILK 226 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--------ccHHHHHHHhhc
Confidence 5432 23467889999976543345678999999999999999999998643211 112222222111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVV 635 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl 635 (672)
... .. . ......+.+++.+||+.||++|| ++.+++
T Consensus 227 ~~~-------~~--~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 227 SEP-------PY--P---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred cCC-------CC--C---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 110 00 0 11223567888899999999997 555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=317.46 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=204.0
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEcC--------CcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLDD--------GSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAY 424 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~ 424 (672)
+++.+-...+.+.||+|.||.|++|.... ...||||.+++... .+.+.+..|+++|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 44433333556799999999999998431 35799999986443 4678899999999998 69999999999
Q ss_pred EEcCCeEEEEEeecCCCChhHHhhcCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 005880 425 YFAREEKLLVSEYMPNGSLFWLLHGNR---------GPGR--TPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKS 493 (672)
Q Consensus 425 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp 493 (672)
|..++..++|+||++.|+|.++|+..+ .... ..++....+.++.|||.|++||+ +.++|||||.+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAa 446 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAA 446 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhh
Confidence 999999999999999999999998776 1111 23889999999999999999999 88999999999
Q ss_pred CCEEeCCCCcEEEeccCCCccCCCCCCC---C-----CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 005880 494 TNVLLDKTGNARVSDFGLSIFAPPSTVP---R-----SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVI 564 (672)
Q Consensus 494 ~NIll~~~~~~kl~DfG~a~~~~~~~~~---~-----t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~ 564 (672)
+|||+.++..+||+|||+|+........ + ...|||||.+. ...|+.|+|||||||+|||++| |..||.+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--DRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--cCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999976554221 1 23499999664 5799999999999999999999 7788743
Q ss_pred CCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 565 DGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
-. ...+.+. .++++. +......+..++.++++.||+.+|++||++.|+.+.++..
T Consensus 525 ~~-----------~~~~l~~-~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 IP-----------PTEELLE-FLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CC-----------cHHHHHH-HHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 10 0112222 223221 1111233455788999999999999999999999999985
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=281.95 Aligned_cols=239 Identities=27% Similarity=0.433 Sum_probs=193.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|++|.||+++.. +++.||+|.+..... .....+.+|++++++++|+|++++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999855 678999999986554 3557899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC-
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST- 519 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 519 (672)
++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||.+.......
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999998754 35899999999999999999999 8899999999999999999999999999997665432
Q ss_pred ----CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 520 ----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 520 ----~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
..++..|+|||... +..++.++||||+|+++|+|++|+.||.... ..... ....... ..
T Consensus 155 ~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----------~~~~~-~~~~~~~-~~-- 217 (254)
T cd06627 155 DDASVVGTPYWMAPEVIE--MSGASTASDIWSLGCTVIELLTGNPPYYDLN-----------PMAAL-FRIVQDD-HP-- 217 (254)
T ss_pred cccccccchhhcCHhhhc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHH-HHHhccC-CC--
Confidence 35677899999654 3457899999999999999999999986321 11111 1111110 00
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. . ......+.+++.+||..+|++|||+.|++.
T Consensus 218 ---~~--~---~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 ---PL--P---EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CC--C---CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 0 112345778888999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=289.00 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=192.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 3578999999999999965 689999999875332 345788999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++... .++++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||.+......
T Consensus 84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999754 35889999999999999999999 789999999999999999999999999998765543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|+|++|+.||...... ...++....... ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~--~~- 219 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLC--RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----------IRDQIRAKQETA--DV- 219 (258)
T ss_pred cccccCCChhhcCHHHHc--ccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----------HHHHHHHHhccc--cc-
Confidence 345677899999764 445889999999999999999999999754211 122222111110 00
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM--SHVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl 635 (672)
.........+.+++.+||+.||.+||++ +|++
T Consensus 220 --------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 --------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011123567788889999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.92 Aligned_cols=262 Identities=24% Similarity=0.304 Sum_probs=188.3
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcC--CeEEEEEe
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR--EEKLLVSE 436 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~e 436 (672)
...+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +||||+++++++... ...++|||
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 44578999999999999965 6889999988542 222445677899999999 999999999998654 36799999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|++ ++|..++... .++|..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 90 ~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 90 YME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred ccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 996 5999888643 4789999999999999999999 7899999999999999999999999999987553
Q ss_pred CC----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHH
Q 005880 517 PS----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWV 583 (672)
Q Consensus 517 ~~----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~ 583 (672)
.. ...++..|+|||++.. ...++.++||||||+++|||+||+.||......+... ...+....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeec-cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 32 2346778999997643 3467889999999999999999999996432110000 00000000000
Q ss_pred HHHHhhhccccccc----hhhccc-cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 584 QSVVREEWTAEVFD----LELMRY-KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 584 ~~~~~~~~~~~~~d----~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
... .......+++ ...... ........++.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESI-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHH-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 0000000110 000000 0001123567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=282.85 Aligned_cols=232 Identities=23% Similarity=0.287 Sum_probs=179.6
Q ss_pred cCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCChhH
Q 005880 368 LGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445 (672)
Q Consensus 368 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 445 (672)
||+|+||.||+++. .++..+|+|.+........ |+.....+ +||||+++++++..++..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 69999999999995 4688999999865432111 22222212 69999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCCC-CCCCC
Q 005880 446 LLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPPS-TVPRS 523 (672)
Q Consensus 446 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~-~~~~t 523 (672)
++.... .+++.++..++.|+++||.||| +.+++||||||+||+++.++ .++|+|||+++..... ...++
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 997542 5899999999999999999999 78999999999999999988 9999999998766543 45678
Q ss_pred CcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccc
Q 005880 524 NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRY 603 (672)
Q Consensus 524 ~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 603 (672)
..|+|||++. +..++.++||||||+++|||++|+.||...... ..+...+.... .. ..
T Consensus 170 ~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~---------~~--- 227 (267)
T PHA03390 170 LDYFSPEKIK--GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-------ELDLESLLKRQ-QK---------KL--- 227 (267)
T ss_pred CcccChhhhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-------hhhHHHHHHhh-cc---------cC---
Confidence 8999999764 456789999999999999999999999743221 11222222211 00 00
Q ss_pred cChHHHHHHHHHHHHhccCCCCCCCCC-HHHHH
Q 005880 604 KDIEEEMVGLLQVAMACTSASPDQRPN-MSHVV 635 (672)
Q Consensus 604 ~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl 635 (672)
.........+.+++.+||+.+|.+||+ ++|++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 001123345778888999999999996 58886
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.01 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=187.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcch--------------HHHHHHHHHHHcCCCCCceeeeEEEEEcCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGG--------------KREFEQHMEVLGRLRHPNLVGLKAYYFARE 429 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 429 (672)
.+.||+|+||.||+|... +++.||||.++...... ...+.+|+++++.++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999954 68999999986433211 125778999999999999999999999999
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
..++||||++ |+|.+++... ..+++.....++.|+++||+||| +.+|+||||+|+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999996 6999998643 34899999999999999999999 789999999999999999999999999
Q ss_pred CCCccCCCC-------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005880 510 GLSIFAPPS-------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG 570 (672)
Q Consensus 510 G~a~~~~~~-------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~ 570 (672)
|+++..... ...++..|+|||.+.. ...++.++|||||||++|||++|+.||......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhccc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 998765410 1234667999997643 3457899999999999999999999997543211
Q ss_pred CCCCCCCChhHHHHHHHhhh----ccccc----cchhhc-cccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 571 MGCGGAVDLPRWVQSVVREE----WTAEV----FDLELM-RYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~----~~~~~----~d~~~~-~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+....... +.... ..+... .... .......+.+++.+||+.+|++||++.|++.
T Consensus 242 --------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 --------QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --------HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111100000 00000 000000 0000 0112345778999999999999999999984
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=295.69 Aligned_cols=187 Identities=23% Similarity=0.360 Sum_probs=158.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 435 (672)
.+.||+|+||.||+|+.. +|+.||+|++... ......++.+|++++++++||||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 467999999999999954 7899999998643 223445778899999999999999999988643 3468999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+. ++|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 101 ELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred eccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 9995 588888752 2788999999999999999999 789999999999999999999999999999866
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
... ...++..|+|||.+. +..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCCCCCCCCcccccccCHHHHh--CCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 543 234677899999764 567899999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.71 Aligned_cols=191 Identities=26% Similarity=0.339 Sum_probs=158.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--------eEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFARE--------EKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l 433 (672)
.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 468999999999999965 689999998864322 22345678999999999999999999987654 3489
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||+. ++|.+++.... ..+++.+++.++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 97 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 999996 58888876432 35899999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCC---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 514 FAPPS---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 514 ~~~~~---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
..... ...++..|+|||.+.. ...++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcC-CcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 55332 2234667999997642 345688999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.07 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=187.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC----------e
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE----------E 430 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~ 430 (672)
+.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+.. .
T Consensus 11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 4578999999999999965 58999999987432 223456788999999999999999999987654 7
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++|+||+++ ++...+.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 8999999976 7777776432 35899999999999999999999 7899999999999999999999999999
Q ss_pred CCccCCCCC------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 511 LSIFAPPST------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 511 ~a~~~~~~~------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
++....... ..++..|+|||.+.. ...++.++|||||||++|||++|++||...... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---------~~~~~~~ 231 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLG-EERYGPAIDVWSCGCILGELFTKKPIFQANQEL---------AQLELIS 231 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Confidence 987654321 234667999997642 345688999999999999999999999643211 0011111
Q ss_pred HHHhhhcc---ccc--------cchhhcccc----ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 585 SVVREEWT---AEV--------FDLELMRYK----DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 585 ~~~~~~~~---~~~--------~d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........ ..+ .+....... ........+.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11100000 000 000000000 00011346788899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=284.03 Aligned_cols=242 Identities=26% Similarity=0.360 Sum_probs=194.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++.+....++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 478999999999999844 688999999875432 24567788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++..... ....+++..++.++.|+++||+||| +.+++||||+|+||++++++.+||+|||++......
T Consensus 85 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 85 DLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 99999876321 2346899999999999999999999 889999999999999999999999999998766443
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||.+. +..++.++|+||||+++|||++|+.||.... .......... .....
T Consensus 160 ~~~~~~~~~~Pe~~~--~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------------~~~~~~~~~~-~~~~~---- 220 (256)
T cd08530 160 TQIGTPHYMAPEVWK--GRPYSYKSDIWSLGCLLYEMATFAPPFEARS------------MQDLRYKVQR-GKYPP---- 220 (256)
T ss_pred cccCCccccCHHHHC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHhc-CCCCC----
Confidence 344677899999654 5678889999999999999999999996432 1111111111 11100
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........+.+++.+|+..+|++||++.|+++
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 ------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11223456888999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.44 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=191.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|... +|+.+|+|+++..... ....+.+|++++++++|+||+++++++.+++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 467999999999999964 6899999998754332 456788999999999999999999999999999999999965
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST-- 519 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 519 (672)
+|.+++.... ..+++..+..++.|+++||+||| +.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 83 DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 8888886542 35899999999999999999999 7899999999999999999999999999987665432
Q ss_pred ---CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHh--hhc
Q 005880 520 ---VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVR--EEW 591 (672)
Q Consensus 520 ---~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~--~~~ 591 (672)
..++..|+|||.+.. ....+.++||||||+++|+|+||+.||......+... ...+.....+...... ...
T Consensus 155 ~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLG-DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 345678999997643 2368899999999999999999999986432110000 0000000000000000 000
Q ss_pred cccccchhhcc-ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMR-YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.....+..... .........++.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000000 0001123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=279.65 Aligned_cols=240 Identities=26% Similarity=0.377 Sum_probs=194.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 439 (672)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999966 689999999875542 3467889999999999999999999999988 88999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++.... .+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999997542 5899999999999999999999 789999999999999999999999999998766543
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||.+. +...+.++||||||+++|+|++|+.||.... +..............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIR--GEEYGRAADIWSLGCTVIEMATGKPPWSELG-----------NPMAALYKIGSSGEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------chHHHHHhccccCCC
Confidence 234677899999654 4458899999999999999999999996432 111111111110000
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. .........+.+++.+|++.+|++||++.|+++
T Consensus 223 ~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 P----------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred c----------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 001122456888889999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=289.00 Aligned_cols=251 Identities=22% Similarity=0.266 Sum_probs=186.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 467999999999999965 689999999865332 234678899999999999999999999999999999999995 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++.... ...+++..+..++.|++.||+||| +.+++||||+|+||+++. ++.+||+|||++......
T Consensus 86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 8888875433 234688889999999999999999 789999999999999985 567999999999754322
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh--ccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE--WTA 593 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 593 (672)
...++..|+|||++.. ...++.++|||||||++|+|+||+.||...... +-+....... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~------------~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLG-SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI------------DELFKIFRILGTPNE 225 (294)
T ss_pred ccccCceeecccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHHHHhCCCCh
Confidence 2345678999997643 346788999999999999999999999653211 0011110000 000
Q ss_pred cc-------cchh--hc--cccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EV-------FDLE--LM--RYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~-------~d~~--~~--~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .+.. .. .... ......++.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 00 0000 0112235778888999999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=282.26 Aligned_cols=242 Identities=24% Similarity=0.421 Sum_probs=195.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||++... ++..||+|++..... .....+.+|++++++++|+|++++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 467999999999999965 689999999875433 45677899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++..... ....+++..+..++.++++||+||| +.+++|+||+|+||++++++.++|+|||.+......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 85 DLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999976431 2256899999999999999999999 789999999999999999999999999998765443
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||.+. +..++.++||||+|+++|+|++|+.||... +..+......... .
T Consensus 160 ~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~------------~~~~~~~~~~~~~-----~ 220 (258)
T cd08215 160 AKTVVGTPYYLSPELCQ--NKPYNYKSDIWSLGCVLYELCTLKHPFEGE------------NLLELALKILKGQ-----Y 220 (258)
T ss_pred ecceeeeecccChhHhc--cCCCCccccHHHHHHHHHHHHcCCCCCCCC------------cHHHHHHHHhcCC-----C
Confidence 234667899999654 456889999999999999999999998643 1222222222211 0
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+ + + ......+.+++.+||..+|++|||+.|+++
T Consensus 221 ~~-~---~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PP-I---P--SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC-C---C--CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 0 112345778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.60 Aligned_cols=247 Identities=15% Similarity=0.180 Sum_probs=174.8
Q ss_pred HhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCCcch--H---------HHHHHHHHHHcCCCCCceeeeEEEEEcC
Q 005880 364 SAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASIGG--K---------REFEQHMEVLGRLRHPNLVGLKAYYFAR 428 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~e~~~l~~l~h~niv~l~~~~~~~ 428 (672)
+.+.||+|+||.||+|...+ +..+|+|......... . .....+...+..++|+|++++++++...
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 34679999999999999654 3456666543221111 1 1122334456678999999999977654
Q ss_pred C----eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcE
Q 005880 429 E----EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA 504 (672)
Q Consensus 429 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~ 504 (672)
. ..++++|++. .++.+.+... ...++..+..|+.|+++||+||| +.+|+||||||+|||++.++.+
T Consensus 96 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 96 RCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCcE
Confidence 3 3467888774 4676666532 23578889999999999999999 7899999999999999999999
Q ss_pred EEeccCCCccCCCC------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005880 505 RVSDFGLSIFAPPS------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG 572 (672)
Q Consensus 505 kl~DfG~a~~~~~~------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~ 572 (672)
+|+|||+++..... ...+|..|+|||+.. +..++.++|||||||++|||++|+.||.......
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~--~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--- 240 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN--GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--- 240 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch---
Confidence 99999999754311 235788999999654 5678999999999999999999999997542211
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
....... .+....+...... .......+.+++..|++.+|++||++.++++.+
T Consensus 241 -----~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 -----NLIHAAK----CDFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred -----HHHHHhH----HHHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111000 0011111111111 112235678888899999999999999999876
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=296.82 Aligned_cols=238 Identities=24% Similarity=0.350 Sum_probs=195.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
...||+|.|+.|.+|+. .+|..||+|.+.+.... ..+.+.+|+++|..++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 47899999999999994 46999999999865433 3456899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
.+++++..+. .........++.|+.+|++|+| +..|+|||||++|||++.+.++||+|||++..+...
T Consensus 141 e~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 141 ELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred hhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeecccccc
Confidence 9999998764 2556888899999999999999 899999999999999999999999999999887754
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
+.+|++.|.|||+++.. ...++.+|+||+|+++|.|+.|..||++..- ...-...++.
T Consensus 212 qt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------k~Lr~rvl~g-------- 270 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------KELRPRVLRG-------- 270 (596)
T ss_pred cccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccc------------ccccchheee--------
Confidence 67789999999998754 4678999999999999999999999975421 1111111111
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+..-+..+. .+..+++++++-.+|.+|++++++.+
T Consensus 271 -k~rIp~~ms---~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 271 -KYRIPFYMS---CDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -eecccceee---chhHHHHHHhhccCccccCCHHHhhh
Confidence 111111111 23456777999999999999999865
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=285.41 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=187.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCC---CCCceeeeEEEEEcCCe-----EEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRL---RHPNLVGLKAYYFAREE-----KLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~~l 433 (672)
.+.||+|+||.||+|+.+ +++.||+|+++..... ....+.+|+.++.++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 467999999999999976 4899999999743221 234566777766555 69999999999988776 899
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
+|||+. ++|.+++..... ..+++..++.++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++.
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999996 589988875432 35899999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 514 FAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 514 ~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
..... ...++..|+|||++. +..++.++|||||||++|||++|++||...... +........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------------~~~~~~~~~ 221 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------------DQLDKIFDV 221 (287)
T ss_pred eccCCcccccccccccccChHHhc--cCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------------HHHHHHHHH
Confidence 66433 234567899999764 457889999999999999999999998653221 111111111
Q ss_pred h-------cccc------ccchhhcc--ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 E-------WTAE------VFDLELMR--YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~-------~~~~------~~d~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. +... .+...... ..........+.+++.+||+.||.+||++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000 00000000 0001123356778999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.45 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=193.3
Q ss_pred HhcccCcCCeEEEEEEEE----cCCcEEEEEEcccCCc----chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASI----GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
+.+.||+|++|.||+++. .+++.||||.+++... ...+.+.+|++++.++ +||||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 347899999999999984 3578899999875322 2345688999999999 599999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++|+|.+++... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 84 LDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999998643 34889999999999999999999 78999999999999999999999999999876
Q ss_pred CCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 515 APPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 515 ~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.... ...++..|+|||.+.......+.++||||||+++|||++|+.||...... .......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~ 226 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--------NSQSEISRRILK 226 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--------chHHHHHHHHHc
Confidence 5432 23467789999976543334788999999999999999999999643211 111122221111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.. +. .. ......+.+++.+||+.||++|||+.++.+.|+..
T Consensus 227 ~~-------~~--~~---~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 SK-------PP--FP---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cC-------CC--CC---cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 10 00 00 11223567888899999999999999998877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.51 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=197.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-----eEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-----EKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 435 (672)
+.+.||+|++|.||+|+.. +|..||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..++||
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 3578999999999999965 58999999987543 334578899999999999999999999988765 789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||++ ++|.+++... .++++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 84 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 84 ELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9997 5898888643 26999999999999999999999 789999999999999999999999999999765
Q ss_pred CCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 516 PPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 516 ~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
... ...++..|+|||++... ..++.++||||||+++|+|++|+.||...... +......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~------------~~~~~i~ 220 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI------------DQLNLIV 220 (330)
T ss_pred cccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH------------HHHHHHH
Confidence 433 23456779999976532 27889999999999999999999999654311 1111111
Q ss_pred hhh--------------ccccccch-hhcccc----ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHHhcCCC
Q 005880 588 REE--------------WTAEVFDL-ELMRYK----DIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL--IEELRGVEV 646 (672)
Q Consensus 588 ~~~--------------~~~~~~d~-~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~~~~ 646 (672)
... .....+.. ...... ........+.+++.+||+.+|++||++.++++. ++++...+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred HhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 000 00000000 000000 001123457888999999999999999999984 777665433
Q ss_pred CC
Q 005880 647 SP 648 (672)
Q Consensus 647 ~~ 648 (672)
..
T Consensus 301 ~~ 302 (330)
T cd07834 301 EP 302 (330)
T ss_pred CC
Confidence 33
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.94 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=192.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|+.. +++.||||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999975 578999999875432 23334567899999999 999999999999999999999999 88
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ...+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999887543 235899999999999999999999 789999999999999999999999999999766542
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC----CCCCCCChhHHHHHHHhhhccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM----GCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ...++.++||||||+++|||++|++||......+.. ...+...-..|...........
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 TDYVSTRWYRAPEILLR-STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred CCCCCcccccCceeeec-CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 3446778999997643 345788999999999999999999998654221100 0000000011111111110000
Q ss_pred cccchhhcc--ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMR--YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+...... ..........+.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 0000111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.95 Aligned_cols=260 Identities=19% Similarity=0.268 Sum_probs=187.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc----CCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA----REEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++.+++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 467999999999999954 68999999987532 2245677889999999999999999988763 3467899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+. |+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++.....
T Consensus 90 ~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 90 ME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 95 6899988643 34899999999999999999999 78999999999999999999999999999865432
Q ss_pred C---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHH
Q 005880 518 S---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQS 585 (672)
Q Consensus 518 ~---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~ 585 (672)
. ...++..|+|||.+.. ...++.++|||||||++|||++|+.||.......... ...+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLS-LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred cCcCCCcccccccccccccChHHhcC-CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 1 2356778999997643 3457899999999999999999999996542110000 0000000000000
Q ss_pred HHhhhccccccchhhc-cccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 586 VVREEWTAEVFDLELM-RYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~-~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .......+.... .... .......+.+++.+||+.+|++||++.+++.
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 239 IGS-DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hch-hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 000000000000 0000 0112456888999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=291.90 Aligned_cols=270 Identities=21% Similarity=0.288 Sum_probs=190.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 435 (672)
.+.||+|+||.||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46899999999999995 468999999986532 123456889999999999999999999987542 468999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+.. +|..+.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 100 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 100 PYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 99964 7776652 24889999999999999999999 789999999999999999999999999999765
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhh
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 590 (672)
... ...++..|+|||++.. ...++.++|||||||++|||++|+.||.......... ...+...+.+..... ..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 245 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILN-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE-DK 245 (342)
T ss_pred CCCCCCceeeecccChhhhcC-ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc-cc
Confidence 433 3345778999997642 2457889999999999999999999997432100000 000000000000000 00
Q ss_pred ccccccch-hhccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHHhcCCCCC
Q 005880 591 WTAEVFDL-ELMRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVKL--IEELRGVEVSP 648 (672)
Q Consensus 591 ~~~~~~d~-~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~~~~~~ 648 (672)
........ ........ ......+.+++.+||+.||++||++.|++.. ++..+.....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 00000000 00000000 0122357788999999999999999999944 77776544333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.70 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=190.6
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 435 (672)
.+.||+|+||.||+|.. .+|..||||++.... ......+.+|++++++++||||+++++++..+. ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 46799999999999984 478999999986432 223456889999999999999999999987543 458999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 100 e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 100 PFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 999 7799888863 24899999999999999999999 889999999999999999999999999999766
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhh
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 590 (672)
... ...++..|+|||.+.. ...++.++|||||||++|+|++|+.||.......... .........+........
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILN-WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ccCccccccCCcccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 543 3456788999997642 2457899999999999999999999996432110000 000000011111110000
Q ss_pred ccccccchhhccc--cCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHHHHhcC
Q 005880 591 WTAEVFDLELMRY--KDI----EEEMVGLLQVAMACTSASPDQRPNMSHVV--KLIEELRGV 644 (672)
Q Consensus 591 ~~~~~~d~~~~~~--~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl--~~L~~i~~~ 644 (672)
. ..... ..... ... ......+.+++.+|++.||++|||+.+++ ..++.....
T Consensus 248 ~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 248 A-KNYVK-KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred H-HHHHH-hccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0 00000 00000 000 11223577899999999999999999998 445555433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.38 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=188.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++||||+++++++.. ....++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 478999999999999954 78999999886422 2245678899999999999999999999876 55788999998 5
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... ++++.....++.|+++||+||| +.+|+||||+|+||++++++.++|+|||.+......
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 6899888643 3788889999999999999999 889999999999999999999999999998765433
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC---CCCCCCChhHHHHHHHhhhccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM---GCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||.+. .+..++.++|||||||++|||+||+.||......... ....+....++.............
T Consensus 164 ~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 164 GYVSTRYYRAPEIML-TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCcccccccCceeee-ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 345677899999753 2356889999999999999999999999643210000 000000111122111111100000
Q ss_pred cchhhccccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
............ .....+.+++.+|++.+|++|||+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 123567888999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=291.77 Aligned_cols=259 Identities=23% Similarity=0.234 Sum_probs=184.4
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--------------C
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--------------E 429 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------~ 429 (672)
.+.||+|+||.||+|.. .+|..||+|.+........+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 46799999999999995 46899999998765555667889999999999999999999876543 3
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEec
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSD 508 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~D 508 (672)
..++||||++ ++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 5689999996 5898888532 4889999999999999999999 789999999999999984 56789999
Q ss_pred cCCCccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCC---CCCC
Q 005880 509 FGLSIFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGC---GGAV 577 (672)
Q Consensus 509 fG~a~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~---~~~~ 577 (672)
||.++..... ...++..|+|||++.. +..++.++|||||||++|||++|+.||......+.... ....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhC-ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9998755321 2245678999997542 45678899999999999999999999964321100000 0000
Q ss_pred ChhHHHHHHHhhhcccccc-chhhcccc---ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 578 DLPRWVQSVVREEWTAEVF-DLELMRYK---DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~-d~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
............ ...... +......+ .......++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000 000000 00000000 00112245778899999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=284.67 Aligned_cols=191 Identities=28% Similarity=0.444 Sum_probs=169.8
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+||+|+||.||-+.. .+|+.+|.|++.+.... .+.....|-.+|++++.+.||.+-..|...+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 5799999999999994 47999999988654432 4456788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.-+|.... ..-+++....-++.+|+-||++|| +.+||.||+||+|||+|+.|+++|+|.|+|..+...
T Consensus 271 DLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 9999987654 255999999999999999999999 889999999999999999999999999999888765
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
..+||.||||||++. +..|+...|.||+||++|||+.|+.||...
T Consensus 344 ~~rvGT~GYMAPEvl~--ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQ--NEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred ccccCcccccCHHHHc--CCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 457899999999886 446999999999999999999999999654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.17 Aligned_cols=266 Identities=19% Similarity=0.235 Sum_probs=190.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-----EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 436 (672)
.+.||+|+||.||+|+. .+|+.||||.++.. .......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 46799999999999995 46899999998753 222345678899999999999999999988654 34799999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 90 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 90 LMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred CCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 995 6898888643 34899999999999999999999 7899999999999999999999999999997654
Q ss_pred CC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHh
Q 005880 517 PS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 588 (672)
.. ...++..|+|||.+.. ...++.++|||||||++|+|++|+.||.......... ...+....+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLN-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCcccccccccccCccChHHHhc-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 33 2346778999997643 2358899999999999999999999996432100000 0000000000000000
Q ss_pred ---hhccc---cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHHhc
Q 005880 589 ---EEWTA---EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL--IEELRG 643 (672)
Q Consensus 589 ---~~~~~---~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~ 643 (672)
..... ...+..... ........+.+++.+||+.+|++|||+.|+++. ++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFAR--LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhhhHHHHhcCcccccCHHH--HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000 000000000 001223457889999999999999999999876 665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=270.16 Aligned_cols=243 Identities=22% Similarity=0.299 Sum_probs=189.1
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEc----CCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFA----REEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~ 437 (672)
..++||-|-.|.|..+.. .+|+.+|+|++.+ ....++|++.--.. .|||||+++++|.. .....+|||.
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 458999999999999994 4799999999974 34567788764444 69999999999864 3456799999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCcc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIF 514 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~ 514 (672)
|+||.|+..++... ...+++.+.-.|+.||+.|+.||| +.+|.||||||+|+|... +-.+||+|||+|+.
T Consensus 141 meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 141 MEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred ccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 99999999998664 467999999999999999999999 899999999999999964 45699999999987
Q ss_pred CCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 515 APPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
.... +..-|+.|.|||++. ..+|+...|+||+||++|-|+.|.+||....+.. +..=++..++.+
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---------ispgMk~rI~~g 282 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------ISPGMKRRIRTG 282 (400)
T ss_pred cCCCccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccccCCcc---------CChhHHhHhhcc
Confidence 7643 445578899999875 4579999999999999999999999998654321 111122222221
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. .++-+ +......+...++|+..|+.+|.+|.|+.|+++
T Consensus 283 q-y~FP~------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 Q-YEFPE------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred C-ccCCC------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 11111 122334455677888999999999999999974
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=277.50 Aligned_cols=239 Identities=23% Similarity=0.325 Sum_probs=185.0
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccC-----CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA-----SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 435 (672)
+.+.||+|+||.||+|.. .+|..||+|.+... .......+.+|++++++++|+||+++++++.+. ...++|+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 357899999999999995 46899999987532 122346788999999999999999999998764 4578999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++++|.+++... ..+++....+++.|++.||.||| +.+++||||||+||+++.++.++|+|||+++..
T Consensus 86 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 86 EYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 999999999998743 24789999999999999999999 789999999999999999999999999999754
Q ss_pred CCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 516 PPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 516 ~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
... ...++..|+|||++. +..++.++|||||||++|||++|+.||.... ...-+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~ 222 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVIS--GEGYGRKADVWSVACTVVEMLTEKPPWAEYE------------AMAAIFKIA 222 (264)
T ss_pred ccccccCccccccCCcccccCHhhhc--CCCCCccccHHHHHHHHHHHHhCCCCCCccC------------HHHHHHHHH
Confidence 321 234677899999764 4567899999999999999999999996321 111111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... .. . .. ......+.+++.+|+. +|..||++.+++.
T Consensus 223 ~~~~-~~----~--~p---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 TQPT-KP----M--LP---DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCCC-CC----C--CC---cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1100 00 0 01 1122456777889999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=290.70 Aligned_cols=292 Identities=20% Similarity=0.178 Sum_probs=197.0
Q ss_pred hcccCcCCeEEEEEEEEc-C--CcEEEEEEcccCC--cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcC----CeEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-D--GSVVAVKRLKDAS--IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR----EEKLLV 434 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~lv 434 (672)
.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|++++.++ +||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999955 3 7899999987432 12356788899999999 599999999875432 356788
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+||+. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 89885 6899988643 35899999999999999999999 78999999999999999999999999999975
Q ss_pred CCCC---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHH
Q 005880 515 APPS---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRW 582 (672)
Q Consensus 515 ~~~~---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~ 582 (672)
.... ...++..|+|||++.. ...++.++|||||||++|+|++|+.||.......... ...+....++
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5421 2356788999997542 3567899999999999999999999986432110000 0000000011
Q ss_pred HHHHHhhhccccccchhhccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSD 658 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~ 658 (672)
........................ ......+.+++.+|++.||++|||+.|+++. .-++....+...+.|...++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~-~~~~~~~~~~~~~~~~~~~~ 312 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH-PYLAIWHDPDDEPVCQKPFD 312 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC-hhhhhhcCcccccccccccc
Confidence 111111000000000000000000 0113467889999999999999999998743 11222222333344555565
Q ss_pred CCCccCCCCC
Q 005880 659 SPCLSEDTLG 668 (672)
Q Consensus 659 ~~~~~~~~~~ 668 (672)
-+...+|+-+
T Consensus 313 ~~~~~~~~~~ 322 (332)
T cd07857 313 FSFESEDSME 322 (332)
T ss_pred CCccccccHH
Confidence 5555555433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.88 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=183.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--------eEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFARE--------EKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l 433 (672)
.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 467999999999999955 6899999998643322 2346788999999999999999999876443 4589
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
|+||+.+ +|...+.... ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 9999965 7777776432 35899999999999999999999 7899999999999999999999999999987
Q ss_pred cCCCCC----------------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q 005880 514 FAPPST----------------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577 (672)
Q Consensus 514 ~~~~~~----------------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~ 577 (672)
...... ..++..|+|||.+.. ...++.++|||||||++|||++|++||......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--------- 233 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--------- 233 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhC-CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---------
Confidence 554321 123566999997642 345789999999999999999999999643221
Q ss_pred ChhHHHHHHHhhh------------ccccccc-hhh-ccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 578 DLPRWVQSVVREE------------WTAEVFD-LEL-MRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 578 ~~~~~~~~~~~~~------------~~~~~~d-~~~-~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.......... ......+ ... ...... ......+.+++.+|++.||++|||+.|++.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 ---DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ---HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111111000 0000000 000 000000 111246788999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=275.18 Aligned_cols=231 Identities=28% Similarity=0.380 Sum_probs=187.3
Q ss_pred cCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 368 LGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998754332 345789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... .+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 99997543 4899999999999999999999 789999999999999999999999999998765442
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||... +...+.++|+||||+++||+++|+.||.... ............
T Consensus 152 ~~~~~~~~~~Pe~~~--~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------------~~~~~~~~~~~~-------- 209 (250)
T cd05123 152 TFCGTPEYLAPEVLL--GKGYGKAVDWWSLGVLLYEMLTGKPPFYAED------------RKEIYEKILKDP-------- 209 (250)
T ss_pred CCcCCccccChHHhC--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------------HHHHHHHHhcCC--------
Confidence 345677899999654 4567889999999999999999999996431 112222222111
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSH 633 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 633 (672)
..... .....+.+++.+||..||++||++.+
T Consensus 210 -~~~~~---~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 -LRFPE---FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCC---CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 00001 11345778888999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=287.93 Aligned_cols=188 Identities=26% Similarity=0.385 Sum_probs=158.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 435 (672)
.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++.+++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 36799999999999984 578999999987532 22356788899999999999999999988643 3467888
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
+++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 877 78998888642 3899999999999999999999 789999999999999999999999999998765
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
... ...++..|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cccccccccCCCccCHHHHhC-ccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 443 3456788999997642 24678899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=294.06 Aligned_cols=259 Identities=21% Similarity=0.275 Sum_probs=188.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe------EEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE------KLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 435 (672)
...||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 467999999999999965 58899999986432 2234667889999999999999999998876554 89999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+ +++|.+++.. .++++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 100 e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 100 HLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 999 6799999864 24899999999999999999999 789999999999999999999999999999765
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhh
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 590 (672)
... ...++..|+|||++.. ...++.++|||||||++|||++|+.||.......... .........+......+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cccccCCcccccccCHHHHhC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 433 3456778999997642 2367889999999999999999999996432110000 000000001111000000
Q ss_pred ccccccch-hhccccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 WTAEVFDL-ELMRYKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ~~~~~~d~-~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+.. ......... .....+.+++.+||+.||++|||+.||++
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 -ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred -HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000 000000000 12356888999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=279.69 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=186.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC-----CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-----SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.+.||+|+||.||+++.. .+..+++|.++.. ......++.+|+.++++++||||+++++++.+....++||||
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 4578999999999999854 3455666665532 122345677899999999999999999999988999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++++|.+++..... ....+++..++.++.|+++||.||| +.+++|+||||+||++++ +.++|+|||.+.....
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999998875322 2246899999999999999999999 789999999999999975 5699999999876543
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ...++..|+|||.+ .+..++.++||||||+++|+|++|+.||... ............. .
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~-~ 222 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------------NFLSVVLRIVEGP-T 222 (260)
T ss_pred CcccccCCCCCcCccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------------cHHHHHHHHHcCC-C
Confidence 2 34467789999965 3456788999999999999999999998532 1222222221110 0
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+ .........+.+++.+||+.+|++||++.|+++
T Consensus 223 -----~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 -----P-----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----C-----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 001223346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=282.87 Aligned_cols=236 Identities=25% Similarity=0.350 Sum_probs=189.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++.+++ ||||+++++++.+.+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 467999999999999965 68999999987532 223467889999999998 9999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST 519 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 519 (672)
+++|.+++.... .+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999997542 5999999999999999999999 7899999999999999999999999999987554321
Q ss_pred -------------------------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005880 520 -------------------------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 520 -------------------------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~ 574 (672)
..++..|+|||++. ...++.++||||||++++++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------- 226 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN--EKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------- 226 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhC--CCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------
Confidence 23467899999654 4568899999999999999999999996432
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH----HHHH
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM----SHVV 635 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl 635 (672)
............. ... ......+.+++.+||+.+|.+||++ .|++
T Consensus 227 ----~~~~~~~~~~~~~---------~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 227 ----EYLTFQKILKLEY---------SFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred ----HHHHHHHHHhcCC---------CCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1111111111100 000 1123457788889999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=281.04 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=191.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 367999999999999965 58999999997643 2235678889999999999999999999999999999999997 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||+|+||++++++.+||+|||.++.....
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 9999997542 35899999999999999999999 789999999999999999999999999998765433
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh------
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE------ 590 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 590 (672)
....+..|+|||.+.. ...++.++|||||||++|||++|+.||..+.. .+.+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~ 221 (282)
T cd07829 155 YTHEVVTLWYRAPEILLG-SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE------------IDQLFKIFQILGTPTEE 221 (282)
T ss_pred cCccccCcCcCChHHhcC-CcCCCccccHHHHHHHHHHHHhCCCCCCCccH------------HHHHHHHHHHhCCCcHH
Confidence 2234567999997643 24788899999999999999999999865321 11111111000
Q ss_pred cc---ccc--cchhhccc------cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 WT---AEV--FDLELMRY------KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ~~---~~~--~d~~~~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ... .+...... .........+.+++.+||+.||++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 000 00000000 000111346889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=268.47 Aligned_cols=248 Identities=24% Similarity=0.287 Sum_probs=198.1
Q ss_pred cccCcCCeEEEEEEEEcC------CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC-CeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDD------GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-EEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 437 (672)
..+-+|.||.||+|.+.+ .+.|-||.++... .-....+..|--.+..+.|||+.++.+++.++ +..+++|.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 468899999999996543 4567788887543 22456778888889999999999999998754 567899999
Q ss_pred cCCCChhHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 438 MPNGSLFWLLHGNRG---PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+.-|+|..+|...++ ...+.++-.+...++.|++.|++||| +++|||.||.++|.+||+..++||+|=.+++.
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999983332 23456788889999999999999999 89999999999999999999999999999998
Q ss_pred CCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 515 APPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 515 ~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
+-+. ...+...||+||.+. ...|+.++|||||||++|||+| |+.|+. +.|..+....+
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~--n~~yssasDvWsfGVllWELmtlg~~Pya------------eIDPfEm~~yl 511 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQ--NSHYSSASDVWSFGVLLWELMTLGKLPYA------------EIDPFEMEHYL 511 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHh--hhhhcchhhhHHHHHHHHHHHhcCCCCcc------------ccCHHHHHHHH
Confidence 7665 233456799999654 6789999999999999999998 888985 23433333333
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.+.... .....++.+++.++.-||+.+|++||+++|++.-|.++.
T Consensus 512 kdGyRl-----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 512 KDGYRL-----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred hcccee-----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 332221 112345567999999999999999999999999998874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.47 Aligned_cols=193 Identities=27% Similarity=0.376 Sum_probs=162.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEccc--CCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc--------CCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKD--ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--------REEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l 433 (672)
..+||+|.||.||+|+. ++|+.||+|++-- ...+......+|+++|..++|+|++.++..|.. ....|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 47899999999999994 4688899987642 223345677899999999999999999888753 234789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||++|+. +|.-+|.... ..++..++.+++.++..||.|+| +..|+|||+||.|+||+.+|.+||+|||+++
T Consensus 102 Vf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 9999977 8988886543 56999999999999999999999 8899999999999999999999999999997
Q ss_pred cCCCC---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 005880 514 FAPPS---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGG 567 (672)
Q Consensus 514 ~~~~~---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~ 567 (672)
.+... ..+.|..|++||.+.+ ...|+++.|||+.|||+.||+||.+-+.+..+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG-~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLG-DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhc-ccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 66543 2233778999998875 47899999999999999999999998876654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=268.86 Aligned_cols=238 Identities=26% Similarity=0.389 Sum_probs=190.2
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHH---HHHHHHHcCCCCCceeeeEEEEEcCCe
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREF---EQHMEVLGRLRHPNLVGLKAYYFAREE 430 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~ 430 (672)
.+.+|. .+.++||+|.||.|-+++ ..+|+.+|+|++++.-+-.+.+. ..|-++|+..+||.+..+-..|...++
T Consensus 165 vTm~dF--dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 165 VTMEDF--DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eccchh--hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 344443 345789999999999999 45799999999997665544443 568889999999999999989999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.+.||||+.||.|+.+|.+.+ .+++....-+-..|+.||.||| +.+||.||||.+|.++|.||++||.|||
T Consensus 243 lCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecc
Confidence 999999999999999997654 4778877888899999999999 8899999999999999999999999999
Q ss_pred CCccCCC-----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 511 LSIFAPP-----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 511 ~a~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
+++..-. .+.+||+.|.|||++. ...|+.++|.|.+|||+|||+.|+.||..... ...+.-
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVle--DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------------~kLFeL 379 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLE--DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------------EKLFEL 379 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhc--cccccceeehhhhhHHHHHHHhccCcccccch------------hHHHHH
Confidence 9975432 3788999999999875 57899999999999999999999999975321 112222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP 629 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 629 (672)
+.-+ .+.-+..+.++... |+...|.+||.+|.
T Consensus 380 Il~e---------d~kFPr~ls~eAkt---LLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 380 ILME---------DLKFPRTLSPEAKT---LLSGLLKKDPKKRL 411 (516)
T ss_pred HHhh---------hccCCccCCHHHHH---HHHHHhhcChHhhc
Confidence 2211 11222233444444 44488999999996
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=308.26 Aligned_cols=140 Identities=26% Similarity=0.399 Sum_probs=125.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.++||+|+||.||+|... +++.||||+++.... .....+.+|+.++..++||||+++++++...+..++||||+++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 689999999975432 2346788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
++|.+++.... .+++..++.|+.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999997542 4789999999999999999999 7899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=271.83 Aligned_cols=220 Identities=20% Similarity=0.229 Sum_probs=173.0
Q ss_pred CCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhc
Q 005880 371 GGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHG 449 (672)
Q Consensus 371 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 449 (672)
|.+|.||+++. .+|+.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 468999999997543 234455555566799999999999999999999999999999999865
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--CCCCCCccc
Q 005880 450 NRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TVPRSNGYR 527 (672)
Q Consensus 450 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~t~~y~ 527 (672)
. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++++|||.+...... ...++..|+
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence 4 24899999999999999999999 789999999999999999999999999987655443 334466799
Q ss_pred CCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChH
Q 005880 528 APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIE 607 (672)
Q Consensus 528 aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 607 (672)
|||.+ .+..++.++||||+|+++|||++|+.|+....... ... .. + .. ..
T Consensus 150 aPE~~--~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~--~~-~--~~--~~--- 199 (237)
T cd05576 150 APEVG--GISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTH--TT-L--NI--PE--- 199 (237)
T ss_pred CCccc--CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------ccc--cc-c--CC--cc---
Confidence 99965 34567899999999999999999998875321100 000 00 0 00 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHH
Q 005880 608 EEMVGLLQVAMACTSASPDQRPNMSHV 634 (672)
Q Consensus 608 ~~~~~l~~li~~Cl~~dP~~RPt~~ev 634 (672)
.....+.+++.+|++.||++||++.+.
T Consensus 200 ~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 200 WVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 112356778889999999999998544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=240.91 Aligned_cols=190 Identities=25% Similarity=0.355 Sum_probs=164.0
Q ss_pred HhcccCcCCeEEEEEEE-EcCCcEEEEEEccc--CCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKD--ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
-.++||+|.||+||+|+ .++++.||+|+++- ....-.....+|+-+++.++|.|||++++....++..-+|+|||.
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd- 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD- 84 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-
Confidence 35789999999999999 55689999999873 333345678899999999999999999999999999999999994
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
.+|..+...-. ..++.+....++.|+++||.|.| ++++.|||+||.|.+|+.+|+.|++|||+++.+.-.
T Consensus 85 qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 85 QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 48988887654 35889999999999999999999 899999999999999999999999999999877543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhC-CCCCC
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG-KCPSV 563 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg-~~P~~ 563 (672)
....|..|++|.++.. ..-|++..|+||-|||+.|+... ++-|.
T Consensus 157 cysaevvtlwyrppdvlfg-akly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eeeceeeeeeccCcceeee-eehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 3456788999999875 46789999999999999999974 44453
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=278.11 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=195.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC--CC----ceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR--HP----NLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~l~~~~~~~~~~~lv~e~ 437 (672)
...+|+|.||.|-.+..+ .+..||||+++.... ..+...-|+++++++. .| -+|.+.+++...++.++|+|.
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfel 172 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFEL 172 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEec
Confidence 456999999999999954 478999999986543 3455677999999993 22 378889999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-----------------
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK----------------- 500 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~----------------- 500 (672)
+ |-+++++|..+. -.+++..++..|+.|++++++||| +.+++|-||||+|||+..
T Consensus 173 l-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 173 L-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred c-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 8 669999998764 367999999999999999999999 899999999999999832
Q ss_pred ---CCcEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC---C
Q 005880 501 ---TGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM---G 572 (672)
Q Consensus 501 ---~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~---~ 572 (672)
+..+|++|||.|+..... ..+.|..|+|||++. +-.++..+||||+||||+|++||..-|....+.+.+ +
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViL--gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVIL--GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchhee--ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 123899999999876554 567799999999887 567899999999999999999999999876644322 1
Q ss_pred CCCCCChhH-HHHHHHhhh-ccccccc---------------hhh---ccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 573 CGGAVDLPR-WVQSVVREE-WTAEVFD---------------LEL---MRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 573 ~~~~~~~~~-~~~~~~~~~-~~~~~~d---------------~~~---~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
-..+ .++. .+.....++ +...-+| +.. ......+.+...|++|+.+||..||.+|+|+.
T Consensus 323 rIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 323 RILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 1111 1111 111110000 0000111 000 00112245667899999999999999999999
Q ss_pred HHHH
Q 005880 633 HVVK 636 (672)
Q Consensus 633 evl~ 636 (672)
|++.
T Consensus 402 EAL~ 405 (415)
T KOG0671|consen 402 EALS 405 (415)
T ss_pred HHhc
Confidence 9974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=289.95 Aligned_cols=243 Identities=25% Similarity=0.370 Sum_probs=198.6
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEc-----CCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFA-----REEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e~ 437 (672)
.+.||+|.+|.||+++ .++|+.+|+|++..... ..++.+.|.++++.+ .|||++.++|++.. +++.||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 4679999999999999 66899999998865433 567778889999888 69999999999873 5689999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
|.+|+..|++++.. ...+.|..+..|++.+++||.||| ++.++|||||-.|||++.++.+||+|||.+.....
T Consensus 103 C~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred cCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999998766 356999999999999999999999 88999999999999999999999999999976654
Q ss_pred -----CCCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 -----STVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 -----~~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
.+..||+.|||||++... ...|+..+|+||+|++..||.-|.+|+.+.-+ ...+-.+.+.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------------mraLF~IpRN 243 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------------MRALFLIPRN 243 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------------hhhhccCCCC
Confidence 377889999999987643 45677899999999999999999999864321 1111111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
--+.+ ........++.++|..||.+|-++||++.++++
T Consensus 244 ------PPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 ------PPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------CCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11122 223456678999999999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=300.83 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=195.1
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.++||+|+||.|..++.+ +++.||+|++.+.. ..+..-|..|-.+|..-+.+-|+.++-.|.++.+.|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 45688999999999999954 68999999998733 235667999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+||+|-.++.... ++++....-++..|+-||.-|| +.|+|||||||+|||+|..|++||+|||.+..+..+
T Consensus 158 pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred cCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999997653 4888888999999999999999 899999999999999999999999999998766643
Q ss_pred ------CCCCCCcccCCCccccC--C-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ------TVPRSNGYRAPELSSSD--G-RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~--~-~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
..+||+.|++||++... + +.|++.+|.||+||++|||+.|.-||+.+ .+++-+..+.+-
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------------slveTY~KIm~h 296 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------------SLVETYGKIMNH 296 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------------HHHHHHHHHhch
Confidence 56799999999998653 3 67999999999999999999999999744 344445555444
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN---MSHVV 635 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl 635 (672)
.....+.+ ...+.++ ..+||.+.+ -+|+.|.. +.++-
T Consensus 297 k~~l~FP~-----~~~VSee---akdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 297 KESLSFPD-----ETDVSEE---AKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred hhhcCCCc-----ccccCHH---HHHHHHHHh-cChhhhcccccHHHHH
Confidence 22211111 1123333 444454544 47888887 66654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=285.11 Aligned_cols=231 Identities=22% Similarity=0.280 Sum_probs=183.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
...+|.|+|+.|-++.. .+++..+||++.+. ..+..+|+.++... +||||+++.+.+.+..+.|+|||++.+|-
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 45699999999999994 46889999999765 23445677666665 69999999999999999999999999998
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe-CCCCcEEEeccCCCccCCCC--C
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNARVSDFGLSIFAPPS--T 519 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~~~--~ 519 (672)
+.+.+...+ .....+..|+.+|+.|+.||| +.+||||||||+|||+ +..++++|+|||.++..... +
T Consensus 403 ll~ri~~~~------~~~~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~t 472 (612)
T KOG0603|consen 403 LLRRIRSKP------EFCSEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDT 472 (612)
T ss_pred HHHHHHhcc------hhHHHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcc
Confidence 877776543 233777889999999999999 7899999999999999 58999999999999988776 4
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..-|..|.|||++. ...+++++|+||||++||+|++|+.||.....+ .+....+ ......
T Consensus 473 p~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------~ei~~~i-~~~~~s------ 532 (612)
T KOG0603|consen 473 PALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------IEIHTRI-QMPKFS------ 532 (612)
T ss_pred cchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------HHHHHhh-cCCccc------
Confidence 45578899999775 678999999999999999999999999754322 1111111 111000
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+.+ ...+|+.+||+.||.+||+|.|+..
T Consensus 533 ----~~vS~---~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ----ECVSD---EAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccCH---HHHHHHHHhccCChhhCcChhhhcc
Confidence 12233 3455666999999999999999863
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=277.66 Aligned_cols=239 Identities=22% Similarity=0.351 Sum_probs=188.2
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|.||+||-|+ .++|+.||||++.+.. ...+.++++|+.||++++||.||.+...|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999999 5589999999997543 335678999999999999999999999999999999999999554
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC---CcEEEeccCCCccCCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT---GNARVSDFGLSIFAPPS 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~ 518 (672)
-|..+|.... .++++..-.-++.||+.||.||| ..+|+|+||||+|||+... -++||||||+|+.+...
T Consensus 649 MLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 649 MLEMILSSEK----GRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred HHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 4555555433 45888888889999999999999 7899999999999999643 47999999999998875
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
..+||+.|.|||++.. ..|...-|+||.|||+|--++|..||..+. ++.+.++ ...++
T Consensus 721 sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----------dIndQIQ---NAaFM-- 782 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----------DINDQIQ---NAAFM-- 782 (888)
T ss_pred hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCcc-----------chhHHhh---ccccc--
Confidence 6789999999999864 467788999999999999999999997542 2222211 11110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
+- .....+...+.+++|...|+..-++|-+.++-+
T Consensus 783 -yP-----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 783 -YP-----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -cC-----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11 111223334556777788888888888876543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=268.94 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=189.5
Q ss_pred HHhcccCcCCeEEEEEEE-EcCCcEEEEEEcc--cC-Ccc----hHHHHHHHHHHHcCCCCCceeeeEEEEE-cCCeEEE
Q 005880 363 ASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK--DA-SIG----GKREFEQHMEVLGRLRHPNLVGLKAYYF-AREEKLL 433 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~--~~-~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l 433 (672)
-..++||+|+|+.||+|. +...+.||||+-. +. ..+ ..+...+|.+|-+.|+||.||++++|+. +.+..+-
T Consensus 466 LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 466 LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence 345789999999999999 5567899999854 21 111 1234578999999999999999999996 4556789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC---CCCcEEEeccC
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD---KTGNARVSDFG 510 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG 510 (672)
|+|||+|.+|+-+|+.++ .+++.+...|+.||+.||.||.+- +.+|||-||||.|||+- ..|.+||.|||
T Consensus 546 VLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 999999999999998764 489999999999999999999865 68999999999999984 45789999999
Q ss_pred CCccCCCC------------CCCCCCcccCCCccccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q 005880 511 LSIFAPPS------------TVPRSNGYRAPELSSSD--GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGA 576 (672)
Q Consensus 511 ~a~~~~~~------------~~~~t~~y~aPE~l~~~--~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~ 576 (672)
+++.++.. ...||..|.+||.+... ....+.|+||||.|||+|..+.|+.||..+...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------- 690 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------- 690 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--------
Confidence 99887653 34568899999987654 456788999999999999999999999654221
Q ss_pred CChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 577 VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
+.++.+..+...-.-.....+.+.. +...+|++||++.-++|.+..++.
T Consensus 691 -------QdILqeNTIlkAtEVqFP~KPvVss---eAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 -------QDILQENTILKATEVQFPPKPVVSS---EAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------HHHHhhhchhcceeccCCCCCccCH---HHHHHHHHHHHhhhhhhhhHHHHc
Confidence 2233332221111111111122233 344567799999999998887765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.85 Aligned_cols=234 Identities=28% Similarity=0.407 Sum_probs=189.0
Q ss_pred CeEEEEEEEEc-CCcEEEEEEcccCCcch-HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhc
Q 005880 372 GFGTAYKAVLD-DGSVVAVKRLKDASIGG-KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHG 449 (672)
Q Consensus 372 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 449 (672)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999998655444 68899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----CCCCCCc
Q 005880 450 NRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----TVPRSNG 525 (672)
Q Consensus 450 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~~~~t~~ 525 (672)
.. .+++..++.++.++++++.||| +.+++|+||+|+||++++++.++|+|||.+...... ...++..
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 43 2889999999999999999999 789999999999999999999999999999876553 4556778
Q ss_pred ccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccC
Q 005880 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKD 605 (672)
Q Consensus 526 y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 605 (672)
|++||.+. +..++.++||||||+++|+|++|..||.... +............... ...
T Consensus 152 ~~~pE~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----------~~~~~~~~~~~~~~~~---------~~~ 209 (244)
T smart00220 152 YMAPEVLL--GKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----------QLLELFKKIGKPKPPF---------PPP 209 (244)
T ss_pred CCCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------cHHHHHHHHhccCCCC---------ccc
Confidence 99999654 5677889999999999999999999986421 1111221111111000 000
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 606 IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 606 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.......+.+++.+|+..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0003346888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=238.99 Aligned_cols=206 Identities=25% Similarity=0.382 Sum_probs=167.8
Q ss_pred ccCHHHHHHHHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccC-CcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCe
Q 005880 354 RFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA-SIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREE 430 (672)
Q Consensus 354 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 430 (672)
.|++.+-.......||+|++|.|-+-+ ..+|+..|||+++.. ..+..++..+|+.+..+- .+|.+|.++|.+.....
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 366655444566789999999998888 457999999999753 334566778888876554 79999999999999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++.||.| ..+|+.+-..--. ....+++..+=+|+..+.+||.|||+ +..+||||+||+|||++.+|++|+||||
T Consensus 120 vwIcME~M-~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999 4477665432211 22458899999999999999999995 5789999999999999999999999999
Q ss_pred CCccCCCC----CCCCCCcccCCCccccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 511 LSIFAPPS----TVPRSNGYRAPELSSSD--GRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 511 ~a~~~~~~----~~~~t~~y~aPE~l~~~--~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
++-.+..+ ...|-..|+|||.+... ...|+.|+||||+|+.+.||.+++.||..
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99777655 24566789999977543 33688999999999999999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=289.15 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=180.8
Q ss_pred hcccCcCCeE-EEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFG-TAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+++|.|+.| .||+|.++ |+.||||++-.. .....++|+..|+.- +|||||++++.-.++.+.||..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 4679999987 68999997 889999998533 334668999999887 5999999999999999999999999 559
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---C--CcEEEeccCCCccCCC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---T--GNARVSDFGLSIFAPP 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~DfG~a~~~~~ 517 (672)
|.+++.... .......-...+.+..|+++||+||| +.+||||||||.||||+. + .+++|+|||+++....
T Consensus 589 L~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 589 LQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999998741 11111111455788999999999999 899999999999999975 3 4799999999987765
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG-KCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+ ...||.||+|||++... ..+.++||||+|||+|+.++| .+||...-..+ ..++.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------------~NIl~ 727 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------------ANILT 727 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhh--------------hhhhc
Confidence 3 56689999999987643 456699999999999999996 99996532211 11222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...... ......++ +-.+||.+|+++||..||++.+|+.
T Consensus 728 ~~~~L~-------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 728 GNYTLV-------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Ccccee-------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 211111 11111122 5567888999999999999999973
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=280.94 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=173.1
Q ss_pred HhcccCcCCeEEEEEEEE-----------------cCCcEEEEEEcccCCcchHHHH--------------HHHHHHHcC
Q 005880 364 SAEMLGKGGFGTAYKAVL-----------------DDGSVVAVKRLKDASIGGKREF--------------EQHMEVLGR 412 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~e~~~l~~ 412 (672)
..++||+|+||.||+|.. .+++.||||+++.......++| ..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 357899999999999964 2356899999875433222333 346677777
Q ss_pred CCCCce-----eeeEEEEEc--------CCeEEEEEeecCCCChhHHhhcCCCC-------------------CCCCCCH
Q 005880 413 LRHPNL-----VGLKAYYFA--------REEKLLVSEYMPNGSLFWLLHGNRGP-------------------GRTPLDW 460 (672)
Q Consensus 413 l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~ 460 (672)
++|.++ ++++++|.. .+..++||||+++|+|.++++..... ....++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 766654 677787753 35679999999999999999753210 1123578
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------CCCCCCcccCCCcccc
Q 005880 461 TTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------TVPRSNGYRAPELSSS 534 (672)
Q Consensus 461 ~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------~~~~t~~y~aPE~l~~ 534 (672)
..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++..... ....++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 889999999999999999 789999999999999999999999999999765432 1223678999997643
Q ss_pred CCC--------------------CCCchhHHHHHHHHHHHHHhCCC-CCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 535 DGR--------------------KQSQKSDVYSFGVLLLELLTGKC-PSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 535 ~~~--------------------~~~~~~DV~S~Gvvl~el~tg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
... ....+.||||+||++|||++|.. ||...............++..|.. ...
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~---- 458 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKG---- 458 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcc----
Confidence 211 11235799999999999999875 654211000000000111122211 000
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASP---DQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~ 636 (672)
...+. ...........+++.+++..+| .+|+|++|+++
T Consensus 459 ~~~~~-----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDF-----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCc-----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 01111 1111223356677778998766 78999999973
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=287.88 Aligned_cols=259 Identities=17% Similarity=0.169 Sum_probs=162.6
Q ss_pred HhcccCcCCeEEEEEEEEc-C----CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEE------EEcCCeEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-D----GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY------YFAREEKL 432 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~~~~~ 432 (672)
..+.||+|+||.||+|+.. + +..||||++..... .+....| .+....+.+++.++.. ...+.+.+
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 3578999999999999965 4 68999999864332 1111111 1122222222222211 23556789
Q ss_pred EEEeecCCCChhHHhhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 433 LVSEYMPNGSLFWLLHGNRGP---------------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
+||||+++++|.+++...... .........+..++.|+++||+||| +.+|+||||||+|||
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDLKP~NIL 287 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDVKPQNII 287 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcCCHHHEE
Confidence 999999999999998754210 0011223456689999999999999 789999999999999
Q ss_pred eCC-CCcEEEeccCCCccCCC------CCCCCCCcccCCCccccCCC--------------------CCCchhHHHHHHH
Q 005880 498 LDK-TGNARVSDFGLSIFAPP------STVPRSNGYRAPELSSSDGR--------------------KQSQKSDVYSFGV 550 (672)
Q Consensus 498 l~~-~~~~kl~DfG~a~~~~~------~~~~~t~~y~aPE~l~~~~~--------------------~~~~~~DV~S~Gv 550 (672)
+++ ++.+||+|||+++.... ....++++|+|||.+..... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 986 58999999999976532 24567889999996532211 2345679999999
Q ss_pred HHHHHHhCCCCCCCCCCCC-CCCCCCCCChhHHHHHHHhhhccccccchhhc-cccChHHHHHHHHHHHHhccCCCCCCC
Q 005880 551 LLLELLTGKCPSVIDGGGA-GMGCGGAVDLPRWVQSVVREEWTAEVFDLELM-RYKDIEEEMVGLLQVAMACTSASPDQR 628 (672)
Q Consensus 551 vl~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~R 628 (672)
++|||+++..++....... ........+...|....... ..+... .....+.......+|+.+||+.||++|
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999776653210000 00000011222332211110 000000 000001112234578899999999999
Q ss_pred CCHHHHHH
Q 005880 629 PNMSHVVK 636 (672)
Q Consensus 629 Pt~~evl~ 636 (672)
||+.|+++
T Consensus 442 ~ta~e~L~ 449 (566)
T PLN03225 442 ISAKAALA 449 (566)
T ss_pred CCHHHHhC
Confidence 99999985
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=260.35 Aligned_cols=232 Identities=25% Similarity=0.355 Sum_probs=182.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchH---HHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGK---REFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+..+||+|+||.|.+|..+ +.+.+|||++++..+-.. +--..|-++|+-. +-|.+++++.++..-+..|.||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 4578999999999999965 467899999987543222 2224566666655 5788999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC--
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP-- 516 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~-- 516 (672)
.||+|...++.-. .+.+....-+|..||-||-+|| +.+||.||||.+||++|.+|++||+|||+++.--
T Consensus 433 nGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 433 NGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred cCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999988887543 3777888899999999999999 8999999999999999999999999999997432
Q ss_pred ---CCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 517 ---PSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 517 ---~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
..+..||+.|+|||++.. ..|+..+|.|||||+||||+.|++||+++++. +.++++....
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------------elF~aI~ehn--- 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------------ELFQAIMEHN--- 566 (683)
T ss_pred CcceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHH------------HHHHHHHHcc---
Confidence 236789999999998763 58999999999999999999999999865432 2333333222
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN 630 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 630 (672)
..-++... .+...+....+.+.|.+|..
T Consensus 567 ------vsyPKslS---kEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ------VSYPKSLS---KEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------CcCccccc---HHHHHHHHHHhhcCCccccC
Confidence 11222222 33455666888899999853
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=262.63 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=192.1
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEcCCc-EEEEEEcccCCcch---HHHHHHHHHHHcCCCCCceeeeEEEEEcCCe
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLDDGS-VVAVKRLKDASIGG---KREFEQHMEVLGRLRHPNLVGLKAYYFAREE 430 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 430 (672)
..++|+ .....||-|+||.|-++..++.. .+|+|++++..+.+ .+.+..|-.+|...+.|.||++|-.|.+++.
T Consensus 417 v~l~dl--~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDL--KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhh--hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 344444 23456999999999999976433 48999998755443 3446678899999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.|++||-|-||.|...|+.. ..++..+..-++..+.+|++||| +++||.|||||+|.++|.+|-+||.|||
T Consensus 495 vYmLmEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehh
Confidence 99999999999999999754 35888888899999999999999 8999999999999999999999999999
Q ss_pred CCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 511 LSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 511 ~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
+|+.+... +.+||+.|.|||++... ..+.++|.||+|+++|||++|++||... +...-...+
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~------------dpmktYn~I 631 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGV------------DPMKTYNLI 631 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCC------------chHHHHHHH
Confidence 99988765 67899999999988744 5677899999999999999999999743 333334444
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN 630 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 630 (672)
++.-...++ +. .....-.+++++..+.+|.+|..
T Consensus 632 LkGid~i~~-------Pr---~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 632 LKGIDKIEF-------PR---RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred Hhhhhhhhc-------cc---ccchhHHHHHHHHHhcCcHhhhc
Confidence 433211111 01 12233456777888899999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=231.74 Aligned_cols=186 Identities=23% Similarity=0.382 Sum_probs=159.6
Q ss_pred HHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCC--eEEEEEeec
Q 005880 363 ASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFARE--EKLLVSEYM 438 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~ 438 (672)
++.+++|+|.++.||.|. ..+.+.++||+++.. ..+.+.+|+++|+.|+ ||||+++++...++. ...||+||+
T Consensus 41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 456889999999999999 567889999999865 4578899999999997 999999999998765 456999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAPP 517 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~ 517 (672)
.+.+...+- +.++...+..++.++++||.|.| +.||+|||+||.|++||.. -..+|+|+|+|.+..+
T Consensus 118 ~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 118 NNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred ccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 998776654 24777888999999999999999 8999999999999999965 4699999999988877
Q ss_pred CC----CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 518 ST----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 518 ~~----~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
.. .+.+..|.-||++.. -..|+..-|+|||||++..|+..+.||..
T Consensus 186 ~~eYnVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CceeeeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccC
Confidence 62 334667889998753 46788899999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=244.36 Aligned_cols=190 Identities=24% Similarity=0.393 Sum_probs=161.3
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-----eEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-----EKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 437 (672)
..||-|+||.||.++. ++|+.||+|++... +....+.+-+|+++|.-.+|.|++..++...-.. +.|+|+|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4699999999999984 57999999998753 3335678889999999999999999988875432 56789999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
| ..+|..++-.. .+++...+.-+.+||++||.||| +.+|.||||||.|.|++.+...||||||+++..+.
T Consensus 139 m-QSDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 M-QSDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred H-HhhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 8 45888877533 56888999999999999999999 88999999999999999999999999999997765
Q ss_pred CC------CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 518 ST------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 518 ~~------~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
.. .+.|..|+|||++++ .+.|+.+.||||.|||+.||+..+.-|...+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG-aRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG-ARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc-chhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 42 233667999999874 5789999999999999999999999987544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=233.23 Aligned_cols=206 Identities=34% Similarity=0.535 Sum_probs=179.1
Q ss_pred cCcCCeEEEEEEEEcC-CcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhH
Q 005880 368 LGKGGFGTAYKAVLDD-GSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW 445 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 445 (672)
||+|.+|.||++...+ |+.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999865432 35789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCCCC-----C
Q 005880 446 LLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPPS-----T 519 (672)
Q Consensus 446 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~-----~ 519 (672)
++.... ..+++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++|+|||.+...... .
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 997542 35899999999999999999999 789999999999999999 899999999999766543 2
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..+...|++||.+... ...+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 4456789999965422 3778899999999999998
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246778889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=257.35 Aligned_cols=193 Identities=24% Similarity=0.404 Sum_probs=164.8
Q ss_pred cccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchH---HHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK---REFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||-|+||+|.+++ .++...+|+|.+++.+.-.+ ..++.|-.||...+.+-||+++..|.+.+..|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 579999999999998 55577899999987654333 34577889999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC-----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP----- 516 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----- 516 (672)
++..+|.+.. -+.+....-++..+.-|+++.| +.|+|||||||+|||||.||++||.|||++.-+.
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999987654 3777777888889999999999 8999999999999999999999999999984221
Q ss_pred ----C--------------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHH
Q 005880 517 ----P--------------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLE 554 (672)
Q Consensus 517 ----~--------------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~e 554 (672)
. ...+||..|+|||++.. ..++..+|.||.||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHHHH
Confidence 0 02346778999998863 468889999999999999
Q ss_pred HHhCCCCCCCCCCCC
Q 005880 555 LLTGKCPSVIDGGGA 569 (672)
Q Consensus 555 l~tg~~P~~~~~~~~ 569 (672)
|+.|++||..+...+
T Consensus 864 m~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGE 878 (1034)
T ss_pred HhhCCCCccCCCCCc
Confidence 999999998776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=245.29 Aligned_cols=127 Identities=24% Similarity=0.279 Sum_probs=106.4
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-----C---CceeeeEEEEEc----CCe
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-----H---PNLVGLKAYYFA----REE 430 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~----~~~ 430 (672)
...+||.|.|++||++.. .+.+.||+|+.+.+.. ..+....||++|++++ | .+||+++++|.. +.+
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 357899999999999994 4578999999985543 4566788999998883 3 479999999974 458
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL 498 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll 498 (672)
.++|+|++ |.+|..++....- +-++...+.+|++||+.||.|||.. .+|||-||||+|||+
T Consensus 161 VCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~e---cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHRE---CGIIHTDLKPENVLL 221 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHh---cCccccCCCcceeee
Confidence 89999999 7788888876542 4488999999999999999999975 479999999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=233.35 Aligned_cols=239 Identities=23% Similarity=0.367 Sum_probs=185.3
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---GKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+||+|+|+.|..+++ ++.+.+|+|++++.-.. +..=.+.|-.+..+. +||.+|.+..+|..+...++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 46899999999999995 46889999999864322 222345566666555 69999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.-++++.+ .++++...-+...|.-||.||| +.|||.||||.+|||+|.+|++||.|+|+++.--.
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999987776543 4899999999999999999999 89999999999999999999999999999975422
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
++..||+.|.|||++. +..|+..+|.|++||+++||+.|+.||+.-+.+.. ..+..+++.+++-+..++
T Consensus 406 d~tstfcgtpnyiapeilr--geeygfsvdwwalgvlmfemmagrspfdivgm~n~-----d~ntedylfqvilekqir- 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILR--GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-----DMNTEDYLFQVILEKQIR- 477 (593)
T ss_pred cccccccCCCcccchhhhc--ccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-----ccchhHHHHHHHhhhccc-
Confidence 3678999999999886 56899999999999999999999999985432221 223344444444433211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN 630 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 630 (672)
.+..+ ..+...+++.-+++||.+|..
T Consensus 478 -------iprsl---svkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 -------IPRSL---SVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------cccee---ehhhHHHHHHhhcCCcHHhcC
Confidence 11111 122344566889999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=253.81 Aligned_cols=191 Identities=21% Similarity=0.359 Sum_probs=163.8
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcch--------HHHHHHHHHHHcCCC---CCceeeeEEEEEcCCe
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGG--------KREFEQHMEVLGRLR---HPNLVGLKAYYFAREE 430 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~ 430 (672)
.+.+.+|+|+||.|+.|.++ +...|+||.+.+.+.-. .-..-.||+||..++ |+||++++++|++++.
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 34578999999999999966 46789999987644311 113567999999997 9999999999999999
Q ss_pred EEEEEeec-CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 431 KLLVSEYM-PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 431 ~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
+||+||-. ++.+|++++... +.+++.+..-|++||+.|+++|| +.+|||||||-+||.++.+|-+||+||
T Consensus 644 yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeec
Confidence 99999965 677999999755 45999999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005880 510 GLSIFAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSV 563 (672)
Q Consensus 510 G~a~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~ 563 (672)
|.+...... ...||.+|.|||++.+ ....+..-|||++|++||.++...-||.
T Consensus 715 gsaa~~ksgpfd~f~gtv~~aapevl~g-~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGPFDVFVGTVDYAAPEVLGG-EKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCCcceeeeeccccchhhhCC-CccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999776654 6789999999998754 3455777899999999999999988875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=230.91 Aligned_cols=191 Identities=35% Similarity=0.522 Sum_probs=168.2
Q ss_pred hcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999765 899999999866554 57789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++..... .+++..+..++.++++++.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999975431 1789999999999999999999 789999999999999999999999999998766543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...++..|++||.+. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 344567799999764 556778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=233.56 Aligned_cols=184 Identities=23% Similarity=0.320 Sum_probs=154.6
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEEe
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVSE 436 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 436 (672)
..+|.|.- .|..+.. -.++.||+|++... .....++..+|...+..+.|+||++++.++.-.. +.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777777 5555552 25889999987542 2335677889999999999999999999986433 5689999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|| .++|...++- .++-.++..|..|++.|+.||| +.+|+||||||+||++..+..+||.|||+|+...
T Consensus 102 ~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 102 LM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhcccC
Confidence 99 6699988872 3788899999999999999999 8999999999999999999999999999998766
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
.. .+..|..|+|||++.+. .+.+.+||||.||++.||++|+.-|.+
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cccccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecC
Confidence 54 55668889999988644 489999999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=222.31 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=189.4
Q ss_pred cccCHHHHHHHHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEE-EEcCC
Q 005880 353 KRFELEDLLRASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAY-YFARE 429 (672)
Q Consensus 353 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~ 429 (672)
+..+++|. +.+.+.+|+|.||.+-++..+ +.+.+++|.+..... ..++|.+|..---.| .|.||+.-++. |...+
T Consensus 18 ~kv~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 18 KKVDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 44555553 456788999999999999966 568899999876543 678899998765555 58999988765 45567
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC--CCCcEEEe
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD--KTGNARVS 507 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~--~~~~~kl~ 507 (672)
.++.++||++.|+|.+-+... .+.+....+++.|+++|+.|+| +.++||||||.+||||- +..++|||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred eEEEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEee
Confidence 778999999999999888643 2788889999999999999999 89999999999999983 34589999
Q ss_pred ccCCCccCCCC--CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 508 DFGLSIFAPPS--TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 508 DfG~a~~~~~~--~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
|||+.+..... ...-+..|.|||+... ......+.+|||.||+++|..+||+.||+.+... ...+..|
T Consensus 166 DFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-------d~~Y~~~ 238 (378)
T KOG1345|consen 166 DFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-------DKPYWEW 238 (378)
T ss_pred ecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-------CchHHHH
Confidence 99998766543 2223557999996533 2334567899999999999999999999844322 2334444
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.+...+.. ..+. ..+.... ....++-++-+..+|++|-...++.++....
T Consensus 239 ~~w~~rk~--~~~P----~~F~~fs---~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 239 EQWLKRKN--PALP----KKFNPFS---EKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred HHHhcccC--ccCc----hhhcccC---HHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 43322221 1111 1111112 2345555689999999996666666665443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-28 Score=254.17 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=196.9
Q ss_pred HhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.+|+|.||.|||++ ...++..|||+++-....+..-.++|+-+++..+|||||.++|.|..++..++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 34789999999999999 45799999999987666677788999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 517 (672)
|++.-+.. .++++.++...++...+||+||| +.+-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 99 lQdiy~~T-----gplselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 99 LQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred ccceeeec-----ccchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 99887643 46999999999999999999999 88999999999999999999999999999865543
Q ss_pred CCCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 518 STVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 518 ~~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....||+.|||||+... ....|..++|||+.|+...|+---++|.... ...+-..-. ....+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl------------hpmr~l~Lm-----TkS~~ 232 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL------------HPMRALFLM-----TKSGF 232 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc------------chHHHHHHh-----hccCC
Confidence 36789999999997543 3567889999999999999998888775321 111111111 11223
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
++.-... -......+-++++.|+-++|.+||+++.++.
T Consensus 233 qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 3222211 1234456778888999999999999987653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=247.74 Aligned_cols=203 Identities=25% Similarity=0.299 Sum_probs=167.4
Q ss_pred ccCHHHHHH---HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC------CCceeeeEE
Q 005880 354 RFELEDLLR---ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR------HPNLVGLKA 423 (672)
Q Consensus 354 ~~~~~~l~~---~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~ 423 (672)
++.+.|++. .+....|+|-|++|.+|... -|..||||+++.... ..+.=..|+++|.+|. --|+++++.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 444555442 23457899999999999954 488999999986544 3455578999999995 358999999
Q ss_pred EEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-C
Q 005880 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-G 502 (672)
Q Consensus 424 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~ 502 (672)
.|...++.|||||-+ .-+|.++|+.... ..-+....+..++.|+.-||..|. ..+|+|.||||+||||++. .
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcc
Confidence 999999999999988 5599999986542 345888999999999999999999 8899999999999999975 5
Q ss_pred cEEEeccCCCccCCCCCC---CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPSTV---PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~~~---~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
.+||||||.|........ ..+..|+|||++. |..|+...|+||.||.||||.||+..|.+..
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiL--G~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIIL--GLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceee--cCcccCCccceeeceeeEEeeccceecCCCC
Confidence 689999999987766533 3356799999876 6788999999999999999999999987643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=234.37 Aligned_cols=189 Identities=26% Similarity=0.392 Sum_probs=161.6
Q ss_pred HhcccCcCCeEEEEEEEEc----CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
..++||+|.|++||++... ..+.||+|.+...+ ....+..|+++|..+ .+.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 3578999999999999943 46889999987654 456789999999999 4999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccC--
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFA-- 515 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~-- 515 (672)
++..-.++... ++...+..+++.+.+||+++| ..|||||||||+|++.+. -+.-.|.|||+|...
T Consensus 118 ~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 118 EHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99998888753 678899999999999999999 899999999999999985 578899999998510
Q ss_pred ---------------CC--------------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHH
Q 005880 516 ---------------PP--------------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSF 548 (672)
Q Consensus 516 ---------------~~--------------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~ 548 (672)
.+ ....||+||+|||++.. ....++++||||.
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k-~~~QttaiDiws~ 264 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR-CPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh-ccCcCCccceeec
Confidence 00 02357889999999864 4566889999999
Q ss_pred HHHHHHHHhCCCCCCCCCC
Q 005880 549 GVLLLELLTGKCPSVIDGG 567 (672)
Q Consensus 549 Gvvl~el~tg~~P~~~~~~ 567 (672)
|||++-+++++.||....+
T Consensus 265 GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred cceeehhhccccccccCcc
Confidence 9999999999999986544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=208.14 Aligned_cols=168 Identities=23% Similarity=0.282 Sum_probs=126.7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 520 (672)
|+|.++++... .+++|.+++.|+.|+++||+||| +.+ ||+||+++.++.+|+ ||+++.......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH----~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~ 64 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH----RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQS 64 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH----hcC------CcccEeEcCccceee--ccceEeeccccC
Confidence 78999997542 45999999999999999999999 444 999999999999999 999988776666
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhh
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLEL 600 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 600 (672)
.++..|+|||++. +..++.++|||||||++|||+||+.||..... ............... ++..
T Consensus 65 ~g~~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----------~~~~~~~~~~~~~~~---~~~~ 128 (176)
T smart00750 65 RVDPYFMAPEVIQ--GQSYTEKADIYSLGITLYEALDYELPYNEERE-----------LSAILEILLNGMPAD---DPRD 128 (176)
T ss_pred CCcccccChHHhc--CCCCcchhhHHHHHHHHHHHHhCCCCccccch-----------hcHHHHHHHHHhccC---Cccc
Confidence 7899999999775 55788999999999999999999999964321 112222222111100 0000
Q ss_pred ccccChHHHH--HHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 601 MRYKDIEEEM--VGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 601 ~~~~~~~~~~--~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
........ ..+.+++.+||+.+|.+||++.|+++.+..+.
T Consensus 129 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 129 --RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred --cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00111122 25889999999999999999999999887664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-26 Score=263.58 Aligned_cols=189 Identities=19% Similarity=0.199 Sum_probs=135.6
Q ss_pred CCCC-CceeeeEEEE-------EcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC
Q 005880 412 RLRH-PNLVGLKAYY-------FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483 (672)
Q Consensus 412 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 483 (672)
.++| +||+++++++ ......+.++||+ +++|.+++.... ..+++.+++.++.||++||+||| +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH----S 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH----h
Confidence 3556 6888888877 2234566788887 669999997432 45999999999999999999999 8
Q ss_pred CCcEecCCCCCCEEeCC-------------------CCcEEEeccCCCccCCCC---------------------CCCCC
Q 005880 484 LKLTHGNIKSTNVLLDK-------------------TGNARVSDFGLSIFAPPS---------------------TVPRS 523 (672)
Q Consensus 484 ~~iiH~Dlkp~NIll~~-------------------~~~~kl~DfG~a~~~~~~---------------------~~~~t 523 (672)
.+|+||||||+||||+. ++.+|++|||+++..... ...+|
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 89999999999999954 445677777776532110 12357
Q ss_pred CcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccc
Q 005880 524 NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRY 603 (672)
Q Consensus 524 ~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 603 (672)
..|+|||++. +..++.++|||||||++|||++|.+|+.... ..+.... .. .+.+..
T Consensus 179 ~~Y~APE~~~--~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------------~~~~~~~-~~----~~~~~~--- 234 (793)
T PLN00181 179 SWYTSPEEDN--GSSSNCASDVYRLGVLLFELFCPVSSREEKS--------------RTMSSLR-HR----VLPPQI--- 234 (793)
T ss_pred cceEChhhhc--cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------------HHHHHHH-Hh----hcChhh---
Confidence 7799999765 4578999999999999999999988864210 1111111 10 111110
Q ss_pred cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 604 KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 604 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.........++.+||+.+|.+||+|.|+++
T Consensus 235 ---~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 ---LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ---hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 111233557788999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=210.71 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=188.0
Q ss_pred cCHHHHHHHHhcccCcCCeEEEEEEEEcCCcEEEEEEccc--CCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEE
Q 005880 355 FELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKD--ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKL 432 (672)
Q Consensus 355 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 432 (672)
+++.++ .+..+|.+...|..|+|+++ |..+++|+++- ......++|..|.-.|+-..||||+.++|.|.......
T Consensus 187 id~~~l--nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSL--NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhh--hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 344444 34567999999999999998 55566777753 33334578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe--ccC
Q 005880 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS--DFG 510 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~--DfG 510 (672)
++..||+.|+|+..|+.... ..++-.+..+++.++|+|++|||+- ++-|..--|.+..|++|++.+++|+ |--
T Consensus 264 ~isq~mp~gslynvlhe~t~---vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred EeeeeccchHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccce
Confidence 99999999999999997652 5578889999999999999999954 3334445689999999999998875 322
Q ss_pred CCccCCCCCCCCCCcccCCCccccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 511 LSIFAPPSTVPRSNGYRAPELSSSDGR-KQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 511 ~a~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
++ +......-++.|++||.++.... ..-.++|+|||.+++|||.|...||..-.+-+ ++.. +.-+
T Consensus 339 fs--fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---cgmk---------iale 404 (448)
T KOG0195|consen 339 FS--FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---CGMK---------IALE 404 (448)
T ss_pred ee--eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---hhhh---------hhhc
Confidence 21 11122233578999997754321 23358999999999999999999997543221 1110 0001
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
+ . +...++.+. ..+.+++.-|++.||.+||.++.|+-.|++++
T Consensus 405 g-l------rv~ippgis---~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 G-L------RVHIPPGIS---RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred c-c------cccCCCCcc---HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 0 111122333 34566777899999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=251.48 Aligned_cols=184 Identities=33% Similarity=0.617 Sum_probs=128.9
Q ss_pred ChhhHHHHHHHHhcCCCC-CCCCCCCCCCCCCcccceEEcC-CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCC
Q 005880 25 TSPDLNALLDFKASSDEA-NKLTTWNSTSDPCSWTGVSCLQ-NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFT 101 (672)
Q Consensus 25 ~~~d~~all~~k~~~~~~-~~~~~W~~~~~~c~w~gv~c~~-~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~ 101 (672)
.+.|..||++||+++.++ +.+.+|+.+.+||.|.||+|.. ++|+.|+|++|+++|.++. +..+++|+.|+|++|+++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 558999999999998644 4578998888999999999974 7999999999999987765 778888888888888888
Q ss_pred CCCC-C-CCcccccceeeccccccCC----------------------CCChhhhccCCCCeEecccCccccccchhhcC
Q 005880 102 GPVP-S-LSNLTALKLLFLSHNNFNG----------------------EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNH 157 (672)
Q Consensus 102 ~~~p-~-~~~l~~L~~L~l~~N~l~g----------------------~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 157 (672)
|.+| . +.++++|++|+|++|+++| .+|..++++++|++|+|++|.+++.+|..+++
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 186 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhh
Confidence 7766 3 3356666666665555554 55555566666666666666666666666666
Q ss_pred CCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc
Q 005880 158 LTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA 208 (672)
Q Consensus 158 l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~ 208 (672)
+++|++|+|++|++++.++ +..+++|+.|+|++|++++.+|..+.+++.+.
T Consensus 187 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 239 (968)
T PLN00113 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239 (968)
T ss_pred CcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCC
Confidence 6666666666666655332 34566666666666666666665555544443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=213.48 Aligned_cols=152 Identities=20% Similarity=0.210 Sum_probs=119.1
Q ss_pred hcccCcCCeEEEEEEEEc--CCcEEEEEEcccC-----CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD--DGSVVAVKRLKDA-----SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|+|+++.+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 467999999999999864 5788899987532 11235679999999999999999853322 2467999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC-CCCCEEeCCCCcEEEeccCCCccCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNI-KSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
+++++|... . . .. ...++.++++||+||| +.+|+|||| ||+|||++.++++||+|||+++...
T Consensus 100 ~~G~~L~~~-~-~-------~~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 100 TEGVPLHLA-R-P-------HG---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cCCCCHHHh-C-c-------cc---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999632 1 1 01 1467889999999999 889999999 9999999999999999999998654
Q ss_pred CC-------------CCCCCCcccCCCccccC
Q 005880 517 PS-------------TVPRSNGYRAPELSSSD 535 (672)
Q Consensus 517 ~~-------------~~~~t~~y~aPE~l~~~ 535 (672)
.. ...++..|+|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 32 23356679999976543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=201.43 Aligned_cols=263 Identities=22% Similarity=0.214 Sum_probs=192.3
Q ss_pred HhcccCcCCeEEEEEEEEcCC--cEEEEEEcccCCcchHHHHHHHHHHHcCCCC----CceeeeEEEE-EcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLDDG--SVVAVKRLKDASIGGKREFEQHMEVLGRLRH----PNLVGLKAYY-FAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~e 436 (672)
+...||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ..+...++||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 457899999999999996543 5788888765433333367888888888762 6889999888 47778999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-----CcEEEeccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-----GNARVSDFGL 511 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DfG~ 511 (672)
.+ |.+|.++..... ...++..+..+|+.|++.+|.+|| +.|++||||||.|+.+... -.+.|.|||+
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 98 889999886543 356999999999999999999999 8999999999999999854 3599999999
Q ss_pred CccCC-----------C----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q 005880 512 SIFAP-----------P----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGA 576 (672)
Q Consensus 512 a~~~~-----------~----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~ 576 (672)
++... . ....||..|+++. ...+...+.+.|+||++.++.|++.|..||.......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~--~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~------- 244 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN--VHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD------- 244 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHH--HhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-------
Confidence 98221 1 1233788999999 5567888999999999999999999999996433211
Q ss_pred CChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCC
Q 005880 577 VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDS 655 (672)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~ 655 (672)
...-+....... .... ....... .+.++...+-..+..++|....+.+.+++............+++
T Consensus 245 --~~~~~~~~~~~~----~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 245 --LKSKFEKDPRKL----LTDR---FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred --hHHHHHHHhhhh----cccc---ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence 111111111111 1110 0111122 34444445556899999999999999998876665555555543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=181.32 Aligned_cols=266 Identities=18% Similarity=0.219 Sum_probs=196.1
Q ss_pred hcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC-CceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH-PNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.++||+|+||.+|.|. ..+|+.||||.-.... ...++..|.++...++| ..|..+.-|..+.....+|||.+ |.+
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 4789999999999999 7789999999865433 33467778888888864 56666666777788889999999 889
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC---CCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD---KTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++.-.. +.++..+++-++-|++.-++|+| .+++|||||||+|.|.. ....+.++|||+|+.....
T Consensus 97 LEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 97 LEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred HHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 999987543 45899999999999999999999 78999999999999986 3456999999999765432
Q ss_pred -----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 519 -----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 519 -----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
...||.+|.+-. ...+...+.+.|+=|+|.++...-.|..||++-.... ....-+.+
T Consensus 169 t~~HIpyre~r~ltGTaRYASin--Ah~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t----------k~QKyEkI 236 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASIN--AHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT----------KKQKYEKI 236 (341)
T ss_pred ccccCccccCCccceeeeehhhh--hhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh----------HHHHHHHH
Confidence 456788888766 3334556778899999999999999999998643221 01111112
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDS 659 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 659 (672)
.+..+...+. .. ... .+.++.-.+.-|-..--++-|+..-+.+.++-+.+...+...-.++|++..
T Consensus 237 ~EkK~s~~ie--~L-C~G---~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 237 SEKKMSTPIE--VL-CKG---FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred HHhhcCCCHH--HH-hCC---CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 2221111111 00 111 223566666788888889999999998888888777777666777776544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-20 Score=194.07 Aligned_cols=254 Identities=30% Similarity=0.375 Sum_probs=190.0
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCC-ceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHP-NLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 467899999999999977 78899998754332 367899999999999988 799999999777778999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPP-- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~-- 517 (672)
+++.+++...... ..+.......+..|++.++.|+| +.+++|||+||+||+++..+ .++++|||.++....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999777644311 25889999999999999999999 78899999999999999988 799999999874432
Q ss_pred ---------CCCCCCCcccCCCccccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 518 ---------STVPRSNGYRAPELSSSDG-RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 518 ---------~~~~~t~~y~aPE~l~~~~-~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
....++..|+|||.+.... ..+....|+||+|++++++++|..||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------~~~~~~~~~~ 227 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------SATSQTLKII 227 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------ccHHHHHHHH
Confidence 2456788999999765321 57888999999999999999999997543210 0011111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...... ........ .........+.+++..|+..+|..|.++.+....
T Consensus 228 ~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTP-SLASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCc-ccccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 00000000 0001122456778889999999999999887765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=182.24 Aligned_cols=268 Identities=17% Similarity=0.209 Sum_probs=198.6
Q ss_pred HHhcccCcCCeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 363 ASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.++++||+|.||.++.|+ +-+++.||||.-...+ ...++..|.+..+.| ..+.|..++-+.....+..||+|.+ |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 457899999999999999 5679999999765433 456777888877777 4789998887777788889999999 8
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-----cEEEeccCCCccC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-----NARVSDFGLSIFA 515 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~DfG~a~~~ 515 (672)
.+|.|++.-.. +.++..++..+|.|++.-++|+| ++.+|.|||||+|.||..-+ .+.|+|||+|+..
T Consensus 108 PSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 108 PSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred cCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 89999987553 46999999999999999999999 88999999999999997533 4899999999866
Q ss_pred CCC------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 516 PPS------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 516 ~~~------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
... ...||.+||+-. ..-+...+.+.|+=|+|-|+...+.|..||.+-... ...+-.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSIN--THlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~---------tnK~kY 248 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSIN--THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD---------TNKEKY 248 (449)
T ss_pred cCccccccCccccccccccceeeeEee--ccccchhhhhhhHHHhhhhhhhhccCCCccccccCc---------chHHHH
Confidence 542 346789999887 556778889999999999999999999999865422 122222
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDSVSDS 659 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 659 (672)
+.+-.......+-+ . ....++++...++.+ -+.+-.+-|+.+-+...+..+.+...--....++|+...
T Consensus 249 eKIGe~Kr~T~i~~---L-c~g~P~efa~Yl~yv---R~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 249 EKIGETKRSTPIEV---L-CEGFPEEFATYLRYV---RRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred HHhccccccCCHHH---H-HhcCHHHHHHHHHHH---HhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 22211111111111 1 122344444444444 447888889999998888888765544455566665544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=183.04 Aligned_cols=138 Identities=17% Similarity=0.235 Sum_probs=107.5
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--h-------HHH-----------------HHHHHHHHcCCCCCcee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--G-------KRE-----------------FEQHMEVLGRLRHPNLV 419 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~niv 419 (672)
..||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999878999999999753211 1 112 23499999999887764
Q ss_pred eeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhhCCCCCcEecCCCCCCEEe
Q 005880 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI-HFTCKSLKLTHGNIKSTNVLL 498 (672)
Q Consensus 420 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~iiH~Dlkp~NIll 498 (672)
....+.. ...++||||++++++....... .++++.....++.|++.+|.|+ | +.+|+||||||+||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H----~~giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ----DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEE
Confidence 4433322 2348999999988776543221 3488999999999999999999 6 6799999999999999
Q ss_pred CCCCcEEEeccCCCccC
Q 005880 499 DKTGNARVSDFGLSIFA 515 (672)
Q Consensus 499 ~~~~~~kl~DfG~a~~~ 515 (672)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.3e-22 Score=218.76 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=174.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHH----HHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKR----EFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..++|.|++|.|+..... .....+.|..+.. .....+ .+..|+-+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999988877733 3444444443210 111111 255677777888999998887777766666666999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++ +|+.++... ..+...++..++.|+..|++|+| ..+|.|||+|++|++++.+|.+||+|||.+.....
T Consensus 403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999 999999764 24788899999999999999999 89999999999999999999999999999865432
Q ss_pred ---------CCCCCCCcccCCCccccCCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 518 ---------STVPRSNGYRAPELSSSDGRKQ-SQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 518 ---------~~~~~t~~y~aPE~l~~~~~~~-~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
....|+..|+|||++.. ..| ....||||.|+++..|.+|+.||......+.. . ....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~-------~----~~~~ 539 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS-------F----KTNN 539 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccc-------h----hhhc
Confidence 25667889999997653 344 45789999999999999999999765432210 0 0000
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.......... ...-......+-..++.++|+.||.+|.|+++|++
T Consensus 540 ~~~~~~~~~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 540 YSDQRNIFEG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccccC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000000 00111233445667888999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=173.92 Aligned_cols=183 Identities=18% Similarity=0.175 Sum_probs=138.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc----hHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG----GKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
...|++|+||+||.+.. ++..++.+.+.....- ....+.+|+++|++++ |+++.+++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997766 5788888877654431 1236889999999995 5889999886 45689999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC-CCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNI-KSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
|.+|...+.. ....++.|++++|.++| +.||+|||| ||+||++++++.++|+|||++......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9998654321 11357789999999999 889999999 799999999999999999999855433
Q ss_pred CC------------------CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 005880 519 TV------------------PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGG 568 (672)
Q Consensus 519 ~~------------------~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~ 568 (672)
.. ..++.|++|+.-.......-...+.++-|.-+|.++|++.++..++++
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 21 124556677632211222225678899999999999999998776544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=208.21 Aligned_cols=130 Identities=34% Similarity=0.596 Sum_probs=69.7
Q ss_pred CCChhhHHHHHHHHhcCCCCCCCCCCCCCCCCC-----cccceEEcCC------cEeEEEecCCCcccCCCC-CCCCCCc
Q 005880 23 ASTSPDLNALLDFKASSDEANKLTTWNSTSDPC-----SWTGVSCLQN------RVSHLVLENLQLSGSLQP-LTSLTQL 90 (672)
Q Consensus 23 ~~~~~d~~all~~k~~~~~~~~~~~W~~~~~~c-----~w~gv~c~~~------~v~~L~l~~~~l~~~~~~-l~~l~~L 90 (672)
.+...|..||+++|++++.+. ..+|+. ++| .|.||.|... +|+.|+|++|+|.|.++. ++.|++|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~-~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPL-RFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcc-cCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 345679999999999886433 248963 455 7999999531 244555555555444333 4444444
Q ss_pred cEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhh
Q 005880 91 RVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV 155 (672)
Q Consensus 91 ~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 155 (672)
+.|+|++|+|+|.+| .++++++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l 510 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence 444444444444444 34444444444444444444444444444444444444444444444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=196.01 Aligned_cols=215 Identities=25% Similarity=0.383 Sum_probs=162.6
Q ss_pred HcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCc-Ee
Q 005880 410 LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKL-TH 488 (672)
Q Consensus 410 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~i-iH 488 (672)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... ..++|.....+.+++++||+||| ..+| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh----~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH----NSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh----cCcceee
Confidence 456899999999999999999999999999999999998643 56999999999999999999999 4444 99
Q ss_pred cCCCCCCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccC--CCC---CCchhHHHHHHHHHHHHH
Q 005880 489 GNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSD--GRK---QSQKSDVYSFGVLLLELL 556 (672)
Q Consensus 489 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~--~~~---~~~~~DV~S~Gvvl~el~ 556 (672)
+.++++|.++|....+||+|||+....... ......-|.|||++... ... .+.++||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999999998766431 01112349999987653 122 577899999999999999
Q ss_pred hCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 557 TGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 557 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.+.||....... +..+.+..+.. .....+-|..... .+....+..++.+||..+|++||++++|-.
T Consensus 153 ~r~~~~~~~~~~~--------~~~eii~~~~~--~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 153 FRSGPFDLRNLVE--------DPDEIILRVKK--GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred hccCccccccccC--------ChHHHHHHHHh--cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9999997643221 11122222211 1111122222111 123336888999999999999999999999
Q ss_pred HHHHHhcCC
Q 005880 637 LIEELRGVE 645 (672)
Q Consensus 637 ~L~~i~~~~ 645 (672)
.++.+....
T Consensus 220 ~~~~~~~~~ 228 (484)
T KOG1023|consen 220 KLLTINKGG 228 (484)
T ss_pred hhhhhcccc
Confidence 998876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-21 Score=212.46 Aligned_cols=241 Identities=23% Similarity=0.286 Sum_probs=174.9
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCC-cchHHHHH---HHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS-IGGKREFE---QHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+++|=.|.+|+.+.|. |+||++-+.. .-..+.|. .|++ ...++|||++++.-+...+...|||-+|..+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 467999999999999999888 8889875433 22334444 4444 4556899999998887777778899899855
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC--CCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA--PPS 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~--~~~ 518 (672)
+|+|.+.. ++-+...+..-|+.|++.||...| +.+|+|||||.+||||+.-.-+.|+||..-+.. +.+
T Consensus 106 -nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 106 -NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred -hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 89998864 345788889999999999999999 899999999999999999989999999765432 111
Q ss_pred ----------CCCCCCcccCCCccccCC---------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCC
Q 005880 519 ----------TVPRSNGYRAPELSSSDG---------RKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578 (672)
Q Consensus 519 ----------~~~~t~~y~aPE~l~~~~---------~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~ 578 (672)
+..+...|.|||-+...+ ...+++.||||+|||+.||++ |++||...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------------- 242 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------------- 242 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------------
Confidence 222344699999765422 125789999999999999998 58887521
Q ss_pred hhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 005880 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 640 (672)
+.+... +.+ -.|++..- ..++ ...+.+++..|++.||.+|.++++.++.-++
T Consensus 243 --QL~aYr-~~~----~~~~e~~L-e~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 243 --QLLAYR-SGN----ADDPEQLL-EKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred --HHHhHh-ccC----ccCHHHHH-HhCc--CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111110 000 11111100 0001 1247788899999999999999999988433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=175.89 Aligned_cols=138 Identities=19% Similarity=0.246 Sum_probs=110.0
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--h------------------------HHHHHHHHHHHcCCCCCcee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--G------------------------KREFEQHMEVLGRLRHPNLV 419 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~niv 419 (672)
..||+|+||.||+|+..+|+.||||+++..... . ...+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999778999999998754211 0 12246789999999999886
Q ss_pred eeEEEEEcCCeEEEEEeecCCCChhHH-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEE
Q 005880 420 GLKAYYFAREEKLLVSEYMPNGSLFWL-LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVL 497 (672)
Q Consensus 420 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIl 497 (672)
....+... ..++||||++++++... +.. ..++......++.|++.++.++| . .+|+||||||+||+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH----~~~givHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY----QEAGLVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCChhhEE
Confidence 55544433 34899999998865433 332 24678889999999999999999 6 89999999999999
Q ss_pred eCCCCcEEEeccCCCccCC
Q 005880 498 LDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~ 516 (672)
++ +++++|+|||++....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 99 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=180.16 Aligned_cols=165 Identities=15% Similarity=0.180 Sum_probs=126.4
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHH---------HHHHHHHHcCCCCCceeeeEEEEEcC-------
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKRE---------FEQHMEVLGRLRHPNLVGLKAYYFAR------- 428 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~~------- 428 (672)
.+.+|.|+||.||+... ++..+|||.++......... +++|++.+.+++|++|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 47899999999999766 57789999997544333222 68999999999999999999886643
Q ss_pred -CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe
Q 005880 429 -EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS 507 (672)
Q Consensus 429 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 507 (672)
...++||||++|.+|.++.. ++. ....+++.+|..+| +.+++|||+||+||++++++ ++|+
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999987732 222 24568999999999 88999999999999999988 9999
Q ss_pred ccCCCccCCCCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh
Q 005880 508 DFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557 (672)
Q Consensus 508 DfG~a~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t 557 (672)
|||........... +.+. ....+..++||||||+.+.....
T Consensus 177 Dfg~~~~~~e~~a~--------d~~v-ler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------DRID-LERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ECCCcccccchhhH--------HHHH-HHhHhcccccccceeEeehHHHH
Confidence 99987655322111 1111 12345679999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=168.21 Aligned_cols=133 Identities=14% Similarity=0.174 Sum_probs=105.0
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-----CCCceeeeEEEEEcCC---eEE-EEE
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-----RHPNLVGLKAYYFARE---EKL-LVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~ 435 (672)
.+.||+|+||.||. .-.++.. +||++........+++.+|++++..+ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 3334444 69988765444667899999999999 5799999999998763 333 789
Q ss_pred ee--cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhhCCCCCcEecCCCCCCEEeCC----CCcEEEec
Q 005880 436 EY--MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL-AFIHFTCKSLKLTHGNIKSTNVLLDK----TGNARVSD 508 (672)
Q Consensus 436 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~~iiH~Dlkp~NIll~~----~~~~kl~D 508 (672)
|| +++|+|.+++.... +++. ..++.+++.++ +||| +++|+||||||+||+++. +++++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 55799999996432 4444 35677888887 9999 889999999999999974 34799999
Q ss_pred cCC
Q 005880 509 FGL 511 (672)
Q Consensus 509 fG~ 511 (672)
|+.
T Consensus 153 g~G 155 (210)
T PRK10345 153 NIG 155 (210)
T ss_pred CCC
Confidence 543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-19 Score=177.91 Aligned_cols=230 Identities=22% Similarity=0.347 Sum_probs=145.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccC---CcchHHHHHHHHHHHcCCCC----------CceeeeEEEEEcC--
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA---SIGGKREFEQHMEVLGRLRH----------PNLVGLKAYYFAR-- 428 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~~~-- 428 (672)
++.||.|+++.||.++.. +|+.+|||++.-. .....+++++|.-....+.+ -.++-.++...-.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 367999999999999965 5899999987532 22345667777655544322 1222222222211
Q ss_pred ----------C-----eEEEEEeecCCCChhHHhhc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 005880 429 ----------E-----EKLLVSEYMPNGSLFWLLHG---NRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGN 490 (672)
Q Consensus 429 ----------~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~D 490 (672)
. ..+++|+-+ .+||.+++.. ... ....+....++.+..|+++.+++|| +.|++|+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLH----SYGLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHH----HTTEEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHh----hcceEecc
Confidence 1 236788888 6688887642 111 1223556677888899999999999 78999999
Q ss_pred CCCCCEEeCCCCcEEEeccCCCccCCCCC--CCCCCcccCCCccccC------CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005880 491 IKSTNVLLDKTGNARVSDFGLSIFAPPST--VPRSNGYRAPELSSSD------GRKQSQKSDVYSFGVLLLELLTGKCPS 562 (672)
Q Consensus 491 lkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~t~~y~aPE~l~~~------~~~~~~~~DV~S~Gvvl~el~tg~~P~ 562 (672)
|||+|++++++|.++|+||+......... ...+..|.+||..... ...++.+.|.|++|+++|.|++|+.||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 99999999999999999998776554432 2334679999965332 235788999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCC
Q 005880 563 VIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR 628 (672)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 628 (672)
........ ..| ...... +..+.+..||..+|+.+|++|
T Consensus 251 ~~~~~~~~---------~~~----------------~f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEAD---------PEW----------------DFSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGST---------SGG----------------GGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred CCCCcccc---------ccc----------------cchhcC---CcCHHHHHHHHHHccCCcccC
Confidence 75432210 000 111222 344457778889999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=170.76 Aligned_cols=193 Identities=20% Similarity=0.273 Sum_probs=138.8
Q ss_pred CCCceeeeEEEEEcC---------------------------CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHH
Q 005880 414 RHPNLVGLKAYYFAR---------------------------EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466 (672)
Q Consensus 414 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 466 (672)
+|||||++.++|.+. ...|+||..++. +|.+++..+. .+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 699999999887643 235899998854 9999997543 566777889
Q ss_pred HHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe--CCCC--cEEEeccCCCccCCC--------C---CCCCCCcccCCCc
Q 005880 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL--DKTG--NARVSDFGLSIFAPP--------S---TVPRSNGYRAPEL 531 (672)
Q Consensus 467 ~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll--~~~~--~~kl~DfG~a~~~~~--------~---~~~~t~~y~aPE~ 531 (672)
+.|+++|+.||| +++|.|||+|++|||+ |+|+ ...|+|||++-.... + ...|...-||||+
T Consensus 347 laQlLEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 999999999999 8999999999999998 3444 478999998743222 1 3345667899998
Q ss_pred cccCCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChH
Q 005880 532 SSSDGRK----QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIE 607 (672)
Q Consensus 532 l~~~~~~----~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 607 (672)
.....+. .-.|+|.|+.|.+.||+++..-||...++.. .+... +++.....+ .+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-------L~~r~-----Yqe~qLPal----------p~ 480 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-------LDTRT-----YQESQLPAL----------PS 480 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-------echhh-----hhhhhCCCC----------cc
Confidence 7543222 2358999999999999999999998643211 11111 112111111 12
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 608 EEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 608 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
.....+.+++...++.||.+|++..-..+.|.
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 23445778888999999999999887777664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-19 Score=191.91 Aligned_cols=185 Identities=31% Similarity=0.408 Sum_probs=155.6
Q ss_pred ccCcCCeEEEEEEE----EcCCcEEEEEEcccCCcch--HHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 367 MLGKGGFGTAYKAV----LDDGSVVAVKRLKDASIGG--KREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+|+|.||.|++++ .+.|..+|+|.+++..... ......|..++...+ ||.+|++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 2347889999887654321 224456777888886 9999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|...+.... .+++.....+...+|-+++++| +.+|+|||+|++||+++.+|++++.|||+++..-..
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999998887543 4777777888889999999999 899999999999999999999999999999866443
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
..+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 152 ~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 347899999999874 456789999999999999999999963
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=161.37 Aligned_cols=134 Identities=21% Similarity=0.368 Sum_probs=113.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|++++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 5778999986543221 124678899999999999998888887778888999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+++++|.+++.... + .+..++.+++.+|.++| +.+++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 2 88899999999999999 88999999999999999 78999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=163.47 Aligned_cols=139 Identities=18% Similarity=0.209 Sum_probs=107.5
Q ss_pred HHhcccCcCCeEEEEEEE--EcCCcEEEEEEcccCCcc------------------------hHHHHHHHHHHHcCCCCC
Q 005880 363 ASAEMLGKGGFGTAYKAV--LDDGSVVAVKRLKDASIG------------------------GKREFEQHMEVLGRLRHP 416 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~ 416 (672)
.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+.+|++.+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 356789999999999998 568999999998743210 012357899999999753
Q ss_pred c--eeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC-cEecCCCC
Q 005880 417 N--LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK-LTHGNIKS 493 (672)
Q Consensus 417 n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~-iiH~Dlkp 493 (672)
. +.+++++ ...++||||+++++|....... ......+...++.|++.++++|| ..+ |+||||||
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp 177 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSE 177 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCCh
Confidence 3 3444433 2358999999998887654222 23556667899999999999999 788 99999999
Q ss_pred CCEEeCCCCcEEEeccCCCccC
Q 005880 494 TNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 494 ~NIll~~~~~~kl~DfG~a~~~ 515 (672)
+||+++ +++++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999987643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=160.44 Aligned_cols=131 Identities=18% Similarity=0.307 Sum_probs=107.7
Q ss_pred ccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 367 MLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.||+|+||.||+|.+ +|..|++|........ ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 4788999986532211 1356788999999999888766666666677789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
++++|.+++.... . .++.+++++|.+|| +.+++|||++|+||+++ ++.+++.|||++...
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875321 0 78999999999999 88999999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.7e-18 Score=189.72 Aligned_cols=186 Identities=26% Similarity=0.405 Sum_probs=146.8
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC---CCceeeeEEEEEcCCeEEEEEeecC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR---HPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.+.+|+|+||+||+|...+|+.||+|+=+....- +|.--.+++.+|+ -+-|..+...+...+..+||+||.+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 345789999999999999888999999987754321 1111122333443 2345566666667788899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-------CCCcEEEeccCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-------KTGNARVSDFGLS 512 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~DfG~a 512 (672)
.|+|.+++... ..++|...+.++.|+++-+++|| ..+||||||||+|.||. +...++|+|||.+
T Consensus 778 ~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 778 YGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred cccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 99999999844 35899999999999999999999 88999999999999994 2335899999998
Q ss_pred ccCCC---C----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005880 513 IFAPP---S----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPS 562 (672)
Q Consensus 513 ~~~~~---~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~ 562 (672)
..+.. . ....|-++--+| +..|+.++..+|-|.++.+++-|+.|+..-
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~E--M~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIE--MREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHH--HhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 65432 2 344567788899 556899999999999999999999998653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=155.95 Aligned_cols=136 Identities=15% Similarity=0.185 Sum_probs=106.7
Q ss_pred HHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc----------------------hHHHHHHHHHHHcCCCCCc--
Q 005880 362 RASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG----------------------GKREFEQHMEVLGRLRHPN-- 417 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-- 417 (672)
+...+.||+|+||.||++...+|+.||||+++..... ....+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 3445789999999999999888999999987532200 1123677888898888774
Q ss_pred eeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 418 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
+...++ ....++||||+++++|..+... .....++.++++++.++| ..+|+||||||+||+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nil 157 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEFNIL 157 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEE
Confidence 444443 2455899999999998765421 234678899999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCC
Q 005880 498 LDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~ 516 (672)
+++++.++|+|||.+....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=178.13 Aligned_cols=131 Identities=19% Similarity=0.287 Sum_probs=108.1
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEE-cccC-Cc------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKR-LKDA-SI------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|.+.+.. +++|+ +.+. .. ...+.+.+|++++.+++|++++....++.+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 478999999999999976444 33433 2221 11 123568899999999999999988888888788899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|+++++|.+++. ....++.+++++|.||| +.+++||||||+||++ +++.++|+|||+++.
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999998874 35678999999999999 8899999999999999 678999999999865
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.4e-18 Score=149.88 Aligned_cols=143 Identities=28% Similarity=0.375 Sum_probs=130.9
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|.|++|.|+..+|.+..|.+|+.|++++|+|+..+++++.|++|+.|+++-|++. .+|..||.++.|+.|||+
T Consensus 32 ~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 3678999999999999999999999999999999999998889999999999999999999 999999999999999999
Q ss_pred cCcccc-ccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc
Q 005880 144 FNNFSG-QIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA 208 (672)
Q Consensus 144 ~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~ 208 (672)
+|+++. .+|..|..++.|+.|+|+.|.|.- |...+.+++|+.|.+.+|.+- ++|..++.+..+.
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr 176 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR 176 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH
Confidence 999973 579999999999999999999987 666789999999999999998 8998887766554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-15 Score=144.14 Aligned_cols=136 Identities=21% Similarity=0.255 Sum_probs=97.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--hHHH----------------------HHHHHHHHcCCCCCc--e
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--GKRE----------------------FEQHMEVLGRLRHPN--L 418 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i 418 (672)
.+.||+|+||.||+|...+|+.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888999999998753221 1111 134555555554332 4
Q ss_pred eeeEEEEEcCCeEEEEEeecCCCChhH-HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCE
Q 005880 419 VGLKAYYFAREEKLLVSEYMPNGSLFW-LLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNV 496 (672)
Q Consensus 419 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NI 496 (672)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++| . .+|+||||||+||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh----~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLY----REAGLVHGDLSEYNI 146 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHh----hccCcCcCCCChhhE
Confidence 444433 24589999999865422 121110 11 567889999999999999 6 8999999999999
Q ss_pred EeCCCCcEEEeccCCCccCC
Q 005880 497 LLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 497 ll~~~~~~kl~DfG~a~~~~ 516 (672)
+++ ++.++|+|||.+....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-15 Score=137.79 Aligned_cols=134 Identities=19% Similarity=0.152 Sum_probs=112.2
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC--CceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH--PNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 568999999999999864 7899999865443 5678999999999976 5899999888877889999999988766
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
..+ +......++.+++++|+++|... ..+++|||++|+||++++.+.+++.|||.+...
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 433 45677889999999999999332 257999999999999999899999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-16 Score=163.47 Aligned_cols=117 Identities=23% Similarity=0.336 Sum_probs=101.0
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
..|+.|++|...+|.++|.+.+. ....++.....++.|++.|+.| .+.+|||+||.||+...+..+||+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh-------ccchhhhccccccccccchhhhhhhh
Confidence 46799999999999999976542 2457889999999999999998 48899999999999999999999999
Q ss_pred CCCccCCCC-----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh
Q 005880 510 GLSIFAPPS-----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557 (672)
Q Consensus 510 G~a~~~~~~-----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t 557 (672)
|+....... ...+|..||+||.+ .+..|+.|+||||+|++|+|+++
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi--~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI--RGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHH--hhhhhhhhcchhhHHHHHHHHHH
Confidence 998655432 35678899999965 47799999999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.7e-15 Score=145.23 Aligned_cols=137 Identities=20% Similarity=0.231 Sum_probs=106.4
Q ss_pred HHhcccC-cCCeEEEEEEEEcCCcEEEEEEcccCC-------------cchHHHHHHHHHHHcCCCCCce--eeeEEEEE
Q 005880 363 ASAEMLG-KGGFGTAYKAVLDDGSVVAVKRLKDAS-------------IGGKREFEQHMEVLGRLRHPNL--VGLKAYYF 426 (672)
Q Consensus 363 ~~~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~ 426 (672)
.....|| .|+.|+||.+... +..++||++.... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3356788 8999999999886 6778999875321 1133567889999999998875 67777654
Q ss_pred cCC----eEEEEEeecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC
Q 005880 427 ARE----EKLLVSEYMPN-GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT 501 (672)
Q Consensus 427 ~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~ 501 (672)
.+. ..++||||+++ .+|.+++... +++.. .+.+++++|.+|| +.||+||||||.|||++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPD 178 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCC
Confidence 322 23599999997 6999888642 24443 3578999999999 8999999999999999999
Q ss_pred CcEEEeccCCCcc
Q 005880 502 GNARVSDFGLSIF 514 (672)
Q Consensus 502 ~~~kl~DfG~a~~ 514 (672)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-15 Score=169.37 Aligned_cols=203 Identities=21% Similarity=0.306 Sum_probs=134.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.|..|+||.||..+.+ ..+.+|+|+-+ ... +.+- ++.....|.+| |+
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----ilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----ILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccc-cch-----hhhc--cccccCCccee---------------------ch
Confidence 3478999999999999865 46788885432 221 1110 22222333333 33
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC------
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP------ 516 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~------ 516 (672)
=...++... +++. +++.+++||| +.+|+|||+||+|.+|+.-|++|+.|||+.+..-
T Consensus 138 c~tllk~~g-----~lPv--------dmvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 138 CATLLKNIG-----PLPV--------DMVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred hhhhcccCC-----CCcc--------hhhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 344443221 1221 2278899999 8999999999999999999999999999875321
Q ss_pred --------------CCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 517 --------------PSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 517 --------------~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
....++|+.|+|||++. ...|+..+|.|++|+|+||.+-|..||+++..++ .
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil--rqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------------l 266 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------------L 266 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhh--hhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------------H
Confidence 12457899999999875 4578999999999999999999999998764332 2
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
+..++...... ....+....+..+++.+.|+.+|.+|--....+
T Consensus 267 fg~visd~i~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 267 FGQVISDDIEW---------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred Hhhhhhhhccc---------cccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 22222222110 001122233456677789999999996443333
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.3e-16 Score=138.67 Aligned_cols=128 Identities=23% Similarity=0.375 Sum_probs=118.8
Q ss_pred CCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCcc
Q 005880 82 QPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHL 161 (672)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 161 (672)
+.+.++.+++.|-||+|+++..+|.+..|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..|+.++.|
T Consensus 27 ~gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 27 PGLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred ccccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4477889999999999999999999999999999999999999 99999999999999999999999 899999999999
Q ss_pred CeeeccCCcccC-cC--CCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccccc
Q 005880 162 LTLKLEANRFSG-PI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212 (672)
Q Consensus 162 ~~L~l~~N~l~~-~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~~n 212 (672)
+.|||..|+++. .. .++.+..|..|+|++|.|. .+|..+++++.++.+++
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~l 157 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSL 157 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEee
Confidence 999999999987 33 4677889999999999999 99999999999988754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.5e-16 Score=160.78 Aligned_cols=140 Identities=29% Similarity=0.399 Sum_probs=113.1
Q ss_pred cEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccC--------------------
Q 005880 66 RVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN-------------------- 124 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~-------------------- 124 (672)
+...|+|++|+|..++.+ +.+|+.|-+||||+|++...+|.+..|.+|++|+|++|.|.
T Consensus 127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~ 206 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN 206 (1255)
T ss_pred CcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence 455677777777766655 67888888889999988888888888888888888888654
Q ss_pred -----CCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCC
Q 005880 125 -----GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 125 -----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
..+|.++..|.+|..+|||.|++. .+|..+.++.+|+.|+||+|+|+. ........+|++|+||.|+|+ .+|
T Consensus 207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP 284 (1255)
T KOG0444|consen 207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLP 284 (1255)
T ss_pred ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cch
Confidence 257888888999999999999998 899999999999999999999987 445556677888888888888 777
Q ss_pred CcCCCCCCc
Q 005880 199 KSLSGFPDS 207 (672)
Q Consensus 199 ~~l~~~~~~ 207 (672)
+.+.+++.+
T Consensus 285 ~avcKL~kL 293 (1255)
T KOG0444|consen 285 DAVCKLTKL 293 (1255)
T ss_pred HHHhhhHHH
Confidence 776666543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.2e-15 Score=151.98 Aligned_cols=139 Identities=31% Similarity=0.286 Sum_probs=103.3
Q ss_pred ceEEcCCcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCC
Q 005880 59 GVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136 (672)
Q Consensus 59 gv~c~~~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 136 (672)
|+.-....+.+|+|+.|+++..-.. +.+|+.|+.|+||+|.|..+-+ ++...++|++|+|++|+|+..-+.+|..|..
T Consensus 263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~ 342 (873)
T KOG4194|consen 263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ 342 (873)
T ss_pred cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence 4444446788999999999877666 7888999999999999987666 7778888999999999988666677777778
Q ss_pred CCeEecccCccccccchhhcCCCccCeeeccCCcccCcC-----CCCCCCCCCeeeccCCcCCCCCC
Q 005880 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI-----TGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 137 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-----~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
|++|+|++|.++..--..|..+++|++|||++|.|++.+ ++..|++|+.|+|.+|+|. .||
T Consensus 343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~ 408 (873)
T KOG4194|consen 343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIP 408 (873)
T ss_pred hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecc
Confidence 888888888777444456777777777777777776633 2335666666666666666 455
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=147.32 Aligned_cols=141 Identities=21% Similarity=0.210 Sum_probs=99.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcch----------------------------------------HHHHHH
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGG----------------------------------------KREFEQ 405 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~~ 405 (672)
+.||+|++|.||+|++++|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999999999999999986432100 012445
Q ss_pred HHHHHcCC----CCCceeeeEEEE-EcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 005880 406 HMEVLGRL----RHPNLVGLKAYY-FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR-GLAFIHF 479 (672)
Q Consensus 406 e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 479 (672)
|.+.+.++ +|.+-+.+-.++ ......++||||++|++|.++...... .. .+.+++..+++ .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~- 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL- 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH-
Confidence 55555444 233323332233 234567999999999999887653211 12 24456666666 467788
Q ss_pred hCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 480 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
..|++|+|++|.||+++++++++++|||++....+
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 78999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.6e-14 Score=137.06 Aligned_cols=150 Identities=24% Similarity=0.403 Sum_probs=115.8
Q ss_pred HHHHcCCCCCceeeeEEEEEcCC-----eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC
Q 005880 407 MEVLGRLRHPNLVGLKAYYFARE-----EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481 (672)
Q Consensus 407 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 481 (672)
+.-+-.+.|.|||+++.|+.+.. +..+++|||+.|++..+|++.+.. ...+......+|+.||..||.|||..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 33455567999999999986543 467899999999999999876532 34577788899999999999999954
Q ss_pred CCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc---------CCCCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHH
Q 005880 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF---------APPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLL 552 (672)
Q Consensus 482 ~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~---------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl 552 (672)
+++|+|+++.-+-|++..++-+|++----... .......+-++|.||| +......+.++|||+||...
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~--sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE--SGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCC--cCcccccccchhhhhhhHHH
Confidence 68999999999999999998888753211110 0111223457899999 66666777899999999999
Q ss_pred HHHHhCCCC
Q 005880 553 LELLTGKCP 561 (672)
Q Consensus 553 ~el~tg~~P 561 (672)
+||.-+..-
T Consensus 273 lemailEiq 281 (458)
T KOG1266|consen 273 LEMAILEIQ 281 (458)
T ss_pred HHHHHheec
Confidence 999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.8e-15 Score=163.51 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=177.3
Q ss_pred cccCcCCeEEEEEEEEc--CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD--DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|.|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++++|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 45899999999988853 34567777765443 223344455777767776 99999999999999999999999999
Q ss_pred CChhHHh-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCC-
Q 005880 441 GSLFWLL-HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPP- 517 (672)
Q Consensus 441 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~- 517 (672)
|++.+.+ +... ...+....-.++.|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|.....
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999888 4322 235556677889999999999993 46899999999999999999 999999999976655
Q ss_pred C-------CCCC-CCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S-------TVPR-SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~-------~~~~-t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...| +..|+|||..... ....+..|+||.|+++.-+++|..|+....... .....|......
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~- 249 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-------GRYSSWKSNKGR- 249 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc-------ccceeecccccc-
Confidence 2 4456 8899999976532 355788999999999999999999997654322 122222211100
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
+ ....+.. ......++..+++..+|..|.+.+++.
T Consensus 250 ------~--~~~~~~~---~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 ------F--TQLPWNS---ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------c--ccCcccc---CChhhhhcccccccCCchhcccccccc
Confidence 0 0011111 122345666688889999999988774
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-15 Score=151.20 Aligned_cols=139 Identities=28% Similarity=0.394 Sum_probs=109.7
Q ss_pred EeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 67 VSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 67 v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
++.|++.+|.+...++..-+++.|+.||...|.++..+|.++.|.+|.-|||.+|++. .+| +|+++..|++|+++.|+
T Consensus 162 l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~ 239 (565)
T KOG0472|consen 162 LSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQ 239 (565)
T ss_pred HHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccH
Confidence 3445555555555555544467777777777777777778888888888888888888 777 78888888888888888
Q ss_pred cccccchhhc-CCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 147 FSGQIPLTVN-HLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 147 l~g~~p~~~~-~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
|. .+|++.. ++.+|..|||..|++.. |.....+++|+.||+|+|.++ .+|.+++++ .+.|.
T Consensus 240 i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L 302 (565)
T KOG0472|consen 240 IE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFL 302 (565)
T ss_pred HH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeeh
Confidence 88 7888776 89999999999999988 777788999999999999999 789888887 55544
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.2e-14 Score=140.36 Aligned_cols=157 Identities=20% Similarity=0.241 Sum_probs=121.8
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccc-cccCC----------------
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH-NNFNG---------------- 125 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~-N~l~g---------------- 125 (672)
...+.|+|+.|+|+.+++. |+.+++|+.||||+|+|+.+-| .|..|.+|..|-+-+ |+|+.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3567899999999998887 9999999999999999998777 676666665555444 55541
Q ss_pred --------------------------------------------------------------------------------
Q 005880 126 -------------------------------------------------------------------------------- 125 (672)
Q Consensus 126 -------------------------------------------------------------------------------- 125 (672)
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence
Q ss_pred -------------------------------------CCC-hhhhccCCCCeEecccCccccccchhhcCCCccCeeecc
Q 005880 126 -------------------------------------EFP-DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLE 167 (672)
Q Consensus 126 -------------------------------------~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 167 (672)
.-| .-|..|++|+.|+|++|+|++.-+..|..+..|++|+|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 001 124567888888888888887777788888888888888
Q ss_pred CCcccC--cCCCCCCCCCCeeeccCCcCCCCCCCcCC---CCCCccccccccccCCCCc
Q 005880 168 ANRFSG--PITGLDLRNLQDFNVSGNHLSGQIPKSLS---GFPDSAFTQNAALCGSPMQ 221 (672)
Q Consensus 168 ~N~l~~--~~~~~~l~~L~~l~l~~N~l~g~~p~~l~---~~~~~~~~~n~~lc~~~~~ 221 (672)
.|+|.. .-.+.++.+|+.|+|.+|+|+..-|..|. .+..+.+..||+.|+|-+.
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 888765 33355789999999999999988886665 4556677899999999765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.1e-14 Score=149.32 Aligned_cols=157 Identities=23% Similarity=0.274 Sum_probs=133.6
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..+..|+|+.|.|..+-.. .....+|++|+|++|+|+...+ +|..|..|+.|+|++|+++..--..|..+++|+.|||
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 4677899999999876544 6777899999999999999888 8999999999999999999666667889999999999
Q ss_pred ccCccccccch---hhcCCCccCeeeccCCcccC--cCCCCCCCCCCeeeccCCcCCCCCCCcCCCC--CCccccccccc
Q 005880 143 SFNNFSGQIPL---TVNHLTHLLTLKLEANRFSG--PITGLDLRNLQDFNVSGNHLSGQIPKSLSGF--PDSAFTQNAAL 215 (672)
Q Consensus 143 ~~N~l~g~~p~---~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~--~~~~~~~n~~l 215 (672)
++|.|++.|.. .|..|++|+.|+|.+|+|.. .-.+..+.+|++|||.+|.|...-|+.|..+ ..|.+..-..+
T Consensus 373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssfl 452 (873)
T KOG4194|consen 373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFL 452 (873)
T ss_pred cCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceE
Confidence 99999988854 58889999999999999987 3346799999999999999997777777654 44555555689
Q ss_pred cCCCCc
Q 005880 216 CGSPMQ 221 (672)
Q Consensus 216 c~~~~~ 221 (672)
|+|.+.
T Consensus 453 CDCql~ 458 (873)
T KOG4194|consen 453 CDCQLK 458 (873)
T ss_pred EeccHH
Confidence 998753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.1e-14 Score=150.19 Aligned_cols=153 Identities=25% Similarity=0.308 Sum_probs=133.5
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.++..+||+.|+|.-.+.-+-++.+|+.|+||+|+|+..--..+...+|++|+||+|+|+ .+|+.+.+|++|+.|.+.+
T Consensus 222 ~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~ 300 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANN 300 (1255)
T ss_pred hhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhcc
Confidence 467889999999998877799999999999999999987778888999999999999999 9999999999999999999
Q ss_pred Cccc-cccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc---ccccccCCC
Q 005880 145 NNFS-GQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT---QNAALCGSP 219 (672)
Q Consensus 145 N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~---~n~~lc~~~ 219 (672)
|+++ ..||..|++|.+|+.+..++|+|.- |.....+..|+.|.|+.|.|. ++|+.+--++.+..+ .|+.+--.|
T Consensus 301 NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 301 NKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred CcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 9986 3489999999999999999999986 666789999999999999999 899988777765544 566665444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.8e-13 Score=140.39 Aligned_cols=249 Identities=19% Similarity=0.205 Sum_probs=176.1
Q ss_pred cccCHHHHHHHHhcccCc--CCeEEEEEEEE---cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCC-CCCceeeeEEE
Q 005880 353 KRFELEDLLRASAEMLGK--GGFGTAYKAVL---DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRL-RHPNLVGLKAY 424 (672)
Q Consensus 353 ~~~~~~~l~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~ 424 (672)
..+++.+-...+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....++ .|+|.++.+..
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 344555544445678999 99999999986 4688899998442221 2233334566655666 49999998888
Q ss_pred EEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhhCCCCCcEecCCCCCCEEeCC
Q 005880 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFIHFTCKSLKLTHGNIKSTNVLLDK 500 (672)
Q Consensus 425 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~~iiH~Dlkp~NIll~~ 500 (672)
+...+..++-+|++ +.+|..+.+... ..++....+.+..+..+ ||.++| ..+++|-|+||.||+...
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTS 257 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheeccc
Confidence 89999999999999 468888876443 23566667777777777 999999 889999999999999999
Q ss_pred C-CcEEEeccCCCccCCCCCC----------CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005880 501 T-GNARVSDFGLSIFAPPSTV----------PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA 569 (672)
Q Consensus 501 ~-~~~kl~DfG~a~~~~~~~~----------~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~ 569 (672)
+ ...++.|||+...+..... .+...|++||+. ...++.+.|||++|.++.+..++..+......
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~---~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-- 332 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL---NGLATFASDIFSLGEVILEAILGSHLPSVGKN-- 332 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh---ccccchHhhhcchhhhhHhhHhhcccccCCCC--
Confidence 9 8899999999887765421 344569999975 35788999999999999999998777643211
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..|.+ .+... +..+.. +.-..++...+..+++.+|..|++.+.+.+
T Consensus 333 ----------~~W~~--~r~~~----ip~e~~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 ----------SSWSQ--LRQGY----IPLEFC-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----------CCccc--ccccc----Cchhhh-----cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11211 00000 000111 111123444777899999999999887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.8e-12 Score=118.19 Aligned_cols=130 Identities=17% Similarity=0.138 Sum_probs=94.4
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCcee-eeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLV-GLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
+.++.|.++.||++... |..|++|....... ....+.+|++++..+.+.+++ +++++ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 56889999999999876 77899998765432 234567889998888665554 34443 234468999999998775
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCC-CCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK-SLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
+. . .....++.+++++|+.||.... ...++|||++|.||+++ ++.++++|||.+.
T Consensus 80 ~~----~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TE----D---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc----c---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 42 0 0113456789999999993211 12259999999999999 6689999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.9e-11 Score=126.76 Aligned_cols=164 Identities=21% Similarity=0.226 Sum_probs=126.8
Q ss_pred EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCH
Q 005880 381 LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDW 460 (672)
Q Consensus 381 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~ 460 (672)
..++.+|.|+..+...........+-++.|+.+|||||+++++.+...+..|+|+|.+. .|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 44688888888876554345567788899999999999999999999999999999873 46666653 335
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCC-----CCCCcccCCCccccC
Q 005880 461 TTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV-----PRSNGYRAPELSSSD 535 (672)
Q Consensus 461 ~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----~~t~~y~aPE~l~~~ 535 (672)
....-.+.||+.||.|||+ +.+++|++|.-+-|+|++.|+.||++|.++........ .--..|..|+.+.
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~---d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~-- 178 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLND---DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID-- 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHhc---cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC--
Confidence 5667788999999999984 46799999999999999999999999988755443321 1123477777332
Q ss_pred CCCCCchhHHHHHHHHHHHHHhCCCC
Q 005880 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561 (672)
Q Consensus 536 ~~~~~~~~DV~S~Gvvl~el~tg~~P 561 (672)
..+-..|.|-|||+++|++.|..+
T Consensus 179 --~s~~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 179 --PSEWSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred --ccccchhhhhHHHHHHHHhCcccC
Confidence 112457999999999999999433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.9e-12 Score=141.65 Aligned_cols=108 Identities=37% Similarity=0.580 Sum_probs=95.2
Q ss_pred ccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeecc
Q 005880 112 ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVS 189 (672)
Q Consensus 112 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~ 189 (672)
.++.|+|++|.++|.+|..+++|++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.++ ...+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999998555 5689999999999
Q ss_pred CCcCCCCCCCcCCCC----CCccccccccccCCC
Q 005880 190 GNHLSGQIPKSLSGF----PDSAFTQNAALCGSP 219 (672)
Q Consensus 190 ~N~l~g~~p~~l~~~----~~~~~~~n~~lc~~~ 219 (672)
+|+|+|.+|..+..+ ..+.+.+|+.+|+.|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999877643 356677899999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.1e-11 Score=136.07 Aligned_cols=168 Identities=17% Similarity=0.260 Sum_probs=123.6
Q ss_pred cCCChhhHHHHHHHHhcCCCCCCCCC----CCCCCCCCcccc----------------eEEcCC----------------
Q 005880 22 KASTSPDLNALLDFKASSDEANKLTT----WNSTSDPCSWTG----------------VSCLQN---------------- 65 (672)
Q Consensus 22 ~~~~~~d~~all~~k~~~~~~~~~~~----W~~~~~~c~w~g----------------v~c~~~---------------- 65 (672)
...+..+...+++..+.+..++.+.+ |+.++++|.-.+ |.|..+
T Consensus 58 ~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~~ 137 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASSA 137 (754)
T ss_pred CCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccccccccccC
Confidence 34566789999999998887777766 988889995433 667322
Q ss_pred -----------------------------------------cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCC
Q 005880 66 -----------------------------------------RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPV 104 (672)
Q Consensus 66 -----------------------------------------~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~ 104 (672)
+.+.|+|++++|+..+..+. ++|+.|+|++|+|+..+
T Consensus 138 ~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP 215 (754)
T PRK15370 138 SGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLP 215 (754)
T ss_pred CCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCC
Confidence 34567788888876655453 47888999999988765
Q ss_pred CCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCC
Q 005880 105 PSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQ 184 (672)
Q Consensus 105 p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~ 184 (672)
+.+. ++|+.|+|++|+|+ .+|..+.. +|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. ++..-..+|+
T Consensus 216 ~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~--~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~~sL~ 286 (754)
T PRK15370 216 ENLQ--GNIKTLYANSNQLT-SIPATLPD--TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLPEELR 286 (754)
T ss_pred hhhc--cCCCEEECCCCccc-cCChhhhc--cccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccCCCCc
Confidence 5443 58889999999888 67876653 7888888888888 7777764 578888888888885 2222235788
Q ss_pred eeeccCCcCCCCCCCcC
Q 005880 185 DFNVSGNHLSGQIPKSL 201 (672)
Q Consensus 185 ~l~l~~N~l~g~~p~~l 201 (672)
.|+|++|+|+ .+|..+
T Consensus 287 ~L~Ls~N~Lt-~LP~~l 302 (754)
T PRK15370 287 YLSVYDNSIR-TLPAHL 302 (754)
T ss_pred EEECCCCccc-cCcccc
Confidence 8888888888 466543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-11 Score=135.39 Aligned_cols=140 Identities=15% Similarity=0.116 Sum_probs=91.6
Q ss_pred cccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcc----------------------------------hH------HHHH
Q 005880 366 EMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIG----------------------------------GK------REFE 404 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~------~~~~ 404 (672)
+.||+|++|.||+|++++ |+.||||+.+..-.. .. -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999887 999999998743100 01 1244
Q ss_pred HHHHHHcCC----CCCceeeeEEEEEc-CCeEEEEEeecCCCChhHHh--hcCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005880 405 QHMEVLGRL----RHPNLVGLKAYYFA-REEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477 (672)
Q Consensus 405 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 477 (672)
+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++- .... .....+.......++.|+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qi------- 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQV------- 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHH-------
Confidence 455444444 24444444444433 45678999999999997742 2111 001112222222233333
Q ss_pred HhhCCCCCcEecCCCCCCEEeCCCC----cEEEeccCCCccCCC
Q 005880 478 HFTCKSLKLTHGNIKSTNVLLDKTG----NARVSDFGLSIFAPP 517 (672)
Q Consensus 478 H~~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~~ 517 (672)
+ ..|++|+|++|.||+++.++ ++++.|||++.....
T Consensus 277 f----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2 46999999999999999888 999999999876654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.6e-12 Score=117.12 Aligned_cols=123 Identities=27% Similarity=0.354 Sum_probs=41.8
Q ss_pred CCCCCCccEEEcccCCCCCCCCCCC-cccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhh-cCCCcc
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVPSLS-NLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHL 161 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L 161 (672)
+.+...++.|+|++|+|+. +..++ .+.+|+.|+|++|.|+ .++ .+..|++|++|++++|+|+ .+...+ ..+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred ccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 4555567777788777774 44555 4677777888888777 443 4677777888888888887 454444 357778
Q ss_pred CeeeccCCcccCc---CCCCCCCCCCeeeccCCcCCCCCCC----cCCCCCCccccc
Q 005880 162 LTLKLEANRFSGP---ITGLDLRNLQDFNVSGNHLSGQIPK----SLSGFPDSAFTQ 211 (672)
Q Consensus 162 ~~L~l~~N~l~~~---~~~~~l~~L~~l~l~~N~l~g~~p~----~l~~~~~~~~~~ 211 (672)
+.|+|++|+|... .....+++|+.|+|.+|.++ ..+. .+..+|.+.+.+
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence 8888888877662 23456778888888888877 3332 234566666554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7e-13 Score=132.53 Aligned_cols=132 Identities=27% Similarity=0.358 Sum_probs=121.3
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhh-ccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVS-SLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~ 143 (672)
.++.+||...|-|...++.++.+.+|..|+|..|+|.. .|+|+.+..|+.|+++.|+++ .+|.+.+ .|.+|..|||.
T Consensus 183 ~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~-lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR 260 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIRF-LPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLR 260 (565)
T ss_pred HHHHhcccchhhhhcCChhhcchhhhHHHHhhhccccc-CCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence 37889999999999999999999999999999999995 559999999999999999999 8998887 89999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSL 201 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l 201 (672)
.|+++ ..|.++..+.+|.+||+|+|.|++ |...+++ .|+.|-+.+|.+. +|-.++
T Consensus 261 dNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr-TiRr~i 316 (565)
T KOG0472|consen 261 DNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR-TIRREI 316 (565)
T ss_pred ccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH-HHHHHH
Confidence 99999 999999999999999999999999 7778888 9999999999987 554444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=109.94 Aligned_cols=136 Identities=14% Similarity=0.153 Sum_probs=97.8
Q ss_pred cccCcCCeEEEEEEEEcC-------CcEEEEEEcccCC----------------------cchHHHHH----HHHHHHcC
Q 005880 366 EMLGKGGFGTAYKAVLDD-------GSVVAVKRLKDAS----------------------IGGKREFE----QHMEVLGR 412 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~~ 412 (672)
..||.|--+.||.|...+ +..+|||+.+... ....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 4799999774210 00122333 79999988
Q ss_pred CCC--CceeeeEEEEEcCCeEEEEEeecCCCChh-HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhhCCCCCcEe
Q 005880 413 LRH--PNLVGLKAYYFAREEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI-HFTCKSLKLTH 488 (672)
Q Consensus 413 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~iiH 488 (672)
+.. -++.+++++ ...++||||+.++.+. ..++. ..++..+...+..+++.+|..| | +.+|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H----~~glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK----ECNLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH----hCCeec
Confidence 853 455566654 5678999999765442 12221 1244556778889999999999 7 789999
Q ss_pred cCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 489 GNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 489 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|||++.||+++ ++.++|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-12 Score=142.70 Aligned_cols=126 Identities=32% Similarity=0.435 Sum_probs=108.3
Q ss_pred CcEeEEEecCCCcccCC-CCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~-~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..+..|+|.+|.|+... +.|-+..+|+.|+|++|+|...+. .+.+|..|+.|+||+|+|+ .+|..+.++..|++|..
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 36778899999998654 558899999999999999996555 7889999999999999999 99999999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-cCCCC-CCCCCCeeeccCCcC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGL-DLRNLQDFNVSGNHL 193 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~-~l~~L~~l~l~~N~l 193 (672)
.+|+|. .+| ++.++++|+.+|++.|+|+. .++.. .-++|++|||++|.-
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999998 788 89999999999999999987 33332 337999999999973
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.1e-13 Score=139.12 Aligned_cols=151 Identities=26% Similarity=0.389 Sum_probs=88.6
Q ss_pred EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
.+.|..|.+..+++.+++|..|++|||+.|+++..++.+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++.
T Consensus 102 ~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~ 179 (722)
T KOG0532|consen 102 SLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ 179 (722)
T ss_pred HHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh
Confidence 3444444444444445666666666666666665555555544 666666666666 66666665566666666666666
Q ss_pred cccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc--ccccccCCCCcccc
Q 005880 149 GQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT--QNAALCGSPMQACK 224 (672)
Q Consensus 149 g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~--~n~~lc~~~~~~c~ 224 (672)
.+|..++++.+|+.|.+..|++.. +.....| .|..||+|.|+++ .||-.|.++..|... .|+-|...|.+.|.
T Consensus 180 -slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~ 255 (722)
T KOG0532|consen 180 -SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICE 255 (722)
T ss_pred -hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHHh
Confidence 566666666666666666666655 3333322 4667777777777 677776666665543 23334444444553
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.3e-11 Score=114.76 Aligned_cols=120 Identities=29% Similarity=0.335 Sum_probs=52.8
Q ss_pred cEeEEEecCCCcccCCCCCC-CCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhh-hccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQPLT-SLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~l~ 143 (672)
++++|+|++|.|+. ++.++ .+.+|+.|||++|+|+. ++.+..+++|+.|+|++|+|+ .+++.+ ..+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccccc-ccchhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECc
Confidence 57889999999985 45676 68999999999999996 567889999999999999999 676655 468999999999
Q ss_pred cCccccccc-hhhcCCCccCeeeccCCcccCcCC-----CCCCCCCCeeec
Q 005880 144 FNNFSGQIP-LTVNHLTHLLTLKLEANRFSGPIT-----GLDLRNLQDFNV 188 (672)
Q Consensus 144 ~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~-----~~~l~~L~~l~l 188 (672)
+|+|...-- ..+..+++|+.|+|.+|.++.... ...+++|+.||-
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 999974221 367789999999999999986322 246889998874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-10 Score=112.65 Aligned_cols=143 Identities=20% Similarity=0.191 Sum_probs=110.4
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCC--ceeeeEEEEEcC---CeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHP--NLVGLKAYYFAR---EEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 439 (672)
+.|+.|.++.||++...+|..+++|....... ....++.+|.++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999999765332 2356788999999998753 456677776553 25689999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC-------------------------------------- 481 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 481 (672)
+.++.+.+.. ..++..++..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765531 23677888889999999999998421
Q ss_pred --------------CCCCcEecCCCCCCEEeCC--CCcEEEeccCCCcc
Q 005880 482 --------------KSLKLTHGNIKSTNVLLDK--TGNARVSDFGLSIF 514 (672)
Q Consensus 482 --------------~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~ 514 (672)
....++|+|+.|.||++++ ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0245799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.4e-10 Score=101.22 Aligned_cols=131 Identities=20% Similarity=0.304 Sum_probs=100.6
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEE-cccCCcc-------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKR-LKDASIG-------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+++|+-+.+|.+.+. |..+++|. +++.-.. ....-.+|.+++.+++--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 44466664 3322111 123456799999988766666556667788888999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
++|-.|.+.+... ...++..+-+-+.-|| ..+|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888643 2567777888888999 89999999999999998765 99999999863
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.7e-11 Score=134.89 Aligned_cols=109 Identities=22% Similarity=0.265 Sum_probs=85.6
Q ss_pred CCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeecc
Q 005880 88 TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLE 167 (672)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 167 (672)
.+|++|+|++|+|++.++. ..+|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|.. .++|+.|+++
T Consensus 342 ~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS 410 (788)
T PRK15387 342 SGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVL---PSELKELMVS 410 (788)
T ss_pred cccceEecCCCccCCCCCC---Ccccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence 4799999999999975543 356888999999999 578643 57999999999999 57754 3679999999
Q ss_pred CCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 168 ANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 168 ~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
+|+|++. |. ...+|+.|++++|+|+ .+|..+.+++.+...
T Consensus 411 ~N~LssI-P~-l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~L 450 (788)
T PRK15387 411 GNRLTSL-PM-LPSGLLSLSVYRNQLT-RLPESLIHLSSETTV 450 (788)
T ss_pred CCcCCCC-Cc-chhhhhhhhhccCccc-ccChHHhhccCCCeE
Confidence 9999872 22 2457899999999999 899887776665443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-10 Score=131.98 Aligned_cols=137 Identities=23% Similarity=0.336 Sum_probs=103.9
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
...++.|+|++|+|+..+..+. .+|++|+|++|+|+..+..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|+
T Consensus 198 p~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 198 PEQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred ccCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 3578999999999998766554 589999999999997554553 47999999999999 8888876 489999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcC-CCCCCcccccc
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSL-SGFPDSAFTQN 212 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l-~~~~~~~~~~n 212 (672)
+|+|+ .+|..+. ++|+.|+|++|+|++... .-..+|+.|++++|+|+ .+|..+ .++..+.+.+|
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~-~lp~sL~~L~Ls~N~Lt-~LP~~l~~sL~~L~Ls~N 335 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPA-HLPSGITHLNVQSNSLT-ALPETLPPGLKTLEAGEN 335 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccccCcc-cchhhHHHHHhcCCccc-cCCccccccceeccccCC
Confidence 99999 6787664 589999999999987221 11246888888888888 466433 33444444444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.8e-09 Score=98.11 Aligned_cols=141 Identities=15% Similarity=0.255 Sum_probs=103.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEE-cccCCc-------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKR-LKDASI-------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+-+|+-+.|+++.+. |+...||. +.+.-. -..++-.+|++++.+++--.|.-..=++.+.....|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 57889999999999987 77767764 322111 1245678899999988655555444456677777899999
Q ss_pred cCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEeccCCCc
Q 005880 438 MPN-GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVSDFGLSI 513 (672)
Q Consensus 438 ~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~ 513 (672)
+++ .++.+++...-. ..........++..|-+.+.-|| ..+||||||..+||++..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 966 477888765432 12222333788999999999999 89999999999999997655 35899999975
Q ss_pred c
Q 005880 514 F 514 (672)
Q Consensus 514 ~ 514 (672)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.9e-10 Score=127.53 Aligned_cols=113 Identities=19% Similarity=0.189 Sum_probs=61.6
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccC
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 145 (672)
+++.|++.+|+|+..+. .+++|++|+|++|+|+..++. .++|+.|+|++|.|+ .+|..+ .+|+.|+|++|
T Consensus 223 ~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N 292 (788)
T PRK15387 223 HITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGN 292 (788)
T ss_pred CCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCc---ccccceeeccCCchh-hhhhch---hhcCEEECcCC
Confidence 45566666666665432 135566666666666644321 245666666666665 444422 34666677777
Q ss_pred ccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCC
Q 005880 146 NFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 146 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~ 194 (672)
+|+ .+|.. +++|+.|+|++|+|++.... ..+|+.|++++|+|+
T Consensus 293 ~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~l--p~~L~~L~Ls~N~L~ 335 (788)
T PRK15387 293 QLT-SLPVL---PPGLQELSVSDNQLASLPAL--PSELCKLWAYNNQLT 335 (788)
T ss_pred ccc-ccccc---ccccceeECCCCccccCCCC--cccccccccccCccc
Confidence 766 45542 35677777777777662111 123444444455444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-11 Score=127.35 Aligned_cols=133 Identities=26% Similarity=0.370 Sum_probs=121.6
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
..++.|||+.|+++-.+..++.|+ |+.|-+++|+++..++.++.+..|..||.+.|++. .+|..++.|.+|+.|.+..
T Consensus 121 ~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrR 198 (722)
T KOG0532|consen 121 EALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRR 198 (722)
T ss_pred hHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhh
Confidence 578899999999998888888776 99999999999988889999999999999999999 9999999999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLS 202 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~ 202 (672)
|++. .+|.++..| .|..||+|+|+++. |+.+..|+.|++|-|.+|.|. +-|..+.
T Consensus 199 n~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 199 NHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 9999 889999855 69999999999998 888999999999999999999 6676554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-10 Score=123.55 Aligned_cols=240 Identities=18% Similarity=0.176 Sum_probs=167.3
Q ss_pred cccCcCCeEEEEEEEEc--CCcEEEEEEcccCCcchHHH--HHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD--DGSVVAVKRLKDASIGGKRE--FEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..||.|.|+.||+...+ ++..+++|.+.+.......+ -..|+.+...+ .|.+++++...+......|+--||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 57999999999998844 67899999887644332222 24455555555 588999988888777788899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCCCC-
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~- 518 (672)
+++.....- ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.+..+.-.
T Consensus 351 ~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 351 GSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cchhhhhHH-----HHhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhccccccccccceec
Confidence 988766521 134777889999999999999999 8999999999999999876 78899999998643222
Q ss_pred -CCCCCCccc-CCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYR-APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~-aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
......++. ..|++. ....+-.+.|+||||.-+.|.+++.+--.. ..+|. .+.
T Consensus 422 ~~~~~~~r~~p~~~~~~-e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------------~~~~~----------~i~ 476 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILL-EDYPHLSKADIFSLGLSVDEAITGSPLSES--------------GVQSL----------TIR 476 (524)
T ss_pred ccccccccccccchhhc-cccccccccccccccccccccccCcccCcc--------------cccce----------eee
Confidence 222333444 245443 345677899999999999999998654221 11111 000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.......+. ....+..+...+...++..||.+.++....+...
T Consensus 477 ~~~~p~~~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 477 SGDTPNLPG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cccccCCCc---hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111111111 1134555666888999999999998876655443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-11 Score=116.86 Aligned_cols=120 Identities=24% Similarity=0.238 Sum_probs=83.0
Q ss_pred CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
+.....|+.||||+|.|+..-.+..-+++++.|++|+|.+. .+-. +..|++|+.||||+|.++ .+-..-.+|.+.++
T Consensus 280 ~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred cchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 44556677788888887765556666777788888888777 4443 777777888888888777 55555566777778
Q ss_pred eeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCC--CcCCCCCCc
Q 005880 164 LKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIP--KSLSGFPDS 207 (672)
Q Consensus 164 L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p--~~l~~~~~~ 207 (672)
|.|+.|.|..-.....+-+|..||+++|++. .+- ..++++|.+
T Consensus 357 L~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCL 401 (490)
T KOG1259|consen 357 LKLAQNKIETLSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCL 401 (490)
T ss_pred eehhhhhHhhhhhhHhhhhheeccccccchh-hHHHhcccccccHH
Confidence 8888887766555566777777888888776 332 345555544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.4e-11 Score=114.84 Aligned_cols=126 Identities=26% Similarity=0.290 Sum_probs=87.1
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccC
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 145 (672)
.+++|||++|.|+.+-....-++.++.|+||+|+|.. +..+..|.+|+.||||+|.++ .+-..--+|-+++.|.|+.|
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 3566777777777666666666777777777777774 334677777777777777777 55566666677777777777
Q ss_pred ccccccchhhcCCCccCeeeccCCcccC---cCCCCCCCCCCeeeccCCcCCC
Q 005880 146 NFSGQIPLTVNHLTHLLTLKLEANRFSG---PITGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 146 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~---~~~~~~l~~L~~l~l~~N~l~g 195 (672)
.|. .+ ..+++|-+|..||+++|+|.. ....++++-|++|.|.+|.|.+
T Consensus 363 ~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 363 KIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 775 22 356677777777777777765 2235667777777777777773
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.8e-09 Score=128.14 Aligned_cols=102 Identities=20% Similarity=0.185 Sum_probs=46.7
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccC
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 145 (672)
.++.|++.++.+...+..+ .+.+|+.|+|++|++...+..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|
T Consensus 590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c 667 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDC 667 (1153)
T ss_pred ccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCC
Confidence 3444444444444333333 23445555555555444333444445555555544433334442 444445555555444
Q ss_pred ccccccchhhcCCCccCeeeccCC
Q 005880 146 NFSGQIPLTVNHLTHLLTLKLEAN 169 (672)
Q Consensus 146 ~l~g~~p~~~~~l~~L~~L~l~~N 169 (672)
.....+|..++++++|+.|++++|
T Consensus 668 ~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 668 SSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred CCccccchhhhccCCCCEEeCCCC
Confidence 433344444445555555555443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.3e-09 Score=128.72 Aligned_cols=134 Identities=24% Similarity=0.278 Sum_probs=115.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|.+|.|......+..+++|+.|+|++|...+.+|.++++++|+.|+|++|.....+|..+++|++|+.|++++
T Consensus 611 ~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~ 690 (1153)
T PLN03210 611 ENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR 690 (1153)
T ss_pred cCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence 57899999999999877778999999999999987767888999999999999999877779999999999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSL 201 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l 201 (672)
|..-+.+|..+ ++++|+.|+|++|...+..+. ...+|+.|++++|.+. .+|..+
T Consensus 691 c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~-~~~nL~~L~L~~n~i~-~lP~~~ 744 (1153)
T PLN03210 691 CENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD-ISTNISWLDLDETAIE-EFPSNL 744 (1153)
T ss_pred CCCcCccCCcC-CCCCCCEEeCCCCCCcccccc-ccCCcCeeecCCCccc-cccccc
Confidence 76555888876 799999999999876554432 2468999999999987 788654
|
syringae 6; Provisional |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-08 Score=102.08 Aligned_cols=142 Identities=14% Similarity=0.072 Sum_probs=101.3
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc-----------hHHHHHHHHHHHcCCCCCc--eeeeEEEEEc----
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG-----------GKREFEQHMEVLGRLRHPN--LVGLKAYYFA---- 427 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~---- 427 (672)
.+.+-+.....|++..+. |+.|.||+....... ....+.+|.+.+.++..-+ ....+++...
T Consensus 27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 345555555567777664 788999977533211 1124778888888774333 3344555543
Q ss_pred -CCeEEEEEeecCCC-ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-----
Q 005880 428 -REEKLLVSEYMPNG-SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK----- 500 (672)
Q Consensus 428 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~----- 500 (672)
....++|||++++. +|.+++.... ..+.+...+..++.++++.++-|| ..||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCC
Confidence 23578999999876 8998885321 123556778899999999999999 899999999999999975
Q ss_pred --CCcEEEeccCCCcc
Q 005880 501 --TGNARVSDFGLSIF 514 (672)
Q Consensus 501 --~~~~kl~DfG~a~~ 514 (672)
++.+.++||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46899999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.7e-09 Score=100.66 Aligned_cols=138 Identities=22% Similarity=0.282 Sum_probs=99.5
Q ss_pred HHHHHHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc----------------------chHHHHHHHHHHHcCCCC
Q 005880 358 EDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI----------------------GGKREFEQHMEVLGRLRH 415 (672)
Q Consensus 358 ~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h 415 (672)
.+...++++.||-|--+.||.|....|.++|||.-+.... ......++|+++|.+|.-
T Consensus 89 r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 89 RGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred cChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 3445567899999999999999999999999995431110 012356789999999865
Q ss_pred C--ceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 005880 416 P--NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKS 493 (672)
Q Consensus 416 ~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp 493 (672)
. .+.+.+++ +...+||||+++-.|...- ++......|+..|++-+..+- ..||||+|+++
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~----~~GiVHGDlSe 230 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY----RRGIVHGDLSE 230 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH----HcCccccCCch
Confidence 4 66666644 5678999999886664321 223333444555555554444 47999999999
Q ss_pred CCEEeCCCCcEEEeccCCCc
Q 005880 494 TNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 494 ~NIll~~~~~~kl~DfG~a~ 513 (672)
-||++++||.+.++||--+.
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred heEEEecCCCEEEEeCcccc
Confidence 99999999999999996443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.6e-08 Score=102.84 Aligned_cols=172 Identities=23% Similarity=0.260 Sum_probs=130.4
Q ss_pred CeEEEEEEE-EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEE----cCCeEEEEEeecCC-CChhH
Q 005880 372 GFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYF----AREEKLLVSEYMPN-GSLFW 445 (672)
Q Consensus 372 ~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~ 445 (672)
.-.+.||+. ..||..|++|+++............-+++++++.|+|||++.+++. .+...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346889998 4589999999996544434444456678899999999999998886 34567899999985 56766
Q ss_pred HhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 446 LLHGNRG----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 446 ~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
+-..... ......++..+|.++.|+..||.++| +.|+.-+-|.+.+|+++.+.+++|+..|.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 5433221 12345788999999999999999999 778888999999999999999999988887655
Q ss_pred CCCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 005880 516 PPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561 (672)
Q Consensus 516 ~~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P 561 (672)
..+. . |.+. --.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~-------~--~~le-----~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDP-------T--EPLE-----SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCC-------C--cchh-----HHhhhhHHHHHHHHHHHhhcccc
Confidence 4432 0 1111 12367999999999999998643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.8e-09 Score=97.80 Aligned_cols=125 Identities=22% Similarity=0.292 Sum_probs=82.4
Q ss_pred EEEEEEEcCCcEEEEEEcccCCc---------------------c-----hHHHHHHHHHHHcCCCCC--ceeeeEEEEE
Q 005880 375 TAYKAVLDDGSVVAVKRLKDASI---------------------G-----GKREFEQHMEVLGRLRHP--NLVGLKAYYF 426 (672)
Q Consensus 375 ~Vy~~~~~~g~~vavK~~~~~~~---------------------~-----~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 426 (672)
.||.|...+|..+|||+.+.... . .....++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998742100 0 123467899999999765 455665442
Q ss_pred cCCeEEEEEeecC--CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhhCCCCCcEecCCCCCCEEeCCCCc
Q 005880 427 AREEKLLVSEYMP--NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF-IHFTCKSLKLTHGNIKSTNVLLDKTGN 503 (672)
Q Consensus 427 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~~iiH~Dlkp~NIll~~~~~ 503 (672)
..++||||++ +..+..+.... ++......++.++++.+.. +| ..+|+||||.+.||+++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-e
Confidence 4579999998 55554443321 1233456677777775555 46 7899999999999999988 9
Q ss_pred EEEeccCCCccC
Q 005880 504 ARVSDFGLSIFA 515 (672)
Q Consensus 504 ~kl~DfG~a~~~ 515 (672)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-10 Score=114.82 Aligned_cols=149 Identities=23% Similarity=0.264 Sum_probs=120.3
Q ss_pred EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEeccc-Cc
Q 005880 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF-NN 146 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N~ 146 (672)
.++-++-+|+.+|..+. ..-+.|+|..|+|+.++| .|+.+++|+.||||+|+|+-.-|..|.+|.+|..|-+-+ |+
T Consensus 50 ~VdCr~~GL~eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred eEEccCCCcccCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 34555666776766554 356889999999999888 899999999999999999988899999999987766655 99
Q ss_pred cccccc-hhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCC-cCC---CCCCccccccccccCCC
Q 005880 147 FSGQIP-LTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPK-SLS---GFPDSAFTQNAALCGSP 219 (672)
Q Consensus 147 l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~-~l~---~~~~~~~~~n~~lc~~~ 219 (672)
|+ .+| ..|++|..|+.|.+.-|++.-.. .+..+++|..|.+-+|.+. .++. .|. ....+....|+..|+|.
T Consensus 128 I~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 128 IT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred hh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence 99 555 48999999999999999998733 3568999999999999998 6775 444 44455566789889886
Q ss_pred Cc
Q 005880 220 MQ 221 (672)
Q Consensus 220 ~~ 221 (672)
++
T Consensus 206 L~ 207 (498)
T KOG4237|consen 206 LP 207 (498)
T ss_pred cc
Confidence 64
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.6e-09 Score=82.84 Aligned_cols=61 Identities=38% Similarity=0.404 Sum_probs=40.5
Q ss_pred cccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcc
Q 005880 111 TALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171 (672)
Q Consensus 111 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 171 (672)
++|++|+|++|+|+...+..|.++++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566777777777744345666677777777777777755555667777777777777764
|
... |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.7e-10 Score=124.40 Aligned_cols=135 Identities=30% Similarity=0.374 Sum_probs=111.8
Q ss_pred EeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 67 VSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 67 v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
+..|+|++|.+...+.++..+.+|+.|+++.|.|...+-+.+++.+|++|+|.+|.+. .+|.++..+.+|+.||+|+|+
T Consensus 47 L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~ 125 (1081)
T KOG0618|consen 47 LKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNH 125 (1081)
T ss_pred eEEeeccccccccCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhc
Confidence 8899999999999988899999999999999999987769999999999999999999 999999999999999999999
Q ss_pred cccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCC
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPD 206 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~ 206 (672)
|. .+|..+..++.+..+.+++|......+.. .++.+++..|.+.+.++..+..+..
T Consensus 126 f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~---~ik~~~l~~n~l~~~~~~~i~~l~~ 181 (1081)
T KOG0618|consen 126 FG-PIPLVIEVLTAEEELAASNNEKIQRLGQT---SIKKLDLRLNVLGGSFLIDIYNLTH 181 (1081)
T ss_pred cC-CCchhHHhhhHHHHHhhhcchhhhhhccc---cchhhhhhhhhcccchhcchhhhhe
Confidence 98 99999999999999999999222111111 1555566666666666655555444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.1e-09 Score=118.08 Aligned_cols=138 Identities=30% Similarity=0.407 Sum_probs=110.2
Q ss_pred CcEeEEEecCCCcccCCCCCCCCC-CccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLT-QLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..++.|++.+|.++...+....+. +|+.|++++|++...+..+.++++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 116 ~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred cceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 468899999999998877777775 999999999999976668899999999999999999 888888888999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCc-ccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANR-FSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~ 205 (672)
+|+++ .+|..+..+..|++|.+++|+ +.-+.....+.++..|.+.+|++. .+|..+..++
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~ 255 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhcccc
Confidence 99999 888887777789999999995 343555566666666667777666 3344444443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.9e-09 Score=82.42 Aligned_cols=60 Identities=45% Similarity=0.515 Sum_probs=51.5
Q ss_pred CCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCcc
Q 005880 88 TQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147 (672)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 147 (672)
++|++|+|++|+|+..++ .|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 478889999999988776 788899999999999999866667889999999999999876
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.9e-10 Score=115.50 Aligned_cols=131 Identities=24% Similarity=0.291 Sum_probs=96.1
Q ss_pred CcEeEEEecCCCcccCCCC-CCCC---CCccEEEcccCCCCCCC----C-CCCcc-cccceeeccccccCCC----CChh
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSL---TQLRVLSLKYNRFTGPV----P-SLSNL-TALKLLFLSHNNFNGE----FPDS 130 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l---~~L~~L~L~~N~l~~~~----p-~~~~l-~~L~~L~l~~N~l~g~----~p~~ 130 (672)
.+++.|+|++|.+.+..+. +..+ ++|++|+|++|++++.. . .+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 5889999999988754433 3333 45999999999988421 1 35566 8899999999998853 3445
Q ss_pred hhccCCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCcC------CCCCCCCCCeeeccCCcCCC
Q 005880 131 VSSLFRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGPI------TGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 131 ~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~------~~~~l~~L~~l~l~~N~l~g 195 (672)
+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.. ....+++|++|++++|.+++
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 66777899999999998842 4445666778999999999887521 13467889999999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-09 Score=121.65 Aligned_cols=235 Identities=21% Similarity=0.228 Sum_probs=152.4
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+-+-+|.++.++.+.-. .|...+.|.......- ..+....+-.++-..+||-++....-+......+||++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 46778999998887733 3444444443322211 1122222222332335677776655555677889999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC-----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP----- 516 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----- 516 (672)
+|...|+... ..+..........+..+++||| ...+.|||++|.|++...++..++.|||......
T Consensus 890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~----s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLH----SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CchhhhhcCC-----CcccccccchhHHHHhhhhccc----cchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999998653 2444444556667788999999 6679999999999999999999999998432110
Q ss_pred ----------------C---------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 517 ----------------P---------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 517 ----------------~---------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
. ....+|..|.+||.+. +...+..+|.|+.|++++|.++|.+||...
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l--g~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL--GRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc--cccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0234577899999654 667788999999999999999999999765
Q ss_pred CCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH
Q 005880 566 GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 632 (672)
.....+ +.+... .........+...+..+++...+..+|.+|-.|.
T Consensus 1039 tpq~~f------------~ni~~~---------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF------------ENILNR---------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhh------------hccccC---------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 433211 111111 1111111122233445566677788888887766
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.7e-09 Score=115.00 Aligned_cols=153 Identities=29% Similarity=0.330 Sum_probs=127.1
Q ss_pred CcccceEEcCCcEe---EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCccc-ccceeeccccccCCCCChh
Q 005880 55 CSWTGVSCLQNRVS---HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLT-ALKLLFLSHNNFNGEFPDS 130 (672)
Q Consensus 55 c~w~gv~c~~~~v~---~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~l~~N~l~g~~p~~ 130 (672)
+.+.+..+....+. .+++..+.+...+..+..++.++.|++.+|.++.+.+....+. +|+.|++++|++. .+|..
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~ 158 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158 (394)
T ss_pred cccccccccccCCCCCceeeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhh
Confidence 55666666665555 5899999887777778888999999999999998888888885 9999999999999 88889
Q ss_pred hhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCC-CCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 131 VSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITG-LDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 131 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++.-... ..+..|++|++++|.+. .++..+..+..+..
T Consensus 159 ~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~ 236 (394)
T COG4886 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG 236 (394)
T ss_pred hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccc
Confidence 999999999999999999 8888887999999999999999984443 45666999999999755 56666666655544
Q ss_pred c
Q 005880 210 T 210 (672)
Q Consensus 210 ~ 210 (672)
.
T Consensus 237 l 237 (394)
T COG4886 237 L 237 (394)
T ss_pred c
Confidence 4
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6e-10 Score=95.73 Aligned_cols=134 Identities=20% Similarity=0.223 Sum_probs=94.4
Q ss_pred cEeEEEecCCCcccCCCC---CCCCCCccEEEcccCCCCCCCCCCC-cccccceeeccccccCCCCChhhhccCCCCeEe
Q 005880 66 RVSHLVLENLQLSGSLQP---LTSLTQLRVLSLKYNRFTGPVPSLS-NLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~---l~~l~~L~~L~L~~N~l~~~~p~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 141 (672)
..-.++|+++.|-..... +....+|+..+|++|.|...++.|. ..+.++.|+|++|.|+ .+|.++..++.|+.|+
T Consensus 28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 345678888877644433 6777888888999999988777554 4568888999999998 8888888899999999
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcC
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSL 201 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l 201 (672)
+++|.|. ..|..+..|.+|..|+..+|.+.. +.....-..+-..++.+|.+.+.-|..+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 9999988 778888888888888888777654 2221111222233445556655555433
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-08 Score=70.79 Aligned_cols=38 Identities=50% Similarity=1.015 Sum_probs=29.1
Q ss_pred hhhHHHHHHHHhcCCC-C-CCCCCCCCC--CCCCcccceEEc
Q 005880 26 SPDLNALLDFKASSDE-A-NKLTTWNST--SDPCSWTGVSCL 63 (672)
Q Consensus 26 ~~d~~all~~k~~~~~-~-~~~~~W~~~--~~~c~w~gv~c~ 63 (672)
.+|++||++||+++.. + +.+.+|+.+ ++||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999873 3 568999987 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.2e-09 Score=110.02 Aligned_cols=131 Identities=22% Similarity=0.177 Sum_probs=93.0
Q ss_pred CcEeEEEecCCCcccCC-------CCCCCCCCccEEEcccCCCCCCCC-CCCcccc---cceeeccccccCC----CCCh
Q 005880 65 NRVSHLVLENLQLSGSL-------QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTA---LKLLFLSHNNFNG----EFPD 129 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~-------~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~---L~~L~l~~N~l~g----~~p~ 129 (672)
..++.|+++++.+.+.. ..+..+++|+.|+|++|.+.+..+ .+..+.+ |++|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 45778888887776311 125668889999999988886544 4444444 8999999988873 3344
Q ss_pred hhhcc-CCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCcC------CCCCCCCCCeeeccCCcCCC
Q 005880 130 SVSSL-FRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGPI------TGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 130 ~~~~l-~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~------~~~~l~~L~~l~l~~N~l~g 195 (672)
.+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.. ....+++|+.|++++|.+++
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 56666 7889999999988843 3445667788999999998887511 12345688999999988874
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=95.13 Aligned_cols=267 Identities=15% Similarity=0.157 Sum_probs=150.7
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEE----EE--cCCe-EEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAY----YF--AREE-KLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~----~~--~~~~-~~lv~e 436 (672)
+..||+|+.+.+|-.--- +. .+-|+..........+... .|.+. .||-+-.-+.+ .+ ++.. .-++|+
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 356999999999954321 12 2347666544333333222 23333 46544331111 11 1222 346777
Q ss_pred ecCCC-ChhHHhhcC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 437 YMPNG-SLFWLLHGN-RGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 437 ~~~~g-~L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
.+++. ...++.... +...-...+|...++.+..+|.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|=..-..
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH----~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH----EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH----hcCCcccccCccceeeecCceEEEEcccceee
Confidence 77553 222222211 1122345899999999999999999999 78889999999999999999999998654333
Q ss_pred CCCC----CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 515 APPS----TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTG-KCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
...+ ..++...|.+||.-.. .+..-+...|-|.+||++++++.| ++||.+-.....-....+.++..-....
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 2222 4567788999995321 133456788999999999999987 9999753221100000010111000000
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHHHHhc
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSAS--PDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~L~~i~~ 643 (672)
.........-.+......-+......++. +|+... +.-|||++.-+..|.++.+
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 00000000001111111122233344444 777543 5689999999888877653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-07 Score=101.83 Aligned_cols=152 Identities=19% Similarity=0.255 Sum_probs=98.2
Q ss_pred CHHHHHHHHh-cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc------------------------------------
Q 005880 356 ELEDLLRASA-EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG------------------------------------ 398 (672)
Q Consensus 356 ~~~~l~~~~~-~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------------------------------ 398 (672)
.++|+...+. +-|+.++.|.||+|++++|+.||||+.+..-..
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 3444444444 568899999999999999999999987532110
Q ss_pred ----hHHHHHHHHHHHcCC-----CCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHH
Q 005880 399 ----GKREFEQHMEVLGRL-----RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG 469 (672)
Q Consensus 399 ----~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ 469 (672)
.+-++.+|..-+.++ +.+++.-..=|..-.....|+|||++|-.+.+...-.. ..++. ..++..
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~---k~ia~~ 272 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDR---KELAEL 272 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCH---HHHHHH
Confidence 011244555545444 23444333323334567889999999999988743222 11342 233333
Q ss_pred HHHH-HHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 470 AARG-LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 470 ia~~-L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++++ +..+- ..++.|.|..|.||+++.+|++.+.|||+.....+.
T Consensus 273 ~~~~f~~q~~----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 273 LVRAFLRQLL----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHH----hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3332 11221 359999999999999999999999999998776653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.4e-07 Score=86.56 Aligned_cols=106 Identities=25% Similarity=0.302 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHcCCCC--CceeeeEEEEEcC----CeEEEEEeecCCC-ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 005880 400 KREFEQHMEVLGRLRH--PNLVGLKAYYFAR----EEKLLVSEYMPNG-SLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472 (672)
Q Consensus 400 ~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 472 (672)
.....+|.+.+.++.. =.+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 4567788887777743 3345566666542 2458999999874 7999987532 1556678899999999
Q ss_pred HHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEeccCCCcc
Q 005880 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVSDFGLSIF 514 (672)
Q Consensus 473 ~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~ 514 (672)
.++-|| ..+|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 130 ~i~~lH----~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLH----DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHH----HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 89999999999999999877 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.3e-08 Score=108.10 Aligned_cols=144 Identities=24% Similarity=0.420 Sum_probs=95.7
Q ss_pred HHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--------------CCCCCCcccCCCcc
Q 005880 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--------------TVPRSNGYRAPELS 532 (672)
Q Consensus 467 ~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--------------~~~~t~~y~aPE~l 532 (672)
+.+++.||.|+|. +.++||++|.|++|.++..+.+||+.|+++...... -......|.|||++
T Consensus 105 l~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3445699999993 678999999999999999999999999987654441 11123459999976
Q ss_pred ccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHH
Q 005880 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMV 611 (672)
Q Consensus 533 ~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 611 (672)
. +...+.++|+||+||++|.+.. |+.-+...+.... .-.. ....+....... .....
T Consensus 182 ~--~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----------~~~~-------~~~~~~~~~~~s--~~~p~ 239 (700)
T KOG2137|consen 182 L--GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----------YSFS-------RNLLNAGAFGYS--NNLPS 239 (700)
T ss_pred c--cccccccccceeeeeEEEEEecCCcchhhccCCcch-----------hhhh-------hccccccccccc--ccCcH
Confidence 5 4678899999999999999994 4444433221110 0000 000111111111 22334
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHH
Q 005880 612 GLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 612 ~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
++.+=+.+.+..++..||++.++.
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhh
Confidence 566666688999999999777664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-08 Score=101.74 Aligned_cols=129 Identities=26% Similarity=0.252 Sum_probs=67.4
Q ss_pred CcEeEEEecCCCcccCCCC---CCCCCCccEEEcccCCCCCCCCC--CCcccccceeeccccccC---------------
Q 005880 65 NRVSHLVLENLQLSGSLQP---LTSLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNNFN--------------- 124 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~---l~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~l~~N~l~--------------- 124 (672)
.+|+.|||+.|-+....+- ...|++|+.|+|+.|++.-...+ -..++.|+.|.|+.+.|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 4677777777766543322 45677777788887777654431 123344444444444443
Q ss_pred ----------CCCChhhhccCCCCeEecccCccccccc--hhhcCCCccCeeeccCCcccC-cCCC-------CCCCCCC
Q 005880 125 ----------GEFPDSVSSLFRLYRLDLSFNNFSGQIP--LTVNHLTHLLTLKLEANRFSG-PITG-------LDLRNLQ 184 (672)
Q Consensus 125 ----------g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~-~~~~-------~~l~~L~ 184 (672)
+.--....-+..|++|||++|++- ..+ ...+.++.|..|+++.+.++. ..+. ..+++|+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 122222233445555566555554 333 234555555555555555544 1111 2345666
Q ss_pred eeeccCCcCC
Q 005880 185 DFNVSGNHLS 194 (672)
Q Consensus 185 ~l~l~~N~l~ 194 (672)
+|+++.|++.
T Consensus 305 ~L~i~~N~I~ 314 (505)
T KOG3207|consen 305 YLNISENNIR 314 (505)
T ss_pred eeecccCccc
Confidence 6666666654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-06 Score=84.41 Aligned_cols=133 Identities=16% Similarity=0.105 Sum_probs=85.5
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCc--eeeeEEEEEcCCeEEEEEeecCCCC-
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPN--LVGLKAYYFAREEKLLVSEYMPNGS- 442 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 442 (672)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567788876533 3455788999998885433 4567777777777889999998863
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhhCCC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARG---------------------------------------LAFIHFTCKS 483 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~~LH~~~~~ 483 (672)
+...+.. +......++..+++. ..+|......
T Consensus 82 ~~~~~~~---------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 82 FSRIISD---------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred hhhhhcC---------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 2211110 001111111111111 2222212223
Q ss_pred CCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 484 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
..++|+|+.|.||++++++ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 4579999999999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=80.95 Aligned_cols=138 Identities=18% Similarity=0.155 Sum_probs=101.6
Q ss_pred cCcCCeEEEEEEEEcCCcEEEEEEcccCC------cchHHHHHHHHHHHcCCCC--CceeeeEEEEEc----CCeEEEEE
Q 005880 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDAS------IGGKREFEQHMEVLGRLRH--PNLVGLKAYYFA----REEKLLVS 435 (672)
Q Consensus 368 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~----~~~~~lv~ 435 (672)
-|+||-+.|++-.+. |..+-+|+-...- .-....|.+|+..+.++.. -.+.+.+.+... ....+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 366888889987776 4468888765211 2256789999999988853 234444422211 12457999
Q ss_pred eecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc--EEEeccCCC
Q 005880 436 EYMPN-GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN--ARVSDFGLS 512 (672)
Q Consensus 436 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a 512 (672)
|-+++ -+|.+++.... ..+.+...+..+..++++.++-|| +.++.|+|+.+.||+++.++. ++++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 97753 58888886432 234677888999999999999999 899999999999999986666 999999866
Q ss_pred c
Q 005880 513 I 513 (672)
Q Consensus 513 ~ 513 (672)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 4
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.7e-09 Score=113.45 Aligned_cols=125 Identities=31% Similarity=0.343 Sum_probs=87.7
Q ss_pred CccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccch-hhcCCCccCeeecc
Q 005880 89 QLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPL-TVNHLTHLLTLKLE 167 (672)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~ 167 (672)
.|.+.+.++|++.-.-.++.-++.|+.|||++|+++. .- .+..|+.|++|||++|.|+ .+|. ....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 4666777888887655577778888888888888884 32 7788888888888888888 5654 344454 8888888
Q ss_pred CCcccCcCCCCCCCCCCeeeccCCcCCCCCC----CcCCCCCCccccccccccC
Q 005880 168 ANRFSGPITGLDLRNLQDFNVSGNHLSGQIP----KSLSGFPDSAFTQNAALCG 217 (672)
Q Consensus 168 ~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p----~~l~~~~~~~~~~n~~lc~ 217 (672)
+|.++.-....+|++|..|||++|-|.+--- -.+..+..|-+.|||--|.
T Consensus 241 nN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 8888877777788888888888888774211 1122333444456654443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-09 Score=115.48 Aligned_cols=124 Identities=27% Similarity=0.270 Sum_probs=100.8
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChh-hhccCCCCeEeccc
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDS-VSSLFRLYRLDLSF 144 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~ 144 (672)
.+...+.+.|.|...-..+.-++.|+.|||++|+++..- .+..|++|++|||++|.|. .+|.- ...+ .|+.|.|+|
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrn 241 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRN 241 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhh-hheeeeecc
Confidence 456677778888766666788899999999999999654 7888999999999999999 66642 3333 499999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccC---cCCCCCCCCCCeeeccCCcCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSG---PITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~---~~~~~~l~~L~~l~l~~N~l~ 194 (672)
|.++ .+ ..+.+|.+|+.|||+.|-|++ -.+.+.|..|..|+|.+|.+.
T Consensus 242 N~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 242 NALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9998 33 368899999999999999988 334567888999999999987
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-07 Score=102.12 Aligned_cols=105 Identities=33% Similarity=0.384 Sum_probs=66.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
..+..|+|.+|.|......+..+.+|++|+|++|.|+.+ ..+..++.|+.|++++|.++ .+ ..+..+.+|+.+++++
T Consensus 95 ~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i-~~l~~l~~L~~L~l~~N~i~-~~-~~~~~l~~L~~l~l~~ 171 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL-EGLSTLTLLKELNLSGNLIS-DI-SGLESLKSLKLLDLSY 171 (414)
T ss_pred cceeeeeccccchhhcccchhhhhcchheeccccccccc-cchhhccchhhheeccCcch-hc-cCCccchhhhcccCCc
Confidence 456677777777765554466677777777777777743 34555566777777777776 33 2344466777777777
Q ss_pred Cccccccchh-hcCCCccCeeeccCCcccC
Q 005880 145 NNFSGQIPLT-VNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 145 N~l~g~~p~~-~~~l~~L~~L~l~~N~l~~ 173 (672)
|.++ .+... ...+.+|+.+++.+|.+..
T Consensus 172 n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 172 NRIV-DIENDELSELISLEELDLGGNSIRE 200 (414)
T ss_pred chhh-hhhhhhhhhccchHHHhccCCchhc
Confidence 7776 33332 4566666777777766554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.4e-07 Score=100.33 Aligned_cols=124 Identities=29% Similarity=0.321 Sum_probs=77.2
Q ss_pred EeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 67 VSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 67 v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
+..+++..|.+......+..+++|+.|+|..|+|.++...+..+++|++|+|++|+|+.. ..+..++.|+.|++++|.
T Consensus 74 l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~ 151 (414)
T KOG0531|consen 74 LKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNL 151 (414)
T ss_pred HHhhccchhhhhhhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhheeccCc
Confidence 444455566655434446667777777777777775444466677777777777777633 235555667777777777
Q ss_pred cccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCC
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~ 194 (672)
|+ .+ ..+..+++|+.+++++|+++.... ...+.+|+.+++++|.+.
T Consensus 152 i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 152 IS-DI-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred ch-hc-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 76 22 244456677777777777766444 356666777777777665
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-07 Score=82.06 Aligned_cols=107 Identities=20% Similarity=0.230 Sum_probs=91.6
Q ss_pred CcEeEEEecCCCcccCCCCCC-CCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQPLT-SLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
.+++.++|++|.+...++.|. ..+.++.|+|++|.|+..+.++..++.|+.|+++.|.|. ..|..+..|.+|-.||..
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 578899999999998888854 456899999999999987779999999999999999999 899999999999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
+|.+. .||..+-.-+++-..++.+|.+.+
T Consensus 132 ~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 132 ENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred CCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 99998 888775544455556667777765
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.7e-07 Score=62.12 Aligned_cols=36 Identities=39% Similarity=0.452 Sum_probs=20.6
Q ss_pred ccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 112 ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 112 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
+|++|+|++|+|+ .+|..|++|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4566666666666 55555666666666666666665
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=76.68 Aligned_cols=137 Identities=20% Similarity=0.253 Sum_probs=91.3
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchH-------------------HH-----HHHHHHHHcCCC--CCcee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK-------------------RE-----FEQHMEVLGRLR--HPNLV 419 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------~~-----~~~e~~~l~~l~--h~niv 419 (672)
..|.+|.-+.||+|...++..+|||+++....... ++ ..+|+.-|.++. +=.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 36888999999999988899999999864322111 11 134555555552 33333
Q ss_pred eeEEEEEcCCeEEEEEeecCCCCh-hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe
Q 005880 420 GLKAYYFAREEKLLVSEYMPNGSL-FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL 498 (672)
Q Consensus 420 ~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll 498 (672)
+.+++. +..|||||+..... .-.|+ ..++...+...+..++++.+.-|-. ..++||+||+.-|||+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~---~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYK---EAGLVHGDLSEYNILV 200 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHH---hcCcccccchhhheEE
Confidence 444432 45799999955311 11111 1223333567777888888887762 3789999999999999
Q ss_pred CCCCcEEEeccCCCccCC
Q 005880 499 DKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 499 ~~~~~~kl~DfG~a~~~~ 516 (672)
. ++.+.|+|||-|....
T Consensus 201 ~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred E-CCeEEEEECccccccC
Confidence 9 8899999999876544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-05 Score=86.27 Aligned_cols=152 Identities=18% Similarity=0.194 Sum_probs=92.1
Q ss_pred HHHHHHHHh-cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcch------------------------------------
Q 005880 357 LEDLLRASA-EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGG------------------------------------ 399 (672)
Q Consensus 357 ~~~l~~~~~-~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------------------ 399 (672)
++++...+. +.||.-..|.||+|++++|+.||||+-+..-...
T Consensus 157 ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 157 IEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 344443333 5788899999999999999999999765321100
Q ss_pred -HHHHHHHHHHHcC----CCCCce---eeeEEEEE-cCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 005880 400 -KREFEQHMEVLGR----LRHPNL---VGLKAYYF-AREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 470 (672)
Q Consensus 400 -~~~~~~e~~~l~~----l~h~ni---v~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 470 (672)
+-+|.+|.+-..+ ++|-+. |.+=.+++ -.....|+||||+|..+.+.-.-.+ ..++...+..-+.++
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----~gi~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----RGISPHDILNKLVEA 312 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH----cCCCHHHHHHHHHHH
Confidence 1123444433322 234441 11212222 2457889999999988765532111 124444333333322
Q ss_pred HHHHHHHHhhCCCCCcEecCCCCCCEEeCC----CCcEEEeccCCCccCCCC
Q 005880 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDK----TGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 471 a~~L~~LH~~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DfG~a~~~~~~ 518 (672)
..-+-+ ..|++|+|=.|.||+++. ++++.+-|||+.......
T Consensus 313 ~~~qIf------~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 313 YLEQIF------KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHH------hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 221222 358999999999999983 678999999998766543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 672 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-08 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-08 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 6e-94
Identities = 116/300 (38%), Positives = 175/300 (58%), Gaps = 21/300 (7%)
Query: 352 TKRFELEDLLRA-----SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI-GGKREFEQ 405
KRF L +L A + +LG+GGFG YK L DG++VAVKRLK+ GG+ +F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 406 HMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK 465
+E++ H NL+ L+ + E+LLV YM NGS+ L R + PLDW R +
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQR 135
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-----ST- 519
IA G+ARGLA++H C K+ H ++K+ N+LLD+ A V DFGL+ +T
Sbjct: 136 IALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579
V + G+ APE S+ K S+K+DV+ +GV+LLEL+TG+ D V L
Sbjct: 195 VRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRA--FDLARLANDDD--VML 248
Query: 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
WV+ +++E+ + D++L + +EE+ L+QVA+ CT +SP +RP MS VV+++E
Sbjct: 249 LDWVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 1e-85
Identities = 98/302 (32%), Positives = 144/302 (47%), Gaps = 28/302 (9%)
Query: 352 TKRFELEDLLRA-----SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQH 406
+ R L DL A ++G G FG YK VL DG+ VA+KR S G EFE
Sbjct: 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
+E L RHP+LV L + R E +L+ +YM NG+L L+G + W RL+I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEI 144
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP------STV 520
GAARGL ++H + H ++KS N+LLD+ +++DFG+S STV
Sbjct: 145 CIGAARGLHYLHTRA----IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 521 PR-SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579
+ + GY PE + ++KSDVYSFGV+L E+L + I V+L
Sbjct: 201 VKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSA--IVQSLP----REMVNL 252
Query: 580 PRWVQSVVREEWTAEVFDLELM-RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
W ++ D L + + E + A+ C + S + RP+M V+ +
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
Query: 639 EE 640
E
Sbjct: 311 EY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 4e-79
Identities = 93/302 (30%), Positives = 148/302 (49%), Gaps = 33/302 (10%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKD----ASIGGKREFEQHM 407
T F+ E + +G+GGFG YK ++ + VAVK+L + K++F+Q +
Sbjct: 24 TNNFD-ERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA 467
+V+ + +H NLV L + ++ LV YMPNGSL L G PL W R KIA
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIA 139
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP------ST-V 520
GAA G+ F+H H +IKS N+LLD+ A++SDFGL+ + ++ +
Sbjct: 140 QGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI 195
Query: 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP 580
+ Y APE + + KSD+YSFGV+LLE++TG +D L
Sbjct: 196 VGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGL--PAVDEH------REPQLLL 244
Query: 581 RWVQSVVREEWT-AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
+ + EE T + D ++ + + VA C ++RP++ V +L++
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 640 EL 641
E+
Sbjct: 303 EM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 67/301 (22%), Positives = 107/301 (35%), Gaps = 39/301 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY- 424
E+ +G FG +KA L VAVK + E + L ++H N++
Sbjct: 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAE 87
Query: 425 ---YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ L++ + GSL L N + W IA ARGLA++H
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDI 141
Query: 482 KSLKLT------HGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-------GYRA 528
LK H +IKS NVLL A ++DFGL++ Y A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 529 PEL---SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585
PE+ + + R + D+Y+ G++L EL + + G + +
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA------DGPVDEYMLPFEEEIGQ 255
Query: 586 VVREEWTAEVFDLELMRYK-----DIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640
E EV + R M L + C + R + V + I +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
Query: 641 L 641
+
Sbjct: 316 M 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-54
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 50/312 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREF--EQHMEVLGRLRHPNLVGL-- 421
E++G+G +G YK LD VAVK A+ ++ F E+++ + + H N+
Sbjct: 19 ELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 422 ---KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
+ R E LLV EY PNGSL L DW + ++A RGLA++H
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 479 -----FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN--------- 524
++H ++ S NVL+ G +SDFGLS+ + + R
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 525 ----GYRAPE-----LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575
Y APE ++ D ++ D+Y+ G++ E+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY---- 244
Query: 576 AVDLPRWVQSVVREEWTAEVFDLELMR------YKDIEEEMVGLLQVAMACTSASPDQRP 629
+ V + E + E R +K+ + L + C + R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 630 NMSHVVKLIEEL 641
+ + EL
Sbjct: 305 TAQXAEERMAEL 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 43/291 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK-------REFEQHMEVLGRLRHPN 417
+ +GKGGFG +K + D SVVA+K L G+ +EF++ + ++ L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
+V L +V E++P G L+ L P+ W+ +L++ A G+ ++
Sbjct: 85 IVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYM 138
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTG-----NARVSDFGLS-IFAPPSTVPRSN-GYRAPE 530
++ + H +++S N+ L A+V+DFGLS + N + APE
Sbjct: 139 Q--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPE 196
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590
++ ++K+D YSF ++L +LTG+ P G +++ + E
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF------DEYSYGKI----KFINMIREE- 245
Query: 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
L +D + +++ C S P +RP+ S++VK + EL
Sbjct: 246 ------GLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-53
Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 35/283 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLKA 423
L + G +K G+ + VK LK + R+F + L HPN++ +
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 424 YYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ ++ +MP GSL+ +LH +D + +K A ARG+AF+H
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLH--T 129
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPE-LSSSDGRKQS 540
+ + S +V++D+ AR+S + + + APE L
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 541 QKSDVYSFGVLLLELLTGKCP-SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599
+ +D++SF VLL EL+T + P + + GM V E L
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VALE-------GLR 229
Query: 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
I + L++ C + P +RP +V ++E+++
Sbjct: 230 PTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-53
Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 34/279 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
E++G+G FG KA VA+K+++ S ++ F + L R+ HPN+V L
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYG-- 68
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
LV EY GSL+ +LHG + ++G+A++H + +
Sbjct: 69 ACLNPVCLVMEYAEGGSLYNVLHGAEPLP--YYTAAHAMSWCLQCSQGVAYLH-SMQPKA 125
Query: 486 LTHGNIKSTNVLLDKTGN-ARVSDFGLSIFAPPSTVPR--SNGYRAPELSSSDGRKQSQK 542
L H ++K N+LL G ++ DFG + S + APE+ G S+K
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE--GSNYSEK 183
Query: 543 SDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMR 602
DV+S+G++L E++T + P +G G A + V + R L+
Sbjct: 184 CDVFSWGIILWEVITRRKPF------DEIG-GPAFRIMWAVHNGTR---------PPLI- 226
Query: 603 YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
K++ + + L+ C S P QRP+M +VK++ L
Sbjct: 227 -KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 81/283 (28%), Positives = 137/283 (48%), Gaps = 36/283 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLKA 423
E +G G FGT ++A GS VAVK L + + EF + + ++ RLRHPN+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+V+EY+ GSL+ LLH + R LD RL +A A+G+ ++H ++
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH--NRN 157
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-----YRAPELSSSDGRK 538
+ H N+KS N+L+DK +V DFGLS + + + + APE+
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--RDEP 215
Query: 539 QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598
++KSDVYSFGV+L EL T + P + + + V +V +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPW------GNL------NPAQVVAAVGFK-------CK 256
Query: 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
L +++ ++ +++ C + P +RP+ + ++ L+ L
Sbjct: 257 RLEIPRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-50
Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 47/291 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK----DASIGGKREFEQHMEVLGRLRHPNLVGL 421
E++G GGFG Y+A G VAVK + + Q ++ L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ LV E+ G L +L G R + + A ARG+ ++H
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLH-DE 124
Query: 482 KSLKLTHGNIKSTNVLLDKTGNAR--------VSDFGLSIFAPPSTVPRSNG---YRAPE 530
+ + H ++KS+N+L+ + ++DFGL+ +T + G + APE
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590
+ S+ SDV+S+GVLL ELLTG+ P G+ D V
Sbjct: 185 VIR--ASMFSKGSDVWSYGVLLWELLTGEVPF------RGI------DGLAVAYGVAMN- 229
Query: 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
L L E L++ C + P RP+ ++++ + +
Sbjct: 230 ------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 66/315 (20%), Positives = 117/315 (37%), Gaps = 56/315 (17%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E+LGKG FG A K + G V+ +K L +R F + ++V+ L HPN++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ + ++EY+ G+L ++ W+ R+ A A G+A++H S+
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLH----SM 127
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR----------------- 527
+ H ++ S N L+ + N V+DFGL+
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 528 --APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585
APE+ + GR +K DV+SFG++L E++
Sbjct: 188 WMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNAD---------------PDYLPRTM 230
Query: 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR--- 642
L+ + + + C P++RP+ + +E LR
Sbjct: 231 DFGLNVRG---FLDRYCPPNCPPS---FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 643 --GVEVSPCHENFDS 655
+ + P E D
Sbjct: 285 AGHLPLGPQLEQLDR 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLKA 423
+ +G G FGT YK VAVK L + + + F+ + VL + RH N++
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 424 YYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
Y + +L +V+++ SL+ LH + + + IA ARG+ ++H
Sbjct: 88 Y--STAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLH---- 137
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG------YRAPE-LSSS 534
+ + H ++KS N+ L + ++ DFGL+ + S + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
D S +SDVY+FG++L EL+TG+ P + + + ++ V R + +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQI-----IEMVGRGSLSPD 246
Query: 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+ + + + M L+ C D+RP+ ++ IEEL
Sbjct: 247 LSKV----RSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 62/304 (20%), Positives = 107/304 (35%), Gaps = 45/304 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY- 424
+ +GKG +G + G VAVK E + +RH N++G A
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 425 ---YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH--- 478
+ + L+++Y NGSL+ L T LD + LK+A + GL +H
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 479 -FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---------YRA 528
T + H ++KS N+L+ K G ++D GL++ T Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 529 PELSSSDGRKQS----QKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP---- 580
PE+ + +D+YSFG++L E+ G LP
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG---------GIVEEYQLPYHDL 265
Query: 581 RWVQSVVREEWTAEVFD---LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637
+ +E + + ++ C + +P R V K
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 638 IEEL 641
+ ++
Sbjct: 326 LAKM 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-47
Identities = 64/306 (20%), Positives = 112/306 (36%), Gaps = 49/306 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREF--EQHMEVLGRLRHPNLVGLKA 423
E +GKG +G ++ G VAVK ++ + E + LRH N++G A
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 424 Y----YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
+ + L++ Y GSL+ L T LD + L+I A GLA +H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 480 TCKSLKLT----HGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---------Y 526
+ H ++KS N+L+ K G ++D GL++ ST G Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 527 RAPEL----SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP-- 580
APE+ D ++ D+++FG++L E+ + G P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN---------GIVEDYKPPFY 234
Query: 581 --RWVQSVVREEWTAEVFD---LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
+ D + + + L ++ C +P R +
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 636 KLIEEL 641
K + ++
Sbjct: 295 KTLTKI 300
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 8e-47
Identities = 61/189 (32%), Positives = 93/189 (49%), Gaps = 14/189 (7%)
Query: 28 DLNALLDFKASSDEANKLTTWNSTSDPC--SWTGVSC----LQNRVSHLVLENLQLSGSL 81
D ALL K L++W T+D C +W GV C RV++L L L L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 82 Q-P--LTSLTQLRVLSL-KYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136
P L +L L L + N GP+P +++ LT L L+++H N +G PD +S +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI-TGL-DLRNL-QDFNVSGNHL 193
L LD S+N SG +P +++ L +L+ + + NR SG I L +S N L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 194 SGQIPKSLS 202
+G+IP + +
Sbjct: 187 TGKIPPTFA 195
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 32/157 (20%), Positives = 49/157 (31%), Gaps = 45/157 (28%)
Query: 68 SHLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGE 126
+ + L L G S + + L N + + L L L +N G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDF 186
P ++ L L+ L++SFNN G+IP G +L+
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIP-----------------------QGGNLQRFDVS 296
Query: 187 NVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQAC 223
+ N LCGSP+ AC
Sbjct: 297 AYAN---------------------NKCLCGSPLPAC 312
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 59/311 (18%), Positives = 117/311 (37%), Gaps = 66/311 (21%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLKA 423
E++GKG FG Y VA++ + + F++ + + RH N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+ +++ +L+ ++ + LD +IA +G+ ++H +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH----A 148
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG---------YRAPEL-- 531
+ H ++KS NV D G ++DFGL I R + + APE+
Sbjct: 149 KGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 532 -----SSSDGRKQSQKSDVYSFGVLLLELLTGKCP-------SVIDGGGAGMGCGGAVDL 579
+ D S+ SDV++ G + EL + P ++I MG G +L
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTGMKPNL 263
Query: 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
+ + +E+ +L + C + ++RP + ++ ++E
Sbjct: 264 SQ----------------------IGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298
Query: 640 ELRGVEVSPCH 650
+L H
Sbjct: 299 KLPKRNRRLSH 309
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 70/306 (22%), Positives = 113/306 (36%), Gaps = 49/306 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREF--EQHMEVLGRLRHPNLVGLKA 423
E +GKG FG ++ G VAVK +R + E + LRH N++G A
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 424 ----YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH- 478
+ LVS+Y +GSLF L+ R + +K+A A GLA +H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 479 ---FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---------Y 526
T + H ++KS N+L+ K G ++D GL++ +T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 527 RAPE-LSSSDGRKQ---SQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP-- 580
APE L S K +++D+Y+ G++ E+ G LP
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG---------GIHEDYQLPYY 268
Query: 581 --RWVQSVVREEWTAEVFD---LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
V E + E + + ++ C A+ R +
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 636 KLIEEL 641
K + +L
Sbjct: 329 KTLSQL 334
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-44
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 12/188 (6%)
Query: 23 ASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQ 82
S +++ L+ FK + N L W+S +PC++ GV+C ++V+ + L + L+
Sbjct: 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFS 67
Query: 83 P----LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPD--SVSSLFR 136
L SLT L L L + G V +L L LS N+ +G S+ S
Sbjct: 68 AVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127
Query: 137 LYRLDLSFNNFSGQIPLT-VNHLTHLLTLKLEANRFSGPI-----TGLDLRNLQDFNVSG 190
L L++S N ++ L L L L AN SG L+ +SG
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISG 187
Query: 191 NHLSGQIP 198
N +SG +
Sbjct: 188 NKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-34
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 7/156 (4%)
Query: 50 STSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSN 109
S ++ W + HL + ++SG + ++ L L + N F+ +P L +
Sbjct: 164 SGANVVGWVLSDGCGE-LKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 110 LTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
+AL+ L +S N +G+F ++S+ L L++S N F G IP L L L L N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279
Query: 170 RFSGPIT---GLDLRNLQDFNVSGNHLSGQIPKSLS 202
+F+G I L ++SGNH G +P
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 6/139 (4%)
Query: 69 HLVLENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
L L +SG +L+ L++ N+ +G V +S L+ L +S NNF+
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFS 213
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQ 184
P + L LD+S N SG ++ T L L + +N+F GPI L L++LQ
Sbjct: 214 TGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQ 272
Query: 185 DFNVSGNHLSGQIPKSLSG 203
+++ N +G+IP LSG
Sbjct: 273 YLSLAENKFTGEIPDFLSG 291
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-30
Identities = 52/149 (34%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 63 LQNRVSHLVLENLQLSGSLQP---LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFL 118
L + L L + SG + P L+ L L+ N FTG +P +LSN + L L L
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL 425
Query: 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI-TG 177
S N +G P S+ SL +L L L N G+IP + ++ L TL L+ N +G I +G
Sbjct: 426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485
Query: 178 L-DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
L + NL ++S N L+G+IPK +
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLE 514
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 32/198 (16%)
Query: 72 LENLQLSGSLQP-LTSLTQLRVLSLKYN--RFTGPVP-SLSNLTALKLLFLSHNNFNGEF 127
+ ++G + + + N F G L+ L+ ++ + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI-TGL-DLRNLQD 185
+ + + LD+S+N SG IP + + +L L L N SG I + DLR L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 186 FNVSGNHLSGQIPKSLSG--------------------------FPDSAFTQNAALCGSP 219
++S N L G+IP+++S FP + F N LCG P
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744
Query: 220 MQACKTMVTDPKKPGSDG 237
+ C D
Sbjct: 745 LPRCDPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-28
Identities = 49/143 (34%), Positives = 67/143 (46%), Gaps = 7/143 (4%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNNFNGE 126
L + + Q G + P L L+ LSL N+FTG +P L L LS N+F G
Sbjct: 251 LLNISSNQFVGPI-PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPL-TVNHLTHLLTLKLEANRFSGPI---TGLDLRN 182
P S L L LS NNFSG++P+ T+ + L L L N FSG + +
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369
Query: 183 LQDFNVSGNHLSGQIPKSLSGFP 205
L ++S N+ SG I +L P
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNP 392
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-28
Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 6/149 (4%)
Query: 61 SCLQN--RVSHLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLL 116
S L + ++ L L L G + Q L + L L L +N TG +P LSN T L +
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT 176
LS+N GE P + L L L LS N+FSG IP + L+ L L N F+G I
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 177 GLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ ++ N ++G+ +
Sbjct: 556 -AAMFKQS-GKIAANFIAGKRYVYIKNDG 582
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 2/139 (1%)
Query: 69 HLVLENLQLSGSL-QPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGE 126
L+L+ L+G + L++ T L +SL NR TG +P + L L +L LS+N+F+G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDF 186
P + L LDL+ N F+G IP + + + A + I ++
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG 589
Query: 187 NVSGNHLSGQIPKSLSGFP 205
+ G + L+
Sbjct: 590 AGNLLEFQGIRSEQLNRLS 608
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 35/160 (21%), Positives = 61/160 (38%), Gaps = 26/160 (16%)
Query: 69 HLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGE 126
+ L N +L+G + + L L +L L N F+G +P L + +L L L+ N FNG
Sbjct: 494 WISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553
Query: 127 FPDS--------------------VSSLFRLYRLDLSFNNFS--GQIPLTVNHLTHLLTL 164
P + + + + N G +N L+
Sbjct: 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 165 KLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+ + + G T + ++ ++S N LSG IPK +
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 67/331 (20%), Positives = 117/331 (35%), Gaps = 60/331 (18%)
Query: 336 AQQAGYERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKD 394
++ Y +G MV K + + LG+GGF L DG A+KR+
Sbjct: 13 GRENLYFQGHMVII-DNKHYLFI-------QKLGEGGFSYVDLVEGLHDGHFYALKRILC 64
Query: 395 ASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEK----LLVSEYMPNGSLFWLLHGN 450
+ E ++ ++ HPN++ L AY L+ + G+L+ +
Sbjct: 65 HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-R 123
Query: 451 RGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510
L L + G RGL IH + H ++K TN+LL G + D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLG 179
Query: 511 LSIFAPPSTVPRSNG--------------YRAPEL-SSSDGRKQSQKSDVYSFGVLLLEL 555
A YRAPEL S +++DV+S G +L +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 556 LTGKCP---SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVG 612
+ G+ P G + + +P+ + + + +
Sbjct: 240 MFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-----------------HSSALWQLLNS 282
Query: 613 LLQVAMACTSASPDQRPNMSHVVKLIEELRG 643
++ V P QRP++ ++ +E L+
Sbjct: 283 MMTV-------DPHQRPHIPLLLSQLEALQP 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 37/219 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV--------VAVKRLKDASIGGKREFEQHMEVLGRLRHPN 417
E LG+G F +K V + V +K L A F + ++ +L H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
LV +E +LV E++ GSL L N+ ++ +L++A A + F+
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFL 129
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNAR--------VSDFGLSIFAPPSTVPRSNGYR-- 527
+ L HGN+ + N+LL + + + +SD G+SI V + +
Sbjct: 130 ----EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPKDILQER 180
Query: 528 ----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
PE + + + +D +SFG L E+ + G P
Sbjct: 181 IPWVPPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 73/303 (24%), Positives = 112/303 (36%), Gaps = 69/303 (22%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV-VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E +G+G FG + L + VAVK + K +F Q +L + HPN+V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
++ +V E + G L L T L++ AA G+ ++ S
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLE----S 231
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-------APELSSSDG 536
H ++ + N L+ + ++SDFG+S S G R APE + + G
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYG 290
Query: 537 RKQSQKSDVYSFGVLLLELLT-GKCP-----------SVIDGG--GAGMGCGGAVDLPRW 582
R S +SDV+SFG+LL E + G P V GG C P
Sbjct: 291 R-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC------PDA 343
Query: 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
V LM C + P QRP+ S + + ++ +R
Sbjct: 344 VF--------------RLME----------------QCWAYEPGQRPSFSTIYQELQSIR 373
Query: 643 GVE 645
Sbjct: 374 KRH 376
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 62/307 (20%)
Query: 366 EMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG 420
+ LGKG FG+ D G VVAVK+L+ ++ R+FE+ +E+L L+H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 421 LKA--YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
K Y R L+ EY+P GSL L ++ +D L+ + +G+ ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG 131
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR----------- 527
+ + H ++ + N+L++ ++ DFGL+ P ++
Sbjct: 132 ----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD----KEFFKVKEPGESPIFW 183
Query: 528 -APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586
APE S K S SDV+SFGV+L EL T S G V +
Sbjct: 184 YAPE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 587 VR-----------EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
+ + E++ +M C + + +QRP+ +
Sbjct: 242 IELLKNNGRLPRPDGCPDEIY--MIMT----------------ECWNNNVNQRPSFRDLA 283
Query: 636 KLIEELR 642
++++R
Sbjct: 284 LRVDQIR 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 73/303 (24%), Positives = 126/303 (41%), Gaps = 54/303 (17%)
Query: 366 EMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG 420
+ LGKG FG+ D G VVAVK+L+ ++ R+FE+ +E+L L+H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 421 LKA--YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
K Y R L+ EY+P GSL L ++ +D L+ + +G+ ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG 162
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST---VPRSNG-----YRAPE 530
+ + H ++ + N+L++ ++ DFGL+ P + G + APE
Sbjct: 163 ----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR-- 588
S K S SDV+SFGV+L EL T S G V ++
Sbjct: 219 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 589 ---------EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
+ E++ +M C + + +QRP+ + ++
Sbjct: 277 KNNGRLPRPDGCPDEIY--MIMTE----------------CWNNNVNQRPSFRDLALRVD 318
Query: 640 ELR 642
++R
Sbjct: 319 QIR 321
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 61/305 (20%)
Query: 366 EMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG 420
LGKG FG+ D G++VAVK+L+ + +R+F++ +++L L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 421 LKA--YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
+ Y R+ LV EY+P+G L L +R LD + L ++ +G+ ++
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLG 144
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR----------- 527
S + H ++ + N+L++ + +++DFGL+ P + Y
Sbjct: 145 ----SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD----KDYYVVREPGQSPIFW 196
Query: 528 -APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-----SVIDGGGAGMGCGGAVDLP 580
APE S S++SDV+SFGV+L EL T + G L
Sbjct: 197 YAPE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 581 RWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
++ R AEV ELM+ C + SP RP+ S +
Sbjct: 255 ELLEEGQRLPAPPACPAEVH--ELMKL----------------CWAPSPQDRPSFSALGP 296
Query: 637 LIEEL 641
++ L
Sbjct: 297 QLDML 301
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLK 422
+G+G F T YK + + VA L+D + + F++ E+L L+HPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 423 AYY--FAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
+ + +K + V+E M +G+L L + + +GL F+H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146
Query: 479 FTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPPSTVPRSNG---YRAPELSSS 534
++ + H ++K N+ + TG+ ++ D GL+ S G + APE+
Sbjct: 147 --TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 203
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
K + DVY+FG+ +LE+ T + P
Sbjct: 204 --EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 65/321 (20%), Positives = 113/321 (35%), Gaps = 64/321 (19%)
Query: 351 GTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV 409
G R + +L +GGF Y+A + G A+KRL R Q +
Sbjct: 26 GELRLRVR-------RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 410 LGRLR-HPNLVGLKAYYFAREEK-------LLVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
+ +L HPN+V + +E+ L+ + G L L + R PL
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCD 136
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP 521
T LKI R + +H + + H ++K N+LL G ++ DFG +
Sbjct: 137 TVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 522 RSNG-----------------YRAPELSSSDGRKQ-SQKSDVYSFGVLLLELLTGKCPSV 563
+ YR PE+ +K D+++ G +L L + P
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-- 252
Query: 564 IDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSA 623
+ G G +P +Y + +LQV
Sbjct: 253 FEDGAKLRIVNGKYSIPPHDT-----------------QYTVFHSLIRAMLQV------- 288
Query: 624 SPDQRPNMSHVVKLIEELRGV 644
+P++R +++ VV ++E+
Sbjct: 289 NPEERLSIAEVVHQLQEIAAA 309
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ +G G FG + + VA+K +++ ++ + +F + EV+ +L HP LV L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ LV+E+M +G L L RG T L + G+A++ +
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYL----EEAC 124
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRKQ 539
+ H ++ + N L+ + +VSDFG++ F S G + +PE +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE--VFSFSRY 182
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
S KSDV+SFGVL+ E+ + GK P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 72/302 (23%), Positives = 113/302 (37%), Gaps = 54/302 (17%)
Query: 366 EMLGKGGFGTAYKAVLD-----DGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
LG+G FG D G VAVK LK ++ + ++ +E+L L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 420 GLKA--YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
K L+ E++P+GSL L N+ ++ +LK A +G+ ++
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR------AP 529
S + H ++ + NVL++ ++ DFGL+ I + AP
Sbjct: 143 G----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG-----GAVDLPRWV 583
E K SDV+SFGV L ELLT S M L +
Sbjct: 199 E--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 584 QSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639
+ R EV+ +LMR C P R + ++++ E
Sbjct: 257 KEGKRLPCPPNCPDEVY--QLMR----------------KCWEFQPSNRTSFQNLIEGFE 298
Query: 640 EL 641
L
Sbjct: 299 AL 300
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 47/270 (17%), Positives = 90/270 (33%), Gaps = 32/270 (11%)
Query: 325 EKILYSSSPYPAQQAGY--ERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLD 382
K+L S + + + + F+L L +LG+G F Y+A
Sbjct: 28 FKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQG 87
Query: 383 D------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436
D +K K A+ Q ME L + + + + +LV E
Sbjct: 88 DLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147
Query: 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNV 496
G+L ++ + + + A + +H ++ HG+IK N
Sbjct: 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNF 203
Query: 497 LL-----------DKTGNARVSDFGLSIFAPP-------STVPRSNGYRAPELSSSDGRK 538
+L D + + D G SI + ++G++ E+ S +
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--NKP 261
Query: 539 QSQKSDVYSFGVLLLELLTGKCPSVIDGGG 568
+ + D + + +L G V + GG
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 35/215 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGS-----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
++LG G FGT YK + VA+K L+ S +E V+ + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L L+++ MP G L + ++ + L A+G+ ++
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLE- 134
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------------ 527
+L H ++ + NVL+ + +++DFGL+ +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLA-----KLLGAEEKEYHAEGGKVPIKWM 186
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
A E S R + +SDV+S+GV + EL+T G P
Sbjct: 187 ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ LG G FG VA+K +K+ S+ + EF + +V+ L H LV L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ +++EYM NG L L R L++ + ++ +S +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYL----ESKQ 140
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRKQ 539
H ++ + N L++ G +VSDFGLS + S G + PE K
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE--VLMYSKF 198
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
S KSD+++FGVL+ E+ + GK P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ LG G FG VAVK +K+ S+ + EF Q + + +L HP LV
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+V+EY+ NG L L + L+ + L++ G+AF+ +S +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFL----ESHQ 124
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRKQ 539
H ++ + N L+D+ +VSDFG++ + S G + APE K
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE--VFHYFKY 182
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
S KSDV++FG+L+ E+ + GK P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
E LG G FG + + + VAVK LK S+ F ++ +L+H LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRL---- 73
Query: 426 FA---REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+A +E +++EYM NGSL L + P L L +AA A G+AFI +
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI----E 126
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDG 536
H ++++ N+L+ T + +++DFGL+ + G + APE + + G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE-AINYG 185
Query: 537 RKQSQKSDVYSFGVLLLELLT-GKCP 561
+ KSDV+SFG+LL E++T G+ P
Sbjct: 186 -TFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV-VAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG G +G Y+ V S+ VAVK LK+ ++ EF + V+ ++HPNLV L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+++E+M G+L L R R + L +A + + ++ +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL----EKK 130
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRK 538
H ++ + N L+ + +V+DFGLS T G + APE S + +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNK- 188
Query: 539 QSQKSDVYSFGVLLLELLT-GKCP 561
S KSDV++FGVLL E+ T G P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 73/307 (23%), Positives = 114/307 (37%), Gaps = 64/307 (20%)
Query: 366 EMLGKGGFGTAYKAVLDD-----GSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
LG+G FG D G +VAVK LK DA + ++Q +++L L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 420 GLKA--YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
K LV EY+P GSL L + + L A G+A++
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR---------- 527
H + H ++ + NVLLD ++ DFGL+ P YR
Sbjct: 151 H----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG----HEYYRVREDGDSPVF 202
Query: 528 --APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG-----GAVDL 579
APE + K SDV+SFGV L ELLT + + L
Sbjct: 203 WYAPE-CLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 580 PRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
++ R ++ AEV+ LM+ C RP +++
Sbjct: 261 TELLERGERLPRPDKCPAEVY--HLMKN----------------CWETEASFRPTFENLI 302
Query: 636 KLIEELR 642
+++ +
Sbjct: 303 PILKTVH 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGL 421
+ +G+G F Y+A L DG VA+K+++ + + + ++L +L HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
A + E +V E G L ++ + + + T K L +H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN-G---YRAPELSSSDG 536
S ++ H +IK NV + TG ++ D GL F+ +T S G Y +PE
Sbjct: 154 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--E 210
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
+ KSD++S G LL E+ + P
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRHPNLVGLK 422
LGKG FG Y A ++A+K L A + K E + E+ LRHPN++ L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
YF ++ L+ EY P G+++ L + + + T A L++ H
Sbjct: 76 -GYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTA-TYITELANALSYCH--- 126
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---YRAPELSSSDGRK 538
S ++ H +IK N+LL G +++DFG S+ AP S G Y PE+ GR
Sbjct: 127 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE--GRM 183
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
+K D++S GVL E L GK P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ LG G FG + A + + VAVK +K S+ F V+ L+H LV L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+E +++E+M GSL L + + + +A A G+AFI
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRN 304
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRKQ 539
H ++++ N+L+ + +++DFGL+ + G + APE + +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGSF 362
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
+ KSDV+SFG+LL+E++T G+ P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV-VAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG G +G Y+ V S+ VAVK LK+ ++ EF + V+ ++HPNLV L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+++E+M G+L L R R + L +A + + ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLE----KK 337
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRK 538
H N+ + N L+ + +V+DFGLS T G + APE S K
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNK 395
Query: 539 QSQKSDVYSFGVLLLELLT-GKCP 561
S KSDV++FGVLL E+ T G P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E++G GGFG +KA DG +KR+K + +RE ++ L +L H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 425 YFAREEKL----------------LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA 468
+ + + E+ G+L + RG LD L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFE 129
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-- 525
+G+ +IH S KL + ++K +N+ L T ++ DFGL RS G
Sbjct: 130 QITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 526 -YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y +PE S + ++ D+Y+ G++L ELL
Sbjct: 186 RYMSPEQIS--SQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 366 EMLGKGGFGTAYKAVL---DDGSV-VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+++G G G L V VA+K LK + +R+F ++G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+ ++V+EYM NGSL L + G + + G G+ ++
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLS-- 168
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR------APELS 532
L H ++ + NVL+D +VSDFGLS + P + G + APE
Sbjct: 169 --DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-- 224
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ R S SDV+SFGV++ E+L G+ P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/241 (22%), Positives = 81/241 (33%), Gaps = 30/241 (12%)
Query: 330 SSSPYPAQQAGYERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVA 388
+ Q GY+ F + F+ LG G +G +K +DG + A
Sbjct: 35 GEASETLQSPGYDPSRPESF-FQQSFQRL-------SRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 389 VKRLKDASIGGKREFEQHMEV---LGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLF 444
VKR G K + EV +HP V L+ + L L +E SL
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE-QAWEEGGILYLQTELC-GPSLQ 144
Query: 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA 504
L LA +H S L H ++K N+ L G
Sbjct: 145 QHCEAWGAS----LPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRC 196
Query: 505 RVSDFGLSIFAPPSTVPRSN----GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKC 560
++ DFGL + + Y APEL +DV+S G+ +LE+
Sbjct: 197 KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNME 253
Query: 561 P 561
Sbjct: 254 L 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ +GKG FG G+ VAVK +K+ + + F V+ +LRH NLV L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 426 FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ L +V+EYM GSL L R GR+ L LK + + ++ +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL----EGN 136
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------------APELS 532
H ++ + NVL+ + A+VSDFGL+ + APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLT---------K-EASSTQDTGKLPVKWTAPE-- 184
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ +K S KSDV+SFG+LL E+ + G+ P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV-----VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
+++G G FG YK +L S VA+K LK + + +F ++G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L+ + ++++EYM NG+L L G + + G A G+ ++
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA- 164
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR------APEL 531
++ H ++ + N+L++ +VSDFGLS + P ++G + APE
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE- 220
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ RK + SDV+SFG+++ E++T G+ P
Sbjct: 221 -AISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGS-----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
++LG G FGT YK + VA+K L+ S +E V+ + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L L+++ MP G L + ++ + L A+G+ ++
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLE- 134
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNG-----YRAPELS 532
+L H ++ + NVL+ + +++DFGL+ + A G + A E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-- 189
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
S R + +SDV+S+GV + EL+T G P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM----EVLGRLRHPNLVGLK 422
LGKG FG Y A + ++A+K L + + K E + E+ LRHPN++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
YF +++ L+ E+ P G L+ L + GR + + A L + H
Sbjct: 81 -NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSA-TFMEELADALHYCH--- 131
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---TVPRSNGYRAPELSSSDGRK 538
K+ H +IK N+L+ G +++DFG S+ AP T+ + Y PE+ G+
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE--GKT 188
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
+K D++ GVL E L G P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 51/207 (24%), Positives = 81/207 (39%), Gaps = 14/207 (6%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+G G +G K DG ++ K + K+ + +L L+HPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 423 AYYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
R L V EY G L ++ + LD L++ L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRR 130
Query: 481 CKSLKLT-HGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN----GYRAPELSSS 534
H ++K NV LD N ++ DFGL+ I ++ ++ Y +PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN- 189
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
++KSD++S G LL EL P
Sbjct: 190 -RMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+ +G+G FG A +DG +K + S + E + + VL ++HPN+V +
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ +V +Y G LF ++ +G L L +H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---- 142
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSN-G---YRAPELSSSDGR 537
K+ H +IKS N+ L K G ++ DFG++ + + R+ G Y +PE+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE--NK 200
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
+ KSD+++ G +L EL T K
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHA 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLV 419
LG+G FG + A D +VAVK LKD ++ +++F++ E+L L+H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR-----------LKIAA 468
+ ++V EYM +G L L + +D R L IA+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGY 526
A G+ ++ S H ++ + N L+ ++ DFG+S +++ +
Sbjct: 141 QIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 527 ---R--APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
R PE S K + +SDV+SFGV+L E+ T GK P
Sbjct: 197 LPIRWMPPE-SIMYR-KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
LG+G FG + + + VA+K LK ++ F Q +V+ +LRH LV L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ E +V+EYM GSL L +G L + +AA A G+A++ +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVE----RMN 300
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRKQ 539
H ++++ N+L+ + +V+DFGL+ + G + APE ++ +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE--AALYGRF 358
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
+ KSDV+SFG+LL EL T G+ P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 80/335 (23%), Positives = 130/335 (38%), Gaps = 78/335 (23%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV---VAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPNLVG 420
+++G+G FG KA + + A+KR+K+ AS R+F +EVL +L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR-----------LKIAAG 469
L R L EY P+G+L L +R P L AA
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG-YR- 527
ARG+ ++ + H ++ + N+L+ + A+++DFGLS R Y
Sbjct: 151 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLS---------RGQEVYVK 197
Query: 528 -----------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGG 575
A E S + + SDV+S+GVLL E+++ G P GM C
Sbjct: 198 KTMGRLPVRWMAIE-SLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTC-- 247
Query: 576 AVDLPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631
+L + R EV+ +LMR C P +RP+
Sbjct: 248 -AELYEKLPQGYRLEKPLNCDDEVY--DLMRQ----------------CWREKPYERPSF 288
Query: 632 SHVVKLIEELRGVEVSPCHENFDSVSDSPCLSEDT 666
+ ++ + + +E + N D
Sbjct: 289 AQILVSLNRM--LEERKTYVNTTLYEKFTYAGIDC 321
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGS-----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
++LG G FGT +K V V +K ++ + + HM +G L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L LV++Y+P GSL + +RG L L A+G+ ++
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYYLE- 132
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------------ 527
+ H N+ + NVLL +V+DFG++ +P +
Sbjct: 133 ---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL-----LPPDDKQLLYSEAKTPIKWM 184
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
A E S K + +SDV+S+GV + EL+T G P
Sbjct: 185 ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+++G G FG L S VA+K LK + +R+F ++G+ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+ + ++V+EYM NGSL L + + + G A G+ ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLS-- 164
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR------APELS 532
+ H ++ + N+L++ +VSDFGL + P + G + +PE
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE-- 220
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ RK + SDV+S+G++L E+++ G+ P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 27/224 (12%)
Query: 353 KRFEL--EDLLRASAEMLGKGGFGTAYKAVL--DDGSV-VAVKRLK-DASIGGKREFEQH 406
K+ L ++LL A E LG G FG+ + V + VA+K LK E +
Sbjct: 2 KKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
+++ +L +P +V L E +LV E G L L G R + + ++
Sbjct: 61 AQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAEL 115
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
+ G+ ++ + H ++ + NVLL A++SDFGLS + A S +
Sbjct: 116 LHQVSMGMKYL----EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171
Query: 525 GYR------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ APE + RK S +SDV+S+GV + E L+ G+ P
Sbjct: 172 AGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 68/314 (21%), Positives = 104/314 (33%), Gaps = 85/314 (27%)
Query: 366 EMLGKGGFGTAYKAVLDDGS------VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNL 418
LG G FG Y+ + VAVK L + S + +F ++ + H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR--LKIAAGAARGLAF 476
V + ++ E M G L L R P L +A A G +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARV---SDFGLSIFAPPSTVPRSNGYR------ 527
+ + H +I + N LL G RV DFG++ + R+ YR
Sbjct: 197 L----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-----RDIYRAGYYRKGGCAM 247
Query: 528 ------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-----------SVIDGG-- 567
PE + +G + K+D +SFGVLL E+ + G P V GG
Sbjct: 248 LPVKWMPPE-AFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305
Query: 568 GAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ 627
C V+ +M C P+
Sbjct: 306 DPPKNC------------------PGPVY--RIMT----------------QCWQHQPED 329
Query: 628 RPNMSHVVKLIEEL 641
RPN + +++ IE
Sbjct: 330 RPNFAIILERIEYC 343
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 45/226 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+ LG+GGFG ++A D A+KR++ + + + ++ L +L HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR--- 67
Query: 424 YYFAREEKL---------------LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA 468
Y+ A EK + + +L ++G + + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFL 125
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----------IFAPP 517
A + F+H S L H ++K +N+ +V DFGL + P
Sbjct: 126 QIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 518 STVPRSNG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLT 557
R G Y +PE G S K D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIH--GNSYSHKVDIFSLGLILFELLY 225
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 34/202 (16%), Positives = 62/202 (30%), Gaps = 22/202 (10%)
Query: 22 KASTSPDLNALLDFKASSDEAN---------KLTTWNSTSDPCSWT---GVSCLQN-RVS 68
A D AL + + + N WN + W GVS N RV+
Sbjct: 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVT 84
Query: 69 HLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPV-----PSLSNLTALKLLFLSHNN 122
L LE SG + + LT+L VL+L + +S + + +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 123 FNGEFPDSVS--SLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLD 179
+ F D L + ++ + I + + +N + +
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMR 204
Query: 180 LRNLQDFNVSGNHLSGQIPKSL 201
L L+ F + + +
Sbjct: 205 LTKLRQFYMGNSPFVAENICEA 226
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 25/149 (16%), Positives = 49/149 (32%), Gaps = 7/149 (4%)
Query: 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRF-TGPVP-SLSNLTALKLLFLSHN 121
NR +L +++++ + YN T PV SL + L +L +N
Sbjct: 282 CNRGISGEQLKDDW-QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-- 179
G + S +L L+L++N + + L N+ D
Sbjct: 341 QLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 180 -LRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
+ + + S N + K+ +
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 25/179 (13%), Positives = 56/179 (31%), Gaps = 26/179 (14%)
Query: 43 NKLTTWNS-TSDPCSWTGVSCLQNRVSHLVLENLQLS------GSLQP-LTSLTQLRVLS 94
N+ + D + + ++ + + ++ L + +L +L
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEK------IQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336
Query: 95 LKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP-- 152
YN+ G +P+ + L L L++N + ++ L + N IP
Sbjct: 337 CLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNI 395
Query: 153 LTVNHLTHLLTLKLEANRFSG---------PITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
++ + + N T N+ N+S N +S + S
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-19
Identities = 23/156 (14%), Positives = 48/156 (30%), Gaps = 26/156 (16%)
Query: 72 LENLQLSG-------SLQPLTSLTQLRVLSLKYNRFTGPV--------PSLSNLTALKLL 116
+ENL + ++ S++ + + YN P+ + +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSG-------QIPLTVNHLTHLLTLKLEAN 169
LS+N + + S+ L ++L N + + L ++ L N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 170 RFSG---PITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+ + L L ++S N S P
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 32/183 (17%), Positives = 64/183 (34%), Gaps = 23/183 (12%)
Query: 43 NKLTTWNSTSDPCSWTGVSCL---QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNR 99
NKL + D S + +S + N + + + + ++L N+
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSV--DGKNFDPLDPTPFKGINVSSINLSNNQ 444
Query: 100 FTGPVPS-LSNLTALKLLFLSHNNFNG-------EFPDSVSSLFRLYRLDLSFNNFSGQI 151
+ S + L + L N + ++ + + L +DL FN + +
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-L 503
Query: 152 P--LTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDF------NVSGNHLSGQIPKSLS 202
L +L+ + L N FS P L+ L+ F + GN + P+ ++
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT 563
Query: 203 GFP 205
P
Sbjct: 564 LCP 566
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 22/147 (14%), Positives = 48/147 (32%), Gaps = 10/147 (6%)
Query: 72 LENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSL--SNLTALKLLFLSHNNFNGEFPD 129
+ L + + L + L++N+ T + L L + LS+N+F+ FP
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 130 SVSSLFRLYRL------DLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL 183
+ L D N + P + L L++ +N + N+
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI-TPNI 589
Query: 184 QDFNVSGNHLSGQIPKSLSGFPDSAFT 210
++ N + + ++
Sbjct: 590 SVLDIKDNPNISIDLSYVCPYIEAGMY 616
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-18
Identities = 22/168 (13%), Positives = 50/168 (29%), Gaps = 38/168 (22%)
Query: 69 HLVLENLQLSGSLQPLTS-------LTQLRVLSLKYNRFTGPVP---------------- 105
+ L++ Q+ +T LT+LR + + F
Sbjct: 180 RITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239
Query: 106 ----SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF--------SGQIPL 153
NL L + + + + P + +L + ++++ N Q
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 154 TVNHLTHLLTLKLEANRF-SGPITGL--DLRNLQDFNVSGNHLSGQIP 198
+ + + N + P+ ++ L N L G++P
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 20/152 (13%), Positives = 49/152 (32%), Gaps = 10/152 (6%)
Query: 66 RVSHLVLENLQLSGSLQPLTSL-TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
+ + + S++ + + + + N T ++ LT L+ ++ ++ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI-TGL-DLRN 182
E + + L ++L L +++ + T L L
Sbjct: 220 AENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274
Query: 183 LQDFNVSGNHLSG--QIPKSLSGFPDSAFTQN 212
+Q NV+ N Q+ D+ +
Sbjct: 275 MQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 15/160 (9%), Positives = 41/160 (25%), Gaps = 10/160 (6%)
Query: 49 NSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFT-----GP 103
+ G + +S + +++ + + L +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 104 VPSL-SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLL 162
+ + NN +V L +L + + + F + +
Sbjct: 175 IKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE 233
Query: 163 TLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+ + +L++L D V ++P L
Sbjct: 234 YAQQYKT---EDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 25/167 (14%), Positives = 52/167 (31%), Gaps = 24/167 (14%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSG----SLQP---LTSLTQLRVLSL 95
N LT S L ++ L L T+L L + L
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYL------LTSIDLRFNKLTKLSDDFRATTLPYLVGIDL 520
Query: 96 KYNRFTGPVPSLSNLTALKLLFLSH------NNFNGEFPDSVSSLFRLYRLDLSFNNFSG 149
YN F+ N + LK + + N E+P+ ++ L +L + N+
Sbjct: 521 SYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580
Query: 150 QIPLTVNHLTHLLTLKLEANRFSG-PITGL-DLRNLQDFNVSGNHLS 194
+ + ++ L ++ N ++ + + + +
Sbjct: 581 -VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 16/104 (15%), Positives = 30/104 (28%), Gaps = 10/104 (9%)
Query: 105 PSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTL 164
+N K + + + S++S R+ L L SG++P + LT L L
Sbjct: 55 QPGANWNFNK----ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVL 110
Query: 165 KLEANRFSGPITGL------DLRNLQDFNVSGNHLSGQIPKSLS 202
L ++ + + H
Sbjct: 111 ALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 17/104 (16%), Positives = 36/104 (34%), Gaps = 6/104 (5%)
Query: 106 SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLK 165
+ + ALK ++ + N N + + + + + Q +++N + L
Sbjct: 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLS 87
Query: 166 LEANRFSGPITG--LDLRNLQDFNVSGNHLSGQ----IPKSLSG 203
LE SG + L L+ + + PK +S
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 41/221 (18%), Positives = 86/221 (38%), Gaps = 35/221 (15%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQH-----------------MEVL 410
L +G F D A+K+ + + + KR+F + ++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 411 GRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL----- 464
+++ + + +++ ++ EYM N S+ ++T +
Sbjct: 98 TDIKNEYCLTCE-GIITNYDEVYIIYEYMENDSILKFDEYF---FVLDKNYTCFIPIQVI 153
Query: 465 -KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRS 523
I ++IH + H ++K +N+L+DK G ++SDFG S + + S
Sbjct: 154 KCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS 210
Query: 524 NG---YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G + PE S++ K D++S G+ L + P
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ +GKG FG G+ VAVK +K+ + + F V+ +LRH NLV L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 426 FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ L +V+EYM GSL L R GR+ L LK + + ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE----GN 308
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-----SNGYR------APELSS 533
H ++ + NVL+ + A+VSDFGL+ + + + APE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLT---------KEASSTQDTGKLPVKWTAPE--A 357
Query: 534 SDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+K S KSDV+SFG+LL E+ + G+ P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 68/314 (21%), Positives = 106/314 (33%), Gaps = 85/314 (27%)
Query: 366 EMLGKGGFGTAYKAVLDDGS------VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNL 418
LG G FG Y+ + VAVK L + S + +F ++ + H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSL--FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
V + ++ E M G L F R + L L +A A G +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARV---SDFGLSIFAPPSTVPRSNGYR------ 527
+ + H +I + N LL G RV DFG++ + R++ YR
Sbjct: 156 L----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-----RDIYRASYYRKGGCAM 206
Query: 528 ------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-----------SVIDGG-- 567
PE + +G + K+D +SFGVLL E+ + G P V GG
Sbjct: 207 LPVKWMPPE-AFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264
Query: 568 GAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ 627
C V+ +M C P+
Sbjct: 265 DPPKNC------------------PGPVY--RIMT----------------QCWQHQPED 288
Query: 628 RPNMSHVVKLIEEL 641
RPN + +++ IE
Sbjct: 289 RPNFAIILERIEYC 302
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV----VAVKRLKD---ASIGGKREFEQHMEVLGRLRHPNL 418
E LG G FG + D S VAVK LK + +F + + + L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
+ L Y + +V+E P GSL L ++G T + A A G+ ++
Sbjct: 84 IRL--YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYL 137
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR------AP 529
S + H ++ + N+LL ++ DFGL + + AP
Sbjct: 138 E----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
E S R S SD + FGV L E+ T G+ P
Sbjct: 194 E--SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+G+G FG ++ + VA+K K S + +F Q + + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L ++ E G L L + LD + + A + LA++
Sbjct: 81 LIGV-ITENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE-- 133
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSS 534
S + H +I + NVL+ ++ DFGLS + ST +++ + APE S
Sbjct: 134 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE--SI 189
Query: 535 DGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ R+ + SDV+ FGV + E+L G P
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 350 EGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKR-LKDASIGGKREFEQHME 408
E T + + ++LG G GT + D VAVKR L + RE ++
Sbjct: 14 EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQ 69
Query: 409 VLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA 467
+L HPN++ R+ + + E +L + + L+ + +
Sbjct: 70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLE---PITLL 124
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN-----ARVSDFGLSI--------F 514
GLA +H SL + H ++K N+L+ A +SDFGL F
Sbjct: 125 QQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 515 APPSTVPRSNGYRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ S VP + G+ APE LS + D++S G + +++
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 30/231 (12%), Positives = 58/231 (25%), Gaps = 41/231 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL---KDASIGGKREFEQHMEVLGRLRHPNLVGL 421
E L G + ++ A+K + S + RL +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 422 KAYY--------------------------FAREEKLLVSEYMPNGSLFWLLH--GNRGP 453
+ +A LL+ + L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYV 186
Query: 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513
R + A R A + S L HG+ N+ + G + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDNLFIMPDGRLMLGDVSAL- 241
Query: 514 FAPPSTVPRSNG---YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + P S+ Y E ++ + + + G+ + + P
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
LG+G FG + + + VA+K LK ++ F Q +V+ +LRH LV L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 330
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ E +V+EYM GSL L +G L + +AA A G+A++ +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVE----RMN 383
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSSDGRKQ 539
H ++++ N+L+ + +V+DFGL+ + G + APE ++ +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE--AALYGRF 441
Query: 540 SQKSDVYSFGVLLLELLT-GKCP 561
+ KSDV+SFG+LL EL T G+ P
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP 464
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 73/318 (22%), Positives = 117/318 (36%), Gaps = 89/318 (27%)
Query: 366 EMLGKGGFGTAYKAVLDDGS------VVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLV 419
LG+G FG + A + +VAVK LK+AS +++F++ E+L L+H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR----------GPGRTPLDWTTRLKIAAG 469
L+V EYM +G L L + PL L +A+
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR-- 527
A G+ ++ L H ++ + N L+ + ++ DFG+S + ++ YR
Sbjct: 167 VAAGMVYLA----GLHFVHRDLATRNCLVGQGLVVKIGDFGMS-----RDIYSTDYYRVG 217
Query: 528 ----------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-----------SVID 565
PE S K + +SDV+SFGV+L E+ T GK P +
Sbjct: 218 GRTMLPIRWMPPE-SILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 566 GG--GAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSA 623
G C P V +MR C
Sbjct: 276 GRELERPRAC------PPEVY--------------AIMR----------------GCWQR 299
Query: 624 SPDQRPNMSHVVKLIEEL 641
P QR ++ V ++ L
Sbjct: 300 EPQQRHSIKDVHARLQAL 317
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+LGKG +G Y L + +A+K + + + + + + L+H N+V Y
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV---QY 84
Query: 425 Y--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
F+ + + E +P GSL LL GP + T GL ++H
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL--KDNEQTIGFYTKQILEGLKYLH--- 139
Query: 482 KSLKLTHGNIKSTNVLLD-KTGNARVSDFGLS-----IFAPPSTVPRSNGYRAPELSSSD 535
++ H +IK NVL++ +G ++SDFG S I T + Y APE+
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
R + +D++S G ++E+ TGK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 43/226 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+LG+G FG KA D A+K+++ + +L L H +V A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 425 Y------------FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 471
+ ++ L + EY NG+L+ L+H ++
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQIL 126
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---------IFAPPSTVPR 522
L++IH S + H ++K N+ +D++ N ++ DFGL+ + +P
Sbjct: 127 EALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 523 SNG----------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
S+ Y A E+ G ++K D+YS G++ E++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIYP 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 366 EMLGKGGFGTAYKAVLDDGS------VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNL 418
LG+G FG Y+ V VA+K + + AS+ + EF V+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-----GPGRTPLDWTTRLKIAAGAARG 473
V L + L++ E M G L L R P P + +++A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR---- 527
+A+++ + K H ++ + N ++ + ++ DFG++ I+ ++ YR
Sbjct: 151 MAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-------ETDYYRKGGK 199
Query: 528 --------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+PE S DG + SDV+SFGV+L E+ T + P
Sbjct: 200 GLLPVRWMSPE-SLKDG-VFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 353 KRFELE-DLLRASAEMLGKGGFGTAYKAVLDDGSV---VAVKRLKDASI--GGKREFEQH 406
K L+ LL + LG G FGT K V VAVK LK+ + K E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
V+ +L +P +V + E +LV E G L L NR + +++
Sbjct: 69 ANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIEL 122
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
+ G+ ++ + H ++ + NVLL A++SDFGLS + A +
Sbjct: 123 VHQVSMGMKYL----EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 525 GYR------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ APE + K S KSDV+SFGVL+ E + G+ P
Sbjct: 179 HGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 70/301 (23%), Positives = 109/301 (36%), Gaps = 67/301 (22%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
E++G+G FG Y L D AVK L IG +F ++ HPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 421 LKAYYFAREEKLL-VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E L V YM +G L + + A+G+ ++
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLA- 145
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------------ 527
S K H ++ + N +LD+ +V+DFGL+ + Y
Sbjct: 146 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLA-----RDMYDKEYYSVHNKTGAKLPVK 197
Query: 528 --APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQ 584
A E S +K + KSDV+SFGVLL EL+T G P + D+ ++
Sbjct: 198 WMALE-SLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY------PDV---NTFDITVYLL 246
Query: 585 SVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEE 640
R E ++ E+M C + RP+ S +V I
Sbjct: 247 QGRRLLQPEYCPDPLY--EVMLK----------------CWHPKAEMRPSFSELVSRISA 288
Query: 641 L 641
+
Sbjct: 289 I 289
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 76/307 (24%), Positives = 117/307 (38%), Gaps = 65/307 (21%)
Query: 368 LGKGGFGTAYKAVL------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPNLV 419
LG G FG +A D VAVK LK A + + ++VL L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR-------------LKI 466
L L+++EY G L L R L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
+ A+G+AF+ S H ++ + N+LL ++ DFGL+ I + V + N
Sbjct: 151 SYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 525 G---YR--APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578
+ APE S + + +SDV+S+G+ L EL + G P GM
Sbjct: 207 ARLPVKWMAPE-SIFNCV-YTFESDVWSYGIFLWELFSLGSSPY------PGMPVDS--K 256
Query: 579 LPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHV 634
+ ++ R E AE++D +M+ C A P +RP +
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYD--IMKT----------------CWDADPLKRPTFKQI 298
Query: 635 VKLIEEL 641
V+LIE+
Sbjct: 299 VQLIEKQ 305
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 24/226 (10%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAVL--DDGSV-VAVKRLK-DASIGGKREFE 404
+ K F D L + LG G FG+ + V + VA+K LK E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 405 QHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
+ +++ +L +P +V L E +LV E G L L G R + +
Sbjct: 385 REAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVA 439
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPR 522
++ + G+ ++ + H N+ + NVLL A++SDFGLS + A S
Sbjct: 440 ELLHQVSMGMKYL----EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 523 SNGYR------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ + APE + RK S +SDV+S+GV + E L+ G+ P
Sbjct: 496 RSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 68/321 (21%), Positives = 110/321 (34%), Gaps = 91/321 (28%)
Query: 366 EMLGKGGFGTAYKAVLDDGS------VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNL 418
E LG+ FG YK L + VA+K LK A + EF + RL+HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG-----------RTPLDWTTRLKIA 467
V L + ++ Y +G L L ++ L+ + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR 527
A A G+ ++ S + H ++ + NVL+ N ++SD GL V ++ Y+
Sbjct: 135 AQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLF-----REVYAADYYK 185
Query: 528 ------------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP-----------SV 563
APE + G K S SD++S+GV+L E+ + G P +
Sbjct: 186 LLGNSLLPIRWMAPE-AIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 564 IDGG--GAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACT 621
+ C P WV LM C
Sbjct: 244 RNRQVLPCPDDC------PAWVY--------------ALMIE----------------CW 267
Query: 622 SASPDQRPNMSHVVKLIEELR 642
+ P +RP + +
Sbjct: 268 NEFPSRRPRFKDIHSRLRAWG 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLKD--ASIGGKREFEQHMEVLGRLRHPNLV 419
++LG+G FG+ + L VAVK +K +S EF + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 420 GL-----KAYYFAREEKLLVSEYMPNGSLFWLLHGNR-GPGRTPLDWTTRLKIAAGAARG 473
L + + +++ +M G L L +R G + T LK A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR---- 527
+ ++ + H ++ + N +L V+DFGLS I+ + YR
Sbjct: 160 MEYL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY-------SGDYYRQGRI 208
Query: 528 --------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
A E S +D + KSDV++FGV + E+ T G P
Sbjct: 209 AKMPVKWIAIE-SLADRV-YTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
++GKG FG Y D + A+K L + F + ++ L HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 421 LKAYYFAREE-KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E ++ YM +G L + + + ARG+ ++
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGMEYL-- 140
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR-------APE 530
K H ++ + N +LD++ +V+DFGL+ I + + + A E
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
S R + KSDV+SFGVLL ELLT G P
Sbjct: 199 -SLQTYR-FTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 66/322 (20%)
Query: 366 EMLGKGGFGTAYKAVL--------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RH 415
+ LG+G FG A + VAVK LKD A+ + ME++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSL-----------FWLLHGNRGPGRTPLDWTTRL 464
N++ L ++ EY G+L + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPR 522
ARG+ ++ S K H ++ + NVL+ + +++DFGL+ I
Sbjct: 161 SCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 523 SNGYR-----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGA 576
+NG APE + D + +SDV+SFGVL+ E+ T G P G+
Sbjct: 217 TNGRLPVKWMAPE-ALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPY------PGI---PV 265
Query: 577 VDLPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632
+L + ++ R T E++ +MR C A P QRP
Sbjct: 266 EELFKLLKEGHRMDKPANCTNELYM--MMR----------------DCWHAVPSQRPTFK 307
Query: 633 HVVKLIEELRGVEVSPCHENFD 654
+V+ ++ + + + + +
Sbjct: 308 QLVEDLDRILTLTTNEEYLDLS 329
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGSV----VAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+LG+G FG Y+ V + VAVK K D ++ K +F ++ L HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L E ++ E P G L L N+ L T + + + +A++
Sbjct: 78 LIGI-IEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLE-- 130
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSS 534
S+ H +I N+L+ ++ DFGLS + +++ R +PE S
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE--SI 186
Query: 535 DGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ R+ + SDV+ F V + E+L+ GK P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLKD--ASIGGKREFEQHMEVLGRLRHPNLV 419
MLGKG FG+ +A L VAVK LK + EF + + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 420 GL------KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGR-TPLDWTTRLKIAAGAAR 472
L +++ +M +G L L +R L T ++ A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR--- 527
G+ ++ S H ++ + N +L + V+DFGLS I+ + YR
Sbjct: 149 GMEYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY-------SGDYYRQGC 197
Query: 528 ---------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
A E S +D + SDV++FGV + E++T G+ P
Sbjct: 198 ASKLPVKWLALE-SLADNL-YTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 42/226 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEV--LGRL-RHPNLVGL 421
E +G G FG+ +K V DG + A+KR K G E EV L +H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 422 KAYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
Y+ +A ++ + + +EY GSL + N + RGL +IH
Sbjct: 76 --YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYIH 132
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVS-------------------DFGL--SIFAPP 517
S+ L H +IK +N+ + +T + D G I +P
Sbjct: 133 ----SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 518 STV--PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
R + A E+ + K+D+++ + ++ +
Sbjct: 189 VEEGDSR---FLANEVLQENYT-HLPKADIFALALTVVCAAGAEPL 230
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 78/314 (24%), Positives = 125/314 (39%), Gaps = 71/314 (22%)
Query: 366 EMLGKGGFGTAYKAVLDDG------SVVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNL 418
+ LG+G FG KA + VAVK LK+ AS R+ VL ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSL-------------------FWLLHGNRGPGRTPLD 459
+ L LL+ EY GSL P L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPP 517
+ A ++G+ ++ +KL H ++ + N+L+ + ++SDFGLS ++
Sbjct: 149 MGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 518 STVPRSNGYR-----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGM 571
S V RS G A E S D + +SDV+SFGVLL E++T G P G+
Sbjct: 205 SYVKRSQGRIPVKWMAIE-SLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPY------PGI 256
Query: 572 GCGGAVDLPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ 627
L +++ R + + E++ LM C PD+
Sbjct: 257 ---PPERLFNLLKTGHRMERPDNCSEEMYR--LML----------------QCWKQEPDK 295
Query: 628 RPNMSHVVKLIEEL 641
RP + + K +E++
Sbjct: 296 RPVFADISKDLEKM 309
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 74/313 (23%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
+ LG+G FG +A VAVK LK+ A+ R +++L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 418 LVGLKAYYFAREEKLLV-SEYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLK 465
+V L L+V E+ G+L L R + L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG 525
+ A+G+ F+ S K H ++ + N+LL + ++ DFGL+ + +
Sbjct: 153 YSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLA-----RDIYKDPD 203
Query: 526 YR------------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMG 572
Y APE + D + +SDV+SFGVLL E+ + G P G+
Sbjct: 204 YVRKGDARLPLKWMAPE-TIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY------PGVK 255
Query: 573 CGGAVDLPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR 628
+ R ++ R + T E++ M C P QR
Sbjct: 256 ID--EEFCRRLKEGTRMRAPDYTTPEMYQ--TMLD----------------CWHGEPSQR 295
Query: 629 PNMSHVVKLIEEL 641
P S +V+ + L
Sbjct: 296 PTFSELVEHLGNL 308
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+G+G FG ++ + VA+K K S + +F Q + + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L ++ E G L L + LD + + A + LA++
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE-- 508
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------APELSSS 534
S + H +I + NVL+ ++ DFGLS + ST +++ + APE S
Sbjct: 509 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE--SI 564
Query: 535 DGRKQSQKSDVYSFGVLLLELLT-GKCP 561
+ R+ + SDV+ FGV + E+L G P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 68/303 (22%), Positives = 111/303 (36%), Gaps = 61/303 (20%)
Query: 368 LGKGGFGTAYKAVL------DDGSVVAVKRLK-DASIGGKREFEQHMEVLGRL-RHPNLV 419
LG G FG +A D VAVK LK A K ++++ L +H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR---------GPGRTPLDWTTRLKIAAGA 470
L L+++EY G L L + L ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR- 527
A+G+AF+ S H ++ + NVLL A++ DFGL+ I + + + N
Sbjct: 174 AQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 528 ----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582
APE S D + +SDV+S+G+LL E+ + G P G +
Sbjct: 230 VKWMAPE-SIFDC-VYTVQSDVWSYGILLWEIFSLGLNPY--------PGILVNSKFYKL 279
Query: 583 VQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
V+ + ++ +M+ AC + P RP + +
Sbjct: 280 VKDGYQMAQPAFAPKNIYS--IMQ----------------ACWALEPTHRPTFQQICSFL 321
Query: 639 EEL 641
+E
Sbjct: 322 QEQ 324
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK--REFEQHMEVLGRLRHPNLV 419
LGKG F Y+A + G VA+K + A + + E +++ +L+HP+++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE----VKIHCQLKHPSIL 74
Query: 420 GLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
L Y F + LV E NG + L P + R G+ ++H
Sbjct: 75 ELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEAR-HFMHQIITGMLYLH 129
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-----SNGYRAPELSS 533
S + H ++ +N+LL + N +++DFGL+ + Y +PE+++
Sbjct: 130 ----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+SDV+S G + LL G+ P
Sbjct: 186 --RSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 57/296 (19%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRLKD-ASIGGKREFEQHMEVLGRLRHPNLVG 420
E++G+G FG Y L D AVK L IG +F ++ HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 421 LKAYYFAREEKLL-VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E L V YM +G L + + A+G+ F+
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA- 209
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYR-------APE 530
S K H ++ + N +LD+ +V+DFGL+ ++ + A E
Sbjct: 210 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR- 588
S +K + KSDV+SFGVLL EL+T G P + D+ ++ R
Sbjct: 267 -SLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY------PDV---NTFDITVYLLQGRRL 315
Query: 589 ---EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
E ++ E+M C + RP+ S +V I +
Sbjct: 316 LQPEYCPDPLY--EVML----------------KCWHPKAEMRPSFSELVSRISAI 353
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 74/310 (23%), Positives = 123/310 (39%), Gaps = 68/310 (21%)
Query: 366 EMLGKGGFGTAYKAVL--------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RH 415
+ LG+G FG A + VAVK LKD A+ + ME++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGR-----------TPLDWTTRL 464
N++ L ++ EY G+L L R PG + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPR 522
ARG+ ++ S K H ++ + NVL+ + +++DFGL+ I
Sbjct: 207 SCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 523 SNGYR------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGG 575
+NG R APE + D + +SDV+SFGVL+ E+ T G P G+
Sbjct: 263 TNG-RLPVKWMAPE-ALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPY------PGI---P 310
Query: 576 AVDLPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631
+L + ++ R T E++ +MR C A P QRP
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNELYM--MMRD----------------CWHAVPSQRPTF 352
Query: 632 SHVVKLIEEL 641
+V+ ++ +
Sbjct: 353 KQLVEDLDRI 362
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 71/307 (23%), Positives = 118/307 (38%), Gaps = 66/307 (21%)
Query: 368 LGKGGFGTAYKAVL--------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
LG+G FG A + + VAVK LK A+ + ME++ + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSL-----------FWLLHGNRGPGRTPLDWTTRLKI 466
++ L ++ EY G+L + L +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN 524
A ARG+ ++ S K H ++ + NVL+ + +++DFGL+ I +N
Sbjct: 197 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 525 GYR-----APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578
G APE + D + +SDV+SFGVLL E+ T G P G+ +
Sbjct: 253 GRLPVKWMAPE-ALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPY------PGV---PVEE 301
Query: 579 LPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHV 634
L + ++ R T E++ +MR C A P QRP +
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELY--MMMR----------------DCWHAVPSQRPTFKQL 343
Query: 635 VKLIEEL 641
V+ ++ +
Sbjct: 344 VEDLDRI 350
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKA---VLDDGSVVAVKRLK-----DASIGGKREFEQ 405
R+++ + LG GG T Y A +L+ VA+K + + FE+
Sbjct: 12 RYKIV-------DKLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEET--LKRFER 60
Query: 406 HMEVLGRLRHPNLVGLKAYYFAREEKL--LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ +L H N+V + E+ LV EY+ +L + + PL T
Sbjct: 61 EVHNSSQLSHQNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTA 113
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRS 523
+ G+ H +++ H +IK N+L+D ++ DFG++ +++ ++
Sbjct: 114 INFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 524 NG------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
N Y +PE + G + +D+YS G++L E+L G+ P
Sbjct: 170 NHVLGTVQYFSPEQAK--GEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 64/330 (19%), Positives = 113/330 (34%), Gaps = 80/330 (24%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
++LG G FG A VAVK LK+ A + ++++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR-------------- 463
+V L L+ EY G L L R
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 464 ----LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST 519
L A A+G+ F+ + H ++ + NVL+ ++ DFGL+
Sbjct: 171 FEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLA-----RD 221
Query: 520 VPRSNGYR------------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDG 566
+ + Y APE S +G + KSDV+S+G+LL E+ + G P
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPE-SLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY---- 275
Query: 567 GGAGMGCGGAVDLPRWVQSVVR----EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTS 622
G+ + + +Q+ + T E++ +M+ C +
Sbjct: 276 --PGIPVD--ANFYKLIQNGFKMDQPFYATEEIYI--IMQS----------------CWA 313
Query: 623 ASPDQRPNMSHVVKLIEELRGVEVSPCHEN 652
+RP+ ++ + ++N
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAEEAMYQN 343
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 47/216 (21%), Positives = 80/216 (37%), Gaps = 28/216 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE-FEQHMEVLGRLRHPNLVGLKA 423
++LG+G ++ G + A+K + S + + EVL +L H N+V L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 424 YYFAREEKL--LVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
+ L+ E+ P GSL+ +L N L + L + G+ +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG----LPESEFLIVLRDVVGGMNHLR- 129
Query: 480 TCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPEL 531
+ H NIK N++ D +++DFG + S Y P++
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 532 ------SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+K D++S GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 33/238 (13%), Positives = 66/238 (27%), Gaps = 46/238 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR---------- 414
+LG+ +A + G V +Q E + RLR
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 415 ------------------HPNLVGLKAYYFAREEKLLVSEYM-PNGSLFWLLH--GNRGP 453
++ ++ Y +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513
L RL++ R LA +H L H ++ +++LD+ G ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 514 FA-PPSTVPRSNGYRAPELSSSDGRKQ---------SQKSDVYSFGVLLLELLTGKCP 561
S G+ PEL + + D ++ G+++ + P
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 49/213 (23%), Positives = 81/213 (38%), Gaps = 38/213 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G FG ++ G AVK RL+ + + L P +V
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIV--- 113
Query: 423 AYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
Y + + E + GSL L+ L L A GL ++H
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLH- 167
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGN-ARVSDFGLSIFAPPSTVPRSNGYR----------A 528
+ ++ HG++K+ NVLL G+ A + DFG ++ P + +S A
Sbjct: 168 ---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ K D++S ++L +L G P
Sbjct: 225 PEVVMGKPC--DAKVDIWSSCCMMLHMLNGCHP 255
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 31/216 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+ +G GG ++ + + + A+K L++A + + L +L+ + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 424 Y-YFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y Y ++ + +V E N L L + +D R + IH
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH--- 144
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-------SNGYRAPEL--- 531
+ H ++K N L+ G ++ DFG++ P T + Y PE
Sbjct: 145 -QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 532 ------SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ K S KSDV+S G +L + GK P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 10/163 (6%)
Query: 51 TSDPCSWTGVSCLQNRVSHLVLENLQLSG--SLQPLTSLTQLRVLSLKYNRFTGPVPS-L 107
+ ++ G+ L+ HL ++ L SL L L + +
Sbjct: 386 ITMSSNFLGLEQLE----HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441
Query: 108 SNLTALKLLFLSHNNFNGEF-PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL 166
+ L++L++L ++ N+F F PD + L L LDLS P N L+ L L +
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 167 EANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
N F T L +LQ + S NH+ + L FP S
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 5/142 (3%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNNFNGE 126
+L L + L QL L +++ +L L L +SH +
Sbjct: 377 YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGL--DLRNL 183
F + L L L ++ N+F + L +L L L + L +L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 184 QDFNVSGNHLSGQIPKSLSGFP 205
Q N+S N+
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 32/144 (22%), Positives = 49/144 (34%), Gaps = 10/144 (6%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFN 124
+NL LS L S +L+VL L + +L+ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG---PITGLDLR 181
+ S L L +L N + + HL L L + N P +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFP 205
NL+ ++S N + L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLH 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 35/164 (21%), Positives = 59/164 (35%), Gaps = 12/164 (7%)
Query: 50 STSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-S 106
+ + G+S L+ L + + P T L L L L + P +
Sbjct: 434 RVAFNGIFNGLSSLE----VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 107 LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHL-THLLTLK 165
++L++L++L +SHNNF L L LD S N+ + H + L L
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 166 LEANRFSGPITGLD----LRNLQDFNVSGNHLSGQIPKSLSGFP 205
L N F+ +++ + V + P G P
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 39/146 (26%), Positives = 54/146 (36%), Gaps = 12/146 (8%)
Query: 72 LENLQLSG---SLQPLTS-----LTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
LE L LS S + S T L+ L L +N + L L+ L H+N
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 124 NGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI---TGLD 179
SV SL L LD+S + N L+ L LK+ N F +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 180 LRNLQDFNVSGNHLSGQIPKSLSGFP 205
LRNL ++S L P + +
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 32/162 (19%), Positives = 49/162 (30%), Gaps = 13/162 (8%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFT 101
+ L + S S L +L + + + L+ L VL + N F
Sbjct: 406 SNLKQMSEFSVFLSLRN---LI----YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 102 GPVP--SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLT 159
+ L L L LS P + +SL L L++S NNF L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 160 HLLTLKLEANRFSGPI---TGLDLRNLQDFNVSGNHLSGQIP 198
L L N +L N++ N +
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 26/127 (20%), Positives = 44/127 (34%), Gaps = 4/127 (3%)
Query: 83 PLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141
P + L L +N S + L++L LS + SL L L
Sbjct: 23 PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82
Query: 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHL-SGQIP 198
L+ N + L+ L L + L+ L++ NV+ N + S ++P
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 199 KSLSGFP 205
+ S
Sbjct: 143 EYFSNLT 149
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 31/142 (21%), Positives = 50/142 (35%), Gaps = 8/142 (5%)
Query: 68 SHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNG 125
S L+L + + L+ L+ L + +L LK L ++HN
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 126 -EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHL----LTLKLEANRFSGPITG-LD 179
+ P+ S+L L LDLS N + L + L+L L N + G
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 180 LRNLQDFNVSGNHLSGQIPKSL 201
L + N S + K+
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-16
Identities = 31/163 (19%), Positives = 50/163 (30%), Gaps = 26/163 (15%)
Query: 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSH 120
+ + R+++L + LT++ SL V S + L L +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNV---SSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 121 NNFNGEFPDSVSSLFRLYR-------------------LDLSFN--NFSGQIPLTVNHLT 159
F + SL RL LDLS N +F G + T
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 160 HLLTLKLEANRFSGPITGLD-LRNLQDFNVSGNHLSGQIPKSL 201
L L L N + L L+ + ++L S+
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 28/181 (15%), Positives = 49/181 (27%), Gaps = 15/181 (8%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG 102
NK+ + + + L L ++ +L L+L+ N +
Sbjct: 159 NKIQS----IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSL 214
Query: 103 PVP--SLSNLTALKLLFLSHNNFNGEF---PDSVSSLFRLYRLDLSFNNFS------GQI 151
V + L L++ L F E S+L L L + + I
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 152 PLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQ 211
N LT++ + L + Q + L FT
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334
Query: 212 N 212
N
Sbjct: 335 N 335
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 51/216 (23%), Positives = 80/216 (37%), Gaps = 42/216 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK--REFEQHMEVLGRLRHPN 417
LGKGGF ++ D V A K L K E + + L H +
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQH 76
Query: 418 LVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
+VG + F + + +V E SL L R G +
Sbjct: 77 VVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRR---KALTEP-EAR-YYLRQIVLGCQY 130
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----------- 525
+H ++ H ++K N+ L++ ++ DFGL +T +G
Sbjct: 131 LH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYDGERKKVLCGTPN 180
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ S + S + DV+S G ++ LL GK P
Sbjct: 181 YIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 47/216 (21%), Positives = 80/216 (37%), Gaps = 28/216 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE-FEQHMEVLGRLRHPNLVGLKA 423
++LG+G ++ G + A+K + S + + EVL +L H N+V L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 424 YYFAREEKL--LVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
+ L+ E+ P GSL+ +L N L + L + G+ +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG----LPESEFLIVLRDVVGGMNHLR- 129
Query: 480 TCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLSIFAPPSTVPRSN----GYRAPEL 531
+ H NIK N++ D +++DFG + S Y P++
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 532 ------SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+K D++S GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 54/237 (22%)
Query: 366 EMLGKGGFGTAYKAVLDDG------SVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNL 418
+G+G FG ++A ++VAVK LK +AS + +F++ ++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR-------------------GPGRTPLD 459
V L + L+ EYM G L L PG PL
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPP 517
+L IA A G+A++ K H ++ + N L+ + +++DFGLS I+
Sbjct: 173 CAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY--- 225
Query: 518 STVPRSNGYR------------APELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCP 561
++ Y+ PE S + + +SDV+++GV+L E+ + G P
Sbjct: 226 ----SADYYKADGNDAIPIRWMPPE-SIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 42/216 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK--REFEQHMEVLGRLRHPN 417
LGKGGF ++ D V A K L K E + + L H +
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQH 102
Query: 418 LVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAF 476
+VG + F + + +V E SL L + R G +
Sbjct: 103 VVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRR---KALT-EPEAR-YYLRQIVLGCQY 156
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG----------- 525
+H ++ H ++K N+ L++ ++ DFGL +T +G
Sbjct: 157 LH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYDGERKKVLCGTPN 206
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ S + S + DV+S G ++ LL GK P
Sbjct: 207 YIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 31/216 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+ +G GG ++ + + + A+K L++A + + L +L+ + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 424 Y-YFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y Y ++ + +V E N L L + +D R + IH
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH--- 125
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-------SNGYRAPEL--- 531
+ H ++K N L+ G ++ DFG++ P T + Y PE
Sbjct: 126 -QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 532 ------SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ K S KSDV+S G +L + GK P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E++G G A VA+KR+ + E + ++ + + HPN+V +
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV---S 77
Query: 424 YY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFI 477
YY F +++L LV + + GS+ ++ G IA GL ++
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR---------- 527
H H ++K+ N+LL + G+ +++DFG+S F N R
Sbjct: 138 H----KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 528 APE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
APE + G K+D++SFG+ +EL TG P
Sbjct: 194 APEVMEQVRG--YDFKADIWSFGITAIELATGAAP 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 37/229 (16%)
Query: 353 KRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQH 406
R ED +L+ ++G+G FG + + + V A+K L + + E
Sbjct: 69 MRLHREDFEILK----VIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 407 ME---VLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
E VL + L Y F + L LV +Y G L LL ++ R P +
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMA- 177
Query: 463 RLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP 521
+ A + +H L H +IK N+L+D G+ R++DFG +
Sbjct: 178 --RFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 522 RSN---G---YRAPE--LSSSDGRKQSQKS-DVYSFGVLLLELLTGKCP 561
+S+ G Y +PE + G+ + D +S GV + E+L G+ P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 34/266 (12%), Positives = 78/266 (29%), Gaps = 47/266 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL---KDASIGGKREFEQHMEVLGRLR------- 414
+LG+ +A + G V + ++ ++ + L LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 415 ---------------HPNLVGLKAYYFAREEKLLVSEYM----PNGSLFWLLH--GNRGP 453
P + + ++S + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 454 GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513
L RL++ R LA +H L H ++ +++LD+ G ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 514 FAPPSTVPRSNG------YRAPEL---SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564
S V A + + D ++ G+ + + P+
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 565 DGGGAGMG--CGGAVDLPRWVQSVVR 588
D G ++P+ V++++
Sbjct: 320 DAALGGSEWIFRSCKNIPQPVRALLE 345
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG G FG YKA + G++ A K ++ S ++ +E+L HP +V L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFIHFTC 481
Y+ + ++ E+ P G++ ++ T +I L F+H
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEPQIQVVCRQMLEALNFLH--- 134
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR----------APEL 531
S ++ H ++K+ NVL+ G+ R++DFG+S + ++ R APE+
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 532 SSSDGRKQSQ---KSDVYSFGVLLLELLTGKCP 561
+ K + K+D++S G+ L+E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 349 FEGTKRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKRE 402
F+ + + +LRA +GKG FG K + D + A+K + + E
Sbjct: 6 FDENEDVNFDHFEILRA----IGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNE 58
Query: 403 FEQHM---EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPL 458
+++ L HP LV L Y F EE + +V + + G L + L +
Sbjct: 59 VRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKE 114
Query: 459 DWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518
+ T +L I L ++ + ++ H ++K N+LLD+ G+ ++DF ++ P
Sbjct: 115 E-TVKLFICE-LVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168
Query: 519 TVPRS----NGYRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
T + Y APE SS G S D +S GV ELL G+ P
Sbjct: 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 30/224 (13%)
Query: 352 TKRFELED--LLRASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM- 407
++ ED + +LG+G F T A A+K L+ I + +
Sbjct: 24 PRKKRPEDFKFGK----ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR 79
Query: 408 --EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
+V+ RL HP V L + F +EKL Y NG L + R G TR
Sbjct: 80 ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDET-CTRF 134
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRS 523
A L ++H + H ++K N+LL++ + +++DFG + + +P S R+
Sbjct: 135 -YTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 524 N---G---YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
N G Y +PEL + +S SD+++ G ++ +L+ G P
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAGLPP 231
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 47/263 (17%), Positives = 82/263 (31%), Gaps = 49/263 (18%)
Query: 347 VFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK 400
++F+G EL+ +G+G +G A+ ++ A+K +++ +
Sbjct: 14 LYFQGGSLLELQKKYHLKGA-IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 401 REFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFW--------------L 446
+ + ++ +L HPN+ L Y + LV E G L +
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 447 LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT-----------------CKSLKLTHG 489
P + + R + + H
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 490 NIKSTNVLLDKTGNARV--SDFGLSIFAPPSTVPRSN---------GYRAPELSSSDGRK 538
+IK N L + + DFGLS + APE+ ++
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
K D +S GVLL LL G P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 31/216 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+ +G GG ++ + + + A+K L++A + + L +L+ + ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 424 Y-YFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
Y Y ++ + +V E N L L + +D R + IH
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH--- 172
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-------SNGYRAPEL--- 531
+ H ++K N L+ G ++ DFG++ P T + Y PE
Sbjct: 173 -QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 532 ------SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ K S KSDV+S G +L + GK P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 40/227 (17%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKR-LKDASIGGKREFEQHMEVLGRL-RHPNLVGLKA 423
++LG G GT G VAVKR L D E +++L HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESDDHPNVIRYYC 76
Query: 424 YYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ E N +L L+ + + A G+A +H
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 482 KSLKLTHGNIKSTNVLLDKTG-------------NARVSDFGLS-IFAPPSTVPRSN--- 524
SLK+ H ++K N+L+ + +SDFGL + R+N
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 525 -----GYRAPEL-----SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G+RAPEL + R+ ++ D++S G + +L+
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 4e-22
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 367 MLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLK 422
+LGKGGFG V G + A K+L+ I ++ + ++L ++ +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFT 480
Y + ++ L LV M G L + ++ + G P R AA GL +H
Sbjct: 251 -YAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEA---RAVFYAAEICCGLEDLH-- 303
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRS----NGYRAPELSSSDG 536
++ + ++K N+LLD G+ R+SD GL++ P + GY APE+ ++
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCP 561
S D ++ G LL E++ G+ P
Sbjct: 362 YTFS--PDWWALGCLLYEMIAGQSP 384
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 56/235 (23%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKA---VLDDGSVVAVKRLK-----DASIGGKREFEQ 405
R+EL E+LG GG + A VAVK L+ D S F +
Sbjct: 13 RYELG-------EILGFGGMSEVHLARDLRDH--RDVAVKVLRADLARDPSF--YLRFRR 61
Query: 406 HMEVLGRLRHPNLV-----------GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG 454
+ L HP +V Y +V EY+ +L ++H
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTEG--- 111
Query: 455 RTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514
P+ +++ A A + L F H + H ++K N+++ T +V DFG++
Sbjct: 112 --PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 515 APPSTVPRSNG--------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
S + Y +PE + G +SDVYS G +L E+LTG+ P
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 367 MLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHME---VLGRLRHPNLVGLK 422
++G+G F + G V A+K + + + E E VL + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFT 480
+ F E L LV EY G L LL ++ R P + + A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMA---RFYLAEIVMAIDSVH-- 179
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN---G---YRAPELSSS 534
L H +IK N+LLD+ G+ R++DFG + RS G Y +PE+ +
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 535 DGRKQSQKS-----DVYSFGVLLLELLTGKCP 561
G S D ++ GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 38/223 (17%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKA---VLDDGSVVAVKRLKDASIGGKREFEQHME-- 408
+ L L+ G+GG G Y+A V + +VA+K + ++ F M+
Sbjct: 35 PYRLRRLV-------GRGGMGDVYEAEDTVRE--RIVALKLMS-ETLSSDPVFRTRMQRE 84
Query: 409 --VLGRLRHPNLVGLKAYYFAREEKL--LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
GRL+ P++V + + F + + + L +L + PL +
Sbjct: 85 ARTAGRLQEPHVVPI--HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAV 137
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN 524
I L H + TH ++K N+L+ A + DFG++ + +
Sbjct: 138 AIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193
Query: 525 G------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE S + ++D+Y+ +L E LTG P
Sbjct: 194 NTVGTLYYMAPERFS--ESHATYRADIYALTCVLYECLTGSPP 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 7e-22
Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 350 EGTKRFELEDLLRASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLK-DASIGGKREFEQHM 407
+ + +D + LG G G +K G V+A K + + + + + +
Sbjct: 25 QKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 82
Query: 408 EVLGRLRHPNLVGLKAYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
+VL P +VG +Y F + ++ + E+M GSL +L + GR P
Sbjct: 83 QVLHECNSPYIVG---FYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILG-- 134
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---TVP 521
K++ +GL ++ + K+ H ++K +N+L++ G ++ DFG+S S +
Sbjct: 135 KVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ Y +PE G S +SD++S G+ L+E+ G+ P
Sbjct: 192 GTRSYMSPER--LQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 359 DLLRASAEMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLR 414
R +LG+GGFG + + G + A K+L + ++ ++ M ++L ++
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 415 HPNLVGLKAYYFAREEKL-LVSEYMPNGSLFW-LLHGNRGPGRTPLDWTTRLKI-AAGAA 471
+V L Y F + L LV M G + + + + + R A
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTAQIV 299
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI-FAPPSTVPRS----NGY 526
GL +H + + ++K NVLLD GN R+SD GL++ T + G+
Sbjct: 300 SGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
APEL + S D ++ GV L E++ + P
Sbjct: 356 MAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 8e-22
Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 27/213 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE-FEQHMEVLGRLRHPNLVGL-- 421
E LG GGFG + + D G VA+K+ + RE + ++++ +L HPN+V
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 422 ----KAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAARGLA 475
+ LL EY G L L N L + + + L
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG----LKEGPIRTLLSDISSALR 135
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNAR---VSDFGLSIFAPPSTVPRSN----GYRA 528
++H ++ H ++K N++L + D G + + Y A
Sbjct: 136 YLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PEL +K + D +SFG L E +TG P
Sbjct: 192 PELLE--QKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-22
Identities = 32/145 (22%), Positives = 51/145 (35%), Gaps = 11/145 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFN 124
L +L + L+P L L+VL+L++N + + + T L L L N+
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ 110
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG----PITGLDL 180
+ L LDLS N S T L +L L L N+ +
Sbjct: 111 KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFP 205
+L+ +S N + P
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIG 195
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-21
Identities = 35/175 (20%), Positives = 62/175 (35%), Gaps = 9/175 (5%)
Query: 49 NSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP- 105
S + T VS + + L L ++S ++ + L L VL L N +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 106 -SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSG--QIPLTVNHLTHLL 162
L + ++LS+N + +S + + L RL L P L +L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 163 TLKLEANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
L L N + + L L+ ++ N+L+ + G P + L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 32/140 (22%), Positives = 49/140 (35%), Gaps = 6/140 (4%)
Query: 72 LENLQLSG-SLQ--PLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEF 127
E S L P T + VL+L +N+ P + + + L L + N +
Sbjct: 6 HEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRNLQD 185
P+ L L L+L N S T T+L L L +N +NL
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 186 FNVSGNHLSGQIPKSLSGFP 205
++S N LS +
Sbjct: 126 LDLSHNGLSSTKLGTQVQLE 145
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 16/150 (10%)
Query: 72 LENLQLSG------SLQPLTSLTQLRVLSLKYNRFTGPVP---SLSNLTALKLLFLSHNN 122
L L LS L L L+ L L N+ + ++LK L LS N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV---NHLTHLLTLKLEANRFSGPI---- 175
P ++ RL+ L L+ + + T + L L ++ S
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 176 TGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
GL NL ++S N+L+ S + P
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLP 272
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-19
Identities = 28/150 (18%), Positives = 54/150 (36%), Gaps = 14/150 (9%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L L L ++ L L L +N + + + L L+ L LS+N
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 125 GEFPD--SVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT-----G 177
+ + + L +L+LS N P + + L L L + +T
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 178 LDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
L ++++ ++S + LS + G +
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-19
Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 27/174 (15%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFT---------GPVPSLSNLTALKLL 116
L L LS ++ L L +L +L L++N GP+ L L+ L +L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT 176
L N F+ + LF L +DL NN + N+ L +L L+ N +
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 177 GL---DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNA--------ALCGSP 219
+ RNL + ++ N S++ F + + LC +P
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCE-SIAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-19
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 66 RVSHLVLENLQLSGSLQP----LTSLTQLRVLSLKYNRFTGPVP-SLSNL--TALKLLFL 118
R+ L L N+QL SL + T +R LSL ++ + + L T L +L L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP---- 174
S+NN N DS + L +L L +NN +++ L ++ L L+ +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 175 -ITGLD------LRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ +D L+ L+ N+ N + G +G
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 33/173 (19%), Positives = 50/173 (28%), Gaps = 32/173 (18%)
Query: 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNF 123
N + HL +L +++ L S+ S L L+ L + N+
Sbjct: 282 NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341
Query: 124 NGEFPDSVSSLFRLYRLDLS----------------------------FNNFSGQIPLTV 155
G + + L L L LS N S
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401
Query: 156 NHLTHLLTLKLEANRFSGPITG---LDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ L HL L L N +TG L N+ + +S N S + P
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVP 454
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 38/230 (16%)
Query: 350 EGTKRFELED--LLRASAEMLGKGGFGTAY----KAVLDDGSVVAVKRLKDASIGGKREF 403
EG ++ + LL+ +LG+G FG + + D + A+K LK A++ +
Sbjct: 16 EGHEKADPSQFELLK----VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 404 EQHME--VLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDW 460
ME +L + HP +V L Y F E KL L+ +++ G LF L +
Sbjct: 72 RTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEED 127
Query: 461 TTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAP 516
K A A L +H SL + + ++K N+LLD+ G+ +++DFGLS I
Sbjct: 128 V---KFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180
Query: 517 PSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ + R +Q +D +SFGVL+ E+LTG P
Sbjct: 181 KKAYSFCGTVE---YMAPEV--VNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 37/220 (16%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAVLD---DGSVVAVKRLKDAS-IGGKREFEQHMEV 409
++E++ + GG G Y A+ D +G V +K L + + +
Sbjct: 81 QYEVK-------GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF 132
Query: 410 LGRLRHPNLVGLKAYYFAREEKL-------LVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
L + HP++V + + F +V EY+ SL L
Sbjct: 133 LAEVVHPSIVQI--FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAE 183
Query: 463 RLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL-SIFAPPSTVP 521
+ L+++H S+ L + ++K N++L + ++ D G S +
Sbjct: 184 AIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY 238
Query: 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ G++APE+ + + +D+Y+ G L L
Sbjct: 239 GTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPT 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-21
Identities = 49/220 (22%), Positives = 81/220 (36%), Gaps = 38/220 (17%)
Query: 366 EMLGKG--GFGTAYKAV-LDDGSVVAVKR--LKDASIGGKREFEQHMEVLGRLRHPNLVG 420
++GKG T A G V V+R L+ S + + V HPN+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV- 89
Query: 421 LKAYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGL 474
Y F + +L +V+ +M GS L+ IA G + L
Sbjct: 90 --PYRATFIADNELWVVTSFMAYGSAKDLIC-THFMDGMNELA-----IAYILQGVLKAL 141
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR------- 527
+IH + H ++K++++L+ G +S + + S R
Sbjct: 142 DYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSN-LSMISHGQRQRVVHDFPKYSV 196
Query: 528 ------APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+PE+ + + KSD+YS G+ EL G P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-21
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 350 EGTKRFELED--LLRASAEMLGKGGFGTAYKA-VLDDGSVVAVKRLKDASIGGKREFEQH 406
E + D + R ++G+GGFG Y D G + A+K L I K+
Sbjct: 181 ELNIHLTMNDFSVHR----IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA 236
Query: 407 M------EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD 459
+ ++ P +V + Y F +KL + + M G L + L + G
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEA 292
Query: 460 WTTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518
++ AA GL +H + + + ++K N+LLD+ G+ R+SD GL+
Sbjct: 293 ---DMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
Query: 519 TVPRS----NGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P + +GY APE+ G +D +S G +L +LL G P
Sbjct: 346 K-PHASVGTHGYMAPEV-LQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
E +GKG FG +K + VVA+K + + + + +Q + VL + P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT---K 84
Query: 424 YY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFI 477
YY + ++ KL ++ EY+ GS LL PLD +IA +GL ++
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLD---ETQIATILREILKGLDYL 135
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR---------- 527
H S K H +IK+ NVLL + G +++DFG++ + + R
Sbjct: 136 H----SEKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWM 186
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
APE+ K+D++S G+ +EL G+ P
Sbjct: 187 APEVIKQSA--YDSKADIWSLGITAIELARGEPP 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 352 TKRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQ 405
R + ED +++ ++G+G FG + L V A+K L + + +
Sbjct: 63 DLRMKAEDYEVVK----VIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115
Query: 406 HME---VLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
E ++ P +V L Y F + L +V EYMP G L L+ P W
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWA 170
Query: 462 TRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520
+ A L IH S+ H ++K N+LLDK+G+ +++DFG + +
Sbjct: 171 ---RFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 521 PRSN---G---YRAPE-LSSSDGRKQSQKS-DVYSFGVLLLELLTGKCP 561
R + G Y +PE L S G + D +S GV L E+L G P
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 67/269 (24%), Positives = 107/269 (39%), Gaps = 35/269 (13%)
Query: 309 WRNYVKNKTRSKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELED--LLRASAE 366
W ++ ++ + S P+ +G E + + R + + L+
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK---- 154
Query: 367 MLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHPNLVGLK 422
+LGKG FG G A+K LK I K E + VL RHP L LK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 423 AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFT 480
Y F ++L V EY G LF+ L R D R + A L ++H
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRER---VFSED---RARFYGAEIVSALDYLH-- 265
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTV-----PRSNGYRAPELS 532
+ + ++K N++LDK G+ +++DFGL I + P Y APE+
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE---YLAPEVL 321
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ D + GV++ E++ G+ P
Sbjct: 322 E--DNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 350 EGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHM 407
E F EDL +G+G +G+ K V G ++AVKR++ +++ +
Sbjct: 14 EQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 408 EVLGRL-RHPNLVGLKAYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+V+ R P +V +Y RE + E M + S +
Sbjct: 72 DVVMRSSDCPYIVQ---FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL 127
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-----IFAPPS 518
KI + L + ++LK+ H +IK +N+LLD++GN ++ DFG+S A
Sbjct: 128 GKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 519 TVPRSNG---YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G Y APE S+ + +SDV+S G+ L EL TG+ P
Sbjct: 185 DA----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 32/226 (14%), Positives = 61/226 (26%), Gaps = 54/226 (23%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKA---VLDDGSVVAVKRLK---DASIGGKREFEQHM 407
R+ L G ++A LD VA+ + +E
Sbjct: 32 RYRLL-------IFHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRT 82
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKL--LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK 465
L R+ P + + +V+E++ GSL + + P ++
Sbjct: 83 LRLSRIDKPGVARV--LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-------IR 133
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG 525
A H + + V + G+ ++ P + P+
Sbjct: 134 AMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA---TMPDAN-PQD-- 183
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM 571
D+ G L LL + P G +G+
Sbjct: 184 ------------------DIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 37/213 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFE---QHMEVLGRLRHPNLVGL 421
+G G FG Y A + + VVA+K++ + +++ + + L +LRHPN +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI-- 117
Query: 422 KAYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLA 475
Y + RE LV EY GS LL ++ P ++IAA GA +GLA
Sbjct: 118 -QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-------LQEVEIAAVTHGALQGLA 168
Query: 476 FIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAP 529
++H S + H ++K+ N+LL + G ++ DFG + S + +N + AP
Sbjct: 169 YLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAP 219
Query: 530 ELSSSDGRKQ-SQKSDVYSFGVLLLELLTGKCP 561
E+ + Q K DV+S G+ +EL K P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E +G+G GT Y A+ + G VA++++ K + V+ ++PN+V Y
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV---NY 82
Query: 425 Y--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ ++L +V EY+ GSL ++ T +D + + L F+H
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFG----LSIFAPPSTVPRSN---G---YRAPEL 531
S ++ H +IKS N+LL G+ +++DFG ++ + + G + APE+
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-----PEQSKRSTMVGTPYWMAPEV 187
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ K D++S G++ +E++ G+ P
Sbjct: 188 VTRKA--YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 53/231 (22%), Positives = 94/231 (40%), Gaps = 45/231 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKREFEQHME----------- 408
+ +GKG +G A +D + A+K +L + +R +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 409 ----------VLGRLRHPNLVGLK-AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRT 456
+L +L HPN+V L E+ L +V E + G + + P
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLK 132
Query: 457 PLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFA 515
PL +G+ ++H K+ H +IK +N+L+ + G+ +++DFG+S F
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 516 PP----STVPRSNGYRAPELSSSDGRKQS-QKSDVYSFGVLLLELLTGKCP 561
S + + APE S + S + DV++ GV L + G+CP
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 47/234 (20%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVL 410
FEL E++G G +G YK + G + A+K + D + + E +Q + +L
Sbjct: 23 AGIFELV-------ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINML 74
Query: 411 GRL-RHPNLVG-----LKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ H N+ +K +++L LV E+ GS+ L+ +G +W
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEW--- 130
Query: 464 LKIAA---GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520
IA RGL+ +H K+ H +IK NVLL + ++ DFG+S + +
Sbjct: 131 --IAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQL 179
Query: 521 PRSNGYR----------APELSSSDGRKQS---QKSDVYSFGVLLLELLTGKCP 561
R+ G R APE+ + D + KSD++S G+ +E+ G P
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 356 ELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQ-HME---VL 410
+LE + LG+G +G K + G ++AVKR+ + +E ++ M+ +
Sbjct: 8 DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISM 60
Query: 411 GRLRHPNLVGLKAYY--FAREEKL-LVSEYMPNGSLFWLL-HGNRGPGRTPLDWTTRLKI 466
+ P V +Y RE + + E M + SL P D KI
Sbjct: 61 RTVDCPFTVT---FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--KI 114
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-- 524
A + L +H L + H ++K +NVL++ G ++ DFG+S + +
Sbjct: 115 AVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG 171
Query: 525 --GYRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE + + S KSD++S G+ ++EL + P
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 45/219 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE--------FEQHMEVLGRLRHP 416
+ LG G G A VA++ + E +E+L +L HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 417 NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAA 471
++ +K ++ A E+ +V E M G LF D
Sbjct: 201 CIIKIKNFFDA-EDYYIVLELMEGGELF--------------DKVVGNKRLKEATCKLYF 245
Query: 472 R----GLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPSTVPR-- 522
+ ++H + H ++K NVLL ++ +++DFG S +++ R
Sbjct: 246 YQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 523 --SNGYRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+ Y APE L S ++ D +S GV+L L+G
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 53/219 (24%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGG-KREFEQHMEVLGRLRHPNLVG 420
+GKG F A + G VA+K +L S+ RE + ++ L HPN+V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHPNIVK 78
Query: 421 LKAYY--FAREEKL-LVSEYMPNGSLF--WLLHGNRGPGRTPLDWTTRLKIAAGAAR--- 472
L + E+ L L+ EY G +F + HG R+K AR
Sbjct: 79 L---FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------------RMK--EKEARSKF 120
Query: 473 -----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG- 525
+ + H ++ H ++K+ N+LLD N +++DFG S F + G
Sbjct: 121 RQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGA 176
Query: 526 --YRAPELSSSDGRK-QSQKSDVYSFGVLLLELLTGKCP 561
Y APEL G+K + DV+S GV+L L++G P
Sbjct: 177 PPYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 42/227 (18%)
Query: 354 RFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHM 407
+ + D L+ +LGKG FG K +L G A+K L+ I K E +
Sbjct: 1 KVTMNDFDYLK----LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 408 ---EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
VL RHP L LK Y F ++L V EY G LF+ L + R
Sbjct: 54 TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEE---R 106
Query: 464 LKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPST 519
+ A L ++H S + + +IK N++LDK G+ +++DFGL I +
Sbjct: 107 ARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 520 V-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P Y APE+ + D + GV++ E++ G+ P
Sbjct: 163 KTFCGTPE---YLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 47/207 (22%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+G+G G A G VAVK + + + ++ +H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
Y EE ++ E++ G+L ++ + L+ + + LA++H +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLH----AQ 160
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFG----LSIFAPPSTVPRSN---G---YRAPELSSS 534
+ H +IKS ++LL G ++SDFG +S VP+ G + APE+ S
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-----KDVPKRKSLVGTPYWMAPEVISR 215
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + D++S G++++E++ G+ P
Sbjct: 216 SL--YATEVDIWSLGIMVIEMVDGEPP 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 356 ELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRL 413
+LE+L +G G G +K G V+AVK+++ + + ++V+ +
Sbjct: 26 DLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 414 -RHPNLVGLKAYY--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG 469
P +V + F + + E M + R G P K+
Sbjct: 81 HDCPYIVQ---CFGTFITNTDVFIAMELMGTCAEKLKK---RMQGPIPERILG--KMTVA 132
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSN--- 524
+ L ++ + + H ++K +N+LLD+ G ++ DFG+S + +
Sbjct: 133 IVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAG 186
Query: 525 --GYRAPE---LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE ++DV+S G+ L+EL TG+ P
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 35/161 (21%), Positives = 58/161 (36%), Gaps = 7/161 (4%)
Query: 50 STSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG--PVPSL 107
S S CS++ + R HL L L +L+ L +++ +
Sbjct: 363 SFSGCCSYSDLGTNSLR--HLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 108 SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKL 166
+L L L +S+ N +F L L L ++ N+F V + T+L L L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 167 EANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ G+ L LQ N+S N+L +
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-19
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 10/149 (6%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
+N+ LS L+ ++ ++L+ L L + L L L L+ N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG---PITGLDLR 181
P S S L L L + + L L L + N P +L
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210
NL ++S N++ L ++
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQV 182
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 28/143 (19%), Positives = 45/143 (31%), Gaps = 6/143 (4%)
Query: 69 HLVLENLQLSG--SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG 125
HL ++ L SL +L L + Y LT+L L ++ N+F
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 126 EFPDSV-SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRN 182
+V ++ L LDLS + L L L + N + L +
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 183 LQDFNVSGNHLSGQIPKSLSGFP 205
L + S N +
Sbjct: 523 LSTLDCSFNRIETSKGILQHFPK 545
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 36/162 (22%), Positives = 49/162 (30%), Gaps = 7/162 (4%)
Query: 49 NSTSDPCSWTGVSCLQN-RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSL 107
N S + L +S L S L LR L L +N +
Sbjct: 338 NKGSISFKKVALPSLSYLDLSRNALSFSG-CCSYSDL-GTNSLRHLDLSFNGAIIMSANF 395
Query: 108 SNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL 166
L L+ L H+ S SL +L LD+S+ N LT L TLK+
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455
Query: 167 EANRFSGPITGL---DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
N F + NL ++S L
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 35/157 (22%), Positives = 54/157 (34%), Gaps = 12/157 (7%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFT 101
+ L ++ ++ + L +L + LT L L + N F
Sbjct: 409 STLK---RVTEFSAFLSLEKLL----YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 102 GPVPS--LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLT 159
S +N T L L LS +L RL L++S NN N L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 160 HLLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHLS 194
L TL NR L ++L FN++ N ++
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 30/144 (20%), Positives = 52/144 (36%), Gaps = 9/144 (6%)
Query: 71 VLENLQLSGSLQPLTSL-----TQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
V+ N+ Q L+ + + + + L +N S SN + L+ L LS
Sbjct: 10 VVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRN 182
+ L L L L+ N P + + LT L L + + + L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 183 LQDFNVSGNHLSG-QIPKSLSGFP 205
L+ NV+ N + ++P S
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLT 153
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 35/143 (24%), Positives = 52/143 (36%), Gaps = 13/143 (9%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L NL L+G S P + LT L L + + L LK L ++HN +
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 125 G-EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHL----LTLKLEANRFSG-PITGL 178
+ P S+L L +DLS+N + L L+L + N
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201
Query: 179 DLRNLQDFNVSGNHLSGQIPKSL 201
L + + GN S I K+
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 22/143 (15%), Positives = 42/143 (29%), Gaps = 7/143 (4%)
Query: 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHN 121
+ + ++ L + + L Y L + + L+
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR 181
+ + + V F+ L + L L +L L N+ S + L
Sbjct: 296 SIK--YLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGSISFKKVALP 350
Query: 182 NLQDFNVSGNHLSGQIPKSLSGF 204
+L ++S N LS S S
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDL 373
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 35/144 (24%), Positives = 53/144 (36%), Gaps = 9/144 (6%)
Query: 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSH 120
CL N VS + L + + L+ + + + LS+ + P+L +L LK L L+
Sbjct: 282 HCLAN-VSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQ-FPTL-DLPFLKSLTLTM 337
Query: 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHL--THLLTLKLEANRFSGPITGL 178
N + +L L LDLS N S + + L L L L N
Sbjct: 338 NKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANF 395
Query: 179 -DLRNLQDFNVSGNHLSGQIPKSL 201
L LQ + + L S
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSA 419
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 24/171 (14%), Positives = 46/171 (26%), Gaps = 16/171 (9%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLT-SLTQLRVLSLKYNRFT 101
N + T + L + + +Q +L L+L+ N +
Sbjct: 163 NYIQT----ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNS 217
Query: 102 GPVP--SLSNLTALKLLFLSHNNFNGEF------PDSVSSLFRLYR--LDLSFNNFSGQI 151
+ L NL L + L F E P + L + L++ N
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277
Query: 152 PLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+ + L ++ + L Q ++ L L
Sbjct: 278 IVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLP 328
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 44/221 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHME----VLGRLRHPNLVG 420
++LG+G +G + + + AVK LK + E +++ +L RLRH N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 421 LK-AYYFAREEKL-LVSEYMPNGS--LF-WLLHGNRGPGRTPLDWTTRLKIAAGAAR--- 472
L Y ++K+ +V EY G + + R + A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-------------RFPVCQ--AHGYF 115
Query: 473 -----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR----- 522
GL ++H S + H +IK N+LL G ++S G++ P
Sbjct: 116 CQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 523 --SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
S ++ PE+++ K D++S GV L + TG P
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 350 EGTKRFELED--LLRASAEMLGKGGFGTAY----KAVLDDGSVVAVKRLKDASIGGKREF 403
G ++ E LLR +LGKGG+G + + G + A+K LK A I +
Sbjct: 9 RGPEKIRPECFELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 404 EQHM----EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPL 458
H +L ++HP +V L Y F KL L+ EY+ G LF L G
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE---GIFME 120
Query: 459 DWTTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IF 514
D A + L +H + + ++K N++L+ G+ +++DFGL I
Sbjct: 121 D---TACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173
Query: 515 APPSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
T Y APE+ G ++ D +S G L+ ++LTG P
Sbjct: 174 DGTVTHTFCGTIE---YMAPEILMRSGHNRA--VDWWSLGALMYDMLTGAPP 220
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-19
Identities = 29/158 (18%), Positives = 54/158 (34%), Gaps = 16/158 (10%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGE 126
L L L+ + +L L L YN+ P + ++ L SHN
Sbjct: 575 LGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-Y 633
Query: 127 FPDSVS--SLFRLYRLDLSFNNFSGQIP-----LTVNHLTHLLTLKLEANRFSGPITGL- 178
P+ + S++ + +D S+N + + + T+ L N T L
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 179 -DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
+ +S N ++ IP++ D + L
Sbjct: 694 ATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 6e-19
Identities = 36/205 (17%), Positives = 58/205 (28%), Gaps = 25/205 (12%)
Query: 23 ASTSPDLNALLDFKASSDEAN------------KLTTWNSTSDPCSW---TGVSCLQN-R 66
A D AL + D N WN + W GV N R
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR 324
Query: 67 VSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTG--PVPSLSNLTALKLLFLSHNNF 123
V+ L L G + + LT+L+VLS + T + LT H
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLT-VNHLTHLLTLKLEANRFSGPITGL---- 178
+ RL DL + + + + + + + + IT +
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAI 444
Query: 179 -DLRNLQDFNVSGNHLSGQIPKSLS 202
L LQ + + +
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDW 469
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 29/208 (13%), Positives = 64/208 (30%), Gaps = 20/208 (9%)
Query: 7 LHFTLLILAVHFSLLKASTSPD-LNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQN 65
T + ++ L+ S + + + +S
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
++ +L +++ + + LT+L+++ + FT ++ + +
Sbjct: 429 QIGNL---TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD----WEDANSDYAKQYE 481
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD------ 179
S S+L L ++L Q+P + L L +L + NR
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 180 -----LRNLQDFNVSGNHLSGQIPKSLS 202
+Q F + N+L P S S
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASAS 568
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 22/154 (14%), Positives = 43/154 (27%), Gaps = 9/154 (5%)
Query: 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG--PVPSLSNLTALKLLFLSHN 121
NR + + ++++ + YN SL + L LL HN
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSG---PITG 177
++ + +L L L +N +IP + L N+
Sbjct: 584 KV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNA 640
Query: 178 LDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQ 211
+ + + S N + + D
Sbjct: 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 9e-17
Identities = 23/180 (12%), Positives = 49/180 (27%), Gaps = 24/180 (13%)
Query: 43 NKLTT-----WNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP--LTSLTQLRVLSL 95
N+ + + T +Q + L L + +L +L
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQ----IFYMGYNNLEEFPASASLQKMVKLGLLDC 580
Query: 96 KYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFR-LYRLDLSFNNFSGQIP-- 152
+N+ + + L L L +N E P+ + + L S N IP
Sbjct: 581 VHNKVRH-LEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 153 LTVNHLTHLLTLKLEANRFSG-------PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ + ++ N+ + N +S N + + +
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 24/154 (15%), Positives = 47/154 (30%), Gaps = 24/154 (15%)
Query: 72 LENLQLSG-------SLQPLTSLTQLRVLSLKYNRFTGPVPSLS------NLTALKLLFL 118
+E L S ++ S+ + + YN+ ++S + L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFS-------GQIPLTVNHLTHLLTLKLEANRF 171
S+N + ++ + + LS N + + L T+ L N+
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 172 SG---PITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
+ L L + +VS N S P
Sbjct: 741 TSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 22/162 (13%), Positives = 50/162 (30%), Gaps = 8/162 (4%)
Query: 49 NSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFT-----GP 103
+S + G L +S +++ L +L + L + P
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416
Query: 104 VPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163
+ S ++ + N ++ L +L + + + F+ +
Sbjct: 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476
Query: 164 LKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
K N ++ +L++L D + Q+P L P
Sbjct: 477 AKQYENE---ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 26/150 (17%), Positives = 48/150 (32%), Gaps = 23/150 (15%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSG-SLQ------PLTSLTQLRVLSL 95
N +T+ S L + L L T+L L + +
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYL------LTTIDLRFNKLTSLSDDFRATTLPYLSNMDV 760
Query: 96 KYNRFTGPVPSLSNLTALKLLFLSH------NNFNGEFPDSVSSLFRLYRLDLSFNNFSG 149
YN F+ N + LK + H N ++P +++ L +L + N+
Sbjct: 761 SYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
Query: 150 QIPLTVNHLTHLLTLKLEANRF-SGPITGL 178
+ + L L + N S +T +
Sbjct: 821 -VDEKL--TPQLYILDIADNPNISIDVTSV 847
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 11/91 (12%), Positives = 28/91 (30%), Gaps = 2/91 (2%)
Query: 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PIT 176
+ + + + + R+ L L+ G++P + LT L L + + +
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 177 GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
G + + + K +
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 27/208 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E LG G FG ++ V G V K + K + + ++ +L HP L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 425 YFAREEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFIHF 479
+ + E +L+ E++ G LF + + + R GL +H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAE-------VINYMRQACEGLKHMH- 166
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARV--SDFGLSIFAPPSTVPRSN----GYRAPELSS 533
+ H +IK N++ + + V DFGL+ P + + + APE+
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ +D+++ GVL LL+G P
Sbjct: 224 REP--VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 40/213 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E LG+G +G+ YKA+ + G +VA+K++ S +E + + ++ + P++V Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVV---KY 89
Query: 425 Y--FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA---GAARGLAFIH 478
Y + + L +V EY GS+ ++ T +IA +GL ++H
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-------LTEDEIATILQSTLKGLEYLH 142
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYR----------A 528
++ H +IK+ N+LL+ G+A+++DFG++ + + R A
Sbjct: 143 ----FMRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFWMA 193
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
PE+ G + +D++S G+ +E+ GK P
Sbjct: 194 PEVIQEIG--YNCVADIWSLGITAIEMAEGKPP 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
M G+G FGT G VA+K++ RE Q M+ L L HPN+V L++Y
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSY 87
Query: 425 YFAREEK-------LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL---KIAAGAARGL 474
++ E+ +V EY+P+ +L P ++ ++ R +
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL----IRSI 142
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLS-IFAP--PST---VPRSNGYR 527
+H S+ + H +IK NVL+++ G ++ DFG + +P P+ R YR
Sbjct: 143 GCLH--LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--YR 198
Query: 528 APEL--SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
APEL + + D++S G + E++ G+
Sbjct: 199 APELIFGNQH---YTTAVDIWSVGCIFAEMMLGE 229
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 9/131 (6%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L +L L+ +L PL+ LT+L L L N+ + + L+ LTAL L L+ N
Sbjct: 245 LTDLDLANNQISNLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLED-- 301
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
+S+L L L L FNN S P+ + LT L L N+ S + +L N+ +
Sbjct: 302 ISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKVSDVSSLANLTNINWLS 359
Query: 188 VSGNHLSGQIP 198
N +S P
Sbjct: 360 AGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 36/135 (26%), Positives = 54/135 (40%), Gaps = 9/135 (6%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L+L ++ PL LT L L L N+ + +SNL L L L NN +
Sbjct: 267 LTELKLGANQISNISPLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDIS 325
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
P VSSL +L RL N S L +LT++ L N+ S +L +
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSDVSSLA--NLTNINWLSAGHNQISDLTPLANLTRITQLG 381
Query: 188 VSGNHLSGQIPKSLS 202
++ + +
Sbjct: 382 LNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-16
Identities = 42/131 (32%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L+LS + L+ LT L+ LS N+ T P L+NLT L+ L +S N +
Sbjct: 136 LNRLELSSNTISDISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKVSD-- 191
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
++ L L L + N S PL LT+L L L N+ T L NL D +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGTLASLTNLTDLD 249
Query: 188 VSGNHLSGQIP 198
++ N +S P
Sbjct: 250 LANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 35/127 (27%), Positives = 54/127 (42%), Gaps = 8/127 (6%)
Query: 72 LENLQLSG---SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
L+ L L+PL +LT L L + N+ + L+ LT L+ L ++N + P
Sbjct: 158 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-SVLAKLTNLESLIATNNQISDITP 216
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNV 188
+ L L L L+ N I T+ LT+L L L N+ S L L + +
Sbjct: 217 --LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKL 272
Query: 189 SGNHLSG 195
N +S
Sbjct: 273 GANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 30/127 (23%), Positives = 57/127 (44%), Gaps = 7/127 (5%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L L + P++SLT+L+ L N+ + SL+NLT + L HN +
Sbjct: 311 LTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLT 369
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
P +++L R+ +L L+ ++ +++ T+K P T D + + +
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPD 427
Query: 188 VSGNHLS 194
++ N S
Sbjct: 428 ITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-15
Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 6/127 (4%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
VL ++ T L Q+ L + L L + S+N
Sbjct: 28 KTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTD--I 83
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNV 188
+ +L +L + ++ N + PL +LT+L L L N+ + +L NL +
Sbjct: 84 TPLKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 141
Query: 189 SGNHLSG 195
S N +S
Sbjct: 142 SSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-15
Identities = 24/129 (18%), Positives = 49/129 (37%), Gaps = 6/129 (4%)
Query: 70 LVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPD 129
+ ++ ++ + T+L + L T V ++L + L D
Sbjct: 7 TITQDTPIN-QIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKS--ID 62
Query: 130 SVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVS 189
V L L +++ S N + PL +LT L+ + + N+ + +L NL +
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLF 120
Query: 190 GNHLSGQIP 198
N ++ P
Sbjct: 121 NNQITDIDP 129
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 352 TKRFELED--LLRASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHM- 407
+L+ ++ LG G FG + G+ A+K L + ++ E H
Sbjct: 35 QNTAQLDQFDRIK----TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTL 89
Query: 408 ---EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+L + P LV L+ + F L +V EY+ G +F L R GR R
Sbjct: 90 NEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEP-HAR 144
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST---- 519
AA ++H SL L + ++K N+L+D+ G +V+DFG + T
Sbjct: 145 F-YAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199
Query: 520 -VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P APE+ S G ++ D ++ GVL+ E+ G P
Sbjct: 200 GTPE---ALAPEIILSKGYNKA--VDWWALGVLIYEMAAGYPP 237
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 36/209 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E+LG G F + G + A+K +K + E + VL +++H N+V L+
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----GLA 475
Y + LV + + G LF D K A+ + +
Sbjct: 75 YESTTHYYLVMQLVSGGELF--------------DRILERGVYTEKDASLVIQQVLSAVK 120
Query: 476 FIHFTCKSLKLTHGNIKSTNVLL-DKTGNARV--SDFGLSIFAPPS---TVPRSNGYRAP 529
++H + H ++K N+L N+++ +DFGLS T + GY AP
Sbjct: 121 YLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAP 176
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
E+ + S+ D +S GV+ LL G
Sbjct: 177 EVLAQKPY--SKAVDCWSIGVITYILLCG 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E+LG G FG +K G +A K +K + K E + + V+ +L H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 425 YFAREEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFIHF 479
+ ++ + +LV EY+ G LF ++ T LD + G+ +H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIID--ESYNLTELD-------TILFMKQICEGIRHMH- 204
Query: 480 TCKSLKLTHGNIKSTNVLL-DKTGNA-RVSDFGLSIFAPPSTVPRSN----GYRAPELSS 533
+ + H ++K N+L ++ ++ DFGL+ P + N + APE+ +
Sbjct: 205 ---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
D S +D++S GV+ LL+G P
Sbjct: 262 YDF--VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE--FEQHMEVLGRLRHPNLVGLK 422
+ LG G +G A+K ++ S+ + + VL L HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
++ + LV E G LF + R + I G+ ++H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVTYLH---- 153
Query: 483 SLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPR----SNGYRAPELSSSD 535
+ H ++K N+LL K +A ++ DFGLS + + Y APE+
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-- 211
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
+K +K DV+S GV+L LL G P
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 9/128 (7%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L +L++ L PL +L+QL L + N+ + + ++ +LT LK+L + N +
Sbjct: 223 LNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISD-- 279
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLRNLQDF 186
+++L +L L L+ N + + LT+L TL L N + I L L +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSA 338
Query: 187 NVSGNHLS 194
+ + +
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L +L L+ + PL SLT L + N+ T + ++N+T L L + +N
Sbjct: 179 LYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITD-- 235
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDF 186
+++L +L L++ N S + LT L L + +N+ S I+ L+ L L
Sbjct: 236 LSPLANLSQLTWLEIGTNQISDINAVK--DLTKLKMLNVGSNQISD-ISVLNNLSQLNSL 292
Query: 187 NVSGNHLSGQIPKSLSGFP 205
++ N L + + + G
Sbjct: 293 FLNNNQLGNEDMEVIGGLT 311
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 31/131 (23%), Positives = 54/131 (41%), Gaps = 8/131 (6%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L L+ + PL +LT++ L+L N + LSN+T L L ++ +
Sbjct: 112 LRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD-- 169
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
+++L LY L L++N PL LT L N+ + ++ L
Sbjct: 170 VTPIANLTDLYSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQITDITPVANMTRLNSLK 227
Query: 188 VSGNHLSGQIP 198
+ N ++ P
Sbjct: 228 IGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 11/133 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L + P+ ++T+L L + N+ T + L+NL+ L L + N +
Sbjct: 201 LHYFTAYVNQITDITPVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISD-- 257
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGL-DLRNLQD 185
++V L +L L++ N S L N+L+ L +L L N+ + + L NL
Sbjct: 258 INAVKDLTKLKMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 186 FNVSGNHLSGQIP 198
+S NH++ P
Sbjct: 316 LFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 9/141 (6%)
Query: 58 TGVSCLQN--RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKL 115
+ +S L N ++ L L L PL+++T L L++ ++ V ++NLT L
Sbjct: 123 SDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYS 181
Query: 116 LFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI 175
L L++N ++SL L+ N + P+ ++T L +LK+ N+ + +
Sbjct: 182 LSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITD-L 236
Query: 176 TGL-DLRNLQDFNVSGNHLSG 195
+ L +L L + N +S
Sbjct: 237 SPLANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 28/137 (20%), Positives = 50/137 (36%), Gaps = 7/137 (5%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
VL+ ++ + L + L + + + + LT L+ L L+ N
Sbjct: 26 RAVLQKASVTD-VVTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITD--I 81
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNV 188
+S+L +L L + N + L +LT+L L L + S +L + N+
Sbjct: 82 SPLSNLVKLTNLYIGTNKITDISALQ--NLTNLRELYLNEDNISDISPLANLTKMYSLNL 139
Query: 189 SGNHLSGQIPKSLSGFP 205
NH LS
Sbjct: 140 GANHNLS-DLSPLSNMT 155
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 23/128 (17%), Positives = 47/128 (36%), Gaps = 9/128 (7%)
Query: 72 LENLQLS----GSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L + P L + L+ T V L ++ L ++
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS-- 58
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
+ L L L+L+ N + PL+ +L L L + N+ + +L NL++
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKITDISALQNLTNLRELY 116
Query: 188 VSGNHLSG 195
++ +++S
Sbjct: 117 LNEDNISD 124
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E LG G FG ++ G+ A K + K + ++ + LRHP LV L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL--KIAAGAAR----GLAFIH 478
+ E +++ E+M G LF + ++ A R GL +H
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHN----------KMSEDEAVEYMRQVCKGLCHMH 272
Query: 479 FTCKSLKLTHGNIKSTNVLL-DKTGNA-RVSDFGLSIFAPPSTVPRSN----GYRAPELS 532
H ++K N++ K N ++ DFGL+ P + + APE++
Sbjct: 273 ----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
G+ +D++S GVL LL+G P
Sbjct: 329 E--GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 69/251 (27%), Positives = 106/251 (42%), Gaps = 34/251 (13%)
Query: 330 SSSPYPAQQAGYERGSMVFFEGTKRFELED--LLRASAEMLGKGGFGTAY----KAVLDD 383
+E + ++ +E+ LL+ +LG G +G + + D
Sbjct: 26 GDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----VLGTGAYGKVFLVRKISGHDT 81
Query: 384 GSVVAVKRLKDASIGGKREFEQHM----EVLGRLRH-PNLVGLKAYYFAREEKL-LVSEY 437
G + A+K LK A+I K + +H +VL +R P LV L Y F E KL L+ +Y
Sbjct: 82 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDY 140
Query: 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNV 496
+ G LF L R ++I L +H L + + +IK N+
Sbjct: 141 INGGELFTHL---SQRERFTEH---EVQIYVGEIVLALEHLH----KLGIIYRDIKLENI 190
Query: 497 LLDKTGNARVSDFGLSIFAPPSTVPRSN---G---YRAPELSSSDGRKQSQKSDVYSFGV 550
LLD G+ ++DFGLS R+ G Y AP++ + D +S GV
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 551 LLLELLTGKCP 561
L+ ELLTG P
Sbjct: 251 LMYELLTGASP 261
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 31/164 (18%), Positives = 54/164 (32%), Gaps = 8/164 (4%)
Query: 49 NSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVPS 106
D + V + L+ ++ + L+ L L +
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQELDLTATHLSELPSG 296
Query: 107 LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQI-PLTVNHLTHLLTLK 165
L L+ LK L LS N F S S+ L L + N ++ + +L +L L
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 166 LEANRFSG----PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
L + + +L +LQ N+S N ++ P
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 34/136 (25%), Positives = 54/136 (39%), Gaps = 13/136 (9%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG----PVPSLSNLTALKLLFLSHN 121
L+ L LS L L+ L+L+ N F SL L L++L LS
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--D 179
+ + + +SL + +DLS N + ++HL + L L +N S + L
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSLLPI 545
Query: 180 LRNLQDFNVSGNHLSG 195
L + N+ N L
Sbjct: 546 LSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-17
Identities = 34/146 (23%), Positives = 53/146 (36%), Gaps = 8/146 (5%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG---PVPSLSNLTALKLLFLSHNNF 123
HL ++ L L +L LR L L ++ L NL+ L+ L LS+N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGL--DL 180
++ +L LDL+F + + +L L L L + L L
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFPD 206
LQ N+ GNH + +
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQT 474
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-16
Identities = 30/145 (20%), Positives = 44/145 (30%), Gaps = 12/145 (8%)
Query: 72 LENLQLSG----SLQPLT--SLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L L L+ + T S +L L L N +LS ALK LF +
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRN 182
+ + L L L N+ S L L + N L+
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 183 LQ--DFNVSGNHLSGQIPKSLSGFP 205
N++GN ++G I
Sbjct: 179 ATNLSLNLNGNDIAG-IEPGAFDSA 202
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 31/160 (19%), Positives = 49/160 (30%), Gaps = 11/160 (6%)
Query: 50 STSDPCSWTGVSCLQNRVSHLV-LENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSL 107
+TS C++ V+ ENL L+ + P T L +N +
Sbjct: 1 TTSSDQK-----CIEKEVNKTYNCENLGLN-EI-PGTLPNSTECLEFSFNVLPTIQNTTF 53
Query: 108 SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLE 167
S L L L L+ D+ S RL L L+ N ++ L L
Sbjct: 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 168 ANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
S + + L+ + NH+S
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 29/138 (21%), Positives = 55/138 (39%), Gaps = 10/138 (7%)
Query: 50 STSDPCSWTGVSCLQNRVSHLVLENLQLSG----SLQPLTSLTQLRVLSLKYNRFTG-PV 104
S + G+ LQ HL L+ L +L +L +L L + +
Sbjct: 438 DISSEQLFDGLPALQ----HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493
Query: 105 PSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTL 164
+ ++L + + LSHN +++S L +Y L+L+ N+ S +P + L+ T+
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTI 552
Query: 165 KLEANRFSGPITGLDLRN 182
L N + +
Sbjct: 553 NLRQNPLDCTCSNIYFLE 570
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 24/147 (16%), Positives = 47/147 (31%), Gaps = 12/147 (8%)
Query: 69 HLVLENLQLS----GSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
L +N + + L T L L+L N G P + + L
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215
Query: 125 GEFPDSVS--SLFRLYRLDLSFNNFSGQIPLTVNHL--THLLTLKLEANRFSGPITGL-- 178
+ ++ L+ + P L + ++ L+ + F +
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH 275
Query: 179 DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
LQ+ +++ HLS ++P L G
Sbjct: 276 CFSGLQELDLTATHLS-ELPSGLVGLS 301
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 29/150 (19%), Positives = 47/150 (31%), Gaps = 7/150 (4%)
Query: 63 LQN-RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP---SLSNLTALKLLFL 118
LQ L L ++G + L+ + + S + +L L
Sbjct: 176 LQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 119 SHNNFNGEFPDSVSSLFRLY--RLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT 176
+ P L + ++L + F T + + L L L A S +
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS 295
Query: 177 GL-DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
GL L L+ +S N S S FP
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFP 325
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 23/136 (16%), Positives = 51/136 (37%), Gaps = 7/136 (5%)
Query: 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
+ ++ + L+ S + SL + + V +++ + L + F
Sbjct: 212 TQNLLVIFKGLKNST----IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRN 182
++ L LDL+ + S ++P + L+ L L L AN+F + +
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326
Query: 183 LQDFNVSGNHLSGQIP 198
L ++ GN ++
Sbjct: 327 LTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 23/149 (15%), Positives = 41/149 (27%), Gaps = 14/149 (9%)
Query: 72 LENLQLSG------SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLS-HNNF 123
LE+L L L +L+VL + N +S+L L L+ + N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIP--LTVNHLTHLLTLKLEANRFS----GPITG 177
L+ I L + + L E G
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 178 LDLRNLQDFNVSGNHLSGQIPKSLSGFPD 206
L +++ N+ ++ + F
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSG 279
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 45/218 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKREFEQHMEVLGRLRHPNLV 419
+ LG+G +G AV VAVK R D K+E + + L H N+V
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR------- 472
+ + L EY G LF + + P A+
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP----------DAQRFFHQLM 115
Query: 473 -GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-------SN 524
G+ ++H + +TH +IK N+LLD+ N ++SDFGL+ + R +
Sbjct: 116 AGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 525 GYRAPELSSSDGRK-QSQKSDVYSFGVLLLELLTGKCP 561
Y APEL R+ ++ DV+S G++L +L G+ P
Sbjct: 172 PYVAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 353 KRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQH 406
+ ++ED L + MLGKG FG K L A+K LK + + E
Sbjct: 12 IKLKIEDFILHK----MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 407 M---EVLGR-LRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
M VL HP L + F +E L V EY+ G L + + + L
Sbjct: 65 MVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLS-R 119
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAPPS 518
AA GL F+H S + + ++K N+LLDK G+ +++DFG+ +
Sbjct: 120 ATF-YAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 519 TV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
T P Y APE+ S D +SFGVLL E+L G+ P
Sbjct: 175 TNTFCGTPD---YIAPEILLGQKYNHS--VDWWSFGVLLYEMLIGQSP 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 31/211 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH---MEVLGRLRHPNLVGL 421
+LGKG FG G AVK + + K + E +++L +L HPN++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFI 477
++ + LV E G LF + R AA R G+ ++
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFS----EVDAARIIRQVLSGITYM 142
Query: 478 HFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPR----SNGYRAPE 530
H K+ H ++K N+LL K+ +A R+ DFGLS S + + Y APE
Sbjct: 143 H----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ +K DV+S GV+L LL+G P
Sbjct: 199 VLH---GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK--REFEQHMEVLGRLRHPN 417
+ LG G FG G VAVK +++ + GK RE ++ L RHP+
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPH 72
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAAR--- 472
++ L + +V EY+ G LF + HG R++ AR
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-------------RVEEME--ARRLF 117
Query: 473 -----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----STVPRS 523
+ + H + H ++K NVLLD NA+++DFGLS T S
Sbjct: 118 QQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 173
Query: 524 NGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ S G + D++S GV+L LL G P
Sbjct: 174 PNYAAPEVISGRLYAGP----EVDIWSCGVILYALLCGTLP 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 74/263 (28%), Positives = 114/263 (43%), Gaps = 47/263 (17%)
Query: 319 SKLLESEKILYSSSPYPAQQAGYERGSMVFFEGTKRFELED--LLRASAEMLGKGGFGTA 376
S+ E E + + +P PA G + D L+ ++GKG FG
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGP----SSNPHAKPSDFHFLK----VIGKGSFG-- 52
Query: 377 YKAVL----DDGSVVAVKRLKDASIGGKREFEQHM---EVLGR-LRHPNLVGLKAYYFAR 428
K +L + AVK L+ +I K+E + M VL + ++HP LVGL + F
Sbjct: 53 -KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQT 110
Query: 429 EEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFTCKSLKL 486
+KL V +Y+ G LF+ L R R + AA A L ++H SL +
Sbjct: 111 ADKLYFVLDYINGGELFYHLQRER---CFLEP---RARFYAAEIASALGYLH----SLNI 160
Query: 487 THGNIKSTNVLLDKTGNARVSDFGLS---IFAPPSTV-----PRSNGYRAPELSSSDGRK 538
+ ++K N+LLD G+ ++DFGL I +T P Y APE+
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE---YLAPEVLHKQPYD 217
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
++ D + G +L E+L G P
Sbjct: 218 RT--VDWWCLGAVLYEMLYGLPP 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 43/231 (18%)
Query: 351 GTKRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFE 404
L+D LLR ++G+G + K +L + A+K +K + + +
Sbjct: 2 AMDPLGLQDFDLLR----VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDID 54
Query: 405 QHM---EVLGR-LRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD 459
V + HP LVGL F E +L V EY+ G L + + + P +
Sbjct: 55 WVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEE 110
Query: 460 WTTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFA 515
+ +A + L ++H + + ++K NVLLD G+ +++D+G+ +
Sbjct: 111 ---HARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
Query: 516 PPSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+T P Y APE+ G D ++ GVL+ E++ G+ P
Sbjct: 164 GDTTSTFCGTPN---YIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 55/322 (17%), Positives = 103/322 (31%), Gaps = 30/322 (9%)
Query: 17 HFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTS-------DPCSWTGVSCLQNRVSH 69
H ++++ T L L N LTT + + + +
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRD---NALTTIHFIPSIPDIFLSGNKLVTLPKINLTANL 405
Query: 70 LVLENLQLSG--SLQPLTSLTQLRVLSLKYNRFTG--PVPSLSNLTALKLLFLSHNNFNG 125
+ L +L L L + L++L L NRF+ + S +L+ LFL N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 126 EFPDSV-----SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDL 180
+ + L L L L+ N + P +HLT L L L +NR +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTMVTDPKKPGSDGAIA 240
NL+ ++S N L P T N +C + +
Sbjct: 526 ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNH----------- 574
Query: 241 SPLNPGNNPTNVVSSTPSSIPTNTDPNNKPASPQKTSSSKISSVAVIAIVVGDFLVLAII 300
+ + P ++ P S + + + K ++ + + +
Sbjct: 575 TNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMT 634
Query: 301 SLLLYCYFWRNYVKNKTRSKLL 322
L + + ++ KT +L+
Sbjct: 635 ILTVTKFRGFCFICYKTAQRLV 656
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 33/146 (22%), Positives = 51/146 (34%), Gaps = 13/146 (8%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNF 123
E L LS ++ L QL++L L + + NL L++L L +
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQI--PLTVNHLTHLLTLKLEANRFSGPITGL--- 178
PD+ LF L+ L L F S + +L L L L N+
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 179 DLRNLQDFNVSGNHLSGQIPKSLSGF 204
L +L+ + S N + L
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPL 171
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 27/139 (19%), Positives = 48/139 (34%), Gaps = 8/139 (5%)
Query: 63 LQNRVSHLVLENLQLS----GSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLF 117
L + + + + L + +R L L + L LK+L
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSS-VRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 118 LSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFS--GPI 175
L++N N ++ L L L+LS+N L + + L+ N +
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 176 TGLDLRNLQDFNVSGNHLS 194
T L LQ ++ N L+
Sbjct: 357 TFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 27/126 (21%), Positives = 41/126 (32%), Gaps = 7/126 (5%)
Query: 87 LTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEF-PDSVSSLFRLYRLDLSF 144
L L L +N S L L+LL L ++ +L L LDL
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITG----LDLRNLQDFNVSGNHLSG-QIPK 199
+ P L HL L+L S + +L+ L ++S N + +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 200 SLSGFP 205
S
Sbjct: 143 SFGKLN 148
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 22/149 (14%), Positives = 47/149 (31%), Gaps = 8/149 (5%)
Query: 65 NRVSHLVLENLQLSGS---LQPLTSLTQLRVLSLKYNRFTG-PVPSLSNL--TALKLLFL 118
N + + N + S L + ++ + + L ++++ L L
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273
Query: 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFS--GPIT 176
SH +L L L+L++N + L +L L L N
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 177 GLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
L + ++ NH++ ++
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 26/171 (15%), Positives = 49/171 (28%), Gaps = 27/171 (15%)
Query: 68 SHLVLENLQLSGSLQP---LTSLTQLRVLSLKYNRFT--GPVPSLSNLTALKLLFLSHNN 122
L L LS ++ +L L L L N+ PS L +LK + S N
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159
Query: 123 FNGEFPDSVSSLF--RLYRLDLSFNNFSGQIP--------------LTVNHLTHLLTLKL 166
+ L L L+ N+ ++ L + ++
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219
Query: 167 EANRFSGPITGLD------LRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQ 211
FS I+ ++ +++ + +G S+
Sbjct: 220 ITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 25/167 (14%), Positives = 46/167 (27%), Gaps = 32/167 (19%)
Query: 72 LENLQLSG----SLQP---LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKL--LFLSHN 121
L L LS SL L L+ + N+ L L L L+ N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 122 NFNGEFPDSVSSLFRLYR------LDLSFNNFSGQIPLTVNH------------LTHLLT 163
+ +R LD+S N ++ I ++ H++
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
Query: 164 LKLEANRFS----GPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPD 206
+ GL +++ ++S + + D
Sbjct: 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 23/110 (20%), Positives = 38/110 (34%), Gaps = 6/110 (5%)
Query: 91 RVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQ 150
R+ ++ T VP L + L LS N S L +L L+L
Sbjct: 7 RIAFYRFCNLTQ-VPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 151 IPLTV-NHLTHLLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHLSGQI 197
I +L +L L L +++ L +L + + LS +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 28/158 (17%), Positives = 52/158 (32%), Gaps = 26/158 (16%)
Query: 61 SCLQNRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP----SLSNLTALK 114
L++ + L L +++ + L L+VL+L YN L + +
Sbjct: 287 ETLKD-LKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344
Query: 115 LLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP 174
L N+ + L +L LDL N + T++ + + + L N+
Sbjct: 345 ---LQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK---- 392
Query: 175 ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212
L L N++ N + L F
Sbjct: 393 -----LVTLPKINLTANLIHLS-ENRLENLDILYFLLR 424
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 37/182 (20%), Positives = 74/182 (40%), Gaps = 15/182 (8%)
Query: 21 LKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLV-LENLQLSG 79
KA + L + + N LT + V+ L + + +++L ++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYIT-----LANINVTDLTG-IEYAHNIKDLTINN 75
Query: 80 ----SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSL 134
+ P++ L+ L L + T +P+LS LT+L LL +SH+ + +++L
Sbjct: 76 IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 135 FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLRNLQDFNVSGNHL 193
++ +DLS+N I + L L +L ++ + G+ D L +
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTI 193
Query: 194 SG 195
G
Sbjct: 194 GG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 18/125 (14%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 83 PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142
P ++ L + T + + + + +L + L++ N + + L +
Sbjct: 18 PDSTFKAYLNGLLGQSS-TANI-TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTI 73
Query: 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLD-LRNLQDFNVSGNHLSGQIPKS 200
+ + + P++ L++L L++ + I L L +L ++S + I
Sbjct: 74 NNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 201 LSGFP 205
++ P
Sbjct: 132 INTLP 136
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 10/60 (16%), Positives = 26/60 (43%), Gaps = 6/60 (10%)
Query: 72 LENLQLSG-----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGE 126
+ ++ LS + PL +L +L+ L+++++ + + L L+ G+
Sbjct: 138 VNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 3e-18
Identities = 67/252 (26%), Positives = 103/252 (40%), Gaps = 43/252 (17%)
Query: 330 SSSPYPAQQAGYERGSMVFFEGTKRFELED--LLRASAEMLGKGGFGTAYKAVL----DD 383
+ P ++ R +L D L +LGKG FG K +L
Sbjct: 313 QGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM----VLGKGSFG---KVMLSERKGT 365
Query: 384 GSVVAVKRLKDASIGGKREFEQHM---EVLGR-LRHPNLVGLKAYYFAREEKL-LVSEYM 438
+ AVK LK + + E M VL + P L L F ++L V EY+
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 424
Query: 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497
G L + + GR AA A GL F+ S + + ++K NV+
Sbjct: 425 NGGDLMYHIQQV---GRFKEP---HAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVM 474
Query: 498 LDKTGNARVSDFGLS---IFAPPSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFG 549
LD G+ +++DFG+ I+ +T P Y APE+ + + + D ++FG
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD---YIAPEIIA--YQPYGKSVDWWAFG 529
Query: 550 VLLLELLTGKCP 561
VLL E+L G+ P
Sbjct: 530 VLLYEMLAGQAP 541
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 39/224 (17%)
Query: 354 RFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQHM 407
++ L+D +LR LG G FG + L +G A+K LK + ++ E H
Sbjct: 2 KYSLQDFQILR----TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HT 53
Query: 408 ----EVLGRLRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
+L + HP ++ + F +++ ++ +Y+ G LF LL R R P
Sbjct: 54 NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNP-VA 108
Query: 463 RLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV-- 520
+ AA L ++H S + + ++K N+LLDK G+ +++DFG + + P T
Sbjct: 109 KF-YAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 163
Query: 521 ---PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P Y APE+ S+ +S D +SFG+L+ E+L G P
Sbjct: 164 CGTPD---YIAPEVVSTKPYNKS--IDWWSFGILIYEMLAGYTP 202
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 31/212 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
LG G FG + G +K + KD S + E +EVL L HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 424 YYFAREEKLLVSEYMPNGSLF-WLLHGNRGPGR-TPLDWTTRLKIAAGAAR----GLAFI 477
+ +V E G L ++ + A + LA+
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY-------VAELMKQMMNALAYF 140
Query: 478 HFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPRSN----GYRAPE 530
H S + H ++K N+L D + ++ ++ DFGL+ + Y APE
Sbjct: 141 H----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 531 -LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
R + K D++S GV++ LLTG P
Sbjct: 197 VFK----RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 59/216 (27%), Positives = 86/216 (39%), Gaps = 42/216 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE--FEQHMEVLGRLRHPNLVGLK 422
MLGKG FG K AVK + AS K + +E+L +L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----G 473
+V E G LF D + AA + G
Sbjct: 88 EILEDSSSFYIVGELYTGGELF--------------DEIIKRKRFSEHDAARIIKQVFSG 133
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPR----SNGY 526
+ ++H + H ++K N+LL K + ++ DFGLS +T + + Y
Sbjct: 134 ITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 527 RAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
APE L +K DV+S GV+L LL+G P
Sbjct: 190 IAPEVLR----GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 45/216 (20%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKREFEQHMEVLGRLRHPNLVGL 421
LG+G +G AV VAVK R D K+E + + L H N+V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR--------G 473
+ + L EY G LF + + P A+ G
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP----------DAQRFFHQLMAG 117
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-------SNGY 526
+ ++H + +TH +IK N+LLD+ N ++SDFGL+ + R + Y
Sbjct: 118 VVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 527 RAPELSSSDGRK-QSQKSDVYSFGVLLLELLTGKCP 561
APEL R+ ++ DV+S G++L +L G+ P
Sbjct: 174 VAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 67/230 (29%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 351 GTKRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFE 404
R +L D L +LGKG FG K +L + AVK LK + + E
Sbjct: 13 NRDRMKLTDFNFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVE 65
Query: 405 QHM---EVLGR-LRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD 459
M VL + P L L F ++L V EY+ G L + + GR
Sbjct: 66 CTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV---GRFKEP 121
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAP 516
AA A GL F+ S + + ++K NV+LD G+ +++DFG+ I+
Sbjct: 122 -HAVF-YAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 517 PSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+T P Y APE+ + +S D ++FGVLL E+L G+ P
Sbjct: 176 VTTKTFCGTPD---YIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAP 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 38/213 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+G+G +G AV A K++ + F+Q +E++ L HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----GLA 475
+ + LV E G LF + AA + +A
Sbjct: 75 FEDNTDIYLVMELCTGGELF--------------ERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 476 FIHFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPR----SNGYRA 528
+ H L + H ++K N L + ++ ++ DFGL+ P + R + Y +
Sbjct: 121 YCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
P++ + D +S GV++ LL G P
Sbjct: 177 PQVLE---GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 350 EGTKRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREF 403
+ + L+D LLR ++G+G + K +L + A++ +K + +
Sbjct: 44 KASSSLGLQDFDLLR----VIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDI 96
Query: 404 EQHM---EVLGR-LRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPL 458
+ V + HP LVGL F E +L V EY+ G L + + + P
Sbjct: 97 DWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPE 152
Query: 459 DWTTRLKI-AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IF 514
+ + +A + L ++H + + ++K NVLLD G+ +++D+G+ +
Sbjct: 153 E---HARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205
Query: 515 APPSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+T P Y APE+ G D ++ GVL+ E++ G+ P
Sbjct: 206 PGDTTSTFCGTPN---YIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 45/223 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH-------------MEVLG 411
LG G +G + S A+K +K + R + + + +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 412 RLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGA 470
L HPN++ L + ++ LV+E+ G LF +++ ++ AA
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD----------AANI 151
Query: 471 AR----GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPR- 522
+ G+ ++H + H +IK N+LL +K ++ DFGLS F R
Sbjct: 152 MKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 523 ---SNGYRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ Y APE L +K ++K DV+S GV++ LL G P
Sbjct: 208 RLGTAYYIAPEVLK----KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 42/215 (19%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKR-LKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+++G G FG ++A L + VA+K+ L+D RE ++++ ++HPN+V LKA+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-RE----LQIMRIVKHPNVVDLKAF 100
Query: 425 YFAREEKL------LVSEYMPNGSLFWLL-HGNRGPGRTPLD----WTTRLKIAAGAARG 473
+++ +K LV EY+P +++ H + P+ + +L R
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL------LRS 153
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLS-IFAP--PST---VPRSNGY 526
LA+IH S+ + H +IK N+LLD +G ++ DFG + I P+ R Y
Sbjct: 154 LAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--Y 207
Query: 527 RAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
RAPE +++ + D++S G ++ EL+ G+
Sbjct: 208 RAPELIFGATN---YTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/221 (22%), Positives = 82/221 (37%), Gaps = 49/221 (22%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM--------EVLGRLRHP 416
+ LG G G A VA+K + E E+L +L HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 417 NLVGLKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDW---TTRL--KIAAG 469
++ +K ++ + + +V E M G LF D RL
Sbjct: 76 CIIKIKNFF---DAEDYYIVLELMEGGELF--------------DKVVGNKRLKEATCKL 118
Query: 470 AAR----GLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPSTVPR 522
+ ++H + H ++K NVLL ++ +++DFG S +++ R
Sbjct: 119 YFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 523 ----SNGYRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+ Y APE L S ++ D +S GV+L L+G
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK--REFEQHMEVLGRLRHPNLVGLK 422
MLGKG FG K AVK + AS K + +E+L +L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFIH 478
+V E G LF + R AA + G+ ++H
Sbjct: 88 EILEDSSSFYIVGELYTGGELF-----DEIIKRKRFS----EHDAARIIKQVFSGITYMH 138
Query: 479 FTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPR----SNGYRAPE- 530
+ H ++K N+LL K + ++ DFGLS +T + + Y APE
Sbjct: 139 ----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
L +K DV+S GV+L LL+G P
Sbjct: 195 LR----GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 351 GTKRFELED--LLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFE 404
+ R +++ +R +LGKG FG K +L + G + AVK LK I + E
Sbjct: 16 SSNRLGIDNFEFIR----VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVE 68
Query: 405 QHM---EVLGR-LRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD 459
M +L HP L L F ++L V E++ G L + + + R
Sbjct: 69 CTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEA 124
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS---IFAP 516
R AA L F+H + + ++K NVLLD G+ +++DFG+ I
Sbjct: 125 -RARF-YAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178
Query: 517 PSTV-----PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+T P Y APE+ D ++ GVLL E+L G P
Sbjct: 179 VTTATFCGTPD---YIAPEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--------RLKDASIGGKRE-FEQHMEVLGRL-R 414
E+LG+G + + AVK + RE + +++L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAG 469
HPN++ LK Y LV + M G LF D+ T K
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELF--------------DYLTEKVTLSEKETRK 128
Query: 470 AAR----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR--- 522
R + +H L + H ++K N+LLD N +++DFG S P R
Sbjct: 129 IMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 523 -SNGYRAPE----LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+ Y APE + + ++ D++S GV++ LL G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 43/216 (19%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKR-LKDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+++G G FG Y+A L D G +VA+K+ L+D RE ++++ +L H N+V L+
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RE----LQIMRKLDHCNIVRLRY 114
Query: 424 YYFAREEKL------LVSEYMPNGSLFWLL-HGNRGPGRTPLD----WTTRLKIAAGAAR 472
++++ EK LV +Y+P +++ + H +R P+ + +L R
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL------FR 167
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLS---IFAPPST---VPRSNG 525
LA+IH S + H +IK N+LLD T ++ DFG + + P+ R
Sbjct: 168 SLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 526 YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE ++D + DV+S G +L ELL G+
Sbjct: 222 YRAPELIFGATD---YTSSIDVWSAGCVLAELLLGQ 254
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKRE-FEQHMEVLGRLRHPNL 418
E LG G F K G A K + + + G RE E+ + +L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR- 472
+ L Y R + +L+ E + G LF D+ + + A +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELF--------------DFLAQKESLSEEEATSFIKQ 123
Query: 473 ---GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA---RVSDFGLSIFAPPSTVPRSN- 524
G+ ++H + K+ H ++K N++L DK ++ DFGL+ ++
Sbjct: 124 ILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 525 ---GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APE+ + + ++D++S GV+ LL+G P
Sbjct: 180 GTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK--REFEQHMEVLGRLRHPN 417
+ LG G FG G VAVK +++ + GK RE ++ L RHP+
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPH 77
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAAR--- 472
++ L + +V EY+ G LF + +G RL +R
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-------------RLDEK--ESRRLF 122
Query: 473 -----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----STVPRS 523
G+ + H + H ++K NVLLD NA+++DFGLS T S
Sbjct: 123 QQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 178
Query: 524 NGYRAPELSSSDGRK-QSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ S GR + D++S GV+L LL G P
Sbjct: 179 PNYAAPEVIS--GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVL 410
K++ + D + S ++LG G G + G A+K L D+ ++E + H +
Sbjct: 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEVDHHWQAS 79
Query: 411 GRLRHPNLVGLKAYY----FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
G P++V + Y + L++ E M G LF +R R +T R
Sbjct: 80 G---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELF-----SRIQERGDQAFTER--E 129
Query: 467 AAGAAR----GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPP-- 517
AA R + F+H S + H ++K N+L K +A +++DFG +
Sbjct: 130 AAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 518 -STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
T + Y APE+ K + D++S GV++ LL G P
Sbjct: 186 LQTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 54/219 (24%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKREFEQHMEVLGRLRHPNLVGL 421
+G G FG A +VAVK D ++ +RE + LRHPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV--QRE----IINHRSLRHPNIVRF 81
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAAR------- 472
K ++ EY G L+ + G R AR
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICNAG-------------RFSEDE--ARFFFQQLL 126
Query: 473 -GLAFIHFTCKSLKLTHGNIKSTNVLLD--KTGNARVSDFGLSIFAPPSTVPRSN----G 525
G+++ H S+++ H ++K N LLD ++ DFG S + + P+S
Sbjct: 127 SGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182
Query: 526 YRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ DG+ +DV+S GV L +L G P
Sbjct: 183 YIAPEVLLRQEYDGKI----ADVWSCGVTLYVMLVGAYP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 43/208 (20%), Positives = 81/208 (38%), Gaps = 28/208 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E LG+G FG ++ V K +K + ++ + +L RH N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69
Query: 425 YFAREEKLLVSEYMPNGSLF-WLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFIHF 479
+ + EE +++ E++ +F + + L F+H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNERE-------IVSYVHQVCEALQFLH- 119
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARV--SDFGLSIFAPPSTVPRSN----GYRAPELSS 533
S + H +I+ N++ ++ + +FG + P R Y APE+
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
D S +D++S G L+ LL+G P
Sbjct: 177 HDV--VSTATDMWSLGTLVYVLLSGINP 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKRE-FEQHMEVLGRLRHPNL 418
E LG G F K G A K + + + G RE E+ + +L ++ HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR- 472
+ L Y R + +L+ E + G LF D+ + + A +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELF--------------DFLAQKESLSEEEATSFIKQ 123
Query: 473 ---GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA---RVSDFGLSIFAPPSTVPRSN- 524
G+ ++H + K+ H ++K N++L DK ++ DFGL+ ++
Sbjct: 124 ILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 525 ---GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APE+ + + ++D++S GV+ LL+G P
Sbjct: 180 GTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 58/225 (25%), Positives = 85/225 (37%), Gaps = 52/225 (23%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGG----------KREFEQHMEVLGRLR 414
+LGKGGFGT + L D VA+K + + G E +V
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 415 HPNLVGLKAYY--FAREEKL-LVSEY-MPNGSLFWLLHGNRGPGRTPLDW-TTRLKIAAG 469
HP ++ L F +E LV E +P LF D+ T + + G
Sbjct: 97 HPGVIRL---LDWFETQEGFMLVLERPLPAQDLF--------------DYITEKGPLGEG 139
Query: 470 AARGLAF------IHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPPSTVPR 522
+R F I C S + H +IK N+L+D + G A++ DFG
Sbjct: 140 PSRCF-FGQVVAAIQH-CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 523 SNG---YRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCP 561
+G Y PE S V+S G+LL +++ G P
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVCGDIP 238
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 53/221 (23%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGK--REFEQHMEVLGRLRHPN 417
E LG+G FG A VA+K LK + + + RE + L LRHP+
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPH 70
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLL--HGNRGPGRTPLDWTTRLKIAAGAAR--- 472
++ L + ++V EY G LF + R+ R
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-------------RMTED--EGRRFF 114
Query: 473 -----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----STVPRS 523
+ + H K+ H ++K N+LLD N +++DFGLS T S
Sbjct: 115 QQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170
Query: 524 NGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ + G + DV+S G++L +L G+ P
Sbjct: 171 PNYAAPEVINGKLYAGP----EVDVWSCGIVLYVMLVGRLP 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 39/215 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE--FEQHMEVLGRLRHPNLVGLK 422
E LGKG F + V G A K + + + E+ + +L+HPN+V L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----G 473
LV + + G LF + A+ +
Sbjct: 72 DSIQEESFHYLVFDLVTGGELF--------------EDIVAREFYSEADASHCIQQILES 117
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNARV--SDFGLSIFAPPSTVPR----SNGY 526
+A+ H S + H N+K N+LL K A V +DFGL+I S + GY
Sbjct: 118 IAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+PE+ S+ D+++ GV+L LL G P
Sbjct: 174 LSPEVLK--KDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 46/216 (21%), Positives = 80/216 (37%), Gaps = 36/216 (16%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM--------EVLGRLRHP 416
LG G FG + AV + V VK +K + E +L R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 417 NLVGLKAYY--FAREEKL-LVSEYMPNGS-LFWLL--HGNRGPGRTPLDWTTRLKIAAGA 470
N++ + F + LV E +G LF + H LD I
Sbjct: 90 NIIKV---LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYIFRQL 139
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----STVPRSNGY 526
+ ++ + H +IK N+++ + ++ DFG + + T + Y
Sbjct: 140 VSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 527 RAPELSSSDGRK-QSQKSDVYSFGVLLLELLTGKCP 561
APE+ G + + +++S GV L L+ + P
Sbjct: 196 CAPEVLM--GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 45/220 (20%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM--------EVLGRLR-H 415
+++G+G + V G AVK ++ + E + + +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGA 470
P+++ L Y + LV + M G LF D+ T K
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELF--------------DYLTEKVALSEKETRSI 205
Query: 471 AR----GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR---- 522
R ++F+H + + H ++K N+LLD R+SDFG S P R
Sbjct: 206 MRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261
Query: 523 SNGYRAPE----LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+ GY APE ++ D+++ GV+L LL G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 50/223 (22%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKR------EFEQHMEVLGRLRHPNL 418
E LG G F K G A K +K + R E E+ + +L +RHPN+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL--------KIAAGA 470
+ L + + + +L+ E + G LF D L A
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF--------------D---FLAEKESLTEDEATQF 113
Query: 471 AR----GLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLSIFAPPSTVPR 522
+ G+ ++H S ++ H ++K N++L ++ DFG++ +
Sbjct: 114 LKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 523 SN----GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + APE+ + + ++D++S GV+ LL+G P
Sbjct: 170 NIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 45/230 (19%), Positives = 81/230 (35%), Gaps = 32/230 (13%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK--REFEQ 405
+ +++ LG+G F + + G A K LK G E
Sbjct: 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH 77
Query: 406 HMEVLGRLRH-PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
+ VL + P ++ L Y E +L+ EY G +F + +
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF---------SLCLPELAEMV 128
Query: 465 --KIAAGAAR----GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNARV--SDFGLSIFA 515
+ G+ ++H + H ++K N+LL + DFG+S
Sbjct: 129 SENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 516 PPSTVPRSN----GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ R Y APE+ + D + +D+++ G++ LLT P
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 50/223 (22%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKRE-FEQHMEVLGRLRHPNL 418
E LG G F K G A K R K + G RE E+ + +L ++HPN+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL--------KIAAGA 470
+ L Y + + +L+ E + G LF D L + A
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELF--------------D---FLAEKESLTEEEATEF 119
Query: 471 AR----GLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLSIFAPPSTVPR 522
+ G+ ++H SL++ H ++K N++L ++ DFGL+ +
Sbjct: 120 LKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 523 SN----GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + APE+ + + ++D++S GV+ LL+G P
Sbjct: 176 NIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 29/214 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK-----RLKDASIGGKREFEQHMEVLGRLRHPNLV 419
E++GKG F + + + G AVK + + + ++ + L+HP++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLA 475
L Y + +V E+M L R + +A+ R L
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLC-----FEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 476 FIHFTCKSLKLTHGNIKSTNVLL-DKTGNARV--SDFGLSI-FAPPSTVPR----SNGYR 527
+ H + H ++K VLL K +A V FG++I V + +
Sbjct: 145 YCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
APE+ + DV+ GV+L LL+G P
Sbjct: 201 APEVVK--REPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 51/228 (22%), Positives = 84/228 (36%), Gaps = 60/228 (26%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGG----------KREFEQHMEVLGRLR 414
+LG GGFG+ Y + + D VA+K ++ I E + +L ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME----VVLLKKVS 104
Query: 415 H--PNLVGLKAY-YFAREEKL-LVSEY-MPNGSLFWLLHGNRGPGRTPLDW-TTRLKIAA 468
++ L +F R + L+ E P LF D+ T R +
Sbjct: 105 SGFSGVIRL--LDWFERPDSFVLILERPEPVQDLF--------------DFITERGALQE 148
Query: 469 GAAR--------GLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPPST 519
AR + H + + H +IK N+L+D G ++ DFG +
Sbjct: 149 ELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204
Query: 520 VPRSNG---YRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCP 561
+G Y PE GR V+S G+LL +++ G P
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVCGDIP 248
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 46/217 (21%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKA 423
E +G G + + + AVK + + E +E+L R +HPN++ LK
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----GL 474
Y + +V+E M G L D R + A+ +
Sbjct: 84 VYDDGKYVYVVTELMKGGELL--------------DKILRQKFFSEREASAVLFTITKTV 129
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA---RVSDFGLSIFAPP-----STVPRSNG 525
++H + + H ++K +N+L D++GN R+ DFG + T +
Sbjct: 130 EYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 526 YRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ APE L + D++S GVLL +LTG P
Sbjct: 186 FVAPEVLE---RQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 53/212 (25%), Positives = 82/212 (38%), Gaps = 39/212 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE--FEQHMEVLGRLRHPNLVGLK 422
E LGKG F + V G A K + + + E+ + +L+HPN+V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----G 473
LV + + G LF + A+ +
Sbjct: 95 DSIQEESFHYLVFDLVTGGELF--------------EDIVAREFYSEADASHCIQQILES 140
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNARV--SDFGLSIFAPPSTVPR----SNGY 526
+A+ H S + H N+K N+LL K A V +DFGL+I S + GY
Sbjct: 141 IAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558
+PE+ S+ D+++ GV+L LL G
Sbjct: 197 LSPEVLK--KDPYSKPVDIWACGVILYILLVG 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 33/248 (13%)
Query: 330 SSSPYPAQQAGYERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVA 388
+ P P + + + K+ + D + ++++LG G G + A
Sbjct: 32 PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA 91
Query: 389 VKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY----FAREEKLLVSEYMPNGSLF 444
+K L+D +RE E H P++V + Y R+ L+V E + G LF
Sbjct: 92 LKMLQDCPK-ARREVELHWRASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147
Query: 445 WLLHGNRGPGRTPLDWTTRLKIAAGAAR----GLAFIHFTCKSLKLTHGNIKSTNVLL-D 499
+R R +T R A+ + + ++H S+ + H ++K N+L
Sbjct: 148 -----SRIQDRGDQAFTER--EASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTS 196
Query: 500 KTGNA--RVSDFGLSIFAPP----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLL 553
K NA +++DFG + +T + Y APE+ K + D++S GV++
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGVIMY 254
Query: 554 ELLTGKCP 561
LL G P
Sbjct: 255 ILLCGYPP 262
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 27/138 (19%), Positives = 47/138 (34%), Gaps = 17/138 (12%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
LE L LS L SL+ LR L L N L +++ L ++NN +
Sbjct: 60 LELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-RV 114
Query: 128 PDSVSSLFR-LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR---FSGPITGLDLRNL 183
S + + L+ N + L + + L L+ N + L
Sbjct: 115 S---CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 184 QDFNVSGNHLSGQIPKSL 201
+ N+ N + + +
Sbjct: 172 EHLNLQYNFIY-DVKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 27/139 (19%), Positives = 51/139 (36%), Gaps = 12/139 (8%)
Query: 72 LENLQLSG----SLQPLT--SLTQLRVLSLKYNRFTG-PVPSL-SNLTALKLLFLSHNNF 123
+N+ L+ L+ L ++++ L LK N L ++ L+ L L +N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRN 182
+ V +L LDLS N + + + + L N+ +N
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN 238
Query: 183 LQDFNVSGNHLSGQIPKSL 201
L+ F++ GN +
Sbjct: 239 LEHFDLRGNGFHCGTLRDF 257
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 26/144 (18%), Positives = 49/144 (34%), Gaps = 17/144 (11%)
Query: 72 LENLQLSG---SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG-E 126
+E L + S + + + L N+ T + ++ L L N +
Sbjct: 101 IETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-----LR 181
F + +S L L+L +N + V L TL L +N+ + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNK----LAFMGPEFQSAA 214
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFP 205
+ ++ N L I K+L
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQ 237
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 12/144 (8%)
Query: 65 NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHN 121
NR + + L S ++ L L N + L+ T L+LL LS N
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR 181
+ SL L LDL+ N + + TL N S ++ +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ 120
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFP 205
++ ++ N ++
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRS 144
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 24/131 (18%), Positives = 49/131 (37%), Gaps = 17/131 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
++ L LSG + L T+L +L+L N L +L+ L+ L L++N
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ- 93
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNL 183
+ + L + NN S ++ + + L N+ + + +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 184 QDFNVSGNHLS 194
Q ++ N +
Sbjct: 147 QYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 19/117 (16%), Positives = 35/117 (29%), Gaps = 7/117 (5%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
LE+L L ++ +L+ L L N+ P + + + L +N
Sbjct: 171 LEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQ 184
++ L DL N F L + + +TG +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECT 284
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 17/86 (19%), Positives = 33/86 (38%)
Query: 109 NLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEA 168
N K+ ++ ++ S + + LDLS N S + T L L L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 169 NRFSGPITGLDLRNLQDFNVSGNHLS 194
N + L L+ +++ N++
Sbjct: 68 NVLYETLDLESLSTLRTLDLNNNYVQ 93
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 45/237 (18%), Positives = 87/237 (36%), Gaps = 53/237 (22%)
Query: 357 LEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR- 414
ED+ + ++LG+G + L AVK ++ + + +E+L + +
Sbjct: 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 415 HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL--------KI 466
H N++ L ++ + LV E M GS+ + +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSIL-----------------SHIHKRRHFNELE 112
Query: 467 AAGAAR----GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPST 519
A+ + L F+H + + H ++K N+L + ++ DF L +
Sbjct: 113 ASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 520 VPRSN------------GYRAPEL---SSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
Y APE+ S + ++ D++S GV+L LL+G P
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 33/140 (23%), Positives = 50/140 (35%), Gaps = 25/140 (17%)
Query: 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTN 495
+ +L + NR + L I A + F+H S L H ++K +N
Sbjct: 141 QLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSN 194
Query: 496 VLLDKTGNARVSDFGLS-----------IFAPPSTVPRSNG------YRAPELSSSDGRK 538
+ +V DFGL + P G Y +PE G
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH--GNN 252
Query: 539 QSQKSDVYSFGVLLLELLTG 558
S K D++S G++L ELL
Sbjct: 253 YSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 15/56 (26%), Positives = 30/56 (53%), Gaps = 2/56 (3%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLV 419
+ +G+GGFG ++A D A+KR++ + + + ++ L +L HP +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 50/224 (22%)
Query: 361 LRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGG-KREFEQHMEVLGRLR-HPN 417
L + LG+G F K V AVK + ++E + L HPN
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPN 67
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL--------KIAAG 469
+V L + + LV E + G LF R+ A+
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELF-----------------ERIKKKKHFSETEASY 110
Query: 470 AAR----GLAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPP----- 517
R ++ +H + + H ++K N+L D+ N ++ DFG + PP
Sbjct: 111 IMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 518 STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
T + Y APEL + + D++S GV+L +L+G+ P
Sbjct: 167 KTPCFTLHYAAPEL--LNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 26/132 (19%), Positives = 50/132 (37%), Gaps = 3/132 (2%)
Query: 73 ENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVS 132
E L + + L L+ L L++ S++NL LK L + ++ + ++
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 133 SLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL-EANRFSG-PITGLDLRNLQDFNVSG 190
L +L LDL P L L L + + P+ L L+ ++ G
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286
Query: 191 NHLSGQIPKSLS 202
++P ++
Sbjct: 287 CVNLSRLPSLIA 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 18/142 (12%)
Query: 72 LENLQLSGSLQPLTS-------LTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
L++L+L + + S L L+ L ++ + + P++ +L L+ L L
Sbjct: 185 LQSLRLEWT--GIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-----D 179
+P L RL L + +PL ++ LT L L L ++ L
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN---LSRLPSLIAQ 299
Query: 180 LRNLQDFNVSGNHLSGQIPKSL 201
L V HL Q+ +
Sbjct: 300 LPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 28/150 (18%), Positives = 57/150 (38%), Gaps = 26/150 (17%)
Query: 72 LENLQLSG----SLQP-LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG 125
L+++ + L + L L+L N P S+++L L+ L +
Sbjct: 106 LQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALP-ASIASLNRLRELSIRACPELT 164
Query: 126 EFPDSVSS---------LFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT 176
E P+ ++S L L L L + +P ++ +L +L +LK+ + ++
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP----LS 219
Query: 177 GL-----DLRNLQDFNVSGNHLSGQIPKSL 201
L L L++ ++ G P
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 9/136 (6%)
Query: 72 LENLQLSGS--LQPL-TSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
ENL GS L+P L+Q + +N ++ +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATA 72
Query: 129 DSVSSL--FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQD 185
D + L+L Q P L+HL + ++A P T L+
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLET 131
Query: 186 FNVSGNHLSGQIPKSL 201
++ N L +P S+
Sbjct: 132 LTLARNPLR-ALPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 1/102 (0%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEF 127
L + N LS + L +L L L+ P LK L L +
Sbjct: 210 SLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
P + L +L +LDL ++P + L + + +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 27/137 (19%), Positives = 45/137 (32%), Gaps = 15/137 (10%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
LE L LS L SL+ LR L L N L +++ L ++NN +
Sbjct: 60 LELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-RV 114
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG---PITGLDLRNLQ 184
S + L+ N + L + + L L+ N L+
Sbjct: 115 SC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 185 DFNVSGNHLSGQIPKSL 201
N+ N + + +
Sbjct: 173 HLNLQYNFIY-DVKGQV 188
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 25/136 (18%), Positives = 41/136 (30%), Gaps = 5/136 (3%)
Query: 72 LENLQLSG-SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDS 130
L L L+ +Q L + L N + V S K ++L++N
Sbjct: 82 LRTLDLNNNYVQELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLD 139
Query: 131 VSSLFRLYRLDLSFNNFSG-QIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVS 189
R+ LDL N L L L+ N + L+ ++S
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLS 199
Query: 190 GNHLSGQIPKSLSGFP 205
N L+ +
Sbjct: 200 SNKLA-FMGPEFQSAA 214
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 12/144 (8%)
Query: 65 NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHN 121
NR + + L S ++ L L N + L+ T L+LL LS N
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR 181
+ SL L LDL+ N + + TL N S ++ +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ 120
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFP 205
++ ++ N ++
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRS 144
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 24/131 (18%), Positives = 49/131 (37%), Gaps = 17/131 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
++ L LSG + L T+L +L+L N L +L+ L+ L L++N
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ- 93
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNL 183
+ + L + NN S ++ + + L N+ + + +
Sbjct: 94 ----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 184 QDFNVSGNHLS 194
Q ++ N +
Sbjct: 147 QYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 22/146 (15%), Positives = 51/146 (34%), Gaps = 23/146 (15%)
Query: 86 SLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144
+ + ++ + + + +K L LS N + ++ +L L+LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDFNVSGNHLSGQIPKS--- 200
N + L L+ L TL L N + L +++ + + N++S ++ S
Sbjct: 68 NVLYETLDLE--SLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS-RVSCSRGQ 120
Query: 201 -----------LSGFPDSAFTQNAAL 215
++ D + +
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRV 146
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 17/127 (13%), Positives = 38/127 (29%), Gaps = 3/127 (2%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
HL L+ + ++ +L+ L L N+ P + + + L +N
Sbjct: 173 HLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 129 DSVSSLFRLYRLDLSFNNFS-GQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
++ L DL N F G + + + T+ + + + +
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 188 VSGNHLS 194
Sbjct: 291 YGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 11/148 (7%), Positives = 29/148 (19%), Gaps = 17/148 (11%)
Query: 72 LENLQLSG----SLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGE 126
+ + L ++ L L L+ N F ++ ++
Sbjct: 216 VTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG---------PITG 177
+ L L+ LK + +
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 178 LDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ ++ + I +
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQ 360
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 60/250 (24%), Positives = 95/250 (38%), Gaps = 48/250 (19%)
Query: 330 SSSPYPAQQAGYERGSMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVA 388
SS A + +G+ R L D +E LG+G Y+ A
Sbjct: 24 SSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE-LGRGATSIVYRCKQKGTQKPYA 82
Query: 389 VKRLKDASIGGKREFEQHME----VLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444
+K LK K ++ + VL RL HPN++ LK + E LV E + G LF
Sbjct: 83 LKVLK------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF 136
Query: 445 WLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----GLAFIHFTCKSLKLTHGNIKSTN 495
D + AA A + +A++H + H ++K N
Sbjct: 137 --------------DRIVEKGYYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPEN 178
Query: 496 VLL-DKTGNARV--SDFGLSIFAPPSTVPR----SNGYRAPELSSSDGRKQSQKSDVYSF 548
+L +A + +DFGLS + + + GY APE+ + D++S
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA--YGPEVDMWSV 236
Query: 549 GVLLLELLTG 558
G++ LL G
Sbjct: 237 GIITYILLCG 246
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 37/178 (20%), Positives = 60/178 (33%), Gaps = 19/178 (10%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG 102
N L+ S S G + L+ +L L + L QL L +++
Sbjct: 357 NGLSFKGCCS--QSDFGTTSLK----YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 103 --PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLT 159
+L L L +SH + F + L L L ++ N+F + L
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 160 HLLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
+L L L + L +LQ N++ N L PD F + +L
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ--------LKSVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 32/144 (22%), Positives = 49/144 (34%), Gaps = 10/144 (6%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
+NL LS L S +L+VL L + +L+ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG---PITGLDLR 181
+ S L L +L N + + HL L L + N P +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFP 205
NL+ ++S N + L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLH 173
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 25/109 (22%), Positives = 37/109 (33%), Gaps = 8/109 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNNF 123
L L +S L+ L VL + N F + L L L LS
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFS 172
P + +SL L L+++ N + LT L + L N +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 33/143 (23%), Positives = 51/143 (35%), Gaps = 13/143 (9%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L L L+G SL + L+ L+ L + +L LK L ++HN
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 125 -GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHL----LTLKLEANRFSG-PITGL 178
+ P+ S+L L LDLS N + L + L+L L N +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 179 DLRNLQDFNVSGNHLSGQIPKSL 201
L + N S + K+
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 35/154 (22%), Positives = 53/154 (34%), Gaps = 18/154 (11%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFT--GPVPSLSNLTALKLLFLSHNNF 123
L+ L SL+ + L L+ L++ +N SNLT L+ L LS N
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 124 NGEFPDSVSSLFRL----YRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITG-- 177
+ + L ++ LDLS N + I L L L N S +
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 178 -LDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210
L L+ + + +L F SA
Sbjct: 221 IQGLAGLEVHRLVLGEFRNE--GNLEKFDKSALE 252
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 26/178 (14%), Positives = 48/178 (26%), Gaps = 17/178 (9%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNR--- 99
N + + G+ + + E L L L + +
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 100 -FTGPVPSLSNLTALKLLFLSHNNFNGEFPDS-VSSLFRLYRLDLSFNNFSGQIPLTVNH 157
+ + LT + L S L ++ F F
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LK 323
Query: 158 LTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
L L L +N+ + +DL +L+ ++S N L S G + +L
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL------SFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 7/65 (10%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L L LS L P SL+ L+VL++ N+ P LT+L+ ++L N ++
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
Query: 125 GEFPD 129
P
Sbjct: 532 CSCPR 536
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 48/214 (22%), Positives = 76/214 (35%), Gaps = 42/214 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL-KDASIGGKRE-FEQHMEVLGRLRHPNLVGLK 422
E LGKG F + V + G A + + E+ + L+HPN+V L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----KIAAGAAR----G 473
L+ + + G LF + A+ +
Sbjct: 77 DSISEEGHHYLIFDLVTGGELF--------------EDIVAREYYSEADASHCIQQILEA 122
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLL-DKTGNARV--SDFGLSIFAPP-----STVPRSNG 525
+ H + + H N+K N+LL K A V +DFGL+I + G
Sbjct: 123 VLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 526 YRAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
Y +PE L + D+++ GV+L LL G
Sbjct: 179 YLSPEVL---RKDPYGKPVDLWACGVILYILLVG 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 44/250 (17%)
Query: 331 SSPYPAQQAGY--ERGSMVFFEG---TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDG 384
GY ++GS V R+E+ ++ GKG FG KA
Sbjct: 70 GMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVI-------GKGSFGQVVKAYDHKVH 122
Query: 385 SVVAVKRLKDASIGGKREFEQHM---EVLGRLRH------PNLVGLKAYYFAREEKLLVS 435
VA+K +++ KR Q +L LR N++ + + R +
Sbjct: 123 QHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178
Query: 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTN 495
E + + +L+ L+ N+ G L R K A + L +H ++ H ++K N
Sbjct: 179 ELL-SMNLYELIKKNKFQGF-SLP-LVR-KFAHSILQCLDALH----KNRIIHCDLKPEN 230
Query: 496 VLLDKTGNA--RVSDFGLSIFA--PPSTVPRSNGYRAPE--LSSSDGRKQSQKSDVYSFG 549
+LL + G + +V DFG S + T +S YRAPE L G + D++S G
Sbjct: 231 ILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVIL----GARYGMPIDMWSLG 286
Query: 550 VLLLELLTGK 559
+L ELLTG
Sbjct: 287 CILAELLTGY 296
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 38/148 (25%), Positives = 58/148 (39%), Gaps = 13/148 (8%)
Query: 72 LENLQLSG-------SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNF 123
LE+L SL L L + + + L++L++L ++ N+F
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
Query: 124 NGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGL--D 179
F + + L L LDLS Q+ T N L+ L L + N F T
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
Query: 180 LRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
L +LQ + S NH+ + L FP S
Sbjct: 222 LNSLQVLDYSLNHIMTSKKQELQHFPSS 249
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 37/136 (27%), Positives = 51/136 (37%), Gaps = 14/136 (10%)
Query: 72 LENLQLSG---SLQPLTS-----LTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
L L LS S + S T L+ L L +N + L L+ L H+N
Sbjct: 54 LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 113
Query: 124 NGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITG---L 178
SV SL L LD+S + + N L+ L LK+ N F
Sbjct: 114 KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
Query: 179 DLRNLQDFNVSGNHLS 194
+LRNL ++S L
Sbjct: 173 ELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 41/174 (23%), Positives = 60/174 (34%), Gaps = 26/174 (14%)
Query: 55 CSWTGVSCLQNRVSHL------VLENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG 102
CS T + C ++ + L+L SL LTQL LSL N +
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 103 ---PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHL 158
S T+LK L LS N + L +L LD +N +V L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 159 THLLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210
+L+ L + G+ L +L+ ++GN F FT
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF-------QENFLPDIFT 172
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 6/109 (5%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG 125
L + + P T L L L L + + ++L++L++L +SHNNF
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTV--NHLTHLLTLKLEANRFS 172
L L LD S N+ + + L L L N F+
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 23/108 (21%), Positives = 34/108 (31%), Gaps = 10/108 (9%)
Query: 111 TALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQ--IPLTVNHLTHLLTLKLEA 168
++ L L N L +L +L LS N S + + T L L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 169 NRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
N L L L+ + ++L Q+ S F L
Sbjct: 88 NGVITMSSNFLGLEQLEHLDFQHSNLK-QMS------EFSVFLSLRNL 128
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 44/223 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLR------- 414
LG G F T + A + + + VA+K ++ K E ++L R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 415 ----HPNLVGLKAYYFAREEKL----LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
+++ L ++ + +V E + +L L+ G PL + +I
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYV--KQI 136
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD------KTGNARVSDFGLSIFAPP--S 518
+ GL ++H + + H +IK NVL++ +++D G + + +
Sbjct: 137 SKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 519 TVPRSNGYRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
++ YR+PE L G +D++S L+ EL+TG
Sbjct: 194 NSIQTREYRSPEVLL----GAPWGCGADIWSTACLIFELITGD 232
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 34/170 (20%), Positives = 48/170 (28%), Gaps = 17/170 (10%)
Query: 49 NSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSL-----TQLRVLSLKYNRFTG- 102
+ + ++ L L N+ + L L L+VLS+
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 103 PVPSLSNLTALKLLFLSHNNFNGE-------FPDSVSSLFRLYRLDLSFNNFSGQIPLTV 155
+ AL L LS N GE P +L L + SG
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 156 NHLTHLLTLKLEANRFSG---PITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
L L L N + L N+S L Q+PK L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 28/152 (18%), Positives = 45/152 (29%), Gaps = 12/152 (7%)
Query: 61 SCLQNRVSHLVLENLQLSG-SLQPLTSLTQLRVLSLKYNRFTGPVP-----SLSNLTALK 114
L+ + L + S + + L L L N G L+
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 115 LLFLSHNNFN---GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANR 170
+L L + G ++ +L LDLS N+ + + L +L L
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 171 FSGPITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
GL L ++S N L P
Sbjct: 265 LKQVPKGL-PAKLSVLDLSYNRLDR-NPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 17/160 (10%)
Query: 65 NRVSHLVLENLQLSGSLQP---LTSLTQLRVLSLKYNRFTGPVPSLSNL-----TALKLL 116
+ + L LENL+++G+ P + L +L+L+ + L+ L LK+L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLT----VNHLTHLLTLKLEANRFS 172
++ + + V L LDLS N G+ L L L L
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 173 -----GPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207
LQ ++S N L +P
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 28/183 (15%), Positives = 45/183 (24%), Gaps = 26/183 (14%)
Query: 50 STSDPCSWTGVSCLQNRVSHLVLENLQLS-------GSLQPLTSLTQLRVLSLKYNRFTG 102
S P + +CL L L ++ LSLK
Sbjct: 18 SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77
Query: 103 ---------PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP- 152
+ ++ L+ L L + G P + L+ N S
Sbjct: 78 ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRD 137
Query: 153 -----LTVNHLTHLLTLKLEANR---FSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGF 204
L L L + FS + L ++S N G+ +
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV-FPALSTLDLSDNPELGERGLISALC 196
Query: 205 PDS 207
P
Sbjct: 197 PLK 199
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 9/132 (6%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L++L++ + + L L L+L+ T P +LS+L L +L L H N N
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRN 182
S L+RL L++S + + + +L +L + + L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249
Query: 183 LQDFNVSGNHLS 194
L+ N+S N +S
Sbjct: 250 LRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 11/144 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
LE L L S+ L+ L L VL L++ S L LK+L +SH +
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIP-LTVNHLTHLLTLKLEANRFSGPITGL--DLR 181
+ L L ++ N + +P L V HL +L L L N S + +L
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
Query: 182 NLQDFNVSGNHLSGQIPKSLSGFP 205
LQ+ + G L+ P + G
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLN 296
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 19/137 (13%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
LE L+L+ +++P +L LR L L+ NR P+ + L+ L L +S N
Sbjct: 58 LEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV 117
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGL----- 178
L+ L L++ N+ I + L L L LE +T +
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN----LTSIPTEAL 172
Query: 179 -DLRNLQDFNVSGNHLS 194
L L + +++
Sbjct: 173 SHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 39/175 (22%), Positives = 60/175 (34%), Gaps = 31/175 (17%)
Query: 55 CSWTG--VSCLQNRVSHL------VLENLQLSG----SLQP--LTSLTQLRVLSLKYNRF 100
CS V C + R + L L +L S L L L N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 101 TG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLT 159
+ + +NL L+ L L N + L L +LD+S N + L
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 160 HLLTLKLEANR--------FSGPITGLDLRNLQDFNVSGNHLSGQIPK-SLSGFP 205
+L +L++ N FSG L +L+ + +L+ IP +LS
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSG------LNSLEQLTLEKCNLT-SIPTEALSHLH 176
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 28/146 (19%), Positives = 55/146 (37%), Gaps = 8/146 (5%)
Query: 53 DPCSWTGVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTG-PVPSLSNL 110
S+ + L+ L + + ++ P L LS+ + T P ++ +L
Sbjct: 192 RDYSFKRLYRLK----VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL 247
Query: 111 TALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR 170
L+ L LS+N + + L RL + L + P L +L L + N+
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 171 FSGPITGL--DLRNLQDFNVSGNHLS 194
+ + + NL+ + N L+
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 30/107 (28%), Positives = 41/107 (38%), Gaps = 10/107 (9%)
Query: 111 TALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR 170
T +LL L N D +S L L+L+ N S P N+L +L TL L +NR
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 171 FSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
G+ L NL ++S N + D F L
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENK--------IVILLDYMFQDLYNL 130
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 13/146 (8%)
Query: 55 CSWTGVSCLQNRVSHLV-LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSN 109
TGV+ ++ V +L L L+L L PL +LT++ L L N V +++
Sbjct: 48 AFGTGVTTIEG-VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VSAIAG 105
Query: 110 LTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
L ++K L L+ ++ L L L L N + PL LT+L L +
Sbjct: 106 LQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNA 161
Query: 170 RFSGPITGL-DLRNLQDFNVSGNHLS 194
+ S +T L +L L N +S
Sbjct: 162 QVSD-LTPLANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 33/136 (24%), Positives = 54/136 (39%), Gaps = 11/136 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L+ L L ++ PL LT L+ LS+ + + + L+NL+ L L N +
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKISDI- 188
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
++SL L + L N S PL + ++L + L + NL N
Sbjct: 189 -SPLASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQTITN-QPVFYNNNLVVPN 244
Query: 188 VSGNHLSGQI-PKSLS 202
V I P ++S
Sbjct: 245 VVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 21/129 (16%), Positives = 51/129 (39%), Gaps = 8/129 (6%)
Query: 71 VLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDS 130
+ + ++ + P +L ++ + T V ++L + L +
Sbjct: 3 ITQPTAIN-VIFPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT--IEG 58
Query: 131 VSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDFNVS 189
V L L L+L N + PL +LT + L+L N ++ + L++++ +++
Sbjct: 59 VQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLKN-VSAIAGLQSIKTLDLT 115
Query: 190 GNHLSGQIP 198
++ P
Sbjct: 116 STQITDVTP 124
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 28/127 (22%), Positives = 44/127 (34%), Gaps = 6/127 (4%)
Query: 72 LENLQLSG-SLQ--PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
+E L S S+ +L +L L++N T L N L + LS+N
Sbjct: 207 VEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMY 265
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFN 187
+ RL RL +S N + L + L L L N L++
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLY 324
Query: 188 VSGNHLS 194
+ N +
Sbjct: 325 LDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 24/140 (17%), Positives = 52/140 (37%), Gaps = 13/140 (9%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEF 127
H+ ++ + + +T L ++++ K + P L + ++LL L+
Sbjct: 27 HIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD------LR 181
+ + + +L + FN P ++ L L LE N ++ L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND----LSSLPRGIFHNTP 141
Query: 182 NLQDFNVSGNHLSGQIPKSL 201
L ++S N+L +I
Sbjct: 142 KLTTLSMSNNNLE-RIEDDT 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 34/157 (21%), Positives = 60/157 (38%), Gaps = 28/157 (17%)
Query: 72 LENLQLSG-SLQ--PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN---- 124
L+NLQLS L L+ + L ++ YN + +L+ A++ L SHN+ N
Sbjct: 167 LQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSINVVRG 222
Query: 125 GEFP---------------DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
+ + L +DLS+N + + L L + N
Sbjct: 223 PVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
Query: 170 RFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
R + G + L+ ++S NHL + ++ F
Sbjct: 283 RLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 27/138 (19%), Positives = 53/138 (38%), Gaps = 16/138 (11%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
++ L + L P ++ L VL L+ N + P N L L +S+NN
Sbjct: 95 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLRNL 183
D+ + L L LS N + + L + + L + N ++ L +
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNL----LSTLAIPIAV 207
Query: 184 QDFNVSGNHLSGQIPKSL 201
++ + S N ++ + +
Sbjct: 208 EELDASHNSIN-VVRGPV 224
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 27/126 (21%), Positives = 41/126 (32%), Gaps = 10/126 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
L + LS + + +L L + NR + LK+L LSHN+
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL- 308
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQD 185
+ RL L L N+ + L + L L L N + RN+
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVAR 365
Query: 186 FNVSGN 191
V
Sbjct: 366 PAVDDA 371
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREF------E-QHMEVLGRLRHP 416
+G G +GT YKA G VA+K ++ GG E + L HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 417 NLVGLK----AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD---WTTRLKIAA 468
N+V L RE K+ LV E++ L L PG +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF---- 129
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-- 525
RGL F+H + + H ++K N+L+ G +++DFGL+ I++ + +
Sbjct: 130 --LRGLDFLH----ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV 181
Query: 526 ---YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE+ + D++S G + E+ K
Sbjct: 182 TLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 3e-13
Identities = 47/142 (33%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 58 TGVSCLQNRVSHLVLENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTAL 113
G+ L N + L L+G ++PLT+L L L L N+ + SL +L L
Sbjct: 59 QGIQYLPN------VTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LSSLKDLKKL 111
Query: 114 KLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173
K L L HN + + + L +L L L N + L + LT L TL LE N+ S
Sbjct: 112 KSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQISD 167
Query: 174 PITGLD-LRNLQDFNVSGNHLS 194
I L L LQ+ +S NH+S
Sbjct: 168 -IVPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 7e-13
Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 7/145 (4%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
LE+L L + L+ LT+L LSL+ N+ + + L+ LT L+ L+LS N+
Sbjct: 133 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI--SD 189
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
+++ L L L+L + ++L T+K P D + + N
Sbjct: 190 LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 249
Query: 188 VSGNHLSGQIPKSLSGFPDSAFTQN 212
V + S + +
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTIGKA 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 38/140 (27%), Positives = 56/140 (40%), Gaps = 10/140 (7%)
Query: 58 TGVSCLQN--RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKL 115
T + ++ N + S+Q + L + L L N+ T + L+NL L
Sbjct: 34 TDAVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGW 91
Query: 116 LFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI 175
LFL N S+ L +L L L N S L HL L +L L N+ + I
Sbjct: 92 LFLDENKIKD--LSSLKDLKKLKSLSLEHNGISDINGL--VHLPQLESLYLGNNKITD-I 146
Query: 176 TGLD-LRNLQDFNVSGNHLS 194
T L L L ++ N +S
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 38/136 (27%), Positives = 55/136 (40%), Gaps = 11/136 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L L L L L +L+ LSL++N + + L +L L+ L+L +N
Sbjct: 89 LGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD-- 145
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLRNLQDF 186
+S L +L L L N S +PL LT L L L N S + L L+NL
Sbjct: 146 ITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHIS-DLRALAGLKNLDVL 202
Query: 187 NVSGNHLSGQIPKSLS 202
+ + S
Sbjct: 203 ELFSQECLNKPINHQS 218
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 12/89 (13%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 107 LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL 166
L + + L + ++ + ++ + +L ++ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGI--QYLPNVTKLFL 72
Query: 167 EANRFSGPITGLD-LRNLQDFNVSGNHLS 194
N+ + I L L+NL + N +
Sbjct: 73 NGNKLTD-IKPLTNLKNLGWLFLDENKIK 100
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 50/240 (20%), Positives = 86/240 (35%), Gaps = 59/240 (24%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+ LG G FG + ++ G A+K++ RE ++++ L H N++ L Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDY 68
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL-----------------KIA 467
++ ++ P+ N K+
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 468 AGAA-------------------RGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVS 507
R + FIH SL + H +IK N+L++ K ++
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH----SLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 508 DFGLS-IFAP--PST---VPRSNGYRAPEL--SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
DFG + P PS R YRAPEL +++ + D++S G + EL+ GK
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRF--YRAPELMLGATE---YTPSIDLWSIGCVFGELILGK 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIG----GKREFEQHMEVLGRLRHPNLV 419
E LG G + T YK + G VA+K +K D+ G RE + ++ L+H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIV 66
Query: 420 GLKAYYFAREEKL-LVSEYMPNGSLFWLL-HGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
L E KL LV E+M N L + G L+ +GLAF
Sbjct: 67 RLYDV-IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPEL 531
H K+ H ++K N+L++K G ++ DFGL+ F P S+ YRAP++
Sbjct: 125 H----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDV 179
Query: 532 ---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
S R S D++S G +L E++TGK
Sbjct: 180 LMGS----RTYSTSIDIWSCGCILAEMITGK 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK-DASIGGK-----REFEQHMEVLGRLRHPNLV 419
E +G+G +G YKA G +VA+KR++ DA G RE + +L L HPN+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHHPNIV 82
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L + LV E+M L +L N+ L + RG+A H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG----LQDSQIKIYLYQLLRGVAHCH- 136
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPEL-- 531
++ H ++K N+L++ G +++DFGL+ F P ++ YRAP++
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLM 192
Query: 532 -SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
S +K S D++S G + E++TGK
Sbjct: 193 GS----KKYSTSVDIWSIGCIFAEMITGK 217
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 27/127 (21%), Positives = 44/127 (34%), Gaps = 6/127 (4%)
Query: 72 LENLQLSG---SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
+E L S ++ +L +L L++N T L N L + LS+N
Sbjct: 213 VEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMY 271
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFN 187
+ RL RL +S N + L + L L L N L++
Sbjct: 272 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLY 330
Query: 188 VSGNHLS 194
+ N +
Sbjct: 331 LDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 25/141 (17%), Positives = 54/141 (38%), Gaps = 15/141 (10%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEF 127
H+ ++ + + +T L ++++ K + P L + ++LL L+
Sbjct: 33 HIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGLD------L 180
+ + + +L + FN +P V ++ L L LE N ++ L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND----LSSLPRGIFHNT 146
Query: 181 RNLQDFNVSGNHLSGQIPKSL 201
L ++S N+L +I
Sbjct: 147 PKLTTLSMSNNNLE-RIEDDT 166
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 23/143 (16%)
Query: 72 LENLQLSG---SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
L+NLQLS + L+ + L ++ YN + +L+ A++ L SHN+ N
Sbjct: 173 LQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSIN-VVR 227
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD------LRN 182
V L L L NN + + + L+ + L N + + ++
Sbjct: 228 GPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNE----LEKIMYHPFVKMQR 279
Query: 183 LQDFNVSGNHLSGQIPKSLSGFP 205
L+ +S N L + P
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIP 301
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 27/130 (20%), Positives = 46/130 (35%), Gaps = 16/130 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L L L SL + +L LS+ N + T+L+ L LS N
Sbjct: 125 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQ 184
S+ + L+ ++S+N S T+ + L N + + G L
Sbjct: 185 -HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPVNVELT 235
Query: 185 DFNVSGNHLS 194
+ N+L+
Sbjct: 236 ILKLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 29/138 (21%), Positives = 44/138 (31%), Gaps = 10/138 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNG 125
L + LS + + +L L + NR + LK+L LSHN+
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQD 185
+ RL L L N+ L ++ L L L N + RN+
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 371
Query: 186 FNVSGNHLSGQIPKSLSG 203
V +I L
Sbjct: 372 PAVDDADQHCKIDYQLEH 389
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 11/145 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
+++L LS + L + L+VL LK +R + +L +L+ L LS N+ +
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSG-QIPLTVNHLTHLLTLKLEANRFSGPITGLD---L 180
L L L+L N + + +LT+L TL++ I +D L
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFP 205
+L + + L +SL
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIR 172
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 26/145 (17%), Positives = 50/145 (34%), Gaps = 11/145 (7%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L+ L L +++ SL L L L N + L++LK L L N +
Sbjct: 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
Query: 125 GEFPDSV-SSLFRLYRLDLSFNNFSGQIP-LTVNHLTHLLTLKLEANRFSGPITGL--DL 180
S+ +L L L + +I + LT L L+++A + +
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFP 205
R++ + + + +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILS 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 29/142 (20%), Positives = 41/142 (28%), Gaps = 15/142 (10%)
Query: 72 LENLQLSG--------SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
L+ L LS + + L +L L L + N F S ++ L LS
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL 183
+ L LD+S NN L L L L + N+ L
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASLFPVL 475
Query: 184 QDFNVSGNHLSGQIPKSLSGFP 205
+S N L
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 37/223 (16%), Positives = 66/223 (29%), Gaps = 33/223 (14%)
Query: 13 ILAVHFSLLKASTSPDLNAL---------LDFKASSDEANKLTTWNSTSDPCSWTGVSCL 63
+L + +L + +L L S KL S S+ + L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 64 QNRVSHL---VLENLQLSG-------SLQPLTSLTQLRVLSLKYNRFTG------PVPSL 107
+ L ++ L+G ++ L ++ ++++
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 108 SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLT---VNHLTHLLTL 164
S L +K + + ++ L L LDLS N + L TL
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 165 KLEANRFS----GPITGLDLRNLQDFNVSGNHLSGQIPKSLSG 203
L N L L+NL ++S N +P S
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 32/122 (26%), Positives = 48/122 (39%), Gaps = 4/122 (3%)
Query: 83 PLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141
P ++ L L +N+ T L L++L L + N D+ SL L LD
Sbjct: 21 PSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80
Query: 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGL--DLRNLQDFNVSGNHLSGQIP 198
LS N+ S L+ L L L N + +T L +L NLQ + +I
Sbjct: 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 199 KS 200
+
Sbjct: 141 RI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 20/132 (15%), Positives = 47/132 (35%), Gaps = 3/132 (2%)
Query: 72 LENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDS 130
+ L ++ LT+L LR+ + F+ + LT+L L + + S
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGN--VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167
Query: 131 VSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSG 190
+ S+ ++ L L + + + + + L+ + L+L + + +
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 191 NHLSGQIPKSLS 202
G + S
Sbjct: 228 LAFRGSVLTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 18/87 (20%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSH 120
+C+ + L + N L S L +L+ L + N+ +P S L ++ +S
Sbjct: 427 TCIPQTLEVLDVSNNNLD-SFS--LFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISR 482
Query: 121 NNFNGEFPDSVSSLFRLYRLDLSFNNF 147
N L L ++ L N +
Sbjct: 483 NQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 20/160 (12%), Positives = 46/160 (28%), Gaps = 24/160 (15%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNG 125
L ++ L L + Q L S+ + L+L + + L++++ L L N
Sbjct: 152 ELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 126 EFPDSVSSLFRLYRL-----------DLSFNNFSG---------QIPLTVNHLTHLLTLK 165
+ + D SFN ++ L L
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 166 LEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ + ++ ++ ++ +L + S
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE 310
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 22/103 (21%), Positives = 35/103 (33%), Gaps = 8/103 (7%)
Query: 72 LENLQLSG-SLQ--PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
+ L LS ++ L VL + N L L+ L++S N P
Sbjct: 412 MRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS-FSL--FLPRLQELYISRNKLK-TLP 467
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171
D+ L + +S N + LT L + L N +
Sbjct: 468 DASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 17/152 (11%), Positives = 45/152 (29%), Gaps = 2/152 (1%)
Query: 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALK 114
+ V + +L+ LT + +L L + T
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 115 LLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP 174
L + + + + RL + + + L + + +E ++
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 175 ITGL--DLRNLQDFNVSGNHLSGQIPKSLSGF 204
L++L+ ++S N + + K+ +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 12/58 (20%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPS-LSNLTALKLLFLSHNNFN 124
L+ L +S +L + L V+ + N+ LT+L+ ++L N ++
Sbjct: 453 LQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 33/131 (25%), Positives = 47/131 (35%), Gaps = 8/131 (6%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
LE LQL ++ L L L L N T P + L+ L+ L+L +N
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGLDLRNL 183
+ + + L RLDL I L +L L L L L
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGL 220
Query: 184 QDFNVSGNHLS 194
++ +SGNH
Sbjct: 221 EELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 27/102 (26%), Positives = 44/102 (43%), Gaps = 2/102 (1%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEF 127
+L L + + LT L L L + N F P S L++LK L++ ++ +
Sbjct: 200 YLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
++ L L L+L+ NN S L +L+ L L N
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 28/158 (17%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSL-KYNRFTG-PVPSLSNLTALKLLFLSHNNF 123
L L L S+ + L L L + + + L LK L L N
Sbjct: 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL----- 178
+++ L L L++S N+F P + + L+ L L + ++ ++ +
Sbjct: 209 K--DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ----VSLIERNAF 262
Query: 179 -DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
L +L + N++ N +LS P FT L
Sbjct: 263 DGLASLVELNLAHN--------NLSSLPHDLFTPLRYL 292
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 24/113 (21%), Positives = 38/113 (33%), Gaps = 14/113 (12%)
Query: 89 QLRVLSLKYNRFTGPVPSLSNL-TALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
Q + + VP + + + L L NN D+ L L L L N+
Sbjct: 55 QFSKVVCTRRGLSE-VPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 148 SGQIPLTVNHLTHLLTLKLEANRFSGPITGL------DLRNLQDFNVSGNHLS 194
N L L TL+L N +T + L L++ + N +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNW----LTVIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 38/204 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
++LG G G + A+K L+D +RE E H P++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQ---CPHIVRIVDV 79
Query: 425 Y----FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
Y R+ L+V E + G LF +R R +T R A+ + +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELF-----SRIQDRGDQAFTER--EASEIMKSIGEAIQY 132
Query: 481 CKSLKLTHGNIKSTNVLL-DKTGNA--RVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGR 537
S+ + H ++K N+L K NA +++DFG A E G
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------AKET---TGE 173
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP 561
K + D++S GV++ LL G P
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPP 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 36/211 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM-------EV--LGRLRH 415
++G+G +G K D G +VA+K+ + M E+ L +LRH
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFL-------ESDDDKMVKKIAMREIKLLKQLRH 83
Query: 416 PNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
NLV L ++++ LV E++ + ++ L LD+ K G+
Sbjct: 84 ENLVNLLEV-CKKKKRWYLVFEFVDH-TILDDLELFPNG----LDYQVVQKYLFQIINGI 137
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRA 528
F H S + H +IK N+L+ ++G ++ DFG + A P + YRA
Sbjct: 138 GFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRA 192
Query: 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
PEL D K + DV++ G L+ E+ G+
Sbjct: 193 PELLVGD-VKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 1e-12
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK-DASIGGK-----REFEQHMEVLGRLRHPNLV 419
E +G+G +G YKA + G A+K+++ + G RE + +L L+H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKHSNIV 63
Query: 420 GLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
L +++L LV E++ L LL G L+ T G+A+ H
Sbjct: 64 KLYDV-IHTKKRLVLVFEHLDQ-DLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH 117
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPE-- 530
++ H ++K N+L+++ G +++DFGL+ F P ++ YRAP+
Sbjct: 118 ----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVL 172
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
+ S +K S D++S G + E++ G
Sbjct: 173 MGS---KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 56/283 (19%), Positives = 102/283 (36%), Gaps = 48/283 (16%)
Query: 300 ISLLLYCYFWRNYVKNKTRSKLLESEKILYSSSPYPAQQAGYERG---SMVF---FEGTK 353
+ L YC VK + + Y + Y ++ + V F K
Sbjct: 3 LHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLK 62
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREF-EQHME 408
R++ + +G G G A VA+K+L KR + E +
Sbjct: 63 RYQNL-------KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE--LV 113
Query: 409 VLGRLRHPNLVGLKAYYFAR------EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
++ + H N++ L + + ++ LV E M L + LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVI---QMELDHER 165
Query: 463 RLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST--- 519
+ G+ +H S + H ++K +N+++ ++ DFGL+ A S
Sbjct: 166 MSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 520 ---VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
V R YRAPE+ + D++S G ++ E++ K
Sbjct: 222 PYVVTRY--YRAPEVILG--MGYKENVDIWSVGCIMGEMVRHK 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 38/216 (17%)
Query: 366 EMLGKGGFGTAYKA--VLDDGSVVAVKRLK-DASIGGK-----REFEQHMEVLGRLRHPN 417
+G+G +G +KA + + G VA+KR++ G RE + L HPN
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPN 75
Query: 418 LVGLK----AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLD---WTTRLKIAAG 469
+V L RE KL LV E++ L L PG +L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL----- 129
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG--- 525
RGL F+H S ++ H ++K N+L+ +G +++DFGL+ I++ + ++
Sbjct: 130 -LRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVT 182
Query: 526 --YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPE+ + D++S G + E+ K
Sbjct: 183 LWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 38/131 (29%), Positives = 53/131 (40%), Gaps = 8/131 (6%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
LE LQLS +++ L L L L NR T P + L+ LK L+L +N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGLDLRNL 183
+ + + L RLDL I L++L L L L L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKL 209
Query: 184 QDFNVSGNHLS 194
+ ++SGNHLS
Sbjct: 210 DELDLSGNHLS 220
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 28/129 (21%), Positives = 48/129 (37%), Gaps = 10/129 (7%)
Query: 72 LENLQLSG-----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
L L L + L+ LR L+L +P+L+ L L L LS N+ +
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS 220
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRN 182
P S L L +L + + ++L L+ + L N + L +
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280
Query: 183 LQDFNVSGN 191
L+ ++ N
Sbjct: 281 LERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 10/126 (7%)
Query: 88 TQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
T R+L+L N+ V S +L L++L LS N+ + + L L L+L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKSLSGF 204
+ +L+ L L L N + + +L+ ++ K LS
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL-------KRLSYI 176
Query: 205 PDSAFT 210
+ AF
Sbjct: 177 SEGAFE 182
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 44/221 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS------IGGKREFEQHMEVLGRLRHPNL 418
+G+G FG +KA G VA+K++ + I RE +++L L+H N+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENV 78
Query: 419 VGLK-------AYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 470
V L + Y + + LV ++ + L LL + ++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQML 133
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG---- 525
GL +IH K+ H ++K+ NVL+ + G +++DFGL+ F+ +
Sbjct: 134 LNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 526 ----YRAPEL---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YR PEL R D++ G ++ E+ T
Sbjct: 190 VTLWYRPPELLLGE----RDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 11/128 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L L L L L +L+ LSL++N + + L +L L+ L+L +N
Sbjct: 92 LGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD-- 148
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLRNLQDF 186
+S L +L L L N S +PL LT L L L N S + L L+NL
Sbjct: 149 ITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISD-LRALAGLKNLDVL 205
Query: 187 NVSGNHLS 194
+
Sbjct: 206 ELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
+ L L+G ++PL +L L L L N+ + SL +L LK L L HN +
Sbjct: 70 VTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-- 126
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDF 186
+ + L +L L L N + L + LT L TL LE N+ S I L L LQ+
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQISD-IVPLAGLTKLQNL 183
Query: 187 NVSGNHLS 194
+S NH+S
Sbjct: 184 YLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 28/128 (21%), Positives = 42/128 (32%), Gaps = 11/128 (8%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L + + + V + L + LFL+ N
Sbjct: 26 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIK 84
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDF 186
P +++L L L L N L L L +L LE N S I GL L L+
Sbjct: 85 P--LANLKNLGWLFLDENKVKDLSSL--KDLKKLKSLSLEHNGISD-INGLVHLPQLESL 139
Query: 187 NVSGNHLS 194
+ N ++
Sbjct: 140 YLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 31/124 (25%), Positives = 55/124 (44%), Gaps = 7/124 (5%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
LE+L L + L+ LT+L LSL+ N+ + + L+ LT L+ L+LS N+ +
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHISD-- 192
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
+++ L L L+L + ++L T+K P D + + N
Sbjct: 193 LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 252
Query: 188 VSGN 191
V +
Sbjct: 253 VKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 13/92 (14%), Positives = 32/92 (34%), Gaps = 6/92 (6%)
Query: 104 VPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163
+ S L + + + L + ++ + ++ + +L ++
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQGI--QYLPNVTK 72
Query: 164 LKLEANRFSGPITGLD-LRNLQDFNVSGNHLS 194
L L N+ + I L L+NL + N +
Sbjct: 73 LFLNGNKLTD-IKPLANLKNLGWLFLDENKVK 103
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREF- 403
+E K + +G G +G+ A+ G VA+K+L I KR +
Sbjct: 20 WELPKTYVSP-------THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFAREEKL------LVSEYMPNGSLFWLLHGNRGPGRTP 457
E + +L ++H N++GL + LV +M L ++
Sbjct: 73 E--LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-------GLK 122
Query: 458 LDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAP 516
+ +GL +IH S + H ++K N+ +++ ++ DFGL+
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 517 PST---VPRSNGYRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
T V R YRAPE LS +Q D++S G ++ E+LTGK
Sbjct: 179 EMTGYVVTRW--YRAPEVILSW---MHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 46/241 (19%), Positives = 81/241 (33%), Gaps = 57/241 (23%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGK--REFEQH 406
+ ++ + G +G V +G VA+KR+ + G+
Sbjct: 18 HAMQSPYTVQ-------RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 407 M-------EV--LGRLRHPNLVGLKAYYFAREEKL-----LVSEYMPNGSLFWLLHGNRG 452
E+ L HPN++GL+ + EE LV+E M L ++H R
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 453 PGRTPLDWTTRLK------IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506
+ GL +H + H ++ N+LL + +
Sbjct: 130 V----------ISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLADNNDITI 175
Query: 507 SDFGLSIFAPPST------VPRSNGYRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTG 558
DF L+ R YRAPE + ++ D++S G ++ E+
Sbjct: 176 CDFNLAREDTADANKTHYVTHRW--YRAPELVMQFK---GFTKLVDMWSAGCVMAEMFNR 230
Query: 559 K 559
K
Sbjct: 231 K 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGK----REFEQHMEVLGRLRHPNL 418
+G+G +G +K D G +VA+K + K RE + +L +L+HPNL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE----IRMLKQLKHPNL 64
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L F R+ +L LV EY + ++ L + + I + + F
Sbjct: 65 VNLLE-VFRRKRRLHLVFEYCDH-TVLHELDRYQR----GVPEHLVKSITWQTLQAVNFC 118
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPEL 531
H H ++K N+L+ K ++ DFG + + PS + YR+PEL
Sbjct: 119 H----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPEL 173
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
D + DV++ G + ELL+G
Sbjct: 174 LVGD-TQYGPPVDVWAIGCVFAELLSGV 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 47/249 (18%)
Query: 331 SSPYPAQQAGYERGSMVF---FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSV 386
SSP PA+ G+ R V +E + + +G G +G AV G+
Sbjct: 2 SSPPPARS-GFYR-QEVTKTAWEVRAVYRD-------LQPVGSGAYGAVCSAVDGRTGAK 52
Query: 387 VAVKRLKDA---SIGGKREF-EQHMEVLGRLRHPNLVGLKAYYFAREEKL------LVSE 436
VA+K+L + KR + E + +L +RH N++GL + E LV
Sbjct: 53 VAIKKLYRPFQSELFAKRAYRE--LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110
Query: 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNV 496
+M L L+ L + +GL +IH + + H ++K N+
Sbjct: 111 FMGT-DLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNL 159
Query: 497 LLDKTGNARVSDFGLS-IFAPPST---VPRSNGYRAPE--LSSSDGRKQSQKSDVYSFGV 550
+++ ++ DFGL+ T V R YRAPE L+ + +Q D++S G
Sbjct: 160 AVNEDCELKILDFGLARQADSEMTGYVVTRW--YRAPEVILNWM---RYTQTVDIWSVGC 214
Query: 551 LLLELLTGK 559
++ E++TGK
Sbjct: 215 IMAEMITGK 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGK-----REFEQHMEVLGRLRHPNL 418
E +G+G +GT +KA + +VA+KR++ D G RE + +L L+H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNI 63
Query: 419 VGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFI 477
V L ++KL LV E+ L G LD +GL F
Sbjct: 64 VRLHDV-LHSDKKLTLVFEFCDQ-DLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFC 117
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPEL 531
H S + H ++K N+L+++ G ++++FGL+ F P S YR P++
Sbjct: 118 H----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDV 172
Query: 532 ---SSSDGRKQSQKSDVYSFGVLLLELLTGKCP-----SVID 565
+ + S D++S G + EL P V D
Sbjct: 173 LFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 30/210 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHP----- 416
++GKG FG KA + VA+K +K+ K Q +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 417 -NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA 475
+V LK ++ R LV E + + +L+ LL + K A L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALL 171
Query: 476 FIHFTCKSLKLTHGNIKSTNVLL--DKTGNARVSDFGLSIFA--PPSTVPRSNGYRAPE- 530
F+ L + H ++K N+LL K ++ DFG S +S YR+PE
Sbjct: 172 FLA--TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEV 229
Query: 531 -LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
L G D++S G +L+E+ TG+
Sbjct: 230 LL----GMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM------EV--LGRLRHP 416
+ LG+G F T YKA + +VA+K++K +G + E + + E+ L L HP
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 417 NLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPL--DWTTRLKIAAGAARG 473
N++GL F + + LV ++M L ++ N + +G
Sbjct: 73 NIIGLLD-AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT------LQG 124
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YR 527
L ++H + H ++K N+LLD+ G +++DFGL+ F P+ ++ YR
Sbjct: 125 LEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYR 179
Query: 528 APEL---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
APEL + R D+++ G +L ELL
Sbjct: 180 APELLFGA----RMYGVGVDMWAVGCILAELLLRV 210
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 29/158 (18%), Positives = 53/158 (33%), Gaps = 10/158 (6%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG 125
L +E ++ L+ L +L L YN+F + + L L++L L+ N +G
Sbjct: 58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG 117
Query: 126 EF-PDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFS----GPITGL 178
+ L L L L NN P + ++ L L N+ +
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 179 DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALC 216
++ +S L L +N ++
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 35/160 (21%), Positives = 56/160 (35%), Gaps = 14/160 (8%)
Query: 61 SCLQNRVSHLVLENLQ-LSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFL 118
S N S N + + ++ L ++ S+ T L+ L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306
Query: 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSG-PIT 176
+ N N ++ L L +L+LS N I + +L L L L N
Sbjct: 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQ 365
Query: 177 GLD-LRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
L NL++ + N L KS+ PD F + +L
Sbjct: 366 SFLGLPNLKELALDTNQL-----KSV---PDGIFDRLTSL 397
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 23/99 (23%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 104 VPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLL 162
VP L + + LS N+ S S L L L + I L+ L+
Sbjct: 25 VPELP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 163 TLKLEANRFSG-PITGLD-LRNLQDFNVSGNHL-SGQIP 198
LKL+ N+F + L NL+ ++ +L +
Sbjct: 83 ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLS 121
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 25/158 (15%), Positives = 44/158 (27%), Gaps = 35/158 (22%)
Query: 72 LENLQLSG----SLQP---LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFL----- 118
LE L L +QP ++ + VL L +N+ L N L
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190
Query: 119 -----SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLK-------- 165
+ E + + LDLS N F + ++
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 166 -----LEANRFSGP----ITGLDLRNLQDFNVSGNHLS 194
F P GL+ ++ ++S + +
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 28/127 (22%), Positives = 45/127 (35%), Gaps = 13/127 (10%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L + +L L+ T L L+ N+ T ++ LT L L N
Sbjct: 66 LTKLICTSNNITTL-DLSQNTNLTYLACDSNKLTNL--DVTPLTKLTYLNCDTNKLT--- 119
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
VS L L+ + N + + V+H T L L N+ + L +
Sbjct: 120 KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLD 176
Query: 188 VSGNHLS 194
S N ++
Sbjct: 177 CSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 27/134 (20%), Positives = 43/134 (32%), Gaps = 10/134 (7%)
Query: 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
++ L N ++ + + LT L L N T LS T L L N
Sbjct: 42 ATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT--LDLSQNTNLTYLACDSNKLT 98
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQ 184
V+ L +L L+ N + L V+ L L N + I L
Sbjct: 99 -NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EIDVSHNTQLT 151
Query: 185 DFNVSGNHLSGQIP 198
+ + N ++
Sbjct: 152 ELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 35/162 (21%), Positives = 58/162 (35%), Gaps = 20/162 (12%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLV------LENLQLSG----SLQPLTSLTQLRV 92
NKLT + + +P T ++C +N ++ + L L + +T TQL
Sbjct: 116 NKLTKLDVSQNP-LLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTT 174
Query: 93 LSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP 152
L +N+ T +S L L NN + ++ +L LD S N +
Sbjct: 175 LDCSFNKITEL--DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--- 226
Query: 153 LTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194
+ V LT L N + + L L + L
Sbjct: 227 IDVTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 31/147 (21%), Positives = 47/147 (31%), Gaps = 32/147 (21%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTAL------------- 113
L L S + +T LTQL N T V +LS LT L
Sbjct: 214 LTFLDCSSNKLTEI-DVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLT 272
Query: 114 ---KLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR 170
+L++ V+ +LY LD + L ++ L+ L L
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTE 329
Query: 171 FSGPITGLD---LRNLQDFNVSGNHLS 194
+T LD L+ + H+
Sbjct: 330 ----LTELDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 20/112 (17%), Positives = 39/112 (34%), Gaps = 8/112 (7%)
Query: 83 PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142
P + + + S L L L +++ + L L +L
Sbjct: 16 PDDNFASEVAAAFEMQATD--TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLIC 71
Query: 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194
+ NN + L ++ T+L L ++N+ + + L L N N L+
Sbjct: 72 TSNNITT---LDLSQNTNLTYLACDSNKLTN-LDVTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 20/141 (14%), Positives = 38/141 (26%), Gaps = 17/141 (12%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L L+ L ++ T+L+ LS S+ + AL F +
Sbjct: 320 LVYLYLNNTELTEL-DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTI-TM 376
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQD-- 185
P + L+ + N + ++ + IT +L
Sbjct: 377 PKETLTN-----NSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAV 431
Query: 186 ---FNVSGNHLSGQIPKSLSG 203
F + G +
Sbjct: 432 TYTFTSENGAIVGTVTTPFEA 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 25/135 (18%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
LE L +S L L + + L+++ + N +P L +L+ + +N E
Sbjct: 133 LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLE-EL 188
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFN 187
P+ + +L L + N+ ++P + L ++ N +L L
Sbjct: 189 PE-LQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNILEELPELQNLPFLTTIY 243
Query: 188 VSGNHLSGQIPKSLS 202
N L +P
Sbjct: 244 ADNNLLK-TLPDLPP 257
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 31/169 (18%), Positives = 46/169 (27%), Gaps = 44/169 (26%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTG-------------------PVPSLS 108
LE + L L +L L + N +P L
Sbjct: 175 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 234
Query: 109 NLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEA 168
NL L ++ +N PD SL L D + LT L +
Sbjct: 235 NLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQ----SLTFLDVSENIF 289
Query: 169 NRFSGPITGL---------------DLRNLQDFNVSGNHLSGQIPKSLS 202
+ S L +L++ NVS N L ++P
Sbjct: 290 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 337
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 28/157 (17%), Positives = 47/157 (29%), Gaps = 23/157 (14%)
Query: 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSH 120
CL + L L NL LS SL L L N T +L +L + +
Sbjct: 67 DCLDRQAHELELNNLGLS-SLPE--LPPHLESLVASCNSLTELPELPQSLKSLLVDNNNL 123
Query: 121 NNFNGEFP---------------DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLK 165
+ P + + L +D+ N+ ++P + L +
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIA 179
Query: 166 LEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLS 202
N+ +L L N L ++P
Sbjct: 180 AGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPL 215
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 24/140 (17%), Positives = 42/140 (30%), Gaps = 12/140 (8%)
Query: 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNN 122
+ E +++ S Q L L + +L +L S N+
Sbjct: 46 WERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVA---SCNS 102
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRN 182
E P+ SL L + + S P L L + N+ +
Sbjct: 103 LT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKLPELQNSSF 154
Query: 183 LQDFNVSGNHLSGQIPKSLS 202
L+ +V N L ++P
Sbjct: 155 LKIIDVDNNSLK-KLPDLPP 173
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 40/184 (21%), Positives = 62/184 (33%), Gaps = 38/184 (20%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLV-----LENLQLSG-SLQPLTSL-TQLRVLSL 95
N L T P S ++ N ++ L L L +S L+ L L L+
Sbjct: 247 NLLKTLPDL--PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 304
Query: 96 KYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV 155
N +L L +S+N E P + RL RL SFN+ + ++P
Sbjct: 305 SSNEIRSLCDLPPSLEELN---VSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP--- 353
Query: 156 NHLTHLLTLKLEANRFS------GPITGLD-----------LRNLQDFNVSGNHLSGQIP 198
+L L +E N + L +NL+ +V N L + P
Sbjct: 354 ELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP 412
Query: 199 KSLS 202
Sbjct: 413 DIPE 416
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 23/127 (18%), Positives = 43/127 (33%), Gaps = 16/127 (12%)
Query: 72 LENLQLSG-SLQPL-TSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPD 129
LE L S L + L+ L ++YN ++ L++ N+ E P+
Sbjct: 339 LERLIASFNHLAEVPELPQNLKQLHVEYNPLREFPDIPESVEDLRM-----NSHLAEVPE 393
Query: 130 SVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFN 187
+ L +L + N + P + L++ + R P L+D
Sbjct: 394 LPQN---LKQLHVETNPLR-EFPDIPESVED---LRMNSERVVDPYEFAHETTDKLEDDV 446
Query: 188 VSGNHLS 194
+H
Sbjct: 447 FEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 21/136 (15%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
+ +N L SL L V +LT L + + + E P
Sbjct: 241 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLP---ELPQSLTFLDVSENIFSGLS-ELP 296
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRNLQDF 186
+ LY L+ S N + + L L + N+ + L L+
Sbjct: 297 PN------LYYLNASSNEIR-SLC---DLPPSLEELNVSNNK----LIELPALPPRLERL 342
Query: 187 NVSGNHLSGQIPKSLS 202
S NHL+ ++P+
Sbjct: 343 IASFNHLA-EVPELPQ 357
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 15/110 (13%), Positives = 33/110 (30%), Gaps = 15/110 (13%)
Query: 105 PSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTL 164
P + T L+ +N E P ++ +++ + P +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 165 KLEANRFSGPITGLDLR------------NLQDFNVSGNHLSGQIPKSLS 202
+L L+L +L+ S N L+ ++P+
Sbjct: 64 RLRDCLDRQ-AHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQ 111
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 27/160 (16%), Positives = 54/160 (33%), Gaps = 18/160 (11%)
Query: 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNF 123
++S++ + + ++ ++ L L L N+ T SL L L L LS N+
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR--------FSGPI 175
+ S+++ L L L+ N ++P + ++ + L N F P
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 176 TGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
+ ++ N + S F
Sbjct: 288 YNTKKASYSGVSLFSNPV------QYWEIQPSTFRCVYVR 321
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 30/132 (22%), Positives = 51/132 (38%), Gaps = 10/132 (7%)
Query: 69 HLVLENLQL-SGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
+ L L S ++ + +L + + T P +LT L L N
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKIT 205
Query: 125 GEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL-DLRN 182
+ + L L +L LSFN+ S ++ + HL L L N+ GL D +
Sbjct: 206 -KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 264
Query: 183 LQDFNVSGNHLS 194
+Q + N++S
Sbjct: 265 IQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 21/113 (18%), Positives = 41/113 (36%), Gaps = 14/113 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF-- 123
L L LS ++ L + LR L L N+ L++ +++++L +NN
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 277
Query: 124 --NGEF--PDSVSSLFRLYRLDLSFNNFSGQI--PLTVNHLTHLLTLKLEANR 170
+ +F P + + L N P T + ++L +
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 30/166 (18%), Positives = 57/166 (34%), Gaps = 36/166 (21%)
Query: 72 LENLQLSG-SLQ--PLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEF 127
LE L LS L+ P L+ L + N T + L + ++ L N
Sbjct: 102 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161
Query: 128 --PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR--------FSG---- 173
+ + +L + ++ N + IP L L L+ N+ G
Sbjct: 162 IENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHLDGNKITKVDAASLKGLNNL 218
Query: 174 --------PITGLD------LRNLQDFNVSGNHLSGQIPKSLSGFP 205
I+ +D +L++ +++ N L ++P L+
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 32/135 (23%), Positives = 49/135 (36%), Gaps = 20/135 (14%)
Query: 88 TQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
+L L+ N+ T NL L L L +N + P + + L +L RL LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPITGL------DLRNLQDFNVSGNHLSGQIPKS 200
++P + L L++ N IT + L + + N L
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENE----ITKVRKSVFNGLNQMIVVELGTNPL------K 158
Query: 201 LSGFPDSAFTQNAAL 215
SG + AF L
Sbjct: 159 SSGIENGAFQGMKKL 173
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 41/219 (18%)
Query: 368 LGKGGFGTAYKAVLDD---GSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G +G YKA D A+K+++ S+ RE + +L L+HPN++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 423 AYYFAREEKL--LVSEYMPNGSLFWLLHGNRGPGRT----PLDWTTRLKIAAGAARGLAF 476
+ + ++ L+ +Y + L+ ++ +R L + G+ +
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 477 IHFTCKSLKLTHGNIKSTNVLLDKTGNAR----VSDFGLS-IFAPPSTVPRSNG------ 525
+H + + H ++K N+L+ G R ++D G + +F P P ++
Sbjct: 144 LH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVT 198
Query: 526 --YRAPEL---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
YRAPEL + R ++ D+++ G + ELLT +
Sbjct: 199 FWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSE 233
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 52/268 (19%), Positives = 80/268 (29%), Gaps = 49/268 (18%)
Query: 55 CSWTGVSCLQNR-----------VSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFT 101
S V+C + + L L L + L T+L L+L T
Sbjct: 10 ASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT 68
Query: 102 GPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTH 160
+ L L L LSHN P +L L LD+SFN + +PL L
Sbjct: 69 K-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE 125
Query: 161 LLTLKLEANRFSGPITGL--DLRNLQDFNVSGNHLSGQIPKS-----------------L 201
L L L+ N GL L+ +++ N+L+ ++P L
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 202 SGFPDSAFT----QNAALCGSPMQ-ACKTM------VTDPKKPGSDGAIASPLNPGNNPT 250
P F A L G+P C+ + + + +N
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVA 244
Query: 251 NVVSSTPSSIPTNTDPNNKPASPQKTSS 278
+V P P +
Sbjct: 245 SVQCDNSDKFPVYKYPGKGCPTLGDEGD 272
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 366 EMLGKGGFGTAYKA-VLDDGSVVAVKRLK-DASIG----GKREFEQHMEVLGRLRHPNLV 419
+ LG+G + T YK ++VA+K ++ + G RE + +L L+H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPL--DWTTRLKIAAGAARGLAFI 477
L + LV EY+ L L + +L RGLA+
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYC 116
Query: 478 HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNG-----YRAPEL 531
H K+ H ++K N+L+++ G +++DFGL+ + P+ N YR P++
Sbjct: 117 H----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDI 171
Query: 532 ---SSSDGRKQSQKSDVYSFGVLLLELLTGK 559
S S + D++ G + E+ TG+
Sbjct: 172 LLGS----TDYSTQIDMWGVGCIFYEMATGR 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 48/228 (21%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREF- 403
F KR++ + +G G G A VA+K+L KR +
Sbjct: 21 FTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR 73
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFAREEKL------LVSEYMPNGSLFWLLHGNRGPGRTP 457
E + ++ + H N++GL + ++ +V E M +L ++ +
Sbjct: 74 E--LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-------QME 123
Query: 458 LDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517
LD + G+ +H S + H ++K +N+++ ++ DFGL+ A
Sbjct: 124 LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 518 ST------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
S V R YRAPE+ + D++S G ++ E++ G
Sbjct: 180 SFMMTPYVVTRY--YRAPEVILG--MGYKENVDIWSVGCIMGEMIKGG 223
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 30/138 (21%), Positives = 47/138 (34%), Gaps = 20/138 (14%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
+ + L G + + L +L L N + + L L+ L LS N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 125 GEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGL---- 178
+ L RL+ L L ++ + L L L L+ N + L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA----LQALPDDT 148
Query: 179 --DLRNLQDFNVSGNHLS 194
DL NL + GN +S
Sbjct: 149 FRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 30/104 (28%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG 125
+L L++ L +L L L L L NR + P + L +L L L N
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
P + L RL L L NN S + L L L+L N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 29/120 (24%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 84 LTSL-----TQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRL 137
L ++ + + L NR + P S L +L+L N + + L L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 138 YRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFS--GPITGLDLRNLQDFNVSGNHLS 194
+LDLS N + + L L TL L+ GP L LQ + N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 54/221 (24%)
Query: 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497
+ S + L + + A+G+ F+ S K H ++ + N+L
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNIL 225
Query: 498 LDKTGNARVSDFGLSIFAPPSTVPRSNGYR------------APELSSSDGRKQSQKSDV 545
L + ++ DFGL+ + + Y APE + R + +SDV
Sbjct: 226 LSEKNVVKICDFGLA-----RDIYKDPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDV 278
Query: 546 YSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR----EEWTAEVFDLEL 600
+SFGVLL E+ + G P G + R ++ R + T E++ +
Sbjct: 279 WSFGVLLWEIFSLGASPY--------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMY--QT 328
Query: 601 MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
M C P QRP S +V+ + L
Sbjct: 329 ML----------------DCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 26/96 (27%), Positives = 39/96 (40%), Gaps = 9/96 (9%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPN 417
+ LG+G FG +A VAVK LK+ A+ R +++L + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 418 LVGLKAYYFAREEKLLV-SEYMPNGSLFWLLHGNRG 452
+V L L+V E+ G+L L R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 25/131 (19%), Positives = 44/131 (33%), Gaps = 7/131 (5%)
Query: 68 SHLVLENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
L L L L L L +LS++ N+ + L L+ L++L L N
Sbjct: 104 PSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEI 162
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL 183
++ L ++ +DL+ + L T+K R+ P + +
Sbjct: 163 --TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSY 220
Query: 184 QDFNVSGNHLS 194
D V
Sbjct: 221 VDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 36/130 (27%), Positives = 54/130 (41%), Gaps = 16/130 (12%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKL--LFLSHNNFNG 125
L+ L LS L PL LT+L LS+ NR +L+ + + L LFL +N
Sbjct: 65 LKELHLSHNQISDLSPLKDLTKLEELSVNRNRLK----NLNGIPSACLSRLFLDNNEL-- 118
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQ 184
DS+ L L L + N + L L+ L L L N + GL L+ +
Sbjct: 119 RDTDSLIHLKNLEILSIRNNKLKSIVML--GFLSKLEVLDLHGNEITN-TGGLTRLKKVN 175
Query: 185 DFNVSGNHLS 194
+++G
Sbjct: 176 WIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 25/128 (19%), Positives = 42/128 (32%), Gaps = 12/128 (9%)
Query: 72 LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF 127
L L L+ ++ + + + + T LK L LSHN
Sbjct: 21 AVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQI--SD 77
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDF 186
+ L +L L ++ N + L L L+ N L L+NL+
Sbjct: 78 LSPLKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNNELRD-TDSLIHLKNLEIL 133
Query: 187 NVSGNHLS 194
++ N L
Sbjct: 134 SIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 17/89 (19%), Positives = 30/89 (33%), Gaps = 6/89 (6%)
Query: 107 LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL 166
L L + S L + + +N + T+L L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQSLAGM--QFFTNLKELHL 70
Query: 167 EANRFSGPITGLD-LRNLQDFNVSGNHLS 194
N+ S ++ L L L++ +V+ N L
Sbjct: 71 SHNQISD-LSPLKDLTKLEELSVNRNRLK 98
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 46/251 (18%)
Query: 329 YSSSPYPAQQAGYERGSMVF---FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDG 384
+ + ++ + R + +E +R++ +G G +G+ A G
Sbjct: 3 HHHHHHSQERPTFYR-QELNKTIWEVPERYQNL-------SPVGSGAYGSVCAAFDTKTG 54
Query: 385 SVVAVKRLKDA---SIGGKREF-EQHMEVLGRLRHPNLVGLKAYYFAREEKL------LV 434
VAVK+L I KR + E + +L ++H N++GL + LV
Sbjct: 55 LRVAVKKLSRPFQSIIHAKRTYRE--LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKST 494
+ M L ++ L + RGL +IH S + H ++K +
Sbjct: 113 THLMGA-DLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPS 161
Query: 495 NVLLDKTGNARVSDFGLS-IFAPPST---VPRSNGYRAPE--LSSSDGRKQSQKSDVYSF 548
N+ +++ ++ DFGL+ A T R YRAPE L+ +Q D++S
Sbjct: 162 NLAVNEDCELKILDFGLARHTADEMTGYVATRW--YRAPEIMLNW---MHYNQTVDIWSV 216
Query: 549 GVLLLELLTGK 559
G ++ ELLTG+
Sbjct: 217 GCIMAELLTGR 227
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 32/154 (20%), Positives = 49/154 (31%), Gaps = 19/154 (12%)
Query: 68 SHLVLENLQLSG---SLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNF 123
L L L++S + P L L L +N+ + L + L L L HN
Sbjct: 170 DGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR--------FSGPI 175
S+S L L L L N S ++P + L L + L N F
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG 288
Query: 176 TGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209
G+ ++ N + + F
Sbjct: 289 FGVKRAYYNGISLFNNPV------PYWEVQPATF 316
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 20/130 (15%)
Query: 88 TQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
+L L+ N + L L L L +N + + S L +L +L +S N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPITGL------DLRNLQDFNVSGNHLSGQIPKS 200
+IP N + L+ L++ NR I + LRN+ + GN L
Sbjct: 114 LV-EIP--PNLPSSLVELRIHDNR----IRKVPKGVFSGLRNMNCIEMGGNPL------E 160
Query: 201 LSGFPDSAFT 210
SGF AF
Sbjct: 161 NSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 28/151 (18%), Positives = 47/151 (31%), Gaps = 28/151 (18%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG---PVPSLSNLTALKLLFLSHNN 122
L L++ + + L + + + N + L L L +S
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAK 183
Query: 123 FNGEFPDSVSSLFR-LYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGLD- 179
P L L L L N I L + L L L N+ I ++
Sbjct: 184 LT-GIP---KDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ----IRMIEN 234
Query: 180 -----LRNLQDFNVSGNHLSGQIPKSLSGFP 205
L L++ ++ N LS ++P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 14/113 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF-- 123
L L L ++ L+ L LR L L N+ + L +L L++++L NN
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK 278
Query: 124 --NGEFPD--SVSSLFRLYRLDLSFNNFSGQI--PLTVNHLTHLLTLKLEANR 170
+F + L N P T +T L ++ +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 38/214 (17%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGK-----REFEQHMEVLGRLRHPNL 418
LG+G +G YKA+ VA+KR++ + G RE + +L L+H N+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQHRNI 95
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
+ LK+ L+ EY N L + N + G+ F H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH 149
Query: 479 FTCKSLKLTHGNIKSTNVLLD-----KTGNARVSDFGLS-IFAPPSTVPRSNG-----YR 527
S + H ++K N+LL +T ++ DFGL+ F P ++ YR
Sbjct: 150 ----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYR 204
Query: 528 APE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
PE L S R S D++S + E+L
Sbjct: 205 PPEILLGS---RHYSTSVDIWSIACIWAEMLMKT 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 45/247 (18%)
Query: 335 PAQQAGYERGSMVF---FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVK 390
A MV F+ R+ +G+G +G A + VA+K
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNL-------SYIGEGAYGMVCSAYDNLNKVRVAIK 58
Query: 391 RLK--DASIGGKREF-EQHMEVLGRLRHPNLVGLKAYYFAREEKL-----LVSEYMPNGS 442
++ + +R E +++L R RH N++G+ A + +V + M
Sbjct: 59 KISPFEHQTYCQRTLRE--IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-D 115
Query: 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502
L+ LL L RGL +IH S + H ++K +N+LL+ T
Sbjct: 116 LYKLLKTQ------HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTC 165
Query: 503 NARVSDFGL--SIFAPPSTVPRSNG------YRAPE--LSSSDGRKQSQKSDVYSFGVLL 552
+ ++ DFGL YRAPE L+S ++ D++S G +L
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK---GYTKSIDIWSVGCIL 222
Query: 553 LELLTGK 559
E+L+ +
Sbjct: 223 AEMLSNR 229
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 61/412 (14%), Positives = 110/412 (26%), Gaps = 137/412 (33%)
Query: 305 YCY------FWRNYVKNKTRSKLLESEKILYSS--------SPYPAQQAGY------ERG 344
Y Y F +V N + + K + S S +
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 345 SMVFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFE 404
E ++F +E++LR + YK ++ +K
Sbjct: 76 E----EMVQKF-VEEVLRIN------------YKFLMS--------PIKTEQRQPSMMTR 110
Query: 405 QHMEVLGRLRHPNLVGLKAYYFAREEKLL-----VSEYMPNGSLFWLLHGNRGPGRTPLD 459
++E RL + N V Y +R + L + E P ++ + G G G+T +
Sbjct: 111 MYIEQRDRLYNDNQV-FAKYNVSRLQPYLKLRQALLELRPAKNVL--IDGVLGSGKTWV- 166
Query: 460 WTTRLKIAAGAARGLAFI-HFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518
A K L N S +L+ L P+
Sbjct: 167 -------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK-------LLYQIDPN 212
Query: 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVD 578
RS+ +L + + ++ LL C V+ +
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRR--------LLKSKPYENCLLVLL------------N 252
Query: 579 LPRWVQSVVREEWTAEVFDLE---LM--RYKDI----------------------EEEMV 611
V+ F+L L+ R+K + +E+
Sbjct: 253 --------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 612 GLLQVAMACTSASPDQRPNMSH-----VVKLI-EELRGVEVSPCH-ENFDSV 656
LL + P P + +I E +R +N+ V
Sbjct: 305 SLL---LKYLDCRPQDLPREVLTTNPRRLSIIAESIR---DGLATWDNWKHV 350
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 53/390 (13%), Positives = 122/390 (31%), Gaps = 121/390 (31%)
Query: 106 SLSNLTALKLLFLSHNNFN------GEF--PDSV-SSLFRLY-RLDLSFN---NFSGQIP 152
++ L +F P++V L +L ++D ++ + S I
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 153 LTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212
L ++ + L L++ + L L N+Q+ K+ + AF +
Sbjct: 225 LRIHSIQAELRRLLKSKPY--ENCLLVLLNVQN------------AKAWN-----AFNLS 265
Query: 213 AALCGSPMQACKTMVTDPKKPGSDGAIASPLNPGNNPTNVVSSTPSSIPTNTDPNNKPAS 272
CK ++T + L+ T++ D ++ +
Sbjct: 266 ----------CKILLTT-----RFKQVTDFLS-AATTTHISL----------DHHSMTLT 299
Query: 273 PQKTSS--SKISSVAV----IAIVVGDFLVLAIISLLLYCY-----FWRNYVKNKTRSKL 321
P + S K ++ + L+II+ + W++ +K + +
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 322 LESEKILYSSSPYPAQQAGYERGSMVFFEGTK--------------RFELEDLLRASAEM 367
S +L P ++ ++R S VF + ++ ++ ++
Sbjct: 360 ESSLNVL---EPAEYRKM-FDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVV---NKL 411
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVG---- 420
S+V K+ K+++I E + +E L H ++V
Sbjct: 412 HKY--------------SLVE-KQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNI 455
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLL--H 448
K + + +Y + + H
Sbjct: 456 PKTFDSDDLIPPYLDQY-----FYSHIGHH 480
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 30/158 (18%), Positives = 46/158 (29%), Gaps = 26/158 (16%)
Query: 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSH 120
+CL N + L + L+ +L P + L + N T L L+ +S
Sbjct: 36 ACLNNGNAVLNVGESGLT-TL-PDCLPAHITTLVIPDNNLTSLPALPPELRTLE---VSG 90
Query: 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP------LTVNHLT-------HLLTLKLE 167
N P L L + + N LT L L +
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149
Query: 168 ANRFSGPITGLD--LRNLQDFNVSGNHLSGQIPKSLSG 203
N+ + L L N L+ +P SG
Sbjct: 150 DNQ----LASLPALPSELCKLWAYNNQLT-SLPMLPSG 182
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 30/134 (22%), Positives = 45/134 (33%), Gaps = 17/134 (12%)
Query: 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFP 128
L + QL+ SL L+ LS+ N+ S L L +N P
Sbjct: 125 KLWIFGNQLT-SLPV--LPPGLQELSVSDNQLASLPALPSELCKLW---AYNNQLT-SLP 177
Query: 129 DSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNV 188
S L L +S N + +P + L L + L++ V
Sbjct: 178 MLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPS-----GLKELIV 228
Query: 189 SGNHLSGQIPKSLS 202
SGN L+ +P S
Sbjct: 229 SGNRLT-SLPVLPS 241
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 34/163 (20%), Positives = 59/163 (36%), Gaps = 17/163 (10%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLV-----LENLQLSGSLQPLTSL----TQLRVL 93
N+L + + P + NR++ L L+ L +SG+ LTSL ++L+ L
Sbjct: 191 NQLAS--LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGN--RLTSLPVLPSELKEL 246
Query: 94 SLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPL 153
+ NR T +P L + L L + N P+S+ L ++L N S +
Sbjct: 247 MVSGNRLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302
Query: 154 TVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQ 196
+ +T RF + + L
Sbjct: 303 ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 56/234 (23%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK---DASIGGKREFE 404
+ ++L LG+G + ++A+ + + V VK LK I KRE
Sbjct: 32 WGNQDDYQLV-------RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--KRE-- 80
Query: 405 QHMEVLGRLR-HPNLVGLKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPL-DW 460
+++L LR PN++ L + LV E++ N L L D+
Sbjct: 81 --IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDY 130
Query: 461 TTR------LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSI 513
R L + L + H S+ + H ++K NV++D + R+ D+GL+
Sbjct: 131 DIRFYMYEIL-------KALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
Query: 514 FAPPST------VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
F P R ++ PEL D + D++S G +L ++ K P
Sbjct: 180 FYHPGQEYNVRVASRY--FKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 50/251 (19%), Positives = 94/251 (37%), Gaps = 77/251 (30%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK--DASIGGKREF-E 404
+ + F+L+ +LG+G +G A G +VA+K+++ D + R E
Sbjct: 7 YNISSDFQLK-------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 405 QHMEVLGRLRHPNLVGLKAYYFAREEKL-----LVSEYMPNGSLFWLLHGNRGPGRTPLD 459
+++L +H N++ + + ++ E M LH
Sbjct: 60 --IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LH----------- 101
Query: 460 WTTRLKIAAGAA--------------RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505
++ + R + +H + H ++K +N+L++ + +
Sbjct: 102 -----RVISTQMLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLK 152
Query: 506 VSDFGLSIFAPPSTVPRSNG---------------YRAPE--LSSSDGRKQSQKSDVYSF 548
V DFGL+ S S YRAPE L+S+ K S+ DV+S
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA---KYSRAMDVWSC 209
Query: 549 GVLLLELLTGK 559
G +L EL +
Sbjct: 210 GCILAELFLRR 220
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 33/121 (27%), Positives = 48/121 (39%), Gaps = 8/121 (6%)
Query: 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALK 114
+ + V L L + L+ L L L + L L +NR P+L+ L L+
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLE 489
Query: 115 LLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN---NFSGQIPLTVNHLTHLLTLKLEANRF 171
+L S N E D V++L RL L L N + PL L+ L L+ N
Sbjct: 490 VLQASDNAL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLV--SCPRLVLLNLQGNSL 545
Query: 172 S 172
Sbjct: 546 C 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 30/192 (15%), Positives = 61/192 (31%), Gaps = 8/192 (4%)
Query: 7 LHFTLLILAVHFSLLKASTSPDL--NALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQ 64
L + + +L ++ + +L + C T + ++
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 65 N-RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
E LQ +L+ + + + L+ +++L L+H +
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRN 182
+ L + LDLS N +P + L L L+ N + G+ L
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPR 509
Query: 183 LQDFNVSGNHLS 194
LQ+ + N L
Sbjct: 510 LQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 31/129 (24%), Positives = 45/129 (34%), Gaps = 15/129 (11%)
Query: 73 ENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVS 132
+ L + +RVL L + T + L L + L LSHN P +++
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 133 SLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-------LRNLQD 185
+L L L S N + V +L L L L NR + L
Sbjct: 484 ALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR----LQQSAAIQPLVSCPRLVL 537
Query: 186 FNVSGNHLS 194
N+ GN L
Sbjct: 538 LNLQGNSLC 546
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 33/191 (17%), Positives = 58/191 (30%), Gaps = 34/191 (17%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHL-----VLENLQLSG-SLQPL-TSLTQLRVLSL 95
N+L+T P S + N+++ L +LE + L L T L VLS+
Sbjct: 110 NRLSTL--PELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSV 167
Query: 96 KYNRFTGPVPSLSNLTALKL------------------------LFLSHNNFNGEFPDSV 131
+ N+ T +L AL + N P+++
Sbjct: 168 RNNQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226
Query: 132 SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGN 191
SL + L N S +I +++ T FS + + +
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
Query: 192 HLSGQIPKSLS 202
+S
Sbjct: 287 WFPENKQSDVS 297
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 29/140 (20%), Positives = 49/140 (35%), Gaps = 24/140 (17%)
Query: 72 LENLQLSG-------SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
E L G SL + Q L L + +P + + +L ++ N
Sbjct: 36 WEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNAL- 92
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL--DLRN 182
P+ +S L LD N S +P L L ++ N+ +T L
Sbjct: 93 ISLPELPAS---LEYLDACDNRLS-TLP---ELPASLKHLDVDNNQ----LTMLPELPAL 141
Query: 183 LQDFNVSGNHLSGQIPKSLS 202
L+ N N L+ +P+ +
Sbjct: 142 LEYINADNNQLT-MLPELPT 160
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 49/275 (17%), Positives = 85/275 (30%), Gaps = 93/275 (33%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREF- 403
+ ++ ++G+G +G Y A + VA+K++ I KR
Sbjct: 22 VHVPDNYIIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR 74
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFAREEKL-----LVSEYMPNGSLFWLLHGNRGPGRTPL 458
E + L RL+ ++ L + +V E
Sbjct: 75 EITI--LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD------------------- 113
Query: 459 DWTTRLK--IAAGAA--------------RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502
+ LK G FIH + H ++K N LL++
Sbjct: 114 ---SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDC 166
Query: 503 NARVSDFGL--SIFAPPSTVPRSNG-------------------------YRAPE--LSS 533
+ +V DFGL +I + T ++ YRAPE L
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGG 568
+ ++ D++S G + ELL + D
Sbjct: 227 ENY---TKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 53/255 (20%), Positives = 90/255 (35%), Gaps = 60/255 (23%)
Query: 342 ERGSMVFFEG---TKRFELEDLLRASAEMLGKGGFGTAYKAV--LDDGSVVAVKRLKDAS 396
+ G +V G +R+E+ L G+G FG + + S VA+K +++
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNL-------GEGTFGKVVECLDHARGKSQVALKIIRNV- 56
Query: 397 IGGKREFEQHM---EVLGRLRHP------NLVGLKAYYFAREEKLLVSEYMPNGSLFWLL 447
+ E VL +++ V + ++ + E + + F L
Sbjct: 57 ---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFL 112
Query: 448 HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNA--- 504
N P +A L F+H +LTH ++K N+L +
Sbjct: 113 KEN---NFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLY 165
Query: 505 ----------------RVSDFGLSIFA--PPSTVPRSNGYRAPE--LSSSDGRKQSQKSD 544
RV+DFG + F +T+ + YR PE L +Q D
Sbjct: 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL----ELGWAQPCD 221
Query: 545 VYSFGVLLLELLTGK 559
V+S G +L E G
Sbjct: 222 VWSIGCILFEYYRGF 236
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 29/149 (19%), Positives = 61/149 (40%), Gaps = 9/149 (6%)
Query: 61 SCLQNRVSHLVLENLQLSGS----LQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKL 115
S + S++ ++N +SG+ + + ++ L N T + +LT L+
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 116 LFLSHNNFN--GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFS 172
L L N + + + + L +LD+S N+ S + LL+L + +N +
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 173 GPITGLDLRNLQDFNVSGNHLSGQIPKSL 201
I ++ ++ N + IPK +
Sbjct: 413 DTIFRCLPPRIKVLDLHSNKIK-SIPKQV 440
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 34/147 (23%), Positives = 55/147 (37%), Gaps = 18/147 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L +S L + SL++LR+L + +NR + L+ L LSHN
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLT--VNHLTHLLTLKLEANRFS----GPITGL 178
L LDLSFN F +P+ +++ L L L PI L
Sbjct: 83 KISCH---PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 179 DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
++ + + + + P+ L F
Sbjct: 139 NISKVL-LVLGETYGEKEDPEGLQDFN 164
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 39/211 (18%), Positives = 75/211 (35%), Gaps = 12/211 (5%)
Query: 1 MDAHKTLHFTLLILAVHFSLLKASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGV 60
+D L + + L S L+ L + + +N T+ +
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 61 SCLQN-RVSHLVLENLQLSGSLQ------PLTSLTQLRVLSLKYNRFTGPVPSL-SNLTA 112
+ + V + + N++L G L TSL L + + + F P + +
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 113 LKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFS 172
+ + + + S + LD S N + + HLT L TL L+ N+
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 173 --GPITGL--DLRNLQDFNVSGNHLSGQIPK 199
I + +++LQ ++S N +S K
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 37/155 (23%), Positives = 53/155 (34%), Gaps = 20/155 (12%)
Query: 72 LENLQLSG-SLQPL-----TSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN- 124
L L +S +Q L +L L L +N+ + LK L LS N F+
Sbjct: 47 LRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISC-HPTVNLKHLDLSFNAFDA 104
Query: 125 ----GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDL 180
EF ++ +L L LS + +V + HL K+ D
Sbjct: 105 LPICKEF----GNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDP 157
Query: 181 RNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
LQDFN H+ K D + A L
Sbjct: 158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 24/150 (16%), Positives = 46/150 (30%), Gaps = 5/150 (3%)
Query: 72 LENLQLSG-SLQ--PLTSLTQLRVLSLKYNRFT--GPVPSLSNLTALKLLFLSHNNFNGE 126
LE L LS L L+ L L +N F N++ LK L LS +
Sbjct: 71 LEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS 130
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDF 186
++ L L + + + + +L + LD+
Sbjct: 131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190
Query: 187 NVSGNHLSGQIPKSLSGFPDSAFTQNAALC 216
N+ +++ + + + S +
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 7/105 (6%)
Query: 92 VLSLKYNRFTGPVPSLSNLTA-LKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQ 150
++ N VP +L+ +L +S N + + + SL +L L +S N
Sbjct: 4 LVDRSKNGLIH-VPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 151 IPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLS 194
L L L N+ NL+ ++S N
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKISCHP--TVNLKHLDLSFNAFD 103
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 49/280 (17%), Positives = 88/280 (31%), Gaps = 108/280 (38%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM 407
++ R+E+ ++G G +G +A + VVA+K++ FE +
Sbjct: 49 WQIPDRYEIR-------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLI 94
Query: 408 -------EV--LGRLRHPNLVGL----KAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGP 453
E+ L RL H ++V + + ++L +V E
Sbjct: 95 DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-------------- 140
Query: 454 GRTPLDWTTRLK--IAAGAA--------------RGLAFIHFTCKSLKLTHGNIKSTNVL 497
+ K G+ ++H S + H ++K N L
Sbjct: 141 --------SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCL 188
Query: 498 LDKTGNARVSDFGLS-IFAPPSTVPRSNG------------------------------- 525
+++ + +V DFGL+ P
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248
Query: 526 YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSV 563
YRAPE L ++ DV+S G + ELL +V
Sbjct: 249 YRAPELILLQ---ENYTEAIDVWSIGCIFAELLNMIKENV 285
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 51/272 (18%), Positives = 91/272 (33%), Gaps = 66/272 (24%)
Query: 331 SSPYPAQQAGY--ERGSMVFFEG---TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDG 384
SS E + +G F + + G G FG +D+
Sbjct: 8 SSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKM-------GDGTFGRVLLCQHIDNK 60
Query: 385 SVVAVKRLKDASIGGKREFEQHM---EVLGRLRH-----PNLVGLKAYYFAREEKLLVSE 436
AVK +++ K+ ++L ++++ N+V + + L+ E
Sbjct: 61 KYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNV 496
+ SL+ ++ N + L ++ + LTH ++K N+
Sbjct: 117 PL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENI 168
Query: 497 LLDKTGNA-------------------------RVSDFGLSIFA--PPSTVPRSNGYRAP 529
LLD ++ DFG + F ++ + YRAP
Sbjct: 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAP 228
Query: 530 E--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
E L SD++SFG +L EL TG
Sbjct: 229 EVIL----NLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 56/228 (24%), Positives = 87/228 (38%), Gaps = 50/228 (21%)
Query: 366 EMLGKGGFGTAYKAV--LDDGSVVAVKRLKDASIGGKREFEQHM---EVLGRLRHP---- 416
+ LG+G FG + + G VAVK +K+ R E +VL L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNS 75
Query: 417 --NLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
V + ++ +V E + S + + N G P K+A + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSV 131
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNA-------------------RVSDFGLSIFA 515
F+H S KLTH ++K N+L ++ +V DFG + +
Sbjct: 132 NFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 516 --PPSTVPRSNGYRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
ST+ + YRAPE L SQ DV+S G +L+E G
Sbjct: 188 DEHHSTLVSTRHYRAPEVIL----ALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 32/137 (23%), Positives = 51/137 (37%), Gaps = 16/137 (11%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
L +L LS + + LR L L N S+L AL++L L +N+
Sbjct: 66 LHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIP----LTVNHLTHLLTLKLEANRFS----GPIT 176
++ + +L +L LS N S + P N L L+ L L +N+ +
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQ 184
Query: 177 GLDLRNLQDFNVSGNHL 193
L + N L
Sbjct: 185 KLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 7/84 (8%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFT----GPVPSLSNLTALKLLFLSHNN 122
L+L N + + + QL+ L L N+ + + + L L LL LS N
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNN 146
+ L + L +N
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 26/109 (23%), Positives = 42/109 (38%), Gaps = 24/109 (22%)
Query: 88 TQLRVLSLKYNRFT--GPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145
+ +L L +N + + + LT L L LSHN+ N ++ + L LDLS N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 146 NFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194
+ L L+ FS L+ L+ + NH+
Sbjct: 99 H------LHT----------LDEFLFSD------LQALEVLLLYNNHIV 125
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 51/239 (21%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREF-EQ 405
F+ R+ + LG GG G + AV D VA+K++ K E
Sbjct: 7 FDLGSRYMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE- 58
Query: 406 HMEVLGRLRHPNLVGLKAYYFAREEKL--------------LVSEYMPNGSLFWLLHGNR 451
++++ RL H N+V + +L +V EYM L +L
Sbjct: 59 -IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG- 115
Query: 452 GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFG 510
PL RGL +IH S + H ++K N+ ++ ++ DFG
Sbjct: 116 -----PLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 511 L--SIFAPPSTVPRSNG------YRAPE--LSSSDGRKQSQKSDVYSFGVLLLELLTGK 559
L + S + YR+P LS + ++ D+++ G + E+LTGK
Sbjct: 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGK 222
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 18/143 (12%)
Query: 72 LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFN 124
+ L LS L+ ++ L++LRVL L +NR L+ L +SHN
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL- 112
Query: 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV--NHLTHLLTLKLEANRFS----GPITGL 178
+ L LDLSFN+F +P+ +LT L L L A +F P+ L
Sbjct: 113 QNISCCP--MASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 179 DLRNLQDFNVSGNHLSGQIPKSL 201
L + ++ H+ G +SL
Sbjct: 170 HLSCIL-LDLVSYHIKGGETESL 191
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 27/119 (22%), Positives = 43/119 (36%), Gaps = 7/119 (5%)
Query: 77 LSGSLQPLTSLTQLRVLSLKYNRFT-GPVPSL-SNLTALKLLFLSHNNFNGEFPDSVSSL 134
+++ L L + N + ++ +L LS N G +
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP- 450
Query: 135 FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF-SGPITGLD-LRNLQDFNVSGN 191
++ LDL N IP V HL L L + +N+ S P D L +LQ + N
Sbjct: 451 -KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 31/174 (17%), Positives = 56/174 (32%), Gaps = 9/174 (5%)
Query: 29 LNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQN-RVSHLVLENLQLSGSLQ----- 82
+ L + N T+ CS V +L + NL ++ +
Sbjct: 239 MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT 298
Query: 83 -PLTSLTQLRVLSLKYNRFTGPVPSL-SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRL 140
T+L L + +K F +L S + + LS ++ S L
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL 358
Query: 141 DLSFNNFSGQIPLTVNHLTHLLTLKLEANRF-SGPITGLDLRNLQDFNVSGNHL 193
+ + N F+ + + L L TL L+ N + L +N+ L
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 35/155 (22%), Positives = 58/155 (37%), Gaps = 21/155 (13%)
Query: 55 CSWTGVSCLQNR-----------VSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFT 101
CS V C ++ + LE + + P + +LR + L N+ +
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS 69
Query: 102 G-PVPSLSNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHL 158
+ L +L L L N E P S+ LF L L L+ N + + + L
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 159 THLLTLKLEANRFSGPITGL--DLRNLQDFNVSGN 191
+L L L N+ G LR +Q +++ N
Sbjct: 128 HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 23/87 (26%), Positives = 33/87 (37%), Gaps = 8/87 (9%)
Query: 69 HLV-LENLQLSG----SLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSH 120
L L +L L G L L L++L L N+ V + +L L LL L
Sbjct: 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 121 NNFNGEFPDSVSSLFRLYRLDLSFNNF 147
N + S L + + L+ N F
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 6/114 (5%)
Query: 82 QPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141
T ++ L +LS L A K L LS NN E S+S + L L
Sbjct: 20 VVATEAEKVE-LHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILS 76
Query: 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDFNVSGNHLS 194
L N +I L L + N+ + ++G++ L NL+ +S N ++
Sbjct: 77 LGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 30/141 (21%), Positives = 48/141 (34%), Gaps = 16/141 (11%)
Query: 55 CSWTGVSCLQNRVSHLV-LENLQLSG----SLQPLTSLTQLRVLSLKYNRFTGPVPSLSN 109
+ + +S L ++L LS + L+ + LR+LSL N +
Sbjct: 32 GMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKIENLDAV 91
Query: 110 LTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN---NFSGQIPLTVNHLTHLLTLKL 166
L+ L++S+N + L L L +S N N+ L L L L L
Sbjct: 92 ADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLL 147
Query: 167 EANRFSGPITGLDLRNLQDFN 187
N P+ N
Sbjct: 148 AGN----PLYNDYKENNATSE 164
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 42/160 (26%), Positives = 65/160 (40%), Gaps = 22/160 (13%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQ--PLTSLTQLRVLSLKYNRF 100
N + + +++G+S LQ LV L+ SL+ P+ L L+ L++ +N
Sbjct: 86 NPIQS----LALGAFSGLSSLQ----KLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 101 TG-PVPSL-SNLTALKLLFLSHNNF----NGEFPDSVSSLFRLY-RLDLSFNNFSGQIPL 153
+P SNLT L+ L LS N + + + L LDLS N + I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 154 TVNHLTHLLTLKLEANRFSG-PITGLD-LRNLQDFNVSGN 191
L L L+ N+ P D L +LQ + N
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 9/113 (7%)
Query: 88 TQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
+ L L +N S + L++L LS + SL L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 147 FSGQIPLTV-NHLTHLLTLKLEANRF----SGPITGLDLRNLQDFNVSGNHLS 194
+ L + L+ L L + PI L+ L++ NV+ N +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELNVAHNLIQ 137
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 61/248 (24%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDA---SIGGKREF- 403
+++EL + LGKG +G +K++ G VVAVK++ DA S +R F
Sbjct: 5 RHVLRKYELV-------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR 57
Query: 404 EQHMEVLGRLR-HPNLVGLKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGPGRTPLDW 460
E + +L L H N+V L A ++ LV +YM L ++ N L+
Sbjct: 58 E--IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILE- 107
Query: 461 TTRLK-IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL--SIFAPP 517
+ + + + ++H S L H ++K +N+LL+ + +V+DFGL S
Sbjct: 108 PVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 518 STVPRSNG------------------------YRAPE--LSSSDGRKQSQKSDVYSFGVL 551
YRAPE L S+ K ++ D++S G +
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST---KYTKGIDMWSLGCI 220
Query: 552 LLELLTGK 559
L E+L GK
Sbjct: 221 LGEILCGK 228
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 26/153 (16%), Positives = 54/153 (35%), Gaps = 20/153 (13%)
Query: 72 LENLQLSG----SLQP---LTSLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNN 122
L L L G +L + LT+L++L + + + LT L+ L + ++
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGL--- 178
P S+ S+ + L L + + V+ + + L+L + L
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
Query: 179 ------DLRNLQDFNVSGNHLSGQIPKSLSGFP 205
++ ++ L Q+ K L+
Sbjct: 246 ETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 14/84 (16%), Positives = 24/84 (28%), Gaps = 4/84 (4%)
Query: 68 SHLVLENLQLS----GSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNF 123
L+ S G L R + + + L+ ++ L L S N
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289
Query: 124 NGEFPDSVSSLFRLYRLDLSFNNF 147
L L ++ L N +
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 16/118 (13%), Positives = 33/118 (27%), Gaps = 6/118 (5%)
Query: 87 LTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSF 144
+ L L P + SNL + +++S + + +L ++ +++
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 145 NNFSGQIPLTV-NHLTHLLTLKLEANR---FSGPITGLDLRNLQDFNVSGNHLSGQIP 198
I L L L + F ++ N IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 3e-07
Identities = 41/240 (17%), Positives = 73/240 (30%), Gaps = 61/240 (25%)
Query: 368 LGKGGFGTAYKAVLDDGSVVAVKRL---KDASIGGKREF---EQHMEVL----------- 410
+G+G FG ++ + D + VA+K + + G + E E++
Sbjct: 28 IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 411 GRLRHPNLVGLKAYY------------------------------FAREEKLLVSEYMPN 440
R +GL + + F ++ +V E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK 500
G T I LA SL+ H ++ NVLL K
Sbjct: 147 GIDL------EQMRTKLSSLATAKSILHQLTASLAVAE---ASLRFEHRDLHWGNVLLKK 197
Query: 501 TGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKC 560
T ++ ST+P S G + + + R + V+ + +L TG
Sbjct: 198 TSLKKLHYTLNG---KSSTIP-SCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 28/115 (24%), Positives = 41/115 (35%), Gaps = 8/115 (6%)
Query: 65 NRVSHLVLENLQLSGS--LQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNN 122
+ V LVL+N + + +L LS T + +L L LK L LS N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNR 75
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPIT 176
+G L L+LS N + L +L +L L +T
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 21/113 (18%), Positives = 42/113 (37%), Gaps = 6/113 (5%)
Query: 82 QPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141
+ + + +L + + + N L+ L + ++ L +L +L+
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLE 70
Query: 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGL-DLRNLQDFNVSGN 191
LS N SG + + +L L L N+ I L L NL+ ++
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 21/161 (13%), Positives = 48/161 (29%), Gaps = 24/161 (14%)
Query: 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTAL 113
CS C +++V+ + P L + + S L
Sbjct: 9 CSNRVFLCQESKVTEI------------PSDLPRNAIELRFVLTKLRVIQKGAFSGFGDL 56
Query: 114 KLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRF 171
+ + +S N+ V S+L +L+ + + N I +L +L L +
Sbjct: 57 EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116
Query: 172 SG--PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210
+ + ++ N ++ ++F
Sbjct: 117 KHLPDVHKIHSLQKVLLDIQDN-------INIHTIERNSFV 150
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 18/125 (14%), Positives = 36/125 (28%), Gaps = 11/125 (8%)
Query: 73 ENLQLS----GSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEF 127
+N+ + S L+ +L L N + + +L +NN
Sbjct: 137 DNINIHTIERNSFVGLSFE--SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGLDLRNLQDF 186
D LD+S +P +L L + + L L +
Sbjct: 195 NDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTLEK--LVALMEA 251
Query: 187 NVSGN 191
+++
Sbjct: 252 SLTYP 256
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-07
Identities = 31/115 (26%), Positives = 38/115 (33%), Gaps = 8/115 (6%)
Query: 65 NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNN 122
V LVL+N + + L LSL V +L L LK L LS N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENR 82
Query: 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPIT 176
G L L L+LS N L L L +L L +T
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC----EVT 133
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 42/229 (18%)
Query: 366 EMLGKGGFGTAYKAV---------LDDGSVVAVK------RLKDASIGGKREFEQHM-EV 409
+ G Y+A ++K RL + +R +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 410 LGRLRHPNLVGL-KAYYFAREEK---LLVSEYMPNG-SLFWLLHGNRGPGRTPLDWTTRL 464
+L L+ + F + LV + G SL L + + L + L
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVS---PKHVLSERSVL 162
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV--SDFGLS-IFAPPST-V 520
++A L F+H + HGN+ + N+ +D ++V + +G + + P V
Sbjct: 163 QVACRLLDALEFLH----ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 521 PRSNGYRAP-----ELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCP 561
G R+P E S D G S++SD+ S G +L+ L G P
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 22/111 (19%), Positives = 34/111 (30%), Gaps = 5/111 (4%)
Query: 84 LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143
T+ + R L L+ + + L + S N D L RL L ++
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 72
Query: 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGL-DLRNLQDFNVSGN 191
N L L L L N + L L++L + N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 15/113 (13%)
Query: 72 LENLQLSGSLQP-----LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGE 126
L L G P +L Q + N + L LK L +++N
Sbjct: 21 DRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRI 79
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLK---LEANRFSGPIT 176
+L L L L+ N+ ++ L L +L + N P+T
Sbjct: 80 GEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN----PVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 18/92 (19%), Positives = 32/92 (34%), Gaps = 5/92 (5%)
Query: 105 PSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTL 164
+N + L L + ++L + +D S N ++ L L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTL 69
Query: 165 KLEANRFS--GPITGLDLRNLQDFNVSGNHLS 194
+ NR G L +L + ++ N L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 43/157 (27%), Positives = 63/157 (40%), Gaps = 26/157 (16%)
Query: 70 LVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGE 126
L L++ +LS SL LT+LR+L L N+ P L L+ L+++ N
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 127 FPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRFSGPITGL------ 178
P V L L L L N +P V + LT L L L N + L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE----LQSLPKGVFD 154
Query: 179 DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
L +L++ + N L K + P+ AF + L
Sbjct: 155 KLTSLKELRLYNNQL-----KRV---PEGAFDKLTEL 183
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 34/104 (32%), Positives = 42/104 (40%), Gaps = 4/104 (3%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNG 125
L L+ QL SL P SLT+L LSL YN P LT+LK L L +N
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171
Query: 126 EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
+ L L L L N + L L L+L+ N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 37/134 (27%), Positives = 51/134 (38%), Gaps = 18/134 (13%)
Query: 69 HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVPSLS-----NLTALKLLFLSHN 121
L + + +L +L L L L L N+ SL +LT L L L +N
Sbjct: 89 TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK----SLPPRVFDSLTKLTYLSLGYN 143
Query: 122 NFNGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRF-SGPITGL 178
P V L L L L N ++P + LT L TLKL+ N+ P
Sbjct: 144 ELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 179 D-LRNLQDFNVSGN 191
D L L+ + N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 4/108 (3%)
Query: 65 NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHN 121
++ + N +++ ++ + + + L NR L +LK L L N
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169
DS L + L L N + P + L L TL L AN
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 32/175 (18%), Positives = 53/175 (30%), Gaps = 44/175 (25%)
Query: 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSL-----TQLRVLSLKYNRFTG--PVPSL 107
C T V C S Q L + L L N FT
Sbjct: 11 CEGTTVDC-----------------SNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIF 53
Query: 108 SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKL 166
L L+ + S+N + + + L+ N + + L L TL L
Sbjct: 54 KKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLML 112
Query: 167 EANRFSGPITGL------DLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
+NR IT + L +++ ++ N + ++ AF +L
Sbjct: 113 RSNR----ITCVGNDSFIGLSSVRLLSLYDNQI-----TTV---APGAFDTLHSL 155
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 42/214 (19%), Positives = 78/214 (36%), Gaps = 32/214 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGL-KA 423
+G G FG Y + G VA+K + + E ++ ++ VG+
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQ--GGVGIPTI 70
Query: 424 YYFAREEK--LLVSEYM-PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+ E ++V E + P+ + + T L +A + +IH
Sbjct: 71 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIH-- 122
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNA---RVSDFGLSI-FAPPST---VPRSNGY------R 527
S H ++K N L+ + DFGL+ + T +P R
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 528 APELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+++ G +QS++ D+ S G +L+ G P
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 1e-05
Identities = 35/206 (16%), Positives = 66/206 (32%), Gaps = 27/206 (13%)
Query: 24 STSPDLNALLDFKASSDEANKLTTWNSTSDPC--SWTGVSCLQNRVSHLV-LENLQLSGS 80
S + +++ K L + + SW L + + L NL++ G+
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 81 LQ---PLTSLTQLRVLSLKYNRFTGPVP------SLSNLTALKLLFLSHNNFNGEFPDSV 131
L+ L + V L NL L L + +
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242
Query: 132 SSLF------RLYRLDLSFNNFSGQIP---LTVNHLTHLLTLKLEANRFSGP-----ITG 177
LF L L + + L + L L T+ + A + +
Sbjct: 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDH 302
Query: 178 LD-LRNLQDFNVSGNHLSGQIPKSLS 202
+D +++L+ N+ N+LS ++ K L
Sbjct: 303 VDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 17/98 (17%), Positives = 30/98 (30%), Gaps = 2/98 (2%)
Query: 98 NRFTGPVPSLSNLTALKLLFLSHNNFNGEFPD-SVSSLFRLYRLDLSFNNFSGQIPLTVN 156
+ + L L L++ + + L L L + + P +
Sbjct: 18 DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH 77
Query: 157 HLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHL 193
L L L N + +LQ+ +SGN L
Sbjct: 78 FTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 14/81 (17%), Positives = 23/81 (28%), Gaps = 3/81 (3%)
Query: 128 PDSVSSLFRLYRLDLSFNNFSGQIPL-TVNHLTHLLTLKLEANRFS--GPITGLDLRNLQ 184
+ L L + + L + L L L + + P L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 185 DFNVSGNHLSGQIPKSLSGFP 205
N+S N L K++ G
Sbjct: 84 RLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 24/110 (21%), Positives = 38/110 (34%), Gaps = 18/110 (16%)
Query: 55 CSW-TGVSCLQN-------------RVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYN 98
+G+ C ++ ++ L +EN Q L+ L L +LR L++ +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 99 RFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
+ L L LS N +V L L L LS N
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 36/215 (16%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVK--RLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+G+G FG ++ L + VA+K + + + E+ + + G PN+ Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV-----Y 72
Query: 425 YFAREEK--LLVSEYM-PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
YF +E +LV + + P+ L G + T A + IH
Sbjct: 73 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIH--- 123
Query: 482 KSLKLTHGNIKSTNVLLDKTGNAR-----VSDFGLS-IFAPPST---VPRSNGY------ 526
L + +IK N L+ + + V DFG+ + P T +P
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
R +++ GR+QS++ D+ + G + + L G P
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 45/230 (19%), Positives = 81/230 (35%), Gaps = 44/230 (19%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKR----EFEQH----------MEVLG 411
+G+GGFG Y A ++ V + E ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 412 RLRHPNLVGL-KAYYFAREEK------LLVSEYMPNG-SLFWLLHGNRGPGRTPLDWTTR 463
R R +G+ K + +K ++ + G L + R T
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAKRFSR--KTV 154
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV--SDFGLS-IFAPPST- 519
L+++ L +IH + HG+IK++N+LL+ +V D+GL+ + P
Sbjct: 155 LQLSLRILDILEYIH----EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 520 --VPRSNGYR---APELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCP 561
E +S D G S++ D+ G +++ LTG P
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 43/228 (18%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-DASIGGKREFEQH----------MEVLGRL 413
+ +G GGFG Y A + A +K + G E ++
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 414 RHPNLVGL-KAYYFAREEK------LLVSEYMPNG-SLFWLLHGNRGPGRTPLDWTTRLK 465
+ + +G+ Y E +V E + G L + N +T L+
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG-----TFKKSTVLQ 155
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV--SDFGLS-IFAPPST-VP 521
+ L +IH + HG+IK+ N+LL +V +D+GLS + P
Sbjct: 156 LGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 522 RSNGYRAP-----ELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCP 561
R E +S D G S++SDV G +L L GK P
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 45/262 (17%), Positives = 82/262 (31%), Gaps = 84/262 (32%)
Query: 367 MLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH-MEVLGRLRH--PNLVGLK 422
LG G F T + + + VA+K +K S E + +L +R+ PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPN-- 99
Query: 423 AYYFAREEKLLVS-EYM-PNG------------SLFWLLHGNRGPGRTPLDWTTRLKIAA 468
+LL + NG L + + PL + I
Sbjct: 100 -REMVV--QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNY-QGLPLPCVKK--IIQ 153
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLL------------------------------ 498
+GL ++H C+ + H +IK N+LL
Sbjct: 154 QVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 499 -------------------DKTGNARVSDFGLSIFA--PPSTVPRSNGYRAPELSSSDGR 537
+ +++D G + + + ++ YR+ E+ G
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI--GS 268
Query: 538 KQSQKSDVYSFGVLLLELLTGK 559
+ +D++S + EL TG
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 70 LVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGE 126
L L++ L+ +L LT+L L+L YN+ +LT L L L++N
Sbjct: 40 LDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 127 FPDSV-SSLFRLYRLDLSFNNFSGQIPLTV-NHLTHLLTLKLEANRF-SGPITGLD-LRN 182
P V L +L +L L N +P V + LT L L+L N+ S P D L N
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 183 LQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAAL 215
LQ ++S N L +S+ P AF + L
Sbjct: 157 LQTLSLSTNQL-----QSV---PHGAFDRLGKL 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 32/212 (15%)
Query: 368 LGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGL-KAYY 425
+G G FG Y + VA+K + + +E ++ L+ G+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKIYRILQ--GGTGIPNVRW 70
Query: 426 FAREEK--LLVSEYM-PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
F E +LV + + P+ + + L T L +A + F+H
Sbjct: 71 FGVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVH---- 120
Query: 483 SLKLTHGNIKSTNVLLDKTGNAR---VSDFGLS-IFAPPST---VPRSNGY------RAP 529
S H +IK N L+ A + DFGL+ + ST +P R
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 530 ELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+++ G +QS++ D+ S G +L+ L G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 49/184 (26%), Positives = 69/184 (37%), Gaps = 28/184 (15%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVS------------HLVLENLQLSGSLQPLTSLTQL 90
+T + ++ S + + + +L L +L + L LT L
Sbjct: 29 KSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DISALKELTNL 87
Query: 91 RVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSFNNFS 148
L L N+ P LT LK L L N PD V L L L+L+ N
Sbjct: 88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 149 GQIPLTV-NHLTHLLTLKLEANRF-SGPITGLD-LRNLQDFNVSGNHLSGQIPKSLSGFP 205
+P V + LT+L L L N+ S P D L L+D + N L KS+ P
Sbjct: 147 -SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL-----KSV---P 197
Query: 206 DSAF 209
D F
Sbjct: 198 DGVF 201
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 46/154 (29%), Positives = 64/154 (41%), Gaps = 20/154 (12%)
Query: 55 CSWTGVSCLQNRVS-----------HLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFT 101
CS T V C R + L L + Q++ L+P SL L+ L L N+
Sbjct: 19 CSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG 77
Query: 102 G-PVPSLSNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSFNNFSGQIPLTVNHLT 159
PV +LT L +L L N P +V L L L + N + +P + LT
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLT 135
Query: 160 HLLTLKLEANRF-SGPITGLD-LRNLQDFNVSGN 191
HL L L+ N+ S P D L +L + GN
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.83 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.75 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.74 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.74 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.73 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.72 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.72 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.72 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.72 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.71 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.71 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.66 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.66 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.66 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.65 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.64 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.64 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.63 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.63 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.63 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.63 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.63 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.63 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.63 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.63 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.63 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.62 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.62 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.62 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.62 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.61 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.61 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.6 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.6 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.59 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.59 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.59 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.59 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.59 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.59 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.56 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.56 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.55 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.55 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.52 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.52 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.52 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.5 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.49 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.47 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.46 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.45 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.43 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.42 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.39 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.32 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.29 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.26 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.25 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.22 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.93 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.71 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.66 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.35 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.05 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.0 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.3 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.25 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.24 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.55 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.41 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.37 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.17 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.01 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.0 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.28 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.13 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.47 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.21 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.9 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.92 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.36 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=442.92 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=203.3
Q ss_pred hcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.++||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 478999999999999864 47899999998877667789999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEec
Q 005880 439 PNGSLFWLLHGNRGP----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
++|+|.++++..... ...+++|.++++|+.|||+||+||| +.+||||||||+|||+++++++||+|
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCcEEEcc
Confidence 999999999865321 2346999999999999999999999 78999999999999999999999999
Q ss_pred cCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChh
Q 005880 509 FGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLP 580 (672)
Q Consensus 509 fG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 580 (672)
||+++..... ...+|+.|||||++. +..++.++|||||||++|||+| |+.||... ...
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~------------~~~ 267 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------------SNT 267 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHT--TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS------------CHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhc--CCCCCccccccchHHHHHHHHcCCCCCCCCC------------CHH
Confidence 9999865432 345788999999765 5689999999999999999999 89999643 223
Q ss_pred HHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 581 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
+.+..+..... ...+ .....++.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 268 ~~~~~i~~g~~--------~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 268 EAIDCITQGRE--------LERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHTCC--------CCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCC--------CCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 33333322211 1111 1223467888999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=440.86 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=206.4
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3578999999999999864 4788999999877766778999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 438 MPNGSLFWLLHGNR--------GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 438 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
|++|+|.++|+... ......++|.++++|+.|+|+||+||| +++||||||||+|||+++++++||+||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEEECCc
Confidence 99999999997642 123356999999999999999999999 789999999999999999999999999
Q ss_pred CCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhH
Q 005880 510 GLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPR 581 (672)
Q Consensus 510 G~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 581 (672)
|+|+..... ...+|..|||||++. +..++.++|||||||++|||+| |+.||... ...+
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~------------~~~~ 238 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL------------SNNE 238 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------------CHHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------------CHHH
Confidence 999765432 234688999999875 4689999999999999999999 89999643 2233
Q ss_pred HHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 582 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.+..+...... ..+ .....++.+++.+||+.||++||||.||++.|+++.+
T Consensus 239 ~~~~i~~~~~~--------~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 VIECITQGRVL--------QRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHHHTCCC--------CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC--------CCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33333332211 011 1233467889999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=432.60 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=200.4
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||+||+|++++ .||||+++... ....++|.+|++++++++|||||+++|++. ++..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 45789999999999999763 59999987433 334578999999999999999999999875 45689999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---- 517 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 517 (672)
+|.++|+... .+++|.++..|+.|||+||+||| +.+||||||||+|||+++++++||+|||+|+....
T Consensus 117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999997543 45999999999999999999999 78999999999999999999999999999986543
Q ss_pred ---CCCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 ---STVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
....||+.|||||++... ...++.++|||||||++|||+||+.||.... ....+.........
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~------------~~~~~~~~~~~~~~- 255 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN------------NRDQIIFMVGRGYA- 255 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC------------CHHHHHHHHHTTCC-
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC------------hHHHHHHHHhcCCC-
Confidence 145789999999987543 4568999999999999999999999996432 12222223322211
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.+.... ........+.+++.+||+.||++||||.||++.|+.++.
T Consensus 256 ---~p~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 256 ---SPDLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ---CCCSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ---CCCccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111111 011233467888999999999999999999999998864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=436.87 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=203.6
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..++|||
T Consensus 30 ~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 30 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEE
Confidence 3578999999999999963 468899999975433 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEE
Q 005880 437 YMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~k 505 (672)
||++|+|.++|+..... ....++|.++++|+.|||+||+||| +.+||||||||+|||+++++++|
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCCCCEE
Confidence 99999999999754311 1246999999999999999999999 78999999999999999999999
Q ss_pred EeccCCCccCCC-------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCC
Q 005880 506 VSDFGLSIFAPP-------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAV 577 (672)
Q Consensus 506 l~DfG~a~~~~~-------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~ 577 (672)
|+|||+++.... ....+|..|||||++. +..++.++|||||||++|||+| |+.||...
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~------------ 251 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------------ 251 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC------------
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHh--CCCCCccchhhhHHHHHHHHHhCCCCCCCCC------------
Confidence 999999986532 2356788999999775 4689999999999999999999 89999643
Q ss_pred ChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
...+.+..+..... .. ..+.+...+.+++.+||+.||++||||.||++.|+.+.
T Consensus 252 ~~~~~~~~i~~~~~-~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 252 SNQDVVEMIRNRQV-LP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp CHHHHHHHHHTTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CHHHHHHHHHcCCC-CC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22233333322211 11 11223456788999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=428.00 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=200.1
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC----eEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE----EKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|++. |+.||||+++.... ....++.|+..+.+++|||||+++|++.+++ ..+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 478999999999999985 89999999975432 2233455666777899999999999998654 57999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----CCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC----KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+|.++++.. +++|..+.+|+.|+|+||+|||+.+ .+.+||||||||+|||+++++++||+|||+|+...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999854 3899999999999999999999431 13499999999999999999999999999997653
Q ss_pred CC---------CCCCCCcccCCCccccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC-CCC--CCCCChh
Q 005880 517 PS---------TVPRSNGYRAPELSSSD----GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG-MGC--GGAVDLP 580 (672)
Q Consensus 517 ~~---------~~~~t~~y~aPE~l~~~----~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~-~~~--~~~~~~~ 580 (672)
.. ...||+.|||||++... ...+++++|||||||++|||+||++||........ +.. .......
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 32 34689999999987532 12467899999999999999999998865433211 100 0111222
Q ss_pred HHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 581 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.+......+ ..++.........+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 240 ~~~~~~~~~-----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 240 EMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcc-----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 222222221 12222211111234566788999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=428.58 Aligned_cols=239 Identities=20% Similarity=0.328 Sum_probs=199.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 367999999999999965 6999999999765555667789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... .+++.++..|+.||+.||+||| +.+||||||||+|||++.++++||+|||+|+.....
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 9999753 3899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...||+.|||||++. +..|+.++|||||||++|||++|+.||.... ..+.+..+... .. +
T Consensus 229 ~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------------~~~~~~~i~~~-~~-----~ 288 (346)
T 4fih_A 229 SLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------------PLKAMKMIRDN-LP-----P 288 (346)
T ss_dssp CCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHHS-SC-----C
T ss_pred ccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------------HHHHHHHHHcC-CC-----C
Confidence 567999999999875 5678999999999999999999999996432 22222222221 11 1
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... .....++.+++.+||+.||++|||+.|+++
T Consensus 289 ~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKNL---HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSCG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 122335678888999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=422.28 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=197.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.++||+|+||.||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+++..|||||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999964 699999999975432 24799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCCC----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~---- 518 (672)
.++++.. .++++.++..|+.||++||+||| +.+||||||||+|||++.++ ++||+|||+|+.....
T Consensus 138 ~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 138 GQLIKQM-----GCLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999754 35999999999999999999999 88999999999999999987 6999999999876432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...||+.|||||++. +..++.++|||||||++|||+||+.||......+ + ...+..+...
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------~---~~~i~~~~~~ 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVM--GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---------L---CLKIASEPPP 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---------C---HHHHHHSCCG
T ss_pred ceecCCccccCccccCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---------H---HHHHHcCCCC
Confidence 346899999999875 5679999999999999999999999997543221 1 1222222110
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. ...+. ....+.+++.+||+.||++|||+.|+++.|....+
T Consensus 275 ~~------~~~~~---~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 275 IR------EIPPS---CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GG------GSCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ch------hcCcc---CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 00 01111 22356778889999999999999999998877654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=410.00 Aligned_cols=238 Identities=25% Similarity=0.420 Sum_probs=191.4
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc----CCeEEEEEeec
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA----REEKLLVSEYM 438 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 438 (672)
+.||+|+||.||+|... ++..||||++.... ....+.|.+|++++++++|||||++++++.+ ++..++|||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 57999999999999965 68999999997543 2345679999999999999999999999865 34578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeCC-CCcEEEeccCCCccC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLDK-TGNARVSDFGLSIFA 515 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~ 515 (672)
++|+|.++++.. ..+++..+..|+.||++||+||| +++ ||||||||+|||++. ++.+||+|||+|+..
T Consensus 112 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH----~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 112 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999754 35999999999999999999999 555 999999999999984 799999999999865
Q ss_pred CCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 516 PPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 516 ~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
... ...||+.|||||++. ..++.++|||||||++|||+||+.||.... ........+. ....
T Consensus 183 ~~~~~~~~~GTp~YmAPE~~~---~~y~~~~DiwSlGvilyelltg~~Pf~~~~-----------~~~~~~~~i~-~~~~ 247 (290)
T 3fpq_A 183 RASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----------NAAQIYRRVT-SGVK 247 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----------SHHHHHHHHT-TTCC
T ss_pred CCCccCCcccCccccCHHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----------cHHHHHHHHH-cCCC
Confidence 543 567999999999874 358999999999999999999999996421 2222222222 2111
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...++ .. ...++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~------~~---~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PASFD------KV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGGGG------GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCC------cc---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 11 1234678888999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=424.65 Aligned_cols=240 Identities=22% Similarity=0.384 Sum_probs=195.8
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+|||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 47899999999999995 4699999999975432 34578999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ...+++.+++.|+.||+.||+||| +.+||||||||+|||+++++++||+|||+|+.....
T Consensus 109 ~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 109 DLFKRINAQK---GVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp BHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred cHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 9999997543 245799999999999999999999 789999999999999999999999999999877643
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...||+.|||||++. +..|+.++|||||||++|||+||+.||... +..+.+..+.......
T Consensus 182 ~~~~~GT~~YmAPE~l~--~~~y~~~~DiwSlGvilyemltG~~PF~~~------------~~~~~~~~i~~~~~~~--- 244 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICE--NKPYNNKSDIWALGCVLYELCTLKHAFEAG------------SMKNLVLKIISGSFPP--- 244 (350)
T ss_dssp HHHHHSCCTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHHTCCCC---
T ss_pred ccccCCCccccCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------------CHHHHHHHHHcCCCCC---
Confidence 356899999999875 567999999999999999999999999643 3344444444433210
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ...++.+|+.+||+.||++|||+.|+++
T Consensus 245 -----~~~~---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 -----VSLH---YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -----CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcc---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 2235778888999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=425.37 Aligned_cols=239 Identities=20% Similarity=0.334 Sum_probs=199.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 468999999999999965 6999999999766555667899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.++++.. .+++.++..|+.||++||+||| +.+||||||||+|||++.+|.+||+|||+|+.....
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 9999754 3899999999999999999999 789999999999999999999999999999876442
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...||+.|||||++. +..|+.++|||||||++|||++|+.||.... ..+.+..+... . .+
T Consensus 306 ~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------------~~~~~~~i~~~-~-----~~ 365 (423)
T 4fie_A 306 SLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------------PLKAMKMIRDN-L-----PP 365 (423)
T ss_dssp CCEECTTTCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHHS-C-----CC
T ss_pred ccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------------HHHHHHHHHcC-C-----CC
Confidence 456899999999875 5678999999999999999999999996432 22222222221 1 11
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.......+ ..++.+|+.+||..||++|||+.|+++
T Consensus 366 ~~~~~~~~---s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RLKNLHKV---SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCSCTTSS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCcccccC---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111222 235677888999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=420.93 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=203.8
Q ss_pred HHhcccCcCCeEEEEEEEEcC------CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCC-CceeeeEEEEEcC-CeEEE
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD------GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRH-PNLVGLKAYYFAR-EEKLL 433 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~~l 433 (672)
.+.+.||+|+||.||+|++.. ++.||||+++.... ...++|.+|+++|.+++| ||||+++|+|.++ +..++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 346789999999999999542 36899999986543 345789999999999965 8999999999764 56899
Q ss_pred EEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 434 VSEYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
|||||++|+|.++|+.... .....++|.++..|+.|||+||+||| +.+||||||||+|||+++++
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGG
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCccceeeCCCC
Confidence 9999999999999976431 12345899999999999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 574 (672)
.+||+|||+|+..... ...+|..|||||++. +..++.++|||||||++|||+| |+.||....
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~-------- 292 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------- 292 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC--------
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHh--cCCCCCcccEeehHHHHHHHHhCCCCCCCCCC--------
Confidence 9999999999876443 234678899999875 4689999999999999999998 899996432
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
..+.+...+.++.... .+ +....++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 293 ----~~~~~~~~i~~g~~~~-------~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 ----IDEEFCRRLKEGTRMR-------AP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ----CSHHHHHHHHHTCCCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHcCCCCC-------CC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1222333333322111 11 12234578889999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=408.77 Aligned_cols=238 Identities=20% Similarity=0.311 Sum_probs=198.9
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|+||||++
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 357899999999999995 469999999997532 2245789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 116 gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 116 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999754 35999999999999999999999 789999999999999999999999999999876432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...||+.|||||++. +..|+.++||||+||++|||+||+.||... +..+.+..+......
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~------------~~~~~~~~i~~~~~~ 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLPPFRAG------------NEGLIFAKIIKLEYD 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHH--HSCBCHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCC
T ss_pred CcccccCcccCcccCCHHHHc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHcCCCC
Confidence 457999999999875 457899999999999999999999999643 233344444433210
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+ .... ..++.+++.+||+.||++|||++|++.
T Consensus 253 ---~------p~~~---s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 ---F------PEKF---FPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---C------CTTC---CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---C------Cccc---CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0 1112 234677888999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=398.25 Aligned_cols=237 Identities=24% Similarity=0.371 Sum_probs=184.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||+||+|+. .+|+.||||++++... ...+.+.+|++++++++|||||++++++.+++..|+||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 47899999999999995 4799999999975432 23567999999999999999999999999999999999999 6
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... .++++.++..++.|++.||+||| +++|+||||||+|||+++++++||+|||+|+.....
T Consensus 97 g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 97 NELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 8999999754 35999999999999999999999 789999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...||+.|+|||++... ..++.++||||+||++|||+||+.||... +.....+.+......
T Consensus 168 ~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~------------~~~~~~~~i~~~~~~---- 230 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDE------------SIPVLFKNISNGVYT---- 230 (275)
T ss_dssp -------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCC----
T ss_pred cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCC------------CHHHHHHHHHcCCCC----
Confidence 56789999999987532 23468999999999999999999999642 233334333332210
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ..++.+++.+||+.||++|||+.|+++
T Consensus 231 -----~p~~~---s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -----LPKFL---SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCC---CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01112 234677888999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=403.04 Aligned_cols=233 Identities=24% Similarity=0.338 Sum_probs=186.9
Q ss_pred HhcccCcCCeEEEEEEEEc----CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
+.+.||+|+||+||+|+.. +++.||||++++... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 4578999999999999852 478999999975432 2345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++++||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 108 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999997543 5999999999999999999999 78999999999999999999999999999986532
Q ss_pred -----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 -----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 -----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
....||+.|||||++. +..++.++||||+||++|||+||+.||... +..+.+..+.+...
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyemltG~~PF~~~------------~~~~~~~~i~~~~~- 243 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVN--RRGHTQSADWWSFGVLMFEMLTGTLPFQGK------------DRKETMTMILKAKL- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC-
T ss_pred CCccccccccCcccCCHHHhc--cCCCCCCCcccchHHHHHHHHhCCCCCCCc------------CHHHHHHHHHcCCC-
Confidence 2567899999999875 467899999999999999999999999643 33334444433221
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
..+... ..++.+++.+||+.||++|||+
T Consensus 244 --------~~p~~~---s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 --------GMPQFL---SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --------CCCTTS---CHHHHHHHHHHTCSSGGGSTTC
T ss_pred --------CCCCcC---CHHHHHHHHHHcccCHHHCCCC
Confidence 011112 2346778889999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=391.62 Aligned_cols=240 Identities=23% Similarity=0.355 Sum_probs=182.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------------
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------------ 429 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------ 429 (672)
..+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 3478999999999999964 689999999975433 34567999999999999999999999987544
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEecc
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
..|+||||+++|+|.+++..... ....++..++.|+.|+++||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999986532 234677889999999999999999 789999999999999999999999999
Q ss_pred CCCccCCCC-----------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005880 510 GLSIFAPPS-----------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG 572 (672)
Q Consensus 510 G~a~~~~~~-----------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~ 572 (672)
|+|+..... ...||+.|||||++. +..|+.++|||||||++|||++ ||...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyell~---Pf~~~------- 230 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH--GNSYSHKVDIFSLGLILFELLY---PFSTQ------- 230 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHT--TCCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHc--CCCCCCHHHHHHHHHHHHHHcc---CCCCc-------
Confidence 999866432 246899999999875 5689999999999999999996 77421
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+....+.... ... + .+..........+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~~~-~~~----~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 ----MERVRTLTDVR-NLK----F------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ----HHHHHHHHHHH-TTC----C------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cHHHHHHHHHh-cCC----C------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111111 110 0 1111223345667899999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=390.18 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=191.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEc------CCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFA------REEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~ 435 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+..|+||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 478999999999999964 799999999975432 345678899999999999999999999764 35789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
|||+ |+|.+++... .++++.++..|+.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+..
T Consensus 139 E~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 139 DLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp ECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred eCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9995 6899999754 35999999999999999999999 789999999999999999999999999999865
Q ss_pred CC---------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 516 PP---------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 516 ~~---------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
.. ....||+.|+|||++.. ...++.++||||+||++|||++|++||.+.. ..+.+..+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~-~~~~~~~~DiWSlG~il~ell~G~~pF~g~~------------~~~~l~~I 275 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLS-LHEYTQAIDLWSVGCIFGEMLARRQLFPGKN------------YVHQLQLI 275 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS------------HHHHHHHH
T ss_pred ccCccccccccccceeChHhcCHHHhcC-CCCCCChhheehhHHHHHHHHHCCCCCCCCC------------HHHHHHHH
Confidence 32 24678999999998653 2467999999999999999999999997542 22222222
Q ss_pred Hhhhcccc--ccc-----------hhhc--cccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAE--VFD-----------LELM--RYKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~--~~d-----------~~~~--~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........ ... .... ...... ....++.+|+.+||..||++|||+.|+++
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 21110000 000 0000 000000 01235678888999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=383.67 Aligned_cols=186 Identities=23% Similarity=0.407 Sum_probs=162.8
Q ss_pred hcccCcCCeEEEEEEEEc----CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|..+ +|||||++++++.++++.|+||||++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 478999999999999853 46889999987543 456788999999988 69999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAPPS 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~ 518 (672)
+|+|.+++. .+++.++..++.|+++||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 104 g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 104 HESFLDILN--------SLSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp CCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred cccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999984 3889999999999999999999 8899999999999999876 79999999999754321
Q ss_pred ---------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 ---------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 ---------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...||+.|+|||++.. ...++.++||||+||++|||+||+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-CPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2468999999998753 346899999999999999999999999643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=370.51 Aligned_cols=268 Identities=34% Similarity=0.530 Sum_probs=224.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|+..+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 36799999999999998889999999998766667788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++..... ....++|..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99976542 2346999999999999999999999 789999999999999999999999999999764322
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|..|+|||++. +..++.++|||||||++|||+||+.||......+ ......|.............++
T Consensus 199 ~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFI--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE------MVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp CCCEEETTTCCHHHHH--HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS------CCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccCCCccccCHHHhc--CCCCCcccchHhHHHHHHHHHhCCCcccccCcHH------HHHHHHHhhhccccccHHHhcC
Confidence 233678899999765 4578999999999999999999999997654332 3455666655555555555555
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
+.... ....+....+.+++.+||+.||++|||+.||++.|+.+.+.+.
T Consensus 271 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 271 PNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred hhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 44332 2235677789999999999999999999999999999986543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=394.34 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=192.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHH---HHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKR---EFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +|+.||||++++.... ... ....++++++.++|||||++++++.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 478999999999999965 6999999999643211 122 234456788889999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
++||+|.++|... ..+++..+..++.||+.||+||| +.+||||||||+|||++.+|++||+|||+|+....
T Consensus 274 ~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 274 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999754 34999999999999999999999 89999999999999999999999999999987654
Q ss_pred C---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 S---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
. ..+||+.|||||++.. +..|+.++||||+||++|||++|++||...... +............
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~-~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~---------~~~~i~~~i~~~~---- 410 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKHEIDRMTLTMA---- 410 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC---------CHHHHHHHHHHCC----
T ss_pred CCCCCccCCcCccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhhcCCC----
Confidence 3 5789999999998742 457899999999999999999999999754321 2222222222211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
...+..+. .++.+|+.+||+.||++|++ +.||++
T Consensus 411 -----~~~p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -----VELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCCCTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCCCccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111222 34677888999999999998 567654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=395.66 Aligned_cols=243 Identities=22% Similarity=0.387 Sum_probs=201.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..++|||||++|+
T Consensus 161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 3578999999999999964 699999999987666667889999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC--CcEEEeccCCCccCCCC--
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT--GNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~-- 518 (672)
|.+++.... ..+++.++..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999996443 35899999999999999999999 7899999999999999854 89999999999887654
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...||+.|+|||++. +..|+.++||||+||++|||++|+.||... +..+.+..+...... +
T Consensus 313 ~~~~~GT~~y~APEv~~--~~~y~~~~DiWSlGvilyeml~G~~Pf~~~------------~~~~~~~~i~~~~~~---~ 375 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGE------------NDDETLRNVKSCDWN---M 375 (573)
T ss_dssp EEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------------SHHHHHHHHHTTCCC---C
T ss_pred eeeeEECccccCHHHhC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------------CHHHHHHHHHhCCCC---C
Confidence 457899999999875 567899999999999999999999999643 222333333332211 0
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .....+. ..+.+|+.+||+.||++|||+.|+++
T Consensus 376 ~~--~~~~~~s---~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DD--SAFSGIS---EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CS--GGGTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc--ccccCCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 0111222 34667888999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=365.01 Aligned_cols=263 Identities=25% Similarity=0.323 Sum_probs=202.4
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC----eEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE----EKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. ++.||||+++.... ....+.+|+.++.+++||||+++++++.... ..++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 478999999999999976 79999999975432 4456677999999999999999999998744 46999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC----------CcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL----------KLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~----------~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
|+|.++++.. .+++..++.++.|+++||+||| +. +|+||||||+||+++.++.+||+|||
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999754 3899999999999999999999 67 99999999999999999999999999
Q ss_pred CCccCCCC-------CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCC----CCC
Q 005880 511 LSIFAPPS-------TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGC----GGA 576 (672)
Q Consensus 511 ~a~~~~~~-------~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~----~~~ 576 (672)
+++..... ...+|..|+|||++... ...++.++|||||||++|||+||+.||........... ...
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99755432 34678999999987532 13456789999999999999999999976543221100 011
Q ss_pred CChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 577 VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.....+......... ...+. ...........+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 257 ~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 257 PSLEDMQEVVVHKKK-RPVLR----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHHTTSCC-CCCCC----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccC-CCCcc----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222222221111 11111 1111123456789999999999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.42 Aligned_cols=281 Identities=40% Similarity=0.658 Sum_probs=224.6
Q ss_pred ccccCHHHHHHHH-----hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 352 TKRFELEDLLRAS-----AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 352 ~~~~~~~~l~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
.+.|++.++.... .+.||+|+||.||+|+..+|+.||||+++..... ....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3456666654432 4689999999999999888999999999754322 334789999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEE
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~k 505 (672)
.+.+..++||||+++|+|.+++..... ...++++..+..|+.|+++||+|||..+ ..+|+||||||+||+++.++.+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEE
Confidence 999999999999999999999986542 3456999999999999999999999322 12999999999999999999999
Q ss_pred EeccCCCccCCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCh
Q 005880 506 VSDFGLSIFAPPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579 (672)
Q Consensus 506 l~DfG~a~~~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~ 579 (672)
|+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||+||+.||....... ......
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~ 248 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN----DDDVML 248 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH--HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT----TSCSBH
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhc--cCCCCccccchhHHHHHHHHHhCCCccccccccc----ccchhH
Confidence 9999999866432 345789999999764 4568999999999999999999999996321110 113456
Q ss_pred hHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
.+|+.............+..... ....+....+.+++.+||+.||++|||+.||++.|++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHhhchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 66666665555555555544432 33466778899999999999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.27 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=204.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 478999999999999965 6899999999776666778899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99998643 45899999999999999999999 789999999999999999999999999999765432
Q ss_pred --------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 519 --------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 519 --------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
...+|..|+|||++. +..++.++||||||+++|||++|..||......... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~- 240 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---FGLNVRGFL- 240 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---SSBCHHHHH-
T ss_pred ccccccccccccccccCCCcceeCHHHhc--CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---Hhhhhhccc-
Confidence 345788999999764 568899999999999999999999998654322100 011111111
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... . . ......+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 241 ---~~~-----~------~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 241 ---DRY-----C------P---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ---HHT-----C------C---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---ccc-----C------C---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 110 0 0 1112347788899999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=353.42 Aligned_cols=239 Identities=23% Similarity=0.389 Sum_probs=197.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 46899999999999995 57899999999766555677899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 9999754 3899999999999999999999 789999999999999999999999999998765533
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ............. ...
T Consensus 175 ~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~------------~~~~~~~~~~~~~-~~~--- 236 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------------PLRALYLIATNGT-PEL--- 236 (297)
T ss_dssp CCCSCGGGCCHHHHH--CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHHHCS-CCC---
T ss_pred CccCCcCccChhhhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCC-CCC---
Confidence 456789999999765 4578999999999999999999999996432 1222222222111 011
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.........+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011122345778888999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.21 Aligned_cols=254 Identities=33% Similarity=0.472 Sum_probs=195.8
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||+|+. +|+.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 357899999999999987 488999999875443 23467899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|.+++.... ....+++..++.++.|+++||+||| +.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 120 SLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp BHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999997543 1234899999999999999999999 777 999999999999999999999999999755432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.............
T Consensus 194 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~Pf~~~~------------~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLR--DEPSNEKSDVYSFGVILWELATLQQPWGNLN------------PAQVVAAVGFKCKRLE 259 (309)
T ss_dssp --------CCTTSCHHHHT--TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC------------HHHHHHHHHHSCCCCC
T ss_pred cccccCCCCccccChhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhcCCCCC
Confidence 456789999999764 5578999999999999999999999996432 2222222211111000
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCC
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSP 648 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 648 (672)
.. ......+.+++.+||+.||++|||+.|+++.|+.+.+...++
T Consensus 260 -------~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 260 -------IP---RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -------CC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 01 112235778888999999999999999999999998755544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=350.89 Aligned_cols=238 Identities=20% Similarity=0.312 Sum_probs=196.9
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 47999999999999976 79999999998666656788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----C
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-----T 519 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----~ 519 (672)
+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 131 ~~l~~~------~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 131 DIVSQV------RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHTTC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 998643 4899999999999999999999 789999999999999999999999999998765432 4
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
..+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+......... . +.
T Consensus 201 ~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------------~~~~~~~~~~~~-~-----~~ 260 (321)
T 2c30_A 201 LVGTPYWMAPEVIS--RSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------------PVQAMKRLRDSP-P-----PK 260 (321)
T ss_dssp CCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHHSS-C-----CC
T ss_pred ccCCccccCHhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHhcCC-C-----CC
Confidence 56789999999764 5678999999999999999999999996431 122222221111 0 01
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ......+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 261 LKNS---HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CTTG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCcc---ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 112235778888999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=364.14 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=202.6
Q ss_pred HhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 433 (672)
..+.||+|+||.||+|+.. ++..||||+++.... ...+++.+|+++++++ +||||+++++++.+.+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 3578999999999999852 356799999976533 3456899999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 434 VSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
||||+++|+|.+++...... ....+++.+++.++.|+++||+||| +.+|+||||||+|||++.++
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEEECCCC
Confidence 99999999999999865421 1235899999999999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 574 (672)
.+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||+| |+.||....
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-------- 310 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------- 310 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH--TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhc--CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--------
Confidence 9999999999865432 233466899999765 5678999999999999999999 999996432
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
..+......... ... .. ......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 311 ----~~~~~~~~~~~~-~~~-------~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 311 ----VEELFKLLKEGH-RMD-------KP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ----GGGHHHHHHTTC-CCC-------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCC-CCC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 122222221111 100 00 12234578888999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.63 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=204.0
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|+..+++.||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 478999999999999998899999999986543 4578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9997543 45899999999999999999999 789999999999999999999999999999866432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+.......... ...
T Consensus 166 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~------------~~~~~~~~~~~~~~---~~~ 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------------SNSEVVEDISTGFR---LYK 228 (269)
T ss_dssp STTCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHTTCC---CCC
T ss_pred CcccccccCCHHHhc--CCCCCchhhhHHHHHHHHHHhcCCCCCCCCC------------CHHHHHHHHhcCcc---CCC
Confidence 344567899999764 4578999999999999999999 99999643 22222222222110 000
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
+ ......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 229 ~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 P--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C--------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0 11123577888899999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=348.21 Aligned_cols=271 Identities=33% Similarity=0.526 Sum_probs=214.5
Q ss_pred cccCHHHHHHHHh-----------cccCcCCeEEEEEEEEcCCcEEEEEEcccCC----cchHHHHHHHHHHHcCCCCCc
Q 005880 353 KRFELEDLLRASA-----------EMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS----IGGKREFEQHMEVLGRLRHPN 417 (672)
Q Consensus 353 ~~~~~~~l~~~~~-----------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~n 417 (672)
..|.++++...+. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4566666665542 6799999999999987 48899999986432 234678999999999999999
Q ss_pred eeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 418 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
|+++++++.+.+..++||||+++|+|.+++.... ...++++..++.++.|+++||+||| +.+|+||||||+||+
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANIL 165 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEE
Confidence 9999999999999999999999999999997543 2346999999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005880 498 LDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG 570 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~ 570 (672)
+++++.+||+|||+++..... ...++..|+|||++. ..++.++||||||+++|||++|+.||......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-- 240 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-- 240 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT---TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc---CCCCccchhHHHHHHHHHHHHCCCCcccCcch--
Confidence 999999999999999765432 346788999999764 35789999999999999999999999754322
Q ss_pred CCCCCCCChhHHHHHHHhhh-ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 571 MGCGGAVDLPRWVQSVVREE-WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..+..+........ .....++.... .........+.+++.+||+.||.+|||+.||++.|+++..
T Consensus 241 ------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 ------QLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp ------SBTTHHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ------HHHHHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 12223333222211 11122222221 1234566788999999999999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.82 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=200.6
Q ss_pred HhcccCcCCeEEEEEEEEc----CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 3478999999999999974 35569999998643 334678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.++++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999997543 35999999999999999999999 789999999999999999999999999999876442
Q ss_pred --------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 --------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 --------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...+|..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+........
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~------------~~~~~~~~~~~ 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMT------------NRDVISSVEEG 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC------------HHHHHHHHHTT
T ss_pred ccceeeccCCCCcccccCHhHhc--CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC------------HHHHHHHHHcC
Confidence 223456799999764 4578999999999999999999 999996432 22222222221
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
... .........+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 271 ~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 YRL-----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC-----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 100 00112234678889999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.69 Aligned_cols=238 Identities=22% Similarity=0.317 Sum_probs=196.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 47899999999999996 579999999997543 234567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999997543 4899999999999999999999 789999999999999999999999999999765543
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|+.|+|||++... ...+.++||||+||++|||++|+.||... +..+...........
T Consensus 171 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~------------~~~~~~~~i~~~~~~----- 232 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQ------------NLKELRERVLRGKYR----- 232 (328)
T ss_dssp GTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCC-----
T ss_pred ccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCCC-----
Confidence 55689999999987532 33458999999999999999999999643 333333333332211
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ....+.+++.+||..||.+|||+.|+++
T Consensus 233 ----~p~~---~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 ----IPFY---MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCTT---SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111 1234678888999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.52 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=202.6
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|...++..||||+++.... ..+++.+|++++.+++||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 478999999999999999888999999976544 4577999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 9997542 35899999999999999999999 789999999999999999999999999999766543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||+| |+.||.... ............. ...
T Consensus 164 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------------~~~~~~~~~~~~~---~~~ 226 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT------------NSEVVLKVSQGHR---LYR 226 (268)
T ss_dssp SCCCCGGGCCHHHHH--HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC------------HHHHHHHHHTTCC---CCC
T ss_pred CCCcCcccCCHHHHh--ccCCchhhhhHHHHHHHHHHHcCCCCCccccC------------hHHHHHHHHcCCC---CCC
Confidence 234456799999764 4578899999999999999999 999996432 2222222222110 011
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
+ . .....+.+++.+||+.||++|||+.|+++.|+.+++...
T Consensus 227 ~-----~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 227 P-----H---LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp C-----T---TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred C-----C---cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 1 1 112357788899999999999999999999999976543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=346.35 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=192.4
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcC--CCCCceeeeEEEEEcC----CeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGR--LRHPNLVGLKAYYFAR----EEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 47899999999999998 5899999998643 34555666666555 7999999999997643 4578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----CCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC----KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
++|+|.++++.. .+++..++.++.|+++||+|||... .+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 999999999643 4899999999999999999999321 146899999999999999999999999999965
Q ss_pred CCCC---------CCCCCCcccCCCccccCCC----CCCchhHHHHHHHHHHHHHhC----------CCCCCCCCCCCCC
Q 005880 515 APPS---------TVPRSNGYRAPELSSSDGR----KQSQKSDVYSFGVLLLELLTG----------KCPSVIDGGGAGM 571 (672)
Q Consensus 515 ~~~~---------~~~~t~~y~aPE~l~~~~~----~~~~~~DV~S~Gvvl~el~tg----------~~P~~~~~~~~~~ 571 (672)
.... ...+|..|+|||++..... .+++++|||||||++|||+|| +.||......
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~--- 239 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN--- 239 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS---
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC---
Confidence 4332 3368899999997753211 345799999999999999999 7777543221
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
....... .......... +..............+.+++.+||+.||++|||+.||++.|+++
T Consensus 240 ----~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 ----DPSFEDM-RKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp ----SCCHHHH-HHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ----Ccchhhh-hHHHhccCCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111222 1111111111 11111111134566789999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.55 Aligned_cols=247 Identities=30% Similarity=0.510 Sum_probs=197.8
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcch-------HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGG-------KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|+. .+++.||||++....... .+.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 47899999999999996 478999999986433221 167899999999999999999999986554 69999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeCCCCc-----EEEecc
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLDKTGN-----ARVSDF 509 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~~~~~-----~kl~Df 509 (672)
|+++|+|.+++.... ..+++..++.++.|+++||+||| +.+ |+||||||+||+++.++. +||+||
T Consensus 102 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp CCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 999999999887543 46999999999999999999999 777 999999999999988776 999999
Q ss_pred CCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 510 GLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 510 G~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
|+++..... ...+|..|+|||++......++.++|||||||++|||++|+.||..... .-..+.....
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------~~~~~~~~~~ 243 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----------GKIKFINMIR 243 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----------CHHHHHHHHH
T ss_pred CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----------cHHHHHHHHh
Confidence 999865544 5668899999998755566788999999999999999999999965421 1122222222
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
........ .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 244 ~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRPTI----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCCCC----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 22111110 011234578888899999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.36 Aligned_cols=247 Identities=24% Similarity=0.415 Sum_probs=192.2
Q ss_pred hcccCcCCeEEEEEEEEc----CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 478999999999999964 57789999997543 3345789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.++++... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 130 ~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 130 NGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999997543 45899999999999999999999 789999999999999999999999999999866432
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+........
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~------------~~~~~~~i~~~- 266 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMS------------NQDVIKAVDEG- 266 (373)
T ss_dssp ------------CTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC------------HHHHHHHHHTT-
T ss_pred ccceeccCCCcCCCccChhhhc--cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHHcC-
Confidence 112356799999764 4578999999999999999998 999996431 22222222111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.. .+........+.+++.+||+.||++||++.||++.|+++.+.
T Consensus 267 ~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 YR----------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp EE----------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC----------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 10 001112334688899999999999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=369.83 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=202.6
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|...++..||||+++.... ..+.|.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 3578999999999999998889999999986543 5788999999999999999999999986 6678999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.++++... ...+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 270 LDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp HHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred HHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99997542 134889999999999999999999 789999999999999999999999999999876542
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. ...++.++|||||||++|||+| |+.||... ...+....+......
T Consensus 343 ~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~t~g~~P~~~~------------~~~~~~~~i~~~~~~---- 404 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------------SNPEVIRALERGYRM---- 404 (454)
T ss_dssp CSSSSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------------CHHHHHHHHHHTCCC----
T ss_pred CCCcccccccCHHHhc--cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHHcCCCC----
Confidence 233466899999775 4578999999999999999999 99999643 222233222221110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
+........+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 405 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 00112234678889999999999999999999999988643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=365.85 Aligned_cols=248 Identities=29% Similarity=0.405 Sum_probs=201.8
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-eEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE-EKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|... |+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+++|+
T Consensus 197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 3578999999999999986 7899999998654 5678999999999999999999999988765 7899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--CC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TV 520 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~ 520 (672)
|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 274 L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 274 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp HHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 999998643 234799999999999999999999 789999999999999999999999999999865443 33
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
.++..|+|||++. +..++.++|||||||++|||+| |+.||...... +....+... ...
T Consensus 347 ~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------------~~~~~i~~~-~~~------ 405 (450)
T 1k9a_A 347 KLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------DVVPRVEKG-YKM------ 405 (450)
T ss_dssp CCCTTTSCHHHHH--SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------------THHHHHHTT-CCC------
T ss_pred CCCcceeCHHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcC-CCC------
Confidence 4577899999765 4678999999999999999998 99999654221 122222111 100
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
... ......+.+++.+||+.||++|||+.|+++.|+.+...+.
T Consensus 406 -~~p---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 406 -DAP---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp -CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred -CCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 011 1223467888899999999999999999999999976543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=343.30 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=200.2
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
..+.||+|+||.||+|...++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp EEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 3578999999999999999888999999986544 457899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 107 LNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp HHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99997533 35999999999999999999999 789999999999999999999999999999866442
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++||||||+++|||+| |+.||.... ..+.......... ..
T Consensus 179 ~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------------~~~~~~~~~~~~~---~~ 241 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------------NSETAEHIAQGLR---LY 241 (283)
T ss_dssp TSTTSCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------------HHHHHHHHHTTCC---CC
T ss_pred cCCccCcccCCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccC------------hhHHHHHHhcccC---CC
Confidence 344567899999765 4578999999999999999998 999996432 2222222221110 00
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
. . ......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 242 ~-----~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 242 R-----P---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp C-----C---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----C---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0 0 1112357788899999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.86 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=198.5
Q ss_pred hcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 437 (672)
.+.||+|+||.||+|++ .+|+.||||+++.......+.+.+|++++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 47899999999999984 25899999999876666678899999999999999999999998654 458999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 95 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 95 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred CCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 99999999997653 35899999999999999999999 78999999999999999999999999999987643
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC--CCC-CCCCChhHHHHHH
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG--MGC-GGAVDLPRWVQSV 586 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~--~~~-~~~~~~~~~~~~~ 586 (672)
. ...++..|+|||++. +..++.++||||||+++|||+||..|+........ ... .............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ---------CTTCGGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhc--CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 2 223455699999765 45789999999999999999999999853210000 000 0000000011111
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
..... ..+........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 245 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 245 LKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11110 0011122334678889999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.36 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=200.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|+.. +++.||||+++.... ...++|.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3578999999999999976 789999999975432 23457889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST-- 519 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 519 (672)
+|.++++... ..+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999997542 35899999999999999999999 7899999999999999999999999999998654431
Q ss_pred -----CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 520 -----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 520 -----~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
..++..|+|||++. +..++.++|||||||++|||+| |+.||.... ..+. ..........
T Consensus 270 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~t~g~~p~~~~~------------~~~~-~~~~~~~~~~ 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLS------------NQQT-REFVEKGGRL 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC------------HHHH-HHHHHTTCCC
T ss_pred ecCCCCCCCcCcCCHhHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------------HHHH-HHHHHcCCCC
Confidence 11245699999765 4578999999999999999998 999986431 1111 1112111100
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
+........+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 335 ----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 ----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0011123457788999999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.17 Aligned_cols=270 Identities=20% Similarity=0.247 Sum_probs=207.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--eEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE--EKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 478999999999999965 58999999997543 234677889999999999999999999998765 77999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe----CCCCcEEEeccCCCccCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~a~~~~ 516 (672)
|+|.+++..... ...+++.+++.++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999986432 234899999999999999999999 7899999999999999 788889999999998765
Q ss_pred CC----CCCCCCcccCCCcccc------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 517 PS----TVPRSNGYRAPELSSS------DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~------~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
.. ...+|..|+|||++.. .+..++.++|||||||++|||+||+.||...... ....+.+...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~ 239 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--------RRNKEVMYKI 239 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG--------GGCHHHHHHH
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--------chhHHHHHHH
Confidence 43 4457889999997642 1467889999999999999999999999743221 1223333333
Q ss_pred Hhhhcccc---c-------c--chhhc-cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCC
Q 005880 587 VREEWTAE---V-------F--DLELM-RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSP 648 (672)
Q Consensus 587 ~~~~~~~~---~-------~--d~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 648 (672)
........ + + ..... ...........+.+++.+||+.||++|||+.|+++...+..-....+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~~ 314 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSH 314 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-----
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCcc
Confidence 33221100 0 0 00000 01122455667888999999999999999999999998876544433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=339.42 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=202.6
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. |+.||||+++... ....+.+.+|++++++++||||+++++++.+. +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 478999999999999986 8899999997543 23456899999999999999999999999877 778999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
|+|.+++.... ...+++..++.++.|+++||+||| +.+ |+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 99999998643 236899999999999999999999 667 999999999999999999999999998777667
Q ss_pred CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|..|+|||++... ...++.++|||||||++|||++|+.||... ..................
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------------~~~~~~~~~~~~~~~~~~-- 232 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL------------SNMEIGMKVALEGLRPTI-- 232 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS------------CHHHHHHHHHHSCCCCCC--
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc------------ChHHHHHHHHhcCCCCCC--
Confidence 77889999999987532 122344899999999999999999999643 222222222222211110
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
. ......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 233 -----~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 -----P---PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 1122357788889999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=356.70 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=205.8
Q ss_pred HhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 433 (672)
+.+.||+|+||.||+|+.. .+..||||+++.... ...+++.+|+++++++ +||||+++++++.+++..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 3478999999999999952 236799999976433 3457899999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 434 VSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
||||+++|+|.+++...... ....+++..++.|+.|+++||+||| +.+|+||||||+||++++++
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceEEEcCCC
Confidence 99999999999999865421 1245999999999999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 574 (672)
.+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||++ |+.||...
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~ellt~g~~p~~~~--------- 297 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--------- 297 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---------
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------
Confidence 9999999999865432 233467899999765 5678999999999999999999 99998632
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCC
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCH 650 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 650 (672)
...+.......... .. .. ......+.+++.+||+.||++|||+.||++.|+++.........
T Consensus 298 ---~~~~~~~~~~~~~~-~~-------~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 298 ---PVEELFKLLKEGHR-MD-------KP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp ---CHHHHHHHHHTTCC-CC-------CC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred ---CHHHHHHHHHcCCC-CC-------CC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 22223222222211 00 01 11223578888899999999999999999999999865544443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.37 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=194.2
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
+.||+|+||.||+|.. .+|+.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 5799999999999996 468999999998766667788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe--CCCCcEEEeccCCCccCCCC----
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL--DKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll--~~~~~~kl~DfG~a~~~~~~---- 518 (672)
+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 175 DRIIDES----YNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 9887543 45899999999999999999999 7899999999999999 56789999999999876543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||... +..+.+..+....+.. ...
T Consensus 247 ~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~------------~~~~~~~~i~~~~~~~--~~~ 310 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVN--YDFVSFPTDMWSVGVIAYMLLSGLSPFLGD------------NDAETLNNILACRWDL--EDE 310 (373)
T ss_dssp CCCSSCTTCCHHHHT--TCBCCHHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHTCCCS--CSG
T ss_pred cccCCCcEeChhhcc--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhccCCC--Chh
Confidence 345789999999764 567899999999999999999999999643 2223333333322110 000
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 311 ---~~~---~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 ---EFQ---DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---GGT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhc---cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011 12235778888999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=355.28 Aligned_cols=269 Identities=17% Similarity=0.183 Sum_probs=202.5
Q ss_pred hcccCcCCeEEEEEEEEcC------CcEEEEEEcccCCcch-----------HHHHHHHHHHHcCCCCCceeeeEEEEEc
Q 005880 365 AEMLGKGGFGTAYKAVLDD------GSVVAVKRLKDASIGG-----------KREFEQHMEVLGRLRHPNLVGLKAYYFA 427 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 427 (672)
.+.||+|+||.||+|...+ ++.||||++....... ...+.+|+..+..++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4789999999999999764 4789999987543211 1223456667788899999999999876
Q ss_pred C----CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC--CC
Q 005880 428 R----EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD--KT 501 (672)
Q Consensus 428 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~--~~ 501 (672)
. ...++||||+ +|+|.+++.... ..+++..++.|+.|+++||+||| +.+|+||||||+|||++ .+
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEESSCT
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEecCCC
Confidence 4 4579999999 999999997643 45999999999999999999999 78999999999999999 88
Q ss_pred CcEEEeccCCCccCCCC------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005880 502 GNARVSDFGLSIFAPPS------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA 569 (672)
Q Consensus 502 ~~~kl~DfG~a~~~~~~------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~ 569 (672)
+.+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||+||+.||......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN--GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC--CCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 99999999999765321 234889999999764 557899999999999999999999999753211
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCC
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPC 649 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 649 (672)
.....+....... ....+++..+.. . ....++.+++..||+.||++||++.+|++.|+++.+......
T Consensus 268 -------~~~~~~~~~~~~~-~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 268 -------PKYVRDSKIRYRE-NIASLMDKCFPA-A---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp -------HHHHHHHHHHHHH-CHHHHHHHHSCT-T---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred -------HHHHHHHHHHhhh-hHHHHHHHhccc-c---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 1111111111111 122222222211 1 113457888889999999999999999999999987666666
Q ss_pred CCCCCCCC
Q 005880 650 HENFDSVS 657 (672)
Q Consensus 650 ~~~~~~~~ 657 (672)
...+++..
T Consensus 336 ~~~~dw~~ 343 (364)
T 3op5_A 336 DGKLDLSV 343 (364)
T ss_dssp CCCCCC--
T ss_pred CCccceEe
Confidence 66666543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=341.13 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=193.7
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++||||+++++++.+++..++||||++ |+
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 478999999999999998899999999974332 235678999999999999999999999999999999999997 48
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 888887543 45899999999999999999999 789999999999999999999999999999865432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc--
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV-- 595 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 595 (672)
...+|..|+|||++.. ...++.++|||||||++|||++|+.||......+ ....+............
T Consensus 177 ~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---------QLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp -CCCCCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---------HHHHHHHHHCCCCTTTSGG
T ss_pred cCCcccCCcCCHHHhcC-CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHHHHCCCChHHhhh
Confidence 4467889999997643 3568999999999999999999999997543221 11111111111000000
Q ss_pred -cch------h--hccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 -FDL------E--LMRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 -~d~------~--~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+. . ....... .....++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0 0000000 011245778999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.54 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=198.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+++..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 478999999999999954 68999999985432 22356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... .++++..++.++.|+++||+||| +.+|+||||||+||+++.++++||+|||+++.....
T Consensus 96 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 96 PTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999754 35899999999999999999999 789999999999999999999999999999766432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...+|..|+|||++. +..++.++||||||+++|||+||+.||.... ..........+..
T Consensus 167 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------------~~~~~~~~~~~~~--- 229 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAK--GEATDECTDIYSIGIVLYEMLVGEPPFNGET------------AVSIAIKHIQDSV--- 229 (294)
T ss_dssp --------CCSSCCHHHHH--TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------------HHHHHHHHHSSCC---
T ss_pred cccCccccCccccCHhHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------------hHHHHHHHhhccC---
Confidence 345789999999764 4678899999999999999999999996432 1222222222111
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHhcCC
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-NMSHVVKLIEELRGVE 645 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~~ 645 (672)
......... .....+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus 230 -~~~~~~~~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 -PNVTTDVRK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -CCHHHHSCT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -CCcchhccc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 000000011 1234577888899999999999 9999999999876433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.11 Aligned_cols=240 Identities=22% Similarity=0.327 Sum_probs=187.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--------------------------hHHHHHHHHHHHcCCCCCc
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--------------------------GKREFEQHMEVLGRLRHPN 417 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~n 417 (672)
.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 478999999999999964 6899999998654311 1356889999999999999
Q ss_pred eeeeEEEEEc--CCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCC
Q 005880 418 LVGLKAYYFA--REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTN 495 (672)
Q Consensus 418 iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~N 495 (672)
|+++++++.+ .+..++||||+++|+|.+++.. .++++..+..++.|+++||+||| +.+|+||||||+|
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKPSN 167 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGG
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHH
Confidence 9999999987 5678999999999999886542 35999999999999999999999 7899999999999
Q ss_pred EEeCCCCcEEEeccCCCccCCCC-----CCCCCCcccCCCccccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005880 496 VLLDKTGNARVSDFGLSIFAPPS-----TVPRSNGYRAPELSSSDGR-KQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA 569 (672)
Q Consensus 496 Ill~~~~~~kl~DfG~a~~~~~~-----~~~~t~~y~aPE~l~~~~~-~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~ 569 (672)
|+++.++.+||+|||+++..... ...+|..|+|||++..... .++.++|||||||++|||++|+.||...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---- 243 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE---- 243 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc----
Confidence 99999999999999999766542 4568899999998753322 2478999999999999999999999642
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+.......... ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 244 --------~~~~~~~~~~~~~~~-------~~~~~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 --------RIMCLHSKIKSQALE-------FPDQPD---IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --------SHHHHHHHHHHCCCC-------CCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------cHHHHHHHHhcccCC-------CCCccc---cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 222222222221110 000111 2235778888999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=339.63 Aligned_cols=262 Identities=18% Similarity=0.196 Sum_probs=206.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++.+....++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 47899999999999995 578999999986543 345688899999999 7999999999999999999999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc-----EEEeccCCCccCCC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN-----ARVSDFGLSIFAPP 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DfG~a~~~~~ 517 (672)
|.+++.... .++++..+..++.|+++||+||| +.+|+||||||+||+++.++. +||+|||+++....
T Consensus 92 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 92 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999998643 35899999999999999999999 889999999999999987776 99999999976543
Q ss_pred C------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 518 S------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 518 ~------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
. ...+|..|+|||++. +..++.++|||||||++|||++|+.||...... ........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------~~~~~~~~ 232 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA---------TNKQKYER 232 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---------CHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhc--CCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc---------ccHHHHHH
Confidence 2 345788999999764 567899999999999999999999999764321 12222222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCC
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDS 655 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~ 655 (672)
.......... +.. .. .....+.+++.+||+.||++|||+.+|++.|+++.+.........+++
T Consensus 233 ~~~~~~~~~~--~~~--~~---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 233 IGEKKQSTPL--REL--CA---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp HHHHHHHSCH--HHH--TT---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHhhccCccH--HHH--Hh---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 2111110000 000 00 123467888899999999999999999999999986554444444444
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.61 Aligned_cols=261 Identities=18% Similarity=0.187 Sum_probs=205.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 47899999999999995 578999999987543 234688999999999 9999999999999999999999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc-----EEEeccCCCccCCC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN-----ARVSDFGLSIFAPP 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DfG~a~~~~~ 517 (672)
|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++. +||+|||+++....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 91 LEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred HHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 999998642 35999999999999999999999 789999999999999998887 99999999976532
Q ss_pred ------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 518 ------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 518 ------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||..... ....+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~---------~~~~~~~~~ 231 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHL--GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA---------DTLKERYQK 231 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------SSHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHc--CCCCCchhHHHHHHHHHHHHhcCCCCcccccc---------ccHHHHHHH
Confidence 2446789999999764 56789999999999999999999999975432 223333333
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCC
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDS 655 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~ 655 (672)
........ ..... ... .. ++.+++..||+.||.+||++.+|++.|+++.+.........+++
T Consensus 232 i~~~~~~~---~~~~~-~~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 232 IGDTKRAT---PIEVL-CEN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp HHHHHHHS---CHHHH-TTT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred HHhhhccC---CHHHH-hcc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 22221100 00000 001 11 68888999999999999999999999999876444443334443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.65 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=192.8
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|+.. ++.||||++.... ..+.+.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 478999999999999986 7889999997543 5678999999999999999999999876 4578999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc-EEEeccCCCccCCCC--CCC
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN-ARVSDFGLSIFAPPS--TVP 521 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~~--~~~ 521 (672)
+++..... ...+++..++.++.|+++||+|||+.. ..+|+||||||+||+++.++. +||+|||++...... ...
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence 99986531 235789999999999999999999321 178999999999999998886 799999999765443 456
Q ss_pred CCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhc
Q 005880 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELM 601 (672)
Q Consensus 522 ~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 601 (672)
+|..|+|||++. +..++.++||||||+++|||++|+.||..... ............. ....
T Consensus 165 gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~-~~~~------ 225 (307)
T 2eva_A 165 GSAAWMAPEVFE--GSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----------PAFRIMWAVHNGT-RPPL------ 225 (307)
T ss_dssp CCTTSSCHHHHT--CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----------SHHHHHHHHHTTC-CCCC------
T ss_pred CCCceEChhhhC--CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----------cHHHHHHHHhcCC-CCCc------
Confidence 789999999764 56789999999999999999999999964321 1111111111111 0000
Q ss_pred cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 602 RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 602 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
.......+.+++.+||+.||++|||+.|+++.|+.+.+.-
T Consensus 226 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 226 ----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0112235778888999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.07 Aligned_cols=237 Identities=25% Similarity=0.345 Sum_probs=195.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||+|++++.. ......+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 478999999999999965 68999999997532 22456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--- 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 517 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 90 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999754 34899999999999999999999 78999999999999999999999999999976432
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... +.......+.....
T Consensus 161 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~------------~~~~~~~~i~~~~~---- 222 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------------DHERLFELILMEEI---- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGS--SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC----
T ss_pred cccccccChhhCChhhhc--CCCCCchhhcccchhHHHHHhcCCCCCCCC------------CHHHHHHHHHcCCC----
Confidence 2455789999999764 457899999999999999999999999643 22233333332211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ...++.+++.+||+.||++|| ++.|+++
T Consensus 223 -----~~p~~---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -----RFPRT---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTT---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCC---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00111 123567888899999999999 8999876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.01 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=197.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 478999999999999965 68999999987543 3556789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC--CCcEEEeccCCCccCCCC---
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK--TGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~--- 518 (672)
.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 89 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 89 FERINTSA----FELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99997542 35899999999999999999999 789999999999999987 789999999999877554
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|+.|+|||++. +..++.++|||||||++|||++|+.||... ...+.+..+...... ++
T Consensus 161 ~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~------------~~~~~~~~i~~~~~~---~~ 223 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAE------------TNQQIIENIMNAEYT---FD 223 (321)
T ss_dssp EEEESCGGGSCHHHHT--TCEECHHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHTCCC---CC
T ss_pred ccccCChhhcCcHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCcCC------------CHHHHHHHHHcCCCC---CC
Confidence 345788999999764 456789999999999999999999999643 222333333332211 01
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .. ....++.+++.+||..||++|||+.|+++
T Consensus 224 ~~~--~~---~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 EEA--FK---EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH--HT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhh--hc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 01 12245778888999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.53 Aligned_cols=246 Identities=25% Similarity=0.417 Sum_probs=203.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|...+++.||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 478999999999999998889999999986544 4578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 9997653 35899999999999999999999 789999999999999999999999999999866432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+.......... ...
T Consensus 164 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------------~~~~~~~~i~~~~~---~~~ 226 (267)
T 3t9t_A 164 GTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------------SNSEVVEDISTGFR---LYK 226 (267)
T ss_dssp STTCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHTTCC---CCC
T ss_pred cccccccccChhhhc--CCCccchhchhhhHHHHHHHhccCCCCCCCC------------CHHHHHHHHhcCCc---CCC
Confidence 344567899999764 4578999999999999999999 89998643 22222222222110 000
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.. .....+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 227 -----~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 -----PR---LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -----CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----Cc---cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01 1123577888899999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=369.34 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=202.2
Q ss_pred HhcccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||.||+|++.. +..||||+++.... ..++|.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 35789999999999999764 88999999986543 56789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ...+++..++.|+.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 303 L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 303 LLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp HHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred HHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999998643 245899999999999999999999 789999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++|||||||++|||+| |+.||.... ..+....+ .....
T Consensus 376 ~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~------------~~~~~~~~-~~~~~--- 437 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYELL-EKDYR--- 437 (495)
T ss_dssp CTTCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------------GGGHHHHH-HTTCC---
T ss_pred cCCCcCCcceeCHhHHh--cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC------------HHHHHHHH-HcCCC---
Confidence 223456899999765 4578999999999999999999 999986432 12222221 11110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.... ......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 438 ----~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 ----MERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCC---CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 0011 122345788889999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.80 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=201.4
Q ss_pred hcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 478999999999999974 348899999986433 3457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe
Q 005880 438 MPNGSLFWLLHGNRGP-------------------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL 498 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll 498 (672)
+++|+|.+++...... ....+++.+++.++.|+++||+||| +.+|+||||||+||++
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLV 207 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEE
Confidence 9999999999864311 1256999999999999999999999 7899999999999999
Q ss_pred CCCCcEEEeccCCCccCCC-------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005880 499 DKTGNARVSDFGLSIFAPP-------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAG 570 (672)
Q Consensus 499 ~~~~~~kl~DfG~a~~~~~-------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~ 570 (672)
+.++.+||+|||+++.... ....++..|+|||++. +..++.++||||||+++|||+| |+.||...
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~----- 280 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM----- 280 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc--cCCcCcccccHHHHHHHHHHHhcCCCcCCCC-----
Confidence 9999999999999865432 2345677899999765 4578999999999999999999 99999643
Q ss_pred CCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 571 MGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
...+.......... .. .. ......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 281 -------~~~~~~~~~~~~~~-~~-------~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 281 -------AHEEVIYYVRDGNI-LA-------CP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp -------CHHHHHHHHHTTCC-CC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------ChHHHHHHHhCCCc-CC-------CC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 22222222222211 00 00 1123457888899999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.51 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=196.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 478999999999999965 6899999999754322 357899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC----cEEEeccCCCc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG----NARVSDFGLSI 513 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~ 513 (672)
+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 97 ~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 97 VSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999643 35999999999999999999999 78999999999999998876 79999999998
Q ss_pred cCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 514 FAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 514 ~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
..... ...||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+...
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~------------~~~~~~~i~~~ 233 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT------------KQETLANITAV 233 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------------HHHHHHHHHTT
T ss_pred EcCCCCccccCCCCccEECchHHc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHhc
Confidence 76543 456899999999764 4578999999999999999999999996432 22223222222
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .+++.. ... ....+.+++.+||..||++|||+.|+++
T Consensus 234 ~~---~~~~~~--~~~---~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY---DFDEEF--FSQ---TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC---CCCHHH--HTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC---CCCchh--ccC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 011111 011 1235678888999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=355.65 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=199.9
Q ss_pred hcccCcCCeEEEEEEEEc------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|++. +++.||||+++... .....++.+|+.++++++||||+++++++.+....++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 478999999999999953 46789999997543 33556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEeccCCC
Q 005880 438 MPNGSLFWLLHGNRG--PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVSDFGLS 512 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a 512 (672)
+++|+|.+++..... .....+++.+++.++.|+++||+||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 999999999976432 12245899999999999999999999 78999999999999999555 5999999999
Q ss_pred ccCC-------CCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 513 IFAP-------PSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 513 ~~~~-------~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
+... .....+|..|+|||++. +..++.++|||||||++|||++ |+.||... ...+...
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~ellt~g~~pf~~~------------~~~~~~~ 297 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------------SNQEVLE 297 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------------CHHHHHH
T ss_pred cccccccccccCCCcCCcccEECHHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------------CHHHHHH
Confidence 6432 12344578899999765 4578999999999999999998 99999643 2222222
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
........ + .. ......+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 298 ~i~~~~~~----~----~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 FVTSGGRM----D----PP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHTTCCC----C----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCC----C----CC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 22222110 0 01 1122357788999999999999999999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=341.66 Aligned_cols=242 Identities=22% Similarity=0.368 Sum_probs=196.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 4578999999999999965 6899999998754321 36789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC----cEEEeccCCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG----NARVSDFGLS 512 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a 512 (672)
|+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 95 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 95 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp CCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999643 35899999999999999999999 78999999999999999887 8999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.......
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------------~~~~~~~~~~ 231 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT------------KQETLANVSA 231 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------------HHHHHHHHHH
T ss_pred eECCCCCccccccCCcCcCCceeec--CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC------------HHHHHHHHHh
Confidence 876432 456889999999764 5678999999999999999999999996432 1222222221
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... . +.... .. .....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~--~-~~~~~--~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 232 VNY--E-FEDEY--FS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp TCC--C-CCHHH--HT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCC--C-cCccc--cc---cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 0 00000 00 11235778888999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=348.86 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=189.8
Q ss_pred HhcccCcCCeEEEEEEEEcC-C---cEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeE------
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-G---SVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEK------ 431 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------ 431 (672)
..+.||+|+||.||+|+... + ..||||+++.. .....+++.+|++++++++||||+++++++......
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 45789999999999999653 3 27999999754 333567899999999999999999999999877655
Q ss_pred EEEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 432 LLVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
++||||+++|+|.+++..... .....+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 999999999999999965431 12235899999999999999999999 7899999999999999999999999999
Q ss_pred CCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 511 LSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 511 ~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
+++..... ...++..|+|||++. +..++.++|||||||++|||++ |+.||..... .+.
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------~~~ 248 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------------AEI 248 (323)
T ss_dssp C-----------------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGH
T ss_pred ccccccccccccccccccCcccccCchhhc--CCCCCCccchhhHHHHHHHHHhCCCCCccccCh------------HHH
Confidence 99765432 233466899999764 4578999999999999999999 9999964321 122
Q ss_pred HHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.......... .........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 249 ~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 YNYLIGGNRL-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHHHTTCCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2222222110 0011223457888999999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.95 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=196.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999965 58999999986432 22456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 100 GDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 9999999754 35999999999999999999999 789999999999999999999999999999876443
Q ss_pred --CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...||..|+|||++... +..++.++|||||||++|||++|+.||...... ..............
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~---- 237 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---------SSKEIVHTFETTVV---- 237 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---------CHHHHHHHHHHCCC----
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---------cHHHHHHHHhhccc----
Confidence 56789999999987542 346889999999999999999999999754321 22222222211110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-MSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 636 (672)
... ......+.+++.+||+.||++||+ +.++.+
T Consensus 238 -----~~p---~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYP---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCC---TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCC---CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001 112245778888999999999998 666653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=354.49 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=199.5
Q ss_pred HhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCe-EEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREE-KLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~lv 434 (672)
+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 357899999999999984 2458999999976433 3456799999999999 79999999999987554 8999
Q ss_pred EeecCCCChhHHhhcCCCCC------------------------------------------------------------
Q 005880 435 SEYMPNGSLFWLLHGNRGPG------------------------------------------------------------ 454 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~------------------------------------------------------------ 454 (672)
|||+++|+|.++++......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 99999999999998653210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-------CCCCCCcc
Q 005880 455 -RTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGY 526 (672)
Q Consensus 455 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y 526 (672)
...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..... ...+|..|
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hccccCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 123899999999999999999999 789999999999999999999999999999865332 33456789
Q ss_pred cCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccC
Q 005880 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKD 605 (672)
Q Consensus 527 ~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 605 (672)
+|||++. +..++.++|||||||++|||+| |+.||..... .+.+............ .
T Consensus 262 ~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------~~~~~~~~~~~~~~~~-------~-- 318 (359)
T 3vhe_A 262 MAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------------DEEFCRRLKEGTRMRA-------P-- 318 (359)
T ss_dssp CCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------------SHHHHHHHHHTCCCCC-------C--
T ss_pred EChhhhc--CCCCCchhhhhhHHHHHHHHHhcCCCCCCccch------------hHHHHHHHHcCCCCCC-------C--
Confidence 9999765 4678999999999999999998 9999964321 1122222222211110 0
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 606 IEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 606 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
......+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 319 -~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 319 -DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1122357888899999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.57 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=191.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 478999999999999965 789999999864332 234678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 517 (672)
|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 92 L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 92 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999744 35999999999999999999999 78999999999999999999999999999975432
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....+|..|+|||++.. ...++.++|||||||++|||++|+.||....... ........... .
T Consensus 163 ~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~---~ 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----------QEYSDWKEKKT---Y 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHC-SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-----------HHHHHHHTTCT---T
T ss_pred ccCCCccCcCccCcHHhcc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-----------HHHHHHhcccc---c
Confidence 24568899999998753 2334789999999999999999999997543211 11111111100 0
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ........+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 LN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 00112235678888999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.58 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=198.1
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
..+.||+|+||.||+|...++..||||+++.... ..++|.+|++++++++||||+++++++.+ +..++||||+++|+|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 3578999999999999998888899999986543 46789999999999999999999999865 678999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 266 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 266 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99997432 134899999999999999999999 789999999999999999999999999999866432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||+| |+.||... ...+....+.....
T Consensus 339 ~~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~------------~~~~~~~~i~~~~~----- 399 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVERGYR----- 399 (452)
T ss_dssp ----CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------------CHHHHHHHHHTTCC-----
T ss_pred cCCcccccccCHhHHh--cCCCCccccHHhHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHHcCCC-----
Confidence 233466899999765 4578999999999999999999 99999643 22222222222110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
. +........+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 400 ---~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 ---M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0 00112334678889999999999999999999999988643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=335.66 Aligned_cols=242 Identities=26% Similarity=0.409 Sum_probs=185.8
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc----chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI----GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... |+.||||+++.... ...+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 478999999999999976 89999999875432 2346789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC---cEecCCCCCCEEeCC--------CCcEEEecc
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK---LTHGNIKSTNVLLDK--------TGNARVSDF 509 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~---iiH~Dlkp~NIll~~--------~~~~kl~Df 509 (672)
++|.+++.. ..+++..++.++.|+++||+||| +.+ |+||||||+||+++. ++.+||+||
T Consensus 91 ~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH----~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 91 GPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH----DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH----HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred CCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH----hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999963 34899999999999999999999 556 999999999999986 678999999
Q ss_pred CCCccCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 510 GLSIFAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 510 G~a~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
|+++..... ...++..|+|||++. +..++.++||||||+++|||++|+.||.... ........
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------------~~~~~~~~ 226 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIR--ASMFSKGSDVWSYGVLLWELLTGEVPFRGID------------GLAVAYGV 226 (271)
T ss_dssp CC-------------CCGGGSCHHHHH--HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------------HHHHHHHH
T ss_pred CcccccccccccCCCCccceeCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHhh
Confidence 999765443 456788999999764 4578999999999999999999999996432 11111111
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
........ ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 227 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALP----------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCC----------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111100 0011234578888899999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=341.73 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=189.5
Q ss_pred HhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
..+.||+|+||.||+|.... +..||+|+++... ....+.+.+|+.++++++||||+++++++ .++..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 97 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELC 97 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecC
Confidence 35789999999999999642 4679999987543 33456799999999999999999999997 456789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 9999999997543 35899999999999999999999 789999999999999999999999999999766543
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||..... .+....+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~------------~~~~~~i~~~~~ 235 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------NDVIGRIENGER 235 (281)
T ss_dssp ---------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGHHHHHHTTCC
T ss_pred cccccccCCCcccccChhhcc--cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH------------HHHHHHHHcCCC
Confidence 233466899999764 4578999999999999999997 9999964321 122222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
. . .. ......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 236 ~-~-------~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 L-P-------MP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp C-C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-C-------CC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 01 1123457788889999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=350.32 Aligned_cols=242 Identities=22% Similarity=0.385 Sum_probs=198.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 478999999999999965 6899999999876555667899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC--CCcEEEeccCCCccCCCC---
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK--TGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~--- 518 (672)
.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 136 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 136 FDRIAAED----YKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99997542 35899999999999999999999 789999999999999974 578999999999876544
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+..+....+. ++
T Consensus 208 ~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------------~~~~~~~i~~~~~~---~~ 270 (387)
T 1kob_A 208 KVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED------------DLETLQNVKRCDWE---FD 270 (387)
T ss_dssp EEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------------HHHHHHHHHHCCCC---CC
T ss_pred eeeccCCCccCchhcc--CCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------------HHHHHHHHHhCCCC---CC
Confidence 346789999999764 4578999999999999999999999996432 22223322222111 11
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .. .....++.+++.+||+.||++|||+.|+++
T Consensus 271 ~~--~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 271 ED--AF---SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp SS--TT---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cc--cc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 10 01 112235778888999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.19 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=192.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCc----EEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|+.. +|+ .||+|.++... ....+++.+|++++++++||||+++++++.+.. .++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence 478999999999999954 444 46888886432 335678999999999999999999999998754 78999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.|+.|+++||+||| +.+|+||||||+||+++.++++||+|||+++.....
T Consensus 99 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp TTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999998654 45999999999999999999999 789999999999999999999999999999765432
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |+.||..... .... ......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------~~~~-~~~~~~ 235 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------SEIS-SILEKG 235 (327)
T ss_dssp CC-------CCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGHH-HHHHTT
T ss_pred cccccccCCCccccccChHHhc--cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH------------HHHH-HHHHcC
Confidence 233467899999765 5678999999999999999999 9999964321 1111 111111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... .........+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 236 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCC----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 100 0011223457888999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.28 Aligned_cols=242 Identities=26% Similarity=0.407 Sum_probs=195.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+|+.||||++..... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999995 5789999999875432 234678999999999999999999999999999999999996
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-C
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-T 519 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~ 519 (672)
|+|.+++.... .++++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 138 g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 68888886432 45899999999999999999999 789999999999999999999999999999876543 5
Q ss_pred CCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 520 VPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
..+|..|+|||++.. ....++.++|||||||++|||++|+.||... ...............
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~------------~~~~~~~~~~~~~~~------ 271 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------------NAMSALYHIAQNESP------ 271 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------CHHHHHHHHHHSCCC------
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------------ChHHHHHHHHhcCCC------
Confidence 678999999998743 2457899999999999999999999999643 222222222222110
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
... .. .....+.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~~-~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQ-SG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCC-CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC-CC---CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 01 112357788889999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.56 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=192.8
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC--CCCceeeeEEEEEcC----CeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL--RHPNLVGLKAYYFAR----EEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~~~lv~e~ 437 (672)
..+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++... +||||+++++++... ...++||||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 3578999999999999986 899999998643 334455566665554 899999999999877 688999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC--------CcEecCCCCCCEEeCCCCcEEEecc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL--------KLTHGNIKSTNVLLDKTGNARVSDF 509 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--------~iiH~Dlkp~NIll~~~~~~kl~Df 509 (672)
+++|+|.++++.. .+++..++.++.|+++||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 117 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 117 HENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH----TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH----SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH----HhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 9999999999754 3899999999999999999999 66 9999999999999999999999999
Q ss_pred CCCccCCCC---------CCCCCCcccCCCccccCCCCCCc------hhHHHHHHHHHHHHHhCC----------CCCCC
Q 005880 510 GLSIFAPPS---------TVPRSNGYRAPELSSSDGRKQSQ------KSDVYSFGVLLLELLTGK----------CPSVI 564 (672)
Q Consensus 510 G~a~~~~~~---------~~~~t~~y~aPE~l~~~~~~~~~------~~DV~S~Gvvl~el~tg~----------~P~~~ 564 (672)
|+++..... ...+|..|+|||++.. ...+. ++|||||||++|||+||. .||..
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999765432 3467899999997753 23333 499999999999999994 44433
Q ss_pred CCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 565 DGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.... ...... ........... +.........+....+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 265 ~~~~-------~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPS-------DPSYED-MREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCS-------SCCHHH-HHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCC-------CCchhh-hHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 2111 111111 11111111111 11111111235667789999999999999999999999999998754
Q ss_pred C
Q 005880 645 E 645 (672)
Q Consensus 645 ~ 645 (672)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.81 Aligned_cols=252 Identities=27% Similarity=0.368 Sum_probs=201.8
Q ss_pred HhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 357899999999999985 245889999997543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 437 YMPNGSLFWLLHGNRGP-------------------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
|+++|+|.+++...... ....+++.+++.++.|+++||+||| +.+|+||||||+||+
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLAARNIL 182 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccchheEE
Confidence 99999999999865421 1234899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005880 498 LDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGA 569 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~ 569 (672)
++.++.+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||+| |+.||.....
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 258 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-- 258 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc--CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999765432 334567899999764 4578999999999999999999 9999964321
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
...... ........ .. ......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 259 ----------~~~~~~-~~~~~~~~-------~~---~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ----------ERLFNL-LKTGHRME-------RP---DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ----------GGHHHH-HHTTCCCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------HHHHHH-hhcCCcCC-------CC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111111 11111100 01 11234578888899999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=336.67 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=190.1
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++ .....++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 3478999999999999865 359999987543 23457899999999999999999999965 566789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---- 517 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 517 (672)
+|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999996543 45999999999999999999999 78999999999999999999999999999975543
Q ss_pred ---CCCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 ---STVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
....+|..|+|||++.. .+..++.++||||||+++|||++|+.||..... ...+..........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------------RDQIIEMVGRGSLS 244 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC------------HHHHHHHHHHTSCC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch------------HHHHHHHhcccccC
Confidence 13457899999997642 245678899999999999999999999964321 11222222222111
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.... .. .......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 245 ~~~~----~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLS----KV--RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTT----SS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchh----hc--cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1100 00 01223467888999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.38 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=192.6
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+..+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 478999999999999998899999999865432 2347788999999999999999999999999999999999975 9
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999987543 35899999999999999999999 789999999999999999999999999998755422
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc-----
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT----- 592 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 592 (672)
...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+......+....
T Consensus 158 ~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------------~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS------------EADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp ----CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccCchheeC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHHHCCCChhh
Confidence 3457889999997642 3468999999999999999999999996432 11112222111000
Q ss_pred ------ccccchhhccc------cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 ------AEVFDLELMRY------KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ------~~~~d~~~~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+++..... .........+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00011110000 000112245678888999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.42 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=195.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 4578999999999999965 689999999975432 3456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC---CcEEEeccCCCccCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT---GNARVSDFGLSIFAPP 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~ 517 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.+ +.+||+|||++.....
T Consensus 113 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 113 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999998743 35899999999999999999999 7899999999999999865 4599999999987654
Q ss_pred C----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 S----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
. ...+|+.|+|||++. +..++.++|||||||++|||++|+.||... +.......+.......
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~------------~~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDE------------DQHRLYAQIKAGAYDY 249 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCCC
T ss_pred CcccccCCCCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCC------------CHHHHHHHHHhCCCCC
Confidence 3 356899999999764 457899999999999999999999999643 2222333322221110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+ .. ......+.+++.+||+.||++|||+.|+++
T Consensus 250 --~~~---~~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 --PSP---EW---DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp --CTT---GG---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --Ccc---cc---cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00 112245778888999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.77 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=192.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999965 68999999997532 22456678899999988 79999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++....
T Consensus 108 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 108 GGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999754 34899999999999999999999 78999999999999999999999999999986432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... +..+....+......
T Consensus 179 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~------------~~~~~~~~i~~~~~~-- 242 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAPFEAE------------NEDDLFEAILNDEVV-- 242 (353)
T ss_dssp -------CCGGGCCHHHHH--HHHCTTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCC--
T ss_pred ccccccCCCcCeEChhhcC--CCCcCCccCCCcchHHHHHHHhCCCCCCCC------------CHHHHHHHHHcCCCC--
Confidence 2456899999999775 457899999999999999999999999643 223333333332211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM------SHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~ 636 (672)
.... ....+.+++.+||+.||++||++ .|+++
T Consensus 243 -------~p~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 -------YPTW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCTT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0111 12346778889999999999998 66654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.44 Aligned_cols=242 Identities=21% Similarity=0.313 Sum_probs=195.1
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 357899999999999995 4789999999875443 2456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC---CCCcEEEeccCCCccCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD---KTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~ 517 (672)
|+|.+.+... ..+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||+++....
T Consensus 95 g~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 95 GELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999998754 34899999999999999999999 78999999999999998 467899999999976654
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ...||+.|+|||++. +..++.++||||+||++|||++|+.||... +..+....+.....
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyell~G~~Pf~~~------------~~~~~~~~i~~~~~- 230 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLR--KDPYGKPVDLWACGVILYILLVGYPPFWDE------------DQHRLYQQIKAGAY- 230 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHHTCC-
T ss_pred CCceeecccCCcccCCHHHhc--CCCCCCccccHHHHHHHHHHHhCCCCCCCc------------cHHHHHHHHHhCCC-
Confidence 3 456899999999764 457899999999999999999999999643 22223333322211
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+........ ....+.+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~---~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 ----DFPSPEWDT---VTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CCCTTTTTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCCcccccc---CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 100001111 2235778888999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=339.62 Aligned_cols=237 Identities=23% Similarity=0.345 Sum_probs=196.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||+|++++.. ....+.+.+|..+++.++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 478999999999999965 68999999997532 22456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 91 GELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp CBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 9999999754 34899999999999999999999 889999999999999999999999999999876543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...+|+.|+|||++. +..++.++|||||||++|||++|+.||... +.......+.....
T Consensus 162 ~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~------------~~~~~~~~i~~~~~------- 220 (318)
T 1fot_A 162 TLCGTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDS------------NTMKTYEKILNAEL------- 220 (318)
T ss_dssp CCCSCTTTCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHCCC-------
T ss_pred cccCCccccCHhHhc--CCCCCcccchhhhHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCC-------
Confidence 567899999999764 457899999999999999999999999643 22233333333211
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ...++.+++.+||..||++|| ++.|+++
T Consensus 221 --~~p~~---~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 --RFPPF---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCTT---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCC---CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00111 123567888899999999999 8888874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.44 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=202.2
Q ss_pred HhcccCcCCeEEEEEEEEc--------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 433 (672)
..+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 4578999999999999863 467899999975432 3456789999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 434 VSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
||||+++|+|.+++...... ....+++..++.++.|+++||+||| +.+|+||||||+||+++.++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEEEcCCC
Confidence 99999999999999865421 1234899999999999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 574 (672)
.+||+|||+++..... ...++..|+|||++. +..++.++||||||+++|||++ |+.||...
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------- 263 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--------- 263 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC---------
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhc--CCCcChHHHHHHHHHHHHHHHhCCCCCcCcC---------
Confidence 9999999999765432 234567899999764 4578999999999999999999 99998642
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
...+......... ... .. ......+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 264 ---~~~~~~~~~~~~~-~~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 264 ---PVEELFKLLKEGH-RMD-------KP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ---CHHHHHHHHHHTC-CCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---CHHHHHHHHhcCC-CCC-------CC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2222222222211 000 00 1122457888889999999999999999999999976443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=341.92 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=194.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe----EEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE----KLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e 436 (672)
.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|++++.+++||||+++++++..... .++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 47899999999999995 5789999999976432 234578999999999999999999999876543 499999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.++++.. .++++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 97 ~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 97 YVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp CCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999754 35899999999999999999999 7899999999999999999999999999997654
Q ss_pred CC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 PS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.. ...+|..|+|||++. +..++.++|||||||++|||++|+.||... ...........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~------------~~~~~~~~~~~ 233 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTGD------------SPVSVAYQHVR 233 (311)
T ss_dssp --------------CCTTCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHH
T ss_pred ccccccccccccCcCcccCCHHHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCC------------ChHHHHHHHhc
Confidence 32 345789999999764 557899999999999999999999999643 22222222222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH-HHHHHHHHHHhcCCCCCCCC
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM-SHVVKLIEELRGVEVSPCHE 651 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-~evl~~L~~i~~~~~~~~~~ 651 (672)
..... +.. ... .....+.+++.+||+.||++||++ +++.+.+..+.....+..+.
T Consensus 234 ~~~~~----~~~-~~~---~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~ 289 (311)
T 3ork_A 234 EDPIP----PSA-RHE---GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289 (311)
T ss_dssp CCCCC----HHH-HST---TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred CCCCC----ccc-ccC---CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence 21110 000 011 122457788889999999999955 55556777766554444333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=340.70 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=186.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||||++ |
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 4578999999999999954 689999999875432 245778899999999999999999999999999999999997 6
Q ss_pred ChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++..... .....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 99998865321 12245899999999999999999999 789999999999999999999999999999765432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc----
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW---- 591 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 591 (672)
...+|..|+|||++.. ...++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 164 ~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTND------------EEQLKLIFDIMGTPNE 230 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHHHCSCCT
T ss_pred cCCCCcccccccCchHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------------HHHHHHHHHHhCCCCh
Confidence 4467889999998642 34689999999999999999999999964321 111111111000
Q ss_pred --ccc-----ccchhhcc--ccCh---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 --TAE-----VFDLELMR--YKDI---------EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 --~~~-----~~d~~~~~--~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .+.+.... .... ......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 00000000 0000 012246788999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=342.13 Aligned_cols=239 Identities=22% Similarity=0.326 Sum_probs=189.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC-------------
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------------- 429 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------- 429 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 478999999999999976 79999999997433 335678999999999999999999999986543
Q ss_pred --------------------------------------------eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHH
Q 005880 430 --------------------------------------------EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK 465 (672)
Q Consensus 430 --------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~ 465 (672)
..++||||+++|+|.+++..... .....+..++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHHH
Confidence 27899999999999999986542 34567888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----------------CCCCCCcccC
Q 005880 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-----------------TVPRSNGYRA 528 (672)
Q Consensus 466 i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----------------~~~~t~~y~a 528 (672)
++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..... ...+|..|+|
T Consensus 169 i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 169 IFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 9999999999999 789999999999999999999999999999766442 2457889999
Q ss_pred CCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHH
Q 005880 529 PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEE 608 (672)
Q Consensus 529 PE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 608 (672)
||++. +..++.++|||||||++|||++|..|+.. ........ .... .......
T Consensus 245 PE~~~--~~~~~~~~Di~slG~il~el~~~~~~~~~--------------~~~~~~~~-~~~~----------~~~~~~~ 297 (332)
T 3qd2_B 245 PEQIH--GNNYSHKVDIFSLGLILFELLYSFSTQME--------------RVRIITDV-RNLK----------FPLLFTQ 297 (332)
T ss_dssp HHHHH--CCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------------HHHHHHHH-HTTC----------CCHHHHH
T ss_pred hHHhc--CCCCcchhhHHHHHHHHHHHHHcCCChhH--------------HHHHHHHh-hccC----------CCccccc
Confidence 99765 45789999999999999999998776421 01111111 1100 0011123
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 609 EMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 609 ~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+.+++.+||+.||++|||+.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3456788999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=351.67 Aligned_cols=195 Identities=23% Similarity=0.306 Sum_probs=169.9
Q ss_pred hcccCcC--CeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKG--GFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+| +||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4789999 99999999976 69999999997543 2345678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++..... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus 110 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 110 YGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999986532 35899999999999999999999 78999999999999999999999999998754321
Q ss_pred ----------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 518 ----------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 518 ----------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
....+|..|+|||++......++.++|||||||++|||++|+.||....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1346788899999876443678999999999999999999999997543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=369.42 Aligned_cols=243 Identities=26% Similarity=0.324 Sum_probs=196.6
Q ss_pred ccCcCCeEEEEEEEEc---CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 367 MLGKGGFGTAYKAVLD---DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 46789999998643 3356889999999999999999999999976 56899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..|+.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999997543 45999999999999999999999 789999999999999999999999999999876432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++. +..++.++|||||||++|||+| |+.||.... ..+....+......
T Consensus 494 ~~~~~~~~~~~y~APE~~~--~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~------------~~~~~~~i~~~~~~- 558 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------------GPEVMAFIEQGKRM- 558 (613)
T ss_dssp --------CCTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------------SHHHHHHHHTTCCC-
T ss_pred eeccCCCCccceeCHhhhc--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC------------HHHHHHHHHcCCCC-
Confidence 122346899999764 4578999999999999999998 999996432 12222222221110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. .......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 559 -------~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 559 -------EC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp -------CC---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 00 11233467889999999999999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=349.41 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=191.2
Q ss_pred hcccCcCCeEEEEEEEEc--CC--cEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD--DG--SVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|... ++ ..||||.++... ....++|.+|+.++++++||||+++++++.. ++..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 468999999999999954 22 468999987533 3356789999999999999999999999765 45789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 174 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 174 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999997543 45889999999999999999999 789999999999999999999999999999765332
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...++..|+|||++. +..++.++|||||||++|||+| |.+||...... +.. .....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---------~~~---~~~~~ 311 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------DIT---VYLLQ 311 (373)
T ss_dssp ------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---------CHH---HHHHT
T ss_pred ccccccccCCCCCcccccChHHhc--CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---------HHH---HHHHc
Confidence 233466799999765 4678999999999999999999 67777543211 111 11111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCC
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSP 648 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 648 (672)
... ... . ......+.+++.+||+.||++|||+.|+++.|+++...-...
T Consensus 312 ~~~---~~~-----p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 312 GRR---LLQ-----P---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp TCC---CCC-----C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCC---CCC-----C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 110 000 1 112235788889999999999999999999999997544433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.96 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=191.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 478999999999999965 689999999975332 2357889999999999999999999999999999999999975
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
++.+.+.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 6666555432 35999999999999999999999 789999999999999999999999999999765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc--c
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA--E 594 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 594 (672)
...+|..|+|||++.. ...++.++|||||||++|||++|..||.... +..+....+.+..... +
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-----------~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----------DVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----------SHHHHHHHHHHHHCCCCTT
T ss_pred ccCCccccCCcChHHHcC-CCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-----------CHHHHHHHHHHHhCCCChh
Confidence 4456889999997643 2347999999999999999999988865321 2222222222211000 0
Q ss_pred cc-------ch--------hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VF-------DL--------ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~-------d~--------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. +. ..............+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00 00000000112345678888999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.66 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=191.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.++||||+++++++.+.+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 47899999999999996 5789999999864321 23467899999999999999999999999999999999999 7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 93 g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 93 GELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 8999988654 34899999999999999999999 779999999999999999999999999999866543
Q ss_pred --CCCCCCcccCCCccccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRK-QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~-~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+|+.|+|||++. +.. .++++|||||||++|||++|+.||.......... .+
T Consensus 164 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------------~i 220 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVIN--GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------------KV 220 (336)
T ss_dssp TCCCTTSTTTSCGGGSC--CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------------CC
T ss_pred cccccCCcCcCCHHHHc--CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------------HH
Confidence 456889999999775 334 3789999999999999999999997543221100 00
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.......... ....+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~~~~~p~~---~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSCVYVMPDF---LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSCCCCCTT---SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcCCCCCccc---CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000111 1235678888999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.13 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=202.3
Q ss_pred HhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 435 (672)
..+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 357899999999999985 3468999999975433 3457899999999999 9999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 436 EYMPNGSLFWLLHGNRG-------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
||+++|+|.+++..... .....+++..++.++.|+++||+||| +.+|+||||||+||+++.++
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEETTT
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEcCCC
Confidence 99999999999986542 11235899999999999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 574 (672)
.+||+|||+++..... ...++..|+|||++. +..++.++||||||+++|||+| |+.||.....
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------- 253 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------- 253 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-------
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-------
Confidence 9999999999876543 223456799999765 4578999999999999999999 9999964321
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.........+..... .. ......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 254 -----~~~~~~~~~~~~~~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 254 -----DSKFYKMIKEGFRML-------SP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp -----SHHHHHHHHHTCCCC-------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hhHHHHHhccCCCCC-------Cc---ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111222222221100 00 1123457888889999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.34 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=197.2
Q ss_pred hcccCcCCeEEEEEEEEc-CC-------cEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DG-------SVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 478999999999999954 33 5799999987666677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc--------EEEec
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN--------ARVSD 508 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~D 508 (672)
|+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++. +||+|
T Consensus 93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999998643 34899999999999999999999 789999999999999998887 99999
Q ss_pred cCCCccCCCC-CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 509 FGLSIFAPPS-TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 509 fG~a~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
||++...... ...++..|+|||++.. ...++.++|||||||++|||++|..|+.... +.........
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~~~ 232 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----------DSQRKLQFYE 232 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHC-GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----------CHHHHHHHHH
T ss_pred CcccccccCccccCCcCcccCHHHhCC-CCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----------chHHHHHHhh
Confidence 9999765443 3346788999997653 2568999999999999999999655543221 1111111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..... . .. ....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 233 ~~~~~----~------~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DRHQL----P------AP---KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCCC----C------CC---SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccCCC----C------CC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11000 0 00 11246788889999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=340.99 Aligned_cols=243 Identities=21% Similarity=0.365 Sum_probs=178.6
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.||+|+||.||+|... +|+.||||++... ....+.+|++++..++ ||||+++++++.++...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999965 6899999998643 4567889999999997 99999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEeccCCCccCCCC--
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~-- 518 (672)
.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 94 FERIKKK-----KHFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999864 35999999999999999999999 78999999999999998765 8999999999865443
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||....... ......+....+......
T Consensus 165 ~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~i~~~~~~--- 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLN--QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-----TCTSAVEIMKKIKKGDFS--- 234 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------CCCHHHHHHHHTTTCCC---
T ss_pred cccccCCCcCccCHHHhc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-----ccccHHHHHHHHHcCCCC---
Confidence 445688999999764 5678999999999999999999999997543211 011222233222222110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
+.. ........++.+++.+||+.||++|||+.|++
T Consensus 235 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 235 FEG-----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CCS-----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCc-----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 000 00011234578888899999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.74 Aligned_cols=237 Identities=21% Similarity=0.272 Sum_probs=196.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 478999999999999965 68999999986532 22456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 99999997542 4899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 197 ~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~------------~~~~~~~~i~~~~~------- 255 (350)
T 1rdq_E 197 TLCGTPEALAPEIIL--SKGYNKAVDWWALGVLIYEMAAGYPPFFAD------------QPIQIYEKIVSGKV------- 255 (350)
T ss_dssp CCEECGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC-------
T ss_pred cccCCccccCHHHhc--CCCCCCcCCEecccHhHhHHhhCCCCCCCC------------CHHHHHHHHHcCCC-------
Confidence 456799999999765 457899999999999999999999999643 22333333333211
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
..... ....+.+++.+||+.||++||+ +.|+++
T Consensus 256 --~~p~~---~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 --RFPSH---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTT---CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCC---CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 00111 2235778888999999999998 777764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.14 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=195.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +++.||+|++++... ...+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 589999999864221 1234588999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.++++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++.....
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999754 3899999999999999999999 789999999999999999999999999999766543
Q ss_pred ----CCCCCCcccCCCccccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ----TVPRSNGYRAPELSSSDGR--KQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~--~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...||+.|+|||++..... .++.++|||||||++|||++|+.||... +.......+......
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------------~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------------SLVGTYSKIMNHKNS 291 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHTHHHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC------------ChhhHHHHHHhcccc
Confidence 5678999999998764322 2789999999999999999999999643 233333443332211
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ--RPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~ 636 (672)
.... ..... ...+.+++.+||..+|.+ ||++.||++
T Consensus 292 ~~~p-----~~~~~---s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 LTFP-----DDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCCC-----TTCCC---CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccCC-----Ccccc---cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1110 01111 234677888999999988 999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=345.97 Aligned_cols=246 Identities=19% Similarity=0.286 Sum_probs=194.9
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-----cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-----IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 106 (351)
T 3c0i_A 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106 (351)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 34578999999999999964 68999999986321 1246789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc---EEEeccCCCc
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN---ARVSDFGLSI 513 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~ 513 (672)
|+++|+|.+++..... ....+++..+..++.|+++||+||| +.+|+||||||+||+++.++. +||+|||+++
T Consensus 107 ~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 107 FMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp CCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred CCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999888764321 1235899999999999999999999 789999999999999986654 9999999997
Q ss_pred cCCCC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 514 FAPPS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 514 ~~~~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||.... .........
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------------~~~~~~i~~ 246 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVK--REPYGKPVDVWGCGVILFILLSGCLPFYGTK-------------ERLFEGIIK 246 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------------HHHHHHHHH
T ss_pred EecCCCeeecCCcCCcCccCHHHHc--CCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------------HHHHHHHHc
Confidence 76543 346889999999764 4578999999999999999999999996421 122222222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ..+.. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~---~~~~~--~~---~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYK---MNPRQ--WS---HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCC---CCHHH--HT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC---CCccc--cc---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2110 11100 01 11245778888999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=341.60 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=199.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc----CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA----REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 47899999999999996 5789999999876665567889999999999999999999999873 347789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++..... ....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 114 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 114 RGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 9999999975321 1246999999999999999999999 789999999999999999999999999998765421
Q ss_pred -------------CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 519 -------------TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 519 -------------~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
...+|..|+|||++... ...++.++||||||+++|||++|+.||...... ......
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~--- 258 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-------GDSVAL--- 258 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-------TSCHHH---
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-------cchhhH---
Confidence 12358899999976532 123688999999999999999999998532100 001111
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCC
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 647 (672)
...... .. +........+.+++.+||+.||.+|||+.|+++.|+.+......
T Consensus 259 -~~~~~~-------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 259 -AVQNQL-------SI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp -HHHCC---------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred -HhhccC-------CC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 111100 00 00011234578888999999999999999999999998654443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.07 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=185.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..++||+|+||+||+|+.. +|+.||||++..... ....++..|+..+.++ +||||+++++++.+.+..++||||+
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~- 139 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-
Confidence 3578999999999999976 799999999865332 2334555566655555 8999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++.... ..++|..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 140 ~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 140 GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 779999887543 45999999999999999999999 789999999999999999999999999999766543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+|.+|+|||++. ..++.++|||||||++|||++|..|+.... .| ... ....
T Consensus 212 ~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~el~~g~~~~~~~~--------------~~-~~~-~~~~---- 268 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQ---GSYGTAADVFSLGLTILEVACNMELPHGGE--------------GW-QQL-RQGY---- 268 (311)
T ss_dssp ---CCCCCGGGCCGGGGG---TCCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------------HH-HHH-TTTC----
T ss_pred CCcccCCCccccCHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------------HH-HHH-hccC----
Confidence 445789999999764 368999999999999999999977764210 11 111 1111
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+... ......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFT-----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111110 112345788899999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.15 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=198.0
Q ss_pred cccCcCCeEEEEEEEEc---CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVLD---DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||+|... ++..||||+++... ....+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 47999999999999853 57889999998643 33567899999999999999999999999 556789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999997443 45899999999999999999999 789999999999999999999999999999766432
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||++. +..++.++||||||+++|||+| |+.||.... ..+....+.....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------------~~~~~~~i~~~~~- 231 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------------GPEVMAFIEQGKR- 231 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------------THHHHHHHHTTCC-
T ss_pred eeccccccccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------------HHHHHHHHhcCCc-
Confidence 233467899999764 4578899999999999999999 999996432 1222222222110
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. .. ......+.+++.+||+.||++||++.|+++.|+++..
T Consensus 232 ~~-------~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 ME-------CP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CC-------CC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-------CC---CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 01 1223467888899999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=347.23 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=198.3
Q ss_pred HhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 435 (672)
..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++.++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 457899999999999995 245689999997542 23457899999999999 8999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 436 EYMPNGSLFWLLHGNRGP------------------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
||+++|+|.+++...... ....+++..++.++.|+++||+||| +.+|+||||||+||+
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVL 204 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEE
Confidence 999999999999865321 1134899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005880 498 LDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGA 569 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~ 569 (672)
++.++.+||+|||++...... ...+|..|+|||++. +..++.++|||||||++|||+| |+.||......
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 281 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD- 281 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc--cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-
Confidence 999999999999999765432 223466799999765 4578999999999999999998 99999654211
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
..+........... .. ......+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 282 -----------~~~~~~~~~~~~~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 -----------ANFYKLIQNGFKMD-------QP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp -----------HHHHHHHHTTCCCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----------HHHHHHHhcCCCCC-------CC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 12222222221110 00 11234577888899999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.06 Aligned_cols=241 Identities=21% Similarity=0.288 Sum_probs=197.0
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 3578999999999999965 478999999987665677889999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe---CCCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 93 LFERVVHK-----RVFRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp HHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99998754 34899999999999999999999 7899999999999999 78899999999999765543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...+|..|+|||++. ..++.++||||||+++|||++|+.||.... ..+........... .
T Consensus 164 ~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------------~~~~~~~~~~~~~~--~ 226 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPT------------DSEVMLKIREGTFT--F 226 (277)
T ss_dssp CBCCCCSCTTTCCHHHHT---TCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHCCCC--C
T ss_pred chhccCCCCCccChHHhc---ccCCchhhehhHHHHHHHHHHCCCCCCCCC------------HHHHHHHHHhCCCC--C
Confidence 456788999999764 348999999999999999999999996432 22222222222110 0
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ......+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDW------LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHH------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cchhh------hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 012345778889999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=367.56 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=201.6
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++||||+++|+|
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 4578999999999999998888999999986543 46789999999999999999999999865 678999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.++++... ...+++.+++.|+.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 349 ~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 349 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred HHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 99997432 134899999999999999999999 789999999999999999999999999999876532
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. ...++.++|||||||++|||+| |+.||... ...+....+......
T Consensus 422 ~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~------------~~~~~~~~i~~~~~~---- 483 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVERGYRM---- 483 (535)
T ss_dssp CSTTSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC------------CHHHHHHHHHTTCCC----
T ss_pred cCCcCcccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHHcCCCC----
Confidence 334567899999765 4578999999999999999999 99999643 222222222221100
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.........+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 484 -------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 00112234578889999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.13 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=191.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||+|... +|..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 3578999999999999964 68999999987543 235678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe---CCCCcEEEeccCCCccCCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~ 518 (672)
+|.+++..... ....+++..++.++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99998864321 1245899999999999999999999 7899999999999999 45678999999999765433
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||++. ..++.++||||||+++|||++|+.||... ...+............
T Consensus 181 ~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~------------~~~~~~~~~~~~~~~~- 244 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGT------------SLEEVQQKATYKEPNY- 244 (285)
T ss_dssp ------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCCC-
T ss_pred ccCcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCC------------CHHHHHhhhccCCccc-
Confidence 456788999999763 46889999999999999999999999643 2222222211111100
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... ... ....+.+++.+||+.||++|||+.|+++
T Consensus 245 --~~~---~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 --AVE---CRP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC-----CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccc---cCc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 1235678888999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.15 Aligned_cols=266 Identities=19% Similarity=0.253 Sum_probs=207.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--eEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFARE--EKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 478999999999999965 589999999975432 34577889999999999999999999998765 67999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe----CCCCcEEEeccCCCccCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~a~~~~ 516 (672)
|+|.+++..... ...+++..++.++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 94 g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp EEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999975431 234899999999999999999999 7899999999999999 778889999999998765
Q ss_pred CC----CCCCCCcccCCCccccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 517 PS----TVPRSNGYRAPELSSSD------GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~------~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
.. ...+|..|+|||++... ...++.++|||||||++|||++|+.||...... ....+.+...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~--------~~~~~~~~~~ 239 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--------RRNKEVMYKI 239 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT--------TTCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc--------cchHHHHHHH
Confidence 43 45678999999976421 145678999999999999999999999754321 1223333333
Q ss_pred Hhhhccccc------------cchhhc-cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 587 VREEWTAEV------------FDLELM-RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 587 ~~~~~~~~~------------~d~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
......... ...... ...........+.+++.+||+.||++||++.|+++.++++...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 332211100 000000 0111245566788999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=354.81 Aligned_cols=245 Identities=20% Similarity=0.271 Sum_probs=195.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.++||+|+||.||+|+.. +++.||||++++.... ....+.+|..++..++||||+++++++.+++..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 478999999999999976 4789999999753221 233488999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999998632 35999999999999999999999 789999999999999999999999999999765432
Q ss_pred ----CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ----TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...||+.|+|||++.. ....++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~------------~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------------SLVETYGKIMNHKE 298 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHTHHH
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC------------ChhHHHHhhhhccc
Confidence 3578999999998752 2456899999999999999999999999743 22333333332211
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQ--RPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~ 636 (672)
.... ..........+.+++.+||..+|++ ||++.|+++
T Consensus 299 ~~~~-------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 RFQF-------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HCCC-------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccC-------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1000 0000112234677888999888888 999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.53 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=195.3
Q ss_pred hcccCcCCeEEEEEEEEcC-----CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDD-----GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|.... +..||||+++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4789999999999998653 24699999975432 34567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999997643 35899999999999999999999 789999999999999999999999999999766432
Q ss_pred --------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 --------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 --------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...++..|+|||++. +..++.++|||||||++|||++ |+.||... ...+....+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~pf~~~------------~~~~~~~~~~~~ 266 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWEL------------SNHEVMKAINDG 266 (333)
T ss_dssp ----------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHTT
T ss_pred cccccccCCCCccccccCchhcc--cCCCCchhhhHHHHHHHHHHHcCCCCCcccC------------CHHHHHHHHHCC
Confidence 123456799999764 5678999999999999999999 99999632 122222222211
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
... +........+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 267 ~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 FRL-----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCC-----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CcC-----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 100 00011234578888999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=349.96 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=189.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +++.||||++++.... ..+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 478999999999999965 5889999999754322 234578899998877 89999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++....
T Consensus 137 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 137 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999754 34999999999999999999999 78999999999999999999999999999975322
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....||+.|+|||++. +..++.++|||||||++|||++|+.||......+.. .......+........
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~--~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~----~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP----DQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------CCHHHHHHHHHHCC---
T ss_pred CccccccCCcccCCchhhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc----chhhHHHHHHHHhccc---
Confidence 2566899999999775 467899999999999999999999999754322100 0111122222211111
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
...... ....+.+++.+||+.||++||++
T Consensus 279 -----~~~p~~---~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRS---LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTT---SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCc---CCHHHHHHHHHHhcCCHhHcCCC
Confidence 011111 22356788889999999999996
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=333.84 Aligned_cols=245 Identities=30% Similarity=0.444 Sum_probs=199.4
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|...++..||||+++.... ..+.+.+|++++++++||||+++++++. .+..++||||+++++|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 478999999999999998888999999976543 4678999999999999999999999976 55689999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9996432 125899999999999999999999 789999999999999999999999999999866543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+......... ..
T Consensus 169 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~------------~~~~~~~~~~~~~-~~---- 229 (279)
T 1qpc_A 169 GAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------------TNPEVIQNLERGY-RM---- 229 (279)
T ss_dssp TCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------------CHHHHHHHHHTTC-CC----
T ss_pred CCCCccCccChhhhc--cCCCCchhhhHHHHHHHHHHHhCCCCCCccc------------CHHHHHHHHhccc-CC----
Confidence 234567899999764 4578899999999999999999 99998642 2222222222111 00
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.... .....+.+++.+||+.||++|||+.++++.|+++..
T Consensus 230 ---~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 230 ---VRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ---CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCcc---cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 0011 122457888889999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.60 Aligned_cols=243 Identities=21% Similarity=0.294 Sum_probs=186.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+++.. +|+.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 478999999999999965 789999999975433 346788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc--EEEeccCCCccCCC----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN--ARVSDFGLSIFAPP---- 517 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~---- 517 (672)
.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++. +||+|||+++....
T Consensus 104 ~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 104 YERICNA-----GRFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9999754 24899999999999999999999 789999999999999987765 99999999974332
Q ss_pred CCCCCCCcccCCCccccCCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 518 STVPRSNGYRAPELSSSDGRKQS-QKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 518 ~~~~~t~~y~aPE~l~~~~~~~~-~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
....+|..|+|||++.. ..++ .++|||||||++|||++|+.||...... ......+.........
T Consensus 175 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~~---- 240 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--------RDYRKTIQRILSVKYS---- 240 (361)
T ss_dssp ------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--------CCHHHHHHHHHTTCCC----
T ss_pred CCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--------HHHHHHHHHHhcCCCC----
Confidence 24568899999998753 3444 4599999999999999999999754321 2233333332222110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...... ....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ---~~~~~~---~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 ---IPDDIR---ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCTTSC---CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCCcCC---CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000001 12356788889999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.04 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=196.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 799999999975322 2356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 101 GELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 9999999743 35999999999999999999999 889999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...+|+.|+|||++.. ....+.++|||||||++|||++|+.||... +.......+.....
T Consensus 172 ~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~------------~~~~~~~~i~~~~~----- 233 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDD------------HVPTLFKKICDGIF----- 233 (476)
T ss_dssp BCCCCSCSTTCCHHHHTT-CCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------------SSHHHHHHHHTTCC-----
T ss_pred ccccCCCcCeEChhhccC-CCCCCCcceehhhHHHHHHHhhCCCCCCCC------------CHHHHHHHHhcCCc-----
Confidence 4568899999998753 233478999999999999999999999643 22233333322211
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ----~~p~~---~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ----YTPQY---LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCcc---CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00111 1235778888999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.57 Aligned_cols=249 Identities=20% Similarity=0.224 Sum_probs=193.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC-----CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA-----SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 3578999999999999964 6889999998643 233567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCC
Q 005880 438 MPNGSLFWLLHGNRGP-----------------------------------GRTPLDWTTRLKIAAGAARGLAFIHFTCK 482 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 482 (672)
+++|+|.+++...... ....+++..++.++.|+++||+|||
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---- 185 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---- 185 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH----
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----
Confidence 9999999998521100 0122467788999999999999999
Q ss_pred CCCcEecCCCCCCEEeCCCC--cEEEeccCCCccCCC---------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHH
Q 005880 483 SLKLTHGNIKSTNVLLDKTG--NARVSDFGLSIFAPP---------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVL 551 (672)
Q Consensus 483 ~~~iiH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~---------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvv 551 (672)
+.+|+||||||+||+++.++ .+||+|||+++.... ....+|..|+|||++......++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 78999999999999998776 899999999975422 2456788999999876555788999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 552 LLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 552 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
+|||++|+.||... ...+............. .+. .......+.+++.+||+.||.+|||+
T Consensus 266 l~el~~g~~pf~~~------------~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 266 LHLLLMGAVPFPGV------------NDADTISQVLNKKLCFE--NPN------YNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHSSCSSCCS------------SHHHHHHHHHHCCCCTT--SGG------GGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHCCCCCCCC------------ChHHHHHHHHhcccccC--Ccc------cccCCHHHHHHHHHHcCCChhHCCCH
Confidence 99999999999643 22223333332221100 000 01123457788889999999999999
Q ss_pred HHHHH
Q 005880 632 SHVVK 636 (672)
Q Consensus 632 ~evl~ 636 (672)
.|+++
T Consensus 326 ~~~l~ 330 (345)
T 3hko_A 326 MRALQ 330 (345)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.40 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=180.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 468999999999999976 58899999997543 456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCCCC--
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~-- 518 (672)
.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 136 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 136 FDRIVEK-----GYYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp HHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 9999754 35899999999999999999999 789999999999999975 889999999999866543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||..... .......+...... ..
T Consensus 207 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~i~~~~~~--~~ 271 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILR--GCAYGPEVDMWSVGIITYILLCGFEPFYDERG-----------DQFMFRRILNCEYY--FI 271 (349)
T ss_dssp ------CGGGSCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-----------HHHHHHHHHTTCCC--CC
T ss_pred cccccCCCCccCHHHhc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-----------cHHHHHHHHhCCCc--cC
Confidence 456789999999764 55789999999999999999999999964321 11112222221110 00
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+ ........+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SP------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00112345778888999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.77 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=185.7
Q ss_pred hcccCcCCeEEEEEEEE----cCCcEEEEEEcccCCc----chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASI----GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 47899999999999996 4789999999976432 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 102 YLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999754 34899999999999999999999 7899999999999999999999999999987543
Q ss_pred C-----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 517 P-----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 517 ~-----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
. ....+|..|+|||++. +..++.++|||||||++|||++|+.||... +.......+.....
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~------------~~~~~~~~i~~~~~ 238 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILM--RSGHNRAVDWWSLGALMYDMLTGAPPFTGE------------NRKKTIDKILKCKL 238 (327)
T ss_dssp ------CTTSSCCTTSCHHHHT--TSCCCTHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHHTCC
T ss_pred cCCccccccCCCcCccCHhhCc--CCCCCCcccchhHHHHHHHHHHCCCCCCCC------------CHHHHHHHHHhCCC
Confidence 2 2456889999999764 457899999999999999999999999643 22223333322211
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ....+.+++.+||+.||++|| ++.|+++
T Consensus 239 ---------~~p~~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ---------NLPPY---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---------CCCTT---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---------CCCCC---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00111 123577888899999999999 6677765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=337.65 Aligned_cols=258 Identities=26% Similarity=0.312 Sum_probs=195.8
Q ss_pred hcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 436 (672)
.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 47899999999999984 368999999997433 23457899999999999999999999999876 66899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 106 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred eCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999996543 35899999999999999999999 7899999999999999999999999999997665
Q ss_pred CC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC--CCCCCCCCChhHHHHHH
Q 005880 517 PS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA--GMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 517 ~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~ 586 (672)
.. ...+|..|+|||++. +..++.++||||||+++|||+||+.|+....... .............+...
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeec--CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 42 345677799999764 4578899999999999999999999864210000 00000000000011111
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
..... ...........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 256 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11110 00001122346788899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.88 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=201.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 3478999999999999976 488999999975443 56789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 96 L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 96 LLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp HHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred HHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999997643 246899999999999999999999 779999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||.... ........... ...
T Consensus 169 ~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~------------~~~~~~~~~~~-~~~-- 231 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYELLEKD-YRM-- 231 (288)
T ss_dssp ETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------------GGGHHHHHHTT-CCC--
T ss_pred ccCCccccCcCChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHhcc-CCC--
Confidence 223456799999764 4578999999999999999999 999986432 11222221111 100
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... ......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 232 -----~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 232 -----ERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -----CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCC---CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 001 1123457888889999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=344.01 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=200.0
Q ss_pred hcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 47899999999999984 3688999999987766667789999999999999999999999874 4568899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 108 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 108 LPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999997543 35899999999999999999999 78999999999999999999999999999986643
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC--CCCCCCCChhHHHHHHH
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG--MGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~ 587 (672)
. ...++..|+|||++. +..++.++||||||+++|||++|+.||........ ............+....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhc--cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 2 334567799999764 45788999999999999999999999853211000 00000000001111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 647 (672)
.... ...........+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 258 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 258 EEGQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hccc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 1110 0011112334678889999999999999999999999998754433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.80 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcE----EEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSV----VAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 478999999999999954 4443 8888875432 223456788999999999999999999885 56788999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 97 PLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp TTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999999997543 35899999999999999999999 789999999999999999999999999999876433
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++.+|+|||++. +..++.++|||||||++|||+| |+.||...... +.........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~~ 234 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------------EVPDLLEKGE 234 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------------HHHHHHHTTC
T ss_pred cccccccCCCCcccccChHHhc--cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------------HHHHHHHcCC
Confidence 234567899999764 4578999999999999999999 99999753211 1111111111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
. . ..+ ......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 235 ~-~--~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 R-L--AQP--------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp B-C--CCC--------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C-C--CCC--------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0 000 0112246778889999999999999999999999854
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.92 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=200.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcE--EEEEEcccCC-cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSV--VAVKRLKDAS-IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|.. ||||+++... ....+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 578999999999999954 5664 4999987532 23456789999999999 89999999999999999999999999
Q ss_pred CCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEec
Q 005880 440 NGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 440 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
+|+|.+++..... .....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kL~D 185 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIAD 185 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCCeEEEcc
Confidence 9999999976530 12246899999999999999999999 78999999999999999999999999
Q ss_pred cCCCccCCC----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 509 FGLSIFAPP----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 509 fG~a~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
||+++.... ....++..|+|||++. +..++.++|||||||++|||+| |+.||... ...+..
T Consensus 186 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~pf~~~------------~~~~~~ 251 (327)
T 1fvr_A 186 FGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------------TCAELY 251 (327)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHH
T ss_pred cCcCccccccccccCCCCCccccChhhhc--cccCCchhcchHHHHHHHHHHcCCCCCCCCC------------cHHHHH
Confidence 999874432 2334577899999764 4578899999999999999998 99999643 222222
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCC
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHE 651 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~ 651 (672)
.... ..... ... ......+.+++.+||+.||++|||+.|+++.|+++..........
T Consensus 252 ~~~~-~~~~~-------~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 308 (327)
T 1fvr_A 252 EKLP-QGYRL-------EKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308 (327)
T ss_dssp HHGG-GTCCC-------CCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred HHhh-cCCCC-------CCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence 2211 11000 001 112245778888999999999999999999999998765554433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.20 Aligned_cols=257 Identities=26% Similarity=0.330 Sum_probs=197.9
Q ss_pred hcccCcCCeEEEEEEEEc-----CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC--CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-----DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 436 (672)
.+.||+|+||.||++.+. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 478999999999998743 58899999998643 23467799999999999999999999999874 57889999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++... .+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999754 3899999999999999999999 7899999999999999999999999999998765
Q ss_pred CC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCh--hHHHHHH
Q 005880 517 PS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL--PRWVQSV 586 (672)
Q Consensus 517 ~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~ 586 (672)
.. ...++..|+|||++. +..++.++||||||+++|||+||+.||................. ...+...
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 43 334567799999764 45788999999999999999999999853210000000000000 0000011
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.... . ...........+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 264 ~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 264 LERG---------E-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHTT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhcc---------c-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1110 0 001112233468889999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.40 Aligned_cols=242 Identities=26% Similarity=0.294 Sum_probs=195.2
Q ss_pred cccCcCCeEEEEEEEEc---CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD---DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 467899999975432 246789999999999999999999999864 568899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..++.|+.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999754 35899999999999999999999 789999999999999999999999999999766432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...++..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+....+.....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~--~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~------------~~~~~~~i~~~~~ 590 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------------GSEVTAMLEKGER 590 (635)
T ss_dssp ----------CGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------------HHHHHHHHHTTCC
T ss_pred ccccccCCCCceeeeChhhhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHHcCCC
Confidence 223456799999774 5578999999999999999998 999996432 2222222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.. .......++.+++..||+.||++|||+.+|++.|+++.
T Consensus 591 -~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 591 -MG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -CC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CC----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00 01122346788899999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.56 Aligned_cols=262 Identities=19% Similarity=0.208 Sum_probs=201.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEE-EcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY-FAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|++++..++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 47899999999999995 579999999986543 234688999999999988877766655 5567789999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC---CCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD---KTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999997543 35999999999999999999999 78999999999999994 7889999999999765432
Q ss_pred -----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 519 -----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 519 -----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||....... ..... ....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~---~~~~ 231 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT------KRQKY---ERIS 231 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS------SSSHH---HHHH
T ss_pred cccccccccccccccccccCChhhhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh------hhhhh---hhhc
Confidence 345788999999764 5578999999999999999999999997643221 11111 1111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDS 655 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~ 655 (672)
....... . +.. .. .....+.+++.+||+.||++|||+.||++.|+++......+....+++
T Consensus 232 ~~~~~~~-~-~~~--~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 232 EKKMSTP-I-EVL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp HHHHHSC-H-HHH--TT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred ccccCCc-h-HHH--Hh---hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 1110000 0 000 01 112457888899999999999999999999999986655554444444
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.77 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=193.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|.. .+|+.||||+++... .....++.+|++++++++||||+++++++...+..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 47899999999999996 478999999997532 23456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++..... ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 117 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 117 GDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp CBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 999999864221 1245899999999999999999999 789999999999999999999999999998765432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||.... ............... ...
T Consensus 192 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~~~~~~-~~~ 258 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----------MNLYSLCKKIEQCDY-PPL 258 (310)
T ss_dssp -------CCSSCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTC-------------CCHHHHHHHHHTTCS-CCC
T ss_pred cccccCCCeeEeChHHhC--CCCCCchhhHHHHHHHHHHHHhCCCCCcccc----------hhHHHHHHHhhcccC-CCC
Confidence 345788999999764 5678999999999999999999999996432 122223222222111 000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
. . ......+.+++.+||+.||++|||+.||++.|+++....
T Consensus 259 ~------~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 P------S---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp C------T---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred c------c---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 0 0 112235778888999999999999999999999997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=331.60 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=194.1
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
..||+|+||.||+|.. .+++.||||.++.......+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999995 468999999998766556788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccCCC-----C
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFAPP-----S 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~-----~ 518 (672)
+++.... +...+++..+..++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||++..... .
T Consensus 108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 9998653 2345789999999999999999999 789999999999999987 89999999999976643 2
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||++......++.++||||||+++|||++|+.||..... ......... ... ..+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~-~~~-----~~~ 245 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE----------PQAAMFKVG-MFK-----VHP 245 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS----------HHHHHHHHH-HHC-----CCC
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc----------hhHHHHhhc-ccc-----ccc
Confidence 4567889999998754334578999999999999999999999964211 000111100 000 000
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. . ......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~--~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EI--P---ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CC--C---TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cc--c---ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0 112235778888999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.00 Aligned_cols=238 Identities=24% Similarity=0.335 Sum_probs=187.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccC---CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA---SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 3578999999999999954 6899999999753 22234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 517 (672)
+|+|.+++... ..+++..+..++.|+++||+||| + .+|+||||||+|||++.++.+||+|||+++....
T Consensus 232 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 232 GGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp SCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh----hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999754 35899999999999999999999 5 7999999999999999999999999999976432
Q ss_pred ----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 ----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
....||..|+|||++. +..++.++|||||||++|||++|+.||... +.......+......
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~------------~~~~~~~~i~~~~~~- 367 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------------DHEKLFELILMEEIR- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCC-
T ss_pred CcccccccCCccccCHhhcC--CCCCCCccchhhhHHHHHHHhhCCCCCCCC------------CHHHHHHHHHhCCCC-
Confidence 2456899999999764 567899999999999999999999999643 222333333222110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
.... ....+.+++.+||+.||++|| ++.|+++
T Consensus 368 --------~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 --------FPRT---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CCTT---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCcc---CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111 123577888899999999999 9999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.90 Aligned_cols=237 Identities=24% Similarity=0.323 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 478999999999999976 47899999997532 22456788999999988 89999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999997542 4899999999999999999999 78999999999999999999999999999976432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... +..+....+......
T Consensus 176 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~------------~~~~~~~~i~~~~~~-- 239 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------------DEDELFQSIMEHNVA-- 239 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHT--TCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCC--
T ss_pred cccccccCCccccChhhhc--CCCcCCcccccchHHHHHHHHcCCCCCCCC------------CHHHHHHHHHhCCCC--
Confidence 2556899999999765 457899999999999999999999999643 223333333332110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM-----SHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 636 (672)
.... ...++.+++.+||+.||++||++ .|+++
T Consensus 240 -------~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 -------YPKS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------CCTT---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------CCCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111 22357788889999999999964 66654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=338.05 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=200.0
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcC--CCCCceeeeEEEEEcCC----eEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGR--LRHPNLVGLKAYYFARE----EKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~ 437 (672)
..+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++.. ++||||+++++++.... ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 3578999999999999985 899999998643 45677888888876 78999999999998876 78999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhh----CCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT----CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
+++|+|.+++... .+++..++.++.|+++||+|||.. +.+.+|+||||||+||+++.++++||+|||+++
T Consensus 122 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 122 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 9999999999753 389999999999999999999932 114689999999999999999999999999996
Q ss_pred cCCC---------CCCCCCCcccCCCccccCCC----CCCchhHHHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 005880 514 FAPP---------STVPRSNGYRAPELSSSDGR----KQSQKSDVYSFGVLLLELLTG----------KCPSVIDGGGAG 570 (672)
Q Consensus 514 ~~~~---------~~~~~t~~y~aPE~l~~~~~----~~~~~~DV~S~Gvvl~el~tg----------~~P~~~~~~~~~ 570 (672)
.... ....+|..|+|||++..... .++.++|||||||++|||+|| +.||......
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~-- 273 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS-- 273 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS--
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC--
Confidence 5543 23467889999998753211 233789999999999999999 6677543221
Q ss_pred CCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 571 MGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
......+......... .+.........+....+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 274 -----~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 274 -----DPSVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp -----SCCHHHHHHHHTTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----cccHHHHHHHHHHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 1222333332222211 111111011134566788999999999999999999999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.55 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=195.6
Q ss_pred hcccCcCCeEEEEEEEEc-CC---cEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeE-EEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DG---SVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEK-LLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~~ 438 (672)
.+.||+|+||.||+|... ++ ..||+|+++.... ...+.+.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 478999999999999853 23 3799999975433 3457889999999999999999999999876655 9999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
.+|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999997643 45899999999999999999999 789999999999999999999999999999754331
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...++..|+|||.+. +..++.++||||||+++|||++|..|+.... +..+........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-----------~~~~~~~~~~~~ 244 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-----------DPFDLTHFLAQG 244 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHT--TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----------CGGGHHHHHHTT
T ss_pred cccccccCcCCCCCccccChhhhc--cCCCChhhchhhHHHHHHHHhhCCCCCCccC-----------CHHHHHHHhhcC
Confidence 344567899999764 5678999999999999999999666654321 111122211111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... ... ......+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 245 ~~~--------~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 245 RRL--------PQP---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CCC--------CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC--------CCC---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 100 001 1122357888899999999999999999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.68 Aligned_cols=239 Identities=24% Similarity=0.417 Sum_probs=191.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc----CCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA----REEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 357999999999999964 68899999987543 3345778999999999999999999999875 3457899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeC-CCCcEEEeccCCCcc
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLD-KTGNARVSDFGLSIF 514 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~ 514 (672)
+++|+|.+++... ..+++..++.++.|+++||+||| +.+ |+||||||+||+++ +++.+||+|||++..
T Consensus 111 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999754 34899999999999999999999 667 99999999999998 789999999999976
Q ss_pred CCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 515 APPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 515 ~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
.... ...++..|+|||++. ..++.++||||||+++|||++|+.||.... .............
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------~~~~~~~~~~~~~- 246 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----------NAAQIYRRVTSGV- 246 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----------SHHHHHHHHTTTC-
T ss_pred ccccccccccCCcCcCCHHHHh---ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-----------cHHHHHHHHhccC-
Confidence 5544 456789999999764 358999999999999999999999996422 2222222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....++ ......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPASFD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccC---------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111 011235788899999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=344.21 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=183.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEE--------cCCeEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYF--------AREEKLL 433 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~~~~~l 433 (672)
..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.++. ||||+++++++. .....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 3578999999999999964 68999999997666556778999999999996 999999999995 2335789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
||||++ |+|.+++..... ..++++.+++.++.|+++||+||| +.+ |+||||||+||+++.++.+||+|||+
T Consensus 112 v~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 999995 799998865321 245999999999999999999999 677 99999999999999999999999999
Q ss_pred CccCCCC-----------------CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005880 512 SIFAPPS-----------------TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGC 573 (672)
Q Consensus 512 a~~~~~~-----------------~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~ 573 (672)
++..... ...+|..|+|||++.. .+..++.++|||||||++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 9766432 2347888999997632 35678899999999999999999999996432110
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 574 GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
. ....... .. . ......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 261 --------~----~~~~~~~---~~----~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 --------I----VNGKYSI---PP----H---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------CCC---CT----T---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------h----hcCcccC---Cc----c---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 0010000 00 0 001123677888999999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.87 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=195.8
Q ss_pred hcccCcCCeEEEEEEEEcC----CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+..+ +..||||.++... ....+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence 4789999999999998543 3469999997643 3356789999999999999999999999764 56789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+++|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 96 YGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 999999997543 35899999999999999999999 789999999999999999999999999999766443
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||++. +..++.++||||||+++|||+| |+.||..... .+...........
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~------------~~~~~~~~~~~~~ 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------------KDVIGVLEKGDRL 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG------------GGHHHHHHHTCCC
T ss_pred ccccccCCCCcceeCchhhc--cCCCCchhccHHHHHHHHHHHhCCCCCcccCCh------------HHHHHHHhcCCCC
Confidence 334567899999764 4578999999999999999998 9999964321 1111211111100
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
. .. ......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 234 -~-------~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 -P-------KP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -C-------CC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 00 11223577888899999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.30 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=190.9
Q ss_pred HhcccCcCCeEEEEEEEEc----CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe-----EE
Q 005880 364 SAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE-----KL 432 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~ 432 (672)
+.+.||+|+||.||+|... ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+. .+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 4578999999999999854 34589999997543 2345678999999999999999999999987553 49
Q ss_pred EEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRG-PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
+||||+++|+|.+++..... .....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 99999999999999854321 22356999999999999999999999 88999999999999999999999999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++..... ...++..|+|||++. +..++.++||||||+++|||++ |+.||.... .....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------------~~~~~ 259 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ------------NHEMY 259 (313)
T ss_dssp C----------------CCGGGSCHHHHH--SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------------GGGHH
T ss_pred ceecccccccCcccccCCCccccCchhhc--CCCccchhhhHHHHHHHHHHHhcCCCCCccCC------------HHHHH
Confidence 9765432 234567899999764 5678999999999999999999 888986432 11222
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
......... .........+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 260 ~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 260 DYLLHGHRL-----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHTTCCC-----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCC-----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222221110 0011223457888899999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=343.28 Aligned_cols=236 Identities=27% Similarity=0.370 Sum_probs=192.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999965 68999999997532 22456678899998876 89999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999754 24899999999999999999999 78999999999999999999999999999976432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....||..|+|||++. +..++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 173 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~------------~~~~~~~~i~~~~~--- 235 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------------DEEELFHSIRMDNP--- 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC---
T ss_pred CcccCCCCCcccCChhhhc--CCCCCChhhhHHHHHHHHHHhcCCCCCCCC------------CHHHHHHHHHhCCC---
Confidence 2556899999999765 457899999999999999999999999643 22223333322211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS-HVV 635 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 635 (672)
. .... ....+.+++.+||..||++||++. |++
T Consensus 236 ----~--~p~~---~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ----F--YPRW---LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----C--CCTT---SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----C--CCcc---cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 0111 123567888899999999999997 664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.12 Aligned_cols=261 Identities=26% Similarity=0.382 Sum_probs=191.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHH--HcCCCCCceeeeEEEEEc-----CCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEV--LGRLRHPNLVGLKAYYFA-----REEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 47899999999999987 58999999986432 3444444444 556899999999986642 2356899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC---------CcEecCCCCCCEEeCCCCcEEEec
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL---------KLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~---------~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
+++|+|.+++.... .++..++.++.|+++||+||| +. +|+||||||+|||++.++.+||+|
T Consensus 94 ~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp CTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred CCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 99999999997543 589999999999999999999 67 999999999999999999999999
Q ss_pred cCCCccCCCC-------------CCCCCCcccCCCccccCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005880 509 FGLSIFAPPS-------------TVPRSNGYRAPELSSSDG-----RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAG 570 (672)
Q Consensus 509 fG~a~~~~~~-------------~~~~t~~y~aPE~l~~~~-----~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~ 570 (672)
||+++..... ...+|..|+|||++.... ..++.++|||||||++|||++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999765421 345788999999775311 3456789999999999999999887754332211
Q ss_pred CCCC------CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 571 MGCG------GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 571 ~~~~------~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.... ...... ..............+... ..........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFE-DMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCTTHHHHCSSCCHH-HHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHH-HHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1000 001111 111111111111111111 11122355678999999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.91 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=192.0
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5799999999999994 47899999999876555678899999999885 799999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc---EEEeccCCCccCCCC--
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN---ARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~-- 518 (672)
.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++. +||+|||++......
T Consensus 99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKR-----RHFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999754 34899999999999999999999 789999999999999998776 999999998755321
Q ss_pred ----------CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCh----hH
Q 005880 519 ----------TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL----PR 581 (672)
Q Consensus 519 ----------~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~----~~ 581 (672)
...+|..|+|||++... ...++.++|||||||++|||++|+.||......+..-. ..... ..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD-RGEACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc-ccccchhHHHH
Confidence 23478899999987531 13578899999999999999999999976543220000 00000 11
Q ss_pred HHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 582 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+..... ...... . ......+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~i~~~~~--~~~~~~---~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGKY--EFPDKD---W---AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCCC--CCCHHH---H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccCc--ccCchh---c---ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111111110 000000 0 012245788889999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=334.21 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=192.8
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC-CeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-EEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~ 442 (672)
..+.||+|+||.||+|... |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|+
T Consensus 25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 3578999999999999875 8899999997543 567899999999999999999999997654 46899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--CC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TV 520 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~ 520 (672)
|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 102 L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 102 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 999997542 124789999999999999999999 789999999999999999999999999999765543 34
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
.++..|+|||++. +..++.++||||||+++|||+| |+.||.... ..+........ ....
T Consensus 175 ~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~------------~~~~~~~~~~~-~~~~----- 234 (278)
T 1byg_A 175 KLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPRVEKG-YKMD----- 234 (278)
T ss_dssp -CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC------------GGGHHHHHTTT-CCCC-----
T ss_pred CccccccCHHHhC--CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC------------HHHHHHHHhcC-CCCC-----
Confidence 5677899999764 4578999999999999999998 999996432 11222222111 1000
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
.. ......+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 235 --~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 235 --AP---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --Cc---ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00 112345778888999999999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.34 Aligned_cols=261 Identities=19% Similarity=0.223 Sum_probs=199.6
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEE-EcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY-FAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+. .+++.||||++.... ...++.+|++++..++|++++..++++ ...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 47899999999999995 578999999875433 234588899999999988877776665 5667889999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe---CCCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 999997543 35999999999999999999999 7899999999999999 78899999999999765432
Q ss_pred -----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 519 -----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 519 -----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||....... .... .....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~---~~~~~ 231 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT------KRQK---YERIS 231 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS------SSSH---HHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhc--CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh------hhhh---hhhhh
Confidence 345788999999764 5578999999999999999999999997643322 1111 11111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFD 654 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~ 654 (672)
....... .. .. .. .....+.+++.+||+.||++|||+.||++.|+++...........++
T Consensus 232 ~~~~~~~-~~-~~--~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 4hgt_A 232 EKKMSTP-IE-VL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp HHHHHSC-HH-HH--TT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred cccccch-hh-hh--hc---cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence 1110000 00 00 00 11246788889999999999999999999999998655544444444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.99 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=188.9
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCC--CceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRH--PNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++.+++| |||+++++++.+++..++|||+ .+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CC
Confidence 478999999999999988899999999875432 345778999999999976 9999999999999999999995 58
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 93 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 93 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 8999999864 35899999999999999999999 78999999999999997 678999999999866432
Q ss_pred -----CCCCCCcccCCCcccc---------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 519 -----TVPRSNGYRAPELSSS---------DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~---------~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
...+|..|+|||++.. ....++.++|||||||++|||++|+.||.... .......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----------~~~~~~~ 231 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----------NQISKLH 231 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----------SHHHHHH
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----------hHHHHHH
Confidence 3468999999998743 12578999999999999999999999996421 1112222
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
........... ... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~-------~~~---~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 AIIDPNHEIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHCTTSCCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCCcccCC-------ccc---CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 22211110000 011 12357788889999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=343.11 Aligned_cols=241 Identities=20% Similarity=0.280 Sum_probs=190.4
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCC--CCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLR--HPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++..++..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 47899999999999998889999999986533 234578999999999996 5999999999999999999999 568
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.... .+++.++..++.|+++||+||| +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 89999998643 5899999999999999999999 88999999999999995 589999999999866432
Q ss_pred -----CCCCCCcccCCCccccC---------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 519 -----TVPRSNGYRAPELSSSD---------GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~---------~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
...+|+.|+|||++... ...++.++|||||||++|||++|+.||.... .....+.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----------~~~~~~~ 278 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----------NQISKLH 278 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----------CHHHHHH
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----------HHHHHHH
Confidence 45689999999987531 2468999999999999999999999996421 1122222
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
........... ... ....+.+++.+||+.||++|||+.|+++.
T Consensus 279 ~~~~~~~~~~~-------~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIIDPNHEIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHCTTSCCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCccccCCC-------Ccc---chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 22221111000 011 12357788889999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.63 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=191.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCc----EEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|+.. +++ .||+|.++.. .....+.+.+|++++++++||||+++++++.... .++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 478999999999999954 444 3578877543 3345678999999999999999999999998754 78999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp SSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999998653 35899999999999999999999 789999999999999999999999999999766432
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...++..|+|||++. +..++.++|||||||++|||++ |+.||..... .+.... ....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------~~~~~~-~~~~ 235 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------SEISSI-LEKG 235 (327)
T ss_dssp ---------CCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGHHHH-HHTT
T ss_pred cccccccCCCccccccCHHHHc--CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH------------HHHHHH-HHcC
Confidence 233466899999765 5678999999999999999999 9999964321 111111 1111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... .........+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 236 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 ERL----------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 100 0011122357788899999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=328.53 Aligned_cols=238 Identities=30% Similarity=0.485 Sum_probs=192.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 478999999999999965 578999999864322 2356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 94 GTVYRELQKL-----SKFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 9999999754 34899999999999999999999 889999999999999999999999999998655443
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... ...+...........
T Consensus 165 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------~~~~~~~~~~~~~~~----- 225 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------------TYQETYKRISRVEFT----- 225 (279)
T ss_dssp ---CCCCTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHTCCC-----
T ss_pred cccCCCCCccCHhHhc--cCCCCccchhHhHHHHHHHHHHCCCCCCCC------------cHHHHHHHHHhCCCC-----
Confidence 456789999999764 567889999999999999999999999632 222222222221100
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
... .....+.+++.+||+.||++|||+.|+++.
T Consensus 226 ----~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 ----FPD---FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCT---TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCC---cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001 122356788889999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.12 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=189.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.||||++++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999965 589999999975432 2345688999999887 89999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 94 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 94 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999754 24899999999999999999999 78999999999999999999999999999976422
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....+|..|+|||++. +..++.++|||||||++|||++|+.||......... ................
T Consensus 165 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP----DQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------CHHHHHHHHHHCC---
T ss_pred CcccccCCCccccCccccC--CCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc----ccccHHHHHHHHHcCC---
Confidence 2456899999999765 457899999999999999999999999653221100 0011111111111111
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
...... ....+.+++.+||+.||++||++
T Consensus 236 -----~~~p~~---~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -----IRIPRS---LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCCCTT---SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCC---CCHHHHHHHHHHhcCCHhHCCCC
Confidence 000111 22356788889999999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=331.31 Aligned_cols=250 Identities=19% Similarity=0.251 Sum_probs=192.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++.+++||||+++++++..++..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 478999999999999965 6899999999754322 347789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... .++++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 119 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 119 VDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999754 34899999999999999999999 789999999999999999999999999998765432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||.... ...+.........
T Consensus 190 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~~~~~~~~~~~~-- 252 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFS--ESHATYRADIYALTCVLYECLTGSPPYQGDQ-------------LSVMGAHINQAIP-- 252 (309)
T ss_dssp -------CCGGGCCGGGTC--C----CCCHHHHHHHHHHHHHHSSCSSCSCH-------------HHHHHHHHHSCCC--
T ss_pred ccccccCCCcCccCHHHHc--CCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------------HHHHHHHhccCCC--
Confidence 345788999999764 5678899999999999999999999996421 1122222221110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHhcCCC
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-NMSHVVKLIEELRGVEV 646 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~~~ 646 (672)
.+.. ... .....+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 253 --~~~~-~~~---~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 253 --RPST-VRP---GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --CGGG-TST---TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --Cccc-cCC---CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0000 011 1223577888899999999999 99999999998765443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.45 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=196.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|+||.||+|+.. +|+.||||+++..... ..+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 4578999999999999965 6899999998753321 36789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC----cEEEeccCCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG----NARVSDFGLS 512 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a 512 (672)
|+++++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp CCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999753 35899999999999999999999 78999999999999999887 7999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...... ...+|..|+|||++. +..++.++||||||+++|||++|+.||.... ..+.......
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~i~~ 232 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT------------KQETLANITS 232 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------------HHHHHHHHHT
T ss_pred eecCccccccccCCCCCccCccccc--CCCCCCccccHHHHHHHHHHHHCCCCCCCCC------------HHHHHHHHHh
Confidence 766543 455788999999764 5678999999999999999999999996431 2222222222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .+++... . .....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~---~~~~~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSY---DFDEEFF--S---HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCC---CCCHHHH--T---TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccc---ccChhhh--c---ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 110 0111110 0 11235778888999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=343.49 Aligned_cols=189 Identities=30% Similarity=0.420 Sum_probs=155.4
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCC--eEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFARE--EKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~ 438 (672)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..++||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 47899999999999995 46899999998653 2334567889999999997 999999999998644 689999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP- 517 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 517 (672)
+ |+|.+++... .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7 6999999753 4899999999999999999999 78999999999999999999999999999976432
Q ss_pred -------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 518 -------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 518 -------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
....+|..|+|||++.. ...++.++|||||||++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 13467889999998753 357899999999999999999999999643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=332.66 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=193.6
Q ss_pred hcccCcCCeEEEEEEEEcC----CcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|+..+ +..||+|.++... ....+.+.+|++++++++||||+++++++.. ++..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 4789999999999999542 2368999987543 3345789999999999999999999998654 55789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 110 ~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 110 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp TTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999997543 45899999999999999999999 789999999999999999999999999999765432
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...++..|+|||++. +..++.++||||||+++|||++ |.+||...... + .......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---------~---~~~~~~~ 247 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------D---ITVYLLQ 247 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---------T---HHHHHHT
T ss_pred chhccccccCCCCCccccChHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---------H---HHHHHhc
Confidence 334466899999764 4578999999999999999999 45555432211 1 1111111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... ... .. .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 248 ~~~---~~~-----~~---~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 248 GRR---LLQ-----PE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp TCC---CCC-----CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---CCC-----Cc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 110 000 01 112357888899999999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=327.69 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=176.8
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 47899999999999996 5789999999864321 2346789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.... .++++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 96 GEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 99999998543 45899999999999999999999 789999999999999999999999999999765432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||........ ......
T Consensus 168 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~~~~~~------- 226 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIAT--RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------LNKVVL------- 226 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CCS-------
T ss_pred cceeccCCCCcCCcchhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------------HHHHhh-------
Confidence 345788999999764 45788999999999999999999999975432210 000000
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........ ....+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 --ADYEMPSF---LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --SCCCCCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cccCCccc---cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000111 1235778888999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.54 Aligned_cols=242 Identities=26% Similarity=0.288 Sum_probs=193.5
Q ss_pred ccCcCCeEEEEEEEEc---CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 367 MLGKGGFGTAYKAVLD---DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.||+|+||.||+|.+. +++.||||+++.... ...+++.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 7999999999999643 468899999975432 2357899999999999999999999998 567789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++.... .+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999998643 4899999999999999999999 789999999999999999999999999999766443
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...++..|+|||++. +..++.++||||||+++|||++ |+.||.... ..+..... .....
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------------~~~~~~~~-~~~~~ 238 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------------GSEVTAML-EKGER 238 (291)
T ss_dssp EEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------------HHHHHHHH-HTTCC
T ss_pred ccccccCCCCceeeChHHhc--cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC------------HHHHHHHH-HcCCC
Confidence 223457799999764 4568899999999999999999 999996432 11222211 11110
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. .. ......+.+++.+||+.||++||++.|+++.|+++..
T Consensus 239 ~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 MG-------CP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CC-------CC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 00 1123457888899999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.83 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=199.5
Q ss_pred HhcccCcCCeEEEEEEEE-----cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC--eEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVL-----DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE--EKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 436 (672)
+.+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 357899999999999984 368999999998766666788999999999999999999999987654 6789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 999999999998653 35899999999999999999999 7899999999999999999999999999998765
Q ss_pred CC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCC--CCCCC-CCCChhHHHHH
Q 005880 517 PS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGA--GMGCG-GAVDLPRWVQS 585 (672)
Q Consensus 517 ~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~--~~~~~-~~~~~~~~~~~ 585 (672)
.. ...++..|+|||++. +..++.++||||||+++|||+||+.||....... ..... ........+..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhc--CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 43 233456799999764 4568899999999999999999999975320000 00000 00000001111
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
....... ..........+.+++.+||+.||++|||+.||++.|+++++
T Consensus 275 ~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 275 LLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111100 00111223467888999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.11 Aligned_cols=253 Identities=20% Similarity=0.247 Sum_probs=188.7
Q ss_pred hcccCcCCeEEEEEEEEc----CCcEEEEEEcccCCcc-----------hHHHHHHHHHHHcCCCCCceeeeEEEEEc--
Q 005880 365 AEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASIG-----------GKREFEQHMEVLGRLRHPNLVGLKAYYFA-- 427 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 427 (672)
.+.||+|+||.||+|... ++..||||++...... ....+.+|+..+..++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 478999999999999975 5788999998754321 12346678889999999999999999987
Q ss_pred --CCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC--c
Q 005880 428 --REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG--N 503 (672)
Q Consensus 428 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~--~ 503 (672)
....++||||+ +++|.+++.... .+++.+++.++.|+++||+||| +.+|+||||||+||+++.++ .
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSSTTS
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCCCc
Confidence 67889999999 999999997542 5999999999999999999999 78999999999999999877 9
Q ss_pred EEEeccCCCccCCC------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005880 504 ARVSDFGLSIFAPP------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM 571 (672)
Q Consensus 504 ~kl~DfG~a~~~~~------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~ 571 (672)
+||+|||+++.... ....+|..|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--- 266 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK--GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--- 266 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC---
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCccccccc---
Confidence 99999999976532 1346788999999765 457899999999999999999999999643211
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.............. + ................+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 267 -----~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 -----PVAVQTAKTNLLDE----L-PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -----HHHHHHHHHHHHHT----T-THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -----cHHHHHHHHhhccc----c-cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 01111111111111 0 0000000000012336788888999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=333.28 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=190.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 478999999999999975 5899999998654332 3567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 88 VLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp HHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred hHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999988754 34899999999999999999999 789999999999999999999999999999776532
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH---------
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV--------- 587 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 587 (672)
...+|..|+|||++.. ...++.++||||||+++|||++|+.||...... +....+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---------DQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -------GGGCCHHHHHT-CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHHHCSCCHHHHH
T ss_pred cCCCcCCccccChHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHhccccccccc
Confidence 3467889999998643 356799999999999999999999999643211 0111111100
Q ss_pred ---hhhccccccchhhccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 588 ---REEWTAEVFDLELMRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 588 ---~~~~~~~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..........+........ ......+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000000000 112345778999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.58 Aligned_cols=244 Identities=20% Similarity=0.262 Sum_probs=193.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||++++... ...+.+.+|.+++..++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 478999999999999975 699999999975322 1234578999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++.....
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999997542 35899999999999999999999 789999999999999999999999999999766543
Q ss_pred ----CCCCCCcccCCCccccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ----TVPRSNGYRAPELSSSD-----GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~-----~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...||..|+|||++... ...++.++|||||||++|||++|+.||... +..+....+...
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------------~~~~~~~~i~~~ 285 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD------------STAETYGKIVHY 285 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHTH
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC------------CHHHHHHHHHhc
Confidence 34789999999987531 346899999999999999999999999643 222333333322
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR---PNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~ 636 (672)
...... +.. . .....++.+++.+||. +|++| |++.|+++
T Consensus 286 ~~~~~~--p~~--~---~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 KEHLSL--PLV--D---EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHCCC--C---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccCcCC--Ccc--c---cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 110000 000 0 1122356788889999 99998 58888864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.68 Aligned_cols=239 Identities=25% Similarity=0.347 Sum_probs=185.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHH-HcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEV-LGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +++.||||++++.... ....+.+|..+ ++.++||||+++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999965 5889999999764332 33456667776 577899999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++....
T Consensus 123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999997543 4889999999999999999999 78999999999999999999999999999975322
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....||..|+|||++. +..++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~------------~~~~~~~~i~~~~~--- 256 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------NTAEMYDNILNKPL--- 256 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------------BHHHHHHHHHHSCC---
T ss_pred CccccccCCccccCHHHhC--CCCCCchhhhHHHHHHHHHHHcCCCCCCCC------------CHHHHHHHHHhccc---
Confidence 2557899999999765 567899999999999999999999999643 22333333333211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
....... ..+.+++.+||+.||++||++.+.++.+
T Consensus 257 ------~~~~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 ------QLKPNIT---NSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp ------CCCSSSC---HHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ------CCCCCCC---HHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1111122 3467788899999999999986544433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.22 Aligned_cols=242 Identities=17% Similarity=0.232 Sum_probs=193.7
Q ss_pred hcccCcCCeEEEEEEE------EcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC---CCceeeeEEEEEcCCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAV------LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR---HPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.||+|+||.||+|. ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4789999999999994 456899999999754 3456777888777776 999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-----------CCcE
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-----------TGNA 504 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-----------~~~~ 504 (672)
||+++|+|.+++..........+++..++.|+.|+++||+||| +.+|+||||||+|||++. ++.+
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 9999999999997533222356999999999999999999999 889999999999999998 8999
Q ss_pred EEeccCCCccCC---C----CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q 005880 505 RVSDFGLSIFAP---P----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577 (672)
Q Consensus 505 kl~DfG~a~~~~---~----~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~ 577 (672)
||+|||+++... . ....||.+|+|||++. +..++.++|||||||++|||+||+.||.......
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------- 292 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------- 292 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT--TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc--CCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence 999999996542 1 2556899999999765 4568999999999999999999999996432211
Q ss_pred ChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHHhc
Q 005880 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR-PNMSHVVKLIEELRG 643 (672)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~L~~i~~ 643 (672)
............ . ..+.+++..|++.+|.+| |++.++.+.|+++..
T Consensus 293 ----------------~~~~~~~~~~~~-~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ----------------CKPEGLFRRLPH-L---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----------------EEECSCCTTCSS-H---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------------eeechhccccCc-H---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 000111111111 2 245567779999999999 688999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.77 Aligned_cols=190 Identities=24% Similarity=0.376 Sum_probs=166.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-----CCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-----HPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||.||+|+. .+++.||||+++... ...+.+..|++++++++ ||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 47899999999999996 468999999997532 24567788999998886 999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC------------------
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK------------------ 500 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~------------------ 500 (672)
+++|.+++..... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 119 -GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp -CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred -CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999986542 35899999999999999999999 789999999999999975
Q ss_pred -------CCcEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 501 -------TGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 501 -------~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
++.+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL--NLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc--CCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999865543 566799999999765 557899999999999999999999999643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.95 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=184.8
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHc-CCCCCceeeeEEEEEc----CCeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLG-RLRHPNLVGLKAYYFA----REEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 439 (672)
+.||+|+||.||+|+.. +|+.||||+++. ...+.+|++++. ..+||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999965 689999999863 245778888874 4589999999999875 557899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAP 516 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 516 (672)
+|+|.+++.... ...+++..+..|+.|+++||+||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999998643 245999999999999999999999 789999999999999997 7899999999998665
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
.. ...+|..|+|||++. +..++.++|||||||++|||++|+.||........ .......+......
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------SPGMKTRIRMGQYE 285 (400)
T ss_dssp -----------CTTCCGGGSC--CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS--------CCSHHHHHHHTCCC
T ss_pred CCCccccCCCCCCccCHhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc--------cHHHHHHHHcCccc
Confidence 42 456789999999764 56789999999999999999999999976432210 00111111111110
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
...+ .. .....++.+++.+||+.||++|||+.|+++.
T Consensus 286 --~~~~---~~---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 --FPNP---EW---SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --CCTT---TT---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCc---cc---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 01 1122357788889999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.88 Aligned_cols=244 Identities=24% Similarity=0.338 Sum_probs=194.1
Q ss_pred hcccCcCCeEEEEEEEE----cCCcEEEEEEcccCC----cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDAS----IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++.++ +||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 47899999999999997 368999999987532 12345678899999999 6999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++++||+|||+++..
T Consensus 139 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 139 DYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999754 34899999999999999999999 789999999999999999999999999999765
Q ss_pred CCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 516 PPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 516 ~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
... ...+|..|+|||++......++.++|||||||++|||++|+.||...... .............
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--------NSQAEISRRILKS 281 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--------CCHHHHHHHHHHC
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--------chHHHHHHHHhcc
Confidence 432 34689999999987644456789999999999999999999999754322 1222222222211
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVKL 637 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 637 (672)
.. ... ......+.+++.+||+.||++|| ++.|+++.
T Consensus 282 ~~---------~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 EP---------PYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CC---------CCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CC---------CCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 10 001 11223567888899999999999 89998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.20 Aligned_cols=262 Identities=17% Similarity=0.181 Sum_probs=199.2
Q ss_pred hcccCcCCeEEEEEEEEcC---------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceee---------------
Q 005880 365 AEMLGKGGFGTAYKAVLDD---------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG--------------- 420 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------------- 420 (672)
.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 4789999999999999663 789999998744 46889999999999999987
Q ss_pred eEEEEEc-CCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC
Q 005880 421 LKAYYFA-REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD 499 (672)
Q Consensus 421 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~ 499 (672)
+++++.. ++..++||||+ +|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGEEEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEEc
Confidence 6778776 67889999999 999999998652 245999999999999999999999 78999999999999999
Q ss_pred CCC--cEEEeccCCCccCCCC------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 500 KTG--NARVSDFGLSIFAPPS------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 500 ~~~--~~kl~DfG~a~~~~~~------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
.++ .+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK--GCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999765421 236788999999764 557899999999999999999999999754
Q ss_pred CCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 566 GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
... ...+........ . ......+... .... ....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 272 ~~~-------~~~~~~~~~~~~-~-~~~~~~~~~~-~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPN-------TEDIMKQKQKFV-D-KPGPFVGPCG-HWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTC-------HHHHHHHHHHHH-H-SCCCEECTTS-CEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcC-------HHHHHHHHHhcc-C-Chhhhhhhcc-ccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 211 001111111111 1 1111111110 0011 1245778888999999999999999999999997654
Q ss_pred CCCCCCCCC
Q 005880 646 VSPCHENFD 654 (672)
Q Consensus 646 ~~~~~~~~~ 654 (672)
.......++
T Consensus 339 ~~~~~~~~d 347 (352)
T 2jii_A 339 RVSPYDPIG 347 (352)
T ss_dssp TCCTTSCCC
T ss_pred CCCcCcccc
Confidence 444333333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.27 Aligned_cols=241 Identities=23% Similarity=0.325 Sum_probs=194.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 478999999999999965 58999999986543 234567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc---EEEeccCCCccCCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN---ARVSDFGLSIFAPPS 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~ 518 (672)
+|.+.+... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++......
T Consensus 91 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 91 ELFEDIVAR-----EFYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999888754 34899999999999999999999 789999999999999986655 999999999766543
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... ................
T Consensus 162 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------------~~~~~~~~~~~~~~~~- 226 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDE------------DQHRLYAQIKAGAYDY- 226 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCCC-
T ss_pred ccccCCCCCcCCcCchhhc--CCCCCcccchHHHHHHHHHHHHCCCCCCCC------------chhHHHHHHHhccccC-
Confidence 356788999999764 557899999999999999999999999643 2222222222221110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+ .. ......+.+++.+||+.||++|||+.|+++
T Consensus 227 -~~~---~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -PSP---EW---DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CTT---TT---TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -Cch---hh---cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 00 112235778888999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=335.92 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=200.5
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 3578999999999999854 368899999975433 345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 437 YMPNGSLFWLLHGNRG-----PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
|+++|+|.+++..... ....++++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 9999999999975320 11245799999999999999999999 78999999999999999999999999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++..... ...++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~------------~~~~~~ 250 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------------SNEQVL 250 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------------CHHHHH
T ss_pred ccccccccccccccCCCCCCCccChhhhc--cCCCCchhhHHHHHHHHHHHHhcCCCccccC------------CHHHHH
Confidence 9755332 233467899999764 4578999999999999999999 89998632 222222
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
......... . .. ......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 251 ~~~~~~~~~-~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RFVMEGGLL-D-------KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHTTCCC-C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHcCCcC-C-------CC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 222222110 0 01 1123457788889999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=330.35 Aligned_cols=241 Identities=21% Similarity=0.343 Sum_probs=193.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 578999999999999965 6899999999865544567789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe---CCCCcEEEeccCCCccCCCC--
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~-- 518 (672)
.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||++ ++++.+||+|||++......
T Consensus 94 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 94 FDRILER-----GVYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 9998754 24899999999999999999999 7899999999999999 78899999999999765443
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||.... .......+...... +.
T Consensus 165 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~i~~~~~~---~~ 227 (304)
T 2jam_A 165 STACGTPGYVAPEVLA--QKPYSKAVDCWSIGVITYILLCGYPPFYEET------------ESKLFEKIKEGYYE---FE 227 (304)
T ss_dssp HHHHSCCCBCCTTTBS--SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHHCCCC---CC
T ss_pred ccccCCCCccChHHhc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------------HHHHHHHHHcCCCC---CC
Confidence 234788999999764 5678999999999999999999999996431 22222222221110 00
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .. ......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~--~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SP--FW---DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TT--TT---TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cc--cc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00 112245778888999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=322.33 Aligned_cols=250 Identities=21% Similarity=0.363 Sum_probs=198.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|+.. +|+.||||.++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 3578999999999999976 6899999998753221 36789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC----cEEEeccCCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG----NARVSDFGLS 512 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a 512 (672)
|+++++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999753 35899999999999999999999 78999999999999999877 8999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...... ...++..|+|||++. +..++.++||||||+++|||++|+.||.... ..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~ 225 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET------------KQETLTNISA 225 (283)
T ss_dssp EECC--------CCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------------HHHHHHHHHT
T ss_pred eeccCCCcccccCCCcCccCcceec--CCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------------hHHHHHHhHh
Confidence 866543 345788999999764 5678999999999999999999999996432 1122222211
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHhcC
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELRGV 644 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~~~ 644 (672)
... ....... ......+.+++.+||+.||++|||+.|+++ .++.+.+.
T Consensus 226 ~~~---~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 226 VNY---DFDEEYF-----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TCC---CCCHHHH-----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ccc---CCcchhc-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 110 0011100 111235778888999999999999999997 56666543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=344.14 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=199.1
Q ss_pred HhcccCcCCeEEEEEEEEcC-C-----cEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-G-----SVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 435 (672)
..+.||+|+||.||+|.... + ..||+|.++.... ...+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 35789999999999999642 2 4799999976432 3457799999999999 8999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEE
Q 005880 436 EYMPNGSLFWLLHGNRG---------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl 506 (672)
||+++|+|.+++..... .....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEEEGGGEEEB
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEECCCCeEEE
Confidence 99999999999975320 01235899999999999999999999 789999999999999999999999
Q ss_pred eccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCC
Q 005880 507 SDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVD 578 (672)
Q Consensus 507 ~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~ 578 (672)
+|||+++..... ...++..|+|||++. +..++.++|||||||++|||+| |..||.....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----------- 272 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----------- 272 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-----------
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhc--cCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-----------
Confidence 999999755332 223466899999765 4578999999999999999999 9999864321
Q ss_pred hhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
............... .. ......+.+++.+||+.||.+|||+.||++.|+++..
T Consensus 273 -~~~~~~~~~~~~~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 273 -NSKFYKLVKDGYQMA-------QP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -SHHHHHHHHHTCCCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hHHHHHHHhcCCCCC-------CC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 112222222221100 00 1112357788899999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=327.41 Aligned_cols=240 Identities=24% Similarity=0.396 Sum_probs=194.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc----------------
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA---------------- 427 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------------- 427 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ..+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 478999999999999976 79999999997543 357789999999999999999998864
Q ss_pred CCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEe
Q 005880 428 REEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVS 507 (672)
Q Consensus 428 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 507 (672)
....++||||+++|+|.+++.... ...+++..++.++.|+++||.||| +.+|+||||||+||++++++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCCCCEEEC
Confidence 345789999999999999997543 245899999999999999999999 7899999999999999999999999
Q ss_pred ccCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 508 DFGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 508 DfG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
|||++...... ...++..|+|||++. +..++.++||||||+++|||++|..|+... ..+.
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------------~~~~ 228 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQIS--SQDYGKEVDLYALGLILAELLHVCDTAFET--------------SKFF 228 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHH--CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------------HHHH
T ss_pred cchhheeccccccccccCCcccccChhhhc--cCCCcchhhhHHHHHHHHHHHhcCCcchhH--------------HHHH
Confidence 99999766543 455788999999764 457899999999999999999999886321 1111
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
... ..... . . .....+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 229 ~~~-~~~~~----~------~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 TDL-RDGII----S------D---IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHH-HTTCC----C------T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHh-hcccc----c------c---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111 11111 0 1 11234678888999999999999999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.73 Aligned_cols=243 Identities=21% Similarity=0.351 Sum_probs=194.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--------chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--------GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++.++ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 378999999999999975 799999999864331 1145678999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+++|+|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 179 ~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp ECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 9999999999999753 35899999999999999999999 78999999999999999999999999999976
Q ss_pred CCCC----CCCCCCcccCCCccccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 515 APPS----TVPRSNGYRAPELSSSD----GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~~----~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
.... ...+|..|+|||++... ...++.++|||||||++|||++|+.||.... .......+
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------------~~~~~~~i 317 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------------QILMLRMI 317 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHH
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------------HHHHHHHH
Confidence 6543 45678999999986532 3357889999999999999999999996421 12222222
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...... ...+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~~~~--~~~~~~---~---~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQ--FSSPEW---D---DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCC--CCHHHH---S---SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCC--CCCccc---c---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221110 000000 0 11235778889999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=335.06 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=199.1
Q ss_pred HhcccCcCCeEEEEEEEE------cCCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCC-eEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFARE-EKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv 434 (672)
+.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 357899999999999984 3468999999976443 2456789999999999 7999999999987654 58999
Q ss_pred EeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc
Q 005880 435 SEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN 503 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~ 503 (672)
|||+++|+|.+++...... ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCC
Confidence 9999999999999865421 0223899999999999999999999 789999999999999999999
Q ss_pred EEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCC
Q 005880 504 ARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGG 575 (672)
Q Consensus 504 ~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~ 575 (672)
+||+|||+++..... ...+|..|+|||++. +..++.++||||||+++|||+| |+.||.....
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------- 256 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------- 256 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--------
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhc--cccccchhHHHHHHHHHHHHHhCCCCCCcccch--------
Confidence 999999999766433 233467899999765 4578999999999999999998 9999964321
Q ss_pred CCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
...+............ . ......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 257 ----~~~~~~~~~~~~~~~~-------~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 257 ----DEEFCRRLKEGTRMRA-------P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ----SHHHHHHHHHTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hHHHHHHhccCccCCC-------C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112222222111000 0 1122357888889999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.71 Aligned_cols=187 Identities=22% Similarity=0.306 Sum_probs=157.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 435 (672)
.+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+++++.++||||+++++++... ...++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 478999999999999954 6899999999754 233467788999999999999999999999654 3579999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+++ +|.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 99976 57666642 3899999999999999999999 789999999999999999999999999999876
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
... ...+|..|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp --CCCC----CCCTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcccCCCcccccccCHHHHc--CCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543 456799999999875 457899999999999999999999999643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.84 Aligned_cols=246 Identities=21% Similarity=0.286 Sum_probs=186.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 435 (672)
.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 47899999999999996 469999999996532 224567899999999999999999999997653 459999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 999 88999999753 3899999999999999999999 789999999999999999999999999999876
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc-
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT- 592 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 592 (672)
... ...+|..|+|||++.. ...++.++||||+||++|||++|+.||.... ..+.+..+......
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~------------~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD------------HLDQLKEIMKVTGTP 245 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHCCC
T ss_pred ccccCcCcCCCCcCCHHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHhcCCC
Confidence 543 4567899999998653 2578999999999999999999999996432 22222222111000
Q ss_pred -----------------c---cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 -----------------A---EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 -----------------~---~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ........ .........+.+++.+||..||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 00000000 000112345778888999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=334.54 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=187.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +|+.||||+++..... ....+.+|++++++++||||+++++++.+++..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 478999999999999965 7899999998754321 12245679999999999999999999999999999999997 59
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999887653 45899999999999999999999 789999999999999999999999999999765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh------c
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE------W 591 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 591 (672)
...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+....+.+.. .
T Consensus 158 ~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------------~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGST------------VEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp -----CGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCCCCTTT
T ss_pred ccccCcccccChhhhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHHhCCCChHh
Confidence 3456889999997643 3568999999999999999999999996532 111111111100 0
Q ss_pred cccccchh------h--ccccC----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAEVFDLE------L--MRYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~~~d~~------~--~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........ . ..... .......+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0 00000 0011245678899999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.09 Aligned_cols=233 Identities=20% Similarity=0.272 Sum_probs=190.6
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc--------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG--------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.||+|+||.||+|+. .+|+.||||+++..... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 47899999999999995 46899999998754321 2346788999999999999999999999999999999
Q ss_pred eecCCC-ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 436 EYMPNG-SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 436 e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
||+.+| +|.+++.... .+++..+..|+.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999777 9999997543 4999999999999999999999 78999999999999999999999999999987
Q ss_pred CCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 515 APPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 515 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
.... ...+|..|+|||++.. ....+.++|||||||++|||++|+.||......
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------- 236 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------- 236 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTT-CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------
T ss_pred CCCCCceeccCCCccccChhhhcC-CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------
Confidence 6544 3457899999997653 233488999999999999999999999632110
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.......... ....+.+++.+||+.||++|||+.|+++.
T Consensus 237 -----~~~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HhhccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001111 12357788889999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=345.95 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=184.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 434 (672)
+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 3578999999999999964 689999999864321 11235889999999999999999999975 4568999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC---CcEEEeccCC
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT---GNARVSDFGL 511 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~ 511 (672)
|||+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 9999999999988654 35899999999999999999999 7899999999999999754 4599999999
Q ss_pred CccCCCC----CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 512 SIFAPPS----TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 512 a~~~~~~----~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
++..... ...+|..|+|||++.. ....++.++|||||||++|||++|+.||....... .+...
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------~~~~~---- 356 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--------SLKDQ---- 356 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--------CHHHH----
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--------HHHHH----
Confidence 9876543 4567899999998743 23567889999999999999999999997543211 11111
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....... +.+.. . ......+.+++.+||+.||++|||+.|+++
T Consensus 357 i~~~~~~--~~~~~--~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYN--FIPEV--W---AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCC--CCHHH--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCC--CCchh--h---cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111100 00000 0 112345788889999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.22 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=193.3
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 3478999999999999965 68999999986433 334678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC----
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---- 517 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 517 (672)
+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999998643 35899999999999999999999 78999999999999999999999999999975432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....++..|+|||++.. ...++.++||||||+++|||++|+.||....... .. .........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------~~-~~~~~~~~~--- 226 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----------QE-YSDWKEKKT--- 226 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTC-SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS----------HH-HHHHHTTCT---
T ss_pred hcccCCccccCccChHHHhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH----------HH-HHHhhhccc---
Confidence 24567889999997643 2334789999999999999999999997543211 11 111111100
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... ........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC-------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 00112235678888999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.39 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=191.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
..+.||+|+||.||+|+.. ++..||||+++... ......+.+|+++++.++||||+++++++.+....++||||+++
T Consensus 41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999965 68999999997543 23467889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAPP 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~ 517 (672)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 121 g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 121 GELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999988654 34899999999999999999999 789999999999999976 45599999999976654
Q ss_pred C----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 S----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
. ...+|+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+....+.......
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~------------~~~~~~~~i~~~~~~~ 256 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQ------------TDQEILRKVEKGKYTF 256 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCCC
T ss_pred CccccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCCCC
Confidence 3 456899999999864 46899999999999999999999999643 2233333333322110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+ .... ....+.+++.+||+.||++|||+.|+++
T Consensus 257 --~~~---~~~~---~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 --DSP---EWKN---VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --CSG---GGTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --Cch---hccc---CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 0111 2235778888999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.45 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=197.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 478999999999999965 57899999986432 12356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 99999997542 4899999999999999999999 889999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||.... .............
T Consensus 170 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~~~~~~~------ 229 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIE--GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------------HTETHRRIVNVDL------ 229 (284)
T ss_dssp CCCCSCGGGCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------------HHHHHHHHHTTCC------
T ss_pred ccccCCCCcCCHHHhc--cCCCCcccchhhHHHHHHHHHHCCCCCCCCC------------HhHHHHHHhcccc------
Confidence 456788999999764 4578899999999999999999999996431 1222222221110
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHh
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELR 642 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~ 642 (672)
..... ....+.+++.+||+.||.+|||+.|+++ .++...
T Consensus 230 ---~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 230 ---KFPPF---LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ---CCCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ---CCCCc---CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 00111 1235678888999999999999999986 444443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=349.07 Aligned_cols=243 Identities=15% Similarity=0.202 Sum_probs=185.3
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccC---CcchHHHHHHHH---HHHcCCCCCceeeeE-------EEEEcCCe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA---SIGGKREFEQHM---EVLGRLRHPNLVGLK-------AYYFAREE 430 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~~ 430 (672)
.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++||||++++ +++.+++.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 47899999999999995 57999999999732 333567899999 556666899999998 77665532
Q ss_pred -----------------EEEEEeecCCCChhHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 005880 431 -----------------KLLVSEYMPNGSLFWLLHGNRG--PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNI 491 (672)
Q Consensus 431 -----------------~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dl 491 (672)
.++||||+ +|+|.+++..... .....+++..++.|+.|+++||+||| +.+|+||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDi 232 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYL 232 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTTEECSCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCC
Confidence 78999999 6899999975321 11234557899999999999999999 789999999
Q ss_pred CCCCEEeCCCCcEEEeccCCCccCCCC--CCCCCCcccCCCccccC---------CCCCCchhHHHHHHHHHHHHHhCCC
Q 005880 492 KSTNVLLDKTGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSD---------GRKQSQKSDVYSFGVLLLELLTGKC 560 (672)
Q Consensus 492 kp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~---------~~~~~~~~DV~S~Gvvl~el~tg~~ 560 (672)
||+|||++.++.+||+|||+++..... ...+ ..|+|||++... ...++.++|||||||++|||++|+.
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 999999999999999999999865543 4556 899999977532 0168999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HH
Q 005880 561 PSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK--LI 638 (672)
Q Consensus 561 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L 638 (672)
||........ ...+. ...... ...+.+++.+||+.||++|||+.|+++ .+
T Consensus 312 Pf~~~~~~~~---------------------~~~~~----~~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 312 PITKDAALGG---------------------SEWIF----RSCKNI---PQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp CC------CC---------------------SGGGG----SSCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred CCcccccccc---------------------hhhhh----hhccCC---CHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 9965432210 00000 001111 235778888999999999999999986 44
Q ss_pred HHH
Q 005880 639 EEL 641 (672)
Q Consensus 639 ~~i 641 (672)
+++
T Consensus 364 ~~~ 366 (377)
T 3byv_A 364 EQL 366 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=330.17 Aligned_cols=243 Identities=22% Similarity=0.358 Sum_probs=191.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 478999999999999976 5899999999876666678899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC-----CCC
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA-----PPS 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~-----~~~ 518 (672)
.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++... ...
T Consensus 104 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 104 DAIMLELD----RGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 99987532 35899999999999999999999 789999999999999999999999999987432 123
Q ss_pred CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++.. .+..++.++||||||+++|||++|+.||... +.............. ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------~~~~~~~~~~~~~~~-~~ 242 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------------NPMRVLLKIAKSDPP-TL 242 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS------------CHHHHHHHHHHSCCC-CC
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC------------CHHHHHHHHhccCCc-cc
Confidence 4568899999997631 3467889999999999999999999999642 222222222222110 00
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .......+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0112235778888999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.81 Aligned_cols=238 Identities=21% Similarity=0.307 Sum_probs=194.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 478999999999999965 58899999986532 23456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 100 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999998754 35899999999999999999999 789999999999999999999999999999765422
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... ...+..........
T Consensus 171 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------~~~~~~~~~~~~~~---- 232 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETS------------CLKETYLRIKKNEY---- 232 (294)
T ss_dssp CBCCCCSCCSSCCHHHHT--TSCBCTHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHTTCC----
T ss_pred ccccccCCCCcCCcchhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHhhccC----
Confidence 345788999999764 456889999999999999999999999643 22222222222110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
..... ....+.+++.+||+.||++|||+.|+++.
T Consensus 233 -----~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----SIPKH---INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CCCTT---SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCccc---cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00111 12357788889999999999999999873
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=354.23 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=196.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 368999999999999965 69999999996532 22456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 99999997543 245899999999999999999999 789999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...||+.|+|||++. +..++.++|||||||++|||++|+.||...... .........+.... ..+
T Consensus 342 ~~~~~GT~~Y~APEvl~--~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--------~~~~~i~~~i~~~~---~~~ 408 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------IKREEVERLVKEVP---EEY 408 (576)
T ss_dssp EECCCSCGGGCCHHHHT--TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--------CCHHHHHHHHHHCC---CCC
T ss_pred ccccCCCccccCHHHHc--CCCCCccchHHHHHHHHHHHHhCCCCCcccccc--------hhHHHHHHHhhccc---ccC
Confidence 457899999999775 457899999999999999999999999754321 11112221111110 000
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
.. .....+.+++.+||+.||++|| ++.||++
T Consensus 409 ------p~---~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 ------SE---RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ------CT---TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ------Cc---cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01 1123577888899999999999 6788864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.35 Aligned_cols=256 Identities=20% Similarity=0.247 Sum_probs=199.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC-CceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH-PNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.++||+|+||.||+|+. .+++.||||++.... ...++.+|++++..++| +++..+..++...+..++||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 47899999999999995 568999999876543 23458899999999987 55666666777788899999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe---CCCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++.... ..+++.+++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 89 L~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 89 LEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 999997543 35999999999999999999999 7899999999999999 58899999999999765432
Q ss_pred -----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 519 -----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 519 -----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||...... ...+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------~~~~~~~~i~ 229 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKKQKYEKIS 229 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS---------SHHHHHHHHH
T ss_pred cccccccccccccCCCccccCHHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccch---------hHHHHHHHHh
Confidence 446788999999764 567899999999999999999999999754321 2222222222
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPC 649 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 649 (672)
.... ...+..-. .....++.+++..||+.||++||++.+|+++|+++......+.
T Consensus 230 ~~~~-~~~~~~l~------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 230 EKKV-ATSIEALC------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp HHHH-HSCHHHHH------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred hccc-cccHHHHh------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 2211 11111000 0112467889999999999999999999999999866444443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.51 Aligned_cols=238 Identities=24% Similarity=0.356 Sum_probs=187.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 478999999999999976 78999999986432 22356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999997542 4899999999999999999999 779999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++.. ....+.++||||||+++|||++|+.||... ..............
T Consensus 167 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------~~~~~~~~~~~~~~----- 228 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISG-RLYAGPEVDIWSCGVILYALLCGTLPFDDE------------HVPTLFKKIRGGVF----- 228 (276)
T ss_dssp ----------CCTGGGTT-SCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC-----
T ss_pred eecccCCccccCHHHHcC-CCCCCccchHHHHHHHHHHHHhCCCCCCCC------------cHHHHHHHhhcCcc-----
Confidence 3456889999997642 223468999999999999999999999632 22222222221110
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... .....+.+++.+||+.||++|||+.|+++
T Consensus 229 ----~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ----YIPE---YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ----CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cCch---hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0001 11235778888999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.59 Aligned_cols=194 Identities=22% Similarity=0.391 Sum_probs=152.9
Q ss_pred hcccCcCCeEEEEEEEEc---CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD---DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 439 (672)
+++||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999965 57899999997554 34578899999999999999999999964 668899999996
Q ss_pred CCChhHHhhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe----CCCCcEEEeccCC
Q 005880 440 NGSLFWLLHGNR----GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL----DKTGNARVSDFGL 511 (672)
Q Consensus 440 ~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~ 511 (672)
|+|.+++.... ......+++..++.|+.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 58888775321 112235999999999999999999999 7899999999999999 6778999999999
Q ss_pred CccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 512 SIFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 512 a~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
++..... ...+|..|+|||++.. ...++.++|||||||++|||++|+.||....
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CC----------------CCCTTCCHHHHTT-CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcC-CCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9865432 3567899999998753 2468999999999999999999999997654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=335.11 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=184.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 478999999999999954 7899999999754332 34567899999999999999999999999999999999997 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-----CCCcEEEeccCCCccCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-----KTGNARVSDFGLSIFAP 516 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~DfG~a~~~~ 516 (672)
+|.+++.... .+++..+..|+.|+++||+||| +.+|+||||||+||+++ +++.+||+|||+++...
T Consensus 118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999997653 4899999999999999999999 78999999999999994 55569999999997654
Q ss_pred CC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 517 PS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 517 ~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
.. ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+..........
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~------------~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS------------EIDQLFKIFEVLG 255 (329)
T ss_dssp -----------CCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHC
T ss_pred CcccccCCCcCCccccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC------------HHHHHHHHHHHhC
Confidence 22 3456889999998653 3458999999999999999999999996432 1122222211100
Q ss_pred ccc------c-----cchhhc--cccChHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TAE------V-----FDLELM--RYKDIEE-----EMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~~------~-----~d~~~~--~~~~~~~-----~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... . ...... ....... ...++.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0 000000 0000010 1245778999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=347.78 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=196.2
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+....++||||+++
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 3578999999999999965 78999999986432 23567899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC---CCCcEEEeccCCCccCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD---KTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~ 517 (672)
|+|.+.+... ..+++..+..++.|+++||.||| +.+|+||||||+||+++ .++.+||+|||+++....
T Consensus 106 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999988654 34899999999999999999999 78999999999999995 456799999999986654
Q ss_pred C----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 518 S----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 518 ~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
. ...+|+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+....+.......
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~------------~~~~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGK------------NEYDILKRVETGKYAF 241 (486)
T ss_dssp C----CCTTGGGGCCGGGGG---SCCCHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCCS
T ss_pred CCccCCCcCCCCCCCHHHhC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCCCC
Confidence 3 456889999999874 35899999999999999999999999643 2223333333222111
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. .... ......+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~-----~~~~---~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D-----LPQW---RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C-----SGGG---GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-----Cccc---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 0011 1122357788889999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.27 Aligned_cols=242 Identities=20% Similarity=0.317 Sum_probs=192.4
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 67999999999999965 68999999987533 23467899999999999 4699999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~ 518 (672)
+|.+++.... ...+++.+++.++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999986543 245999999999999999999999 789999999999999997 789999999999876543
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 188 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------------~~~~~~~i~~~~~--- 250 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED------------NQETYLNISQVNV--- 250 (327)
T ss_dssp ------CCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHTCC---
T ss_pred cccccccCCcCccCCeeec--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------chHHHHHHHhccc---
Confidence 456889999999764 5678999999999999999999999996432 1222222211110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+...... ......+.+++.+||+.||++|||+.|+++
T Consensus 251 --~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 --DYSEETF---SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --CCCTTTT---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --ccCchhh---cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0000001 112345778888999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.64 Aligned_cols=237 Identities=21% Similarity=0.314 Sum_probs=194.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 478999999999999965 57899999986532 23456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 126 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 126 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999998754 34899999999999999999999 789999999999999999999999999999765422
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... ...+..........
T Consensus 197 ~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~------------~~~~~~~~~~~~~~---- 258 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETS------------CLKETYLRIKKNEY---- 258 (335)
T ss_dssp CBCCCCSCCSSCCHHHHH--TSCBCTHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHTCC----
T ss_pred cccccCCCccccCHHHhc--cCCCCchhhHHHHHHHHHHHHHCcCCCCCC------------CHHHHHHHHhcCCC----
Confidence 355788999999765 456789999999999999999999999642 22222222222111
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 259 -----~~~~~---~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKH---INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTT---SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCcc---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111 1234678888999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=349.19 Aligned_cols=240 Identities=24% Similarity=0.359 Sum_probs=192.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-------------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-------------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE 430 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 430 (672)
.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 478999999999999965 589999999875332 235678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC---cEEEe
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG---NARVS 507 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 507 (672)
.++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999998754 34899999999999999999999 78999999999999998775 69999
Q ss_pred ccCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHH
Q 005880 508 DFGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 508 DfG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
|||+++..... ...+|+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+.+
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~------------~~~~~~ 256 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQ------------NDQDII 256 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCCCCCC------------CHHHHH
Confidence 99999876543 456899999999864 46899999999999999999999999643 223333
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+....... +.. .... ....+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~i~~~~~~~---~~~--~~~~---~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYF---DFN--DWKN---ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCC---CHH--HHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCC---Ccc--ccCC---CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3333222110 100 0011 1245778888999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.67 Aligned_cols=250 Identities=23% Similarity=0.265 Sum_probs=189.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC-----cchHHHHHHHHHHHcCC---CCCceeeeEEEEEcCC-----e
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS-----IGGKREFEQHMEVLGRL---RHPNLVGLKAYYFARE-----E 430 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~-----~ 430 (672)
.+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+++++++ +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 47899999999999995 578999999986322 11235677788777766 4999999999998755 4
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++||||++ |+|.+++..... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred EEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 789999996 699999986542 34899999999999999999999 7899999999999999999999999999
Q ss_pred CCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 511 LSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 511 ~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
+++..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------------~~~~~~~i 231 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS------------EADQLGKI 231 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHH--TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS------------HHHHHHHH
T ss_pred cccccCCCcccCCccccccccCchHHc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHH
Confidence 99866543 345788999999765 4578999999999999999999999996432 12222222
Q ss_pred Hhhhcc-------cccc--chhhc--cccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWT-------AEVF--DLELM--RYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~-------~~~~--d~~~~--~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...... .... ..... ..... .+....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 211000 0000 00000 00000 012245778889999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.57 Aligned_cols=238 Identities=26% Similarity=0.397 Sum_probs=194.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 478999999999999954 68999999987543 3356789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.. .++++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 107 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 107 ALDLLEP------GPLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp HHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 9999964 34899999999999999999999 789999999999999999999999999999765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||... ............. ... +
T Consensus 177 ~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------~~~~~~~~~~~~~-~~~-~- 239 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELARGEPPHSEL------------HPMKVLFLIPKNN-PPT-L- 239 (303)
T ss_dssp CCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------CHHHHHHHHHHSC-CCC-C-
T ss_pred CccCCCcCccCHHHHh--cCCCCchhhhHHHHHHHHHHccCCCCCCCc------------CHHHHHHHhhcCC-CCC-C-
Confidence 456788999999764 457889999999999999999999998632 1112221111111 000 0
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 240 -----~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 -----EG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----CS---SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----cc---ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01 112357788889999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=334.97 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=191.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc--hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG--GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 478999999999999965 5899999998654332 3566889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 110 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 110 ILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp HHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred hHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 998887643 34899999999999999999999 789999999999999999999999999999765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC---CCCCCChhHHHHHHHhhhccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG---CGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ...++.++|||||||++|||++|+.||......+... ...+.....+...........
T Consensus 181 ~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ---CCCCCTTCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred cCCCcCCccccCcccccC-CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 4567889999997642 3468999999999999999999999996532110000 000000000000000000000
Q ss_pred cccchhhccccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+........ ......+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000111000000 012346888999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=337.06 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=191.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc-----hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG-----GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 3478999999999999964 6899999999753221 134688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++ +|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 975 8988887543 45889999999999999999999 78999999999999999999999999999986643
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ...+|..|+|||++.. ...++.++|||||||++|||++|.+||.... ..+.+..+......
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~~~~~~~------------~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDS------------DLDQLTRIFETLGT 231 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHCC
T ss_pred CcccCCcccccccccCchHhhC-CCCCCchhhhHhHHHHHHHHHHCCCCCCCCC------------HHHHHHHHHHHcCC
Confidence 2 4567889999997642 3458899999999999999999999986432 12222222221100
Q ss_pred c--c-ccc----hhh---cccc--Ch----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 593 A--E-VFD----LEL---MRYK--DI----EEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 593 ~--~-~~d----~~~---~~~~--~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. + ..+ +.. ...+ .. ......+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0 000 000 0000 00 1122467889999999999999999999763
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.47 Aligned_cols=247 Identities=12% Similarity=0.024 Sum_probs=175.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHH---HHHcCCCCCceeeeE-------EEEEcC--
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHM---EVLGRLRHPNLVGLK-------AYYFAR-- 428 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~-- 428 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+ ++++. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 478999999999999965 789999999986543 2345677784 55556 799988755 454433
Q ss_pred ---------------CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhhCCCCCcE
Q 005880 429 ---------------EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR------LKIAAGAARGLAFIHFTCKSLKLT 487 (672)
Q Consensus 429 ---------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~~ii 487 (672)
...++||||++ |+|.+++.... ..+.+..+ ..++.|+++||+||| +.+|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~iv 216 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ----SKGLV 216 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCCc
Confidence 33799999998 89999998642 23455566 788899999999999 78999
Q ss_pred ecCCCCCCEEeCCCCcEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 488 HGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 488 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
||||||+|||++.++.+||+|||+++..... ...+|..|+|||++......++.++|||||||++|||+||+.||...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999999877554 34567899999987543367899999999999999999999999865
Q ss_pred CCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 566 GGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....... | ............. ..+........+.+++.+||+.||++|||+.|+++
T Consensus 297 ~~~~~~~---------~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 297 TPGIKGS---------W-----KRPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CTTCTTC---------C-----CBCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred Ccccccc---------h-----hhhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3321000 0 0000000000000 00000112345778888999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=336.19 Aligned_cols=241 Identities=20% Similarity=0.295 Sum_probs=189.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
..+.||+|+||.||+|... +|+.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 3578999999999999965 689999999975432 245678888777 7999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC----CcEEEeccCCCccCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT----GNARVSDFGLSIFAPP 517 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~~~~~ 517 (672)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++.++ +.+||+|||+++....
T Consensus 102 ~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 102 ELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp BHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999754 35899999999999999999999 7899999999999998543 3599999999986543
Q ss_pred C-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 518 S-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 518 ~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
. ...+|..|+|||++. +..++.++|||||||++|||++|+.||..... ....+....+......
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLE--RQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---------DTPEEILARIGSGKFS 241 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHH--HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---------SCHHHHHHHHHHCCCC
T ss_pred CCCceeccCCCccccCHHHhc--CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---------CCHHHHHHHHccCCcc
Confidence 2 456789999999775 34578899999999999999999999974321 1223333333222211
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....... .....+.+++.+||..||++|||+.|+++
T Consensus 242 -----~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -----LSGGYWN---SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CCSTTTT---TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----cCccccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011 12235678888999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.61 Aligned_cols=241 Identities=26% Similarity=0.363 Sum_probs=196.9
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 3578999999999999965 78999999986432 2356789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe---CCCCcEEEeccCCCccCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~ 516 (672)
+|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 110 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 110 GGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp SCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999998754 35899999999999999999999 7899999999999999 567899999999997765
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
.. ...+|+.|+|||++. ..++.++||||+||++|||++|+.||... +..+.+..+......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~------------~~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLH---GTYDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDILKKVEKGKYT 245 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHH---TCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCC
T ss_pred cccccccCCCCccccCceeec---CCCCCcceeHHHHHHHHHHHHCCCCCCCC------------CHHHHHHHHHcCCCC
Confidence 44 346789999999874 36899999999999999999999999643 222333333322211
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .... ......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~-----~~~~---~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FE-----LPQW---KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CC-----SGGG---GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----Cccc---ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11 0111 112235778888999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.11 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=193.8
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
+.||+|+||.||+|+.. +|+.||||++.+... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 56999999999999975 699999999975332 23467889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|.+++..... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++++||+|||+++.....
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999975432 2346999999999999999999999 789999999999999999999999999999866443
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...||+.|+|||++. +..++.++|||||||++|||++|+.||...... .........+.....
T Consensus 346 ~~~~~GT~~Y~APE~l~--~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--------~~~~~~~~~i~~~~~----- 410 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLL--GEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--------VENKELKQRVLEQAV----- 410 (543)
T ss_dssp BCCCCSCTTTSCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--------CCHHHHHHHHHHCCC-----
T ss_pred cccccCCccccChhhhc--CCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--------hhHHHHHHHHhhccc-----
Confidence 347899999999775 467899999999999999999999999754321 122233333222211
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
..... ....+.+++.+||+.||++||++
T Consensus 411 ----~~p~~---~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ----TYPDK---FSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----CCCTT---SCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----CCCcc---cCHHHHHHHHHhccCCHhHCCCC
Confidence 00111 22356778889999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.04 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=191.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC----cchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS----IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 478999999999999964 68999999997532 2346789999999999999999999999854 4578999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++| |.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9876 777776543 245899999999999999999999 78999999999999999999999999999976543
Q ss_pred C-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 518 S-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 518 ~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
. ...++..|+|||++......++.++||||||+++|||++|+.||... +..+....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------~~~~~~~~i~~~~ 229 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------------NIYKLFENIGKGS 229 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHHCC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc------------hHHHHHHHHhcCC
Confidence 2 44578899999987543344578999999999999999999999642 2222332222221
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
. .... .....+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~---------~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 Y---------AIPG---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C---------CCCS---SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C---------CCCC---ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 0001 122357788889999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.63 Aligned_cols=189 Identities=24% Similarity=0.332 Sum_probs=161.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-----EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 436 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 478999999999999964 68999999997532 23457889999999999999999999999766 57899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|++ |+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 111 IAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred cCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 996 6999999754 35999999999999999999999 7899999999999999999999999999998654
Q ss_pred C---------------------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 517 P---------------------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 517 ~---------------------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
. ....+|..|+|||++.. ...++.++|||||||++|||++|..||..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-CCCCCcccccchHHHHHHHHHhccccccc
Confidence 2 24567889999997532 45789999999999999999997666653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.80 Aligned_cols=239 Identities=24% Similarity=0.377 Sum_probs=190.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 478999999999999965 58999999997543 457789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 112 SDIIRLRN----KTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp HHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 99996432 35899999999999999999999 789999999999999999999999999999765432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...++..|+|||++. +..++.++||||||+++|||++|+.||.... ........... ......
T Consensus 184 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~-~~~~~~-- 246 (314)
T 3com_A 184 TVIGTPFWMAPEVIQ--EIGYNCVADIWSLGITAIEMAEGKPPYADIH------------PMRAIFMIPTN-PPPTFR-- 246 (314)
T ss_dssp CCCSCGGGCCHHHHS--SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHHS-CCCCCS--
T ss_pred ccCCCCCccChhhcC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCC------------hHHHHHHHhcC-CCcccC--
Confidence 456788999999764 4578899999999999999999999996421 11111111111 100000
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........+.+++.+||+.||++|||+.|+++
T Consensus 247 ------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112345778889999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.86 Aligned_cols=184 Identities=25% Similarity=0.375 Sum_probs=162.3
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEc--CCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFA--REEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||||+++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 47899999999999985 57899999999743 4578999999999997 9999999999987 5678999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCCC-
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPPS- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~- 518 (672)
++|.+++. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++ .+||+|||+++.....
T Consensus 118 ~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 118 TDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999985 2789999999999999999999 78999999999999999776 8999999999865543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVI 564 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~ 564 (672)
...++..|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 186 ~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccChhhhcC-CCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4457888999997642 35789999999999999999999999954
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.42 Aligned_cols=241 Identities=20% Similarity=0.281 Sum_probs=191.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
..+.||+|+||.||+|... +++.||||+++... .....++.+|+..+.++ +||||+++++++.+++..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 3478999999999999975 79999999987532 33567788999999998 99999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC------------------
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT------------------ 501 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~------------------ 501 (672)
+|+|.+++..... ....+++..++.++.|+++||+||| +.+|+||||||+||+++.+
T Consensus 95 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 95 GGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp TCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC--------------------
T ss_pred CCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999975421 1135899999999999999999999 7899999999999999844
Q ss_pred -CcEEEeccCCCccCCCC-CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCh
Q 005880 502 -GNARVSDFGLSIFAPPS-TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579 (672)
Q Consensus 502 -~~~kl~DfG~a~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~ 579 (672)
..+||+|||.+...... ...+|..|+|||++.. ...++.++|||||||++|||++|.+|+... .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~------------~- 235 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPRNG------------D- 235 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTT-CCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------------H-
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcC-CCCCCchhhHHHHHHHHHHHhcCCCCCcch------------h-
Confidence 47999999999876554 4568899999998652 346678999999999999999999876421 1
Q ss_pred hHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ..... ....... ... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 -~-~~~~~-~~~~~~~-------~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -Q-WHEIR-QGRLPRI-------PQV---LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -H-HHHHH-TTCCCCC-------SSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H-HHHHH-cCCCCCC-------Ccc---cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 11111 1111110 011 1235778888999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.53 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=188.9
Q ss_pred hcccCcCCeEEEEEEEEc--CCc--EEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD--DGS--VVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++..+. .++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 478999999999999853 333 68999987542 234678899999999999999999999987654 8899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 102 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999997542 35899999999999999999999 78999999999999999999999999999977644
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
. ...++..|+|||++. +..++.++||||||+++|||++ |+.||... +..+.......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------------~~~~~~~~~~~ 239 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------------NGSQILHKIDK 239 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHT
T ss_pred cccchhhhccCCCCceeeCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCcccC------------CHHHHHHHHHc
Confidence 3 234566899999764 4567899999999999999999 99999643 22233333222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..... .........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 240 ~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 EGERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp SCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCCCC----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 21110 0011223457888899999999999999999999998864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=334.25 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=196.0
Q ss_pred hcccCcCCeEEEEEEEE------cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVL------DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+. .+++.||||++.... .....++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 47899999999999984 247789999997543 33566889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCC
Q 005880 438 MPNGSLFWLLHGNRG--PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLS 512 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a 512 (672)
+++|+|.+++..... .....+++..++.++.|+++||.||| +.+|+||||||+||+++. +..+||+|||++
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 999999999986542 12245899999999999999999999 789999999999999984 446999999998
Q ss_pred ccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 513 IFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 513 ~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
+..... ...++..|+|||++. +..++.++||||||+++|||+| |+.||.... ..+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------------~~~~~~ 256 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------------NQEVLE 256 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------------HHHHHH
T ss_pred cccccccccccCCCcCCCcceeCHhHhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------------HHHHHH
Confidence 643221 234577899999764 4578999999999999999998 999986431 222222
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
........ . .. ......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 257 ~~~~~~~~----~----~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRM----D----PP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCC----C----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC----C----CC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 22221110 0 01 1122357788899999999999999999999998864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=345.60 Aligned_cols=183 Identities=23% Similarity=0.354 Sum_probs=147.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-----EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 436 (672)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++... ...|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 478999999999999954 68999999987532 23457889999999999999999999998543 56899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+ +|+|.+++... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 138 ~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 138 IA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred cc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 98 57999999754 35999999999999999999999 7899999999999999999999999999998654
Q ss_pred CC--------------------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhC
Q 005880 517 PS--------------------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG 558 (672)
Q Consensus 517 ~~--------------------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg 558 (672)
.. ...+|..|+|||++. ....++.++|||||||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL-LQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhh-CCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 235688899999753 245789999999999999999994
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.32 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=189.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEc--------CCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFA--------REEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l 433 (672)
.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++.. .+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 47899999999999996 5789999999864432 235678899999999999999999999986 346899
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||+++ +|.+.+.... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 102 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 9999975 7877776543 35999999999999999999999 7899999999999999999999999999997
Q ss_pred cCCC---------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 514 FAPP---------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 514 ~~~~---------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
.... ....+|..|+|||++.. ...++.++|||||||++|||+||+.||...... .....+.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~i~ 242 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---------HQLALIS 242 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHH
T ss_pred cccccccccccccCCcccccCccCchhhcC-CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Confidence 6542 13456888999997643 356799999999999999999999999753211 1111111
Q ss_pred HHHhhhccccccc------------hhhccccChHHH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 585 SVVREEWTAEVFD------------LELMRYKDIEEE------MVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 585 ~~~~~~~~~~~~d------------~~~~~~~~~~~~------~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ...+... ..........+. ...+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 243 QLCGS-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHCC-CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCC-CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11100 0000000 000000111111 234778999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.82 Aligned_cols=190 Identities=27% Similarity=0.377 Sum_probs=164.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCC------CCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRL------RHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|... +++.||||+++... ...+++.+|+++++.+ +|+||+++++++...+..++||||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 478999999999999865 58999999997543 2456677888877766 578999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc--EEEeccCCCccC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN--ARVSDFGLSIFA 515 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~~ 515 (672)
+. ++|.+++..... ..+++..+..|+.|+++||+||| +.+|+||||||+|||++.++. +||+|||+++..
T Consensus 181 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 181 LS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp CC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred cC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 95 699999986542 35899999999999999999999 779999999999999999887 999999999766
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
... ...+|..|+|||++. +..++.++|||||||++|||+||++||...
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 253 HQRVYTYIQSRFYRAPEVIL--GARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCCCCSSCSCGGGCCHHHHH--TBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccCCCCCccChHHHh--CCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 543 556889999999775 457899999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.29 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=179.8
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc-h-HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG-G-KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+. .+|+.||||+++..... . .+.+.++...++.++||||+++++++.+++..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 47899999999999996 47899999999754322 2 2344455556888999999999999999999999999997 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC-CcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL-KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++..... ....+++..++.++.|+++||+||| +. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 88887754211 1245999999999999999999999 65 9999999999999999999999999999766443
Q ss_pred --CCCCCCcccCCCccc--cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 --TVPRSNGYRAPELSS--SDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~--~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...+|..|+|||++. ..+..++.++|||||||++|||+||+.||.... ............... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~-~ 233 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----------TPFQQLKQVVEEPSP-Q 233 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----------CHHHHHHHHHHSCCC-C
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----------chHHHHHHHhccCCC-C
Confidence 346789999999753 235678999999999999999999999996421 111122222222110 0
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. . . ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-----~-~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 L-----P-A---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C-----C-T---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c-----c-c---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 0 0 112335788888999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=333.13 Aligned_cols=250 Identities=19% Similarity=0.311 Sum_probs=191.2
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|...+ .||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 4789999999999999763 48999987432 2234567889999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus 116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999997543 45899999999999999999999 78999999999999998 679999999998654311
Q ss_pred ------CCCCCCcccCCCccccC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 519 ------TVPRSNGYRAPELSSSD-------GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~-------~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
...++..|+|||++... ...++.++||||||+++|||++|+.||.... .......
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------------~~~~~~~ 254 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP------------AEAIIWQ 254 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC------------HHHHHHH
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHH
Confidence 23467889999987531 3457899999999999999999999996432 1222222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCC
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVS 647 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 647 (672)
.... ....... .. ....+.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 255 ~~~~-~~~~~~~------~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 255 MGTG-MKPNLSQ------IG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHTT-CCCCCCC------SS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred hccC-CCCCCCc------CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 2111 1111100 01 122477888899999999999999999999998765443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.91 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=174.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 435 (672)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 47899999999999995 46899999999753 223457788999999999999999999998754 5679999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 114 e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 114 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp ECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 999 7899998864 24899999999999999999999 789999999999999999999999999999876
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc--
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW-- 591 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 591 (672)
... ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ....+..+.+...
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~------------~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------------HIDQLKLILRLVGTP 249 (367)
T ss_dssp --------CCCTTCCHHHHTT-CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCSC
T ss_pred cccCCCcCcCcCccChHHHcC-CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHHhCCC
Confidence 543 4568899999998653 3578999999999999999999999996432 1222222211100
Q ss_pred ----cccccch-------hhcc--ccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 ----TAEVFDL-------ELMR--YKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ----~~~~~d~-------~~~~--~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+... .+.. ..... .....+.+++.+||..||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 0000 00000 11245778889999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=328.53 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=189.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 434 (672)
+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++..+. .++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 3578999999999999965 589999999865321 12345889999999999999999999987654 8999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc---EEEeccCC
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN---ARVSDFGL 511 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~ 511 (672)
|||+++|+|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 9999999999998754 35899999999999999999999 789999999999999987654 99999999
Q ss_pred CccCCCC----CCCCCCcccCCCcccc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHH
Q 005880 512 SIFAPPS----TVPRSNGYRAPELSSS-DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586 (672)
Q Consensus 512 a~~~~~~----~~~~t~~y~aPE~l~~-~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (672)
++..... ...+|..|+|||++.. ....++.++|||||||++|||++|+.||...... ..+...+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~--- 232 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--------VSLKDQI--- 232 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--------SCHHHHH---
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--------HHHHHHH---
Confidence 9876554 3357889999997642 3457889999999999999999999999754321 1121111
Q ss_pred HhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...... ..+... ......+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~--~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYN--FIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCC--CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCccc--cCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 000000 112345788889999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=324.04 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=194.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---------chHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---------GGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 433 (672)
.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++.+++ ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 478999999999999965 689999999864321 12456889999999995 9999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||+++|+|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999754 35899999999999999999999 7899999999999999999999999999997
Q ss_pred cCCCC----CCCCCCcccCCCcccc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 514 FAPPS----TVPRSNGYRAPELSSS----DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 514 ~~~~~----~~~~t~~y~aPE~l~~----~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
..... ...++..|+|||++.. ....++.++||||||+++|||++|+.||... ........
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------~~~~~~~~ 240 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------------KQMLMLRM 240 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHH
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc------------cHHHHHHH
Confidence 66543 3457889999997642 2456789999999999999999999999642 12222222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........ .. +........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~--~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNYQF--GS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCCCC--CT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCccc--Cc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 22221110 00 011122345788889999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=331.04 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=177.4
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 47899999999999995 468999999987533 2345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGN---RGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++... .......+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 99998641 1112345899999999999999999999 789999999999999999999999999998655321
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...+|..|+|||++.. ...++.++||||||+++|||++|+.||..... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~ 242 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPYHKYPP------------MKVLMLTLQN 242 (303)
T ss_dssp ------------CCCTTCCHHHHHH-HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG------------GGHHHHHHTS
T ss_pred CccchhhhcccCCCccccCHHHhcc-ccCCCchhhHHHHHHHHHHHHhCCCCCccCch------------hhHHHHHhcc
Confidence 3457889999997642 24578999999999999999999999964321 1111111111
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... .. ................+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~-~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPP-SL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCC-CT-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCC-cc-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 100 00 0000000000112235778888999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.13 Aligned_cols=252 Identities=17% Similarity=0.263 Sum_probs=194.2
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcch-----------------HHHHHHHHHHHcCCCCCceeeeEEEEEc
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGG-----------------KREFEQHMEVLGRLRHPNLVGLKAYYFA 427 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 427 (672)
.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++.+++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 47899999999999999 89999999986432211 1789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChhHH------hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCC
Q 005880 428 REEKLLVSEYMPNGSLFWL------LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDK 500 (672)
Q Consensus 428 ~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~ 500 (672)
.+..++||||+++|+|.++ +... ....+++..++.++.|+++||+||| + .+|+||||||+||+++.
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIH----NEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHH----HTSCEECCCCCGGGEEECT
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHh----ccCCEeecCCChHhEEEcC
Confidence 9999999999999999998 5432 1356999999999999999999999 6 89999999999999999
Q ss_pred CCcEEEeccCCCccCCCC---CCCCCCcccCCCccccCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q 005880 501 TGNARVSDFGLSIFAPPS---TVPRSNGYRAPELSSSDGRKQSQ-KSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGA 576 (672)
Q Consensus 501 ~~~~kl~DfG~a~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~-~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~ 576 (672)
++.+||+|||++...... ...++..|+|||++... ..++. ++||||||+++|||++|+.||.....
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 257 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS--------- 257 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC---------
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc---------
Confidence 999999999999865443 55678899999976532 24555 99999999999999999999975422
Q ss_pred CChhHHHHHHHhhhcccccc----chhhcc---ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 577 VDLPRWVQSVVREEWTAEVF----DLELMR---YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~----d~~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+............... ...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 258 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 --LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112222222111100000 000000 0000112346788899999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.16 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=192.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC--------CCceeeeEEEEE----cCCeE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR--------HPNLVGLKAYYF----AREEK 431 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~~~ 431 (672)
.+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|++++++++ |+||+++++++. .....
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 47899999999999995 468999999997542 24577889999998885 788999999987 55678
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC-CcEecCCCCCCEEeCCCC--------
Q 005880 432 LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL-KLTHGNIKSTNVLLDKTG-------- 502 (672)
Q Consensus 432 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-~iiH~Dlkp~NIll~~~~-------- 502 (672)
++||||+ +++|.+.+.... ...+++..++.|+.|+++||+||| +. +|+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 9999999 566666665432 245899999999999999999999 66 999999999999999775
Q ss_pred -----------------------------------------cEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCC
Q 005880 503 -----------------------------------------NARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQ 539 (672)
Q Consensus 503 -----------------------------------------~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~ 539 (672)
.+||+|||+++..... ...+|..|+|||++. +..+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~ 270 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI--GSGY 270 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH--TSCC
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc--CCCC
Confidence 7999999999766543 456799999999775 4568
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh------------hhccccccchh--------
Q 005880 540 SQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR------------EEWTAEVFDLE-------- 599 (672)
Q Consensus 540 ~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~d~~-------- 599 (672)
+.++|||||||++|||+||+.||....... ...-......... .......+...
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEE------YTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSS------SCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccc------cCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999997654321 0001111111110 00000001000
Q ss_pred ----------hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 600 ----------LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 600 ----------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........+....+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001122455677899999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.01 Aligned_cols=190 Identities=25% Similarity=0.398 Sum_probs=166.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 468999999999999965 68999999987543 3345789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCC---CC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP---PS 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~---~~ 518 (672)
|.+++.... .+++..+..++.|+++||+||| + ++|+||||||+||+++.++.+||+|||++.... ..
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999997542 4899999999999999999999 5 389999999999999999999999999986432 23
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 189 ~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp --CCCCTTCCHHHHT--TCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCCCCCCeECHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 557899999999764 567899999999999999999999999653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=333.47 Aligned_cols=250 Identities=19% Similarity=0.277 Sum_probs=185.0
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc-----------hHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG-----------GKREFEQHMEVLGRLRHPNLVGLKAYYFAR----- 428 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 428 (672)
.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 4689999999999999888999999998643221 137899999999999999999999998643
Q ss_pred CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEec
Q 005880 429 EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 429 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
...++||||++ |+|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEEcCCCCEEEEe
Confidence 35799999997 68888887543 46999999999999999999999 78999999999999999999999999
Q ss_pred cCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 509 FGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 509 fG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
||+++..... ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ......
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------------~~~~~~ 244 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGST------------FYNQLN 244 (362)
T ss_dssp TTC---------------CGGGCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHH
T ss_pred cCcccccccccccceecccceecCcHHhcC-CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC------------HHHHHH
Confidence 9999754432 4457888999997653 2568999999999999999999999996432 122222
Q ss_pred HHHhhhccc--------------cccchhhcc--ccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 585 SVVREEWTA--------------EVFDLELMR--YKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 585 ~~~~~~~~~--------------~~~d~~~~~--~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
......... ..+...... .... ......+.+++.+||+.||++|||+.|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 221110000 000000000 0000 111245788999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.45 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=191.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 478999999999999965 68999999997543 2345678999999999999999999998864 567899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC-----cEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK-----LTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
+|+|.+++..... ....+++..++.++.|+++||+||| +.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH----RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----HHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh----cccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999975421 2245899999999999999999999 445 99999999999999999999999999977
Q ss_pred CCCC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 515 APPS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 515 ~~~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
.... ...++..|+|||++. +..++.++||||||+++|||++|+.||... ...+....+...
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------~~~~~~~~i~~~ 231 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAF------------SQKELAGKIREG 231 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHH--CC-CCHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHT
T ss_pred eccccccccccCCCccccChHHhc--cCCCCchhhHHHHHHHHHHHHHCCCCCccc------------CHHHHHHHHhhc
Confidence 6543 235788999999764 457899999999999999999999999643 122222222221
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 638 (672)
. ...+ . ......+.+++.+||+.||++|||+.||++.+
T Consensus 232 ~-~~~~-------~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 232 K-FRRI-------P---YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp C-CCCC-------C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred c-cccC-------C---cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1 1110 0 11223577888899999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=336.72 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=184.6
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC---------------
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR--------------- 428 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------- 428 (672)
.+.||+|+||.||+|+. .+|+.||||++.... ....+|+++++.++||||+++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 47899999999999995 579999999986432 2234799999999999999999998543
Q ss_pred -----------------------CeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC
Q 005880 429 -----------------------EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485 (672)
Q Consensus 429 -----------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ 485 (672)
...++||||++ |+|.+.+..... ....+++..+..++.|+++||+||| +.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH----~~g 161 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIH----SLG 161 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----TTT
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCc
Confidence 34789999997 588777754211 1245999999999999999999999 889
Q ss_pred cEecCCCCCCEEeC-CCCcEEEeccCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 005880 486 LTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKC 560 (672)
Q Consensus 486 iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~ 560 (672)
|+||||||+||+++ .++.+||+|||+++..... ...+|..|+|||++.. ...++.++||||+||++|||++|+.
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-ATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-CCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999999998 6899999999999865433 4567889999997642 3458999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCChhHHHHHHHhhhc-------------cccccchhhccccCh-----HHHHHHHHHHHHhccC
Q 005880 561 PSVIDGGGAGMGCGGAVDLPRWVQSVVREEW-------------TAEVFDLELMRYKDI-----EEEMVGLLQVAMACTS 622 (672)
Q Consensus 561 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~d~~~~~~~~~-----~~~~~~l~~li~~Cl~ 622 (672)
||.... ..+.+..+..... ..+..-+... .... ......+.+++.+||+
T Consensus 241 pf~~~~------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 241 LFSGET------------SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp SSCCSS------------HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred CCCCCC------------hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC-cccHHhhCCCCCCHHHHHHHHHHcc
Confidence 997532 1111222111000 0000000000 0000 1123457888999999
Q ss_pred CCCCCCCCHHHHHH
Q 005880 623 ASPDQRPNMSHVVK 636 (672)
Q Consensus 623 ~dP~~RPt~~evl~ 636 (672)
.||++|||+.|+++
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.51 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=190.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----CeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-----EEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.+++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 478999999999999955 688999999975432 2447789999999999999999999999755 368999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
++ |+|.+++... .+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 112 ~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 112 ME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 96 5999999753 3899999999999999999999 78999999999999999999999999999976543
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
. ...+|..|+|||++. .+..++.++|||||||++|||++|+.||...... +....+......
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~i~~~~~~ 250 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---------DQLNHILGILGS 250 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHH-TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---------GHHHHHHHHHCS
T ss_pred CCCccccccccccccCCCCCHHhc-CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---------HHHHHHHHHhCC
Confidence 2 346789999999754 2456899999999999999999999999654211 111111110000
Q ss_pred hc---cccccch-------hhc--cccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 590 EW---TAEVFDL-------ELM--RYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 590 ~~---~~~~~d~-------~~~--~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .....+. ... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000 000 00000 011245788999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=326.89 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=187.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEc------CCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFA------REEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e 436 (672)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|++++.++ +||||+++++++.. .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 47899999999999996 4789999999875432 467889999999998 79999999999987 467899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 108 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp CCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred cCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 999999999998643 245899999999999999999999 7899999999999999999999999999997654
Q ss_pred CC-----CCCCCCcccCCCccccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 PS-----TVPRSNGYRAPELSSSD---GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~-----~~~~t~~y~aPE~l~~~---~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.. ...++..|+|||++... +..++.++|||||||++|||++|+.||.... ..........
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~ 248 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------------PMRALFLIPR 248 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------------HHHHHHHHHH
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------------HHHHHHHhhc
Confidence 32 34578899999987522 4568899999999999999999999996321 1111111111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .... . ... ....+.+++.+||..||++|||+.|+++
T Consensus 249 ~~-~~~~-----~-~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 NP-APRL-----K-SKK---WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SC-CCCC-----S-CSC---SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cc-cccC-----C-ccc---cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 0000 0 011 1235778888999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=357.55 Aligned_cols=232 Identities=25% Similarity=0.324 Sum_probs=191.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|.+++..+ +||+|+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 478999999999999965 68899999997532 22456788899999988 79999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC--
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-- 517 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 517 (672)
+|+|.++++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++++||+|||+++....
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999998543 4899999999999999999999 78999999999999999999999999999985432
Q ss_pred ---CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 ---STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ---~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... +..+....+.....
T Consensus 497 ~~~~~~~GT~~Y~APE~l~--~~~~~~~~DvwSlGvilyelltG~~Pf~~~------------~~~~~~~~i~~~~~--- 559 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------------DEDELFQSIMEHNV--- 559 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHT--CCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHSSCC---
T ss_pred cccccccCCCcccCHhhhc--CCCCCccceEechHHHHHHHHcCCCCCCCC------------CHHHHHHHHHhCCC---
Confidence 2567899999999774 567899999999999999999999999643 22333333333221
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
..... ...++.+++.+||+.||++||++
T Consensus 560 ------~~p~~---~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ------AYPKS---MSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ------CCCTT---SCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ------CCCcc---CCHHHHHHHHHHccCCHHHCCCC
Confidence 11111 22356788889999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=327.14 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=184.7
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEE--------------cCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYF--------------ARE 429 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------------~~~ 429 (672)
.+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++. +..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 478999999999999976 48999999998666556788999999999999999999999874 346
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-CCCcEEEec
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSD 508 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D 508 (672)
..++||||++ |+|.+++.. .++++..++.++.|+++||+||| +.+|+||||||+||+++ +++.+||+|
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 7899999997 699999964 24899999999999999999999 78999999999999997 567999999
Q ss_pred cCCCccCCCC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChh
Q 005880 509 FGLSIFAPPS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP 580 (672)
Q Consensus 509 fG~a~~~~~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~ 580 (672)
||+++..... ...++..|+|||++.. ...++.++|||||||++|||++|+.||.... ..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~ 231 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH------------EL 231 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHC-TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------------HH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcC-cccCCchhhhHhHHHHHHHHHhCCCCCCCCC------------HH
Confidence 9999866432 2334778999997643 3578999999999999999999999996432 11
Q ss_pred HHHHHHHhhhcc-------------ccccchhhccc-cCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 581 RWVQSVVREEWT-------------AEVFDLELMRY-KDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 581 ~~~~~~~~~~~~-------------~~~~d~~~~~~-~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+........... ........... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 122222111000 00000000000 000 012346788899999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.73 Aligned_cols=258 Identities=18% Similarity=0.228 Sum_probs=183.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 435 (672)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 478999999999999954 68999999997532 234567889999999999999999999997654 679999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||++ |+|.+++.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 9996 578888852 3889999999999999999999 789999999999999999999999999999866
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC---CCCCCCChhHH------
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM---GCGGAVDLPRW------ 582 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~---~~~~~~~~~~~------ 582 (672)
... ...+|..|+|||++. +..++.++|||||||++|||++|+.||......+.. ....+...+++
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccccCCceecCCccCHHHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 543 456788999999765 457899999999999999999999999653210000 00000000000
Q ss_pred -HHHHHhhhccc------cccchhhcccc--ChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 583 -VQSVVREEWTA------EVFDLELMRYK--DIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 583 -~~~~~~~~~~~------~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.......... ..+........ ........+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000 00000000000 01123457889999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=355.12 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=197.7
Q ss_pred HHhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 363 ASAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.+.||+|+||.||+|.... +..||||+++.... ...+.+.+|+.++++++||||+++++++. ++..++||||
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 345789999999999999642 56799999875432 34578999999999999999999999984 5678999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 472 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 472 CTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp CTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999997543 35899999999999999999999 78999999999999999999999999999987654
Q ss_pred C------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 518 S------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 518 ~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
. ...++..|+|||++. +..++.++|||||||++|||++ |+.||... ...+....+....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~------------~~~~~~~~i~~~~ 609 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGV------------KNNDVIGRIENGE 609 (656)
T ss_dssp ----------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHHTC
T ss_pred CcceeccCCCCCcceeCHHHhc--CCCCCchhhHHHHHHHHHHHHHcCCCCCCCC------------CHHHHHHHHHcCC
Confidence 3 233467899999764 4578999999999999999997 99999643 2222222222221
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. . .. ......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 610 ~~-~-------~~---~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 RL-P-------MP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CC-C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-C-------CC---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 10 0 01 1123457788899999999999999999999998853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=336.12 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=183.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe------EEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE------KLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e~~ 438 (672)
.+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 478999999999999987777799998854322 22479999999999999999999975443 78999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-CCCcEEEeccCCCccCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~ 517 (672)
+++.+........ ....+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||+++....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 7754433332111 1245899999999999999999999 78999999999999999 799999999999976543
Q ss_pred C----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc--
Q 005880 518 S----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW-- 591 (672)
Q Consensus 518 ~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 591 (672)
. ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+.+..+.+...
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------------~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQPLFPGES------------GIDQLVEIIKVLGTP 261 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHCCC
T ss_pred CCCCcccccCcCccCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHHhCCC
Confidence 2 4567889999997643 3468999999999999999999999997532 1111111111000
Q ss_pred --------cccccchhhc--cccChH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 --------TAEVFDLELM--RYKDIE-----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 --------~~~~~d~~~~--~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.......... ...... ....++.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000 000000 12246788999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.98 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=193.1
Q ss_pred hcccCcCCeEEEEEEEE--cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCC------ceeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL--DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHP------NLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+++++.++|+ +++++++++.+.+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 47899999999999986 368999999997543 2456788999998888655 59999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC----------------
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---------------- 500 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---------------- 500 (672)
|+ +++|.+++.... ..++++..+..++.|+++||+||| +.+|+||||||+||+++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99 889999997653 246899999999999999999999 789999999999999987
Q ss_pred ---CCcEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q 005880 501 ---TGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575 (672)
Q Consensus 501 ---~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~ 575 (672)
++.+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------- 240 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL--ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK------- 240 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT--TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-------
T ss_pred cccCCCceEeeCcccccCccccccccCCccccChHHhh--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-------
Confidence 668999999999866543 456789999999765 557899999999999999999999999643211
Q ss_pred CCChhHHHHHHHhh--------hccccccc---------------------hhhccccChHHHHHHHHHHHHhccCCCCC
Q 005880 576 AVDLPRWVQSVVRE--------EWTAEVFD---------------------LELMRYKDIEEEMVGLLQVAMACTSASPD 626 (672)
Q Consensus 576 ~~~~~~~~~~~~~~--------~~~~~~~d---------------------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~ 626 (672)
.....+...... ......+. +..............+.+++.+||+.||+
T Consensus 241 --~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 241 --EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp --HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred --HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 011111111000 00000000 00000011123456788999999999999
Q ss_pred CCCCHHHHHH
Q 005880 627 QRPNMSHVVK 636 (672)
Q Consensus 627 ~RPt~~evl~ 636 (672)
+|||+.|+++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.65 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=187.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeE------EEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEK------LLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~lv~ 435 (672)
.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 478999999999999954 689999999975432 2357889999999999999999999999876654 9999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||++ |+|.+++. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 127 e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 127 PFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp ECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred cccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 9996 68888874 23899999999999999999999 789999999999999999999999999999866
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc-
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT- 592 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 592 (672)
... ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+.+.........
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~------------~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------------YLDQLTQILKVTGVP 261 (371)
T ss_dssp -----CTTCCCTTSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCCC
T ss_pred ccCcCCcccCccccCHHHhcC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------------hHHHHHHHHHHhCCC
Confidence 543 4567899999997643 2578999999999999999999999996432 22222222111000
Q ss_pred -----ccccc-------hhhc--cccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 -----AEVFD-------LELM--RYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 -----~~~~d-------~~~~--~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....+ .... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 0000 00000 012346788999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=338.30 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=186.1
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC----C--eEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR----E--EKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +|+.||||++.... +.+.+|++++++++||||+++++++... + ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 478999999999999975 68999999986432 2335799999999999999999998642 1 35689999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-CcEEEeccCCCccCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-GNARVSDFGLSIFAP 516 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~ 516 (672)
+++ +|.+.+..... ....+++..+..++.|+++||+||| +.+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 975 67666543111 1245999999999999999999999 8899999999999999965 578999999998654
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh--
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE-- 590 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 590 (672)
.. ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+.+..+.+..
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~------------~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDS------------GVDQLVEIIKVLGT 275 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHCS
T ss_pred cCCCceeeeeCCCcCCHHHHcC-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHHhCC
Confidence 32 4567899999997642 3468999999999999999999999997532 111222221110
Q ss_pred -----------ccccccchhhccccCh-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHh
Q 005880 591 -----------WTAEVFDLELMRYKDI-----EEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELR 642 (672)
Q Consensus 591 -----------~~~~~~d~~~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~ 642 (672)
...+..-+.... ... .....++.+|+.+||..||++|||+.|+++ .++++.
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCHHHHHhhChhhhhhccCccCC-CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 000000000000 000 011246788899999999999999999985 344443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=339.98 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=183.2
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+++..++||||++ |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 3679999999998777778999999998643 345678999999876 89999999999999999999999995 699
Q ss_pred hHHhhcCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC-------------CcEEEec
Q 005880 444 FWLLHGNRGPGR--TPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT-------------GNARVSD 508 (672)
Q Consensus 444 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~-------------~~~kl~D 508 (672)
.+++........ ....+..++.++.|++.||+||| +.+|+||||||+||+++.+ +.+||+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999986542111 11234456789999999999999 7899999999999999754 4899999
Q ss_pred cCCCccCCCC---------CCCCCCcccCCCcccc-----CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005880 509 FGLSIFAPPS---------TVPRSNGYRAPELSSS-----DGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGC 573 (672)
Q Consensus 509 fG~a~~~~~~---------~~~~t~~y~aPE~l~~-----~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~ 573 (672)
||+++..... ...+|.+|+|||++.. ....++.++|||||||++|||+| |+.||......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----- 246 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----- 246 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----
Confidence 9999876542 2457899999998754 12578999999999999999999 99999643110
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 574 GGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ........ +..............++.+++.+||+.||++|||+.||++
T Consensus 247 -----~----~~i~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 -----E----SNIIRGIF-----SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----H----HHHHHTCC-----CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H----HHHhcCCC-----CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 11111111 1000011112344567889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.17 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=192.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 478999999999999975 68999999986432 235678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC---CcEEEeccCCCccCCCC
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT---GNARVSDFGLSIFAPPS 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~ 518 (672)
+|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.+ +.+||+|||++......
T Consensus 107 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 107 ELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999988654 24899999999999999999999 7899999999999999754 47999999999866543
Q ss_pred C----CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 T----VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ~----~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
. ..++..|+|||++. ..++.++||||||+++|+|++|+.||... ...+.............
T Consensus 178 ~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------~~~~~~~~~~~~~~~~~ 242 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGK------------NEYDILKRVETGKYAFD 242 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHT---TCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCCCCC
T ss_pred CccccccCcccccChHHhc---CCCCCchhhHhHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHcCCCCCC
Confidence 2 23466799999764 34889999999999999999999999643 22222222222211100
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... .....+.+++.+||+.||++|||+.|+++
T Consensus 243 -----~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 -----LPQWR---TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----SGGGT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----chhhh---hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00011 12235778888999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=326.55 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=172.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHH-HHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHME-VLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|... +|+.||||+++.... ....++..|+. +++.++||||+++++++.+++..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 478999999999999975 689999999975432 23445666665 77888999999999999999999999999975
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC-CcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL-KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
+|.+++..........+++..+..++.|+++||.||| +. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 8887776321111245899999999999999999999 66 9999999999999999999999999999766543
Q ss_pred --CCCCCCcccCCCcccc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 --TVPRSNGYRAPELSSS--DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~--~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...++..|+|||++.. .+..++.++|||||||++|||++|+.||....... +.+...... .
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~----~ 246 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----------DQLTQVVKG----D 246 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCS----C
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----------HHHHHHhcC----C
Confidence 3367889999997632 24568899999999999999999999997532110 000000000 0
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+.... .........+.+++.+||+.||++|||+.|+++
T Consensus 247 --~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 --PPQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 000112235788888999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=330.08 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=190.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-----------CCceeeeEEEEEcCC---
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-----------HPNLVGLKAYYFARE--- 429 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~--- 429 (672)
.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 47899999999999995 568999999997533 24567889999988876 899999999998654
Q ss_pred -eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCC-CcEecCCCCCCEEeC------CC
Q 005880 430 -EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL-KLTHGNIKSTNVLLD------KT 501 (672)
Q Consensus 430 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-~iiH~Dlkp~NIll~------~~ 501 (672)
..++||||+ +++|.+++..... ..+++..+..++.|++.||+||| +. +|+||||||+||+++ ..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCCcCc
Confidence 788999999 8999999986532 35899999999999999999999 66 999999999999994 44
Q ss_pred CcEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCh
Q 005880 502 GNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579 (672)
Q Consensus 502 ~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~ 579 (672)
+.+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||+||+.||....... ....
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~ 246 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFLFEPDEGHS------YTKD 246 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH--TCCCCTHHHHHHHHHHHHHHHHSSCCC---------------CH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHh--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc------cCCh
Confidence 57999999999766543 456789999999765 4578999999999999999999999997543221 0001
Q ss_pred hHHHHHHHhh------------hccccccch------------------hhccccChHHHHHHHHHHHHhccCCCCCCCC
Q 005880 580 PRWVQSVVRE------------EWTAEVFDL------------------ELMRYKDIEEEMVGLLQVAMACTSASPDQRP 629 (672)
Q Consensus 580 ~~~~~~~~~~------------~~~~~~~d~------------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 629 (672)
...+...... ......++. ..............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111111110 000000000 0001112245567888999999999999999
Q ss_pred CHHHHHH
Q 005880 630 NMSHVVK 636 (672)
Q Consensus 630 t~~evl~ 636 (672)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.53 Aligned_cols=241 Identities=20% Similarity=0.278 Sum_probs=187.9
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCC--CCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLR--HPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++...+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 47899999999999998889999999986433 234578899999999997 5999999999999999999999 568
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||++++ +.+||+|||+++.....
T Consensus 112 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 112 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 8999999854 35899999999999999999999 789999999999999964 89999999999866432
Q ss_pred -----CCCCCCcccCCCccccC---------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 519 -----TVPRSNGYRAPELSSSD---------GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~---------~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
...++..|+|||++... ...++.++||||||+++|||++|+.||.... .......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~~~~~~ 250 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----------NQISKLH 250 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----------SHHHHHH
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----------HHHHHHH
Confidence 34578899999986531 2468889999999999999999999996421 1112222
Q ss_pred HHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
........... ... ....+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~-------~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIIDPNHEIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHCTTSCCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcccccCC-------ccc---chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 22221111000 011 12357788889999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.69 Aligned_cols=240 Identities=21% Similarity=0.375 Sum_probs=184.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc-------------CCe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-------------REE 430 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------~~~ 430 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|++++++++||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 478999999999999964 78999999996432 345788999999999999999999998865 356
Q ss_pred EEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 431 KLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 431 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
.++||||+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 789999999999999998543 45788999999999999999999 7899999999999999999999999999
Q ss_pred CCccCCCC-------------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005880 511 LSIFAPPS-------------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM 571 (672)
Q Consensus 511 ~a~~~~~~-------------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~ 571 (672)
+++..... ...++..|+|||++.. ...++.++|||||||++|||++ ||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~---p~~~~------ 231 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY---PFSTG------ 231 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTS-CSCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccC-CCCCcchhhHHHHHHHHHHHHh---ccCCc------
Confidence 99765421 3346788999997642 2468899999999999999998 54311
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+............ ..+.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~~~~~~---~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 -----MERVNILKKLRSVS---IEFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HHHHHHHHHHHSTT---CCCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hhHHHHHHhccccc---cccCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111222111110 0001110 1122345778888999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=323.35 Aligned_cols=248 Identities=19% Similarity=0.241 Sum_probs=189.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----CeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-----EEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 478999999999999965 689999999975432 3456788999999999999999999998754 678999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
++ |+|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 96 6999998753 4899999999999999999999 78999999999999999999999999999976543
Q ss_pred C---------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHH
Q 005880 518 S---------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRW 582 (672)
Q Consensus 518 ~---------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 582 (672)
. ...+|..|+|||++.. +..++.++|||||||++|||++|+.||.... ..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~ 231 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRD------------YRHQ 231 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHS-CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHH
T ss_pred ccccccCccccccchhhccccccccCCeeecc-CCCccchhhHHHHHHHHHHHHhCCCCCCCCC------------cHHH
Confidence 2 2356888999997642 3678999999999999999999999997432 1111
Q ss_pred HHHHHhhh---c----cccccch-------hhc--cccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 583 VQSVVREE---W----TAEVFDL-------ELM--RYKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 583 ~~~~~~~~---~----~~~~~d~-------~~~--~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
........ . ....... ... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111000 0 0000000 000 00000 112345778899999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.65 Aligned_cols=242 Identities=21% Similarity=0.299 Sum_probs=165.5
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc----CCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA----REEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|+.. +|+.||||++.... ....+....+..++||||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 56999999999999966 68999999986532 122222234566799999999999876 4457899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAPP 517 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~ 517 (672)
|+|.+++.... ...+++.+++.++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 111 g~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 111 GELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 99999998653 246999999999999999999999 789999999999999986 45599999999976654
Q ss_pred C---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 S---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
. ...+|..|+|||++. +..++.++|||||||++|||++|+.||........ ............
T Consensus 184 ~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~---- 249 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--------SPGMKRRIRLGQ---- 249 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------
T ss_pred cccccCCCCcCccChhhhC--CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--------hhhHHHhhhccc----
Confidence 3 455688999999763 56788999999999999999999999975432210 000000000000
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 -~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 -YGFP---NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCC---TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cccC---chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0000122345778888999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=327.54 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=177.0
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe-------EEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE-------KLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~e 436 (672)
.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++.+..++||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 367999999999999964 689999999865432 33456778888888999999999999976433 789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCccC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSIFA 515 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~ 515 (672)
|+++ +|.+.+.... .....+++..+..++.|++.||.|||.. +.+|+||||||+||+++. ++.+||+|||+++..
T Consensus 107 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp CCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred cccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 9976 5544443211 0124589999999999999999999943 679999999999999997 899999999999876
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh-
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE- 590 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 590 (672)
... ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ....+..+.+..
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~------------~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN------------SAGQLHEIVRVLG 249 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHC
T ss_pred CCCCCcccccCCcceeCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC------------hHHHHHHHHHHcC
Confidence 543 4457889999997642 3458999999999999999999999997532 111222221110
Q ss_pred --------------ccccccchhhcc-----ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 --------------WTAEVFDLELMR-----YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 --------------~~~~~~d~~~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
......+..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000 0000113456888999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=326.29 Aligned_cols=192 Identities=27% Similarity=0.345 Sum_probs=163.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CC-----ceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HP-----NLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +++.||||+++... ....++..|++++..++ |+ +|+++++++...+..++||||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 478999999999999965 68899999997542 24567788888888774 44 499999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC--CCCcEEEeccCCCccC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD--KTGNARVSDFGLSIFA 515 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DfG~a~~~ 515 (672)
++ |+|.+++..... ..+++..+..++.|++.||.|||.. +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus 138 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp CC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred CC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 95 599999986542 3589999999999999999999932 46899999999999995 4788999999999876
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
... ...+|..|+|||++. +..++.++|||||||++|||+||+.||...
T Consensus 212 ~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 212 GQRIYQYIQSRFYRSPEVLL--GMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCCCCSSCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccCCccccChHHHc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543 566889999999765 457899999999999999999999999743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.10 Aligned_cols=247 Identities=20% Similarity=0.273 Sum_probs=187.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe------EEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE------KLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 435 (672)
.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 467999999999999964 689999999975432 235678999999999999999999999987653 49999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||++ |+|.+++. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 109 e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 109 PFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp ECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred cccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9996 68888774 23899999999999999999999 789999999999999999999999999999866
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc--
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW-- 591 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 591 (672)
... ...+|..|+|||++.. ...++.++|||||||++|||++|+.||.... ..+.+..+.....
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------------YLDQLTQILKVTGVP 243 (353)
T ss_dssp -------CCSBCCSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC------------HHHHHHHHHHHHCBC
T ss_pred CCCccccccCcCcCCHHHHhC-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHHHHhCCC
Confidence 543 4567899999997653 2578899999999999999999999997432 1222222211100
Q ss_pred ----cccccch------------hhccc-cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 ----TAEVFDL------------ELMRY-KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ----~~~~~d~------------~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...+.+. ..... .........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 00000 000122346788889999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.47 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=188.2
Q ss_pred hcccCcCCeEEEEEEEE--cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCC---CCCceeeeEEEEE-----cCCeEE
Q 005880 365 AEMLGKGGFGTAYKAVL--DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRL---RHPNLVGLKAYYF-----AREEKL 432 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~~~~ 432 (672)
.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|+++++.+ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 47899999999999997 4688999999864322 1233566777776655 8999999999987 456788
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
+||||++ |+|.+++..... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 96 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 9999997 699999976542 34899999999999999999999 789999999999999999999999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+..... ...++..|+|||++. +..++.++|||||||++|||++|+.||.... .......+..
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~i~~ 233 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------------DVDQLGKILD 233 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHH
T ss_pred ccccCCCCccccccccceeCHHHHh--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------------HHHHHHHHHH
Confidence 766532 456788999999764 4578999999999999999999999996432 1122222221
Q ss_pred hh-------ccccccchh--hc------cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EE-------WTAEVFDLE--LM------RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~-------~~~~~~d~~--~~------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. +......+. .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10 000000000 00 00000112345678888999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.05 Aligned_cols=243 Identities=22% Similarity=0.297 Sum_probs=173.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc-h-HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG-G-KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+++..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 478999999999999975 6899999999754332 2 234445556788889999999999999999999999999 55
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCC-CCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS-LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
.+..+..... ..+++..+..++.|+++||+||| + ++|+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH----HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH----hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 6655554322 35899999999999999999999 5 38999999999999999999999999999765433
Q ss_pred --CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 --TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...++..|+|||++.. ....++.++|||||||++|||++|+.||.... ...+...........
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~~~~~~~~~~~~- 248 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----------TDFEVLTKVLQEEPP- 248 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----------SHHHHHHHHHHSCCC-
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----------ccHHHHHHHhccCCC-
Confidence 3457889999998742 24568899999999999999999999996421 122222222222110
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....... ....+.+++.+||+.||.+|||+.|+++
T Consensus 249 -----~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 -----LLPGHMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----CCCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CCCccCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000011 1235778888999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.29 Aligned_cols=190 Identities=25% Similarity=0.386 Sum_probs=162.4
Q ss_pred hcccCcCCeEEEEEEEEc-CC-cEEEEEEcccCCcchHHHHHHHHHHHcCCCCCc------eeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD-DG-SVVAVKRLKDASIGGKREFEQHMEVLGRLRHPN------LVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|... ++ +.||||+++... ...+.+.+|++++++++|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 478999999999999964 34 789999997543 34567888999998887665 9999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEe------------------
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLL------------------ 498 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll------------------ 498 (672)
|+ +++|.+++.... ...+++.+++.++.|+++||+||| +.+|+||||||+||++
T Consensus 103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 99 667777776543 245899999999999999999999 8899999999999999
Q ss_pred -CCCCcEEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 499 -DKTGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 499 -~~~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
+.++.+||+|||+++..... ...+|..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL--ELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCcEEEeecCccccccccccCCcCCCcccCCeeee--cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999865543 556899999999765 567899999999999999999999999743
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.82 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=180.2
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||++ |+|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 368999999997665566799999999975433 2356899999998 79999999999999999999999995 699
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-----CCcEEEeccCCCccCCCC
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-----TGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~~~~ 518 (672)
.+++.... ....+..++.++.|+++||+||| +.+|+||||||+||+++. ...+||+|||+++.....
T Consensus 105 ~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 105 QEYVEQKD----FAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp HHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred HHHHHhcC----CCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99998654 22444566789999999999999 789999999999999953 336889999999765432
Q ss_pred --------CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 519 --------TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 519 --------~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...+|.+|+|||++... ...++.++|||||||++|||+| |+.||..... ........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------------~~~~~~~~ 243 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------------RQANILLG 243 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------------HHHHHHTT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------------HHHHHHhc
Confidence 35689999999987532 3567889999999999999999 8999853211 11111111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ....... ........+.+++.+||+.||++|||+.||++
T Consensus 244 ~-~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 A-CSLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-CCCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-CCccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 0000000 01123345678889999999999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.15 Aligned_cols=232 Identities=21% Similarity=0.378 Sum_probs=188.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc------hHHHHHHHHHHHcCCC--CCceeeeEEEEEcCCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG------GKREFEQHMEVLGRLR--HPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|++++++++ |+||+++++++...+..++|+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 47899999999999995 46899999998754321 2346778999999996 599999999999999999999
Q ss_pred eecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-CCCcEEEeccCCCc
Q 005880 436 EYMPN-GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSI 513 (672)
Q Consensus 436 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a~ 513 (672)
||+.+ ++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++ +++.+||+|||+++
T Consensus 128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99976 8999999753 35899999999999999999999 78999999999999999 78999999999998
Q ss_pred cCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 514 FAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 514 ~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
..... ...+|..|+|||++.. ....+.++|||||||++|||++|+.||.... ......
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------------~~~~~~ 259 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------EIIRGQ 259 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------------HHHHCC
T ss_pred ccccccccCCCCCccCCChHHhcc-CCCCCccchHHhHHHHHHHHHHCCCCCCChh------------------hhhccc
Confidence 76543 4567889999997643 2344789999999999999999999995320 111110
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. .+ ... ...++.+++.+||+.||++|||+.|+++
T Consensus 260 ~---~~------~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V---FF------RQR---VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C---CC------SSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c---cc------ccc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 011 1235778888999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.56 Aligned_cols=232 Identities=24% Similarity=0.400 Sum_probs=182.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc------hHHHHHHHHHHHcCC----CCCceeeeEEEEEcCCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG------GKREFEQHMEVLGRL----RHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~l 433 (672)
.+.||+|+||.||+|+. .+|+.||||+++..... ....+.+|++++.++ +||||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 47899999999999985 46899999999754321 223456788888887 89999999999999999999
Q ss_pred EEee-cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC-CCCcEEEeccCC
Q 005880 434 VSEY-MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGL 511 (672)
Q Consensus 434 v~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~ 511 (672)
|+|| +++++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||+
T Consensus 116 v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999 7899999999754 34899999999999999999999 77999999999999999 889999999999
Q ss_pred CccCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 512 SIFAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 512 a~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
++..... ...++..|+|||++.. ....+.++||||||+++|||++|+.||.... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------------~~~~ 247 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------------------EILE 247 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------------HHHH
T ss_pred hhhcccCcccccCCcccccCceeeec-CCCCCccchHHHHHHHHHHHHHCCCCCCChH------------------HHhh
Confidence 9876543 4567889999997653 2334569999999999999999999995310 1111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~---------~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 AE---------LHFPA---HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TC---------CCCCT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hc---------cCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 00011 12235778888999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.42 Aligned_cols=228 Identities=15% Similarity=0.126 Sum_probs=178.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++.+++||||+++++++.+++..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 368999999999999975 4899999999764332 347889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 520 (672)
++|.+++... ....++.+|+.|+++||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999532 355678899999999999999 7899999999999999999999998554
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhh
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLEL 600 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 600 (672)
|++ .++.++|||||||++|||+||+.||............. .........+..
T Consensus 175 -----~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------------~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 -----TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------------RDTAGQPIEPAD 227 (286)
T ss_dssp -----CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------------BCTTSCBCCHHH
T ss_pred -----ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------------HHhccCCCChhh
Confidence 333 35789999999999999999999998654322110000 000000000000
Q ss_pred ccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 601 MRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 601 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
.... ....+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 228 -~~~~---~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 228 -IDRD---IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -HCTT---SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -cccC---CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0011 22357788889999999999 9999999999987644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=343.37 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=197.4
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEc------CCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA------REEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~ 435 (672)
+.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 457899999999999996 46899999998754 33346779999999999999999999998765 66779999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc---EEEeccCCC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN---ARVSDFGLS 512 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a 512 (672)
||+++|+|.+++..... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 99999999999986432 235889999999999999999999 789999999999999997665 999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...... ...++..|+|||++. +..++.++|||||||++|||++|+.||..... ...|......
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----------~~~~~~~i~~ 238 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLE--QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----------PVQWHGKVRE 238 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSC--CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----------HHHSSTTCC-
T ss_pred cccccccccccccCCcccCChHHhc--cCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----------hhhhhhhhhc
Confidence 876543 346788999999764 56789999999999999999999999964311 0111000000
Q ss_pred hhc----cccc------cchhhccc-cChHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHHHhcCC
Q 005880 589 EEW----TAEV------FDLELMRY-KDIEEEMVGLLQVAMACTSASPDQRPNMSH-----VVKLIEELRGVE 645 (672)
Q Consensus 589 ~~~----~~~~------~d~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-----vl~~L~~i~~~~ 645 (672)
... .... +....... .........+.+++.+||..||++|||+.| ..+.++.+....
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000 0000 00000000 011224456888999999999999999988 567777776544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=342.06 Aligned_cols=232 Identities=18% Similarity=0.247 Sum_probs=186.4
Q ss_pred hcccCcCCeEEEEEEEEc--CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCe-----EEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLD--DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREE-----KLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e 436 (672)
.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++.+++||||+++++++...+. .|+|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 478999999999999975 68999999987543 2345678999999999999999999999987665 699999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++++|.+++.. .+++.+++.|+.|+++||.||| +.+|+||||||+||+++.+ .+||+|||+++...
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 9999999887753 4899999999999999999999 7899999999999999986 89999999998766
Q ss_pred CC-CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 517 PS-TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 517 ~~-~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
.. ...+|.+|+|||++.. .++.++|||||||++|||++|..||....... +.
T Consensus 233 ~~~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~--------------- 285 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LP--------------- 285 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CC---------------
T ss_pred cCCccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc---------cc---------------
Confidence 54 5568999999998753 34889999999999999999998875421110 00
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-NMSHVVKLIEEL 641 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i 641 (672)
...........+.+++.+||+.||++|| +++++.+.|..+
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000011224577899999999999999 567777777665
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=307.58 Aligned_cols=223 Identities=20% Similarity=0.287 Sum_probs=172.6
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHH-cCCCCCceeeeEEEEEc----CCeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVL-GRLRHPNLVGLKAYYFA----REEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 439 (672)
+.||+|+||.||+|.. .+++.||||+++. ...+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999996 4689999999863 34677888887 55699999999999876 667899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAP 516 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 516 (672)
+|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 999999998653 246999999999999999999999 789999999999999998 7889999999886432
Q ss_pred CCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 517 PSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 517 ~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
+..++.++|||||||++|||++|+.||......... ........
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------------~~~~~~~~ 215 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------------PGMKTRIR 215 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------------CCSCCSSC
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------------HHHHHHHh
Confidence 245788999999999999999999999654321100 00000000
Q ss_pred chhhccc-cChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRY-KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
....... .........+.+++.+||+.||++|||+.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 000112345788888999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=313.01 Aligned_cols=237 Identities=15% Similarity=0.148 Sum_probs=173.0
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCC-Cce---------ee----------
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRH-PNL---------VG---------- 420 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni---------v~---------- 420 (672)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+.++..++| +|. +.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 36899999999999994 5799999999873322 235789999999999987 221 11
Q ss_pred --eEEEEEc-----CCeEEEEEeecCCCChhHHhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 005880 421 --LKAYYFA-----REEKLLVSEYMPNGSLFWLLHGNR--GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNI 491 (672)
Q Consensus 421 --l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dl 491 (672)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.|+.|+++||+||| +.+|+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~iiHrDi 237 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYL 237 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEECSCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCc
Confidence 1111111 12356777766 789999885210 011345889999999999999999999 789999999
Q ss_pred CCCCEEeCCCCcEEEeccCCCccCCCC--CCCCCCcccCCCcccc--------CCCCCCchhHHHHHHHHHHHHHhCCCC
Q 005880 492 KSTNVLLDKTGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSS--------DGRKQSQKSDVYSFGVLLLELLTGKCP 561 (672)
Q Consensus 492 kp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~--------~~~~~~~~~DV~S~Gvvl~el~tg~~P 561 (672)
||+|||++.++.+||+|||+++..... ...+ ..|+|||++.. .+..++.++|||||||++|||+||+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998766543 4556 89999997731 344678899999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 562 SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
|....... ............. ..+.+++.+||+.||++|||+.|++
T Consensus 317 f~~~~~~~-------------------------~~~~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 317 NTDDAALG-------------------------GSEWIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp CCTTGGGS-------------------------CSGGGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCcchhh-------------------------hHHHHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHH
Confidence 96542211 0001111111122 3577888899999999999977664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.42 Aligned_cols=240 Identities=17% Similarity=0.184 Sum_probs=181.1
Q ss_pred HHHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCC--------cchHHHHHHHHHHHcCCC---------CCceeeeEEE
Q 005880 362 RASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS--------IGGKREFEQHMEVLGRLR---------HPNLVGLKAY 424 (672)
Q Consensus 362 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l~~~ 424 (672)
+...+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|++++++++ ||||+++.+.
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 45678999999999999998 68999999997542 123477889999888875 8888888776
Q ss_pred EE------------------------------cCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 005880 425 YF------------------------------AREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474 (672)
Q Consensus 425 ~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L 474 (672)
+. +.+..++||||+++|++.+.+.. ..+++..+..|+.|+++||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHH
Confidence 53 26789999999999977666643 2489999999999999999
Q ss_pred HHHHhhCCCCCcEecCCCCCCEEeCCCC--------------------cEEEeccCCCccCCCCCCCCCCcccCCCcccc
Q 005880 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTG--------------------NARVSDFGLSIFAPPSTVPRSNGYRAPELSSS 534 (672)
Q Consensus 475 ~~LH~~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~t~~y~aPE~l~~ 534 (672)
+|||+ +.+|+||||||+|||++.++ .+||+|||+++........+|..|+|||++..
T Consensus 175 ~~lH~---~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 175 AVAEA---SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHH---HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCC
T ss_pred HHHHH---hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcC
Confidence 99992 25899999999999999887 89999999999887777789999999998753
Q ss_pred CCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHH
Q 005880 535 DGRKQSQKSDVYSFGVL-LLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGL 613 (672)
Q Consensus 535 ~~~~~~~~~DV~S~Gvv-l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 613 (672)
.. +.++||||+|++ .+++++|..||.. ..|.......-........ ............++
T Consensus 252 --~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 252 --DG-DYQFDIYRLMKKENNNRWGEYHPYSN---------------VLWLHYLTDKMLKQMTFKT-KCNTPAMKQIKRKI 312 (336)
T ss_dssp --CS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------------HHHHHHHHHHHHHTCCCSS-CCCSHHHHHHHHHH
T ss_pred --CC-ccceehhhhhCCCCcccccccCCCcc---------------hhhhhHHHHhhhhhhccCc-ccchhhhhhcCHHH
Confidence 23 889999998777 7889999999742 1222211111000000000 00011123455678
Q ss_pred HHHHHhccCCCCCCCCCHHHHH
Q 005880 614 LQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 614 ~~li~~Cl~~dP~~RPt~~evl 635 (672)
.+++.+||+.| |+.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 89999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-30 Score=286.36 Aligned_cols=181 Identities=20% Similarity=0.102 Sum_probs=128.6
Q ss_pred ccCcCCeEEEEEEE-EcCCcEEEEEEcccCC----------cchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEE
Q 005880 367 MLGKGGFGTAYKAV-LDDGSVVAVKRLKDAS----------IGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 434 (672)
..+.|++|.++.++ .--|+.+|||++.... ....++|.+|+++|+++ .|+||+++++++.++++.|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777665 3458999999986432 12346799999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||++|++|.++|.... +++.. +|+.||++||+|+| +.|||||||||+|||++++|++||+|||+|+.
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence 99999999999998543 45554 58899999999999 88999999999999999999999999999987
Q ss_pred CCCC-----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005880 515 APPS-----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPS 562 (672)
Q Consensus 515 ~~~~-----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~ 562 (672)
.... ...||++|+|||++. +.+..++|+||+|++++++.++..++
T Consensus 389 ~~~~~~~~~t~vGTp~YmAPE~l~---g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDCSWPTNLVQSFFVFVNELFA---ENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC---CCSHHHHHHHHHHHHHHC--------------------CCCCTTHHHH
T ss_pred CCCCCccccCceechhhccHHHhC---CCCCCcccccccccchhhhccccchh
Confidence 6543 234688999999874 35677899999999988876665443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=254.78 Aligned_cols=183 Identities=32% Similarity=0.617 Sum_probs=167.1
Q ss_pred CCChhhHHHHHHHHhcCCCCCCCCCCCCCCCCCc--ccceEEcC----CcEeEEEecCCCccc--CCC-CCCCCCCccEE
Q 005880 23 ASTSPDLNALLDFKASSDEANKLTTWNSTSDPCS--WTGVSCLQ----NRVSHLVLENLQLSG--SLQ-PLTSLTQLRVL 93 (672)
Q Consensus 23 ~~~~~d~~all~~k~~~~~~~~~~~W~~~~~~c~--w~gv~c~~----~~v~~L~l~~~~l~~--~~~-~l~~l~~L~~L 93 (672)
.|.+.|.+||++||+++.++..+.+|+.+++||. |.||+|.. ++|+.|+|++|++++ .++ .+.++++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 4778999999999999876667889988889998 99999975 799999999999998 444 49999999999
Q ss_pred Eccc-CCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcc
Q 005880 94 SLKY-NRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171 (672)
Q Consensus 94 ~L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 171 (672)
+|++ |.+++.+| .|+++++|++|+|++|++++.+|..|+++++|++|+|++|+|++.+|..+.++++|++|+|++|++
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 9995 99999888 899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCC--CCCCC-CCCeeeccCCcCCCCCCCcCCCCC
Q 005880 172 SGPIT--GLDLR-NLQDFNVSGNHLSGQIPKSLSGFP 205 (672)
Q Consensus 172 ~~~~~--~~~l~-~L~~l~l~~N~l~g~~p~~l~~~~ 205 (672)
++.++ +..+. +|+.|++++|+++|.+|..+..+.
T Consensus 162 ~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred cCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 97444 56777 999999999999999998887654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=265.14 Aligned_cols=188 Identities=29% Similarity=0.399 Sum_probs=151.4
Q ss_pred cCCChhhHHHHHHHHhcCCCCCCCCCCCCCCCCCcccceEEcCCcEeEEEecCCCcccC---C-----------------
Q 005880 22 KASTSPDLNALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGS---L----------------- 81 (672)
Q Consensus 22 ~~~~~~d~~all~~k~~~~~~~~~~~W~~~~~~c~w~gv~c~~~~v~~L~l~~~~l~~~---~----------------- 81 (672)
+++...|++||++||+++.++..+++|+.++|||+|.||+|+.++|+.|+|+++.+.|. +
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~ 86 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSN 86 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTT
T ss_pred ccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcC
Confidence 34456799999999999865557899998889999999999999999999999999885 2
Q ss_pred -------CCCCCCCCccEEEcccCCCCCCCC---CCCcccccceeeccccccCCCCChhh-hccCCCCeEecccCccccc
Q 005880 82 -------QPLTSLTQLRVLSLKYNRFTGPVP---SLSNLTALKLLFLSHNNFNGEFPDSV-SSLFRLYRLDLSFNNFSGQ 150 (672)
Q Consensus 82 -------~~l~~l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~ 150 (672)
+.++.+++|++|+|++|.++|.+| .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++.
T Consensus 87 ~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 166 (768)
T 3rgz_A 87 SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166 (768)
T ss_dssp SCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEE
T ss_pred CCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCc
Confidence 246777888888888888887655 57788888888888888887777766 7788888888888888877
Q ss_pred cchh---hcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 151 IPLT---VNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 151 ~p~~---~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
.|.. +.++++|++|++++|++++..+...+++|++|++++|++++.+|. +..++.+...
T Consensus 167 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L 228 (768)
T 3rgz_A 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHL 228 (768)
T ss_dssp THHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEE
T ss_pred CChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEE
Confidence 7766 778888888888888888877777888888888888888887776 6666655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-26 Score=255.29 Aligned_cols=178 Identities=14% Similarity=0.153 Sum_probs=143.8
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--------hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--------GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
.+.||+|+||.||+|... ++.+|+|+....... ..+++.+|++++++++||||+++..++...++.++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 468999999999999544 788899886432211 13458999999999999999977777777888899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.. +..++.|+++||+||| +.+|+||||||+|||+++ ++||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999864 4589999999999999 789999999999999999 99999999998876
Q ss_pred CC------------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005880 517 PS------------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPS 562 (672)
Q Consensus 517 ~~------------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~ 562 (672)
.. ...+|+.|+|||++......|+.++|+|+..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 53 34578899999987643345778889999999999988888776
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=247.27 Aligned_cols=183 Identities=25% Similarity=0.335 Sum_probs=154.1
Q ss_pred hhhHHHHHHHHhcCCCCCC---------CCCCCCCCCCCcc---cceEEcC-CcEeEEEecCCCcccCCCC-CCCCCCcc
Q 005880 26 SPDLNALLDFKASSDEANK---------LTTWNSTSDPCSW---TGVSCLQ-NRVSHLVLENLQLSGSLQP-LTSLTQLR 91 (672)
Q Consensus 26 ~~d~~all~~k~~~~~~~~---------~~~W~~~~~~c~w---~gv~c~~-~~v~~L~l~~~~l~~~~~~-l~~l~~L~ 91 (672)
..|+.||.+|+++++++++ ..+|+.+++||.| .||+|+. ++|+.|+|+++++.|.+++ +++|++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~ 108 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccce
Confidence 4699999999998765432 2479988999999 9999965 7999999999999997766 99999999
Q ss_pred EEEcccCC------------------------------------------------------------------------
Q 005880 92 VLSLKYNR------------------------------------------------------------------------ 99 (672)
Q Consensus 92 ~L~L~~N~------------------------------------------------------------------------ 99 (672)
+|+|++|.
T Consensus 109 ~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l 188 (636)
T 4eco_A 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188 (636)
T ss_dssp EEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTT
T ss_pred EEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhh
Confidence 99999884
Q ss_pred ------CCCCCC-CCCcccccceeeccccccCCC-----------------CChhhh--ccCCCCeEecccCccccccch
Q 005880 100 ------FTGPVP-SLSNLTALKLLFLSHNNFNGE-----------------FPDSVS--SLFRLYRLDLSFNNFSGQIPL 153 (672)
Q Consensus 100 ------l~~~~p-~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p~ 153 (672)
++| +| .++++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+|.
T Consensus 189 ~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp TCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred ccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH
Confidence 345 45 788999999999999999986 999998 999999999999999999999
Q ss_pred hhcCCCccCeeeccCCc-ccC-cCC--CCCC------CCCCeeeccCCcCCCCCCC--cCCCCCCcccc
Q 005880 154 TVNHLTHLLTLKLEANR-FSG-PIT--GLDL------RNLQDFNVSGNHLSGQIPK--SLSGFPDSAFT 210 (672)
Q Consensus 154 ~~~~l~~L~~L~l~~N~-l~~-~~~--~~~l------~~L~~l~l~~N~l~g~~p~--~l~~~~~~~~~ 210 (672)
.|+++++|++|+|++|+ ++| .+| ...+ ++|++|++++|+++ .+|. .+..++.+...
T Consensus 268 ~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L 335 (636)
T 4eco_A 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGML 335 (636)
T ss_dssp TTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEE
T ss_pred HHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEE
Confidence 99999999999999998 887 454 2333 78888899888888 8888 77766655443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-24 Score=251.41 Aligned_cols=181 Identities=24% Similarity=0.328 Sum_probs=155.3
Q ss_pred ChhhHHHHHHHHhcCCCCCCCCCCCCCC-----CC--Ccc------------cceEEcC-CcEeEEEecCCCcccCCCC-
Q 005880 25 TSPDLNALLDFKASSDEANKLTTWNSTS-----DP--CSW------------TGVSCLQ-NRVSHLVLENLQLSGSLQP- 83 (672)
Q Consensus 25 ~~~d~~all~~k~~~~~~~~~~~W~~~~-----~~--c~w------------~gv~c~~-~~v~~L~l~~~~l~~~~~~- 83 (672)
...|+.||++||++++++ +|+.++ +| |+| .||+|+. ++|+.|+|++|+|.|.+++
T Consensus 267 ~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred chHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 346999999999998754 786543 66 999 9999984 8999999999999998776
Q ss_pred CCCCCCccEEEc-ccCCCCCC-----------------------------------------------------------
Q 005880 84 LTSLTQLRVLSL-KYNRFTGP----------------------------------------------------------- 103 (672)
Q Consensus 84 l~~l~~L~~L~L-~~N~l~~~----------------------------------------------------------- 103 (672)
|++|++|++|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77765443
Q ss_pred -----------------CC-CCCcccccceeeccccccCC-----------------CCChhhh--ccCCCCeEecccCc
Q 005880 104 -----------------VP-SLSNLTALKLLFLSHNNFNG-----------------EFPDSVS--SLFRLYRLDLSFNN 146 (672)
Q Consensus 104 -----------------~p-~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~L~l~~N~ 146 (672)
+| .|++|++|++|+|++|+|+| .+|..++ ++++|+.|+|++|+
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 55 78899999999999999998 3999988 99999999999999
Q ss_pred cccccchhhcCCCccCeeeccCCc-ccC-cCC---------CCCCCCCCeeeccCCcCCCCCCC--cCCCCCCcccc
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANR-FSG-PIT---------GLDLRNLQDFNVSGNHLSGQIPK--SLSGFPDSAFT 210 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~-l~~-~~~---------~~~l~~L~~l~l~~N~l~g~~p~--~l~~~~~~~~~ 210 (672)
+.|.+|..|+++++|+.|+|++|+ |+| .+| ...+++|+.|+|++|+|+ .+|. .+..++.+..+
T Consensus 503 l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L 578 (876)
T 4ecn_A 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL 578 (876)
T ss_dssp TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEE
T ss_pred CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEE
Confidence 999999999999999999999998 887 443 235669999999999999 8998 77777665543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-24 Score=221.22 Aligned_cols=186 Identities=19% Similarity=0.280 Sum_probs=155.7
Q ss_pred CCChhhHHHHHHHHhcC--CCCCCCCCC----CCCCCCCcccceEEc----------CCcEeEEEecCCCcccCCCCCCC
Q 005880 23 ASTSPDLNALLDFKASS--DEANKLTTW----NSTSDPCSWTGVSCL----------QNRVSHLVLENLQLSGSLQPLTS 86 (672)
Q Consensus 23 ~~~~~d~~all~~k~~~--~~~~~~~~W----~~~~~~c~w~gv~c~----------~~~v~~L~l~~~~l~~~~~~l~~ 86 (672)
++..+|++||++||+++ +..+.+.+| ....++|.|.|+.|. ..+|+.|+|++|+++..++.++.
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~~lp~~l~~ 102 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFR 102 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCSSCCSCGGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCchhcChhhhh
Confidence 34567999999999975 334456789 445689999999995 27999999999999977777889
Q ss_pred CCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcC---------
Q 005880 87 LTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNH--------- 157 (672)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~--------- 157 (672)
+++|++|+|++|.++..+..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..++.
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 99999999999999944448999999999999999999 89999999999999999999999899988765
Q ss_pred CCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 158 LTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 158 l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
+++|++|+|++|+|+. +..+..+++|++|+|++|+++ .+|..+..++.+...
T Consensus 182 l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234 (328)
T ss_dssp STTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred CCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence 8999999999999985 333567889999999999998 477667666655443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=233.91 Aligned_cols=161 Identities=34% Similarity=0.570 Sum_probs=137.9
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-C------------------------------------
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-S------------------------------------ 106 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~------------------------------------ 106 (672)
.+++.|+|++|.++|.++. ++.+++|++|+|++|.++|.+| .
T Consensus 514 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (768)
T 3rgz_A 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593 (768)
T ss_dssp TTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred CCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence 4567777777777765554 7777888888888887776655 1
Q ss_pred ----------------------------------CCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccc
Q 005880 107 ----------------------------------LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP 152 (672)
Q Consensus 107 ----------------------------------~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 152 (672)
++++++|++|||++|+++|.+|..|+++++|+.|+|++|+|+|.+|
T Consensus 594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip 673 (768)
T 3rgz_A 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673 (768)
T ss_dssp EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence 3345778999999999999999999999999999999999999999
Q ss_pred hhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCC--cCCCCCCccccccccccCCCCccccc
Q 005880 153 LTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPK--SLSGFPDSAFTQNAALCGSPMQACKT 225 (672)
Q Consensus 153 ~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~--~l~~~~~~~~~~n~~lc~~~~~~c~~ 225 (672)
..|+++++|+.|+|++|+++|.+| +..+++|++|||++|+|+|.||. .+..++...|.||+++||.|+..|..
T Consensus 674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 999999999999999999999665 56899999999999999999996 47788899999999999999988864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.8e-23 Score=207.96 Aligned_cols=139 Identities=16% Similarity=0.187 Sum_probs=113.2
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc------------------chHHHHHHHHHHHcCCCCCceeeeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI------------------GGKREFEQHMEVLGRLRHPNLVGLKAYYF 426 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 426 (672)
.+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999997799999999964321 13457899999999999 4 56665443
Q ss_pred cCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEE
Q 005880 427 AREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV 506 (672)
Q Consensus 427 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl 506 (672)
.+..++||||+++|+|.+ +.. .....++.|+++||.||| +.+|+||||||+|||++ ++.+||
T Consensus 172 -~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 172 -WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp -EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-TTEEEE
T ss_pred -ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-CCcEEE
Confidence 356699999999999988 421 124479999999999999 78999999999999999 999999
Q ss_pred eccCCCccCCCCCCCCCCcccCCCcc
Q 005880 507 SDFGLSIFAPPSTVPRSNGYRAPELS 532 (672)
Q Consensus 507 ~DfG~a~~~~~~~~~~t~~y~aPE~l 532 (672)
+|||+++.. ..|.|||++
T Consensus 234 ~DFG~a~~~--------~~~~a~e~l 251 (282)
T 1zar_A 234 IDFPQSVEV--------GEEGWREIL 251 (282)
T ss_dssp CCCTTCEET--------TSTTHHHHH
T ss_pred EECCCCeEC--------CCCCHHHHH
Confidence 999998743 457889865
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.9e-21 Score=191.04 Aligned_cols=152 Identities=24% Similarity=0.245 Sum_probs=134.0
Q ss_pred cEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
.++.|+|++|++++..+. +.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 578999999999988775 8999999999999999999888 68999999999999999997777888999999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCC---CccccccccccC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQNAALCG 217 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~n~~lc~ 217 (672)
+|+|++..+..|.++++|++|+|++|+|++..+ +..+++|++|+|++|+|++..|..+..++ .+.+.+|++.|.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999997666678999999999999999998443 56899999999999999976666666554 555668998887
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-20 Score=184.42 Aligned_cols=152 Identities=24% Similarity=0.256 Sum_probs=99.6
Q ss_pred CCCCCCCCCCCcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCccc
Q 005880 45 LTTWNSTSDPCSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLT 111 (672)
Q Consensus 45 ~~~W~~~~~~c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~ 111 (672)
..-|..+.+.|+|++|.|.. .+++.|+|++|.+++..+. |..+++|++|+|++|+|++.++ .|.+++
T Consensus 9 ~~~~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 88 (229)
T 3e6j_A 9 HSAACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT 88 (229)
T ss_dssp --CCCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhccCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCC
Confidence 34465667889999999964 2456677777777666444 6666677777777777765555 456667
Q ss_pred ccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeecc
Q 005880 112 ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVS 189 (672)
Q Consensus 112 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~ 189 (672)
+|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.. .+..+++|+.|+|+
T Consensus 89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 167 (229)
T 3e6j_A 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167 (229)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 7777777777776544555666667777777777776 66666666777777777777766622 23456666777777
Q ss_pred CCcCCCCC
Q 005880 190 GNHLSGQI 197 (672)
Q Consensus 190 ~N~l~g~~ 197 (672)
+|.+.+..
T Consensus 168 ~N~~~c~c 175 (229)
T 3e6j_A 168 GNPWDCEC 175 (229)
T ss_dssp TSCBCTTB
T ss_pred CCCccCCc
Confidence 77666443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.6e-20 Score=185.08 Aligned_cols=129 Identities=24% Similarity=0.280 Sum_probs=79.9
Q ss_pred cEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
.++.|+|++|++++.++. |.++++|++|+|++|+++..++ .|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 467788888888776653 7777778888887777776655 35667777777777777765444555666666666666
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~ 194 (672)
+|+|++..|..|.++++|++|+|++|+|++..+ +..+++|+.|+|++|+++
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 170 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK 170 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc
Confidence 666665555555555555555555555554221 233444444444444444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-21 Score=196.52 Aligned_cols=158 Identities=31% Similarity=0.513 Sum_probs=110.7
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCccc-ccceeeccccccCCCCChhhhccCCCCeEe
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLT-ALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 141 (672)
.+++.|+|++|.+++.++. +..+++|++|+|++|++++.+| .+++++ +|++|+|++|+++|.+|..++.+. |+.|+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence 5788899999998876655 8888888899999888887777 777777 888888888888877777777765 77777
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccC-----------------------cCC--CCCCCCCCeeeccCCcCCCC
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-----------------------PIT--GLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-----------------------~~~--~~~l~~L~~l~l~~N~l~g~ 196 (672)
|++|++++.+|..+.++++|+.|+|++|++++ .++ +..+++|+.|+|++|+|+|.
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 283 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence 77777776666666666666666666555554 222 23455666666666666666
Q ss_pred CCCc--CCCCCCccccccccccCCCCccc
Q 005880 197 IPKS--LSGFPDSAFTQNAALCGSPMQAC 223 (672)
Q Consensus 197 ~p~~--l~~~~~~~~~~n~~lc~~~~~~c 223 (672)
+|.. +.++..+.+.+|+++||.|++.|
T Consensus 284 ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 284 IPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred CCCCccccccChHHhcCCCCccCCCCCCC
Confidence 6643 33344555667888888777666
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-19 Score=174.09 Aligned_cols=145 Identities=26% Similarity=0.252 Sum_probs=116.0
Q ss_pred CCcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccc
Q 005880 54 PCSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH 120 (672)
Q Consensus 54 ~c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 120 (672)
.|.|.+|.|.. .+++.|+|++|++++.++. +..+++|++|+|++|++++.++ .|.++++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 37899999964 3578888888888877665 7788888888888888887766 468888888888888
Q ss_pred cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCC
Q 005880 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 121 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p 198 (672)
|++++..+..|.++++|++|+|++|+|++..+..+.++++|+.|+|++|+|++..+ +..+++|+.|++++|.+.+..|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 88886555667888888888888888886666667888888888888888887333 4568888888888888876554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-19 Score=173.45 Aligned_cols=151 Identities=17% Similarity=0.167 Sum_probs=115.8
Q ss_pred EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC--CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
.+++++|.++..+..+. ..+++|+|++|+|++.+| .|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 92 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92 (220)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCc
Confidence 56777777777665553 346788888888888755 47788888888888888887666788888888888888888
Q ss_pred cccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCCCCC---ccccccccccCCCCc
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPD---SAFTQNAALCGSPMQ 221 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~---~~~~~n~~lc~~~~~ 221 (672)
|++..|..|.++++|++|+|++|+|++. ..+..+++|+.|+|++|+|++..|..|..++. +.+.+|++.|++++.
T Consensus 93 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~ 172 (220)
T 2v70_A 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLA 172 (220)
T ss_dssp CCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGH
T ss_pred cCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchH
Confidence 8877777788888888888888888873 33567888888888888888777777665554 455678888887654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.7e-20 Score=194.84 Aligned_cols=166 Identities=23% Similarity=0.204 Sum_probs=143.0
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CC-CCCCccEEEcccCCCCCCCC-CCCcccccceeeccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LT-SLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH 120 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~-~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 120 (672)
|.|.-|.|.. ..++.|+|++|+|++.++. +. .+++|++|+|++|+|++..+ .|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6788899964 3578999999999998877 65 99999999999999999887 799999999999999
Q ss_pred cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC-cCCC----CCCCCCCeeeccCCcCCC
Q 005880 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITG----LDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 121 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~----~~l~~L~~l~l~~N~l~g 195 (672)
|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++ +... ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99997777789999999999999999998889999999999999999999998 3322 468999999999999994
Q ss_pred CCCCcCCCCC-----CccccccccccCCCC
Q 005880 196 QIPKSLSGFP-----DSAFTQNAALCGSPM 220 (672)
Q Consensus 196 ~~p~~l~~~~-----~~~~~~n~~lc~~~~ 220 (672)
..+..+..++ .+.+.+|++.|+|.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 3335565554 467789999999865
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=176.16 Aligned_cols=144 Identities=19% Similarity=0.197 Sum_probs=131.1
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC--CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH 120 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 120 (672)
|.|..+.|.. ..++.|+|++|+|++.++. |..+++|++|+|++|+|++.++ .|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 7899999964 2577999999999998654 8899999999999999999888 899999999999999
Q ss_pred cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCC
Q 005880 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 121 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++.. .+..+++|+.|+|++|.+++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999888888999999999999999999888999999999999999999999943 46689999999999999997665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7.7e-19 Score=177.83 Aligned_cols=155 Identities=24% Similarity=0.232 Sum_probs=136.5
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..+++.|+|++|.+++. +.+..+++|++|+|++|.+++.++ .++++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 62 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp CTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 36899999999999974 579999999999999999999888 5899999999999999999777778999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCC---ccccccccccC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPD---SAFTQNAALCG 217 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~---~~~~~n~~lc~ 217 (672)
++|+|++..|..+.++++|+.|+|++|++++..+ +..+++|+.|++++|++++..|..+..++. +.+.+|++.|.
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 9999997777778999999999999999998444 568999999999999999877766665554 55668998888
Q ss_pred CC
Q 005880 218 SP 219 (672)
Q Consensus 218 ~~ 219 (672)
+|
T Consensus 221 ~~ 222 (272)
T 3rfs_A 221 CP 222 (272)
T ss_dssp TT
T ss_pred Cc
Confidence 76
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-19 Score=173.30 Aligned_cols=150 Identities=22% Similarity=0.208 Sum_probs=113.5
Q ss_pred EEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 70 LVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 70 L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
+++++++++.++..+. ++|+.|+|++|+|++.++ .|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 16 v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 93 (220)
T 2v9t_B 16 VDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93 (220)
T ss_dssp EECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred EEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence 4445566666655554 678888888888888777 7888888888888888888777888888888888888888888
Q ss_pred cccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCCcCCCCC---CccccccccccCCCCc
Q 005880 149 GQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQNAALCGSPMQ 221 (672)
Q Consensus 149 g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~n~~lc~~~~~ 221 (672)
+..+..|.++++|++|+|++|+|++.. .+..+++|+.|+|++|+|++..+..|..++ .+.+.+|++.|+|.+.
T Consensus 94 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~ 171 (220)
T 2v9t_B 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLK 171 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccH
Confidence 544455788888888888888888733 356788888888888888866655565544 4456678888887654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-19 Score=172.77 Aligned_cols=142 Identities=22% Similarity=0.246 Sum_probs=128.0
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeecccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHN 121 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N 121 (672)
|.|..|.|.. ..++.|+|++|+|++.++. |..+++|++|+|++|+|++..| .|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 7899999964 3689999999999998875 9999999999999999999877 8999999999999999
Q ss_pred ccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCC
Q 005880 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 122 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~ 196 (672)
+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+ +..+++|+.|+|++|.+...
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9995555567899999999999999998889999999999999999999998443 56799999999999999753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=177.53 Aligned_cols=155 Identities=24% Similarity=0.211 Sum_probs=126.5
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.|++... ...+++|++|+|++|+|+..+..+.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 55 ~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp TTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred CCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 567777777777776544 3778888888888888886655788999999999999999977678899999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCC---CccccccccccCCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQNAALCGSP 219 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~n~~lc~~~ 219 (672)
|+|++..+..|..+++|+.|+|++|+|++..+ +..+++|+.|+|++|+|+ .+|..+..++ .+.+.+|++.|+|.
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 99997666678899999999999999987333 356899999999999999 8887766544 45567899999886
Q ss_pred Cc
Q 005880 220 MQ 221 (672)
Q Consensus 220 ~~ 221 (672)
+.
T Consensus 213 ~~ 214 (290)
T 1p9a_G 213 IL 214 (290)
T ss_dssp GH
T ss_pred cH
Confidence 43
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-18 Score=169.73 Aligned_cols=158 Identities=21% Similarity=0.231 Sum_probs=134.0
Q ss_pred ccceEEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccC
Q 005880 57 WTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLF 135 (672)
Q Consensus 57 w~gv~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 135 (672)
|..-.|.. +.+++++++++..+..+. ++|++|+|++|+|++..| .|.++++|++|+|++|+|++..+..|.+++
T Consensus 14 ~~~~~Cs~---~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 88 (229)
T 3e6j_A 14 PSQCSCSG---TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT 88 (229)
T ss_dssp CTTCEEET---TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCCCEEeC---CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCC
Confidence 45566764 468999999998887664 899999999999999887 799999999999999999855556789999
Q ss_pred CCCeEecccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCC---Cccccc
Q 005880 136 RLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQ 211 (672)
Q Consensus 136 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~ 211 (672)
+|+.|+|++|+|++..+..|..+++|++|+|++|+|+. +.....+++|+.|+|++|+|++..+..|..++ .+.+.+
T Consensus 89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 168 (229)
T 3e6j_A 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168 (229)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 99999999999997767778999999999999999997 44567899999999999999965555565554 455668
Q ss_pred cccccCCC
Q 005880 212 NAALCGSP 219 (672)
Q Consensus 212 n~~lc~~~ 219 (672)
|++.|+++
T Consensus 169 N~~~c~c~ 176 (229)
T 3e6j_A 169 NPWDCECR 176 (229)
T ss_dssp SCBCTTBG
T ss_pred CCccCCcc
Confidence 99999875
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-19 Score=170.65 Aligned_cols=151 Identities=20% Similarity=0.206 Sum_probs=123.2
Q ss_pred eEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCC--CCcccccceeeccccccCCCCChhhhccCCCCeEecccC
Q 005880 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPS--LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145 (672)
Q Consensus 68 ~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 145 (672)
+.|++++|+|+..+..+.. +|++|+|++|+|++.++. ++++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4567788888777665544 899999999999998873 899999999999999999888999999999999999999
Q ss_pred ccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCC-cCCC-CCCccccccccccCCCC
Q 005880 146 NFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPK-SLSG-FPDSAFTQNAALCGSPM 220 (672)
Q Consensus 146 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~-~l~~-~~~~~~~~n~~lc~~~~ 220 (672)
+|++..|..|.++++|++|+|++|+|++.. .+..+++|++|+|++|.|++..+- ++.. +....+.++...|+.|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 999888888999999999999999999843 356899999999999999987762 1111 11223345556676653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=166.49 Aligned_cols=163 Identities=23% Similarity=0.290 Sum_probs=124.1
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC--CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH 120 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 120 (672)
|.|+.+.|.. .+++.|+|++|.+++.++. +..+++|++|+|++|+|++.+| .|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6788888864 2678899999999888765 7889999999999999998877 788999999999999
Q ss_pred cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCC-CCCeeeccCCcCCCCCCC
Q 005880 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR-NLQDFNVSGNHLSGQIPK 199 (672)
Q Consensus 121 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~-~L~~l~l~~N~l~g~~p~ 199 (672)
|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|++|+|++|.+++..+...+. .|+...+..+......|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 9999888888889999999999999999888888999999999999999988754322111 122234445556666677
Q ss_pred cCCCCCCccccccccccC
Q 005880 200 SLSGFPDSAFTQNAALCG 217 (672)
Q Consensus 200 ~l~~~~~~~~~~n~~lc~ 217 (672)
.+...+-..+..+...|.
T Consensus 168 ~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 168 KVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTTSBGGGSCTTTCCCC
T ss_pred HHcCCChhhCcHhhcCcC
Confidence 666655444444444444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-18 Score=173.47 Aligned_cols=156 Identities=23% Similarity=0.212 Sum_probs=98.5
Q ss_pred CcEeEEEecCCC-cccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEe
Q 005880 65 NRVSHLVLENLQ-LSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~-l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 141 (672)
.+++.|+|++|. +....+. +..+++|++|+|++|++++.+| .+.++++|++|+|++|++++..+..|+++++|++|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 456666666665 5554332 6666666666666666666655 566667777777777777654445566677777777
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCCC---CCcccccccccc
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGF---PDSAFTQNAALC 216 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~---~~~~~~~n~~lc 216 (672)
|++|+|++..+..+.++++|+.|+|++|++++. ..+..+++|+.|++++|++++..|..+..+ ..+.+.+|++.|
T Consensus 160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 777777644444566677777777777777663 234566777777777777775444434433 344556777777
Q ss_pred CCCC
Q 005880 217 GSPM 220 (672)
Q Consensus 217 ~~~~ 220 (672)
++++
T Consensus 240 ~~~~ 243 (285)
T 1ozn_A 240 DCRA 243 (285)
T ss_dssp SGGG
T ss_pred CCCc
Confidence 7664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=173.67 Aligned_cols=134 Identities=16% Similarity=0.147 Sum_probs=103.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcE--EEEEEcccCCcc------------------------hHHHHHHHHHHHcCCCCCc
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSV--VAVKRLKDASIG------------------------GKREFEQHMEVLGRLRHPN 417 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~n 417 (672)
.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 36799999999999997 68989 999987543111 1236889999999998876
Q ss_pred e--eeeEEEEEcCCeEEEEEeecCC-C----ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 005880 418 L--VGLKAYYFAREEKLLVSEYMPN-G----SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGN 490 (672)
Q Consensus 418 i--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~D 490 (672)
+ ..++++ +..++||||+.+ | +|.++... .++..+..++.|+++||.|||. +.+|+|||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~---~~givHrD 196 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ---EAELVHAD 196 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH---TSCEECSS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH---HCCEEeCC
Confidence 4 334432 356899999942 4 66665432 2244577899999999999993 36899999
Q ss_pred CCCCCEEeCCCCcEEEeccCCCccC
Q 005880 491 IKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 491 lkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.8e-18 Score=184.49 Aligned_cols=156 Identities=20% Similarity=0.129 Sum_probs=93.8
Q ss_pred cEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
+++.|+|++|++++..+. |.++++|++|+|++|+|++..| .|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 577788888887776544 6666666666666666666554 55556666666666665553333334444444444444
Q ss_pred cCccc-----------------------------------------------------------------------cccc
Q 005880 144 FNNFS-----------------------------------------------------------------------GQIP 152 (672)
Q Consensus 144 ~N~l~-----------------------------------------------------------------------g~~p 152 (672)
+|+|+ +..|
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 235 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRP 235 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECG
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCc
Confidence 44444 3333
Q ss_pred hhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCCC---CCccccccccccCCCCc
Q 005880 153 LTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGF---PDSAFTQNAALCGSPMQ 221 (672)
Q Consensus 153 ~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~---~~~~~~~n~~lc~~~~~ 221 (672)
..|.++++|+.|+|++|++++. ..+..+++|+.|+|++|+|++..+..+..+ ..+.+.+|++.|+|.+.
T Consensus 236 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309 (452)
T ss_dssp GGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred ccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence 4444444555555555555441 223467788888888888885555555444 45566789999998754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-18 Score=176.05 Aligned_cols=158 Identities=26% Similarity=0.291 Sum_probs=133.1
Q ss_pred CCcEeEEEecCCCcccCCC--CCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCC-CCChhhhccCCCCe
Q 005880 64 QNRVSHLVLENLQLSGSLQ--PLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNG-EFPDSVSSLFRLYR 139 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~--~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~ 139 (672)
..+++.|+|++|.+++..+ .+..+++|++|+|++|.+++.++ .+.++++|++|+|++|.+++ .+|..+.++++|++
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 3577788888888887765 48888999999999999988777 68889999999999999986 58888999999999
Q ss_pred EecccCccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCCcCCCCC----Cccccccc
Q 005880 140 LDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGFP----DSAFTQNA 213 (672)
Q Consensus 140 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~----~~~~~~n~ 213 (672)
|+|++|+|++..|..+.++++|+.|+|++|++++.. .+..+++|+.|+|++|++++..|..+..++ .+.+.+|+
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~ 259 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCC
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCC
Confidence 999999999888889999999999999999998833 456789999999999999998888776654 45566899
Q ss_pred cccCCCCc
Q 005880 214 ALCGSPMQ 221 (672)
Q Consensus 214 ~lc~~~~~ 221 (672)
..|++++.
T Consensus 260 ~~~~c~~~ 267 (306)
T 2z66_A 260 FACTCEHQ 267 (306)
T ss_dssp EECSGGGH
T ss_pred eecccChH
Confidence 88887643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=178.18 Aligned_cols=145 Identities=19% Similarity=0.301 Sum_probs=122.5
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhc---------cC
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSS---------LF 135 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~---------l~ 135 (672)
.+++.|+|++|.++..+..++.+++|++|+|++|.++..++.++++++|++|+|++|++.+.+|..++. ++
T Consensus 104 ~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~ 183 (328)
T 4fcg_A 104 SHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183 (328)
T ss_dssp TTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEEST
T ss_pred CCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCC
Confidence 578899999999986655688999999999999999954448889999999999999888899988765 88
Q ss_pred CCCeEecccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 136 RLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 136 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
+|++|+|++|+|+ .+|..++++++|++|+|++|++++ +..+..+++|++|+|++|++.+.+|..+..++.+...
T Consensus 184 ~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 258 (328)
T 4fcg_A 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258 (328)
T ss_dssp TCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred CCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence 9999999999998 888889999999999999999988 3345678899999999999998999888777766544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=195.31 Aligned_cols=142 Identities=20% Similarity=0.188 Sum_probs=125.8
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..++.|+|++|+|++.++. |.++++|++|+|++|+|++++| .|.+|++|++|+|++|+|++..|..|.+|++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 4689999999999998865 9999999999999999999888 7999999999999999999766678999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-cCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPD 206 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~ 206 (672)
++|+|++..+..|+++++|++|+|++|++++ ..+ ...+++|++|++++|+|++..|..+..+..
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~ 198 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 198 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHT
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhh
Confidence 9999997666789999999999999999987 333 467999999999999999877777654443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=168.61 Aligned_cols=155 Identities=20% Similarity=0.249 Sum_probs=99.5
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCC-CCChhhhccCCCCeEe
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNG-EFPDSVSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ 141 (672)
.+++.|+|++|.+++..+. +..+++|++|+|++|.+++..+ .++++++|++|+|++|++++ .+|..++++++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 3556666666666655533 5666666666666666666555 56666666666666666664 2466666666666666
Q ss_pred cccCccccccchhhcCCCccC----eeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCC---Cccccccc
Q 005880 142 LSFNNFSGQIPLTVNHLTHLL----TLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQNA 213 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~----~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~n~ 213 (672)
|++|+|++..+..+..+++|+ .|++++|++++ +.......+|+.|+|++|+|++..+..+..++ .+.+.+|+
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 666666655555555555555 66666666665 23334455899999999999955554455444 55677899
Q ss_pred cccCCC
Q 005880 214 ALCGSP 219 (672)
Q Consensus 214 ~lc~~~ 219 (672)
+.|+|+
T Consensus 236 ~~c~c~ 241 (276)
T 2z62_A 236 WDCSCP 241 (276)
T ss_dssp BCCCTT
T ss_pred ccccCC
Confidence 999986
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.9e-18 Score=178.20 Aligned_cols=161 Identities=25% Similarity=0.267 Sum_probs=135.0
Q ss_pred CCCCCCCCcccceEEcC-------------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccc
Q 005880 48 WNSTSDPCSWTGVSCLQ-------------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTA 112 (672)
Q Consensus 48 W~~~~~~c~w~gv~c~~-------------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~ 112 (672)
|.....+|.|.|+ |.. .+++.|+|++|++++.++. +.++++|++|+|++|++++..| .|.++++
T Consensus 23 ~~~~~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (353)
T 2z80_A 23 SNQASLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101 (353)
T ss_dssp ----CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCccCCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCC
Confidence 4444578999998 642 3789999999999998774 9999999999999999999877 7999999
Q ss_pred cceeeccccccCCCCChhhhccCCCCeEecccCccccccch--hhcCCCccCeeeccCCc-ccCc--CCCCCCCCCCeee
Q 005880 113 LKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPL--TVNHLTHLLTLKLEANR-FSGP--ITGLDLRNLQDFN 187 (672)
Q Consensus 113 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~-l~~~--~~~~~l~~L~~l~ 187 (672)
|++|+|++|++++..+..|+++++|++|+|++|+++ .+|. .+.++++|++|++++|+ +++. ..+..+++|++|+
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 999999999999544455899999999999999999 5655 78999999999999995 6552 3466899999999
Q ss_pred ccCCcCCCCCCCcCCCCCCcccc
Q 005880 188 VSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 188 l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
+++|++++..|..+..++.+...
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L 203 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHL 203 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEE
T ss_pred CCCCCcCccCHHHHhccccCCee
Confidence 99999998889998888776554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.2e-17 Score=156.31 Aligned_cols=150 Identities=20% Similarity=0.183 Sum_probs=127.3
Q ss_pred eEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 68 ~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
+.+++++++++..+..+ .++|++|+|++|++++.++ .+.++++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 57889999998877655 4699999999999998877 58899999999999999996666678999999999999999
Q ss_pred cccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCC---CccccccccccCCC
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQNAALCGSP 219 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~n~~lc~~~ 219 (672)
|++..+..|.++++|++|+|++|+|++..+ +..+++|+.|++++|++++..+..+..++ .+.+.+|++.|.++
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 997666678999999999999999998443 56899999999999999965555555544 45566898888775
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-18 Score=199.77 Aligned_cols=137 Identities=26% Similarity=0.300 Sum_probs=122.2
Q ss_pred CCCCCccEEEcccCCCCCCCC--CCCcccccceeeccccccC-----CCCChhhhccCCCCeEecccCccccccchhhcC
Q 005880 85 TSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNFN-----GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNH 157 (672)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 157 (672)
..+++|++|+|++|++++..+ .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|.+
T Consensus 423 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 502 (844)
T 3j0a_A 423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502 (844)
T ss_dssp TTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSS
T ss_pred hcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccc
Confidence 478899999999999998766 4677899999999999997 455677899999999999999999888889999
Q ss_pred CCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccccccccccCCCCc
Q 005880 158 LTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQ 221 (672)
Q Consensus 158 l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~~n~~lc~~~~~ 221 (672)
+++|+.|+|++|+|++..+..-.++|+.|+|++|+|+|.+|..+.++..+.+.+|++.|+|++.
T Consensus 503 l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 503 LTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELS 566 (844)
T ss_dssp CCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSCC
T ss_pred hhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccccH
Confidence 9999999999999998554433489999999999999999999999999999999999999865
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-18 Score=188.73 Aligned_cols=156 Identities=23% Similarity=0.232 Sum_probs=138.0
Q ss_pred CCcccceEEcC-------------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeec
Q 005880 54 PCSWTGVSCLQ-------------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFL 118 (672)
Q Consensus 54 ~c~w~gv~c~~-------------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l 118 (672)
.|.|.|+ |+. .+++.|+|++|.+++..+. |.++++|++|+|++|++++.+| .|+++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899998 853 3799999999999998765 9999999999999999999887 7999999999999
Q ss_pred cccccCCCCChhhhccCCCCeEecccCcccc-ccchhhcCCCccCeeeccCCcccCcC---CCCCCCCCCeeeccCCcCC
Q 005880 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSG-QIPLTVNHLTHLLTLKLEANRFSGPI---TGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 119 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~~l~~L~~l~l~~N~l~ 194 (672)
++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|++++|++.+.+ .+..+++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998777789999999999999999996 46788999999999999999965532 4678999999999999999
Q ss_pred CCCCCcCCCCCCcccc
Q 005880 195 GQIPKSLSGFPDSAFT 210 (672)
Q Consensus 195 g~~p~~l~~~~~~~~~ 210 (672)
+.+|..+..++.+...
T Consensus 162 ~~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHL 177 (549)
T ss_dssp EECTTTTTTCSEEEEE
T ss_pred ccChhhhhccccCceE
Confidence 9999998887766543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.1e-17 Score=162.99 Aligned_cols=133 Identities=25% Similarity=0.274 Sum_probs=120.8
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++. +..+++|++|+|++|+|++.++ .|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 6899999999999998776 8999999999999999999887 6899999999999999999766667899999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQI 197 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~ 197 (672)
++|+|++..+..|.++++|++|+|++|+|++.. .+..+++|+.|+|++|++++..
T Consensus 139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 999999766668999999999999999999844 3568999999999999999763
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-17 Score=167.33 Aligned_cols=145 Identities=22% Similarity=0.208 Sum_probs=120.3
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccc-cCCCCChhhhccCCCCeEe
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNN-FNGEFPDSVSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~L~ 141 (672)
.+++.|+|++|.+++.++. |..+++|++|+|++|.+++..| .+.++++|++|+|++|. +++..|..|.++++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 4788999999999887765 8889999999999999998766 78899999999999997 7766688889999999999
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
|++|++++..|..+.++++|++|+|++|++++..+ +..+++|+.|++++|++++..+..+..++.+..
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 181 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCE
Confidence 99999997778888899999999999999987333 567889999999999998555555666655543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.5e-17 Score=164.18 Aligned_cols=134 Identities=26% Similarity=0.271 Sum_probs=122.7
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++. +..+++|++|+|++|++++.++ .++++++|++|+|++|++++..|..++++++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 6899999999999988876 7999999999999999999888 5899999999999999999777777899999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p 198 (672)
++|+|++..|..++++++|+.|+|++|++++..+ +..+++|+.|++++|.+.|..|
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999998777788999999999999999999444 5689999999999999998766
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=8.3e-17 Score=162.64 Aligned_cols=157 Identities=18% Similarity=0.190 Sum_probs=132.5
Q ss_pred CCCCcccceEEcC-CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCCh
Q 005880 52 SDPCSWTGVSCLQ-NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPD 129 (672)
Q Consensus 52 ~~~c~w~gv~c~~-~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~ 129 (672)
.++|.|.|+.|.- ..++.+++++++|+..+..+. ++|+.|+|++|++++.++ .|.++++|++|+|++|++++..+.
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~ 79 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence 4789999999964 567899999999998776664 689999999999998887 799999999999999999955555
Q ss_pred hhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCc
Q 005880 130 SVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207 (672)
Q Consensus 130 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~ 207 (672)
.|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+ +..+++|++|+|++|.|++..+..|..++.+
T Consensus 80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 159 (270)
T 2o6q_A 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSL 159 (270)
T ss_dssp TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccc
Confidence 56889999999999999997666778999999999999999998443 5689999999999999996555556666655
Q ss_pred ccc
Q 005880 208 AFT 210 (672)
Q Consensus 208 ~~~ 210 (672)
...
T Consensus 160 ~~L 162 (270)
T 2o6q_A 160 KEL 162 (270)
T ss_dssp CEE
T ss_pred cee
Confidence 443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=180.25 Aligned_cols=153 Identities=21% Similarity=0.257 Sum_probs=134.5
Q ss_pred CCCcccc--eEEcC----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC--CCCcccccceee
Q 005880 53 DPCSWTG--VSCLQ----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLF 117 (672)
Q Consensus 53 ~~c~w~g--v~c~~----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~ 117 (672)
..|.|.+ |.|.. .+++.|+|++|.+++..+. |.++++|++|+|++|.+.+.++ .|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4566666 77864 4689999999999998655 9999999999999999987664 699999999999
Q ss_pred ccccccCCCCChhhhccCCCCeEecccCccccccchh--hcCCCccCeeeccCCcccCcCC---CCCCCCCCeeeccCCc
Q 005880 118 LSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLT--VNHLTHLLTLKLEANRFSGPIT---GLDLRNLQDFNVSGNH 192 (672)
Q Consensus 118 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~~~~~---~~~l~~L~~l~l~~N~ 192 (672)
|++|++++..|..|+++++|++|+|++|++++.+|.. +.++++|++|+|++|++++..+ +..+++|++|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999877766 9999999999999999998544 5689999999999999
Q ss_pred CCCCCCCcCCCCC
Q 005880 193 LSGQIPKSLSGFP 205 (672)
Q Consensus 193 l~g~~p~~l~~~~ 205 (672)
+++..|..+..+.
T Consensus 166 l~~~~~~~l~~l~ 178 (455)
T 3v47_A 166 VKSICEEDLLNFQ 178 (455)
T ss_dssp BSCCCTTTSGGGT
T ss_pred ccccChhhhhccc
Confidence 9998888877653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.1e-17 Score=176.37 Aligned_cols=155 Identities=23% Similarity=0.268 Sum_probs=121.2
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-C-------------------------CCcccccceee
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-S-------------------------LSNLTALKLLF 117 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~-------------------------~~~l~~L~~L~ 117 (672)
.+++.|+|++|+|++.++. |..+++|++|+|++|+|++.++ . |.++++|++|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 112 ANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred ccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 5788889998888877765 7888888888888888775544 2 45566677777
Q ss_pred ccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCC
Q 005880 118 LSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 118 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g 195 (672)
|++|+++ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++
T Consensus 192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 7777777 555 377788888888888888887788899999999999999999883 345689999999999999996
Q ss_pred CCCCcCCC---CCCccccccccccCCCCc
Q 005880 196 QIPKSLSG---FPDSAFTQNAALCGSPMQ 221 (672)
Q Consensus 196 ~~p~~l~~---~~~~~~~~n~~lc~~~~~ 221 (672)
..+..+.. +..+.+.+|++.|+|.+.
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~CdC~l~ 298 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNCNCDIL 298 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred cChhHhccccCCCEEEcCCCCccCCCCch
Confidence 55555554 445667799999999764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.2e-17 Score=152.24 Aligned_cols=134 Identities=25% Similarity=0.211 Sum_probs=119.0
Q ss_pred CcEeEEEecCCCcc-cCCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLS-GSLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~-~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|+++ +.++. +..+++|++|+|++|.+++. +.+.++++|++|+|++|++++.+|..+.++++|+.|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 67999999999998 44444 79999999999999999987 88999999999999999999889999999999999999
Q ss_pred ccCcccccc-chhhcCCCccCeeeccCCcccCcCC-----CCCCCCCCeeeccCCcCCCCCCCc
Q 005880 143 SFNNFSGQI-PLTVNHLTHLLTLKLEANRFSGPIT-----GLDLRNLQDFNVSGNHLSGQIPKS 200 (672)
Q Consensus 143 ~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~l~~L~~l~l~~N~l~g~~p~~ 200 (672)
++|+|++.. +..+..+++|+.|++++|++++..+ +..+++|++|++++|.+. .+|++
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 999999532 2789999999999999999998544 568999999999999998 67754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-17 Score=185.68 Aligned_cols=169 Identities=16% Similarity=0.121 Sum_probs=137.3
Q ss_pred CCCCCCCCCCCCc----ccceEEcC------------------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCC
Q 005880 44 KLTTWNSTSDPCS----WTGVSCLQ------------------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRF 100 (672)
Q Consensus 44 ~~~~W~~~~~~c~----w~gv~c~~------------------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l 100 (672)
.+.+|.++.+||. |.++.|.. .+++.|++++|.+...++. +..+++|++|+|++|.|
T Consensus 8 ~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp ---CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCC
Confidence 4678988778874 76665531 3568899999999888776 78899999999999999
Q ss_pred CCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcC--CC
Q 005880 101 TGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TG 177 (672)
Q Consensus 101 ~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~ 177 (672)
++.+| .|+++++|++|+|++|.|++..|..|+++++|++|+|++|+|++..+..|+++++|++|+|++|+|++.. .+
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 99887 8999999999999999999888888999999999999999999555555799999999999999999844 36
Q ss_pred CCCCCCCeeeccCCcCCCCCCCcCCCCCCcccccc
Q 005880 178 LDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212 (672)
Q Consensus 178 ~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~~n 212 (672)
..+++|+.|+|++|.|++.-+..+.++..+.+.+|
T Consensus 168 ~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 168 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred hcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 78999999999999999754455555555555444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.3e-17 Score=186.73 Aligned_cols=155 Identities=22% Similarity=0.212 Sum_probs=109.8
Q ss_pred cEeEEEecCCCcccCCC--CCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCC-CCChhhhccCCCCeEe
Q 005880 66 RVSHLVLENLQLSGSLQ--PLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNG-EFPDSVSSLFRLYRLD 141 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~--~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ 141 (672)
+++.|++++|.+.+.++ .+..+++|++|+|++|.+++.+| .+.++++|++|+|++|++++ .+|..++++++|+.|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 45555555555555544 25666677777777777766665 56777777777777777776 3677777777788888
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCCCC----Cccccccccc
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP----DSAFTQNAAL 215 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~----~~~~~~n~~l 215 (672)
|++|++++..|..+.++++|++|+|++|++++. ..+..+++|+.|+|++|+|+ .+|..+..++ .+.+.+|++.
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVA 558 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcc
Confidence 888888777777777888888888888888773 34567788888888888888 6776665443 4556688888
Q ss_pred cCCCCc
Q 005880 216 CGSPMQ 221 (672)
Q Consensus 216 c~~~~~ 221 (672)
|+|++.
T Consensus 559 c~c~~~ 564 (606)
T 3vq2_A 559 CICEHQ 564 (606)
T ss_dssp CSSTTH
T ss_pred cCCccH
Confidence 888764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=5.1e-17 Score=165.89 Aligned_cols=144 Identities=24% Similarity=0.197 Sum_probs=123.2
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..++.|+|++|.+++..+. |..+++|++|+|++|.|++..+ .+.+++|++|+|++|+|+ .+|..+.++++|++|+|+
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 5789999999999987655 8999999999999999997654 488999999999999999 899999999999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
+|+|++..|..|.++++|++|+|++|+|++..+ +..+++|+.|+|++|+|++..+..+..++.+...
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 177 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence 999997777889999999999999999998433 4578999999999999994444445556655443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.1e-17 Score=151.72 Aligned_cols=132 Identities=23% Similarity=0.220 Sum_probs=111.1
Q ss_pred CcccceEEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhc
Q 005880 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSS 133 (672)
Q Consensus 55 c~w~gv~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 133 (672)
|+|++|.|.. ++++..+..+ .++|+.|+|++|++++.++ .+.++++|++|+|++|+|++..+..|.+
T Consensus 7 C~~~~l~~~~----------~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 74 (177)
T 2o6r_A 7 CSGTEIRCNS----------KGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK 74 (177)
T ss_dssp EETTEEECCS----------SCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred eCCCEEEecC----------CCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccC
Confidence 6787776654 5555555433 3689999999999998877 5799999999999999999666677899
Q ss_pred cCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCC
Q 005880 134 LFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 134 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p 198 (672)
+++|+.|+|++|+|++..+..+.++++|++|+|++|+|++..+ +..+++|++|++++|.+++..|
T Consensus 75 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 75 LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999999999999997777778999999999999999998433 3578999999999999997665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-17 Score=156.94 Aligned_cols=140 Identities=18% Similarity=0.258 Sum_probs=120.0
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|+++..+ .+..+++|++|+|++|.++. ++.+.++++|++|+|++|++++..|..++++++|++|+|++
T Consensus 44 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 44 NSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp HTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred CCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 46889999999998544 78899999999999997764 45788999999999999999988899999999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCc-ccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANR-FSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA 208 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~ 208 (672)
|++++..|..++++++|++|+|++|+ ++.......+++|+.|++++|++++ ++ .+..++.+.
T Consensus 122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~ 184 (197)
T 4ezg_A 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLN 184 (197)
T ss_dssp SBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCC
T ss_pred CccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCC
Confidence 99998889999999999999999998 6654456789999999999999985 54 455554443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=167.24 Aligned_cols=141 Identities=21% Similarity=0.191 Sum_probs=124.9
Q ss_pred CcEeEEEecCCCcccCCC-CCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQ-PLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..++.|+|++|++++..+ .+.++++|++|+|++|++++..+ .+.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 368999999999999887 49999999999999999998877 7999999999999999999888889999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-cC--CCCCCCCCCeeeccCCcCCCCCCCcCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~ 205 (672)
++|++++..+..++++++|++|+|++|++++ .+ .+..+++|++|++++|++++..+..+..++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 173 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhh
Confidence 9999997777689999999999999999987 33 356899999999999999976666655444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.3e-17 Score=173.30 Aligned_cols=168 Identities=16% Similarity=0.152 Sum_probs=134.2
Q ss_pred CCCCCCCCCCCCc----ccceEEcC------------------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCC
Q 005880 44 KLTTWNSTSDPCS----WTGVSCLQ------------------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRF 100 (672)
Q Consensus 44 ~~~~W~~~~~~c~----w~gv~c~~------------------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l 100 (672)
.+++|..+.+||. |.++.|.. .+++.|++++|.++..++. +..+++|++|+|++|.+
T Consensus 2 ~~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i 81 (390)
T 3o6n_A 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81 (390)
T ss_dssp -----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred CcCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcc
Confidence 3678987778874 55544431 4678899999999988776 78899999999999999
Q ss_pred CCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccch-hhcCCCccCeeeccCCcccCcCC--
Q 005880 101 TGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPL-TVNHLTHLLTLKLEANRFSGPIT-- 176 (672)
Q Consensus 101 ~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~~~-- 176 (672)
++.++ .|.++++|++|+|++|++++..|..|+++++|++|+|++|+|+ .+|. .|.++++|++|+|++|++++..+
T Consensus 82 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 160 (390)
T 3o6n_A 82 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160 (390)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred cccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhh
Confidence 99887 8999999999999999999888888999999999999999999 5555 46899999999999999998433
Q ss_pred CCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccccc
Q 005880 177 GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212 (672)
Q Consensus 177 ~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~~n 212 (672)
+..+++|++|++++|++++.-...+.++..+.+.+|
T Consensus 161 ~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 161 FQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp TSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred ccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 678999999999999999653345555555555444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.5e-17 Score=167.13 Aligned_cols=139 Identities=26% Similarity=0.268 Sum_probs=82.7
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCC--C-CCCcccccceeecc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPV--P-SLSNLTALKLLFLS 119 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~--p-~~~~l~~L~~L~l~ 119 (672)
|.|.+|.|.. .+++.|+|++|+++..++. |.++++|++|+|++|+++... + .+..+++|++|+|+
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 8999999964 3789999999999987766 789999999999999988431 2 33445555555555
Q ss_pred ccccCCCCChhhhccCCCCeEecccCccccccc-hhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCC
Q 005880 120 HNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIP-LTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 120 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~ 194 (672)
+|.++ .+|..+.++++|++|+|++|++++..+ ..+.++++|++|++++|++++..+ +..+++|++|++++|.++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 55555 344444444555555555554443222 234444444444444444443221 233444444444444444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-17 Score=190.72 Aligned_cols=177 Identities=20% Similarity=0.173 Sum_probs=116.8
Q ss_pred hhhHHHHHHHHhcCCCC--CCCCCCCCC-CCCCcccceEEcCCcEeEEEecCCCcccCC---------------------
Q 005880 26 SPDLNALLDFKASSDEA--NKLTTWNST-SDPCSWTGVSCLQNRVSHLVLENLQLSGSL--------------------- 81 (672)
Q Consensus 26 ~~d~~all~~k~~~~~~--~~~~~W~~~-~~~c~w~gv~c~~~~v~~L~l~~~~l~~~~--------------------- 81 (672)
..++++|+++..+.... ..-..|... +..+.|.++.++..+++.|+|.+|.+....
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~ 210 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIE 210 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCccccc
Confidence 45788999998765322 223456433 456789999888777776666554443221
Q ss_pred -------CCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchh
Q 005880 82 -------QPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLT 154 (672)
Q Consensus 82 -------~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 154 (672)
..+..+++|+.|+|++|.++.+++.+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..
T Consensus 211 n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~ 288 (727)
T 4b8c_D 211 NRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAE 288 (727)
T ss_dssp -----------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSS
T ss_pred cceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChh
Confidence 1266788999999999999966568889999999999999999 89999999999999999999999 88999
Q ss_pred hcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCC
Q 005880 155 VNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGF 204 (672)
Q Consensus 155 ~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~ 204 (672)
|++|++|++|+|++|+|+. +..+..+++|+.|+|++|.|+|.+|..+..+
T Consensus 289 ~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 289 LGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK 339 (727)
T ss_dssp GGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred hcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence 9999999999999999986 4456789999999999999999888776543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=5.7e-17 Score=183.50 Aligned_cols=141 Identities=18% Similarity=0.127 Sum_probs=127.8
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++. |.++++|++|+|++|++++..| .|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 5789999999999998874 9999999999999999999888 7999999999999999999888999999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-c--CCCCCCCCCCeeeccCCcCCCCCCCcCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-P--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP 205 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~ 205 (672)
++|++++..|..++++++|++|+|++|++++ . ..+..+++|++|++++|++++..|..+..+.
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 177 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHH
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhh
Confidence 9999997777899999999999999999986 3 3467899999999999999987777665544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=9.9e-17 Score=165.57 Aligned_cols=132 Identities=21% Similarity=0.131 Sum_probs=57.3
Q ss_pred cEeEEEecCCCcccCCCC-----CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCC--CC--hhhhccC
Q 005880 66 RVSHLVLENLQLSGSLQP-----LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGE--FP--DSVSSLF 135 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-----l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~--~p--~~~~~l~ 135 (672)
+++.|+|++|.+++..+. +..+++|++|+|++|++++.++ .++++++|++|+|++|++.+. ++ ..+++++
T Consensus 118 ~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~ 197 (310)
T 4glp_A 118 ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP 197 (310)
T ss_dssp CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence 344455555554443221 2344455555555555544444 444455555555555544421 11 1123444
Q ss_pred CCCeEecccCccccccch----hhcCCCccCeeeccCCcccCcCC--CCCC---CCCCeeeccCCcCCCCCCC
Q 005880 136 RLYRLDLSFNNFSGQIPL----TVNHLTHLLTLKLEANRFSGPIT--GLDL---RNLQDFNVSGNHLSGQIPK 199 (672)
Q Consensus 136 ~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~~--~~~l---~~L~~l~l~~N~l~g~~p~ 199 (672)
+|++|+|++|+|+ .+|. .++++++|++|+|++|+|++..+ ...+ ++|++|+|++|+|+ .+|.
T Consensus 198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~ 268 (310)
T 4glp_A 198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPK 268 (310)
T ss_dssp CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCS
T ss_pred CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhh
Confidence 4555555555444 2222 12344445555555555444211 2222 34455555555544 4443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9.4e-17 Score=146.63 Aligned_cols=125 Identities=25% Similarity=0.206 Sum_probs=107.7
Q ss_pred CcEeEEEecCCCcc-cCCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLS-GSLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~-~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|++++|.++ +.++. +..+++|++|+|++|.+++. +.++++++|++|+|++|++++.+|..+.++++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 57889999999998 44444 78999999999999999987 88899999999999999999778988888999999999
Q ss_pred ccCccccc-cchhhcCCCccCeeeccCCcccCcCC-----CCCCCCCCeeeccC
Q 005880 143 SFNNFSGQ-IPLTVNHLTHLLTLKLEANRFSGPIT-----GLDLRNLQDFNVSG 190 (672)
Q Consensus 143 ~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~l~~L~~l~l~~ 190 (672)
++|+|++. .|..+..+++|++|++++|++++..+ ...+++|+.||+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999863 44789999999999999999988554 45788999998864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=174.82 Aligned_cols=154 Identities=21% Similarity=0.190 Sum_probs=131.8
Q ss_pred cccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccc
Q 005880 56 SWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNN 122 (672)
Q Consensus 56 ~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~ 122 (672)
.|..|.|.. .+++.|+|++|++++..+. |.++++|++|+|++|.+++..| .|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 467888853 3688999999999998765 9999999999999999999877 89999999999999999
Q ss_pred cCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC--cCCCCCCCCCCeeeccCCcCCCCCCCc
Q 005880 123 FNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNLQDFNVSGNHLSGQIPKS 200 (672)
Q Consensus 123 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l~g~~p~~ 200 (672)
+++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++ +..+..+++|+.|+|++|++++..+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 995555668999999999999999998889999999999999999999988 334678999999999999999554455
Q ss_pred CCCCCCccc
Q 005880 201 LSGFPDSAF 209 (672)
Q Consensus 201 l~~~~~~~~ 209 (672)
+..++.+..
T Consensus 172 l~~l~~L~~ 180 (477)
T 2id5_A 172 LSHLHGLIV 180 (477)
T ss_dssp HTTCTTCCE
T ss_pred hcccCCCcE
Confidence 655555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=177.72 Aligned_cols=151 Identities=23% Similarity=0.363 Sum_probs=124.2
Q ss_pred CCCCCCCCCCC-----cccce-EEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeec
Q 005880 45 LTTWNSTSDPC-----SWTGV-SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFL 118 (672)
Q Consensus 45 ~~~W~~~~~~c-----~w~gv-~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l 118 (672)
+.+|..+.++| .|.|+ .|..++++.|+|++|+|++.++.+. ++|++|+|++|+|+. +| ..+++|++|+|
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~L 107 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDA 107 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEEC
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEc
Confidence 44676666788 79999 7988899999999999999766563 789999999999995 55 66899999999
Q ss_pred cccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCC
Q 005880 119 SHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 119 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
++|+|++ +|. +++ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ ++. .+++|+.|+|++|+|++ +|
T Consensus 108 s~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-lp 176 (571)
T 3cvr_A 108 CDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-LP 176 (571)
T ss_dssp CSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CC
T ss_pred cCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-cc
Confidence 9999996 888 766 99999999999996 776 68999999999999998 333 67899999999999996 88
Q ss_pred CcCC-CCCCcccccc
Q 005880 199 KSLS-GFPDSAFTQN 212 (672)
Q Consensus 199 ~~l~-~~~~~~~~~n 212 (672)
. |. ++..+.+.+|
T Consensus 177 ~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 177 E-LPESLEALDVSTN 190 (571)
T ss_dssp C-CCTTCCEEECCSS
T ss_pred h-hhCCCCEEECcCC
Confidence 7 54 3344444444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-16 Score=149.69 Aligned_cols=125 Identities=28% Similarity=0.227 Sum_probs=104.6
Q ss_pred EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
.+++++|+|+..+..+. ++|++|+|++|+|+..++.|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 14 ~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~ 91 (193)
T 2wfh_A 14 VVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91 (193)
T ss_dssp EEECTTSCCSSCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEEcCCCCCCcCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccC
Confidence 56777788887665553 5899999999999865558899999999999999999777788999999999999999999
Q ss_pred cccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCC
Q 005880 149 GQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 149 g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g 195 (672)
+..|..|.++++|+.|+|++|+|++..+ +..+++|+.|+|++|.+.+
T Consensus 92 ~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8777789999999999999999987333 4578889999888888764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-16 Score=168.64 Aligned_cols=133 Identities=21% Similarity=0.238 Sum_probs=117.1
Q ss_pred CCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeec
Q 005880 88 TQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKL 166 (672)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 166 (672)
++|++|+|++|.+++.+| .++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 689999999999999888 7999999999999999999888999999999999999999999888899999999999999
Q ss_pred cCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCC---CCCccccccccccCCCC
Q 005880 167 EANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSG---FPDSAFTQNAALCGSPM 220 (672)
Q Consensus 167 ~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~---~~~~~~~~n~~lc~~~~ 220 (672)
++|++++. ..+..+++|++|+|++|+|++..+..+.. +..+.+.+|+..|++|.
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 99999884 34678999999999999999655545554 44556678999999873
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=180.38 Aligned_cols=144 Identities=17% Similarity=0.121 Sum_probs=130.0
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..++.|+|++|.+++..+. |.++++|++|+|++|++++..| .|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 4789999999999998665 9999999999999999999887 7999999999999999999889999999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-c-CCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-P-ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA 208 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~-~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~ 208 (672)
++|++++..|..++++++|++|+|++|++++ + .....+++|++|++++|.+++..|..+..++.+.
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 180 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccc
Confidence 9999997778889999999999999999998 4 3455699999999999999977777666666544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=175.76 Aligned_cols=155 Identities=23% Similarity=0.290 Sum_probs=130.8
Q ss_pred CCcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCC--C-CCCcccccceeeccccccCCCCChh-hhccCCCC
Q 005880 64 QNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPV--P-SLSNLTALKLLFLSHNNFNGEFPDS-VSSLFRLY 138 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~--p-~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~ 138 (672)
..+++.|+|++|.+++..+. +..+++|++|+|++|++++.. | .+.++++|++|+|++|++++.+|.. +..+++|+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 36789999999999985544 899999999999999999854 3 6899999999999999999867764 78889999
Q ss_pred eEecccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCc-CCCCC---Cccccccc
Q 005880 139 RLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKS-LSGFP---DSAFTQNA 213 (672)
Q Consensus 139 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~-l~~~~---~~~~~~n~ 213 (672)
+|+|++|+|++.+|..+. ++|+.|+|++|+|+. +.....+++|+.|+|++|+|+ .+|.. +..++ .+.+.+|+
T Consensus 432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCC
T ss_pred EEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCC
Confidence 999999999988887665 789999999999997 444568999999999999999 68865 66555 45567899
Q ss_pred cccCCCCc
Q 005880 214 ALCGSPMQ 221 (672)
Q Consensus 214 ~lc~~~~~ 221 (672)
+.|+|++.
T Consensus 509 ~~c~c~~~ 516 (562)
T 3a79_B 509 WDCTCPGI 516 (562)
T ss_dssp BCCCHHHH
T ss_pred cCCCcchH
Confidence 99998754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=178.21 Aligned_cols=159 Identities=19% Similarity=0.173 Sum_probs=138.1
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC--CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+.+.++.+..+++|++|+|++|.+++.+| .+.++++|++|+|++|.+++.+|..+.++++|+.|+|
T Consensus 373 ~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 452 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452 (570)
T ss_dssp SCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred CccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEEC
Confidence 56778888888887776668889999999999999998876 6899999999999999999999999999999999999
Q ss_pred ccCccc-cccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCCCCC---cccccccccc
Q 005880 143 SFNNFS-GQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPD---SAFTQNAALC 216 (672)
Q Consensus 143 ~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~---~~~~~n~~lc 216 (672)
++|+++ +.+|..+..+++|++|+|++|++++. ..+..+++|+.|++++|++++..|..+..++. +.+.+|++.|
T Consensus 453 ~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 532 (570)
T 2z63_A 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532 (570)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence 999998 68999999999999999999999984 34568999999999999999877777766554 4566899999
Q ss_pred CCCCccc
Q 005880 217 GSPMQAC 223 (672)
Q Consensus 217 ~~~~~~c 223 (672)
++|...+
T Consensus 533 ~~~~~~~ 539 (570)
T 2z63_A 533 SCPRIDY 539 (570)
T ss_dssp CTTTTHH
T ss_pred CCcchHH
Confidence 9876544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.4e-16 Score=178.99 Aligned_cols=157 Identities=25% Similarity=0.279 Sum_probs=134.1
Q ss_pred CcEeEEEecCCCcccCCCC--CCCCCCccEEEcccCCCCCCCC-CCCcccccceeecccccc-CCCCChhhhccCCCCeE
Q 005880 65 NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNF-NGEFPDSVSSLFRLYRL 140 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l-~g~~p~~~~~l~~L~~L 140 (672)
..++.+++..+++....+. +..+++|+.++++.|.+++..+ .+..+++|+.|+|++|++ .+.+|..|..+++|++|
T Consensus 420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L 499 (635)
T 4g8a_A 420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 499 (635)
T ss_dssp TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence 3556667776666655443 7888999999999999999888 788999999999999985 44678899999999999
Q ss_pred ecccCccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCCcCCCC----CCcccccccc
Q 005880 141 DLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGF----PDSAFTQNAA 214 (672)
Q Consensus 141 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~----~~~~~~~n~~ 214 (672)
+|++|+|++..|..|.++++|++|+|++|+|++.. .+..+++|+.|+|++|+|++..|..+..+ ..+.+.+||+
T Consensus 500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 99999999999999999999999999999999844 35789999999999999999999887655 4466779999
Q ss_pred ccCCCCc
Q 005880 215 LCGSPMQ 221 (672)
Q Consensus 215 lc~~~~~ 221 (672)
.|+|.+.
T Consensus 580 ~C~C~~~ 586 (635)
T 4g8a_A 580 ACTCEHQ 586 (635)
T ss_dssp CCSGGGH
T ss_pred cccCCcH
Confidence 9999764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.6e-16 Score=183.53 Aligned_cols=158 Identities=23% Similarity=0.282 Sum_probs=136.1
Q ss_pred CcccceEEcCCcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCC-C-CCCcccccceeeccccccCCCCChhh
Q 005880 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPV-P-SLSNLTALKLLFLSHNNFNGEFPDSV 131 (672)
Q Consensus 55 c~w~gv~c~~~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~-p-~~~~l~~L~~L~l~~N~l~g~~p~~~ 131 (672)
|.|..|.+...+++.|+|++|.+++..+. |.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|++++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 56777777668999999999999987655 999999999999999777665 4 79999999999999999998889999
Q ss_pred hccCCCCeEecccCccccccchh--hcCCCccCeeeccCCcccCcC---CCCCCCCCCeeeccCCcCCCCCCCcCC----
Q 005880 132 SSLFRLYRLDLSFNNFSGQIPLT--VNHLTHLLTLKLEANRFSGPI---TGLDLRNLQDFNVSGNHLSGQIPKSLS---- 202 (672)
Q Consensus 132 ~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~~~~---~~~~l~~L~~l~l~~N~l~g~~p~~l~---- 202 (672)
+++++|++|+|++|++++.+|.. |+++++|++|+|++|++++.. .+..+++|++|+|++|.+++..|..+.
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999877776 999999999999999998833 257899999999999999988887764
Q ss_pred -CCCCcccccc
Q 005880 203 -GFPDSAFTQN 212 (672)
Q Consensus 203 -~~~~~~~~~n 212 (672)
++..+.+.+|
T Consensus 174 ~~L~~L~L~~n 184 (844)
T 3j0a_A 174 KTLSFFSLAAN 184 (844)
T ss_dssp CSSCCCEECCS
T ss_pred CccceEECCCC
Confidence 3444444444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.7e-16 Score=176.84 Aligned_cols=138 Identities=23% Similarity=0.224 Sum_probs=70.3
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC--CCCcccccceeeccccccCCCCChhhhccCCCCeEe
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 141 (672)
.+++.|+|++|.+.+..+. +..+++|++|+|++|++++..| .+.++++|++|+|++|.+++..|..++++++|++|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 4566666666666555433 5555555556555555555443 255555555555555555555555555555555555
Q ss_pred cccCccccc---cchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCC
Q 005880 142 LSFNNFSGQ---IPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLS 202 (672)
Q Consensus 142 l~~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~ 202 (672)
|++|++++. .+..+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++..|..+.
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 521 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGT
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhC
Confidence 555555441 113344455555555555555442 1233444444444444444444444333
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-15 Score=145.95 Aligned_cols=128 Identities=25% Similarity=0.288 Sum_probs=110.3
Q ss_pred cEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCc
Q 005880 91 RVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR 170 (672)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 170 (672)
+.+++++|+++..+..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 689999999997665554 68999999999999 899999999999999999999998878899999999999999999
Q ss_pred ccCcC--CCCCCCCCCeeeccCCcCCCCCCCcCCCC---CCccccccccccCCCCc
Q 005880 171 FSGPI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGF---PDSAFTQNAALCGSPMQ 221 (672)
Q Consensus 171 l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~---~~~~~~~n~~lc~~~~~ 221 (672)
|++.. .+..+++|+.|+|++|+|++..+..|..+ ..+.+.+|++.|+|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~ 145 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQ 145 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCH
Confidence 99944 36789999999999999995444455544 45566789999998764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.6e-16 Score=149.99 Aligned_cols=128 Identities=22% Similarity=0.366 Sum_probs=112.9
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
.+++.|++++|.++. ++.+..+++|++|+|++|++++..+ .++++++|++|+|++|++++..|..++++++|++|+|+
T Consensus 66 ~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 66 HNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 579999999997764 3468999999999999999998544 89999999999999999998899999999999999999
Q ss_pred cCc-cccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCC
Q 005880 144 FNN-FSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 144 ~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g 195 (672)
+|+ ++ .+| .+..+++|+.|++++|++++......+++|+.|++++|++.+
T Consensus 145 ~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 145 YNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred CCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 998 65 677 799999999999999999996677889999999999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=175.46 Aligned_cols=154 Identities=23% Similarity=0.312 Sum_probs=110.0
Q ss_pred CcEeEEEecCCCcccCCC-CCCCCCCccEEEcccCCCCC--CCC-CCCcccccceeeccccccCCCCChh-hhccCCCCe
Q 005880 65 NRVSHLVLENLQLSGSLQ-PLTSLTQLRVLSLKYNRFTG--PVP-SLSNLTALKLLFLSHNNFNGEFPDS-VSSLFRLYR 139 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~-~l~~l~~L~~L~L~~N~l~~--~~p-~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~ 139 (672)
.+++.|+|++|.+++..+ .++.+++|++|+|++|++++ .+| .++++++|++|+|++|++++.+|.. +..+++|+.
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 567777777777777443 37777777777777777775 233 4677777777777777777656654 666777777
Q ss_pred EecccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCc-CCCCC---Ccccccccc
Q 005880 140 LDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKS-LSGFP---DSAFTQNAA 214 (672)
Q Consensus 140 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~-l~~~~---~~~~~~n~~ 214 (672)
|+|++|++++.+|..+. ++|+.|+|++|+|+. +.....+++|+.|++++|+|+ .+|.. +..++ .+.+.+|++
T Consensus 404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCC
Confidence 77777777777766554 678888888888875 333457889999999999998 67765 55544 455668999
Q ss_pred ccCCCCc
Q 005880 215 LCGSPMQ 221 (672)
Q Consensus 215 lc~~~~~ 221 (672)
.|+|++.
T Consensus 481 ~c~c~~~ 487 (520)
T 2z7x_B 481 DCSCPRI 487 (520)
T ss_dssp CCCHHHH
T ss_pred cccCCch
Confidence 8888754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.7e-17 Score=182.63 Aligned_cols=143 Identities=18% Similarity=0.334 Sum_probs=130.4
Q ss_pred CcEeEEEecCCCccc------------------CCCCCC--CCCCccEEEcccCCCCCCCC-CCCcccccceeeccccc-
Q 005880 65 NRVSHLVLENLQLSG------------------SLQPLT--SLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNN- 122 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~------------------~~~~l~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~- 122 (672)
.+++.|+|++|.++| .++.++ ++++|++|+|++|++.+.+| .++++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 689999999999999 666788 99999999999999999988 89999999999999998
Q ss_pred cCC-CCChhhhcc------CCCCeEecccCccccccch--hhcCCCccCeeeccCCcccCcCC-CCCCCCCCeeeccCCc
Q 005880 123 FNG-EFPDSVSSL------FRLYRLDLSFNNFSGQIPL--TVNHLTHLLTLKLEANRFSGPIT-GLDLRNLQDFNVSGNH 192 (672)
Q Consensus 123 l~g-~~p~~~~~l------~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~-~~~l~~L~~l~l~~N~ 192 (672)
++| .+|..++++ ++|++|+|++|+++ .+|. .++++++|++|+|++|+++|.++ +..+++|+.|++++|+
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~ 364 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ 364 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSE
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCc
Confidence 999 899999987 99999999999999 8998 99999999999999999998554 5578899999999999
Q ss_pred CCCCCCCcCCCCCC-ccc
Q 005880 193 LSGQIPKSLSGFPD-SAF 209 (672)
Q Consensus 193 l~g~~p~~l~~~~~-~~~ 209 (672)
++ .+|..+..++. +..
T Consensus 365 l~-~lp~~l~~l~~~L~~ 381 (636)
T 4eco_A 365 IT-EIPANFCGFTEQVEN 381 (636)
T ss_dssp EE-ECCTTSEEECTTCCE
T ss_pred cc-cccHhhhhhcccCcE
Confidence 99 89988876665 443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-16 Score=164.37 Aligned_cols=134 Identities=24% Similarity=0.279 Sum_probs=86.3
Q ss_pred CcEeEEEecCCCcccCCCC-C--CCCCCccEEEcccCCCCCCCCCCCcc-----cccceeeccccccCCCCChhhhccCC
Q 005880 65 NRVSHLVLENLQLSGSLQP-L--TSLTQLRVLSLKYNRFTGPVPSLSNL-----TALKLLFLSHNNFNGEFPDSVSSLFR 136 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l--~~l~~L~~L~L~~N~l~~~~p~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~~ 136 (672)
.++++|+|++|.+++..+. + ..+++|++|+|++|++++.++.++++ ++|++|+|++|++++..|..|+++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 4677777777777765444 3 66777777777777777663345555 67777777777777666667777777
Q ss_pred CCeEecccCccccc--cchhh--cCCCccCeeeccCCcccC--cCC---CCCCCCCCeeeccCCcCCCCCC
Q 005880 137 LYRLDLSFNNFSGQ--IPLTV--NHLTHLLTLKLEANRFSG--PIT---GLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 137 L~~L~l~~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~~--~~~---~~~l~~L~~l~l~~N~l~g~~p 198 (672)
|++|+|++|+++|. +|..+ .++++|++|+|++|+|++ .++ ...+++|+.|+|++|++++.+|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 77777777776654 23344 666777777777777764 111 1255667777777777766554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.8e-17 Score=176.08 Aligned_cols=150 Identities=18% Similarity=0.078 Sum_probs=126.9
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhh-ccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVS-SLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l 142 (672)
..++.|+|++|.+++.++. .+++|+.|+|++|.|++.+| .++++++|++|+|++|.|++.+|..+. ++++|+.|+|
T Consensus 99 ~~L~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L 176 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CCcCEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence 5677888888888776553 46899999999999999887 899999999999999999998998887 7999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCC---CccccccccccCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFP---DSAFTQNAALCGS 218 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~---~~~~~~n~~lc~~ 218 (672)
++|.|++. |. +..+++|+.|+|++|+|++ +..+..+++|+.|+|++|.|++ +|..+..++ .+.+.+|++.|++
T Consensus 177 s~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred CCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence 99999965 33 4469999999999999999 3446688999999999999994 887776555 4556689888875
Q ss_pred C
Q 005880 219 P 219 (672)
Q Consensus 219 ~ 219 (672)
.
T Consensus 254 ~ 254 (487)
T 3oja_A 254 L 254 (487)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.63 E-value=3.8e-16 Score=154.68 Aligned_cols=139 Identities=14% Similarity=0.096 Sum_probs=121.2
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCC-CCCCCC-CCCcccccceeeccc-cccCCCCChhhhccCCCCeE
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNR-FTGPVP-SLSNLTALKLLFLSH-NNFNGEFPDSVSSLFRLYRL 140 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L 140 (672)
..++.|+|++|++++.++. +..+++|++|+|++|. +++..+ .|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 5799999999999998875 8999999999999997 888777 789999999999999 99996666789999999999
Q ss_pred ecccCccccccchhhcCCCccC---eeeccCC-cccCcC--CCCCCCCCC-eeeccCCcCCCCCCCcCCCCCC
Q 005880 141 DLSFNNFSGQIPLTVNHLTHLL---TLKLEAN-RFSGPI--TGLDLRNLQ-DFNVSGNHLSGQIPKSLSGFPD 206 (672)
Q Consensus 141 ~l~~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~~~~--~~~~l~~L~-~l~l~~N~l~g~~p~~l~~~~~ 206 (672)
+|++|++++ +|. +..+++|+ +|++++| ++++.. .+..+++|+ .|++++|+++ .+|......+.
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~ 180 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCE
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCC
Confidence 999999995 776 88899998 9999999 998833 366899999 9999999999 77765433343
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=9.3e-16 Score=175.97 Aligned_cols=136 Identities=24% Similarity=0.312 Sum_probs=111.9
Q ss_pred CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCC----C----hhhhccCCCCeEecccCccccccch-
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEF----P----DSVSSLFRLYRLDLSFNNFSGQIPL- 153 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~----p----~~~~~l~~L~~L~l~~N~l~g~~p~- 153 (672)
+..+++|++|+|++|++++.++ .+.++++|++|+|++|++++.. | ..|.++++|+.|+|++|+|+ .+|.
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~ 554 (680)
T 1ziw_A 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVE 554 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTT
T ss_pred cccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHH
Confidence 7788889999999999998777 5888999999999999888531 1 23788899999999999998 5554
Q ss_pred hhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCC----cCCCCCCccccccccccCCCC
Q 005880 154 TVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPK----SLSGFPDSAFTQNAALCGSPM 220 (672)
Q Consensus 154 ~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~----~l~~~~~~~~~~n~~lc~~~~ 220 (672)
.|.++++|+.|+|++|+|++..+ +..+++|+.|+|++|+|++..|. .+.++..+.+.+|++.|+|+.
T Consensus 555 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred HcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 68999999999999999998333 45789999999999999976665 356777888889999999874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-16 Score=163.19 Aligned_cols=147 Identities=18% Similarity=0.205 Sum_probs=101.6
Q ss_pred cEeEEEecCCCccc-CCCC-CC-------CCCCccEEEcccCCCCCCCC-CC--CcccccceeeccccccCCCCChhhhc
Q 005880 66 RVSHLVLENLQLSG-SLQP-LT-------SLTQLRVLSLKYNRFTGPVP-SL--SNLTALKLLFLSHNNFNGEFPDSVSS 133 (672)
Q Consensus 66 ~v~~L~l~~~~l~~-~~~~-l~-------~l~~L~~L~L~~N~l~~~~p-~~--~~l~~L~~L~l~~N~l~g~~p~~~~~ 133 (672)
.++.|+|++|.+.. ..+. +. ++++|++|+|++|++++.+| .+ .++++|++|+|++|++++. |..+++
T Consensus 64 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 36777777777743 3332 32 57788888888888887666 44 7788888888888888865 777777
Q ss_pred c-----CCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcC------CCCCCCCCCeeeccCCcCCC--CCCCc
Q 005880 134 L-----FRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI------TGLDLRNLQDFNVSGNHLSG--QIPKS 200 (672)
Q Consensus 134 l-----~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~------~~~~l~~L~~l~l~~N~l~g--~~p~~ 200 (672)
+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.+.. ....+++|++|+|++|+|++ .++..
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 222 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHH
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHH
Confidence 7 78888888888888766677888888888888888876531 12567788888888888872 22322
Q ss_pred ----CCCCCCccccccc
Q 005880 201 ----LSGFPDSAFTQNA 213 (672)
Q Consensus 201 ----l~~~~~~~~~~n~ 213 (672)
+.++..+.+.+|.
T Consensus 223 ~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 223 LAAARVQLQGLDLSHNS 239 (312)
T ss_dssp HHHTTCCCSEEECTTSC
T ss_pred HHhcCCCCCEEECCCCc
Confidence 2455555555553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-15 Score=158.20 Aligned_cols=155 Identities=21% Similarity=0.354 Sum_probs=121.6
Q ss_pred CCcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccc
Q 005880 54 PCSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH 120 (672)
Q Consensus 54 ~c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 120 (672)
.|.|+.+.|.. ..++.|+|++|.+++.++. |.++++|++|+|++|++++..| .++++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 47899999963 3688999999999998874 9999999999999999999877 899999999999999
Q ss_pred cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC----cCCCCCCCCCCeeeccCCcCCCC
Q 005880 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG----PITGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 121 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~----~~~~~~l~~L~~l~l~~N~l~g~ 196 (672)
|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++. +..+..+++|+.|++++|.++ .
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~ 185 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 185 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-c
Confidence 9999 7787665 688888888888887666778888888888888888853 222446777777777777777 4
Q ss_pred CCCcC-CCCCCcccccc
Q 005880 197 IPKSL-SGFPDSAFTQN 212 (672)
Q Consensus 197 ~p~~l-~~~~~~~~~~n 212 (672)
+|..+ .++..+.+.+|
T Consensus 186 l~~~~~~~L~~L~l~~n 202 (330)
T 1xku_A 186 IPQGLPPSLTELHLDGN 202 (330)
T ss_dssp CCSSCCTTCSEEECTTS
T ss_pred CCccccccCCEEECCCC
Confidence 55433 33444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=173.10 Aligned_cols=139 Identities=17% Similarity=0.105 Sum_probs=121.5
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++|.|++.++ .++|++|+|++|.|++.++. .+++|+.|+|++|.|++..|..++++++|+.|+|+
T Consensus 79 l~~L~~L~Ls~N~l~~l~~----~~~L~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 79 LSTLRTLDLNNNYVQELLV----GPSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp CTTCCEEECCSSEEEEEEE----CTTCCEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred CCCCCEEEecCCcCCCCCC----CCCcCEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 3689999999999997654 38999999999999987763 46889999999999999889999999999999999
Q ss_pred cCccccccchhhc-CCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 144 FNNFSGQIPLTVN-HLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 144 ~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
+|+|++.+|..+. .+++|+.|+|++|+|++..+...+++|+.|+|++|.|++ +|..+..++.+..
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~ 218 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW 218 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCC-CCHhHcCCCCccE
Confidence 9999998998886 899999999999999997666679999999999999996 5555666555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=156.30 Aligned_cols=142 Identities=30% Similarity=0.374 Sum_probs=120.6
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++|.+++..+ +..+++|++|+|++|.+++ +|.+.++++|++|+|++|++++ + ..+..+++|+.|+|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~ 142 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 142 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred CCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEcc
Confidence 3689999999999998766 9999999999999999997 4569999999999999999995 4 578999999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc---ccccc
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA---FTQNA 213 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~---~~~n~ 213 (672)
+|++++. ..+..+++|+.|+|++|++++..+...+++|+.|++++|.+++ +|. +..++.+. +.+|+
T Consensus 143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQE 211 (291)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEE
T ss_pred CCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCc
Confidence 9999954 6789999999999999999986568889999999999999984 553 55555544 44554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.8e-16 Score=182.29 Aligned_cols=153 Identities=18% Similarity=0.219 Sum_probs=134.0
Q ss_pred CcccceEE---cCCcEeEEEecCCCccc------------------CCCCCC--CCCCccEEEcccCCCCCCCC-CCCcc
Q 005880 55 CSWTGVSC---LQNRVSHLVLENLQLSG------------------SLQPLT--SLTQLRVLSLKYNRFTGPVP-SLSNL 110 (672)
Q Consensus 55 c~w~gv~c---~~~~v~~L~l~~~~l~~------------------~~~~l~--~l~~L~~L~L~~N~l~~~~p-~~~~l 110 (672)
+...|+.- ...+++.|+|++|.|+| .++.++ ++++|++|+|++|++.+.+| .|++|
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 44555432 23689999999999999 666687 99999999999999999998 89999
Q ss_pred cccceeeccccc-cCC-CCChhhhccC-------CCCeEecccCccccccch--hhcCCCccCeeeccCCcccCcCCCCC
Q 005880 111 TALKLLFLSHNN-FNG-EFPDSVSSLF-------RLYRLDLSFNNFSGQIPL--TVNHLTHLLTLKLEANRFSGPITGLD 179 (672)
Q Consensus 111 ~~L~~L~l~~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~ 179 (672)
++|+.|+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. .++++++|+.|+|++|+|+....+..
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp~~~~ 593 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLEAFGT 593 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCCCCCT
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccchhhcC
Confidence 999999999998 998 8999998887 9999999999999 8999 99999999999999999995225678
Q ss_pred CCCCCeeeccCCcCCCCCCCcCCCCCC-ccc
Q 005880 180 LRNLQDFNVSGNHLSGQIPKSLSGFPD-SAF 209 (672)
Q Consensus 180 l~~L~~l~l~~N~l~g~~p~~l~~~~~-~~~ 209 (672)
+++|+.|+|++|+++ .+|..+..++. +..
T Consensus 594 L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~ 623 (876)
T 4ecn_A 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEG 623 (876)
T ss_dssp TSEESEEECCSSCCS-CCCTTSCEECTTCCE
T ss_pred CCcceEEECcCCccc-cchHHHhhccccCCE
Confidence 999999999999999 99988877666 543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=165.25 Aligned_cols=141 Identities=23% Similarity=0.215 Sum_probs=101.5
Q ss_pred ccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeecccccc
Q 005880 57 WTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNF 123 (672)
Q Consensus 57 w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l 123 (672)
|..|.|.. ..++.|+|++|++++..+. |.++++|++|+|++|+|++..+ .|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 56788853 4678899999999887754 8888889999999988888776 788888888888888888
Q ss_pred CCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcC---CCCCCCCCCeeeccCCcCCCCCC
Q 005880 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI---TGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 124 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+..+.+ .+..+++|++|+|++|+++ .+|
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 8555567888888888888888888655556666666666666664333211 2334555555555555555 444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=172.55 Aligned_cols=109 Identities=23% Similarity=0.260 Sum_probs=93.0
Q ss_pred CcEeEEEecCCCcccCCC-CCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQ-PLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++ .|+.+++|++|+|++|.|++.+| .|+++++|++|+|++|.|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 478889999999988876 48889999999999999998887 6788999999999999998544455688999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
++|+|++..|..|+++++|++|+|++|+|++
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 9999998888888889999999998888876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.5e-16 Score=163.04 Aligned_cols=135 Identities=10% Similarity=0.061 Sum_probs=97.2
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcc--------------hHH--------HHHHHHHHHcCCCCCceeee
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIG--------------GKR--------EFEQHMEVLGRLRHPNLVGL 421 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~h~niv~l 421 (672)
+.+.||+|++|.||+|...+|+.||||+++..... ... ...+|...|.++.+.++.-.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 35689999999999999989999999987532100 011 12356666777655443222
Q ss_pred EEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC
Q 005880 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT 501 (672)
Q Consensus 422 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~ 501 (672)
.-+.. ...+|||||+++++|.++... .....++.|++.+|.||| +.+||||||||.|||++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH----~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA----KHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeCC
Confidence 22222 234799999999988765421 123568899999999999 7899999999999999877
Q ss_pred C----------cEEEeccCCCccC
Q 005880 502 G----------NARVSDFGLSIFA 515 (672)
Q Consensus 502 ~----------~~kl~DfG~a~~~ 515 (672)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999977543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.2e-15 Score=157.00 Aligned_cols=153 Identities=24% Similarity=0.328 Sum_probs=126.8
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeecccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHN 121 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N 121 (672)
|.|+.+.|.. .+++.|+|++|.+++.++. +.++++|++|+|++|++++..| .++++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 7899999963 3689999999999988764 9999999999999999999877 8999999999999999
Q ss_pred ccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC----cCCCCCCCCCCeeeccCCcCCCCC
Q 005880 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG----PITGLDLRNLQDFNVSGNHLSGQI 197 (672)
Q Consensus 122 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~----~~~~~~l~~L~~l~l~~N~l~g~~ 197 (672)
+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|+++. +..+..+ +|+.|++++|++++ +
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l 187 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-I 187 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-C
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-c
Confidence 999 7888776 799999999999996666679999999999999999964 2223344 88889999998884 6
Q ss_pred CCcC-CCCCCcccccc
Q 005880 198 PKSL-SGFPDSAFTQN 212 (672)
Q Consensus 198 p~~l-~~~~~~~~~~n 212 (672)
|..+ .++..+.+.+|
T Consensus 188 ~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 188 PKDLPETLNELHLDHN 203 (332)
T ss_dssp CSSSCSSCSCCBCCSS
T ss_pred CccccCCCCEEECCCC
Confidence 6544 34555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=153.04 Aligned_cols=143 Identities=22% Similarity=0.279 Sum_probs=115.2
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|+++... .+..+++|++|+|++|+|++.++ +.++++|++|+|++|++++ +|.... ++|+.|+|++
T Consensus 41 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~ 115 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDN 115 (263)
T ss_dssp TTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCS
T ss_pred CcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccC
Confidence 57889999999988654 78889999999999999998777 8899999999999999984 555333 8899999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCc---ccccccccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS---AFTQNAALC 216 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~---~~~~n~~lc 216 (672)
|+|++ +| .+.++++|+.|+|++|+|++......+++|+.|++++|++++. ..+..++.+ .+.+|+..+
T Consensus 116 N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 116 NELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp SCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 99985 44 5889999999999999998865677889999999999999865 455555544 444565443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=155.53 Aligned_cols=125 Identities=23% Similarity=0.306 Sum_probs=86.3
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.+++..+ +..+++|++|+|++|++++. +.+.++++|++|+|++|++++ +|. +.++++|++|+|++
T Consensus 63 ~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~ 138 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDL 138 (308)
T ss_dssp TTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCS
T ss_pred CCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCC
Confidence 567777777777776555 77777777777777777763 467777777777777777774 443 67777777777777
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g 195 (672)
|++++..+ +..+++|+.|+|++|++++..+...+++|+.|++++|++++
T Consensus 139 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 139 NQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187 (308)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred CccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCc
Confidence 77774333 66777777777777777764445666777777777777764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.7e-15 Score=158.21 Aligned_cols=136 Identities=26% Similarity=0.250 Sum_probs=118.8
Q ss_pred ceEEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCC-cccccceeeccccccCCCCChhhhccCC
Q 005880 59 GVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLS-NLTALKLLFLSHNNFNGEFPDSVSSLFR 136 (672)
Q Consensus 59 gv~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 136 (672)
+-.|.. ..+++++++|+..+..+. ..|+.|+|++|+|++.++ .+. ++++|++|+|++|+|++..|..|.++++
T Consensus 15 ~C~C~~---~~l~c~~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~ 89 (361)
T 2xot_A 15 NCLCAS---NILSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89 (361)
T ss_dssp TCEEET---TEEECCSSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CCEECC---CEEEeCCCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCC
Confidence 456654 478999999998877664 468999999999999888 566 9999999999999999777788999999
Q ss_pred CCeEecccCccccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCc
Q 005880 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKS 200 (672)
Q Consensus 137 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~ 200 (672)
|++|+|++|+|++..+..|.++++|+.|+|++|+|++. ..+..+++|+.|+|++|+|+ .+|..
T Consensus 90 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~ 154 (361)
T 2xot_A 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154 (361)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGG
T ss_pred CCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHH
Confidence 99999999999977777899999999999999999983 34678999999999999999 56654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=155.88 Aligned_cols=142 Identities=23% Similarity=0.362 Sum_probs=121.9
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.+++. +.+..+++|++|+|++|++++. +.+.++++|++|+|++|++++ ++. ++++++|+.|+|++
T Consensus 85 ~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~ 160 (308)
T 1h6u_A 85 TKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGN 160 (308)
T ss_dssp CSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCS
T ss_pred CCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccC
Confidence 6899999999999875 5699999999999999999985 459999999999999999995 444 99999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCc---ccccccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS---AFTQNAA 214 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~---~~~~n~~ 214 (672)
|++++ ++. +.++++|+.|+|++|++++..+...+++|++|++++|++++..| +..++.+ .+.+|+.
T Consensus 161 n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 161 AQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp SCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEE
T ss_pred CcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCee
Confidence 99995 444 99999999999999999986667889999999999999996553 5555554 4445654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8e-16 Score=176.53 Aligned_cols=136 Identities=24% Similarity=0.268 Sum_probs=112.5
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++. |.++++|++|+|++|.+++.+| .++++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 4788999999999887765 8888999999999999998877 6788899999999999998544446888999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCc
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKS 200 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~ 200 (672)
++|++++..|..|+++++|++|+|++|++++..+ +..+++|++|++++|.+++..|..
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence 9999987667788899999999999998887433 457888888888888888666543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=167.19 Aligned_cols=146 Identities=19% Similarity=0.136 Sum_probs=128.3
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++..+. |.++++|++|+|++|++++.++ .|.++++|++|+|++|++++..|..|.++++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 6899999999999988655 9999999999999999998877 6899999999999999999888999999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
++|++++..|..|.++++|+.|+|++|++++..+ +..+++|+.|+|++|.+++..+..+..++.+...
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 205 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVL 205 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEE
T ss_pred CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCccccee
Confidence 9999998888899999999999999999988433 5678999999999999997777677766655443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=8.4e-16 Score=158.57 Aligned_cols=140 Identities=21% Similarity=0.234 Sum_probs=118.8
Q ss_pred CcEeEEEecCCCcccCCCC-C--CCCCCccEEEcccCCCCCCCC-----CCCcccccceeeccccccCCCCChhhhccCC
Q 005880 65 NRVSHLVLENLQLSGSLQP-L--TSLTQLRVLSLKYNRFTGPVP-----SLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l--~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 136 (672)
.++++|+|++|.+++..+. + ..+++|++|+|++|++++..+ .+..+++|++|+|++|++++..|..|+++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 3599999999999987776 5 899999999999999998665 2457999999999999999888899999999
Q ss_pred CCeEecccCccccc--cc--hhhcCCCccCeeeccCCcccCcCC-----CCCCCCCCeeeccCCcCCCCCCCcCCCC
Q 005880 137 LYRLDLSFNNFSGQ--IP--LTVNHLTHLLTLKLEANRFSGPIT-----GLDLRNLQDFNVSGNHLSGQIPKSLSGF 204 (672)
Q Consensus 137 L~~L~l~~N~l~g~--~p--~~~~~l~~L~~L~l~~N~l~~~~~-----~~~l~~L~~l~l~~N~l~g~~p~~l~~~ 204 (672)
|++|+|++|++.+. ++ ..++++++|++|+|++|+++.... ...+++|++|+|++|+|++.+|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 99999999998763 32 234789999999999999986222 2467999999999999998888776654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.2e-15 Score=149.24 Aligned_cols=142 Identities=18% Similarity=0.226 Sum_probs=113.7
Q ss_pred CcEeEEEecCCC-cccCCCC-CCCCCCccEEEccc-CCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCC--
Q 005880 65 NRVSHLVLENLQ-LSGSLQP-LTSLTQLRVLSLKY-NRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLY-- 138 (672)
Q Consensus 65 ~~v~~L~l~~~~-l~~~~~~-l~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-- 138 (672)
.+++.|+|++|. +++..+. |..+++|++|+|++ |++++.++ .|.++++|++|+|++|++++ +|. ++++++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 578999999997 8877764 88899999999998 99998776 68889999999999999985 776 88888888
Q ss_pred -eEecccC-ccccccchhhcCCCccC-eeeccCCcccC-cCCCCCCCCCCeeeccCCc-CCCCCCCcCCCC-CCcc
Q 005880 139 -RLDLSFN-NFSGQIPLTVNHLTHLL-TLKLEANRFSG-PITGLDLRNLQDFNVSGNH-LSGQIPKSLSGF-PDSA 208 (672)
Q Consensus 139 -~L~l~~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~-l~g~~p~~l~~~-~~~~ 208 (672)
.|++++| ++++..+..|.++++|+ .|++++|+++. +...+..++|+.|++++|+ +++..+..|..+ +.+.
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~ 208 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCS
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCc
Confidence 9999999 88866666788999999 99999999885 3333344789999999994 885445566655 5444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=152.89 Aligned_cols=138 Identities=28% Similarity=0.400 Sum_probs=120.6
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|.+... +.+..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +| .+.++++|++|+|++
T Consensus 46 ~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~ 121 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (291)
T ss_dssp HTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred CcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCC
Confidence 5789999999999876 558999999999999999999777 9999999999999999995 44 499999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
|+|++ + ..+..+++|+.|+|++|++++......+++|+.|++++|++++..| +..++.+...
T Consensus 122 n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L 183 (291)
T 1h6t_A 122 NGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183 (291)
T ss_dssp SCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred CcCCC-C-hhhcCCCCCCEEEccCCcCCcchhhccCCCCCEEEccCCccccchh--hcCCCccCEE
Confidence 99995 4 4789999999999999999987567789999999999999996554 6666655443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.8e-15 Score=158.89 Aligned_cols=108 Identities=24% Similarity=0.310 Sum_probs=85.7
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChh-hhccCCCCeEe
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDS-VSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ 141 (672)
.+++.|+|++|.+++.++. +..+++|++|+|++|.+++.+| .++++++|++|+|++|+++ .+|.. |.++++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 4678888888888877663 7888888888888888888777 5788888888888888888 45544 57888888888
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccC
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
|++|++++..|..+.++++|++|++++|++++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 88888887667778888888888888887765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=9e-16 Score=172.19 Aligned_cols=143 Identities=20% Similarity=0.179 Sum_probs=124.6
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++..+. |.++++|++|+|++|++++..| .|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 4789999999999988765 9999999999999999999877 7999999999999999999877889999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-cC--CCCCCCCCCeeeccCCcCCCCCCCcCCCCCCc
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~ 207 (672)
++|++++..+..++++++|++|+|++|++++ .+ .+..+++|++|++++|++++..|..+..+..+
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 175 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence 9999996555579999999999999999987 33 35689999999999999997767666555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=143.93 Aligned_cols=127 Identities=17% Similarity=0.125 Sum_probs=100.1
Q ss_pred CcEeEEEecCCCcccCCCCCCCCC-CccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLT-QLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
.+++.|+|++|+++.. +.+..+. +|++|+|++|.|++. +.+.++++|++|+|++|+|++..|..+..+++|++|+|+
T Consensus 19 ~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96 (176)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence 5688888888888865 4555555 888889988888876 788888888888898888885444455888888888888
Q ss_pred cCccccccch--hhcCCCccCeeeccCCcccCcCC-----CCCCCCCCeeeccCCcCC
Q 005880 144 FNNFSGQIPL--TVNHLTHLLTLKLEANRFSGPIT-----GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 144 ~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~-----~~~l~~L~~l~l~~N~l~ 194 (672)
+|+|+ .+|. .+..+++|+.|++++|+++.... ...+++|+.||+++|.+.
T Consensus 97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 88886 6666 78888888888888888876333 457888888888888765
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=158.42 Aligned_cols=148 Identities=18% Similarity=0.099 Sum_probs=106.8
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhh-ccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVS-SLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~ 143 (672)
.++.|++++|.+++.++ ..+++|++|+|++|++++..+ .++++++|++|+|++|++++..|..+. .+++|++|+|+
T Consensus 100 ~L~~L~l~~n~l~~~~~--~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~ 177 (317)
T 3o53_A 100 SIETLHAANNNISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (317)
T ss_dssp TCCEEECCSSCCSEEEE--CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred CcCEEECCCCccCCcCc--cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECC
Confidence 34444444444444332 236778888888888888777 788888888888888888877677664 68888888888
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCC---ccccccccccCC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPD---SAFTQNAALCGS 218 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~---~~~~~n~~lc~~ 218 (672)
+|+|++. |. ...+++|++|+|++|+|++ +..+..+++|+.|+|++|+|+ .+|..+..++. +.+.+|+..|++
T Consensus 178 ~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 178 YNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp TSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred CCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 8888844 43 3358888888888888887 334567888899999999888 67876665544 445567776653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=6.9e-15 Score=153.07 Aligned_cols=141 Identities=17% Similarity=0.256 Sum_probs=112.5
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCC--CCC-CCCcccccceeeccccccCCCCChhhhccCCCCeE
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTG--PVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRL 140 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~--~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 140 (672)
..++.|++++|.+++.++. +..+++|++|+|++|.++. ..+ .+.++++|++|+|++|+++ .+|..+. ++|++|
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L 197 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL 197 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence 4788999999999887765 7888999999999998864 444 6788888888888888888 5776654 688888
Q ss_pred ecccCccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 141 DLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 141 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
+|++|++++..|..+.++++|+.|+|++|++++.. .+..+++|+.|++++|+++ .+|..+..++.+..
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~ 267 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 267 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCE
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCE
Confidence 88888888777888888888888888888888733 3567788888888888888 78877776665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.6e-15 Score=164.49 Aligned_cols=142 Identities=30% Similarity=0.384 Sum_probs=122.9
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++|.|++.++ +..+++|+.|+|++|.|++ +|.+.+|++|+.|+|++|+|++ + +.+..|++|+.|+|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls 139 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 139 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECC
T ss_pred CCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECC
Confidence 4689999999999998766 9999999999999999997 5689999999999999999995 4 469999999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc---ccccc
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA---FTQNA 213 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~---~~~n~ 213 (672)
+|+|++. ..+..|++|+.|+|++|+|++..++..+++|+.|+|++|+|++ +| .+..++.|. +.+|+
T Consensus 140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 140 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp SSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEE
T ss_pred CCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCc
Confidence 9999964 6799999999999999999996668899999999999999995 44 455555544 44554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=9.7e-16 Score=139.83 Aligned_cols=123 Identities=18% Similarity=0.267 Sum_probs=106.7
Q ss_pred CCCCccEEEcccCCCC-CCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 86 SLTQLRVLSLKYNRFT-GPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 86 ~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
..++|+.|+|++|.++ +.+| .+..+++|++|+|++|++++. ..++++++|++|+|++|++++.+|..+.++++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999999 6666 779999999999999999965 78999999999999999999889999999999999
Q ss_pred eeccCCcccC-c--CCCCCCCCCCeeeccCCcCCCCCC---CcCCCCCCcccc
Q 005880 164 LKLEANRFSG-P--ITGLDLRNLQDFNVSGNHLSGQIP---KSLSGFPDSAFT 210 (672)
Q Consensus 164 L~l~~N~l~~-~--~~~~~l~~L~~l~l~~N~l~g~~p---~~l~~~~~~~~~ 210 (672)
|++++|++++ + .....+++|++|++++|++++..+ ..+..++.+...
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L 145 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEE
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccc
Confidence 9999999998 3 456789999999999999996544 356666666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.1e-15 Score=139.51 Aligned_cols=124 Identities=18% Similarity=0.258 Sum_probs=107.6
Q ss_pred CCCCCccEEEcccCCCC-CCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccC
Q 005880 85 TSLTQLRVLSLKYNRFT-GPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLL 162 (672)
Q Consensus 85 ~~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 162 (672)
...++|+.|+|++|.++ +.+| .+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34588999999999998 6666 679999999999999999955 8899999999999999999988999998999999
Q ss_pred eeeccCCcccC-c--CCCCCCCCCCeeeccCCcCCCCCC---CcCCCCCCcccc
Q 005880 163 TLKLEANRFSG-P--ITGLDLRNLQDFNVSGNHLSGQIP---KSLSGFPDSAFT 210 (672)
Q Consensus 163 ~L~l~~N~l~~-~--~~~~~l~~L~~l~l~~N~l~g~~p---~~l~~~~~~~~~ 210 (672)
+|+|++|+|++ + ..+..+++|+.|++++|.+++..+ ..+..++.+...
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L 152 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence 99999999998 3 346789999999999999995443 367777776655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.9e-15 Score=152.79 Aligned_cols=140 Identities=19% Similarity=0.225 Sum_probs=88.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccC--CC---------------
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFN--GE--------------- 126 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~--g~--------------- 126 (672)
.+++.|+|++|.++..+..+. ++|++|+|++|++++.++ .+.++++|+.|+|++|.++ +.
T Consensus 102 ~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l 179 (332)
T 2ft3_A 102 RKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179 (332)
T ss_dssp TTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBC
T ss_pred CCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEEC
Confidence 456666666666654443332 445555555555554443 2444444444444444443 12
Q ss_pred -------CChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCC
Q 005880 127 -------FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQI 197 (672)
Q Consensus 127 -------~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~ 197 (672)
+|..+. ++|++|+|++|++++..|..+.++++|+.|+|++|++++..+ +..+++|+.|++++|+++ .+
T Consensus 180 ~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 256 (332)
T 2ft3_A 180 SEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV 256 (332)
T ss_dssp CSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BC
T ss_pred cCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ec
Confidence 333332 578888888888887777788888888888888888887443 567888888888888888 78
Q ss_pred CCcCCCCCCccc
Q 005880 198 PKSLSGFPDSAF 209 (672)
Q Consensus 198 p~~l~~~~~~~~ 209 (672)
|..+..++.+..
T Consensus 257 p~~l~~l~~L~~ 268 (332)
T 2ft3_A 257 PAGLPDLKLLQV 268 (332)
T ss_dssp CTTGGGCTTCCE
T ss_pred ChhhhcCccCCE
Confidence 877766655443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=8.2e-16 Score=159.17 Aligned_cols=156 Identities=19% Similarity=0.173 Sum_probs=128.7
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CC-CcccccceeeccccccCCCCChhhhccCCCCeEe
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SL-SNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLD 141 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~-~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 141 (672)
..++.|+|++|.+++..+. +..+++|++|+|++|.+++..+ .+ .++++|++|+|++|++++ +|. ...+++|++|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEE
Confidence 5799999999999988764 8899999999999999999776 55 479999999999999995 443 34589999999
Q ss_pred cccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCC-CCCCCcCCCCCCcccc---cccccc
Q 005880 142 LSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLS-GQIPKSLSGFPDSAFT---QNAALC 216 (672)
Q Consensus 142 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~-g~~p~~l~~~~~~~~~---~n~~lc 216 (672)
|++|+|+ .+|..+..+++|+.|+|++|+|++ +.....+++|+.|++++|.++ +.+|..+..++.+... ++..+.
T Consensus 198 Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~ 276 (317)
T 3o53_A 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276 (317)
T ss_dssp CCSSCCC-EECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHH
T ss_pred CCCCcCC-cchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhcc
Confidence 9999999 466679999999999999999998 445678899999999999999 7788877777665443 344444
Q ss_pred CCCCccc
Q 005880 217 GSPMQAC 223 (672)
Q Consensus 217 ~~~~~~c 223 (672)
+.....|
T Consensus 277 ~~~~~~~ 283 (317)
T 3o53_A 277 GQNEEEC 283 (317)
T ss_dssp SSSSCCC
T ss_pred CCchhcc
Confidence 4443344
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-15 Score=168.14 Aligned_cols=137 Identities=23% Similarity=0.274 Sum_probs=98.9
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++. |..+++|++|+|++|++++..| .|+++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 5677777777777776643 7777777777777777777666 6777777777777777777 56665 6777777777
Q ss_pred ccCcccc-ccchhhcCCCccCeeeccCCcccCcCCCCCCCCC--CeeeccCCcC--CCCCCCcCCCCC
Q 005880 143 SFNNFSG-QIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL--QDFNVSGNHL--SGQIPKSLSGFP 205 (672)
Q Consensus 143 ~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L--~~l~l~~N~l--~g~~p~~l~~~~ 205 (672)
++|+|++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|++++|.+ ++.+|..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK-SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG-GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch-hhccccccceeeEEEeecccccccccccccccccc
Confidence 7777776 467777777777777777777766 233445566 7777777777 667777666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.3e-15 Score=166.43 Aligned_cols=137 Identities=28% Similarity=0.282 Sum_probs=102.8
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+++.|+|++|.+++.++. |.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 5677888888888877653 7888888888888888887766 6788888888888888887 67766 7788888888
Q ss_pred ccCcccc-ccchhhcCCCccCeeeccCCcccCcCCCCCCCCC--CeeeccCCcC--CCCCCCcCCCCC
Q 005880 143 SFNNFSG-QIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNL--QDFNVSGNHL--SGQIPKSLSGFP 205 (672)
Q Consensus 143 ~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L--~~l~l~~N~l--~g~~p~~l~~~~ 205 (672)
++|+|++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|++++|.+ ++..|..+..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT-TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCcccc-CchhhhhhceeeEEEeecccccccccCcccccccC
Confidence 8888875 345778888888888888888876 233344455 8888888888 777777666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.9e-16 Score=178.48 Aligned_cols=141 Identities=23% Similarity=0.217 Sum_probs=119.3
Q ss_pred cCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 63 ~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
....++.|+|++|.+..+++.+..+++|++|+|++|.|+.+++.|++|++|++|+|++|+|+ .+|..|++|++|++|+|
T Consensus 222 ~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred cCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 34689999999999997777788999999999999999954448999999999999999999 89999999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcCCC--CCC-CCCCeeeccCCcCCCCCCCcCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITG--LDL-RNLQDFNVSGNHLSGQIPKSLSGFP 205 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~l-~~L~~l~l~~N~l~g~~p~~l~~~~ 205 (672)
++|.|+ .+|..|++|++|+.|+|++|+|++.++. ..+ ..+..|+|++|.++|.+|..+..+.
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 999998 8999999999999999999999985442 111 1223578999999999998776553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-14 Score=135.30 Aligned_cols=104 Identities=22% Similarity=0.182 Sum_probs=76.2
Q ss_pred eEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 68 ~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
+.|++++|+|+..+..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 12 ~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 12 TTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 356777777777665553 678888888888888766 67788888888888888885555566778888888888888
Q ss_pred cccccchhhcCCCccCeeeccCCcccC
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
|++..+..|.++++|++|+|++|+++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 875555567777777777777776654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.5e-14 Score=152.13 Aligned_cols=149 Identities=27% Similarity=0.219 Sum_probs=126.5
Q ss_pred cceEEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCC
Q 005880 58 TGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136 (672)
Q Consensus 58 ~gv~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 136 (672)
....|....+ .++++++++..+..+. ++|++|+|++|++++.++ .+.++++|++|+|++|++++..|..|+++++
T Consensus 26 ~~~~C~~~~~--c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (353)
T 2z80_A 26 ASLSCDRNGI--CKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101 (353)
T ss_dssp -CCEECTTSE--EECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCCCCeE--eeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCC
Confidence 3567766555 8999999998887665 589999999999999877 8999999999999999999888889999999
Q ss_pred CCeEecccCccccccchhhcCCCccCeeeccCCcccCc-C--CCCCCCCCCeeeccCCc-CCCCCCCcCCCCCCcccc
Q 005880 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP-I--TGLDLRNLQDFNVSGNH-LSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 137 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~--~~~~l~~L~~l~l~~N~-l~g~~p~~l~~~~~~~~~ 210 (672)
|++|+|++|+|++..+..+.++++|++|+|++|++++. . .+..+++|++|++++|+ +++..|..+..++.+...
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 99999999999965555599999999999999999983 3 35689999999999994 665556778877776544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=159.05 Aligned_cols=127 Identities=35% Similarity=0.403 Sum_probs=59.8
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccC
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 145 (672)
+++.|++++|.+++..+ +..+++|+.|+|++|.+++.++ +..+++|+.|+|++|++++..| ++.+++|+.|+|++|
T Consensus 244 ~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n 319 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 319 (466)
T ss_dssp TCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSS
T ss_pred CCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCC
Confidence 34444444444443322 4444444444444444444333 4444455555555555543222 444555555555555
Q ss_pred ccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCC
Q 005880 146 NFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 146 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
++++..| +..+++|+.|++++|++++......+++|+.|++++|++++..|
T Consensus 320 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 320 NISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp CCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGG
T ss_pred cCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccch
Confidence 5554333 44455555555555555544334445555555555555554444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-14 Score=135.60 Aligned_cols=111 Identities=25% Similarity=0.282 Sum_probs=100.3
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..++.|+|++|++++.++. +..+++|++|+|++|+|++.++ .+.++++|++|+|++|+|++..+..+.++++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 5799999999999988776 7999999999999999998887 5799999999999999999777777899999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI 175 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 175 (672)
++|+|++..+..+.++++|++|+|++|++++..
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 999999655556789999999999999998744
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-14 Score=145.52 Aligned_cols=126 Identities=24% Similarity=0.295 Sum_probs=112.8
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++|.+++.++ +..+++|++|+|++|++++..+ +.. ++|+.|+|++|++++ +| .+.++++|+.|+|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 3689999999999998776 9999999999999999998544 444 999999999999995 44 69999999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~ 196 (672)
+|+|++ +| .+..+++|+.|+|++|++++......+++|+.|++++|.+++.
T Consensus 137 ~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 137 NNKLKS-IV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TSCCCB-CG-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCcCCC-Ch-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 999995 45 7999999999999999999986677899999999999999854
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-14 Score=161.69 Aligned_cols=146 Identities=24% Similarity=0.222 Sum_probs=128.5
Q ss_pred EEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCe
Q 005880 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYR 139 (672)
Q Consensus 61 ~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 139 (672)
.|....+ .++++++++..++.+. ++|++|+|++|++++.+| .|.++++|++|+|++|++++..|..|+++++|++
T Consensus 3 ~C~~~~~--c~~~~~~l~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 78 (549)
T 2z81_A 3 SCDASGV--CDGRSRSFTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH 78 (549)
T ss_dssp EECTTSE--EECTTSCCSSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCce--EECCCCccccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCE
Confidence 5766555 7899999998887764 799999999999999887 8999999999999999999888899999999999
Q ss_pred EecccCccccccchhhcCCCccCeeeccCCcccC-cC--CCCCCCCCCeeeccCCcCCCCCC-CcCCCCCCcccc
Q 005880 140 LDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PI--TGLDLRNLQDFNVSGNHLSGQIP-KSLSGFPDSAFT 210 (672)
Q Consensus 140 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~--~~~~l~~L~~l~l~~N~l~g~~p-~~l~~~~~~~~~ 210 (672)
|+|++|++++..|..|+++++|++|+|++|++++ .. .+..+++|++|++++|++.+.+| ..+..++.+...
T Consensus 79 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L 153 (549)
T 2z81_A 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153 (549)
T ss_dssp EECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred EECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCee
Confidence 9999999998877789999999999999999986 33 46789999999999999766777 578887776554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=162.23 Aligned_cols=104 Identities=29% Similarity=0.303 Sum_probs=62.9
Q ss_pred ccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCC
Q 005880 90 LRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169 (672)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 169 (672)
|+.|+|++|+|++. |.++++++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++++++|+.|+|++|
T Consensus 443 L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 443 VRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp CSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred ceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 56666666666653 34666666666666666666 566666666666666666666664 55 5666666666666666
Q ss_pred cccCcC---CCCCCCCCCeeeccCCcCCCCC
Q 005880 170 RFSGPI---TGLDLRNLQDFNVSGNHLSGQI 197 (672)
Q Consensus 170 ~l~~~~---~~~~l~~L~~l~l~~N~l~g~~ 197 (672)
+|++.. .+..+++|+.|+|++|+|++..
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 666532 2345666666666666666443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-14 Score=133.81 Aligned_cols=104 Identities=21% Similarity=0.260 Sum_probs=79.1
Q ss_pred eEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCc
Q 005880 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146 (672)
Q Consensus 68 ~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 146 (672)
+.+++++|+|+..+..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 568888888877666554 788888888888888777 67888888888888888885444556788888888888888
Q ss_pred cccccchhhcCCCccCeeeccCCcccC
Q 005880 147 FSGQIPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 147 l~g~~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
|++..+..|.++++|+.|+|++|++..
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred cceeCHHHhccccCCCEEEeCCCCccc
Confidence 885444457777777777777777664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.52 E-value=3.2e-14 Score=154.82 Aligned_cols=139 Identities=19% Similarity=0.137 Sum_probs=113.4
Q ss_pred EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCcc
Q 005880 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 147 (672)
.++.++++++..+..+. ++|++|+|++|+|++..| .|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 58 ~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 58 KVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 45566667777666554 689999999999999877 899999999999999999988889999999999999999999
Q ss_pred ccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCC-cCCCCCCccc
Q 005880 148 SGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPK-SLSGFPDSAF 209 (672)
Q Consensus 148 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~-~l~~~~~~~~ 209 (672)
++..+..|.++++|++|+|++|+|++.. .+..+++|+.|++++|+..+.+|. .|..++.+..
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~ 200 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCE
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCE
Confidence 9766677999999999999999998732 356788888888888544445654 4555554443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=6.5e-17 Score=155.36 Aligned_cols=142 Identities=22% Similarity=0.321 Sum_probs=119.1
Q ss_pred cEeEEEecCCCcccCCC-------CCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCC
Q 005880 66 RVSHLVLENLQLSGSLQ-------PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLY 138 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~-------~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 138 (672)
+++.++++.+.+.|..+ .+..+++|++|+|++|++++ +|.+.++++|++|+|++|+++ .+|..+..+++|+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 45566666666666554 37788999999999999998 558999999999999999999 8999999999999
Q ss_pred eEecccCccccccchhhcCCCccCeeeccCCcccC-cC--CCCCCCCCCeeeccCCcCCCCCCCc----------CCCCC
Q 005880 139 RLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PI--TGLDLRNLQDFNVSGNHLSGQIPKS----------LSGFP 205 (672)
Q Consensus 139 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~--~~~~l~~L~~l~l~~N~l~g~~p~~----------l~~~~ 205 (672)
.|+|++|+|++ +| .+.++++|+.|+|++|++++ +. ....+++|++|++++|.+++.+|.. +..++
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~ 174 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCS
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCC
Confidence 99999999995 66 68999999999999999997 22 3578999999999999999887763 56666
Q ss_pred Cccccc
Q 005880 206 DSAFTQ 211 (672)
Q Consensus 206 ~~~~~~ 211 (672)
.+...+
T Consensus 175 ~L~~Ld 180 (198)
T 1ds9_A 175 NLKKLD 180 (198)
T ss_dssp SCSEEC
T ss_pred CcEEEC
Confidence 666543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.5e-14 Score=155.49 Aligned_cols=138 Identities=22% Similarity=0.185 Sum_probs=91.9
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|...+.+ ++..+++|++|+|++|++++. | ++.+++|+.|+|++|++++. .++++++|+.|+|++
T Consensus 148 ~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~ 221 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSS 221 (457)
T ss_dssp TTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCS
T ss_pred CcCCEEECCCCCccccc-ccccCCcCCEEECCCCcccee-c-cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcC
Confidence 46778888888655554 577778888888888888874 3 77777788888888887753 377777788888888
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCC----------CCCeeeccCCcCCCCCCC-cCCCCCCcccccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR----------NLQDFNVSGNHLSGQIPK-SLSGFPDSAFTQN 212 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~----------~L~~l~l~~N~l~g~~p~-~l~~~~~~~~~~n 212 (672)
|+|++ +| ++.+++|+.|++++|+|++.. ...++ +|+.|++++|.+.|.+|. .+.++..+.+.+|
T Consensus 222 N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~-~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n 296 (457)
T 3bz5_A 222 NKLTE-ID--VTPLTQLTYFDCSVNPLTELD-VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHN 296 (457)
T ss_dssp SCCSC-CC--CTTCTTCSEEECCSSCCSCCC-CTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTC
T ss_pred Ccccc-cC--ccccCCCCEEEeeCCcCCCcC-HHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCC
Confidence 88875 55 777777888888888777732 22222 445566666666666652 2234444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=3.6e-14 Score=132.47 Aligned_cols=108 Identities=19% Similarity=0.191 Sum_probs=95.3
Q ss_pred CccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccC
Q 005880 89 QLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEA 168 (672)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 168 (672)
..+.|++++|+|+..+..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 10 ~~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 10 SGTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 35799999999998665664 8999999999999988899999999999999999999976666789999999999999
Q ss_pred CcccCcCC--CCCCCCCCeeeccCCcCCCCCC
Q 005880 169 NRFSGPIT--GLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 169 N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p 198 (672)
|+|++..+ +..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99998443 5689999999999999986543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.8e-14 Score=153.29 Aligned_cols=123 Identities=22% Similarity=0.220 Sum_probs=80.3
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.+++.+ ++.+++|++|+|++|+|++. | ++++++|++|+|++|++++ +| ++++++|++|++++
T Consensus 64 ~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~ 136 (457)
T 3bz5_A 64 TGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCAR 136 (457)
T ss_dssp TTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTT
T ss_pred CCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCC
Confidence 45666666666666642 66666666666666666664 2 6666666777777776664 44 66666677777777
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
|+|++ +| ++++++|++|++++|+..+.++...+++|+.|++++|++++ +|
T Consensus 137 N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~ 186 (457)
T 3bz5_A 137 NTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD 186 (457)
T ss_dssp SCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC
T ss_pred Cccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec
Confidence 76664 33 66666677777777666555566667777777777777774 44
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=159.99 Aligned_cols=128 Identities=26% Similarity=0.338 Sum_probs=116.4
Q ss_pred cCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 63 ~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
...+++.|+|++|.|++. +.+..+++|+.|+|++|+|++ ++.+.+|++|+.|+|++|+|++. ..++.|++|+.|+|
T Consensus 85 ~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp GCTTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred cCCCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 346899999999999974 479999999999999999997 46799999999999999999964 78999999999999
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~ 196 (672)
++|+|++..| +..+++|+.|+|++|+|++...+..+++|+.|+|++|++++.
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCSEEEECC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCChHHccCCCCCEEEccCCcCcCC
Confidence 9999997766 999999999999999999966678899999999999999864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=162.89 Aligned_cols=151 Identities=21% Similarity=0.214 Sum_probs=105.7
Q ss_pred CCCCCCCCCCCcccceE--------EcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCccccccee
Q 005880 45 LTTWNSTSDPCSWTGVS--------CLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLL 116 (672)
Q Consensus 45 ~~~W~~~~~~c~w~gv~--------c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L 116 (672)
..+|..+.+||.|+|.. |....++.|++++|+|+..+..+. ++|++|+|++|+|+..++ .+++|++|
T Consensus 12 w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L 86 (622)
T 3g06_A 12 WSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTL 86 (622)
T ss_dssp HHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEE
T ss_pred HHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEE
Confidence 45687777899997653 334568889999999886665554 788888888888886444 56788888
Q ss_pred eccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCC
Q 005880 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 117 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~ 196 (672)
+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++... .+++|++|+|++|+++ .
T Consensus 87 ~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~--~l~~L~~L~Ls~N~l~-~ 155 (622)
T 3g06_A 87 EVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPV--LPPGLQELSVSDNQLA-S 155 (622)
T ss_dssp EECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCS-C
T ss_pred EcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCC--CCCCCCEEECcCCcCC-C
Confidence 88888888 5676 66788888888888874 554 45677777777777776222 2366777777777776 3
Q ss_pred CCCcCCCCCCccccc
Q 005880 197 IPKSLSGFPDSAFTQ 211 (672)
Q Consensus 197 ~p~~l~~~~~~~~~~ 211 (672)
+|..+.++..+.+.+
T Consensus 156 l~~~~~~L~~L~L~~ 170 (622)
T 3g06_A 156 LPALPSELCKLWAYN 170 (622)
T ss_dssp CCCCCTTCCEEECCS
T ss_pred cCCccCCCCEEECCC
Confidence 555444444444333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.4e-14 Score=148.83 Aligned_cols=142 Identities=26% Similarity=0.352 Sum_probs=115.0
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|.+.+..+ +..+++|++|+|++|.+++..+ +..+++|++|+|++|.+++ + +.+..+++|+.|++++
T Consensus 199 ~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~ 274 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGS 274 (347)
T ss_dssp TTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCS
T ss_pred CccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccC
Confidence 578899999999887655 8889999999999999998766 8899999999999999985 4 4688999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCCCC-CcCCCCCCcccccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIP-KSLSGFPDSAFTQN 212 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p-~~l~~~~~~~~~~n 212 (672)
|++++ + ..+..+++|+.|++++|++++.. .+..+++|+.|++++|++++..| ..+.++..+.+.+|
T Consensus 275 n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 275 NQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343 (347)
T ss_dssp SCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC
T ss_pred CccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhh
Confidence 99985 4 45888999999999999998733 24678999999999999997666 23334444444444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.5e-14 Score=155.12 Aligned_cols=129 Identities=29% Similarity=0.330 Sum_probs=117.1
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.+++.++ +..+++|+.|+|++|++++.++ ++++++|+.|+|++|++++..| +..+++|+.|++++
T Consensus 265 ~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 340 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340 (466)
T ss_dssp TTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred CCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCC
Confidence 579999999999998765 8999999999999999998665 8899999999999999997665 88999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKS 200 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~ 200 (672)
|++++. ..+.++++|+.|++++|++++..+...+++|+.|++++|.+++ +|..
T Consensus 341 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~-~p~~ 393 (466)
T 1o6v_A 341 NKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN-APVN 393 (466)
T ss_dssp SCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC-CCBC
T ss_pred CccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC-Cchh
Confidence 999965 4789999999999999999997778899999999999999995 4543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-14 Score=135.44 Aligned_cols=124 Identities=18% Similarity=0.099 Sum_probs=104.9
Q ss_pred CCCCCCCccEEEcccCCCCCCCCCCCccc-ccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCcc
Q 005880 83 PLTSLTQLRVLSLKYNRFTGPVPSLSNLT-ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHL 161 (672)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 161 (672)
.+.++.+|+.|+|++|+++.. |.+..+. +|++|+|++|+|++. ..|+++++|++|+|++|+|++..|..+..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 366788999999999999965 7777776 999999999999964 689999999999999999996544556999999
Q ss_pred CeeeccCCcccC-cC--CCCCCCCCCeeeccCCcCCCCCCCc----CCCCCCcccc
Q 005880 162 LTLKLEANRFSG-PI--TGLDLRNLQDFNVSGNHLSGQIPKS----LSGFPDSAFT 210 (672)
Q Consensus 162 ~~L~l~~N~l~~-~~--~~~~l~~L~~l~l~~N~l~g~~p~~----l~~~~~~~~~ 210 (672)
++|+|++|+|+. +. ....+++|+.|++++|.++ .+|.. +..++.+...
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L 145 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 145 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence 999999999977 32 4568999999999999998 67764 6667766554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.4e-14 Score=147.58 Aligned_cols=144 Identities=19% Similarity=0.175 Sum_probs=103.0
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC--CCCcccccce-eecc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKL-LFLS 119 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~-L~l~ 119 (672)
|+|+.|.|.. ..+++|+|++|+|+.+++. |.+|++|++|+|++|++.+.+| .|.++++|+. +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 7899999964 3688999999999988875 8999999999999999988666 5778888764 5667
Q ss_pred ccccCCCCChhhhccCCCCeEecccCccccccchhhc-------------------------CC-CccCeeeccCCcccC
Q 005880 120 HNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVN-------------------------HL-THLLTLKLEANRFSG 173 (672)
Q Consensus 120 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-------------------------~l-~~L~~L~l~~N~l~~ 173 (672)
+|+|++..|..|.++++|++|++++|+|++..+..+. .+ ..|+.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 7888866677788888888888888888744332221 12 245667777777765
Q ss_pred -cCCCCCCCCCCeeeccCCcCCCCCC
Q 005880 174 -PITGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 174 -~~~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
+...+...+|+.|++++|+..+.+|
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~ 194 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELP 194 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCC
T ss_pred CChhhccccchhHHhhccCCcccCCC
Confidence 2233344456666665432222555
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.5e-14 Score=154.32 Aligned_cols=118 Identities=22% Similarity=0.226 Sum_probs=81.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.|+.++ ..+++|++|+|++|+|++.++ +.+ +|++|+|++|+|++ +|. .+++|+.|+|++
T Consensus 80 ~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 149 (571)
T 3cvr_A 80 PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADN 149 (571)
T ss_dssp TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCC
Confidence 46788888888887544 456778888888888877443 554 77777777777775 666 567777777777
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPK 199 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~ 199 (672)
|+|++ +|. .+++|+.|+|++|+|++... .. ++|+.|+|++|+|+ .+|.
T Consensus 150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~-~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 150 NQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP-ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC-TTCCEEECCSSCCS-SCCC
T ss_pred CccCc-CCC---cCCCcCEEECCCCCCCCcch-hh-CCCCEEECcCCCCC-chhh
Confidence 77774 655 46677777777777776222 22 67777777777777 6665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=129.66 Aligned_cols=104 Identities=18% Similarity=0.205 Sum_probs=92.3
Q ss_pred ccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCC
Q 005880 90 LRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN 169 (672)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 169 (672)
-+.+++++|+++..++.+. ++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3789999999987666665 89999999999999888999999999999999999999755556799999999999999
Q ss_pred cccCcCC--CCCCCCCCeeeccCCcCCC
Q 005880 170 RFSGPIT--GLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 170 ~l~~~~~--~~~l~~L~~l~l~~N~l~g 195 (672)
+|++..+ +..+++|+.|+|++|.|..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 9998443 5689999999999999984
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.6e-14 Score=146.65 Aligned_cols=136 Identities=24% Similarity=0.366 Sum_probs=70.2
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC---------------------CCCcccccceeeccccccC
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP---------------------SLSNLTALKLLFLSHNNFN 124 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p---------------------~~~~l~~L~~L~l~~N~l~ 124 (672)
+++.|++++|.+.+..+ +..+++|+.|+|++|.+++..+ .+..+++|+.|+|++|+++
T Consensus 156 ~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~ 234 (347)
T 4fmz_A 156 GLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKIT 234 (347)
T ss_dssp TCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCcEEEecCCCcCCchh-hccCCCCCEEEccCCcccccccccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccC
Confidence 45555555555544332 4455555555555555554332 1445555555555555555
Q ss_pred CCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCC
Q 005880 125 GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGF 204 (672)
Q Consensus 125 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~ 204 (672)
+ +|. +..+++|++|++++|++++ + ..+..+++|++|++++|++++......+++|+.|++++|++++..|..+..+
T Consensus 235 ~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 310 (347)
T 4fmz_A 235 D-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310 (347)
T ss_dssp C-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHHTC
T ss_pred C-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHhhcc
Confidence 2 332 5555555555555555553 2 2455555555555555555553334455556666666666655555444443
Q ss_pred CC
Q 005880 205 PD 206 (672)
Q Consensus 205 ~~ 206 (672)
+.
T Consensus 311 ~~ 312 (347)
T 4fmz_A 311 TN 312 (347)
T ss_dssp TT
T ss_pred cc
Confidence 33
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=145.20 Aligned_cols=107 Identities=25% Similarity=0.264 Sum_probs=88.3
Q ss_pred CcccceEEcCCcEeEEEecCC-CcccCCCCCCCCCCccEEEccc-CCCCCCCC-CCCcccccceeeccccccCCCCChhh
Q 005880 55 CSWTGVSCLQNRVSHLVLENL-QLSGSLQPLTSLTQLRVLSLKY-NRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSV 131 (672)
Q Consensus 55 c~w~gv~c~~~~v~~L~l~~~-~l~~~~~~l~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~ 131 (672)
|.|.+|.|. ++ +|++++. |..+++|+.|+|++ |+|++.++ .|++|++|+.|+|++|+|++..|..|
T Consensus 8 C~~~~v~~~----------~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 76 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76 (347)
T ss_dssp SSSSCEECC----------SSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGG
T ss_pred ccCCEEEcC----------CCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHh
Confidence 777766664 44 7877777 89999999999996 99998887 78999999999999999998888889
Q ss_pred hccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC
Q 005880 132 SSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 132 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
.+|++|+.|+|++|+|++..+..+..++ |+.|+|++|+|..
T Consensus 77 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 77 HFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred cCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999999999999999965555555555 8888888888775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.45 E-value=5.2e-13 Score=145.01 Aligned_cols=131 Identities=21% Similarity=0.301 Sum_probs=93.9
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|.+++... + .++|++|+|++|++++ +|.++++++|++|++++|++++ +|..+ .+|++|++++
T Consensus 111 ~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~ 182 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGN 182 (454)
T ss_dssp TTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCS
T ss_pred CCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcC
Confidence 456667777666665332 1 1678888888888887 5578888888888888888884 66544 4788888888
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
|++++ +| .++++++|+.|++++|++++.... ..+|+.|++++|+++ .+|. +..++.+..
T Consensus 183 n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~--~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~ 241 (454)
T 1jl5_A 183 NQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL--PLSLESIVAGNNILE-ELPE-LQNLPFLTT 241 (454)
T ss_dssp SCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC--CTTCCEEECCSSCCS-SCCC-CTTCTTCCE
T ss_pred CcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC--cCcccEEECcCCcCC-cccc-cCCCCCCCE
Confidence 88885 66 588888888888888888872221 247788888888877 6773 555554443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=152.18 Aligned_cols=124 Identities=19% Similarity=0.297 Sum_probs=87.1
Q ss_pred CCCCCCccEEE-cccCCCCCCCC------CCCc--ccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchh
Q 005880 84 LTSLTQLRVLS-LKYNRFTGPVP------SLSN--LTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLT 154 (672)
Q Consensus 84 l~~l~~L~~L~-L~~N~l~~~~p------~~~~--l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 154 (672)
++.|++|+.|+ ++.|.+..... .+.. ...|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..
T Consensus 405 l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~ 481 (567)
T 1dce_A 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA 481 (567)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG
T ss_pred HHHHHhcccCcchhhcccchhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh
Confidence 45567777777 55554332110 0111 1247788888888884 676 888888888888888888 78888
Q ss_pred hcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCC-CCcCCCCCCcccc
Q 005880 155 VNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQI-PKSLSGFPDSAFT 210 (672)
Q Consensus 155 ~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~-p~~l~~~~~~~~~ 210 (672)
|+++++|+.|+|++|+|++...+..+++|+.|+|++|+|++.. |..+..++.|..+
T Consensus 482 ~~~l~~L~~L~Ls~N~l~~lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 482 LAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred hhcCCCCCEEECCCCCCCCCcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 8888888888888888888335667888888888888888766 7777666655443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.43 E-value=6.1e-13 Score=144.43 Aligned_cols=136 Identities=18% Similarity=0.154 Sum_probs=98.9
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++|.+++.+. .+++|++|+|++|++++... + .++|++|+|++|++++ +| .|+++++|++|+++
T Consensus 90 ~~~L~~L~l~~n~l~~lp~---~~~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPE---LPQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp CTTCSEEECCSSCCSSCCC---CCTTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCcccc---ccCCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 3567777888777777443 23678888888888776332 2 1678888888888884 77 58888888888888
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccccc
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~~n 212 (672)
+|++++ +|..+ .+|++|++++|++++...+..+++|+.|++++|++++ +|....++..+.+.+|
T Consensus 162 ~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~n 225 (454)
T 1jl5_A 162 NNSLKK-LPDLP---PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNN 225 (454)
T ss_dssp SSCCSC-CCCCC---TTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCCCCTTCCEEECCSS
T ss_pred CCcCcc-cCCCc---ccccEEECcCCcCCcCccccCCCCCCEEECCCCcCCc-CCCCcCcccEEECcCC
Confidence 888884 66543 4788888888888884456778888888888888884 6666666666666655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.42 E-value=2.8e-15 Score=156.36 Aligned_cols=126 Identities=18% Similarity=0.171 Sum_probs=71.4
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCC-CC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGP-VP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
+++.|++++|.+.+.++.+..+++|++|+|++|.+++. +| .+.++++|++|+|++|++++..|..++++++|++|+|+
T Consensus 71 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~ 150 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150 (336)
T ss_dssp TCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred cceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence 45555555555555555555566666666666665543 33 45556666666666666665555566666666666666
Q ss_pred cC-ccccc-cchhhcCCCccCeeeccCC-cccCc-C--CCCCCC-CCCeeeccCC
Q 005880 144 FN-NFSGQ-IPLTVNHLTHLLTLKLEAN-RFSGP-I--TGLDLR-NLQDFNVSGN 191 (672)
Q Consensus 144 ~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~-~--~~~~l~-~L~~l~l~~N 191 (672)
+| .+++. +|..+.++++|++|+|++| ++++. + ....++ +|++|++++|
T Consensus 151 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred CCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 66 45542 4555556666666666666 55541 1 123455 6666666666
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.9e-12 Score=145.19 Aligned_cols=51 Identities=27% Similarity=0.370 Sum_probs=22.9
Q ss_pred CccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccccc
Q 005880 159 THLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQN 212 (672)
Q Consensus 159 ~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~~n 212 (672)
++|+.|+|++|+|++.. ..+++|+.|+|++|+|+ .+|..+.++..+.+.+|
T Consensus 221 ~~L~~L~Ls~N~L~~lp--~~l~~L~~L~Ls~N~L~-~lp~~~~~L~~L~Ls~N 271 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP--VLPSELKELMVSGNRLT-SLPMLPSGLLSLSVYRN 271 (622)
T ss_dssp TTCCEEECCSSCCSCCC--CCCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSS
T ss_pred CCCCEEEccCCccCcCC--CCCCcCcEEECCCCCCC-cCCcccccCcEEeCCCC
Confidence 44555555555555411 23344555555555554 34443333444433333
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-14 Score=149.91 Aligned_cols=157 Identities=15% Similarity=0.128 Sum_probs=114.0
Q ss_pred CCcccceEEcCCcEeEEEecCCCcccCCCCCCCC--CCccEEEcccCCCCCCCCCCCcccccceeeccccccCCC-CChh
Q 005880 54 PCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSL--TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGE-FPDS 130 (672)
Q Consensus 54 ~c~w~gv~c~~~~v~~L~l~~~~l~~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~-~p~~ 130 (672)
|..|.++.|....++.|+++++.+.. ..+..+ ++|+.|++++|.+++.++.+.++++|++|+|++|.+++. +|..
T Consensus 36 c~~W~~~~~~~~~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~ 113 (336)
T 2ast_B 36 CKRWYRLASDESLWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 113 (336)
T ss_dssp CHHHHHHHTCSTTSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHH
T ss_pred HHHHHHHhcCchhheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHH
Confidence 44688887776667888888887662 224455 678888888888888877777888888888888888765 7777
Q ss_pred hhccCCCCeEecccCccccccchhhcCCCccCeeeccCC-cccC-cCC--CCCCCCCCeeeccCC-cCCCC-CCCcCC--
Q 005880 131 VSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEAN-RFSG-PIT--GLDLRNLQDFNVSGN-HLSGQ-IPKSLS-- 202 (672)
Q Consensus 131 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~~-~~~--~~~l~~L~~l~l~~N-~l~g~-~p~~l~-- 202 (672)
+.++++|++|+|++|++++..|..++++++|++|+|++| .+++ .++ ...+++|++|++++| .+++. +|..+.
T Consensus 114 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l 193 (336)
T 2ast_B 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV 193 (336)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhc
Confidence 888888888888888888778888888888888888888 5664 122 346778888888888 77753 454333
Q ss_pred --CCCCcccccc
Q 005880 203 --GFPDSAFTQN 212 (672)
Q Consensus 203 --~~~~~~~~~n 212 (672)
++..+.+.+|
T Consensus 194 ~~~L~~L~l~~~ 205 (336)
T 2ast_B 194 SETITQLNLSGY 205 (336)
T ss_dssp CTTCCEEECCSC
T ss_pred ccCCCEEEeCCC
Confidence 3444444444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=136.93 Aligned_cols=105 Identities=17% Similarity=0.145 Sum_probs=92.3
Q ss_pred cEEEcccC-CCCCCCCCCCcccccceeeccc-cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccC
Q 005880 91 RVLSLKYN-RFTGPVPSLSNLTALKLLFLSH-NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEA 168 (672)
Q Consensus 91 ~~L~L~~N-~l~~~~p~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 168 (672)
..+++++| +|+++++ |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 45799998 9998776 99999999999996 999987778999999999999999999998899999999999999999
Q ss_pred CcccCcC-CCCCCCCCCeeeccCCcCCCC
Q 005880 169 NRFSGPI-TGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 169 N~l~~~~-~~~~l~~L~~l~l~~N~l~g~ 196 (672)
|+|++.. ..+...+|+.|+|++|.|...
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 9999833 334444499999999999843
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2e-14 Score=137.89 Aligned_cols=126 Identities=22% Similarity=0.231 Sum_probs=108.1
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++|.+++.+ .+..+++|++|+|++|.++..++.+..+++|++|+|++|++++ +| .++++++|+.|+|+
T Consensus 47 l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~ 123 (198)
T 1ds9_A 47 LKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred CCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence 468999999999999855 8889999999999999999655467778999999999999995 66 69999999999999
Q ss_pred cCccccccc-hhhcCCCccCeeeccCCcccCcCC------------CCCCCCCCeeeccCCcCC
Q 005880 144 FNNFSGQIP-LTVNHLTHLLTLKLEANRFSGPIT------------GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 144 ~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~------------~~~l~~L~~l~l~~N~l~ 194 (672)
+|+|++..+ ..+..+++|++|++++|++++..+ ...+++|+.|| +|.++
T Consensus 124 ~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 999994332 478999999999999999988432 35788999887 77766
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.9e-13 Score=142.71 Aligned_cols=134 Identities=21% Similarity=0.241 Sum_probs=92.8
Q ss_pred CcEeEEEecCCCcccCCC-----CCCCCC-CccEEEcccCCCCCCCC-CCCcc-----cccceeeccccccCCCCChhhh
Q 005880 65 NRVSHLVLENLQLSGSLQ-----PLTSLT-QLRVLSLKYNRFTGPVP-SLSNL-----TALKLLFLSHNNFNGEFPDSVS 132 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~-----~l~~l~-~L~~L~L~~N~l~~~~p-~~~~l-----~~L~~L~l~~N~l~g~~p~~~~ 132 (672)
.+++.|+|++|.+++... .+..++ +|++|+|++|+|++..+ .+..+ ++|++|+|++|++++..+..++
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 457888888888877664 266677 78888888888877655 45554 7888888888888876666555
Q ss_pred cc-----CCCCeEecccCccccccchhhcC-----CCccCeeeccCCcccCcCC------CCCCC-CCCeeeccCCcCCC
Q 005880 133 SL-----FRLYRLDLSFNNFSGQIPLTVNH-----LTHLLTLKLEANRFSGPIT------GLDLR-NLQDFNVSGNHLSG 195 (672)
Q Consensus 133 ~l-----~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~~~~~------~~~l~-~L~~l~l~~N~l~g 195 (672)
.. ++|++|+|++|+|++..+..+.. .++|++|+|++|+|++... ...++ +|++|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 43 77888888888887665554433 3578888888888774211 12333 78888888888876
Q ss_pred CCC
Q 005880 196 QIP 198 (672)
Q Consensus 196 ~~p 198 (672)
..+
T Consensus 182 ~~~ 184 (362)
T 3goz_A 182 KNC 184 (362)
T ss_dssp SCH
T ss_pred hhH
Confidence 554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.26 E-value=3.1e-13 Score=143.79 Aligned_cols=150 Identities=20% Similarity=0.254 Sum_probs=120.3
Q ss_pred CCcEeEEEecCCCcccCCC----C-CCCC---------CCccEEEcccCCCC-CCCC----CCCcccccceeeccccccC
Q 005880 64 QNRVSHLVLENLQLSGSLQ----P-LTSL---------TQLRVLSLKYNRFT-GPVP----SLSNLTALKLLFLSHNNFN 124 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~----~-l~~l---------~~L~~L~L~~N~l~-~~~p----~~~~l~~L~~L~l~~N~l~ 124 (672)
..+++.|+|++|.++.... . +..+ ++|++|+|++|+++ +.++ .+.++++|++|+|++|+++
T Consensus 121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 4789999999999974322 1 5555 89999999999998 4444 4668899999999999998
Q ss_pred --C---CCChhhhccCCCCeEecccCccc----cccchhhcCCCccCeeeccCCcccCc----CC--C--CCCCCCCeee
Q 005880 125 --G---EFPDSVSSLFRLYRLDLSFNNFS----GQIPLTVNHLTHLLTLKLEANRFSGP----IT--G--LDLRNLQDFN 187 (672)
Q Consensus 125 --g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~l~~N~l~~~----~~--~--~~l~~L~~l~ 187 (672)
| .+|..+.++++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|+|++. ++ . ..+++|+.|+
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 3 35558899999999999999996 67899999999999999999999873 22 1 4589999999
Q ss_pred ccCCcCCC----CCCCcC----CCCCCccccccc
Q 005880 188 VSGNHLSG----QIPKSL----SGFPDSAFTQNA 213 (672)
Q Consensus 188 l~~N~l~g----~~p~~l----~~~~~~~~~~n~ 213 (672)
|++|.+++ .+|..+ .++..+.+.+|+
T Consensus 281 L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred CcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 99999997 488665 444455555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.25 E-value=3.7e-13 Score=143.23 Aligned_cols=122 Identities=21% Similarity=0.278 Sum_probs=58.4
Q ss_pred CCCCCccEEEcccCCCCC----CCC-CCCcccccceeeccccccCCCCChhhh----cc---------CCCCeEecccCc
Q 005880 85 TSLTQLRVLSLKYNRFTG----PVP-SLSNLTALKLLFLSHNNFNGEFPDSVS----SL---------FRLYRLDLSFNN 146 (672)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~----~l---------~~L~~L~l~~N~ 146 (672)
..+++|++|+|++|.+++ .+| .+.++++|++|+|++|.+++..+..+. .+ ++|++|+|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 445555555555555554 122 344555555555555555432222222 22 555555555555
Q ss_pred cc-cccc---hhhcCCCccCeeeccCCccc--C-----cCCCCCCCCCCeeeccCCcCC----CCCCCcCCCCCC
Q 005880 147 FS-GQIP---LTVNHLTHLLTLKLEANRFS--G-----PITGLDLRNLQDFNVSGNHLS----GQIPKSLSGFPD 206 (672)
Q Consensus 147 l~-g~~p---~~~~~l~~L~~L~l~~N~l~--~-----~~~~~~l~~L~~l~l~~N~l~----g~~p~~l~~~~~ 206 (672)
|+ +.+| ..+..+++|++|+|++|+|+ | +.....+++|+.|+|++|.++ +.+|..+..++.
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence 54 3333 24445555555555555554 1 112334555555555555553 344444443333
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-11 Score=129.33 Aligned_cols=125 Identities=13% Similarity=0.078 Sum_probs=100.6
Q ss_pred EEcCCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCCh-hhhccCCCC
Q 005880 61 SCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPD-SVSSLFRLY 138 (672)
Q Consensus 61 ~c~~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~ 138 (672)
.|.. +.++.++++|+.+|..+ .++|++|+|++|+|+.+++ .|.+|++|++|+|++|++.+.+|. .|.++++|.
T Consensus 8 ~C~~---~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~ 82 (350)
T 4ay9_X 8 HCSN---RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLH 82 (350)
T ss_dssp EEET---TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCC
T ss_pred EeeC---CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhh
Confidence 5654 35789999999887766 3689999999999998777 699999999999999999877775 578898877
Q ss_pred e-EecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccC
Q 005880 139 R-LDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSG 190 (672)
Q Consensus 139 ~-L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~ 190 (672)
+ +++++|+|++..|..|.++++|++|++++|+|++..+ .....++..|++++
T Consensus 83 ~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 83 EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp EEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred hhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence 5 6778899997778899999999999999999987333 23333444555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=122.84 Aligned_cols=136 Identities=14% Similarity=0.067 Sum_probs=105.3
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
..++.|+.+.||++... |..+++|+...........+.+|+++++.+. |..+.++++++.+.+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677788999999855 6889999987532223456889999998884 677888999998888999999999999998
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC------------------------------------------- 481 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------- 481 (672)
+.+.. ......++.+++++|+.||...
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76421 1123478899999999999610
Q ss_pred ------------CCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 482 ------------KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 482 ------------~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
....++|+|++|.||+++++..+.|+||+.+
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 0145899999999999987656679999865
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-12 Score=136.71 Aligned_cols=130 Identities=19% Similarity=0.161 Sum_probs=107.7
Q ss_pred EEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-----CCCccc-ccceeeccccccCCCCChhhhcc-----CC
Q 005880 69 HLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-----SLSNLT-ALKLLFLSHNNFNGEFPDSVSSL-----FR 136 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-----~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~ 136 (672)
.++|+.|+++|.++. +...++|++|+|++|.|++..+ .+.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 468899999998877 4555669999999999998764 466788 89999999999998888888886 99
Q ss_pred CCeEecccCccccccchhhcC----C-CccCeeeccCCcccCcCC------CCC-CCCCCeeeccCCcCCCCCC
Q 005880 137 LYRLDLSFNNFSGQIPLTVNH----L-THLLTLKLEANRFSGPIT------GLD-LRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 137 L~~L~l~~N~l~g~~p~~~~~----l-~~L~~L~l~~N~l~~~~~------~~~-l~~L~~l~l~~N~l~g~~p 198 (672)
|++|+|++|+|++..+..+.. + ++|++|+|++|+|++... ... .++|++|+|++|++++..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 999999999999877775554 4 899999999999987332 123 3699999999999995443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-12 Score=142.39 Aligned_cols=143 Identities=18% Similarity=0.136 Sum_probs=98.9
Q ss_pred CCcEeEEEecCCCcccCC-----CC-CCCCCCccEEEcccCCCCCC----CC-CCCcccccceeeccccccCCCCChhhh
Q 005880 64 QNRVSHLVLENLQLSGSL-----QP-LTSLTQLRVLSLKYNRFTGP----VP-SLSNLTALKLLFLSHNNFNGEFPDSVS 132 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~-----~~-l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~ 132 (672)
..++++|+|++|.++... +. +..+++|++|+|++|.++.. ++ .+.++++|++|+|++|.+++..+..+.
T Consensus 226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence 367888899888876532 11 44678888888888888863 23 566778888888888888755555554
Q ss_pred cc-----CCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCcC--CCC-----CCCCCCeeeccCCcCCC-
Q 005880 133 SL-----FRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGPI--TGL-----DLRNLQDFNVSGNHLSG- 195 (672)
Q Consensus 133 ~l-----~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~--~~~-----~l~~L~~l~l~~N~l~g- 195 (672)
.. ++|+.|+|++|.+++. +|..+..+++|++|+|++|++++.. ... ..++|+.|++++|.+++
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~ 385 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChh
Confidence 43 5788888888888765 5666777788888888888876521 111 25678888888888875
Q ss_pred ---CCCCcCCCCCC
Q 005880 196 ---QIPKSLSGFPD 206 (672)
Q Consensus 196 ---~~p~~l~~~~~ 206 (672)
.+|..+..++.
T Consensus 386 ~~~~l~~~l~~~~~ 399 (461)
T 1z7x_W 386 SCSSLAATLLANHS 399 (461)
T ss_dssp HHHHHHHHHHHCCC
T ss_pred hHHHHHHHHHhCCC
Confidence 66655443333
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=8.4e-11 Score=117.43 Aligned_cols=131 Identities=15% Similarity=0.111 Sum_probs=97.5
Q ss_pred ccC-cCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCc--eeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 367 MLG-KGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPN--LVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 367 ~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.++ .|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998877888999997653 2346788898888885444 45688888888889999999999888
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC------------------------------------------ 481 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------ 481 (672)
. ... .+ ...++.++++.|+.||...
T Consensus 103 ~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 103 L--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp T--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred C--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 4 211 11 2367788888888888421
Q ss_pred ------------CCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 482 ------------KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 482 ------------~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
....++|||++|.||+++++..+.|+|||.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01129999999999999877667799999763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.09 E-value=8.1e-13 Score=131.22 Aligned_cols=155 Identities=17% Similarity=0.195 Sum_probs=109.4
Q ss_pred CCcccceEEcCC--cEeEEEecC---CCcccCCCC--CCCCCCccEEEcccCCCCCCCC--CCCcccccce--eeccccc
Q 005880 54 PCSWTGVSCLQN--RVSHLVLEN---LQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKL--LFLSHNN 122 (672)
Q Consensus 54 ~c~w~gv~c~~~--~v~~L~l~~---~~l~~~~~~--l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~--L~l~~N~ 122 (672)
.|.|.|+.|..+ +|+.+...+ ..+.+.+.+ +..++. .|...+|..++.+. .+...+.|.. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 478999999764 777666554 233333321 222222 44556666666555 4777778877 8889885
Q ss_pred cCCCCChh----hhccCCCCeEecccCcccc--ccchhhcCCCccCeeeccCCcccCcCCCCCCC--CCCeeeccCCcCC
Q 005880 123 FNGEFPDS----VSSLFRLYRLDLSFNNFSG--QIPLTVNHLTHLLTLKLEANRFSGPITGLDLR--NLQDFNVSGNHLS 194 (672)
Q Consensus 123 l~g~~p~~----~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~--~L~~l~l~~N~l~ 194 (672)
.. .++.. ..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++......+. +|++|+|++|.++
T Consensus 155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 155 RS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp HH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTG
T ss_pred HH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCc
Confidence 44 34432 3578899999999999997 56778889999999999999999853333333 8999999999999
Q ss_pred CCCCC-------cCCCCCCccccc
Q 005880 195 GQIPK-------SLSGFPDSAFTQ 211 (672)
Q Consensus 195 g~~p~-------~l~~~~~~~~~~ 211 (672)
+.+|. .+..+|.|..++
T Consensus 234 ~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 234 DTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cccCcchhHHHHHHHHCcccCeEC
Confidence 88874 256677776654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.05 E-value=3.1e-12 Score=139.37 Aligned_cols=148 Identities=18% Similarity=0.171 Sum_probs=115.0
Q ss_pred CcEeEEEecCCCcccC-----CCCCCCCCCccEEEcccCCCCCCC-----C-CCCcccccceeeccccccCCC----CCh
Q 005880 65 NRVSHLVLENLQLSGS-----LQPLTSLTQLRVLSLKYNRFTGPV-----P-SLSNLTALKLLFLSHNNFNGE----FPD 129 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~-----~~~l~~l~~L~~L~L~~N~l~~~~-----p-~~~~l~~L~~L~l~~N~l~g~----~p~ 129 (672)
.+++.|+|++|.+++. ...+..+++|++|+|++|.++... + .+..+++|++|+|++|++++. ++.
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 278 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence 4899999999999874 233778899999999999988632 2 234689999999999999954 788
Q ss_pred hhhccCCCCeEecccCccccccchhhcCC-----CccCeeeccCCcccCcC----C--CCCCCCCCeeeccCCcCCCCCC
Q 005880 130 SVSSLFRLYRLDLSFNNFSGQIPLTVNHL-----THLLTLKLEANRFSGPI----T--GLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 130 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~~~~----~--~~~l~~L~~l~l~~N~l~g~~p 198 (672)
.+.++++|++|+|++|.+++..+..+... ++|+.|+|++|++++.. + ...+++|++|++++|.+++..+
T Consensus 279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 358 (461)
T 1z7x_W 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358 (461)
T ss_dssp HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence 88899999999999999986655555433 79999999999998732 1 2467899999999999986544
Q ss_pred CcC--------CCCCCcccccc
Q 005880 199 KSL--------SGFPDSAFTQN 212 (672)
Q Consensus 199 ~~l--------~~~~~~~~~~n 212 (672)
..+ ..+..+.+.+|
T Consensus 359 ~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 359 RELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHcCCCCceEEEECCCC
Confidence 332 25555555555
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=6.2e-10 Score=116.91 Aligned_cols=142 Identities=16% Similarity=0.209 Sum_probs=105.5
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcc--cCC-cchHHHHHHHHHHHcCCC--CCceeeeEEEEEcC---CeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLK--DAS-IGGKREFEQHMEVLGRLR--HPNLVGLKAYYFAR---EEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 437 (672)
+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568899999999998764 578888876 322 123457888999998886 45678888888765 458999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC------------------------------------
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC------------------------------------ 481 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 481 (672)
++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9988774321 123678889999999999999999621
Q ss_pred ------------------CCCCcEecCCCCCCEEeCCCCc--EEEeccCCCccC
Q 005880 482 ------------------KSLKLTHGNIKSTNVLLDKTGN--ARVSDFGLSIFA 515 (672)
Q Consensus 482 ------------------~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~~ 515 (672)
....++|||+++.||++++++. +.|.||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 0256999999999999997753 689999988643
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.2e-11 Score=127.03 Aligned_cols=131 Identities=18% Similarity=0.123 Sum_probs=79.3
Q ss_pred CcEeEEEecCCCcccCCCC-----CC-CCCCccEEEcccCCCCCCCC-C-CCcccccceeeccccccCCCCChhhh----
Q 005880 65 NRVSHLVLENLQLSGSLQP-----LT-SLTQLRVLSLKYNRFTGPVP-S-LSNLTALKLLFLSHNNFNGEFPDSVS---- 132 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-----l~-~l~~L~~L~L~~N~l~~~~p-~-~~~l~~L~~L~l~~N~l~g~~p~~~~---- 132 (672)
..++.|+|++|.++..... +. ..++|+.|+|++|.|+.... . ...+++|+.|+|++|+|+..-...+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 4677777777777643211 22 23577777777777764221 2 23456777777777777644333332
Q ss_pred -ccCCCCeEecccCcccc----ccchhhcCCCccCeeeccCCcccCc------CCCCCCCCCCeeeccCCcCCC
Q 005880 133 -SLFRLYRLDLSFNNFSG----QIPLTVNHLTHLLTLKLEANRFSGP------ITGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 133 -~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~------~~~~~l~~L~~l~l~~N~l~g 195 (672)
..++|++|+|++|.|+. .++..+..+++|++|+|++|+|+.. ......++|+.|+|++|.|+.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 34567777777777763 2444456677777777777777641 112345567777777777763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=7.2e-11 Score=124.34 Aligned_cols=132 Identities=17% Similarity=0.197 Sum_probs=102.9
Q ss_pred CcEeEEEecCCCcccCCC-C-CCCCCCccEEEcccCCCCCCCC-CC-----CcccccceeeccccccCC----CCChhhh
Q 005880 65 NRVSHLVLENLQLSGSLQ-P-LTSLTQLRVLSLKYNRFTGPVP-SL-----SNLTALKLLFLSHNNFNG----EFPDSVS 132 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~-~-l~~l~~L~~L~L~~N~l~~~~p-~~-----~~l~~L~~L~l~~N~l~g----~~p~~~~ 132 (672)
.+++.|+|++|.++.... . ...+++|+.|+|++|.|+.... .+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 589999999999864321 1 2346789999999999985432 22 346889999999999974 3555667
Q ss_pred ccCCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCcC--C----CCCCCCCCeeeccCCcCCCC
Q 005880 133 SLFRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGPI--T----GLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 133 ~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~--~----~~~l~~L~~l~l~~N~l~g~ 196 (672)
.+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+..- . ....++|++|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 889999999999999853 3567788899999999999997621 1 22568899999999998843
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.7e-10 Score=115.75 Aligned_cols=181 Identities=20% Similarity=0.198 Sum_probs=121.9
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCc--eeeeEEEEEcCC---eEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPN--LVGLKAYYFARE---EKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~ 439 (672)
+.++.|.+..||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 457889999999863 45888886532 24567899999998773 333 334444433332 3478999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC-------------------------------------- 481 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 481 (672)
|.+|.+... ..++..++..++.++++.|+.||...
T Consensus 100 G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 988865432 12677888899999999999999510
Q ss_pred ----------------CCCCcEecCCCCCCEEeCC--CCcEEEeccCCCccCCCC----CCCCC---C----------cc
Q 005880 482 ----------------KSLKLTHGNIKSTNVLLDK--TGNARVSDFGLSIFAPPS----TVPRS---N----------GY 526 (672)
Q Consensus 482 ----------------~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~----~~~~t---~----------~y 526 (672)
....++|+|++|.||++++ +..+.|+||+.+....+. ..... . +|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1135899999999999998 456789999998655432 00000 0 12
Q ss_pred --cC-CCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005880 527 --RA-PELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSV 563 (672)
Q Consensus 527 --~a-PE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~ 563 (672)
.. |+.. .......+.|++|.++|++.+|+.+|.
T Consensus 253 ~~~~~~~~~----~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVL----EKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHH----HHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHH----HHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 1211 011223689999999999999987763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.4e-08 Score=105.07 Aligned_cols=53 Identities=9% Similarity=0.269 Sum_probs=36.2
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFL 118 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l 118 (672)
.+++.|+|.+ +++.+.+. |.++++|+.|+|++|.++.+.+ .|.++.++..|.+
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~ 155 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPL 155 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECT
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecC
Confidence 5788889988 78776655 8899999999999998764444 4444444443333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.71 E-value=2.1e-08 Score=103.89 Aligned_cols=60 Identities=10% Similarity=0.058 Sum_probs=46.9
Q ss_pred CCcEeEEEecCCCcc--------------------cCCCC-CCC--------CCCccEEEcccCCCCCCCC-CCCccccc
Q 005880 64 QNRVSHLVLENLQLS--------------------GSLQP-LTS--------LTQLRVLSLKYNRFTGPVP-SLSNLTAL 113 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~--------------------~~~~~-l~~--------l~~L~~L~L~~N~l~~~~p-~~~~l~~L 113 (672)
..+++.|||++|++. .+++. |.+ +++|+.|+|.+ +++.+.+ .|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 457889999998887 11222 667 89999999999 8887666 79999999
Q ss_pred ceeeccccccC
Q 005880 114 KLLFLSHNNFN 124 (672)
Q Consensus 114 ~~L~l~~N~l~ 124 (672)
+.|+|++|.++
T Consensus 127 ~~l~l~~n~i~ 137 (329)
T 3sb4_A 127 KICQIRKKTAP 137 (329)
T ss_dssp CEEEBCCSSCC
T ss_pred ceEEcCCCCcc
Confidence 99999999875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.66 E-value=2.2e-09 Score=120.62 Aligned_cols=85 Identities=15% Similarity=0.067 Sum_probs=35.6
Q ss_pred ccccceeecccc--ccCCCCChhhhc-cCCCCeEecccCcccc-ccchhhcCCCccCeeeccCCcccCc-CC--CCCCCC
Q 005880 110 LTALKLLFLSHN--NFNGEFPDSVSS-LFRLYRLDLSFNNFSG-QIPLTVNHLTHLLTLKLEANRFSGP-IT--GLDLRN 182 (672)
Q Consensus 110 l~~L~~L~l~~N--~l~g~~p~~~~~-l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~-~~--~~~l~~ 182 (672)
+++|++|+|++| .+++..+..++. +++|+.|+|++|++++ .++..+..+++|+.|+|++|+|++. ++ ...+++
T Consensus 435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~ 514 (592)
T 3ogk_B 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514 (592)
T ss_dssp CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSS
T ss_pred CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCc
Confidence 444444444421 233333333332 4445555555554443 2233334444555555555544331 11 123444
Q ss_pred CCeeeccCCcCC
Q 005880 183 LQDFNVSGNHLS 194 (672)
Q Consensus 183 L~~l~l~~N~l~ 194 (672)
|+.|+|++|+++
T Consensus 515 L~~L~ls~n~it 526 (592)
T 3ogk_B 515 LRYLWVQGYRAS 526 (592)
T ss_dssp CCEEEEESCBCC
T ss_pred cCeeECcCCcCC
Confidence 555555555544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=4.7e-08 Score=96.88 Aligned_cols=100 Identities=21% Similarity=0.228 Sum_probs=66.6
Q ss_pred CCCCccE--EEcccCCCCC---CCC-CCCcccccceeeccccccCC--CCChhhhccCCCCeEecccCccccccchhhcC
Q 005880 86 SLTQLRV--LSLKYNRFTG---PVP-SLSNLTALKLLFLSHNNFNG--EFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNH 157 (672)
Q Consensus 86 ~l~~L~~--L~L~~N~l~~---~~p-~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 157 (672)
..+.|+. ++++.|+... .++ ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..
T Consensus 139 ~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~ 216 (267)
T 3rw6_A 139 SDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDK 216 (267)
T ss_dssp GCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGG
T ss_pred CCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhh
Confidence 3344544 5666664331 112 12467788888888888886 5567777888888888888888854 34444
Q ss_pred CC--ccCeeeccCCcccCcCC---------CCCCCCCCeee
Q 005880 158 LT--HLLTLKLEANRFSGPIT---------GLDLRNLQDFN 187 (672)
Q Consensus 158 l~--~L~~L~l~~N~l~~~~~---------~~~l~~L~~l~ 187 (672)
+. +|++|+|++|.+++..+ ...+++|+.||
T Consensus 217 l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 217 IKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 54 78888888888887443 23577777775
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.2e-08 Score=114.68 Aligned_cols=125 Identities=12% Similarity=0.054 Sum_probs=88.2
Q ss_pred cEeEEEecCCC-ccc-CCCC-CCCCCCccEEEcccCCCCCCC----C-CCCcccccceeeccccccC----CCCChhhhc
Q 005880 66 RVSHLVLENLQ-LSG-SLQP-LTSLTQLRVLSLKYNRFTGPV----P-SLSNLTALKLLFLSHNNFN----GEFPDSVSS 133 (672)
Q Consensus 66 ~v~~L~l~~~~-l~~-~~~~-l~~l~~L~~L~L~~N~l~~~~----p-~~~~l~~L~~L~l~~N~l~----g~~p~~~~~ 133 (672)
+++.|+|+++. ++. .+.. ..++++|++|+|++|.+++.- + .+.++++|+.|+|++|.++ +.++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999886 211 0111 347889999999999987652 2 2457889999999999997 345556678
Q ss_pred cCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC-----cCCCCCCCCCCeeeccCC
Q 005880 134 LFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-----PITGLDLRNLQDFNVSGN 191 (672)
Q Consensus 134 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-----~~~~~~l~~L~~l~l~~N 191 (672)
+++|+.|+|++|.+.+ +|..+.++++|+.|+++++.... ......+++|+.|+++++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 280 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence 8999999999999985 77888889999999987643221 112234455555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=2e-08 Score=94.56 Aligned_cols=111 Identities=15% Similarity=0.152 Sum_probs=72.2
Q ss_pred CCCCCCccEEEcccC-CCCCC-----CCCCCcccccceeeccccccCCC----CChhhhccCCCCeEecccCccccc---
Q 005880 84 LTSLTQLRVLSLKYN-RFTGP-----VPSLSNLTALKLLFLSHNNFNGE----FPDSVSSLFRLYRLDLSFNNFSGQ--- 150 (672)
Q Consensus 84 l~~l~~L~~L~L~~N-~l~~~-----~p~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~--- 150 (672)
+...++|++|+|++| .|... ...+...++|++|+|++|+|... +...+...++|++|+|++|+|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 455677777777777 76631 11345567777788888777632 334455557788888888887743
Q ss_pred -cchhhcCCCccCeeec--cCCcccCcC--C----CCCCCCCCeeeccCCcCC
Q 005880 151 -IPLTVNHLTHLLTLKL--EANRFSGPI--T----GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 151 -~p~~~~~l~~L~~L~l--~~N~l~~~~--~----~~~l~~L~~l~l~~N~l~ 194 (672)
+...+...++|++|+| ++|.|+..- . ....++|++|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4556666777888888 778776411 1 124567888888888764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=9.3e-07 Score=88.49 Aligned_cols=135 Identities=19% Similarity=0.190 Sum_probs=97.1
Q ss_pred ccCcCCeE-EEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 367 MLGKGGFG-TAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 367 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+..|..| .||+.... ++..++||+-... ...++.+|...|+.+. +--+-++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34456555 68988754 4677889986532 4567888999888774 33366788899888999999999999888
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT------------------------------------------- 480 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------- 480 (672)
.+..... ......++.++++.|+.||..
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7765422 123345677777777778721
Q ss_pred -----------CCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 481 -----------CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 481 -----------~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
.....++|+|+.+.||++++++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 001127999999999999987777899998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.4e-06 Score=89.07 Aligned_cols=136 Identities=16% Similarity=0.067 Sum_probs=96.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCC---ceeeeEEEEE-cCCeEEEEEeecCCC
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHP---NLVGLKAYYF-AREEKLLVSEYMPNG 441 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g 441 (672)
+.++.|....||+. |..++||+-.. ......+.+|.++|+.+.+. .+.+++.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888999987 56678887432 22456789999999988642 3556666664 455678999999998
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC---------------------------------------- 481 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 481 (672)
++.+..-. .++..++..++.++++.|+.||...
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88764221 2455666677777777777777421
Q ss_pred ----------------CCCCcEecCCCCCCEEeCC---CCc-EEEeccCCCcc
Q 005880 482 ----------------KSLKLTHGNIKSTNVLLDK---TGN-ARVSDFGLSIF 514 (672)
Q Consensus 482 ----------------~~~~iiH~Dlkp~NIll~~---~~~-~kl~DfG~a~~ 514 (672)
....++|+|+++.||++++ ++. ..|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 48999997643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.4e-08 Score=110.91 Aligned_cols=108 Identities=14% Similarity=0.089 Sum_probs=59.0
Q ss_pred CCCccEEEcccCCCCCCCC-CCC-cccccceeecc--c----cccCCC-----CChhhhccCCCCeEecccCccccccch
Q 005880 87 LTQLRVLSLKYNRFTGPVP-SLS-NLTALKLLFLS--H----NNFNGE-----FPDSVSSLFRLYRLDLSFNNFSGQIPL 153 (672)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~l~--~----N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~~p~ 153 (672)
+++|+.|+++.|.+++... .+. ++++|+.|+|+ + |++++. ++..+.++++|+.|+|++ ++++..+.
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 5666666666666664332 332 45666666666 3 444421 112245566666666655 55544444
Q ss_pred hhcC-CCccCeeeccCCcccCcC--CC-CCCCCCCeeeccCCcCCC
Q 005880 154 TVNH-LTHLLTLKLEANRFSGPI--TG-LDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 154 ~~~~-l~~L~~L~l~~N~l~~~~--~~-~~l~~L~~l~l~~N~l~g 195 (672)
.++. +++|+.|+|++|.+++.. .. ..+++|+.|+|++|.+++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 4544 666666666666665411 11 235666666666666643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.31 E-value=5.2e-08 Score=91.74 Aligned_cols=109 Identities=19% Similarity=0.235 Sum_probs=86.4
Q ss_pred CCcEeEEEecCC-CcccC-----CCCCCCCCCccEEEcccCCCCCCC----C-CCCcccccceeeccccccCCC----CC
Q 005880 64 QNRVSHLVLENL-QLSGS-----LQPLTSLTQLRVLSLKYNRFTGPV----P-SLSNLTALKLLFLSHNNFNGE----FP 128 (672)
Q Consensus 64 ~~~v~~L~l~~~-~l~~~-----~~~l~~l~~L~~L~L~~N~l~~~~----p-~~~~l~~L~~L~l~~N~l~g~----~p 128 (672)
...+++|+|++| .+... ...+...++|++|+|++|.|+..- . .+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 467999999999 88642 122677889999999999997421 1 355668899999999999853 45
Q ss_pred hhhhccCCCCeEec--ccCccccc----cchhhcCCCccCeeeccCCccc
Q 005880 129 DSVSSLFRLYRLDL--SFNNFSGQ----IPLTVNHLTHLLTLKLEANRFS 172 (672)
Q Consensus 129 ~~~~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 172 (672)
..+...+.|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 66777889999999 88999854 4455667799999999999885
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=2.4e-07 Score=96.59 Aligned_cols=128 Identities=17% Similarity=0.167 Sum_probs=69.2
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CC--Ccccccceeeccc--cccCCC-----CChhh--h
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SL--SNLTALKLLFLSH--NNFNGE-----FPDSV--S 132 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~--~~l~~L~~L~l~~--N~l~g~-----~p~~~--~ 132 (672)
.+++.|+|++|.-. .++.+. +++|+.|+|..+.++...- .+ ..+++|+.|+|+. |...|. +...+ .
T Consensus 172 P~L~~L~L~g~~~l-~l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~ 249 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGKKP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD 249 (362)
T ss_dssp TTCCEEEEECCBTC-BCCSCB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTT
T ss_pred CCCcEEEEeCCCCc-eecccc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcC
Confidence 46777777665211 122232 6677777777666543211 22 2566777777653 222111 11112 2
Q ss_pred ccCCCCeEecccCccccccchhhc---CCCccCeeeccCCcccCc----CC--CCCCCCCCeeeccCCcCC
Q 005880 133 SLFRLYRLDLSFNNFSGQIPLTVN---HLTHLLTLKLEANRFSGP----IT--GLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 133 ~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~~~----~~--~~~l~~L~~l~l~~N~l~ 194 (672)
.+++|+.|+|++|.+++..+..+. .+++|++|+|+.|+|++. +. ...+++|+.|+|++|.++
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 356777777777777654443333 466777777777777551 11 124567777777777665
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.5e-06 Score=90.78 Aligned_cols=80 Identities=6% Similarity=-0.034 Sum_probs=55.2
Q ss_pred ccc-CcCCeEEEEEEEEc-------CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCC-C--CceeeeEEEEEcC---
Q 005880 366 EML-GKGGFGTAYKAVLD-------DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLR-H--PNLVGLKAYYFAR--- 428 (672)
Q Consensus 366 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 428 (672)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78999999998764 26778899865432 111245778888887774 2 3466778777554
Q ss_pred CeEEEEEeecCCCChhH
Q 005880 429 EEKLLVSEYMPNGSLFW 445 (672)
Q Consensus 429 ~~~~lv~e~~~~g~L~~ 445 (672)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.05 E-value=4.5e-07 Score=101.66 Aligned_cols=131 Identities=16% Similarity=0.091 Sum_probs=90.7
Q ss_pred CcEeEEEecCC-CcccC-CCC-CCCCCCccEEEcccCCCCCCCC-C----CCcccccceeeccccc--cCC-CCChhhhc
Q 005880 65 NRVSHLVLENL-QLSGS-LQP-LTSLTQLRVLSLKYNRFTGPVP-S----LSNLTALKLLFLSHNN--FNG-EFPDSVSS 133 (672)
Q Consensus 65 ~~v~~L~l~~~-~l~~~-~~~-l~~l~~L~~L~L~~N~l~~~~p-~----~~~l~~L~~L~l~~N~--l~g-~~p~~~~~ 133 (672)
.+++.|+|++| .++.. ++. +.++++|++|+|++|.+++..+ . ...+++|+.|+|++|. ++. .++..+.+
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~ 209 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHh
Confidence 58999999998 55432 222 4578999999999999887543 2 3377899999999997 221 12222355
Q ss_pred cCCCCeEecccC-ccccccchhhcCCCccCeeeccCCcc--------------------------cC----cCCC--CCC
Q 005880 134 LFRLYRLDLSFN-NFSGQIPLTVNHLTHLLTLKLEANRF--------------------------SG----PITG--LDL 180 (672)
Q Consensus 134 l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l--------------------------~~----~~~~--~~l 180 (672)
+++|+.|+|++| .++ .+|..+.++++|+.|+++.+.. .. .++. ..+
T Consensus 210 ~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~ 288 (594)
T 2p1m_B 210 CPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288 (594)
T ss_dssp CTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred CCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence 689999999998 555 4888888888888888665521 11 0110 146
Q ss_pred CCCCeeeccCCcCCCC
Q 005880 181 RNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 181 ~~L~~l~l~~N~l~g~ 196 (672)
++|+.|+|++|.+++.
T Consensus 289 ~~L~~L~L~~~~l~~~ 304 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSY 304 (594)
T ss_dssp TTCCEEECTTCCCCHH
T ss_pred CCCCEEEccCCCCCHH
Confidence 7899999999987754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.03 E-value=1.8e-05 Score=83.91 Aligned_cols=124 Identities=10% Similarity=0.080 Sum_probs=80.2
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
..++.+.|.++ ++.+... |.++++|+.|+|..| ++.+.. .|.+ .+|+.+.| .|+++..-+..|.++++|+.+++
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 45777788744 5554444 788888888888875 443333 5555 67777777 44455344566777777888877
Q ss_pred ccCccc-----cccchhhcCCCccCeeeccCCcccC--cCCCCCCCCCCeeeccCCcCC
Q 005880 143 SFNNFS-----GQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 143 ~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l~ 194 (672)
.+|.+. ..-+..|.+|++|+.++|.+ +++. .-.+..+.+|+.|+|.+| ++
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-cc
Confidence 777664 23345677777777777773 3543 334556777777777544 44
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.6e-05 Score=80.66 Aligned_cols=142 Identities=18% Similarity=0.211 Sum_probs=79.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-----CCCceeeeE-E--EEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-----RHPNLVGLK-A--YYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~e~ 437 (672)
+.|+.|..+.||+....+|. +++|+.... ..++..|.++++.+ ..|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34666778899999876554 889988752 23334455544444 234444311 0 12246678999999
Q ss_pred cCCCChh--------------HHhhcCC--C--C-C----CCCCCHHHHH------------------------------
Q 005880 438 MPNGSLF--------------WLLHGNR--G--P-G----RTPLDWTTRL------------------------------ 464 (672)
Q Consensus 438 ~~~g~L~--------------~~l~~~~--~--~-~----~~~l~~~~~~------------------------------ 464 (672)
++|..+. ..+|... . . . ...-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122110 0 0 0 0112343211
Q ss_pred -HHHHHHHHHHHHHHh--------h-CCCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 465 -KIAAGAARGLAFIHF--------T-CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 465 -~i~~~ia~~L~~LH~--------~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
.+...+.+++.+|+. . .....++|||+++.||+++.++.+.|+||+.+
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 111223445666653 0 01478999999999999988889999999965
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.3e-06 Score=89.24 Aligned_cols=130 Identities=15% Similarity=0.187 Sum_probs=89.6
Q ss_pred CcEeEEEecCCCccc---------CCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhh--
Q 005880 65 NRVSHLVLENLQLSG---------SLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVS-- 132 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~---------~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~-- 132 (672)
.+++.|.+.++.... .+.. +..+++|+.|+|++|.-.. ++.+ .+++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l~~~-~~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-IGKK-PRPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-CCSC-BCTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-eccc-cCCCCcEEEEecCCCChHHHHHHHHc
Confidence 588999987654321 1212 5678999999999884112 3334 389999999999988754444555
Q ss_pred ccCCCCeEeccc--Cccccc-----cchhh--cCCCccCeeeccCCcccCcC-----CCCCCCCCCeeeccCCcCCCC
Q 005880 133 SLFRLYRLDLSF--NNFSGQ-----IPLTV--NHLTHLLTLKLEANRFSGPI-----TGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 133 ~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~~~~-----~~~~l~~L~~l~l~~N~l~g~ 196 (672)
.+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+.... ....+++|++|+|+.|.|++.
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 789999999964 332221 11122 35789999999999987521 113578999999999999863
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.94 E-value=3.4e-05 Score=81.67 Aligned_cols=122 Identities=13% Similarity=0.124 Sum_probs=66.9
Q ss_pred cEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 66 RVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
.++.+.|.+ .++.+... |.++++|+.++|++|+++.+.. .|. ..+|+.+.|.+| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 477777765 55544443 7778888888888887776555 343 466777777643 553334456666666666666
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccC--cCCCCCCCCCCeeeccCCcC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNLQDFNVSGNHL 193 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l 193 (672)
.| ++..-...|.+ .+|+.+.| .|+++. .-.+..+++|+.+++.+|.+
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence 54 33222223333 44555555 222322 22333445555555544443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=4.6e-05 Score=80.69 Aligned_cols=74 Identities=15% Similarity=0.110 Sum_probs=48.2
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-------chHHHHHHHHHHHcCCCC--Ccee-eeEEEEEcCCeEEEE
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-------GGKREFEQHMEVLGRLRH--PNLV-GLKAYYFAREEKLLV 434 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~lv 434 (672)
+.+|.|.++.||++... +++.++||....... .....+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 468899998653211 123456778888877632 3333 45543 45566899
Q ss_pred EeecCCC
Q 005880 435 SEYMPNG 441 (672)
Q Consensus 435 ~e~~~~g 441 (672)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.0001 Score=74.87 Aligned_cols=140 Identities=16% Similarity=0.113 Sum_probs=92.0
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC---CCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR---HPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.|+.|.+..+|+.... +..++||+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45888999999998864 677888987533 3567889998888773 3567888888888888999999999876
Q ss_pred hhH-----------HhhcCCC-C--C--------------CCCCCHHHHH---HHHH--H--------------HHHHH-
Q 005880 443 LFW-----------LLHGNRG-P--G--------------RTPLDWTTRL---KIAA--G--------------AARGL- 474 (672)
Q Consensus 443 L~~-----------~l~~~~~-~--~--------------~~~l~~~~~~---~i~~--~--------------ia~~L- 474 (672)
+.. .||.... . + ...-+|.... ++.. + +.+.+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 521 2332211 0 0 0112565432 1111 1 11111
Q ss_pred HHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccC
Q 005880 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFG 510 (672)
Q Consensus 475 ~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG 510 (672)
..|........++|+|+.+.|++++.++ +.|.||+
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2232112246799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00012 Score=73.65 Aligned_cols=74 Identities=19% Similarity=0.197 Sum_probs=54.5
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC---CceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH---PNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+|.|..+.||+.+..+|+.|+||+-..........|..|.+.|+.+.- --+.+++++. ..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 56899999999999999999999998765444345578889988877732 1244455442 3478999998765
Q ss_pred h
Q 005880 443 L 443 (672)
Q Consensus 443 L 443 (672)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00031 Score=74.85 Aligned_cols=76 Identities=14% Similarity=0.201 Sum_probs=49.5
Q ss_pred CCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCCCC------CCcccCCCccccC-CCCCCchhHHHHHHHHHHHH
Q 005880 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR------SNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLEL 555 (672)
Q Consensus 483 ~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~------t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el 555 (672)
...++|||++|.||++++++ ++++||+.+....+....+ ...|.+|+..... +.......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 57899999999999998876 9999999886544321111 1235666532211 11122345667888888888
Q ss_pred HhCC
Q 005880 556 LTGK 559 (672)
Q Consensus 556 ~tg~ 559 (672)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0011 Score=67.82 Aligned_cols=144 Identities=12% Similarity=0.025 Sum_probs=81.6
Q ss_pred ccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCC--ceeeeEEE-----EEcCCeEEEEEeecC
Q 005880 367 MLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHP--NLVGLKAY-----YFAREEKLLVSEYMP 439 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~ 439 (672)
.++ |....||+....+|+.+++|....... ....+..|..++..+... .+.+++.. ....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 777899998877787899999864321 345667777777666321 23334332 122456688999998
Q ss_pred CCChh-----H---------Hhhc----CCCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhhC-
Q 005880 440 NGSLF-----W---------LLHG----NRGPGRTPLDWTTR----LKI---------------AAGAARGLAFIHFTC- 481 (672)
Q Consensus 440 ~g~L~-----~---------~l~~----~~~~~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~~- 481 (672)
|..+. . .+|. .....+...++... ..+ ...+.+.++.+....
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 0 0111 11011122333221 001 111122233333221
Q ss_pred --CCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 482 --KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 482 --~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
....++|||+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235689999999999999 4 899999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00034 Score=70.87 Aligned_cols=141 Identities=11% Similarity=0.025 Sum_probs=73.5
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCce-eeeEEEEEcCCeEEEEEeec-CCCCh
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL-VGLKAYYFAREEKLLVSEYM-PNGSL 443 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~L 443 (672)
+.|+.|....+|+. ..+++|+...... ...+..+|+.+++.+....+ .+++++ +.+..++|+||+ ++-++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999998 4578888764321 11123457766665532223 344443 444567899999 55444
Q ss_pred hH------------------HhhcCCCCCCCCCC-HHHHHHHHHH--------------HHHHHH----HHHhhCCCCCc
Q 005880 444 FW------------------LLHGNRGPGRTPLD-WTTRLKIAAG--------------AARGLA----FIHFTCKSLKL 486 (672)
Q Consensus 444 ~~------------------~l~~~~~~~~~~l~-~~~~~~i~~~--------------ia~~L~----~LH~~~~~~~i 486 (672)
.. .+|..........+ +.....+... +.+.+. .+........+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 11111100000011 1111111110 111111 11111123458
Q ss_pred EecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 487 THGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 487 iH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
+|+|+.+.||+ ..++.+.++||..+...
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 99999999999 56677899999987543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.25 E-value=7.7e-05 Score=68.47 Aligned_cols=83 Identities=10% Similarity=0.132 Sum_probs=50.1
Q ss_pred CCccEEEcccCCCCCC-CCCCCcccccceeeccccc-cCCCCChhhhcc----CCCCeEecccCc-cccccchhhcCCCc
Q 005880 88 TQLRVLSLKYNRFTGP-VPSLSNLTALKLLFLSHNN-FNGEFPDSVSSL----FRLYRLDLSFNN-FSGQIPLTVNHLTH 160 (672)
Q Consensus 88 ~~L~~L~L~~N~l~~~-~p~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~ 160 (672)
.+|+.|||+++.++.. +..+.++++|+.|+|+++. ++..--..++.+ ++|++|+|+++. ||..==..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 3678888888776632 2346677777777777774 554323334443 257777777753 65332234556666
Q ss_pred cCeeeccCCc
Q 005880 161 LLTLKLEANR 170 (672)
Q Consensus 161 L~~L~l~~N~ 170 (672)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7666666653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.24 E-value=6.4e-05 Score=69.02 Aligned_cols=81 Identities=11% Similarity=0.034 Sum_probs=41.6
Q ss_pred cEeEEEecCCCcccC-CCCCCCCCCccEEEcccCC-CCCC-CCCCCcc----cccceeeccccc-cCCCCChhhhccCCC
Q 005880 66 RVSHLVLENLQLSGS-LQPLTSLTQLRVLSLKYNR-FTGP-VPSLSNL----TALKLLFLSHNN-FNGEFPDSVSSLFRL 137 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~-~~~l~~l~~L~~L~L~~N~-l~~~-~p~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~L 137 (672)
++++|||+++.++.. +..+..+++|+.|+|+++. |+.. +..++.+ ++|++|+|+++. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 466666666655421 2225566666666666653 4421 1123332 356666666653 553323345556666
Q ss_pred CeEecccCc
Q 005880 138 YRLDLSFNN 146 (672)
Q Consensus 138 ~~L~l~~N~ 146 (672)
+.|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.002 Score=65.77 Aligned_cols=145 Identities=9% Similarity=0.066 Sum_probs=79.7
Q ss_pred cccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-----CCceeeeE-E--EEEcCCeEEEEEee
Q 005880 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-----HPNLVGLK-A--YYFAREEKLLVSEY 437 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 437 (672)
+.|+.|....+|+....+| .+++|...... ...++..|++++..+. -|.++... | +....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788899999987766 57789886521 2234556666665553 23333210 1 11224567899999
Q ss_pred cCCCChhH--------------HhhcC--CCCCC-----CCCCHHHHHH------------HHHHHHHHHHHHHhhC---
Q 005880 438 MPNGSLFW--------------LLHGN--RGPGR-----TPLDWTTRLK------------IAAGAARGLAFIHFTC--- 481 (672)
Q Consensus 438 ~~~g~L~~--------------~l~~~--~~~~~-----~~l~~~~~~~------------i~~~ia~~L~~LH~~~--- 481 (672)
++|..+.. .+|.. ..... ....|..... +...+.+.+++++...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865421 12211 00000 0112333111 0112445566665432
Q ss_pred CCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 482 ~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13569999999999999987666899998653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0017 Score=66.57 Aligned_cols=144 Identities=15% Similarity=0.090 Sum_probs=72.0
Q ss_pred ccCcCCeEE-EEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC--CceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 367 MLGKGGFGT-AYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH--PNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 367 ~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.|+.|.... +|+....+|..+++|....... .++..|++++..+.. -.+.+++.+.... -++|||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 455555544 6677654467777876543221 233455555555531 2345566553333 3789999977666
Q ss_pred hHHhhcCC---------------------CCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh--h
Q 005880 444 FWLLHGNR---------------------GPGRTPLDWTTRL-------K-------------IAAGAARGLAFIHF--T 480 (672)
Q Consensus 444 ~~~l~~~~---------------------~~~~~~l~~~~~~-------~-------------i~~~ia~~L~~LH~--~ 480 (672)
.+++.... ......++..... . ....+.+.++.+.. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54443211 0001112221100 0 00111122233311 1
Q ss_pred CCCCCcEecCCCCCCEEeCCC----CcEEEeccCCCccC
Q 005880 481 CKSLKLTHGNIKSTNVLLDKT----GNARVSDFGLSIFA 515 (672)
Q Consensus 481 ~~~~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~~~ 515 (672)
.....++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124579999999999999875 67999999987543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00057 Score=59.63 Aligned_cols=36 Identities=31% Similarity=0.278 Sum_probs=18.5
Q ss_pred CCCeEecccCccccccchhhcCCCccCeeeccCCcc
Q 005880 136 RLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171 (672)
Q Consensus 136 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 171 (672)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 455555555555533333445555555555555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0017 Score=68.46 Aligned_cols=107 Identities=11% Similarity=0.080 Sum_probs=68.1
Q ss_pred CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
|.++..|+.+.+..+..+-.--.|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.+|++|+.
T Consensus 261 F~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~ 338 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLER 338 (394)
T ss_dssp TTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred eeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCE
Confidence 667777888887665443111267777778877775 4455233345677778888887654 55333456777788888
Q ss_pred eeccCCcccC--cCCCCCCCCCCeeeccCCcC
Q 005880 164 LKLEANRFSG--PITGLDLRNLQDFNVSGNHL 193 (672)
Q Consensus 164 L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l 193 (672)
+.|..+ ++. .-.+.++.+|+.+++.+|..
T Consensus 339 i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 339 IAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp EEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred EEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 877544 432 33456777788887777643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0032 Score=65.71 Aligned_cols=143 Identities=17% Similarity=0.192 Sum_probs=83.0
Q ss_pred cccCcCCeEEEEEEEEc--------CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCce-eeeEEEEEcCCeEEEEEe
Q 005880 366 EMLGKGGFGTAYKAVLD--------DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL-VGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 436 (672)
+.+..|-...+|+.... ++..+++|+.... ........+|.++++.+.-..+ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666778889998864 2478999986432 2245566789988877742222 455655432 28999
Q ss_pred ecCCCChhH-----------------HhhcCCCC-CCCCC-CHHHHHHHHHHHHH-------------------HHHHHH
Q 005880 437 YMPNGSLFW-----------------LLHGNRGP-GRTPL-DWTTRLKIAAGAAR-------------------GLAFIH 478 (672)
Q Consensus 437 ~~~~g~L~~-----------------~l~~~~~~-~~~~l-~~~~~~~i~~~ia~-------------------~L~~LH 478 (672)
|++|.+|.. -||..... ++.+. -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865531 11222111 11222 25556655544422 233333
Q ss_pred h----hCCCCCcEecCCCCCCEEeCCC----CcEEEeccCCCc
Q 005880 479 F----TCKSLKLTHGNIKSTNVLLDKT----GNARVSDFGLSI 513 (672)
Q Consensus 479 ~----~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~ 513 (672)
. ......++|+|+.+.||+++++ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 2223469999999999999876 789999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.91 E-value=0.01 Score=55.86 Aligned_cols=103 Identities=12% Similarity=0.046 Sum_probs=67.7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCCCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 520 (672)
-+|.++|.... .+++++++|.++.|.+++|.-+-.. +.+ ..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARR--RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT--TCC-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhc--ccC-CceecCCcceEEecCCceeccc-cccc-------
Confidence 37899998654 6799999999999999998776211 111 1223456899999999988874 2111
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P 561 (672)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1233567899642 3567899999999999998875555
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0019 Score=56.31 Aligned_cols=37 Identities=24% Similarity=0.237 Sum_probs=21.0
Q ss_pred ccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 112 ALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 112 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3555566666665333344556666666666666553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0011 Score=69.23 Aligned_cols=73 Identities=11% Similarity=0.058 Sum_probs=42.6
Q ss_pred cccCcCCeEEEEEEEEcC---------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCc-eeeeEEEEEcCCeEEEEE
Q 005880 366 EMLGKGGFGTAYKAVLDD---------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPN-LVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 435 (672)
+.++.|....+|+....+ +..+++|+...... ...+...|.++++.+...+ ..++++.. . .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998654 26788888754321 1112356777777664333 33555443 2 36899
Q ss_pred eecCCCCh
Q 005880 436 EYMPNGSL 443 (672)
Q Consensus 436 e~~~~g~L 443 (672)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0085 Score=64.16 Aligned_cols=73 Identities=11% Similarity=0.086 Sum_probs=46.0
Q ss_pred cccCcCCeEEEEEEEEcC-CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCce-eeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 366 EMLGKGGFGTAYKAVLDD-GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL-VGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.|+.|-...+|+....+ +..+++|+...... ..-+..+|..++..+...++ .++++++ . + .+||||+++-+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF-T-N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C--eEEEEeeCCccC
Confidence 467888889999999775 47788988753221 11122578888877764444 4566665 2 2 259999987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0088 Score=63.64 Aligned_cols=72 Identities=14% Similarity=0.176 Sum_probs=47.8
Q ss_pred cccCcCCeEEEEEEEEcC--------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCce-eeeEEEEEcCCeEEEEEe
Q 005880 366 EMLGKGGFGTAYKAVLDD--------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL-VGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 436 (672)
+.|+.|....+|++...+ +..+++|+..... ....+.+|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 457788889999998753 5789999874321 12455578888877743333 45666542 2 38999
Q ss_pred ecCCCCh
Q 005880 437 YMPNGSL 443 (672)
Q Consensus 437 ~~~~g~L 443 (672)
|++|-+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.54 E-value=0.00042 Score=64.82 Aligned_cols=109 Identities=11% Similarity=0.145 Sum_probs=57.0
Q ss_pred CCCCCccEEEcccC-CCCCC-----CCCCCcccccceeeccccccCCC----CChhhhccCCCCeEecccCccccc----
Q 005880 85 TSLTQLRVLSLKYN-RFTGP-----VPSLSNLTALKLLFLSHNNFNGE----FPDSVSSLFRLYRLDLSFNNFSGQ---- 150 (672)
Q Consensus 85 ~~l~~L~~L~L~~N-~l~~~-----~p~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~---- 150 (672)
.+-+.|+.|+|++| +|... -..+..-+.|+.|+|++|+|... +-+.+..-+.|+.|+|++|+|+..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 44456666666664 55421 01234445666677777666522 223334445677777777777632
Q ss_pred cchhhcCCCccCeeeccCCc---ccCc----CC--CCCCCCCCeeeccCCcC
Q 005880 151 IPLTVNHLTHLLTLKLEANR---FSGP----IT--GLDLRNLQDFNVSGNHL 193 (672)
Q Consensus 151 ~p~~~~~l~~L~~L~l~~N~---l~~~----~~--~~~l~~L~~l~l~~N~l 193 (672)
+-..+..-+.|+.|+|++|. +... +. ...-+.|+.|+++.|.+
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 22334445567777776542 2211 10 12345677777776654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0084 Score=61.62 Aligned_cols=32 Identities=22% Similarity=0.399 Sum_probs=27.9
Q ss_pred CCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 483 ~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.017 Score=60.29 Aligned_cols=101 Identities=16% Similarity=0.069 Sum_probs=44.2
Q ss_pred CCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 85 TSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
.++..|+.+.+..+ ++.+-. .+.++.+|+.+.+..+ ++..-...|.++.+|+.+.+.+|.++..-...|.+|.+|+.
T Consensus 237 ~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~ 314 (379)
T 4h09_A 237 YGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSS 314 (379)
T ss_dssp TTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCE
T ss_pred cCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCE
Confidence 33444444444433 222222 3444555555555432 33122233445555555555555555222334555555555
Q ss_pred eeccCCcccC--cCCCCCCCCCCeeec
Q 005880 164 LKLEANRFSG--PITGLDLRNLQDFNV 188 (672)
Q Consensus 164 L~l~~N~l~~--~~~~~~l~~L~~l~l 188 (672)
+.|..| ++. .-.+.++.+|+.+.+
T Consensus 315 i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 315 VTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred EEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 555433 321 223344455555433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.015 Score=61.11 Aligned_cols=120 Identities=13% Similarity=0.041 Sum_probs=60.3
Q ss_pred cEeEEEecCCCcccCCC-CCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 66 RVSHLVLENLQLSGSLQ-PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.++.+.+.+.. +.... .+..+..|+.+.+..|..+-....+.++..|+.+.+..+.+. ...|..+.+|+.+.+..
T Consensus 231 ~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~ 306 (394)
T 4fs7_A 231 GVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD 306 (394)
T ss_dssp CCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred CCceEEECCCc-eecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec---ccccccccccccccccc
Confidence 45666665432 22222 266677777777776644322225555566666555554322 13345555566665544
Q ss_pred CccccccchhhcCCCccCeeeccCCcccC--cCCCCCCCCCCeeeccCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNLQDFNVSGN 191 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N 191 (672)
| ++..-...|.++++|+.++|.++ ++. .-.+.++.+|+.+++..|
T Consensus 307 ~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 307 S-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred c-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 3 44222334555666666665433 332 233445555666655544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.01 E-value=0.003 Score=58.98 Aligned_cols=85 Identities=13% Similarity=0.182 Sum_probs=61.7
Q ss_pred Ccccccceeecccc-ccCC----CCChhhhccCCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCc--C-
Q 005880 108 SNLTALKLLFLSHN-NFNG----EFPDSVSSLFRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGP--I- 175 (672)
Q Consensus 108 ~~l~~L~~L~l~~N-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~--~- 175 (672)
.+-+.|+.|+|++| +|.. .+-+.+..-+.|+.|+|++|+|... +-..+..-+.|+.|+|++|+|... .
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 45578999999986 7653 1334456667899999999999733 334555678899999999999751 1
Q ss_pred ---CCCCCCCCCeeeccCCc
Q 005880 176 ---TGLDLRNLQDFNVSGNH 192 (672)
Q Consensus 176 ---~~~~l~~L~~l~l~~N~ 192 (672)
....-+.|+.|+|++|.
T Consensus 118 la~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHhhCCceeEEECCCCc
Confidence 13345679999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.016 Score=60.93 Aligned_cols=97 Identities=8% Similarity=0.092 Sum_probs=69.1
Q ss_pred CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccC--cCCCCCCCCC
Q 005880 106 SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNL 183 (672)
Q Consensus 106 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L 183 (672)
.|.++.+|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|.++.+|+.+.|..| ++. .-.+..+.+|
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 6788899999998876554 445678888999999996 5566344457888999999999765 443 4456788999
Q ss_pred CeeeccCCcCCCCCC-CcCCCCCCc
Q 005880 184 QDFNVSGNHLSGQIP-KSLSGFPDS 207 (672)
Q Consensus 184 ~~l~l~~N~l~g~~p-~~l~~~~~~ 207 (672)
+.+.+..+ ++ .|. ..|.++..|
T Consensus 337 ~~i~ip~s-v~-~I~~~aF~~C~~L 359 (394)
T 4gt6_A 337 ERIAIPSS-VT-KIPESAFSNCTAL 359 (394)
T ss_dssp CEEEECTT-CC-BCCGGGGTTCTTC
T ss_pred CEEEECcc-cC-EEhHhHhhCCCCC
Confidence 99988654 55 554 345544433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.092 Score=54.94 Aligned_cols=101 Identities=11% Similarity=0.031 Sum_probs=43.1
Q ss_pred CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
+..+..|+.+.+..+.+.. ..+..+.+|+.+.+.++ ++..-...|.++.+|+.++|.++ ++..-...|.+|++|+.
T Consensus 272 F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~ 347 (394)
T 4fs7_A 272 FYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSN 347 (394)
T ss_dssp TTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCE
T ss_pred cccccccceeccCceeecc--ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCE
Confidence 4444455554444332110 13444555555555433 33122233445555555555432 43222334555555555
Q ss_pred eeccCCcccC--cCCCCCCCCCCeeecc
Q 005880 164 LKLEANRFSG--PITGLDLRNLQDFNVS 189 (672)
Q Consensus 164 L~l~~N~l~~--~~~~~~l~~L~~l~l~ 189 (672)
+.+..| ++. .-.+.++.+|+.+++.
T Consensus 348 i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 348 INFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp ECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred EEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 555443 322 2233444555555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.13 Score=53.40 Aligned_cols=107 Identities=12% Similarity=0.100 Sum_probs=76.9
Q ss_pred CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccC
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLL 162 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 162 (672)
+....+|+.+.+..+ ++.... .+.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 556677888887655 332223 6788889999998776 55344566778889999998654 5533345788899999
Q ss_pred eeeccCCcccC--cCCCCCCCCCCeeeccCCcCC
Q 005880 163 TLKLEANRFSG--PITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 163 ~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l~ 194 (672)
.+.+.+|.++. .-.+.++.+|+.+.|.+| ++
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~ 322 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK 322 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence 99998888764 455678889999988644 44
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.77 E-value=0.015 Score=37.96 Aligned_cols=32 Identities=19% Similarity=0.252 Sum_probs=22.4
Q ss_pred CcccceeeeehhhHHHHHHHHHHHHHHhhhee
Q 005880 279 SKISSVAVIAIVVGDFLVLAIISLLLYCYFWR 310 (672)
Q Consensus 279 ~~~~~~~ii~ivvg~~~~l~ii~~l~~~~~~r 310 (672)
+..+...+.++++|+++.+++++.+++++++|
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 34556778889999888777776666655444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.47 E-value=0.074 Score=56.15 Aligned_cols=142 Identities=15% Similarity=0.159 Sum_probs=83.2
Q ss_pred cccCcCCeEEEEEEEEcC--------CcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCc-eeeeEEEEEcCCeEEEEEe
Q 005880 366 EMLGKGGFGTAYKAVLDD--------GSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPN-LVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 436 (672)
+.+..|-...+|+....+ +..+++|+...... ..-+..+|.++++.+...+ ..++++.+ . .++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 456677888999998763 57888988654321 1123356777776664222 33455432 2 378999
Q ss_pred ecCCCChhH--H---------------hhcCC------CC--CCCCCCHHHHHHHHHHH-------------------HH
Q 005880 437 YMPNGSLFW--L---------------LHGNR------GP--GRTPLDWTTRLKIAAGA-------------------AR 472 (672)
Q Consensus 437 ~~~~g~L~~--~---------------l~~~~------~~--~~~~l~~~~~~~i~~~i-------------------a~ 472 (672)
|++|.+|.. + ||... .. +..+.-|.++.++..++ .+
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865421 0 11100 00 12233455555554332 22
Q ss_pred HHHHHHhh--------------------CCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 473 GLAFIHFT--------------------CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 473 ~L~~LH~~--------------------~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
.+.+|... .....++|+|+.+.||+ ++++.+.++||..+.
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 33444321 11345899999999999 788899999998774
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.21 E-value=0.024 Score=38.16 Aligned_cols=29 Identities=21% Similarity=0.390 Sum_probs=14.2
Q ss_pred eeehhhHHHHHHHHHHHHHHhhheecccc
Q 005880 286 VIAIVVGDFLVLAIISLLLYCYFWRNYVK 314 (672)
Q Consensus 286 ii~ivvg~~~~l~ii~~l~~~~~~rr~~~ 314 (672)
|++.++|.++++++++++++++++||+.+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34445554554555555555555554443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.90 E-value=0.025 Score=37.94 Aligned_cols=30 Identities=30% Similarity=0.574 Sum_probs=14.4
Q ss_pred eeehhhHHHHHHHHHHHHHHhhheeccccc
Q 005880 286 VIAIVVGDFLVLAIISLLLYCYFWRNYVKN 315 (672)
Q Consensus 286 ii~ivvg~~~~l~ii~~l~~~~~~rr~~~~ 315 (672)
+++.++|.++++++++.+++++++||+.++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 444445544445455555555555444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.92 E-value=0.064 Score=35.93 Aligned_cols=30 Identities=23% Similarity=0.413 Sum_probs=14.5
Q ss_pred eeeehhhHHHHHHHHHHHHHHhhheeccccc
Q 005880 285 AVIAIVVGDFLVLAIISLLLYCYFWRNYVKN 315 (672)
Q Consensus 285 ~ii~ivvg~~~~l~ii~~l~~~~~~rr~~~~ 315 (672)
.++++++| +++++++.++++++.+||+.++
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR~~~~ 42 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRRQQKI 42 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHHCSCC
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehhhhhc
Confidence 35566666 3334444444444555554443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.40 E-value=0.44 Score=49.85 Aligned_cols=29 Identities=24% Similarity=0.378 Sum_probs=24.3
Q ss_pred CcEecCCCCCCEEe------CCCCcEEEeccCCCc
Q 005880 485 KLTHGNIKSTNVLL------DKTGNARVSDFGLSI 513 (672)
Q Consensus 485 ~iiH~Dlkp~NIll------~~~~~~kl~DfG~a~ 513 (672)
.++|+|+.+.||++ +++..++++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456779999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.80 E-value=3.9 Score=38.38 Aligned_cols=114 Identities=11% Similarity=0.086 Sum_probs=79.2
Q ss_pred CCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhhCCCCCcEecCCC
Q 005880 414 RHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLA-FIHFTCKSLKLTHGNIK 492 (672)
Q Consensus 414 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~~iiH~Dlk 492 (672)
.||++ -...-.+++...+.|+.-+++.=...++ ..+...+++++.+++.... +++ .-+|--|.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSA------RRLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCS------SSEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhh------CceeEEEe
Confidence 68888 3444466777777777664443344443 2678899999998887665 443 45777899
Q ss_pred CCCEEeCCCCcEEEeccCCCccCCCCCCCCCCcccCCCccccCCCCCCchhHHH-HHHHHHHHHHhCCCCCC
Q 005880 493 STNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVY-SFGVLLLELLTGKCPSV 563 (672)
Q Consensus 493 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~-S~Gvvl~el~tg~~P~~ 563 (672)
|+||++|.++.+++.-.|+- +-++|.- .+ ..|.| .+=+++..++.++..|+
T Consensus 112 P~NL~f~~~~~p~i~hRGi~------------~~lpP~e-------~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVK------------ESLPPDE-------WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGGEEECTTCCEEESCCEET------------TTBSSCS-------CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CceEEEeCCCcEEEEEcCCc------------ccCCCCC-------CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999987753 2344551 12 23443 67788899999888874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.36 E-value=3 Score=38.98 Aligned_cols=117 Identities=10% Similarity=0.042 Sum_probs=79.9
Q ss_pred CCCCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 005880 413 LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIK 492 (672)
Q Consensus 413 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlk 492 (672)
..||+++.. .+-.+++...+.|+.-+++.=+..+ ...+...+++++..|+....+++ .-+|--|.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~------~r~tf~L~ 106 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNR------TRYTFVLA 106 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGG------SSEECCCS
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhc------CceEEEEe
Confidence 368888876 4556666666666654432212223 23778999999999998876665 34677899
Q ss_pred CCCEEeCCCCcEEEeccCCCccCCCCCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005880 493 STNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSV 563 (672)
Q Consensus 493 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~ 563 (672)
|+||+++.++.+++.-.|+-.. ++|. ..++..=.-.+=+++..+++++..|+
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNV------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTT------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCCCCEEEEEccCccC------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999987775321 2333 11222223467789999999998885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 672 | ||||
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 |
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-57
Identities = 63/298 (21%), Positives = 111/298 (37%), Gaps = 31/298 (10%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
E +GKG FG ++ G VAVK E + LRH N++G A
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 426 FAREEKL----LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH--- 478
LVS+Y +GSLF L+ R + +K+A A GLA +H
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 479 -FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP---------PSTVPRSNGYRA 528
T + H ++KS N+L+ K G ++D GL++ P+ + Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 529 PEL----SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584
PE+ + + +++D+Y+ G++ E+ I +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD--LVPSDPSV 238
Query: 585 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
+R+ + + E + + ++ C A+ R + K + +L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-57
Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
E LG G FG + + + VAVK LK S+ F ++ +L+H LV L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+E +++EYM NGSL L G L L +AA A G+AFI
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIE----ERN 129
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------TVPRSNGYRAPELSSSDGRKQ 539
H ++++ N+L+ T + +++DFGL+ + + APE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTF 187
Query: 540 SQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599
+ KSDV+SFG+LL E++T + P +Q++ R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI-----------PYPGMTNPEVIQNLER--------GYR 228
Query: 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
++R + EE+ Q+ C P+ RP ++ ++E+
Sbjct: 229 MVRPDNCPEELY---QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ +G G FGT YK V + + + + F+ + VL + RH N++ Y
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ +V+++ SL+ LH + + IA A+G+ ++H
Sbjct: 74 T-APQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS---- 124
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-------STVPRSNGYRAPE-LSSSDGR 537
+ H ++KS N+ L + ++ DFGL+ + S + APE + D
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 538 KQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597
S +SDVY+FG++L EL+TG+ P ++ + +V + +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY------------SNINNRDQIIFMVGRGYLSPDLS 232
Query: 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
+ + M ++ C D+RP ++ IE L
Sbjct: 233 ---KVRSNCPKAMK---RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-54
Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 37/284 (13%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ +GKG FG G+ VAVK +K+ + + F V+ +LRH NLV L
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 426 FAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ L +V+EYM GSL L GR+ L LK + + ++
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE----GN 122
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQK 542
H ++ + NVL+ + A+VSDFGL+ A + T + APE +K S K
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR--EKKFSTK 180
Query: 543 SDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMR 602
SDV+SFG+LL E+ + + L V V + ++
Sbjct: 181 SDVWSFGILLWEIYSFGRVP-----------YPRIPLKDVVPRVEK--------GYKMDA 221
Query: 603 YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646
+ +V C RP+ + + +E ++ E+
Sbjct: 222 PDGCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 60/283 (21%), Positives = 113/283 (39%), Gaps = 39/283 (13%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ +G G FG + + VA+K +++ ++ + +F + EV+ +L HP LV L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ LV E+M +G L L R T L + G+A++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE----EAC 121
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------TVPRSNGYRAPELSSSDGRKQ 539
+ H ++ + N L+ + +VSDFG++ F + +PE+ S +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRY 179
Query: 540 SQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599
S KSDV+SFGVL+ E+ + ++ + + R
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDISTGFR----------- 220
Query: 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
L + + + Q+ C P+ RP S +++ + E+
Sbjct: 221 LYKPRLASTHVY---QIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-51
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 41/283 (14%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYY 425
+ LG G FG VA+K +K+ S+ + EF + +V+ L H LV L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK 485
+ +++EYM NG L L R L++ + ++
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---- 120
Query: 486 LTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------YRAPELSSSDGRKQ 539
H ++ + N L++ G +VSDFGLS + S G + PE+ K
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 178
Query: 540 SQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598
S KSD+++FGVL+ E+ + GK P + + + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPY------------ERFTNSETAEHIAQ--------GL 218
Query: 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
L R E++ + +C D+RP ++ I ++
Sbjct: 219 RLYRPHLASEKVY---TIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 1e-50
Identities = 64/309 (20%), Positives = 117/309 (37%), Gaps = 61/309 (19%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNL 418
+G+G FG ++A + ++VAVK LK +AS + +F++ ++ +PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG-------------------PGRTPLD 459
V L + L+ EYM G L L PG PL
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518
+L IA A G+A++ K H ++ + N L+ + +++DFGLS +
Sbjct: 139 CAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG 572
+ PE + + +SDV+++GV+L E+ +
Sbjct: 195 YYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQ----------- 241
Query: 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632
+ EE V D ++ E + L + C S P RP+
Sbjct: 242 ---------PYYGMAHEEVIYYVRDGNILAC--PENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 633 HVVKLIEEL 641
+ ++++ +
Sbjct: 291 SIHRILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 35/296 (11%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
LG G G +K G V+A K + + + + + ++VL P +VG
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+++ E + E+M GSL +L + K++ +GL ++
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH-- 124
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---TVPRSNGYRAPELSSSDGRKQS 540
K+ H ++K +N+L++ G ++ DFG+S S + + Y +PE G S
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ--GTHYS 181
Query: 541 QKSDVYSFGVLLLELLTGKCP------SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
+SD++S G+ L+E+ G+ P ++ G A + P ++ R +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 595 VFDLELMRYKDIEEEMVG--------------LLQVAMACTSASPDQRPNMSHVVK 636
+ M ++ + +V C +P +R ++ ++
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 74/295 (25%), Positives = 119/295 (40%), Gaps = 46/295 (15%)
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGR 412
+ LE LG+G FG + + + VA+K LK ++ F Q +V+ +
Sbjct: 17 ESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKK 68
Query: 413 LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
LRH LV L A + E +V+EYM GSL L G G L + +AA A
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIAS 124
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG------Y 526
G+A++ H ++++ N+L+ + +V+DFGL+ + G +
Sbjct: 125 GMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586
APE + + + KSDV+SFG+LL EL T + R V
Sbjct: 181 TAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPG------------MVNREVLDQ 226
Query: 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
V + R E L + C P++RP ++ +E+
Sbjct: 227 VERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 1e-49
Identities = 59/289 (20%), Positives = 116/289 (40%), Gaps = 43/289 (14%)
Query: 366 EMLGKGGFGTAYKAVL----DDGSVVAVKRLK-DASIGGKREFEQHMEVLGRLRHPNLVG 420
+++G G FG L VA+K LK + +R+F ++G+ HPN++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
L+ ++++E+M NGSL L N G + + G A G+ ++
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADM 147
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----TVPRSNGYRAPEL----S 532
H ++ + N+L++ +VSDFGLS F T + G + P
Sbjct: 148 N----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592
+ RK + SDV+S+G+++ E+++ D + + ++ ++
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-----------MTNQDVINAIEQDY-- 250
Query: 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
R + L Q+ + C + RP +V ++++
Sbjct: 251 ---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-49
Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 47/292 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGS----VVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNLVG 420
E++G+G FG Y L D AVK L + IG +F ++ HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 421 LKAYYFAREEK-LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L E L+V YM +G L + + A+G+ F+
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLAS 148
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---------TVPRSNGYRAPE 530
K H ++ + N +LD+ +V+DFGL+ + A E
Sbjct: 149 ----KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 531 LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590
S +K + KSDV+SFGVLL EL+T P D V+ +++
Sbjct: 205 --SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----------VNTFDITVYLLQGR 251
Query: 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642
L++ + + + +V + C + RP+ S +V I +
Sbjct: 252 --------RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 3e-49
Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG G +G Y+ V VAVK LK+ ++ EF + V+ ++HPNLV L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+++E+M G+L L R + L +A + + ++
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE----KK 134
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST------VPRSNGYRAPELSSSDGRK 538
H ++ + N L+ + +V+DFGLS T + APE + K
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNK 192
Query: 539 QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598
S KSDV++FGVLL E+ T +DL + + + + D
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEK--------DY 233
Query: 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+ R + E++ ++ AC +P RP+ + + + E +
Sbjct: 234 RMERPEGCPEKVY---ELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 3e-49
Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 44/291 (15%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK---REFEQHM 407
K F +G G FG Y A + + VVA+K++ + ++ + +
Sbjct: 14 EKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIA 467
L +LRHPN + + Y LV EY + L + PL +
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVT 121
Query: 468 AGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS-IFAPPSTVPRSNGY 526
GA +GLA++H S + H ++K+ N+LL + G ++ DFG + I AP ++ + +
Sbjct: 122 HGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYW 177
Query: 527 RAPE-LSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585
APE + + D + K DV+S G+ +EL K P ++ +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------------FNMNAMSALYH 225
Query: 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ + E A ++ E + +C P RP ++K
Sbjct: 226 IAQNESPA-------LQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 4e-49
Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 39/283 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLK 422
+G G +G K DG ++ K L S+ K+ + +L L+HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 423 AYYFAREEKLL--VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH-F 479
R L V EY G L ++ R LD L++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-----STVPRSNGYRAPELSSS 534
+ + H ++K NV LD N ++ DFGL+ + Y +PE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN- 187
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
++KSD++S G LL EL P + ++E +
Sbjct: 188 -RMSYNEKSDIWSLGCLLYELCALMPP---------------------FTAFSQKELAGK 225
Query: 595 VFDLELMRY-KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ + + R +E+ ++ + RP++ +++
Sbjct: 226 IREGKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 55/280 (19%), Positives = 109/280 (38%), Gaps = 38/280 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
LG G FG YKA + + A K + S ++ +++L HPN+V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
++ ++ E+ G++ ++ PL + + L ++H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH----DN 129
Query: 485 KLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPEL---SSSDG 536
K+ H ++K+ N+L G+ +++DFG+S + R + + APE+ +S
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596
R K+DV+S G+ L+E+ + P ++ R + + + E
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPH------------HELNPMRVLLKIAKSEP----- 232
Query: 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
L + L+ C + D R S +++
Sbjct: 233 -PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 46/300 (15%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAVL---DDGSVVAVKRLK-DASIGGKREFEQHMEV 409
+ ++LL A E LG G FG+ + V VA+K LK E + ++
Sbjct: 4 FLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 410 LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG 469
+ +L +P +V L E +LV E G L L G R + + ++
Sbjct: 63 MHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQ 117
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--------STVP 521
+ G+ ++ H ++ + NVLL A++SDFGLS S
Sbjct: 118 VSMGMKYLEE----KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 522 RSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPR 581
+ APE + RK S +SDV+S+GV + E L+ G ++
Sbjct: 174 WPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMA 223
Query: 582 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+++ R E E L + C + RP+ V + +
Sbjct: 224 FIEQGKRMECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 48/293 (16%)
Query: 353 KRFELED--LLRASAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQH 406
+++ LED + R LGKG FG Y A ++A+K L A + G + + +
Sbjct: 1 RQWALEDFEIGR----PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 56
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
+E+ LRHPN++ L Y+ L+ EY P G+++ L D
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 111
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG- 525
A L++ H S ++ H +IK N+LL G +++DFG S+ AP S G
Sbjct: 112 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 167
Query: 526 --YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWV 583
Y PE+ GR +K D++S GVL E L GK P
Sbjct: 168 LDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPP---------------------F 204
Query: 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
++ +E + +E + E L+ +P QRP + V++
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 42/282 (14%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G F T YK + + VA L+D + ++ F++ E+L L+HPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 423 AYYFAREEK----LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
+ + + +LV+E M +G+L L + + +GL F+H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 479 FTCKSLKLTHGNIKSTNVLL-DKTGNARVSDFGLSIFAPPS---TVPRSNGYRAPELSSS 534
++ + H ++K N+ + TG+ ++ D GL+ S V + + APE+
Sbjct: 130 --TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
K + DVY+FG+ +LE+ T + P C A + R V S V+ +
Sbjct: 187 --EKYDESVDVYAFGMCMLEMATSEYPY--------SECQNAAQIYRRVTSGVKPASFDK 236
Query: 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
V E+ ++ C + D+R ++ ++
Sbjct: 237 VAIPEVK-------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-48
Identities = 68/304 (22%), Positives = 109/304 (35%), Gaps = 55/304 (18%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRLK-DASIGGKREFEQHMEVLGRL-RHPN 417
+ LG G FG +A D VAVK LK A + + ++VL L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP-------------GRTPLDWTTRL 464
+V L L+++EY G L L R LD L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN 524
+ A+G+AF+ S H ++ + N+LL ++ DFGL+ +
Sbjct: 149 SFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 525 G-------YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577
G + APE + +SDV+S+G+ L EL + +
Sbjct: 205 GNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSS-----------PYPGM 251
Query: 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637
+ +++E + R E + + C A P +RP +V+L
Sbjct: 252 PVDSKFYKMIKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 638 IEEL 641
IE+
Sbjct: 302 IEKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 64/290 (22%), Positives = 119/290 (41%), Gaps = 46/290 (15%)
Query: 366 EMLGKGGFGTAYKAVLDDGS-----VVAVKRLKDASIGGKR-EFEQHMEVLGRLRHPNLV 419
+++G G FG YK +L S VA+K LK +R +F ++G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L+ + ++++EYM NG+L L G + + G A G+ ++
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLA- 127
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP--------STVPRSNGYRAPEL 531
++ H ++ + N+L++ +VSDFGLS S + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 532 SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591
S RK + SDV+SFG+++ E++T + V + + +
Sbjct: 185 IS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------NHEVMKAINDGF 230
Query: 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
R + + Q+ M C +RP + +V ++++L
Sbjct: 231 ----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 9e-47
Identities = 68/316 (21%), Positives = 126/316 (39%), Gaps = 52/316 (16%)
Query: 366 EMLGKGGFGTAYKAVLDDGS---VVAVKRLKD-ASIGGKREFEQHMEVLGRL-RHPNLVG 420
+++G+G FG KA + A+KR+K+ AS R+F +EVL +L HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGN-----------RGPGRTPLDWTTRLKIAAG 469
L R L EY P+G+L L + + L L AA
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----G 525
ARG+ + + H ++ + N+L+ + A+++DFGLS
Sbjct: 136 VARGMDY----LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585
+ A E S + + SDV+S+GVLL E+++ + +
Sbjct: 192 WMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----------MTCAELYEK 238
Query: 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV----KLIEEL 641
+ + L + + ++E+ + C P +RP+ + ++ +++EE
Sbjct: 239 LPQ--------GYRLEKPLNCDDEVY---DLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 642 RGVEVSPCHENFDSVS 657
+ + +E F
Sbjct: 288 KTYVNTTLYEKFTYAG 303
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-46
Identities = 69/308 (22%), Positives = 110/308 (35%), Gaps = 56/308 (18%)
Query: 347 VFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAVLDD---GSVVAVKRLKDASIGG--KR 401
V+ + K LED + LG G FGT K VAVK LK+ + K
Sbjct: 1 VYLD-RKLLTLED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 53
Query: 402 EFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
E V+ +L +P +V + E +LV E G L L NR +
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR-----HVKDK 107
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---- 517
+++ + G+ ++ + H ++ + NVLL A++SDFGLS
Sbjct: 108 NIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 518 ----STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMG 572
+ + APE + K S KSDV+SFGVL+ E + G+ P
Sbjct: 164 YKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPY---------- 211
Query: 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632
+ + + E R + + C + + RP +
Sbjct: 212 --RGMKGSEVTAMLEKGE-----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 633 HVVKLIEE 640
V +
Sbjct: 259 AVELRLRN 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-46
Identities = 68/307 (22%), Positives = 109/307 (35%), Gaps = 54/307 (17%)
Query: 351 GTKRFELEDLLRASAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASIG---GKREF 403
G K L E LG G FG + D VAVK LK + +F
Sbjct: 6 GEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ + + L H NL+ L +V+E P GSL L ++G T
Sbjct: 59 IREVNAMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTL 113
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP------ 517
+ A A G+ ++ S + H ++ + N+LL ++ DFGL P
Sbjct: 114 SRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575
+ APE R S SD + FGV L E+ T I
Sbjct: 170 MQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIG---------- 217
Query: 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
++ + + + +E L R +D ++ + V + C + P+ RP +
Sbjct: 218 -LNGSQILHKIDKE-------GERLPRPEDCPQD---IYNVMVQCWAHKPEDRPTFVALR 266
Query: 636 KLIEELR 642
+ E +
Sbjct: 267 DFLLEAQ 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-45
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 51/299 (17%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKRE-FEQHME 408
R EL +G+G FG ++ + + VA+K K+ + RE F Q
Sbjct: 8 RIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 409 VLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAA 468
+ + HP++V L ++ E G L L + LD + + A
Sbjct: 61 TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAY 115
Query: 469 GAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN---- 524
+ LA++ S + H +I + NVL+ ++ DFGLS + ST +++
Sbjct: 116 QLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 525 --GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRW 582
+ APE S + R+ + SDV+ FGV + E+L D+
Sbjct: 172 PIKWMAPE--SINFRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGR 221
Query: 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
+++ R + + L+ C + P +RP + + + +
Sbjct: 222 IENGERLPMP-----------PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 1e-45
Identities = 55/290 (18%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGR 412
+++ E LG G FG ++ G+ A K + K + ++ +
Sbjct: 27 HYDIH-------EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79
Query: 413 LRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 472
LRHP LV L + E +++ E+M G LF + + ++ +
Sbjct: 80 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCK 135
Query: 473 GLAFIHFTCKSLKLTHGNIKSTNVLL--DKTGNARVSDFGLSIFAPPS----TVPRSNGY 526
GL +H H ++K N++ ++ ++ DFGL+ P + +
Sbjct: 136 GLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF 191
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586
APE+ ++G+ +D++S GVL LL+G P G + +++V
Sbjct: 192 AAPEV--AEGKPVGYYTDMWSVGVLSYILLSGLSPF------------GGENDDETLRNV 237
Query: 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+W ++ + I E+ ++ A P+ R + ++
Sbjct: 238 KSCDWN-----MDDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-44
Identities = 59/307 (19%), Positives = 107/307 (34%), Gaps = 60/307 (19%)
Query: 366 EMLGKGGFGTAYKAVLDDGS------VVAVKRLKDASIGGKRE-FEQHMEVLGRL-RHPN 417
++LG G FG A S VAVK LK+ + +RE ++++ +L H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 418 LVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGP------------------GRTPLD 459
+V L L+ EY G L L R L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518
+ L A A+G+ F+ H ++ + NVL+ ++ DFGL+
Sbjct: 163 FEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMG 572
+ APE + KSDV+S+G+LL E+ +
Sbjct: 219 NYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGVNPY--------- 267
Query: 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS 632
+ + +++ ++ + EE+ ++Q +C + +RP+
Sbjct: 268 --PGIPVDANFYKLIQN-------GFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFP 315
Query: 633 HVVKLIE 639
++ +
Sbjct: 316 NLTSFLG 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 46/291 (15%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVL 410
K++ E +G+G GT Y A+ + G VA++++ K + V+
Sbjct: 19 KKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 411 GRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 470
++PN+V Y +E +V EY+ GSL ++ T +D +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCREC 125
Query: 471 ARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-----STVPRSNG 525
+ L F+H S ++ H +IKS N+LL G+ +++DFG P ST+ +
Sbjct: 126 LQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585
+ APE+ + + K D++S G++ +E++ G+ P + R +
Sbjct: 182 WMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPY------------LNENPLRALYL 227
Query: 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ EL + + L C ++R + +++
Sbjct: 228 IATNGT------PELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-44
Identities = 59/280 (21%), Positives = 105/280 (37%), Gaps = 40/280 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNLVGLKA 423
+ LG+G +G AV VAVK + ++ ++ + + L H N+V
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
+ + L EY G LF + + G + + G+ ++H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH----G 121
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPR-------SNGYRAPELSSSDG 536
+ +TH +IK N+LLD+ N ++SDFGL+ + R + Y APEL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKRR 180
Query: 537 RKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596
++ DV+S G++L +L G+ + D + +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-----------LPWDQPSDSCQEYSDWKEK------- 222
Query: 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
L +K I+ + LL +P R + + K
Sbjct: 223 KTYLNPWKKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-43
Identities = 63/307 (20%), Positives = 118/307 (38%), Gaps = 49/307 (15%)
Query: 366 EMLGKGGFGTAYKAVL------DDGSVVAVKRL-KDASIGGKREFEQHMEVLGRLRHPNL 418
LG+G FG Y+ V + + VA+K + + AS+ + EF V+ ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRG-----PGRTPLDWTTRLKIAAGAARG 473
V L + L++ E M G L L R P P + +++A A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 474 LAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGY 526
+A+++ + K H ++ + N ++ + ++ DFG++ + +
Sbjct: 146 MAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 527 RAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSV 586
+PE + SDV+SFGV+L E+ T Q +
Sbjct: 202 MSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQ--------------------PYQGL 239
Query: 587 VREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646
E+ V + L+ D +M L ++ C +P RP+ ++ I+E +E
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKEE--MEP 295
Query: 647 SPCHENF 653
+F
Sbjct: 296 GFREVSF 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (391), Expect = 2e-42
Identities = 56/278 (20%), Positives = 103/278 (37%), Gaps = 37/278 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
E LG G FG ++ V G V K + K + + ++ +L HP L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 425 YFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSL 484
+ + E +L+ E++ G LF + + + A GL +H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMH----EH 146
Query: 485 KLTHGNIKSTNVLLDKTGNARV--SDFGLSIFAPPSTVP----RSNGYRAPELSSSDGRK 538
+ H +IK N++ + + V DFGL+ P + + + APE+ D
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI--VDREP 204
Query: 539 QSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598
+D+++ GVL LL+G P D +Q+V R +W
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPF------------AGEDDLETLQNVKRCDWE-----F 247
Query: 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ + + E ++ P +R + ++
Sbjct: 248 DEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGL 421
++LG+G F T A L A+K L+ I + +V+ RL HP V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ E+ Y NG L + D T A L ++H
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH--- 125
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-------STVPRSNGYRAPELSSS 534
+ H ++K N+LL++ + +++DFG + P ++ + Y +PEL +
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT- 183
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + SD+++ G ++ +L+ G P
Sbjct: 184 -EKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 54/289 (18%), Positives = 107/289 (37%), Gaps = 46/289 (15%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSV----VAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLV 419
++LG G FGT YK + + +G VA+K L++A S +E V+ + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
L L+++ MP G L + ++ L A+G+ ++
Sbjct: 75 RLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLED 129
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELS 532
+L H ++ + NVL+ + +++DFGL+ + A E
Sbjct: 130 ----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 533 SSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592
R + +SDV+S+GV + EL+T + S++ +
Sbjct: 186 L--HRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------IPASEISSILEKGE- 230
Query: 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641
R + + + + C D RP ++ ++
Sbjct: 231 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 56/304 (18%)
Query: 366 EMLGKGGFGTAYKAVL--------DDGSVVAVKRLK-DASIGGKREFEQHMEVLGRL-RH 415
+ LG+G FG A + + VAVK LK DA+ + ME++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 416 PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPG-----------RTPLDWTTRL 464
N++ L ++ EY G+L L R PG L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN 524
A ARG+ ++ S K H ++ + NVL+ + +++DFGL+ +
Sbjct: 139 SCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 525 -------GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577
+ APE R + +SDV+SFGVLL E+ T
Sbjct: 195 TNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG------------ 240
Query: 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637
+ +++E R L + C A P QRP +V+
Sbjct: 241 VPVEELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 638 IEEL 641
++ +
Sbjct: 291 LDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 54/296 (18%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 348 FFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQH 406
+E ++ + E LG+G FG ++ V K +K + ++
Sbjct: 3 LYE---KYMIA-------EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKE 51
Query: 407 MEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKI 466
+ +L RH N++ L + + EE +++ E++ +F ++ + L+ +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSY 107
Query: 467 AAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARV--SDFGLSIFAPPS----TV 520
L F+H S + H +I+ N++ ++ + +FG + P +
Sbjct: 108 VHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLP 580
+ Y APE+ S +D++S G L+ LL+G P A
Sbjct: 164 FTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINP------------FLAETNQ 209
Query: 581 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ +++++ E+T FD E +K+I E + + R S ++
Sbjct: 210 QIIENIMNAEYT---FDEEA--FKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 61/303 (20%), Positives = 106/303 (34%), Gaps = 54/303 (17%)
Query: 366 EMLGKGGFGTAYKAV------LDDGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNL 418
+ LG+G FG +A VAVK LK+ + R +++L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 419 VGLKAYYFAREEK--LLVSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLK 465
V + +++ E+ G+L L R + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-------S 518
+ A+G+ F+ S K H ++ + N+LL + ++ DFGL+
Sbjct: 139 YSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVD 578
+ APE R + +SDV+SFGVLL E+ + V
Sbjct: 195 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGAS-----------PYPGVK 241
Query: 579 LPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLI 638
+ ++E R + + + Q + C P QRP S +V+ +
Sbjct: 242 IDEEFCRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 639 EEL 641
L
Sbjct: 292 GNL 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (368), Expect = 6e-40
Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 58/308 (18%)
Query: 348 FFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGG------- 399
F+E +E + E+LG+G + + AVK + G
Sbjct: 1 FYE---NYEPK-------EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ 50
Query: 400 --KREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRT 456
+ + +++L ++ HPN++ LK Y LV + M G LF L
Sbjct: 51 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----- 105
Query: 457 PLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516
L KI + +H L + H ++K N+LLD N +++DFG S
Sbjct: 106 TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161
Query: 517 PS----TVPRSNGYRAPEL----SSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGG 568
P V + Y APE+ + + ++ D++S GV++ LL G P
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------- 214
Query: 569 AGMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQR 628
Q ++ + + + D + + L+ P +R
Sbjct: 215 ----------FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKR 261
Query: 629 PNMSHVVK 636
+
Sbjct: 262 YTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (368), Expect = 4e-39
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK------REFEQHMEVLGRLRHPNL 418
++G+GGFG Y D G + A+K L I K + ++ P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 419 VGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
V + + ++ + + M G L + L + AA GL +H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNG---YRAPELSSSD 535
+ + + ++K N+LLD+ G+ R+SD GL+ S G Y APE+
Sbjct: 125 ----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQK 179
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G +D +S G +L +LL G P
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 9e-39
Identities = 56/294 (19%), Positives = 108/294 (36%), Gaps = 47/294 (15%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE-FEQHMEV 409
++ ++LG G F A +VA+K + ++ GK E + V
Sbjct: 8 RDIYDFR-------DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 410 LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG 469
L +++HPN+V L Y + L+ + + G LF + ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQ 115
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLL---DKTGNARVSDFGLSIFAPPSTVPRSN-- 524
+ ++H + H ++K N+L D+ +SDFGLS P +V +
Sbjct: 116 VLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 171
Query: 525 --GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRW 582
GY APE+ + + S+ D +S GV+ LL G P
Sbjct: 172 TPGYVAPEVLA--QKPYSKAVDCWSIGVIAYILLCGYPP-----------------FYDE 212
Query: 583 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ + E+ ++ + + DI + ++ P++R ++
Sbjct: 213 NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 9e-38
Identities = 66/309 (21%), Positives = 116/309 (37%), Gaps = 56/309 (18%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGK---REFEQHM 407
+ R+EL E+LG GG + A L VAVK L+ F +
Sbjct: 6 SDRYELG-------EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 58
Query: 408 EVLGRLRHPNLVGLKAYYFAREEKL----LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ L HP +V + A +V EY+ +L ++H P+
Sbjct: 59 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRA 113
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518
+++ A A + L F H + H ++K N+++ T +V DFG++ S
Sbjct: 114 IEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575
V + Y +PE + G +SDVYS G +L E+LTG+ P
Sbjct: 170 QTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPF------------T 215
Query: 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
VRE+ R++ + ++ ++ + + +P+ R
Sbjct: 216 GDSPVSVAYQHVREDPI-----PPSARHEGLSADLDAVV---LKALAKNPENRY--QTAA 265
Query: 636 KLIEELRGV 644
++ +L V
Sbjct: 266 EMRADLVRV 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 54/283 (19%), Positives = 100/283 (35%), Gaps = 41/283 (14%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
++LG G G + A+K L+D +RE E H + P++V +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRAS---QCPHIVRIVDV 73
Query: 425 YFAREEK----LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
Y L+V E + G LF + G +I + ++H
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 481 CKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAPPS----TVPRSNGYRAPELSS 533
S+ + H ++K N+L +++DFG + T + Y APE+
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593
K + D++S GV++ LL G P G P + +
Sbjct: 187 --PEKYDKSCDMWSLGVIMYILLCGYPPF--------YSNHGLAISPGMKTRIRMGQ--- 233
Query: 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
++ + ++ EE+ L++ P QR ++ +
Sbjct: 234 --YEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-37
Identities = 55/312 (17%), Positives = 119/312 (38%), Gaps = 45/312 (14%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE-FEQH 406
F+ R+ +G+G +G A + VA+K++ + +
Sbjct: 4 FDVGPRYTNL-------SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE 56
Query: 407 MEVLGRLRHPNLVGLKAYY----FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTT 462
+++L R RH N++G+ + + + + ++ L+ LL L
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDH 110
Query: 463 RLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518
RGL +IH S + H ++K +N+LL+ T + ++ DFGL+ A P
Sbjct: 111 ICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAG 570
+ YRAPE+ + + ++ D++S G +L E+L+ + +D
Sbjct: 167 GFLTEYVATRWYRAPEI-MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
Query: 571 MGCGGAVDLPRWVQSVVREEWTAEVFDLELMR------YKDIEEEMVGLLQVAMACTSAS 624
+G G+ + + + + + + + + + LL + +
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFN 282
Query: 625 PDQRPNMSHVVK 636
P +R + +
Sbjct: 283 PHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (345), Expect = 8e-37
Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 28/286 (9%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKA 423
E +G+G +G YKA + G A+K+++ G + + +L L+H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 424 YYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKS 483
++ +LV E++ L L+ T G+A+ H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH----D 118
Query: 484 LKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSSDGRK 538
++ H ++K N+L+++ G +++DFGL+ ++ YRAP++ K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK-K 177
Query: 539 QSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594
S D++S G + E++ G S D G + W ++
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 595 VFDLELMRY----KDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
E + + K ++E + LL P+QR ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 3e-36
Identities = 50/305 (16%), Positives = 92/305 (30%), Gaps = 53/305 (17%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGR 412
R+ L +G G FG Y + G VA+K + + ++
Sbjct: 8 RYRLG-------RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKM 58
Query: 413 LRHPNLVGLKAYYFAREEKL-LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 471
++ + + A + +V E + +R T L +A
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMI 113
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVL---LDKTGNARVSDFGLSIFAPPS---------- 518
+ +IH S H ++K N L K + DFGL+ +
Sbjct: 114 SRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169
Query: 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGA 576
+ + Y + G +QS++ D+ S G +L+ G P
Sbjct: 170 NKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLK---------- 217
Query: 577 VDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ ++ + K E L C S D +P+ S++ +
Sbjct: 218 ---AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQ 271
Query: 637 LIEEL 641
L L
Sbjct: 272 LFRNL 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-36
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM---EVLGR-LRHPNLVG 420
+MLGKG FG + A A+K LK + + E M VL HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 421 LKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT 480
+ + +E V EY+ G L + + D + AA GL F
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQF---- 118
Query: 481 CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF-----APPSTVPRSNGYRAPELSSSD 535
S + + ++K N+LLDK G+ +++DFG+ A +T + Y APE+
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-- 176
Query: 536 GRKQSQKSDVYSFGVLLLELLTGKCP 561
G+K + D +SFGVLL E+L G+ P
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAY 424
+++G G FG Y+A L D G +VA+K++ KR + ++++ +L H N+V L+ +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 425 YFAREEK------LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 478
+++ EK LV +Y+P H +R L R LA+IH
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIH 139
Query: 479 FTCKSLKLTHGNIKSTNVLLDKTGNA-RVSDFGLSIFA----PPSTVPRSNGYRAPELSS 533
S + H +IK N+LLD ++ DFG + P + S YRAPEL
Sbjct: 140 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 534 SDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ DV+S G +L ELL G+
Sbjct: 196 G-ATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (336), Expect = 2e-35
Identities = 46/307 (14%), Positives = 88/307 (28%), Gaps = 53/307 (17%)
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLG 411
+++ +G+G FG ++ L + VA+K S +
Sbjct: 5 VHYKVG-------RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYK 55
Query: 412 RLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 471
L + Y+ ++ + SL LL T A
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQML 111
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDK-----TGNARVSDFGLSIFA----------- 515
+ IH L + +IK N L+ + V DFG+ F
Sbjct: 112 ARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167
Query: 516 -PPSTVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCG 574
+ + Y + GR+QS++ D+ + G + + L G
Sbjct: 168 REKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSL------------PW 213
Query: 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHV 634
+ Q R + L + EE + + + D P+ ++
Sbjct: 214 QGLKAATNKQKYERIGEKKQSTPLRELC-AGFPEEFYKYMH---YARNLAFDATPDYDYL 269
Query: 635 VKLIEEL 641
L ++
Sbjct: 270 QGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 60/289 (20%), Positives = 112/289 (38%), Gaps = 31/289 (10%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLK-----DASIGGKREFEQHMEVLGRLRHPNLV 419
+ LG+G F T YKA + +VA+K++K +A G R + +++L L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 420 GLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHF 479
GL + + LV ++M + + L + +GL ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH- 117
Query: 480 TCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSS 534
+ H ++K N+LLD+ G +++DFGL+ ++ YRAPEL
Sbjct: 118 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 535 DGRKQSQKSDVYSFGVLLLELLTGKCP-------SVIDGGGAGMGCGGAVDLPRWVQSVV 587
R D+++ G +L ELL + +G P
Sbjct: 175 A-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ + + ++++ L+Q +P R + +K
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-35
Identities = 52/299 (17%), Positives = 104/299 (34%), Gaps = 53/299 (17%)
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKR------EFEQ 405
++ E LG G F K G A K +K R + E+
Sbjct: 10 DYYDTG-------EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 406 HMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLK 465
+ +L ++HPN++ L Y + + +L+ E + G LF L L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATE 117
Query: 466 IAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR----VSDFGLSIFAPPSTVP 521
G+ ++H SL++ H ++K N++L + + DFGL+
Sbjct: 118 FLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 522 R----SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAV 577
+ + + APE+ + ++D++S GV+ LL+G P
Sbjct: 174 KNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASP---------------- 215
Query: 578 DLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ +A ++ E + + ++ P +R + ++
Sbjct: 216 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 28/287 (9%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLK 422
E +G+G +G YKA G VVA+K+++ + G + + +L L HPN+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 423 AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCK 482
+ LV E++ ++ + +GLAF C
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAF----CH 119
Query: 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN-----GYRAPELSSSDGR 537
S ++ H ++K N+L++ G +++DFGL+ ++ YRAPE+ +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CK 178
Query: 538 KQSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593
S D++S G + E++T + S ID G D W ++
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 594 EVFDLELMRYKD----IEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+ ++E+ LL P++R + +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 66/344 (19%), Positives = 121/344 (35%), Gaps = 45/344 (13%)
Query: 347 VFFEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREF 403
+E + + +G G +G AV G+ VA+K+L +
Sbjct: 12 TAWEVRAVYRDL-------QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 404 EQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVSEYMPNGSLFWLLHGNRGPGRTP 457
+ + +L +RH N++GL + E + LV +M + H
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------K 117
Query: 458 LDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517
L + +GL +IH + + H ++K N+ +++ ++ DFGL+ A
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAGM 571
+ + YRAPE+ + + +Q D++S G ++ E++TGK +D M
Sbjct: 174 EMTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 572 GCGGAVDLPRWVQSVVREEWTAEVFDLELMR------YKDIEEEMVGLLQVAMACTSASP 625
G + E EL + + V LL+
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDA 289
Query: 626 DQRPNMSHVVK--LIEELRGVEVSPCHENFDSVSDSPCLSEDTL 667
+QR + E L E P + +D D + D
Sbjct: 290 EQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEW 333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (324), Expect = 1e-33
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVGL 421
LG G FG + +G A+K LK + ++ +L + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ ++ ++ +Y+ G LF LL ++ AA L ++H
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH--- 121
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP--PSTVPRSNGYRAPELSSSDGRKQ 539
S + + ++K N+LLDK G+ +++DFG + + P T+ + Y APE+ S +
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS--TKPY 178
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
++ D +SFG+L+ E+L G P
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 68/324 (20%), Positives = 116/324 (35%), Gaps = 47/324 (14%)
Query: 352 TKRFELEDLLRASAEMLGKGGFGTAYKA--VLDDGSVVAVKRLKDASIGGKREFEQHMEV 409
+++E +G+G +G +KA + + G VA+KR++ + EV
Sbjct: 6 DQQYECV-------AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 58
Query: 410 -----LGRLRHPNLVGLKAYYFAREEKLLVSEYMPN----GSLFWLLHGNRGPGRTPLDW 460
L HPN+V L + L L PG +
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPT 115
Query: 461 TTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTV 520
T + RGL F+H S ++ H ++K N+L+ +G +++DFGL+
Sbjct: 116 ETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 171
Query: 521 PRSN----GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAGMG 572
S YRAPE+ + D++S G + E+ K S +D G +
Sbjct: 172 LTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
Query: 573 CGGAVDLPRWVQSVVREEWTAEVFDLELMR--YKDIEEEMVGLLQVAMACTSASPDQRPN 630
G W + V + + DI+E LL C + +P +R +
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRIS 286
Query: 631 MSHVVK--LIEELRGVEVSPCHEN 652
+ ++L C EN
Sbjct: 287 AYSALSHPYFQDLER-----CKEN 305
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-33
Identities = 50/297 (16%), Positives = 99/297 (33%), Gaps = 59/297 (19%)
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE------FEQ 405
++++ +LG GGFG+ Y + + D VA+K ++ I E
Sbjct: 4 SQYQVG-------PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 406 HMEVLGRLR--HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTR 463
+ +L ++ ++ L ++ + +L+ E + RG L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELA 112
Query: 464 LKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPPS---T 519
+ C + + H +IK N+L+D G ++ DFG +
Sbjct: 113 RSFFWQVLEAVRH----CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD 168
Query: 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDL 579
+ Y PE R + + V+S G+LL +++ G P
Sbjct: 169 FDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF----------------- 210
Query: 580 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
E E+ ++ + + E L++ C + P RP +
Sbjct: 211 ----------EHDEEIIRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 52/203 (25%), Positives = 79/203 (38%), Gaps = 16/203 (7%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVGL 421
++LGKG FG G A+K L+ I K E VL RHP L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
K + + V EY G LF+ L R A L ++H
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH--- 122
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGYRAPELSSSD---GRK 538
S + + +IK N++LDK G+ +++DFGL PE + +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 539 QSQKSDVYSFGVLLLELLTGKCP 561
+ D + GV++ E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 63/339 (18%), Positives = 126/339 (37%), Gaps = 39/339 (11%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLK--DASIGGKREFEQ 405
+E +R++ +G G +G+ A G VAVK+L SI + +
Sbjct: 14 WEVPERYQNL-------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 406 HMEVLGRLRHPNLVGLKAYY-----FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDW 460
+ +L ++H N++GL + + + ++ L ++ + L
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTD 120
Query: 461 TTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA--PPS 518
+ RGL +IH S + H ++K +N+ +++ ++ DFGL+ +
Sbjct: 121 DHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP----SVIDGGGAGMGCG 574
+ YRAPE+ + +Q D++S G ++ ELLTG+ ID +
Sbjct: 177 GYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAM----ACTSASPDQRPN 630
G + + E + L M + +G +A+ D+R
Sbjct: 236 GTPGAELL-KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 631 MSHVVK--LIEELRGVEVSPCHENFDSVSDSPCLSEDTL 667
+ + + + P + +D +S L D
Sbjct: 295 AAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEW 333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 2e-30
Identities = 46/202 (22%), Positives = 82/202 (40%), Gaps = 17/202 (8%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKRE---FEQHMEVLGRLRHPNLVGL 421
+ LG G FG + G+ A+K L + ++ +L + P LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 422 KAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC 481
+ + +V EY+ G +F L AA ++H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH--- 158
Query: 482 KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS--IFAPPSTVPRSNGYRAPELSSSDGRKQ 539
SL L + ++K N+L+D+ G +V+DFG + + T+ + APE+ +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL--SKGY 215
Query: 540 SQKSDVYSFGVLLLELLTGKCP 561
++ D ++ GVL+ E+ G P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-30
Identities = 55/300 (18%), Positives = 103/300 (34%), Gaps = 35/300 (11%)
Query: 353 KRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQHMEV 409
+++E E +G+G +GT +KA + +VA+KR++ G + + +
Sbjct: 2 QKYEKL-------EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL 54
Query: 410 LGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAG 469
L L+H N+V L + ++ LV E+ + N D
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQ 109
Query: 470 AARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN----G 525
+GL F H + H ++K N+L+++ G ++++FGL+ S
Sbjct: 110 LLKGLGFCHS----RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP-----SVIDGGGAGMGCGGAVDLP 580
+ P + S D++S G + EL P V D G
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 581 RWVQSVVREEWTAEVFDLELMR----YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636
+W ++ + LLQ +P QR + ++
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 9e-30
Identities = 71/307 (23%), Positives = 116/307 (37%), Gaps = 53/307 (17%)
Query: 351 GTKRFELEDLLRASAEMLGKGGFGTAYKAVL----DDGSVVAVKRLKDASIGGKREFEQH 406
G + FEL ++LG G +G + D G + A+K LK A+I K + +H
Sbjct: 22 GIENFELL-------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 407 ----MEVLGRLRH-PNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWT 461
+VL +R P LV L + + L+ +Y+ G LF L R
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEH 129
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVP 521
L +H L + + +IK N+LLD G+ ++DFGLS
Sbjct: 130 EVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 522 RSN------GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGG 575
R+ Y AP++ + D +S GVL+ ELLTG P +DG
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG--------- 236
Query: 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635
+ + E + + E +++ L+Q P +R
Sbjct: 237 --------EKNSQAEISRRILKSEPPYPQEMSALAKDLIQ---RLLMKDPKKRL--GCGP 283
Query: 636 KLIEELR 642
+ +E++
Sbjct: 284 RDADEIK 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-29
Identities = 44/216 (20%), Positives = 84/216 (38%), Gaps = 30/216 (13%)
Query: 366 EMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLK 422
+G+G FG +KA G VA+K++ + G + +++L L+H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 423 AYYFAREEK--------LLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 474
+ LV ++ + L + + ++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGL 130
Query: 475 AFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSN---------G 525
+ K+ H ++K+ NVL+ + G +++DFGL+ + + N
Sbjct: 131 YY----IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 526 YRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
YR PEL + R D++ G ++ E+ T
Sbjct: 187 YRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (276), Expect = 3e-27
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 32/222 (14%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHM 407
+ ++L LG+G + ++A+ + + V VK LK K++ ++ +
Sbjct: 31 WGNQDDYQLV-------RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREI 80
Query: 408 EVLGRLR-HPNLVGLKAYYFAREEKL--LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRL 464
++L LR PN++ L + LV E++ N L L
Sbjct: 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIR 132
Query: 465 KIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD-KTGNARVSDFGLSIFAPPSTVPR- 522
+ L + H S+ + H ++K NV++D + R+ D+GL+ F P
Sbjct: 133 FYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 523 ---SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
S ++ PEL D + D++S G +L ++ K P
Sbjct: 189 RVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 41/226 (18%), Positives = 82/226 (36%), Gaps = 34/226 (15%)
Query: 349 FEGTKRFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASI--GGKREFEQ 405
F KR++ + +G G G A VA+K+L + +
Sbjct: 13 FTVLKRYQNL-------KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 65
Query: 406 HMEVLGRLRHPNLVGLKAYYFAR------EEKLLVSEYMPNGSLFWLLHGNRGPGRTPLD 459
+ ++ + H N++ L + + ++ LV E M + D
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------D 117
Query: 460 WTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPST 519
+ G+ +H H ++K +N+++ ++ DFGL+ A S
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 520 VPR----SNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
+ + YRAPE+ G + D++S G ++ E++ K
Sbjct: 174 MMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.2 bits (243), Expect = 9e-23
Identities = 44/228 (19%), Positives = 81/228 (35%), Gaps = 33/228 (14%)
Query: 354 RFELEDLLRASAEMLGKGGFGTAYKAV-LDDGSVVAVKRLKDASIGGKREFEQHMEVLGR 412
R+ L LG G F T + A + + + VA+K ++ + E +++L R
Sbjct: 14 RYILV-------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQR 65
Query: 413 LRHPNLVGLKAYYFAREEKLL--VSEYMPNGSLFWLLHGNRGP---------GRTPLDWT 461
+ + + KLL + PNG ++ G +
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 462 TRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPPSTV 520
+I+ GL ++H C + H +IK NVL++ + ++
Sbjct: 126 YVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 521 PRSN-------GYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCP 561
YR+PE+ G +D++S L+ EL+TG
Sbjct: 183 DEHYTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.1 bits (201), Expect = 1e-17
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 28 DLNALLDFKASSDEANKLTTWNSTSDPC--SWTGVSCLQN----RVSHLVLENLQLSGSL 81
D ALL K L++W T+D C +W GV C + RV++L L L L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 82 QPLTSLTQLR-----VLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136
+SL L + N P+++ LT L L+++H N +G PD +S +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPI 175
L LD S+N SG +P +++ L +L+ + + NR SG I
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 3e-10
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 1/82 (1%)
Query: 48 WNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVPS 106
+ + G L ++ L L N ++ G+L LT L L L++ +N G +P
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 107 LSNLTALKLLFLSHNNFNGEFP 128
NL + ++N P
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 16/54 (29%), Positives = 25/54 (46%), Gaps = 1/54 (1%)
Query: 118 LSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171
L +N G P ++ L L+ L++SFNN G+IP +L N+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 27/85 (31%), Positives = 34/85 (40%), Gaps = 24/85 (28%)
Query: 141 DLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKS 200
DL N G +P + L L NVS N+L G+IP+
Sbjct: 250 DLRNNRIYGTLPQGLTQLK----------------------FLHSLNVSFNNLCGEIPQG 287
Query: 201 --LSGFPDSAFTQNAALCGSPMQAC 223
L F SA+ N LCGSP+ AC
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.4 bits (129), Expect = 1e-08
Identities = 20/60 (33%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 95 LKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPL 153
L+ NR G +P L+ L L L +S NN GE P +L R + N PL
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.1 bits (189), Expect = 7e-17
Identities = 29/206 (14%), Positives = 59/206 (28%), Gaps = 37/206 (17%)
Query: 366 EMLGKGGFGTAYKAVLDDGSVVAVKRLKDAS----------IGGKREFEQHMEVLGRLRH 415
+++G+G + + VK K G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 416 PNLVGLK----AYYFAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAA 471
L L+ +A E ++ E + L+ + ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR------------VRVENPDEVLDMIL 113
Query: 472 RGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPSTVPRSNGY--RAP 529
+A + + HG++ NVL+ + G + DF S+ R
Sbjct: 114 EEVAKFY----HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGE---EGWREILERDV 165
Query: 530 E-LSSSDGRKQSQKSDVYSFGVLLLE 554
+ + R + D+ S +L+
Sbjct: 166 RNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.3 bits (194), Expect = 2e-16
Identities = 48/172 (27%), Positives = 64/172 (37%), Gaps = 28/172 (16%)
Query: 47 TWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPS 106
T N SD ++ L L L QL + L SLT L L L N+ + P
Sbjct: 205 TNNQISDITPLGILTNLD----ELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP- 258
Query: 107 LSNLTALKLLFLSHNNFNGEFP--------------------DSVSSLFRLYRLDLSFNN 146
LS LT L L L N + P +S+L L L L FNN
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIP 198
S P++ LT L L N+ S + +L N+ + N +S P
Sbjct: 319 ISDISPVS--SLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.7 bits (164), Expect = 1e-12
Identities = 41/165 (24%), Positives = 62/165 (37%), Gaps = 30/165 (18%)
Query: 48 WNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSL 107
N D + ++ L L L N Q+S L PL+ LT+L L L N+ + P
Sbjct: 228 GNQLKDIGTLASLTNLT----DLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLA 282
Query: 108 S---------------------NLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
NL L L L NN + P VSSL +L RL + N
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340
Query: 147 FSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGN 191
S ++ +LT++ L N+ S +L + ++
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 19/82 (23%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 83 PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142
T+L + L T V S ++L + L D V L L +++
Sbjct: 17 TDTALAEKMKTVLGKTNVTDTV-SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 73
Query: 143 SFNNFSGQIPLTVNHLTHLLTL 164
S N + PL +LT L+ +
Sbjct: 74 SNNQLTDITPL--KNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 8e-05
Identities = 14/60 (23%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN 124
++V+ L + L + S+ + L L ++ N+ T + L NLT L + +++N
Sbjct: 44 DQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIA 101
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 19/73 (26%), Positives = 30/73 (41%), Gaps = 6/73 (8%)
Query: 127 FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQD 185
F D+ +L + L N + + T L + TL+ + I G++ L NL
Sbjct: 16 FTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQ 70
Query: 186 FNVSGNHLSGQIP 198
N S N L+ P
Sbjct: 71 INFSNNQLTDITP 83
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (146), Expect = 1e-10
Identities = 33/117 (28%), Positives = 45/117 (38%), Gaps = 2/117 (1%)
Query: 89 QLRVLSLKYNRFTG-PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147
L L L NR + P + L +L L L N P + L RL L L NN
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 148 SGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLR-NLQDFNVSGNHLSGQIPKSLSG 203
S + L L L+L N + L LQ F S + + +P+ L+G
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 3/88 (3%)
Query: 62 CLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHN 121
L ++ + N + + L L L+ L L N + + L+ S +
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSS 258
Query: 122 NFNGEFPDSVSSLFRLYRLDLSFNNFSG 149
P L L+ N+ G
Sbjct: 259 EVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.001
Identities = 34/152 (22%), Positives = 49/152 (32%), Gaps = 7/152 (4%)
Query: 54 PCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTA 112
PC C L + + +Q + L NR + P S
Sbjct: 1 PCP-GACVCYNEPKVTTSCPQQGLQAVPVGIPAASQ--RIFLHGNRISHVPAASFRACRN 57
Query: 113 LKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQI-PLTVNHLTHLLTLKLEANRF 171
L +L+L N + + L L +LDLS N + P T + L L TL L+
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 172 SGPITGLDL--RNLQDFNVSGNHLSGQIPKSL 201
GL LQ + N L +
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.7 bits (138), Expect = 1e-09
Identities = 29/153 (18%), Positives = 47/153 (30%), Gaps = 14/153 (9%)
Query: 55 CSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG-PVPSLSNLTAL 113
C V C + + P +L L+ N+ T NL L
Sbjct: 10 CHLRVVQCSDLGLEKV------------PKDLPPDTALLDLQNNKITEIKDGDFKNLKNL 57
Query: 114 KLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173
L L +N + P + + L +L RL LS N L L + E +
Sbjct: 58 HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRK 117
Query: 174 PITG-LDLRNLQDFNVSGNHLSGQIPKSLSGFP 205
+ L+ + + + SG + G
Sbjct: 118 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 9e-08
Identities = 33/178 (18%), Positives = 57/178 (32%), Gaps = 6/178 (3%)
Query: 30 NALLDFKASSDEANKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQP---LTS 86
N L + + + + V N++ + L L S
Sbjct: 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148
Query: 87 LTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
+ +L + + T L +L L L N S+ L L +L LSFN+
Sbjct: 149 MKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 147 FSGQIPLTVNHLTHLLTLKLEANRF-SGPITGLDLRNLQDFNVSGNHLSGQIPKSLSG 203
S ++ + HL L L N+ P D + +Q + N++S
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 29/159 (18%), Positives = 55/159 (34%), Gaps = 13/159 (8%)
Query: 45 LTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPV 104
L T S ++ +S++ + + ++ P L L L N+ T
Sbjct: 131 LGTNPLKSSGIENGAFQGMKK-LSYIRIADTNITTI--PQGLPPSLTELHLDGNKITKVD 187
Query: 105 P-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163
SL L L L LS N+ + S+++ L L L+ N ++P + ++
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246
Query: 164 LKLEANR--------FSGPITGLDLRNLQDFNVSGNHLS 194
+ L N F P + ++ N +
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 4e-09
Identities = 28/108 (25%), Positives = 41/108 (37%), Gaps = 7/108 (6%)
Query: 91 RVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQ 150
RVL L + T L L + L LSHN P ++++L L L ++ + +
Sbjct: 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALE 56
Query: 151 IPLTVNHLTHLLTLKLEANRFSG---PITGLDLRNLQDFNVSGNHLSG 195
V +L L L L NR + L N+ GN L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 1e-08
Identities = 29/105 (27%), Positives = 42/105 (40%), Gaps = 4/105 (3%)
Query: 70 LVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPD 129
L L + L+ L L L + L L +NR P+L+ L L++L S N D
Sbjct: 3 LHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE--NVD 59
Query: 130 SVSSLFRLYRLDLSFNNF-SGQIPLTVNHLTHLLTLKLEANRFSG 173
V++L RL L L N + L+ L L+ N
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 16/73 (21%), Positives = 36/73 (49%), Gaps = 2/73 (2%)
Query: 48 WNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSL 107
+ + S ++++ L ++ ++S + PL SL L + LK N+ + V L
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD-VSPL 213
Query: 108 SNLTALKLLFLSH 120
+N + L ++ L++
Sbjct: 214 ANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 14/61 (22%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 83 PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142
PL +L++L L N+ + + L++L L + L +N + P +++ L+ + L
Sbjct: 168 PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 143 S 143
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 105 PSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTL 164
L+NL+ L L N + ++SL L + L N S PL + ++L +
Sbjct: 167 TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIV 222
Query: 165 KLE 167
L
Sbjct: 223 TLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 12/68 (17%), Positives = 23/68 (33%), Gaps = 3/68 (4%)
Query: 80 SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYR 139
+ P +L ++ + T V + ++L + L + V L L
Sbjct: 11 VIFPDPALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67
Query: 140 LDLSFNNF 147
L+L N
Sbjct: 68 LELKDNQI 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 5e-06
Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 8/75 (10%)
Query: 87 LTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNN 146
L L++ N+ L+ L S N+ E P+ + L +L + +N
Sbjct: 283 PPSLEELNVSNNKLIELPALPPR---LERLIASFNHLA-EVPELPQN---LKQLHVEYNP 335
Query: 147 FSGQIPLTVNHLTHL 161
+ P + L
Sbjct: 336 LR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 20/77 (25%), Positives = 34/77 (44%), Gaps = 9/77 (11%)
Query: 109 NLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEA 168
+L+ L +S+N E P + RL RL SFN+ + ++P +L L +E
Sbjct: 282 LPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP---ELPQNLKQLHVEY 333
Query: 169 NRFSG-PITGLDLRNLQ 184
N P + +L+
Sbjct: 334 NPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 9e-05
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 8/88 (9%)
Query: 117 FLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT 176
N + E L L++S N ++P L L N + +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VP 320
Query: 177 GLDLRNLQDFNVSGNHLSG--QIPKSLS 202
L +NL+ +V N L IP+S+
Sbjct: 321 EL-PQNLKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 9e-05
Identities = 22/69 (31%), Positives = 28/69 (40%), Gaps = 6/69 (8%)
Query: 72 LENLQLSG-SLQPL-TSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPD 129
LE L +S L L +L L +N VP L LK L + +N EFPD
Sbjct: 286 LEELNVSNNKLIELPALPPRLERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLR-EFPD 341
Query: 130 SVSSLFRLY 138
S+ L
Sbjct: 342 IPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 18/67 (26%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 62 CLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHN 121
CL + L L NL LS SL L L L N T +L +L + +
Sbjct: 35 CLDRQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLK 91
Query: 122 NFNGEFP 128
+ P
Sbjct: 92 ALSDLPP 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 13/90 (14%), Positives = 26/90 (28%), Gaps = 6/90 (6%)
Query: 90 LRVLSLKYNRFT--GPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFR----LYRLDLS 143
++ L ++ + L L +++ L +SS R L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSG 173
N V + K++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 16/93 (17%), Positives = 27/93 (29%), Gaps = 17/93 (18%)
Query: 72 LENLQLS-------GSLQPLTSLTQLRVLSLKYNRFTGP-----VPSLSNLTALKLLFLS 119
+++L + + L L Q +V+ L T +L AL L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 120 HNNFNGEFPDSVSSLF-----RLYRLDLSFNNF 147
N V ++ +L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 17/102 (16%), Positives = 29/102 (28%), Gaps = 11/102 (10%)
Query: 48 WNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGS-----LQPLTSLTQLRVLSLKYNRFTG 102
G+ + + L L + +S S L + LR L L N
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 103 PVPSL------SNLTALKLLFLSHNNFNGEFPDSVSSLFRLY 138
L+ L L ++ E D + +L +
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 4e-05
Identities = 17/97 (17%), Positives = 30/97 (30%), Gaps = 13/97 (13%)
Query: 107 LSNLTALKLLFLSHNNFNGE----FPDSVSSLFRLYRLDLSFNNFSGQIPLTV-----NH 157
+ L++L+L+ + + ++ + L LDLS N L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 158 LTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194
L L L +S + LQ L
Sbjct: 425 GCLLEQLVLYDIYWSEEM----EDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 9/115 (7%), Positives = 26/115 (22%), Gaps = 19/115 (16%)
Query: 113 LKLLFLSHNNFNGE-FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRF 171
++ L + + + + + L + + L + ++ L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR---CKDISSALR-------- 52
Query: 172 SGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSPMQACKTM 226
L + N+ N L + + + L
Sbjct: 53 -------VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 5e-05
Identities = 18/89 (20%), Positives = 26/89 (29%), Gaps = 2/89 (2%)
Query: 84 LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143
T+ + R L L+ + + L + S N D L RL L ++
Sbjct: 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVN 71
Query: 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFS 172
N L L L L N
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 13/72 (18%), Positives = 23/72 (31%), Gaps = 3/72 (4%)
Query: 104 VPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163
+N + L L + ++L + +D S N ++ L L T
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKT 67
Query: 164 LKLEANRFSGPI 175
L + NR
Sbjct: 68 LLVNNNRICRIG 79
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 63 LQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFT--GPVPSLSNLTALKLLFLSH 120
L V + L S +++ + L + LS + L+ L L
Sbjct: 21 LSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 121 NNFNGEFPDSVSSLFRLYRLDLSFNNF 147
+ ++++ L RL+LS +
Sbjct: 81 LRLSDPIVNTLAKNSNLVRLNLSGCSG 107
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 17/90 (18%), Positives = 28/90 (31%), Gaps = 3/90 (3%)
Query: 103 PVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLL 162
P+ +S + + + N P + L LS N T+ T L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 163 TLKLEANRFSGPITGLDLRNLQDFNVSGNH 192
L L+ + L L ++S N
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQ 88
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 35/180 (19%), Positives = 54/180 (30%), Gaps = 15/180 (8%)
Query: 55 CSWTGVSCLQNRVSHL------VLENLQLSGSL-------QPLTSLTQLRVLSLKYNRFT 101
C T V C + + L L+ + L L L LK N+ T
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 102 GPVPSLSNLTALKLLFLSHNNFNGE-FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTH 160
G P+ + N E L +L L+L N S +P + HL
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 161 LLTLKLEANRFSGPITGLDLRNLQ-DFNVSGNHLSGQIPKSLSGFPDSAFTQNAALCGSP 219
L +L L +N F+ +++G P + + C S
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 13/40 (32%), Positives = 21/40 (52%), Gaps = 1/40 (2%)
Query: 80 SLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLS 119
+ PL LT+L+ L L N + + +L+ L L +L L
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 18/74 (24%), Positives = 32/74 (43%), Gaps = 2/74 (2%)
Query: 43 NKLTTWNSTSDPCSWTGVSCLQNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTG 102
L +S+ S + L + Q++ L+PL +LT L L + N+ +
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKVSD 186
Query: 103 PVPSLSNLTALKLL 116
+ L+ LT L+ L
Sbjct: 187 -ISVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.002
Identities = 19/105 (18%), Positives = 35/105 (33%), Gaps = 5/105 (4%)
Query: 77 LSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFR 136
L + + L L + + + R + LK+L LS N E +
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 137 LYRLDLSFNNFSGQIPLTVNHLTHLLTL-----KLEANRFSGPIT 176
L L L N+ S +++ + +L+ + PI
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.002
Identities = 13/61 (21%), Positives = 20/61 (32%), Gaps = 7/61 (11%)
Query: 86 SLTQLRVLSLKYNRFTGPVPS------LSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYR 139
L+ L L+YN + L L L+ N F E D V + ++
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFS 329
Query: 140 L 140
Sbjct: 330 T 330
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 672 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.62 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.54 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.52 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.48 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.28 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.94 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.81 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.31 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.21 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.18 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.03 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=409.68 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=196.0
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||.||+|++.+++.||||+++.... ..++|.+|++++++++|||||+++|++.+++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 468999999999999998899999999986543 5678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..++|..++.|+.|+|+||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9987543 46899999999999999999999 789999999999999999999999999999866543
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...+|..|+|||++. +..++.++|||||||++|||+|+..|+... ....+.+..+..... ...+
T Consensus 161 ~~~gt~~y~aPE~l~--~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----------~~~~~~~~~i~~~~~---~~~p 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----------RSNSEVVEDISTGFR---LYKP 224 (263)
T ss_dssp ----CTTSCCHHHHT--TCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----------CCHHHHHHHHHHTCC---CCCC
T ss_pred ceecCcccCChHHhc--CCCCCchhhhcchHHHHHHHHHCCCCCCCC-----------CCHHHHHHHHHhcCC---CCCc
Confidence 345678899999875 557999999999999999999964444321 122233333222211 1111
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.....++.+++.+||+.||++||||+||++.|+++++
T Consensus 225 --------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 --------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122457888999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=408.85 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=199.1
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++. ++..++||||+++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 478999999999999875 35999999743 3335678999999999999999999999875 456899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.++++... .++++..+..|+.|+|+||+||| +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus 90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999997543 45999999999999999999999 789999999999999999999999999999766432
Q ss_pred ---CCCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ---TVPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...+|+.|+|||++... ...++.++|||||||++|||+||+.||.... ....+...........
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~------------~~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------------NRDQIIFMVGRGYLSP 229 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC------------CHHHHHHHHHHTSCCC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC------------hHHHHHHHHhcCCCCC
Confidence 35678999999987543 3468999999999999999999999996432 1222222232222111
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..... ......++.+++.+||+.||++||||.||++.|+.+.+
T Consensus 230 ----~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 ----DLSKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ----CGGGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cchhc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11110 01223467888899999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=404.21 Aligned_cols=246 Identities=29% Similarity=0.425 Sum_probs=199.3
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
+.+.||+|+||.||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|++. ++..++||||+++|+|
T Consensus 17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred EeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcH
Confidence 3578999999999999999889999999976543 5678999999999999999999999875 4567999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++.... ..+++|..+++|+.|||+||+||| +.+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 95 ~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 95 VDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp HHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred HHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99876443 235899999999999999999999 789999999999999999999999999999876543
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|..|+|||++. +..++.++|||||||++|||+||..|+... ....+....+.....
T Consensus 168 ~~~~gt~~y~APE~~~--~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-----------~~~~~~~~~i~~~~~------ 228 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPG-----------MTNPEVIQNLERGYR------ 228 (272)
T ss_dssp TTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTT-----------CCHHHHHHHHHTTCC------
T ss_pred cccCCcccccChHHHh--CCCCCchhhhhhhHHHHHHHHhCCCCCCCC-----------CCHHHHHHHHHhcCC------
Confidence 345778899999875 457899999999999999999976665422 122222222222110
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
..... ....++.+++.+||+.||++||||.||++.|+.+.
T Consensus 229 --~~~p~---~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 --MVRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcc---cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 00111 12235778889999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=401.97 Aligned_cols=238 Identities=24% Similarity=0.384 Sum_probs=198.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 47899999999999995 57999999999766555678899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-----
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS----- 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 518 (672)
.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+++.....
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 9988753 3899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||... +..+.+......... ..
T Consensus 175 ~~~gt~~Y~aPE~~~--~~~~~~~~DiwSlGvilyemltG~~Pf~~~------------~~~~~~~~~~~~~~~-~~--- 236 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------------NPLRALYLIATNGTP-EL--- 236 (293)
T ss_dssp CCCSCGGGCCHHHHS--SSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------CHHHHHHHHHHHCSC-CC---
T ss_pred ccccCCCccChhhhc--CCCCCchhceehHhHHHHHHhhCCCCCCCC------------CHHHHHHHHHhCCCC-CC---
Confidence 456899999999875 457899999999999999999999999643 222223333322211 11
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
... ......+.+++.+||+.||++|||+.|++
T Consensus 237 --~~~---~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 237 --QNP---EKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp --SSG---GGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred --CCc---ccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 011 11223577888899999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=401.41 Aligned_cols=239 Identities=30% Similarity=0.488 Sum_probs=198.8
Q ss_pred HHhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 363 ASAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 34578999999999999965 68999999986432 224577899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++++||+|||+|+.....
T Consensus 89 ~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 89 PLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred CCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999754 35999999999999999999999 789999999999999999999999999999876554
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||... +..+....+.+....
T Consensus 160 ~~~~~~Gt~~Y~APE~~~--~~~~~~~~DiwSlGvilyell~G~~Pf~~~------------~~~~~~~~i~~~~~~--- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------------TYQETYKRISRVEFT--- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHTTCCC---
T ss_pred cccccCCCCcccCHHHHc--CCCCCchhhhhhHhHHHHHHhcCCCCCCCC------------CHHHHHHHHHcCCCC---
Confidence 456889999999875 457899999999999999999999999643 223333333322210
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..... ..++.+++.+||+.||++|||+.|+++
T Consensus 223 ------~p~~~---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 ------FPDFV---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCccC---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111 235677888999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=406.82 Aligned_cols=246 Identities=24% Similarity=0.424 Sum_probs=193.4
Q ss_pred hcccCcCCeEEEEEEEEc-CC---cEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DG---SVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||+||+|+.+ +| ..||||++.... ....++|.+|+++|++++|||||+++|++.+++..++||||++
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 468999999999999965 23 368999987543 3355789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++.... ..++|.++..|+.|+|+||+||| +.+|+||||||+|||++.++++||+|||+++.....
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999987643 35999999999999999999999 789999999999999999999999999999876532
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |+.||... ...+.+..+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~------------~~~~~~~~i~~ 248 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQ--YRKFTSASDVWSYGIVMWEVMSYGERPYWDM------------TNQDVINAIEQ 248 (299)
T ss_dssp -------------CGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHT
T ss_pred CcceeeecccccCCccccCHHHHh--cCCCCcccccccchHHHHHHHhCCCCCCCCC------------CHHHHHHHHHc
Confidence 133577899999764 5689999999999999999998 89999643 22223332222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.... +...+....+.+++.+||+.||++||||.||++.|+++.+
T Consensus 249 ~~~~-----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 DYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TCCC-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCC-----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 2110 1111233467888999999999999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=396.32 Aligned_cols=243 Identities=24% Similarity=0.394 Sum_probs=202.4
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCChh
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSLF 444 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 444 (672)
.+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|++.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 478999999999999999899999999986554 5678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC------
Q 005880 445 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS------ 518 (672)
Q Consensus 445 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 518 (672)
+++.... ..+++..+++|+.|+|+||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9987543 45899999999999999999999 789999999999999999999999999999765433
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |+.||... ...+....+.. ... ...
T Consensus 160 ~~~~t~~y~aPE~~~--~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~------------~~~~~~~~i~~-~~~--~~~ 222 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAEHIAQ-GLR--LYR 222 (258)
T ss_dssp CSCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS------------CHHHHHHHHHT-TCC--CCC
T ss_pred ccCCCCCcCCcHHhc--CCCCCcceeecccchhhHhHHhcCCCCCCCC------------CHHHHHHHHHh-CCC--CCC
Confidence 345678899999775 4578999999999999999998 89999643 22233332222 111 111
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
+ .....++.+++.+||+.||++|||++|+++.|.+|
T Consensus 223 p--------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 P--------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp C--------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred c--------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1 11224678889999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=404.32 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=203.1
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||+||+|++. +|+.||||+++.... ..++|.+|++++++++|||||+++|++.+++..++||||+++|+
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 3578999999999999975 589999999976543 56789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++.... ...+++..++.|+.|+|+||+||| +.+|+||||||+|||+++++++||+|||+++.....
T Consensus 100 l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 100 LLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp HHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred hHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999997643 256999999999999999999999 789999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...++..|+|||++. +..++.++|||||||++|||++|..||... .+..+.. .........
T Consensus 173 ~~~~~g~~~y~aPE~~~--~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-----------~~~~~~~-~~i~~~~~~--- 235 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------IDLSQVY-ELLEKDYRM--- 235 (287)
T ss_dssp ETTEEECGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-----------CCHHHHH-HHHHTTCCC---
T ss_pred eccccccccccChHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCc-----------chHHHHH-HHHhcCCCC---
Confidence 223577899999775 457899999999999999999987776532 1222222 222222111
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.... ....++.+++.+||+.||++||||.||++.|+.+.+
T Consensus 236 ----~~~~---~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ----ERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----CCCc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 123457888899999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=401.81 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=200.8
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 478999999999999964 6899999999876666678899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----C
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP-----S 518 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-----~ 518 (672)
.+++.... .++++.++..++.|+++||.||| +.+|+||||||+|||++.++++||+|||+|+.... .
T Consensus 97 ~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 97 DAVMLELE----RPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99986533 35999999999999999999999 78999999999999999999999999999976543 3
Q ss_pred CCCCCCcccCCCcccc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 TVPRSNGYRAPELSSS---DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~---~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...||+.|+|||++.. .+..++.++|||||||++|||+||+.||.... ..+.+..+...... .
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~------------~~~~~~~i~~~~~~-~- 234 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN------------PMRVLLKIAKSEPP-T- 234 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC------------GGGHHHHHHHSCCC-C-
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC------------HHHHHHHHHcCCCC-C-
Confidence 6778999999998743 24568999999999999999999999996432 12223333332211 0
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... .....++.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~---~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----LAQP---SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----CSSG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCcc---ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011 112235778888999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=399.95 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=191.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||+||+|+.. +|+.||||+++.... ...+++.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 478999999999999964 699999999875432 245678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP----- 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 517 (672)
|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+|||+++++++||+|||+|+....
T Consensus 90 L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 90 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999643 35999999999999999999999 78999999999999999999999999999986532
Q ss_pred --CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 518 --STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 518 --~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
....||+.|+|||++.. ...++.++||||+||++|||+||+.||....... ............
T Consensus 161 ~~~~~~GT~~Y~APE~~~~-~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----------~~~~~~~~~~~~--- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----------QEYSDWKEKKTY--- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHC-SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----------HHHHHHHTTCTT---
T ss_pred cccceeeCcCccCHhHhcC-CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----------HHHHHHhcCCCC---
Confidence 24578999999998753 2335688999999999999999999997543211 111111111100
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
. ..... ...++.+++.+||+.||++|||++|++
T Consensus 226 ~----~~~~~---~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 226 L----NPWKK---IDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp S----TTGGG---SCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred C----Ccccc---CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 0 00111 123466788899999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=399.68 Aligned_cols=242 Identities=26% Similarity=0.337 Sum_probs=197.3
Q ss_pred ccCcCCeEEEEEEEEc---CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 367 MLGKGGFGTAYKAVLD---DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999854 35689999997543 3346789999999999999999999999865 56889999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|.+++...+ ..+++.++.+|+.|+|+||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999986543 46999999999999999999999 789999999999999999999999999999866432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |+.||.... ..+....+.... ..
T Consensus 167 ~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~------------~~~~~~~i~~~~-~~ 231 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------------GPEVMAFIEQGK-RM 231 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------------THHHHHHHHTTC-CC
T ss_pred ccccccccCccccChHHHh--CCCCCccchhhcchHHHHHHHhCCCCCCCCCC------------HHHHHHHHHcCC-CC
Confidence 345678899999775 4578999999999999999998 899996432 122222222221 11
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
+ ..+ ....++.+++.+||+.||++||||.+|++.|+.+.
T Consensus 232 ~-------~p~---~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 E-------CPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp C-------CCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------CCC---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 111 22345778899999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=396.87 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=194.4
Q ss_pred cccCcCCeEEEEEEEEcC---CcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 366 EMLGKGGFGTAYKAVLDD---GSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
+.||+|+||.||+|.+++ ++.||||+++... ....++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 4689999997533 2245689999999999999999999999865 467899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.++++... .+++.++++|+.|||+||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999998643 5999999999999999999999 789999999999999999999999999999866432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |+.||... ...+....+.+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~------------~~~~~~~~i~~~~~ 228 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM------------KGSEVTAMLEKGER 228 (277)
T ss_dssp EEEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC------------CHHHHHHHHHTTCC
T ss_pred ccccccccCCCceecCchhhc--CCCCCchhhhccchhhhhHHhhCCCCCCCCC------------CHHHHHHHHHcCCC
Confidence 345788999999775 4578999999999999999998 89999643 22222222222111
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
. ... .....++.+++.+||+.||++||||.||++.|+...
T Consensus 229 -~-------~~p---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 -M-------GCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -C-------CCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -C-------CCC---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 0 011 112345778899999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=397.47 Aligned_cols=247 Identities=23% Similarity=0.397 Sum_probs=195.6
Q ss_pred hcccCcCCeEEEEEEEEcCC-----cEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDDG-----SVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.++||+|+||.||+|.+++. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 46899999999999997642 4799999975433 34567999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
.+|++.+++.... ..++|.++++++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999887553 45999999999999999999999 789999999999999999999999999999865432
Q ss_pred --------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 --------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 --------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...+|..|+|||++. +..++.++|||||||++|||++|..|+.... ...+.+..+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----------~~~~~~~~i~~~- 229 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----------SNHEVMKAINDG- 229 (283)
T ss_dssp ----------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----------CHHHHHHHHHTT-
T ss_pred CccceEeccCCCCccccCHHHHc--cCCCCCcccccccHHHHHHHHhCCCCccccC-----------CHHHHHHHHhcc-
Confidence 234678899999775 5689999999999999999999776664321 222222222211
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
... +........+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 230 ~~~----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FRL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 110 1111233467889999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=390.65 Aligned_cols=238 Identities=25% Similarity=0.420 Sum_probs=190.9
Q ss_pred cccCcCCeEEEEEEEEc-CCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEc----CCeEEEEEeec
Q 005880 366 EMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFA----REEKLLVSEYM 438 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 438 (672)
+.||+|+||+||+|+.. +++.||+|++.... ....+.|.+|++++++++|||||++++++.+ +...++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 57999999999999965 68899999987543 3345679999999999999999999999875 34578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCEEeC-CCCcEEEeccCCCccC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLK--LTHGNIKSTNVLLD-KTGNARVSDFGLSIFA 515 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~ 515 (672)
++|+|.+++... ..+++..+..++.|+++||+||| +.+ |+||||||+|||++ +++.+||+|||+++..
T Consensus 95 ~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH----~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 95 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH----HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999754 35899999999999999999999 556 99999999999997 5789999999999866
Q ss_pred CCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 516 PPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 516 ~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
... ...||+.|+|||++. ..++.++|||||||++|||++|+.||.... +.......+.. ...
T Consensus 166 ~~~~~~~~~GT~~Y~aPE~~~---~~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----------~~~~~~~~i~~-~~~ 230 (270)
T d1t4ha_ 166 RASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----------NAAQIYRRVTS-GVK 230 (270)
T ss_dssp CTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----------SHHHHHHHHTT-TCC
T ss_pred cCCccCCcccCccccCHHHhC---CCCCCcCchhhHHHHHHHHHHCCCCCCCcc-----------cHHHHHHHHHc-CCC
Confidence 543 467899999999874 358999999999999999999999996421 22222222221 111
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...++ .. ...++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~------~~---~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PASFD------KV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CGGGG------GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccC------cc---CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 11 1234678888999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=395.03 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=185.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEc--CCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFA--REEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+ ++..|+||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 478999999999999964 689999999976443 245678999999999999999999999875 456789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhC-CCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTC-KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
+|+|.+++..... ....+++..++.++.|+++||+|||+.. ...+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 9999999864321 1246999999999999999999999542 1246999999999999999999999999999876543
Q ss_pred -----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc
Q 005880 519 -----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA 593 (672)
Q Consensus 519 -----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (672)
...+|+.|+|||++. +..+++++|||||||++|||+||+.||... +..+....+..... .
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyel~tg~~Pf~~~------------~~~~~~~~i~~~~~-~ 232 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAF------------SQKELAGKIREGKF-R 232 (269)
T ss_dssp --------CCCSCCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHHTCC-C
T ss_pred CCccccCCCCcccCCHHHHc--CCCCChHHHHHhhCHHHHHHhhCCCCCCCC------------CHHHHHHHHHcCCC-C
Confidence 456899999999874 567899999999999999999999999642 22233333322211 1
Q ss_pred cccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 EVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+ ... ...++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~-------~~~---~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 RI-------PYR---YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC-------CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-------Ccc---cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 011 2235778888999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=394.81 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=198.4
Q ss_pred HHhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 363 ASAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 363 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.+.||+|+||.||+|+.++++.||||+++.... ..+.|.+|+.++++++|||||+++|++. ++..++||||+++|+
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence 34678999999999999999888999999975543 5678999999999999999999999985 566899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
|..++.... ...++|.+++.|+.|||+||+||| +.+|+||||||+|||+++++++||+|||+++.....
T Consensus 98 l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 98 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999987543 135999999999999999999999 789999999999999999999999999999866433
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...+|..|+|||++. ...++.++|||||||++|||+||..|+... ....+.+..+.+... ..
T Consensus 171 ~~~~~gt~~y~aPE~~~--~~~~~~ksDI~S~Giil~el~t~~~p~~~~-----------~~~~~~~~~i~~~~~-~~-- 234 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPG-----------MVNREVLDQVERGYR-MP-- 234 (285)
T ss_dssp -----CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-----------CCHHHHHHHHHTTCC-CC--
T ss_pred eccccccccccChHHHh--CCCCCcHHhhhcchHHHHHHHhCCCCCCCC-----------CCHHHHHHHHHhcCC-CC--
Confidence 345788999999775 457899999999999999999977666432 122233333222211 01
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcC
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGV 644 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 644 (672)
.. .....++.+++.+||+.||++||||++|+++|+.....
T Consensus 235 -----~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 -----CP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CC---cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11 12234577888999999999999999999999987643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=397.80 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=197.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 47899999999999995 47899999999754432 345789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-C
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-T 519 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~ 519 (672)
|+|..++... .++++.++..++.||++||.||| +.+|+||||||+|||++.++++||+|||+|+..... .
T Consensus 100 g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 100 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 9998776543 35999999999999999999999 789999999999999999999999999999876544 6
Q ss_pred CCCCCcccCCCccccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 520 VPRSNGYRAPELSSSD-GRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~-~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
..||+.|+|||++... ...++.++|||||||++|||++|+.||... ...+.+........ ....
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------------~~~~~~~~i~~~~~-~~~~-- 235 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------------NAMSALYHIAQNES-PALQ-- 235 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------CHHHHHHHHHHSCC-CCCS--
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------------CHHHHHHHHHhCCC-CCCC--
Confidence 6789999999987542 356899999999999999999999999642 22222222222211 0110
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~~---~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ----SGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCC---CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 1235778888999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=394.84 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=198.6
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC----eEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE----EKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+++ |+.||||+++.... ....++.|+..+.+++|||||++++++.+++ ..++||||+++
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 467999999999999974 89999999964421 2222344555666789999999999998654 57899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhh----CCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFT----CKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+|.++++.. .++|..+++++.|+|.||+|||+. +++++|+||||||+||||++++++||+|||+++...
T Consensus 86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999854 389999999999999999999942 124699999999999999999999999999997653
Q ss_pred C---------CCCCCCCcccCCCccccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCC-CC-CCCCChhH
Q 005880 517 P---------STVPRSNGYRAPELSSSDGR----KQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGM-GC-GGAVDLPR 581 (672)
Q Consensus 517 ~---------~~~~~t~~y~aPE~l~~~~~----~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~-~~-~~~~~~~~ 581 (672)
. ....||.+|+|||++..... .++.++|||||||++|||+||..||......... .. ........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 3 24568999999998653211 3577999999999999999999988654432211 00 01111122
Q ss_pred HHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 582 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.......... +++.........+....+.+++.+||+.||++||||.||++.|+++.+
T Consensus 240 ~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2222222221 222221111123455678899999999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=389.50 Aligned_cols=245 Identities=29% Similarity=0.425 Sum_probs=192.7
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||.||+|+++ |+.||||++++.. ..++|.+|++++++++||||++++|++.+ ++..++||||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 3578999999999999986 7899999997643 45789999999999999999999999865 456799999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--CC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--TV 520 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~ 520 (672)
|.+++.... ...++|..+++|+.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 88 L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 88 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 999997542 235899999999999999999999 789999999999999999999999999999876544 45
Q ss_pred CCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccchh
Q 005880 521 PRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDLE 599 (672)
Q Consensus 521 ~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 599 (672)
.++..|+|||++. +..+++++|||||||++|||+| |++||.... ..+....+.. +...++
T Consensus 161 ~~~~~y~aPE~l~--~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~------------~~~~~~~i~~-~~~~~~---- 221 (262)
T d1byga_ 161 KLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPRVEK-GYKMDA---- 221 (262)
T ss_dssp -CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC------------GGGHHHHHTT-TCCCCC----
T ss_pred cccccCCChHHHh--CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC------------HHHHHHHHHc-CCCCCC----
Confidence 5678999999775 4578999999999999999998 687775432 2222222221 111111
Q ss_pred hccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 600 LMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 600 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
......++.+++.+||+.||++||||.||++.|++++.
T Consensus 222 ------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 ------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11122457788899999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=402.12 Aligned_cols=192 Identities=24% Similarity=0.385 Sum_probs=168.9
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+++|++++|||||+++++|.++++.++||||+++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 478999999999999964 78999999997543 3346789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC---CC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP---ST 519 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---~~ 519 (672)
|.+++.... .+++..+..++.|+++||.|||+. ++|+||||||+|||++.++++||+|||+|+.... ..
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh---CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 999997543 489999999999999999999931 4899999999999999999999999999975532 35
Q ss_pred CCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005880 520 VPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDG 566 (672)
Q Consensus 520 ~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~ 566 (672)
..||..|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 163 ~~GT~~Y~APEvl~--~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -CCSSCCCCHHHHH--CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccCCccccCchHHc--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 68999999999876 4679999999999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=399.29 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=196.0
Q ss_pred HhcccCcCCeEEEEEEEEcC-C-----cEEEEEEcccC-CcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD-G-----SVVAVKRLKDA-SIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 435 (672)
+.+.||+|+||+||+|+... + ..||||++... .......+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 46789999999999999643 2 36999998653 333456899999999998 8999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 436 EYMPNGSLFWLLHGNRG------------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
||+++|+|.++++.... .....+++..++.|+.|+++||+||| +.+|+||||||+||+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVL 196 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSGGGEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCchhccc
Confidence 99999999999976532 11235899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005880 498 LDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGA 569 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~ 569 (672)
++.++++||+|||+|+..... ...+|+.|+|||++. +..++.++|||||||++|||+| |+.||......
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~- 273 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD- 273 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc--CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999765433 234588999999775 4678999999999999999998 89999643211
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIE 639 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 639 (672)
+.+........... ... ....++.+|+.+||+.||++||||+||++.|.
T Consensus 274 -----------~~~~~~~~~~~~~~-------~p~---~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 -----------ANFYKLIQNGFKMD-------QPF---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -----------HHHHHHHHTTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----------HHHHHHHhcCCCCC-------CCC---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 12223333321110 111 12345788899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=392.41 Aligned_cols=241 Identities=23% Similarity=0.378 Sum_probs=182.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc-chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI-GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|++++++++|||||++++++.+++..|+||||+++|+
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 578999999999999965 689999999975443 234678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC---CCCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD---KTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~- 518 (672)
|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++. +++.+||+|||+++.....
T Consensus 94 L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 94 LFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp HHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred HHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999754 35999999999999999999999 78999999999999995 5789999999999876543
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+.+.....
T Consensus 165 ~~~~~~GT~~y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~------------~~~~~~~~i~~~~~~~-- 228 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLA--QKPYSKAVDCWSIGVIAYILLCGYPPFYDE------------NDAKLFEQILKAEYEF-- 228 (307)
T ss_dssp --------CTTSCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHTTCCCC--
T ss_pred eeeeeeeCccccCcHHHc--CCCCCcHHHhhhhhHHHHHHHhCCCCCCCC------------CHHHHHHHHhccCCCC--
Confidence 456899999999875 557899999999999999999999999643 2222233333322110
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 229 -~--~~~~~~---~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 -D--SPYWDD---ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -C--TTTTTT---SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C--CccccC---CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 001111 2235778888999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-47 Score=396.40 Aligned_cols=243 Identities=22% Similarity=0.376 Sum_probs=201.4
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 3578999999999999964 699999999987766677889999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC--CCcEEEeccCCCccCCCC--
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK--TGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~-- 518 (672)
|.+++.... ..+++..+..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999996443 35999999999999999999999 789999999999999964 678999999999877654
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||... +..+.+..+.......
T Consensus 182 ~~~~~gT~~Y~aPEv~~--~~~~~~~~DiwSlGvilyell~G~~Pf~~~------------~~~~~~~~i~~~~~~~--- 244 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGE------------NDDETLRNVKSCDWNM--- 244 (350)
T ss_dssp EEEECSCTTTCCHHHHH--TCCBCHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHTCCCS---
T ss_pred cceecCcccccCHHHHc--CCCCChhHhhhhhhHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCCCC---
Confidence 457899999999875 567899999999999999999999999643 2333344433332111
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.. .... ...++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~--~~~~---~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDS--AFSG---ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCG--GGGG---CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred Ccc--cccC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0111 1235678888999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=390.68 Aligned_cols=239 Identities=21% Similarity=0.307 Sum_probs=196.8
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 3578999999999999964 69999999986432 2245679999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 92 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999998754 35999999999999999999999 789999999999999999999999999999876432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||... +..+....+.+....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~------------~~~~~~~~i~~~~~~ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLPPFRAG------------NEYLIFQKIIKLEYD 228 (288)
T ss_dssp -------CCCCGGGCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHTTCCC
T ss_pred cccccccccCCccccCceeec--cCCCCcccceehhhHHHHHHhhCCCCCCCc------------CHHHHHHHHHcCCCC
Confidence 456899999999875 457899999999999999999999999643 222333333322210
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL 637 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 637 (672)
+ .... ..++.+++.+||+.||++|||++|+++.
T Consensus 229 ---~------p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 ---F------PEKF---FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---C------CTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---C------CccC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0 1111 2346788889999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-47 Score=395.41 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=200.7
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 357899999999999996 4799999999987666567789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeC--CCCcEEEeccCCCccCCCC--
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLD--KTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~~-- 518 (672)
|.+++.... .++++.+++.|+.||++||+||| +.+|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 113 L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 113 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 998876443 45999999999999999999999 78999999999999998 6789999999999887654
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...+|+.|+|||++. +..++.++||||+||++|||+||+.||... +..+.+..+.+.... +
T Consensus 185 ~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvilyelltG~~Pf~~~------------~~~~~~~~i~~~~~~---~ 247 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGE------------DDLETLQNVKRCDWE---F 247 (352)
T ss_dssp EEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------------SHHHHHHHHHHCCCC---C
T ss_pred eeeccCcccccCHHHHc--CCCCCCccchHHHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCCC---C
Confidence 356889999999774 567899999999999999999999999643 223333333332211 0
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. ...... ...++.+++.+||+.||.+|||+.|+++
T Consensus 248 ~--~~~~~~---~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 D--EDAFSS---VSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp C--SSTTTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C--cccccC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 001111 2235678888999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=391.03 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=201.0
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 3578999999999999964 3578999999764433 45679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEE
Q 005880 437 YMPNGSLFWLLHGNRG-------------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVL 497 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIl 497 (672)
|+++|+|.++++.... .....+++..++.|+.|+|+||+||| +.+||||||||+|||
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCL 172 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeEeeEEcccceE
Confidence 9999999999975321 12345899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCCC
Q 005880 498 LDKTGNARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK-CPSVIDGGGA 569 (672)
Q Consensus 498 l~~~~~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~-~P~~~~~~~~ 569 (672)
++.++.+||+|||+++..... ...++..|+|||++. +..++.++|||||||++|||++|. +||...
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~---- 246 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---- 246 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc--cCCCChhhhhccchhhHHHHHccCCCCCCCC----
Confidence 999999999999999754332 345677899999765 568999999999999999999996 566432
Q ss_pred CCCCCCCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 570 GMGCGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
+..+....+.... ... .. .....++.+|+.+||+.||++||||.||+++|++|.
T Consensus 247 --------~~~e~~~~v~~~~-~~~-------~p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 --------AHEEVIYYVRDGN-ILA-------CP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --------CHHHHHHHHHTTC-CCC-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------CHHHHHHHHHcCC-CCC-------CC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2233333332221 111 11 122345788999999999999999999999999885
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=386.42 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=190.6
Q ss_pred HhcccCcCCeEEEEEEEEcC----CcEEEEEEcccCCcc-hHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 364 SAEMLGKGGFGTAYKAVLDD----GSVVAVKRLKDASIG-GKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
+.+.||+|+||.||+|++.. +..||||+++..... ..+.|.+|++++++++|||||+++|++. ++..++||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 35789999999999998642 457999998754333 4567999999999999999999999985 56789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999887543 45899999999999999999999 789999999999999999999999999999876432
Q ss_pred ------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc
Q 005880 519 ------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW 591 (672)
Q Consensus 519 ------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |++||..... .+....+.....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~--~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------------~~~~~~i~~~~~ 227 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------NDVIGRIENGER 227 (273)
T ss_dssp ---------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGHHHHHHTTCC
T ss_pred cceeccceecCcccchhhHhc--cCCCCCccccccchHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCC
Confidence 344678899999775 4578999999999999999998 8999865421 122222222211
Q ss_pred cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 592 TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 592 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. ..+. ....+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 228 -~~-------~~~~---~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 -LP-------MPPN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -CC-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC-------CCCC---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 1111 23457788889999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=385.55 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=197.8
Q ss_pred hcccCcCCeEEEEEEEEcCC----cEEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEc-CCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLDDG----SVVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA-REEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 438 (672)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996532 36899999753 34456789999999999999999999999875 56889999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
++|+|.++++... ..+++..+++++.|+|+||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999998654 45789999999999999999999 789999999999999999999999999999865432
Q ss_pred ---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh
Q 005880 519 ---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE 589 (672)
Q Consensus 519 ---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (672)
...+|..|+|||++. +..++.++||||||+++|||+||+.||..... ..++...+...
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----------~~~~~~~i~~g 250 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQG 250 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------------CHHHHHTT
T ss_pred ccccceecccccccccccChHHHh--cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----------HHHHHHHHHcC
Confidence 245678899999765 46789999999999999999998888764321 11122222222
Q ss_pred hccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 590 EWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 590 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
.. ... ... ....+.+++.+||+.||++||+|.||++.|+++..
T Consensus 251 ~~---~~~-----p~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 251 RR---LLQ-----PEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CC---CCC-----CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---CCC-----ccc---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 111 111 22357788899999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=381.87 Aligned_cols=242 Identities=22% Similarity=0.362 Sum_probs=196.5
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc------chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI------GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
+.+.||+|+||.||+|+. .+|+.||||++++... ...+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999996 4799999999864322 235789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC----cEEEeccCCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG----NARVSDFGLS 512 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a 512 (672)
|+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 94 ~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 94 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999754 35999999999999999999999 78999999999999998776 4999999999
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+..... ...+|+.|+|||++. +..++.++|||||||++|||+||+.||.... ..+....+..
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~~~~~~~i~~ 230 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT------------KQETLANVSA 230 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHT
T ss_pred hhcCCCccccccCCCCcccCHHHHc--CCCCCCcccchhhhHHHHHHHcCCCCCCCCC------------HHHHHHHHHh
Confidence 876543 456788999999775 4578999999999999999999999997432 2222222222
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.... +.... ... ....+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~---~~~~~--~~~---~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYE---FEDEY--FSN---TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCC---CCHHH--HTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC---CCchh--cCC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2110 00000 011 1235678888999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=381.36 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=189.4
Q ss_pred hcccCcCCeEEEEEEEEcC--C--cEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLDD--G--SVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|++.. + ..||||+++... ....++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 4689999999999998542 2 478999987532 2345689999999999999999999999965 467899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|++.+++.... ..+++..++.++.|+|+||.||| +.+|+||||||+||+++.++++||+|||+++....
T Consensus 92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999998887543 45999999999999999999999 78999999999999999999999999999987644
Q ss_pred C--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 518 S--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 518 ~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
. ...++..|+|||++. +..++.++|||||||++|||+| |+.||... +..+.+..+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------------~~~~~~~~i~~ 229 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------------NGSQILHKIDK 229 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHHHHHHT
T ss_pred CCCcceecCccccCcccCCHHHHh--CCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------------CHHHHHHHHHh
Confidence 3 234577899999775 4578999999999999999998 89999643 33333344433
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEEL 641 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 641 (672)
+..... ... .....+.+++.+||+.||++||||.||++.|++.
T Consensus 230 ~~~~~~-------~~~---~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLP-------RPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC-------Ccc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 321111 111 1224577888899999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=387.09 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=193.3
Q ss_pred hcccCcCCeEEEEEEEEc-CCc----EEEEEEcccC-CcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGS----VVAVKRLKDA-SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 438 (672)
.+.||+|+||+||+|++. +|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 478999999999999964 444 6899998753 334577899999999999999999999999864 567888999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS 518 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 518 (672)
.+|+|.+++.... ..+++..+++|+.|||+||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 93 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp TTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred cCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999887653 46999999999999999999999 789999999999999999999999999999876432
Q ss_pred -------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 519 -------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 519 -------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
...+|..|+|||++. +..++.++|||||||++|||+| |++||.... ..+... .+..+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~------------~~~~~~-~i~~~ 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------------ASEISS-ILEKG 229 (317)
T ss_dssp CC--------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------------GGGHHH-HHHHT
T ss_pred cccccccccccCccccChHHHh--cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC------------HHHHHH-HHHcC
Confidence 234688999999775 4578999999999999999999 788886432 111222 22221
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
.. .... ......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 230 ~~-------~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 230 ER-------LPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CC-------CCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------CCCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 10 0011 122345788899999999999999999999998875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=384.33 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=198.6
Q ss_pred hcccCcCCeEEEEEEEEc-CCc--EEEEEEcccC-CcchHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGS--VVAVKRLKDA-SIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||.||+|+++ +|. .||||+++.. .....++|.+|+++|+++ +|||||+++|++.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 478999999999999965 444 5788888643 333556899999999999 79999999999999999999999999
Q ss_pred CCChhHHhhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEec
Q 005880 440 NGSLFWLLHGNR-----------GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSD 508 (672)
Q Consensus 440 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 508 (672)
+|+|.++++... ......++|..+.+++.|||+||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCceEEcc
Confidence 999999997642 122356999999999999999999999 78999999999999999999999999
Q ss_pred cCCCccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCCCCCCCCCCCCChhHHH
Q 005880 509 FGLSIFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKC-PSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 509 fG~a~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~-P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
||+++..... ...+|..|+|||.+. +..++.++|||||||++|||++|.. ||... +..+..
T Consensus 171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------------~~~~~~ 236 (309)
T d1fvra_ 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------------TCAELY 236 (309)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------------CHHHHH
T ss_pred ccccccccccccccceecCCcccchHHhc--cCCCCccceeehhHHHHHHHHhcCCCCCCCC------------CHHHHH
Confidence 9999765432 445788999999775 4578999999999999999999765 56432 223333
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCC
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEV 646 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 646 (672)
..+.... . ...... ...++.+++.+||+.||++||||.||++.|+++.+...
T Consensus 237 ~~i~~~~-~-------~~~~~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 237 EKLPQGY-R-------LEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHGGGTC-C-------CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhcC-C-------CCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 2222211 0 111111 22357788889999999999999999999999986443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-46 Score=380.87 Aligned_cols=238 Identities=23% Similarity=0.353 Sum_probs=198.5
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
+.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+++..|+||||++
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 357899999999999996 469999999997432 2245789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++++||+|||+|+.....
T Consensus 88 gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 88 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred Cccccccccccc-----cccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 999999987653 4889999999999999999999 899999999999999999999999999999877554
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccc
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFD 597 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 597 (672)
...||+.|+|||++. +..++.++||||+||++|||+||+.||... +..+....+......
T Consensus 159 ~~~~Gt~~Y~APE~l~--~~~y~~~~DiwSlGvilyemltG~~Pf~~~------------~~~~~~~~i~~~~~~----- 219 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDS------------NTMKTYEKILNAELR----- 219 (316)
T ss_dssp CCCCSCTTTCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHCCCC-----
T ss_pred ccccCcccccCHHHHc--CCCCCchhhccccchhHHHHHhCCCCCCCc------------CHHHHHHHHHcCCCC-----
Confidence 567899999999774 557899999999999999999999999643 233333333332210
Q ss_pred hhhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 598 LELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 598 ~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ..++.+++.+||..||.+|| |++|+++
T Consensus 220 ----~p~~~---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 ----FPPFF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCTTS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCC---CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111 23467788899999999996 8999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=382.99 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=196.5
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+++|++++||||+++++++.+++..|+||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 57899999999999996 579999999997532 22457789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++++|.+||+|||+|+.....
T Consensus 90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999998653 4899999999999999999999 889999999999999999999999999999865432
Q ss_pred ---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccc
Q 005880 519 ---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEV 595 (672)
Q Consensus 519 ---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (672)
...||+.|+|||++. +..++.++||||+||++|||++|++||... +..+..........
T Consensus 161 ~~~~~~GT~~Y~aPE~~~--~~~y~~~~DiwSlGvilyeml~G~~pf~~~------------~~~~~~~~i~~~~~---- 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------------DHERLFELILMEEI---- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGS--SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC----
T ss_pred ccccceeCHHHhhhhhcc--CCCCChhhcccchhhHHHHHHHCCCCCCCc------------CHHHHHHHHhcCCC----
Confidence 456799999999775 567899999999999999999999999743 22333333332211
Q ss_pred cchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 596 FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 596 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
..+... ..++.+++.+||+.||++||+ +.|+++
T Consensus 223 -----~~p~~~---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RFPRTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccC---CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 011112 234677888999999999995 778776
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-45 Score=373.99 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=195.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc---chHHHHHHHHHHHcCCCCCceeeeEEEEEcCC----eEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI---GGKREFEQHMEVLGRLRHPNLVGLKAYYFARE----EKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 436 (672)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.|.+|++++++++|||||++++++...+ ..|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 47899999999999995 5799999999975433 23457899999999999999999999997654 3789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+++|+|.+++.... ++++.++..|+.|+++||+||| +.+|+||||||+|||++.++..+++|||.+....
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999887543 5999999999999999999999 7899999999999999999999999999986553
Q ss_pred CC--------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 517 PS--------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 517 ~~--------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.. ...||+.|+|||++. +..+++++|||||||++|||+||+.||... +..+......+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~~DiwSlGvilyelltG~~Pf~~~------------~~~~~~~~~~~ 228 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTGD------------SPVSVAYQHVR 228 (277)
T ss_dssp ----------------TTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------------SHHHHHHHHHH
T ss_pred cccccccccccccCcccccCHHHHc--CCCCCcceecccchHHHHHHHhCCCCCCCc------------CHHHHHHHHHh
Confidence 32 456899999999764 567899999999999999999999999643 22333333333
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHh
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRP-NMSHVVKLIEELR 642 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~ 642 (672)
+.... +. ...... ..++.+++.+||+.||++|| |++|+++.|.++.
T Consensus 229 ~~~~~----~~-~~~~~~---s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 229 EDPIP----PS-ARHEGL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCCC----GG-GTSSSC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCC----Cc-hhccCC---CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 32211 11 111122 23577888899999999999 8999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=382.74 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=189.6
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcC-CeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAR-EEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lv 434 (672)
+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|.+++.++ +|+||+.+++++... ...++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 4578999999999999954 246899999975433 3456788888888777 689999999998765 467999
Q ss_pred EeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCc
Q 005880 435 SEYMPNGSLFWLLHGNRG-----------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGN 503 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~ 503 (672)
|||+++|+|.++++.... .....+++.++..++.|+++||+||| +.+|+||||||+|||++++++
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGC
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeECCCCc
Confidence 999999999999975431 11245899999999999999999999 789999999999999999999
Q ss_pred EEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCCCC
Q 005880 504 ARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK-CPSVIDGGGAGMGCGG 575 (672)
Q Consensus 504 ~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~-~P~~~~~~~~~~~~~~ 575 (672)
+||+|||+|+..... ...||..|+|||++. +..++.++|||||||++|||+||. +||....
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~--------- 241 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--------- 241 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhh--cCCCCcccceeehHHHHHHHHhCCCCCCCCCC---------
Confidence 999999999765432 345788999999875 467899999999999999999975 5665321
Q ss_pred CCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 576 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..+.+.....++..... . .....++.+++.+||+.||++||||.||++.|+++.+
T Consensus 242 ---~~~~~~~~~~~~~~~~~-------~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 ---IDEEFCRRLKEGTRMRA-------P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ---CSHHHHHHHHHTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHhcCCCCCC-------C---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12233333333221111 1 1123457888999999999999999999999998853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-45 Score=372.74 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=196.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc---------hHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG---------GKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 433 (672)
.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++ ||||+++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 57899999999999996 47899999998653321 1346889999999997 9999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||+++|+|.++++.. .++++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999754 35999999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCC----CCCCCCcccCCCcccc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 514 FAPPS----TVPRSNGYRAPELSSS----DGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 514 ~~~~~----~~~~t~~y~aPE~l~~----~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
..... ...||..|+|||++.. ....++.++||||+||++|||+||+.||.... .......
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~------------~~~~~~~ 226 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------------QMLMLRM 226 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHH
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC------------HHHHHHH
Confidence 76543 4567899999998653 23457899999999999999999999996432 2222222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
+...... ...+ . ......++.+++.+||+.||++|||+.||+
T Consensus 227 i~~~~~~--~~~~---~---~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 227 IMSGNYQ--FGSP---E---WDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHTCCC--CCTT---T---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHhCCCC--CCCc---c---cccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 3332211 0000 1 111223577888899999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=382.63 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=196.5
Q ss_pred HhcccCcCCeEEEEEEEEcC--------CcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDD--------GSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLL 433 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 433 (672)
+.+.||+|+||.||+|+..+ +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..++
T Consensus 17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 45789999999999998532 34799999976543 3457888999999888 89999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 434 VSEYMPNGSLFWLLHGNRGP-----------GRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
||||+++|+|.+++...... ....+++.+++.++.|+++||+||| +.+|+||||||+|||++.++
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTC
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeecccceeecCCC
Confidence 99999999999999765421 2346899999999999999999999 88999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLT-GKCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 574 (672)
.+||+|||+++..... ...++..|+|||++. +..+++++|||||||++|||++ |++||...
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~--~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~--------- 241 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--------- 241 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---------
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhc--CCCCCchhhhHHhHHHHHHhccCCCCCCCCC---------
Confidence 9999999999866432 345678899999775 4689999999999999999998 68887532
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
...+.. ..+..+.... .... ....+.+++.+||+.||++||||.||++.|+++..
T Consensus 242 ---~~~~~~-~~i~~~~~~~-------~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 ---PVEELF-KLLKEGHRMD-------KPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---CHHHHH-HHHHTTCCCC-------CCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHH-HHHHcCCCCC-------CCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 122222 2222221111 1111 22357888999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=382.46 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=202.8
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEe
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSE 436 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 436 (672)
..+.||+|+||.||+|.+. +++.||||+++... ......|.+|++++++++|||||+++|++..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999864 35789999997543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCC
Q 005880 437 YMPNGSLFWLLHGNR-----GPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGL 511 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~ 511 (672)
|+++|+|.+++.... ......+++..+.+++.|+|+||.||| +.+|+||||||+|||+++++++||+|||+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999986432 112345899999999999999999999 78999999999999999999999999999
Q ss_pred CccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCCCCCCChhHHH
Q 005880 512 SIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGK-CPSVIDGGGAGMGCGGAVDLPRWV 583 (672)
Q Consensus 512 a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~ 583 (672)
++..... ...+|+.|+|||.+. +..++.++|||||||++|||+||. .||.. ....++.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~--~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------------~~~~~~~ 245 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQG------------LSNEQVL 245 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------------SCHHHHH
T ss_pred ceeccCCcceeeccceecccccCCHHHHc--cCCCCcccccccHHHHHHHHHhCCCCCCCC------------CCHHHHH
Confidence 9865432 335688999999765 567899999999999999999985 66642 3344444
Q ss_pred HHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhc
Q 005880 584 QSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRG 643 (672)
Q Consensus 584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 643 (672)
..+.+.... . .. ......+.+++.+||+.||++||||.||++.|++..+
T Consensus 246 ~~i~~~~~~-~-------~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFVMEGGLL-D-------KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHTTCCC-C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHhCCCC-C-------Cc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 444333211 1 01 1122458888999999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-45 Score=378.85 Aligned_cols=237 Identities=21% Similarity=0.272 Sum_probs=197.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPN 440 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 440 (672)
.+.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+.+..++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 478999999999999964 79999999986432 22456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC--
Q 005880 441 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 441 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 518 (672)
|+|.+++.... .+++..+..++.||+.||.||| +.+||||||||+|||++.++++||+|||+|+.....
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999997543 4899999999999999999999 789999999999999999999999999999877654
Q ss_pred CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccccccch
Q 005880 519 TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVFDL 598 (672)
Q Consensus 519 ~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 598 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||... +.......+.....
T Consensus 197 ~~~Gt~~Y~APE~~~--~~~~~~~~DiwSlGvilyemltG~~Pf~~~------------~~~~~~~~i~~~~~------- 255 (350)
T d1rdqe_ 197 TLCGTPEALAPEIIL--SKGYNKAVDWWALGVLIYEMAAGYPPFFAD------------QPIQIYEKIVSGKV------- 255 (350)
T ss_dssp CCEECGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC-------
T ss_pred cccCccccCCHHHHc--CCCCCccccccchhHHHHHHHhCCCCCCCc------------CHHHHHHHHhcCCC-------
Confidence 566899999999875 567899999999999999999999999643 22333333333221
Q ss_pred hhccccChHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 005880 599 ELMRYKDIEEEMVGLLQVAMACTSASPDQRP-----NMSHVVK 636 (672)
Q Consensus 599 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 636 (672)
..... ...++.+++.+||+.||.+|+ |++|+++
T Consensus 256 --~~p~~---~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSH---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTT---CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCcc---CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01111 223567888899999999994 8999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=381.77 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=188.7
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCC-CCCceeeeEEEEEc----CCeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRL-RHPNLVGLKAYYFA----REEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~ 439 (672)
+.||+|+||.||+|+. .+|+.||||++++ ...+.+|++++.++ +|||||++++++.+ +...|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5699999999999995 5789999999864 35678899987654 89999999999875 456799999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAP 516 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 516 (672)
+|+|.+++.... ...+++.++..|+.|+++||+||| +.+|+||||||+|||++. ++.+||+|||+|+...
T Consensus 93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccceeeecc
Confidence 999999997542 246999999999999999999999 789999999999999985 5679999999998665
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT 592 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (672)
.. ...||+.|+|||++. +..++.++|||||||++|||+||+.||........ ...+ .. ...
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~--~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---------~~~~---~~-~i~ 230 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGM---KT-RIR 230 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCC--GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------CCC
T ss_pred CCCccccccCCcccCCcHHHc--CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---------HHHH---HH-HHh
Confidence 43 556899999999765 55789999999999999999999999976543210 0000 00 000
Q ss_pred ccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
...++. ..........++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCSSSC---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCC---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000 00001123346788899999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-46 Score=379.51 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=189.4
Q ss_pred cccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcch-----HHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 366 EMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGG-----KREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999995 469999999997543221 3468899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
++++..+.... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88777666433 45889999999999999999999 789999999999999999999999999999766542
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcc--
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWT-- 592 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 592 (672)
...+|..|+|||++.. +..++.++|||||||++|||+||++||..... .+.+..+.+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------------~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------------LDQLTRIFETLGTPT 221 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHHHCCCC
T ss_pred ccccceecChhhccHHHHcc-CCCCChhhhhhhcchHHHHHHhCcCCCCCCCH------------HHHHHHHHHhcCCCC
Confidence 4568899999998643 35689999999999999999999999964321 1112221111000
Q ss_pred cccc-c-------hhhccc--cCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 593 AEVF-D-------LELMRY--KDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 593 ~~~~-d-------~~~~~~--~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.+.. + ...... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 0 000000 000 011245788899999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=378.43 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=200.5
Q ss_pred HhcccCcCCeEEEEEEEEc------CCcEEEEEEcccCCc-chHHHHHHHHHHHcCC-CCCceeeeEEEEEcCCeEEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD------DGSVVAVKRLKDASI-GGKREFEQHMEVLGRL-RHPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 435 (672)
+.+.||+|+||.||+|++. +++.||||+++.... ....+|.+|+.+++++ +|||||+++|++.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 4578999999999999852 457899999976443 3556799999999999 6999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC
Q 005880 436 EYMPNGSLFWLLHGNRG-------------PGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG 502 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~ 502 (672)
||+++|+|.++++.... .....+++..+..++.||++||+||| +.+|+||||||+||+++.++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEETTT
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccccccccccccC
Confidence 99999999999976532 12346999999999999999999999 78999999999999999999
Q ss_pred cEEEeccCCCccCCCC-------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCCC
Q 005880 503 NARVSDFGLSIFAPPS-------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTG-KCPSVIDGGGAGMGCG 574 (672)
Q Consensus 503 ~~kl~DfG~a~~~~~~-------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg-~~P~~~~~~~~~~~~~ 574 (672)
.+|++|||+++..... ...+|+.|+|||++. +..++.++|||||||++|||+|+ .+||....
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-------- 252 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-------- 252 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhc--CCCCCCcccccchHHHHHHHHhCCCCCCCCCC--------
Confidence 9999999999876543 345678899999775 46789999999999999999995 44443321
Q ss_pred CCCChhHHHHHHHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHh
Q 005880 575 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELR 642 (672)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 642 (672)
....+......+.... .. ......+.+|+.+||+.||++||||.||+++|+++.
T Consensus 253 ----~~~~~~~~i~~~~~~~-------~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 253 ----VDSKFYKMIKEGFRML-------SP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ----SSHHHHHHHHHTCCCC-------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHhcCCCCC-------Cc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1122233333321111 01 112345788899999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-45 Score=381.79 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=191.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc---chHHHH---HHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI---GGKREF---EQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 437 (672)
.+.||+|+||.||+|+.. +|+.||||++..... .....+ .+|+++++.++|||||++++++.+++..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 478999999999999965 699999999864321 122233 3457788889999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP 517 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 517 (672)
+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 89 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred cCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999754 34889999999999999999999 78999999999999999999999999999987654
Q ss_pred C---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 518 S---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 518 ~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
. ...||+.|+|||++.. +..++.++|||||||++|||+||+.||...... +..... +...
T Consensus 160 ~~~~~~~GT~~y~APE~~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~~----~~~~--- 222 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKHEID----RMTL--- 222 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---------CHHHHH----HHSS---
T ss_pred CcccccccccccchhHHhhc-CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH----Hhcc---
Confidence 3 5678999999998742 457899999999999999999999999754322 111111 1110
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
.......... ..++.+++.+||+.||++||| ++|+++
T Consensus 223 --~~~~~~~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 --TMAVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SCCCCCCSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --cCCCCCCCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011111122 234678888999999999999 677764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=375.79 Aligned_cols=242 Identities=21% Similarity=0.345 Sum_probs=197.7
Q ss_pred HhcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 364 SAEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
+.+.||+|+||+||+|... +|+.||||+++.... +...+.+|+++|+.++|||||++++++.+++..|+||||+++|+
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 3478999999999999965 689999999976543 45678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCC--CcEEEeccCCCccCCCC--
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKT--GNARVSDFGLSIFAPPS-- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~-- 518 (672)
|.+++.... ..+++.++..|+.||++||+||| +.+|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 88 L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 88 IFERINTSA----FELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 999997543 35899999999999999999999 7899999999999999854 58999999999877654
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAEVF 596 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (672)
...+|+.|+|||.+. +..++.++||||+||++|||++|+.||... +..+.+..+.+.... +
T Consensus 160 ~~~~~~t~~y~ape~~~--~~~~~~~~DiWSlGvily~ll~G~~Pf~~~------------~~~~~~~~i~~~~~~---~ 222 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAE------------TNQQIIENIMNAEYT---F 222 (321)
T ss_dssp EEEEESCGGGSCHHHHT--TCEECHHHHHHHHHHHHHHHHHSSCTTCCS------------SHHHHHHHHHHTCCC---C
T ss_pred ccccccccccccchhcc--CCCCCchhhcccHHHHHHHHHhCCCCCCCC------------CHHHHHHHHHhCCCC---C
Confidence 345788999999654 567899999999999999999999999643 223333333333211 1
Q ss_pred chhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 597 DLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 597 d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+... .+. ...++.+++.+||..||++|||+.|+++
T Consensus 223 ~~~~--~~~---~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEA--FKE---ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHH--HTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhh--ccC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 011 1234678888999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=375.60 Aligned_cols=237 Identities=27% Similarity=0.390 Sum_probs=192.4
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCC---cchHHHHHHHHHHHc-CCCCCceeeeEEEEEcCCeEEEEEeecC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDAS---IGGKREFEQHMEVLG-RLRHPNLVGLKAYYFAREEKLLVSEYMP 439 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~ 439 (672)
.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 578999999999999965 69999999997432 223456677777665 6899999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC-
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 518 (672)
+|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++++||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999997543 4899999999999999999999 789999999999999999999999999999865432
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhcccc
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTAE 594 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||.+. +..+....+.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvilyemltG~~PF~~~------------~~~~~~~~i~~~~~--- 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------------DEEELFHSIRMDNP--- 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------SHHHHHHHHHHCCC---
T ss_pred ccccccCCCCCcCCHHHHc--CCCCCchhhhhhhhHHHHHHHhCCCCCCCC------------CHHHHHHHHHcCCC---
Confidence 456899999999875 567899999999999999999999999643 22222222222211
Q ss_pred ccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 005880 595 VFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMS-HVVK 636 (672)
Q Consensus 595 ~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 636 (672)
...... ..++.+++.+||+.||++|||+. |+++
T Consensus 221 ------~~p~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ------FYPRWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCTTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011112 23467888899999999999995 7753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=368.28 Aligned_cols=251 Identities=23% Similarity=0.289 Sum_probs=189.4
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|++++++++|||||++++++.+++..++||||+.++
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~ 86 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence 47899999999999996 5799999999965432 23578999999999999999999999999999999999999664
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+.+++.... ...+++..+..++.|+++||+||| +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 -~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 87 -LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp -HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred -hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 444443332 245999999999999999999999 789999999999999999999999999999765432
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc-cccc
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW-TAEV 595 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 595 (672)
...+|..|+|||++.. ...++.++||||+||++|||++|+.||.... -.+.......... ..+.
T Consensus 159 ~~~~~gt~~y~apE~~~~-~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~------------~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDS------------EIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp TTCCBCCCTTCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCCCCTT
T ss_pred ceeecccceeeehhhhcc-ccCCCccccccccchhhhHHhhCCCCCCCCC------------HHHHHHHHHHhcCCCchh
Confidence 4567899999997653 3456899999999999999999999996432 1111111111100 0000
Q ss_pred cch----------hhc--cccChH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 596 FDL----------ELM--RYKDIE----EEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 596 ~d~----------~~~--~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
..+ ... ...... ....++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 000 000000 11245778888999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.1e-44 Score=362.92 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=192.5
Q ss_pred hcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||+||+|+.++|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++..++++||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 478999999999999999999999999975432 235789999999999999999999999999999999999998877
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC----
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS---- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 518 (672)
+..+.... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||.+......
T Consensus 87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 76666533 45999999999999999999999 789999999999999999999999999999765432
Q ss_pred -CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc------
Q 005880 519 -TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW------ 591 (672)
Q Consensus 519 -~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 591 (672)
...+++.|+|||++.. ...++.++||||+||++|||++|+.||.... ..+..........
T Consensus 158 ~~~~~~~~y~~pE~~~~-~~~~~~~~DiwslGv~l~el~~G~~pf~~~~------------~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS------------EADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp ----CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCCCCTTT
T ss_pred ceecccchhhhHHHHhC-CCCCCcceeehhcCcHHHHHHHCCCCCCCCC------------HHHHHHHHHHhhCCCChhh
Confidence 3457888999998653 3567999999999999999999999996432 1111111111000
Q ss_pred cc-----cccchhhcc------ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 592 TA-----EVFDLELMR------YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 592 ~~-----~~~d~~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. ...+..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000000 0001112245778888999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=365.23 Aligned_cols=232 Identities=21% Similarity=0.383 Sum_probs=187.1
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcc------hHHHHHHHHHHHcCCC--CCceeeeEEEEEcCCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIG------GKREFEQHMEVLGRLR--HPNLVGLKAYYFAREEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 435 (672)
.+.||+|+||.||+|+. .+|+.||||+++..... ...++.+|+.++++++ |||||++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 47899999999999996 47999999998643221 2244678999999886 899999999999999999999
Q ss_pred eecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-CCcEEEeccCCCc
Q 005880 436 EYMPN-GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-TGNARVSDFGLSI 513 (672)
Q Consensus 436 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~ 513 (672)
||+.+ +++.+++... ..+++.++..++.|+++||+||| +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus 89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECccccce
Confidence 99976 6788887654 35999999999999999999999 789999999999999985 4799999999997
Q ss_pred cCCCC---CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhh
Q 005880 514 FAPPS---TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREE 590 (672)
Q Consensus 514 ~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (672)
..... ...||..|+|||++.. ...++.++||||+||++|||+||+.||.... ...+..
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------------~i~~~~ 220 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------EIIRGQ 220 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHH-SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------------HHHHCC
T ss_pred ecccccccccccCCCcCCHHHHcC-CCCCCcccccccceeeehhHhhCCCCCCCch------------------HHhhcc
Confidence 66543 5678999999998753 2345778999999999999999999995321 111111
Q ss_pred ccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 591 WTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 591 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
. .+ ..... .++.+++.+||+.||++|||++|+++
T Consensus 221 ~---~~------~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V---FF------RQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C---CC------SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c---CC------CCCCC---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 01 11122 34678888999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=358.86 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=184.8
Q ss_pred hcccCcCCeEEEEEEEE-cC-CcEEEEEEcccCCc--chHHHHHHHHHHHcCC---CCCceeeeEEEEEc-----CCeEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DD-GSVVAVKRLKDASI--GGKREFEQHMEVLGRL---RHPNLVGLKAYYFA-----REEKL 432 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~ 432 (672)
.+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+++++.+ +||||+++++++.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 47899999999999996 34 67899999864322 1234566777776655 89999999999863 24678
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 433 LVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 433 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
++|||+++|++........ ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 92 ~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 9999998887765554332 45899999999999999999999 789999999999999999999999999998
Q ss_pred ccCCCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 513 IFAPPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 513 ~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
+..... ...||+.|+|||++. +..++.++||||+||++|||+||+.||.... ..+.+..+..
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~--~~~y~~~~DiwSlG~il~ell~g~~pf~~~~------------~~~~~~~i~~ 229 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------------DVDQLGKILD 229 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHH
T ss_pred hhhcccccCCCcccChhhcCcchhc--CCCCChhehhhchHHHHHHHHHCCCCCCCCC------------HHHHHHHHHH
Confidence 765442 667899999999775 5689999999999999999999999996432 1112222211
Q ss_pred hh-------cccc------ccchhhc--cccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 589 EE-------WTAE------VFDLELM--RYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 589 ~~-------~~~~------~~d~~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. +... .+..... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 10 0000 0000000 00000111234667888999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=362.55 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=187.5
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceeeeEEEEEcC------CeEEEEEee
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVGLKAYYFAR------EEKLLVSEY 437 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~ 437 (672)
.++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++||||+++++++... .+.++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 368999999999999965 699999999975432 234799999999999999999998643 246899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCC
Q 005880 438 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAP 516 (672)
Q Consensus 438 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~ 516 (672)
+++|.+..+.+... ....+++.++..++.|+++||+||| +++|+||||||+|||++.++ .+||+|||+++...
T Consensus 101 ~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 101 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp CSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred cCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 98764444432211 1246999999999999999999999 89999999999999999775 89999999998765
Q ss_pred CC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhh---
Q 005880 517 PS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVRE--- 589 (672)
Q Consensus 517 ~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 589 (672)
.. ...++..|+|||++.. ...++.++||||+||++|||++|+.||..... .+....+.+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~------------~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------------VDQLVEIIKVLGT 241 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------------HHHHHHHHHHHCC
T ss_pred CCcccccccccccccChHHhhc-ccCCCcceeecccceEEEehhhCCCCCCCCCH------------HHHHHHHHHHhCC
Confidence 43 4567889999997643 35789999999999999999999999964321 1111111110
Q ss_pred -------hccccccchhhcc-------ccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHHhc
Q 005880 590 -------EWTAEVFDLELMR-------YKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK--LIEELRG 643 (672)
Q Consensus 590 -------~~~~~~~d~~~~~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~~ 643 (672)
.......+..... ..........+.+|+.+||+.||++|||+.|+++ .++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000000000 0000112235778888999999999999999986 3555543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=359.25 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=187.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcCC------eEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFARE------EKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 435 (672)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+ +.++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 47899999999999996 4699999999975332 24567899999999999999999999997654 569999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+ +++|..+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+++..
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhcccccccccccccceecc
Confidence 999 66888887643 4999999999999999999999 789999999999999999999999999999877
Q ss_pred CCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhc--
Q 005880 516 PPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEW-- 591 (672)
Q Consensus 516 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 591 (672)
... ...+|+.|+|||++.. ...++.++||||+||++|||++|+.||..... ............
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~------------~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------------LDQLKEIMKVTGTP 238 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHHHCCC
T ss_pred CCccccccccccccCHHHHcC-CCCCCccchhhcchHHHHHHHHCcCCCCCCCh------------HHHHHHHHhccCCC
Confidence 654 5678999999998753 35678999999999999999999999965321 111111100000
Q ss_pred -------------------cccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHHhc
Q 005880 592 -------------------TAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKL--IEELRG 643 (672)
Q Consensus 592 -------------------~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~ 643 (672)
..+....... .........+.+|+.+||..||++|||+.|+++. ++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000000 0001112346788889999999999999999873 555443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=357.66 Aligned_cols=190 Identities=25% Similarity=0.389 Sum_probs=159.8
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC-cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCC----eEEEEEeec
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS-IGGKREFEQHMEVLGRLRHPNLVGLKAYYFARE----EKLLVSEYM 438 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 438 (672)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 47899999999999995 579999999997543 234568899999999999999999999997643 234555667
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCC-
Q 005880 439 PNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPP- 517 (672)
Q Consensus 439 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 517 (672)
.+|+|.+++... .+++..+..++.|++.||+||| +.+||||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 799999999753 3899999999999999999999 78999999999999999999999999999976533
Q ss_pred -------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 518 -------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 518 -------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
....+|..|+|||++.. +..++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTT-BCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccceeeccccccceechHHHhhc-CCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 24457889999998753 457789999999999999999999999653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=350.53 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=185.7
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccC--CcchHHHHHHHHHHHcCCCCCceeeeEEEEEc--------CCeEEE
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDA--SIGGKREFEQHMEVLGRLRHPNLVGLKAYYFA--------REEKLL 433 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l 433 (672)
.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. ++..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 47899999999999996 47999999998643 22345778999999999999999999999865 345789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 434 VSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 434 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||||++++.+..+.... ..++...+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 95 v~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 95 VFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecceee
Confidence 99999887766554322 45889999999999999999999 7899999999999999999999999999997
Q ss_pred cCCCC---------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHH
Q 005880 514 FAPPS---------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQ 584 (672)
Q Consensus 514 ~~~~~---------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 584 (672)
..... ...+|..|+|||++.. ...+++++||||+||++|||++|+.||..... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~------------~~~~~ 232 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE------------QHQLA 232 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcC-CCCCCcHHHcccCCceeeeHhhCCCCCCCCCH------------HHHHH
Confidence 65432 3457899999998653 34689999999999999999999999964321 11111
Q ss_pred HHHhhh--ccccc------------cchhhccccChHHH------HHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 585 SVVREE--WTAEV------------FDLELMRYKDIEEE------MVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 585 ~~~~~~--~~~~~------------~d~~~~~~~~~~~~------~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
.+.+.. ...+. ............+. ...+.+|+.+||+.||++|||++|++
T Consensus 233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 111100 00000 00000000111111 23567889999999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-41 Score=344.82 Aligned_cols=262 Identities=18% Similarity=0.186 Sum_probs=203.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC-CceeeeEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH-PNLVGLKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+|++.++.++| +|++.+++++......++||||+ +|+
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 478999999999999954 68999999886533 33457788888888865 89999999999999999999999 789
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC-----CCcEEEeccCCCccCCC
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK-----TGNARVSDFGLSIFAPP 517 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~~~ 517 (672)
|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+|+....
T Consensus 87 l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 87 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 999987643 35899999999999999999999 899999999999999974 57899999999976532
Q ss_pred ------------CCCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHH
Q 005880 518 ------------STVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQS 585 (672)
Q Consensus 518 ------------~~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 585 (672)
....||+.|+|||++. +..++.++|||||||++|||+||+.||...... ........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~--~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~---------~~~~~~~~ 227 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA---------TNKQKYER 227 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---------CHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhc--CCCCChHHHHHHhhHHHHHHHhCCCcCCCccch---------hHHHHHHH
Confidence 1346899999999765 567999999999999999999999999754322 12222222
Q ss_pred HHhhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCCCCCCCCCCCC
Q 005880 586 VVREEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVEVSPCHENFDS 655 (672)
Q Consensus 586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~~~ 655 (672)
+........ -..+ .+. ...++.+++..|++.+|++||+++.+.+.|+++.+.........+++
T Consensus 228 i~~~~~~~~--~~~l--~~~---~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 228 IGEKKQSTP--LREL--CAG---FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HHHHHHHSC--HHHH--TTT---SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHhccCCCC--hHHh--cCC---CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 211111000 0000 011 12357788889999999999999999999999865444444555554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=347.09 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=194.2
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCC--cchHHHHHHHHHHHcCCCCCceeeeEEEEEcCCeEEEEEeecCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDAS--IGGKREFEQHMEVLGRLRHPNLVGLKAYYFAREEKLLVSEYMPNG 441 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 441 (672)
.+.||+|+||+||+|+. .+|+.||||+++... .....++.+|+.+++.++||||+++++++.+....++|+|++.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 47899999999999996 478999999986433 234678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCCCC---
Q 005880 442 SLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAPPS--- 518 (672)
Q Consensus 442 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 518 (672)
+|..++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||.++.....
T Consensus 87 ~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 87 LKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp HHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ccccccccc-----cccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 998888654 35889999999999999999999 789999999999999999999999999999876543
Q ss_pred --CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc---
Q 005880 519 --TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA--- 593 (672)
Q Consensus 519 --~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 593 (672)
...++..|+|||++.. ...++.++||||+||++|||++|+.||... .+..+....+.......
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~~DiwSlG~il~ell~g~~p~~~~-----------~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPG-----------NDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-----------SSHHHHHHHHHHHHCCCCTT
T ss_pred ceeeccccchhhhhHhcc-CCCCCchhhccccchHHHHHhhCCCCCCCC-----------CCHHHHHHHHHhhcCCCChh
Confidence 3345677999997643 345789999999999999999999997532 22233333222211000
Q ss_pred ------cc--------cchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 ------EV--------FDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 ------~~--------~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
.. .................+.+++.+||+.||.+|||++||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000001112235678888999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=348.97 Aligned_cols=252 Identities=19% Similarity=0.198 Sum_probs=188.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCceee-eEEEEEcCCeEEEEEeecCCCC
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLVG-LKAYYFAREEKLLVSEYMPNGS 442 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~ 442 (672)
.+.||+|+||.||+|+. .+|+.||||++.... ...++.+|+++++.++|+|++. +.+++.+.+..++||||+ +|+
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 47899999999999996 468999999887543 2346788999999998776555 455566778889999999 567
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCC---CCcEEEeccCCCccCCCC-
Q 005880 443 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDK---TGNARVSDFGLSIFAPPS- 518 (672)
Q Consensus 443 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~- 518 (672)
|.+.+.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++. +..+||+|||+|+.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 89 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred hhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 766665433 45999999999999999999999 789999999999999863 557999999999865431
Q ss_pred -----------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH
Q 005880 519 -----------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV 587 (672)
Q Consensus 519 -----------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (672)
...||+.|+|||++. +..++.++|||||||++|||+||+.||....... ....+....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~---------~~~~~~~~~ 229 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---------KRQKYERIS 229 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHT--TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------------HHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHh--CCCCCChhhEEecCHHHHHHHhCCCcccccchHH---------HHHHHHHhh
Confidence 346899999999764 5678999999999999999999999997543221 111111111
Q ss_pred hhhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHhcCC
Q 005880 588 REEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPNMSHVVKLIEELRGVE 645 (672)
Q Consensus 588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 645 (672)
.... .. ..+.. .. ....++.+++..||+.+|++||++.++.+.|+.+...+
T Consensus 230 ~~~~-~~-~~~~~--~~---~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 EKKM-ST-PIEVL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHH-HS-CHHHH--TT---TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccC-CC-ChhHh--cc---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1100 00 00000 01 12245788888999999999999999999999886533
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=353.79 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=192.7
Q ss_pred HhcccCcCCeEEEEEEEEc----CCcEEEEEEcccCCc----chHHHHHHHHHHHcCCCC-CceeeeEEEEEcCCeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLD----DGSVVAVKRLKDASI----GGKREFEQHMEVLGRLRH-PNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 434 (672)
+.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+....++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 4578999999999999842 489999999875322 235678899999999976 8999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCcc
Q 005880 435 SEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIF 514 (672)
Q Consensus 435 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~ 514 (672)
|||+.+|+|.+++.... .+....+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999997653 3778999999999999999999 78999999999999999999999999999976
Q ss_pred CCCC------CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHh
Q 005880 515 APPS------TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVR 588 (672)
Q Consensus 515 ~~~~------~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (672)
.... ...+++.|+|||.+......++.++|||||||++|||+||+.||......+ ...........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--------~~~~i~~~~~~ 250 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQAEISRRILK 250 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHHHHHHHHHH
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHhccc
Confidence 5432 456788999999886555678899999999999999999999997654321 11111111111
Q ss_pred hhccccccchhhccccChHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 005880 589 EEWTAEVFDLELMRYKDIEEEMVGLLQVAMACTSASPDQRPN-----MSHVVK 636 (672)
Q Consensus 589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 636 (672)
.. ..... ....++.+++.+||+.||++||| ++|+++
T Consensus 251 ~~---------~~~~~---~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SE---------PPYPQ---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC---------CCCCT---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC---------CCCcc---cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 00111 12345777888999999999994 788864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.3e-41 Score=347.03 Aligned_cols=186 Identities=25% Similarity=0.364 Sum_probs=160.8
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcC--CeEEEEEeecC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAR--EEKLLVSEYMP 439 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~ 439 (672)
+.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||||++
T Consensus 39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 357899999999999996 57999999999754 3567899999999995 99999999999843 56899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC-cEEEeccCCCccCCCC
Q 005880 440 NGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG-NARVSDFGLSIFAPPS 518 (672)
Q Consensus 440 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~ 518 (672)
+|+|..+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 116 ~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 116 NTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred CCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99997764 24899999999999999999999 88999999999999998655 6999999999876543
Q ss_pred ----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005880 519 ----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVID 565 (672)
Q Consensus 519 ----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~ 565 (672)
...+|..|+|||.+.. ...++.++||||+||++|||++|+.||...
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CcccccccCccccCcccccC-CCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 4557889999997643 345799999999999999999999999653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-41 Score=350.67 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=185.9
Q ss_pred hcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEcC-----CeEEEEEe
Q 005880 365 AEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFAR-----EEKLLVSE 436 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 436 (672)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++|++++|||||++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 47899999999999995 5799999999975432 3456789999999999999999999998643 34467778
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccCC
Q 005880 437 YMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFAP 516 (672)
Q Consensus 437 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 516 (672)
|+.+|+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||++....
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccccccccccccccchhcccC
Confidence 88899999999643 4999999999999999999999 7899999999999999999999999999997665
Q ss_pred CC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHHhhhccc-
Q 005880 517 PS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVVREEWTA- 593 (672)
Q Consensus 517 ~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 593 (672)
.. ...++..|+|||++.. ...++.++||||+||++|||++|+.||.... .......+.......
T Consensus 173 ~~~~~~~g~~~y~apE~~~~-~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~------------~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------------HIDQLKLILRLVGTPG 239 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTT-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------------HHHHHHHHHHHHCCCC
T ss_pred cccccccccccccCchhhcC-CccCCcccchhhhhHHHHHHHhCCCCCCCCC------------HHHHHHHHHHhcCCCC
Confidence 43 5567788999997542 3457899999999999999999999996432 111111111110000
Q ss_pred -ccc-----------chhhcc--ccCh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 005880 594 -EVF-----------DLELMR--YKDI----EEEMVGLLQVAMACTSASPDQRPNMSHVVK 636 (672)
Q Consensus 594 -~~~-----------d~~~~~--~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 636 (672)
+.. ...... .... ......+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 000000 0000 011235678889999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=344.57 Aligned_cols=245 Identities=19% Similarity=0.234 Sum_probs=180.2
Q ss_pred hcccCcCCeEEEEEEEEc-CCcEEEEEEcccCCc--chHHHHHHHHHHHcCCCCCceeeeEEEEEc------CCeEEEEE
Q 005880 365 AEMLGKGGFGTAYKAVLD-DGSVVAVKRLKDASI--GGKREFEQHMEVLGRLRHPNLVGLKAYYFA------REEKLLVS 435 (672)
Q Consensus 365 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~ 435 (672)
.++||+|+||+||+|+.. +|+.||||+++.... ....++.+|+.++++++|||||++++++.. ....|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 478999999999999965 699999999975432 344578999999999999999999999964 35789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEEEeccCCCccC
Q 005880 436 EYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNARVSDFGLSIFA 515 (672)
Q Consensus 436 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 515 (672)
||+.++ +.+.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+++..
T Consensus 102 Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 102 ELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp ECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhhhcc
Confidence 999665 444443 23899999999999999999999 789999999999999999999999999998766
Q ss_pred CCC----CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhHHHHHHH----
Q 005880 516 PPS----TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPRWVQSVV---- 587 (672)
Q Consensus 516 ~~~----~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 587 (672)
... ...+|..|+|||++. +..+++++||||+||++|||++|+.||.... .......+.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~------------~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKILFPGRD------------YIDQWNKVIEQLG 235 (355)
T ss_dssp -----------CCTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHHHC
T ss_pred ccccccccccccccccChhhhc--CCCCCCCcccccccchHHHHhhCCCCCCCCC------------HHHHHHHHHHhcc
Confidence 543 456789999999875 4688999999999999999999999996432 111111111
Q ss_pred ------------------hhhccc------cccchhhcccc--ChHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 005880 588 ------------------REEWTA------EVFDLELMRYK--DIEEEMVGLLQVAMACTSASPDQRPNMSHVV 635 (672)
Q Consensus 588 ------------------~~~~~~------~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 635 (672)
...... ..+........ ........+.+|+.+||..||++|||++||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 110000 00000000000 1122345688899999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-36 Score=314.27 Aligned_cols=259 Identities=19% Similarity=0.274 Sum_probs=182.5
Q ss_pred HhcccCcCCeEEEEEEEE-cCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-----------CCceeeeEEEEEc--CC
Q 005880 364 SAEMLGKGGFGTAYKAVL-DDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-----------HPNLVGLKAYYFA--RE 429 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~--~~ 429 (672)
+.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++ |+||+++++++.. ..
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 358899999999999996 5799999999976533 3467788998887774 5789999988864 34
Q ss_pred eEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCC------c
Q 005880 430 EKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTG------N 503 (672)
Q Consensus 430 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~------~ 503 (672)
..+++++++..+.......... ....+++..+..++.|+++||+|||+ ..+|+||||||+|||++.++ .
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCcccccce
Confidence 5667777665554433322221 23568999999999999999999993 27899999999999998654 3
Q ss_pred EEEeccCCCccCCCC--CCCCCCcccCCCccccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCChhH
Q 005880 504 ARVSDFGLSIFAPPS--TVPRSNGYRAPELSSSDGRKQSQKSDVYSFGVLLLELLTGKCPSVIDGGGAGMGCGGAVDLPR 581 (672)
Q Consensus 504 ~kl~DfG~a~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~DV~S~Gvvl~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 581 (672)
++++|||.+...... ...+|..|+|||++. ...++.++||||+||+++||++|+.||....... ......
T Consensus 171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~------~~~~~~ 242 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFLFEPDEGHS------YTKDDD 242 (362)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHH--TCCCCTHHHHHHHHHHHHHHHHSSCCC---------------CHHH
T ss_pred eeEeecccccccccccccccccccccChhhcc--ccCCCccccccchHHHHHHHHHCCCCCCCCcccc------ccchhH
Confidence 999999999765443 566889999999765 4578999999999999999999999997543221 111111
Q ss_pred HHHHHHh------------hhccccccch------------------hhccccChHHHHHHHHHHHHhccCCCCCCCCCH
Q 005880 582 WVQSVVR------------EEWTAEVFDL------------------ELMRYKDIEEEMVGLLQVAMACTSASPDQRPNM 631 (672)
Q Consensus 582 ~~~~~~~------------~~~~~~~~d~------------------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 631 (672)
....... .......++. ..............+.+++.+||..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1111100 0000000000 000112234566788999999999999999999
Q ss_pred HHHHH
Q 005880 632 SHVVK 636 (672)
Q Consensus 632 ~evl~ 636 (672)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.8e-32 Score=282.15 Aligned_cols=202 Identities=37% Similarity=0.620 Sum_probs=158.2
Q ss_pred CCChhhHHHHHHHHhcCCCCCCCCCCCCCCCCC--cccceEEcC----CcEeEEEecCCCcccC---CCCCCCCCCccEE
Q 005880 23 ASTSPDLNALLDFKASSDEANKLTTWNSTSDPC--SWTGVSCLQ----NRVSHLVLENLQLSGS---LQPLTSLTQLRVL 93 (672)
Q Consensus 23 ~~~~~d~~all~~k~~~~~~~~~~~W~~~~~~c--~w~gv~c~~----~~v~~L~l~~~~l~~~---~~~l~~l~~L~~L 93 (672)
-|.++|++||++||+++.++..+++|+.++||| +|.||+|+. .||++|+|++++++|. ++.+++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 378899999999999998777899999889999 599999975 3799999999999973 3459999999999
Q ss_pred Eccc-CCCCCCCC-CCCcccccceeeccccccCCC------------------------CChhhhccCCCCeEecccCcc
Q 005880 94 SLKY-NRFTGPVP-SLSNLTALKLLFLSHNNFNGE------------------------FPDSVSSLFRLYRLDLSFNNF 147 (672)
Q Consensus 94 ~L~~-N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~------------------------~p~~~~~l~~L~~L~l~~N~l 147 (672)
+|++ |+++|.+| .|++|++|++|+|++|+|.+. +|..+++++.|+.+++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9996 89999888 899999999999999887754 445566666666666666666
Q ss_pred ccccchhhcC----------------------------------------------------------------------
Q 005880 148 SGQIPLTVNH---------------------------------------------------------------------- 157 (672)
Q Consensus 148 ~g~~p~~~~~---------------------------------------------------------------------- 157 (672)
+|.+|..+..
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~ 241 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 6655543322
Q ss_pred -CCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCc--CCCCCCccccccccccCCCCcccc
Q 005880 158 -LTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKS--LSGFPDSAFTQNAALCGSPMQACK 224 (672)
Q Consensus 158 -l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~--l~~~~~~~~~~n~~lc~~~~~~c~ 224 (672)
+++|+.|+|++|+|+|.+| +..+++|++|+|++|+|+|.+|+. +.++..+.+.+|+.+||.|+++|.
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 3356667777777776443 456778888888888888888852 455666677788889998888883
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=8.6e-22 Score=186.10 Aligned_cols=160 Identities=14% Similarity=0.125 Sum_probs=117.5
Q ss_pred HhcccCcCCeEEEEEEEEcCCcEEEEEEcccCCc------------------chHHHHHHHHHHHcCCCCCceeeeEEEE
Q 005880 364 SAEMLGKGGFGTAYKAVLDDGSVVAVKRLKDASI------------------GGKREFEQHMEVLGRLRHPNLVGLKAYY 425 (672)
Q Consensus 364 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~~ 425 (672)
+++.||+|+||.||+|+..+|+.||||+++.... .......+|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999988999999998753111 0123456788899999999999887653
Q ss_pred EcCCeEEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCEEeCCCCcEE
Q 005880 426 FAREEKLLVSEYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHFTCKSLKLTHGNIKSTNVLLDKTGNAR 505 (672)
Q Consensus 426 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~iiH~Dlkp~NIll~~~~~~k 505 (672)
..+++|||++++.+.+ ++......++.|++++|+||| +.+|+||||||+|||++++ .++
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETT-EEE
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCC-CEE
Confidence 2379999998765533 233445679999999999999 7899999999999999965 489
Q ss_pred EeccCCCccCCCCCCCCCCcccC------CCccccCCCCCCchhHHHHHHH
Q 005880 506 VSDFGLSIFAPPSTVPRSNGYRA------PELSSSDGRKQSQKSDVYSFGV 550 (672)
Q Consensus 506 l~DfG~a~~~~~~~~~~t~~y~a------PE~l~~~~~~~~~~~DV~S~Gv 550 (672)
|+|||.|........ ..|.. .|.+ ...|+.++||||..-
T Consensus 143 liDFG~a~~~~~~~~---~~~l~rd~~~~~~~f---~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 143 IIDFPQSVEVGEEGW---REILERDVRNIITYF---SRTYRTEKDINSAID 187 (191)
T ss_dssp ECCCTTCEETTSTTH---HHHHHHHHHHHHHHH---HHHHCCCCCHHHHHH
T ss_pred EEECCCcccCCCCCc---HHHHHHHHHHHHHHH---cCCCCCcccHHHHHH
Confidence 999999976543211 11211 1111 245677889999653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=3.3e-19 Score=168.19 Aligned_cols=125 Identities=20% Similarity=0.168 Sum_probs=88.6
Q ss_pred EEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC--CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCcc
Q 005880 70 LVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNF 147 (672)
Q Consensus 70 L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 147 (672)
++.++++|+.+|+.+. +++++|+|++|+|++.++ .|.++++|+.|+|++|++++..+..+..+++|++|+|++|+|
T Consensus 13 v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l 90 (192)
T d1w8aa_ 13 VDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90 (192)
T ss_dssp EECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred EEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence 4455566666655553 567777777777776443 567777777777777777777777777777777777777777
Q ss_pred ccccchhhcCCCccCeeeccCCcccCcC--CCCCCCCCCeeeccCCcCCCC
Q 005880 148 SGQIPLTVNHLTHLLTLKLEANRFSGPI--TGLDLRNLQDFNVSGNHLSGQ 196 (672)
Q Consensus 148 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~ 196 (672)
++..|..|.++++|++|+|++|+|++.. .+..+++|++|+|++|.+.+.
T Consensus 91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 7666667777777777777777777732 245677777777777777644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.9e-18 Score=168.88 Aligned_cols=154 Identities=25% Similarity=0.204 Sum_probs=99.7
Q ss_pred cEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccC--------------------
Q 005880 66 RVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFN-------------------- 124 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~-------------------- 124 (672)
.++.|+|++|.|++.++. |.++++|++|+|++|+|+. +|.++.+++|++|+|++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~ 110 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSS
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence 455555665555554433 5555555555555555553 233444555555555555554
Q ss_pred ---CCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCC
Q 005880 125 ---GEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPK 199 (672)
Q Consensus 125 ---g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~ 199 (672)
+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++|+|++..+ +..+++|++|+|++|+|+ .+|+
T Consensus 111 ~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~ 189 (266)
T d1p9ag_ 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189 (266)
T ss_dssp CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred ccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccCh
Confidence 3344444455555555666666664445566778889999999999988333 567999999999999999 8998
Q ss_pred cCCCCCC---ccccccccccCCCCc
Q 005880 200 SLSGFPD---SAFTQNAALCGSPMQ 221 (672)
Q Consensus 200 ~l~~~~~---~~~~~n~~lc~~~~~ 221 (672)
.+..++. +.+.+|||.|+|.+.
T Consensus 190 ~~~~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 190 GFFGSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp TTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred hHCCCCCCCEEEecCCCCCCCcchH
Confidence 7766554 556689999998653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=6.2e-17 Score=152.36 Aligned_cols=164 Identities=23% Similarity=0.288 Sum_probs=137.3
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC--CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP--LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSH 120 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~ 120 (672)
|.|..|.|+. ..+++|+|++|.|++.++. |..+++|+.|+|++|.+++.++ .+..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 6799999963 3689999999999876544 7899999999999999999888 889999999999999
Q ss_pred cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCC-CCCCCeeeccCCcCCCCCCC
Q 005880 121 NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLD-LRNLQDFNVSGNHLSGQIPK 199 (672)
Q Consensus 121 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-l~~L~~l~l~~N~l~g~~p~ 199 (672)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+........ ...++.+.+..|.+++..|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 99997778889999999999999999998778889999999999999999987433221 22356677888999988898
Q ss_pred cCCCCCCccccccccccCC
Q 005880 200 SLSGFPDSAFTQNAALCGS 218 (672)
Q Consensus 200 ~l~~~~~~~~~~n~~lc~~ 218 (672)
.+.++.-+.+..|...|..
T Consensus 168 ~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 168 KVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp TTTTSBGGGSCTTTCCCCC
T ss_pred hhcCCEeeecCHhhCcCCC
Confidence 8877766666666555654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=6.9e-16 Score=153.06 Aligned_cols=139 Identities=24% Similarity=0.230 Sum_probs=114.4
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
....+++.++++|+.+|+.+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+ .+|. ++.+++|+.|+|+
T Consensus 10 ~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLS 85 (266)
T ss_dssp TTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECC
T ss_pred CCCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccc
Confidence 445667999999998776664 589999999999998776 7999999999999999999 6664 6789999999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccC--cCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSG--PITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA 208 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~ 208 (672)
+|+|+ .+|..+.++++|+.|++++|++.+ ......+.+++.|++++|.+++..+..+..++.+.
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~ 151 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccch
Confidence 99999 567789999999999999999987 33345778888889988888854445555554443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.61 E-value=2e-15 Score=152.88 Aligned_cols=154 Identities=23% Similarity=0.330 Sum_probs=121.6
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeecccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHN 121 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N 121 (672)
|.|++|.|.. ..++.|+|++|+|+..++. |.++++|++|++++|.++...| .|.++++|++|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 7899999964 4678899999999988875 8999999999999999998877 7999999999999999
Q ss_pred ccCCCCCh------------------------------------------------hhhc--------------------
Q 005880 122 NFNGEFPD------------------------------------------------SVSS-------------------- 133 (672)
Q Consensus 122 ~l~g~~p~------------------------------------------------~~~~-------------------- 133 (672)
+++ .+|. .+..
T Consensus 90 ~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~ 168 (305)
T d1xkua_ 90 QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168 (305)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS
T ss_pred ccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc
Confidence 876 2221 1122
Q ss_pred -cCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 134 -LFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 134 -l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
+++|+.|++++|.+++..+..+.+++.++.|++++|++++. ..+..+++|++|+|++|+|+ .+|.+|..++.+...
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence 33455666666666666777788888999999999999883 33457889999999999998 788887777766544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.3e-15 Score=152.71 Aligned_cols=138 Identities=25% Similarity=0.255 Sum_probs=120.5
Q ss_pred CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccC
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLL 162 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 162 (672)
+.++++|++|+|++|.+....+ .+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+
T Consensus 101 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~ 180 (284)
T d1ozna_ 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180 (284)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred hcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccc
Confidence 7788999999999999988776 788899999999999999966677888999999999999999988888999999999
Q ss_pred eeeccCCcccC--cCCCCCCCCCCeeeccCCcCCCCCCCcCCC---CCCccccccccccCCCCc
Q 005880 163 TLKLEANRFSG--PITGLDLRNLQDFNVSGNHLSGQIPKSLSG---FPDSAFTQNAALCGSPMQ 221 (672)
Q Consensus 163 ~L~l~~N~l~~--~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~---~~~~~~~~n~~lc~~~~~ 221 (672)
.|++++|++++ +..+..+++|++|++++|.+++..|..|.. +..+.+.+|++.|+|++.
T Consensus 181 ~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred hhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch
Confidence 99999999998 344678999999999999999777766655 445566699999998753
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=3.4e-15 Score=149.55 Aligned_cols=145 Identities=19% Similarity=0.156 Sum_probs=100.1
Q ss_pred CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC--------------------------CCCcccccceee
Q 005880 65 NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP--------------------------SLSNLTALKLLF 117 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p--------------------------~~~~l~~L~~L~ 117 (672)
..++.|+|++|+|++.++. |.++++|++|++++|++.+..+ .|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 3578999999999988765 8999999999999999865433 245566677777
Q ss_pred ccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCc--CCCCCCCCCCeeeccCCcCCC
Q 005880 118 LSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGP--ITGLDLRNLQDFNVSGNHLSG 195 (672)
Q Consensus 118 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~l~~L~~l~l~~N~l~g 195 (672)
|++|.+.+..+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++. ..+..+++|+.|++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 777766655555566666677777777777654455666666677777777776652 224456667777777777776
Q ss_pred CCCCcCCCCCCccc
Q 005880 196 QIPKSLSGFPDSAF 209 (672)
Q Consensus 196 ~~p~~l~~~~~~~~ 209 (672)
..|..|..++.+..
T Consensus 192 i~~~~f~~l~~L~~ 205 (284)
T d1ozna_ 192 VHPHAFRDLGRLMT 205 (284)
T ss_dssp ECTTTTTTCTTCCE
T ss_pred cChhHhhhhhhccc
Confidence 66666665554443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=2.2e-15 Score=130.33 Aligned_cols=100 Identities=30% Similarity=0.330 Sum_probs=71.8
Q ss_pred cEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCc
Q 005880 91 RVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANR 170 (672)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 170 (672)
|+|+|++|+|+. ++.+.++++|++|+|++|+|+ .+|+.++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~-l~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCC-CcccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 467777777774 345777777777777777777 67777777777777777777777 444 47777777777777777
Q ss_pred ccCcC---CCCCCCCCCeeeccCCcCC
Q 005880 171 FSGPI---TGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 171 l~~~~---~~~~l~~L~~l~l~~N~l~ 194 (672)
|+... ....+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 76522 2456777777788777776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=3.3e-15 Score=129.21 Aligned_cols=115 Identities=24% Similarity=0.232 Sum_probs=97.2
Q ss_pred EEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 69 HLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 69 ~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
.|+|++|+|+.. +.+..+++|++|+|++|+|+..++.++.+++|+.|++++|+|+ .+| .++++++|++|++++|+|+
T Consensus 2 ~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 2 VLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp EEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC
T ss_pred EEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC
Confidence 689999999854 5699999999999999999987668999999999999999999 566 5999999999999999999
Q ss_pred ccc-chhhcCCCccCeeeccCCcccCcCCC-----CCCCCCCee
Q 005880 149 GQI-PLTVNHLTHLLTLKLEANRFSGPITG-----LDLRNLQDF 186 (672)
Q Consensus 149 g~~-p~~~~~l~~L~~L~l~~N~l~~~~~~-----~~l~~L~~l 186 (672)
... ...+..+++|+.|++++|+++..... ..+++|+.|
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 432 25789999999999999999863221 235666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.54 E-value=1.3e-14 Score=138.30 Aligned_cols=137 Identities=31% Similarity=0.419 Sum_probs=89.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.++++|+|++|.+++.. +++.+++|++|+|++|+|++ +|.+.++++|+.|++++|.+. .+ ..+..+++|+.+++++
T Consensus 68 ~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~ 143 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGN 143 (210)
T ss_dssp TTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCS
T ss_pred CCCCEEeCCCccccCcc-ccccCccccccccccccccc-ccccccccccccccccccccc-cc-cccccccccccccccc
Confidence 45677777777776533 46667777777777777765 345666777777777777765 33 3466677777777777
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
|.+++ +..+.++++|+.+++++|++++..+...+++|+.|+|++|+++ .+| .+..++.|..
T Consensus 144 n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~ 204 (210)
T d1h6ta2 144 NKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDV 204 (210)
T ss_dssp SCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSE
T ss_pred ccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCE
Confidence 77763 2345667777777777777776545666777777777777776 454 3555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.52 E-value=1.8e-14 Score=136.01 Aligned_cols=123 Identities=30% Similarity=0.417 Sum_probs=57.3
Q ss_pred cEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccC
Q 005880 66 RVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFN 145 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 145 (672)
+++.|+|++|++++.. +++++++|++|++++|.+... +.+.++++|+.|++++|.+.. + ..+..+++|+.|++++|
T Consensus 63 nL~~L~Ls~N~l~~~~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 63 NLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSN 138 (199)
T ss_dssp TCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSS
T ss_pred CcCcCccccccccCcc-cccCCcccccccccccccccc-ccccccccccccccccccccc-c-cccchhhhhHHhhhhhh
Confidence 4445555555444332 244445555555555544432 234444555555555444442 1 22444455555555555
Q ss_pred ccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCC
Q 005880 146 NFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 146 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~ 194 (672)
++. .+| .+..+++|+.|++++|++++..++..+++|+.|++++|+++
T Consensus 139 ~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 139 TIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred hhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCC
Confidence 544 222 34445555555555555544333444555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.52 E-value=2.3e-14 Score=135.22 Aligned_cols=137 Identities=24% Similarity=0.349 Sum_probs=116.4
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|++++|+++. ++.+..+++|++|+|++|++++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++
T Consensus 40 ~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFN 115 (199)
T ss_dssp TTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCS
T ss_pred cCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-ccc-ccccccccccccccc
Confidence 578899999999985 4568899999999999999998655 999999999999999998 565 489999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
|.+... ..+..+++|+.|++++|++........+++|+.|++++|++++ ++ .+..++.+..
T Consensus 116 ~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~ 176 (199)
T d2omxa2 116 NQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLER 176 (199)
T ss_dssp SCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCE
T ss_pred cccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccC-Cc-cccCCCCCCE
Confidence 999853 3488999999999999999886567789999999999999995 44 2555554443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6.3e-15 Score=133.90 Aligned_cols=124 Identities=17% Similarity=0.090 Sum_probs=72.5
Q ss_pred CCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
+.+...|++|+|++|+|+.+...+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 44555666666666666654333355666666666666666 443 3666666666666666666433334455666666
Q ss_pred eeccCCcccCc---CCCCCCCCCCeeeccCCcCCCCCCC----cCCCCCCcccc
Q 005880 164 LKLEANRFSGP---ITGLDLRNLQDFNVSGNHLSGQIPK----SLSGFPDSAFT 210 (672)
Q Consensus 164 L~l~~N~l~~~---~~~~~l~~L~~l~l~~N~l~g~~p~----~l~~~~~~~~~ 210 (672)
|+|++|+|+.. .....+++|++|++++|.++ ..|. .+..+|.+.+.
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~L 144 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 144 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred ceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCee
Confidence 66666666541 12345666667777777665 4443 24455555443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.52 E-value=3.4e-15 Score=151.74 Aligned_cols=120 Identities=33% Similarity=0.530 Sum_probs=110.8
Q ss_pred CCccEEEcccCCCCCC--CC-CCCcccccceeeccc-cccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCe
Q 005880 88 TQLRVLSLKYNRFTGP--VP-SLSNLTALKLLFLSH-NNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLT 163 (672)
Q Consensus 88 ~~L~~L~L~~N~l~~~--~p-~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 163 (672)
.+++.|+|++|.++|. +| ++++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|++..|..+.++.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 4789999999999984 55 899999999999997 8999999999999999999999999999999999999999999
Q ss_pred eeccCCcccCcCC--CCCCCCCCeeeccCCcCCCCCCCcCCCCCCc
Q 005880 164 LKLEANRFSGPIT--GLDLRNLQDFNVSGNHLSGQIPKSLSGFPDS 207 (672)
Q Consensus 164 L~l~~N~l~~~~~--~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~ 207 (672)
+++++|++.+.++ +..+++|+.+++++|.++|.+|..+..+..+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l 175 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccc
Confidence 9999999998654 5789999999999999999999988877665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=5.5e-15 Score=134.32 Aligned_cols=122 Identities=16% Similarity=0.112 Sum_probs=103.6
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.++.+|+|++|+|+.....+..+++|+.|+|++|+|+.. +.+..+++|++|+|++|+++...+..+..+++|+.|+|++
T Consensus 18 ~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred CcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 468999999999998754467899999999999999964 7799999999999999999955455567899999999999
Q ss_pred Cccccccc--hhhcCCCccCeeeccCCcccCcCC-----CCCCCCCCeeec
Q 005880 145 NNFSGQIP--LTVNHLTHLLTLKLEANRFSGPIT-----GLDLRNLQDFNV 188 (672)
Q Consensus 145 N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~~-----~~~l~~L~~l~l 188 (672)
|+|+ .++ ..+..+++|++|++++|.++.... ...+++|+.||-
T Consensus 97 N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 97 NSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred cccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 9998 444 468899999999999999987332 456889998873
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.48 E-value=5.2e-14 Score=133.95 Aligned_cols=136 Identities=27% Similarity=0.389 Sum_probs=116.3
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
..++.|++++|.++.. +.+..+++|++|+|++|+|++.. .++++++|++|++++|+++ .+| .+.++++|+.|++++
T Consensus 46 ~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp HTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred cCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 4689999999999864 45889999999999999999854 5789999999999999999 566 589999999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSA 208 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~ 208 (672)
|.++ .+ ..+..+++|+.+++++|++++......+++|+.+++++|++++ ++. +.+++.+.
T Consensus 122 ~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~ 181 (210)
T d1h6ta2 122 NGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQ 181 (210)
T ss_dssp SCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCC
T ss_pred cccc-cc-ccccccccccccccccccccccccccccccccccccccccccc-ccc-ccCCCCCC
Confidence 9997 44 3688999999999999999987777889999999999999995 442 55555443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.42 E-value=3.1e-13 Score=130.13 Aligned_cols=124 Identities=25% Similarity=0.333 Sum_probs=60.2
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|.+++.. ++..+++|++|++++|.++. ++.+.++++|+.|++++|...+..+ +...+.++.+.+++
T Consensus 63 ~~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLA-PLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCG-GGTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeeccc-cccccccccccccccccccc-cccccccccccccccccccccccch--hccccchhhhhchh
Confidence 45666666666655432 35556666666666665553 3445556666666666555543211 11222222222222
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~ 194 (672)
+.+... ..+.++++|+.|++++|++++..++..+++|+.|+|++|+++
T Consensus 139 ~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 139 NQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp SCCCCC--GGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred hhhchh--hhhccccccccccccccccccchhhcccccceecccCCCccC
Confidence 222211 123444555555555555554444445555555555555555
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.8e-13 Score=123.30 Aligned_cols=101 Identities=23% Similarity=0.207 Sum_probs=75.0
Q ss_pred EecCCCcccCCCCCCCCCCccEEEcccC-CCCCCCC-CCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccc
Q 005880 71 VLENLQLSGSLQPLTSLTQLRVLSLKYN-RFTGPVP-SLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 71 ~l~~~~l~~~~~~l~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
+++++++...+..+..+++|+.|+|++| .|+...+ .|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+
T Consensus 14 ~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 14 RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp ECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred EecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 3355566666666778888888888765 4776555 6888888888888888888666777888888888888888888
Q ss_pred cccchhhcCCCccCeeeccCCccc
Q 005880 149 GQIPLTVNHLTHLLTLKLEANRFS 172 (672)
Q Consensus 149 g~~p~~~~~l~~L~~L~l~~N~l~ 172 (672)
.+|..+....+|+.|+|++|.|.
T Consensus 94 -~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 94 -SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp -CCCSTTTCSCCCCEEECCSSCCC
T ss_pred -ccChhhhccccccccccCCCccc
Confidence 56555444456888888888764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.37 E-value=7e-13 Score=138.02 Aligned_cols=137 Identities=31% Similarity=0.347 Sum_probs=90.6
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCC-----------------
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEF----------------- 127 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~----------------- 127 (672)
.+++.|++++|.++.. +.+..+++|+.|++++|.+++..+ ++.+++|+.|++++|++++..
T Consensus 219 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~ 296 (384)
T d2omza2 219 TNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296 (384)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSC
T ss_pred CCCCEEECCCCCCCCc-chhhcccccchhccccCccCCCCc-ccccccCCEeeccCcccCCCCccccccccccccccccc
Confidence 4677888888877753 456777778888888887776443 666777777777777766422
Q ss_pred ---ChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCC
Q 005880 128 ---PDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGF 204 (672)
Q Consensus 128 ---p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~ 204 (672)
+..+..+++|+.|++++|+|++.. .+..+++|++|++++|+|++...+..+++|++|++++|+|++..| +.++
T Consensus 297 l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l 372 (384)
T d2omza2 297 LEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANL 372 (384)
T ss_dssp CSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred cccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCChh--hccC
Confidence 123555667777777777777432 266777777777777777764445667777777777777775443 4444
Q ss_pred CCc
Q 005880 205 PDS 207 (672)
Q Consensus 205 ~~~ 207 (672)
+.+
T Consensus 373 ~~L 375 (384)
T d2omza2 373 TRI 375 (384)
T ss_dssp TTC
T ss_pred CCC
Confidence 433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=4.1e-15 Score=140.07 Aligned_cols=112 Identities=24% Similarity=0.341 Sum_probs=93.3
Q ss_pred CCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccC
Q 005880 83 PLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLL 162 (672)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 162 (672)
.+..|++|++|+|++|+|+. ++.+.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+ .++ .+.++++|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~ 118 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSS
T ss_pred HHhcccccceeECcccCCCC-cccccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccc
Confidence 37778899999999999985 467889999999999999998 78877777778999999999998 443 588899999
Q ss_pred eeeccCCcccCc--C-CCCCCCCCCeeeccCCcCCCCCC
Q 005880 163 TLKLEANRFSGP--I-TGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 163 ~L~l~~N~l~~~--~-~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
.|+|++|+|+.. + .+..+++|+.|+|++|+++...+
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 999999999872 2 35678999999999998875444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.35 E-value=2.1e-12 Score=130.15 Aligned_cols=130 Identities=23% Similarity=0.231 Sum_probs=99.0
Q ss_pred cEeEEEecCCCcccCC---CCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEec
Q 005880 66 RVSHLVLENLQLSGSL---QPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDL 142 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~---~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 142 (672)
.+..++...|...... ..+..+++|+.+++++|.++.....+ +++|+.|++++|.+++..+..|.+++.++.|++
T Consensus 125 ~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~ 202 (305)
T d1xkua_ 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202 (305)
T ss_dssp TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred cccccccccccccccCCCccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence 4556677666543322 22677888888888888887643332 578888888888888888888888888888888
Q ss_pred ccCccccccchhhcCCCccCeeeccCCcccC-cCCCCCCCCCCeeeccCCcCCCCCC
Q 005880 143 SFNNFSGQIPLTVNHLTHLLTLKLEANRFSG-PITGLDLRNLQDFNVSGNHLSGQIP 198 (672)
Q Consensus 143 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~g~~p 198 (672)
++|++++..+..+.++++|++|+|++|+|+. +..+..+++|++|+|++|+|+ .++
T Consensus 203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~ 258 (305)
T d1xkua_ 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIG 258 (305)
T ss_dssp CSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCC
T ss_pred ccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccC
Confidence 8888887777788888888888888888887 444567888888888888888 554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=3e-12 Score=115.06 Aligned_cols=109 Identities=17% Similarity=0.137 Sum_probs=90.1
Q ss_pred CCCCccEEEcccCCCCCCCCCCCcccccceeecccc-ccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCee
Q 005880 86 SLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHN-NFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTL 164 (672)
Q Consensus 86 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 164 (672)
.......++.+++++...+..+..+++|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344567789999999987778899999999999876 4885555779999999999999999997667889999999999
Q ss_pred eccCCcccC-cCCCCCCCCCCeeeccCCcCC
Q 005880 165 KLEANRFSG-PITGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 165 ~l~~N~l~~-~~~~~~l~~L~~l~l~~N~l~ 194 (672)
+|++|+|+. +.......+|+.|+|++|.|.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccccccccccCCCccc
Confidence 999999987 444455557889999888775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=5.4e-12 Score=122.46 Aligned_cols=94 Identities=19% Similarity=0.203 Sum_probs=75.7
Q ss_pred CcccceEEcC-----------CcEeEEEecCCCcccCCCC-CCCCCCccEEEcccCCCCCCCC--CCCcccccceeeccc
Q 005880 55 CSWTGVSCLQ-----------NRVSHLVLENLQLSGSLQP-LTSLTQLRVLSLKYNRFTGPVP--SLSNLTALKLLFLSH 120 (672)
Q Consensus 55 c~w~gv~c~~-----------~~v~~L~l~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~l~~ 120 (672)
|.++.|.|.. ..+++|+|++|.|+..++. |.++++|++|+|++|.+...++ .|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 6788889953 3689999999999987765 8999999999999999987655 577788888887654
Q ss_pred -cccCCCCChhhhccCCCCeEecccCccc
Q 005880 121 -NNFNGEFPDSVSSLFRLYRLDLSFNNFS 148 (672)
Q Consensus 121 -N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 148 (672)
|++....+..|.++++|+.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 6677666677778888888888887776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=3.1e-12 Score=132.98 Aligned_cols=122 Identities=30% Similarity=0.394 Sum_probs=101.3
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC---------------------CCCcccccceeecccccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP---------------------SLSNLTALKLLFLSHNNF 123 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p---------------------~~~~l~~L~~L~l~~N~l 123 (672)
..++.|++++|.+++.. ++..+++|++|++++|.+++..+ .+..+++|+.|+|++|++
T Consensus 241 ~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 241 TNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp TTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCC
T ss_pred cccchhccccCccCCCC-cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCC
Confidence 46778888888877644 46777778888888777776432 245678999999999999
Q ss_pred CCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCC
Q 005880 124 NGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGN 191 (672)
Q Consensus 124 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N 191 (672)
++ ++ .+..+++|++|+|++|+|+ .++ .+.++++|++|+|++|+|++..+...+++|+.|+|++|
T Consensus 320 ~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 95 44 3899999999999999998 455 69999999999999999999777889999999999998
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=8.7e-14 Score=130.78 Aligned_cols=119 Identities=23% Similarity=0.252 Sum_probs=98.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.|+|++|+|+.. +.+..+++|++|+|++|+|+...+.+..+++|+.|++++|+++ .+ +.+.++++|+.|+|++
T Consensus 48 ~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l~~L~~L~L~~ 124 (198)
T d1m9la_ 48 KACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSN 124 (198)
T ss_dssp TTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CH-HHHHHHHHSSEEEESE
T ss_pred cccceeECcccCCCCc-ccccCCccccChhhccccccccccccccccccccccccccccc-cc-cccccccccccccccc
Confidence 6899999999999864 5689999999999999999865444456678999999999999 45 4588999999999999
Q ss_pred Cccccccc--hhhcCCCccCeeeccCCcccCcCC------------CCCCCCCCeee
Q 005880 145 NNFSGQIP--LTVNHLTHLLTLKLEANRFSGPIT------------GLDLRNLQDFN 187 (672)
Q Consensus 145 N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~~------------~~~l~~L~~l~ 187 (672)
|+|+ .++ ..+..+++|+.|+|++|+++.... ...+++|+.||
T Consensus 125 N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 125 NKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred chhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9998 444 468999999999999999976222 12477788776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=4.8e-11 Score=114.44 Aligned_cols=138 Identities=22% Similarity=0.349 Sum_probs=113.7
Q ss_pred CcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEeccc
Q 005880 65 NRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSF 144 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~ 144 (672)
.+++.+++++|.++. ++.+..+++|+.|++++|.+.+.. .+...+.++.+.++++.+... ..+.++++|+.|++++
T Consensus 85 ~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~ 160 (227)
T d1h6ua2 85 TKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGN 160 (227)
T ss_dssp CSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccc-hhccccchhhhhchhhhhchh--hhhccccccccccccc
Confidence 578899999998874 556889999999999999988643 467788999999999998743 3477889999999999
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCcccc
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~~ 210 (672)
|++++.. .++++++|+.|+|++|++++..++..+++|++|+|++|+++ .+| .+.+++.|...
T Consensus 161 n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt-~i~-~l~~l~~L~~L 222 (227)
T d1h6ua2 161 AQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIV 222 (227)
T ss_dssp SCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC-BCG-GGTTCTTCCEE
T ss_pred cccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCC-CCc-ccccCCCCCEE
Confidence 9998433 38899999999999999998656778999999999999999 455 26666665543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=1.6e-09 Score=104.52 Aligned_cols=135 Identities=14% Similarity=0.097 Sum_probs=105.3
Q ss_pred eEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCCCC-hhhhccCCCCeEecc-c
Q 005880 68 SHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGEFP-DSVSSLFRLYRLDLS-F 144 (672)
Q Consensus 68 ~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~-~ 144 (672)
+.++.++.+++..++.+. +++++|+|++|+|+..++ .|.++++|++|+|++|.+...+| ..|.+++++++|++. .
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 468888999997776653 589999999999998777 68999999999999999986665 468889999999986 4
Q ss_pred CccccccchhhcCCCccCeeeccCCcccCcCCCC---CCCCCCeeeccCCcCCCCCCCcCCCC
Q 005880 145 NNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGL---DLRNLQDFNVSGNHLSGQIPKSLSGF 204 (672)
Q Consensus 145 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~l~~L~~l~l~~N~l~g~~p~~l~~~ 204 (672)
|++....+..|.++++|+.|++++|++....... .+..+..+..+++.+...-+..+..+
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~ 151 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence 7888777888999999999999999998744433 34445555666777763333444433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.87 E-value=4.2e-09 Score=107.16 Aligned_cols=116 Identities=22% Similarity=0.252 Sum_probs=85.9
Q ss_pred CCcEeEEEecCCCcccCCCCCCCCCCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecc
Q 005880 64 QNRVSHLVLENLQLSGSLQPLTSLTQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLS 143 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 143 (672)
..+++.|+|++++|+..++ .+++|++|+|++|+|+..+.. +.+|+.|++++|+++ .++. +. +.|++|+++
T Consensus 37 ~~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 37 DRQAHELELNNLGLSSLPE---LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVS 106 (353)
T ss_dssp HHTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCS-CC--TTCCEEECC
T ss_pred HcCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc-hhhh-hc--ccccccccc
Confidence 3568899999999987654 256899999999999955334 457889999999998 5553 21 369999999
Q ss_pred cCccccccchhhcCCCccCeeeccCCcccCcCCCCCCCCCCeeeccCCcC
Q 005880 144 FNNFSGQIPLTVNHLTHLLTLKLEANRFSGPITGLDLRNLQDFNVSGNHL 193 (672)
Q Consensus 144 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~l~~L~~l~l~~N~l 193 (672)
+|.|+ .+|. ++++++|+.|++++|.++..... ...+..+.+.++..
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQL 152 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccc--cccccchhhccccc
Confidence 99998 6774 68899999999999988763321 23344455544443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.81 E-value=1.2e-08 Score=103.75 Aligned_cols=110 Identities=21% Similarity=0.158 Sum_probs=87.7
Q ss_pred CCccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccccchhhcCCCccCeeecc
Q 005880 88 TQLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTHLLTLKLE 167 (672)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~ 167 (672)
.+|+.|||++|.++.. |. .+++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 38 ~~l~~LdLs~~~L~~l-p~--~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSL-PE--LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCSCC-CS--CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred cCCCEEEeCCCCCCCC-CC--CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4689999999999975 43 2578999999999999 889764 57899999999998 55532 2469999999
Q ss_pred CCcccCcCCCCCCCCCCeeeccCCcCCCCCCCcCCCCCCccc
Q 005880 168 ANRFSGPITGLDLRNLQDFNVSGNHLSGQIPKSLSGFPDSAF 209 (672)
Q Consensus 168 ~N~l~~~~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~~~~ 209 (672)
+|+++.......+++|+.|++++|.++ ..|.....+..+..
T Consensus 107 ~n~l~~lp~~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~ 147 (353)
T d1jl5a_ 107 NNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAA 147 (353)
T ss_dssp SSCCSSCCCCTTCTTCCEEECCSSCCS-CCCCCCTTCCEEEC
T ss_pred ccccccccchhhhccceeecccccccc-ccccccccccchhh
Confidence 999998556678999999999999998 55555555544433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=2.2e-09 Score=96.61 Aligned_cols=119 Identities=20% Similarity=0.177 Sum_probs=75.9
Q ss_pred CccEEEcccCCCCCCCCCCCcccccceeeccccccCCCCChhhhccCCCCeEecccCccccc--cchhhcCCCccCeeec
Q 005880 89 QLRVLSLKYNRFTGPVPSLSNLTALKLLFLSHNNFNGEFPDSVSSLFRLYRLDLSFNNFSGQ--IPLTVNHLTHLLTLKL 166 (672)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~l 166 (672)
+.+.|+++++... +.+..+..+..|++.+|... .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|
T Consensus 23 ~~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 23 SQQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SSCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hhCeeecccCCCC---chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 3455666554432 34555555566666666554 5555556788888888888888743 2345677888888888
Q ss_pred cCCcccCcC--CCCCCCCCCeeeccCCcCCCCCCCc-------CCCCCCccccc
Q 005880 167 EANRFSGPI--TGLDLRNLQDFNVSGNHLSGQIPKS-------LSGFPDSAFTQ 211 (672)
Q Consensus 167 ~~N~l~~~~--~~~~l~~L~~l~l~~N~l~g~~p~~-------l~~~~~~~~~~ 211 (672)
++|+|+... ......+|+.|++++|.+++..... +..+|.+...+
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 888887622 2234456888888888887654432 45566666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=2.7e-09 Score=105.60 Aligned_cols=81 Identities=32% Similarity=0.343 Sum_probs=48.0
Q ss_pred CcEeEEEecCCCcccCC-CC-CCCCCCccEEEcccCCCCCCCC-CCCcccccceeecccc-ccCCC-CChhhhccCCCCe
Q 005880 65 NRVSHLVLENLQLSGSL-QP-LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHN-NFNGE-FPDSVSSLFRLYR 139 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~-~~-l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~ 139 (672)
.++++|+|+++.++... .. +..+++|++|+|+++.++...+ .++++++|++|+|+++ .++.. +..-+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 35777777777665321 22 5666777777777777665433 5666677777777763 44421 1222345666777
Q ss_pred EecccC
Q 005880 140 LDLSFN 145 (672)
Q Consensus 140 L~l~~N 145 (672)
|+++++
T Consensus 126 L~ls~c 131 (284)
T d2astb2 126 LNLSWC 131 (284)
T ss_dssp EECCCC
T ss_pred cccccc
Confidence 777663
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=2.7e-09 Score=95.99 Aligned_cols=107 Identities=22% Similarity=0.167 Sum_probs=69.5
Q ss_pred CCCCCCccEEEcccCCCCCCCC-CCCcccccceeeccccccCCC--CChhhhccCCCCeEecccCccccccchhhcCCCc
Q 005880 84 LTSLTQLRVLSLKYNRFTGPVP-SLSNLTALKLLFLSHNNFNGE--FPDSVSSLFRLYRLDLSFNNFSGQIPLTVNHLTH 160 (672)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 160 (672)
+..+..+..|++.+|.... ++ .+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+..-+-.+.+..+
T Consensus 38 l~~~~~~~~l~~~~~~~~~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHHH-HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhhh-hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 3444444445554444332 22 234678888888888888843 2455778888999999999988433324445567
Q ss_pred cCeeeccCCcccCcCC---------CCCCCCCCeeeccCCcC
Q 005880 161 LLTLKLEANRFSGPIT---------GLDLRNLQDFNVSGNHL 193 (672)
Q Consensus 161 L~~L~l~~N~l~~~~~---------~~~l~~L~~l~l~~N~l 193 (672)
|+.|++++|.++.... ...+++|+.|| ++.+
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 8889999998876433 23678888776 5544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=7.6e-09 Score=102.29 Aligned_cols=146 Identities=23% Similarity=0.256 Sum_probs=101.0
Q ss_pred CcEeEEEecCCCcccCC-CCCCCCCCccEEEccc-CCCCCC-CC-CCCcccccceeecccc-ccCCC-CChhhhcc-CCC
Q 005880 65 NRVSHLVLENLQLSGSL-QPLTSLTQLRVLSLKY-NRFTGP-VP-SLSNLTALKLLFLSHN-NFNGE-FPDSVSSL-FRL 137 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~-~~l~~l~~L~~L~L~~-N~l~~~-~p-~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l-~~L 137 (672)
.++++|+|+++.++... ..++.+++|++|+|++ +.++.. +. -..++++|++|+|+++ +++.. +...+..+ ++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 57999999999876533 3378889999999998 466631 12 2356889999999985 45421 23334443 689
Q ss_pred CeEecccC--ccccc-cchhhcCCCccCeeeccCCc-ccC--cCCCCCCCCCCeeeccC-CcCCCCCCCcCCCCCCcccc
Q 005880 138 YRLDLSFN--NFSGQ-IPLTVNHLTHLLTLKLEANR-FSG--PITGLDLRNLQDFNVSG-NHLSGQIPKSLSGFPDSAFT 210 (672)
Q Consensus 138 ~~L~l~~N--~l~g~-~p~~~~~l~~L~~L~l~~N~-l~~--~~~~~~l~~L~~l~l~~-N~l~g~~p~~l~~~~~~~~~ 210 (672)
+.|++++. .++.. +..-+.++++|++|++++|. +++ ......+++|++|+|++ +.+++.....+.+++.+...
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 99999864 45432 33445678899999998864 654 33456788999999998 57776666666666666544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.31 E-value=3.6e-08 Score=100.15 Aligned_cols=132 Identities=21% Similarity=0.249 Sum_probs=89.1
Q ss_pred CCcEeEEEecCCCcccC--------CCC------CCCCCCccEEEcccCCCCCCC----C-CCCcccccceeeccccccC
Q 005880 64 QNRVSHLVLENLQLSGS--------LQP------LTSLTQLRVLSLKYNRFTGPV----P-SLSNLTALKLLFLSHNNFN 124 (672)
Q Consensus 64 ~~~v~~L~l~~~~l~~~--------~~~------l~~l~~L~~L~L~~N~l~~~~----p-~~~~l~~L~~L~l~~N~l~ 124 (672)
..++++|++++|.+... +.. ......|+.|++++|.++..- . .+...+.|+.|+|++|+++
T Consensus 120 ~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 199 (344)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred cccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccc
Confidence 36788999998887421 000 234567888888888876321 1 3456678888888888876
Q ss_pred CC-----CChhhhccCCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCc--C------CCCCCCCCCeee
Q 005880 125 GE-----FPDSVSSLFRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGP--I------TGLDLRNLQDFN 187 (672)
Q Consensus 125 g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~--~------~~~~l~~L~~l~ 187 (672)
.. +...+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|+|++. . ......+|++|+
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ 279 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 279 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEE
Confidence 32 234466778888888888887632 445567788888888888888651 1 112346788888
Q ss_pred ccCCcCCC
Q 005880 188 VSGNHLSG 195 (672)
Q Consensus 188 l~~N~l~g 195 (672)
+++|+++.
T Consensus 280 ls~N~i~~ 287 (344)
T d2ca6a1 280 LQYNEIEL 287 (344)
T ss_dssp CCSSCCBH
T ss_pred CCCCcCCh
Confidence 88888763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=1.2e-06 Score=84.64 Aligned_cols=130 Identities=15% Similarity=0.092 Sum_probs=89.6
Q ss_pred eEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC-CCceeeeEEEEEcCCeEEEEEeecCCCChhHHhhcCC
Q 005880 373 FGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR-HPNLVGLKAYYFAREEKLLVSEYMPNGSLFWLLHGNR 451 (672)
Q Consensus 373 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 451 (672)
.+.||+.... +..++||+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+.....
T Consensus 27 ~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 3689988754 5667788876544434456777888776653 333566778888888999999999998886654311
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------------------
Q 005880 452 GPGRTPLDWTTRLKIAAGAARGLAFIHFTC-------------------------------------------------- 481 (672)
Q Consensus 452 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------------------- 481 (672)
.....++.++++.++.||...
T Consensus 105 ---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 112345666667777777210
Q ss_pred -----CCCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 482 -----KSLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 482 -----~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
....++|+|+.|.||++++++...|.||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01137999999999999987767799998753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=4.6e-08 Score=102.88 Aligned_cols=106 Identities=17% Similarity=0.224 Sum_probs=54.9
Q ss_pred CccEEEcccCCCCCCC--CCCCcccccceeeccccccCC----CCChhhhccCCCCeEecccCccccc----cchhhc-C
Q 005880 89 QLRVLSLKYNRFTGPV--PSLSNLTALKLLFLSHNNFNG----EFPDSVSSLFRLYRLDLSFNNFSGQ----IPLTVN-H 157 (672)
Q Consensus 89 ~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~-~ 157 (672)
+|+.|||++|+++..- .-+..+++|+.|+|++|.++. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4555666666665421 123445556666666665552 2334455566666666666666421 111121 1
Q ss_pred CCccCeeeccCCcccCcC------CCCCCCCCCeeeccCCcCC
Q 005880 158 LTHLLTLKLEANRFSGPI------TGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 158 l~~L~~L~l~~N~l~~~~------~~~~l~~L~~l~l~~N~l~ 194 (672)
..+|++|+|++|+++... ....+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 235666666666665411 1234566666666666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=5.1e-08 Score=102.54 Aligned_cols=108 Identities=22% Similarity=0.262 Sum_probs=83.8
Q ss_pred cEeEEEecCCCcccCC--CCCCCCCCccEEEcccCCCCC----CCC-CCCcccccceeeccccccCCC----CChhhhc-
Q 005880 66 RVSHLVLENLQLSGSL--QPLTSLTQLRVLSLKYNRFTG----PVP-SLSNLTALKLLFLSHNNFNGE----FPDSVSS- 133 (672)
Q Consensus 66 ~v~~L~l~~~~l~~~~--~~l~~l~~L~~L~L~~N~l~~----~~p-~~~~l~~L~~L~l~~N~l~g~----~p~~~~~- 133 (672)
+|+.||++.|+++... .-+..+++|++|+|++|+|+. .+. .+..+++|++|||++|+|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998632 226678999999999999873 122 467889999999999998631 1222222
Q ss_pred cCCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccC
Q 005880 134 LFRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSG 173 (672)
Q Consensus 134 l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~ 173 (672)
..+|+.|+|++|+++.. ++..+..+++|++|+|++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 24799999999999854 56678889999999999999875
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.14 E-value=1.6e-07 Score=95.29 Aligned_cols=132 Identities=17% Similarity=0.196 Sum_probs=99.5
Q ss_pred CcEeEEEecCCCcccCC-----CCCCCCCCccEEEcccCCCCCCCC-C-------------CCcccccceeeccccccCC
Q 005880 65 NRVSHLVLENLQLSGSL-----QPLTSLTQLRVLSLKYNRFTGPVP-S-------------LSNLTALKLLFLSHNNFNG 125 (672)
Q Consensus 65 ~~v~~L~l~~~~l~~~~-----~~l~~l~~L~~L~L~~N~l~~~~p-~-------------~~~l~~L~~L~l~~N~l~g 125 (672)
.+++.|+|++|.++..- ..+...++|+.|+|++|.++..-. . ....+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 57999999999987532 126778899999999998752100 0 1345689999999998873
Q ss_pred C----CChhhhccCCCCeEecccCccccc-----cchhhcCCCccCeeeccCCcccCc----C--CCCCCCCCCeeeccC
Q 005880 126 E----FPDSVSSLFRLYRLDLSFNNFSGQ-----IPLTVNHLTHLLTLKLEANRFSGP----I--TGLDLRNLQDFNVSG 190 (672)
Q Consensus 126 ~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~~~----~--~~~~l~~L~~l~l~~ 190 (672)
. +...+.....|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. + ....+++|++|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 334466788999999999998742 344577889999999999998641 1 234678999999999
Q ss_pred CcCCCC
Q 005880 191 NHLSGQ 196 (672)
Q Consensus 191 N~l~g~ 196 (672)
|.|++.
T Consensus 253 n~i~~~ 258 (344)
T d2ca6a1 253 CLLSAR 258 (344)
T ss_dssp CCCCHH
T ss_pred CccCch
Confidence 999743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=1.8e-05 Score=75.64 Aligned_cols=130 Identities=15% Similarity=0.130 Sum_probs=84.5
Q ss_pred ccCcCCe-EEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCC--CCceeeeEEEEEcCCeEEEEEeecCCCCh
Q 005880 367 MLGKGGF-GTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLR--HPNLVGLKAYYFAREEKLLVSEYMPNGSL 443 (672)
Q Consensus 367 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L 443 (672)
.+..|.. +.||+...++|..+++|.-.... ...+..|.+.++.+. .-.+.+++++..+++..++||+|+++-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 68999998888888999865443 234667777766553 23356678888888889999999988665
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 005880 444 FWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH--------------------------------------------- 478 (672)
Q Consensus 444 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------------------------------------------- 478 (672)
.+.. .. ...++.++++.|+-||
T Consensus 94 ~~~~----------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 94 LSSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccc----------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 3210 11 0112223333333333
Q ss_pred ------hhC---CCCCcEecCCCCCCEEeCCCCcEEEeccCCC
Q 005880 479 ------FTC---KSLKLTHGNIKSTNVLLDKTGNARVSDFGLS 512 (672)
Q Consensus 479 ------~~~---~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a 512 (672)
... ....++|+|+.|.||+++++..+-|+||+.+
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 111 1123799999999999998766789999865
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=2.3e-05 Score=69.79 Aligned_cols=107 Identities=12% Similarity=0.112 Sum_probs=59.6
Q ss_pred CCCCccEEEcccC-CCCCC-----CCCCCcccccceeeccccccCC----CCChhhhccCCCCeEecccCccccc----c
Q 005880 86 SLTQLRVLSLKYN-RFTGP-----VPSLSNLTALKLLFLSHNNFNG----EFPDSVSSLFRLYRLDLSFNNFSGQ----I 151 (672)
Q Consensus 86 ~l~~L~~L~L~~N-~l~~~-----~p~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~ 151 (672)
+.++|+.|+|+++ .++.. ...+...++|+.|+|++|.+.. .+...+...+.|++|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456777777653 34321 0134555667777777776652 2223344556777777777777632 2
Q ss_pred chhhcCCCccCeeeccCCcccCc-----CC----CCCCCCCCeeeccCCc
Q 005880 152 PLTVNHLTHLLTLKLEANRFSGP-----IT----GLDLRNLQDFNVSGNH 192 (672)
Q Consensus 152 p~~~~~l~~L~~L~l~~N~l~~~-----~~----~~~l~~L~~l~l~~N~ 192 (672)
-..+...++|++|+|++|++... .. ....++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 22455566777777777755421 00 1134567777776553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00029 Score=71.78 Aligned_cols=76 Identities=13% Similarity=0.068 Sum_probs=47.0
Q ss_pred cccCcCCeEEEEEEEEcC-CcEEEEEEcccC------C-cchHHHHHHHHHHHcCCC-C--CceeeeEEEEEcCCeEEEE
Q 005880 366 EMLGKGGFGTAYKAVLDD-GSVVAVKRLKDA------S-IGGKREFEQHMEVLGRLR-H--PNLVGLKAYYFAREEKLLV 434 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 434 (672)
+.||.|....||+....+ |+.|+||.-... . .....+...|.+.|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 458999999999998654 678999964321 0 112234456777776552 2 234455543 55667899
Q ss_pred EeecCCCCh
Q 005880 435 SEYMPNGSL 443 (672)
Q Consensus 435 ~e~~~~g~L 443 (672)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.0004 Score=68.76 Aligned_cols=137 Identities=9% Similarity=0.004 Sum_probs=78.4
Q ss_pred EEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCCCce--eeeE-----EEEEcCCeEEEEEeecCCCChh--
Q 005880 374 GTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNL--VGLK-----AYYFAREEKLLVSEYMPNGSLF-- 444 (672)
Q Consensus 374 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~-- 444 (672)
-.||++..++|+.|++|+.+.... ..+++..|.+.+..|....+ +..+ ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999999999999999865432 45677788887776632211 1111 1123456778999999764321
Q ss_pred ----------------HHhhcCCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhhC---CCCCc
Q 005880 445 ----------------WLLHGNRGPGRTPLDWTT-------------------RLKIAAGAARGLAFIHFTC---KSLKL 486 (672)
Q Consensus 445 ----------------~~l~~~~~~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~~~---~~~~i 486 (672)
..........+...++.. +..+...+.+.++.+.... ...++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111111111222233221 1112222333334443221 13568
Q ss_pred EecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 487 THGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 487 iH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
||+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4589999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.11 E-value=0.00012 Score=65.02 Aligned_cols=86 Identities=15% Similarity=0.195 Sum_probs=64.2
Q ss_pred cccccceeecccc-ccCCC----CChhhhccCCCCeEecccCccccc----cchhhcCCCccCeeeccCCcccCc--C--
Q 005880 109 NLTALKLLFLSHN-NFNGE----FPDSVSSLFRLYRLDLSFNNFSGQ----IPLTVNHLTHLLTLKLEANRFSGP--I-- 175 (672)
Q Consensus 109 ~l~~L~~L~l~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~--~-- 175 (672)
+.++|+.|+|+++ .++.. +-..+...+.|+.|+|++|.++.. +...+...+.|+.|+|++|.|+.. .
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 5688999999974 46532 233456678899999999999733 233556678999999999999761 1
Q ss_pred --CCCCCCCCCeeeccCCcCC
Q 005880 176 --TGLDLRNLQDFNVSGNHLS 194 (672)
Q Consensus 176 --~~~~l~~L~~l~l~~N~l~ 194 (672)
.....++|++|++++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 2346788999999999765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=0.00013 Score=64.66 Aligned_cols=108 Identities=17% Similarity=0.161 Sum_probs=58.7
Q ss_pred CCCCccEEEccc-CCCCCCC-----CCCCcccccceeeccccccCCC----CChhhhccCCCCeEecccCccccc----c
Q 005880 86 SLTQLRVLSLKY-NRFTGPV-----PSLSNLTALKLLFLSHNNFNGE----FPDSVSSLFRLYRLDLSFNNFSGQ----I 151 (672)
Q Consensus 86 ~l~~L~~L~L~~-N~l~~~~-----p~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~ 151 (672)
+.++|++|+|++ |.++... ..+...++|+.|+|++|.++.. +-..+...+.|+.|++++|.++.. +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 445666777765 3454211 1344566677777777766532 122344556677777777776532 2
Q ss_pred chhhcCCCccCeeec--cCCcccCc----C--CCCCCCCCCeeeccCCcC
Q 005880 152 PLTVNHLTHLLTLKL--EANRFSGP----I--TGLDLRNLQDFNVSGNHL 193 (672)
Q Consensus 152 p~~~~~l~~L~~L~l--~~N~l~~~----~--~~~~l~~L~~l~l~~N~l 193 (672)
-..+...++|+.++| ++|++... + .....++|+.|+++.|..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 234556666765444 45555331 1 112456777777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=0.00016 Score=63.93 Aligned_cols=108 Identities=19% Similarity=0.239 Sum_probs=71.9
Q ss_pred CCcEeEEEecC-CCcccCC-----CCCCCCCCccEEEcccCCCCCCCC-----CCCcccccceeeccccccCCC----CC
Q 005880 64 QNRVSHLVLEN-LQLSGSL-----QPLTSLTQLRVLSLKYNRFTGPVP-----SLSNLTALKLLFLSHNNFNGE----FP 128 (672)
Q Consensus 64 ~~~v~~L~l~~-~~l~~~~-----~~l~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~l~~N~l~g~----~p 128 (672)
...+++|+|++ +.++... ..+...++|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35788888887 3454211 115677888999999988874211 345678888899988887643 22
Q ss_pred hhhhccCCCCeEec--ccCcccc----ccchhhcCCCccCeeeccCCcc
Q 005880 129 DSVSSLFRLYRLDL--SFNNFSG----QIPLTVNHLTHLLTLKLEANRF 171 (672)
Q Consensus 129 ~~~~~l~~L~~L~l--~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l 171 (672)
..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|+.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 44566777876444 5677753 2445566788888888877654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.88 E-value=0.0088 Score=60.37 Aligned_cols=72 Identities=14% Similarity=0.159 Sum_probs=47.6
Q ss_pred cccCcCCeEEEEEEEEcCC--------cEEEEEEcccCCcchHHHHHHHHHHHcCCCCCcee-eeEEEEEcCCeEEEEEe
Q 005880 366 EMLGKGGFGTAYKAVLDDG--------SVVAVKRLKDASIGGKREFEQHMEVLGRLRHPNLV-GLKAYYFAREEKLLVSE 436 (672)
Q Consensus 366 ~~lg~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e 436 (672)
+.|+.|-.-.+|++...++ ..|.+++.-... ...+..+|..+++.+.-.+++ ++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 4577888899999986543 457677655322 344566788888877433444 5666653 268999
Q ss_pred ecCCCCh
Q 005880 437 YMPNGSL 443 (672)
Q Consensus 437 ~~~~g~L 443 (672)
|+++-.+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.03 E-value=0.012 Score=57.21 Aligned_cols=144 Identities=11% Similarity=0.024 Sum_probs=72.3
Q ss_pred ccCcCCeEEEEEEEEcCCcEEEEEEcccCCcchHHHHHHHHHHHcCCCC-----CceeeeE-E--EEEcCCeEEEEEeec
Q 005880 367 MLGKGGFGTAYKAVLDDGSVVAVKRLKDASIGGKREFEQHMEVLGRLRH-----PNLVGLK-A--YYFAREEKLLVSEYM 438 (672)
Q Consensus 367 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~l~-~--~~~~~~~~~lv~e~~ 438 (672)
.|..|---+.|+....+|+ +++|+..... ..+++..|++++..+.. |..+... | +.........++.+.
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 4566777889999887765 7899886532 23445556666655532 2222110 0 111234556677776
Q ss_pred CCCChhH--------------Hhh----cCCCCCCCCCCH------------------HHHHHHHHHHHHHHHHHHhhCC
Q 005880 439 PNGSLFW--------------LLH----GNRGPGRTPLDW------------------TTRLKIAAGAARGLAFIHFTCK 482 (672)
Q Consensus 439 ~~g~L~~--------------~l~----~~~~~~~~~l~~------------------~~~~~i~~~ia~~L~~LH~~~~ 482 (672)
.+..... .++ ............ ......+......+.-.+...-
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6543311 000 000000000000 0111222222333333322222
Q ss_pred CCCcEecCCCCCCEEeCCCCcEEEeccCCCc
Q 005880 483 SLKLTHGNIKSTNVLLDKTGNARVSDFGLSI 513 (672)
Q Consensus 483 ~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~ 513 (672)
..++||+|+.++||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4679999999999999998777899999764
|